Citrus Sinensis ID: 010947
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 497 | 2.2.26 [Sep-21-2011] | |||||||
| Q6TGC6 | 507 | Serine/threonine-protein | N/A | no | 0.905 | 0.887 | 0.485 | 1e-123 | |
| Q9Y2H1 | 464 | Serine/threonine-protein | yes | no | 0.871 | 0.933 | 0.502 | 1e-122 | |
| Q5R8M1 | 465 | Serine/threonine-protein | yes | no | 0.885 | 0.946 | 0.488 | 1e-122 | |
| Q15208 | 465 | Serine/threonine-protein | no | no | 0.885 | 0.946 | 0.488 | 1e-122 | |
| Q7TSE6 | 464 | Serine/threonine-protein | yes | no | 0.883 | 0.946 | 0.488 | 1e-121 | |
| A2VDV2 | 465 | Serine/threonine-protein | no | no | 0.885 | 0.946 | 0.486 | 1e-121 | |
| Q91VJ4 | 465 | Serine/threonine-protein | no | no | 0.885 | 0.946 | 0.486 | 1e-121 | |
| Q2LZZ7 | 458 | Serine/threonine-protein | yes | no | 0.907 | 0.984 | 0.502 | 1e-121 | |
| Q9NBK5 | 463 | Serine/threonine-protein | yes | no | 0.871 | 0.935 | 0.504 | 1e-121 | |
| Q54Y26 | 530 | Probable serine/threonine | yes | no | 0.921 | 0.864 | 0.459 | 1e-120 |
| >sp|Q6TGC6|CBK1_PNECA Serine/threonine-protein kinase CBK1 OS=Pneumocystis carinii GN=CBK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 442 bits (1138), Expect = e-123, Method: Compositional matrix adjust.
Identities = 223/459 (48%), Positives = 311/459 (67%), Gaps = 9/459 (1%)
Query: 37 DEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLK 96
D + + T ++ A+ K +E+ YK ++ ER +RR E KLA SEE + L
Sbjct: 45 DASSFTKTTHERAASVKLKLEHLYKVTVEQTVERNQRRMDFEAKLAQDRGSEERKKRQLN 104
Query: 97 FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR 156
L +KE++++RL+R K+ +DF + +IGKGAFGEVR+ ++ TG +YAMK L KSEM +
Sbjct: 105 SLGQKESQFLRLRRTKLSLNDFHTVKVIGKGAFGEVRLVQKIDTGKIYAMKTLLKSEMFK 164
Query: 157 RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED 216
+ Q+ HV+AER++LAE DS +V LY SFQD ++LYLIME+LPGGD+MT+L++ DT +ED
Sbjct: 165 KDQLAHVKAERDVLAESDSPWVVSLYYSFQDSQYLYLIMEFLPGGDLMTMLIKYDTFSED 224
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC----KPLDCSTLQ 272
RFY+AE +LAIE++HK +IHRDIKPDN+L+DK GH++LSDFGL K D + Q
Sbjct: 225 VTRFYIAECILAIEAVHKLGFIHRDIKPDNILIDKTGHIKLSDFGLSMGFHKTHDNAYYQ 284
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRT--QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ N S+QN+ T ++++ W+KNRR++AYSTVGTPDYIAPE+
Sbjct: 285 RLFESKINTSTSSTQNSLMVDTISLTMSSKDKIATWKKNRRIMAYSTVGTPDYIAPEIFT 344
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GYG ECDWWSLGAIM+E L+G+PPF S++ T RKI+NWR +L FPE+ LS EA+D
Sbjct: 345 QHGYGQECDWWSLGAIMFECLIGWPPFCSENAHETYRKIINWRENLYFPEDLHLSAEAED 404
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI KLL + +QRLG GA++IK+HP+F GV+W I ++ A FIP++ DT FE+ +
Sbjct: 405 LIRKLLTSADQRLGRYGANDIKLHPFFRGVNWDTIREINAPFIPQLKSITDTSYFEEIDT 464
Query: 451 SDNQTKTSSKTGPWRKMLSSKDIN--FVGYTYKNFEIVN 487
N T S K+ S D N FVGYTYK F+++
Sbjct: 465 IPNITMNSPPVLQ-NKIPSDVDQNLAFVGYTYKRFDMMT 502
|
Protein kinase that seems to play a role in signaling pathways necessary for cell growth and mating. Pneumocystis carinii (taxid: 4754) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9Y2H1|ST38L_HUMAN Serine/threonine-protein kinase 38-like OS=Homo sapiens GN=STK38L PE=1 SV=3 | Back alignment and function description |
|---|
Score = 440 bits (1132), Expect = e-122, Method: Compositional matrix adjust.
Identities = 224/446 (50%), Positives = 300/446 (67%), Gaps = 13/446 (2%)
Query: 41 LSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEK 100
+SN T+++V AK +EN Y + +ER R+ LE + + +++E++ +
Sbjct: 13 MSNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLRRSQHAR 72
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
KETE++RL+R ++G DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+KS+ML + QV
Sbjct: 73 KETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKSDMLEKEQV 132
Query: 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARF 220
H+RAER++L E D +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTE+E +F
Sbjct: 133 AHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLTEEETQF 192
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE--QDFTI 278
Y++ETVLAI++IH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E ++ T
Sbjct: 193 YISETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTH 252
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
+ S QN + + + W+KNRR LAYSTVGTPDYIAPEV ++ GY C
Sbjct: 253 NPPSDFSFQN--------MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLC 304
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCN 398
DWWSLG IMYEML+GYPPF S+ P T RK++NW+ L FP E +S +AKDLI + +
Sbjct: 305 DWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCID 364
Query: 399 VNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTS 458
R+G G +EIK HP+F+GVDW I + AA E+ DT NF+ F ESD
Sbjct: 365 SENRIGNSGVEEIKGHPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDDFPESDILQPVP 424
Query: 459 SKTGPWRKMLSSKDINFVGYTYKNFE 484
+ T P K SKD F+ YTYK FE
Sbjct: 425 NTTEPDYK---SKDWVFLNYTYKRFE 447
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q5R8M1|STK38_PONAB Serine/threonine-protein kinase 38 OS=Pongo abelii GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 222/454 (48%), Positives = 305/454 (67%), Gaps = 14/454 (3%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GY CDWWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKD
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKD 355
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI + C R+GA G +EIK + +F+GVDW I + AA E+ DT NF++F E
Sbjct: 356 LILRFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPE 415
Query: 451 SDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
SD T + + +KD F+ YTYK FE
Sbjct: 416 SDILKPTVATSNHPETDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q15208|STK38_HUMAN Serine/threonine-protein kinase 38 OS=Homo sapiens GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 440 bits (1131), Expect = e-122, Method: Compositional matrix adjust.
Identities = 222/454 (48%), Positives = 305/454 (67%), Gaps = 14/454 (3%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GY CDWWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKD
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKD 355
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI + C R+GA G +EIK + +F+GVDW I + AA E+ DT NF++F E
Sbjct: 356 LILRFCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPE 415
Query: 451 SDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
SD T + + +KD F+ YTYK FE
Sbjct: 416 SDILKPTVATSNHPETDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7TSE6|ST38L_MOUSE Serine/threonine-protein kinase 38-like OS=Mus musculus GN=Stk38l PE=1 SV=2 | Back alignment and function description |
|---|
Score = 437 bits (1123), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/452 (48%), Positives = 302/452 (66%), Gaps = 13/452 (2%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
+T +SN T+++V AK +EN Y + +ER R+ LE + + +++E++
Sbjct: 7 ATTTFPMSNHTRERVTVAKLTLENFYSNLILQHEERETRQKKLEVAMEEEGLADEEKKLR 66
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+K++M
Sbjct: 67 RSQHARKETEFLRLKRTRLGLDDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM 126
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E D +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 127 LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLT 186
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY++ETVLAI++IH+ +IHRD+KPDNLLLD GH++LSDFGLC L + E
Sbjct: 187 EEETQFYISETVLAIDAIHQLGFIHRDVKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 246
Query: 274 -QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
++ T + S QN + + + W+KNRR LAYSTVGTPDYIAPEV ++
Sbjct: 247 YRNLTHNPPSDFSFQN--------MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT 298
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLI 392
GY CDWWSLG IMYEML+G+PPF S+ P T RK+++W+ L FP E +S +AKDLI
Sbjct: 299 GYNKLCDWWSLGVIMYEMLIGFPPFCSETPQETYRKVMSWKETLAFPPEVPVSEKAKDLI 358
Query: 393 SKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESD 452
+ + R+G G +EIK HP+F+GVDW I + AA E+ DT NF+ F ESD
Sbjct: 359 LRFCTDSENRIGNGGVEEIKGHPFFEGVDWGHIRERPAAIPIEIRSIDDTSNFDDFPESD 418
Query: 453 NQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
+ T P K SKD F+ YTYK FE
Sbjct: 419 ILQPVPNTTEPDYK---SKDWVFLNYTYKRFE 447
|
Involved in the regulation of structural processes in differentiating and mature neuronal cells. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2VDV2|STK38_BOVIN Serine/threonine-protein kinase 38 OS=Bos taurus GN=STK38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1122), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/454 (48%), Positives = 305/454 (67%), Gaps = 14/454 (3%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++S+ TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSSHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GY CDWWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKD
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKD 355
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI + C R+GA G +EIK + +F+GVDW I + AA E+ DT NF++F E
Sbjct: 356 LILRFCCEWEHRIGAPGVEEIKNNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPE 415
Query: 451 SDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
SD T + + +KD F+ YTYK FE
Sbjct: 416 SDILKPTVATSNHPDTDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Bos taurus (taxid: 9913) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q91VJ4|STK38_MOUSE Serine/threonine-protein kinase 38 OS=Mus musculus GN=Stk38 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1119), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/454 (48%), Positives = 304/454 (66%), Gaps = 14/454 (3%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE- 273
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L + E
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 245
Query: 274 ---QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
+ ++ ++ + N++R A + W++NRR LA+STVGTPDYIAPEV +
Sbjct: 246 YRNLNHSLPSDFTFQNMNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFM 295
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
+ GY CDWWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AK
Sbjct: 296 QTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPVSEKAKG 355
Query: 391 LISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
LI + C R+GA G +EIK + +F+GVDW I + AA E+ DT NF++F E
Sbjct: 356 LILRFCCEWEHRIGAPGVEEIKNNLFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPE 415
Query: 451 SDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
SD T + + +KD F+ YTYK FE
Sbjct: 416 SDILKPTVTTSSHPETDYKNKDWVFINYTYKRFE 449
|
Negative regulator of MAP3K1/2 signaling. Converts MAP3K2 from its phosphorylated form to its non-phosphorylated form and inhibits autophosphorylation of MAP3K2. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2LZZ7|TRC_DROPS Serine/threonine-protein kinase tricorner OS=Drosophila pseudoobscura pseudoobscura GN=trc PE=3 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1117), Expect = e-121, Method: Compositional matrix adjust.
Identities = 231/460 (50%), Positives = 305/460 (66%), Gaps = 9/460 (1%)
Query: 31 SNEESTDEEAL--SNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSE 88
S+ TD ++ S+ T K AK +EN+Y + ER++R LE +L D ++E
Sbjct: 3 SSRTDTDGSSIRFSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLTE 62
Query: 89 EDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK 148
+ +KETEY+RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK
Sbjct: 63 SQRQEKRLQHAQKETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKV 122
Query: 149 LKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM 208
L+K++ML + QV HVRAER++L E D +VK+Y SFQD LYLIME+LPGGDMMTLLM
Sbjct: 123 LRKADMLEKEQVAHVRAERDVLVEADHQWVVKMYYSFQDQVNLYLIMEFLPGGDMMTLLM 182
Query: 209 RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268
+KDTL+E+ +FY++ET LAI+SIHK +IHRDIKPDNLLLD GHL+LSDFGLC L
Sbjct: 183 KKDTLSEEGTQFYISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKK 242
Query: 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328
S DF + S A+P +++ + + W++NRR LAYSTVGTPDYIAPEV
Sbjct: 243 S--HRTDFYRDLSQAKPSDFIGTCASPMDSKR-RAESWKRNRRALAYSTVGTPDYIAPEV 299
Query: 329 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
L+ GYG CDWWSLG IMYEML+GYPPF SD+P T RK++NWR L FP E +S EA
Sbjct: 300 FLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEA 359
Query: 389 KDLISKLLCNVNQRLGA-KGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEK 447
K+ I K C ++RLG+ +G +++K P+F GVDW I + AA EV DT NF++
Sbjct: 360 KETIIKFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDE 419
Query: 448 FEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVN 487
F D + S P + +KD F+ YTYK FE+ N
Sbjct: 420 F--PDVSLEIPSAPIPQGGEI-AKDWVFINYTYKRFEVRN 456
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila pseudoobscura pseudoobscura (taxid: 46245) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9NBK5|TRC_DROME Serine/threonine-protein kinase tricorner OS=Drosophila melanogaster GN=trc PE=1 SV=1 | Back alignment and function description |
|---|
Score = 434 bits (1115), Expect = e-121, Method: Compositional matrix adjust.
Identities = 232/460 (50%), Positives = 302/460 (65%), Gaps = 27/460 (5%)
Query: 41 LSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEK 100
S+ T K AK +EN+Y + ER++R LE +L D +SE + +
Sbjct: 16 FSDHTLDKATKAKVTLENYYSNLVTQYGERKQRLAKLEAQLKDESLSEAQRQEKRLQHAQ 75
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
KETEY+RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV
Sbjct: 76 KETEYLRLKRLRLGVEDFEALKVIGRGAFGEVRLVQKKDTGHVYAMKVLRKADMLEKEQV 135
Query: 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARF 220
HVRAER++L E D +VK+Y SFQD LYLIME+LPGGDMMTLLM+KDTL+E+ +F
Sbjct: 136 AHVRAERDVLVEADHQWVVKMYYSFQDPVNLYLIMEFLPGGDMMTLLMKKDTLSEEGTQF 195
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL----------DCST 270
Y++ET LAI+SIHK +IHRDIKPDNLLLD GHL+LSDFGLC L D S
Sbjct: 196 YISETALAIDSIHKLGFIHRDIKPDNLLLDARGHLKLSDFGLCTGLKKSHRTDFYRDLSQ 255
Query: 271 LQEQDFTIGN--NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328
+ DF IG +L+ S +++R A + W++NRR LAYSTVGTPDYIAPEV
Sbjct: 256 AKPSDF-IGTCASLSCSPMDSKRRA----------ESWKRNRRALAYSTVGTPDYIAPEV 304
Query: 329 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
L+ GYG CDWWSLG IMYEML+GYPPF SD+P T RK++NWR L FP E +S EA
Sbjct: 305 FLQTGYGPACDWWSLGVIMYEMLMGYPPFCSDNPQDTYRKVMNWRETLIFPPEIPISEEA 364
Query: 389 KDLISKLLCNVNQRLGA-KGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEK 447
K+ I C ++RLG+ +G +++K P+F GVDW I + AA EV DT NF++
Sbjct: 365 KETIINFCCEADRRLGSQRGLEDLKSVPFFRGVDWEHIRERPAAIPVEVRSIDDTSNFDE 424
Query: 448 FEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVN 487
F D + S P + +KD F+ YTYK FE+ N
Sbjct: 425 F--PDVSLEIPSAPIPQGGEI-AKDWVFINYTYKRFEVRN 461
|
Has an important role, with fry, in controlling cell structure and proliferation of a variety of polarized outgrowths including epidermal hairs, bristles, arista laterals, and dendrites. Affects cellular morphogenesis by regulating the expression of target genes that encode cytoskeleton-interacting proteins and not via the direct modification of the cytoskeleton. Maintains the integrity of epidermal hairs and is an essential component of the signaling pathway regulating dendritic branching of sensory neurons. Drosophila melanogaster (taxid: 7227) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54Y26|NDRA_DICDI Probable serine/threonine-protein kinase ndrA OS=Dictyostelium discoideum GN=ndrA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 431 bits (1109), Expect = e-120, Method: Compositional matrix adjust.
Identities = 232/505 (45%), Positives = 318/505 (62%), Gaps = 47/505 (9%)
Query: 19 GSGKKKEAGGNGSNEEST----DEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERR 74
GS ++E N +EE T + LS T + AAK YIE +Y ++++ER +RR
Sbjct: 12 GSDDERE---NFEDEEDTTTVYSSDPLSRPTMDRSLAAKMYIEQYYINAQQSVKERGQRR 68
Query: 75 NILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV 134
LE KL + +S ++ N+L K L+KKE++YMR++R K+ DFE++ +IG+GAFGEV +
Sbjct: 69 KDLELKLENMKLSSKESNDLRKELDKKESDYMRIKRLKLKRSDFEVIRIIGRGAFGEVSL 128
Query: 135 CREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194
R + + +YAMK+LKKSEML++ Q HVRAER++LA ++N +VKLY SFQDD +LYLI
Sbjct: 129 VRHRESNDLYAMKRLKKSEMLKKEQAAHVRAERDVLASANTNWVVKLYYSFQDDNYLYLI 188
Query: 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254
MEYLPGGDMM+LL++ D TE++ARFY+AET+LAIES+H YIHRDIKPDNLLLD GH
Sbjct: 189 MEYLPGGDMMSLLIKYDIFTENQARFYIAETILAIESVHTLGYIHRDIKPDNLLLDSKGH 248
Query: 255 LRLSDFGLCKPLDCSTLQEQDF---TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311
++L D GLC L +F +G+ + + E A TQ E++ W+K RR
Sbjct: 249 VKLCDLGLCTGF--HRLHSSEFYQMLVGDAMTIKMKLIE---ATPLTQTERIASWKKARR 303
Query: 312 MLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN 371
LAYS VGTPDY APEV L+ GY E DWWSLG I+YEM+VG+PPF SD+ TC KI+N
Sbjct: 304 ALAYSAVGTPDYTAPEVFLQIGYNKEVDWWSLGVILYEMVVGHPPFLSDNTTETCLKILN 363
Query: 372 WRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAA 431
+ L+ P + LS E DLI +L+C ++ K ADEIK+HP+F GV+W I A
Sbjct: 364 CKETLQIPTDMGLSKEVIDLIKRLVCEKDR---YKSADEIKLHPFFKGVNWDNIRNQSAP 420
Query: 432 FIPEVNDELDTQNFEKFEE----------------------SDNQTKTSSKTGPWRKM-- 467
F+PE+ DT NF+ +EE +DN + T P +K
Sbjct: 421 FVPELKSPTDTSNFDIYEEIPNDIDDDDNNNNNNSNNNINLNDNINSNCTYTTPTKKSNI 480
Query: 468 -----LSSKDINFVGYTYKNFEIVN 487
+ KD+ F+G+T+K F+ VN
Sbjct: 481 MGKGNIKDKDLAFIGFTFKGFDAVN 505
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 497 | ||||||
| 255577946 | 575 | serine/threonine-protein kinase, putativ | 0.995 | 0.860 | 0.872 | 0.0 | |
| 224082842 | 561 | predicted protein [Populus trichocarpa] | 0.993 | 0.880 | 0.885 | 0.0 | |
| 7339534 | 564 | protein kinase MK6 [Mesembryanthemum cry | 0.993 | 0.875 | 0.869 | 0.0 | |
| 356503620 | 542 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.909 | 0.863 | 0.0 | |
| 356545884 | 575 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.853 | 0.857 | 0.0 | |
| 224066229 | 561 | predicted protein [Populus trichocarpa] | 0.993 | 0.880 | 0.855 | 0.0 | |
| 356537081 | 554 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.886 | 0.857 | 0.0 | |
| 449462463 | 557 | PREDICTED: serine/threonine-protein kina | 0.987 | 0.881 | 0.878 | 0.0 | |
| 225433165 | 550 | PREDICTED: serine/threonine-protein kina | 0.991 | 0.896 | 0.857 | 0.0 | |
| 147815455 | 550 | hypothetical protein VITISV_001730 [Viti | 0.991 | 0.896 | 0.857 | 0.0 |
| >gi|255577946|ref|XP_002529845.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223530673|gb|EEF32546.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 935 bits (2416), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 436/500 (87%), Positives = 470/500 (94%), Gaps = 5/500 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEE----STDEEALSNVTKQKVAAAKQYI 56
MDSARSW QK QPR+K+R + +KK+A SN E S D+E+LSN TKQKVAAAKQYI
Sbjct: 1 MDSARSWFQKFQPREKLRSTTRKKDASDESSNNEPKSPSEDDESLSNTTKQKVAAAKQYI 60
Query: 57 ENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGAD 116
ENHYKEQMKNLQER+ERR ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG D
Sbjct: 61 ENHYKEQMKNLQERKERRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVD 120
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DFELLTMIGKGAFGEVRVCRE TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN
Sbjct: 121 DFELLTMIGKGAFGEVRVCRENTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 180
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
CIVKLYCSFQD+EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH+
Sbjct: 181 CIVKLYCSFQDEEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHN 240
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN-LNGSSQNNERPAAP 295
YIHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCST+QE DF++ NN +NG++QN ERPAAP
Sbjct: 241 YIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSTIQEGDFSVVNNSVNGTAQNEERPAAP 300
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
KRTQQEQL+HWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP
Sbjct: 301 KRTQQEQLKHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 360
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHP 415
PFYSDDPMSTCRKIVNWRTHLKFPEEA+LS EAKD+ISKLLCNVNQRLG KGADE+K HP
Sbjct: 361 PFYSDDPMSTCRKIVNWRTHLKFPEEARLSREAKDVISKLLCNVNQRLGTKGADELKAHP 420
Query: 416 WFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
WF+GV+W ++Y MEAAFIPEV D+LDTQNFEKFE+S+NQ +++++TGPWRKMLSSKD+NF
Sbjct: 421 WFNGVEWDKLYHMEAAFIPEVKDDLDTQNFEKFEDSENQNQSTTRTGPWRKMLSSKDLNF 480
Query: 476 VGYTYKNFEIVNDYQVPGMG 495
VGYTYKNFEIVNDYQVPGM
Sbjct: 481 VGYTYKNFEIVNDYQVPGMA 500
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224082842|ref|XP_002306862.1| predicted protein [Populus trichocarpa] gi|222856311|gb|EEE93858.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 931 bits (2407), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/499 (88%), Positives = 468/499 (93%), Gaps = 5/499 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEES---TDEEALSNVTKQKVAAAKQYIE 57
MDSARSW QK QPR+K R S ++KE GG+ NE+S DEEALSNVTKQKVAAAKQYIE
Sbjct: 1 MDSARSWFQKFQPREKFRSSSRRKE-GGDEDNEDSKLEMDEEALSNVTKQKVAAAKQYIE 59
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQER+ERR LEKKLADADVSEEDQ+NLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 60 NHYKEQMKNLQERKERRTTLEKKLADADVSEEDQSNLLKFLEKKETEYMRLQRHKMGVDD 119
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNC
Sbjct: 120 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 179
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ET+LAIESIHKH+Y
Sbjct: 180 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETILAIESIHKHNY 239
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT-IGNNLNGSSQNNERPAAPK 296
IHRDIKPDNLLLD++GHLRLSDFGLCKPLDCST+QE DF+ + NN N ++QN ERPAAPK
Sbjct: 240 IHRDIKPDNLLLDRHGHLRLSDFGLCKPLDCSTIQEGDFSVVNNNGNETTQNGERPAAPK 299
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP
Sbjct: 300 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 359
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
FYSDDPMSTCRKIVNWRTHLKFPEEAKLS EAKD+ISKLLCNV+ RLG GADEIK HPW
Sbjct: 360 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSPEAKDIISKLLCNVSHRLGTNGADEIKAHPW 419
Query: 417 FDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
FDGV+W ++YQMEAAFIPEV D+LDTQNFE FEES+NQT+T+SKTGPWRKMLSSKDINFV
Sbjct: 420 FDGVEWDKLYQMEAAFIPEVKDDLDTQNFENFEESENQTQTTSKTGPWRKMLSSKDINFV 479
Query: 477 GYTYKNFEIVNDYQVPGMG 495
GYTYKNFEIVNDYQVPGM
Sbjct: 480 GYTYKNFEIVNDYQVPGMA 498
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7339534|emb|CAB82852.1| protein kinase MK6 [Mesembryanthemum crystallinum] | Back alignment and taxonomy information |
|---|
Score = 917 bits (2371), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 432/497 (86%), Positives = 465/497 (93%), Gaps = 3/497 (0%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEA--GGNGSNEESTDEEALSNVTKQKVAAAKQYIEN 58
MDSARSWL K QPRDK+R S KKK++ GG + ++DEE SNVTKQ+VAAAKQYIE
Sbjct: 6 MDSARSWLHKYQPRDKLRSSTKKKDSMMGGRDDSAPTSDEETPSNVTKQRVAAAKQYIEK 65
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYKEQMK+LQER+ERR+ILE+KL DADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF
Sbjct: 66 HYKEQMKSLQERKERRSILERKLHDADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 125
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 126 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 185
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET+LAIESIHKH+YI
Sbjct: 186 VKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETILAIESIHKHNYI 245
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLDK+GHLRLSDFGLCKPLDCSTL+E+DF + NN NG S +NE P+RT
Sbjct: 246 HRDIKPDNLLLDKFGHLRLSDFGLCKPLDCSTLEEKDFEV-NNGNGGSPSNEGSTKPRRT 304
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY
Sbjct: 305 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 364
Query: 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFD 418
SDDPMSTCRKIVNWRTHLKFPEEAKLS EAKDLISKLLCNV QRLG+ GA EIK+HPWF+
Sbjct: 365 SDDPMSTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVTQRLGSNGAHEIKLHPWFN 424
Query: 419 GVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGY 478
G+DW RIYQMEAAFIPEVNDELDTQNFEKFEE+DN ++++SK GPWRKMLSSKD+NFVGY
Sbjct: 425 GIDWERIYQMEAAFIPEVNDELDTQNFEKFEEADNSSQSTSKAGPWRKMLSSKDLNFVGY 484
Query: 479 TYKNFEIVNDYQVPGMG 495
TYKNFEIVNDYQVPG+
Sbjct: 485 TYKNFEIVNDYQVPGIA 501
|
Source: Mesembryanthemum crystallinum Species: Mesembryanthemum crystallinum Genus: Mesembryanthemum Family: Aizoaceae Order: Caryophyllales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356503620|ref|XP_003520605.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 911 bits (2354), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/498 (86%), Positives = 461/498 (92%), Gaps = 5/498 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNE---ESTDEEALSNVTKQKVAAAKQYIE 57
MDSARSWLQK QPRDK+R S + K+ NG+NE D+ +LSNVTKQKV AAKQYIE
Sbjct: 1 MDSARSWLQKFQPRDKLRASTRNKD-DTNGTNEIPNVPMDDTSLSNVTKQKVTAAKQYIE 59
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMK+LQER+ERR ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 60 NHYKEQMKSLQERKERRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVDD 119
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVC+EK T HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC
Sbjct: 120 FELLTMIGKGAFGEVRVCKEKATDHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 179
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDE+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ET+LAIESIHKH+Y
Sbjct: 180 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETILAIESIHKHNY 239
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL+E DFT G N NGS+QNNE APKR
Sbjct: 240 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLEETDFTTGQNANGSTQNNEH-VAPKR 298
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
TQQE+LQHWQKNRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF
Sbjct: 299 TQQEKLQHWQKNRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 358
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWF 417
YSDDPMSTCRKIVNW++HL+FPEEA+LS EAKDLISKLLC+VNQRLG+ GADEIK HP+F
Sbjct: 359 YSDDPMSTCRKIVNWKSHLRFPEEARLSPEAKDLISKLLCDVNQRLGSNGADEIKAHPFF 418
Query: 418 DGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVG 477
+GV+W ++YQMEAAFIPEVNDELDTQNFEKFEES++QT +SS+ PWRKM SSKD+NFVG
Sbjct: 419 NGVEWDKLYQMEAAFIPEVNDELDTQNFEKFEESESQTHSSSRVSPWRKMFSSKDLNFVG 478
Query: 478 YTYKNFEIVNDYQVPGMG 495
YTYKNFEIVNDYQVPGM
Sbjct: 479 YTYKNFEIVNDYQVPGMA 496
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545884|ref|XP_003541363.1| PREDICTED: serine/threonine-protein kinase CBK1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 909 bits (2350), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/498 (85%), Positives = 464/498 (93%), Gaps = 7/498 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEES---TDEEALSNVTKQKVAAAKQYIE 57
MDSARSWLQK QPRDK R +GKKKE GNG N++S DE LS+VTKQKVAA KQYIE
Sbjct: 1 MDSARSWLQKFQPRDKTRAAGKKKEEDGNGGNQDSNEPVDEALLSSVTKQKVAATKQYIE 60
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQER+ERR ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 61 NHYKEQMKNLQERKERRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVDD 120
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVCREKT+ HVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVD NC
Sbjct: 121 FELLTMIGKGAFGEVRVCREKTSDHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDRNC 180
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDE+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ET+LAIESIHKH+Y
Sbjct: 181 IVKLYCSFQDDEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETILAIESIHKHNY 240
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDNLLLD+YGHL+LSDFGLCKPLDCS L+E+DF++G N+NGS+Q+ + PKR
Sbjct: 241 IHRDIKPDNLLLDRYGHLKLSDFGLCKPLDCSALEEKDFSVGQNVNGSTQS----STPKR 296
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
+QQEQLQHWQ NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF
Sbjct: 297 SQQEQLQHWQMNRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 356
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWF 417
YSDDPM TCRKIVNW+T+LKFPEEA+LS EAKDLISKLLCNVNQRLG+KGADEIK HP+F
Sbjct: 357 YSDDPMLTCRKIVNWKTYLKFPEEARLSPEAKDLISKLLCNVNQRLGSKGADEIKAHPFF 416
Query: 418 DGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVG 477
GV+W ++YQMEAAFIPEVNDELDTQNFEKF+ESD+Q ++SS++GPWRKMLSSKD+NFVG
Sbjct: 417 KGVEWDKLYQMEAAFIPEVNDELDTQNFEKFDESDSQNQSSSRSGPWRKMLSSKDLNFVG 476
Query: 478 YTYKNFEIVNDYQVPGMG 495
YTYKNFEIVNDYQVPG+
Sbjct: 477 YTYKNFEIVNDYQVPGIA 494
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224066229|ref|XP_002302036.1| predicted protein [Populus trichocarpa] gi|222843762|gb|EEE81309.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 907 bits (2343), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 427/499 (85%), Positives = 462/499 (92%), Gaps = 5/499 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST---DEEALSNVTKQKVAAAKQYIE 57
MDSARSW QK QPR+K R ++KE GG+ NE++ DEEA SNVTKQKVAAAK+YIE
Sbjct: 1 MDSARSWFQKFQPREKFRSPSRRKE-GGDEDNEDTISEMDEEAHSNVTKQKVAAAKRYIE 59
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQER+ERR LEKKLADADVSEEDQ+NLLKFLEKKETEYMRLQRHKMG DD
Sbjct: 60 NHYKEQMKNLQERKERRTTLEKKLADADVSEEDQSNLLKFLEKKETEYMRLQRHKMGVDD 119
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVR+CREKTTG VYAMKKLKKSEMLRRGQVEHV+AERNLL EVDSNC
Sbjct: 120 FELLTMIGKGAFGEVRICREKTTGQVYAMKKLKKSEMLRRGQVEHVKAERNLLTEVDSNC 179
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDD FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+Y
Sbjct: 180 IVKLYCSFQDDGFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNY 239
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT-IGNNLNGSSQNNERPAAPK 296
IHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCST+QE DF+ + NN NG++QN ERPAAP+
Sbjct: 240 IHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSTIQEGDFSVVNNNSNGTTQNEERPAAPR 299
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
RTQQEQL+HWQKNRRMLA+STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP
Sbjct: 300 RTQQEQLEHWQKNRRMLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 359
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
FYSD+P+STC+KIVNWRTHLKFPEEAKLS AKDL SKLLCNV+QRLG GA+EIK HPW
Sbjct: 360 FYSDEPLSTCKKIVNWRTHLKFPEEAKLSPAAKDLTSKLLCNVDQRLGTNGAEEIKAHPW 419
Query: 417 FDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
F+GV+W ++YQMEAAFIPEV D+LDTQNF KFEES+NQ +T+SKTGPWRKMLSSKD+NFV
Sbjct: 420 FNGVEWDKLYQMEAAFIPEVKDDLDTQNFVKFEESENQPQTTSKTGPWRKMLSSKDVNFV 479
Query: 477 GYTYKNFEIVNDYQVPGMG 495
GYTYKNFEIVNDYQVPGM
Sbjct: 480 GYTYKNFEIVNDYQVPGMA 498
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356537081|ref|XP_003537059.1| PREDICTED: serine/threonine-protein kinase tricorner-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 902 bits (2332), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 428/499 (85%), Positives = 461/499 (92%), Gaps = 8/499 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNE---ESTDEEALSNVTKQKVAAAKQYIE 57
MDSARSWLQK QPRDK R +GKKKE GNG N+ E+ DE LS+VTKQKVAAAKQYIE
Sbjct: 1 MDSARSWLQKFQPRDKTRAAGKKKEEDGNGGNQDSNEAIDEALLSSVTKQKVAAAKQYIE 60
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
NHYKEQMKNLQ R ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG +D
Sbjct: 61 NHYKEQMKNLQVAYNSRTILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGVED 120
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELLTMIGKGAFGEVRVCREKT+GHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNC
Sbjct: 121 FELLTMIGKGAFGEVRVCREKTSGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNC 180
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKLYCSFQDDE LYLIMEYLPGGDMMTLLMRKD LTEDEARFYV ETVLAIESIHKH+Y
Sbjct: 181 IVKLYCSFQDDEHLYLIMEYLPGGDMMTLLMRKDILTEDEARFYVGETVLAIESIHKHNY 240
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDNLLLD+YGHL+LSDFGLCKPLDCSTL+E DF++G N+NGS+Q+ + PKR
Sbjct: 241 IHRDIKPDNLLLDRYGHLKLSDFGLCKPLDCSTLEENDFSVGQNVNGSTQS----STPKR 296
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
+QQEQLQHWQ NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF
Sbjct: 297 SQQEQLQHWQINRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 356
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWF 417
YSDDPM TCRKIVNW+T+LKFPEEA+LS EAKDLISKLLCNVNQRLG+KGADEIK HP+F
Sbjct: 357 YSDDPMLTCRKIVNWKTYLKFPEEARLSPEAKDLISKLLCNVNQRLGSKGADEIKAHPFF 416
Query: 418 DGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDINFV 476
GV+W ++YQMEAAFIPEVNDELDTQNFEKF+ESD+QT++SS++GPWRKMLSS KD+NFV
Sbjct: 417 KGVEWNKLYQMEAAFIPEVNDELDTQNFEKFDESDSQTQSSSRSGPWRKMLSSKKDLNFV 476
Query: 477 GYTYKNFEIVNDYQVPGMG 495
GYTYKNFEIVNDYQVPGM
Sbjct: 477 GYTYKNFEIVNDYQVPGMA 495
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449462463|ref|XP_004148960.1| PREDICTED: serine/threonine-protein kinase 38-like [Cucumis sativus] gi|449502113|ref|XP_004161547.1| PREDICTED: serine/threonine-protein kinase 38-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 900 bits (2326), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/500 (87%), Positives = 463/500 (92%), Gaps = 9/500 (1%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST-----DEEALSNVTKQKVAAAKQY 55
MDSARSW Q RD++RGS KKK+ G NE+ST DEEALSN+TKQKVAAAKQY
Sbjct: 1 MDSARSWFN--QRRDRLRGSTKKKD-NSMGENEDSTATDQMDEEALSNITKQKVAAAKQY 57
Query: 56 IENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGA 115
IENHYKEQMKNLQER+ERRN+LEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG
Sbjct: 58 IENHYKEQMKNLQERKERRNVLEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGV 117
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDF+LLT+IGKGAFGEVRVCREKTTG VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS
Sbjct: 118 DDFDLLTIIGKGAFGEVRVCREKTTGQVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 177
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV E VLAIESIHKH
Sbjct: 178 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGEIVLAIESIHKH 237
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+YIHRDIKPDNLLLDK+GHLRLSDFGLCKPLDCS L+EQDF IG+ NG+ QN+ER A P
Sbjct: 238 NYIHRDIKPDNLLLDKFGHLRLSDFGLCKPLDCSILREQDFDIGSTRNGAGQNDERNATP 297
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP
Sbjct: 298 -RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 356
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHP 415
PFYSDDPMSTCRKIVNWRTHLKFP+EAKLS+ AKDLISKLLCNVNQRLG GADEIKVH
Sbjct: 357 PFYSDDPMSTCRKIVNWRTHLKFPDEAKLSLLAKDLISKLLCNVNQRLGTNGADEIKVHS 416
Query: 416 WFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
WF+G +W R+YQMEAAF+PEV DELDTQNFEKFEESD+Q+ TSSKTGPWRKMLSSKDINF
Sbjct: 417 WFEGTEWDRLYQMEAAFVPEVKDELDTQNFEKFEESDSQSSTSSKTGPWRKMLSSKDINF 476
Query: 476 VGYTYKNFEIVNDYQVPGMG 495
VGYTYKNFEIVNDYQ+PGM
Sbjct: 477 VGYTYKNFEIVNDYQLPGMA 496
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225433165|ref|XP_002285280.1| PREDICTED: serine/threonine-protein kinase tricorner [Vitis vinifera] gi|296083669|emb|CBI23658.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 899 bits (2323), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/497 (85%), Positives = 460/497 (92%), Gaps = 4/497 (0%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNG--SNEESTDEEALSNVTKQKVAAAKQYIEN 58
M S W KL+ RDK + S KKEA NG ++ T EEA SNVTKQKVAAAKQYIEN
Sbjct: 1 MKSIGCWFNKLKSRDKAKSS--KKEATNNGKEGSKAVTSEEAPSNVTKQKVAAAKQYIEN 58
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYKEQMKNLQER+ERRNILEKKLADA+VSEE+QNNLLK LEKKETEYMRLQRHKMGADDF
Sbjct: 59 HYKEQMKNLQERKERRNILEKKLADAEVSEEEQNNLLKHLEKKETEYMRLQRHKMGADDF 118
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
E LTMIGKGAFGEVRVCREK TGHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 119 EPLTMIGKGAFGEVRVCREKKTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 178
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+EFLYL+MEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+YI
Sbjct: 179 VKLYCSFQDEEFLYLVMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYI 238
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLD+YGH++LSDFGLCKPLDCS L E+DF++GNNL+G+ Q++ RPAAP+RT
Sbjct: 239 HRDIKPDNLLLDRYGHMKLSDFGLCKPLDCSNLHEKDFSLGNNLSGALQSDGRPAAPRRT 298
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
QQEQLQHWQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY
Sbjct: 299 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
Query: 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFD 418
SD+PM+TCRKIVNWRTHLKFPEEAKLS EAKDLISKLLCNV+QRLG KGADEIK HPWF+
Sbjct: 359 SDEPMTTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVDQRLGTKGADEIKAHPWFE 418
Query: 419 GVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGY 478
GVDW ++YQ+EAAFIPEVNDELDTQNFEKFEE+D+Q +TSSK GPWRKMLSSKDINFVGY
Sbjct: 419 GVDWDKLYQIEAAFIPEVNDELDTQNFEKFEEADDQIQTSSKAGPWRKMLSSKDINFVGY 478
Query: 479 TYKNFEIVNDYQVPGMG 495
TYKNFEIVND VPG+
Sbjct: 479 TYKNFEIVNDQPVPGIA 495
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147815455|emb|CAN61876.1| hypothetical protein VITISV_001730 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 426/497 (85%), Positives = 459/497 (92%), Gaps = 4/497 (0%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNG--SNEESTDEEALSNVTKQKVAAAKQYIEN 58
M S W KL+ RDK + S KKEA NG ++ T EEA SNVTKQKVAAAKQYIEN
Sbjct: 1 MKSIGCWFNKLKSRDKAKSS--KKEATNNGKEGSKAVTSEEAPSNVTKQKVAAAKQYIEN 58
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYKEQMKNLQER+ERRNILEKKLADA+VSEE+QNNLLK LEKKETEYMRLQRHKMGADDF
Sbjct: 59 HYKEQMKNLQERKERRNILEKKLADAEVSEEEQNNLLKHLEKKETEYMRLQRHKMGADDF 118
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
E LTMIGKGAFGEVRVCREK TGHVYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 119 EPLTMIGKGAFGEVRVCREKKTGHVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 178
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+EFLYL+MEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+YI
Sbjct: 179 VKLYCSFQDEEFLYLVMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYI 238
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLD+YGH++LSDFGLCKPLDCS L E+DF++GNNL+G+ Q++ RPAAP+RT
Sbjct: 239 HRDIKPDNLLLDRYGHMKLSDFGLCKPLDCSNLHEKDFSLGNNLSGALQSDGRPAAPRRT 298
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
QQEQLQHWQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY
Sbjct: 299 QQEQLQHWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
Query: 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFD 418
SD+PM+TCRKIVNWRTHLKFPEEAKLS EAKDLISKLLCNV+QRLG KGADEIK HPWF
Sbjct: 359 SDEPMTTCRKIVNWRTHLKFPEEAKLSPEAKDLISKLLCNVDQRLGTKGADEIKAHPWFQ 418
Query: 419 GVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGY 478
GVDW ++YQ+EAAFIPEVNDELDTQNFEKFEE+D+Q +TSSK GPWRKMLSSKDINFVGY
Sbjct: 419 GVDWDKLYQIEAAFIPEVNDELDTQNFEKFEEADDQIQTSSKAGPWRKMLSSKDINFVGY 478
Query: 479 TYKNFEIVNDYQVPGMG 495
TYKNFEIVND VPG+
Sbjct: 479 TYKNFEIVNDQPVPGIA 495
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 497 | ||||||
| TAIR|locus:2054784 | 569 | AT2G20470 [Arabidopsis thalian | 0.989 | 0.864 | 0.816 | 5.8e-224 | |
| TAIR|locus:2129650 | 551 | AT4G14350 [Arabidopsis thalian | 0.991 | 0.894 | 0.794 | 7.1e-219 | |
| TAIR|locus:2024167 | 569 | AT1G03920 [Arabidopsis thalian | 0.919 | 0.803 | 0.847 | 1.2e-216 | |
| TAIR|locus:2090925 | 568 | AT3G23310 [Arabidopsis thalian | 0.993 | 0.869 | 0.777 | 6.6e-216 | |
| TAIR|locus:2204574 | 562 | AT1G30640 [Arabidopsis thalian | 0.987 | 0.873 | 0.685 | 2e-184 | |
| TAIR|locus:2125894 | 519 | AT4G33080 [Arabidopsis thalian | 0.911 | 0.872 | 0.693 | 3.4e-171 | |
| TAIR|locus:2047590 | 527 | AT2G19400 [Arabidopsis thalian | 0.913 | 0.861 | 0.650 | 2.1e-164 | |
| TAIR|locus:2178208 | 516 | AT5G09890 [Arabidopsis thalian | 0.957 | 0.922 | 0.623 | 4.5e-162 | |
| UNIPROTKB|E1C8Z7 | 465 | STK38 "Uncharacterized protein | 0.883 | 0.944 | 0.496 | 3.5e-114 | |
| UNIPROTKB|Q15208 | 465 | STK38 "Serine/threonine-protei | 0.893 | 0.954 | 0.495 | 4.5e-114 |
| TAIR|locus:2054784 AT2G20470 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2162 (766.1 bits), Expect = 5.8e-224, P = 5.8e-224
Identities = 408/500 (81%), Positives = 449/500 (89%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSN---EE---STDEEALSNVTKQKVAAAKQ 54
MDSA+ W QK Q R R G AGG GSN +E TDEEA+SN TKQKVAAAKQ
Sbjct: 1 MDSAKGWFQKRQMRGGSRYKGASGGAGGGGSNGSADEHNVETDEEAVSNTTKQKVAAAKQ 60
Query: 55 YIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG 114
YIENHYKEQMK LQER+ERR++LE+KLADADVSEEDQNNLLKFLEKKETEYMRLQRHK+G
Sbjct: 61 YIENHYKEQMKILQERKERRSMLEQKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKLG 120
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DF+LLTMIGKGAFGEVRVCREKTTG VYAMKKLKK+EMLRRGQVEHVRAERNLLAEVD
Sbjct: 121 VADFDLLTMIGKGAFGEVRVCREKTTGQVYAMKKLKKAEMLRRGQVEHVRAERNLLAEVD 180
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
SN IVKLYCSFQDD+ LYL+MEYLPGGDMMTLLMRKDTLTE+EA+FYVAETVLAIESIH+
Sbjct: 181 SNYIVKLYCSFQDDDHLYLVMEYLPGGDMMTLLMRKDTLTEEEAKFYVAETVLAIESIHR 240
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H+YIHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCS + E DF+ NN NGS++ A
Sbjct: 241 HNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSAIGENDFS--NNSNGSTEQEAGSTA 298
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
PKRTQQEQL+HWQ+NRR LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY
Sbjct: 299 PKRTQQEQLEHWQRNRRTLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 358
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVH 414
PPFYSDDPMSTCRKIVNW++HLKFPEEA LS EAKDLI+ LLC+V +RLG+KGADE+K H
Sbjct: 359 PPFYSDDPMSTCRKIVNWKSHLKFPEEAILSREAKDLINSLLCSVRRRLGSKGADELKAH 418
Query: 415 PWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN 474
WF+ VDW I+ M+AAF+PEVND+LDTQNFEKF+ES+++T+TSSK+GPWRKMLSSKDIN
Sbjct: 419 TWFETVDWDTIFDMDAAFVPEVNDDLDTQNFEKFDESESETQTSSKSGPWRKMLSSKDIN 478
Query: 475 FVGYTYKNFEIVNDYQVPGM 494
FVGYTYKNFEIVNDYQVPGM
Sbjct: 479 FVGYTYKNFEIVNDYQVPGM 498
|
|
| TAIR|locus:2129650 AT4G14350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2114 (749.2 bits), Expect = 7.1e-219, P = 7.1e-219
Identities = 394/496 (79%), Positives = 445/496 (89%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST--DEEALSNVTKQKVAAAKQYIEN 58
M++A++WL KL+ +DK++ S KKKEA N T EEALSN+TK+K AAAK YIEN
Sbjct: 1 METAKAWLSKLKSKDKVKSS-KKKEATSNVKEGPKTAGGEEALSNITKEKAAAAKLYIEN 59
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYK QM++LQER+ERR +LEKKLA A+VSEE+QNNLLK LE KETEYMR QRHKMGADDF
Sbjct: 60 HYKMQMQSLQERKERRKMLEKKLAAAEVSEEEQNNLLKDLEMKETEYMRRQRHKMGADDF 119
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
E LTMIGKGAFGEVR+CREK TG+VYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 120 EPLTMIGKGAFGEVRICREKGTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 179
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFY+ ETVLAIESIHKH+YI
Sbjct: 180 VKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYIGETVLAIESIHKHNYI 239
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLDK GH++LSDFGLCKPLDCS LQE+DFT+ N++G+ Q++ RP A +RT
Sbjct: 240 HRDIKPDNLLLDKDGHMKLSDFGLCKPLDCSNLQEKDFTVARNVSGALQSDGRPVATRRT 299
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
QQEQL +WQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PPFY
Sbjct: 300 QQEQLLNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPPFY 359
Query: 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFD 418
SDDPM+TCRKIVNWR +LKFP+E +LS EAKDLI +LLCNV QRLG KGADEIK HPWF
Sbjct: 360 SDDPMTTCRKIVNWRNYLKFPDEVRLSPEAKDLICRLLCNVEQRLGTKGADEIKGHPWFR 419
Query: 419 GVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGY 478
G +W ++YQM+AAFIP+VNDELDTQNFEKFEE+D Q S+K+GPWRKMLSSKDINFVGY
Sbjct: 420 GTEWGKLYQMKAAFIPQVNDELDTQNFEKFEETDKQVPKSAKSGPWRKMLSSKDINFVGY 479
Query: 479 TYKNFEIVNDYQVPGM 494
TYKN EIVND Q+PG+
Sbjct: 480 TYKNVEIVNDDQIPGI 495
|
|
| TAIR|locus:2024167 AT1G03920 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2093 (741.8 bits), Expect = 1.2e-216, P = 1.2e-216
Identities = 388/458 (84%), Positives = 421/458 (91%)
Query: 37 DEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLK 96
D EALSN TKQKVAAAKQYIENHYKEQMKNL ER+ERR LEKKLADADV EEDQ NL+K
Sbjct: 56 DGEALSNSTKQKVAAAKQYIENHYKEQMKNLNERKERRTTLEKKLADADVCEEDQTNLMK 115
Query: 97 FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR 156
FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV RE TGHV+AMKKLKKSEMLR
Sbjct: 116 FLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVVREINTGHVFAMKKLKKSEMLR 175
Query: 157 RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED 216
RGQVEHVRAERNLLAEVDSNCIVKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTL+ED
Sbjct: 176 RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDNEYLYLIMEYLPGGDMMTLLMRKDTLSED 235
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
EA+FY+AE+VLAIESIH +YIHRDIKPDNLLLD+YGHLRLSDFGLCKPLDCS + +DF
Sbjct: 236 EAKFYIAESVLAIESIHNRNYIHRDIKPDNLLLDRYGHLRLSDFGLCKPLDCSVIDGEDF 295
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
T+GN +G + PKR+QQEQL+HWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM
Sbjct: 296 TVGNAGSGGGSESVS-TTPKRSQQEQLEHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 354
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
ECDWWSLGAIMYEMLVGYPPFY+DDPMSTCRKIVNW+THLKFPEE++LS A+DLI KLL
Sbjct: 355 ECDWWSLGAIMYEMLVGYPPFYADDPMSTCRKIVNWKTHLKFPEESRLSRGARDLIGKLL 414
Query: 397 CNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTK 456
C+VNQRLG+ GA +IK HPWF+GV W +IYQMEAAFIPEVND+LDTQNFEKF+E DNQT+
Sbjct: 415 CSVNQRLGSTGASQIKAHPWFEGVQWEKIYQMEAAFIPEVNDDLDTQNFEKFDEEDNQTQ 474
Query: 457 TSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPGM 494
S+TGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPG+
Sbjct: 475 APSRTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPGI 512
|
|
| TAIR|locus:2090925 AT3G23310 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2086 (739.4 bits), Expect = 6.6e-216, P = 6.6e-216
Identities = 387/498 (77%), Positives = 445/498 (89%)
Query: 1 MDSARSWLQKLQPRDKMRGSGKKKEAGGNGSNEEST--DEEALSNVTKQKVAAAKQYIEN 58
MD+AR+WL+KL+ + K + S KK+ + GN T EEA+SNVTKQK AAAKQYIEN
Sbjct: 1 MDTARAWLKKLKSKGKEKSSNKKETSRGNVKEGSKTAGGEEAVSNVTKQKAAAAKQYIEN 60
Query: 59 HYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDF 118
HYK+Q+++ Q+R+ERR++LE KLA A+VSEE+Q NLLK LEKKETEYMR QRHKMG DDF
Sbjct: 61 HYKKQVQSQQQRKERRDMLENKLAAAEVSEEEQKNLLKDLEKKETEYMRRQRHKMGTDDF 120
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
E LTMIGKGAFGEVR+CREKTTG+VYAMKKLKKSEMLRRGQVEHV+AERNLLAEVDSNCI
Sbjct: 121 EPLTMIGKGAFGEVRICREKTTGNVYAMKKLKKSEMLRRGQVEHVKAERNLLAEVDSNCI 180
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
VKLYCSFQD+E+LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV ETVLAIESIHKH+YI
Sbjct: 181 VKLYCSFQDEEYLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVGETVLAIESIHKHNYI 240
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIKPDNLLLD+ GH++LSDFGLCKPLDCS LQE+DF + +NL+G+ Q++ RP AP+RT
Sbjct: 241 HRDIKPDNLLLDRSGHMKLSDFGLCKPLDCSILQEKDFVVAHNLSGALQSDGRPVAPRRT 300
Query: 299 --QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
Q EQLQ+WQ+NRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG+PP
Sbjct: 301 RSQMEQLQNWQRNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGFPP 360
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
FYSD+PM+TCRKIVNW+ +LKFP+E +LS EAKDLI +LLCNV QR+G KGA+EIK HPW
Sbjct: 361 FYSDEPMTTCRKIVNWKNYLKFPDEVRLSPEAKDLICRLLCNVEQRIGTKGANEIKEHPW 420
Query: 417 FDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
F GV+W ++YQM+AAFIP+VNDELDTQNFEKFEE+D Q + K+GPWRKMLSSKDINFV
Sbjct: 421 FSGVEWEKLYQMKAAFIPQVNDELDTQNFEKFEETDKQVPKTPKSGPWRKMLSSKDINFV 480
Query: 477 GYTYKNFEIVNDYQVPGM 494
GYTYKN EIVN Q+PG+
Sbjct: 481 GYTYKNVEIVNHDQLPGI 498
|
|
| TAIR|locus:2204574 AT1G30640 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1789 (634.8 bits), Expect = 2.0e-184, P = 2.0e-184
Identities = 342/499 (68%), Positives = 405/499 (81%)
Query: 2 DSARSWLQ-KLQPRDKMRGSGKKKEAGGNGSN-EESTDEEALSNVTKQKVAAAKQYIENH 59
+ RSW Q + Q DK S KK GN N +A SN TKQKVAAAKQYIENH
Sbjct: 4 EPTRSWFQIRQQKPDK--SSPTKKGQEGNVKNLGRPPMNDAPSNATKQKVAAAKQYIENH 61
Query: 60 YKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFE 119
YK Q K+LQER+ERR+ILE+ LADADV+ ED+ ++LK EKKE EYMRLQR KMG DDFE
Sbjct: 62 YKIQKKSLQERKERRSILEQNLADADVTVEDKMDILKNFEKKEMEYMRLQRQKMGVDDFE 121
Query: 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
LL++IG+GAFGEVR+C+EK+TG VYAMKKLKKSEMLRRGQVEHV+AERN+LAEVDS IV
Sbjct: 122 LLSIIGRGAFGEVRICKEKSTGSVYAMKKLKKSEMLRRGQVEHVKAERNVLAEVDSPFIV 181
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
KL SFQDDE LYLIMEYLPGGDMMTLLMRKDTL EDE RFYVA+T+LAIESIHKH+Y+H
Sbjct: 182 KLCYSFQDDEHLYLIMEYLPGGDMMTLLMRKDTLREDETRFYVAQTILAIESIHKHNYVH 241
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER----PAAP 295
RDIKPDNLL+ + GH++LSDFGL K L+ + + + + ++R P+AP
Sbjct: 242 RDIKPDNLLITRNGHIKLSDFGLSKSLESKNFPDFKAELVDRSTKPAAEHDRLSKPPSAP 301
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+RTQQEQL HWQ+NRR LA+STVGTPDYIAPEVLLKKGYGMECDWWSLGAIM+EMLVG+P
Sbjct: 302 RRTQQEQLLHWQQNRRTLAFSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMFEMLVGFP 361
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHP 415
PFYS++P++TCRKIVNW+T LKFP+EAKLSIE KDLI +LLCNV QRLG KG EIK HP
Sbjct: 362 PFYSEEPLATCRKIVNWKTCLKFPDEAKLSIEVKDLIRRLLCNVEQRLGTKGVHEIKAHP 421
Query: 416 WFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
WF GV+W R+Y+ A +IP+V ELDTQNFEKF+E + +TSSK+ PWRKM+SSKD NF
Sbjct: 422 WFRGVEWERLYESNAPYIPQVKHELDTQNFEKFDEVPSTCQTSSKSSPWRKMISSKDANF 481
Query: 476 VGYTYKNFEIVNDYQVPGM 494
+GYT+KN EIV+++ +PGM
Sbjct: 482 LGYTFKNLEIVDEHHIPGM 500
|
|
| TAIR|locus:2125894 AT4G33080 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1664 (590.8 bits), Expect = 3.4e-171, P = 3.4e-171
Identities = 323/466 (69%), Positives = 386/466 (82%)
Query: 33 EESTDEEAL-SNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQ 91
E TDEE L S++T +KVAAAKQYIENHYK Q KN+QER+ERR ILE+KLA + V +E+Q
Sbjct: 8 ENGTDEEVLGSSLTMEKVAAAKQYIENHYKAQNKNIQERKERRWILERKLASSGVPKEEQ 67
Query: 92 NNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK 151
N++K LE+KETE+MRL+R+K+ DDFELLT+IG+GAFGEVR+CRE+ +G++YAMKKLKK
Sbjct: 68 INMIKDLERKETEFMRLKRNKISVDDFELLTIIGRGAFGEVRLCRERKSGNIYAMKKLKK 127
Query: 152 SEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD 211
SEM+ RGQVEHVRAERNLLAEV+S+ IVKLY SFQD E+LYLIMEYLPGGDMMTLLMR+D
Sbjct: 128 SEMVMRGQVEHVRAERNLLAEVESHYIVKLYYSFQDPEYLYLIMEYLPGGDMMTLLMRED 187
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
TL ED ARFY+A++VLAIESIH+++YIHRDIKPDNLLLDK GH++LSDFGLCKPLDC L
Sbjct: 188 TLREDVARFYIAQSVLAIESIHRYNYIHRDIKPDNLLLDKDGHMKLSDFGLCKPLDCRNL 247
Query: 272 ---QEQDFTIGNNLNGSSQNNER--PAAPK----RTQQEQLQHWQKNRRMLAYSTVGTPD 322
QE T ++ + +R P R+ QEQLQHWQ NRR LA+STVGTPD
Sbjct: 248 PSIQENRATDDETMS-EPMDVDRCFPDTDNKRSWRSPQEQLQHWQMNRRKLAFSTVGTPD 306
Query: 323 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA 382
YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY+DDP+STCRKIV+WR HLKFPE+A
Sbjct: 307 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYADDPISTCRKIVHWRNHLKFPEDA 366
Query: 383 KLSIEAKDLISKLLCNVNQRLGAKG-ADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELD 441
K S EAKDLI +LLCNV+ RLG G A +IK HPWF V W ++Y+MEAA+ PEVNDELD
Sbjct: 367 KFSSEAKDLICRLLCNVDHRLGTGGGAQQIKDHPWFKDVVWEKLYEMEAAYKPEVNDELD 426
Query: 442 TQNFEKFEESDNQTKTSSKTGPWRKML-SSKDINFVGYTYKNFEIV 486
TQNF KF+E ++ +++G RKML + KD++FVGYTYKNF+ V
Sbjct: 427 TQNFMKFDEVNSPAPERTRSGLSRKMLLAPKDLSFVGYTYKNFDAV 472
|
|
| TAIR|locus:2047590 AT2G19400 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1600 (568.3 bits), Expect = 2.1e-164, P = 2.1e-164
Identities = 303/466 (65%), Positives = 381/466 (81%)
Query: 33 EESTDEEAL-SNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQ 91
E++ ++E L SN T +KVAAAK+YIENHY +M+++Q+R+ERR +LE+K+A DVSE++Q
Sbjct: 19 EDNFEDEGLVSNSTLEKVAAAKKYIENHYNRRMRHIQQRKERRWVLEQKIASLDVSEKEQ 78
Query: 92 NNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK 151
LL+ L++KETEY RL R+++ DDF+LL++IG+GAFGEVR+CREK TG++YAMKKLKK
Sbjct: 79 LELLEDLQRKETEYTRLMRNRLCVDDFDLLSIIGRGAFGEVRLCREKKTGNIYAMKKLKK 138
Query: 152 SEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD 211
SEML RGQVEHVRAERNLLAEV S+CIVKLY SFQD E+LYLIMEYL GGD+MTLLMR++
Sbjct: 139 SEMLSRGQVEHVRAERNLLAEVASDCIVKLYYSFQDPEYLYLIMEYLSGGDVMTLLMREE 198
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC--- 268
TLTE ARFY+A++VLAIESIHKH+Y+HRDIKPDNLLLDKYGH++LSDFGLCKPLDC
Sbjct: 199 TLTETVARFYIAQSVLAIESIHKHNYVHRDIKPDNLLLDKYGHMKLSDFGLCKPLDCRNI 258
Query: 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ-----EQLQHWQKNRRMLAYSTVGTPDY 323
S + + N+N S +E + +R ++ EQLQHWQ NRR LAYSTVGTPDY
Sbjct: 259 SAMNVNEPLNDENINESIDGDENCSIGRRGRRWKSPLEQLQHWQINRRKLAYSTVGTPDY 318
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAK 383
IAPEVLLKKGYG+ECDWWSLGAIMYEMLVGYPPFYSDDP++TCRKIV+WRTHL FPE A+
Sbjct: 319 IAPEVLLKKGYGVECDWWSLGAIMYEMLVGYPPFYSDDPVTTCRKIVSWRTHLVFPEGAR 378
Query: 384 LSIEAKDLISKLLCNVNQRLGAKGA--DEIKVHPWFDGVDWARIYQMEAAFIPEVNDELD 441
L+ EA+DLI +LLC+ RLG+ GA ++IK H WF V+W ++Y+M+AAF P VN ELD
Sbjct: 379 LTPEARDLICRLLCDSEHRLGSHGAGAEQIKAHTWFKDVEWEKLYEMDAAFKPVVNGELD 438
Query: 442 TQNFEKFEESDNQTKTSSKTGP-WRKMLSSKDINFVGYTYKNFEIV 486
TQNF KF+E + + +GP W+ ++ ++INFVGYTY+NF+ V
Sbjct: 439 TQNFMKFDEVECPKPARTGSGPSWKVSITPQNINFVGYTYRNFDAV 484
|
|
| TAIR|locus:2178208 AT5G09890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1578 (560.5 bits), Expect = 4.5e-162, P = 4.5e-162
Identities = 300/481 (62%), Positives = 368/481 (76%)
Query: 17 MRGS-GKKKEAGGNGSNEESTDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRN 75
M G+ G + G G E TD S VT+QK AAAKQ+IENHYK ++ L ER ERR
Sbjct: 1 MDGADGTVRVKPGRGFETE-TDVAVSSPVTRQKAAAAKQFIENHYKNYLQGLHERMERRR 59
Query: 76 ILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVC 135
++K+ +A + E+Q+ +++ L ++ETEYMRLQR K+G DDFELLT+IGKGAFGEVR+C
Sbjct: 60 EFQRKVQEAQLPVEEQDEMMRNLARRETEYMRLQRRKIGIDDFELLTVIGKGAFGEVRLC 119
Query: 136 REKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195
R ++T VYAMKKLKK+EML RGQVEHVR+ERNLLAEVDS IVKL+ SFQD E LYLIM
Sbjct: 120 RLRSTSEVYAMKKLKKTEMLSRGQVEHVRSERNLLAEVDSRYIVKLFYSFQDSECLYLIM 179
Query: 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255
EYLPGGD+MTLLMR+D L+ED ARFY+AE++LAI SIH+H+Y+HRDIKPDNL+LDK GHL
Sbjct: 180 EYLPGGDIMTLLMREDILSEDVARFYIAESILAIHSIHQHNYVHRDIKPDNLILDKSGHL 239
Query: 256 RLSDFGLCKPLD---CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRM 312
+LSDFGLCKPLD S L E D + + S ++ AP + +EQL W++NRR
Sbjct: 240 KLSDFGLCKPLDDKYSSLLLEDDEMLSQDSENQSGKSDADKAPWQMPKEQLLQWKRNRRA 299
Query: 313 LAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNW 372
LAYSTVGT DY+APEVLLKKGYGMECDWWSLGAI+YEMLVGYPPF SDDP TCRKI+NW
Sbjct: 300 LAYSTVGTLDYMAPEVLLKKGYGMECDWWSLGAILYEMLVGYPPFCSDDPRITCRKIINW 359
Query: 373 RTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAF 432
R LKFPEE K+S EA+DLI +LLC+V+ RLG +G +EIK HPWF G W ++Y MEAA+
Sbjct: 360 RVCLKFPEEPKISDEARDLICRLLCDVDSRLGTRGVEEIKSHPWFKGTPWDKLYDMEAAY 419
Query: 433 IPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVP 492
P V+ ELDTQNFEKF E + + + GPWRKML+SKD NF+G+T+K +I +
Sbjct: 420 RPIVDGELDTQNFEKFPEVEGSPSEAPQVGPWRKMLTSKDTNFIGFTFKKSDITRSMESS 479
Query: 493 G 493
G
Sbjct: 480 G 480
|
|
| UNIPROTKB|E1C8Z7 STK38 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1126 (401.4 bits), Expect = 3.5e-114, P = 3.5e-114
Identities = 221/445 (49%), Positives = 301/445 (67%)
Query: 40 ALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLE 99
++SN TK++V K +EN Y + +ER R+ LE+ + + + +E++
Sbjct: 11 SMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEQMMEEEGLKDEEKRIRRSAHA 70
Query: 100 KKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ 159
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + Q
Sbjct: 71 QKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQ 130
Query: 160 VEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR 219
V H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTE+E +
Sbjct: 131 VGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQ 190
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L +F
Sbjct: 191 FYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL--KKAHRTEFY-- 246
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339
NLN S ++ + + + W++NRR LA+STVGTPDYIAPEV ++ GY CD
Sbjct: 247 RNLNHSLPSDF--TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD 304
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNV 399
WWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKDLI + C
Sbjct: 305 WWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISDKAKDLILRFCCEW 364
Query: 400 NQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSS 459
R+GA G +EIK +P+F+GVDW I + AA E+ DT NF++F ESD T +
Sbjct: 365 EHRIGASGVEEIKSNPFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDILKPTVA 424
Query: 460 KTGPWRKMLSSKDINFVGYTYKNFE 484
+ +KD F+ YTYK FE
Sbjct: 425 TSNHPETDYKNKDWVFINYTYKRFE 449
|
|
| UNIPROTKB|Q15208 STK38 "Serine/threonine-protein kinase 38" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1125 (401.1 bits), Expect = 4.5e-114, P = 4.5e-114
Identities = 223/450 (49%), Positives = 302/450 (67%)
Query: 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNL 94
ST ++SN TK++V K +EN Y + +ER R+ LEK + + + +E++
Sbjct: 6 STPCSSMSNHTKERVTMTKVTLENFYSNLIAQHEEREMRQKKLEKVMEEEGLKDEEKRLR 65
Query: 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM 154
+KETE++RL+R ++G +DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++M
Sbjct: 66 RSAHARKETEFLRLKRTRLGLEDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM 125
Query: 155 LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLT 214
L + QV H+RAER++L E DS +VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLT
Sbjct: 126 LEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT 185
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274
E+E +FY+AETVLAI+SIH+ +IHRDIKPDNLLLD GH++LSDFGLC L
Sbjct: 186 EEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGL--KKAHRT 243
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334
+F NLN S ++ + + + W++NRR LA+STVGTPDYIAPEV ++ GY
Sbjct: 244 EFY--RNLNHSLPSDF--TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY 299
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISK 394
CDWWSLG IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKDLI +
Sbjct: 300 NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLTFPPEVPISEKAKDLILR 359
Query: 395 LLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQ 454
C R+GA G +EIK + +F+GVDW I + AA E+ DT NF++F ESD
Sbjct: 360 FCCEWEHRIGAPGVEEIKSNSFFEGVDWEHIRERPAAISIEIKSIDDTSNFDEFPESDIL 419
Query: 455 TKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
T + + +KD F+ YTYK FE
Sbjct: 420 KPTVATSNHPETDYKNKDWVFINYTYKRFE 449
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9Y2H1 | ST38L_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.5022 | 0.8712 | 0.9331 | yes | no |
| Q7TSE6 | ST38L_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.4889 | 0.8832 | 0.9461 | yes | no |
| Q5R8M1 | STK38_PONAB | 2, ., 7, ., 1, 1, ., 1 | 0.4889 | 0.8853 | 0.9462 | yes | no |
| Q54Y26 | NDRA_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.4594 | 0.9215 | 0.8641 | yes | no |
| Q2L6W9 | SAX1_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.4579 | 0.8913 | 0.9306 | yes | no |
| Q2LZZ7 | TRC_DROPS | 2, ., 7, ., 1, 1, ., 1 | 0.5021 | 0.9074 | 0.9847 | yes | no |
| O13310 | ORB6_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.4662 | 0.8772 | 0.9296 | yes | no |
| Q9NBK5 | TRC_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.5043 | 0.8712 | 0.9352 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 497 | |||
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 0.0 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-177 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-156 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-138 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-136 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-136 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-118 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-117 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-117 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-115 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-112 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-111 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-110 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-106 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-104 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-101 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-100 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-96 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-95 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-94 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 7e-92 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-88 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-87 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-85 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-85 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-84 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-80 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-78 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-78 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-74 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-74 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-72 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-70 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 6e-70 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 9e-70 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-69 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-68 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-68 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-67 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-66 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-65 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-59 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-59 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-59 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 5e-58 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-57 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-56 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-56 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-56 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-56 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 9e-55 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-54 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-53 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-53 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-53 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-52 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 5e-52 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-51 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-49 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 8e-49 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-47 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-46 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-46 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-45 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 5e-45 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-44 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-43 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-42 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 7e-41 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-41 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 8e-41 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-40 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-39 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-39 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-38 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-36 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-36 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-36 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-35 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-35 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-34 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 6e-34 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-33 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-32 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-32 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-30 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-30 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 9e-30 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-29 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-29 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 6e-29 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-28 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-28 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-27 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-27 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-27 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 5e-27 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-26 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-26 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-26 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-25 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-25 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-25 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-25 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 9e-25 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-24 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-24 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-24 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-24 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-24 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-23 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-23 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-23 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-22 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 6e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-21 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-21 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-21 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-21 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 8e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-20 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-20 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-20 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-20 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-19 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 6e-19 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-18 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-18 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-17 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-17 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-17 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-17 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-15 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-15 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 4e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-15 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-14 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-13 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-13 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 5e-13 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-13 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-12 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-12 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-11 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-10 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-10 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-09 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-09 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-09 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 5e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 9e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-08 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-08 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 9e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-06 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-06 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-06 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-06 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-06 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-06 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-06 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 9e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-05 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 3e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-05 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-05 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-04 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-04 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-04 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-04 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-04 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 0.001 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 0.001 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.002 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 630 bits (1626), Expect = 0.0
Identities = 223/370 (60%), Positives = 270/370 (72%), Gaps = 7/370 (1%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE + +IG+GAFGEVR+ ++K TGH+YAMKKL+KSEML + QV HVRAER++LAE D+
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VKLY SFQD+ +LYLIMEYLPGGDMMTLLM+KDT TE+E RFY+AET+LAI+SIHK
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
YIHRDIKPDNLLLD GH++LSDFGLC L S E L+ + +N
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYR----ILSHALPSNFLDFIS 176
Query: 296 K-RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
K + + + + W++NRR LAYSTVGTPDYIAPEV L+ GY ECDWWSLG IMYEMLVGY
Sbjct: 177 KPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVH 414
PPF SD+P T RKI+NW+ L+FP+E LS EAKDLI +L C +RLG G +EIK H
Sbjct: 237 PPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSH 296
Query: 415 PWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN 474
P+F GVDW I + A IPE+ DT NF+ FEE D TS GP R + SKD+
Sbjct: 297 PFFKGVDWEHIRERPAPIIPELKSITDTSNFDDFEEIDLDVPTS--PGPPRGKIKSKDLA 354
Query: 475 FVGYTYKNFE 484
F+GYTYK FE
Sbjct: 355 FIGYTYKRFE 364
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 501 bits (1292), Expect = e-177
Identities = 187/366 (51%), Positives = 253/366 (69%), Gaps = 16/366 (4%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE++ +IG+GAFGEV + R+K TG VYAMK L+KS+M++R Q+ HVRAER++LA+ DS
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IVKLY SFQD+E LYL+MEY+PGGD+M LL+RKD E+ ARFY+AE VLA++S+HK
Sbjct: 61 PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+IHRDIKPDN+L+D GH++L+DFGLCK ++ + +E N+
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY------------LNDSHNLL 168
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
R + K RR+ A STVGTPDYIAPEVL YG+ECDWWSLG I+YEML G+P
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHP 415
PFYSD T KI+NW+ L+FP + +S EA DLI +LLC+ RLG+ +EIK HP
Sbjct: 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGS--FEEIKSHP 286
Query: 416 WFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
+F G+DW + + + F+PE++ LDT NF+ FE D++ + + +K+ K + F
Sbjct: 287 FFKGIDWENLRETKPPFVPELSSPLDTSNFDDFE--DDKDLSDYLSQNSKKLNKGKQLAF 344
Query: 476 VGYTYK 481
VG+TYK
Sbjct: 345 VGFTYK 350
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 450 bits (1158), Expect = e-156
Identities = 189/377 (50%), Positives = 257/377 (68%), Gaps = 8/377 (2%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DF + +IGKGAFGEVR+ ++K TG +YAMK L KSEM ++ Q+ HV+AER++LAE DS
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V LY SFQD ++LYLIME+LPGGD+MT+L++ DT +ED RFY+AE VLAIE++HK
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCK---PLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+IHRDIKPDN+L+D+ GH++LSDFGL S ++ +N N N
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVA 180
Query: 293 AAP---KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ ++Q+ W+KNRR++AYSTVGTPDYIAPE+ L++GYG ECDWWSLGAIM+E
Sbjct: 181 VDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGAD 409
L+G+PPF S++ T RKI+NWR L FP++ LS+EA+DLI +L+ N RLG GA
Sbjct: 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAH 300
Query: 410 EIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNF--EKFEESDNQTKTSSKTGPWRKM 467
EIK HP+F GVDW I Q+ A FIP++ DT F ++ E+ ++
Sbjct: 301 EIKSHPFFRGVDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEE 360
Query: 468 LSSKDINFVGYTYKNFE 484
D+ F+GYTYK F+
Sbjct: 361 SVELDLAFIGYTYKRFD 377
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 403 bits (1037), Expect = e-138
Identities = 198/371 (53%), Positives = 256/371 (69%), Gaps = 13/371 (3%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE L +IG+GAFGEVR+ ++K TGH+YAMK L+K++ML + QV H+RAER++L E D
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK++ SFQD LYLIME+LPGGDMMTLLM+KDTL+E+ +FY+AETVLAI++IH+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE--QDFTIGNNLNGSSQNNERPA 293
+IHRDIKPDNLLLD GH++LSDFGLC L + E ++ T + S QN
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQN----- 175
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+ + + W+KNRR LAYSTVGTPDYIAPEV ++ GY CDWWSLG IMYEML+G
Sbjct: 176 ---MNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKV 413
YPPF S+ P T RK++NW+ L FP E +S +AKDLI + + R+G+ G +EIK
Sbjct: 233 YPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKS 292
Query: 414 HPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDI 473
HP+F+GVDW I + AA E+ DT NF++F ESD + P K SKD
Sbjct: 293 HPFFEGVDWGHIRERPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEPDYK---SKDW 349
Query: 474 NFVGYTYKNFE 484
F+ YTYK FE
Sbjct: 350 VFLNYTYKRFE 360
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 398 bits (1025), Expect = e-136
Identities = 173/377 (45%), Positives = 244/377 (64%), Gaps = 15/377 (3%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F + IG GAFGEV + R+ T +YAMK L+K+++L R Q HV+AER++LAE D+
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+VKLY SFQD + LY +M+Y+PGGDMM+LL+R ED ARFY+AE AIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPL----DCSTLQEQDFTIGNNLNGSSQNNERPA 293
IHRDIKPDN+L+D+ GH++L+DFGLC D Q+ D ++ S + +E +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD----HHRQDSMEPSEEWS 178
Query: 294 APKRTQQEQLQ--HWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
R + + L+ ++++R LA+S VGTP+YIAPEVLL+ GY CDWWS+G I+YEML
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEI 411
VG PPF +D P T K++NW T L P +AKLS EA DLI +L C RLG GADEI
Sbjct: 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEI 298
Query: 412 KVHPWFDGVDWAR-IYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS 470
K HP+F G+D+A I + +A +IP++ DT NF+ + ++ S ++ P R + +
Sbjct: 299 KAHPFFKGIDFASLIRRQKAPYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPN 358
Query: 471 K----DINFVGYTYKNF 483
+ F +T++ F
Sbjct: 359 NRKRTEHAFYEFTFRRF 375
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 397 bits (1020), Expect = e-136
Identities = 200/379 (52%), Positives = 258/379 (68%), Gaps = 26/379 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE L +IG+GAFGEVR+ ++K TGHVYAMK L+K++ML + QV H+RAER++L E DS
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK++ SFQD LYLIME+LPGGDMMTLLM+KDTLTE+E +FY+AETVLAI+SIH+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE----------QDFTIGNNLNGS 285
+IHRDIKPDNLLLD GH++LSDFGLC L + E DFT N
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQN----- 175
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
N++R A + W++NRR LA+STVGTPDYIAPEV ++ GY CDWWSLG
Sbjct: 176 -MNSKRKA----------ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGA 405
IMYEML+GYPPF S+ P T +K++NW+ L FP E +S +AKDLI + C R+GA
Sbjct: 225 IMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGA 284
Query: 406 KGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWR 465
G +EIK +P+F+GVDW I + AA E+ DT NF++F +SD T + +
Sbjct: 285 PGVEEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDDTSNFDEFPDSDILKPTVATSNHPE 344
Query: 466 KMLSSKDINFVGYTYKNFE 484
+KD F+ YTYK FE
Sbjct: 345 TDYKNKDWVFINYTYKRFE 363
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 348 bits (895), Expect = e-118
Identities = 134/338 (39%), Positives = 195/338 (57%), Gaps = 53/338 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE + +G G+FG V + R K +G YA+K L K+++++ QVEHV E+ +L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V LY SFQDD LYL+MEY+PGG++ + L + E ARFY A+ VLA+E +H
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSL 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+NLLLD G+++++DFG K +
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVK---------------------------- 152
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
RT Y+ GTP+Y+APE++L KGYG DWW+LG ++YEML GYP
Sbjct: 153 GRT----------------YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLG--AKGADEIK 412
PF+ D+P+ KI+ + ++FP + S +AKDLI LL ++ +RLG G ++IK
Sbjct: 197 PFFDDNPIQIYEKILEGK--VRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252
Query: 413 VHPWFDGVDWARIYQM--EAAFIPEVNDELDTQNFEKF 448
HPWF G+DW + Q EA FIP+V DT NF+ +
Sbjct: 253 NHPWFAGIDWIALLQRKIEAPFIPKVKGPGDTSNFDDY 290
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 345 bits (887), Expect = e-117
Identities = 128/295 (43%), Positives = 180/295 (61%), Gaps = 46/295 (15%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG+FG+V + R+K TG +YAMK LKK ++++R +VEH ERN+L+ ++ IVKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
+FQ +E LYL++EY PGG++ + L ++ +E+ ARFY AE VLA+E +H I+RD+K
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P+N+LLD GH++L+DFGL K L
Sbjct: 121 PENILLDADGHIKLTDFGLAKEL------------------------------------- 143
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ + GTP+Y+APEVLL KGYG DWWSLG ++YEML G PPFY++D
Sbjct: 144 ----SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199
Query: 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
KI+ L+FPE LS EA+DLIS LL + +RLG+ GA+EIK HP+F
Sbjct: 200 EIYEKILKDP--LRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 347 bits (891), Expect = e-117
Identities = 165/375 (44%), Positives = 220/375 (58%), Gaps = 55/375 (14%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE+L +IG+GAFGEV V + K TG VYAMK L K EML+R + R ER++L D
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I L+ +FQD+ LYL+M+Y GGD++TLL + +D L ED ARFY+AE VLAI+S+H+
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
Y+HRDIKPDN+LLDK GH+RL+DFG C L +G+ Q+N
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRL--------------LADGTVQSN----- 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349
VGTPDYI+PE+L K YG ECDWWSLG MYE
Sbjct: 162 ---------------------VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFP-EEAKLSIEAKDLISKLLCNVNQRLGAKGA 408
ML G PFY++ + T KI+N + H +FP + +S EAKDLI +L+C+ RLG G
Sbjct: 201 MLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGL 260
Query: 409 DEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKT---SSKTGPWR 465
+ K HP+F+G+DW I A ++PEV+ DT NF+ ++ T++ SS
Sbjct: 261 QDFKDHPFFEGIDWDNIRNSTAPYVPEVSSPTDTSNFDVDDDDLRNTESLPPSSHGAF-- 318
Query: 466 KMLSSKDINFVGYTY 480
S + FVG+TY
Sbjct: 319 ---SGNHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 342 bits (880), Expect = e-115
Identities = 157/396 (39%), Positives = 233/396 (58%), Gaps = 51/396 (12%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
N+ FL + E ++ + +M A+DF+++ +IG+GAFGEV++ R K++ VYAMK L K
Sbjct: 20 NIDNFLSRYEKAAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKF 79
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT 212
EM++R ER+++A +S IV+L+ +FQDD++LY++MEY+PGGD++ L+ D
Sbjct: 80 EMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ E ARFY AE VLA+++IH +IHRD+KPDN+LLDK GHL+L+DFG C +D + +
Sbjct: 139 IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
D + VGTPDYI+PEVL +
Sbjct: 199 RCD----------------------------------------TAVGTPDYISPEVLKSQ 218
Query: 333 G----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
G YG ECDWWS+G +YEMLVG PFY+D + T KI++ + L FP++ ++S +A
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278
Query: 389 KDLISKLLCNVNQRLGAKGADEIKVHPWF--DGVDWARIYQMEAAFIPEVNDELDTQNFE 446
KDLI L + RLG G DEIK HP+F D + I + A +PE++ ++DT NF+
Sbjct: 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWTFDNIRETVAPVVPELSSDIDTSNFD 338
Query: 447 KFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482
E+ D +T P K + + F+G+TY
Sbjct: 339 DIEDDDKNEETF----PLPKAFAGNQLPFIGFTYSK 370
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 336 bits (864), Expect = e-112
Identities = 169/381 (44%), Positives = 241/381 (63%), Gaps = 18/381 (4%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F + +G GAFGEV + + T +YAMK L+K ++L R QV HV+AER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+VKLY SFQD + LY +M+Y+PGGDMM+LL+R + E ARFY+AE LAIES+HK +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ---------N 288
IHRDIKPDN+L+D GH++L+DFGLC T + + G+++ S +
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRW-THNSKYYQKGSHIRQDSMEPSDLWDDVS 181
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
N R +T +++ ++++R LA+S VGTP+YIAPEVLL+KGY CDWWS+G I++
Sbjct: 182 NCRCGDRLKTLEQRAT--KQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGA 408
EMLVG PPF + P T K++NW L P + KLS EA DLI+KL C+ +RLG GA
Sbjct: 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299
Query: 409 DEIKVHPWFDGVDWAR-IYQMEAAFIPEVNDELDTQNFEKF-EESDNQTKTSSKTGPWRK 466
D+IK HP+F VD++ I A ++P+++ +DT NF+ EES + T W
Sbjct: 300 DDIKAHPFFSEVDFSSDIRTQPAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDT 359
Query: 467 MLSSKDIN----FVGYTYKNF 483
+ S + F +T++ F
Sbjct: 360 LCSPNGKHPEHAFYEFTFRRF 380
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 334 bits (858), Expect = e-111
Identities = 166/380 (43%), Positives = 237/380 (62%), Gaps = 15/380 (3%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F + +G GAFGEV + R+ T +YAMK L+K ++L R QV HV+AER++LAE D+
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+V+LY SFQD + LY +M+Y+PGGDMM+LL+R ED ARFY+AE A+ES+HK +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPL----DCSTLQEQDFTIGNNLNGSSQ--NNER 291
IHRDIKPDN+L+D+ GH++L+DFGLC D Q D ++++ S++ +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
R + + + ++++R LA+S VGTP+YIAPEVLL+ GY CDWWS+G I+YEML
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEI 411
VG PPF + P+ T K++NW+T L P +AKLS EA DLI KL RLG GADEI
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEI 302
Query: 412 KVHPWFDGVDWAR-IYQMEAAFIPEVNDELDTQNFEKF-------EESDNQTKTSSKTGP 463
K HP+F +D++ + Q A +IP++ DT NF+ ++ + G
Sbjct: 303 KAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNG- 361
Query: 464 WRKMLSSKDINFVGYTYKNF 483
W K + F +T++ F
Sbjct: 362 WYKNGKHPEHAFYEFTFRRF 381
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 327 bits (841), Expect = e-110
Identities = 135/300 (45%), Positives = 189/300 (63%), Gaps = 36/300 (12%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
I KGA+G V + ++K+TG +YA+K +KK++M+R+ QV+ V ER++L++ S +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
SFQ + LYL+MEYLPGGD+ +LL +L ED AR Y+AE VLA+E +H + IHRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
PDN+L+D GHL+L+DFGL K +G L N +
Sbjct: 121 PDNILIDSNGHLKLTDFGLSK-------------VG--LVRRQINLNDDEKEDKR----- 160
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
VGTPDYIAPEV+L +G+ DWWSLG I+YE LVG PPF+ + P
Sbjct: 161 -------------IVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422
+ I+N + +++PE+ ++S EA DLISKLL + +RLGAK +EIK HP+F G+DW
Sbjct: 208 EIFQNILNGK--IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 320 bits (822), Expect = e-106
Identities = 149/372 (40%), Positives = 213/372 (57%), Gaps = 50/372 (13%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DF++ +++G+G FGEV+V REK TG +YAMK +KKS +L + V ER++L+ +S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I +L +FQD + LYL+MEY PGGD+++LL R +D ED A+FY+AE VLAI S+H+
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
Y+HRDIKP+N+L+D+ GH++L+DFG L
Sbjct: 121 MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT--------------------------- 153
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWSLGAIMY 348
N+ + + VGTPDYIAPEVL K YG+ECDWWSLG I Y
Sbjct: 154 -------------ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGA 408
EM+ G PF+ T I+N++ LKFPE+ K+S + DLI LLC +RLG +G
Sbjct: 201 EMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLGYEG- 259
Query: 409 DEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML 468
+ HP+F +DW I F+P + + DT NF++ E++ + SS T
Sbjct: 260 --LCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGF 317
Query: 469 SSKDINFVGYTY 480
S KD+ FVG+++
Sbjct: 318 SGKDLPFVGFSF 329
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 315 bits (810), Expect = e-104
Identities = 141/378 (37%), Positives = 209/378 (55%), Gaps = 60/378 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DF++LT +G+G +G+V + ++K TG + A+K++KKS + + +V HV ER++L S
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
+VKL +FQDDE+LYL MEY+PGGD TLL L+ED ARFY+AE A++++H+
Sbjct: 62 WLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG 121
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
YIHRD+KP+N L+D GH++L+DFGL K +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSK---------------GIVT------------- 153
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
A S VG+PDY+APEVL KGY D+WSLG ++YE L G+PP
Sbjct: 154 ----------------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
Query: 357 FYSDDPMSTCRKIVNWRTHLKFP----EEAKLSIEAKDLISKLLCNVNQRLGAKGADEIK 412
F P T + W+ L+ P LS EA DLI+KL+ + ++R G+ ++IK
Sbjct: 198 FSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSL--EDIK 255
Query: 413 VHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQT---------KTSSKTGP 463
HP+F VDW + +++ F+PE+ E+DT F+ FE D+ K + K G
Sbjct: 256 NHPFFKEVDWNELRELKPPFVPELESEIDTGYFDDFENEDDMAKYKDVHEKKKAAGKGGA 315
Query: 464 WRKMLSSKDINFVGYTYK 481
+ FVG+T++
Sbjct: 316 NGRD-PGNRRKFVGFTFR 332
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 304 bits (781), Expect = e-101
Identities = 113/301 (37%), Positives = 167/301 (55%), Gaps = 48/301 (15%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E+L +G+G+FG+V + R+K TG + A+K +KK ++ + E + E +L ++
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI--KKDRERILREIKILKKLKHPN 58
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IV+LY F+D++ LYL+MEY GGD+ LL ++ L+EDEARFY+ + + A+E +H
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+KP+N+LLD+ GH++L+DFGL +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR--------------------------------- 145
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
Q + + VGTP+Y+APEVLL KGYG D WSLG I+YE+L G PPF
Sbjct: 146 ---------QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPF 196
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416
DD + K + P E +S EAKDLI KLL + +RL A+ E HP+
Sbjct: 197 PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAE---EALQHPF 253
Query: 417 F 417
F
Sbjct: 254 F 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 304 bits (779), Expect = e-100
Identities = 163/375 (43%), Positives = 223/375 (59%), Gaps = 55/375 (14%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE++ +IG+GAFGEV V + K T +YAMK L K EML+R + R ERN+L D
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I L+ +FQD+ +LYL+M+Y GGD++TLL + +D L ED ARFY+AE VLAI SIH+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
HY+HRDIKPDN+LLD GH+RL+DFG C ++ QD T+ +++
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN------QDGTVQSSV------------ 162
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--LKKG---YGMECDWWSLGAIMYE 349
VGTPDYI+PE+L ++ G YG ECDWWSLG MYE
Sbjct: 163 ----------------------AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGA 408
ML G PFY++ + T KI+N +FP +S EAKDLI +L+C+ +RLG G
Sbjct: 201 MLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGI 260
Query: 409 DEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTK---TSSKTGPWR 465
++ K H +F+G+DW I +EA +IP+V+ DT NF+ ++ + SS TG
Sbjct: 261 EDFKKHAFFEGIDWENIRNLEAPYIPDVSSPSDTSNFDVDDDVLRNPEIAPPSSHTG--- 317
Query: 466 KMLSSKDINFVGYTY 480
S + FVG+TY
Sbjct: 318 --FSGLHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 296 bits (759), Expect = 1e-96
Identities = 153/394 (38%), Positives = 234/394 (59%), Gaps = 51/394 (12%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
N+ FL + E ++++ +M A+D++++ +IG+GAFGEV++ R K++ VYAMK L K
Sbjct: 20 NIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKF 79
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT 212
EM++R ER+++A +S +V+L+C+FQDD++LY++MEY+PGGD++ L+ D
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ E A+FY AE VLA+++IH IHRD+KPDN+LLDK+GHL+L+DFG C +D + +
Sbjct: 139 VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
D + VGTPDYI+PEVL +
Sbjct: 199 RCD----------------------------------------TAVGTPDYISPEVLKSQ 218
Query: 333 G----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
G YG ECDWWS+G ++EMLVG PFY+D + T KI++ + L FPE+ ++S A
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHA 278
Query: 389 KDLISKLLCNVNQRLGAKGADEIKVHPWF--DGVDWARIYQMEAAFIPEVNDELDTQNFE 446
K+LI L + RLG G +EIK HP+F D +W I + A +PE++ ++D+ NF+
Sbjct: 279 KNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELSSDIDSSNFD 338
Query: 447 KFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTY 480
E+ K +T P K + F+G+TY
Sbjct: 339 DIEDD----KGDVETFPIPKAFVGNQLPFIGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 292 bits (749), Expect = 3e-95
Identities = 155/394 (39%), Positives = 227/394 (57%), Gaps = 51/394 (12%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
N+ FL + + +++ +M A+D+E++ +IG+GAFGEV++ R K+T VYAMK L K
Sbjct: 20 NIDNFLNRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKF 79
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT 212
EM++R ER+++A +S +V+L+ +FQDD +LY++MEY+PGGD++ L+ D
Sbjct: 80 EMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD- 138
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ E ARFY AE VLA+++IH +IHRD+KPDN+LLDK GHL+L+DFG C ++ +
Sbjct: 139 VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
D + VGTPDYI+PEVL +
Sbjct: 199 RCD----------------------------------------TAVGTPDYISPEVLKSQ 218
Query: 333 G----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
G YG ECDWWS+G +YEMLVG PFY+D + T KI+N + L FP++ +S EA
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 278
Query: 389 KDLISKLLCNVNQRLGAKGADEIKVHPWF--DGVDWARIYQMEAAFIPEVNDELDTQNFE 446
K+LI L + RLG G +EIK H +F D W + A +P+++ ++DT NF+
Sbjct: 279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSNFD 338
Query: 447 KFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTY 480
EE K +T P K + FVG+TY
Sbjct: 339 DIEED----KGEEETFPIPKAFVGNQLPFVGFTY 368
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 290 bits (742), Expect = 1e-94
Identities = 157/372 (42%), Positives = 218/372 (58%), Gaps = 49/372 (13%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE+L +IG+GAFGEV V + K V+AMK L K EML+R + R ER++L D+
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK 234
I L+ +FQD+ LYL+M+Y GGD++TLL + +D L ED ARFY+AE V+AI+S+H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
HY+HRDIKPDN+L+D GH+RL+DFG C L +D T+ +++
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKL------MEDGTVQSSV------------ 162
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349
VGTPDYI+PE+L K YG ECDWWSLG MYE
Sbjct: 163 ----------------------AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGA 408
ML G PFY++ + T KI+N + +FP + +S +AKDLI +L+C+ RLG G
Sbjct: 201 MLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGI 260
Query: 409 DEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML 468
++ K HP+F G+DW I EA +IPEV+ DT NF+ + D + + P
Sbjct: 261 EDFKQHPFFTGIDWDNIRNCEAPYIPEVSSPTDTSNFDV--DDDCLKNSETMPPPSHTAF 318
Query: 469 SSKDINFVGYTY 480
S + FVG+TY
Sbjct: 319 SGHHLPFVGFTY 330
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 282 bits (723), Expect = 7e-92
Identities = 125/327 (38%), Positives = 182/327 (55%), Gaps = 18/327 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
F+ + ++GKG G V + R K TG ++A+K L K EM++R +V+ V E+ +LA +D
Sbjct: 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIH 233
+ LY SFQ + +L L+M+Y PGG++ LL R+ L+E+ ARFY AE +LA+E +H
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLH 120
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
++RD+KP+N+LL + GH+ LSDF L K D + + R +
Sbjct: 121 LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSK---------ALRKGSRRS 171
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+ E R S VGT +YIAPEV+ G+G DWW+LG ++YEML G
Sbjct: 172 SVNSIPSETFSEEPSFRSN---SFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK-GADEI 411
PF + T I+ + FP +S A+DLI KLL + ++RLG+K GA EI
Sbjct: 229 TTPFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI 286
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVND 438
K HP+F GV+WA I IP +D
Sbjct: 287 KQHPFFRGVNWALIRHTTPPIIPRPDD 313
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 270 bits (692), Expect = 5e-88
Identities = 113/304 (37%), Positives = 165/304 (54%), Gaps = 49/304 (16%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G FG V + + K+ +A+K +KK ++ GQ EH+ +E+ +L E + IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
+F+D +++Y++MEY GG++ T+L + E ARFY+A VLA E +H I+RD+K
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P+NLLLD G+++L DFG K +L
Sbjct: 121 PENLLLDSNGYVKLVDFGFAK-------------------------------------KL 143
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD--D 361
+ QK ++ GTP+Y+APE++L KGY D+WSLG ++YE+L G PPF D D
Sbjct: 144 KSGQK-----TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFD 418
PM I+ L+FP + AKDLI +LL N +RLG G +IK H WF+
Sbjct: 199 PMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFN 256
Query: 419 GVDW 422
G DW
Sbjct: 257 GFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 6e-87
Identities = 121/339 (35%), Positives = 181/339 (53%), Gaps = 53/339 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DD E + +G G FG V + R++ + H YA+K + E++R Q +HV E+ +L EV
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++L+ + D FLY++MEY+PGG++ + L + FY +E V A+E +H
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSK 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLDK GH++L+DFG K L T
Sbjct: 121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT------------------------- 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
++ GTP+Y+APEV+ KG+ DWW+LG ++YEMLVGYP
Sbjct: 156 -------------------WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCN-VNQRLG--AKGADEIK 412
PF+ D+P KI+ + L+FP L AKDLI KLL +RLG GAD++K
Sbjct: 197 PFFDDNPFGIYEKILAGK--LEFPRHLDLY--AKDLIKKLLVVDRTRRLGNMKNGADDVK 252
Query: 413 VHPWFDGVDWARIYQM--EAAFIPEVNDELDTQNFEKFE 449
H WF VDW + Q + +P+V+ + DT NF+ +
Sbjct: 253 NHRWFKSVDWDDVPQRKLKPPIVPKVSHDGDTSNFDDYP 291
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 1e-85
Identities = 131/361 (36%), Positives = 193/361 (53%), Gaps = 64/361 (17%)
Query: 98 LEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR 157
K +T +L DFE+ +G G+FG VR+ + K TG YA+K LKK E+L+
Sbjct: 7 FTKPDTSSWKLS-------DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM 59
Query: 158 GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE 217
QV+HV E+++L E+ IV + CSFQD+ +Y ++E++ GG++ T L + D
Sbjct: 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDV 119
Query: 218 ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277
A+FY AE VLA E +H I+RD+KP+NLLLD GH++++DFG K +
Sbjct: 120 AKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----------- 168
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337
P RT ++ GTP+Y+APEV+ KG+G
Sbjct: 169 -----------------PDRT----------------FTLCGTPEYLAPEVIQSKGHGKA 195
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKL 395
DWW++G ++YE + GYPPF+ D P KI+ R LKFP + + A+DL+ L
Sbjct: 196 VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGR--LKFPNWFDGR----ARDLVKGL 249
Query: 396 L-CNVNQRLGA--KGADEIKVHPWFDGVDWARIYQME-AAFIP-EVNDELDTQNFEKFEE 450
L + +RLG G ++K HP+F G +W ++Y A IP V DT NFEK+ +
Sbjct: 250 LQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIPVRVKSPGDTSNFEKYPD 309
Query: 451 S 451
S
Sbjct: 310 S 310
|
Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 264 bits (677), Expect = 3e-85
Identities = 130/333 (39%), Positives = 194/333 (58%), Gaps = 30/333 (9%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE + +I GA+G V + R K T +AMKK+ K ++ R Q++ V ER++L ++
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V ++CSF+ L ++MEY+ GGD TLL L D AR Y AETVLA+E +H +
Sbjct: 61 PFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNY 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KPDNLL+ GH++L+DFGL K IG L + N
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLSK-------------IG--LMSLTTNLYEGHIE 165
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K T++ + GTP+YIAPEV+L++GYG DWW++G I+YE LVG
Sbjct: 166 KDTREFLDKQ-----------VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKV 413
PF+ D P ++++ +++PE + L +A+DLIS+LL N +RLG GA E+K
Sbjct: 215 PFFGDTPEELFGQVIS--DDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272
Query: 414 HPWFDGVDWARIYQMEAAFIPEVNDELDTQNFE 446
H +F G+DW + + +A FIP++ E DT F+
Sbjct: 273 HRFFLGLDWNGLLRQKAEFIPQLESEDDTSYFD 305
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 260 bits (667), Expect = 3e-84
Identities = 126/306 (41%), Positives = 182/306 (59%), Gaps = 51/306 (16%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER-NLLAEVDSNCIV 179
L I KGAFG V + ++++TG +A+K LKKS+M+ + QV +V+AER ++ + +S +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
KLY SFQ ++LYL+MEYL GGD +L+ L ED A+ Y+AE VL +E +H+ IH
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RDIKP+NLL+D+ GHL+L+DFGL S+N
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGL-----------------------SRNGL--------- 148
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
+N++ VGTPDY+APE +L G DWWSLG +++E L GYPPF++
Sbjct: 149 --------ENKKF-----VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHA 195
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAK--LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416
+ P + I++ R + +PEE K S EA DLI++LLC + +RLGA G EIK HP+
Sbjct: 196 ETPDAVFDNILSRR--INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPF 253
Query: 417 FDGVDW 422
F ++W
Sbjct: 254 FKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 5e-80
Identities = 116/305 (38%), Positives = 174/305 (57%), Gaps = 28/305 (9%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDF+ +IG+G+F V + +EK T YA+K L K ++++ +V++V+ E+ +L ++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 176 N-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ I+KLY +FQD+E LY ++EY P G+++ + + +L E RFY AE +LA+E +H
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHS 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRD+KP+N+LLDK H++++DFG K LD N P +
Sbjct: 121 KGIIHRDLKPENILLDKDMHIKITDFGTAKVLD--------------------PNSSPES 160
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
K +KNRR A S VGT +Y++PE+L +K G D W+LG I+Y+ML G
Sbjct: 161 NKGDATNIDSQIEKNRRRFA-SFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK-GADEIK 412
PPF + T +KI+ FP +AKDLI KLL + RLG G DE+K
Sbjct: 220 PPFRGSNEYLTFQKILK--LEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELK 275
Query: 413 VHPWF 417
HP+F
Sbjct: 276 AHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 246 bits (629), Expect = 1e-78
Identities = 106/305 (34%), Positives = 155/305 (50%), Gaps = 50/305 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ELL +G G+FG V + K TG + A+K LKK + R E +L +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IV+L +F+D + LYL+MEY GGD+ L R L+EDEA+ + + +E +H +
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRD+KP+N+LLD+ G ++++DFGL K
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--------------------------------- 146
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPP 356
+ + + + + VGTP Y+APEVLL GYG + D WSLG I+YE+L G PP
Sbjct: 147 ------KLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPP 198
Query: 357 FYSD---DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
F + D + R+I+ P+ + S EAKDLI K L + ++R A+ EI
Sbjct: 199 FSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAE---EIL 255
Query: 413 VHPWF 417
HPWF
Sbjct: 256 QHPWF 260
|
Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 246 bits (630), Expect = 5e-78
Identities = 134/371 (36%), Positives = 197/371 (53%), Gaps = 62/371 (16%)
Query: 121 LTMIGKGAFGEV---RVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVDSN 176
L ++GKG +G+V R TG ++AMK LKK+ ++R + H +AERN+L V
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IV L +FQ LYLI+EYL GG++ L R+ ED A FY++E LA+E +H+
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG 120
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
I+RD+KP+N+LLD GH++L+DFGLCK ++ E T
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCK----ESIHEGTVT------------------- 157
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
++ GT +Y+APE+L++ G+G DWWSLGA+MY+ML G PP
Sbjct: 158 ------------------HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKV 413
F +++ T KI+ + L P L+ EA+DL+ KLL N + RLGA A E++
Sbjct: 200 FTAENRKKTIDKIL--KGKLNLP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255
Query: 414 HPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFE-KFEESDNQTKTSSKTGPWRKMLSS 470
HP+F V+W + ++E F P + E D F+ KF T+ + P LS
Sbjct: 256 HPFFRHVNWDDLLARKVEPPFKPLLQSEEDVSQFDSKF------TRQTPVDSPDDSTLSE 309
Query: 471 KDIN-FVGYTY 480
F+G+TY
Sbjct: 310 SANQIFLGFTY 320
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 236 bits (604), Expect = 3e-74
Identities = 122/327 (37%), Positives = 183/327 (55%), Gaps = 48/327 (14%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IGKG+FG+V R++ T +YA+K ++K+ ++ R +V H AER +LA+V+ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
SFQ E LYL++ ++ GG++ L R+ ARFY AE + A+E++HK + I+RD+K
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P+N+LLD GH+ L DFGLCK N+ + N
Sbjct: 121 PENILLDYQGHIALCDFGLCKL---------------NMKDDDKTN-------------- 151
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ GTP+Y+APE+LL GY DWW+LG ++YEML G PPFY ++
Sbjct: 152 ------------TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN 199
Query: 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422
RKI+ + L+FP+ +AKDL+ LL + +RLG GA EIK HP+F + W
Sbjct: 200 EMYRKIL--QEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255
Query: 423 ARIY--QMEAAFIPEVNDELDTQNFEK 447
++ ++ F P V+ +DT NF++
Sbjct: 256 KKLLMKGIQPPFKPAVSSAIDTSNFDE 282
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 7e-74
Identities = 128/368 (34%), Positives = 188/368 (51%), Gaps = 55/368 (14%)
Query: 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVK 180
+IGKG+FG+V + + K G YA+K L+K +L++ + +H+ AERN LL V +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ SFQ + LY +++Y+ GG++ L R+ + E ARFY AE A+ +H + I+R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP+N+LLD GH+ L+DFGLCK E K T
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK-------------------------EGIEHSKTT-- 153
Query: 301 EQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
ST GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS
Sbjct: 154 ---------------STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA-DEIKVHPWF 417
D I+N LK +S+ A+ L+ LL + +RLGAK EIK H +F
Sbjct: 199 RDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF 254
Query: 418 DGVDWARIYQ--MEAAFIPEVNDELDTQNFEK-F--EESDNQTKTSSKTGPWRKMLSSKD 472
++W + + F P V+ +D ++F+ F E N S + + D
Sbjct: 255 SSINWDDLVNKKITPPFNPNVSGPMDLKHFDPEFTEEPVPNSVGKSPDSVLVSASVKEAD 314
Query: 473 INFVGYTY 480
F+G++Y
Sbjct: 315 DAFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 230 bits (589), Expect = 1e-72
Identities = 108/307 (35%), Positives = 161/307 (52%), Gaps = 57/307 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
FELL +IGKGAFG+V + +++ T ++AMK + K + + +G V +V ER +L E++
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+V L+ SFQD+E +YL+++ L GGD+ L +K +E++ +F++ E VLA+E +H
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIKPDN+LLD+ GH+ ++DF + A K
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNI-------------------------------ATKV 150
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
T ST GTP Y+APEVL ++GY + DWWSLG YE L G P+
Sbjct: 151 TPDTLTT-----------STSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPY 199
Query: 358 YSDDPMSTCRKIVNWRTHLK------FPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADE 410
R I + + +P S EA D I+KLL + +RLG +
Sbjct: 200 RGHS-----RTIRDQIRAKQETADVLYPATW--STEAIDAINKLLERDPQKRLGDN-LKD 251
Query: 411 IKVHPWF 417
+K HP+F
Sbjct: 252 LKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 2e-70
Identities = 123/329 (37%), Positives = 179/329 (54%), Gaps = 52/329 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQV-EHVRAERNLLA 171
+FELL ++G GA+G+V + R K GH +YAMK LKK+ ++++ + EH R ER +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVR-KVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 172 EVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
V +V L+ +FQ D L+LI++Y+ GG++ T L +++ TE E R Y+AE VLA++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALD 119
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H+ I+RDIK +N+LLD GH+ L+DFGL K ++ E
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF------------------LAEEEE 161
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLGAIMY 348
R AYS GT +Y+APEV+ G+ DWWSLG + +
Sbjct: 162 R----------------------AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTF 199
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407
E+L G PF D ++ +I K P +S EA+D I KLL + +RLGA G
Sbjct: 200 ELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 408 ADEIKVHPWFDGVDW--ARIYQMEAAFIP 434
ADEIK HP+F G+DW ++ A F P
Sbjct: 260 ADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 6e-70
Identities = 133/376 (35%), Positives = 194/376 (51%), Gaps = 65/376 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL---AEVDSNCIVK 180
IGKG FG+V R+K T +YAMK L K E++ + +V H ERN+L +S IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L SFQ D LYL+ +Y+ GG++ L ++ +ED A+FY+AE VLA+E +HK+ ++R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP+N+LLD GH+ L DFGL K NL + N
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKA---------------NLTDNKTTN----------- 154
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
+ GT +Y+APEVLL +KGY D+WSLG +++EM G+ PFY+
Sbjct: 155 ---------------TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWF 417
+D R I + ++FP+ LS E + + LL N RLGA + A E+K HP+F
Sbjct: 200 EDTQQMYRNIAFGK--VRFPKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF 256
Query: 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML------- 468
+DW + Q+ F P V+ + D NF+ E N + ++ PW +
Sbjct: 257 ADIDWDLLSKKQITPPFKPIVDSDEDVSNFDP--EFTNSSLLNAGIVPWEDVPGLPGANS 314
Query: 469 ----SSKDINFVGYTY 480
SS NF G+T+
Sbjct: 315 TPLSSSVQENFRGFTF 330
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 224 bits (574), Expect = 9e-70
Identities = 111/332 (33%), Positives = 169/332 (50%), Gaps = 51/332 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + K T +YA+K LKK +L+ VE E+ +LA + + +L
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ FQ + L+ +MEY+ GGD+M + R E ARFY AE VL ++ +H+ I+RD
Sbjct: 62 HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++++DFG+CK L G + +
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCKE--------------GILGGVTTS------------- 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTPDYIAPE+L + YG DWW+LG ++YEML G PF DD
Sbjct: 155 --------------TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFD 418
+ I+ +P LS EAK ++ L N +RLG G +IK HP+F
Sbjct: 201 EDELFQSILEDEVR--YPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR 256
Query: 419 GVDWARI--YQMEAAFIPEVNDELDTQNFEKF 448
+DW ++ +++ F P++ D NF+
Sbjct: 257 EIDWDKLERKEIKPPFKPKIKGRFDVSNFDDE 288
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 222 bits (568), Expect = 9e-69
Identities = 121/366 (33%), Positives = 177/366 (48%), Gaps = 51/366 (13%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + REK TG YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
SFQ + L +MEY GG++ L R+ +ED ARFY AE V A+ +H ++RD+
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDL 121
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
K +NL+LDK GH++++DFGLCK + + G +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK---------EGISDGATMK------------------- 153
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+ D
Sbjct: 154 -------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
Query: 363 MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD--EIKVHPWFDG 419
I+ ++FP LS EAK L++ LL + QRLG D EI H +F
Sbjct: 201 EKLFELIL--MEEIRFP--RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256
Query: 420 VDWARIYQ--MEAAFIPEVNDELDTQNF-EKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
++W + Q +E F P+V E DT+ F E+F + + + +F
Sbjct: 257 INWQDVVQKKLEPPFKPQVTSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFP 316
Query: 477 GYTYKN 482
++Y
Sbjct: 317 QFSYSA 322
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 221 bits (566), Expect = 2e-68
Identities = 109/339 (32%), Positives = 175/339 (51%), Gaps = 56/339 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN- 176
F L ++G+G FG+V + K TG +YA+K LKK +++ R +VE + E+ + +S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 177 --CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+V L+ FQ ++ + +MEY GGD+M + + D +E A FY A VL ++ +H+
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLM-MHIHTDVFSEPRAVFYAACVVLGLQYLHE 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ ++RD+K DNLLLD G ++++DFGLCK
Sbjct: 120 NKIVYRDLKLDNLLLDTEGFVKIADFGLCK------------------------------ 149
Query: 295 PKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
E + + ST GTP+++APEVL + Y DWW LG ++YEMLVG
Sbjct: 150 ------EGMGFGDRT------STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADE 410
PF DD IVN +++P LS EA ++ +LL N +RLG+ K A++
Sbjct: 198 ESPFPGDDEEEVFDSIVN--DEVRYPRF--LSREAISIMRRLLRRNPERRLGSGEKDAED 253
Query: 411 IKVHPWFDGVDWARIYQ--MEAAFIPEVNDELDTQNFEK 447
+K P+F ++W + ++ F+P + D NF++
Sbjct: 254 VKKQPFFRDINWDDLLARKIKPPFVPTIKGPEDVSNFDE 292
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 222 bits (566), Expect = 2e-68
Identities = 130/344 (37%), Positives = 197/344 (57%), Gaps = 52/344 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAE 172
+FELL ++G GA+G+V + R+ T TG +YAMK L+K+ ++++ + VEH R ERN+L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 173 V-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
V S +V L+ +FQ + L+LI++Y+ GG+M T L ++D +EDE RFY E +LA+E
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEH 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+HK ++RDIK +N+LLD GH+ L+DFGL K L E+
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF----LSEEK---------------- 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 350
+RT YS GT +Y+APE++ K G+G DWWSLG +++E+
Sbjct: 161 ----ERT----------------YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200
Query: 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KG 407
L G PF + +T ++ P + + EA+DL+ KLL + +RLGA +G
Sbjct: 201 LTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQG 260
Query: 408 ADEIKVHPWFDGVDWARI--YQMEAAFIPEVNDELDTQNF-EKF 448
A EIK HP+F G+DW + ++ F P + +ELD NF E+F
Sbjct: 261 ASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVGNFAEEF 304
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 219 bits (559), Expect = 2e-67
Identities = 130/365 (35%), Positives = 191/365 (52%), Gaps = 56/365 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + K T +A+K LKK +L VE ER +LA + + L
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+C+FQ E L+ +MEYL GGD+M + E ARFY AE + ++ +HK I+RD
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLDK GH++++DFG+CK N+NG +
Sbjct: 122 LKLDNVLLDKDGHIKIADFGMCK---------------ENMNGEGK-------------- 152
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
A + GTPDYIAPE+L + Y DWWS G ++YEML+G PF+ +D
Sbjct: 153 ------------ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420
I+N R H FP +S EAKD +SKL + +RLG G +I+ HP+F G+
Sbjct: 201 EDELFDSILNDRPH--FPR--WISKEAKDCLSKLFERDPTKRLGVDG--DIRQHPFFRGI 254
Query: 421 DWARI--YQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN-FVG 477
DW R+ ++ F P+V D NF++ E N+ S +K+L+S D F G
Sbjct: 255 DWERLEKREIPPPFKPKVKSPSDASNFDR--EFTNEKVRLSPVD--KKLLASMDQEQFRG 310
Query: 478 YTYKN 482
+++ N
Sbjct: 311 FSFTN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 215 bits (549), Expect = 6e-66
Identities = 128/351 (36%), Positives = 193/351 (54%), Gaps = 56/351 (15%)
Query: 121 LTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
L ++G+G+FG+V + R+ T G +YAMK LKK+ + R +V + ER++LAEV+
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILAEVNHPF 59
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IVKL+ +FQ + LYLI+++L GGD+ T L ++ TE++ +FY+AE LA++ +H
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
I+RD+KP+N+LLD+ GH++L+DFGL K
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSK--------------------------------- 146
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
E + H +K AYS GT +Y+APEV+ ++G+ DWWS G +M+EML G PF
Sbjct: 147 ---ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVH 414
D T I+ + L P+ LS EA+ L+ L N RLGA G +EIK H
Sbjct: 199 QGKDRKETMTMIL--KAKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254
Query: 415 PWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGP 463
P+F +DW ++Y +++ F P V DT F+ E ++T S P
Sbjct: 255 PFFSTIDWNKLYRREIKPPFKPAVGRPDDTFYFDP--EFTSRTPKDSPGIP 303
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 213 bits (543), Expect = 6e-65
Identities = 117/348 (33%), Positives = 187/348 (53%), Gaps = 54/348 (15%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHV-YAMKKLKKSEMLRRGQVEHVRAER 167
+++KM +DF + +G G+FG V + K A+K+ +KS+++++ QV+HV +ER
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+L ++ V LY SF+D+ +LYL++E++ GG+ T L R D FY A+ VL
Sbjct: 83 KILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL 142
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
E + + ++RD+KP+NLLLDK G ++++DFG K +D T
Sbjct: 143 IFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRT----------------- 185
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
Y+ GTP+YIAPE+LL G+G DWW+LG +
Sbjct: 186 ---------------------------YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFI 218
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG-- 404
YE+LVG PPFY+++P+ +KI+ + FP+ L K L+ KLL ++ +R G
Sbjct: 219 YEILVGCPPFYANEPLLIYQKILEGIIY--FPK--FLDNNCKHLMKKLLSHDLTKRYGNL 274
Query: 405 AKGADEIKVHPWFDGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEE 450
KGA +K HPWF +DW + +E + P+ + D+ NFE+ +E
Sbjct: 275 KKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYKNVFDSSNFERVQE 322
|
Length = 340 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 2e-59
Identities = 126/365 (34%), Positives = 191/365 (52%), Gaps = 54/365 (14%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKL 181
+IGKG+FG+V + + K+ G YA+K L+K +L++ + H+ AERN LL + +V L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ SFQ E LY +++Y+ GG++ L R+ E ARFY AE AI +H + I+RD
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD GH+ L+DFGLCK ++ ++ T
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETT------------------------ 153
Query: 302 QLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
ST GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS
Sbjct: 154 --------------STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199
Query: 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD--EIKVHPWF 417
D I++ L+ P ++ A DL+ LL + +RLGAK AD EIK H +F
Sbjct: 200 DVSQMYDNILH--KPLQLP--GGKTVAACDLLVGLLHKDQRRRLGAK-ADFLEIKNHVFF 254
Query: 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
++W +Y ++ + P V D ++F+ + + + +T SS F
Sbjct: 255 SPINWDDLYHKRITPPYNPNVAGPADLRHFDPEFTQEAVSSSVGQTPDLTASSSSASSAF 314
Query: 476 VGYTY 480
+G++Y
Sbjct: 315 LGFSY 319
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 198 bits (504), Expect = 3e-59
Identities = 114/374 (30%), Positives = 182/374 (48%), Gaps = 58/374 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS- 175
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY AE + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+K DN++LD GH++++DFG+CK N+ G
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCK---------------ENIFG----------G 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K T+ + GTPDYIAPE++ + YG DWW+ G ++YEML G P
Sbjct: 156 KTTR----------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGADEIK 412
PF +D + I+ ++ +P+ LS EA + LL + +RLG G +I+
Sbjct: 200 PFDGEDEDELFQSIME--HNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIR 255
Query: 413 VHPWFDGVDWARIYQME--AAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGP--WRKML 468
H +F +DW ++ + E F P+V +NF+KF T+ P +
Sbjct: 256 EHAFFRRIDWEKLERREIQPPFKPKVKGRRSAENFDKF-----FTREPPVLTPPDKLVIA 310
Query: 469 SSKDINFVGYTYKN 482
+ F G+++ N
Sbjct: 311 NIDQSEFQGFSFVN 324
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 197 bits (502), Expect = 5e-59
Identities = 114/333 (34%), Positives = 171/333 (51%), Gaps = 53/333 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKL 181
++GKG+FG+V + K T VYA+K LKK +L+ V+ E+ +LA + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+C FQ + L+ +MEY+ GGD+M + R E +RFY AE LA+ +H+H I+RD
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH +L+DFG+CK LNG
Sbjct: 122 LKLDNILLDAEGHCKLADFGMCKE--------------GILNG----------------- 150
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ + GTPDYIAPE+L + YG DWW+LG +MYEM+ G PPF +D+
Sbjct: 151 ----------VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA----DEIKVHPW 416
I++ + +P LS EA ++ + N N+RLG + D IK HP+
Sbjct: 201 EDDLFESILH--DDVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPF 256
Query: 417 FDGVDWARIYQ--MEAAFIPEVNDELDTQNFEK 447
F +DW + Q ++ F P++ + D NF++
Sbjct: 257 FKEIDWVLLEQRKIKPPFKPKIKTKRDVNNFDQ 289
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 194 bits (494), Expect = 5e-58
Identities = 119/369 (32%), Positives = 183/369 (49%), Gaps = 59/369 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181
M+GKG+FG+V + K T +A+K LKK +L VE E+ +L+ + + L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
YC+FQ E L+ +MEYL GGD+M + A FY AE + ++ +H ++RD
Sbjct: 62 YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++++DFG+CK N+ G ++
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCK---------------ENMLGDAKTC------------ 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTPDYIAPE+LL + Y DWWS G ++YEML+G PF+ D
Sbjct: 155 --------------TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420
+ I R L+ EAKD++ KL +RLG KG +I+ HP+F +
Sbjct: 201 EEELFQSI---RMDNPCYPRW-LTREAKDILVKLFVREPERRLGVKG--DIRQHPFFREI 254
Query: 421 DWARI--YQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGY 478
DW+ + ++E F P+V D NF+K E + + + S R +++S D N
Sbjct: 255 DWSALEEREIEPPFKPKVKSANDCSNFDK-EFLNEKPRLSVTD---RMLINSMDQNM--- 307
Query: 479 TYKNFEIVN 487
++NF +N
Sbjct: 308 -FENFSFIN 315
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 192 bits (489), Expect = 4e-57
Identities = 123/366 (33%), Positives = 182/366 (49%), Gaps = 53/366 (14%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKL 181
+IGKG+FG+V + + K G YA+K L+K +L R + +H+ AERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ SFQ E LY +++++ GG++ L R+ + E ARFY AE A+ +H + ++RD
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD GH+ L+DFGLCK G +Q++
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK------------------EGIAQSDT----------- 152
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
+ GTP+Y+APEV+ K+ Y DWW LGA++YEML G PPFY D
Sbjct: 153 ------------TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGA-DEIKVHPWFDG 419
I+ H S+ A ++ +LL + +RLGAK EI+ HP+F+
Sbjct: 201 VAEMYDNIL----HKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES 256
Query: 420 VDWARIYQ--MEAAFIPEVNDELDTQNFE-KFEESD--NQTKTSSKTGPWRKMLSSKDIN 474
+ W + Q + F P V D NF+ F E SS + D
Sbjct: 257 LSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDA 316
Query: 475 FVGYTY 480
FVG++Y
Sbjct: 317 FVGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-56
Identities = 115/329 (34%), Positives = 168/329 (51%), Gaps = 50/329 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + REK TG YAMK L+K ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+FQ + L +MEY GG++ L R+ TE+ ARFY AE V A+E +H ++RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
K +NL+LDK GH++++DFGLCK + + G +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK---------EGISDGATMK------------------- 153
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+ D
Sbjct: 154 -------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200
Query: 363 MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGA--KGADEIKVHPWFDG 419
I+ ++FP LS EAK L++ LL + QRLG A E+ H +F
Sbjct: 201 ERLFELIL--MEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256
Query: 420 VDWARIYQ--MEAAFIPEVNDELDTQNFE 446
++W + Q + F P+V E+DT+ F+
Sbjct: 257 INWQDVVQKKLLPPFKPQVTSEVDTRYFD 285
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 190 bits (483), Expect = 3e-56
Identities = 123/342 (35%), Positives = 176/342 (51%), Gaps = 56/342 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + REK +G YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
SFQ + L +MEY+ GG++ L R+ +ED RFY AE V A++ +H ++RD+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 243 KPDNLLLDKYGHLRLSDFGLCKP--LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
K +NL+LDK GH++++DFGLCK D +T++
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMK---------------------------- 153
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+
Sbjct: 154 ---------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198
Query: 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWF 417
D I+ +KFP LS +AK L+S LL + N+RLG A EI H +F
Sbjct: 199 DHEKLFELIL--MEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
Query: 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKT 457
GV+W +Y ++ F P+V E DT+ F+ EE QT T
Sbjct: 255 TGVNWQDVYDKKLVPPFKPQVTSETDTRYFD--EEFTAQTIT 294
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 189 bits (481), Expect = 5e-56
Identities = 107/331 (32%), Positives = 167/331 (50%), Gaps = 52/331 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + R K +G +YA+K LKK +L+ VE E+ +L+ ++ + +L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
YC FQ + L+ +ME++ GGD+M + + E ARFY AE A+ +H I+RD
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH +L+DFG+CK + F
Sbjct: 122 LKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF------------------------- 156
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
GTPDYIAPE+L + YG DWW++G ++YEML G+ PF +++
Sbjct: 157 ----------------CGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWF 417
I+N + +P LS +A D++ + N RLG+ G + I HP+F
Sbjct: 201 EDDLFEAILN--DEVVYP--TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFF 256
Query: 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFE 446
+DW ++ Q+E F P + D NF+
Sbjct: 257 KELDWEKLNRRQIEPPFRPRIKSREDVSNFD 287
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 7e-56
Identities = 88/299 (29%), Positives = 139/299 (46%), Gaps = 49/299 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++G+G+FG V + +K TG + A+K ++ S ++E + E +L+ + IV+ Y
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEE-ELEALEREIRILSSLQHPNIVRYY 65
Query: 183 CSFQDDE--FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
S +D+E L + +EY+ GG + +LL + L E R Y + + + +H + +HR
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHR 125
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+L+D G ++L+DFG K L E
Sbjct: 126 DIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT------------------------- 160
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY-S 359
S GTP ++APEV+ + YG D WSLG + EM G PP+
Sbjct: 161 --------------GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+PM+ KI + + PE LS EAKD + K L + +R ADE+ HP+
Sbjct: 207 GNPMAALYKIGSSGEPPEIPEH--LSEEAKDFLRKCLRRDPKKRP---TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 186 bits (473), Expect = 9e-55
Identities = 122/367 (33%), Positives = 184/367 (50%), Gaps = 56/367 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG FG+V + +EK TG YAMK LKK ++ + +V H E +L + L
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRD 241
SFQ + L +MEY GG++ L R+ +ED ARFY AE V A++ +H + + ++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKP--LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
+K +NL+LDK GH++++DFGLCK D +T++
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMK--------------------------- 154
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
+ GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+
Sbjct: 155 ----------------TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 198
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRL--GAKGADEIKVHPW 416
D I+ ++FP LS EAK L+S LL + QRL G A EI H +
Sbjct: 199 QDHEKLFELIL--MEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKF 254
Query: 417 FDGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDI 473
F G+ W +Y+ + F P+V E DT+ F++ + T T + + + +
Sbjct: 255 FAGIVWQDVYEKKLVPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMETVDNERRP 314
Query: 474 NFVGYTY 480
+F ++Y
Sbjct: 315 HFPQFSY 321
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 181 bits (461), Expect = 8e-54
Identities = 90/304 (29%), Positives = 130/304 (42%), Gaps = 55/304 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
FE+L IGKG FGEV R K TG A+K +K ++ E + E +L +
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK---EKIINEIQILKKCKHP 57
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
IVK Y S+ + L+++ME+ GG D++ + TLTE + + E + +E +H
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ--TLTESQIAYVCKELLKGLEYLH 115
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ IHRDIK N+LL G ++L DFGL
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSA----------------------------- 146
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
Q + + VGTP ++APEV+ K Y + D WSLG E+ G
Sbjct: 147 -------------QLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEG 193
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
PP+ PM KI K S E KD + K L N +R A+ ++
Sbjct: 194 KPPYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAE---QLL 249
Query: 413 VHPW 416
HP+
Sbjct: 250 KHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 2e-53
Identities = 80/284 (28%), Positives = 133/284 (46%), Gaps = 49/284 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+E++ IGKG+FG+V + R K+ G +Y +K++ S M + E E +L +++
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIESI 232
I+K Y SF++ L ++MEY GGD+ + E++ + + LA++ +
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRDIKP N+ L G ++L DFG+ K L ST+
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVD-------------------- 158
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
LA + VGTP Y++PE+ K Y + D WSLG ++YE+
Sbjct: 159 --------------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
PF ++ + KI+ + P + S E ++L+S LL
Sbjct: 199 LKHPFEGENLLELALKILK-GQYPPIPS--QYSSELRNLVSSLL 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 182 bits (463), Expect = 2e-53
Identities = 119/367 (32%), Positives = 184/367 (50%), Gaps = 55/367 (14%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKL 181
+IGKG+FG+V + R K YA+K L+K +L++ + +H+ +ERN LL V +V L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ SFQ + LY +++Y+ GG++ L R+ E ARFY AE A+ +H + ++RD
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD GH+ L+DFGLCK N T
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCK-----------------------ENIEHNGTTST--- 155
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
GTP+Y+APEVL K+ Y DWW LGA++YEML G PPFYS +
Sbjct: 156 ---------------FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA-DEIKVHPWFDG 419
I+N LK ++ A+ L+ LL + +RLGAK EIK H +F
Sbjct: 201 TAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256
Query: 420 VDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN--- 474
++W + ++ F P V+ D ++F+ E ++ S P ++++
Sbjct: 257 INWDDLINKKITPPFNPNVSGPNDLRHFDP-EFTEEPVPNSIGQSPDSILVTASVKEAAE 315
Query: 475 -FVGYTY 480
F+G++Y
Sbjct: 316 AFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 180 bits (457), Expect = 6e-53
Identities = 111/318 (34%), Positives = 173/318 (54%), Gaps = 54/318 (16%)
Query: 117 DFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQV-EHVRAERNLLAE 172
+FELL ++G GA+G+V + R+ + +G +YAMK LKK+ ++++ + EH R ER +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 173 V-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
+ S +V L+ +FQ D L+LI++Y+ GG++ T L +++ E E + Y E VLA+E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEH 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+HK I+RDIK +N+LLD GH+ L+DFGL K ER
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF------------------HEDEVER 162
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--KKGYGMECDWWSLGAIMYE 349
AYS GT +Y+AP+++ G+ DWWS+G +MYE
Sbjct: 163 ----------------------AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200
Query: 350 MLVGYPPFYSDDPMSTCRKIVN--WRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA- 405
+L G PF D ++ +I ++ +P+E +S AKD+I +LL + +RLG
Sbjct: 201 LLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MSALAKDIIQRLLMKDPKKRLGCG 258
Query: 406 -KGADEIKVHPWFDGVDW 422
ADEIK HP+F ++W
Sbjct: 259 PSDADEIKKHPFFQKINW 276
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (446), Expect = 4e-52
Identities = 79/230 (34%), Positives = 117/230 (50%), Gaps = 46/230 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G+G FG V + R+K TG A+K +KK + +E + E +L +++ IVKLY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSL--LEELLREIEILKKLNHPNIVKLYG 58
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
F+D+ LYL+MEY GG + LL + L+EDE + + + +E +H + IHRD+
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 243 KPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
KP+N+LLD G ++L+DFGL K L
Sbjct: 119 KPENILLDSDNGKVKLADFGLSKLLT---------------------------------- 144
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 350
+ + L + VGTP Y+APEVLL K Y + D WSLG I+YE+
Sbjct: 145 -------SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 5e-52
Identities = 108/329 (32%), Positives = 166/329 (50%), Gaps = 51/329 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
++GKG+FG+V + K G +A+K LKK +L VE E+ +LA N + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
YC+FQ E L+ +ME+L GGD+M + K A FY AE V ++ +H I+RD
Sbjct: 62 YCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN++LD+ GH++++DFG+CK N+ G ++
Sbjct: 122 LKLDNVMLDRDGHIKIADFGMCK---------------ENVFGDNR-------------- 152
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
A + GTPDYIAPE+L Y DWWS G ++YEML+G PF+ DD
Sbjct: 153 ------------ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGV 420
I H +P ++ E+KD++ KL + +RLG G I+ HP+F +
Sbjct: 201 EDELFESIRVDTPH--YPRW--ITKESKDILEKLFERDPTRRLGVVG--NIRGHPFFKTI 254
Query: 421 DWARI--YQMEAAFIPEVNDELDTQNFEK 447
+W + +++ F P+V D NF++
Sbjct: 255 NWTALEKRELDPPFKPKVKSPSDYSNFDR 283
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 1e-51
Identities = 103/322 (31%), Positives = 158/322 (49%), Gaps = 55/322 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG FGEV C+ K TG +YA KKL K + +R + E+ +L +V S IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRD 241
+F+ + L L+M + GGD+ + E A FY A+ + +E +H+ ++RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD +G++R+SD GL + G + G
Sbjct: 121 LKPENVLLDDHGNVRISDLGLA----------VELKGGKKIKGR---------------- 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
GTP Y+APEVL + Y DW++LG +YEM+ G PF
Sbjct: 155 ----------------AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF-RQR 197
Query: 362 PMSTCRKIVNWRT---HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG--ADEIKVHP 415
++ + RT +++P+ K S EAKDL LL + +RLG +G ADE++ HP
Sbjct: 198 KEKVEKEELKRRTLEMAVEYPD--KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHP 255
Query: 416 WFDGVDWARIY--QMEAAFIPE 435
F ++W R+ +E FIP+
Sbjct: 256 LFKDLNWRRLEAGMLEPPFIPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 103/341 (30%), Positives = 170/341 (49%), Gaps = 59/341 (17%)
Query: 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVK 180
+IG+G++ +V + K T +YAMK +KK + ++ V+ E+++ ++ +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ FQ + L+ ++E++ GGD+M + R+ L E+ ARFY AE LA+ +H+ I+R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+K DN+LLD GH++L+D+G+CK ++ D T
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK----EGIRPGDTT----------------------- 153
Query: 301 EQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF-- 357
ST GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF
Sbjct: 154 ---------------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
Query: 358 --YSDDPMSTCRKI---VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GA 408
SD+P V ++ P LS++A ++ L + +RLG G
Sbjct: 199 VGMSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGF 256
Query: 409 DEIKVHPWFDGVDWARIYQMEAA--FIPEVNDELDTQNFEK 447
+IK HP+F +DW + Q + + P + + D NF+
Sbjct: 257 RDIKSHPFFRNIDWDLLEQKQVLPPYKPNIESDRDLDNFDP 297
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 8e-49
Identities = 105/338 (31%), Positives = 176/338 (52%), Gaps = 52/338 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA D
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 177 -CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ +L+ FQ + LY +MEY+ GGD+M + + E +A FY AE + + +H+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+K DN++LD GH++++DFG+CK + ++G
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--------------HMVDG----------- 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ + GTPDYIAPE++ + YG DWW+ G ++YEML G P
Sbjct: 156 ----------------VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNV-NQRLGA--KGADEIK 412
PF +D + I+ ++ +P+ LS EA + L+ ++RLG +G +I+
Sbjct: 200 PFDGEDEDELFQSIM--EHNVSYPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIR 255
Query: 413 VHPWFDGVDWARI--YQMEAAFIPEVNDELDTQNFEKF 448
H +F +DW ++ +++ F P+V + +NF+KF
Sbjct: 256 EHAFFRRIDWDKLENREIQPPFKPKVCGK-GAENFDKF 292
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 4e-47
Identities = 104/336 (30%), Positives = 173/336 (51%), Gaps = 55/336 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
+IG+G++ +V + R K +YAMK +KK + ++ V+ E+++ + SN +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ FQ L+L++EY+ GGD+M + R+ L E+ ARFY AE +A+ +H+ I+RD
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++L+D+G+CK P T
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCK-----------------------EGLGPGDTTST--- 155
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF--YS 359
GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF +
Sbjct: 156 ---------------FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200
Query: 360 DDP-MSTCRKI--VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GADEIK 412
D+P M+T + V ++ P LS++A ++ L + +RLG + G +IK
Sbjct: 201 DNPDMNTEDYLFQVILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIK 258
Query: 413 VHPWFDGVDWARIYQMEAA--FIPEVNDELDTQNFE 446
H +F +DW + + + F P++ D+ +NF+
Sbjct: 259 SHTFFRSIDWDLLEKKQVTPPFKPQITDDYGLENFD 294
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 6e-47
Identities = 103/338 (30%), Positives = 170/338 (50%), Gaps = 52/338 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDS 175
DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+ +LA
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ +L+ FQ + LY +MEY+ GGD+M + + E A FY AE + + +H
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+K DN++LD GH++++DFG+CK N +G +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKE--------------NMWDGVTTK------- 159
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ GTPDYIAPE++ + YG DWW+ G ++YEML G
Sbjct: 160 --------------------TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIK 412
PF +D + I+ ++ +P+ +S EA + L+ + +RLG +G +IK
Sbjct: 200 PFEGEDEDELFQSIM--EHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIK 255
Query: 413 VHPWFDGVDWARI--YQMEAAFIPEVNDELDTQNFEKF 448
H +F +DW ++ +++ + P+ D +NF+KF
Sbjct: 256 EHAFFRYIDWEKLERKEVQPPYKPKACGR-DAENFDKF 292
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 2e-46
Identities = 85/302 (28%), Positives = 136/302 (45%), Gaps = 49/302 (16%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+++L +IG+GAFG V TG A+K++ + ++ ++ + E +LL +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEK-IKEEALKSIMQEIDLLKNLKHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IVK S + + LY+I+EY G + ++ + E YV + + + +H+
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRDIK N+L K G ++L+DFG+ LN S+++
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA----------------TKLNDVSKDDA------ 157
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
S VGTP ++APEV+ G D WSLG + E+L G PP
Sbjct: 158 -------------------SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415
+Y +PM+ +IV H PE S E KD + + + N R AK ++ HP
Sbjct: 199 YYDLNPMAALFRIVQ-DDHPPLPEGI--SPELKDFLMQCFQKDPNLRPTAK---QLLKHP 252
Query: 416 WF 417
W
Sbjct: 253 WI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 4e-46
Identities = 86/302 (28%), Positives = 136/302 (45%), Gaps = 51/302 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
++ L IG+GA GEV ++ TG A+KK++ LR+ E + E ++ +
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMKDCKHPN 76
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHH 236
IV Y S+ + L+++MEY+ GG + ++ + + E + + E + +E +H +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN 136
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRDIK DN+LL K G ++L+DFG L K
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLT------------------------KEKSK 172
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
R S VGTP ++APEV+ +K YG + D WSLG + EM G PP
Sbjct: 173 RN-----------------SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415
+ + P+ I K S E KD ++K L + +R A+E+ HP
Sbjct: 216 YLREPPLRALFLITTKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKR---PSAEELLQHP 271
Query: 416 WF 417
+
Sbjct: 272 FL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 164 bits (414), Expect = 7e-46
Identities = 103/328 (31%), Positives = 148/328 (45%), Gaps = 58/328 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS- 175
+ +L +G+G+FGEV + R++ + A+K L K + +VE E +LA ++
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESI 232
IVKLY FQD+ LYL+MEY+ GG + LL RK L+E EA F +A+ + A+E +
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 233 HKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
H IHRDIKP+N+LLD+ G ++L DFGL K L
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSI---------------- 161
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMY 348
L ++VGTP Y+APEVLL D WSLG +Y
Sbjct: 162 -------------------PALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLY 202
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE---------EAKLSIEAKDLISKLL-CN 398
E+L G PPF + S + + L P +S A DL+ KLL +
Sbjct: 203 ELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKD 262
Query: 399 VNQRLGAKGA--DEIKVHPWFDGVDWAR 424
RL + ++ H D +
Sbjct: 263 PKNRLSSSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-45
Identities = 105/338 (31%), Positives = 171/338 (50%), Gaps = 57/338 (16%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKL 181
+IG+G++ +V + R K T +YAMK +KK + ++ V+ E+++ + ++ +V L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ FQ + L+ ++EY+ GGD+M + R+ L E+ ARFY AE LA+ +H+ I+RD
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+K DN+LLD GH++L+D+G+CK L+ D T
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCK----EGLRPGDTT------------------------ 153
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF---- 357
+ GTP+YIAPE+L + YG DWW+LG +M+EM+ G PF
Sbjct: 154 -------------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
Query: 358 YSDDPMSTCRKI---VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADE 410
SD+P V ++ P LS++A ++ L + +RLG G +
Sbjct: 201 SSDNPDQNTEDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFAD 258
Query: 411 IKVHPWFDGVDWARIYQMEAA--FIPEVNDELDTQNFE 446
I+ HP+F VDW + Q + F P ++ E NF+
Sbjct: 259 IQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNFD 296
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (403), Expect = 5e-45
Identities = 98/328 (29%), Positives = 154/328 (46%), Gaps = 62/328 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M E+ A FY AE +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLD YGH+R+SD GL + E
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEI--------------------PEGET---- 157
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ R VGT Y+APEV+ + Y DWW LG ++YEM+ G
Sbjct: 158 -----------IRGR-------VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199
Query: 356 PFYSDDPMSTCRKIVNW----RTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAK-- 406
PF ++ V R + EE K S A+ + +LL + RLG +
Sbjct: 200 PFRQR------KEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGE 253
Query: 407 GADEIKVHPWFDGVDWARIYQMEAAFIP 434
GA+E+K HP+F ++ R +EA +
Sbjct: 254 GAEEVKAHPFFRTANFKR---LEAGMLE 278
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 156 bits (395), Expect = 4e-44
Identities = 103/315 (32%), Positives = 160/315 (50%), Gaps = 57/315 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NC--IV 179
+IG+G FGEV CR+ TG +YAMK L K + + ER +L+ V + +C IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
+ +F + L I++ + GGD+ L + +E E RFY AE +L +E +H ++
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+KP N+LLD++GH+R+SD GL C DF+ ++P A
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLA----C------DFS-----------KKKPHA----- 154
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPF- 357
+VGT Y+APEVL K Y DW+SLG +++++L G+ PF
Sbjct: 155 -----------------SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
Query: 358 --YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGADEIK 412
+ D R + ++ P+ S E + L+ LL +VN+RLG +GA E+K
Sbjct: 198 QHKTKDKHEIDRMTLT--MAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVK 253
Query: 413 VHPWFDGVDWARIYQ 427
HP+F +DW ++
Sbjct: 254 EHPFFRSLDWQMVFL 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 1e-43
Identities = 91/290 (31%), Positives = 137/290 (47%), Gaps = 50/290 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DFE+L IGKG+FG V K VYAMK++ S+M RR + E + E +LA++DS+
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAID-EARVLAKLDSS 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEA-RFYVAETVLAIESIH 233
I++ Y SF D L ++MEY GD+ LL R L ED+ RF++ + +L + +H
Sbjct: 60 YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLH 118
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+HRDIK NL LD Y ++++ D G+ K L +T
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN---------------------- 156
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
A + VGTP Y++PE+ K Y + D W+LG ++YE G
Sbjct: 157 -------------------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTG 197
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
PF +++ + KI+ P S + LI + L + QR
Sbjct: 198 KHPFDANNQGALILKIIRGVFP---PVSQMYSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-42
Identities = 94/320 (29%), Positives = 149/320 (46%), Gaps = 55/320 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG FGEV C+ + TG +YA KKL K + +R E E+ +LA+V S IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDT----LTEDEARFYVAETVLAIESIHKHHYIH 239
+FQ L L+M + GGD+ + D E A FY A+ + +E +H+ I+
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+KP+N+LLD G++R+SD GL L Q+ + A
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELK-----------------DGQSKTKGYA----- 158
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
GTP ++APE+L + Y D+++LG +YEM+ PF +
Sbjct: 159 -------------------GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199
Query: 360 DDPMSTCRKIVNWRTH--LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA--DEIKVH 414
+++ + + +P+ K S +K LL + +RLG + D ++ H
Sbjct: 200 RGEKVENKELKQRILNDSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257
Query: 415 PWFDGVDWARIYQMEAAFIP 434
P F ++W Q+EA +P
Sbjct: 258 PLFRDLNWR---QLEAGMLP 274
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 7e-41
Identities = 89/307 (28%), Positives = 139/307 (45%), Gaps = 58/307 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ F++L +G+G++G V K TG V A+K + + ++ + E ++L + DS
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV---PV--EEDLQEIIKEISILKQCDS 57
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
IVK Y S+ + L+++MEY G D+M + TLTE+E + +T+ +E +
Sbjct: 58 PYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKTLTEEEIAAILYQTLKGLEYL 115
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H + IHRDIK N+LL++ G +L+DFG+
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGV------------------------------ 145
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
QL R + +GTP ++APEV+ + GY + D WSLG EM
Sbjct: 146 -------SGQLTDTMAKRN----TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAE 194
Query: 353 GYPPFYSDDPMSTCRKIVNWRTH-LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410
G PP+ PM I N L PE K S E D + K L + +R A +
Sbjct: 195 GKPPYSDIHPMRAIFMIPNKPPPTLSDPE--KWSPEFNDFVKKCLVKDPEERPSAI---Q 249
Query: 411 IKVHPWF 417
+ HP+
Sbjct: 250 LLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 8e-41
Identities = 98/325 (30%), Positives = 160/325 (49%), Gaps = 49/325 (15%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA K+L+K + +R E+ +L +V+S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M E+ A FY AE + +E +H+
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+ ++RD+KP+N+LLD YGH+R+SD GL A
Sbjct: 122 NTVYRDLKPENILLDDYGHIRISDLGL-------------------------------AV 150
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K + E ++ VGT Y+APEVL + Y + D+W LG ++YEM+ G
Sbjct: 151 KIPEGESIR-----------GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIK 412
PF ++ + AK S EAK + LL + QRLG + GA E+K
Sbjct: 200 PFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVK 259
Query: 413 VHPWFDGVDWARIYQ--MEAAFIPE 435
HP+F +++ R+ ++ F+P+
Sbjct: 260 RHPFFRNMNFKRLEAGMLDPPFVPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 8e-41
Identities = 103/315 (32%), Positives = 167/315 (53%), Gaps = 59/315 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRRGQVEHVRAERNLLAEVDS-NC--I 178
+IG+G FGEV CR+ TG +YAMK L K + +++G+ + ER +L+ V + +C I
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN-ERIMLSLVSTGDCPFI 59
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
V + +F + L I++ + GGD+ L + +E E RFY E +L +E +H +
Sbjct: 60 VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
+RD+KP N+LLD++GH+R+SD GL C DF+ ++P
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLA----C------DFS-----------KKKP------ 152
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPF 357
+++VGT Y+APEVL K Y DW+SLG +++++L G+ PF
Sbjct: 153 ----------------HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
Query: 358 Y---SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGADEI 411
+ D R + +++ P+ S E K L+ LL +V++RLG +GA E+
Sbjct: 197 RQHKTKDKHEIDRMTLT--VNVELPD--SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEV 252
Query: 412 KVHPWFDGVDWARIY 426
K H +F G+DW ++Y
Sbjct: 253 KEHVFFKGIDWQQVY 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 155 bits (392), Expect = 1e-40
Identities = 65/149 (43%), Positives = 99/149 (66%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++F ++ I +GAFG+V + R+K +YA+K +KK++M+ + V V+AER+ LA S
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV LY S Q +YL+MEYL GGD+ +LL E+ A Y++E LA++ +H+H
Sbjct: 64 PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
IHRD+KPDN+L+ GH++L+DFGL K
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 98/325 (30%), Positives = 157/325 (48%), Gaps = 49/325 (15%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M + E A FY AE +E +H+
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLD +GH+R+SD GL + + TI
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHV------PEGQTI----------------- 158
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K R VGT Y+APEV+ + Y DWW+LG ++YEM+ G
Sbjct: 159 ------------KGR-------VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG--ADEIK 412
PF ++ ++ K S +A+ L LLC + +RLG +G A E+K
Sbjct: 200 PFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVK 259
Query: 413 VHPWFDGVDWARIYQ--MEAAFIPE 435
HP F +++ R+ +E F P+
Sbjct: 260 EHPLFKQINFKRLEAGMLEPPFKPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 3e-39
Identities = 79/307 (25%), Positives = 130/307 (42%), Gaps = 55/307 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVD 174
D E + ++G+G+ G V R K TG +YA+KK+ + R Q+ E L +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL---LRELKTLRSCE 57
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH- 233
S +VK Y +F + + +++EY+ GG + LL + + E + + + ++ +H
Sbjct: 58 SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
K H IHRDIKP NLL++ G ++++DFG+ K L+ + Q F
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF----------------- 160
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
VGT Y++PE + + Y D WSLG + E +G
Sbjct: 161 ------------------------VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALG 196
Query: 354 YPPFYSD---DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
PF + I + + S E +D IS L + +R A
Sbjct: 197 KFPFLPPGQPSFFELMQAICD--GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAA--- 251
Query: 410 EIKVHPW 416
E+ HP+
Sbjct: 252 ELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 4e-39
Identities = 98/326 (30%), Positives = 152/326 (46%), Gaps = 51/326 (15%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F ++GKG FGEV C+ + TG +YA KKL+K + +R E+ +L +V+S
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
+V L +++ + L L++ + GGD+ + M E A FY AE +E + +
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
++RD+KP+N+LLD GH+R+SD GL
Sbjct: 122 RIVYRDLKPENILLDDRGHIRISDLGLAV------------------------------- 150
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
Q+ + R VGT Y+APEV+ + Y DWW LG ++YEM+ G
Sbjct: 151 ------QIPEGETVR-----GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEA-KLSIEAKDLISKLLC-NVNQRLGAK--GADEI 411
PF R+ V+ R E + K S +AK + LL N +RLG + GA +
Sbjct: 200 PFRKRKE-RVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV 258
Query: 412 KVHPWFDGVDWARIYQ--MEAAFIPE 435
K HP F +++ R+ +E F P+
Sbjct: 259 KQHPIFKNINFKRLEANMLEPPFCPD 284
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 98/308 (31%), Positives = 138/308 (44%), Gaps = 62/308 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK--LKKSEMLRRGQVEHVRAERNLLAEV 173
+ F LL IGKG+FGEV +K T V A+K L+++E ++E ++ E L++
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAE----DEIEDIQQEIQFLSQC 56
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
S I K Y SF L++IMEY GG + LL + L E F + E +L +E +H
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAFILREVLLGLEYLH 115
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ IHRDIK N+LL + G ++L+DFG+ S
Sbjct: 116 EEGKIHRDIKAANILLSEEGDVKLADFGV------SG----------------------- 146
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
QL R + VGTP ++APEV+ + GY + D WSLG E+ G
Sbjct: 147 --------QLTSTMSKRN----TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKG 194
Query: 354 YPPFYSD-DPMSTCRKIVNWRTHLKFP---EEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408
PP SD PM I P E K S KD +S L + +R AK
Sbjct: 195 EPP-LSDLHPMRVLFLIPK-----NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAK-- 246
Query: 409 DEIKVHPW 416
E+ H +
Sbjct: 247 -ELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-38
Identities = 85/298 (28%), Positives = 137/298 (45%), Gaps = 46/298 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++G+GAFG V +C + TG A+K++ + +V + E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
Y +DDE L + MEY+PGG + L LTE R Y + + +E +H + +HR
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+L D G+++L DFG K L TI ++ G
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQ---------TICSSGTGMK-------------- 165
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
S GTP +++PEV+ +GYG + D WS+G + EML PP+
Sbjct: 166 ---------------SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF 210
Query: 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+ M+ KI T+ + P +S +A++ + + N +R A+E+ H +
Sbjct: 211 EAMAAIFKIATQPTNPQLPSH--VSPDARNFLRRTFVENAKKR---PSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 84/298 (28%), Positives = 136/298 (45%), Gaps = 53/298 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++G G+FG V G +A+K L + V+ + E LL+++ IV+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
+ ++++ LY+ +E +PGG + LL + + E R Y + +L +E +H + +HR
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+L+D G ++L+DFG+ K + E F
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAK-----QVVEFSF------------------------ 157
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGYPPFYS 359
A S G+P ++APEV+ ++G YG+ D WSLG + EM G PP+
Sbjct: 158 -------------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQ 204
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAK--GADEIKVHP 415
+ ++ KI + P+ LS EAKD I K L QR + A E+ HP
Sbjct: 205 LEGVAAVFKIGRSKELPPIPDH--LSDEAKDFILKCL----QRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 3e-36
Identities = 94/330 (28%), Positives = 142/330 (43%), Gaps = 78/330 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-QVEHVRAERNLLAEVDSN 176
+E L +G+G +G V R+K TG + A+KK++ + G +R E +LL E+
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRL-DNEEEGIPSTALR-EISLLKELKHP 58
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKH 235
IVKL + LYL+ EY D+ L R L+ + + + + + + H H
Sbjct: 59 NIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH 117
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KP N+L+++ G L+L+DFGL + F I P
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARA----------FGI----------------P 151
Query: 296 KRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353
RT Y+ V T Y APE+LL K Y D WS+G I EM+ G
Sbjct: 152 LRT----------------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITG 195
Query: 354 YPPFYSDDPMSTCRKI------------------VNWRTHL-KFPEEAKLSI------EA 388
P F D + KI +++ KFP + + E
Sbjct: 196 KPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEG 255
Query: 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
DL+SK+L N +R+ AK A + HP+F
Sbjct: 256 IDLLSKMLQYNPAKRISAKEALK---HPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 8e-36
Identities = 72/253 (28%), Positives = 116/253 (45%), Gaps = 53/253 (20%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
D+E+L IGKG+FG VR R K+ G + K++ M + + + + +E N+L E+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHP 59
Query: 177 CIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIE 230
IV+ Y D ++ LY++MEY GGD+ L+ + + + E+ + + +LA+
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 231 SIH-----KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
H + +HRD+KP N+ LD +++L DFGL K L
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG------------------ 161
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
+ A + VGTP Y++PE L Y + D WSLG
Sbjct: 162 -----------------------HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198
Query: 346 IMYEMLVGYPPFY 358
++YE+ PPF
Sbjct: 199 LIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 84/337 (24%), Positives = 125/337 (37%), Gaps = 88/337 (26%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRA-ERNLLAEV 173
+++L IG+GA G V +++ TG A+KK+ LRR G + + E L
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKV----ALRRLEGGIPNQALREIKALQAC 56
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
+VKL F L+MEY+P L + L E + + Y+ + + +H
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMH 116
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +HRD+KP NLL+ G L+++DFGL + E P
Sbjct: 117 ANGIMHRDLKPANLLISADGVLKIADFGLARLFS---------------------EEEPR 155
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLV 352
V T Y APE+L + Y D W++G I E+L
Sbjct: 156 LY-------------------SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLN 196
Query: 353 GYPPFYSD-DPMSTCR-----------------------KIV-------NWRTHLKFPEE 381
G P F + D KI FP+
Sbjct: 197 GSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEI--FPDA 254
Query: 382 AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
S EA DL+ LL + ++RL A E HP+F
Sbjct: 255 ---SPEALDLLKGLLVYDPSKRLSAA---EALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 6e-35
Identities = 81/305 (26%), Positives = 123/305 (40%), Gaps = 61/305 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG G FG+V TG + A+K+++ + ++ + E +L + +VK Y
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
E +Y+ MEY GG + LL L E R Y + + + +H H +HRDIK
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIK 126
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
P N+ LD G ++L DFG L T E++
Sbjct: 127 PANIFLDHNGVIKLGDFGCAVKL--------------------------KNNTTTMGEEV 160
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
Q GTP Y+APEV+ KG+G D WSLG ++ EM G P+
Sbjct: 161 QSL-----------AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209
Query: 361 DPMSTCRKIVNWRTHLK--------FPEEAKLSIEAKDLISK-LLCNVNQRLGAKGADEI 411
D ++ P+ +LS E KD + + L + +R A E+
Sbjct: 210 DN--------EFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTAS---EL 258
Query: 412 KVHPW 416
HP+
Sbjct: 259 LQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 5e-34
Identities = 91/318 (28%), Positives = 143/318 (44%), Gaps = 54/318 (16%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+GKG FGEV + K TG +YA KKL K + ++ + E+ +L +V+S IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR--FYVAETVLAIESIHKHHYIHRD 241
+F+ L L+M + GGD+ + + R Y A+ I +H ++RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQE 301
+KP+N+LLD G+ RLSD GL E TQ+
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV-------------------------ELKDGKTITQR- 154
Query: 302 QLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361
GT Y+APE+L ++ Y DW+++G +YEM+ G PF D
Sbjct: 155 ----------------AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF-KDH 197
Query: 362 PMSTCRKIVNWRT---HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA-DEIKVHPW 416
++ + RT +KF E + E+KD+ L RLG++ D+ + H +
Sbjct: 198 KEKVAKEELKRRTLEDEVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEF 256
Query: 417 FDGVDWARIYQMEAAFIP 434
F +++ R +EA IP
Sbjct: 257 FKTINFPR---LEAGLIP 271
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 6e-34
Identities = 80/315 (25%), Positives = 127/315 (40%), Gaps = 61/315 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DD+EL+ +IG GA V A+K++ + + V+ +R E +++ +
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC--QTSVDELRKEVQAMSQCNH 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+VK Y SF + L+L+M YL GG D+M + L E + E + +E +
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFG----LCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H + IHRDIK N+LL + G ++++DFG L D + + F
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTF------------ 166
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIM 347
VGTP ++APEV+ GY + D WS G
Sbjct: 167 -----------------------------VGTPCWMAPEVMEQVHGYDFKADIWSFGITA 197
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA---KLSIEAKDLISKLLCNVNQRLG 404
E+ G P+ PM + A K S + +IS L Q+
Sbjct: 198 IELATGAAPYSKYPPMKVLMLTLQ-NDPPSLETGADYKKYSKSFRKMISLCL----QKDP 252
Query: 405 AK--GADEIKVHPWF 417
+K A+E+ H +F
Sbjct: 253 SKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 87/305 (28%), Positives = 147/305 (48%), Gaps = 56/305 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+ IG+G+ G V + +K+TG A+KK+ + RR E + E ++ +
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHP 76
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHKH 235
IV++Y S+ + L+++ME+L GG +T ++ + E++ V VL A+ +H
Sbjct: 77 NIVEMYSSYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIA-TVCLAVLKALSFLHAQ 134
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK D++LL G ++LSDFG C +Q ++ P
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFC----------------------AQVSKE--VP 170
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+R S VGTP ++APEV+ + YG E D WSLG ++ EM+ G P
Sbjct: 171 RRK-----------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213
Query: 356 PFYSDDPMSTCRKIVNWRTHL--KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
P++++ P+ ++I R +L K K+S + + ++L + QR A E+
Sbjct: 214 PYFNEPPLQAMKRI---RDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAA---ELL 267
Query: 413 VHPWF 417
HP+
Sbjct: 268 NHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 85/332 (25%), Positives = 139/332 (41%), Gaps = 77/332 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E + IG+G +G+V R K TG + A+KK++ + +R E LL ++
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIR-EIKLLQKLRHPN 59
Query: 178 IVKLYCSFQDDE--FLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHK 234
IV+L +Y++ EY+ D+ LL + TE + + Y+ + + ++ +H
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHS 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ +HRDIK N+L++ G L+L+DFGL +P + D+T
Sbjct: 119 NGILHRDIKGSNILINNDGVLKLADFGLARPY--TKRNSADYT----------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVG 353
NR V T Y PE+LL YG E D WS+G I+ E+ +G
Sbjct: 160 --------------NR-------VITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
Query: 354 YPPFYSDDPMSTCRKI-----------------VNWRTHLKFPEEAK----------LSI 386
P F + KI + W +LK + K +
Sbjct: 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDP 258
Query: 387 EAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
A DL+ KLL + +R+ A A + H +F
Sbjct: 259 SALDLLDKLLTLDPKKRISADQALQ---HEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 8e-32
Identities = 87/330 (26%), Positives = 136/330 (41%), Gaps = 77/330 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEVDS 175
++ L IG+G +G V R+K TG + A+KK+K + A R LL E++
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRF---ESEGIPKTALREIKLLKELNH 57
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL F+ LYL+ E++ + R+ L E + Y+ + + + H H
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KP+NLL++ G L+L+DFGL + +P
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFG--------------------------SP 151
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354
R V T Y APE+LL KGY D WS+G I E+L
Sbjct: 152 VRPYTHY---------------VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
Query: 355 PPFYSDDPMSTCRKI---------VNWR--------THLKFPEEAKLSIE---------A 388
P F + KI W FP++A + + A
Sbjct: 197 PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQA 256
Query: 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
DL+S++L + ++R+ A+ A HP+F
Sbjct: 257 LDLLSQMLHYDPHKRITAEQALA---HPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-30
Identities = 97/333 (29%), Positives = 141/333 (42%), Gaps = 80/333 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS---EMLRRGQVEHVRAERNLLAEVD 174
+E+L ++G+GA+G V CR K TG + A+KK K+S E +++ + V+ R L E
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE-- 60
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
N IV L +F+ LYL+ EY+ + L L D R Y+ + + AI H
Sbjct: 61 -N-IVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHS 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H+ IHRDIKP+N+L+ + G L+L DFG + L T
Sbjct: 119 HNIIHRDIKPENILVSESGVLKLCDFGFARALRARP--ASPLT----------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353
V T Y APE+L+ YG D W++G IM E+L G
Sbjct: 160 ---------------------DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
Query: 354 YPPFYSD---DPMSTCRKIV-------------NWRTH-LKFPE-----------EAKLS 385
P F D D + +K + N R + FPE K+S
Sbjct: 199 EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVS 258
Query: 386 IEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
A D + L + +RL DE+ HP+F
Sbjct: 259 SPALDFLKACLRMDPKERL---TCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 71/252 (28%), Positives = 115/252 (45%), Gaps = 48/252 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D+EL+ IG G +G+V R+ TG + A+K +K E ++ E ++L E
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRH 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDM-MTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
IV + S+ + L+++MEY GG + + + L+E + + ET+ + +H+
Sbjct: 60 PNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHE 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRDIK N+LL + G ++L+DFG+ L +T+
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQLT-ATIA---------------------- 156
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLGAIMYEML 351
KR S +GTP ++APEV K GY +CD W+LG E+
Sbjct: 157 -KRK-----------------SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198
Query: 352 VGYPPFYSDDPM 363
PP + PM
Sbjct: 199 ELQPPMFDLHPM 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 87/338 (25%), Positives = 138/338 (40%), Gaps = 93/338 (27%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-----SEMLRRGQVEHVRAERNLLAE 172
++++ +G G FG V + R K TG + A+KK+KK E + + V++ R L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LREVKSLRKLNEH 57
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVL 227
IVKL F++++ LY + EY+ G L LM+ +E R + + +
Sbjct: 58 P---NIVKLKEVFRENDELYFVFEYMEG----NLYQLMKDRKGKPFSESVIRSIIYQILQ 110
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ IHKH + HRD+KP+NLL+ ++++DFGL + + +T
Sbjct: 111 GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR----PPYT---------- 156
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAI 346
Y V T Y APE+LL+ Y D W+LG I
Sbjct: 157 --------------------------DY--VSTRWYRAPEILLRSTSYSSPVDIWALGCI 188
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIV---------NW--------RTHLKFPEEAKLSI--- 386
M E+ P F + KI +W + +FP+ A S+
Sbjct: 189 MAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQL 248
Query: 387 ------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
EA DLI +L + +R A + HP+F
Sbjct: 249 IPNASPEAIDLIKDMLRWDPKKRPTAS---QALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 71/260 (27%), Positives = 113/260 (43%), Gaps = 47/260 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+F++ IGKG F V G V A+KK++ EM+ + E +LL ++D
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIES 231
++K SF ++ L +++E GD+ ++ +K + E Y + A+E
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H +HRDIKP N+ + G ++L D GL + T
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------------------- 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 161 --------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200
Query: 352 VGYPPFYSD--DPMSTCRKI 369
PFY D + S C+KI
Sbjct: 201 ALQSPFYGDKMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-29
Identities = 87/296 (29%), Positives = 141/296 (47%), Gaps = 52/296 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A+K++ + ++ E + E ++ E IV
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKHPNIVNYLD 83
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++MEYL GG + T ++ + + E + E + A+E +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 142
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
DN+LL G ++L+DFG C + P KR+
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQIT------------------------PEQSKRS----- 173
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ +++P+
Sbjct: 174 ------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 364 STCRKI-VNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
I N L+ PE KLS +D +++ L +V +R AK E+ HP+
Sbjct: 222 RALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRGSAK---ELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 62/245 (25%), Positives = 111/245 (45%), Gaps = 48/245 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
DF++L +GKG++G V + + YA+K++ M ++ + + V R +LA V+
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIR-ILASVNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIESI 232
I+ +F D L ++MEY P GD+ + ++ + E E + + ++++
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ +HRD+K N+LL +++ D G+ K L
Sbjct: 120 HEQKILHRDLKSANILLVANDLVKIGDLGISKVL-------------------------- 153
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
++ +A + +GTP Y+APEV + Y + D WSLG ++YEM
Sbjct: 154 -----------------KKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196
Query: 353 GYPPF 357
PPF
Sbjct: 197 FAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 4e-29
Identities = 76/282 (26%), Positives = 132/282 (46%), Gaps = 48/282 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E++ IG+G+FG++ + + K+ +K++ ++M + + E + E LLA++
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVK-EKEASKKEVILLAKMKHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKH 235
IV + SFQ++ L+++MEY GGD+M + R+ +ED+ + + L ++ IH
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 236 HYIHRDIKPDNLLLDKYGHL-RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRDIK N+ L K G + +L DFG+ + L+ S
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM------------------------ 156
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
LAY+ VGTP Y++PE+ + Y + D WSLG ++YE+
Sbjct: 157 -----------------ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLK 199
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
PF ++ KI P S + + LIS+L
Sbjct: 200 HPFEGNNLHQLVLKICQGYFA---PISPNFSRDLRSLISQLF 238
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 73/250 (29%), Positives = 114/250 (45%), Gaps = 48/250 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---D 174
++ L +IG+GA+G V + TG V A+K + V ++ E LL+++
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQ 60
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I K Y S+ L++IMEY GG + TL M+ + E + E ++A++ IHK
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTL-MKAGPIAEKYISVIIREVLVALKYIHK 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRDIK N+L+ G+++L DFG+ L+ ++ + F
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF------------------ 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353
VGTP ++APEV+ + K Y + D WSLG +YEM G
Sbjct: 162 -----------------------VGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
Query: 354 YPPFYSDDPM 363
PP+ D
Sbjct: 199 NPPYSDVDAF 208
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 6e-29
Identities = 93/322 (28%), Positives = 140/322 (43%), Gaps = 72/322 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
FEL+ +IG+G +G+V R K TG + A+K + + + E ++ E N+L +
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYS 60
Query: 175 S--NCIVKLYCSF-------QDDEFLYLIMEYLPGG---DMM-TLLMRKDTLTEDEARFY 221
+ N I Y +F DD+ L+L+ME GG D++ L + L E+ +
Sbjct: 61 NHPN-IATFYGAFIKKNPPGNDDQ-LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI 118
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ ET+ + +H++ IHRDIK N+LL K ++L DFG+ LD STL ++
Sbjct: 119 LRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD-STLGRRN------ 171
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGM 336
+ +GTP ++APEV+ Y
Sbjct: 172 ----------------------------------TFIGTPYWMAPEVIACDEQPDASYDA 197
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV-NWRTHLKFPEEAKLSIEAKDLISKL 395
D WSLG E+ G PP PM KI N LK PE S + D IS+
Sbjct: 198 RSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPE--NWSKKFNDFISEC 255
Query: 396 LC-NVNQRLGAKGADEIKVHPW 416
L N QR +E+ HP+
Sbjct: 256 LIKNYEQR---PFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 87/295 (29%), Positives = 142/295 (48%), Gaps = 50/295 (16%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+ G V + REK +G A+K + + RR E + E ++ + +V++Y
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQHQNVVEMYK 85
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHKHHYIHRDI 242
S+ E L+++ME+L GG +T ++ + L E++ V E+VL A+ +H IHRDI
Sbjct: 86 SYLVGEELWVLMEFLQGG-ALTDIVSQTRLNEEQIA-TVCESVLQALCYLHSQGVIHRDI 143
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
K D++LL G ++LSDFG C + PKR
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQIS------------------------KDVPKRK---- 175
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
S VGTP ++APEV+ + YG E D WSLG ++ EM+ G PP++SD P
Sbjct: 176 -------------SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222
Query: 363 MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWF 417
+ +++ + K K+S +D + ++L + A E+ HP+
Sbjct: 223 VQAMKRLRD-SPPPKLKNAHKISPVLRDFLERML--TREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-28
Identities = 82/298 (27%), Positives = 132/298 (44%), Gaps = 47/298 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++G+GAFG V +C + TG A K+++ +V + E LL + IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 181 LYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
Y +D ++ L + MEY+PGG + L LTE R Y + + + +H + +
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIV 128
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIK N+L D G+++L DFG K L + G +
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASKRLQTICMS------GTGIR--------------- 167
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
S GTP +++PEV+ +GYG + D WSLG + EML PP+
Sbjct: 168 -----------------SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210
Query: 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
+ M+ KI T+ + P + +S A+D + + R A+E+ HP+
Sbjct: 211 EYEAMAAIFKIATQPTNPQLP--SHISEHARDFLGCIFVEARHR---PSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 65/237 (27%), Positives = 113/237 (47%), Gaps = 46/237 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+E + ++G+GAFG V +CR K + +K++ +M + + + E +L +
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKD-ERLAAQNECQVLKLLSHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAETVLAIESIHKH 235
I++ Y +F +D+ L ++MEY PGG + + L ED + + +LA+ +H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 236 HYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+K N+LLDK+ +++ DFG+ K L SS++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL------------------SSKSK----- 157
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
AY+ VGTP YI+PE+ K Y + D W+LG ++YE+
Sbjct: 158 -------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELA 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 78/297 (26%), Positives = 129/297 (43%), Gaps = 64/297 (21%)
Query: 127 GAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV--DSNCIVKLYCS 184
G FG+V V + K T ++ K +K ++ A ++ ++ D+ +KLY S
Sbjct: 27 GKFGKVSVLKHKPTQKLFVQKIIKA---------KNFNAIEPMVHQLMKDNPNFIKLYYS 77
Query: 185 FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244
+ LIM+Y+ GD+ LL ++ L+E E + + + V A+ +HKH+ IH DIK
Sbjct: 78 VTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKL 137
Query: 245 DNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
+N+L D+ + L D+GLCK + + +
Sbjct: 138 ENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------------------------------ 167
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF--YSDD 361
GT DY +PE + Y + DWW++G + YE+L G PF D+
Sbjct: 168 ---------------GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE 212
Query: 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+ + + R K P +S A D + +L N+N RL +EI HP+
Sbjct: 213 ELDL--ESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRL--TNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 57/131 (43%), Positives = 78/131 (59%), Gaps = 7/131 (5%)
Query: 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK 377
+GTPDY+APE+LL K +G DWW+LG ++E L G PPF + P + I+N +
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILN--RDIP 598
Query: 378 FPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435
+PE E KLS+ A++ I LL + +R G K E+K HP F GVDW + FIP+
Sbjct: 599 WPEGEEKLSVNAQNAIEILLTMDPTKRAGLK---ELKQHPLFHGVDWENLQNQTMPFIPQ 655
Query: 436 VNDELDTQNFE 446
+DE DT FE
Sbjct: 656 PDDETDTSYFE 666
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 85/301 (28%), Positives = 138/301 (45%), Gaps = 48/301 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK------KSEMLRRGQVEHVRAERNLLAEVDSN 176
+IG G+FG V + ++G + A+K+++ S+ +R ++ + E LL E+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IV+ S D + L + +EY+PGG + LL E R +V + + + +H
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRDIK N+L+D G +++SDFG+ K L+ N+L+ + N RP+
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLE-----------ANSLSTKT-NGARPS--- 171
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
LQ G+ ++APEV+ + Y + D WSLG ++ EML G P
Sbjct: 172 ------LQ--------------GSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHP 415
F + KI + P S EA D + K + N+R A E+ HP
Sbjct: 212 FPDCTQLQAIFKI-GENASPEIPSNI--SSEAIDFLEKTFEIDHNKR---PTAAELLKHP 265
Query: 416 W 416
+
Sbjct: 266 F 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 89/329 (27%), Positives = 138/329 (41%), Gaps = 74/329 (22%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEVDS 175
+E +G+G + V R+K TG + A+KK+K E + A R LL E+
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
I+ L F + L+ E++ D+ ++ K LT + + Y+ T+ +E +H
Sbjct: 62 PNIIGLLDVFGHKSNINLVFEFMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ +HRD+KP+NLL+ G L+L+DFGL + F GS
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLAR----------SF-------GSP-------- 155
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVG 353
NR+M V T Y APE+L + YG+ D WS+G I E+L+
Sbjct: 156 --------------NRKMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLR 199
Query: 354 YPPFYSDDPMSTCRKIV---------NWRTHLKFPEEAKLSI---------------EAK 389
P D + KI NW P+ + +A
Sbjct: 200 VPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDAL 259
Query: 390 DLISKLLC-NVNQRLGAKGADEIKVHPWF 417
DL+ +LL N N+R+ A+ A E HP+F
Sbjct: 260 DLLQRLLTLNPNKRITARQALE---HPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 4e-27
Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 52/282 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERNLLAEVDS 175
+IGKG +G V + TTG + A+K+++ + + ++ V+ +R+E L ++D
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 176 NCIVKLYCSFQDDEFLYLI-MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
IV+ Y F+ E I +EY+PGG + + L E RF+ + + + +H
Sbjct: 68 LNIVQ-YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHS 126
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+K DNLL+D G ++SDFG+ K D ++ + QN
Sbjct: 127 KGILHRDLKADNLLVDADGICKISDFGISKKSD-------------DIYDNDQNM----- 168
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV--LLKKGYGMECDWWSLGAIMYEMLV 352
S G+ ++APEV +GY + D WSLG ++ EM
Sbjct: 169 ---------------------SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA 207
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLI 392
G P+ ++ ++ K+ N R+ P + LS A D +
Sbjct: 208 GRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFL 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-27
Identities = 83/302 (27%), Positives = 135/302 (44%), Gaps = 47/302 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVD 174
++ L ++G+GAFG V +C + TG A+K+++ +V + E LL +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 175 SNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
IV+ Y +D + L + ME++PGG + L LTE+ R Y + + + +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYL 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H + +HRDIK N+L D G+++L DFG K L TI L+G+
Sbjct: 123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ---------TIC--LSGTGMK---- 167
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
S GTP +++PEV+ +GYG + D WS+G + EML
Sbjct: 168 -----------------------SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT 204
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIK 412
PP+ + M+ KI T+ P +S +D + ++ R ADE+
Sbjct: 205 EKPPWAEFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLR---PSADELL 259
Query: 413 VH 414
H
Sbjct: 260 RH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 73/246 (29%), Positives = 118/246 (47%), Gaps = 45/246 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+ G V + EK TG A+KK+ + RR E + E ++ + +V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRR---ELLFNEVVIMRDYHHENVVDMYN 86
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++ME+L GG +T ++ + E++ + A+ +H IHRDIK
Sbjct: 87 SYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
D++LL G ++LSDFG C + PKR
Sbjct: 146 SDSILLTSDGRIKLSDFGFCAQVS------------------------KEVPKRK----- 176
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
S VGTP ++APEV+ + YG E D WSLG ++ EM+ G PP++++ P+
Sbjct: 177 ------------SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL 224
Query: 364 STCRKI 369
R+I
Sbjct: 225 QAMRRI 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 92/301 (30%), Positives = 145/301 (48%), Gaps = 62/301 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A+K++ + ++ + E + E ++ E+ + IV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLD 83
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTE---DEARFYVA--ETVLAIESIHKHHYI 238
SF + L+++MEYL GG + D +TE DEA+ E + A+E +H + I
Sbjct: 84 SFLVGDELFVVMEYLAGGSLT------DVVTETCMDEAQIAAVCRECLQALEFLHANQVI 137
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
HRDIK DN+LL G ++L+DFG C + P KR+
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGFCAQIT------------------------PEQSKRS 173
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+
Sbjct: 174 -----------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL 216
Query: 359 SDDPMSTCRKI-VNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPW 416
+++P+ I N L+ PE KLS +D +++ L +V +R AK E+ HP+
Sbjct: 217 NENPLRALYLIATNGTPELQNPE--KLSPIFRDFLNRCLEMDVEKRGSAK---ELLQHPF 271
Query: 417 F 417
Sbjct: 272 L 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 80/302 (26%), Positives = 129/302 (42%), Gaps = 48/302 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAEVDSNCIV 179
+G GAF R+ TG + A+K++ Q VE +R E L+A ++ I+
Sbjct: 7 QLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHII 66
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
++ + +D L +E++ GG + LL + E Y + + + +H++ IH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 240 RDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
RD+K NLL+D G LR++DFG L +F
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF---------------------- 164
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
Q QL +GT ++APEVL + YG CD WS+G ++ EM PP+
Sbjct: 165 -QGQL--------------LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209
Query: 359 SD---DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHP 415
++ + ++ KI + T PE LS +D+ L C Q + E+ HP
Sbjct: 210 AEKHSNHLALIFKIASATTAPSIPEH--LSPGLRDVT--LRCLELQPEDRPPSRELLKHP 265
Query: 416 WF 417
F
Sbjct: 266 VF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 74/245 (30%), Positives = 107/245 (43%), Gaps = 49/245 (20%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVD 174
+ +L ++G+G+FG + + + YAMK +L KS VE R E LLA++
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS----SAVEDSRKEAVLLAKMK 56
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDTLTEDEARFYVAETVLAIESI 232
IV SF+ D LY++MEY GGD+M L R ED + + L ++ I
Sbjct: 57 HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHI 116
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ +HRDIK N+ L + G ++L DFG + L P
Sbjct: 117 HEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL-----------------------TSP 153
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
A A + VGTP Y+ PE+ Y + D WSLG I+YE+
Sbjct: 154 GA------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
Query: 353 GYPPF 357
PF
Sbjct: 196 LKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 76/283 (26%), Positives = 123/283 (43%), Gaps = 51/283 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ + ++GKGAFGE + R + K++ + + + + E +L+ +
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDE-ARFYVAETVLAIESIHKH 235
I+ Y F DD L + MEY GG + ++R K L E+E +Y+ + V A+ IHK
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIK N+ L K G ++L DFG+ K L
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS------------------------ 156
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+A + VGTP Y++PE+ Y + D W+LG ++YE+L
Sbjct: 157 -----------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR 199
Query: 356 PFYSDDPMSTCRKIV--NWRTHLKFPEEAKLSIEAKDLISKLL 396
F + +P++ KIV N+ P + S E L+ LL
Sbjct: 200 TFDATNPLNLVVKIVQGNYT-----PVVSVYSSELISLVHSLL 237
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 5e-26
Identities = 85/296 (28%), Positives = 143/296 (48%), Gaps = 52/296 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A+K++ + ++ E + E ++ E + IV
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 83
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++MEYL GG + T ++ + + E + E + A++ +H + IHRDIK
Sbjct: 84 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIK 142
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
DN+LL G ++L+DFG C + P KR+
Sbjct: 143 SDNILLGMDGSVKLTDFGFCAQIT------------------------PEQSKRS----- 173
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ +++P+
Sbjct: 174 ------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 221
Query: 364 STCRKI-VNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
I N L+ PE +LS +D +++ L +V++R AK E+ HP+
Sbjct: 222 RALYLIATNGTPELQNPE--RLSAVFRDFLNRCLEMDVDRRGSAK---ELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 83/285 (29%), Positives = 136/285 (47%), Gaps = 49/285 (17%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+GA G V + TG A++++ + ++ E + E ++ E + IV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKNPNIVNYLD 84
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++MEYL GG + T ++ + + E + E + A+E +H + IHRDIK
Sbjct: 85 SYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIK 143
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
DN+LL G ++L+DFG C + P KR+
Sbjct: 144 SDNILLGMDGSVKLTDFGFCAQIT------------------------PEQSKRSTM--- 176
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
VGTP ++APEV+ +K YG + D WSLG + EM+ G PP+ +++P+
Sbjct: 177 --------------VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 364 STCRKI-VNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQRLGAK 406
I N L+ PE KLS +D +++ L +V +R AK
Sbjct: 223 RALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRGSAK 265
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 81/277 (29%), Positives = 124/277 (44%), Gaps = 53/277 (19%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182
++GKG +G V R+ +T A+K++ + + R Q H E L + + IV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDS-RYVQPLH--EEIALHSYLKHRNIVQYL 71
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIH 239
S ++ F + ME +PGG + LL K E FY + + ++ +H + +H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 240 RDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
RDIK DN+L++ Y G +++SDFG K L + FT
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT--------------------- 170
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPP 356
GT Y+APEV+ K +GYG D WSLG + EM G PP
Sbjct: 171 --------------------GTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
Query: 357 FYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLI 392
F +P + K+ ++ H + PE LS EAK+ I
Sbjct: 211 FIELGEPQAAMFKVGMFKIHPEIPES--LSAEAKNFI 245
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 82/342 (23%), Positives = 128/342 (37%), Gaps = 97/342 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE--------MLRRGQVEHVRAERNL 169
+E L IG+GA+G V R+ TG A+KK++ LR E L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR---------EIAL 51
Query: 170 LAEVDS-NC--IVKLY--CSFQDDE---FLYLIMEYLPGGDMMTLLMR--KDTLTEDEAR 219
L +++S IV+L C + L L+ E++ D+ T L + K L + +
Sbjct: 52 LKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIK 110
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
+ + + ++ +H H +HRD+KP N+L+ G ++++DFGL +
Sbjct: 111 DLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS------------ 158
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339
M S V T Y APEVLL+ Y D
Sbjct: 159 ------------------------------FEMALTSVVVTLWYRAPEVLLQSSYATPVD 188
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKI-----------------VNWRT-HLKFPEE 381
WS+G I E+ P F KI + + P
Sbjct: 189 MWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRS 248
Query: 382 AK-----LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
K + E DL+ K+L N ++R+ A A HP+F
Sbjct: 249 FKSFVPEICEEGLDLLKKMLTFNPHKRISAFEA---LQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-25
Identities = 83/297 (27%), Positives = 143/297 (48%), Gaps = 54/297 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+ G V + K++G + A+KK+ + RR E + E ++ + +V++Y
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRR---ELLFNEVVIMRDYQHENVVEMYN 84
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK 243
S+ + L+++ME+L GG +T ++ + E++ + A+ +H IHRDIK
Sbjct: 85 SYLVGDELWVVMEFLEGG-ALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143
Query: 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQL 303
D++LL G ++LSDFG C +Q ++ P+R
Sbjct: 144 SDSILLTHDGRVKLSDFGFC----------------------AQVSKE--VPRRK----- 174
Query: 304 QHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
S VGTP ++APE++ + YG E D WSLG ++ EM+ G PP++++ P+
Sbjct: 175 ------------SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222
Query: 364 STCRKIVNWRTHL--KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+ I R +L K K+S K + +LL + QR A E+ HP+
Sbjct: 223 KAMKMI---RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQR---ATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 64/236 (27%), Positives = 114/236 (48%), Gaps = 44/236 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ + IG+G+FG+ + + K G Y +K++ S+M + + E R E +L+ +
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPK-EREESRKEVAVLSNMKHPN 60
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+ SF+++ LY++M+Y GGD+ + R ED+ + + LA++ +H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIK N+ L K G ++L DFG+ + L+ ST++
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVE----------------------- 156
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
LA + +GTP Y++PE+ + Y + D W+LG ++YEM
Sbjct: 157 -----------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMC 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 81/298 (27%), Positives = 135/298 (45%), Gaps = 44/298 (14%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKK--LKKSEMLR-RGQVEHVRAERNLLAEVDSNCIV 179
++GKGA+G V C G + A+K+ L S +L + E ++ E +LL + IV
Sbjct: 7 VLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
+ + DD + + ME++PGG + ++L R L E Y + + + +H + +H
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVH 125
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RDIK +N++L G ++L DFG + L L+G+ N
Sbjct: 126 RDIKGNNVMLMPNGIIKLIDFGCARRLAWV-----------GLHGTHSN----------- 163
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
ML S GTP ++APEV+ + GYG + D WS+G ++EM G PP S
Sbjct: 164 ------------MLK-SMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
Query: 360 DDPMSTCRKIVNWRTHL-KFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPW 416
D ++ I R + + P+ S A D ++ C + A ++ H +
Sbjct: 211 MDRLAAMFYIGAHRGLMPRLPD--SFSAAAIDFVT--SCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 44/246 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+ K Y S+ L++IMEYL GG + LL R E + + E + ++ +H
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLDYLHSEKK 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL + G ++L+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPN 201
Query: 358 YSDDPM 363
PM
Sbjct: 202 SDMHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 9e-25
Identities = 74/246 (30%), Positives = 112/246 (45%), Gaps = 44/246 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+ K Y S+ D L++IMEYL GG + LL L E + + E + ++ +H
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLHSEKK 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL ++G ++L+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201
Query: 358 YSDDPM 363
PM
Sbjct: 202 SELHPM 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 82/327 (25%), Positives = 128/327 (39%), Gaps = 84/327 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVD 174
DD E L +G G G V + TG + A+K + ++E A + +L E+D
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTI---------RLEINEAIQKQILRELD 51
Query: 175 ----SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
N IV Y +F ++ + + MEY+ GG + +L + +A VL
Sbjct: 52 ILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLK 111
Query: 229 --IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
KH IHRD+KP N+L++ G ++L DFG+ L S
Sbjct: 112 GLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----------------- 154
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
LA + VGT Y+APE + Y ++ D WSLG
Sbjct: 155 --------------------------LAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLS 188
Query: 347 MYEMLVG-YP-PFYSDDPMST---CRKIVNWRTHLKFPEEA------KLSIEAKDLISKL 395
+ E+ G +P P +D P + IVN E K S + +D ++
Sbjct: 189 LIELATGRFPYPPENDPPDGIFELLQYIVN--------EPPPRLPSGKFSPDFQDFVNLC 240
Query: 396 LC-NVNQRLGAKGADEIKVHPWFDGVD 421
L + +R K E+ HP+ +
Sbjct: 241 LIKDPRERPSYK---ELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 71/269 (26%), Positives = 120/269 (44%), Gaps = 58/269 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVY-AMKKLK-KSEMLRRGQVEHVRAERNLLAEVD- 174
+ +L +G GAFG V R+K G A+K++ + + + E ++ ++++EV
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 175 -------SNCIVKLYCSFQDDEFLYLIMEYLPGGDM----MTLLMRKDTLTEDEARFYVA 223
N IV+ Y +F +++ LY++M+ + G + +L +K TE+
Sbjct: 62 IKEQLRHPN-IVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 224 ETVLAIESIHKHHYI-HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ VLA+ +HK I HRD+ P+N++L + + ++DFGL K
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK------------------ 162
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
QK S VGT Y PE++ + YG + D W+
Sbjct: 163 ------------------------QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWA 198
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVN 371
G I+Y+M PPFYS + +S KIV
Sbjct: 199 FGCILYQMCTLQPPFYSTNMLSLATKIVE 227
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 75/268 (27%), Positives = 120/268 (44%), Gaps = 42/268 (15%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL--KKSEMLRRGQVEHVRAERNLLAEVD 174
++ L ++G+GAFGEV +C + TG A+K++ +V + E LL +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 175 SNCIVKLYCSFQDDE--FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ IV+ Y +D E L + +EY+PGG + L LTE+ R Y + + + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYL 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H + +HRDIK N+L D G+++L DFG K + TI + G
Sbjct: 123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ---------TICMSGTGIK------ 167
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
S GTP +++PEV+ +GYG + D WS+ + EML
Sbjct: 168 -----------------------SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPE 380
PP+ + M+ KI T P+
Sbjct: 205 EKPPWAEYEAMAAIFKIATQPTKPMLPD 232
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 44/246 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IGKG+FGEV + T V A+K + E ++E ++ E +L++ DS
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 63
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
I + Y S+ L++IMEYL GG + LL + L E + E + ++ +H
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLL-KPGPLEETYIATILREILKGLDYLHSERK 122
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL + G ++L+DFG+ L + ++ F
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF--------------------- 161
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
VGTP ++APEV+ + Y + D WSLG E+ G PP
Sbjct: 162 --------------------VGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPN 201
Query: 358 YSDDPM 363
PM
Sbjct: 202 SDLHPM 207
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 81/312 (25%), Positives = 142/312 (45%), Gaps = 59/312 (18%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAE 172
D +E++ +G GAFG+V + K TG A K +++ E ++E E ++L+E
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE-----ELEDFMVEIDILSE 58
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIES 231
IV LY ++ + L++++E+ GG + ++++ + LTE + R+ + + A+
Sbjct: 59 CKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF 118
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H H IHRD+K N+LL G ++L+DFG+ S++N
Sbjct: 119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGV----------------------SAKN--- 153
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAI 346
K T Q +R + +GTP ++APEV+ Y + D WSLG
Sbjct: 154 ----KSTLQ---------KR---DTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGIT 197
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405
+ E+ PP + +PM KI+ + +K S D + L + + R
Sbjct: 198 LIELAQMEPPHHELNPMRVLLKILKSEPP-TLDQPSKWSSSFNDFLKSCLVKDPDDRP-- 254
Query: 406 KGADEIKVHPWF 417
A E+ HP+
Sbjct: 255 -TAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 1e-23
Identities = 86/338 (25%), Positives = 141/338 (41%), Gaps = 85/338 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D++E L I +G +G V R+K TG + A+KKLK + + +R E N+L ++
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 176 NCIVKL----YCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIE 230
IV + S D +Y++MEY+ D+ +L+ K + E + + + + +
Sbjct: 64 PNIVTVKEVVVGSNLDK--IYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVA 120
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H + +HRD+K NLLL+ G L++ DFGL
Sbjct: 121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLA--------------------------- 153
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYE 349
R L+ + + V T Y APE+LL K Y D WS+G I E
Sbjct: 154 ------REYGSPLKPYTQL--------VVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAE 199
Query: 350 ML---------------------VGYP-----PFYSDDPMSTCRKIVN---WRTHLKFPE 380
+L +G P P +S+ P + + + KFP
Sbjct: 200 LLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFP- 258
Query: 381 EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
LS DL+++LL + +R+ A+ A + HP+F
Sbjct: 259 ALSLSDNGFDLLNRLLTYDPAKRISAEDALK---HPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 2e-23
Identities = 69/259 (26%), Positives = 112/259 (43%), Gaps = 47/259 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+F++ IG+G F EV A+KK++ EM+ + E +LL +++
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESI 232
++K SF +D L +++E GD+ ++ +K + E Y + A+E +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRDIKP N+ + G ++L D GL + T
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-------------------- 162
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 163 ---------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
Query: 353 GYPPFYSD--DPMSTCRKI 369
PFY D + S C+KI
Sbjct: 202 LQSPFYGDKMNLFSLCQKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.5 bits (246), Expect = 4e-23
Identities = 92/340 (27%), Positives = 141/340 (41%), Gaps = 97/340 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--------KSEMLRRGQVEHVRAERNL 169
++ + IG+G +G V R+K TG + A+KK++ S +R E +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIR---------EISL 51
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM-MTLLMR---KDTLTEDEARFYVAET 225
L E++ IV+L + LYL+ E+L D+ + M L + Y+ +
Sbjct: 52 LKELNHPNIVRLLDVVHSENKLYLVFEFL---DLDLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ I H H +HRD+KP NLL+D+ G L+L+DFGL + F +
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA----------FGV------- 151
Query: 286 SQNNERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 343
P RT E + W Y APE+LL + Y D WS+
Sbjct: 152 ---------PVRTYTHEVVTLW----------------YRAPEILLGSRQYSTPVDIWSI 186
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKI---------VNWR--THL-----KFPEEAK---- 383
G I EM+ P F D + +I W T L FP+ A+
Sbjct: 187 GCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLS 246
Query: 384 -----LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
L + DL+SK+L + +R+ AK A + HP+F
Sbjct: 247 KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ---HPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 88/343 (25%), Positives = 135/343 (39%), Gaps = 80/343 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
D+E+L +G+G FGEV R+ TG V A+KK+ M + A R +L ++
Sbjct: 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL---MHNEKDGFPITALREIKILKKL 64
Query: 174 DSNCIVKLY---------CSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVA 223
+V L + Y++ Y+ D+ LL LTE + + Y+
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSV-YMVTPYM-DHDLSGLLENPSVKLTESQIKCYML 122
Query: 224 ETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ + I +H++H +HRDIK N+L+D G L+++DFGL +P D
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD---------------- 166
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY-STVGTPDYIAPEVLL-KKGYGMECDWW 341
G N + Y + V T Y PE+LL ++ Y D W
Sbjct: 167 GPPPNPKGGGGGGTR---------------KYTNLVVTRWYRPPELLLGERRYTTAVDIW 211
Query: 342 SLGAIMYEMLVGYPPFY------------------SDDPMSTCRKIVNWRTHLKFP---- 379
+G + EM P +++ R + F
Sbjct: 212 GIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPR 271
Query: 380 --EE--AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
EE KL E DL+SKLL + +RL A A E HP+F
Sbjct: 272 TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE---HPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-23
Identities = 76/258 (29%), Positives = 120/258 (46%), Gaps = 44/258 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ FE+L ++G+GA+G V CR K T + A+KK K SE + +R E +L +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR-ELKMLRTLKQ 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L +F+ LYL+ EY+ + L + + ++ R Y+ + + AI HK+
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKN 119
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIKP+NLL+ L+L DFG + L + G+N N +
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNL----------SEGSNANYTEY-------- 161
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
V T Y +PE+LL YG D WS+G I+ E+ G P
Sbjct: 162 ----------------------VATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199
Query: 356 PFYSD---DPMSTCRKIV 370
F + D + T +K++
Sbjct: 200 LFPGESEIDQLFTIQKVL 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 6e-23
Identities = 81/339 (23%), Positives = 134/339 (39%), Gaps = 81/339 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEVDS 175
+ELL IG GA+G V +K TG A+KK+ + ++ R R LL +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI---SNVFDDLIDAKRILREIKLLRHLRH 58
Query: 176 NCIVKLYCSFQD---DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ L + ++F +Y++ E + D+ ++ LT+D ++++ + + ++
Sbjct: 59 ENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLK 117
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H + IHRD+KP N+L++ L++ DFGL + +D ++ T
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLT------------- 164
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349
V T Y APE+LL Y D WS+G I E
Sbjct: 165 -------------------------EYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAE 199
Query: 350 MLVGYPPF----Y----------------SDDPMSTCRKIVNWRTHLKFPEEAKL----- 384
+L P F Y D T K N+ L + L
Sbjct: 200 LLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFP 259
Query: 385 --SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420
S EA DL+ K+L + +R+ A A HP+ +
Sbjct: 260 GASPEAIDLLEKMLVFDPKKRITADEALA---HPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 82/299 (27%), Positives = 137/299 (45%), Gaps = 53/299 (17%)
Query: 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHV 163
Y ++R + +E++ +G GAFG+V + K TG + A K ++ KSE ++E
Sbjct: 1 YEHVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE----EELEDY 56
Query: 164 RAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYV 222
E +LA + IVKL +F D L++++E+ PGG + +++ D LTE + +
Sbjct: 57 MVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVIC 116
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + A++ +H IHRD+K N+LL G ++L+DFG+ + TLQ +D
Sbjct: 117 RQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK-NVKTLQRRD------- 168
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGME 337
S +GTP ++APEV++ Y +
Sbjct: 169 ---------------------------------SFIGTPYWMAPEVVMCETMKDTPYDYK 195
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
D WSLG + EM PP + +PM KI + +K S+E +D + L
Sbjct: 196 ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPP-TLSQPSKWSMEFRDFLKTAL 253
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 3e-22
Identities = 69/259 (26%), Positives = 112/259 (43%), Gaps = 47/259 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+F + IG+G F EV G A+KK++ +++ E +LL +++
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESI 232
++K Y SF +D L +++E GD+ ++ +K + E Y + A+E +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRDIKP N+ + G ++L D GL + T
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA-------------------- 162
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 163 ---------------------AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 201
Query: 353 GYPPFYSD--DPMSTCRKI 369
PFY D + S C+KI
Sbjct: 202 LQSPFYGDKMNLYSLCKKI 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 6e-22
Identities = 89/342 (26%), Positives = 143/342 (41%), Gaps = 102/342 (29%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAERNLLAEVD 174
+++L IG+G F EV + + TG YA+K +KK S QV ++R E L +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE----QVNNLR-EIQALRRLS 55
Query: 175 SNC-IVKLYCSFQDDEFLY--------LIMEYLPGGDM-MTLLM--RKDTLTEDEARFYV 222
+ I++L E L+ L+ E + DM + L+ RK L E + Y+
Sbjct: 56 PHPNILRL------IEVLFDRKTGRLALVFELM---DMNLYELIKGRKRPLPEKRVKSYM 106
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + +++ +H++ HRDIKP+N+L+ L+L+DFG C + +T
Sbjct: 107 YQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSC----RGIYSKPPYTE---- 157
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWW 341
Y + T Y APE LL G YG + D W
Sbjct: 158 --------------------------------Y--ISTRWYRAPECLLTDGYYGPKMDIW 183
Query: 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKI----------VNWRTH------LKFPEE---- 381
++G + +E+L +P F + + KI V + FP +
Sbjct: 184 AVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTG 243
Query: 382 -AKL----SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
KL S E DL+ KLL + ++R+ AK A HP+F
Sbjct: 244 LRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR---HPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 9e-22
Identities = 92/340 (27%), Positives = 137/340 (40%), Gaps = 97/340 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVDSN 176
F+ + IG+G +G V R K TG V A+KK++ +E G E +LL E++
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET--EGVPSTAIREISLLKELNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYL-----------PGGDMMTLLMRKDTLTEDEARFYVAET 225
IVKL + LYL+ E+L P + L++ Y+ +
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKS----------YLFQL 109
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ + H H +HRD+KP NLL++ G ++L+DFGL +
Sbjct: 110 LQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAF------------------- 150
Query: 286 SQNNERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
P RT E + W Y APE+LL K Y D WSL
Sbjct: 151 -------GVPVRTYTHEVVTLW----------------YRAPEILLGCKYYSTAVDIWSL 187
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKI---------VNWR--THLK-----FPEEAK---- 383
G I EM+ F D + +I V W T L FP+ A+
Sbjct: 188 GCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFS 247
Query: 384 -----LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
L + +DL+S++L + N+R+ AK A HP+F
Sbjct: 248 KVVPPLDEDGRDLLSQMLHYDPNKRISAKAA---LAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 1e-21
Identities = 73/258 (28%), Positives = 119/258 (46%), Gaps = 51/258 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAEVD 174
+E L ++G+G++G V C+ K TG + A+KK +SE M+++ + +R +L ++
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIR----MLKQLR 58
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+V L F+ + LYL+ E++ + L + L E R Y+ + + IE H
Sbjct: 59 HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H+ IHRDIKP+N+L+ + G ++L DFG + L AA
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTL--------------------------AA 152
Query: 295 PKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLV 352
P Y+ V T Y APE+L+ YG D W++G ++ EML
Sbjct: 153 PGE----------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLT 196
Query: 353 GYPPFYSDDPMSTCRKIV 370
G P F D + I+
Sbjct: 197 GEPLFPGDSDIDQLYHII 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 66/252 (26%), Positives = 110/252 (43%), Gaps = 49/252 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVD 174
+DFEL+ IG G +G+V R TG + A+K +K L G+ V+ E ++ +
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK----LEPGEDFAVVQQEIIMMKDCK 64
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ IV + S+ + L++ ME+ GG + + L+E + + ET+ + +H
Sbjct: 65 HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHS 124
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRDIK N+LL GH++L+DFG+ + + + + F
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF------------------ 166
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351
+GTP ++APEV K GY CD W++G E+
Sbjct: 167 -----------------------IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203
Query: 352 VGYPPFYSDDPM 363
PP + PM
Sbjct: 204 ELQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 4e-21
Identities = 82/295 (27%), Positives = 138/295 (46%), Gaps = 54/295 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL-KKSEMLRRGQVEHVRAERNLLAEVD 174
+ +E++ +G GAFG+V + K TG + A K + KSE ++E E ++LA D
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE----EELEDYMVEIDILASCD 60
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIH 233
IVKL +F + L++++E+ GG + +++ + LTE + R +T+ A+ +H
Sbjct: 61 HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
++ IHRD+K N+L G ++L+DFG+ + T+Q +D
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK-NTRTIQRRD------------------ 161
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMY 348
S +GTP ++APEV++ + Y + D WSLG +
Sbjct: 162 ----------------------SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL-CNVNQR 402
EM PP + +PM KI + ++ S E KD + K L NV+ R
Sbjct: 200 EMAQIEPPHHELNPMRVLLKIAKSEPP-TLAQPSRWSSEFKDFLKKCLEKNVDAR 253
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 4e-21
Identities = 70/281 (24%), Positives = 127/281 (45%), Gaps = 48/281 (17%)
Query: 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+ ++GKG++GEV + R +T G Y +KKL RR + + E LL+++ IV
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRR-ERKAAEQEAQLLSQLKHPNIV 62
Query: 180 KLYCSFQ-DDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIESIHKHH 236
S++ +D LY++M + GGD+ L + L E++ + + +A++ +H+ H
Sbjct: 63 AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH 122
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRD+K N+ L + +++ D G+ + L+
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE----------------------------- 153
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
N+ +A + +GTP Y++PE+ K Y + D W+LG +YEM
Sbjct: 154 ------------NQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHA 201
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC 397
F + D S +I+ + P S E +LI+ +L
Sbjct: 202 FNAKDMNSLVYRIIEGKLP---PMPKDYSPELGELIATMLS 239
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 4e-21
Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 64/277 (23%)
Query: 118 FELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
EL +G+GAFGEV + E T V A+K LK+ + E E +++ +
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKV-AVKTLKEGASEE--EREEFLEEASIMKK 57
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAI 229
+ IV+L C+ E LY++ EY+PGGD++ L + LT + + +
Sbjct: 58 LSHPNIVRLLGVCT--QGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
E + +++HRD+ N L+ + +++SDFGL + + E D
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR-----DIYEDD-------------- 156
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI-----APEVLLKKGYGMECDWWSLG 344
Y + APE L + + D WS G
Sbjct: 157 -------------------------YYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFG 191
Query: 345 AIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPE 380
+++E+ +G P+ + + L PE
Sbjct: 192 VLLWEIFTLGEQPYPGMSNEEVLELLED-GYRLPRPE 227
|
Length = 258 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 8e-21
Identities = 95/341 (27%), Positives = 137/341 (40%), Gaps = 84/341 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-D 174
D +E L IG+G +G+V R+K TG + A+KK + EM G E +LL + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSE 59
Query: 175 SNCIVKLYCSFQDDE-----FLYLIMEYLPGGDM---MTLLMRKDT--LTEDEARFYVAE 224
S IV+L +E LYL+ EYL D+ M R L + ++ +
Sbjct: 60 SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ + HKH +HRD+KP NLL+DK G L+++D GL + F+I
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR----------AFSI----- 163
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWS 342
P K E + W Y APEVLL Y D WS
Sbjct: 164 --------PV--KSYTHEIVTLW----------------YRAPEVLLGSTHYSTPVDIWS 197
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIV------------------NWRTHLKFPEE--- 381
+G I EM P F D + I +W ++ +
Sbjct: 198 VGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLS 257
Query: 382 ---AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
LS E DL+ K+L + +R+ AK A HP+FD
Sbjct: 258 RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT---HPYFD 295
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-20
Identities = 86/305 (28%), Positives = 124/305 (40%), Gaps = 55/305 (18%)
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
N Y + ++ E EK AD D E + E +E R M
Sbjct: 17 NQYAKYFPHVLFTSEEA--FEKYCADLD--PEAYKKCVDLPEGEEVPESNNPREHM---- 68
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSN 176
+ L T++G+ V T G K + K ML Q + R+E + LA D
Sbjct: 69 YVLTTLVGRNPTTAAFVA---TRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHF 125
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTL--TEDEARFYVAETVLAIESI 232
IVK + F+ D+ L LIMEY GGD+ + + K+ L E E + VLA++ +
Sbjct: 126 GIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +HRD+K N+ L G ++L DFG K
Sbjct: 186 HSRKMMHRDLKSANIFLMPTGIIKLGDFGFSK---------------------------- 217
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
Q+ +A S GTP Y+APE+ +K Y + D WSLG I+YE+L
Sbjct: 218 -----------QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266
Query: 353 GYPPF 357
+ PF
Sbjct: 267 LHRPF 271
|
Length = 478 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 83/298 (27%), Positives = 126/298 (42%), Gaps = 63/298 (21%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEV 173
+D +E++ IGKG +G+V K G A+K L + E + AE N+L A
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID----EEIEAEYNILKALS 72
Query: 174 DSNCIVKLYCSF-----QDDEFLYLIMEYLPGGDMMTL----LMRKDTLTEDEARFYVAE 224
D +VK Y + ++ + L+L++E GG + L L R + + E + + E
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
++ ++ +H + IHRD+K +N+LL G ++L DFG+ L
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL------------------ 174
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 339
+ R+ ++VGTP ++APEV+ L Y CD
Sbjct: 175 -----------------------TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCD 211
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV-NWRTHLKFPEEAKLSIEAKDLISKLL 396
WSLG E+ G PP PM KI N L PE S E D I K L
Sbjct: 212 VWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPE--LWSNEFNDFIRKCL 267
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-20
Identities = 70/261 (26%), Positives = 109/261 (41%), Gaps = 61/261 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN- 176
FEL+ ++G G +G+V R TG + A+K + +E + E ++ E N+L + +
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHR 73
Query: 177 CIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVL 227
I Y +F DD+ L+L+ME+ G + L+ + + L ED + E +
Sbjct: 74 NIATYYGAFIKKSPPGHDDQ-LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ +H H IHRDIK N+LL + ++L DFG+ LD + + F
Sbjct: 133 GLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----------- 181
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 342
+GTP ++APEV+ Y D WS
Sbjct: 182 ------------------------------IGTPYWMAPEVIACDENPDATYDYRSDIWS 211
Query: 343 LGAIMYEMLVGYPPFYSDDPM 363
LG EM G PP PM
Sbjct: 212 LGITAIEMAEGAPPLCDMHPM 232
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 1e-20
Identities = 81/331 (24%), Positives = 143/331 (43%), Gaps = 68/331 (20%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEM------LRR--GQVE-HVRAERNL--LAE 172
+G+G +G+V + TG + A+KK+K E+ R+ G H R L + E
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ I+ L + + +F+ L+M+ + D+ ++ RK LTE + + + + + + +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQILNGLNVL 135
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
HK +++HRD+ P N+ ++ G +++DFGL + P
Sbjct: 136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYP----------------------P 173
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 351
+ ++ E +Q RR S V T Y APE+L+ + Y D WS+G I E+L
Sbjct: 174 YSDTLSKDETMQ-----RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
Query: 352 VGYPPFYSDDPMSTCRKIVNWR---THLKFPEEAKL---------------------SIE 387
G P F ++ + +I +P+ KL S +
Sbjct: 229 TGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDD 288
Query: 388 AKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
A DL+ LL N +R+ AK A + H +F
Sbjct: 289 AIDLLQSLLKLNPLERISAKEALK---HEYF 316
|
Length = 335 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 79/316 (25%), Positives = 133/316 (42%), Gaps = 67/316 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D+ E+L +GKG +G V + TG AMK+++ L + + E ++L + S
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESI 232
IV Y +F + +Y+ MEY+ G + L + + + ED R V ++ +
Sbjct: 59 PYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 233 -HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H+ IHRD+KP N+L++ G ++L DFG + NL S
Sbjct: 119 KEEHNIIHRDVKPTNVLVNGNGQVKLCDFG----------------VSGNLVAS------ 156
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG------YGMECDWWSLGA 345
LA + +G Y+APE + G Y ++ D WSLG
Sbjct: 157 ---------------------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195
Query: 346 IMYEMLVG---YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQR 402
+ EM +G YPP + + IV+ P S +A+D ++K L +
Sbjct: 196 SILEMALGRYPYPPETYANIFAQLSAIVD-GDPPTLPSG--YSDDAQDFVAKCL----NK 248
Query: 403 LGAKGAD--EIKVHPW 416
+ + ++ HPW
Sbjct: 249 IPNRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 45/156 (28%), Positives = 82/156 (52%), Gaps = 11/156 (7%)
Query: 119 ELLTMIGKGAFGEVRVCR-EKTTGHVY---AMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
L +G+GAFGEV + + G A+K LK+ Q+E E ++ ++D
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS--EQQIEEFLREARIMRKLD 59
Query: 175 SNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIES 231
+VKL C+ ++E LY++MEY+ GGD+++ L + L+ + + + +E
Sbjct: 60 HPNVVKLLGVCT--EEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ ++IHRD+ N L+ + +++SDFGL + L
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 153
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 3e-20
Identities = 95/338 (28%), Positives = 147/338 (43%), Gaps = 86/338 (25%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEVDS 175
+E+L +GKGA+G V ++ T V A+KK+ + R + R R L E+
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA---FRNATDAQRTFREIMFLQEL-G 64
Query: 176 NC--IVKLYCSF--QDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLA 228
+ IVKL ++D+ +YL+ EY M T L +R + L + R+ + + + A
Sbjct: 65 DHPNIVKLLNVIKAENDKDIYLVFEY-----METDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ IH + IHRD+KP N+LL+ ++L+DFGL + L +N
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE----------------LEEN 163
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347
E P + Y V T Y APE+LL Y D WS+G I+
Sbjct: 164 PENPV------------------LTDY--VATRWYRAPEILLGSTRYTKGVDMWSVGCIL 203
Query: 348 YEMLVGYPPFYSDDPMSTCRKIV------------------------NWRTHLKFPEEAK 383
EML+G P F ++ KI+ + + + P +
Sbjct: 204 GEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDEL 263
Query: 384 L---SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
L S +A DL+ KLL N N+RL A+ A E HP+
Sbjct: 264 LPKASDDALDLLKKLLVFNPNKRLTAEEALE---HPYV 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 95/336 (28%), Positives = 134/336 (39%), Gaps = 86/336 (25%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVDS 175
D+ + IG+G +G V R K TG + AMKK++ +SE G E +LL E+
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE--EEGVPSTAIREISLLKELQH 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE------ARFYVAETVLAI 229
IV L + LYLI E+L M L D+L + + + Y+ + + I
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLS----MDLKKYLDSLPKGQYMDAELVKSYLYQILQGI 114
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H +HRD+KP NLL+D G ++L+DFGL + F I
Sbjct: 115 LFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARA----------FGI----------- 153
Query: 290 ERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIM 347
P R E + W Y APEVLL Y D WS+G I
Sbjct: 154 -----PVRVYTHEVVTLW----------------YRAPEVLLGSPRYSTPVDIWSIGTIF 192
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVN---------WR--THLK-----FPEEAK-------- 383
EM P F+ D + +I W T L FP+ K
Sbjct: 193 AEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVK 252
Query: 384 -LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
L + DL+ K+L + +R+ AK A HP+F
Sbjct: 253 NLDEDGLDLLEKMLIYDPAKRISAKKA---LNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 9e-20
Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 12/157 (7%)
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVY----AMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
L +G+GAFGEV K G A+K LK+ + Q+E E ++ ++D
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQ--QIEEFLREARIMRKLD 59
Query: 175 SNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIE 230
IVKL C+ ++E L ++MEY+PGGD++ L R L+ + + + +E
Sbjct: 60 HPNIVKLLGVCT--EEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ ++IHRD+ N L+ + +++SDFGL + L
Sbjct: 118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY 154
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 64/251 (25%), Positives = 106/251 (42%), Gaps = 49/251 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVDS 175
D+EL+ +G G +G+V R TG + A+K +K L G ++ E ++ E
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK----LEPGDDFSLIQQEIFMVKECKH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV + S+ E L++ MEY GG + + L+E + + ET+ + +H
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSK 125
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRDIK N+LL G ++L+DFG+ + + + + F
Sbjct: 126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF------------------- 166
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGAIMYEMLV 352
+GTP ++APEV + GY CD W++G E+
Sbjct: 167 ----------------------IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAE 204
Query: 353 GYPPFYSDDPM 363
PP + PM
Sbjct: 205 LQPPMFDLHPM 215
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-19
Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 60/270 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
D +E++ IGKG +G+V K G + A+K L E + AE N+L +
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI----SDVDEEIEAEYNILQSLP 76
Query: 175 SN-CIVKLYCSF-QDDEF----LYLIMEYLPGGDMMTL----LMRKDTLTEDEARFYVAE 224
++ +VK Y F + D+ L+L++E GG + L L+ L E + +
Sbjct: 77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+L ++ +H + IHRD+K +N+LL G ++L DFG+ L + L+
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN---------- 186
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 339
++VGTP ++APEV+ Y CD
Sbjct: 187 -------------------------------TSVGTPFWMAPEVIACEQQYDYSYDARCD 215
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKI 369
WSLG E+ G PP + P+ T KI
Sbjct: 216 VWSLGITAIELGDGDPPLFDMHPVKTLFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 70/255 (27%), Positives = 110/255 (43%), Gaps = 55/255 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE--MLRRGQVEHVRAERNLLAEV 173
+ L+ +G+GA G V CR K TG ++A+K + L++ Q+ +R E +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQK-QI--LR-ELEINKSC 56
Query: 174 DSNCIVKLYCSFQDDE--FLYLIMEYLPGGDMMTLL--MRKDT-LTEDEARFYVAETVL- 227
S IVK Y +F D+ + + MEY GG + ++ ++K ++ +AE+VL
Sbjct: 57 KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK 116
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ +H IHRDIKP N+LL + G ++L DFG+ L S
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS------------------ 158
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
LA + GT Y+APE + K Y + D WSLG +
Sbjct: 159 -------------------------LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTL 193
Query: 348 YEMLVGYPPFYSDDP 362
E+ PF +
Sbjct: 194 LEVAQNRFPFPPEGE 208
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 8e-19
Identities = 70/279 (25%), Positives = 126/279 (45%), Gaps = 47/279 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK----SEMLRRGQVEHVRAERNLLAEV 173
++++ +IGKG GEV + + A+KK+++ + +L++ +R E + A++
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKK---RFLR-EAKIAADL 59
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM---RKDTLTEDEARFYVAETVLAI- 229
IV +Y D + +Y M Y+ G + +LL +K++L+++ A L+I
Sbjct: 60 IHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 230 -------ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
E +H +HRD+KPDN+LL +G + + D+G E++ + ++
Sbjct: 120 HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI----FKKLEEEDLLDIDV 175
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ + P + VGTPDY+APE LL D ++
Sbjct: 176 DERNICYSSMTIPGK-------------------IVGTPDYMAPERLLGVPASESTDIYA 216
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE 381
LG I+Y+ML P+ RKI +R + P E
Sbjct: 217 LGVILYQMLTLSFPYRRKKG----RKIS-YRDVILSPIE 250
|
Length = 932 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 72/257 (28%), Positives = 113/257 (43%), Gaps = 48/257 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKL 181
+GKG+FG V + ++K +K LK+ + L + E LL+++D IVK
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 182 YCSFQDDEFLYLIMEYLPGGDM----MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
+ SF + + +I EY G D+ L TL+E++ + + +L + +H+
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRI 127
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+K N+ L K L++ DFG+ S L L GS
Sbjct: 128 LHRDLKAKNIFL-KNNLLKIGDFGV------SRL----------LMGSCD---------- 160
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
LA + GTP Y++PE L +GY + D WSLG I+YEM F
Sbjct: 161 ---------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAF 205
Query: 358 YSDDPMSTCRKIVNWRT 374
+ +S +IV T
Sbjct: 206 EGQNFLSVVLRIVEGPT 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 69/251 (27%), Positives = 114/251 (45%), Gaps = 51/251 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAE 172
+ +E L+ IG+G++G V CR + TG + A+KK +SE ++++ + +R +L +
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIR----MLKQ 56
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ +V L F+ L+L+ EY + L + E + + +T+ A+
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFC 116
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
HKH+ IHRD+KP+N+L+ K G ++L DFG + L T D+T
Sbjct: 117 HKHNCIHRDVKPENILITKQGQIKLCDFGFARIL---TGPGDDYT--------------- 158
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEML 351
V T Y APE+L+ YG D W++G + E+L
Sbjct: 159 -----------------------DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELL 195
Query: 352 VGYP--PFYSD 360
G P P SD
Sbjct: 196 TGQPLWPGKSD 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 89/399 (22%), Positives = 153/399 (38%), Gaps = 111/399 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRA---ERNLLA 171
D ++ L+ +G GA+G+V + TG A+KKL R Q H + E LL
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-----SRPFQSAIHAKRTYRELRLLK 69
Query: 172 EVDSNCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
+D ++ L F L YL+ L G D+ + ++ L++D +F V +
Sbjct: 70 HMDHENVIGLLDVFTPASSLEDFQDVYLVTH-LMGADLNNI-VKCQKLSDDHIQFLVYQI 127
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ ++ IH IHRD+KP N+ +++ L++ DFGL +
Sbjct: 128 LRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR--------------------- 166
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLG 344
+ M Y V T Y APE++L Y D WS+G
Sbjct: 167 ---------------------HTDDEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVG 203
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNW-----------------RTHLK-FPEEAK--- 383
IM E+L G F D + ++I+N R +++ P+ K
Sbjct: 204 CIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDF 263
Query: 384 ------LSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEV 436
+ A DL+ K+L + ++R+ A A HP+ E
Sbjct: 264 KEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA---HPYLA----------------EY 304
Query: 437 NDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
+D D +++S + W++++ + +NF
Sbjct: 305 HDPEDEPVAPPYDQSFESRDLTVDE--WKELVYKEIMNF 341
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 84.4 bits (208), Expect = 3e-18
Identities = 69/261 (26%), Positives = 111/261 (42%), Gaps = 61/261 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN- 176
FEL+ ++G G +G+V R TG + A+K + + + E ++ E N+L + +
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSHHR 63
Query: 177 CIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVL 227
I Y +F DD+ L+L+ME+ G + L+ + +TL E+ + E +
Sbjct: 64 NIATYYGAFIKKNPPGMDDQ-LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR 122
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ +H+H IHRDIK N+LL + ++L DFG+ LD + + F
Sbjct: 123 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF----------- 171
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 342
+GTP ++APEV+ Y + D WS
Sbjct: 172 ------------------------------IGTPYWMAPEVIACDENPDATYDFKSDLWS 201
Query: 343 LGAIMYEMLVGYPPFYSDDPM 363
LG EM G PP PM
Sbjct: 202 LGITAIEMAEGAPPLCDMHPM 222
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 67/257 (26%), Positives = 112/257 (43%), Gaps = 64/257 (24%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK-------------LKKSEMLRRGQVE 161
++ L+ IG+GA+G V K TG A+KK L++ ++LRR + E
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
++ +++ + SF D +Y++ E + D+ L+ + L+ D +++
Sbjct: 64 NIIGILDIIRPPS-------FESFND---VYIVQELMET-DLYKLI-KTQHLSNDHIQYF 111
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + ++ IH + +HRD+KP NLLL+ L++ DFGL + E D T
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR----IADPEHDHTGF-- 165
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
+ Y V T Y APE++L KGY D
Sbjct: 166 ------------------------------LTEY--VATRWYRAPEIMLNSKGYTKAIDI 193
Query: 341 WSLGAIMYEMLVGYPPF 357
WS+G I+ EML P F
Sbjct: 194 WSVGCILAEMLSNRPLF 210
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 6e-18
Identities = 65/253 (25%), Positives = 106/253 (41%), Gaps = 69/253 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERN 168
DDFE L +G G G V + +G + A K + +++++R +V H
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLH------ 54
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
E +S IV Y +F D + + ME++ GG + +L + + E+ + + +A
Sbjct: 55 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEN----ILGKISIA 107
Query: 229 IES-----IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ KH +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 108 VLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------------- 153
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
+A S VGT Y++PE L Y ++ D WSL
Sbjct: 154 -----------------------------MANSFVGTRSYMSPERLQGTHYTVQSDIWSL 184
Query: 344 GAIMYEMLVG-YP 355
G + EM +G YP
Sbjct: 185 GLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 1e-17
Identities = 72/257 (28%), Positives = 103/257 (40%), Gaps = 62/257 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKL----KKSEMLRRGQVEHVRAERNLLAEV 173
F L IG G+FG V R+ T V A+KK+ K+S + ++ VR + L
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL---R 73
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
N I C + + +L+MEY G L + K L E E + + +H
Sbjct: 74 HPNTIEYKGC-YLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFG---LCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
H IHRDIK N+LL + G ++L+DFG L P
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------------------------- 167
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIM 347
A S VGTP ++APEV+L + Y + D WSLG
Sbjct: 168 -----------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC 204
Query: 348 YEMLVGYPPFYSDDPMS 364
E+ PP ++ + MS
Sbjct: 205 IELAERKPPLFNMNAMS 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 76/321 (23%), Positives = 129/321 (40%), Gaps = 72/321 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-----L 170
++ + IG GA+G V + +G A+KK+ + A+R L L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHA------FDVPTLAKRTLRELKIL 58
Query: 171 AEVDSNCIVKLYCSFQ--DDEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+ I+ + + +F +Y++M+ L D+ ++ LTE+ R+++ + +
Sbjct: 59 RHFKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLL 117
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH + IHRD+KP NLL+++ LR+ DFG+ + L S + + F
Sbjct: 118 RGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYF---------- 167
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
M Y V T Y APE+LL Y D WS+G
Sbjct: 168 -------------------------MTEY--VATRWYRAPELLLSLPEYTTAIDMWSVGC 200
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGA 405
I EML F + + + I+ + L P E L+ D + K + Q L
Sbjct: 201 IFAEMLGRRQLFPGKNYVHQLKLIL---SVLGSPSEEVLNRIGSDRVRKYI----QNLPR 253
Query: 406 KGADEIKVHPWFDGVDWARIY 426
K V W++I+
Sbjct: 254 KQP-----------VPWSKIF 263
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 50/240 (20%), Positives = 96/240 (40%), Gaps = 55/240 (22%)
Query: 124 IGKGAFGEVRVCR---EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+G+GAFGEV + + A+K LK+ + + E ++ ++ +V+
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVR 60
Query: 181 LY-CSFQDDEFLYLIMEYLPGGDMMTLL---------MRKDTLTEDEARFYVAETVLAIE 230
L +++ LYL++EY+ GGD++ L K TL+ + + + +E
Sbjct: 61 LLGVCTEEEP-LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ ++HRD+ N L+ + +++SDFGL + + + +
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY--------------DDDYYRKKT 165
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
P R W M APE L + + D WS G +++E+
Sbjct: 166 GGKLPIR--------W-----M------------APESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 91/338 (26%), Positives = 137/338 (40%), Gaps = 86/338 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +E + IG+G +G V R++ T A+KK++ E G E +LL E+
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR------FYVAETVLAI 229
IV+L ++ LYL+ EYL + L D+ + D A+ Y+ + + I
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLD----LDLKKHMDS-SPDFAKNPRLIKTYLYQILRGI 115
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H +HRD+KP NLL+D+ + L+L+DFGL + F I
Sbjct: 116 AYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARA----------FGI---------- 155
Query: 289 NERPAAPKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 346
P RT E + W Y APE+LL + Y D WS+G I
Sbjct: 156 ------PVRTFTHEVVTLW----------------YRAPEILLGSRHYSTPVDIWSVGCI 193
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVN---------WR----------THLKFPEE------ 381
EM+ P F D + KI W K+P +
Sbjct: 194 FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVV 253
Query: 382 AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
L DL+SK+L + ++R+ A+ A E H +F
Sbjct: 254 PTLEPAGVDLLSKMLRLDPSKRITARAALE---HEYFK 288
|
Length = 294 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 68/247 (27%), Positives = 109/247 (44%), Gaps = 51/247 (20%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-QVEHVRAERNLLAEVDS 175
+FE L IG+G +G V R+ T+G + A+KK++ + R G + +R E LL +
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR-MDNERDGIPISSLR-EITLLLNLRH 65
Query: 176 NCIVKLYCSFQDD--EFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
IV+L + ++L+MEY D+ +LL M +E + + + + + ++
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQY 123
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H++ IHRD+K NLLL G L+++DFGL +
Sbjct: 124 LHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY-----------------------GL 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 350
PA P T V T Y APE+LL Y D W++G I+ E+
Sbjct: 161 PAKP-MT-----------------PKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAEL 202
Query: 351 LVGYPPF 357
L P
Sbjct: 203 LAHKPLL 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 6e-17
Identities = 62/263 (23%), Positives = 106/263 (40%), Gaps = 62/263 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL---KKSEMLRRGQVEHVRAERNLLA 171
+D E ++ +G G G V + TG V A K + KS + ++ + E ++
Sbjct: 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQ-----ILRELQIMH 58
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA--I 229
E S IV Y +F ++ + + ME++ G + + + + + +A V+
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG-KIAVAVVEGLT 117
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ H +HRDIKP N+L++ G ++L DFG+ L S
Sbjct: 118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-------------------- 157
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+A + VGT Y++PE + Y ++ D WSLG + E
Sbjct: 158 -----------------------IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIE 194
Query: 350 MLVGYPPF--------YSDDPMS 364
+ +G PF DDPM
Sbjct: 195 LALGKFPFAFSNIDDDGQDDPMG 217
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 9e-17
Identities = 84/331 (25%), Positives = 130/331 (39%), Gaps = 79/331 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAEVDSN 176
F+ L +G+G + V R +TTG + A+K++ +E G E +L+ E+
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE---EGTPSTAIREISLMKELKHE 58
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDM---MTLLMRKDTLTEDEARFYVAETVLAIESIH 233
IV+L+ + L L+ EY+ D+ M + L + + + + + I H
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCH 117
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
++ +HRD+KP NLL++K G L+L+DFGL + G +N S
Sbjct: 118 ENRVLHRDLKPQNLLINKRGELKLADFGLAR------------AFGIPVNTFS------- 158
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLV 352
+ V T Y AP+VLL + Y D WS+G IM EM+
Sbjct: 159 ----------------------NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196
Query: 353 GYPPFYSDDPMSTCRKIVN---------WRTHLKFPE----------------EAKLSIE 387
G P F + KI W + PE
Sbjct: 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPL 256
Query: 388 AKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
DL+ +LL N R+ A A + HPWF
Sbjct: 257 GIDLLHRLLQLNPELRISAHDALQ---HPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 69/270 (25%), Positives = 112/270 (41%), Gaps = 80/270 (29%)
Query: 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
A+D + L IG+GAFG V K +G + A+K++ +S + + Q + LL ++
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRI-RSTVDEKEQ-------KRLLMDL 53
Query: 174 D-----SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------DTLTED 216
D S+C IVK Y + + ++ ME +M + + K + E+
Sbjct: 54 DVVMRSSDCPYIVKFYGALFREGDCWICME------LMDISLDKFYKYVYEVLKSVIPEE 107
Query: 217 EARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
TV A+ + + IHRD+KP N+LLD+ G+++L DFG+ L S + +D
Sbjct: 108 ILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRD 167
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KK 332
G Y+APE + +
Sbjct: 168 ------------------------------------------AGCRPYMAPERIDPSARD 185
Query: 333 GYGMECDWWSLGAIMYEMLVG---YPPFYS 359
GY + D WSLG +YE+ G YP + S
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWNS 215
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 66/264 (25%), Positives = 113/264 (42%), Gaps = 54/264 (20%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K D F+++ IG+G +G+V R+K TG + A+KK++ + +R E +L
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIR-EIKILR 61
Query: 172 EVDSNCIVKLYCSFQDD----EFL------YLIMEYLPGGDMMTLLMRK-DTLTEDEARF 220
+++ IV L D +F YL+ EY+ D+M LL +ED +
Sbjct: 62 QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGLVHFSEDHIKS 120
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
++ + + + HK +++HRDIK N+LL+ G ++L+DFGL +
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLAR---------------- 164
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECD 339
+ + V T Y PE+LL ++ YG D
Sbjct: 165 ------------------------LYNSEESRPYTNKVITLWYRPPELLLGEERYGPAID 200
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPM 363
WS G I+ E+ P F ++ +
Sbjct: 201 VWSCGCILGELFTKKPIFQANQEL 224
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 5e-16
Identities = 87/337 (25%), Positives = 131/337 (38%), Gaps = 91/337 (27%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--------KSEMLRRGQVEHVRAERNL 169
+E L IG+G +G V + + T + A+K+++ S LR E L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EICL 52
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
L E+ IV+LY D+ L L+ EY + + + ++ + + +
Sbjct: 53 LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H H+ +HRD+KP NLL++K G L+L+DFGL + F I
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARA----------FGI----------- 151
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGAIM 347
P R YS V T Y P+VL K Y D WS G I
Sbjct: 152 -----PVR----------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF 190
Query: 348 YEML-VGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEE---------------- 381
E+ G P F +D ++I +W K P+
Sbjct: 191 AELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVV 250
Query: 382 AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
KL+ +DL+ LL CN QR+ A+ A + HP+F
Sbjct: 251 PKLNSTGRDLLQNLLVCNPVQRISAEEALQ---HPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 7e-16
Identities = 81/291 (27%), Positives = 122/291 (41%), Gaps = 61/291 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAERNLLAE 172
D + L +G GA+G V ++ TG A+KKL + SE+ + +R LL
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----LLKH 70
Query: 173 VDSNCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+ ++ L F D L YL+M ++ G + LM+ + L+ED +F V + +
Sbjct: 71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH IHRD+KP NL +++ L++ DFGL +
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---------------------- 166
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
Q + M Y V T Y APEV+L Y D WS+G
Sbjct: 167 --------------------QTDSEMTGY--VVTRWYRAPEVILNWMHYTQTVDIWSVGC 204
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKL-SIEAKDLISKL 395
IM EML G P F D + +I+ KL S +AK+ + KL
Sbjct: 205 IMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 1e-15
Identities = 68/258 (26%), Positives = 108/258 (41%), Gaps = 79/258 (30%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERN 168
DDFE ++ +G G G V + K +G + A K + +++++R QV H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH------ 58
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
E +S IV Y +F D + + ME++ GG + +L EA+ + E +L
Sbjct: 59 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL--------KEAK-RIPEEILG 106
Query: 229 IESI----------HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
SI KH +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 107 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------- 157
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
+A S VGT Y++PE L Y ++
Sbjct: 158 ----------------------------------MANSFVGTRSYMSPERLQGTHYSVQS 183
Query: 339 DWWSLGAIMYEMLVG-YP 355
D WS+G + E+ +G YP
Sbjct: 184 DIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 68/252 (26%), Positives = 105/252 (41%), Gaps = 53/252 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEV 173
+E L IG+G FGEV R K T + A+KK+ M + + A R +L +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVL---MENEKEGFPITALREIKILQLL 68
Query: 174 DSNCIVKLY--CSFQDDEF------LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAE 224
+V L C + + YL+ E+ D+ LL K+ T E + +
Sbjct: 69 KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKM 127
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ + IH++ +HRD+K N+L+ K G L+L+DFGL + F++
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA----------FSL------ 171
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 343
++ + T NR V T Y PE+LL ++ YG D W
Sbjct: 172 ----SKNSKPNRYT----------NR-------VVTLWYRPPELLLGERDYGPPIDMWGA 210
Query: 344 GAIMYEMLVGYP 355
G IM EM P
Sbjct: 211 GCIMAEMWTRSP 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 3e-15
Identities = 65/257 (25%), Positives = 107/257 (41%), Gaps = 66/257 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERN 168
DDFE ++ +G G G V K +G + A K + +++++R QV H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLH------ 58
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
E +S IV Y +F D + + ME++ GG + +L + + E + ++
Sbjct: 59 ---ECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPE---QILGKVSIAV 112
Query: 229 IESI----HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
I+ + KH +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------------- 157
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
+A S VGT Y++PE L Y ++ D WS+G
Sbjct: 158 ----------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 345 AIMYEMLVGYPPFYSDD 361
+ EM +G P D
Sbjct: 190 LSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 3e-15
Identities = 93/338 (27%), Positives = 136/338 (40%), Gaps = 96/338 (28%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEML-RRGQVE-----HVRAERNLLA 171
L +G GA+G V +K TG A+KKL + SE+ +R E H++ E N++
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE-NVIG 78
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAI 229
+D FQD YL+M Y M T L + L+ED+ ++ V + + +
Sbjct: 79 LLDVFTSAVSGDEFQD---FYLVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA--------------------- 169
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
M Y V T Y APEV+L Y D WS+G IM
Sbjct: 170 ---------------------EMTGY--VVTRWYRAPEVILNWMHYNQTVDIWSVGCIMA 206
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTH---------------------LKFPEE------ 381
EML G F D + +I+ K+P +
Sbjct: 207 EMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF 266
Query: 382 AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFD 418
K S +A DL+ K+L +V++RL A E HP+FD
Sbjct: 267 PKASPQAVDLLEKMLELDVDKRL---TATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 73/295 (24%), Positives = 123/295 (41%), Gaps = 55/295 (18%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A + + ++G GA G V + + G +A+K + E + +AE L D
Sbjct: 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVD-MEGMSEADKNRAQAEVCCLLNCD 89
Query: 175 SNCIVKLYCSF-----QDDE---FLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYV 222
IVK + F ++ E + L+++Y GD+ + + T E EA
Sbjct: 90 FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLF 149
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ +LA+ +H H IHRDIK N+LL G ++L DFG K + +T+ + +G
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK-MYAATVSDD---VGRTF 205
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
G TP Y+APE+ +K Y + D +S
Sbjct: 206 CG-----------------------------------TPYYVAPEIWRRKPYSKKADMFS 230
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC 397
LG ++YE+L PF ++ K + R P +S E +++++ LL
Sbjct: 231 LGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD---PLPPSISPEMQEIVTALLS 282
|
Length = 496 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 4e-15
Identities = 65/250 (26%), Positives = 109/250 (43%), Gaps = 65/250 (26%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKK--------SEMLRRGQV-EHVRAERNLLAEVD 174
+G GAFG V R++ TG A+KK+ K R ++ +H+R E N++
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE-NII---- 72
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ ++ S +D +Y + E L G D+ LL + L + ++++ + + ++ +H
Sbjct: 73 --SLSDIFISPLED--IYFVTELL-GTDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHS 126
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+KP N+L+++ L++ DFGL + D
Sbjct: 127 AGVVHRDLKPSNILINENCDLKICDFGLARIQD--------------------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353
+M Y V T Y APE++L + Y +E D WS G I EML G
Sbjct: 160 ---------------PQMTGY--VSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG 202
Query: 354 YPPFYSDDPM 363
P F D +
Sbjct: 203 KPLFPGKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 8e-15
Identities = 68/255 (26%), Positives = 103/255 (40%), Gaps = 48/255 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IG G+FG V R+ T V A+KK+ S + + + E L +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
++ + + +L+MEY G L + K L E E + + +H H+
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LL + G ++L+DFG + A+P
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFG---------------------------SASIASP-- 177
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 354
A S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 178 ----------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
Query: 355 PPFYSDDPMSTCRKI 369
PP ++ + MS I
Sbjct: 222 PPLFNMNAMSALYHI 236
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 66/252 (26%), Positives = 100/252 (39%), Gaps = 48/252 (19%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L IG G+FG V T V A+KK+ S + + + E L ++ ++
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
+ + +L+MEY G L + K L E E + + +H H+ IHR
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
DIK N+LL + G ++L+DFG S + PA
Sbjct: 146 DIKAGNILLTEPGQVKLADFG------------------------SASKSSPAN------ 175
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGYPPF 357
S VGTP ++APEV+L + Y + D WSLG E+ PP
Sbjct: 176 ---------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220
Query: 358 YSDDPMSTCRKI 369
++ + MS I
Sbjct: 221 FNMNAMSALYHI 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 9e-14
Identities = 75/265 (28%), Positives = 110/265 (41%), Gaps = 70/265 (26%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
Q++ +D E L IG G G+V R K TGHV A+K+++++ + E+ R +
Sbjct: 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTG----NKEENKRILMD 63
Query: 169 L---LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMT----LLMR-KDTLTEDEARF 220
L L D IVK Y F D +++ ME M T LL R + + ED
Sbjct: 64 LDVVLKSHDCPYIVKCYGYFITDSDVFICMEL-----MSTCLDKLLKRIQGPIPEDILG- 117
Query: 221 YVAETVLAIESIH----KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
TV ++++H KH IHRD+KP N+LLD G+++L DFG+ L
Sbjct: 118 --KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV--------- 166
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKK 332
S+ R A G Y+APE +
Sbjct: 167 --------DSKAKTRSA-------------------------GCAAYMAPERIDPPDPNP 193
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPF 357
Y + D WSLG + E+ G P+
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPY 218
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 67/272 (24%), Positives = 101/272 (37%), Gaps = 59/272 (21%)
Query: 120 LLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRA----ERNLLA 171
+ +G+G FG+V +CR TG A+K L S E R+ E +L
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS------GEEQHRSDFEREIEILR 61
Query: 172 EVDSNCIVKL-YCSFQDDEF-LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLA 228
+D IVK + L LIMEYLP G + L R +D + + ++
Sbjct: 62 TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKG 121
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ + YIHRD+ N+L++ +++SDFGL K L +++D+
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP----EDKDYYYVKEP------ 171
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
E P W Y APE L + D WS G +Y
Sbjct: 172 GESPI-----------FW--------Y---------APECLRTSKFSSASDVWSFGVTLY 203
Query: 349 EMLVGYPPFYSDDP----MSTCRKIVNWRTHL 376
E+ P S M + T L
Sbjct: 204 ELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 1e-13
Identities = 65/255 (25%), Positives = 100/255 (39%), Gaps = 48/255 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
++ + + +L+MEY G L + K L E E + + +H H+
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRD+K N+LL + G ++L DFG + AP
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFG---------------------------SASIMAP-- 167
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 354
A VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 168 ----------------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 355 PPFYSDDPMSTCRKI 369
PP ++ + MS I
Sbjct: 212 PPLFNMNAMSALYHI 226
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 69/265 (26%), Positives = 112/265 (42%), Gaps = 71/265 (26%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKK--------------LKKSEMLRRGQVEHVRAERNL 169
IG+GA+G V + T A+KK L++ ++LR H+ E N+
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLR-----HLDHE-NV 66
Query: 170 LAEVDSNCIVKLYC--SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+A D I+ +F D +Y++ E L D+ ++ TL++D ++++ + +
Sbjct: 67 IAIKD---IMPPPHREAFND---VYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLR 119
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ IH + +HRD+KP NLLL+ L++ DFGL + T ++ DF
Sbjct: 120 GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLART----TSEKGDF----------- 164
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346
M Y V T Y APE+LL Y D WS+G I
Sbjct: 165 ------------------------MTEY--VVTRWYRAPELLLNCSEYTTAIDVWSVGCI 198
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVN 371
E+L P F D + + I
Sbjct: 199 FAELLGRKPLFPGKDYVHQLKLITE 223
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-13
Identities = 62/244 (25%), Positives = 97/244 (39%), Gaps = 51/244 (20%)
Query: 124 IGKGAFGEVRV-CREKT---TGHVYAMKKLKK--SEMLRRGQVEHVRAERNLLAEVDSNC 177
+G+G FG+V + C + TG + A+K LK+ + G + E N+L +
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK----EINILKTLYHEN 67
Query: 178 IVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IVK CS Q + L LIMEY+P G + L K L + + + + +H
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHSQ 126
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HYIHRD+ N+LLD +++ DFGL K + G+ ++ + P
Sbjct: 127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----------PEGHEYYRVREDGDSPVF- 175
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ A E L + + D WS G +YE+L
Sbjct: 176 ---------------------------WYAVECLKENKFSYASDVWSFGVTLYELLTHCD 208
Query: 356 PFYS 359
S
Sbjct: 209 SKQS 212
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 75/294 (25%), Positives = 123/294 (41%), Gaps = 62/294 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTT--GHVYAMKKL----KKSEMLRRGQVE-----HVRAE 166
+EL+ +G+GA+G V R T A+KK+ K + +R E H R
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+N+ D + IV +F + LYL E L D+ ++ LT+ + ++ + +
Sbjct: 62 KNITCLYDMD-IV-FPGNFNE---LYLYEE-LMEADLHQIIRSGQPLTDAHFQSFIYQIL 115
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH + +HRD+KP NLL++ L++ DFGL + + + F
Sbjct: 116 CGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGF---------- 165
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
M Y V T Y APE++L + Y D WS+G
Sbjct: 166 -------------------------MTEY--VATRWYRAPEIMLSFQSYTKAIDVWSVGC 198
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKL----SIEAKDLISKL 395
I+ E+L P F D + +I+ L P+E L S +A++ I L
Sbjct: 199 ILAELLGRKPVFKGKDYVDQLNQILQ---VLGTPDEETLSRIGSPKAQNYIRSL 249
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 6e-13
Identities = 64/245 (26%), Positives = 100/245 (40%), Gaps = 64/245 (26%)
Query: 121 LTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVR---AERNLLAEV 173
+ +GKG FG V +CR + TG V A+KKL+ S EH+R E +L +
Sbjct: 9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS------TAEHLRDFEREIEILKSL 62
Query: 174 DSNCIVKL--YCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIE 230
+ IVK C L L+MEYLP G + L + ++ L + Y ++ +E
Sbjct: 63 QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGME 122
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ Y+HRD+ N+L++ +++ DFGL K L Q+ E
Sbjct: 123 YLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL-------------------PQDKE 163
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPD-----YIAPEVLLKKGYGMECDWWSLGA 345
Y V P + APE L + + + D WS G
Sbjct: 164 ------------------------YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGV 199
Query: 346 IMYEM 350
++YE+
Sbjct: 200 VLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 6e-13
Identities = 64/248 (25%), Positives = 108/248 (43%), Gaps = 56/248 (22%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL--KKSEMLRRGQVEHVRAERNLLAEVD 174
+ E + IG GA G V + TG +YA+K + + +RR + E +L +V+
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR----QICREIEILRDVN 130
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+VK + F + + +++E++ GG + + + D AR + + I +H+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----QILSGIAYLHR 186
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRDIKP NLL++ +++++DFG+ + L Q D P
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVSRILA----QTMD----------------PCN 226
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGY--GMECDWWSLGAIMYE 349
S+VGT Y++PE + L G G D WSLG + E
Sbjct: 227 ---------------------SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265
Query: 350 MLVGYPPF 357
+G PF
Sbjct: 266 FYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 8e-13
Identities = 60/254 (23%), Positives = 108/254 (42%), Gaps = 49/254 (19%)
Query: 124 IGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+G+G FG+V +CR TG A+K LK + ++ E +L + IV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 180 KL--YCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHH 236
K C+ + LIME+LP G + L R K+ + + Y + ++ +
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ 129
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
Y+HRD+ N+L++ +++ DFGL K ++ ++ +T+ ++L+
Sbjct: 130 YVHRDLAARNVLVESEHQVKIGDFGLTKAIETD---KEYYTVKDDLD------------- 173
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
S V + APE L++ + + D WS G +YE+L
Sbjct: 174 -------------------SPVF---WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211
Query: 357 FYSDDPMSTCRKIV 370
S PM+ K++
Sbjct: 212 ESS--PMTLFLKMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (167), Expect = 1e-12
Identities = 60/245 (24%), Positives = 96/245 (39%), Gaps = 46/245 (18%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
AD +E L +G+G++ V + K G + A+K ++ E G E +LL +
Sbjct: 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLKGLK 61
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
IV L+ E L L+ EY+ + L + + ++ + + + IH+
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ +HRD+KP NLL+ G L+L+DFGL + +
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLARA--------------------------KSV 155
Query: 295 PKRT-QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC-DWWSLGAIMYEMLV 352
P T E + W Y P+VLL C D W +G I EM+
Sbjct: 156 PSHTYSNEVVTLW----------------YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199
Query: 353 GYPPF 357
G F
Sbjct: 200 GVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 79/302 (26%), Positives = 125/302 (41%), Gaps = 78/302 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD- 174
DD E++ +G+GA+G V R TG + A+K++ R V + ++ LL ++D
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-------RATVN-SQEQKRLLMDLDI 52
Query: 175 ----SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--------MRKDTLTEDEARF 220
+C V Y + + +++ ME M T L + T+ ED
Sbjct: 53 SMRSVDCPYTVTFYGALFREGDVWICMEV-----MDTSLDKFYKKVYDKGLTIPEDILGK 107
Query: 221 YVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
V A+E +H K IHRD+KP N+L+++ G ++L DFG+ L S + D
Sbjct: 108 IAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID---- 163
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE----VLLKKGYG 335
G Y+APE L +KGY
Sbjct: 164 --------------------------------------AGCKPYMAPERINPELNQKGYD 185
Query: 336 MECDWWSLGAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISK 394
++ D WSLG M E+ G P+ S P +++V + P E K S E +D ++K
Sbjct: 186 VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-EPSPQLPAE-KFSPEFQDFVNK 243
Query: 395 LL 396
L
Sbjct: 244 CL 245
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 1e-12
Identities = 32/135 (23%), Positives = 70/135 (51%), Gaps = 8/135 (5%)
Query: 127 GAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186
G +V + + T + +K L+KS R ER + +V L+
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246
++ ++L++++ GG + + + + + E+ + + AE V+A++++H+ + RD+ P+N
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNN 115
Query: 247 LLLDKYGHLRLSDFG 261
+LLD GH++L+ F
Sbjct: 116 ILLDDRGHIQLTYFS 130
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 63/249 (25%), Positives = 101/249 (40%), Gaps = 48/249 (19%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L +G+G + V R K T ++ A+K+++ E +R E +LL + IV
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALKEIR-LEHEEGAPCTAIR-EVSLLKNLKHANIVT 67
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ + L L+ EYL L + ++ + ++ + + + HK +HR
Sbjct: 68 LHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHR 127
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP NLL+++ G L+L+DFGL + T K
Sbjct: 128 DLKPQNLLINEKGELKLADFGLARAKSVPT-------------------------KTYSN 162
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
E + W Y P+VLL Y D W +G I+YEM G P F
Sbjct: 163 EVVTLW----------------YRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-- 204
Query: 360 DDPMSTCRK 368
P ST ++
Sbjct: 205 --PGSTVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 66/265 (24%), Positives = 110/265 (41%), Gaps = 60/265 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---------KSEMLRRGQVEHVRAE 166
+ ++ L+ +G GA+G V + TG A+KKL K ++H++ E
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
N++ +D + F D +YL+ +L G D+ ++ + LT+D +F + + +
Sbjct: 77 -NVIGLLDVFTPARSLEEFND---VYLVT-HLMGADLNNIV-KCQKLTDDHVQFLIYQIL 130
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD------------------- 171
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345
M Y V T Y APE++L Y D WS+G
Sbjct: 172 -----------------------DEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIV 370
IM E+L G F D + + I+
Sbjct: 207 IMAELLTGRTLFPGTDHIDQLKLIL 231
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 82/350 (23%), Positives = 132/350 (37%), Gaps = 104/350 (29%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
D E IG GAFG V + G A+KK+ + + V R R L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPN---VFQNLVSCKRVFREL------- 50
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDM--------MTLLMRKD---------TLTEDEAR 219
K+ C F+ D L + + L + +T LM+ D L+ D +
Sbjct: 51 ---KMLCFFKHDNVLSAL-DILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVK 106
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
++ + + ++ +H +HRDIKP NLL++ L++ DFGL + ++E D
Sbjct: 107 VFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLAR------VEEPD---- 156
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMEC 338
S++ TQ+ V T Y APE+L+ + Y
Sbjct: 157 -----ESKH--------MTQE-----------------VVTQYYRAPEILMGSRHYTSAV 186
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNW----------------RTHL-----K 377
D WS+G I E+L F + P+ I + R H+ K
Sbjct: 187 DIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHK 246
Query: 378 FPEEAKL-------SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
P L + EA L+ ++L + ++R+ A A HP+ D
Sbjct: 247 PPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADA---LAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 70/285 (24%), Positives = 118/285 (41%), Gaps = 64/285 (22%)
Query: 118 FELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLK---KSEMLRRGQVEHVRAERNLLAEV 173
+E + IG+GA+G+V R+ K G A+K+++ E + + V R+L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 174 DSNCIVKLY----CSFQDDEF-LYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETV 226
N +V+L+ S D E L L+ E++ D+ T L + + + + + + + +
Sbjct: 63 HPN-VVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ +H H +HRD+KP N+L+ G ++L+DFGL +
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---------------------- 158
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
+ +Q M S V T Y APEVLL+ Y D WS+G I
Sbjct: 159 ----------------IYSFQ----MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEEA 382
EM P F + KI+ +W + P +A
Sbjct: 199 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 243
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 44/238 (18%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L +G+G + V R K T ++ A+K+++ G E +LL ++ IV
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ D+ L L+ EYL + + ++ + ++ + + + H+ +HR
Sbjct: 69 LHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHR 128
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP NLL+++ G L+L+DFGL + T K
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSVPT-------------------------KTYSN 163
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGYPPF 357
E + W Y P+VLL Y + D W +G I +EM G P F
Sbjct: 164 EVVTLW----------------YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 1e-11
Identities = 40/99 (40%), Positives = 53/99 (53%), Gaps = 13/99 (13%)
Query: 323 YIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKI-VNWRTHLKFPEE 381
Y APEV CDWWSLGAI++E+L G + C +N T L PE
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTG-------KTLVECHPSGINTHTTLNIPEW 200
Query: 382 AKLSIEAKDLISKLL-CNVNQRLGAKGA--DEIKVHPWF 417
+S EA+ L+ +LL N +RLGA A ++IK HP+F
Sbjct: 201 --VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 1e-11
Identities = 72/268 (26%), Positives = 124/268 (46%), Gaps = 49/268 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+++E++ IG G FGEV + + K T + K + + R + + V E N++ E+
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLV-IEVNVMRELKH 71
Query: 176 NCIVKLYCSF--QDDEFLYLIMEYLPGGDMMTLLMRKDTL---TEDEARFYVAETVL-AI 229
IV+ F + ++ LY++ME+ GD+ + + + E+ A + +L A+
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 230 ESIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
H +HRD+KP N+ L G+ + + T Q NNL
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLST---------GI-RHIGKITAQ------ANNL 175
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRM----LAYSTVGTPDYIAPEVLL--KKGYGM 336
NG RP A ++ + ++ + +A+S VGTP Y +PE+LL K Y
Sbjct: 176 NG------RPIA-------KIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDD 222
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMS 364
+ D W+LG I+YE+ G PF+ + S
Sbjct: 223 KSDMWALGCIIYELCSGKTPFHKANNFS 250
|
Length = 1021 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 66/262 (25%), Positives = 105/262 (40%), Gaps = 54/262 (20%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRAERNLLAEVD 174
+E + IG GA+G V R+ +GH A+K ++ + L V V + L D
Sbjct: 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRL-EAFD 60
Query: 175 SNCIVKLY----CSFQDDEF-LYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVL 227
IV+L S D E + L+ E++ D+ T L + L + + + + +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ +H + +HRD+KP+N+L+ G ++L+DFGL + C
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSC------------------- 160
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
+M V T Y APEVLL+ Y D WS+G I
Sbjct: 161 -----------------------QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 197
Query: 348 YEMLVGYPPFYSDDPMSTCRKI 369
EM P F + KI
Sbjct: 198 AEMFRRKPLFCGNSEADQLGKI 219
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 2e-11
Identities = 59/242 (24%), Positives = 90/242 (37%), Gaps = 52/242 (21%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
L +G+G++ V + G + A+K +K E + + E +LL + I
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR----EASLLKGLKHANI 65
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
V L+ E L + EY+ ++ L R ++ + + + IH H +
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLC--KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
HRD+KP NLL+ G L+L+DFGL K + T + T+
Sbjct: 126 HRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTL------------------ 167
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYP 355
W Y P+VLL Y D W G I EML G P
Sbjct: 168 ---------W----------------YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202
Query: 356 PF 357
F
Sbjct: 203 AF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 43/227 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IGKG FG+V K V A+K + L E +L + D IVKL
Sbjct: 3 IGKGNFGDVYKGVLKGNTEV-AVKTCR--STLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+ +Y++ME +PGG ++T L + K+ LT + + +E + + IHRD+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
N L+ + L++SDFG+ + E++ I +G Q P +
Sbjct: 120 AARNCLVGENNVLKISDFGMSR--------EEEGGIYTVSDGLKQ------IPIK----- 160
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ APE L Y E D WS G +++E
Sbjct: 161 --------------------WTAPEALNYGRYTSESDVWSYGILLWE 187
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 83/354 (23%), Positives = 126/354 (35%), Gaps = 117/354 (33%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH--------VRAE 166
+ ++ L +G+G++ V R K TG + A+K+++ +EH +R E
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIR---------LEHEEGAPFTAIR-E 53
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL-----------PGGDMMTLLMRKDTLTE 215
+LL ++ IV L+ + L L+ EYL GG L+
Sbjct: 54 ASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGG-----------LSM 102
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
R ++ + + + H+ +HRD+KP NLL+ + G L+L+DFGL +
Sbjct: 103 HNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA---------- 152
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKG 333
+ P +T YS V T Y P+VLL
Sbjct: 153 ----------------KSVPSKT----------------YSNEVVTLWYRPPDVLLGSTE 180
Query: 334 YGMECDWWSLGAIMYEMLVGYPPFY-SDDPMSTCRKIV---------NWRTHLKFPEEAK 383
Y D W +G I YEM G P F S D KI W PE
Sbjct: 181 YSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKP 240
Query: 384 LS-------------------IEAKDLISKLL-CNVNQRLGAKGADEIKVHPWF 417
S ++L K L +R+ A E HP+F
Sbjct: 241 YSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI---SAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 4e-11
Identities = 57/238 (23%), Positives = 96/238 (40%), Gaps = 44/238 (18%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L +G+G + V R K T ++ A+K+++ G E +LL ++ IV
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVT 68
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L+ ++ L L+ EYL L +++ + ++ + + + H+ +HR
Sbjct: 69 LHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHR 128
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
D+KP NLL+++ G L+L+DFGL + T K
Sbjct: 129 DLKPQNLLINERGELKLADFGLARAKSIPT-------------------------KTYSN 163
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPF 357
E + W Y P++LL Y + D W +G I YEM G P F
Sbjct: 164 EVVTLW----------------YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 6e-11
Identities = 57/243 (23%), Positives = 98/243 (40%), Gaps = 53/243 (21%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVD 174
D + ++G G G V T + A+K L + L++ + +E +L + D
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQK----QIMSELEILYKCD 57
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
S I+ Y +F + + + E++ GG +L + + R VA V + +
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGG---SLDVYRKIPEHVLGRIAVA-VVKGLTYLWS 113
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 114 LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------------------------- 148
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
+A + VGT Y+APE + + YG+ D WSLG E+ +G
Sbjct: 149 ------------------IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGR 190
Query: 355 PPF 357
P+
Sbjct: 191 FPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 64/263 (24%), Positives = 111/263 (42%), Gaps = 60/263 (22%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM----LRRGQVE-----HVRAERN 168
++ LT +G GA+G V + A+KKL + RR E H++ E N
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE-N 75
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
++ +D + S ++ +YL+ L G D+ ++ + L+++ +F + + +
Sbjct: 76 VIGLLD---VFTPATSIENFNEVYLVTN-LMGADLNNIV-KCQKLSDEHVQFLIYQLLRG 130
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ IH IHRD+KP N+ +++ LR+ DFGL +
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR------------------------ 166
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347
Q + M Y V T Y APE++L Y D WS+G IM
Sbjct: 167 ------------------QADDEMTGY--VATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206
Query: 348 YEMLVGYPPFYSDDPMSTCRKIV 370
E+L G F +D + ++I+
Sbjct: 207 AELLKGKALFPGNDYIDQLKRIM 229
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 6e-11
Identities = 57/259 (22%), Positives = 112/259 (43%), Gaps = 51/259 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + + V A+K LK M V+ E NL+ +
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTLKPGTM----SVQAFLEEANLMKTLQH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+ +V+LY +E +Y+I EY+ G ++ L + + + + A+ + I
Sbjct: 61 DKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +YIHRD++ N+L+ + +++DFGL + +++ ++T E
Sbjct: 121 RKNYIHRDLRAANVLVSESLMCKIADFGLAR-----VIEDNEYTA----------REGAK 165
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-- 351
P + + APE + + ++ D WS G ++YE++
Sbjct: 166 FPIK-------------------------WTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200
Query: 352 --VGYPPFYSDDPMSTCRK 368
+ YP + D MS ++
Sbjct: 201 GKIPYPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 40/146 (27%), Positives = 76/146 (52%), Gaps = 6/146 (4%)
Query: 124 IGKGAFGEVR--VCREKTTGHV-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+G G FG V V K+ V A+K LK+ + G+ E +R E +++A++D CIV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLR-EASVMAQLDHPCIVR 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L + + + L+ME P G ++ L ++ + + + + + + + H++HR
Sbjct: 61 LIGVCKGEPLM-LVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 241 DIKPDNLLLDKYGHLRLSDFGLCKPL 266
D+ N+LL ++SDFG+ + L
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMSRAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 4e-10
Identities = 70/261 (26%), Positives = 103/261 (39%), Gaps = 56/261 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL--LAEVDS 175
++ L IG GA G V + G A+KKL + + Q RA R L L V+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRP---FQNQTHAKRAYRELVLLKCVNH 79
Query: 176 NCIVKLYCSFQD----DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
I+ L F +EF +YL+ME + + M D + + + + + I
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELD---HERMSYLLYQMLCGI 136
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ +H IHRD+KP N+++ L++ DFGL
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-------------------------- 170
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
R A N M Y V T Y APEV+L GY D WS+G IM E
Sbjct: 171 -RTAC-------------TNFMMTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214
Query: 350 MLVGYPPFYSDDPMSTCRKIV 370
++ G F D + K++
Sbjct: 215 LVKGSVIFQGTDHIDQWNKVI 235
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 6e-10
Identities = 64/254 (25%), Positives = 102/254 (40%), Gaps = 61/254 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---- 173
+++ +IGKG++G V + TG A+KK+ EHV +L E+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-------NDVFEHVSDATRILREIKLLR 54
Query: 174 -----DSNCIVKLYCSFQDDEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
D I + EF +Y++ E L D+ ++ D LT + +F++ + +
Sbjct: 55 LLRHPDIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLL 113
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
A++ IH + HRD+KP N+L + L++ DFGL +
Sbjct: 114 RALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARV--------------------- 152
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV---LLKKGYGMECDWWSL 343
N+ P A + V T Y APE+ K Y D WS+
Sbjct: 153 AFNDTPTA-----------------IFWTDYVATRWYRAPELCGSFFSK-YTPAIDIWSI 194
Query: 344 GAIMYEMLVGYPPF 357
G I E+L G P F
Sbjct: 195 GCIFAEVLTGKPLF 208
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 8e-10
Identities = 59/258 (22%), Positives = 99/258 (38%), Gaps = 55/258 (21%)
Query: 119 ELLTMIGKGAFGE--VRVCREKTTGHVYAMKKL----KKSEMLRRGQVEHVRAERNLLAE 172
ELLT+IGK V + + K T + A+KK+ E L+ Q E +
Sbjct: 1 ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQ-----QEIITSRQ 55
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIE 230
+ I+ SF D LY++ + G LL + L E F + + + A++
Sbjct: 56 LQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALD 115
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH +IHR +K ++LL G + LS
Sbjct: 116 YIHSKGFIHRSVKASHILLSGDGKVVLSGL------------------------------ 145
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAY---STVGTPDYIAPEVLLK--KGYGMECDWWSLGA 345
R ++H ++ R + + S P +++PEVL + +GY + D +S+G
Sbjct: 146 ------RYSVSMIKHGKRQRVVHDFPKSSVKNLP-WLSPEVLQQNLQGYNEKSDIYSVGI 198
Query: 346 IMYEMLVGYPPFYSDDPM 363
E+ G+ PF
Sbjct: 199 TACELANGHVPFKDMPAT 216
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 60/239 (25%), Positives = 99/239 (41%), Gaps = 49/239 (20%)
Query: 123 MIGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++GKG FGEV ++KT V K+ E+ + +E +L + D IVK
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIK-----FLSEARILKQYDHPNIVK 56
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIH 239
L + +Y++ME +PGGD ++ L + KD L + + + + + + IH
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIH 116
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+ N L+ + L++SDFG+ + QE D + SS + P
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-------QEDD-----GIYSSSGLKQIPI------ 158
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 357
+ APE L Y E D WS G +++E +G P+
Sbjct: 159 ----------------------KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPY 195
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 74/260 (28%), Positives = 104/260 (40%), Gaps = 60/260 (23%)
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHV-RAERN--LLAEVDSN 176
L IG GA G V + TG A+KKL R Q V H RA R L+ V+
Sbjct: 21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLS-----RPFQNVTHAKRAYRELVLMKLVNHK 75
Query: 177 CIVKLYCSFQD----DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ L F +EF +YL+ME + + M D + + + + + I+
Sbjct: 76 NIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD---HERMSYLLYQMLCGIK 132
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H IHRD+KP N+++ L++ DFGL + T G +
Sbjct: 133 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------------TAGTSF-------- 172
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
M Y V T Y APEV+L GY D WS+G IM EM
Sbjct: 173 --------------------MMTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210
Query: 351 LVGYPPFYSDDPMSTCRKIV 370
+ G F D + KI+
Sbjct: 211 IRGTVLFPGTDHIDQWNKII 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 4e-09
Identities = 58/254 (22%), Positives = 102/254 (40%), Gaps = 60/254 (23%)
Query: 123 MIGKGAFGEVRVCREKT-----TGHV-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+G GAFGEV +G + A+K L+K + + E + E +L++ +
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFL-KEAHLMSNFNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV-LAIE----- 230
IVKL +E Y+IME + GGD+++ L + E + + ++
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 231 -SIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ + H+IHRD+ N L+ + G+ +++ DFGL + + S
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR----------- 168
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
K + W +APE LL + + D WS G
Sbjct: 169 -----------KEGEGLLPVRW-----------------MAPESLLDGKFTTQSDVWSFG 200
Query: 345 AIMYEML-VGYPPF 357
+M+E+L +G P+
Sbjct: 201 VLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 5e-09
Identities = 45/156 (28%), Positives = 80/156 (51%), Gaps = 18/156 (11%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK+ M E AE NL+ ++
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKV-AIKSLKQGSM----SPEAFLAEANLMKQLQH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-------MRKDTLTEDEARFYVAETVLA 228
+V+LY + E +Y+I EY+ G ++ L + + L + A+ +AE +
Sbjct: 61 PRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQ--IAEGMAF 117
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
IE + +YIHRD++ N+L+ + +++DFGL +
Sbjct: 118 IE---RKNYIHRDLRAANILVSETLCCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 5e-09
Identities = 12/50 (24%), Positives = 20/50 (40%), Gaps = 3/50 (6%)
Query: 435 EVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484
+V DT NF+ S+ + + S + F G++Y N E
Sbjct: 1 KVKSPTDTSNFDPEFTSEPPKLSP---PDSEVLSSIDQLEFRGFSYVNPE 47
|
Length = 47 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 54/220 (24%), Positives = 80/220 (36%), Gaps = 38/220 (17%)
Query: 140 TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFLYLIMEYL 198
TGH A+K L+ Q R E L A + IV L S + L+ + EY+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HL 255
PG + +L L E + + + A+ H +HRD+KP N+++ + G H
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY 315
++ DFG IG L G +
Sbjct: 122 KVLDFG----------------IGTLLPGVRDADVA------------------TLTRTT 147
Query: 316 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+GTP Y APE L + D ++ G I E L G
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 9e-09
Identities = 75/283 (26%), Positives = 114/283 (40%), Gaps = 67/283 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKL------KKSEMLRRGQVEHVRAERNLLA 171
++L +IG G+FG V T A+KK+ K E+L + H+ N++
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHI----NIIF 123
Query: 172 EVD---SNCIVKLYCSFQDDEFLYLIMEYLPGG--DMMTLLMRKD-TLTEDEARFYVAET 225
D + C K + + FL ++ME++P M R + L + Y +
Sbjct: 124 LKDYYYTECFKK----NEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
A+ IH HRD+KP NLL+D H L+L DFG K N L G
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK---------------NLLAG 224
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSL 343
+R ++Y + + Y APE++L Y D WSL
Sbjct: 225 -------------------------QRSVSY--ICSRFYRAPELMLGATNYTTHIDLWSL 257
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSI 386
G I+ EM++GYP F + +I+ L P E +L
Sbjct: 258 GCIIAEMILGYPIFSGQSSVDQLVRIIQV---LGTPTEDQLKE 297
|
Length = 440 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 58/296 (19%), Positives = 112/296 (37%), Gaps = 62/296 (20%)
Query: 83 DADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH 142
A S++D ++ L ++K E + +G + ++ + G+ G V V +
Sbjct: 40 SASESDDDDDDGLIPTKQKAREVV----ASLG---YTVIKTLTPGSEGRVFVATKPGQ-- 90
Query: 143 VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGD 202
+L+ GQ E LL V+ ++++ + +++ + D
Sbjct: 91 -------PDPVVLKIGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSD 142
Query: 203 MMTLLMRKDTLTEDEARFYVAETVL-AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261
+ T L ++ + + + +L + +H IHRD+K +N+ ++ + + D G
Sbjct: 143 LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLG 202
Query: 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321
+ F + AP GT
Sbjct: 203 AAQ-----------FPV--------------VAPA-----------------FLGLAGTV 220
Query: 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV-NWRTHL 376
+ APEVL + Y + D WS G +++EML YP +DP ST + V + +HL
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML-AYPSTIFEDPPSTPEEYVKSCHSHL 275
|
Length = 357 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 69/293 (23%), Positives = 113/293 (38%), Gaps = 63/293 (21%)
Query: 86 VSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYA 145
+S ++N +E ++ + L+R ++ L IG GA G V + A
Sbjct: 1 MSRSKRDNNFYSVEIGDSTFTVLKR-------YQNLKPIGSGAQGIVCAAYDAILERNVA 53
Query: 146 MKKLKKSEMLRRGQVEHVRAERNL--LAEVDSNCIVKLYCSFQD----DEF--LYLIMEY 197
+KKL + + Q RA R L + V+ I+ L F +EF +Y++ME
Sbjct: 54 IKKLSRP---FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257
+ + M D + + + + + I+ +H IHRD+KP N+++ L++
Sbjct: 111 MDANLCQVIQMELD---HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST 317
DFGL + S +
Sbjct: 168 LDFGLARTAGTSFMMTPY------------------------------------------ 185
Query: 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV 370
V T Y APEV+L GY D WS+G IM EM+ G F D + K++
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 2e-08
Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 43/236 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G FGEV R + A+K + E L E +L + IV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR--ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA-IESIHKHHYIHRDI 242
+ +Y++ME + GGD +T L + + + + E A +E + H IHRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
N L+ + L++SDFG+ + +E+D +S + K T
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-------EEEDGVY------ASTGGMKQIPVKWT---- 163
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 357
APE L Y E D WS G +++E +G P+
Sbjct: 164 ----------------------APEALNYGRYSSESDVWSFGILLWEAFSLGAVPY 197
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 62/249 (24%), Positives = 100/249 (40%), Gaps = 60/249 (24%)
Query: 118 FELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
F +L GA G C + KT HV +++ GQ E ++L ++
Sbjct: 94 FSILETFTPGAEGFAFACIDNKTCEHV----------VIKAGQRGGTATEAHILRAINHP 143
Query: 177 CIVKLYCSFQDDEFLYLIMEYLP--GGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIH 233
I++L +F ++F LI LP D+ L K + + + +VL AI+ +H
Sbjct: 144 SIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDI-LAIERSVLRAIQYLH 199
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFG-LCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
++ IHRDIK +N+ ++ G + L DFG C P+D +
Sbjct: 200 ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN----------------------- 236
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
N+ Y GT APE+L + YG D WS G +++EM
Sbjct: 237 ---------------ANKY---YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMAT 278
Query: 353 GYPPFYSDD 361
+ + D
Sbjct: 279 CHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 37/143 (25%), Positives = 69/143 (48%), Gaps = 6/143 (4%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G +GEV K A+K LK+ M +VE E ++ E+ +V+L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETV-LAIESIHKHHYIHRD 241
+ Y+I E++ G+++ L + Y+A + A+E + K ++IHRD
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRD 129
Query: 242 IKPDNLLLDKYGHLRLSDFGLCK 264
+ N L+ + ++++DFGL +
Sbjct: 130 LAARNCLVGENHLVKVADFGLSR 152
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 2e-08
Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 22/157 (14%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-- 174
+ +L IGKG FG+V + + G A+K LK + A + LAE
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLK----------DDSTAAQAFLAEASVM 54
Query: 175 -----SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVL 227
N + L Q + LY++ EY+ G ++ L + +T + + +
Sbjct: 55 TTLRHPNLVQLLGVVLQGNP-LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCE 113
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+E + + +++HRD+ N+L+ + ++SDFGL K
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 63/242 (26%), Positives = 95/242 (39%), Gaps = 56/242 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL--LAEVDS 175
++ L IG GA G V + A+KKL + + Q RA R L + V+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP---FQNQTHAKRAYRELVLMKCVNH 75
Query: 176 NCIVKLYCSFQD----DEF--LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
I+ L F +EF +YL+ME + + M D + + + + + I
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGI 132
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ +H IHRD+KP N+++ L++ DFGL + S +
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM------------------ 174
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
M Y V T Y APEV+L GY D WS+G IM E
Sbjct: 175 ----------------------MTPY--VVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 350 ML 351
M+
Sbjct: 211 MV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 55/249 (22%), Positives = 94/249 (37%), Gaps = 60/249 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--- 174
+ +L+ + G+ GEV VC T H +K + V+ V + E+D
Sbjct: 94 YNILSSLTPGSEGEVFVC----TKHGDEQRK--------KVIVKAVTGGKTPGREIDILK 141
Query: 175 --SNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIE 230
S+ I+ L +++ + ++M D+ T + R L ++A + +L A+
Sbjct: 142 TISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQA-ITIQRRLLEALA 199
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+H IHRD+K +N+ LD+ + L DFG LD Q
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC--------------- 244
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
Y GT + +PE+L Y + D WS G +++EM
Sbjct: 245 ------------------------YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280
Query: 351 LVGYPPFYS 359
V +
Sbjct: 281 SVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 4e-07
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLK-------KSEMLRRGQVEHVRAERNLLAEVD 174
+G G FG V+ V + + A+K LK + EM+R ++ H ++D
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMH---------QLD 53
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIH 233
+ IV++ + E L L+ME GG + L +KD +T + + + ++ +
Sbjct: 54 NPYIVRM-IGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE 112
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+++HRD+ N+LL + ++SDFGL K L
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-07
Identities = 64/269 (23%), Positives = 107/269 (39%), Gaps = 57/269 (21%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
D L +G G FG V+ + + V A+K +K+ M +E + L E
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEFIEEAKVMMKLSHEK--- 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTED--EARFYVAETVLAIESI 232
+V+LY +Y++ EY+ G ++ L K E V E + +ES
Sbjct: 61 -LVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES- 118
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+IHRD+ N L+D G +++SDFGL + + + ++T SS ++ P
Sbjct: 119 --KQFIHRDLAARNCLVDDQGCVKVSDFGLSR-----YVLDDEYT-------SSVGSKFP 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML- 351
W PEVLL + + D W+ G +M+E+
Sbjct: 165 V-----------RWS-----------------PPEVLLYSKFSSKSDVWAFGVLMWEVYS 196
Query: 352 VGYPPFYSDDPMSTCRKIVN----WRTHL 376
+G P+ + T K+ +R HL
Sbjct: 197 LGKMPYERFNNSETVEKVSQGLRLYRPHL 225
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 5e-07
Identities = 36/167 (21%), Positives = 61/167 (36%), Gaps = 21/167 (12%)
Query: 115 ADDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D L +G+GAFG+V + + A+K LK E + E L
Sbjct: 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK--ETASNDARKDFEREAEL 61
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--------------TLTE 215
L IVK Y + + ++ EY+ GD+ L LT
Sbjct: 62 LTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ + + + H++HRD+ N L+ +++ DFG+
Sbjct: 122 SQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-07
Identities = 41/153 (26%), Positives = 74/153 (48%), Gaps = 20/153 (13%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLK--------KSEMLRRGQVEHVRAERNLLAEV 173
+G G FG V+ + + K + A+K LK K E+LR E N++ ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR---------EANVMQQL 53
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
D+ IV++ + E L+ME G + L + +TE V + + ++ +
Sbjct: 54 DNPYIVRM-IGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLE 112
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+ +++HRD+ N+LL + ++SDFGL K L
Sbjct: 113 ETNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 51/238 (21%), Positives = 98/238 (41%), Gaps = 47/238 (19%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G FG V + + + V A+K + + M +E E ++ ++ +V+LY
Sbjct: 12 LGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEEDFIE----EAKVMMKLSHPKLVQLYG 66
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+ LY++ E++ G ++ L R+ L++D + +E + ++ +IHRD+
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDL 126
Query: 243 KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
N L+ G +++SDFG+ + + + ++T SS + P
Sbjct: 127 AARNCLVSSTGVVKVSDFGMTR-----YVLDDEYT-------SSSGAKFPV--------- 165
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359
+ PEV Y + D WS G +M+E+ G PF
Sbjct: 166 -------------------KWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 60/250 (24%), Positives = 96/250 (38%), Gaps = 63/250 (25%)
Query: 123 MIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+IG G FGEV R K G A+K LK + Q +E +++ + D I+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEK--QRRDFLSEASIMGQFDHPNII 68
Query: 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI------- 232
L + + ++ EY+ G + L + D +F V + V + I
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD------GQFTVIQLVGMLRGIASGMKYL 122
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
Y+HRD+ N+L++ ++SDFGL + L E D P
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL------EDD----------------P 160
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTP---DYIAPEVLLKKGYGMECDWWSLGAIMYE 349
A AY+T G + APE + + + D WS G +M+E
Sbjct: 161 EA-------------------AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 201
Query: 350 -MLVGYPPFY 358
M G P++
Sbjct: 202 VMSYGERPYW 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 59/268 (22%), Positives = 97/268 (36%), Gaps = 67/268 (25%)
Query: 107 RLQRHKMGADDFELLTMIGKGAFGEVRVC--------REKTTGHVYAMKKLKKSEML--- 155
+L+ F ++ + GAFG++ +C E G + K E L
Sbjct: 139 KLKHDDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAK 198
Query: 156 --RRGQVEHVRAERNLLA--EVDSNCIVKLYCSFQDDEFLYLIME--------YLPGGDM 203
+ G ++ E +LA ++ I+K+ + + Y+I + ++
Sbjct: 199 RVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA- 257
Query: 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263
KD + R + + + A+E IH IHRDIK +N+ L+ G + L DFG
Sbjct: 258 ---FDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
Query: 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323
P ++K R Y VGT
Sbjct: 315 MP----------------------------------------FEKEREAFDYGWVGTVAT 334
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEML 351
+PE+L GY D WS G I+ +ML
Sbjct: 335 NSPEILAGDGYCEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 8/146 (5%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G G FGEV + V A+K +K M VE AE N++ + + +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLH- 67
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARF--YVAETVLAIESIHKHHYIHRD 241
+ E +Y+I E++ G ++ L + + + + A+ + I + +YIHRD
Sbjct: 68 AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127
Query: 242 IKPDNLLLDKYGHLRLSDFGLCKPLD 267
++ N+L+ +++DFGL + ++
Sbjct: 128 LRAANILVSASLVCKIADFGLARVIE 153
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 55/251 (21%), Positives = 106/251 (42%), Gaps = 60/251 (23%)
Query: 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ + +LL IGKG FG+V + + G+ A+K +K + AE +++ +
Sbjct: 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQ 55
Query: 173 VDSNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAI 229
+ + +V+L ++ LY++ EY+ G ++ L + L D + + A+
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
E + ++++HRD+ N+L+ + ++SDFGL K + S+ Q+
Sbjct: 116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQD---------------- 157
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP-DYIAPEVLLKKGYGMECDWWSLGAIMY 348
T P + APE L +K + + D WS G +++
Sbjct: 158 ---------------------------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLW 190
Query: 349 EML----VGYP 355
E+ V YP
Sbjct: 191 EIYSFGRVPYP 201
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 37/148 (25%), Positives = 68/148 (45%), Gaps = 7/148 (4%)
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178
+LL +G G FGEV T V A+K LK M + AE ++ ++ +
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTM----DPKDFLAEAQIMKKLRHPKL 63
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHH 236
++LY +E +Y++ E + G ++ L L + A+ + + +
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
YIHRD+ N+L+ + +++DFGL +
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLAR 151
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 1e-06
Identities = 42/156 (26%), Positives = 73/156 (46%), Gaps = 25/156 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+L +G G FGEV + T V A+K LK M E E ++ ++ +
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTM----SPEAFLQEAQIMKKLRHDK 62
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY-----------VAETV 226
+V+LY ++E +Y++ EY+ G ++ D L E + +AE +
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLL------DFLKSGEGKKLRLPQLVDMAAQIAEGM 116
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ES +YIHRD+ N+L+ + +++DFGL
Sbjct: 117 AYLES---RNYIHRDLAARNILVGENLVCKIADFGL 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-06
Identities = 52/231 (22%), Positives = 95/231 (41%), Gaps = 56/231 (24%)
Query: 149 LKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY-------CSFQDD-----EF--LYLI 194
+KK + V+H E ++ +D + IVK+Y +D E +Y++
Sbjct: 35 VKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIV 94
Query: 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254
EY+ + ++ + L+E+ AR ++ + + ++ IH + +HRD+KP N+ ++
Sbjct: 95 QEYMETD--LANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152
Query: 255 -LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRML 313
L++ DFGL + +D H+ ++ L
Sbjct: 153 VLKIGDFGLARIVD------------------------------------PHYS-HKGYL 175
Query: 314 AYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ V T Y +P +LL Y D W+ G I EML G P F +
Sbjct: 176 SEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL 225
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 2e-06
Identities = 51/235 (21%), Positives = 92/235 (39%), Gaps = 46/235 (19%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+ L +G G FG V + + + V A+K +++ M +E + L
Sbjct: 5 ELTFLKELGSGQFGVVHLGKWRGKIDV-AIKMIREGAMSEDDFIEEAKVMMKLSHPN--- 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHKH 235
+V+LY ++++ EY+ G ++ L + E + V A+E + +
Sbjct: 61 -LVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+IHRD+ N L+ + +++SDFGL + L +Q +T SSQ + P
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLAR----YVLDDQ-YT-------SSQGTKFPV-- 165
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
W PEV + + D WS G +M+E+
Sbjct: 166 ---------KWA-----------------PPEVFDYSRFSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 38/151 (25%), Positives = 73/151 (48%), Gaps = 8/151 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK M +E E ++ ++
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLE----EAQIMKKLRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+ +V+LY + +E +Y++ EY+ G ++ L + L A+ + I
Sbjct: 61 DKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE 119
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ +YIHRD++ N+L+ +++DFGL +
Sbjct: 120 RMNYIHRDLRSANILVGDGLVCKIADFGLAR 150
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 44/253 (17%), Positives = 95/253 (37%), Gaps = 60/253 (23%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L+ +G+G+FG V V + + V A+K + ++ +R + E ++
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRV-AIKTVNENASMR--ERIEFLNEASV 62
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY-------- 221
+ E + + +V+L + ++ME + GD+ + L R +
Sbjct: 63 MKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYL-RSRRPEAENNPGLGPPTLQKF 121
Query: 222 ---VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
AE + + ++HRD+ N ++ + +++ DFG+ + + E D+
Sbjct: 122 IQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-----DIYETDYY- 175
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
R + +L ++APE L + +
Sbjct: 176 ------------RKGG---------------KGLLPVR------WMAPESLKDGVFTTKS 202
Query: 339 DWWSLGAIMYEML 351
D WS G +++EM
Sbjct: 203 DVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 55/270 (20%), Positives = 103/270 (38%), Gaps = 75/270 (27%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVY-----------AMKKLKKSEMLRRGQVEHVRA 165
L +G+GAFG+V G + A+K LK++ + + R
Sbjct: 6 AVRFLEELGEGAFGKV------YKGELTGPNERLSATSVAIKTLKENAEPK--VQQEFRQ 57
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR---------------- 209
E L++++ IV L ++ ++ EYL GD+ L+R
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
K +L + + +E + HH++HRD+ N L+ + +++SDFGL +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR----- 172
Query: 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329
+ S + R +++ +L ++ PE +
Sbjct: 173 -------------DIYSADYYR---------------VQSKSLLPVR------WMPPEAI 198
Query: 330 LKKGYGMECDWWSLGAIMYEML-VGYPPFY 358
L + E D WS G +++E+ G P+Y
Sbjct: 199 LYGKFTTESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 7e-06
Identities = 38/154 (24%), Positives = 76/154 (49%), Gaps = 8/154 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M+ ++ E ++ ++
Sbjct: 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQ----EAQIMKKLRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIH 233
+ +V LY + +E +Y++ E++ G ++ L D L + A+ + I
Sbjct: 61 DKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ +YIHRD++ N+L+ +++DFGL + ++
Sbjct: 120 RMNYIHRDLRAANILVGDNLVCKIADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 41/163 (25%), Positives = 69/163 (42%), Gaps = 21/163 (12%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVY----------AMKKLKKSEMLRRGQVEHVRA 165
+D L IG+G FG+V VY A+K K E
Sbjct: 6 EDITLGRCIGEGQFGDVYQ-------GVYMSPENEKIAVAVKTCKNCTSPSVR--EKFLQ 56
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM-MTLLMRKDTLTEDEARFYVAE 224
E ++ + D IVKL ++ ++++ME P G++ L + K +L Y +
Sbjct: 57 EAYIMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQ 115
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
A+ + ++HRDI N+L+ ++L DFGL + L+
Sbjct: 116 LSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 34/162 (20%), Positives = 72/162 (44%), Gaps = 24/162 (14%)
Query: 121 LTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHV----RAERNLLA 171
+T +G+G FGEV + + E+ + +K L+K++ E++ R E ++
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK------DENLQSEFRRELDMFR 63
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM--------RKDTLTEDEARFYVA 223
++ +V+L ++ E Y+I+EY GD+ L K + + +
Sbjct: 64 KLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALC 123
Query: 224 ETV-LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ L ++ + ++HRD+ N L+ +++S L K
Sbjct: 124 TQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 58/274 (21%), Positives = 102/274 (37%), Gaps = 73/274 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHV-------YAMKKLKKSEMLRRGQVEHVRAERN 168
++ E + IG+GAFG RV + + G + A+K LK+ Q + R E
Sbjct: 5 NNIEYVRDIGQGAFG--RVFQARAPGLLPYEPFTMVAVKMLKEEASADM-QADFQR-EAA 60
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--------------------- 207
L+AE D IVKL + + L+ EY+ GD+ L
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 208 -MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+ L+ E + + + + ++HRD+ N L+ + ++++DFGL +
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR-- 178
Query: 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326
+ D+ +E A P R ++ P
Sbjct: 179 ---NIYSADYYKA---------SENDAIPIR-------------------------WMPP 201
Query: 327 EVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYS 359
E + Y E D W+ G +++E+ G P+Y
Sbjct: 202 ESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 40/174 (22%), Positives = 80/174 (45%), Gaps = 33/174 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVY--AMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
+D + +IG+G FG+V R K G A+K++K+ + +H R+ E+
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA----SKDDH----RDFAGEL 58
Query: 174 DSNC-------IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK---------------- 210
+ C I+ L + + +LYL +EY P G+++ L +
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 118
Query: 211 DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
TL+ + + A+ ++ + + +IHRD+ N+L+ + +++DFGL +
Sbjct: 119 STLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 56/239 (23%), Positives = 104/239 (43%), Gaps = 31/239 (12%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-SEMLRRGQVEHVRAERNLLAEV-DS 175
F++L+++G+G FG+V ++ A+K ++ + R ++E E+ A+ D
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADR 190
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
++K+ FQ++ I+ G ++ +M+ + + +T +A++ H
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTE 250
Query: 236 -HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +H D+KP+N+L++ SD +D T N P
Sbjct: 251 LHLMHTDLKPENILMET------SD----TVVDPVT-----------------NRALPPD 283
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
P R + L R + V T Y +PEV+L G+ D WS+G I+YE+ G
Sbjct: 284 PCRVRICDLGGCCDERHSRT-AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 53/240 (22%), Positives = 95/240 (39%), Gaps = 55/240 (22%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEVDS 175
+F L +G G FGEV K V A+K LK ++L++ + V+A + L +
Sbjct: 7 EFTLERKLGSGYFGEVWEGLWKNRVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKH-- 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY-----VAETVLAIE 230
++ L+ E +Y+I E + G ++ L + A VAE + +E
Sbjct: 64 --LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE 121
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ IHRD+ N+L+ + +++DFGL + L ++D + ++
Sbjct: 122 E---QNSIHRDLAARNILVGEDLVCKVADFGLAR------LIKEDVYLSSDKK------- 165
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
P + + APE + + D WS G ++YEM
Sbjct: 166 ---IPYK-------------------------WTAPEAASHGTFSTKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 25/128 (19%), Positives = 48/128 (37%), Gaps = 11/128 (8%)
Query: 138 KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV--KLYCSFQDDEFLYLIM 195
T Y +K E + E +L + + K+ S + D + YL+M
Sbjct: 18 GTKDEDYVLKINPSRE-----KGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLM 72
Query: 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255
E++ G L +++ +AE + + + H D+ P N+L+D L
Sbjct: 73 EWIEG----ETLDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKIL 128
Query: 256 RLSDFGLC 263
+ D+
Sbjct: 129 GIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 54/263 (20%), Positives = 105/263 (39%), Gaps = 75/263 (28%)
Query: 124 IGKGAFGEVRVCREKTTGHVY----------AMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
+G+ AFG++ GH+Y A+K LK ++ Q + E +L+AE+
Sbjct: 13 LGECAFGKI------YKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAEL 64
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMT-LLMR----------------KDTLTED 216
IV L ++ + ++ EYL GD+ L+MR K +L
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG 124
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
+ + +E + H ++H+D+ N+L+ + H+++SD GL + + + D+
Sbjct: 125 DFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA-----DY 179
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
R Q + L + ++ PE ++ +
Sbjct: 180 Y-------------------RVQPKSLLPIR---------------WMPPEAIMYGKFSS 205
Query: 337 ECDWWSLGAIMYEML-VGYPPFY 358
+ D WS G +++E+ G P+Y
Sbjct: 206 DSDIWSFGVVLWEIFSFGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 3e-05
Identities = 14/67 (20%), Positives = 27/67 (40%), Gaps = 5/67 (7%)
Query: 418 DGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
G+DW ++ +E F+P++ DT NF+ + T + + F
Sbjct: 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEP---F 57
Query: 476 VGYTYKN 482
G++Y
Sbjct: 58 RGFSYVF 64
|
Length = 64 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 55/255 (21%), Positives = 100/255 (39%), Gaps = 63/255 (24%)
Query: 124 IGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+G+GAFG+V +C E+ V A+K LK + R H AE LL +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILV-AVKTLKDASDNARKDF-HREAE--LLTNLQHEH 68
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-------------DTLTEDEARFYVAE 224
IVK Y + + L ++ EY+ GD+ L LT+ + +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ + H++HRD+ N L+ + +++ DFG+ + + + + +G +
Sbjct: 129 IAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY----YRVGGH--- 181
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
P R ++ PE ++ + + E D WSLG
Sbjct: 182 -------TMLPIR-------------------------WMPPESIMYRKFTTESDVWSLG 209
Query: 345 AIMYEMLV-GYPPFY 358
+++E+ G P+Y
Sbjct: 210 VVLWEIFTYGKQPWY 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 44/165 (26%), Positives = 72/165 (43%), Gaps = 19/165 (11%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D LL +G GAFGEV R A+K L E E ++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTL--PESCSEQDESDFLMEALIM 63
Query: 171 AEVDSNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLL-------MRKDTLTEDEARFYV 222
++ + IV+L SF+ ++++E + GGD+ + L R +LT + F
Sbjct: 64 SKFNHQNIVRLIGVSFERLPR-FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCA 122
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR---LSDFGLCK 264
+ + + ++H+IHRDI N LL G R ++DFG+ +
Sbjct: 123 RDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 4e-05
Identities = 61/251 (24%), Positives = 100/251 (39%), Gaps = 63/251 (25%)
Query: 123 MIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVR----AERNLLAEVDS 175
+IG G FGEV R K G A+K LK G E R +E +++ + D
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS------GYTEKQRRDFLSEASIMGQFDH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI--- 232
I+ L + +I E++ G + + L + D +F V + V + I
Sbjct: 65 PNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND------GQFTVIQLVGMLRGIAAG 118
Query: 233 ----HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+ +Y+HRD+ N+L++ ++SDFGL + L+ T D T ++L G
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT---SDPTYTSSLGGK--- 172
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
P R + APE + + + D WS G +M+
Sbjct: 173 -----IPIR-------------------------WTAPEAIAYRKFTSASDVWSYGIVMW 202
Query: 349 E-MLVGYPPFY 358
E M G P++
Sbjct: 203 EVMSYGERPYW 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 4e-05
Identities = 38/159 (23%), Positives = 76/159 (47%), Gaps = 18/159 (11%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-------MRKDTLTEDEARFYVAETVLA 228
+V+LY + +E +Y++ EY+ G ++ L +R L + A+
Sbjct: 61 EKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD-----MAAQIASG 114
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + + +Y+HRD++ N+L+ + +++DFGL + ++
Sbjct: 115 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 153
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 38/171 (22%), Positives = 74/171 (43%), Gaps = 32/171 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKS--------EMLRRGQVEHVR----AERNLLA 171
+G+G FGEV +C + + +MLR + R E +++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV----- 226
+ + I++L D+ L +I EY+ GD+ L ++ E E+ F A +
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQR----EIESTFTHANNIPSVSI 128
Query: 227 -------LAIESIHKH----HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+ I S K+ +++HRD+ N L+ + ++++DFG+ + L
Sbjct: 129 ANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNL 179
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 37/166 (22%), Positives = 72/166 (43%), Gaps = 31/166 (18%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC----- 177
+IG+G FG+V R K G ++ + ++ + R+ E++ C
Sbjct: 2 VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKD--DHRDFAGELEVLCKLGHH 55
Query: 178 --IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEA----------------- 218
I+ L + + +LYL +EY P G+++ L + L D A
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
F A+ ++ + + +IHRD+ N+L+ + +++DFGL +
Sbjct: 116 HF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 1e-04
Identities = 38/172 (22%), Positives = 78/172 (45%), Gaps = 29/172 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D + +IG+G FG+V K G +K +ML+ E+ R+ E++
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDG----LKMNAAIKMLKEFASEN--DHRDFAGELEV 55
Query: 176 NC-------IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DT 212
C I+ L + ++ +LY+ +EY P G+++ L + T
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
LT + + ++ ++ + + +IHRD+ N+L+ + +++DFGL +
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 39/166 (23%), Positives = 71/166 (42%), Gaps = 24/166 (14%)
Query: 124 IGKGAFGEVRVCREKT-TGHVY--AMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+G G+FG VR T G V A+K LK ++ ++ E ++ +D +++
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIR 60
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL--------AIESI 232
LY L ++ E P G ++ D L +D ++ T+ + +
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLL------DRLRKDALGHFLISTLCDYAVQIANGMRYL 113
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL----DCSTLQEQ 274
+IHRD+ N+LL +++ DFGL + L D ++E
Sbjct: 114 ESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEH 159
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 57/274 (20%), Positives = 109/274 (39%), Gaps = 77/274 (28%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHV--------YAMKKLKKSEMLRRGQVEHVRAERN 168
+ L +G+G FG+V + T + A+K LK++ ++ + +E N
Sbjct: 1 NLVLGKTLGEGEFGKVV---KATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFN 55
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM--RK--------------DT 212
LL +V+ ++KLY + D L LI+EY G + + L RK
Sbjct: 56 LLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSY 115
Query: 213 LTEDEARFYVAETVLA--------IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
L + R +++ ++ + + +HRD+ N+L+ + +++SDFGL +
Sbjct: 116 LDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
Query: 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324
+ E+D + KR++ W +
Sbjct: 176 -----DVYEED-----------------SYVKRSKGRIPVKW-----------------M 196
Query: 325 APEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF 357
A E L Y + D WS G +++E++ +G P+
Sbjct: 197 AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 57/248 (22%), Positives = 103/248 (41%), Gaps = 47/248 (18%)
Query: 119 ELLTMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
ELLT+IG+G V + R K TG ++++ E V ++ E ++ +
Sbjct: 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRIN-LEACTNEMVTFLQGELHVSKLFNHP 59
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHK 234
IV +F D L+++ ++ G L+ D ++E + + + A++ IH
Sbjct: 60 NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
Y+HR +K ++L+ G + LS GL
Sbjct: 120 MGYVHRSVKASHILISVDGKVYLS--GL-------------------------------- 145
Query: 295 PKRTQQEQLQHWQKNRRML---AYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 349
R+ + H Q+ R + YS P +++PEVL + +GY + D +S+G E
Sbjct: 146 --RSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACE 202
Query: 350 MLVGYPPF 357
+ G+ PF
Sbjct: 203 LANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 3e-04
Identities = 54/279 (19%), Positives = 98/279 (35%), Gaps = 64/279 (22%)
Query: 117 DFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
D L +G+GAFG+V + + A+K LK + R + E LL
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLT 62
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----------------MRKDTLTE 215
+ IVK Y D + L ++ EY+ GD+ L K L
Sbjct: 63 NLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
+ ++ + + H++HRD+ N L+ +++ DFG+ + + +
Sbjct: 123 SQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---- 178
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335
+ +G + P R ++ PE ++ + +
Sbjct: 179 YRVGGH----------TMLPIR-------------------------WMPPESIMYRKFT 203
Query: 336 MECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWR 373
E D WS G I++E+ G P++ I R
Sbjct: 204 TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 242
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 3e-04
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 22/167 (13%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKK--SEMLRRGQVEHVRAERNL 169
+ +IG G FGEV R K G A+K LK S+ R + E ++
Sbjct: 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL----TEASI 58
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ + D I++L + +I EY+ G + L D +F V + V +
Sbjct: 59 MGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREND------GKFTVGQLVGML 112
Query: 230 ESI-------HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
I + +Y+HRD+ N+L++ ++SDFGL + L+ S
Sbjct: 113 RGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 40/139 (28%), Positives = 53/139 (38%), Gaps = 40/139 (28%)
Query: 222 VAETVL-AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
VA +L AI+ IH IHRDIK +N+L++ + L DFG C F G+
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAA----C-------FARGS 313
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
+ P Y GT D APEVL Y D
Sbjct: 314 W-----------STP-----------------FHYGIAGTVDTNAPEVLAGDPYTPSVDI 345
Query: 341 WSLGAIMYEMLVGYPPFYS 359
WS G +++E V +S
Sbjct: 346 WSAGLVIFEAAVHTASLFS 364
|
Length = 461 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 4e-04
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 10/156 (6%)
Query: 118 FELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
E + ++G GAFG V EK V A+K L++ + E + E ++A
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPV-AIKVLREETS-PKANKEILD-EAYVMAS 65
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIES 231
VD +V+L + LI + +P G ++ + KD + + + +
Sbjct: 66 VDHPHVVRLLG-ICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +HRD+ N+L+ H++++DFGL K LD
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 38/175 (21%), Positives = 70/175 (40%), Gaps = 39/175 (22%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ--------VEHVRAERN------L 169
+G+G FGEV +C M+K + V+ +R + N
Sbjct: 13 LGEGQFGEVHLCE------AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDF 66
Query: 170 LAEV-------DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-----------KD 211
L E+ D N I++L + L +I EY+ GD+ L R
Sbjct: 67 LKEIKIMSRLKDPN-IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
T++ F + ++ + +++HRD+ N L+ K ++++DFG+ + L
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL 180
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 6e-04
Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 118 FELLTMIGKGAFGEVR---VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
F L M+GKG FG VR + E + A+K LK +++ +E E + E D
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLK-ADIFSSSDIEEFLREAACMKEFD 59
Query: 175 SNCIVKLY-CSFQDDEFLYL-----IMEYLPGGDMMTLLMRKD------TLTEDEARFYV 222
++KL S + L I+ ++ GD+ T L+ TL ++
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ +E + ++IHRD+ N +L++ + ++DFGL K
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 34/163 (20%), Positives = 71/163 (43%), Gaps = 18/163 (11%)
Query: 118 FELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV 173
+L ++G+G FG V + + + V A+K +K ++E +E + +
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYS-EIEEFLSEAACMKDF 58
Query: 174 DSNCIVKLY-CSFQDDEFLYL-----IMEYLPGGDMMTLLMRKDT------LTEDEARFY 221
D ++KL F+ + I+ ++ GD+ + L+ L +
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ + L +E + ++IHRD+ N +L + + ++DFGL K
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK 161
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 58/259 (22%), Positives = 106/259 (40%), Gaps = 55/259 (21%)
Query: 116 DDFELLTMIGKGAFGEVR------VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ +G GAFG+V + + V A+K LK + + E + +E +
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKV-AVKMLKPTA--HSSEREALMSELKI 91
Query: 170 LAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETV 226
++ + ++ IV L + + +I EY GD++ L RK LT ++ + +
Sbjct: 92 MSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHL-RLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ + + IHRD+ N+LL +G + ++ DFGL + I N+ N
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLL-THGKIVKICDFGLAR------------DIMNDSNYV 198
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
+ N R P + ++APE + Y E D WS G
Sbjct: 199 VKGNAR--LPVK-------------------------WMAPESIFNCVYTFESDVWSYGI 231
Query: 346 IMYEML-VGYPPFYSDDPM 363
+++E+ +G P Y P+
Sbjct: 232 LLWEIFSLGSNP-YPGMPV 249
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 0.001
Identities = 55/248 (22%), Positives = 97/248 (39%), Gaps = 59/248 (23%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVR----AERNLLAEVDSNCI 178
+IG G FGEV K G +K L+ G E R +E +++ + + I
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKT---LKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--- 235
++L + +I EY+ G + L D + + + + + I + K+
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGIAAGMKYLSD 125
Query: 236 -HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+Y+HRD+ N+L++ ++SDFGL + L +D
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVL-------EDD------------------ 160
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTP---DYIAPEVLLKKGYGMECDWWSLGAIMYE-M 350
P+ T Y+T G + APE + + + D WS G +M+E M
Sbjct: 161 PEGT----------------YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 204
Query: 351 LVGYPPFY 358
G P++
Sbjct: 205 SFGERPYW 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 50/259 (19%), Positives = 96/259 (37%), Gaps = 69/259 (26%)
Query: 124 IGKGAFGEVRVC--------REKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+G+GAFG+V + ++K V A+K+ +S + E LL +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQ------DFQREAELLTVLQH 66
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEAR------------FY 221
IV+ Y + L ++ EY+ GD+ L D
Sbjct: 67 QHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 222 VAETVLA-IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+A + + + + H++HRD+ N L+ + +++ DFG+ + + + + +G
Sbjct: 127 IASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY----YRVGG 182
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
R P R ++ PE +L + + E D
Sbjct: 183 ----------RTMLPIR-------------------------WMPPESILYRKFTTESDI 207
Query: 341 WSLGAIMYEMLV-GYPPFY 358
WS G +++E+ G P+Y
Sbjct: 208 WSFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 50/236 (21%), Positives = 94/236 (39%), Gaps = 62/236 (26%)
Query: 145 AMKKLK-KSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203
A+K LK K+E R E + E + + + IV L ++ L +I Y D+
Sbjct: 39 AIKTLKDKAEGPLR---EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 204 MT-LLMR---------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247
L+MR K TL + V + +E + HH +H+D+ N+
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNV 155
Query: 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQ 307
L+ ++++SD GL + + + + +GN+L P R
Sbjct: 156 LVFDKLNVKISDLGLFREVYAADYYK---LMGNSL-----------LPIR---------- 191
Query: 308 KNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPF--YSD 360
+++PE ++ + ++ D WS G +++E+ G P+ YS+
Sbjct: 192 ---------------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 497 | |||
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.78 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.76 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.72 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.55 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.49 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.4 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.19 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.12 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.07 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.05 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.8 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.78 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.72 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.64 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.54 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.53 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.48 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.48 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.44 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.44 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.34 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.25 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.24 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.18 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.1 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.08 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.04 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.91 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.85 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 97.78 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.74 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.73 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.67 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.57 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.45 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.39 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.39 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.36 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.09 | |
| PLN02236 | 344 | choline kinase | 97.06 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.99 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 96.9 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.89 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.88 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.73 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.67 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.6 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.51 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.45 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.37 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.33 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.16 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.04 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.44 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 95.32 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.0 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.99 | |
| PTZ00296 | 442 | choline kinase; Provisional | 94.81 |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-111 Score=839.46 Aligned_cols=459 Identities=67% Similarity=1.051 Sum_probs=420.0
Q ss_pred CCchhcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHhhhhhHHHHhhcCCC
Q 010947 35 STDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG 114 (497)
Q Consensus 35 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 114 (497)
...+.+.+..|++|+++++.+++++|..++....+|.+|+..+++.+...+++++++.+.++.+..++++++|+++.++.
T Consensus 60 ~~~~~~~s~~T~~k~~~~k~~ien~Y~~~~~~~~~R~er~~~le~~l~~~~~s~~~~~~~~~~~~~kEte~lR~~R~r~~ 139 (550)
T KOG0605|consen 60 SEYEFLVSNKTKRKVAAAKQYIENHYSSQIKYLNERKERRKELEEKLASEDVSEEEQNELLKSLLSKETEYLRLRRTRLS 139 (550)
T ss_pred cccccccCchhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhhccccHHHHHHHHHHHhhHHHHHHHhccccCC
Confidence 34456789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.+||+++++||+|+||.||+|+.+.||+.||||+++|+.+...+|++|++.|++||...++||||+||++|||..++|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||+||||++++|++.+.|+++.++||+++++.||+.||++|||||||||+|+|||..||+||+|||||+.+........
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987765432111
Q ss_pred ---cccccCCCCCCCCCCCCCC--CCc--cchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 275 ---DFTIGNNLNGSSQNNERPA--APK--RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 275 ---~~~~~~~~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
+.....+...+ -....+. .+. ....++..+|+++||.+++++||||.|||||++.+.+|+..||||||||||
T Consensus 300 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~Im 378 (550)
T KOG0605|consen 300 YRLDEQMQINLSEA-KPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIM 378 (550)
T ss_pred hcchhhhhhhhccC-CCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHH
Confidence 00000011111 1111221 223 337788999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhh
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 427 (497)
||||+|+|||+++++.+++++|++|+..+.+|....+|++|+|||.+|||||++|+|..|++||+.||||++|+|+.|++
T Consensus 379 yEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~d~~~RLG~~G~~EIK~HPfF~~v~W~~l~~ 458 (550)
T KOG0605|consen 379 YEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLCDPENRLGSKGAEEIKKHPFFKGVDWDHLRE 458 (550)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhcCHHHhcCcccHHHHhcCCccccCCcchhhc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCcccccCCcccccCcccccccccccCCCCCCCccccccc-------CcCCcccCceeeCCccCCCCCCCCC
Q 010947 428 MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLS-------SKDINFVGYTYKNFEIVNDYQVPGM 494 (497)
Q Consensus 428 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~f~g~~~~~~~~~~~~~~~~~ 494 (497)
.+|||+|.+++++||+||++|.+.+...+++...++|+++.. +++.+|+||||++++.++..+.+.+
T Consensus 459 ~~apfvP~v~~~~DT~yFddF~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~~~~~~~~~~~ 532 (550)
T KOG0605|consen 459 MPAPFVPQVNSELDTQYFDDFPEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFDGLNKANSLLI 532 (550)
T ss_pred CCCCCCCCCCCcccccccccCcccccCcccccccccchhhhhcccccCCcccccccceeeeccccccccccccc
Confidence 999999999999999999999998888888888888887665 5678899999999999999988843
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-83 Score=645.21 Aligned_cols=431 Identities=43% Similarity=0.775 Sum_probs=373.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCHHHHHHHHHHHHhhhhhHHHHhhcCCCCCCeeEEeEeeecCC
Q 010947 50 AAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAF 129 (497)
Q Consensus 50 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~IG~G~f 129 (497)
.+-|.|+|+|-.+.++..+++..|+..||++|...++.+..+....+.+.++|+.|+|+++.++...-|..++.||-|+|
T Consensus 563 qafkFfMEQHVEnvlksyqqr~~Rk~QLEkEM~kagLpd~~q~qMrkmL~QKESnYiRLkRaKMdKSmFvkik~iGvGAF 642 (1034)
T KOG0608|consen 563 QAFKFFMEQHVENVLKSYQQREKRKKQLEKEMVKAGLPDIMQNQMRKMLQQKESNYIRLKRAKMDKSMFVKIKTIGVGAF 642 (1034)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCCHHHHHHHHHHHHhhhhhHHHHHHhhccccceEEEeeeccccc
Confidence 45678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCchhHHHHh
Q 010947 130 GEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR 209 (497)
Q Consensus 130 G~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~ 209 (497)
|+|.+|+..+|...||||.+.|.+++.++++.|++.|++||+..+++|||+||++|||.+++|+||+|++|||++.+|.+
T Consensus 643 GeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIr 722 (1034)
T KOG0608|consen 643 GEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIR 722 (1034)
T ss_pred ceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc----ccccccccCCCCCC
Q 010947 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL----QEQDFTIGNNLNGS 285 (497)
Q Consensus 210 ~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~----~~~~~~~~~~~~~~ 285 (497)
.+.|.|+.|+||++++.+|++++|+.|+|||||||+|||||.+|||||+|||||+.+.+... ..++.....++.-+
T Consensus 723 mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~ 802 (1034)
T KOG0608|consen 723 MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPS 802 (1034)
T ss_pred hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCc
Confidence 99999999999999999999999999999999999999999999999999999998754321 11111111111100
Q ss_pred CCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHH
Q 010947 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMST 365 (497)
Q Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~ 365 (497)
........+.+ .-.....+..+|.++.+.|||+.|+|||++...+|+..|||||.|||||||+.|.+||...++-++
T Consensus 803 ~e~~d~~~~lk---vL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 803 PEWADISKCLK---VLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred hhhccccccch---HHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 00000011110 011112245678889999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhhcCCCcccccCCcccccCc
Q 010947 366 CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNF 445 (497)
Q Consensus 366 ~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f 445 (497)
..+|++|...+.+|....+|+++.+||.+|+|+++.|+|..++++|+.||||++|||..+++..+||||.+..++||+||
T Consensus 880 q~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNF 959 (1034)
T KOG0608|consen 880 QYKVINWRNFLHIPYQGNLSKEALDLIQKLCCSADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNF 959 (1034)
T ss_pred eeeeeehhhccccccccccCHHHHHHHHHHhcChhhhhcccchhhhhcCccccccchHhhhhccCCcCccccCCCccccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccccccccCCCCCCCcccccccCcCCcccCceeeCC
Q 010947 446 EKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNF 483 (497)
Q Consensus 446 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~ 483 (497)
|.++.+..-...+...+.|......-+-+|--|||++|
T Consensus 960 dpvdpeklwnddses~~~~~~~nkhpehaFyEFTfRrF 997 (1034)
T KOG0608|consen 960 DPVDPEKLWNDDSESPNVRDTLNKHPEHAFYEFTFRRF 997 (1034)
T ss_pred CcCCccccccccccCCCcccccccCCccceeEeeeehh
Confidence 99886432111111222333332233468999999986
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-79 Score=592.47 Aligned_cols=328 Identities=44% Similarity=0.781 Sum_probs=286.7
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
....++|+++++||+|+||+|++|+.+.|++.||||+|+|..+...+.++++++|+.||..++||+||+|+++||+...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 46689999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|||+||+.||+|..+|++.+.|+|..+++|+++|++||.|||++|||||||||+|||||.+||++|+|||||+..-....
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~ 180 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGD 180 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999995432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
.+.++|||+.|||||++.+.+|+.+||||||||++||||
T Consensus 181 -----------------------------------------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML 219 (357)
T KOG0598|consen 181 -----------------------------------------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEML 219 (357)
T ss_pred -----------------------------------------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHh
Confidence 122689999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC-CCCcchhcCCCCccCCChhhhhh--
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG-AKGADEIKVHPWFDGVDWARIYQ-- 427 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~-~~~~~eil~Hpff~~i~w~~l~~-- 427 (497)
+|.+||.+.+...++++|...+ +.++. ..+|.+++|||++||. ||.+|+| ..++++|.+||||++|||+.+.+
T Consensus 220 ~G~pPF~~~~~~~~~~~I~~~k--~~~~p-~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~ 296 (357)
T KOG0598|consen 220 TGKPPFYAEDVKKMYDKILKGK--LPLPP-GYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKK 296 (357)
T ss_pred hCCCCCcCccHHHHHHHHhcCc--CCCCC-ccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHHHhcC
Confidence 9999999999999999999743 33333 2599999999999999 9999997 35789999999999999999984
Q ss_pred cCCCcccccCCcccccCcccccccccccCCCCCCCcc----cccccCcCCcccCceeeCC
Q 010947 428 MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPW----RKMLSSKDINFVGYTYKNF 483 (497)
Q Consensus 428 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~f~g~~~~~~ 483 (497)
+.|||+|.+.++.|++||+..........+.....+. ..........|.||||...
T Consensus 297 l~PpF~P~~~~~~~~~~Fd~eft~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~gft~~~~ 356 (357)
T KOG0598|consen 297 LSPPFKPNVTGLEDTSNFDNEFTSYTVDYSPVDSSPDMSAFTAFSRTYNKIFPGFTYVAS 356 (357)
T ss_pred CCCCeecCCCCccccccccHHHHhccccCCccccCcccccccccccccccccCCccccCC
Confidence 8899999999999999999744433222222211111 1112233457999999764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-79 Score=649.74 Aligned_cols=346 Identities=47% Similarity=0.849 Sum_probs=306.4
Q ss_pred HHHHHhhhhhHHHHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC
Q 010947 95 LKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174 (497)
Q Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~ 174 (497)
..++.....-...+...++..+||+++++||+|+||.|.+|+++.|+++||||+++|-.+.++.....|+.|++||...+
T Consensus 54 ~~fl~~~kp~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n 133 (1317)
T KOG0612|consen 54 AEFLNRYKPIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN 133 (1317)
T ss_pred HHHHHHhHHHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC
Confidence 33444444444556777888999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCceeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc
Q 010947 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (497)
Q Consensus 175 hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~ 254 (497)
++|||.|+++|||++++|+|||||+||||.++|.+.++++|+.|+||+++|+.||..||+.|+|||||||+|||||..||
T Consensus 134 s~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH 213 (1317)
T KOG0612|consen 134 SEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH 213 (1317)
T ss_pred cHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc
Confidence 99999999999999999999999999999999999899999999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---
Q 010947 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--- 331 (497)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--- 331 (497)
+||+|||.|-.++.+... .+...||||+|++||++..
T Consensus 214 ikLADFGsClkm~~dG~V----------------------------------------~s~~aVGTPDYISPEvLqs~~~ 253 (1317)
T KOG0612|consen 214 IKLADFGSCLKMDADGTV----------------------------------------RSSVAVGTPDYISPEVLQSQGD 253 (1317)
T ss_pred EeeccchhHHhcCCCCcE----------------------------------------EeccccCCCCccCHHHHHhhcC
Confidence 999999999887643211 1236799999999999972
Q ss_pred --CCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcc
Q 010947 332 --KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGAD 409 (497)
Q Consensus 332 --~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~ 409 (497)
+.|+..|||||+||++||||+|.+|||.++..++|.+|++-+..+.||....+|.+++|||.++||+|+.|+|+.|++
T Consensus 254 ~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~~~e~RLgrngie 333 (1317)
T KOG0612|consen 254 GKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLCDREVRLGRNGIE 333 (1317)
T ss_pred CccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhcChhhhcccccHH
Confidence 569999999999999999999999999999999999999988899999878899999999999999999999999999
Q ss_pred hhcCCCCccCCChhhhhhcCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeC
Q 010947 410 EIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 410 eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (497)
+|+.||||.+++|+.|++..|||+|+++++.||+||+-.+...... ........+-......+|+||||..
T Consensus 334 dik~HpFF~g~~W~~iR~~~pP~vPevssd~DTsnFd~~~dd~~~~--e~~p~~~~~~f~Gn~LPFIGfTy~~ 404 (1317)
T KOG0612|consen 334 DIKNHPFFEGIDWDNIRESVPPVVPEVSSDDDTSNFDVDEDDLRDA--ETFPPRIPKAFSGNHLPFIGFTYTH 404 (1317)
T ss_pred HHHhCccccCCChhhhhhcCCCCCCcCCCCCccccccccccccchh--hccCCCCCCCCcCCcCCeeeeeecc
Confidence 9999999999999999999999999999999999996433221111 1111011123445678999999986
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-77 Score=554.90 Aligned_cols=292 Identities=46% Similarity=0.920 Sum_probs=278.1
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
...+||+.++.||.|+||.|.+++.+.+|..||||++.+..+.+-.|++|+.+|..+|+.+.||++++|+++|+|.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 66789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
|||||++||.|..+|.+.++|++..++||++||++||+|||+++|++|||||+|||||.+||+||+|||+|+.+...
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--- 197 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999976421
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
+++.||||.|+|||++...+|+.++|||||||++|||+.
T Consensus 198 -----------------------------------------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMla 236 (355)
T KOG0616|consen 198 -----------------------------------------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLA 236 (355)
T ss_pred -----------------------------------------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHc
Confidence 458999999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh--
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ-- 427 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~-- 427 (497)
|++||++.++..++++|++ ..+.||. .+|++++|||++||+ |-.+|.|. +|.++|+.||||++++|..+.+
T Consensus 237 G~pPF~~~~~~~iY~KI~~--~~v~fP~--~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ 312 (355)
T KOG0616|consen 237 GYPPFYDDNPIQIYEKILE--GKVKFPS--YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRK 312 (355)
T ss_pred CCCCCcCCChHHHHHHHHh--CcccCCc--ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHHHhhcc
Confidence 9999999999999999998 6788996 899999999999999 99999884 4799999999999999999985
Q ss_pred cCCCccc-ccCCcccccCcccccccc
Q 010947 428 MEAAFIP-EVNDELDTQNFEKFEESD 452 (497)
Q Consensus 428 ~~~p~~p-~~~~~~d~~~f~~~~~~~ 452 (497)
+++||+| .+..+.|++||+...+.+
T Consensus 313 ie~P~~pp~~~~~gdtsnfd~y~e~~ 338 (355)
T KOG0616|consen 313 IEPPFEPPNIHGPGDTSNFDDYEEED 338 (355)
T ss_pred ccCCCCCccccCCccccccccccccc
Confidence 8999998 899999999999877654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-75 Score=595.18 Aligned_cols=325 Identities=37% Similarity=0.695 Sum_probs=292.2
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
.++..++|.++++||+|+||+|+++..+.+++.||||+++|..++.+..++..+.|.+|+... +||+++.||++||+.+
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 478889999999999999999999999999999999999999999999999999999999887 5999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
++|+||||+.||| +.++++.+.|++..++||+++|++||.|||++||||||||.+|||+|.+||+||+||||||.....
T Consensus 443 ~l~fvmey~~Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~ 521 (694)
T KOG0694|consen 443 HLFFVMEYVAGGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQ 521 (694)
T ss_pred eEEEEEEecCCCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCC
Confidence 9999999999999 445556689999999999999999999999999999999999999999999999999999965321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
. ..+.++||||.|||||++.+..|+.++|||||||+|||
T Consensus 522 g-----------------------------------------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlye 560 (694)
T KOG0694|consen 522 G-----------------------------------------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYE 560 (694)
T ss_pred C-----------------------------------------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHH
Confidence 1 11347999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhh
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~ 426 (497)
||+|.+||.|+++.+.+..|++ ....+|. ++|.++.+++++||. +|++|+|+ .++++|+.||||+.|||+.|.
T Consensus 561 ML~Gq~PF~gddEee~FdsI~~--d~~~yP~--~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~ 636 (694)
T KOG0694|consen 561 MLVGESPFPGDDEEEVFDSIVN--DEVRYPR--FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLL 636 (694)
T ss_pred HHcCCCCCCCCCHHHHHHHHhc--CCCCCCC--cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHh
Confidence 9999999999999999999998 5666775 899999999999999 99999997 579999999999999999998
Q ss_pred h--cCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCCc
Q 010947 427 Q--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484 (497)
Q Consensus 427 ~--~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 484 (497)
+ ++|||+|.++++.|++|||+.+..+.+..+++..... -......|.||+|.+.+
T Consensus 637 ~r~i~PPf~P~i~~~~D~snFd~eFt~e~p~Lt~~~~~~l---~~~~q~~F~~Fs~~~~~ 693 (694)
T KOG0694|consen 637 NRRIKPPFVPTIKGPEDVSNFDEEFTSEKPALTPSDPRPL---TEEEQEAFRDFSFVAEW 693 (694)
T ss_pred hccCCCCCCcccCChhhhcccchhhhcCCCccCCCCcccc---chhhHHHhcCccccCCC
Confidence 4 8999999999999999999877776666554332221 12345699999998864
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-69 Score=527.19 Aligned_cols=330 Identities=37% Similarity=0.619 Sum_probs=272.5
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
+...+..++|++++.||.|.-|+||+|+.+.++..+|||+|.|..+..+....++..|.+||+.++||+++.||..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 44567788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
++.|||||||+||||..+++++ +.|++..++||+++++.||+|||-+|||+||||||||||.++|||.|+||.|+...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 9999999999999999999775 56999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCccccccc-ccCCCCCC------CCCCCCCCCC-ccch-HHHHH------HHhhhcccccccccCCCcccCcccccc
Q 010947 267 DCSTLQEQDFT-IGNNLNGS------SQNNERPAAP-KRTQ-QEQLQ------HWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (497)
Q Consensus 267 ~~~~~~~~~~~-~~~~~~~~------~~~~~~~~~~-~~~~-~~~~~------~~~~~~~~~~~~~~Gt~~Y~aPE~l~~ 331 (497)
........... .......+ +....+.... ++.. .+... -...-......++|||-.|+|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 33211000000 00000000 0000000000 0000 00000 000011123458999999999999999
Q ss_pred CCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC-CCcc
Q 010947 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGAD 409 (497)
Q Consensus 332 ~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~-~~~~ 409 (497)
.+++.++|||+|||++||||+|.+||.|.+..+++.+|+. ..+.||..+.+|..|+|||++||. ||.+|++. .||.
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~--~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~ 387 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG--QPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAA 387 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc--CCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchH
Confidence 9999999999999999999999999999999999999997 788999988999999999999999 99999994 6899
Q ss_pred hhcCCCCccCCChhhhhhcCCCcccccCCcc
Q 010947 410 EIKVHPWFDGVDWARIYQMEAAFIPEVNDEL 440 (497)
Q Consensus 410 eil~Hpff~~i~w~~l~~~~~p~~p~~~~~~ 440 (497)
||++||||++++|.-++-..||++|...+..
T Consensus 388 eIK~HpFF~gVnWaLir~~~PP~iP~~~d~~ 418 (459)
T KOG0610|consen 388 EIKRHPFFEGVNWALIRCARPPEIPKPVDGG 418 (459)
T ss_pred HhhcCccccCCChhheeccCCCcCCCccccC
Confidence 9999999999999988889999999976554
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-70 Score=515.15 Aligned_cols=330 Identities=39% Similarity=0.685 Sum_probs=293.6
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
.+.++..++|+.+++||+|.||+|.+|+.+.||+.||||+++|..++.+.++.|...|-++|...+||++..|-++||+.
T Consensus 161 ~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~ 240 (516)
T KOG0690|consen 161 RKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQ 240 (516)
T ss_pred ccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccC
Confidence 45667889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+.+|+||||..||+|..+|.+...|+|..++||-++|++||.|||+.+||+||||.+|+|+|.+||+||+|||||+.-..
T Consensus 241 drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 241 DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999985422
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
.. ..+.++||||.|+|||++....|+.++|||.+||+||
T Consensus 321 ~g-----------------------------------------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMY 359 (516)
T KOG0690|consen 321 YG-----------------------------------------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMY 359 (516)
T ss_pred cc-----------------------------------------ceeccccCChhhcCchhhccccccceeehhhhhHHHH
Confidence 10 0123789999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhh
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l 425 (497)
||++|+.||+..+....+.-|+. ..+.||. .+|++++.|+..||. ||.+|+|. .+|.||.+|+||.+|+|..+
T Consensus 360 EMmCGRLPFyn~dh~kLFeLIl~--ed~kFPr--~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~ 435 (516)
T KOG0690|consen 360 EMMCGRLPFYNKDHEKLFELILM--EDLKFPR--TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEAT 435 (516)
T ss_pred HHHhccCcccccchhHHHHHHHh--hhccCCc--cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHH
Confidence 99999999999999999999987 6889996 899999999999999 99999985 36889999999999999999
Q ss_pred h--hcCCCcccccCCcccccCcccccccccccCCC-CCCCcccccccCcCCcccCceeeCC
Q 010947 426 Y--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTS-SKTGPWRKMLSSKDINFVGYTYKNF 483 (497)
Q Consensus 426 ~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~f~g~~~~~~ 483 (497)
. ++.|||.|++.+++|+++||+.+.+.....++ .+.++...+-....-+|.-|+|.+.
T Consensus 436 ~~Kki~PPfKPqVtSetDTryFD~EFT~q~v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~~ 496 (516)
T KOG0690|consen 436 YRKKIEPPFKPQVTSETDTRYFDEEFTSQPVTLTPPDRYGSTVDEDEERRPHFPQFSYSAS 496 (516)
T ss_pred HHhccCCCCCCCcccccchhhhhhhhhcceeEecCCCCCCcccchhhhhccCCcceeeecc
Confidence 8 48999999999999999999765554333332 2223321122223458999999764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-67 Score=525.89 Aligned_cols=285 Identities=39% Similarity=0.710 Sum_probs=258.9
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 190 (497)
+....||.+.+.||.|+|++|++|+.+.|++.||||++.|.-+.+...+..+..|.++|..| .||.||+||+.|||+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 56678999999999999999999999999999999999999999999999999999999999 89999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|+|+||+++|+|.++|.+.+.|++..+++|++||+.||+|||++|||||||||||||||.+||+||+|||.|+.+....
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987553
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
........ ...+. ..+.++|||..|.+||+|.....++.+|+|+||||||+|
T Consensus 229 ~~~~~~~~------------~~~a~----------------s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQm 280 (604)
T KOG0592|consen 229 KSQENPVD------------PNQAS----------------SRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQM 280 (604)
T ss_pred ccccCccC------------ccccc----------------CcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHH
Confidence 22111000 00000 002379999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhcC
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQME 429 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~ 429 (497)
+.|.|||.+.++.-++++|+. ....||+ .+++.++|||++||. ||.+|++ +++|++||||.+|||+.|.+.+
T Consensus 281 laG~PPFra~NeyliFqkI~~--l~y~fp~--~fp~~a~dLv~KLLv~dp~~Rlt---~~qIk~HpFF~~Vdw~nlw~~~ 353 (604)
T KOG0592|consen 281 LAGQPPFRAANEYLIFQKIQA--LDYEFPE--GFPEDARDLIKKLLVRDPSDRLT---SQQIKAHPFFEGVDWENLWQQT 353 (604)
T ss_pred hcCCCCCccccHHHHHHHHHH--hcccCCC--CCCHHHHHHHHHHHccCcccccc---HHHHhhCcccccCChhhhhhcC
Confidence 999999999999999999997 5667776 799999999999999 9999999 8999999999999999999876
Q ss_pred CC
Q 010947 430 AA 431 (497)
Q Consensus 430 ~p 431 (497)
||
T Consensus 354 PP 355 (604)
T KOG0592|consen 354 PP 355 (604)
T ss_pred CC
Confidence 64
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-68 Score=512.39 Aligned_cols=330 Identities=35% Similarity=0.659 Sum_probs=296.6
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 190 (497)
.+...||.++.+||+|+||+|.++..+.|.+.||||+++|+.++....++....|.++|+.. +-|+++.|+..||+-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 56778999999999999999999999999999999999999999999999999999999987 56899999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|+||||+.||||+..+++-+.|.|..|.||+++|+-||-+||++|||+||||.+|||+|.+||+||+|||+|+.-....
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG 504 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999998543221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
..+.++||||.|+|||++..++|+.++||||+||+||||
T Consensus 505 -----------------------------------------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEm 543 (683)
T KOG0696|consen 505 -----------------------------------------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 543 (683)
T ss_pred -----------------------------------------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHH
Confidence 113378999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhh-
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY- 426 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~- 426 (497)
|.|.+||.|++..+.++.|+. ....+|. .+|.+|.++++.+|. .|.+|+|+. +-.+|..||||+.|||+++.
T Consensus 544 laGQpPFdGeDE~elF~aI~e--hnvsyPK--slSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~ 619 (683)
T KOG0696|consen 544 LAGQPPFDGEDEDELFQAIME--HNVSYPK--SLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLER 619 (683)
T ss_pred HcCCCCCCCCCHHHHHHHHHH--ccCcCcc--cccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhh
Confidence 999999999999999999997 6788886 899999999999999 999999964 56789999999999999998
Q ss_pred -hcCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCCccCCCC
Q 010947 427 -QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDY 489 (497)
Q Consensus 427 -~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~~ 489 (497)
+++|||.|.++-.-+++|||++........++.. +..|++-+...|.||||.|++.+...
T Consensus 620 ~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD---~~v~~nldq~eF~gFsfvNpefv~~~ 680 (683)
T KOG0696|consen 620 REIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPD---KLVMMNLDQSEFEGFSFVNPEFVKPI 680 (683)
T ss_pred ccCCCCCCCccccCCchhhhhHHHhcCCCCCCCch---HHHHhcCchhhcCceeeeChhhcCCC
Confidence 5899999999999999999998876654443322 22244445579999999999877643
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-62 Score=502.61 Aligned_cols=364 Identities=61% Similarity=1.042 Sum_probs=301.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|+++.+|+.||||++.+..........++..|+.+|..++||||++++++|.+..++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999999876666667788999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.+.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876432111000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
......... ..................|...++...++.+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 161 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 161 RILSHALPS---NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred ccccccccc---cccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 000000000 00000000111122233455555556677899999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhhcCCCcccc
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~ 435 (497)
||.+.+..+.+.+++.|...+.+|....+|+++++||.+||++|.+|+++.++.+++.||||++++|+.+....+|++|.
T Consensus 238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~~p~~R~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 317 (364)
T cd05599 238 PFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLGNNGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317 (364)
T ss_pred CCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccCHhhcCCCCCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence 99999999999999998888888877778999999999999999999988889999999999999999999999999999
Q ss_pred cCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCCc
Q 010947 436 VNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484 (497)
Q Consensus 436 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 484 (497)
+.+..|.++|+.+++.+.....+. ........++|..|.||+|++|+
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 364 (364)
T cd05599 318 LKSITDTSNFDDFEEIDLDVPTSP--GPPRGKIKSKDLAFIGYTYKRFE 364 (364)
T ss_pred CCCchhhhhccccccccccccCCC--ccccccccccCCCCCCCeeeCCC
Confidence 999999999998776554332221 11222345689999999999985
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-62 Score=499.22 Aligned_cols=362 Identities=54% Similarity=0.927 Sum_probs=291.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|+++.+++.||||++.+..........++..|+.++..++||||+++++.|++...+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999999876666667778999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||+||+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.+.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~-- 158 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE-- 158 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc--
Confidence 999999999999988999999999999999999999999999999999999999999999999999998654221000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
................ ..........|.+.+.....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 159 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 159 FYRNLNHSLPSDFTFQ----NMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred cccccccccccccccc----ccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 0000000000000000 000001112233334444557799999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhhcCCCcccc
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~ 435 (497)
||.+.+..+.+.+|..+...+.+|....+|+++++||.+|+++|.+|+++++++||++||||++++|+.+...+++..+.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~ 314 (363)
T cd05628 235 PFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRERPAAIPIE 314 (363)
T ss_pred CCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCCCCCHHHHHhCCCCCCcc
Confidence 99999999999999988878888876679999999999999899999888889999999999999999998877666677
Q ss_pred cCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCC
Q 010947 436 VNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNF 483 (497)
Q Consensus 436 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~ 483 (497)
+.+..|+++|+.+........+...+..-.......+..|.||||+.|
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 362 (363)
T cd05628 315 IKSIDDTSNFDEFPDSDILKPTVATSNHPETDYKNKDWVFINYTYKRF 362 (363)
T ss_pred CCCcchhhccCCCCccccccccccccCCcccccCcCCcccCCceeecC
Confidence 888889999998765543222111111111223445678999999865
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-64 Score=486.95 Aligned_cols=263 Identities=32% Similarity=0.546 Sum_probs=236.0
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc----hhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR----RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~----~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
..+.|.+.+.||+|+||.|.+|..+.||+.||||++++..... ......+.+|++||+++.|||||+++++|..++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4567899999999999999999999999999999999876543 223445789999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC---CcEEEccccccccc
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPL 266 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~---g~vkL~DFGla~~~ 266 (497)
+.||||||+.||+|++.+..++.+.+...+.|+.|++.||.|||++||+||||||+|||++.+ ..+||+|||+||..
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~ 329 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS 329 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence 999999999999999999999999999999999999999999999999999999999999877 78999999999976
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC---CcchhHHhH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY---GMECDWWSL 343 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y---~~~~DiwSl 343 (497)
+... ...+.||||.|.|||++.+.++ ..++|+|||
T Consensus 330 g~~s------------------------------------------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl 367 (475)
T KOG0615|consen 330 GEGS------------------------------------------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL 367 (475)
T ss_pred ccce------------------------------------------ehhhhcCCccccChhheecCCeecccchheeeec
Confidence 4221 2347899999999999998664 458899999
Q ss_pred HHHHHHHHhCCCCCCCCChHH-HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 344 GAIMYEMLVGYPPFYSDDPMS-TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
|||||-+|+|++||.+..... ..++|..++..+.-|.+..+|.++.+||.+||. ||++|++ ++|+|+||||+.++
T Consensus 368 GcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s---~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 368 GCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPS---ADEALNHPWFKDAP 444 (475)
T ss_pred cceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcC---HHHHhcChhhhccc
Confidence 999999999999998875554 888999877776667778899999999999999 9999999 99999999999775
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-62 Score=494.13 Aligned_cols=257 Identities=38% Similarity=0.617 Sum_probs=242.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
.+|...+.||+|||+.||.+++..+|+.||+|++.|..+.+..+.+.+.+|++|.+.++|||||++|.+|+|.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 56999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|+|..|+|+.++.++.+++|.+|++|+.||+.||.|||+++|||||||..|++|+.+.+|||+|||||..+..+..
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E---- 173 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE---- 173 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998753311
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
..++.||||.|+|||++...+++..+||||+|||||-||+|+|
T Consensus 174 -------------------------------------rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~P 216 (592)
T KOG0575|consen 174 -------------------------------------RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRP 216 (592)
T ss_pred -------------------------------------ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCC
Confidence 1237899999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc-cCC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF-DGV 420 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff-~~i 420 (497)
||...+..+++.+|.. ....+|. .+|.+|+|||.+||. ||.+||+ +++|+.|+|| .+.
T Consensus 217 PFetk~vkety~~Ik~--~~Y~~P~--~ls~~A~dLI~~lL~~~P~~Rps---l~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 217 PFETKTVKETYNKIKL--NEYSMPS--HLSAEAKDLIRKLLRPNPSERPS---LDEVLDHPFFKSGF 276 (592)
T ss_pred CcccchHHHHHHHHHh--cCccccc--ccCHHHHHHHHHHhcCCcccCCC---HHHHhcCHhhhCCC
Confidence 9999999999999987 5667776 899999999999999 9999999 9999999999 443
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-61 Score=493.58 Aligned_cols=369 Identities=51% Similarity=0.921 Sum_probs=293.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|.+++.||+|+||+||+|.++.+|+.||||++.+..........++.+|+.+++.++|||||+++++|.+..++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998876655666778999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc-
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ- 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~- 274 (497)
||++||+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+|||++.+|++||+|||+|+.+........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 9999999999998888999999999999999999999999999999999999999999999999999975432110000
Q ss_pred -cccccCCCC----CCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 275 -DFTIGNNLN----GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 275 -~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
......... ......................|...+..+..+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 000000000 000000000000011112333444444445556799999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhhcC
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQME 429 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~ 429 (497)
|++|.+||.+.+..+.+.++..|...+.+|....+|.++++||.+||++|.+|+++.++.+++.||||.+++|+.+..+.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~~ 320 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIR 320 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhcCCCcCCCCHHHHccCC
Confidence 99999999999888889999988888888876679999999999999999999988889999999999999999999999
Q ss_pred CCcccccCCcccccCcccccccccccCCCCCC-Cc-ccccccCcCCcccCceeeCCc
Q 010947 430 AAFIPEVNDELDTQNFEKFEESDNQTKTSSKT-GP-WRKMLSSKDINFVGYTYKNFE 484 (497)
Q Consensus 430 ~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~f~g~~~~~~~ 484 (497)
+|++|.+....++.+|........+....... .+ ......+.+.+|.||||++|+
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 377 (377)
T cd05629 321 APFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELDLAFIGYTYKRFD 377 (377)
T ss_pred CCcccCCCCccccccCCccccccCccccccccccccccccccccCcccccceecCCC
Confidence 99999999999998887644332221111111 01 111223467899999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-61 Score=493.04 Aligned_cols=366 Identities=45% Similarity=0.791 Sum_probs=288.3
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++++.||+|+||+||+|+++.+++.||||++.+.......+..++.+|+.+++.++|||||+++++|++.+.+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 69999999999999999999999999999999998776666778889999999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc----
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ---- 272 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~---- 272 (497)
||+||+|.+++.+.+.+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+......
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~ 161 (382)
T cd05625 82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161 (382)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccc
Confidence 9999999999988888999999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccCCCCCCCCC-CCCC-CCCcc-chHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 273 EQDFTIGNNLNGSSQN-NERP-AAPKR-TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~-~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
...........-+... .... ..... ...+.. ......+....+.+||+.|+|||++.+.+|+.++|||||||++||
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 162 SGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERR-AARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred cccccccccccccccccccccccccccccchhhh-hccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 0000000000000000 0000 00000 000000 000011122346789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhh-hhc
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARI-YQM 428 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l-~~~ 428 (497)
|++|.+||.+.++.+...++.+|...+.+|....+|+++++||.+|+.+|.+|+++.+++++++||||++++|... .+.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~ 320 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQ 320 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHccCHhHcCCCCCHHHHhcCCCcCCcChHHHHhcC
Confidence 9999999999999899999998888888887778999999999998779999999888999999999999999874 467
Q ss_pred CCCcccccCCcccccCcccccccccccCC------CCCCCcccccccCcCCcccCceeeCC
Q 010947 429 EAAFIPEVNDELDTQNFEKFEESDNQTKT------SSKTGPWRKMLSSKDINFVGYTYKNF 483 (497)
Q Consensus 429 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~f~g~~~~~~ 483 (497)
.+|++|.+..+.|+++|+.++........ ......|.......+.+|.||||+++
T Consensus 321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 381 (382)
T cd05625 321 SAPYIPKITHPTDTSNFDPVDPDKLWSDDDKEGNVNDTLNGWYKNGKHPEHAFYEFTFRRF 381 (382)
T ss_pred CCCccCcCCCcchhhhcCCCCccccccccccccccccccccccccccccCcccccceeccc
Confidence 89999999999999999876543221110 01111234344556789999999964
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-63 Score=488.03 Aligned_cols=298 Identities=38% Similarity=0.742 Sum_probs=280.3
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
.+...+++.+..||-|+||.|=++..+.....+|+|+++|..+.+..|.+|+..|..||..+++|+||+||-.|.|+.++
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 35567888999999999999999998776667999999999999999999999999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|++||-|-||+|.+.|..++.|.+..++||++.++.|++|||++|||+|||||+|+|++.+|.+||.|||+|+.+..+.
T Consensus 496 YmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~- 574 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR- 574 (732)
T ss_pred hhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999999876431
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
.+.++||||.|.|||++.+++++.++|+||||+++||||
T Consensus 575 -----------------------------------------KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL 613 (732)
T KOG0614|consen 575 -----------------------------------------KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELL 613 (732)
T ss_pred -----------------------------------------ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHH
Confidence 134799999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC--CCCcchhcCCCCccCCChhhhh--
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGADEIKVHPWFDGVDWARIY-- 426 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~--~~~~~eil~Hpff~~i~w~~l~-- 426 (497)
+|.|||.+.+++.+|..|+.+...+.+|. .++..+.+||++|+. +|.+|+| ..|+.+|+.|.||.++||+.++
T Consensus 614 ~G~pPFs~~dpmktYn~ILkGid~i~~Pr--~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~ 691 (732)
T KOG0614|consen 614 TGSPPFSGVDPMKTYNLILKGIDKIEFPR--RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSR 691 (732)
T ss_pred cCCCCCCCCchHHHHHHHHhhhhhhhccc--ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhc
Confidence 99999999999999999999888889995 899999999999998 9999999 7899999999999999999998
Q ss_pred hcCCCcccccCCcccccCccccccccc
Q 010947 427 QMEAAFIPEVNDELDTQNFEKFEESDN 453 (497)
Q Consensus 427 ~~~~p~~p~~~~~~d~~~f~~~~~~~~ 453 (497)
.++|||+|.+.+++|++||+.|....+
T Consensus 692 ~L~pPi~~~va~ptD~s~Fd~~p~dnd 718 (732)
T KOG0614|consen 692 TLPPPIIPSVANPTDVSNFDNFPPDND 718 (732)
T ss_pred cCCCCccccCCCcccchhccCCCcccC
Confidence 489999999999999999999876543
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-60 Score=484.91 Aligned_cols=360 Identities=54% Similarity=0.934 Sum_probs=291.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||.||+|+++.+++.||||++.+..........++..|+.++..++||||+++++.|++.+++|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876666667788999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||+||+|.+++.+.+.+++..++.++.|++.||.|||+.||+||||||+|||++.+|++||+|||+|+.+........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~- 159 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF- 159 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc-
Confidence 9999999999998888999999999999999999999999999999999999999999999999999986543211000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
. ................ ........|..++....++.+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 160 -~-~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 160 -Y-RNLTHNPPSDFSFQNM---NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred -c-cccccCCccccccccc---ccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 0 0000000000000000 0001112233344445567899999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhhcCCCcccc
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~ 435 (497)
||.+.++...+.++.+|...+.+|....+|+++++||.+|+.||.+|+++.+++++++||||++++|..+.+.+++..+.
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~~p~~R~~~~~~~ei~~hp~f~~~~~~~~~~~~~~~~~~ 314 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRERPAAIPIE 314 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhccChhhcCCCCCHHHHhcCCCCCCCCHHHHhcCCCCCCcc
Confidence 99999999999999988777888876678999999999976699999998889999999999999999998776666667
Q ss_pred cCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCCc
Q 010947 436 VNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484 (497)
Q Consensus 436 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 484 (497)
+....|+++|+.+.++.......... ..-..+++..|.+|+|+.++
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 360 (360)
T cd05627 315 IKSIDDTSNFDEFPESDILQPAENTI---EPDYKSKDWVFLNYTYKRFE 360 (360)
T ss_pred CCCcchhhhcCCCCcccccCCCcccc---ccccCcCCcccCCceeecCC
Confidence 88888999998876554322111111 11245678889999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-61 Score=472.44 Aligned_cols=313 Identities=35% Similarity=0.678 Sum_probs=273.0
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+....++.+.|..-++||+|+||+|+-|+.+.||+.||+|.+.|..+..+.......+|..||.++.+++||.|-++|++
T Consensus 177 lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT 256 (591)
T KOG0986|consen 177 LELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET 256 (591)
T ss_pred HHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC
Confidence 44567888999999999999999999999999999999999999888777777788999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
.+.+||||..|.||||..+|.+.+ .|++..++||+++|+.||++||..+||+|||||+|||+|+.||++|+|+|||..
T Consensus 257 kd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 257 KDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred CCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999999999997766 799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
+..... ..+.+||.+|||||++.+..|+..+|||||||
T Consensus 337 i~~g~~------------------------------------------~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGC 374 (591)
T KOG0986|consen 337 IPEGKP------------------------------------------IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGC 374 (591)
T ss_pred cCCCCc------------------------------------------cccccCcccccCHHHHcCCcccCCccHHHHHh
Confidence 753311 12569999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCh----HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCcc
Q 010947 346 IMYEMLVGYPPFYSDDP----MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFD 418 (497)
Q Consensus 346 il~ell~G~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~ 418 (497)
++|||+.|+.||..... .+.-+.+++ .+..+|+ .+|+++++|++.||+ ||++|+|. .|++++++||||+
T Consensus 375 llYemi~G~sPFr~~KeKvk~eEvdrr~~~--~~~ey~~--kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk 450 (591)
T KOG0986|consen 375 LLYEMIAGHSPFRQRKEKVKREEVDRRTLE--DPEEYSD--KFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK 450 (591)
T ss_pred HHHHHHcccCchhhhhhhhhHHHHHHHHhc--chhhccc--ccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence 99999999999976432 355566665 5667775 899999999999999 99999996 4799999999999
Q ss_pred CCChhhhhh--cCCCccccc-----CCcccccCccc-----cccccc----ccCCCCCCCcccc
Q 010947 419 GVDWARIYQ--MEAAFIPEV-----NDELDTQNFEK-----FEESDN----QTKTSSKTGPWRK 466 (497)
Q Consensus 419 ~i~w~~l~~--~~~p~~p~~-----~~~~d~~~f~~-----~~~~~~----~~~~~~~~~~~~~ 466 (497)
++||.++.. ++|||+|.. ++..|+.+|++ ++..+. ...+.+.+.+|++
T Consensus 451 ~lnw~rleagml~PPfiPdp~aVyakDv~DIeqFs~VKGV~ld~~D~~fy~~F~tg~vsipWQn 514 (591)
T KOG0986|consen 451 DLNWRRLEAGMLEPPFIPDPGAVYAKDVLDIEQFSTVKGVKLDDTDTDFYKNFATGSVSIPWQN 514 (591)
T ss_pred cCCHhHHhccCCCCCCCCCccccchhhhhhhhhcccccceecccccHHHHHhccCCcccchHHH
Confidence 999999984 899999996 46678888874 222211 2345566778875
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-59 Score=481.93 Aligned_cols=366 Identities=45% Similarity=0.822 Sum_probs=280.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|++++.||+|+||+||+|+++.++..||||++.+..........++..|+.++..++|||||+++++|.+.+++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999998776667778889999999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|++||+|.+++.+...+++..++.+++||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.+....... ..
T Consensus 82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~-~~ 160 (381)
T cd05626 82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK-YY 160 (381)
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc-cc
Confidence 99999999999888899999999999999999999999999999999999999999999999999987553211000 00
Q ss_pred cccCCCCCCCCC-----CCCCCC--CccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 277 TIGNNLNGSSQN-----NERPAA--PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 277 ~~~~~~~~~~~~-----~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
..+......... ...... ..+.............+..+.+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 000000000000 000000 0000000000000011112346789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhh-hc
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIY-QM 428 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~-~~ 428 (497)
|++|.+||.+.+..+...+++.|...+.+|....+|+++++||.+||+.+.+|.++.+++++++||||.+++|.... ..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~~~~~~~~~ 320 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIRTQ 320 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCChhHHhhcC
Confidence 99999999998888888888887777788876779999999999998844454444559999999999999998754 57
Q ss_pred CCCcccccCCcccccCcccccccccccCCCCC-CCccccccc----CcCCcccCceeeCC
Q 010947 429 EAAFIPEVNDELDTQNFEKFEESDNQTKTSSK-TGPWRKMLS----SKDINFVGYTYKNF 483 (497)
Q Consensus 429 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~f~g~~~~~~ 483 (497)
++|++|.+..+.++++|+...+.......... ...|....+ .....|.||||+++
T Consensus 321 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 380 (381)
T cd05626 321 PAPYVPKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFYEFTFRRF 380 (381)
T ss_pred CCCccCcCCCcchhhhcCCCCcccccccCCccchhhhccccCcccccccccccccEeecc
Confidence 78999999999999999876543221111111 012222221 23568999999875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-60 Score=451.68 Aligned_cols=327 Identities=34% Similarity=0.660 Sum_probs=280.2
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
+.+...+|.++++||+|+|++|.+++.++|.+.||||+++|.-......+..++.|..+.... +||++|-|+.+||++.
T Consensus 245 ~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtes 324 (593)
T KOG0695|consen 245 QGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTES 324 (593)
T ss_pred cccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccc
Confidence 456788999999999999999999999999999999999998777777889999999999765 7999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+++|.||++||||+.++++.+.++|+.++||.++|+.||.|||+.|||+||||.+|+|+|..||+||+|+|+|+.--.+
T Consensus 325 rlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~ 404 (593)
T KOG0695|consen 325 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGP 404 (593)
T ss_pred eEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999853211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
++ .+.++||||.|+|||++.+..|+..+|||+|||+|||
T Consensus 405 ----gd-------------------------------------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfe 443 (593)
T KOG0695|consen 405 ----GD-------------------------------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFE 443 (593)
T ss_pred ----Cc-------------------------------------ccccccCCCcccchhhhcccccCceehHHHHHHHHHH
Confidence 11 1237899999999999999999999999999999999
Q ss_pred HHhCCCCCCC-------CC-hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC---CCcchhcCCCCc
Q 010947 350 MLVGYPPFYS-------DD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWF 417 (497)
Q Consensus 350 ll~G~~PF~~-------~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~---~~~~eil~Hpff 417 (497)
|+.|+.||.- .+ ..-.++-|+. ..+.+|. .+|-.+..+++..|+ ||.+|+|. .|..+++.||||
T Consensus 444 mmagrspfdivgm~n~d~ntedylfqvile--kqiripr--slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ff 519 (593)
T KOG0695|consen 444 MMAGRSPFDIVGMDNPDMNTEDYLFQVILE--KQIRIPR--SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFF 519 (593)
T ss_pred HHcCCCCcceecCCCcccchhHHHHHHHhh--hcccccc--eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhh
Confidence 9999999952 11 2234555555 5667775 788899999999999 99999996 378899999999
Q ss_pred cCCChhhhhh--cCCCcccccCCcccccCcccccccccccCCCCCCCcccccccC-cCCcccCceeeCCccC
Q 010947 418 DGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDINFVGYTYKNFEIV 486 (497)
Q Consensus 418 ~~i~w~~l~~--~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~~~~~~~ 486 (497)
+.|||+.+.+ +-|||.|.+.++.+..||+.-+.++....++... ..+.. ....|.||.|.|+-.|
T Consensus 520 r~idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~~qltpdd~----d~i~ridqsefegfeyinpl~m 587 (593)
T KOG0695|consen 520 RSIDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDE----DAIKRIDQSEFEGFEYINPLLM 587 (593)
T ss_pred hhCCHHHHhhcccCCCCCCccccccCccccccccccCCcccCCCCH----HHHHhcchhhcCcceecchhhc
Confidence 9999999985 7899999999999999999755444333222211 12222 3468999999998654
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-57 Score=466.55 Aligned_cols=330 Identities=43% Similarity=0.867 Sum_probs=276.8
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+.+..+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.+++.++||||++++++|.+
T Consensus 35 ~~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (370)
T cd05621 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD 114 (370)
T ss_pred HHhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc
Confidence 44556677899999999999999999999999999999999987665555556678899999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
+..+|+|||||+||+|.+++.. ..+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+.
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 115 DKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999999998854 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC----CCcchhHHhH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWSL 343 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----y~~~~DiwSl 343 (497)
..... ...+.+||+.|+|||++.+.+ ++.++|||||
T Consensus 194 ~~~~~----------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSl 233 (370)
T cd05621 194 ETGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSV 233 (370)
T ss_pred cCCce----------------------------------------ecccCCCCcccCCHHHHhccCCCCCCCcccCEEee
Confidence 21100 012468999999999997643 7899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCCh-
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDW- 422 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w- 422 (497)
||++|||++|.+||.+.+....+.+|+.....+.+|....++..+++||.+||+++..|+++.++.++++||||+...|
T Consensus 234 G~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 234 GVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 9999999999999999998888999987666677887667899999999999997777777777999999999998655
Q ss_pred -hhhhhcCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeC
Q 010947 423 -ARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 423 -~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (497)
..+....+|+.|.+....|.++|+..+...... .+...+.. .+.+ ...|.||+|.+
T Consensus 314 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-~~~~-~~~~~~~~~~~ 370 (370)
T cd05621 314 WDNIRETAAPVVPELSSDIDSSNFDDIEDDKGDV--ETFPIPKA-FVGN-QLPFIGFTYYR 370 (370)
T ss_pred hHhcCCCCCCcCCCCCCcchhhhcCCcccccccc--ccCCCCcc-cccc-ccccCCCEecC
Confidence 555567899999999999999998755433221 11111211 1223 58999999953
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-57 Score=467.70 Aligned_cols=366 Identities=46% Similarity=0.827 Sum_probs=284.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||.||+|+++.+++.||||++.+..........++.+|+.+|+.++||||+++++.|.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876656667788999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc--
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE-- 273 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-- 273 (497)
|||+||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|..+.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 999999999999888899999999999999999999999999999999999999999999999999987543211000
Q ss_pred --ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 274 --QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 274 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
.....................+....... ......+....+.+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell 238 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERR--RKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238 (376)
T ss_pred ccccccccccccccccccccccccccchhhh--hhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence 00000000000000000000000000000 00000111223568999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhh-hcCC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIY-QMEA 430 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~-~~~~ 430 (497)
+|.+||.+.+..+...++..|...+.+|....+++++.+||.+|+++|.+|++..++.++++||||++++|..+. ...+
T Consensus 239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~~~p~~R~~~~t~~ell~h~~~~~~~~~~~~~~~~~ 318 (376)
T cd05598 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFFKGIDFASLIRRQKA 318 (376)
T ss_pred hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHhcCHhhcCCCCCHHHHhCCCCcCCCCHHHHhhcCCC
Confidence 999999999988888888888777777776789999999999987799999976669999999999999999984 6789
Q ss_pred CcccccCCcccccCcccccccccccCCCCCCCcccc----cccCcCCcccCceeeCC
Q 010947 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRK----MLSSKDINFVGYTYKNF 483 (497)
Q Consensus 431 p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~f~g~~~~~~ 483 (497)
|++|.+..+.++++|+...........++....+.. ........|.-|+|.+|
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 375 (376)
T cd05598 319 PYIPKITHPTDTSNFDPVDPEKLRSDDSGESSPDRNVKPNNRKRTEHAFYEFTFRRF 375 (376)
T ss_pred CCCCcCCCcchhhhcCCCCcccccccccccccccccccccccccCCcccccceeccc
Confidence 999999999999999876554332222222211111 11223457888888876
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-57 Score=463.08 Aligned_cols=331 Identities=45% Similarity=0.858 Sum_probs=279.3
Q ss_pred HHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 107 ~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
.+....+..++|++.+.||+|+||.||+|+++.+++.||+|++.+...........+..|+.+++.++||||++++++|.
T Consensus 34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~ 113 (371)
T cd05622 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ 113 (371)
T ss_pred HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence 35566778899999999999999999999999999999999998766555556667889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
+..++|+|||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.+
T Consensus 114 ~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 114 DDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred cCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 99999999999999999998854 56899999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC----CCcchhHHh
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWS 342 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----y~~~~DiwS 342 (497)
...... .....+||+.|+|||++.+.. ++.++||||
T Consensus 193 ~~~~~~----------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwS 232 (371)
T cd05622 193 NKEGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS 232 (371)
T ss_pred CcCCcc----------------------------------------cccCcccCccccCHHHHhccCCCccCCCccceee
Confidence 321100 012467999999999997543 889999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCC-
Q 010947 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVD- 421 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~- 421 (497)
|||++|||++|.+||.+.+....+.+|+.....+.+|....+|.++++||.+||.+|..|+++.++++|++||||++.+
T Consensus 233 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 233 VGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred hhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 9999999999999999999988999998766667788767899999999999999888888888899999999999855
Q ss_pred -hhhhhhcCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeC
Q 010947 422 -WARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 422 -w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (497)
|..+.+..+|++|.+....++++|++.........+.. .+ ......+..|.||+|.+
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--~~~~~~~~~~~~~~~~~ 370 (371)
T cd05622 313 AWETLRDTVAPVVPDLSSDIDTSNFDDIEEDKGEEETFP--IP--KAFVGNQLPFVGFTYYS 370 (371)
T ss_pred hHHhcCCCCCCCCCCCCCcchhhhcCCCcccccccccCC--CC--ccccccccccCCCeecC
Confidence 45666788999999999999999987554322111111 11 12223358999999964
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-57 Score=462.90 Aligned_cols=350 Identities=53% Similarity=0.966 Sum_probs=285.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|.+++.||+|+||+||+|++..+|+.||||++++...........+..|+.++..++||||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999999877666667788999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+.........
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876433200000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
.. .... ....... .........+.......+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 161 ~~--~~~~-~~~~~~~---------~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~ 228 (350)
T cd05573 161 LN--DSHN-LLFRDNV---------LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228 (350)
T ss_pred cc--cccc-ccccccc---------cccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCC
Confidence 00 0000 0000000 0000000011112335689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhhcCCCcccc
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~ 435 (497)
||.+.+....+.++..|...+.+|....+++++++||.+||+||.+|++. ++++++||||++++|+.+....+|++|.
T Consensus 229 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~dp~~R~~s--~~~ll~hp~~~~~~~~~~~~~~~~~~~~ 306 (350)
T cd05573 229 PFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPEDRLGS--FEEIKSHPFFKGIDWENLRETKPPFVPE 306 (350)
T ss_pred CCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHccChhhcCCC--HHHHhcCCCcCCCCHHHHhhCCCCcCCC
Confidence 99999999999999998888888887678999999999999999999873 8999999999999999999989999999
Q ss_pred cCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceee
Q 010947 436 VNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (497)
Q Consensus 436 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (497)
+..+.++.+|+............+ ............+|.||+|+
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 350 (350)
T cd05573 307 LSSPLDTSNFDDFEDDKDLSDYLS--QNSKKLNKGKQLAFVGFTYK 350 (350)
T ss_pred CCCchhhhhcCCCCcccccccccc--cccccccccccCccCCCccC
Confidence 999999999998765543221111 11111223356799999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-57 Score=457.85 Aligned_cols=323 Identities=46% Similarity=0.824 Sum_probs=277.3
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|.+.+.||+|+||+||+|+++.+|+.||||++++...........+..|+.+++.++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999999876555556677889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||++||+|.+++.+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|..+......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-- 158 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-- 158 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce--
Confidence 999999999999776 68999999999999999999999999999999999999999999999999999865422100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc------cCCCCcchhHHhHHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~------~~~y~~~~DiwSlGvil~ 348 (497)
.....+||+.|+|||++. ...++.++|||||||++|
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~ 200 (330)
T cd05601 159 --------------------------------------NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAY 200 (330)
T ss_pred --------------------------------------eeecccCCccccCHHHhccccccccCCCCCcceeecccceee
Confidence 011357999999999987 456889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhhc
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQM 428 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~ 428 (497)
||++|..||.+.+....+.++++....+.+|....+++++++||.+||++|.+|++ +++++.||||..++|..+...
T Consensus 201 el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~~p~~R~t---~~~l~~h~~~~~~~~~~~~~~ 277 (330)
T cd05601 201 EMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLCGQKERLG---YEGLCCHPFFSKIDWNNIRNS 277 (330)
T ss_pred eeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHccChhhCCC---HHHHhCCCCcCCCCHHHHhhC
Confidence 99999999999988888999988766677887678999999999999999999999 999999999999999999999
Q ss_pred CCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceee
Q 010947 429 EAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (497)
Q Consensus 429 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (497)
.||++|.+....|.++|+...........++...........++..|+||+|.
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (330)
T cd05601 278 LPPFVPTLKSDDDTSNFDEPEKNSTRRSQSSTTQLKPNGFSGKDLPFVGFSFI 330 (330)
T ss_pred CCCccCcCCCcchhhhcCCCccccccccccccccCCCcCCCCCCCCccCceeC
Confidence 99999999999999999765443322211111111122334578999999984
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-57 Score=454.00 Aligned_cols=316 Identities=38% Similarity=0.663 Sum_probs=265.2
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 201 (497)
++||+|+||.||+|+++.+|+.||||++++..........++..|+.+++.++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999999876655666778889999999999999999999999999999999999999
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCC
Q 010947 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (497)
Q Consensus 202 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (497)
+|..++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---------- 150 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA---------- 150 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC----------
Confidence 9999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCC
Q 010947 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (497)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~ 361 (497)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+
T Consensus 151 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 151 -------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred -------------------------------cccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 0114679999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhh--hcCCCccccc
Q 010947 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY--QMEAAFIPEV 436 (497)
Q Consensus 362 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~ 436 (497)
.......+.. ....+|. .+++++++||.+||+ ||.+|++.. ++.++++||||.+++|..+. .+.||+.|.+
T Consensus 200 ~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05571 200 HEKLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQV 275 (323)
T ss_pred HHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 8888877775 3456664 689999999999999 999999532 48999999999999999997 4778999999
Q ss_pred CCcccccCcccccccccccCC-CCCCCcccccccCcCCcccCceeeC
Q 010947 437 NDELDTQNFEKFEESDNQTKT-SSKTGPWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 437 ~~~~d~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (497)
....|+.+|+..........+ ++...+......+....|.+|+|..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05571 276 TSETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFPQFSYSA 322 (323)
T ss_pred CCcchhhhcCcccccCCcccCCCCcccccccccccccccCCCCeeeC
Confidence 999999999753322211111 1111111101123456899999974
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=453.18 Aligned_cols=292 Identities=42% Similarity=0.824 Sum_probs=262.8
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
....++|++.+.||+|+||.||+|+++.+++.||||++.+...........+.+|+.++..++||||++++++|.+++.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 93 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRV 93 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEE
Confidence 34568899999999999999999999999999999999887665556677899999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 999999999999999998889999999999999999999999999999999999999999999999999999865321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 172 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell 209 (329)
T PTZ00263 172 ------------------------------------------TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFI 209 (329)
T ss_pred ------------------------------------------cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHH
Confidence 11457999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh-
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ- 427 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~- 427 (497)
+|.+||.+.+..+.+.++.. ..+.+|. .++.++++||.+||+ ||.+|+++ .++++++.||||.+++|..+..
T Consensus 210 tg~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~~~ 285 (329)
T PTZ00263 210 AGYPPFFDDTPFRIYEKILA--GRLKFPN--WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYAR 285 (329)
T ss_pred cCCCCCCCCCHHHHHHHHhc--CCcCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHHHHhC
Confidence 99999999988888888876 3455664 689999999999999 99999984 4589999999999999999874
Q ss_pred -cCCCcccccCCcccccCccccccc
Q 010947 428 -MEAAFIPEVNDELDTQNFEKFEES 451 (497)
Q Consensus 428 -~~~p~~p~~~~~~d~~~f~~~~~~ 451 (497)
..+|+.+.+....++.+|..+.++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~s 310 (329)
T PTZ00263 286 YYPAPIPVRVKSPGDTSNFEKYPDS 310 (329)
T ss_pred CCCCCcCCCCCCcccchhccCCccc
Confidence 677888888888899999876543
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-56 Score=457.99 Aligned_cols=327 Identities=46% Similarity=0.878 Sum_probs=273.0
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
....+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+..|+.+++.++||||++++++|.++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~ 115 (370)
T cd05596 36 TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD 115 (370)
T ss_pred ccCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 34556778999999999999999999999999999999999877655555666788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+.+|+||||++||+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 116 KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999999998854 5699999999999999999999999999999999999999999999999999976532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC----CCCcchhHHhHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK----GYGMECDWWSLG 344 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~----~y~~~~DiwSlG 344 (497)
.... .....+||+.|+|||++.+. .++.++||||||
T Consensus 195 ~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlG 234 (370)
T cd05596 195 NGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG 234 (370)
T ss_pred CCcc----------------------------------------cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehh
Confidence 1100 01246799999999998753 488999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChh
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
|++|||++|.+||.+.+....+.+|......+.+|....+|.++++||.+||. +| +|+++.+++++++||||++.+|.
T Consensus 235 vilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p-~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 235 VFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDRE-VRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChh-hccCCCCHHHHhcCcccCCCChh
Confidence 99999999999999999888999998766677788767799999999999999 55 44444459999999999998886
Q ss_pred h--hhhcCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceee
Q 010947 424 R--IYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (497)
Q Consensus 424 ~--l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (497)
. +....+|++|.+....++++|++.........+ ...+ .........|.||+|.
T Consensus 314 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~~~~~~~ 369 (370)
T cd05596 314 FDNIRETVAPVVPELSSDIDTSNFDDIEDDDKNEET--FPLP--KAFAGNQLPFIGFTYS 369 (370)
T ss_pred hHHhcCCCcCccCcCCCcchhhhcCCcccccccccc--CCCc--cccccccCccCCCeec
Confidence 5 446778999999999999999876554321111 1111 1122235679999985
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=440.08 Aligned_cols=258 Identities=29% Similarity=0.490 Sum_probs=233.3
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe-E
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF-L 191 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-l 191 (497)
+..++.+.++.||+|+.|+||+|+++.|++.||+|++.- ..+....+.+.+|++++..++||+||.+|++|.++.. +
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~--~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i 153 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILL--NIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI 153 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecc--cCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence 456688889999999999999999999999999999943 2345556678999999999999999999999999985 9
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|+||||.||+|..++...+.++|.....++.+++.||.|||. ++||||||||+|||++..|.|||||||.++.+..+
T Consensus 154 sI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 154 SICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred EeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 9999999999999999988999999999999999999999995 99999999999999999999999999999876422
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
++.+++||..|||||.+.+..|+.++||||||+.++||
T Consensus 233 ------------------------------------------~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~ 270 (364)
T KOG0581|consen 233 ------------------------------------------IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLEL 270 (364)
T ss_pred ------------------------------------------hcccccccccccChhhhcCCcCCcccceecccHHHHHH
Confidence 35689999999999999999999999999999999999
Q ss_pred HhCCCCCCCC-----ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 351 LVGYPPFYSD-----DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 351 l~G~~PF~~~-----~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
++|+.||... +..+.+..|+.. .+..+|.. .+|+++++||..||. ||.+|++ +.|+++|||++..
T Consensus 271 a~GrfP~~~~~~~~~~~~~Ll~~Iv~~-ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s---~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 271 AIGRFPYPPPNPPYLDIFELLCAIVDE-PPPRLPEG-EFSPEFRSFVSCCLRKDPSERPS---AKQLLQHPFIKKF 341 (364)
T ss_pred hhCCCCCCCcCCCCCCHHHHHHHHhcC-CCCCCCcc-cCCHHHHHHHHHHhcCCcccCCC---HHHHhcCHHHhhc
Confidence 9999999875 667888888874 45566763 599999999999999 9999999 9999999999854
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-57 Score=439.40 Aligned_cols=260 Identities=33% Similarity=0.589 Sum_probs=235.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..+|.+.+.||+|+||+||+|+++.++..||||.+.+..+ .....+.+..|+.||+.++|||||.|++++.+++++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999988764 455677889999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC------CcEEEcccccccccCC
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY------GHLRLSDFGLCKPLDC 268 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~------g~vkL~DFGla~~~~~ 268 (497)
||||.||||..++.+++.++|..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+..
T Consensus 88 MEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 9999999999999999999999999999999999999999999999999999999875 4689999999998753
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
. .++.+.||+|-|||||++..+.|+.++|+||+|+|+|
T Consensus 168 ~------------------------------------------~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ily 205 (429)
T KOG0595|consen 168 G------------------------------------------SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILY 205 (429)
T ss_pred h------------------------------------------hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHH
Confidence 3 2344789999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
+|++|++||...+..+.+..|-......+.+. ..++....+|+..+|+ +|.+|.+ .++-..|||...-.
T Consensus 206 q~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~~---~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 206 QCLTGKPPFDAETPKELLLYIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRIS---FEDFFDHPFLAANP 275 (429)
T ss_pred HHHhCCCCccccCHHHHHHHHhccccccCchh-hhccCchhhhhhHHHhcCccccCc---hHHhhhhhhcccCc
Confidence 99999999999999999998887666666554 4678888899999998 9999988 77888888886543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-55 Score=445.16 Aligned_cols=317 Identities=33% Similarity=0.654 Sum_probs=267.7
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
+|.+++.||+|+||+||+|+++.+++.||||++.+...........+..|..++..+ .||+|+.++++|.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 689999999999999999999999999999999886655555566777888888777 5899999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++||+|..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~---- 156 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV---- 156 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC----
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 157 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 199 (323)
T cd05616 157 -------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199 (323)
T ss_pred -------------------------------------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCC
Confidence 0124679999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh--cCC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEA 430 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~ 430 (497)
||.+.+.......|.. ..+.+|. .++.++++||.+||. ||.+|++. .+..+++.||||+.++|..+.. +.+
T Consensus 200 Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05616 200 PFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQP 275 (323)
T ss_pred CCCCCCHHHHHHHHHh--CCCCCCC--cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCC
Confidence 9999998888888876 4455664 689999999999999 99999985 2468999999999999999984 789
Q ss_pred CcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeC
Q 010947 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 431 p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (497)
|+.|.... .|..+|+.+.....+..++. .-..+.......|.||+|.|
T Consensus 276 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05616 276 PYKPKACG-RDAENFDKFFTRHPPVLTPP---DQEVIMNLDQSEFEGFSYVN 323 (323)
T ss_pred CcCCcCCC-chhhhcCchhccCCccCCCC---CccccccccccccCCCcccC
Confidence 99998754 78888888776432222111 11123333447899999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-55 Score=444.55 Aligned_cols=317 Identities=34% Similarity=0.671 Sum_probs=268.9
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC-ceeEEEEEeecCCeEEEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~~~~~~~l~lVm 195 (497)
+|++++.||+|+||.||+|+++.+++.||||++.+.........+.+..|..++..+.|+ +|+.++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999987655556677788899999999764 6888999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++||+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 156 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---- 156 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC----
Confidence 9999999999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 157 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (324)
T cd05587 157 -------------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQP 199 (324)
T ss_pred -------------------------------------ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCC
Confidence 0114679999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhhh--cCC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~ 430 (497)
||.+.+..+.+..+.. ....+|. .+++++++||.+||. ||.+|++.. ..++++.||||+.++|..+.. +.+
T Consensus 200 pf~~~~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~ 275 (324)
T cd05587 200 PFDGEDEDELFQSIME--HNVSYPK--SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKLERREIQP 275 (324)
T ss_pred CCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCC
Confidence 9999998888888876 3445554 689999999999999 999999842 347999999999999998864 678
Q ss_pred CcccccCCcccccCcccccccccccCCCCCCCcccccc-cCcCCcccCceeeC
Q 010947 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML-SSKDINFVGYTYKN 482 (497)
Q Consensus 431 p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~g~~~~~ 482 (497)
|+.|.+....++++|+.+........++ +.+..+ ......|.+|+|.|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05587 276 PFKPKVKGRRSAENFDKFFTREPPVLTP----PDKLVIANIDQSEFQGFSFVN 324 (324)
T ss_pred CccCcCCCcchhhhcCcccccCccccCC----CCccccccccccccCCCcccC
Confidence 9999999889999998876543322221 112223 33446899999875
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-56 Score=448.72 Aligned_cols=289 Identities=45% Similarity=0.849 Sum_probs=260.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||.||+|++..+++.||||++.+..........++..|+.++..++||||++++++|.+.+++|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998876555556678899999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~------ 154 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTY------ 154 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccc------
Confidence 99999999999988889999999999999999999999999999999999999999999999999999754310
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
....+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 155 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~ 196 (333)
T cd05600 155 --------------------------------------ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196 (333)
T ss_pred --------------------------------------cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCC
Confidence 124679999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCc----cCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhcCC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEA----KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEA 430 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~----~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~ 430 (497)
||.+.+..+.+..+..|...+..|... .+|.++++||.+||. +|.+|++ +.++++||||.+++|..+....|
T Consensus 197 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s---~~~ll~h~~~~~~~~~~~~~~~~ 273 (333)
T cd05600 197 PFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGS---LEDIKNHPFFKEVDWNELRELKP 273 (333)
T ss_pred CCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCC---HHHHHhCcccCCCCHHHHhhCCC
Confidence 999999888888888776555555432 579999999999999 8888888 99999999999999999999999
Q ss_pred CcccccCCcccccCccccccc
Q 010947 431 AFIPEVNDELDTQNFEKFEES 451 (497)
Q Consensus 431 p~~p~~~~~~d~~~f~~~~~~ 451 (497)
|++|.+.+..+..+|+.+...
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~ 294 (333)
T cd05600 274 PFVPELESEIDTGYFDDFENE 294 (333)
T ss_pred CCCCCCCCcchhhhccCCCCc
Confidence 999999999988888765443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-56 Score=450.01 Aligned_cols=293 Identities=40% Similarity=0.826 Sum_probs=261.6
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCC-cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTG-HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~-~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
...+..++|++.+.||+|+||.||+|.++.++ ..||+|++.+...........+..|+.+++.++|||||+++++|.+.
T Consensus 24 ~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 24 KNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC
Confidence 34567789999999999999999999876655 68999999887665666677889999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+|+||||++||+|.+++.+...+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+++.+..
T Consensus 104 ~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999999976532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
. ..+.+||+.|+|||++.+..++.++|||||||++|
T Consensus 184 ~--------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 219 (340)
T PTZ00426 184 R--------------------------------------------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIY 219 (340)
T ss_pred C--------------------------------------------cceecCChhhcCHHHHhCCCCCccccccchhhHHH
Confidence 1 11467999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhh
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l 425 (497)
||++|.+||.+.++...+.++.. ....+|. .+++++++||++||. ||.+|++. .+++++++||||.+++|..+
T Consensus 220 ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~ 295 (340)
T PTZ00426 220 EILVGCPPFYANEPLLIYQKILE--GIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295 (340)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 99999999999988888888876 3445564 689999999999999 99999853 46999999999999999998
Q ss_pred h--hcCCCcccccCCcccccCcccccc
Q 010947 426 Y--QMEAAFIPEVNDELDTQNFEKFEE 450 (497)
Q Consensus 426 ~--~~~~p~~p~~~~~~d~~~f~~~~~ 450 (497)
. .+.+|++|.+....+.++|++..+
T Consensus 296 ~~~~~~~~~~p~~~~~~~~~~~~~~~~ 322 (340)
T PTZ00426 296 LHKNVEVPYKPKYKNVFDSSNFERVQE 322 (340)
T ss_pred HhCCCCCCcCCCCCCCcchhhcCCCcc
Confidence 7 478999999999999999876443
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=445.21 Aligned_cols=324 Identities=48% Similarity=0.876 Sum_probs=271.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||.||+++.+.+++.||+|++.+...........+..|+.++..++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998766555566667889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||++||+|.+++.+ ...+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+.+......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-- 158 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-- 158 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc--
Confidence 99999999999976 467999999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhHHhHHHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~DiwSlGvil~e 349 (497)
.....+||+.|+|||++. ...++.++|||||||++||
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~e 200 (332)
T cd05623 159 --------------------------------------QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYE 200 (332)
T ss_pred --------------------------------------eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHH
Confidence 011357999999999986 3568999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCC-ccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhhc
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQM 428 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~ 428 (497)
|++|++||.+.+..+.+.++........+|.. ..+|+++++||++||+.+.+|+++.+++++++||||.+++|..+...
T Consensus 201 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~~~ 280 (332)
T cd05623 201 MLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNC 280 (332)
T ss_pred HhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHhhC
Confidence 99999999999999999999876555556543 36899999999999996677877778999999999999999999999
Q ss_pred CCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceee
Q 010947 429 EAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (497)
Q Consensus 429 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (497)
.+|++|...++.++++++...+......+ ...+.....+.....|.||||.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 331 (332)
T cd05623 281 EAPYIPEVSSPTDTSNFDVDDDCLKNSET--MPPPSHTAFSGHHLPFVGFTYT 331 (332)
T ss_pred CCCccCCCCCCcccccCCCCcccccccCC--CCCCCccccccCCCCcCCeeec
Confidence 99999999999999988654332211111 1111112223456789999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-55 Score=445.20 Aligned_cols=294 Identities=51% Similarity=0.924 Sum_probs=259.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|.+++.||+|+||.||+|+++.+++.||||++.+...........+..|+.++..++||||+.++++|.+.+++|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998766555566677889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||++||+|..++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.+|.+||+|||+|+.+......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-- 158 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-- 158 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce--
Confidence 99999999999977 468999999999999999999999999999999999999999999999999999765322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----CCCCcchhHHhHHHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~y~~~~DiwSlGvil~e 349 (497)
.....+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~e 200 (331)
T cd05624 159 --------------------------------------QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYE 200 (331)
T ss_pred --------------------------------------eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhh
Confidence 0013579999999999875 568899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCC-ccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhhc
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQM 428 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~ 428 (497)
|++|++||.+.+..+.+.++......+.+|.. ..++.++++||.+||+.+.+|+++.+++++++||||++++|..+.+.
T Consensus 201 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~~ 280 (331)
T cd05624 201 MLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNL 280 (331)
T ss_pred hhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhhC
Confidence 99999999999988888888876555566643 35799999999999996668887778999999999999999999999
Q ss_pred CCCcccccCCcccccCccccc
Q 010947 429 EAAFIPEVNDELDTQNFEKFE 449 (497)
Q Consensus 429 ~~p~~p~~~~~~d~~~f~~~~ 449 (497)
.+|++|....+.+.++|+..+
T Consensus 281 ~~~~~p~~~~~~~~~~~~~~~ 301 (331)
T cd05624 281 EAPYIPDVSSPSDTSNFDVDD 301 (331)
T ss_pred CCCccCCCCCcchhhhcCCcc
Confidence 999999999998888887533
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-55 Score=442.97 Aligned_cols=324 Identities=49% Similarity=0.877 Sum_probs=271.3
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||.||+|+++.+++.||||++.+...........+..|+.++..++||||+.++++|.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998876666666777899999999999999999999999999999999
Q ss_pred eecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||++||+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-- 158 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-- 158 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc--
Confidence 99999999999976 457999999999999999999999999999999999999999999999999998765322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----CCCCcchhHHhHHHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~y~~~~DiwSlGvil~e 349 (497)
.....+||+.|+|||++.. ..++.++|||||||++||
T Consensus 159 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (331)
T cd05597 159 --------------------------------------QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE 200 (331)
T ss_pred --------------------------------------cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHH
Confidence 0012469999999999973 457889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCC-ccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCCChhhhhhc
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQM 428 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~ 428 (497)
|++|..||.+.+..+.+..+......+.+|.. ..+|.++++||++||+.|.+|+++.++++++.||||.+++|..+...
T Consensus 201 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~~~~ 280 (331)
T cd05597 201 MLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRNS 280 (331)
T ss_pred HhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHHhhC
Confidence 99999999999888888888875555555542 35899999999999997788887778999999999999999999998
Q ss_pred CCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceee
Q 010947 429 EAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (497)
Q Consensus 429 ~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (497)
.+|++|......++++|+..+...... .+...+-..-..+.-..+.||+|.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 331 (331)
T cd05597 281 TAPYVPEVSSPTDTSNFDVDDDDLRNT--ESLPPSSHGAFSGNHLPFVGFTYT 331 (331)
T ss_pred CCCccCcCCCcchhhhcCCcccccccc--cccCCCCcCcCCcCCCCCCceeeC
Confidence 999999999999999987644322111 111111111223345788899983
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=442.62 Aligned_cols=312 Identities=35% Similarity=0.661 Sum_probs=261.5
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
+.||+|+||+||+|+++.+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999887655556667788899988876 799999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.+...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~--------- 151 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--------- 151 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (320)
T cd05590 152 --------------------------------TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199 (320)
T ss_pred --------------------------------cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC
Confidence 011457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC---CcchhcCCCCccCCChhhhh--hcCCCccc
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GADEIKVHPWFDGVDWARIY--QMEAAFIP 434 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~---~~~eil~Hpff~~i~w~~l~--~~~~p~~p 434 (497)
+..+.+..|.. ....+|. .++.++++||.+||+ ||.+|+++. +.+++++||||.+++|..+. .+.|||.|
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 275 (320)
T cd05590 200 NEDDLFEAILN--DEVVYPT--WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRP 275 (320)
T ss_pred CHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCC
Confidence 98888888876 3444554 689999999999999 999999952 34899999999999999986 47899999
Q ss_pred ccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceee
Q 010947 435 EVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (497)
Q Consensus 435 ~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (497)
.+.+..|.+||+.....+.+..++..... ........|.||+|.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 319 (320)
T cd05590 276 RIKSREDVSNFDPDFIKEDPVLTPIEESL---LPMINQDEFRNFSYT 319 (320)
T ss_pred CCCCcchhhhcCcccccCCccCCCCcccc---cccccccCcCCCccc
Confidence 99999999999864433322222111110 111234578888774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-55 Score=441.02 Aligned_cols=281 Identities=43% Similarity=0.803 Sum_probs=252.4
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L 203 (497)
||+|+||.||+|+++.+++.||+|++.+..........++..|+.++..++||||++++++|.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999877655566677888999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCC
Q 010947 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (497)
Q Consensus 204 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (497)
.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~------------ 148 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD------------ 148 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC------------
Confidence 99998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChH
Q 010947 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (497)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~ 363 (497)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..
T Consensus 149 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~ 199 (312)
T cd05585 149 -----------------------------KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN 199 (312)
T ss_pred -----------------------------ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH
Confidence 011467999999999999999999999999999999999999999999888
Q ss_pred HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh--hcCCCcccccCCcc
Q 010947 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDEL 440 (497)
Q Consensus 364 ~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~~~~~ 440 (497)
+.+..+.. ..+.+|. .+++++++||.+||. ||.+|++..++.+++.||||..++|..+. .+.+|+.|.+.+..
T Consensus 200 ~~~~~~~~--~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (312)
T cd05585 200 EMYRKILQ--EPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAI 275 (312)
T ss_pred HHHHHHHc--CCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCCCcc
Confidence 88888876 4555664 689999999999999 99999988889999999999999998876 46789999999999
Q ss_pred cccCccccc
Q 010947 441 DTQNFEKFE 449 (497)
Q Consensus 441 d~~~f~~~~ 449 (497)
++++|+...
T Consensus 276 ~~~~~~~~~ 284 (312)
T cd05585 276 DTSNFDEEF 284 (312)
T ss_pred chhhcCccc
Confidence 999987533
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-55 Score=438.06 Aligned_cols=285 Identities=42% Similarity=0.862 Sum_probs=256.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|.++.+|+.||||++.........+...+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998766555556677899999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++||+|.+++...+.+++..+..++.|++.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~------ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR------ 154 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998754311
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
....+||+.|+|||++.+..++.++|||||||++|+|++|..
T Consensus 155 --------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~ 196 (291)
T cd05612 155 --------------------------------------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYP 196 (291)
T ss_pred --------------------------------------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 113579999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhhh--cCC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~ 430 (497)
||.+.+..+.+..+... ...+|. .+++.+++||++||. ||.+|++.. ++++++.||||..++|..+.. ..|
T Consensus 197 pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~ 272 (291)
T cd05612 197 PFFDDNPFGIYEKILAG--KLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKLKP 272 (291)
T ss_pred CCCCCCHHHHHHHHHhC--CcCCCc--cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHHHhcCCCCC
Confidence 99999988888888763 455664 679999999999999 999999632 589999999999999998874 678
Q ss_pred CcccccCCcccccCcccc
Q 010947 431 AFIPEVNDELDTQNFEKF 448 (497)
Q Consensus 431 p~~p~~~~~~d~~~f~~~ 448 (497)
|+.|.+....|+.||+..
T Consensus 273 ~~~p~~~~~~~~~~~~~~ 290 (291)
T cd05612 273 PIVPKVSHDGDTSNFDDY 290 (291)
T ss_pred CEeCCCCCccccccccCC
Confidence 999999999999998753
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=437.20 Aligned_cols=316 Identities=35% Similarity=0.691 Sum_probs=266.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lVm 195 (497)
+|++.+.||+|+||+||+|+++.+|+.||||++.+...........+..|..++..+. ||+|++++++|++.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 5889999999999999999999999999999999876555566677888999998875 578888999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++||+|..++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~---- 156 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV---- 156 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc----
Confidence 9999999999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+
T Consensus 157 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~ 199 (323)
T cd05615 157 -------------------------------------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQP 199 (323)
T ss_pred -------------------------------------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCC
Confidence 0114679999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhhh--cCC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~ 430 (497)
||.+.+.......+.. ....+|. .++.++++||.+||. +|.+|++.. ..+++++||||..++|..+.+ +.+
T Consensus 200 pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~ 275 (323)
T cd05615 200 PFDGEDEDELFQSIME--HNVSYPK--SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQP 275 (323)
T ss_pred CCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHHhcCCCCc
Confidence 9999988888888876 3455564 689999999999999 999999853 467999999999999999975 679
Q ss_pred CcccccCCcccccCcccccccccccCCCCCCCcccccccCcC-CcccCceeeC
Q 010947 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKD-INFVGYTYKN 482 (497)
Q Consensus 431 p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~f~g~~~~~ 482 (497)
||.|..... +.++|+.+.......... +....+.+.+ .-|.||+|.|
T Consensus 276 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05615 276 PFKPKVCGK-GAENFDKFFTRGQPVLTP----PDQLVIANIDQADFEGFSYVN 323 (323)
T ss_pred CccCccCCC-chhhcCccccccCCCCCC----CcccccccccccccCCCcccC
Confidence 999986654 578888766543322211 2222333334 4899999875
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-55 Score=438.84 Aligned_cols=313 Identities=37% Similarity=0.694 Sum_probs=261.5
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
++||+|+||+||+|+++.+++.||||++.+...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999887655556667788899999865 899999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--------- 151 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~ 199 (321)
T cd05591 152 --------------------------------TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD 199 (321)
T ss_pred --------------------------------cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC
Confidence 011457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC----CcchhcCCCCccCCChhhhhh--cCCCcc
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK----GADEIKVHPWFDGVDWARIYQ--MEAAFI 433 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~----~~~eil~Hpff~~i~w~~l~~--~~~p~~ 433 (497)
+....+..+.. ....+|. .++.++.+||.+||. ||.+|++.. +++++++||||.+++|..+.. ..+||.
T Consensus 200 ~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~ 275 (321)
T cd05591 200 NEDDLFESILH--DDVLYPV--WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFK 275 (321)
T ss_pred CHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCC
Confidence 99999988886 3444554 689999999999999 999999542 488999999999999999874 678999
Q ss_pred cccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeC
Q 010947 434 PEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 434 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (497)
|......+..+|+.......+..+++. + .....-....|.||+|.|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~ 321 (321)
T cd05591 276 PKIKTKRDVNNFDQDFTKEEPVLTPVD--P-AVIKQINQEEFRGFSFFN 321 (321)
T ss_pred CCCCCcchhhhcCCccccCccccCCCC--c-cccccccccccCCCcccC
Confidence 999888888888754333222222111 1 111122345699998853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-54 Score=437.25 Aligned_cols=316 Identities=37% Similarity=0.663 Sum_probs=263.2
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 201 (497)
+.||+|+||.||+|+++.+|..||+|++.+..........++..|+.+++.++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876555566777888999999999999999999999999999999999999
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCC
Q 010947 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (497)
Q Consensus 202 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (497)
+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~---------- 150 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA---------- 150 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC----------
Confidence 9999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCC
Q 010947 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (497)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~ 361 (497)
.....+||+.|+|||++.+..++.++|+|||||++|||++|..||.+.+
T Consensus 151 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 151 -------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred -------------------------------ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 0114579999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh--cCCCccccc
Q 010947 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (497)
Q Consensus 362 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~ 436 (497)
.......+.. ....+|. .+++++++||.+||+ ||.+|++. .++.++++||||.+++|..+.+ +.||+.|.+
T Consensus 200 ~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05595 200 HERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 275 (323)
T ss_pred HHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 8888777765 3455664 689999999999999 99999953 3589999999999999999874 568999999
Q ss_pred CCcccccCccccccccccc-CCCCCCCcccccccCcCCcccCceeeC
Q 010947 437 NDELDTQNFEKFEESDNQT-KTSSKTGPWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 437 ~~~~d~~~f~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (497)
..+.+++.|+......... .+.....+....-...-..|.+|||..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05595 276 TSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQRTHFPQFSYSA 322 (323)
T ss_pred CChhhhhhcCcccccCCccCCCCcccccccccccccccccCCCcccC
Confidence 9999999987543332211 111111111111111225899999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=436.34 Aligned_cols=316 Identities=35% Similarity=0.668 Sum_probs=264.5
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHH---HhcCCCceeEEEEEeecCCeEEEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL---AEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il---~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
|++++.||+|+||.||+|.++.+|+.||||++++.........+.+..|+.++ ..++||||++++++|.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78899999999999999999999999999999887655555667788887766 456899999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||++||+|..++. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--- 156 (324)
T cd05589 81 MEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGD--- 156 (324)
T ss_pred EcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCC---
Confidence 99999999998874 46799999999999999999999999999999999999999999999999999874321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 --------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~ 198 (324)
T cd05589 157 --------------------------------------RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198 (324)
T ss_pred --------------------------------------cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCC
Confidence 011467999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhh--hcC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY--QME 429 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~--~~~ 429 (497)
+||.+.+..+....+... ...+|. .+++++.+||.+||. ||.+||+.. ++.++++||||++++|..+. .+.
T Consensus 199 ~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~~~~~~~~ 274 (324)
T cd05589 199 SPFPGDDEEEVFDSIVND--EVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274 (324)
T ss_pred CCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHHHHhCCCC
Confidence 999999888888888763 344554 689999999999999 999999743 58999999999999999876 467
Q ss_pred CCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceee
Q 010947 430 AAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (497)
Q Consensus 430 ~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (497)
+|++|.+....|.++|+.-.....+..+++. +.+....+....|.+|+|.
T Consensus 275 ~~~~~~~~~~~d~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05589 275 PPFVPTIKGPEDVSNFDEEFTSEAPVLTPPR--EPRLLTEEEQELFRGFDYV 324 (324)
T ss_pred cCccCCCCCcchhhhcCccccccccccCCCc--cccccchhhhcccCCcccC
Confidence 9999999999999998754433333222222 2222334456789999873
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=435.12 Aligned_cols=311 Identities=39% Similarity=0.714 Sum_probs=260.6
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh-cCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
++||+|+||+||+|+++.+++.||||++++...........+..|..++.. .+||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999987655444455566677777765 4899999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.......
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~--------- 151 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999975421110
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~ 199 (316)
T cd05592 152 --------------------------------KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE 199 (316)
T ss_pred --------------------------------ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC
Confidence 012467999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh--hcCCCcccccC
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY--QMEAAFIPEVN 437 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~~ 437 (497)
+..+.+..+.. ....+|. .++.++.+||.+||. ||.+|++. ..+++.||||..++|..+. +..|||.|...
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~~--~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (316)
T cd05592 200 DEDELFDSILN--DRPHFPR--WISKEAKDCLSKLFERDPTKRLGV--DGDIRQHPFFRGIDWERLEKREIPPPFKPKVK 273 (316)
T ss_pred CHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCC
Confidence 88888888765 2334453 689999999999999 99999983 3589999999999999886 47889999999
Q ss_pred CcccccCcccccccccccCCCCCCCcccccccC-cCCcccCceeeCC
Q 010947 438 DELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDINFVGYTYKNF 483 (497)
Q Consensus 438 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~~~~ 483 (497)
...+..+|+..........++.. .....+ ....|.||.|.|+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05592 274 SPSDASNFDREFTNEKVRLSPVD----KKLLASMDQEQFRGFSFTNP 316 (316)
T ss_pred CcchhhhcCcccccccccCCCcc----ccccccccccccCCCcccCc
Confidence 99999999865544333222222 122233 3468999999774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-54 Score=436.75 Aligned_cols=317 Identities=38% Similarity=0.685 Sum_probs=263.2
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 201 (497)
++||+|+||.||+|+++.+|+.||||++.+...........+..|+.+++.++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998876555566778889999999999999999999999999999999999999
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCC
Q 010947 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (497)
Q Consensus 202 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (497)
+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~---------- 150 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA---------- 150 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc----------
Confidence 9999998888899999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCC
Q 010947 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (497)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~ 361 (497)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+
T Consensus 151 -------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 151 -------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred -------------------------------ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 0114679999999999999999999999999999999999999999988
Q ss_pred hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh--cCCCccccc
Q 010947 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (497)
Q Consensus 362 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~ 436 (497)
..+....+.. ....+|. .+++++.+||.+||+ ||.+|++. .++.++++||||.+++|..+.. ..+|+.|.+
T Consensus 200 ~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~ 275 (328)
T cd05593 200 HEKLFELILM--EDIKFPR--TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQV 275 (328)
T ss_pred HHHHHHHhcc--CCccCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcC
Confidence 8777777765 4455664 689999999999999 99999853 3599999999999999998874 678999999
Q ss_pred CCcccccCcccccccccccCCCCCC---CcccccccCcCCcccCceeeCC
Q 010947 437 NDELDTQNFEKFEESDNQTKTSSKT---GPWRKMLSSKDINFVGYTYKNF 483 (497)
Q Consensus 437 ~~~~d~~~f~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~f~g~~~~~~ 483 (497)
..+.++.+|+.....+......... .....+-.+....|.+|+|...
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (328)
T cd05593 276 TSETDTRYFDEEFTAQTITITPPEKYDEDGMDCMDNERRPHFPQFSYSAS 325 (328)
T ss_pred CCcchhhhcCcccccCCcccCCccccccccccccccccccccCCceeeCC
Confidence 9999999888533322211111100 0000111222356999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=434.00 Aligned_cols=311 Identities=35% Similarity=0.659 Sum_probs=258.7
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh-cCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
++||+|+||.||+|+++.+|..||||++++..............|..++.. .+||||++++++|.+.+++|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 479999999999999999999999999988655444455667778888875 4899999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.....+++..+..++.|++.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~ 199 (316)
T cd05620 152 --------------------------------RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199 (316)
T ss_pred --------------------------------ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence 012467999999999999999999999999999999999999999998
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh--hcCCCcccccC
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY--QMEAAFIPEVN 437 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~--~~~~p~~p~~~ 437 (497)
+..+....+.. ....+|. .++.++++||.+||. ||.+|++. ++++++||||++++|..+. .+.+|+.|...
T Consensus 200 ~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~~--~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~ 273 (316)
T cd05620 200 DEDELFESIRV--DTPHYPR--WITKESKDILEKLFERDPTRRLGV--VGNIRGHPFFKTINWTALEKRELDPPFKPKVK 273 (316)
T ss_pred CHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC--hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 88888877765 3344554 689999999999999 99999982 3589999999999999876 46789999999
Q ss_pred CcccccCcccccccccccCCCCCCCcccccccC-cCCcccCceeeCC
Q 010947 438 DELDTQNFEKFEESDNQTKTSSKTGPWRKMLSS-KDINFVGYTYKNF 483 (497)
Q Consensus 438 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~~~~ 483 (497)
.+.+..+|+.-..+..+....+ ....+.+ .+..|.||+|.++
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05620 274 SPSDYSNFDREFLSEKPRLSYS----DKNLIDSMDQSAFAGFSFINP 316 (316)
T ss_pred CcchhhhcCccccccCcccCCC----cccccccccccCcCCCcccCC
Confidence 9999999876333322211111 1112223 4469999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-55 Score=442.57 Aligned_cols=258 Identities=37% Similarity=0.645 Sum_probs=233.9
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch--hHHHHHHHHHHHHHhcC-CCceeEEEEEeecCC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~--~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~ 189 (497)
.....|.+.+.||+|+||+|++|.+..+|..||+|++.+...... ...+.+.+|+.+++.++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 456789999999999999999999999999999998877533212 34566789999999999 999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC-CcEEEcccccccccC-
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLD- 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~-g~vkL~DFGla~~~~- 267 (497)
.+|+|||||.||+|.+++...++++|.+++.++.|++.||+|||++||+||||||+|||++.+ +++||+|||++....
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~ 173 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG 173 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence 999999999999999999999999999999999999999999999999999999999999999 999999999998663
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC-C-CcchhHHhHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-Y-GMECDWWSLGA 345 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-y-~~~~DiwSlGv 345 (497)
... ...+.||||.|+|||++.+.+ | +.++|+||+||
T Consensus 174 ~~~------------------------------------------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GV 211 (370)
T KOG0583|consen 174 EDG------------------------------------------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGV 211 (370)
T ss_pred CCC------------------------------------------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHH
Confidence 111 123689999999999999988 8 58999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccC-ChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKL-SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~-s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+||-|++|+.||...+...++.+|.. ..+.+|. .+ |+++++||.+||. ||.+|++ +.+|+.||||+.
T Consensus 212 iLy~ml~G~~PF~d~~~~~l~~ki~~--~~~~~p~--~~~S~~~~~Li~~mL~~~P~~R~t---~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 212 ILYVLLCGRLPFDDSNVPNLYRKIRK--GEFKIPS--YLLSPEARSLIEKMLVPDPSTRIT---LLEILEHPWFQK 280 (370)
T ss_pred HHHHHHhCCCCCCCccHHHHHHHHhc--CCccCCC--CcCCHHHHHHHHHHcCCCcccCCC---HHHHhhChhhcc
Confidence 99999999999999999999999886 6777886 56 9999999999999 9999999 999999999996
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=435.82 Aligned_cols=312 Identities=33% Similarity=0.649 Sum_probs=254.9
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
++||+|+||+||+|+++.+++.||||++++...........+..|..++..+ +||||++++++|.+.+.+|+|||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999886655555667788999999888 799999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--------- 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874211100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 199 (329)
T cd05588 152 --------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred --------------------------------ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccc
Confidence 011468999999999999999999999999999999999999999632
Q ss_pred C---------hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC---CCcchhcCCCCccCCChhhhhh
Q 010947 361 D---------PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 361 ~---------~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~---~~~~eil~Hpff~~i~w~~l~~ 427 (497)
. .......+.. ..+.+|. .++.++++||.+||+ ||.+|++. .+++++++||||..++|..+..
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~ 275 (329)
T cd05588 200 GMSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQ 275 (329)
T ss_pred cccccccccchHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHh
Confidence 1 1223444443 3455664 689999999999999 99999985 3578999999999999999874
Q ss_pred --cCCCcccccCCcccccCcccccccccccCCCCCCCccccccc-CcCCcccCceeeC
Q 010947 428 --MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLS-SKDINFVGYTYKN 482 (497)
Q Consensus 428 --~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~g~~~~~ 482 (497)
..||+.|.+....+..+|+.....+....++.. + ..+. .....|.||.|.|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~--~--~~~~~~~~~~~~~~~~~~ 329 (329)
T cd05588 276 KQVLPPYKPNIESDRDLDNFDPQFTDEPVQLTPDD--P--DVIARIDQSEFEGFEYIN 329 (329)
T ss_pred CCCCCCccccCCCcchhhhcCCccccCccccCCCC--c--cccccccccccCCCcccC
Confidence 678899999888888888754433221111111 1 0111 2336889998865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-54 Score=432.82 Aligned_cols=310 Identities=36% Similarity=0.656 Sum_probs=259.3
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh-cCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
+.||+|+||+||+|+++.+++.||||++++..............|..++.. ++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987654444455667778888876 5999999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--------- 151 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..|+.++|+|||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (316)
T cd05619 152 --------------------------------KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH 199 (316)
T ss_pred --------------------------------ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC
Confidence 011467999999999999999999999999999999999999999998
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcc-hhcCCCCccCCChhhhh--hcCCCccccc
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD-EIKVHPWFDGVDWARIY--QMEAAFIPEV 436 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~-eil~Hpff~~i~w~~l~--~~~~p~~p~~ 436 (497)
+..+....+... ...+|. .++.++++||.+||+ ||.+|++ +. ++++||||+.++|..+. ..++|+.|.+
T Consensus 200 ~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~~P~~R~~---~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~ 272 (316)
T cd05619 200 DEEELFQSIRMD--NPCYPR--WLTREAKDILVKLFVREPERRLG---VKGDIRQHPFFREIDWSALEEREIEPPFKPKV 272 (316)
T ss_pred CHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHHHhccCHhhcCC---ChHHHHcCcccCCCCHHHHHhCCCCCCcCCCC
Confidence 888887777643 334453 689999999999999 9999998 54 89999999999999886 4789999999
Q ss_pred CCcccccCcccccccccccCCCCCCCcccccccCcCC-cccCceeeCC
Q 010947 437 NDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDI-NFVGYTYKNF 483 (497)
Q Consensus 437 ~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~f~g~~~~~~ 483 (497)
.++.+.++|+.......+.. +. .....+.+.+. .|.||+|.++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05619 273 KSANDCSNFDKEFLNEKPRL-SV---TDRMLINSMDQNMFENFSFINP 316 (316)
T ss_pred CCccchhhcChhhhcCCccc-CC---CcccccccccccccCCCcccCc
Confidence 99999999987444332211 11 11223455554 5999998763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-54 Score=433.70 Aligned_cols=312 Identities=36% Similarity=0.685 Sum_probs=260.8
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
+.||+|+||+||+|.++.++..||||++++...........+..|..++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999987655556667788899999877 799999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.+.+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--------- 151 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.
T Consensus 152 --------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~ 199 (318)
T cd05570 152 --------------------------------TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199 (318)
T ss_pred --------------------------------cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence 011457999999999999999999999999999999999999999998
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhhh--cCCCcccc
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEAAFIPE 435 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~p~~p~ 435 (497)
+.......+.. ....+|. .++.++++||.+||. ||.+|+++. ...+++.||||+.++|..... +.||+.|.
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (318)
T cd05570 200 DEDELFQSILE--DEVRYPR--WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPK 275 (318)
T ss_pred CHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCC
Confidence 88888887776 3445554 689999999999999 999999921 128999999999999988764 77999999
Q ss_pred cCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceee
Q 010947 436 VNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYK 481 (497)
Q Consensus 436 ~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~ 481 (497)
+....+.++|+.-...+.+..++..... +..-....|.||+|.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 318 (318)
T cd05570 276 IKGRFDVSNFDDEFTKEKPVLTPPDEAI---IRNIDQEEFRGFSYI 318 (318)
T ss_pred CCCcchhhhcCchhccCcccCCCCcccc---cccccccccCCCCCC
Confidence 9999999999753333222222222111 112234699999984
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=434.92 Aligned_cols=312 Identities=33% Similarity=0.639 Sum_probs=256.2
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
+.||+|+||+||+|+.+.+++.||+|++.+...........+..|+.++..+ +||+|+.++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999987665566677888999999887 699999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--------- 151 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+||...
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~ 199 (327)
T cd05617 152 --------------------------------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII 199 (327)
T ss_pred --------------------------------ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc
Confidence 012468999999999999999999999999999999999999999642
Q ss_pred C-------hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC---CCcchhcCCCCccCCChhhhhh--
Q 010947 361 D-------PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWFDGVDWARIYQ-- 427 (497)
Q Consensus 361 ~-------~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~---~~~~eil~Hpff~~i~w~~l~~-- 427 (497)
. .......+.. ....+|. .+|..+++||.+||. ||.+|++. .++++++.||||.+++|+.+..
T Consensus 200 ~~~~~~~~~~~~~~~~~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~ 275 (327)
T cd05617 200 TDNPDMNTEDYLFQVILE--KPIRIPR--FLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQ 275 (327)
T ss_pred CCCcccccHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCC
Confidence 1 2233444443 3445664 689999999999999 99999985 3578999999999999999874
Q ss_pred cCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcC-CcccCceeeC
Q 010947 428 MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKD-INFVGYTYKN 482 (497)
Q Consensus 428 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~f~g~~~~~ 482 (497)
..+||.|.+.+..+.++|+.....+....++. ...++...+ ..|.||.|+|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 327 (327)
T cd05617 276 VTPPFKPQITDDYGLENFDTQFTSEPVQLTPD----DEDVIKRIDQSEFEGFEYIN 327 (327)
T ss_pred CCCCccCCCCCCcchhhcCCccccCcccCCCC----CccccccccccccCCCcCCC
Confidence 67899999998888899976433322111111 111222223 4788998875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-54 Score=435.55 Aligned_cols=316 Identities=36% Similarity=0.653 Sum_probs=260.8
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHH-HHhcCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
+.||+|+||+||+|+++.+|+.||||++.+...........+..|+.+ ++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999987655444455566666654 6779999999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--------- 151 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--------- 151 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~ 199 (325)
T cd05604 152 --------------------------------TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR 199 (325)
T ss_pred --------------------------------CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC
Confidence 011467999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC-CCcchhcCCCCccCCChhhhhh--cCCCccccc
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~ 436 (497)
+..+.+.++... .+.++. .++.++.++|.+||. +|.+|++. .++.+++.||||.+++|..+.+ +++|+.|.+
T Consensus 200 ~~~~~~~~~~~~--~~~~~~--~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05604 200 DVAEMYDNILHK--PLVLRP--GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNV 275 (325)
T ss_pred CHHHHHHHHHcC--CccCCC--CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcC
Confidence 888888888763 333433 689999999999999 99999985 3567999999999999999874 678999999
Q ss_pred CCcccccCcccccccccccCCCCCCC---cccccccCcCCcccCceeeC
Q 010947 437 NDELDTQNFEKFEESDNQTKTSSKTG---PWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 437 ~~~~d~~~f~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~f~g~~~~~ 482 (497)
....|.++|+.....+......+... .........+.+|.||+|..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (325)
T cd05604 276 EGPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAP 324 (325)
T ss_pred CCcchhhhcCCccccCCcccCcccccccccccccccccccccCCCEecC
Confidence 99999999986333222111111111 11112234578999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-54 Score=434.33 Aligned_cols=314 Identities=38% Similarity=0.699 Sum_probs=258.8
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHH-HHHhcCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
+.||+|+||+||+|+++.+|+.||||++.+..........++..|.. +++.++||||+++++.|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765544445556666665 45779999999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--------- 151 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 152 --------------------------------TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred --------------------------------ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 011457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC-CCcchhcCCCCccCCChhhhhh--cCCCccccc
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~ 436 (497)
+..+.+..+... .+.++. .+++++.+||.+||+ ||.+|++. ....+++.||||..++|..+.+ +.+|+.|.+
T Consensus 200 ~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05575 200 DTAEMYDNILNK--PLRLKP--NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPFNPNV 275 (323)
T ss_pred CHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHHHhhccCCCCcCCCC
Confidence 888888888763 344443 679999999999999 99999995 3457999999999999999874 779999999
Q ss_pred CCcccccCcccccccccccCCCCCCCc----ccccccCcCCcccCceee
Q 010947 437 NDELDTQNFEKFEESDNQTKTSSKTGP----WRKMLSSKDINFVGYTYK 481 (497)
Q Consensus 437 ~~~~d~~~f~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~f~g~~~~ 481 (497)
....+.++|+....... .+.+....+ ........+..|.||+|.
T Consensus 276 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05575 276 SGPMDLKHFDPEFTEEP-VPNSVGKSPDSVLVSASVKEADDAFLGFSYA 323 (323)
T ss_pred CCcchhhhcCccccccc-cccccCCCcccccccccccccccccCCCccC
Confidence 99888888875322111 111111111 111233457899999983
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-55 Score=444.67 Aligned_cols=263 Identities=30% Similarity=0.563 Sum_probs=241.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..-|.+.+.||+|+-|.|.+|++..||+..|||++.+.......+...+.+|+-||+.+.||||++||+++.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45699999999999999999999999999999999987555566667789999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
.||++||.|+++|.++++|++.+++.++.||+.|+.|+|..+|+||||||+|+|||..+.|||+|||+|..-..+.
T Consensus 91 lEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk---- 166 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK---- 166 (786)
T ss_pred EEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999997643321
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~ell~G 353 (497)
+..+-||+|+|.|||++.+.+| +.++||||.|||||-||||
T Consensus 167 --------------------------------------lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG 208 (786)
T KOG0588|consen 167 --------------------------------------LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTG 208 (786)
T ss_pred --------------------------------------cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhC
Confidence 1226799999999999999998 7899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
+.||.+++...++.++.. +.+..|. .+|++|+|||++||. ||+.|++ .+||++|||+.+..-....
T Consensus 209 ~LPFdDdNir~LLlKV~~--G~f~MPs--~Is~eaQdLLr~ml~VDp~~RiT---~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 209 KLPFDDDNIRVLLLKVQR--GVFEMPS--NISSEAQDLLRRMLDVDPSTRIT---TEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred CCCCCCccHHHHHHHHHc--CcccCCC--cCCHHHHHHHHHHhccCcccccc---HHHHhhCchhhcCCCCChh
Confidence 999999999999999986 5677775 899999999999999 9999999 9999999999987654443
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=430.98 Aligned_cols=313 Identities=34% Similarity=0.641 Sum_probs=253.2
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
+.||+|+||+||+|+++.+++.||+|++++...........+..|+.++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999987555555667788899988776 899999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--------- 151 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--------- 151 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||...
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 199 (329)
T cd05618 152 --------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199 (329)
T ss_pred --------------------------------ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccC
Confidence 011467999999999999999999999999999999999999999531
Q ss_pred ---------ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC---CCcchhcCCCCccCCChhhhhh
Q 010947 361 ---------DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 361 ---------~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~---~~~~eil~Hpff~~i~w~~l~~ 427 (497)
........+.. ....+|. .++.++++||.+||. ||.+|+++ .+++++++||||++++|..+.+
T Consensus 200 ~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~ 275 (329)
T cd05618 200 GSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ 275 (329)
T ss_pred CCcCCcccccHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHc
Confidence 11223344443 3455664 689999999999999 99999985 2468999999999999998874
Q ss_pred --cCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeC
Q 010947 428 --MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 428 --~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (497)
+.||+.|.+....+..+|+.....+....++......+ ......|.||.|+|
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 329 (329)
T cd05618 276 KQVVPPFKPNISGEFGLDNFDAQFTNEPVQLTPDDDDIVR---KIDQSEFEGFEYIN 329 (329)
T ss_pred CCCCcCccCCCCCcccchhcCcccccCCccCCCCcccccc---cccccccCCCcccC
Confidence 78899999988877777775332221111111110111 12336789998875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-53 Score=422.28 Aligned_cols=275 Identities=33% Similarity=0.638 Sum_probs=234.7
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++|++|++++++|.+.+.+|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987665444445567889999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 197 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--- 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---
Confidence 99999998887543 4699999999999999999999999999999999999999999999999999976432100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
....+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 158 ---------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~ 198 (285)
T cd05631 158 ---------------------------------------VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQ 198 (285)
T ss_pred ---------------------------------------ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCC
Confidence 11357999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcc--cCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh--
Q 010947 355 PPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ-- 427 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~-- 427 (497)
+||.+.+.......+... .....++ ..+|+++.+||++||+ ||.+|++. .+++++++||||.+++|..+.+
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~ 276 (285)
T cd05631 199 SPFRKRKERVKREEVDRRVKEDQEEYS--EKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANM 276 (285)
T ss_pred CCCCCCCcchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhCc
Confidence 999876543322222211 1223343 3689999999999999 99999984 4589999999999999999985
Q ss_pred cCCCcccc
Q 010947 428 MEAAFIPE 435 (497)
Q Consensus 428 ~~~p~~p~ 435 (497)
.+|||.|.
T Consensus 277 ~~~~~~~~ 284 (285)
T cd05631 277 LEPPFCPD 284 (285)
T ss_pred CCcCCCCC
Confidence 68999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=429.45 Aligned_cols=316 Identities=41% Similarity=0.731 Sum_probs=255.8
Q ss_pred CeeEEeEeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhc-hhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeE
Q 010947 117 DFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l 191 (497)
+|++++.||+|+||.||+|+.. .+++.||+|++.+..... ....+++..|+.++..+ +||+|++++++|.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999864 578999999998765433 23456788899999999 589999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||++||+|.+++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 99999999999999998888999999999999999999999999999999999999999999999999999876432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~el 350 (497)
. .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 161 ~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 200 (332)
T cd05614 161 E----------------------------------------RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFEL 200 (332)
T ss_pred C----------------------------------------ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhh
Confidence 0 01246899999999999865 489999999999999999
Q ss_pred HhCCCCCCCCC----hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChh
Q 010947 351 LVGYPPFYSDD----PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWA 423 (497)
Q Consensus 351 l~G~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~ 423 (497)
++|..||.... .......+.. ....+|. .+++.+++||.+||. ||.+|+++. +++++++||||++++|.
T Consensus 201 ltg~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 201 LTGASPFTLEGERNTQSEVSRRILK--CDPPFPS--FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred hcCCCCCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 99999997532 2333444444 2334443 689999999999999 999999765 68999999999999999
Q ss_pred hhh--hcCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeC
Q 010947 424 RIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 424 ~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (497)
.+. .+.+||.|......+..+|........+...+... ..+....|.||+|..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~ 331 (332)
T cd05614 277 ALALRKVNPPFRPSIRNELDVGNFAEEFTNLEPVYSPAGT------PPSGARVFQGYSFVA 331 (332)
T ss_pred HHHhCCCCCCcCCCCCCcchhhhcCcccccCCcccCCCCC------CcccccccCCceecC
Confidence 887 47889999999999988886532221111111111 112345799999973
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-56 Score=404.93 Aligned_cols=260 Identities=33% Similarity=0.600 Sum_probs=237.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.+.|++-.+||+|.|+.||.|.++.||+.||+|++........ ..+.+.+|+.|...++|||||+|..+++...+.|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4568888899999999999999999999999999987655444 567799999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC---CcEEEcccccccccCCCCc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~~ 271 (497)
+|+|.||+|..-+-.+-.++|..+..++.||+.||.|+|.+||||||+||+|+|+... --+||+|||+|..+....
T Consensus 89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~- 167 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE- 167 (355)
T ss_pred EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc-
Confidence 9999999999888777889999999999999999999999999999999999999654 349999999999875221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
++...+|||.|||||++...+|+..+||||-|||||-||
T Consensus 168 -----------------------------------------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL 206 (355)
T KOG0033|consen 168 -----------------------------------------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 206 (355)
T ss_pred -----------------------------------------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHH
Confidence 234679999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
.|++||++++...++++|+......+-|.+..+|+++++||++||. ||.+|++ +.|.|+|||+.+-
T Consensus 207 ~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIt---a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 207 VGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRIT---ADEALKHPWICNR 273 (355)
T ss_pred hCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhcc---HHHHhCCchhcch
Confidence 9999999999999999999987777777888999999999999999 9999999 9999999999853
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-55 Score=398.04 Aligned_cols=259 Identities=38% Similarity=0.632 Sum_probs=239.2
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
.....++|++.+.||+|-||.||+|+.+.++-.||+|++.|+.+....-...+++|++|.+.++||||+++|++|.|...
T Consensus 17 ~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~r 96 (281)
T KOG0580|consen 17 KTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKR 96 (281)
T ss_pred cccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccce
Confidence 44678999999999999999999999999999999999999998777666779999999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 191 LYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.||++||.++|+|...|. ....|++..+..|+.|++.||.|+|..++|||||||+|+|++..|.+||+|||-+-.-.+
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999999998 567899999999999999999999999999999999999999999999999998754321
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
+ +| .+.|||..|.+||+..+.+++..+|+||+||+.|
T Consensus 177 ~----------------------------------------kR---~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~y 213 (281)
T KOG0580|consen 177 N----------------------------------------KR---KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCY 213 (281)
T ss_pred C----------------------------------------Cc---eeeecccccCCHhhcCCCCccchhhHHHHHHHHH
Confidence 1 11 2689999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|+|+|.+||.+.+..+++++|.. ..+.+|. .+|.+++|||.+||. +|.+|+. ..|++.|||...
T Consensus 214 eflvg~ppFes~~~~etYkrI~k--~~~~~p~--~is~~a~dlI~~ll~~~p~~r~~---l~~v~~hpwI~a 278 (281)
T KOG0580|consen 214 EFLVGLPPFESQSHSETYKRIRK--VDLKFPS--TISGGAADLISRLLVKNPIERLA---LTEVMDHPWIVA 278 (281)
T ss_pred HHHhcCCchhhhhhHHHHHHHHH--ccccCCc--ccChhHHHHHHHHhccCcccccc---HHHHhhhHHHHh
Confidence 99999999999999999999987 5677774 899999999999999 9999998 999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-54 Score=423.63 Aligned_cols=266 Identities=37% Similarity=0.657 Sum_probs=229.9
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-----------hhHHHHHHHHHHHHHhcCCCceeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-----------RGQVEHVRAERNLLAEVDSNCIVK 180 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~-----------~~~~~~~~~E~~il~~l~hp~Iv~ 180 (497)
....+.|++++.||+|.||+|.+|++..+++.||||++.|..... ...++.+++|+.||++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678999999999999999999999999999999998865432 123568999999999999999999
Q ss_pred EEEEeecC--CeEEEEEeecCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEE
Q 010947 181 LYCSFQDD--EFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (497)
Q Consensus 181 l~~~~~~~--~~l~lVmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL 257 (497)
|+.+..|. +++|||+|||..|.+...= ...+ +++.+|+.|+..++.||+|||.+|||||||||+|+||+.+|++||
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKI 251 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKI 251 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEe
Confidence 99998874 5899999999999886543 2344 999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC----
Q 010947 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---- 333 (497)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~---- 333 (497)
+|||.|.....+.... ..+++ ...+|||.|+|||.+.++.
T Consensus 252 sDFGVs~~~~~~~~~~-------------------------~d~~L-----------~~tvGTPAF~APE~c~~~~~~~~ 295 (576)
T KOG0585|consen 252 SDFGVSNEFPQGSDEG-------------------------SDDQL-----------SRTVGTPAFFAPELCSGGNSFSY 295 (576)
T ss_pred eccceeeecccCCccc-------------------------cHHHH-----------hhcCCCccccchHhhcCCCCccc
Confidence 9999987653321000 00111 1368999999999998732
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 334 YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 334 y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
-+.+.||||+||+||.|+.|..||.++...+++.+|++ .++.||....+.++++|||.+||+ ||+.|++ +.+|+
T Consensus 296 ~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn--~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~---l~~ik 370 (576)
T KOG0585|consen 296 SGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVN--DPLEFPENPEINEDLKDLIKRLLEKDPEQRIT---LPDIK 370 (576)
T ss_pred cchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhc--CcccCCCcccccHHHHHHHHHHhhcChhheee---hhhhe
Confidence 37899999999999999999999999999999999998 789999888899999999999999 9999999 99999
Q ss_pred CCCCccC
Q 010947 413 VHPWFDG 419 (497)
Q Consensus 413 ~Hpff~~ 419 (497)
.|||...
T Consensus 371 ~Hpwvt~ 377 (576)
T KOG0585|consen 371 LHPWVTR 377 (576)
T ss_pred ecceecc
Confidence 9999853
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-53 Score=423.98 Aligned_cols=283 Identities=40% Similarity=0.723 Sum_probs=244.9
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHH-HHHhcCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
++||+|+||.||+|+++.+|+.||+|++.+...........+..|+. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998766544444555666655 57889999999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|...+.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--------- 151 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--------- 151 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (321)
T cd05603 152 --------------------------------TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (321)
T ss_pred --------------------------------ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence 011457999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC-CCcchhcCCCCccCCChhhhhh--cCCCccccc
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~ 436 (497)
+....+..+.. ..+.+|. ..+.++.++|.+||. ||.+|+++ .++.++++||||..++|..+.. +.+|+.|..
T Consensus 200 ~~~~~~~~i~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (321)
T cd05603 200 DVSQMYDNILH--KPLQLPG--GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYHKRITPPYNPNV 275 (321)
T ss_pred CHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCC
Confidence 88888888876 3445554 678899999999999 99999985 3567999999999999999873 678999998
Q ss_pred CCcccccCccccc
Q 010947 437 NDELDTQNFEKFE 449 (497)
Q Consensus 437 ~~~~d~~~f~~~~ 449 (497)
..+.+...|+...
T Consensus 276 ~~~~~~~~~~~~~ 288 (321)
T cd05603 276 AGPADLRHFDPEF 288 (321)
T ss_pred CCcchhhhcCCcc
Confidence 8888888887533
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-53 Score=424.99 Aligned_cols=281 Identities=39% Similarity=0.717 Sum_probs=243.4
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHH-HHHhcCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
+.||+|+||+||+|+++.+++.||+|++.+..........++..|.. +++.++||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999998765544444445555554 56788999999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--------- 151 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--------- 151 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC---------
Confidence 99999998888899999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 152 --------------------------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred --------------------------------CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 011467999999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC-CcchhcCCCCccCCChhhhhh--cCCCccccc
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK-GADEIKVHPWFDGVDWARIYQ--MEAAFIPEV 436 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~-~~~eil~Hpff~~i~w~~l~~--~~~p~~p~~ 436 (497)
+..+.+..+... ...++ ..++.++++||.+||. ||.+|++.. ...++++|+||..++|+.+.. ..+|+.|.+
T Consensus 200 ~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05602 200 NTAEMYDNILNK--PLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNV 275 (325)
T ss_pred CHHHHHHHHHhC--CcCCC--CCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHHHHhCCCCcCcCCCC
Confidence 888888888763 33443 3689999999999999 999999953 456899999999999999974 678899999
Q ss_pred CCcccccCccc
Q 010947 437 NDELDTQNFEK 447 (497)
Q Consensus 437 ~~~~d~~~f~~ 447 (497)
..+.++.+|+.
T Consensus 276 ~~~~~~~~~~~ 286 (325)
T cd05602 276 SGPNDLRHFDP 286 (325)
T ss_pred CCcchhhhcCC
Confidence 98888888874
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-53 Score=423.79 Aligned_cols=313 Identities=41% Similarity=0.739 Sum_probs=257.6
Q ss_pred EeEeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhc-hhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 121 LTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
++.||+|+||.||+|+.. .+++.||||++++..... .....++..|+.+|+.++||||+++++.|.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999863 578899999998765432 2345668899999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|++||+|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~----- 155 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT----- 155 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-----
Confidence 999999999998888999999999999999999999999999999999999999999999999999874321100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|.+|
T Consensus 156 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~p 199 (323)
T cd05584 156 ------------------------------------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199 (323)
T ss_pred ------------------------------------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCC
Confidence 01245799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh--cCCC
Q 010947 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAA 431 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p 431 (497)
|.+.+.......+.. ....+|. .+++++++||.+||. ||.+|++. .++++++.||||...+|..+.. ..+|
T Consensus 200 f~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~~~~~~~~~~ 275 (323)
T cd05584 200 FTAENRKKTIDKILK--GKLNLPP--YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPP 275 (323)
T ss_pred CCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHHHhcCCCCCC
Confidence 999988888888876 3445554 689999999999999 99999942 2489999999999999999874 6788
Q ss_pred cccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeC
Q 010947 432 FIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 432 ~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~ 482 (497)
+.|......+.+.|+.-.....+...+.. .....+....|.||+|..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05584 276 FKPLLQSEEDVSQFDSKFTRQTPVDSPDD----STLSESANQIFLGFTYVA 322 (323)
T ss_pred cCCCCCCcchhhhcCchhcccccccCccc----cccccccccCcCCCeecC
Confidence 99988888888877642222111111111 111223456799999964
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=433.54 Aligned_cols=254 Identities=34% Similarity=0.610 Sum_probs=233.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|-+...||+|+||.||+|+.+.|.+.||||.+.|..- ...+.+.+++|++|++.++|||||.++.+|.+..++++|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 568888999999999999999999999999999988653 3456788999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||.| +|..+|...+.++|+.++.++.+++.||.|||+++|+|||+||.|||++.+|++|+||||+|+.+....
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----- 154 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----- 154 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCc-----
Confidence 99976 999999999999999999999999999999999999999999999999999999999999999765321
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
.+..+..|||-|||||++.+.+|+..+|+||||||+|||.+|.|
T Consensus 155 ------------------------------------~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~P 198 (808)
T KOG0597|consen 155 ------------------------------------SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQP 198 (808)
T ss_pred ------------------------------------eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCC
Confidence 12336789999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||+..+..+..+.|.. .+...|. .+|.++++|+..||. ||.+|++ ..+++.|||.++
T Consensus 199 PF~a~si~~Lv~~I~~--d~v~~p~--~~S~~f~nfl~gLL~kdP~~Rlt---W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 199 PFYARSITQLVKSILK--DPVKPPS--TASSSFVNFLQGLLIKDPAQRLT---WTDLLGHPFWKG 256 (808)
T ss_pred CchHHHHHHHHHHHhc--CCCCCcc--cccHHHHHHHHHHhhcChhhccc---HHHHhcChHHhh
Confidence 9999999999999986 4455554 799999999999999 9999999 999999999886
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-53 Score=424.37 Aligned_cols=283 Identities=41% Similarity=0.727 Sum_probs=248.8
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 201 (497)
+.||+|+||.||+|.++.+|+.||+|++.+...........+..|+.++..++||||++++++|.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998866555556677888999999999999999999999999999999999999
Q ss_pred chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 202 ~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
+|..++.+...+++..++.++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--------- 151 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--------- 151 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc---------
Confidence 999999888899999999999999999999997 7999999999999999999999999999874321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
.....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~ 199 (325)
T cd05594 152 --------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199 (325)
T ss_pred --------------------------------ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC
Confidence 011357999999999999999999999999999999999999999998
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh--cCCCcccc
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAAFIPE 435 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~ 435 (497)
+.......+.. ....+|. .+++++.+||.+||+ ||.+|++. .++.++++||||.++.|..+.. ..+|+.|.
T Consensus 200 ~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~ 275 (325)
T cd05594 200 DHEKLFELILM--EEIRFPR--TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQ 275 (325)
T ss_pred CHHHHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCc
Confidence 88777777765 4455664 689999999999999 99999853 2589999999999999998874 56899999
Q ss_pred cCCcccccCccccc
Q 010947 436 VNDELDTQNFEKFE 449 (497)
Q Consensus 436 ~~~~~d~~~f~~~~ 449 (497)
...+.++.+|++..
T Consensus 276 ~~~~~~~~~~~~~~ 289 (325)
T cd05594 276 VTSETDTRYFDEEF 289 (325)
T ss_pred CCCcchhhhcCchh
Confidence 99999999887543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-54 Score=405.23 Aligned_cols=259 Identities=30% Similarity=0.491 Sum_probs=220.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
+.|+.+..+|+|+||+||+|+++.||+.||||++..++- +..-.+-..+|+.+|++++|||+|.|+.+|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 468889999999999999999999999999999976541 1222344788999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||+..-|.++-.....++++.++.|+.|++.|+.|+|++++|||||||+||||+.+|.+||||||+|+.+.....
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd---- 156 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD---- 156 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc----
Confidence 9997755555544457799999999999999999999999999999999999999999999999999998753211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G~ 354 (497)
..+..|.|.||.|||.+.+ ..|+..+||||+||++.||++|.
T Consensus 157 -------------------------------------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~ 199 (396)
T KOG0593|consen 157 -------------------------------------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE 199 (396)
T ss_pred -------------------------------------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC
Confidence 1125789999999999998 88999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhccc-----------------CcccCCCC----------ccCChhHHHHHHHHhh-CccccCCCC
Q 010947 355 PPFYSDDPMSTCRKIVNWR-----------------THLKFPEE----------AKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~-----------------~~~~~p~~----------~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
|-|.|.+..+++..|...- ..+.+|.. +.+|.-+.||++.||. ||.+|++
T Consensus 200 pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s-- 277 (396)
T KOG0593|consen 200 PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS-- 277 (396)
T ss_pred cCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc--
Confidence 9999998877766654310 01223321 4678889999999999 9999999
Q ss_pred CcchhcCCCCccC
Q 010947 407 GADEIKVHPWFDG 419 (497)
Q Consensus 407 ~~~eil~Hpff~~ 419 (497)
+++++.||||.+
T Consensus 278 -c~qll~H~yFd~ 289 (396)
T KOG0593|consen 278 -CEQLLHHPYFDG 289 (396)
T ss_pred -HHHHhcChHHHH
Confidence 999999999964
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=408.14 Aligned_cols=249 Identities=33% Similarity=0.571 Sum_probs=221.3
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEE-EeecCCe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC-SFQDDEF 190 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~-~~~~~~~ 190 (497)
.....+|+++++||+|+||+||+|....+|..+|.|.++- .+.+.........|+.+|++++|||||+.|+ .|.+++.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f-~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQF-GMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcch-hhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3455679999999999999999999999999999999984 4555666677889999999999999999998 7766665
Q ss_pred -EEEEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHc--CC--EEEcccCCCCeeecCCCcEEEcccc
Q 010947 191 -LYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHK--HH--YIHRDIKPDNLLLDKYGHLRLSDFG 261 (497)
Q Consensus 191 -l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~--~~--iiHrDLKp~NILl~~~g~vkL~DFG 261 (497)
++||||||.+|||..+++. +..++|..+..|+.|++.||.++|. .. |+||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 9999999999999999864 4569999999999999999999999 45 9999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHH
Q 010947 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341 (497)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~Diw 341 (497)
|++.+.... ..+.+.||||.||+||++.+.+|+.++|||
T Consensus 174 L~r~l~s~~-----------------------------------------tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiW 212 (375)
T KOG0591|consen 174 LGRFLSSKT-----------------------------------------TFAHSLVGTPYYMSPERIHESGYNFKSDIW 212 (375)
T ss_pred hHhHhcchh-----------------------------------------HHHHhhcCCCcccCHHHHhcCCCCcchhHH
Confidence 999875331 234589999999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 342 SlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|+||++|||+.-.+||+|.+-.+.+.+|.++. ..+.|. ...|.++..||..|++ ||+.||+
T Consensus 213 slGCllyEMcaL~~PF~g~n~~~L~~KI~qgd-~~~~p~-~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 213 SLGCLLYEMCALQSPFYGDNLLSLCKKIEQGD-YPPLPD-EHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred HHHHHHHHHHhcCCCcccccHHHHHHHHHcCC-CCCCcH-HHhhhHHHHHHHHHccCCcccCCC
Confidence 99999999999999999999999999999852 223553 3789999999999999 9999998
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-53 Score=426.79 Aligned_cols=280 Identities=42% Similarity=0.761 Sum_probs=243.6
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc---CCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
||+|+||+||+|+++.+|+.||||++.+..........+...|..++... +||+|+.++..|.+...+|+||||++|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876655555556667777877665 799999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--------- 151 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--------- 151 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---------
Confidence 99999998888999999999999999999999999999999999999999999999999999875321100
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHhCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYS 359 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~G~~PF~~ 359 (497)
.....+||+.|+|||++.+. .++.++|+|||||++|+|++|..||.+
T Consensus 152 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~ 199 (330)
T cd05586 152 --------------------------------TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199 (330)
T ss_pred --------------------------------CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCC
Confidence 01246799999999999754 589999999999999999999999999
Q ss_pred CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC-CCcchhcCCCCccCCChhhhhh--cCCCcccc
Q 010947 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWFDGVDWARIYQ--MEAAFIPE 435 (497)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~~--~~~p~~p~ 435 (497)
.+..+.+.++... ...+|. ..+++++++||.+||+ ||.+|+++ .++++++.||||..++|..+.. +.+|+.|.
T Consensus 200 ~~~~~~~~~i~~~--~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~ 276 (330)
T cd05586 200 EDTQQMYRNIAFG--KVRFPK-NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITPPFKPI 276 (330)
T ss_pred CCHHHHHHHHHcC--CCCCCC-ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCccCC
Confidence 9888888887753 344554 3589999999999999 99999975 3689999999999999998874 67899999
Q ss_pred cCCcccccCccc
Q 010947 436 VNDELDTQNFEK 447 (497)
Q Consensus 436 ~~~~~d~~~f~~ 447 (497)
+....+.++|+.
T Consensus 277 ~~~~~~~~~~~~ 288 (330)
T cd05586 277 VDSDEDVSNFDP 288 (330)
T ss_pred CCCCcchhhcCc
Confidence 998888888874
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-54 Score=398.11 Aligned_cols=261 Identities=33% Similarity=0.601 Sum_probs=235.0
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-----hhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-----RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~-----~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
..|...+.||+|..++|..|.++.||+.+|+|++.-..... ..-.+..++|+.||+++ .||+|+.+.++|+++.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 34777788999999999999999999999999996432211 12245577899999987 7999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+++|+|.|+.|.|.++|.+.-.++|..++.++.|++.|++|||.++||||||||+|||++++.++||+|||+|+.+..+
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999987543
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc------cCCCCcchhHHhH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWSL 343 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~------~~~y~~~~DiwSl 343 (497)
.- ....||||+|+|||.+. ..+|+..+|+||+
T Consensus 177 ek------------------------------------------LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~ 214 (411)
T KOG0599|consen 177 EK------------------------------------------LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWAC 214 (411)
T ss_pred hh------------------------------------------HHHhcCCCcccChhheeeecccCCCCccchhhHHHH
Confidence 21 12579999999999986 3679999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
|||||-||.|.+||+.....-+++.|+.++..+.-|++.++|.+++|||++||+ ||.+|++ ++|+|+||||..+-
T Consensus 215 GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Rit---ake~LaHpff~q~~ 290 (411)
T KOG0599|consen 215 GVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRIT---AKEALAHPFFIQIA 290 (411)
T ss_pred HHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhccc---HHHHhcChHHHHHH
Confidence 999999999999999999899999999988888889999999999999999999 9999999 99999999997553
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-52 Score=418.61 Aligned_cols=281 Identities=42% Similarity=0.737 Sum_probs=243.8
Q ss_pred EeEeeecCCeEEEEEEE---cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 121 LTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~---~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
++.||+|+||.||+|+. +.+|+.||+|++.+.... ......+..|+.+|+.++||||++++++|.++..+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999986 467899999999875432 23345577899999999999999999999999999999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccc
Q 010947 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (497)
Q Consensus 198 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 277 (497)
++||+|.+++.+...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~------ 153 (318)
T cd05582 80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK------ 153 (318)
T ss_pred CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC------
Confidence 99999999998888899999999999999999999999999999999999999999999999999875432100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCC
Q 010947 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (497)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF 357 (497)
...+.+||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 154 -----------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~ 198 (318)
T cd05582 154 -----------------------------------KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF 198 (318)
T ss_pred -----------------------------------ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCC
Confidence 012467999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCC--cchhcCCCCccCCChhhhhh--cCCCc
Q 010947 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG--ADEIKVHPWFDGVDWARIYQ--MEAAF 432 (497)
Q Consensus 358 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~--~~eil~Hpff~~i~w~~l~~--~~~p~ 432 (497)
.+.+..+....+.. ....+|. .+++++++||++||+ ||.+|+++.. +++++.||||..++|..+.. ..+|+
T Consensus 199 ~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (318)
T cd05582 199 QGKDRKETMTMILK--AKLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPF 274 (318)
T ss_pred CCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHHHHhcCCCCCc
Confidence 99888888888775 3445554 689999999999999 9999999765 78899999999999998874 67888
Q ss_pred ccccCCcccccCccc
Q 010947 433 IPEVNDELDTQNFEK 447 (497)
Q Consensus 433 ~p~~~~~~d~~~f~~ 447 (497)
.|......+..+|+.
T Consensus 275 ~~~~~~~~~~~~~~~ 289 (318)
T cd05582 275 KPAVGRPDDTFYFDP 289 (318)
T ss_pred CCCCCCcchhhhcCc
Confidence 888877776666654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-51 Score=419.79 Aligned_cols=260 Identities=35% Similarity=0.614 Sum_probs=238.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~l 193 (497)
...|++.+.||+|.||.||+|+.+.||+.||+|++.|.........+.+.+|+.||+.+. |||||.++++|.+...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 456999999999999999999999999999999999988766666778999999999998 9999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC----CcEEEcccccccccCCC
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~----g~vkL~DFGla~~~~~~ 269 (497)
|||+|.||+|.+.+... .++|..+..++.|++.|+.|||+.||+||||||+|+|+... +.+|++|||+|+.....
T Consensus 114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~ 192 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG 192 (382)
T ss_pred EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC
Confidence 99999999999999877 49999999999999999999999999999999999999643 57999999999876531
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
. .....||||.|+|||++...+|+..+|+||+||++|.
T Consensus 193 ~------------------------------------------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yi 230 (382)
T KOG0032|consen 193 E------------------------------------------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYI 230 (382)
T ss_pred c------------------------------------------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHH
Confidence 0 1236899999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|++|.+||.+.+...++.+|......+..+.+..+|..++|||++||. ||..|++ +.++|+|||+.+.
T Consensus 231 LL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~t---a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 231 LLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLT---AAQALQHPWIKSI 299 (382)
T ss_pred HhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCC---HHHHhcCccccCC
Confidence 999999999999999999999876666667778899999999999999 9999999 9999999998865
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-52 Score=415.95 Aligned_cols=260 Identities=31% Similarity=0.495 Sum_probs=226.8
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--Ce
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EF 190 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~ 190 (497)
...+.|+.+..||+|+||.||+|++..||+.||+|++..+.. +.+......+|+.||++++||||++|.+...+. ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 445779999999999999999999999999999999987642 345556678899999999999999999988766 68
Q ss_pred EEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
+|||+|||+. ||..++...+ .|++.+++.|+.||+.||+|||.+||+|||||..|||||.+|.+||+|||||+.+...
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999965 8999987643 6999999999999999999999999999999999999999999999999999977543
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ 348 (497)
... ..++.|-|.||.|||++.+ ..|+.++|+||+||||.
T Consensus 272 ~~~----------------------------------------~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~ 311 (560)
T KOG0600|consen 272 GSA----------------------------------------PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILA 311 (560)
T ss_pred CCc----------------------------------------ccccceEEeeccChHHhcCCcccccceeehhhhHHHH
Confidence 210 1236789999999999997 67999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhc---------ccCcccCCC-----------------CccCChhHHHHHHHHhh-Cccc
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVN---------WRTHLKFPE-----------------EAKLSIEAKDLISKLLC-NVNQ 401 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~---------~~~~~~~p~-----------------~~~~s~~~~dLI~~lL~-dp~~ 401 (497)
||++|+|.|.|.++.+++.+|.. |+ ...+|. ...+++.+.+|+..||+ ||.+
T Consensus 312 El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~k 390 (560)
T KOG0600|consen 312 ELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDK 390 (560)
T ss_pred HHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccc
Confidence 99999999999999999998874 43 223331 13578999999999999 9999
Q ss_pred cCCCCCcchhcCCCCcc
Q 010947 402 RLGAKGADEIKVHPWFD 418 (497)
Q Consensus 402 R~~~~~~~eil~Hpff~ 418 (497)
|.+ |.++|.|+||.
T Consensus 391 R~t---A~~aL~seyF~ 404 (560)
T KOG0600|consen 391 RGT---ASSALQSEYFT 404 (560)
T ss_pred ccc---HHHHhcCcccc
Confidence 999 99999999994
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=423.08 Aligned_cols=254 Identities=32% Similarity=0.562 Sum_probs=225.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
..|.....||+|+.|.||.|+...+++.||||+|....... .+-+.+|+.+|+..+|+|||.++.+|.-.+.++.||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 45888899999999999999999999999999998765332 345889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||+||+|.+.+.. ..++|.+++.++.+++.||+|||.+||||||||.+|||++.+|.+||+|||+|..+.....
T Consensus 350 Eym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~---- 424 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS---- 424 (550)
T ss_pred eecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC----
Confidence 99999999888854 5699999999999999999999999999999999999999999999999999998754321
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
+| .+.+|||.|||||++....|+.++||||||++++||+-|.|
T Consensus 425 --------------------KR-----------------~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEP 467 (550)
T KOG0578|consen 425 --------------------KR-----------------STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEP 467 (550)
T ss_pred --------------------cc-----------------ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCC
Confidence 11 26899999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
||..+++...+..|... ..+.+.....+|++++||+.+||+ |+++|++ |.|+|.||||+
T Consensus 468 PYlnE~PlrAlyLIa~n-g~P~lk~~~klS~~~kdFL~~cL~~dv~~Ras---A~eLL~HpFl~ 527 (550)
T KOG0578|consen 468 PYLNENPLRALYLIATN-GTPKLKNPEKLSPELKDFLDRCLVVDVEQRAS---AKELLEHPFLK 527 (550)
T ss_pred CccCCChHHHHHHHhhc-CCCCcCCccccCHHHHHHHHHHhhcchhcCCC---HHHHhcChhhh
Confidence 99998887777776542 334444445899999999999999 9999999 99999999995
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=399.76 Aligned_cols=275 Identities=33% Similarity=0.665 Sum_probs=233.5
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|++.+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.|.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48899999999999999999999999999999987654444444567789999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 197 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|++||+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+++++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--- 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--- 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---
Confidence 99999999888653 4699999999999999999999999999999999999999999999999999876432100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
....+||+.|+|||++.+..++.++||||+||++|||++|.
T Consensus 158 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~ 198 (285)
T cd05605 158 ---------------------------------------IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGK 198 (285)
T ss_pred ---------------------------------------cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCC
Confidence 01357999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcc--cCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhhh--
Q 010947 355 PPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ-- 427 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~-- 427 (497)
+||.+.+.......+... .....+| ..++..+++||.+||. ||.+|++.. ++++++.||||...+|..+.+
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05605 199 SPFRQRKEKVKREEVERRVKEDQEEYS--EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM 276 (285)
T ss_pred CCCCCCchhhHHHHHHHHhhhcccccC--cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCC
Confidence 999887654433333221 1222333 3589999999999999 999999644 589999999999999999984
Q ss_pred cCCCcccc
Q 010947 428 MEAAFIPE 435 (497)
Q Consensus 428 ~~~p~~p~ 435 (497)
+.|||.|.
T Consensus 277 ~~~~~~~~ 284 (285)
T cd05605 277 LEPPFCPD 284 (285)
T ss_pred CCCCCCCC
Confidence 67899884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-52 Score=401.42 Aligned_cols=254 Identities=29% Similarity=0.588 Sum_probs=234.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..+|++.+.||+|+||+|-+|.....|+.||||.++|+.+.+....-|+++|++||+.++||||+.+|.+|...+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 46799999999999999999999999999999999999998888899999999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||..||+|++++..++.|+|.+++.++.||++|+.|+|+++++|||||.+|||+|.++++||+||||+..+....
T Consensus 132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k---- 207 (668)
T KOG0611|consen 132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK---- 207 (668)
T ss_pred EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999998765332
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~ell~G 353 (497)
+..++||+|-|.+||++.+.+| ++.+|-|||||+||-|+.|
T Consensus 208 --------------------------------------fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 208 --------------------------------------FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred --------------------------------------HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 1236899999999999999998 7899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
..||.|.+...+.++|.++. ..-| .-+.++.-||+.||. +|++|.+ +++|..|-|.+
T Consensus 250 tMPFDG~Dhk~lvrQIs~Ga--YrEP---~~PSdA~gLIRwmLmVNP~RRAT---ieDiAsHWWvN 307 (668)
T KOG0611|consen 250 TMPFDGRDHKRLVRQISRGA--YREP---ETPSDASGLIRWMLMVNPERRAT---IEDIASHWWVN 307 (668)
T ss_pred ccccCCchHHHHHHHhhccc--ccCC---CCCchHHHHHHHHHhcCcccchh---HHHHhhhheee
Confidence 99999999999999998743 3334 246689999999998 9999988 99999999964
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-51 Score=403.51 Aligned_cols=260 Identities=32% Similarity=0.522 Sum_probs=220.6
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC--eEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--FLY 192 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~l~ 192 (497)
..++...+.||+|+||.||++.+..+|..+|||.+.... ....+.+.+|+.+|.+++|||||+.++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 456888899999999999999999999999999987652 222566889999999999999999999755444 699
Q ss_pred EEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-CCcEEEcccccccccCCCC
Q 010947 193 LIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~ 270 (497)
++|||++||+|.+++.+.+ .|+|..++.|..||+.||.|||++|||||||||+|||++. +|.+||+|||+++......
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999998876 7999999999999999999999999999999999999999 7999999999998765310
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC-CCcchhHHhHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYE 349 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-y~~~~DiwSlGvil~e 349 (497)
... ....+..|||.|||||++..+. .++++|||||||++.|
T Consensus 173 ~~~--------------------------------------~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 173 TKS--------------------------------------DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred ccc--------------------------------------cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 000 0012578999999999999632 3359999999999999
Q ss_pred HHhCCCCCCC-CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 350 MLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 350 ll~G~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|+||.+||.. ....+.+..|........+|. .+|.++++||.+|+. ||++||+ |+++|.|||....
T Consensus 215 M~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~--~ls~~a~~Fl~~C~~~~p~~Rpt---a~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEAEALLLIGREDSLPEIPD--SLSDEAKDFLRKCFKRDPEKRPT---AEELLEHPFLKQN 282 (313)
T ss_pred ccCCCCcchhhcchHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHhhcCcccCcC---HHHHhhChhhhcc
Confidence 9999999987 555666666665444446665 799999999999999 9999999 9999999999754
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=400.06 Aligned_cols=266 Identities=34% Similarity=0.658 Sum_probs=226.4
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L 203 (497)
||+|+||+||+|.++.+|+.||+|++.+.........+.+..|+.+++.++||||++++++|.+...+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876654445556788899999999999999999999999999999999999999
Q ss_pred hHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccccc
Q 010947 204 MTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (497)
Q Consensus 204 ~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (497)
..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+......
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~------- 153 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK------- 153 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-------
Confidence 887743 356999999999999999999999999999999999999999999999999998765322100
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCC
Q 010947 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (497)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~ 359 (497)
.....||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 154 ----------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~ 199 (280)
T cd05608 154 ----------------------------------TKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRA 199 (280)
T ss_pred ----------------------------------ccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCC
Confidence 1135799999999999999999999999999999999999999987
Q ss_pred CChH----HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhhh--cCC
Q 010947 360 DDPM----STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (497)
Q Consensus 360 ~~~~----~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~ 430 (497)
.+.. .....+.. ....+|. .+++++.+||.+||+ ||.+|++.. +++++++||||++++|..+.. .++
T Consensus 200 ~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~~~~~~ 275 (280)
T cd05608 200 RGEKVENKELKQRILN--DSVTYPD--KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPP 275 (280)
T ss_pred CCcchhHHHHHHhhcc--cCCCCcc--cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhHHhhccCCC
Confidence 5432 22333332 2334443 689999999999999 999999642 489999999999999999874 678
Q ss_pred Cccc
Q 010947 431 AFIP 434 (497)
Q Consensus 431 p~~p 434 (497)
||.|
T Consensus 276 ~~~~ 279 (280)
T cd05608 276 PFVP 279 (280)
T ss_pred CCCC
Confidence 8877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-52 Score=411.13 Aligned_cols=257 Identities=30% Similarity=0.541 Sum_probs=222.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCC-eEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE-FLY 192 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~-~l~ 192 (497)
.++|.+++.||.|+||.||+|+.+.+|..||||.|++... ...+. .-.+|+..|++++ |||||+|+.++.+.+ .+|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 4679999999999999999999999999999999987542 23232 2356999999998 999999999999888 999
Q ss_pred EEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 193 LIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
+|||||+ .+|..++..+ ..|++..++.|+.||++||+|+|++|+.||||||||||+.....+||+|||||+.+.+...
T Consensus 87 fVfE~Md-~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhhh-hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 9999994 6899998654 5799999999999999999999999999999999999999999999999999997754321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~el 350 (497)
.+..|.|.||.|||++.. .-|+.++|+||+|||++|+
T Consensus 166 ------------------------------------------YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl 203 (538)
T KOG0661|consen 166 ------------------------------------------YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAEL 203 (538)
T ss_pred ------------------------------------------cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHH
Confidence 125789999999999986 5689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhc---------cc--------CcccCCCC---------ccCChhHHHHHHHHhh-CccccC
Q 010947 351 LVGYPPFYSDDPMSTCRKIVN---------WR--------THLKFPEE---------AKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~---------~~--------~~~~~p~~---------~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
.+-+|-|.|.++.+++.+|.. |. ..+.||.- +.+++++.+||.+||. ||.+||
T Consensus 204 ~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp 283 (538)
T KOG0661|consen 204 YSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP 283 (538)
T ss_pred HHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc
Confidence 999999999999888888764 11 12333331 4589999999999999 999999
Q ss_pred CCCCcchhcCCCCccC
Q 010947 404 GAKGADEIKVHPWFDG 419 (497)
Q Consensus 404 ~~~~~~eil~Hpff~~ 419 (497)
+ |.++|+||||..
T Consensus 284 T---A~~al~~pffq~ 296 (538)
T KOG0661|consen 284 T---ASQALQHPFFQV 296 (538)
T ss_pred c---HHHHhcCccccc
Confidence 9 999999999974
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=395.65 Aligned_cols=284 Identities=46% Similarity=0.923 Sum_probs=255.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998876656666778999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++||+|.+++.+...+++..+..++.|++.||.|||+.||+||||+|+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~------ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR------ 154 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC------
Confidence 99999999999988889999999999999999999999999999999999999999999999999998765321
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
....+|++.|+|||.+.+..++.++|+||||+++|+|++|.+
T Consensus 155 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 196 (290)
T cd05580 155 --------------------------------------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYP 196 (290)
T ss_pred --------------------------------------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 013578999999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhhh--cCC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEA 430 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~ 430 (497)
||...+......++.. ....+|. .++..++++|.+||+ ||.+|++.. +++++++||||..++|..+.. +.+
T Consensus 197 p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 272 (290)
T cd05580 197 PFFDDNPIQIYEKILE--GKVRFPS--FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEA 272 (290)
T ss_pred CCCCCCHHHHHHHHhc--CCccCCc--cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHHHhhccCCC
Confidence 9998887777777775 3445554 679999999999999 999999643 689999999999999999984 789
Q ss_pred CcccccCCcccccCccc
Q 010947 431 AFIPEVNDELDTQNFEK 447 (497)
Q Consensus 431 p~~p~~~~~~d~~~f~~ 447 (497)
|+.|...++.|++.|++
T Consensus 273 ~~~~~~~~~~~~~~~~~ 289 (290)
T cd05580 273 PFIPKVKGPGDTSNFDD 289 (290)
T ss_pred CccCCCCCccccccccC
Confidence 99999999989888875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-50 Score=394.20 Aligned_cols=270 Identities=29% Similarity=0.487 Sum_probs=232.4
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
+..+..++|++..+||.|..++||+|+...++..||||++.-.... .....++.|+..|+.++||||++.+++|..+.
T Consensus 20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 4557788999999999999999999999999999999999876543 33778999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+|+||.||.+|++.+++... ..|.|..++.++.+++.||.|||.+|.||||||+.||||+.+|.|||+|||.+-.+.
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999999763 569999999999999999999999999999999999999999999999999987664
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGA 345 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGv 345 (497)
.+.. +.+-.. .+.+|||+|||||++.. .+|+.++||||||+
T Consensus 178 ~~G~------------------------------------R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGI 220 (516)
T KOG0582|consen 178 DSGD------------------------------------RQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGI 220 (516)
T ss_pred ccCc------------------------------------eeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhH
Confidence 3210 011111 46899999999999764 78999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhcccCc------ccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTH------LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~~~~~~i~~~~~~------~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
+..||.+|..||....+...+..-++...+ +........+..++.+|..||. ||.+||+ |+++|+|+||+
T Consensus 221 TA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRpt---AskLlkh~FFk 297 (516)
T KOG0582|consen 221 TACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPT---ASKLLKHAFFK 297 (516)
T ss_pred HHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCC---HHHHhccHHHh
Confidence 999999999999999988887666653322 1111224577789999999999 9999999 99999999998
Q ss_pred CCC
Q 010947 419 GVD 421 (497)
Q Consensus 419 ~i~ 421 (497)
...
T Consensus 298 ~~k 300 (516)
T KOG0582|consen 298 KAK 300 (516)
T ss_pred hcc
Confidence 653
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=391.96 Aligned_cols=274 Identities=34% Similarity=0.675 Sum_probs=231.5
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+..|+.+++.++|++|+.+++.+.+.+.+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999987654444444567789999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 197 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~---- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ---- 156 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc----
Confidence 99999999988543 359999999999999999999999999999999999999999999999999987542110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 198 (285)
T cd05630 157 --------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 198 (285)
T ss_pred --------------------------------------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCC
Confidence 011357999999999999999999999999999999999999
Q ss_pred CCCCCCChH---HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhhh-
Q 010947 355 PPFYSDDPM---STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ- 427 (497)
Q Consensus 355 ~PF~~~~~~---~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~- 427 (497)
+||.+.... .....+... ....++ ..+++++++||.+||+ ||.+|++.. +++++++||||+.++|..+..
T Consensus 199 ~Pf~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05630 199 SPFQQRKKKIKREEVERLVKE-VQEEYS--EKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAG 275 (285)
T ss_pred CCCCCCCccchHHHHHhhhhh-hhhhcC--ccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHHHHhcC
Confidence 999875432 222222211 112233 3688999999999999 999999843 488999999999999998875
Q ss_pred -cCCCcccc
Q 010947 428 -MEAAFIPE 435 (497)
Q Consensus 428 -~~~p~~p~ 435 (497)
..|||+|.
T Consensus 276 ~~~~~~~~~ 284 (285)
T cd05630 276 MLEPPFKPD 284 (285)
T ss_pred CCCCCCCCC
Confidence 77899986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=390.04 Aligned_cols=267 Identities=31% Similarity=0.591 Sum_probs=223.6
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L 203 (497)
||+|+||.||+|+.+.+|+.||+|++.+...........+..|+++++.++||||++++++|.++..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999876554444445567799999999999999999999999999999999999999
Q ss_pred hHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCC
Q 010947 204 MTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (497)
Q Consensus 204 ~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (497)
.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---------- 150 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---------- 150 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce----------
Confidence 9888553 3589999999999999999999999999999999999999999999999999876532110
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCC
Q 010947 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (497)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~ 361 (497)
.....||+.|+|||++.+..++.++|+|||||++|||++|.+||.+..
T Consensus 151 --------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~ 198 (277)
T cd05607 151 --------------------------------ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK 198 (277)
T ss_pred --------------------------------eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc
Confidence 013469999999999999889999999999999999999999998653
Q ss_pred h----HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCC-cchhcCCCCccCCChhhhhh--cCCCcc
Q 010947 362 P----MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG-ADEIKVHPWFDGVDWARIYQ--MEAAFI 433 (497)
Q Consensus 362 ~----~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~-~~eil~Hpff~~i~w~~l~~--~~~p~~ 433 (497)
. .+....+.. ....++. ..+++++++||.+||+ ||.+|+++.. .++++.||||++++|..+.. .+|||+
T Consensus 199 ~~~~~~~~~~~~~~--~~~~~~~-~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~ 275 (277)
T cd05607 199 EKVAKEELKRRTLE--DEVKFEH-QNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPFV 275 (277)
T ss_pred chhhHHHHHHHhhc--ccccccc-ccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHHHHhcCcCCCCCC
Confidence 3 233333332 2222322 3689999999999999 9999999422 36789999999999999984 678887
Q ss_pred cc
Q 010947 434 PE 435 (497)
Q Consensus 434 p~ 435 (497)
|.
T Consensus 276 ~~ 277 (277)
T cd05607 276 PD 277 (277)
T ss_pred CC
Confidence 73
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=389.12 Aligned_cols=261 Identities=30% Similarity=0.493 Sum_probs=221.6
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-----CCe
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-----DEF 190 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~~~ 190 (497)
..|..++.||+|+||.|+.+.++.||+.||||++... ....-..++..+|+.+|+.++|+||+.++.++.. -+.
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 4566689999999999999999999999999998743 2334456778899999999999999999998875 346
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|+|+|+| +.||...+.+...|+++.++++++||+.||.|+|+.||+||||||.|+|++.+..+||+|||||+..+..
T Consensus 101 vYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~- 178 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF- 178 (359)
T ss_pred eEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecccc-
Confidence 99999999 7899999988888999999999999999999999999999999999999999999999999999977532
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~e 349 (497)
... ...+..+-|.+|.|||++.. ..|+.++||||+|||+.|
T Consensus 179 ~~~--------------------------------------~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AE 220 (359)
T KOG0660|consen 179 FED--------------------------------------GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAE 220 (359)
T ss_pred Ccc--------------------------------------cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHH
Confidence 000 01235789999999999875 789999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCc---------------------ccCCC------CccCChhHHHHHHHHhh-Cccc
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTH---------------------LKFPE------EAKLSIEAKDLISKLLC-NVNQ 401 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~---------------------~~~p~------~~~~s~~~~dLI~~lL~-dp~~ 401 (497)
||+|++-|.|.+...++..|+.--+. ...|. -+.+++.|.||+.+||. ||.+
T Consensus 221 mL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~k 300 (359)
T KOG0660|consen 221 MLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKK 300 (359)
T ss_pred HHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccc
Confidence 99999999999877776666531100 01111 14689999999999999 9999
Q ss_pred cCCCCCcchhcCCCCccCC
Q 010947 402 RLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 402 R~~~~~~~eil~Hpff~~i 420 (497)
|++ |+|+|+||||...
T Consensus 301 Rit---a~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 301 RIT---AEEALAHPYLAPY 316 (359)
T ss_pred cCC---HHHHhcChhhhhh
Confidence 999 9999999999864
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=383.32 Aligned_cols=260 Identities=29% Similarity=0.476 Sum_probs=221.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee--cCCeEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFLY 192 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~l~ 192 (497)
.++|+.+..|++|+||.||.|+++.|++.||+|+++...- ..+---...+|+.+|.+++|||||.+-.+.. +-+.+|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 4679999999999999999999999999999999986542 2222223567999999999999999987765 345799
Q ss_pred EEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 193 LIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
||||||+ -||..++..-. +|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||||+.+.....
T Consensus 154 ~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k 232 (419)
T KOG0663|consen 154 IVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLK 232 (419)
T ss_pred eeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcc
Confidence 9999995 59999997754 899999999999999999999999999999999999999999999999999998754311
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~el 350 (497)
..+..|-|.+|.|||++.+ ..|+.++|+||+|||+.||
T Consensus 233 -----------------------------------------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~ 271 (419)
T KOG0663|consen 233 -----------------------------------------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAEL 271 (419)
T ss_pred -----------------------------------------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHH
Confidence 1225789999999999997 5699999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhc---------ccCcccCC--------CC-----------ccCChhHHHHHHHHhh-Cccc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVN---------WRTHLKFP--------EE-----------AKLSIEAKDLISKLLC-NVNQ 401 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~---------~~~~~~~p--------~~-----------~~~s~~~~dLI~~lL~-dp~~ 401 (497)
+++.|-|.|.+..+++.+|.. |+..-.+| .. ..+|..+.||+..||+ ||.+
T Consensus 272 l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~k 351 (419)
T KOG0663|consen 272 LTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGK 351 (419)
T ss_pred HhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccc
Confidence 999999999999999888874 33322222 10 1267999999999999 9999
Q ss_pred cCCCCCcchhcCCCCccCC
Q 010947 402 RLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 402 R~~~~~~~eil~Hpff~~i 420 (497)
|.+ |+|.|.|+||.+.
T Consensus 352 R~t---A~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 352 RIT---AEDGLKHEYFRET 367 (419)
T ss_pred ccc---HHHhhcccccccC
Confidence 999 9999999999975
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=371.80 Aligned_cols=259 Identities=31% Similarity=0.540 Sum_probs=223.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|..++.||+|.||.||+|++..||+.||||+++..... .+-.....+|+.+|+.++||||+.|.++|...+.+.||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~k-dGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAK-DGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccc-cCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 4688889999999999999999999999999999876432 333345778999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||+ .||...+... ..|+...++.|+.+++.||+|||++.|+||||||.|+||+.+|.+||+|||+|+.+....-.
T Consensus 81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~-- 157 (318)
T KOG0659|consen 81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI-- 157 (318)
T ss_pred Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcc--
Confidence 9995 5999888654 46999999999999999999999999999999999999999999999999999987543210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G 353 (497)
....|-|.+|.|||.+.+ ..|+..+|+||+|||+.||+-|
T Consensus 158 ---------------------------------------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr 198 (318)
T KOG0659|consen 158 ---------------------------------------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLR 198 (318)
T ss_pred ---------------------------------------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHcc
Confidence 012378999999999986 6799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhc---------ccCcccCCC---------C------ccCChhHHHHHHHHhh-CccccCCCCCc
Q 010947 354 YPPFYSDDPMSTCRKIVN---------WRTHLKFPE---------E------AKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~---------~~~~~~~p~---------~------~~~s~~~~dLI~~lL~-dp~~R~~~~~~ 408 (497)
.|-|.|.+..+++..|.. |+.-..+|+ . +.+|.++.||+.+|+. ||.+|++ +
T Consensus 199 ~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit---a 275 (318)
T KOG0659|consen 199 VPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRIT---A 275 (318)
T ss_pred CCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhccc---H
Confidence 999999999988888864 332222222 1 3578899999999999 9999999 9
Q ss_pred chhcCCCCccCC
Q 010947 409 DEIKVHPWFDGV 420 (497)
Q Consensus 409 ~eil~Hpff~~i 420 (497)
.|++.||||+..
T Consensus 276 ~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 276 SQALKHPYFKSL 287 (318)
T ss_pred HHHhcchhhhcC
Confidence 999999999864
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=388.50 Aligned_cols=303 Identities=42% Similarity=0.774 Sum_probs=253.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||.||++.++.+++.||+|.+.+...........+..|+.+++.++||||+++++.|.+++++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998765444455667889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++||+|.+++...+.+++..+..++.+++.||.|||+.||+||||||+||+++.+|.+||+|||+++......... .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~-~ 159 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN-L 159 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc-c
Confidence 999999999999888889999999999999999999999999999999999999999999999999987432110000 0
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
.. ...... ..........|++.|+|||.+.+..++.++|+|||||++|||++|..
T Consensus 160 ~~--------------~~~~~~-----------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~ 214 (305)
T cd05609 160 YE--------------GHIEKD-----------TREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 214 (305)
T ss_pred cc--------------cccccc-----------hhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 00 000000 00000113468999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCC-ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhcCCCcc
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFI 433 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~ 433 (497)
||.+.+..+....+... ....|.. ..++.++++||.+||. ||.+||+..++.+++.||||...+|..+.+...+++
T Consensus 215 pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~ 292 (305)
T cd05609 215 PFFGDTPEELFGQVISD--DIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLLRQKAEFI 292 (305)
T ss_pred CCCCCCHHHHHHHHHhc--ccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHhhcCCCCC
Confidence 99998888777777653 2223321 2578999999999999 999999988899999999999999999988888999
Q ss_pred cccCCcccccCcc
Q 010947 434 PEVNDELDTQNFE 446 (497)
Q Consensus 434 p~~~~~~d~~~f~ 446 (497)
|.+.+..|.++|+
T Consensus 293 ~~~~~~~~~~~~~ 305 (305)
T cd05609 293 PQLESEDDTSYFD 305 (305)
T ss_pred CCCCCccccccCC
Confidence 9998888888764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-49 Score=387.17 Aligned_cols=258 Identities=33% Similarity=0.488 Sum_probs=216.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|+++.+++.||||++..... .......+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2334566888999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++++.+..+......+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+.+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--- 156 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA--- 156 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc---
Confidence 99998877766555667999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
.....+||+.|+|||++.+..++.++|+|||||++|||++|.+
T Consensus 157 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~ 199 (287)
T cd07848 157 -------------------------------------NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQP 199 (287)
T ss_pred -------------------------------------cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCC
Confidence 0113579999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCc-----------------ccCCCC-----------ccCChhHHHHHHHHhh-CccccCCCC
Q 010947 356 PFYSDDPMSTCRKIVNWRTH-----------------LKFPEE-----------AKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~-----------------~~~p~~-----------~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
||.+.+..+....+...... ..+|.. ..+|.++++||++||. ||.+|++
T Consensus 200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s-- 277 (287)
T cd07848 200 LFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL-- 277 (287)
T ss_pred CCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC--
Confidence 99987765544433321110 111110 1378899999999999 9999999
Q ss_pred CcchhcCCCCc
Q 010947 407 GADEIKVHPWF 417 (497)
Q Consensus 407 ~~~eil~Hpff 417 (497)
++++++||||
T Consensus 278 -~~~~l~hp~f 287 (287)
T cd07848 278 -TEQCLNHPAF 287 (287)
T ss_pred -HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=395.13 Aligned_cols=258 Identities=32% Similarity=0.580 Sum_probs=233.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
.-|.+.+.||+|.|++|.+|++.-||..||||++.|..+ +.....|+.+|++.|+.++|||||+||.+..+...+|||+
T Consensus 18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 458899999999999999999999999999999998764 3445678999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee-cCCCcEEEcccccccccCCCCccc
Q 010947 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL-DKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl-~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|+-.||||+++++++ ..+.|+.++.|++||+.||.|+|++.+|||||||+|+.+ .+-|-|||+|||++..+.++..
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k-- 174 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK-- 174 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcch--
Confidence 999999999999886 579999999999999999999999999999999999876 5679999999999987754321
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCC-cchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG-MECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~-~~~DiwSlGvil~ell~ 352 (497)
..+.||+..|-|||++.+..|+ +++||||||||||-|++
T Consensus 175 ----------------------------------------L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVC 214 (864)
T KOG4717|consen 175 ----------------------------------------LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVC 214 (864)
T ss_pred ----------------------------------------hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHh
Confidence 1267999999999999999995 68999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChh
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
|.+||...+..+++-.|+..+ ...|. .+|.+++|||.+||. ||.+|.+ .++|..|+|++.+|-.
T Consensus 215 Gq~PFqeANDSETLTmImDCK--YtvPs--hvS~eCrdLI~sMLvRdPkkRAs---lEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 215 GQPPFQEANDSETLTMIMDCK--YTVPS--HVSKECRDLIQSMLVRDPKKRAS---LEEIVSTSWLQAGDRG 279 (864)
T ss_pred CCCccccccchhhhhhhhccc--ccCch--hhhHHHHHHHHHHHhcCchhhcc---HHHHhccccccCCCCC
Confidence 999999999999999999854 44554 899999999999999 9999988 9999999999998744
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-48 Score=382.76 Aligned_cols=275 Identities=35% Similarity=0.663 Sum_probs=233.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|+..+.||+|+||+||+|.+..+++.||+|++.+...........+..|+.+|+.++|++|+.+++.|.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999987654444445567789999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 197 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~--- 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--- 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---
Confidence 99999999888653 3699999999999999999999999999999999999999999999999999875432100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 158 ---------------------------------------~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 198 (285)
T cd05632 158 ---------------------------------------IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198 (285)
T ss_pred ---------------------------------------ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCC
Confidence 11357999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhccc--CcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhh--h
Q 010947 355 PPFYSDDPMSTCRKIVNWR--THLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY--Q 427 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~--~ 427 (497)
+||.+.........+.... ....++ ..++.++.+||.+||. ||.+|++.. ++.+++.||||+.++|+.+. +
T Consensus 199 ~P~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05632 199 SPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGM 276 (285)
T ss_pred CCCCCCCHHHHHHHHHHhhhccccccC--ccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHHHHhcCc
Confidence 9998876554433332211 112233 3688999999999999 999999853 47799999999999999987 4
Q ss_pred cCCCcccc
Q 010947 428 MEAAFIPE 435 (497)
Q Consensus 428 ~~~p~~p~ 435 (497)
+.|||+|.
T Consensus 277 ~~~~~~~~ 284 (285)
T cd05632 277 LDPPFVPD 284 (285)
T ss_pred CCCCCCCC
Confidence 77999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=386.34 Aligned_cols=256 Identities=28% Similarity=0.468 Sum_probs=214.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||.|+||.||+|+++.++..||+|+++.... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 5689999999999999999999999999999999975431 22334577899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||++| +|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-- 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-- 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--
Confidence 999975 8988886544 589999999999999999999999999999999999999999999999999975432110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 159 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~ 199 (288)
T cd07871 159 ---------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMAT 199 (288)
T ss_pred ---------------------------------------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHh
Confidence 0113578999999999875 568999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccC-----------------cccCCC---------CccCChhHHHHHHHHhh-CccccCCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRT-----------------HLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
|.+||.+.+..+....+..... ...+|. ...++++++|||++||+ ||.+|++
T Consensus 200 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t- 278 (288)
T cd07871 200 GRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS- 278 (288)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC-
Confidence 9999999887766655542100 001111 13578899999999999 9999999
Q ss_pred CCcchhcCCCCc
Q 010947 406 KGADEIKVHPWF 417 (497)
Q Consensus 406 ~~~~eil~Hpff 417 (497)
++|+++||||
T Consensus 279 --~~~~l~hp~f 288 (288)
T cd07871 279 --AEAALRHSYF 288 (288)
T ss_pred --HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=387.99 Aligned_cols=261 Identities=28% Similarity=0.444 Sum_probs=212.1
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||+|+||+||+|+++.+++.||||++..... ......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999975432 22234567899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||++ ++|.+++.. .+.+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH-- 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--
Confidence 99995 677777755 35799999999999999999999999999999999999999999999999999875421100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
.....+||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 159 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 199 (303)
T cd07869 159 ---------------------------------------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQ 199 (303)
T ss_pred ---------------------------------------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 0113578999999999875 568999999999999999999
Q ss_pred CCCCCCCCCh-HHHHHHHhc---------ccCccc------------CCC-------CccCChhHHHHHHHHhh-Ccccc
Q 010947 353 GYPPFYSDDP-MSTCRKIVN---------WRTHLK------------FPE-------EAKLSIEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 353 G~~PF~~~~~-~~~~~~i~~---------~~~~~~------------~p~-------~~~~s~~~~dLI~~lL~-dp~~R 402 (497)
|.+||.+... .+....+.. |..... .|. ....++++++||.+||+ ||.+|
T Consensus 200 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R 279 (303)
T cd07869 200 GVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNR 279 (303)
T ss_pred CCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhc
Confidence 9999987543 233333321 000000 000 01245789999999999 99999
Q ss_pred CCCCCcchhcCCCCccCCCh
Q 010947 403 LGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 403 ~~~~~~~eil~Hpff~~i~w 422 (497)
++ +.++++||||+++++
T Consensus 280 ~s---~~~~l~h~~f~~~~~ 296 (303)
T cd07869 280 LS---AQAALSHEYFSDLPP 296 (303)
T ss_pred cC---HHHHhcCcccccCCh
Confidence 99 999999999998864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-50 Score=374.09 Aligned_cols=254 Identities=35% Similarity=0.564 Sum_probs=220.4
Q ss_pred CCCCeeEE-eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh-cCCCceeEEEEEee----c
Q 010947 114 GADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQ----D 187 (497)
Q Consensus 114 ~~~~f~~~-~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~----~ 187 (497)
.++||.+. ++||-|-.|+|..|.++.||+.||+|++..+ ...++|+++.-. ..|||||.++++|. .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 35778775 5799999999999999999999999998643 236788888654 47999999998765 4
Q ss_pred CCeEEEEEeecCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC---CcEEEccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGL 262 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~---g~vkL~DFGl 262 (497)
...+.+|||.|+||+|+..++.++. |+|.++..|+.||..|+.|||+.+|.||||||+|+|.+.+ ..+||+|||+
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence 5679999999999999999988765 9999999999999999999999999999999999999754 4699999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHh
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwS 342 (497)
||.-.... ...+.|-||.|.|||++....|+..||+||
T Consensus 211 AK~t~~~~------------------------------------------~L~TPc~TPyYvaPevlg~eKydkscdmwS 248 (400)
T KOG0604|consen 211 AKETQEPG------------------------------------------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWS 248 (400)
T ss_pred ccccCCCc------------------------------------------cccCCcccccccCHHHhCchhcCCCCCccc
Confidence 99653211 112679999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC----hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 343 LGAIMYEMLVGYPPFYSDD----PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
+|||||-||+|+|||++.. +..+..+|..+...++-|++..+|.+++|+|+.||. +|.+|++ +++++.|||.
T Consensus 249 lgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlT---I~~~m~hpwi 325 (400)
T KOG0604|consen 249 LGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLT---IEEVMDHPWI 325 (400)
T ss_pred hhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhee---HHHhhcCchh
Confidence 9999999999999999865 345678888866666666778899999999999999 9999999 9999999999
Q ss_pred cCC
Q 010947 418 DGV 420 (497)
Q Consensus 418 ~~i 420 (497)
.+.
T Consensus 326 ~~~ 328 (400)
T KOG0604|consen 326 NQY 328 (400)
T ss_pred ccc
Confidence 864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=384.68 Aligned_cols=310 Identities=39% Similarity=0.705 Sum_probs=249.3
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|....+++.||||.+.+...........+..|+.++..++||+|+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999998765544456677899999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 196 EYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||+.|++|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 579999999999999999999999999999999999999999999999999998654321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
.... .... ... ....+.. ..............+||..|+|||++.+..++.++|||||||++|+|++|
T Consensus 161 ~~~~--~~~~--~~~--~~~~~~~------~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g 228 (316)
T cd05574 161 SKAL--RKGS--RRS--SVNSIPS------ETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYG 228 (316)
T ss_pred cccc--cccc--ccc--cccccch------hhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhC
Confidence 0000 0000 000 0000000 00000001112246899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC-CCcchhcCCCCccCCChhhhhhcCCC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWFDGVDWARIYQMEAA 431 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~~~~~p 431 (497)
..||.+.+....+.++.. ....+|....++.++++||.+||+ ||.+|++. .++++++.||||++++|..+.-..+|
T Consensus 229 ~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~ 306 (316)
T cd05574 229 TTPFKGSNRDETFSNILK--KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPP 306 (316)
T ss_pred CCCCCCCchHHHHHHHhc--CCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhcccCCCC
Confidence 999999888888877775 345555544589999999999999 99999983 45899999999999999999988888
Q ss_pred cccccCCc
Q 010947 432 FIPEVNDE 439 (497)
Q Consensus 432 ~~p~~~~~ 439 (497)
-+|.+...
T Consensus 307 ~~~~~~~~ 314 (316)
T cd05574 307 IIPRPDDG 314 (316)
T ss_pred CCCCcccc
Confidence 88876543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=375.16 Aligned_cols=260 Identities=31% Similarity=0.501 Sum_probs=220.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCc-eeEEEEEeecCC-----
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDE----- 189 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~----- 189 (497)
..|+.++.||+|+||+||+|+.+.+|+.||+|+++-.... ++--....+|+.+|+.++|+| ||.|++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 4577777899999999999999999999999999765321 222344678999999999999 999999999887
Q ss_pred -eEEEEEeecCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
.+|||+||+ .-||..++.... .++...++.++.||+.||.|||++||+||||||.||||+.+|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 899999999 569999997755 58888999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSL 343 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSl 343 (497)
.+.-+. + ...+.++|.+|.|||++.+. .|+..+||||+
T Consensus 169 a~~ip~--------------------------~---------------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~ 207 (323)
T KOG0594|consen 169 AFSIPM--------------------------R---------------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSL 207 (323)
T ss_pred HhcCCc--------------------------c---------------cccccEEEeeccCHHHhcCCCcCCCCcchHhH
Confidence 653211 0 01246899999999999985 79999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhc---------ccCcccCCC-------C----------ccCChhHHHHHHHHhh
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVN---------WRTHLKFPE-------E----------AKLSIEAKDLISKLLC 397 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~---------~~~~~~~p~-------~----------~~~s~~~~dLI~~lL~ 397 (497)
|||++||+++.+-|.|.+..++..+|.. |+....+|. . +..++++.+|+.+||+
T Consensus 208 GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~ 287 (323)
T KOG0594|consen 208 GCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQ 287 (323)
T ss_pred HHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhc
Confidence 9999999999999999999888888863 433332222 1 2345689999999999
Q ss_pred -CccccCCCCCcchhcCCCCccCCC
Q 010947 398 -NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 398 -dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
+|.+|.+ |..++.||||..+.
T Consensus 288 y~p~~R~S---a~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 288 YDPAKRIS---AKGALTHPYFSELP 309 (323)
T ss_pred cCcccCcC---HHHHhcChhhcccc
Confidence 9999999 89999999999763
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-48 Score=388.33 Aligned_cols=252 Identities=27% Similarity=0.440 Sum_probs=217.1
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcE-EEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHV-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE- 189 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~-~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~- 189 (497)
.+...++.+...||+|+||+||.+.++ |.. ||+|++......... .+.+.+|+.+|.+++|||||++++++.++.
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 344556666777999999999999876 446 999999876543333 678999999999999999999999999887
Q ss_pred eEEEEEeecCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCC-EEEcccCCCCeeecCCC-cEEEcccccccc
Q 010947 190 FLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHH-YIHRDIKPDNLLLDKYG-HLRLSDFGLCKP 265 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~-iiHrDLKp~NILl~~~g-~vkL~DFGla~~ 265 (497)
.++||||||++|+|..+|.. ...++...+..++.+|+.||+|||+.+ ||||||||+|||++.++ ++||+|||+++.
T Consensus 114 ~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~ 193 (362)
T KOG0192|consen 114 SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSRE 193 (362)
T ss_pred ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcccee
Confidence 79999999999999999988 688999999999999999999999999 99999999999999998 999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc--cCCCCcchhHHhH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--KKGYGMECDWWSL 343 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~--~~~y~~~~DiwSl 343 (497)
...... ...+..||+.|||||++. ...|+.++|||||
T Consensus 194 ~~~~~~-----------------------------------------~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySF 232 (362)
T KOG0192|consen 194 KVISKT-----------------------------------------SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSF 232 (362)
T ss_pred eccccc-----------------------------------------cccCCCCCccccChhhhcCCCCcCCccchhhhH
Confidence 542110 011367999999999999 5699999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
||+||||+||..||.+....+....+......+.+|. .+++.+..||.+|+. ||..||+ ..+|.
T Consensus 233 gIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~--~~~~~l~~l~~~CW~~dp~~RP~---f~ei~ 297 (362)
T KOG0192|consen 233 GIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK--ECPPHLSSLMERCWLVDPSRRPS---FLEIV 297 (362)
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHhCCCCCCcCCC---HHHHH
Confidence 9999999999999999988777777776555666665 489999999999999 9999999 55543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=387.85 Aligned_cols=263 Identities=26% Similarity=0.416 Sum_probs=213.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-----CeE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----EFL 191 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~l 191 (497)
+|++.+.||+|+||.||+|+++.+|..||||++.... ........+.+|+.+++.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 5899999999999999999999999999999987532 1223345678899999999999999999887543 358
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||| +++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999999 579999998888899999999999999999999999999999999999999999999999999975422110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvil~e 349 (497)
.. ......+||+.|+|||++.+ ..++.++|||||||++||
T Consensus 159 ~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~e 200 (338)
T cd07859 159 TA--------------------------------------IFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAE 200 (338)
T ss_pred cc--------------------------------------ccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHH
Confidence 00 00124679999999999876 678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcc--------------------------cCcccCCC-CccCChhHHHHHHHHhh-Cccc
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNW--------------------------RTHLKFPE-EAKLSIEAKDLISKLLC-NVNQ 401 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~--------------------------~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~ 401 (497)
|++|++||.+.+.......+... .....++. ...+++++.+||.+||+ ||.+
T Consensus 201 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 280 (338)
T cd07859 201 VLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKD 280 (338)
T ss_pred HHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCccc
Confidence 99999999887654333222110 00011100 12578899999999999 9999
Q ss_pred cCCCCCcchhcCCCCccCCCh
Q 010947 402 RLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 402 R~~~~~~~eil~Hpff~~i~w 422 (497)
||+ ++++++||||+++..
T Consensus 281 Rpt---~~e~l~hp~f~~~~~ 298 (338)
T cd07859 281 RPT---AEEALADPYFKGLAK 298 (338)
T ss_pred CCC---HHHHhcCchhhhcCc
Confidence 998 999999999997654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=384.94 Aligned_cols=259 Identities=26% Similarity=0.426 Sum_probs=219.9
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++++.||+|+||.||+|+++.+|..||+|++.... .......+.+|+.+|+.++||||+++++++.+++.+|
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 45688999999999999999999999999999999997542 2334567889999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
+||||++||+|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.+|.+||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 9999999999999998888899999999999999999999986 69999999999999999999999999987543110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 159 ------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~ 196 (331)
T cd06649 159 ------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELA 196 (331)
T ss_pred ------------------------------------------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence 11457999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhccc----------------------------------------------CcccCCCCccCC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWR----------------------------------------------THLKFPEEAKLS 385 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~----------------------------------------------~~~~~p~~~~~s 385 (497)
+|..||...+..+... ++... .....+ ...++
T Consensus 197 tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 274 (331)
T cd06649 197 IGRYPIPPPDAKELEA-IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP-NGVFT 274 (331)
T ss_pred hCCCCCCCCCHHHHHH-HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCC-Ccccc
Confidence 9999998765544322 11100 001111 12478
Q ss_pred hhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 386 IEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 386 ~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
+++++||.+||. ||++||+ +.+|++||||+...
T Consensus 275 ~~l~~li~~~L~~~P~~Rpt---~~ell~h~~~~~~~ 308 (331)
T cd06649 275 PDFQEFVNKCLIKNPAERAD---LKMLMNHTFIKRSE 308 (331)
T ss_pred HHHHHHHHHHccCCcccCCC---HHHHhcChHHhhcc
Confidence 899999999999 9999999 99999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=376.02 Aligned_cols=252 Identities=32% Similarity=0.532 Sum_probs=213.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-----Ce
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----EF 190 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~~ 190 (497)
-.|.-.+++|.|+||.||.|....+++.||||+.-.+.-. -.+|..+|..++|||||+|.++|... -+
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 3588899999999999999999999999999998654321 23599999999999999999888632 26
Q ss_pred EEEEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC-CcEEEcccccccc
Q 010947 191 LYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKP 265 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~-g~vkL~DFGla~~ 265 (497)
+.||||||| -+|...+.. +..++.-.++.|..||+.||.|||+.||+||||||.|+|+|.+ |.+||||||.|+.
T Consensus 97 lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 779999996 488888864 5679999999999999999999999999999999999999976 8999999999998
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlG 344 (497)
+..+..+ .+...|..|.|||.+.+ ..|+.+.||||.|
T Consensus 176 L~~~epn------------------------------------------iSYicSRyYRaPELifga~~Yt~~IDiWSaG 213 (364)
T KOG0658|consen 176 LVKGEPN------------------------------------------ISYICSRYYRAPELIFGATEYTTSIDIWSAG 213 (364)
T ss_pred eccCCCc------------------------------------------eeEEEeccccCHHHHcCccccCceeEEhhhh
Confidence 8644211 15677899999999987 6799999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhccc---------------CcccCCC----------CccCChhHHHHHHHHhh-C
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWR---------------THLKFPE----------EAKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dLI~~lL~-d 398 (497)
|+|.||+-|++-|.|++..+++..|+.-- ....+|. ...+++++.||+.++|. +
T Consensus 214 CV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~ 293 (364)
T KOG0658|consen 214 CVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYS 293 (364)
T ss_pred HHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccC
Confidence 99999999999999999888877765310 0112222 13579999999999999 9
Q ss_pred ccccCCCCCcchhcCCCCccCC
Q 010947 399 VNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 399 p~~R~~~~~~~eil~Hpff~~i 420 (497)
|.+|.+ +.|++.||||..+
T Consensus 294 P~~R~~---~~~~l~h~fFdel 312 (364)
T KOG0658|consen 294 PSKRLS---ALEALAHPFFDEL 312 (364)
T ss_pred hhhcCC---HHHHhcchhhHHh
Confidence 999999 9999999999864
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-47 Score=399.08 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=209.9
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC----
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD---- 188 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~---- 188 (497)
....+|.+++.||+|+||.||+|.+..+++.||||++.+.. ....+|+.+|+.++|||||+++++|...
T Consensus 63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34568999999999999999999999999999999886532 1244699999999999999998876432
Q ss_pred ----CeEEEEEeecCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-cEEEcc
Q 010947 189 ----EFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSD 259 (497)
Q Consensus 189 ----~~l~lVmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-~vkL~D 259 (497)
.++|+||||+++ +|..++. ....+++..++.++.||+.||.|||+.|||||||||+|||++.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 357899999975 6666553 346799999999999999999999999999999999999999765 699999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcch
Q 010947 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 338 (497)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~ 338 (497)
||+|+.+..... ..+.+||+.|+|||++.+ ..|+.++
T Consensus 215 FGla~~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~ 252 (440)
T PTZ00036 215 FGSAKNLLAGQR------------------------------------------SVSYICSRFYRAPELMLGATNYTTHI 252 (440)
T ss_pred cccchhccCCCC------------------------------------------cccCCCCcCccCHHHhcCCCCCCcHH
Confidence 999986532110 114678999999999876 4699999
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccC---------------cccCCC----------CccCChhHHHHHH
Q 010947 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT---------------HLKFPE----------EAKLSIEAKDLIS 393 (497)
Q Consensus 339 DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~---------------~~~~p~----------~~~~s~~~~dLI~ 393 (497)
|||||||++|||++|.+||.+.+..+.+.+++.... .+.+|. ....++++++||.
T Consensus 253 DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~ 332 (440)
T PTZ00036 253 DLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFIS 332 (440)
T ss_pred HHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHH
Confidence 999999999999999999999887776666543111 111221 1246889999999
Q ss_pred HHhh-CccccCCCCCcchhcCCCCccCCCh
Q 010947 394 KLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 394 ~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
+||+ ||.+|++ +.|+++||||.++..
T Consensus 333 ~~L~~dP~~R~t---a~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 333 QFLKYEPLKRLN---PIEALADPFFDDLRD 359 (440)
T ss_pred HHCCCChhHCcC---HHHHhCChhHHhhhc
Confidence 9999 9999999 999999999987654
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=368.47 Aligned_cols=282 Identities=30% Similarity=0.547 Sum_probs=227.8
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
..||+|+||.|--|....||..||||++.|.. .....++.+|++++..+ .|+||+.|+.+|.|+..+|||||-|.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 46999999999999999999999999998864 33456788999999887 699999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc---EEEcccccccccCCCCccccccc
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCSTLQEQDFT 277 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~---vkL~DFGla~~~~~~~~~~~~~~ 277 (497)
|.|..++.++..|+|.++..++.+|++||.|||.+||.||||||+|||-....+ ||||||.|...+.....-
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~----- 235 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC----- 235 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCC-----
Confidence 999999999999999999999999999999999999999999999999977655 799999997654322100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhHHhHHHHHHHHHh
Q 010947 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~DiwSlGvil~ell~ 352 (497)
+ ..+.|. ..+.||+..|||||++. ...|+..||.||||||+|-||.
T Consensus 236 -------s-----pastP~-----------------L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLs 286 (463)
T KOG0607|consen 236 -------S-----PASTPE-----------------LLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLS 286 (463)
T ss_pred -------C-----CCCCcc-----------------ccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHh
Confidence 0 000110 12679999999999975 3569999999999999999999
Q ss_pred CCCCCCCCC---------------hHHHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 353 GYPPFYSDD---------------PMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 353 G~~PF~~~~---------------~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|++||.|.- ...++..|.. +...||+ +..+|.+++|||+.||. |+.+|++ +.++++|
T Consensus 287 GYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQE--GkYeFPdkdWahIS~eakdlisnLlvrda~~rls---a~~vlnh 361 (463)
T KOG0607|consen 287 GYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQE--GKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLS---AAQVLNH 361 (463)
T ss_pred CCCCccCccCCcCCccCCCccHHHHHHHHHHHhc--cCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhh---hhhccCC
Confidence 999997531 3445666776 4556665 57799999999999998 9999999 8999999
Q ss_pred CCccCCChhhhhhcCCCcccccCCcccccCcc
Q 010947 415 PWFDGVDWARIYQMEAAFIPEVNDELDTQNFE 446 (497)
Q Consensus 415 pff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~ 446 (497)
||+..+--+.-. .+|+.+-...+-.|.+.|.
T Consensus 362 Pw~~~~~~ekal-ptp~v~~r~~s~~~lslfa 392 (463)
T KOG0607|consen 362 PWVQRCAPEKAL-PTPQVLQRNSSTMDLSLFA 392 (463)
T ss_pred ccccccchhccC-CCCcccccCccchhhHHHH
Confidence 999977543221 1233333333334445443
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=373.09 Aligned_cols=268 Identities=37% Similarity=0.686 Sum_probs=224.6
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L 203 (497)
||+|+||+||+|.++.+|+.||+|++.+...........+..|+.+|+.++||||++++++|...+.+|+||||++||+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876544444555677899999999999999999999999999999999999999
Q ss_pred hHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCC
Q 010947 204 MTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (497)
Q Consensus 204 ~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (497)
.+++.+.. .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---------- 150 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---------- 150 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc----------
Confidence 99997765 799999999999999999999999999999999999999999999999999875432100
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCC
Q 010947 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD 361 (497)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~ 361 (497)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..||.+..
T Consensus 151 --------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 151 --------------------------------IKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred --------------------------------cccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 013468899999999998889999999999999999999999998765
Q ss_pred hHHHHHHHhcc--cCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhhh--cCCCccc
Q 010947 362 PMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEAAFIP 434 (497)
Q Consensus 362 ~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~--~~~p~~p 434 (497)
.......+... .....+| ..+++++.+||.+||. ||.+|++.. ++.+++.||||..++|..+.+ .+|||.|
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 199 EKVEKEELKRRTLEMAVEYP--DKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred ccccHHHHHhccccccccCC--ccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 42222222211 1122333 3679999999999999 999999521 388899999999999999874 6788887
Q ss_pred c
Q 010947 435 E 435 (497)
Q Consensus 435 ~ 435 (497)
+
T Consensus 277 ~ 277 (277)
T cd05577 277 D 277 (277)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=389.05 Aligned_cols=257 Identities=32% Similarity=0.503 Sum_probs=226.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
...|..+..||+|+||.||+|.+..|++.||||++.-.. ...+++.+.+|+.+|++++++||.+.|++|.....++++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 345888899999999999999999999999999997654 355678899999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||||.||++.++|.....+.|..+..++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||.+-.+.....
T Consensus 90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~--- 166 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK--- 166 (467)
T ss_pred HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhh---
Confidence 99999999999998888889999999999999999999999999999999999999999999999999976642210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
+ ..+++|||.|||||++...+|+.++||||||++.|||++|.
T Consensus 167 -----------------------------------r---r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~Ge 208 (467)
T KOG0201|consen 167 -----------------------------------R---RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGE 208 (467)
T ss_pred -----------------------------------c---cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCC
Confidence 1 13789999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
||+....++.....|-.. .+..+. ..+|+.+++||..||. ||+.||+ |.++|+|+|++..
T Consensus 209 PP~s~~hPmrvlflIpk~-~PP~L~--~~~S~~~kEFV~~CL~k~P~~Rps---A~~LLKh~FIk~a 269 (467)
T KOG0201|consen 209 PPHSKLHPMRVLFLIPKS-APPRLD--GDFSPPFKEFVEACLDKNPEFRPS---AKELLKHKFIKRA 269 (467)
T ss_pred CCCcccCcceEEEeccCC-CCCccc--cccCHHHHHHHHHHhhcCcccCcC---HHHHhhhHHHHhc
Confidence 999998885554444331 122222 3789999999999999 9999999 9999999999864
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-47 Score=392.34 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=210.6
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
.+...+|++++.||+|+||.||+|.+..+++.||||+... ..+.+|+.+|+.++|||||+++++|......
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCee
Confidence 3556789999999999999999999999999999997532 2367899999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+|||++ +++|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 159 ~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 159 CLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9999999 578999988888899999999999999999999999999999999999999999999999999874321100
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 238 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 277 (391)
T PHA03212 238 ----------------------------------------NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMA 277 (391)
T ss_pred ----------------------------------------cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 0012468999999999999999999999999999999999
Q ss_pred hCCCCCCCCC-------hHHHHHHHhcccC--ccc--------------------------CCC---CccCChhHHHHHH
Q 010947 352 VGYPPFYSDD-------PMSTCRKIVNWRT--HLK--------------------------FPE---EAKLSIEAKDLIS 393 (497)
Q Consensus 352 ~G~~PF~~~~-------~~~~~~~i~~~~~--~~~--------------------------~p~---~~~~s~~~~dLI~ 393 (497)
+|..||.... .......++.... +.. .|. ...++.++.+||.
T Consensus 278 tg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~ 357 (391)
T PHA03212 278 TCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLIC 357 (391)
T ss_pred HCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHH
Confidence 9998886432 1112222211000 000 010 0135678999999
Q ss_pred HHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 394 KLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 394 ~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+||+ ||.+||+ +.|+++||||..+
T Consensus 358 ~mL~~dP~~Rpt---a~elL~hp~f~~~ 382 (391)
T PHA03212 358 KMLAFDAHHRPS---AEALLDFAAFQDI 382 (391)
T ss_pred HHhcCChhhCCC---HHHHhcChhhccC
Confidence 9999 9999999 9999999999864
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=389.11 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=217.3
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----eE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-----FL 191 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~l 191 (497)
+|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.++||||+++++++.+.. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 5889999999999999999999999999999986532 12234456889999999999999999999998876 89
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||+. ++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999995 68888888888899999999999999999999999999999999999999999999999999976432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~el 350 (497)
. .....+||+.|+|||++.+. .|+.++|||||||++|||
T Consensus 159 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el 198 (372)
T cd07853 159 K----------------------------------------HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAEL 198 (372)
T ss_pred c----------------------------------------cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHH
Confidence 0 01134689999999999874 589999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccC---------------------cccCC-------CCccCChhHHHHHHHHhh-Cccc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRT---------------------HLKFP-------EEAKLSIEAKDLISKLLC-NVNQ 401 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~---------------------~~~~p-------~~~~~s~~~~dLI~~lL~-dp~~ 401 (497)
++|++||.+.+.......|..... ....| ....+++++.+||.+||+ ||.+
T Consensus 199 ~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~ 278 (372)
T cd07853 199 LGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDK 278 (372)
T ss_pred HcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhh
Confidence 999999998887766655542100 00011 112468899999999999 9999
Q ss_pred cCCCCCcchhcCCCCccCCCh
Q 010947 402 RLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 402 R~~~~~~~eil~Hpff~~i~w 422 (497)
||+ +.+++.||||.+..+
T Consensus 279 R~t---~~e~l~hp~~~~~~~ 296 (372)
T cd07853 279 RIS---AADALAHPYLDEGRL 296 (372)
T ss_pred CcC---HHHHhcCHhhCCCcc
Confidence 999 999999999998654
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-48 Score=388.22 Aligned_cols=257 Identities=31% Similarity=0.506 Sum_probs=231.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe-EEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF-LYL 193 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~-l~l 193 (497)
.++|..+++||+|+||.+++++++..++.|++|.+.-.....+ ......+|+.+++++.|||||...++|..++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~-~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEP-ERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCch-hhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4679999999999999999999999999999999987654433 34468899999999999999999999998887 999
Q ss_pred EEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 194 IMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
||+||+||+|.+.+.+.. -|+|+.+..|+.|++.||.|||+++|+|||||+.||+++.++.|||+|||+|+.+....
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~- 160 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED- 160 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch-
Confidence 999999999999997654 59999999999999999999999999999999999999999999999999999876432
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
.++.+.+|||.||.||++.+.+|+.++|||||||++|||+
T Consensus 161 ----------------------------------------~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~ 200 (426)
T KOG0589|consen 161 ----------------------------------------SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMC 200 (426)
T ss_pred ----------------------------------------hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHH
Confidence 1244789999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+-+++|.+.+......+|.... ..|.+...|.+++.||+.||. +|+.||+ +.++|.+|....
T Consensus 201 ~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RPs---a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 201 TLKPAFKASNMSELILKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRPS---ALELLRRPHLLR 263 (426)
T ss_pred hcccccCccchHHHHHHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCCC---HHHHhhChhhhh
Confidence 9999999999999999998643 344445889999999999999 9999999 999999998863
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=365.97 Aligned_cols=257 Identities=46% Similarity=0.823 Sum_probs=220.7
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHH-HhcCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
+.||.|+||.||+|.+..+|+.||||++.+...........+..|..++ ...+||||++++++|...+.+|+||||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999876544444444455666554 455899999999999999999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||+++.....
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~----------- 150 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN----------- 150 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceecccc-----------
Confidence 999999988888999999999999999999999999999999999999999999999999998753210
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
....|++.|+|||.+.+..++.++||||||+++|+|++|.+||.+.
T Consensus 151 ----------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 196 (260)
T cd05611 151 ----------------------------------KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAE 196 (260)
T ss_pred ----------------------------------ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence 1346889999999999888999999999999999999999999988
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChh
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
+.......+..............+++++.++|.+||. +|.+||++.+++|++.||||+.++|+
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 197 TPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred CHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 8877777765432222111223589999999999999 99999998888999999999999996
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=371.80 Aligned_cols=255 Identities=28% Similarity=0.457 Sum_probs=209.0
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcC-CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc---CCCceeEEEEEee-----
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQ----- 186 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~-t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~----- 186 (497)
.+|++++.||+|+||+||+|++.. ++..||+|+++..... ......+.+|+.+++.+ +||||++++++|.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 369999999999999999999854 5788999998754322 22233455677777665 6999999999885
Q ss_pred cCCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
....+|+||||++ |+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999996 6899888653 458999999999999999999999999999999999999999999999999997
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlG 344 (497)
...... ......||+.|+|||++.+..++.++||||||
T Consensus 159 ~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG 196 (290)
T cd07862 159 IYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 196 (290)
T ss_pred eccCCc------------------------------------------ccccccccccccChHHHhCCCCCCccchHHHH
Confidence 643210 01145799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhcccC---------cccCCC--------------CccCChhHHHHHHHHhh-Ccc
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRT---------HLKFPE--------------EAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~~~~---------~~~~p~--------------~~~~s~~~~dLI~~lL~-dp~ 400 (497)
|++|||++|.+||.+.+..+.+.+|+.... ...++. .+.+++.+++||.+||+ ||+
T Consensus 197 ~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 276 (290)
T cd07862 197 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 276 (290)
T ss_pred HHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCch
Confidence 999999999999999888877777764211 000110 02478889999999999 999
Q ss_pred ccCCCCCcchhcCCCCc
Q 010947 401 QRLGAKGADEIKVHPWF 417 (497)
Q Consensus 401 ~R~~~~~~~eil~Hpff 417 (497)
+||+ +.++++||||
T Consensus 277 ~R~s---~~~~l~hp~f 290 (290)
T cd07862 277 KRIS---AYSALSHPYF 290 (290)
T ss_pred hcCC---HHHHhcCCCC
Confidence 9999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=363.06 Aligned_cols=259 Identities=32% Similarity=0.543 Sum_probs=225.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--chhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
++|.+.+.||+|+||.||+|.+..+++.||||++...... .......+.+|+.+++.++||||+++++++.++..+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998764322 12345678899999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||+++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987653211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
. ......|++.|+|||++.+..++.++|+|||||++|||++|
T Consensus 162 ~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 162 T--------------------------------------GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred c--------------------------------------cccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence 0 00135688999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
.+||.+.+......++........+|. .++.++.+||.+||. +|.+||+ +.++++||||
T Consensus 204 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 263 (263)
T cd06625 204 KPPWAEFEAMAAIFKIATQPTNPQLPS--HVSPDARNFLRRTFVENAKKRPS---AEELLRHFFV 263 (263)
T ss_pred CCCccccchHHHHHHHhccCCCCCCCc--cCCHHHHHHHHHHhhcCcccCCC---HHHHhhCCCC
Confidence 999998877777666665545555554 689999999999999 9999998 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=406.41 Aligned_cols=152 Identities=43% Similarity=0.736 Sum_probs=142.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|.+++.||+|+||.||+|.+..+++.||||++++...........+..|+.++..++||||+++++++.+..++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999877665556667789999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
|||++||+|..++...+.+++..++.|+.||+.||.|||..|||||||||+|||++.+|++||+|||+++..
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=368.74 Aligned_cols=254 Identities=28% Similarity=0.462 Sum_probs=207.9
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc---CCCceeEEEEEeec-----C
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQD-----D 188 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~-----~ 188 (497)
+|++++.||+|+||+||+|+++.+|+.||+|+++..... ......+..|+.+++.+ +||||++++++|.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 489999999999999999999999999999998764321 22223355677777655 79999999998864 3
Q ss_pred CeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
..+++||||++ ++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 46899999997 5888888653 35899999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
..... ....+||+.|+|||++.+..++.++|||||||+
T Consensus 159 ~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~ 196 (288)
T cd07863 159 SCQMA------------------------------------------LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCI 196 (288)
T ss_pred cCccc------------------------------------------CCCccccccccCchHhhCCCCCCcchhhhHHHH
Confidence 32110 113578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhccc---------CcccCCC--------------CccCChhHHHHHHHHhh-Ccccc
Q 010947 347 MYEMLVGYPPFYSDDPMSTCRKIVNWR---------THLKFPE--------------EAKLSIEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~~~~~~i~~~~---------~~~~~p~--------------~~~~s~~~~dLI~~lL~-dp~~R 402 (497)
+|+|++|.+||.+........++.... .....+. ...++.++++||.+||+ ||.+|
T Consensus 197 l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 276 (288)
T cd07863 197 FAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKR 276 (288)
T ss_pred HHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccC
Confidence 999999999999888777666665311 1111110 12467889999999999 99999
Q ss_pred CCCCCcchhcCCCCc
Q 010947 403 LGAKGADEIKVHPWF 417 (497)
Q Consensus 403 ~~~~~~~eil~Hpff 417 (497)
|+ +.+++.||||
T Consensus 277 ~t---~~~~l~hp~f 288 (288)
T cd07863 277 IS---AFRALQHPFF 288 (288)
T ss_pred CC---HHHHhcCCCC
Confidence 99 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=377.08 Aligned_cols=258 Identities=28% Similarity=0.440 Sum_probs=217.6
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++.+.||.|+||.||+|.++.++..+|+|++.... .......+.+|+.+++.++||||++++++|.+++.+|
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 45678999999999999999999999999999999987542 2334456889999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
+||||++||+|.+++...+.+++..+..++.+++.||.|||+. +|+||||||+|||++.+|.+||+|||++..+....
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~- 158 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc-
Confidence 9999999999999998888899999999999999999999975 79999999999999999999999999987542110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
....+||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 159 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~ 196 (333)
T cd06650 159 ------------------------------------------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMA 196 (333)
T ss_pred ------------------------------------------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 11357999999999999989999999999999999999
Q ss_pred hCCCCCCCCChHHHHHH--------------------------------------------HhcccCcccCCCCccCChh
Q 010947 352 VGYPPFYSDDPMSTCRK--------------------------------------------IVNWRTHLKFPEEAKLSIE 387 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~--------------------------------------------i~~~~~~~~~p~~~~~s~~ 387 (497)
+|..||........... +.+. ....++. ..++.+
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~ 274 (333)
T cd06650 197 IGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNE-PPPKLPS-GVFGAE 274 (333)
T ss_pred HCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcC-CCccCCC-CCcCHH
Confidence 99999986554332211 1110 0111111 236789
Q ss_pred HHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 388 AKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 388 ~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+++||.+||+ ||.+||+ +.|++.||||+..
T Consensus 275 ~~~li~~~L~~~P~~Rpt---~~ell~h~~~~~~ 305 (333)
T cd06650 275 FQDFVNKCLIKNPAERAD---LKQLMVHAFIKRS 305 (333)
T ss_pred HHHHHHHhccCCcccCcC---HHHHhhCHHHhcC
Confidence 9999999999 9999999 9999999999853
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-46 Score=366.13 Aligned_cols=266 Identities=36% Similarity=0.692 Sum_probs=214.3
Q ss_pred EeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHH---hcCCCceeEEEEEeecCCeEEEEEeecC
Q 010947 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA---EVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~---~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 199 (497)
+||+|+||.||+|.+..+++.||+|++.+..............|..++. ..+||+|+.++++|.+.+.+|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998754433332333444544443 3479999999999999999999999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccccc
Q 010947 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (497)
Q Consensus 200 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (497)
||+|..++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--------- 151 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---------
Confidence 99999999888899999999999999999999999999999999999999999999999999987542110
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-cCCCCcchhHHhHHHHHHHHHhCCCCCC
Q 010947 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFY 358 (497)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~y~~~~DiwSlGvil~ell~G~~PF~ 358 (497)
.....||+.|+|||.+. +..++.++|+|||||++|+|++|..||.
T Consensus 152 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~ 197 (279)
T cd05633 152 ----------------------------------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197 (279)
T ss_pred ----------------------------------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcC
Confidence 01346999999999987 4668999999999999999999999997
Q ss_pred CCChH--HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh--cCCC
Q 010947 359 SDDPM--STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAA 431 (497)
Q Consensus 359 ~~~~~--~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~--~~~p 431 (497)
..... ....... ......+|. .++.++++||.+||. ||.+|++. .++.++++||||++++|..+.. ..+|
T Consensus 198 ~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~~~~~~ 274 (279)
T cd05633 198 QHKTKDKHEIDRMT-LTVNVELPD--SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKYPPP 274 (279)
T ss_pred CCCCcCHHHHHHHh-hcCCcCCcc--ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhHHhcCCCCCC
Confidence 64321 1122211 112333443 689999999999999 99999953 2589999999999999998863 4455
Q ss_pred ccc
Q 010947 432 FIP 434 (497)
Q Consensus 432 ~~p 434 (497)
-+|
T Consensus 275 ~~~ 277 (279)
T cd05633 275 LIP 277 (279)
T ss_pred CCC
Confidence 444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=382.07 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=211.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 188 (497)
.++|.+.+.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 578999999999999999999999999999999997542 2233445678899999999999999999888643
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+|+||||+++ +|...+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 357999999965 6777664 3588999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
.. .....+||+.|+|||++.+..++.++|||||||++|
T Consensus 179 ~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 216 (364)
T cd07875 179 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 216 (364)
T ss_pred CC------------------------------------------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHH
Confidence 11 011457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCc----------------------------------ccCCC----CccCChhHHH
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTH----------------------------------LKFPE----EAKLSIEAKD 390 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~----------------------------------~~~p~----~~~~s~~~~d 390 (497)
+|++|.+||.+.+..+...+++..... ..+|. ....+.++++
T Consensus 217 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 296 (364)
T cd07875 217 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296 (364)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHH
Confidence 999999999988877766665431100 00010 0123567899
Q ss_pred HHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 391 LI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||.+||+ ||.+||+ +.++++||||..
T Consensus 297 ll~~mL~~dP~~R~t---~~e~L~hp~~~~ 323 (364)
T cd07875 297 LLSKMLVIDASKRIS---VDEALQHPYINV 323 (364)
T ss_pred HHHHhcCcCcccCCC---HHHHhcCccccc
Confidence 9999999 9999999 999999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=379.55 Aligned_cols=256 Identities=28% Similarity=0.458 Sum_probs=208.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
.++|++++.||+|+||.||+|.+..+|..||+|++.+.. ........+.+|+.+++.++||||++++++|....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 578999999999999999999999999999999997642 22334556788999999999999999999987543
Q ss_pred -eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+||||+++ +|...+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 57999999965 5666553 3589999999999999999999999999999999999999999999999999875421
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
.. .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 176 ~~------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 213 (359)
T cd07876 176 NF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 213 (359)
T ss_pred Cc------------------------------------------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHH
Confidence 10 011457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhccc--------------------Cccc--------------CCC----CccCChhHHH
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWR--------------------THLK--------------FPE----EAKLSIEAKD 390 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~--------------------~~~~--------------~p~----~~~~s~~~~d 390 (497)
+|++|.+||.+.+.......+.... .... +|. ....++++++
T Consensus 214 el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (359)
T cd07876 214 ELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARD 293 (359)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHH
Confidence 9999999999876544433322100 0000 110 1124678999
Q ss_pred HHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 391 LI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||.+||+ ||.+||+ +.|+++||||..
T Consensus 294 li~~mL~~dP~~R~t---~~e~l~hp~~~~ 320 (359)
T cd07876 294 LLSKMLVIDPDKRIS---VDEALRHPYITV 320 (359)
T ss_pred HHHHHhccCcccCCC---HHHHhcCchhhh
Confidence 9999999 9999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-46 Score=394.54 Aligned_cols=255 Identities=24% Similarity=0.440 Sum_probs=205.6
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC------CceeEEEEEee
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS------NCIVKLYCSFQ 186 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h------p~Iv~l~~~~~ 186 (497)
....+|++++.||+|+||+||+|.+..+++.||||+++... ........|+.++..+.| ++|+.++.+|.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44678999999999999999999999999999999997532 122335567777766654 46899998887
Q ss_pred cC-CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCC-----------
Q 010947 187 DD-EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYG----------- 253 (497)
Q Consensus 187 ~~-~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g----------- 253 (497)
.. .++|+|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~ 280 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRAL 280 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccccccc
Confidence 64 5799999998 88999999888899999999999999999999997 5999999999999998766
Q ss_pred -----cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccc
Q 010947 254 -----HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328 (497)
Q Consensus 254 -----~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~ 328 (497)
.+||+|||++...... ....+||+.|+|||+
T Consensus 281 ~~~~~~vkl~DfG~~~~~~~~--------------------------------------------~~~~~gt~~Y~APE~ 316 (467)
T PTZ00284 281 PPDPCRVRICDLGGCCDERHS--------------------------------------------RTAIVSTRHYRSPEV 316 (467)
T ss_pred CCCCceEEECCCCccccCccc--------------------------------------------cccccCCccccCcHH
Confidence 4999999987532110 114689999999999
Q ss_pred cccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCccc--------------------------CCC--
Q 010947 329 LLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK--------------------------FPE-- 380 (497)
Q Consensus 329 l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~--------------------------~p~-- 380 (497)
+.+..|+.++|||||||++|||++|++||.+.+..+....+......++ .|.
T Consensus 317 ~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 396 (467)
T PTZ00284 317 VLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHL 396 (467)
T ss_pred hhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHH
Confidence 9999999999999999999999999999998776655444322111000 000
Q ss_pred ----------CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 381 ----------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 381 ----------~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
...-++.+.|||.+||+ ||.+|++ ++|+|+||||..
T Consensus 397 ~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t---a~e~L~Hp~~~~ 443 (467)
T PTZ00284 397 ARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN---ARQMTTHPYVLK 443 (467)
T ss_pred HhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC---HHHHhcCccccc
Confidence 00124567899999999 9999999 999999999975
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-46 Score=371.72 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=214.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|.+++.||+|+||.||+|+++.++..||+|+++.... ......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4679999999999999999999999999999999975432 22234567899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||+++ +|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~- 160 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKT- 160 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccc-
Confidence 999975 788877654 45899999999999999999999999999999999999999999999999998754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
....+||+.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 161 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~t 200 (309)
T cd07872 161 ----------------------------------------YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMAS 200 (309)
T ss_pred ----------------------------------------cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 013468999999999875 568999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccC-----------------cccCCC---------CccCChhHHHHHHHHhh-CccccCCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRT-----------------HLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
|.+||.+.+..+....+..... ...+|. ...+++++++||.+||+ ||.+|++
T Consensus 201 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t- 279 (309)
T cd07872 201 GRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS- 279 (309)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC-
Confidence 9999998876655544432100 011111 13578899999999999 9999999
Q ss_pred CCcchhcCCCCccCC
Q 010947 406 KGADEIKVHPWFDGV 420 (497)
Q Consensus 406 ~~~~eil~Hpff~~i 420 (497)
+.|++.||||+++
T Consensus 280 --~~e~l~h~~~~~~ 292 (309)
T cd07872 280 --AEEAMKHAYFRSL 292 (309)
T ss_pred --HHHHhcChhhhhc
Confidence 9999999999865
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=381.18 Aligned_cols=254 Identities=26% Similarity=0.387 Sum_probs=208.0
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|+.++.||+|+||.||+|++..+|+.||||++.... .......+.+|+.+++.++|+||++++++|.+.+.+|+
T Consensus 72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 149 (353)
T PLN00034 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149 (353)
T ss_pred CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEE
Confidence 3467888899999999999999999999999999996542 23344668899999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||||++||+|... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 150 v~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-- 223 (353)
T PLN00034 150 LLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-- 223 (353)
T ss_pred EEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--
Confidence 9999999998643 3467888889999999999999999999999999999999999999999999986532100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----CCCCcchhHHhHHHHHH
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMY 348 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~y~~~~DiwSlGvil~ 348 (497)
.....+||+.|+|||++.. ..++.++|||||||++|
T Consensus 224 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~ 264 (353)
T PLN00034 224 ---------------------------------------PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264 (353)
T ss_pred ---------------------------------------cccccccCccccCccccccccccCcCCCcchhHHHHHHHHH
Confidence 0114579999999999853 23467999999999999
Q ss_pred HHHhCCCCCCCCChHH---HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 349 EMLVGYPPFYSDDPMS---TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 349 ell~G~~PF~~~~~~~---~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
||++|..||......+ ....+.. ......+ ..++.++++||.+||. ||.+||+ +.|+++||||.+-
T Consensus 265 el~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~l~~li~~~l~~~P~~Rpt---~~ell~hp~~~~~ 334 (353)
T PLN00034 265 EFYLGRFPFGVGRQGDWASLMCAICM-SQPPEAP--ATASREFRHFISCCLQREPAKRWS---AMQLLQHPFILRA 334 (353)
T ss_pred HHHhCCCCCCCCCCccHHHHHHHHhc-cCCCCCC--CccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccccC
Confidence 9999999997433222 2222221 1122222 3689999999999999 9999998 9999999999863
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=392.13 Aligned_cols=257 Identities=30% Similarity=0.439 Sum_probs=221.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCC-CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTT-GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t-~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..|.+.+.||+|+||.||+|....+ +..||+|.+.... ......++.|+.+|+.++|||||++++.|.+.+.+|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3499999999999999999998877 7889999765432 34455688899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 195 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
|||++||+|.+++.. ..++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999988753 3579999999999999999999999999999999999999999999999999998654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
.. ....+.+||+.|+|||++.+..++.++|||||||++|||
T Consensus 224 ~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el 264 (478)
T PTZ00267 224 SL---------------------------------------DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264 (478)
T ss_pred cc---------------------------------------ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHH
Confidence 00 001246899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
++|.+||.+.+..+....++... ...+| ..++.++++||.+||. ||.+||+ +++++.|||++.+
T Consensus 265 ~tg~~Pf~~~~~~~~~~~~~~~~-~~~~~--~~~s~~~~~li~~~L~~dP~~Rps---~~~~l~~~~~~~~ 329 (478)
T PTZ00267 265 LTLHRPFKGPSQREIMQQVLYGK-YDPFP--CPVSSGMKALLDPLLSKNPALRPT---TQQLLHTEFLKYV 329 (478)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCC-CCCCC--ccCCHHHHHHHHHHhccChhhCcC---HHHHHhCHHHHHH
Confidence 99999999988888888877532 22333 3689999999999999 9999999 9999999999753
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=363.39 Aligned_cols=258 Identities=37% Similarity=0.683 Sum_probs=213.0
Q ss_pred EeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHH---HHHhcCCCceeEEEEEeecCCeEEEEEeecC
Q 010947 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN---LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~---il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 199 (497)
+||+|+||.||+|.+..+++.||||++.+...........+..|.. ++....||+|+.+++.|.+.+.+|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999998754332222222334443 3444689999999999999999999999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccccc
Q 010947 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (497)
Q Consensus 200 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (497)
||+|..++.+.+.+++..++.++.|++.||.|||+.+|+||||||+||+++.++.+||+|||+++.+....
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--------- 151 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--------- 151 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---------
Confidence 99999999888889999999999999999999999999999999999999999999999999987543110
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHhCCCCCC
Q 010947 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFY 358 (497)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~G~~PF~ 358 (497)
....+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.
T Consensus 152 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~ 197 (278)
T cd05606 152 ----------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197 (278)
T ss_pred ----------------------------------CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCC
Confidence 0135799999999999754 68999999999999999999999998
Q ss_pred CCC---hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhhhhh
Q 010947 359 SDD---PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 359 ~~~---~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~l~~ 427 (497)
+.. .......+.. ....+|. .+|.++.++|.+||. +|.+|+... ++.++++||||++++|..+..
T Consensus 198 ~~~~~~~~~~~~~~~~--~~~~~~~--~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~ 268 (278)
T cd05606 198 QHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFL 268 (278)
T ss_pred CCCccchHHHHHHhhc--cCCCCCC--cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHhhh
Confidence 763 2232223322 2334443 579999999999999 999999543 599999999999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.94 Aligned_cols=256 Identities=43% Similarity=0.841 Sum_probs=226.9
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L 203 (497)
||.|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||||+++++.+.++..+|+||||++||+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876655455667899999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCC
Q 010947 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (497)
Q Consensus 204 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (497)
.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------------- 147 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------------- 147 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------------
Confidence 9999888889999999999999999999999999999999999999999999999999987653211
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCC--
Q 010947 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD-- 361 (497)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~-- 361 (497)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|.+||....
T Consensus 148 -----------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 198 (262)
T cd05572 148 -----------------------------KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDED 198 (262)
T ss_pred -----------------------------ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCC
Confidence 0113578999999999988889999999999999999999999998876
Q ss_pred hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChh
Q 010947 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 362 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~ 423 (497)
......++........+|. .++++++++|.+||+ +|.+|++. ..+.|+++||||++.+|+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 199 PMEIYNDILKGNGKLEFPN--YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHHHHHhccCCCCCCCc--ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 6667777775445666665 458999999999999 99999983 457899999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=392.44 Aligned_cols=263 Identities=28% Similarity=0.460 Sum_probs=224.6
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC--
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-- 189 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-- 189 (497)
+...++|.+.+.||+|+||+||+|++..+|+.||||++..... .......+.+|+.++..++|++|++++..|....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 3456799999999999999999999999999999999976543 3345566888999999999999999988775332
Q ss_pred ------eEEEEEeecCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcc
Q 010947 190 ------FLYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSD 259 (497)
Q Consensus 190 ------~l~lVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~D 259 (497)
.+++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~D 186 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGD 186 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEe
Confidence 478999999999999998642 4699999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchh
Q 010947 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (497)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~D 339 (497)
||+++.+...... ......+||+.|+|||++.+..|+.++|
T Consensus 187 FGls~~~~~~~~~---------------------------------------~~~~~~~Gt~~Y~aPE~~~~~~~s~k~D 227 (496)
T PTZ00283 187 FGFSKMYAATVSD---------------------------------------DVGRTFCGTPYYVAPEIWRRKPYSKKAD 227 (496)
T ss_pred cccCeeccccccc---------------------------------------cccccccCCcceeCHHHhCCCCCCcHHH
Confidence 9999865321100 0012468999999999999999999999
Q ss_pred HHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 340 iwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
||||||++|||++|..||.+.+..+.+.++..... ..+| ..+++++.+||.+||+ ||.+||+ +.++++|||++
T Consensus 228 VwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~-~~~~--~~~~~~l~~li~~~L~~dP~~RPs---~~ell~~p~~~ 301 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY-DPLP--PSISPEMQEIVTALLSSDPKRRPS---SSKLLNMPICK 301 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC-CCCC--CCCCHHHHHHHHHHcccChhhCcC---HHHHHhCHHHH
Confidence 99999999999999999999888888888775322 2334 3789999999999999 9999999 99999999987
Q ss_pred CC
Q 010947 419 GV 420 (497)
Q Consensus 419 ~i 420 (497)
..
T Consensus 302 ~~ 303 (496)
T PTZ00283 302 LF 303 (496)
T ss_pred Hh
Confidence 54
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=359.62 Aligned_cols=255 Identities=36% Similarity=0.614 Sum_probs=214.6
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|++++.||+|+||+||+|++..+++.||+|++......... ......|+.++..++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 78999999999999999999999999999999887543322 22344599999999999999999999999999999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccc
Q 010947 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (497)
Q Consensus 198 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 277 (497)
+++++|.+++.....+++..+..++.|++.||.+||+.||+||||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~------ 153 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNE------ 153 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTS------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------
Confidence 99999999998888999999999999999999999999999999999999999999999999999975411100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-cCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
.....+||+.|+|||++. +..++.++||||||+++|+|++|..|
T Consensus 154 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p 198 (260)
T PF00069_consen 154 -----------------------------------NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP 198 (260)
T ss_dssp -----------------------------------EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred -----------------------------------ccccccccccccccccccccccccccccccccccccccccccccc
Confidence 012467999999999998 88899999999999999999999999
Q ss_pred CCCCC---hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 357 FYSDD---PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 357 F~~~~---~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|.... ......+................+.++.+||.+||. ||.+||+ +.++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~---~~~l~~~~~~ 260 (260)
T PF00069_consen 199 FEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPS---AEELLKHPWF 260 (260)
T ss_dssp STTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTT---HHHHHTSGGG
T ss_pred cccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcC---HHHHhcCCCC
Confidence 99873 333343333211111222111234799999999999 9999999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=387.35 Aligned_cols=261 Identities=30% Similarity=0.479 Sum_probs=228.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
+.|+++..||.|+||+||+|..+.|+-..|-|++.. ......+.+.-|++||+.++||+||+|+++|.-++.++|+.
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili 108 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI 108 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence 458888999999999999999999998899999854 34667888999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||+||-...++.. ...|++.+++.++++++.||.|||+++|||||||..|||++.+|.|+|+|||.+......
T Consensus 109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t----- 183 (1187)
T KOG0579|consen 109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST----- 183 (1187)
T ss_pred eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-----
Confidence 99999998887654 568999999999999999999999999999999999999999999999999987643210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhHHhHHHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~DiwSlGvil~e 349 (497)
+...-+++|||.|||||++. ..+|++++||||||++|.|
T Consensus 184 ------------------------------------~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIE 227 (1187)
T KOG0579|consen 184 ------------------------------------RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIE 227 (1187)
T ss_pred ------------------------------------HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHH
Confidence 00112789999999999986 4789999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhh
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
|..+.||-...+++..+-+|... .+..+-.+...|..+.||+.+||. ||..||+ +.++++||||.+++-+.
T Consensus 228 MAqiEPPHhelnpMRVllKiaKS-ePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~---aaqll~Hpfv~~~~SnK 299 (1187)
T KOG0579|consen 228 MAQIEPPHHELNPMRVLLKIAKS-EPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPP---AAQLLKHPFVQNAPSNK 299 (1187)
T ss_pred HhccCCCccccchHHHHHHHhhc-CCCcccCcchhhhHHHHHHHHHHhcCCccCCC---HHHHhhCcccccCCcch
Confidence 99999999999999999998763 233333335789999999999999 9999999 99999999999887654
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=362.64 Aligned_cols=266 Identities=29% Similarity=0.478 Sum_probs=225.7
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..+.|++++.||.|+||.||+|++..++..||+|++.... ......+..|+.+++.++||||+++++.|..+..+|+
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI 86 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence 3467999999999999999999999999999999997542 3456678889999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||++||+|..++.+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.+|.+||+|||++........
T Consensus 87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 9999999999887754 45799999999999999999999999999999999999999999999999999865321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhHHhHHHHH
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIM 347 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~DiwSlGvil 347 (497)
......|++.|+|||++. ...++.++|+|||||++
T Consensus 166 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 205 (292)
T cd06644 166 ----------------------------------------RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 205 (292)
T ss_pred ----------------------------------------ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHH
Confidence 011356889999999985 34578899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
|||++|.+||...+......++..... ...+....++.++.+||.+||. +|.+||+ +++++.||||..++|....
T Consensus 206 ~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~~~~ 281 (292)
T cd06644 206 IEMAQIEPPHHELNPMRVLLKIAKSEP-PTLSQPSKWSMEFRDFLKTALDKHPETRPS---AAQLLEHPFVSSVTSNRPL 281 (292)
T ss_pred HHHhcCCCCCccccHHHHHHHHhcCCC-ccCCCCcccCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccccccchhH
Confidence 999999999988877666666654221 1222234688999999999999 9999998 9999999999999998865
Q ss_pred h
Q 010947 427 Q 427 (497)
Q Consensus 427 ~ 427 (497)
+
T Consensus 282 ~ 282 (292)
T cd06644 282 R 282 (292)
T ss_pred H
Confidence 4
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=362.76 Aligned_cols=273 Identities=29% Similarity=0.484 Sum_probs=229.0
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc----hhHHHHHHHHHHHHHhcCCCceeEEEE
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR----RGQVEHVRAERNLLAEVDSNCIVKLYC 183 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~----~~~~~~~~~E~~il~~l~hp~Iv~l~~ 183 (497)
+.......++|.++.+||+|||++||+|.+...++.||+|+-....... .+-.+|..+|.+|.+.++||.||++|+
T Consensus 455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYD 534 (775)
T KOG1151|consen 455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYD 534 (775)
T ss_pred hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeee
Confidence 5566677788999999999999999999999999999999875433222 234578999999999999999999999
Q ss_pred Eee-cCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--CEEEcccCCCCeeec---CCCcEEE
Q 010947 184 SFQ-DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--HYIHRDIKPDNLLLD---KYGHLRL 257 (497)
Q Consensus 184 ~~~-~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--~iiHrDLKp~NILl~---~~g~vkL 257 (497)
+|. |.+.+|-|+|||+|.||..+|.....++|.+++.|+.||+.||.||... .|||-||||.|||+- ..|.+||
T Consensus 535 yfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 535 YFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred eeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 987 6778999999999999999999999999999999999999999999975 699999999999994 4588999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc----CC
Q 010947 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK----KG 333 (497)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~----~~ 333 (497)
+||||++.++.+.....+ | -.++....||.||++||++.- ..
T Consensus 615 TDFGLSKIMdddSy~~vd---G-------------------------------meLTSQgAGTYWYLPPEcFvVgkePPK 660 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVD---G-------------------------------MELTSQGAGTYWYLPPECFVVGKEPPK 660 (775)
T ss_pred eecchhhhccCCccCccc---c-------------------------------eeeecccCceeeecCcceeecCCCCCc
Confidence 999999998765432111 0 012234689999999999973 34
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCChHHH-H--HHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcc
Q 010947 334 YGMECDWWSLGAIMYEMLVGYPPFYSDDPMST-C--RKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409 (497)
Q Consensus 334 y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~-~--~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ 409 (497)
.+.++||||+|||+|.+|.|+-||..+-..+. + .-|++ ...+.||..+.+|+++++||++||. ..++|.. +.
T Consensus 661 IsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk-AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~D---V~ 736 (775)
T KOG1151|consen 661 ISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK-ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRID---VQ 736 (775)
T ss_pred cccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc-ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhh---HH
Confidence 68999999999999999999999987644332 2 22443 3567899999999999999999999 8889987 99
Q ss_pred hhcCCCCcc
Q 010947 410 EIKVHPWFD 418 (497)
Q Consensus 410 eil~Hpff~ 418 (497)
++..||||.
T Consensus 737 qLA~dpyll 745 (775)
T KOG1151|consen 737 QLACDPYLL 745 (775)
T ss_pred HHccCcccc
Confidence 999999986
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=373.83 Aligned_cols=256 Identities=21% Similarity=0.339 Sum_probs=207.1
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 185 (497)
.+..++|++.+.||+|+||.||+|.+ ..++..||||++.... .......+..|+.+|..+ +|||||+++++|
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 45667899999999999999999975 2456789999997532 223456688999999999 899999999988
Q ss_pred ecC-CeEEEEEeecCCCchhHHHHhc------------------------------------------------------
Q 010947 186 QDD-EFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (497)
Q Consensus 186 ~~~-~~l~lVmEy~~gg~L~~~l~~~------------------------------------------------------ 210 (497)
... ..+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 764 4689999999999999998642
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCC
Q 010947 211 --------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282 (497)
Q Consensus 211 --------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~ 282 (497)
.++++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~--------- 231 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV--------- 231 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchh---------
Confidence 247888999999999999999999999999999999999999999999999998653211000
Q ss_pred CCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCC
Q 010947 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDD 361 (497)
Q Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~ 361 (497)
...+..+|+.|+|||++.+..|+.++|||||||++|||++ |.+||.+..
T Consensus 232 ------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 232 ------------------------------RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred ------------------------------cccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence 0012456789999999999999999999999999999997 999998866
Q ss_pred hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 362 PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 362 ~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
..+.+...+........| ..+++++++||.+||. ||.+||+ +.+|++
T Consensus 282 ~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs---~~el~~ 329 (338)
T cd05102 282 INEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERPT---FSALVE 329 (338)
T ss_pred ccHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 544444444322333334 3688999999999999 9999999 777653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=354.61 Aligned_cols=260 Identities=31% Similarity=0.529 Sum_probs=219.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--CeE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFL 191 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~l 191 (497)
.+|.+.+.||+|+||.||+|.+..+|..||||++..... ....+...+.+|+.+++.++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 579999999999999999999999999999999864321 1233567788999999999999999999998763 578
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||++||+|.+++.+...+++..+..++.+++.||.|||+.||+|+||||+|||++.++.++|+|||++..+.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
... ......||..|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~ 203 (265)
T cd06652 162 SGT--------------------------------------GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203 (265)
T ss_pred ccc--------------------------------------ccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHh
Confidence 000 011356899999999999888999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCcc
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~ 418 (497)
+|.+||...+......++.........| ..++..+.++|++|+.+|.+||+ +++|++|||++
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~p~~Rp~---~~~il~~~~~~ 265 (265)
T cd06652 204 TEKPPWAEFEAMAAIFKIATQPTNPVLP--PHVSDHCRDFLKRIFVEAKLRPS---ADELLRHTFVH 265 (265)
T ss_pred hCCCCCCccchHHHHHHHhcCCCCCCCc--hhhCHHHHHHHHHHhcChhhCCC---HHHHhcCcccC
Confidence 9999998876666665555432233334 36788999999999999999999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=380.56 Aligned_cols=258 Identities=29% Similarity=0.568 Sum_probs=234.0
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
.....|.+++.||+|.|++|.+|++..|+..||||.+.|.... .....++.+|+++|+.++|||||+||.+......+|
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln-~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLN-PSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccC-hHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 3456799999999999999999999999999999999987653 333455889999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
+||||+.||+++++|.+.+.+.+..++.++.|+++|++|||+++|||||||++||||+.+.++||+|||++..+.....
T Consensus 132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~- 210 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM- 210 (596)
T ss_pred EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccccc-
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999988764321
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHHHHH
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEML 351 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~ell 351 (497)
..+.||+|.|.|||++.+..| ++.+|+||+|+++|-|+
T Consensus 211 -----------------------------------------lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV 249 (596)
T KOG0586|consen 211 -----------------------------------------LQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALV 249 (596)
T ss_pred -----------------------------------------ccccCCCCCccChHhhcCcccCCcceehhhhhhhheeee
Confidence 126899999999999999887 78999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
.|..||.+.+..+...+++..+..+++ .+|.++++||+++|. +|.+|++ +++|..|+|...-
T Consensus 250 ~GsLPFDG~~lk~Lr~rvl~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~---~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 250 EGSLPFDGQNLKELRPRVLRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGP---CDQIMKDRWRNDL 312 (596)
T ss_pred ecccccCCcccccccchheeeeecccc----eeechhHHHHHHhhccCccccCC---HHHhhhhcccchh
Confidence 999999999988888888875555554 589999999999999 9999998 9999999998743
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=381.71 Aligned_cols=263 Identities=24% Similarity=0.369 Sum_probs=216.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
...+|.+++.||.|+||.||+|... .++..||+|.+.... ...+|+.+|+.++|||||+++++|.....+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 3457999999999999999999764 356789999886532 245799999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+|||++. ++|..++.....+++..+..++.||+.||.|||+.|||||||||+|||++.++.+||+|||+++.+.....
T Consensus 162 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~ 240 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD 240 (392)
T ss_pred EEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence 99999994 78999987778899999999999999999999999999999999999999999999999999976542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
. ......+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 241 ~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~ 281 (392)
T PHA03207 241 T---------------------------------------PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMS 281 (392)
T ss_pred c---------------------------------------ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHH
Confidence 0 0012467999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh---HHHHHHHhcc--cCcccC-------------------------CC---CccCChhHHHHHHHHhh-
Q 010947 352 VGYPPFYSDDP---MSTCRKIVNW--RTHLKF-------------------------PE---EAKLSIEAKDLISKLLC- 397 (497)
Q Consensus 352 ~G~~PF~~~~~---~~~~~~i~~~--~~~~~~-------------------------p~---~~~~s~~~~dLI~~lL~- 397 (497)
+|..||.+... ...+..|+.. .....+ |. ...++.++++||.+||+
T Consensus 282 ~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~ 361 (392)
T PHA03207 282 VKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTF 361 (392)
T ss_pred HCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhcc
Confidence 99999987542 2222222210 001111 11 12357789999999999
Q ss_pred CccccCCCCCcchhcCCCCccCCChhhhhh
Q 010947 398 NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 398 dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 427 (497)
||.+||+ +.+++.||||...+|+.+.-
T Consensus 362 dp~~Rps---a~e~l~~p~f~~~~~~~~~~ 388 (392)
T PHA03207 362 DQEFRPS---AQDILSLPLFTKEPINLLNI 388 (392)
T ss_pred ChhhCCC---HHHHhhCchhhccchhhhcC
Confidence 9999999 99999999999999988753
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=374.03 Aligned_cols=256 Identities=28% Similarity=0.443 Sum_probs=209.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 188 (497)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ........+.+|+.+++.++||||++++++|...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 478999999999999999999999999999999997543 2233445677899999999999999999988654
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+|+||||+++ +|...+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+....
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 357999999965 6666664 3589999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
... ....+||+.|+|||++.+..++.++|+|||||++|
T Consensus 172 ~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 209 (355)
T cd07874 172 SFM------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209 (355)
T ss_pred ccc------------------------------------------cCCccccCCccCHHHHcCCCCCchhhHHHHHHHHH
Confidence 110 11457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccC-------------------------cccCC---------C----CccCChhHHH
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRT-------------------------HLKFP---------E----EAKLSIEAKD 390 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~-------------------------~~~~p---------~----~~~~s~~~~d 390 (497)
+|++|..||.+.+..+.+..++..-. .+.+| . ....+.++++
T Consensus 210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (355)
T cd07874 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289 (355)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHH
Confidence 99999999998775554443322000 00000 0 1124567899
Q ss_pred HHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 391 LI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||.+||. ||.+||+ +.|+++||||..
T Consensus 290 li~~mL~~dP~~Rps---~~ell~hp~~~~ 316 (355)
T cd07874 290 LLSKMLVIDPAKRIS---VDEALQHPYINV 316 (355)
T ss_pred HHHHHhcCCchhcCC---HHHHhcCcchhc
Confidence 9999999 9999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-45 Score=363.45 Aligned_cols=260 Identities=27% Similarity=0.480 Sum_probs=215.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|.+++.||.|+||.||+|.++.++..||+|.+..... ......+..|+.+++.++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999875432 22334577899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||++ ++|..++.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 83 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 159 (301)
T cd07873 83 FEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-- 159 (301)
T ss_pred Eeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--
Confidence 99996 588888765 35689999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
......+++.|+|||++.+ ..++.++|||||||++|||++
T Consensus 160 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t 200 (301)
T cd07873 160 ---------------------------------------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMST 200 (301)
T ss_pred ---------------------------------------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHh
Confidence 0013467899999999875 458899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccC-----------------cccCCC---------CccCChhHHHHHHHHhh-CccccCCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRT-----------------HLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
|++||.+.+..+....+..... ...+|. ...+++++++||.+||+ ||.+|++
T Consensus 201 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t- 279 (301)
T cd07873 201 GRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS- 279 (301)
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC-
Confidence 9999998876655544432100 011111 13578899999999999 9999999
Q ss_pred CCcchhcCCCCccCCC
Q 010947 406 KGADEIKVHPWFDGVD 421 (497)
Q Consensus 406 ~~~~eil~Hpff~~i~ 421 (497)
+.++++||||..+-
T Consensus 280 --~~eil~h~~f~~~~ 293 (301)
T cd07873 280 --AEEAMKHPYFHCLG 293 (301)
T ss_pred --HHHHhcCccccccc
Confidence 99999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=375.25 Aligned_cols=256 Identities=27% Similarity=0.460 Sum_probs=211.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 188 (497)
.++|.+++.||+|+||.||+|.+..++..||||++.+... .......+.+|+.+|+.++||||++++++|.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3679999999999999999999999999999999976432 223345577899999999999999999888643
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+|++||++ |++|..++. ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~ 170 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence 4579999998 889988774 46799999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
. ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 171 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 206 (343)
T cd07878 171 E--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred C--------------------------------------------cCCccccccccCchHhcCCccCCchhhhHhHHHHH
Confidence 1 114579999999999977 5789999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcc---------------------cCCC------CccCChhHHHHHHHHhh-Cc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFPE------EAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~~~~dLI~~lL~-dp 399 (497)
|+|++|.+||.+.+..+....+....... ..|. ....++.+.+||.+||. ||
T Consensus 207 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp 286 (343)
T cd07878 207 AELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDS 286 (343)
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCCh
Confidence 99999999998877665555543211100 0110 02357789999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCC
Q 010947 400 NQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i 420 (497)
.+||+ +.+++.||||...
T Consensus 287 ~~R~s---~~ell~hp~~~~~ 304 (343)
T cd07878 287 DKRIS---ASEALAHPYFSQY 304 (343)
T ss_pred hhCCC---HHHHhcCcchhcc
Confidence 99999 9999999999864
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=355.19 Aligned_cols=264 Identities=50% Similarity=0.879 Sum_probs=227.2
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L 203 (497)
||.|+||.||+|.+..+|+.||+|++.+...........+.+|++++..++||||+++++.+.+...+|+||||++|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999876654456677899999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCC
Q 010947 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (497)
Q Consensus 204 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (497)
.+++.+.+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++...........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~--------- 151 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL--------- 151 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc---------
Confidence 99998878899999999999999999999999999999999999999999999999999875432210000
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChH
Q 010947 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (497)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~ 363 (497)
+.. .......++++.|+|||++....++.++|+|||||++|+|++|..||......
T Consensus 152 -----------~~~-------------~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~ 207 (265)
T cd05579 152 -----------NDD-------------EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207 (265)
T ss_pred -----------ccc-------------cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 000 00011356889999999999888999999999999999999999999988888
Q ss_pred HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCCh
Q 010947 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 364 ~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
+....+.. ....+|....++..+.+||.+||+ +|.+||+...+.++++||||++++|
T Consensus 208 ~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 208 EIFQNILN--GKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHHHhc--CCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 88877765 344555544458999999999999 9999999766799999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=354.39 Aligned_cols=259 Identities=31% Similarity=0.540 Sum_probs=218.3
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hchhHHHHHHHHHHHHHhcCCCceeEEEEEeec--CCeE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFL 191 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~l 191 (497)
.+|+..+.||+|+||.||+|.+..++..||+|++..... ........+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 478999999999999999999999999999999875432 123345678899999999999999999998875 3678
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||+++++|.+++.....+++.....++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.+.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
... ......|+..|+|||++.+..++.++|+|||||++|||+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~ 203 (266)
T cd06651 162 SGT--------------------------------------GIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEML 203 (266)
T ss_pred cCC--------------------------------------ccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHH
Confidence 000 001346899999999999888999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
+|.+||...+.......+........+|. .+++.+++|| +||. +|.+||+ +++|+.||||+
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li-~~~~~~p~~Rp~---~~eil~hp~~~ 265 (266)
T cd06651 204 TEKPPWAEYEAMAAIFKIATQPTNPQLPS--HISEHARDFL-GCIFVEARHRPS---AEELLRHPFAQ 265 (266)
T ss_pred HCCCCccccchHHHHHHHhcCCCCCCCch--hcCHHHHHHH-HHhcCChhhCcC---HHHHhcCcccc
Confidence 99999988776666666554433444443 6788999999 5666 9999998 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=360.93 Aligned_cols=241 Identities=20% Similarity=0.255 Sum_probs=209.9
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec----CCeEEEEEee
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DEFLYLIMEY 197 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~l~lVmEy 197 (497)
..||+|++|.||+|.. +|+.||||++++.........+.+.+|+.+|.+++|||||+++++|.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999986 688999999987644333345778899999999999999999999876 4578999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 198 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
++||+|.+++.....+++..+..++.+++.||.|||+ .+++||||||+|||++.+|.+||+|||+++.+....
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~------ 177 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP------ 177 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc------
Confidence 9999999999888889999999999999999999998 599999999999999999999999999988653210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHHHHHHHHhCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvil~ell~G~ 354 (497)
...+||+.|+|||++.+ ..|+.++|||||||++|||++|.
T Consensus 178 --------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~ 219 (283)
T PHA02988 178 --------------------------------------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219 (283)
T ss_pred --------------------------------------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCC
Confidence 13468999999999976 68999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
.||.+.+..+.+..+......+.+|. .+++++++||.+||+ ||.+||+ +.+++.
T Consensus 220 ~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~l~~li~~cl~~dp~~Rps---~~ell~ 274 (283)
T PHA02988 220 IPFENLTTKEIYDLIINKNNSLKLPL--DCPLEIKCIVEACTSHDSIKRPN---IKEILY 274 (283)
T ss_pred CCCCCCCHHHHHHHHHhcCCCCCCCC--cCcHHHHHHHHHHhcCCcccCcC---HHHHHH
Confidence 99999888888888876545555553 689999999999999 9999998 777653
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=359.78 Aligned_cols=274 Identities=43% Similarity=0.772 Sum_probs=227.2
Q ss_pred CeeEEeEeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhc-hhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeE
Q 010947 117 DFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l 191 (497)
+|++.+.||+|+||.||+|+.. .++..||||++++..... .....++..|+.++..+ +||||+++++.|.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 467899999998654332 23446688899999999 699999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||++||+|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.+.....
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999876432110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC--CCcchhHHhHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIMYE 349 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--y~~~~DiwSlGvil~e 349 (497)
. .....+|++.|+|||.+.+.. ++.++|+||||+++|+
T Consensus 161 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~e 200 (288)
T cd05583 161 E----------------------------------------RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFE 200 (288)
T ss_pred c----------------------------------------ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHH
Confidence 0 011356899999999987654 7889999999999999
Q ss_pred HHhCCCCCCCCCh----HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhh
Q 010947 350 MLVGYPPFYSDDP----MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 350 ll~G~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
|++|..||...+. .+....+.. .....| ..++.++.+||.+||. ||++||+..++.++++||||+.++|+.
T Consensus 201 l~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~~ 276 (288)
T cd05583 201 LLTGASPFTVDGEQNSQSEISRRILK--SKPPFP--KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDD 276 (288)
T ss_pred HHhCCCCcccCcccchHHHHHHHHHc--cCCCCC--cccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHHH
Confidence 9999999965432 233333333 222333 3688999999999999 999999988899999999999999998
Q ss_pred hhh--cCCCccc
Q 010947 425 IYQ--MEAAFIP 434 (497)
Q Consensus 425 l~~--~~~p~~p 434 (497)
+.+ ..+||.|
T Consensus 277 ~~~~~~~~~~~~ 288 (288)
T cd05583 277 LAAKRIPAPFKP 288 (288)
T ss_pred HhhhccCCCCCC
Confidence 874 5566643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=377.32 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=214.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-C-----CceeEEEEEeecCC
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-S-----NCIVKLYCSFQDDE 189 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-h-----p~Iv~l~~~~~~~~ 189 (497)
-+|+++++||+|+||.|.+|.+..|++.||||++++.. .-......|+.||..++ | -|+|+++++|...+
T Consensus 186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~ 261 (586)
T KOG0667|consen 186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN 261 (586)
T ss_pred EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence 37899999999999999999999999999999998753 22344667999999886 4 48999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC--cEEEcccccccc
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG--HLRLSDFGLCKP 265 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g--~vkL~DFGla~~ 265 (497)
++|||+|.+ +-+|.++|..+ .+|+...++.++.||+.||.+||++||||+|||||||||...+ .|||+|||.|..
T Consensus 262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence 999999999 67999999765 4699999999999999999999999999999999999997654 699999999875
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
.... .++.+-+..|.|||++.+.+|+.+.|||||||
T Consensus 341 ~~q~--------------------------------------------vytYiQSRfYRAPEVILGlpY~~~IDmWSLGC 376 (586)
T KOG0667|consen 341 ESQR--------------------------------------------VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGC 376 (586)
T ss_pred cCCc--------------------------------------------ceeeeeccccccchhhccCCCCCccceeehhh
Confidence 4311 23677888999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhcccC--------------------------------------------------c
Q 010947 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRT--------------------------------------------------H 375 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~~~~~~i~~~~~--------------------------------------------------~ 375 (497)
|+.||++|.|.|.|+++.+++..|+.--+ .
T Consensus 377 IlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~ 456 (586)
T KOG0667|consen 377 ILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLE 456 (586)
T ss_pred hHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhccc
Confidence 99999999999999999988888764000 0
Q ss_pred ccCC-CC-------c-cCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 376 LKFP-EE-------A-KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 376 ~~~p-~~-------~-~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
...| .. . .-...+.|||.+||. ||..|++ +.++|+||||.+..
T Consensus 457 ~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t---p~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 457 RRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT---PAQALNHPFLTGTS 509 (586)
T ss_pred ccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC---HHHHhcCccccccc
Confidence 0011 00 0 012236899999999 9999998 89999999999653
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=356.31 Aligned_cols=252 Identities=24% Similarity=0.400 Sum_probs=211.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|+++++||+|+||.||+|.+..+++.||||++.+.. .......+.+|+.+++.++||||+++++.|.+.+..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 46889999999999999999999999999999987542 2334456889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||+++|+|..+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++..+....
T Consensus 79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----- 149 (279)
T cd06619 79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----- 149 (279)
T ss_pred ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-----
Confidence 99999998654 457899999999999999999999999999999999999999999999999997553210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
....+||+.|+|||++.+..++.++|+|||||++|+|++|..
T Consensus 150 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 191 (279)
T cd06619 150 --------------------------------------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF 191 (279)
T ss_pred --------------------------------------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 113579999999999999999999999999999999999999
Q ss_pred CCCCCCh-------HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 356 PFYSDDP-------MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 356 PF~~~~~-------~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
||..... ......+... .....+. ...++++++||.+||+ +|.+||+ +++++.||||...+
T Consensus 192 pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~---~~eil~~~~~~~~~ 260 (279)
T cd06619 192 PYPQIQKNQGSLMPLQLLQCIVDE-DPPVLPV-GQFSEKFVHFITQCMRKQPKERPA---PENLMDHPFIVQYN 260 (279)
T ss_pred CchhhcccccccchHHHHHHHhcc-CCCCCCC-CcCCHHHHHHHHHHhhCChhhCCC---HHHHhcCccccccc
Confidence 9975321 1222233221 1122222 3578899999999999 9999998 99999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=361.60 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=215.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|.+..++..||+|.+.... .......+.+|++++..++||||++++++|.+++.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 47999999999999999999999999999999987532 2334456888999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||++||+|.+++.+.+.+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||++.......
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~---- 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM---- 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc----
Confidence 999999999999888889999999999999999999997 699999999999999999999999999986542110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
....+|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 155 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 195 (308)
T cd06615 155 ---------------------------------------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195 (308)
T ss_pred ---------------------------------------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence 11457999999999998888999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhccc-----------------------------------CcccCCCCccCChhHHHHHHHHhh-C
Q 010947 355 PPFYSDDPMSTCRKIVNWR-----------------------------------THLKFPEEAKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~-----------------------------------~~~~~p~~~~~s~~~~dLI~~lL~-d 398 (497)
.||.+.+.......+.... .....|. ..++.++++||.+||. +
T Consensus 196 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~ 274 (308)
T cd06615 196 YPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKN 274 (308)
T ss_pred CCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCC
Confidence 9998665433322221100 0011111 1367899999999999 9
Q ss_pred ccccCCCCCcchhcCCCCccC
Q 010947 399 VNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 399 p~~R~~~~~~~eil~Hpff~~ 419 (497)
|.+||+ +.++++||||..
T Consensus 275 P~~Rpt---~~~ll~~~~~~~ 292 (308)
T cd06615 275 PKERAD---LKELTKHPFIKR 292 (308)
T ss_pred hhhCcC---HHHHhcChhhhh
Confidence 999999 999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=356.53 Aligned_cols=255 Identities=29% Similarity=0.508 Sum_probs=214.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|.+.+.||+|+||.||+|.+..+++.||+|+++... ......+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 457888999999999999999999999999999987543 22345577899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..+......
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~-- 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAK-- 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccc--
Confidence 999999999999988889999999999999999999999999999999999999999999999999998755321000
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHhHHHHHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwSlGvil~ell 351 (497)
.....||+.|+|||++. ...++.++|+|||||++|+|+
T Consensus 163 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~ 203 (267)
T cd06645 163 ---------------------------------------RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELA 203 (267)
T ss_pred ---------------------------------------cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHh
Confidence 01357999999999985 456899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCc-ccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTH-LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpf 416 (497)
+|.+||....+......+...... ........++..+.+||.+||. +|++||+ +++|+.|||
T Consensus 204 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~---~~~ll~~~~ 267 (267)
T cd06645 204 ELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPT---AEKLLQHPF 267 (267)
T ss_pred cCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcC---HHHHhcCCC
Confidence 999999876655444333321111 1111223578899999999999 9999998 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=366.40 Aligned_cols=250 Identities=25% Similarity=0.442 Sum_probs=193.7
Q ss_pred EeEeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec--CCeEEEEEe
Q 010947 121 LTMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFLYLIME 196 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~l~lVmE 196 (497)
.+.||+|+||+||+|+.+ .+++.||+|++..... ...+.+|+.+|+.++||||++++++|.+ +..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 457999999999999976 4678999999875432 2346789999999999999999998854 567899999
Q ss_pred ecCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee----cCCCcEEEcccccc
Q 010947 197 YLPGGDMMTLLMRK---------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLC 263 (497)
Q Consensus 197 y~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl----~~~g~vkL~DFGla 263 (497)
|+. ++|..++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+|
T Consensus 81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 995 5888776432 258999999999999999999999999999999999999 45689999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHh
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 342 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwS 342 (497)
+.+....... ......+||+.|+|||++.+ ..|+.++||||
T Consensus 160 ~~~~~~~~~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws 201 (317)
T cd07868 160 RLFNSPLKPL--------------------------------------ADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 201 (317)
T ss_pred eccCCCCccc--------------------------------------cccCCccccccccCCHHHcCCCCcCchhhHHH
Confidence 8654221000 00114679999999999987 45899999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh---------HHHHHHHhc---------ccCcccCCC------------------------
Q 010947 343 LGAIMYEMLVGYPPFYSDDP---------MSTCRKIVN---------WRTHLKFPE------------------------ 380 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~~---------~~~~~~i~~---------~~~~~~~p~------------------------ 380 (497)
|||++|||++|.+||.+... ...+.++.+ |.....+|.
T Consensus 202 lG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (317)
T cd07868 202 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 281 (317)
T ss_pred HHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHh
Confidence 99999999999999975432 122222221 000000000
Q ss_pred -CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 381 -EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 381 -~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
....+.++.+||.+||+ ||.+|++ ++|+++||||
T Consensus 282 ~~~~~~~~~~dli~~mL~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07868 282 HKVKPDSKAFHLLQKLLTMDPIKRIT---SEQAMQDPYF 317 (317)
T ss_pred cCCCCChHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 01235679999999999 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=371.30 Aligned_cols=257 Identities=34% Similarity=0.633 Sum_probs=223.6
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 201 (497)
++||.|-||+||-|.++.||+.||||++.|-... ..+...+++|+.||..+.||.||.|-+.|++.+.++.|||-+ .|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp-~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFP-TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCC-CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 5899999999999999999999999999987654 445578999999999999999999999999999999999999 66
Q ss_pred chhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC---cEEEcccccccccCCCCcccccc
Q 010947 202 DMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 202 ~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g---~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|+.+++-+ ++.|++...+|++.||+.||.|||-+||+|.||||+|||+.... .+||||||+|+.+.....
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF----- 722 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF----- 722 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh-----
Confidence 77777644 57899999999999999999999999999999999999997653 699999999998753321
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
| .+.+|||.|+|||++.+++|+...|+||+|||+|--|.|..|
T Consensus 723 ---------------------------------R----rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFP 765 (888)
T KOG4236|consen 723 ---------------------------------R----RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFP 765 (888)
T ss_pred ---------------------------------h----hhhcCCccccCHHHHhhccccccccceeeeEEEEEEeccccc
Confidence 1 278999999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC-ChhhhhhcC
Q 010947 357 FYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV-DWARIYQME 429 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i-~w~~l~~~~ 429 (497)
|..+. ++-.+|.+ ..+-+|. +..+|++|.|||..||+ .-.+|.+ ++..+.|||+++. -|-+|+.++
T Consensus 766 FNEdE--dIndQIQN--AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRys---vdk~lsh~Wlq~yq~w~DLRelE 835 (888)
T KOG4236|consen 766 FNEDE--DINDQIQN--AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYS---VDKSLSHPWLQDYQTWLDLRELE 835 (888)
T ss_pred CCCcc--chhHHhhc--cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcc---hHhhccchhhhcchHHHHHHHHH
Confidence 97543 34445555 3445554 45699999999999999 9999998 9999999999876 588888643
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=398.64 Aligned_cols=264 Identities=27% Similarity=0.449 Sum_probs=218.8
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec--
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-- 187 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-- 187 (497)
......++|.+++.||+|+||+||+|+++.++..||+|++..... .......+..|+.+|..++|||||+++++|.+
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~ 85 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA 85 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence 445567899999999999999999999999999999999976543 23345678899999999999999999998864
Q ss_pred CCeEEEEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcC-------CEEEcccCCCCeeecC-----
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKH-------HYIHRDIKPDNLLLDK----- 251 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-------~iiHrDLKp~NILl~~----- 251 (497)
...+||||||+++|+|..+|.. ...+++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 4579999999999999999865 25799999999999999999999985 4999999999999964
Q ss_pred ------------CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccC
Q 010947 252 ------------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (497)
Q Consensus 252 ------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 319 (497)
.+.+||+|||+++.+.... .....+|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s------------------------------------------~~~s~vG 203 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES------------------------------------------MAHSCVG 203 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc------------------------------------------cccccCC
Confidence 3458999999997653211 0114579
Q ss_pred CCcccCcccccc--CCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh
Q 010947 320 TPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC 397 (497)
Q Consensus 320 t~~Y~aPE~l~~--~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~ 397 (497)
|+.|+|||++.+ ..++.++||||||||||||++|.+||...+.......++.... .+|. ...+.++.+||.+||.
T Consensus 204 Tp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p--~lpi-~~~S~eL~dLI~~~L~ 280 (1021)
T PTZ00266 204 TPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGP--DLPI-KGKSKELNILIKNLLN 280 (1021)
T ss_pred CccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCC--CCCc-CCCCHHHHHHHHHHhc
Confidence 999999999964 4589999999999999999999999987665555444443222 2222 2578999999999999
Q ss_pred -CccccCCCCCcchhcCCCCccCCCh
Q 010947 398 -NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 398 -dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
+|.+||+ +.++|.||||+.+..
T Consensus 281 ~dPeeRPS---a~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 281 LSAKERPS---ALQCLGYQIIKNVGP 303 (1021)
T ss_pred CChhHCcC---HHHHhccHHHhhcCC
Confidence 9999999 999999999987643
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=356.73 Aligned_cols=273 Identities=41% Similarity=0.754 Sum_probs=225.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhc-hhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeE
Q 010947 117 DFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l 191 (497)
+|++.+.||.|+||.||+|... .+|..||+|++....... ....+++..|+.++..+ +||+|+.+++.|..+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999874 478999999998654332 23456788899999999 689999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||++||+|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++++||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvil~e 349 (497)
. .....+|++.|+|||++.. ..++.++|+|||||++|+
T Consensus 161 ~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ 200 (290)
T cd05613 161 E----------------------------------------RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYE 200 (290)
T ss_pred c----------------------------------------ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHH
Confidence 0 0113578999999999875 457889999999999999
Q ss_pred HHhCCCCCCCCCh----HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCCh
Q 010947 350 MLVGYPPFYSDDP----MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDW 422 (497)
Q Consensus 350 ll~G~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w 422 (497)
|++|..||..... ......+.. ....+| ..+++.+.+||.+||. ||.+|++. ..+++++.||||..++|
T Consensus 201 ll~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~ 276 (290)
T cd05613 201 LLTGASPFTVDGEKNSQAEISRRILK--SEPPYP--QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW 276 (290)
T ss_pred HhcCCCCCCcCCccccHHHHHHHhhc--cCCCCC--ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence 9999999975433 223333332 222334 3688999999999999 99999853 36899999999999999
Q ss_pred hhhhh--cCCCcc
Q 010947 423 ARIYQ--MEAAFI 433 (497)
Q Consensus 423 ~~l~~--~~~p~~ 433 (497)
+.+.. .++||.
T Consensus 277 ~~~~~~~~~~~~~ 289 (290)
T cd05613 277 DDLAAKKVPAPFK 289 (290)
T ss_pred HHHhhccCCCCCC
Confidence 88753 344443
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=346.43 Aligned_cols=253 Identities=28% Similarity=0.538 Sum_probs=216.4
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-CCeEEEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEFLYLIM 195 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~l~lVm 195 (497)
+|++++.||+|+||.||+|.++.+++.||+|++..... .......+..|+.+++.++||||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 48999999999999999999999999999999976432 23345668889999999999999999998874 45689999
Q ss_pred eecCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 196 EYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 196 Ey~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||+++++|.+++.. ...+++.++..++.+++.||.+||+.||+||||||+||+++.++.++|+|||+++.+.....
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-- 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-- 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC--
Confidence 99999999999865 34689999999999999999999999999999999999999999999999999976532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
......|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 158 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08223 158 ---------------------------------------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATL 198 (257)
T ss_pred ---------------------------------------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcC
Confidence 01135689999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
..||.+.+.......+.... ....| ..+++++.+||.+||+ +|.+||+ +.+++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 257 (257)
T cd08223 199 KHAFNAKDMNSLVYRIIEGK-LPPMP--KDYSPELGELIATMLSKRPEKRPS---VKSILRQPYI 257 (257)
T ss_pred CCCCCCCCHHHHHHHHHhcC-CCCCc--cccCHHHHHHHHHHhccCcccCCC---HHHHhcCCCC
Confidence 99999887766666665422 11223 3688999999999999 9999998 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=354.51 Aligned_cols=255 Identities=31% Similarity=0.509 Sum_probs=216.7
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|++++.||.|+||.||+|.+..++..+|+|.+.... ......+.+|+.+++.++||||+++++.|......|+||||
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 577889999999999999999999999999986542 33456788899999999999999999999999999999999
Q ss_pred cCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 198 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
+++|+|..++.+ ..++++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----- 158 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ----- 158 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-----
Confidence 999999988765 46799999999999999999999999999999999999999999999999999875421100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhHHhHHHHHHHHH
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~DiwSlGvil~ell 351 (497)
......||+.|+|||++. +..++.++|+|||||++|||+
T Consensus 159 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~ 202 (282)
T cd06643 159 ------------------------------------RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMA 202 (282)
T ss_pred ------------------------------------ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHc
Confidence 011357899999999984 355788999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+|.+||.+.+..+...++..... ...+....++.++++||.+||. ||.+||+ ++++++||||...
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~ 268 (282)
T cd06643 203 QIEPPHHELNPMRVLLKIAKSEP-PTLAQPSRWSSEFKDFLKKCLEKNVDARWT---TTQLLQHPFVTVN 268 (282)
T ss_pred cCCCCccccCHHHHHHHHhhcCC-CCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCCCEecc
Confidence 99999998887776666654321 1222223688999999999998 9999999 9999999999853
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=354.34 Aligned_cols=255 Identities=32% Similarity=0.493 Sum_probs=209.3
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++++.||.|+||.||+|.++.++..||||++.... ........+.+|+.++..++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 5899999999999999999999999999999987542 222334567889999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 197 YLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 197 y~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|++ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 997 6888887542 5699999999999999999999999999999999999999999999999999875432110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
......|++.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 157 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~t 197 (285)
T cd07861 157 ---------------------------------------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT 197 (285)
T ss_pred ---------------------------------------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHH
Confidence 0013467899999999875 457999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCc----------------ccCC---------CCccCChhHHHHHHHHhh-CccccCCCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTH----------------LKFP---------EEAKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~----------------~~~p---------~~~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
|.+||.+.+.......+...... ..++ ....+++++++||.+||+ ||.+||+
T Consensus 198 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt-- 275 (285)
T cd07861 198 KKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS-- 275 (285)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC--
Confidence 99999987654433332210000 0000 013478999999999999 9999998
Q ss_pred CcchhcCCCCc
Q 010947 407 GADEIKVHPWF 417 (497)
Q Consensus 407 ~~~eil~Hpff 417 (497)
+.+|+.||||
T Consensus 276 -~~~ll~~~~~ 285 (285)
T cd07861 276 -AKKALNHPYF 285 (285)
T ss_pred -HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=355.90 Aligned_cols=260 Identities=28% Similarity=0.480 Sum_probs=221.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||.|+||.||+|.+..++..||+|++... .......+..|+.+++.++||||+++++.+.++..+|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 45699999999999999999999889999999998754 234556788899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||++||+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-- 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-- 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc--
Confidence 9999999999998764 5799999999999999999999999999999999999999999999999999865422100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhHHhHHHHHH
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~DiwSlGvil~ 348 (497)
......||+.|+|||++. ...++.++|+|||||++|
T Consensus 159 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 159 ---------------------------------------KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred ---------------------------------------ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 011356899999999985 345788999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCCh
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
+|++|.+||.+.+......++.... ...+.....++.++.+||.+||+ +|.+||+ ++++++||||.....
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~~ 270 (280)
T cd06611 200 ELAQMEPPHHELNPMRVLLKILKSE-PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPT---AAELLKHPFVSDQSD 270 (280)
T ss_pred HHHhCCCCcccCCHHHHHHHHhcCC-CCCcCCcccCCHHHHHHHHHHhccChhhCcC---HHHHhcChhhcccch
Confidence 9999999999887777666665422 11222224688999999999999 9999999 999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=352.81 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=214.5
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|++.+.||+|+||.||+|.++.+++.||+|++.... ......+.+|+.++..++||||+++++++.+...+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 3467999999999999999999999999999999997542 2334567889999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+++.+......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK- 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccc-
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHhHHHHHHHH
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwSlGvil~el 350 (497)
.....|++.|+|||.+. ...++.++|+|||||++|||
T Consensus 163 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el 202 (267)
T cd06646 163 ----------------------------------------RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202 (267)
T ss_pred ----------------------------------------cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHH
Confidence 01356899999999985 45578899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCc-ccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCC
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTH-LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpf 416 (497)
++|.+||...++......+...... ...+....++.++.+||++||+ +|.+||+ +++|++|+|
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~~l~ 267 (267)
T cd06646 203 AELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT---AERLLTHLF 267 (267)
T ss_pred HhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC---HHHHhcCCC
Confidence 9999999776554443333221111 1111223578899999999999 9999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=351.73 Aligned_cols=255 Identities=42% Similarity=0.759 Sum_probs=220.5
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++.|.+...+|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 48999999999999999999999999999999987665554567789999999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|++|++|..++....++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~----- 155 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL----- 155 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc-----
Confidence 999999999998877999999999999999999999999999999999999999999999999999876532210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
.....|+..|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 156 -------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 156 -------------------------------------TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred -------------------------------------ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence 0134688999999999988899999999999999999999999
Q ss_pred CCCCCh--HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 357 FYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 357 F~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|...+. ...+...... ....+|. .++.++.++|.+||. ||.+|++.. ..|++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~i~~~l~~~p~~R~~~~-~~~l~~~~~~ 258 (258)
T cd05578 199 YRGHSRTIRDQIRAKQET-ADVLYPA--TWSTEAIDAINKLLERDPQKRLGDN-LKDLKNHPYF 258 (258)
T ss_pred CCCCCccHHHHHHHHhcc-ccccCcc--cCcHHHHHHHHHHccCChhHcCCcc-HHHHhcCCCC
Confidence 988764 2222232221 2333443 688999999999999 999999922 3999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=349.62 Aligned_cols=260 Identities=30% Similarity=0.511 Sum_probs=220.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh------chhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML------RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~------~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
+|.+.+.||.|+||.||+|.+..+++.||+|.+...... .....+.+..|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999999989999999998754322 12234678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
.++||||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999888889999999999999999999999999999999999999999999999999998664221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
..... . .......|++.|+|||++.+..++.++|+|||||++|+|
T Consensus 161 ~~~~~---------------~--------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l 205 (267)
T cd06628 161 LSTKT---------------N--------------------GARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205 (267)
T ss_pred ccCCc---------------c--------------------ccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHH
Confidence 10000 0 000135689999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
++|..||.+.+......++... ....+|. .++.++.+||.+||. ||.+||+ +.+|+.||||
T Consensus 206 ~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 267 (267)
T cd06628 206 LTGKHPFPDCTQLQAIFKIGEN-ASPEIPS--NISSEAIDFLEKTFEIDHNKRPT---AAELLKHPFL 267 (267)
T ss_pred hhCCCCCCCccHHHHHHHHhcc-CCCcCCc--ccCHHHHHHHHHHccCCchhCcC---HHHHhhCCCC
Confidence 9999999887766666665542 2223343 688999999999999 9999998 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=345.17 Aligned_cols=253 Identities=34% Similarity=0.544 Sum_probs=220.4
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|.+.+.||+|+||.||+|..+.+++.||+|.+...... ......+..|+.+++.++||||+++++++.+.+..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 588999999999999999999999999999999765432 3445678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 197 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|++|++|.+++... ..+++..+..++.+++.||.|||+.||+||||||+||+++.++.++|+|||+++.+......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~-- 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-- 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--
Confidence 99999999998764 57899999999999999999999999999999999999999999999999998865422100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
....+|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 158 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 198 (256)
T cd08529 158 ---------------------------------------ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGK 198 (256)
T ss_pred ---------------------------------------hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCC
Confidence 01356899999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
.||...+.......+.... ...++. .++.++.++|.+||+ +|.+||+ +.+++.|||+
T Consensus 199 ~p~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 256 (256)
T cd08529 199 HPFDANNQGALILKIIRGV-FPPVSQ--MYSQQLAQLIDQCLTKDYRQRPD---TFQLLRNPSL 256 (256)
T ss_pred CCCCCCCHHHHHHHHHcCC-CCCCcc--ccCHHHHHHHHHHccCCcccCcC---HHHHhhCCCC
Confidence 9999888777777766522 222332 678899999999999 9999999 9999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=361.95 Aligned_cols=264 Identities=21% Similarity=0.337 Sum_probs=209.8
Q ss_pred EEeEeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 120 LLTMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 120 ~~~~IG~G--~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
++++||+| +||+||++..+.+|+.||||++..... .......+..|+.+++.++|||||+++++|.+++.+|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 56789999 789999999999999999999976432 233456688899999999999999999999999999999999
Q ss_pred cCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 198 LPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 198 ~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
+++|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.++++|||.+............
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~ 160 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence 9999999998653 46999999999999999999999999999999999999999999999999876543211000000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHHHHHHHHhC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvil~ell~G 353 (497)
........+++..|+|||++.+ ..|+.++|||||||++|||++|
T Consensus 161 ----------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 161 ----------------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred ----------------------------------cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHC
Confidence 0000012457888999999976 4699999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcc------------------------------------------cCCCCccCChhHHHH
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHL------------------------------------------KFPEEAKLSIEAKDL 391 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~------------------------------------------~~p~~~~~s~~~~dL 391 (497)
.+||................... ..|....+++++++|
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence 99998765444333332211000 000112357889999
Q ss_pred HHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 392 ISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 392 I~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
|.+||+ ||++||+ ++++++||||+.+.
T Consensus 287 i~~~l~~dP~~Rpt---~~ell~~p~f~~~~ 314 (327)
T cd08227 287 VEQCLQRNPDARPS---ASTLLNHSFFKQIK 314 (327)
T ss_pred HHHHHhhCchhcCC---HHHHhcChhhhhcc
Confidence 999999 9999999 99999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=367.85 Aligned_cols=252 Identities=23% Similarity=0.366 Sum_probs=203.2
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
...+|++++.||+|+||.||+|.+..++..||+|+..+.. ...|+.+++.++||||++++++|.+....|+
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 3457999999999999999999999999999999865432 3468999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||+. |+|..++.. ...+++..+..++.||+.||.|||+.|||||||||+|||++.++.+||+|||+++......
T Consensus 135 v~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-- 211 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-- 211 (357)
T ss_pred EEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc--
Confidence 999995 688888755 4679999999999999999999999999999999999999999999999999987432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
......||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 212 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~ 251 (357)
T PHA03209 212 ----------------------------------------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251 (357)
T ss_pred ----------------------------------------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHH
Confidence 0114579999999999999999999999999999999998
Q ss_pred CCCC-CCCCChH---------HHHHHHhcc--cCcccCC----------------------------CCccCChhHHHHH
Q 010947 353 GYPP-FYSDDPM---------STCRKIVNW--RTHLKFP----------------------------EEAKLSIEAKDLI 392 (497)
Q Consensus 353 G~~P-F~~~~~~---------~~~~~i~~~--~~~~~~p----------------------------~~~~~s~~~~dLI 392 (497)
+..| |...... ..+.+++.. .....+| ....++.++.+||
T Consensus 252 ~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 331 (357)
T PHA03209 252 YPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLV 331 (357)
T ss_pred cCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHH
Confidence 5544 4432111 111111110 0011111 0124677889999
Q ss_pred HHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 393 SKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 393 ~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
.+||+ ||.+||+ +.|+++||||+.+
T Consensus 332 ~~mL~~dP~~Rpt---a~e~l~hp~f~~~ 357 (357)
T PHA03209 332 HKMLTFDAAMRPS---AEEILNYPMFAQL 357 (357)
T ss_pred HHHHcCCcccCcC---HHHHhcCchhccC
Confidence 99999 9999999 9999999999864
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=351.32 Aligned_cols=253 Identities=30% Similarity=0.519 Sum_probs=211.1
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecC-----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD----- 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~----- 188 (497)
...|++.+.||+|+||.||+|....+++.||+|++.... .....+..|+.++..+ +||||++++++|.+.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 456888899999999999999999999999999987542 2335678899999988 799999999998753
Q ss_pred -CeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 189 -EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 189 -~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
..+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 4689999999999999998763 4689999999999999999999999999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 340 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~Di 340 (497)
...... ......||+.|+|||++. ...|+.++|+
T Consensus 161 ~~~~~~-----------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv 199 (272)
T cd06637 161 LDRTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDFKSDL 199 (272)
T ss_pred cccccc-----------------------------------------cCCcccccccccCHhHhccccCcCCCCCchhhH
Confidence 532100 011457999999999986 3468899999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|||||++|||++|..||...........+.. ..........++.++.+||.+||. +|.+||+ +.+++.||||
T Consensus 200 ~slGv~l~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~~ 272 (272)
T cd06637 200 WSLGITAIEMAEGAPPLCDMHPMRALFLIPR--NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPT---TEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHHHhCCCCccccCHHHHHHHHhc--CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCC---HHHHhhCCCC
Confidence 9999999999999999987766555544433 111112223678899999999999 9999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-44 Score=347.40 Aligned_cols=259 Identities=29% Similarity=0.477 Sum_probs=220.9
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||.|+||+||+|....++..+|+|++....... ....+.+|+.+++.++|+||+++++.+.+.+..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998899999999997644322 5667899999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 196 EYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 999999999999764 45999999999999999999999999999999999999999999999999999876432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHH
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell 351 (497)
. +......+|++.|+|||++... .++.++|+|||||++|+|+
T Consensus 159 ~-------------------------------------~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~ 201 (267)
T cd06610 159 T-------------------------------------RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA 201 (267)
T ss_pred c-------------------------------------ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH
Confidence 0 0001245799999999999876 7899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCC---ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEE---AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~---~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
+|..||...+....+.++.... ...++.. ..+++++++||.+||+ ||.+||+ +.+|+.||||
T Consensus 202 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~ll~~p~~ 267 (267)
T cd06610 202 TGAAPYSKYPPMKVLMLTLQND-PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPT---AEELLKHKFF 267 (267)
T ss_pred hCCCCccccChhhhHHHHhcCC-CCCcCCccccccccHHHHHHHHHHcCCChhhCcC---HHHHhhCCCC
Confidence 9999999887776666665432 2222221 3678999999999999 9999998 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=347.51 Aligned_cols=260 Identities=28% Similarity=0.488 Sum_probs=217.2
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechh---hhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~---~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
+|.+.+.||.|+||+||+|.. .+|..+|+|.+.... .........+.+|+++++.++|+||++++++|.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 478889999999999999976 578899999987432 1223345678899999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||||++||+|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++..........
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999888889999999999999999999999999999999999999999999999999988653211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
.. ........||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 160 ~~-----------------------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g 204 (265)
T cd06631 160 TH-----------------------------------SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG 204 (265)
T ss_pred cc-----------------------------------cccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhC
Confidence 00 0001245799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCc-ccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTH-LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
.+||...+.......+...... ...| ..++.++.+||.+||. +|.+||+ +.+++.||||
T Consensus 205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~ 265 (265)
T cd06631 205 KPPLASMDRLAAMFYIGAHRGLMPRLP--DSFSAAAIDFVTSCLTRDQHERPS---ALQLLRHDFL 265 (265)
T ss_pred CCccccCChHHHHHHhhhccCCCCCCC--CCCCHHHHHHHHHHhcCCcccCCC---HHHHhcCCCC
Confidence 9999887665555444432111 1233 3688999999999999 9999998 9999999998
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=353.24 Aligned_cols=264 Identities=19% Similarity=0.301 Sum_probs=217.3
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
.+..++|++.+.||+|+||.||+|..+. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 4567889999999999999999997653 345899999865432 223345778999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEE
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vk 256 (497)
+....|+||||+++|+|.+++.+. ..++...+..++.|++.||.|||++||+||||||+|||++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 999999999999999999999653 2346678899999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCc
Q 010947 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (497)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~ 336 (497)
|+|||+++.......... .....++..|+|||.+.+..++.
T Consensus 160 L~Dfg~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~~pE~~~~~~~~~ 200 (288)
T cd05061 160 IGDFGMTRDIYETDYYRK---------------------------------------GGKGLLPVRWMAPESLKDGVFTT 200 (288)
T ss_pred ECcCCccccccccccccc---------------------------------------cCCCcccccccCHHHhccCCCCh
Confidence 999999886532111000 01234678899999999999999
Q ss_pred chhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC-
Q 010947 337 ECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV- 413 (497)
Q Consensus 337 ~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~- 413 (497)
++|+|||||++|||++ |.+||.+.+..+....+... ....+|. .+++.++++|.+||+ ||.+||+ +.++++
T Consensus 201 ~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~ 274 (288)
T cd05061 201 SSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDG-GYLDQPD--NCPERVTDLMRMCWQFNPKMRPT---FLEIVNL 274 (288)
T ss_pred HhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHHcCCChhHCcC---HHHHHHH
Confidence 9999999999999998 89999988777766666542 2233343 578899999999999 9999999 666654
Q ss_pred -----CCCccCCCh
Q 010947 414 -----HPWFDGVDW 422 (497)
Q Consensus 414 -----Hpff~~i~w 422 (497)
||||.+++|
T Consensus 275 l~~~~~~~~~~~~~ 288 (288)
T cd05061 275 LKDDLHPSFPEVSF 288 (288)
T ss_pred HHhhcCCCCCCCCC
Confidence 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=351.37 Aligned_cols=257 Identities=30% Similarity=0.466 Sum_probs=214.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 469999999999999999999999999999999875432 1223345788999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++++.|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.+|.++|+|||++..+......
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 156 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD--- 156 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCccc---
Confidence 99999999888777778999999999999999999999999999999999999999999999999999865422100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~ 198 (286)
T cd07847 157 --------------------------------------YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198 (286)
T ss_pred --------------------------------------ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCC
Confidence 013458889999999876 55899999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccC-----------------cccCCC----------CccCChhHHHHHHHHhh-CccccCCCC
Q 010947 355 PPFYSDDPMSTCRKIVNWRT-----------------HLKFPE----------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~----------~~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
+||.+.+..+....+..... ....|. ...++..+.+||.+||+ +|.+||+
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~-- 276 (286)
T cd07847 199 PLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLS-- 276 (286)
T ss_pred CCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCC--
Confidence 99998776554433321000 011111 12568899999999999 9999999
Q ss_pred CcchhcCCCCc
Q 010947 407 GADEIKVHPWF 417 (497)
Q Consensus 407 ~~~eil~Hpff 417 (497)
+.+++.||||
T Consensus 277 -~~eil~~~~f 286 (286)
T cd07847 277 -CEELLEHPYF 286 (286)
T ss_pred -HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=349.94 Aligned_cols=246 Identities=32% Similarity=0.559 Sum_probs=202.0
Q ss_pred CeeEEeEe--eecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh-cCCCceeEEEEEeecCCeEEE
Q 010947 117 DFELLTMI--GKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 117 ~f~~~~~I--G~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~l~l 193 (497)
+|++.+.+ |.|+||.||++..+.++..||+|++.+..... .|..+... .+||||+++++.|.+.+.+|+
T Consensus 15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 45555555 99999999999999999999999987653211 12222222 279999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-cEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~ 272 (497)
||||++||+|.+++.....+++..+..++.|++.||.|||+.|++||||||+||+++.++ .++|+|||+++.....
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--- 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--- 163 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---
Confidence 999999999999998877999999999999999999999999999999999999999998 9999999998754321
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
....||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 164 ------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~ 201 (267)
T PHA03390 164 ------------------------------------------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLT 201 (267)
T ss_pred ------------------------------------------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHH
Confidence 02468999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHH-HHHhc-ccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 353 GYPPFYSDDPMSTC-RKIVN-WRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 353 G~~PF~~~~~~~~~-~~i~~-~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|..||......... ..+.. .......+ ..+|+.+++||.+||+ +|.+|+++ ++++++||||+.
T Consensus 202 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~~--~~~~l~h~~~~~ 267 (267)
T PHA03390 202 GKHPFKEDEDEELDLESLLKRQQKKLPFI--KNVSKNANDFVQSMLKYNINYRLTN--YNEIIKHPFLKI 267 (267)
T ss_pred CCCCCCCCCcchhhHHHHHHhhcccCCcc--cccCHHHHHHHHHHhccChhhCCch--HHHHhcCCcccC
Confidence 99999865433221 11111 11222233 3689999999999999 99999962 699999999973
|
|
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=353.53 Aligned_cols=256 Identities=32% Similarity=0.541 Sum_probs=220.1
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..+|++++.||.|+||.||+|.+..+|+.||+|.+.... ......+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEE
Confidence 457999999999999999999999999999999987543 23346688899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||++||+|..++.. ..+++.++..++.+++.||.|||+.|++||||||+||+++.+|.+||+|||++..+.....
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~--- 170 (296)
T cd06655 95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS--- 170 (296)
T ss_pred EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc---
Confidence 999999999998854 5799999999999999999999999999999999999999999999999999876532110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....+|++.|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 171 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~ 212 (296)
T cd06655 171 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (296)
T ss_pred --------------------------------------cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 001356899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcc-cCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 355 PPFYSDDPMSTCRKIVNW-RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~-~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+||.+.+.......+... ...+..| ..+++.+++||.+||. ||.+||+ +.+|+.||||+..
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rpt---~~~il~~~~~~~~ 275 (296)
T cd06655 213 PPYLNENPLRALYLIATNGTPELQNP--EKLSPIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKLA 275 (296)
T ss_pred CCCCCCCHHHHHHHHHhcCCcccCCc--ccCCHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhhc
Confidence 999988776655554432 1122223 4689999999999999 9999998 9999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=355.00 Aligned_cols=254 Identities=30% Similarity=0.505 Sum_probs=213.9
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||.||+|.+..+|..||+|.+.... .......+.+|+.++..++||||++++++|..++.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 46899999999999999999999999999999986531 2334466888999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 196 EYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
||++|++|..++... ..+++..+..++.+++.||.|||+ .||+||||||+||+++.++.+||+|||++..+....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999999888653 379999999999999999999996 699999999999999999999999999987542110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC------CCCcchhHHhHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK------GYGMECDWWSLGA 345 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~------~y~~~~DiwSlGv 345 (497)
....+|++.|+|||++.+. .++.++|+|||||
T Consensus 158 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~ 195 (286)
T cd06622 158 ------------------------------------------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGL 195 (286)
T ss_pred ------------------------------------------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHH
Confidence 1134688999999998643 3588999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHH---HhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 346 IMYEMLVGYPPFYSDDPMSTCRK---IVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~~~~~~---i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
++|+|++|..||........... +... ....+|. .++.++.+||.+||. +|.+||+ +.+++.||||...
T Consensus 196 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~~~~~~~~ 268 (286)
T cd06622 196 SILEMALGRYPYPPETYANIFAQLSAIVDG-DPPTLPS--GYSDDAQDFVAKCLNKIPNRRPT---YAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHhCCCCCCCcchhhHHHHHHHHhhc-CCCCCCc--ccCHHHHHHHHHHcccCcccCCC---HHHHhcChhhhhc
Confidence 99999999999987655444333 3321 2233443 589999999999999 9999999 9999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=350.74 Aligned_cols=257 Identities=35% Similarity=0.538 Sum_probs=221.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||.|+||.||+|.+..++..||+|++.... .......+.+|+.+++.++||||+++++++.++..+|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 46889999999999999999999999999999997543 2334566888999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||+++++|.+++... .+++..+..++.|++.||.|||+.+++||||+|+||+++.+|.++|+|||+++.+......
T Consensus 79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~--- 154 (274)
T cd06609 79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK--- 154 (274)
T ss_pred EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccc---
Confidence 999999999998654 8999999999999999999999999999999999999999999999999999876422100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
....+|++.|+|||++.+..++.++|+|||||++|+|++|.+
T Consensus 155 --------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~ 196 (274)
T cd06609 155 --------------------------------------RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196 (274)
T ss_pred --------------------------------------cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 113578999999999999889999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
||.+.++......+... .....+. ..++.++.++|.+||+ +|.+||+ ++++++||||....
T Consensus 197 p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~l~~~l~~~p~~Rpt---~~~il~~~~~~~~~ 258 (274)
T cd06609 197 PLSDLHPMRVLFLIPKN-NPPSLEG-NKFSKPFKDFVSLCLNKDPKERPS---AKELLKHKFIKKAK 258 (274)
T ss_pred CcccCchHHHHHHhhhc-CCCCCcc-cccCHHHHHHHHHHhhCChhhCcC---HHHHhhChhhcCCC
Confidence 99887776666555542 1222222 2378899999999999 9999998 99999999998653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=354.03 Aligned_cols=256 Identities=30% Similarity=0.518 Sum_probs=218.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..+|++++.||+|+||.||+|.+..++..||+|.+..... .....+..|+.+++.++||||+++++.|.+....|+|
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEe
Confidence 4689999999999999999999999999999999876442 2345688899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||++||+|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 172 (296)
T cd06654 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 172 (296)
T ss_pred ecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccc--
Confidence 999999999998854 57899999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|+
T Consensus 173 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~ 213 (296)
T cd06654 173 ---------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (296)
T ss_pred ---------------------------------------cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCC
Confidence 01346899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+||...++......+... .....+....++..+.+||.+||. +|.+||+ +.+|+.||||..
T Consensus 214 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~eil~~~~~~~ 275 (296)
T cd06654 214 PPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (296)
T ss_pred CCCCCCCHHHhHHHHhcC-CCCCCCCccccCHHHHHHHHHHCcCCcccCcC---HHHHhhChhhhc
Confidence 999988765544333321 111222224688999999999999 9999998 999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=354.14 Aligned_cols=255 Identities=29% Similarity=0.484 Sum_probs=207.6
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++.+.||+|+||.||+|+++.+|+.||+|++..... .......+..|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 48899999999999999999999999999999976432 22233557789999999999999999999999999999999
Q ss_pred ecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 197 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|++ ++|.+++.+ .+.+++..++.++.||+.||.|||+.||+||||||+||+++.++.+||+|||+++.+......
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~--- 155 (284)
T cd07839 80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC--- 155 (284)
T ss_pred cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCC---
Confidence 996 578777755 567999999999999999999999999999999999999999999999999999765321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....+|+.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus 156 --------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~ 197 (284)
T cd07839 156 --------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 197 (284)
T ss_pred --------------------------------------cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcC
Confidence 0134688999999998764 4799999999999999999988
Q ss_pred CCC-CCCChHHHHHHHhccc---------------CcccCCC----------CccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 355 PPF-YSDDPMSTCRKIVNWR---------------THLKFPE----------EAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 355 ~PF-~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
.|| .+.+..+.+..+.... ....++. ...+++++++||.+||. ||.+||+
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t--- 274 (284)
T cd07839 198 RPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS--- 274 (284)
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCC---
Confidence 885 4444444444432100 0000110 12578999999999999 9999998
Q ss_pred cchhcCCCCc
Q 010947 408 ADEIKVHPWF 417 (497)
Q Consensus 408 ~~eil~Hpff 417 (497)
+++++.||||
T Consensus 275 ~~~il~h~~f 284 (284)
T cd07839 275 AEEALQHPYF 284 (284)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=347.23 Aligned_cols=259 Identities=29% Similarity=0.496 Sum_probs=217.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-------hhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-------RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~-------~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
+|.+.+.||.|+||.||+|....+|+.||+|.++...... ....+.+..|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999999999999999986432111 123456888999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+++||||++||+|.+++.+.+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999998754311
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC--CCcchhHHhHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIM 347 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--y~~~~DiwSlGvil 347 (497)
... .......|+..|+|||++.... ++.++|+|||||++
T Consensus 162 ~~~---------------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l 202 (272)
T cd06629 162 YDN---------------------------------------DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV 202 (272)
T ss_pred ccc---------------------------------------cccccccCCccccCHHHhccccCCCCccchhHHHHHHH
Confidence 000 0011356899999999988654 89999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcccCCCC--ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|+|++|..||...+..+....+........+|.. ..++.++++||.+||. +|.+||+ ++++++||||
T Consensus 203 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~ 272 (272)
T cd06629 203 LEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT---ARELLQHPFI 272 (272)
T ss_pred HHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCC---HHHHhhCCCC
Confidence 9999999999876665555554433333344432 3578999999999999 9999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=353.79 Aligned_cols=257 Identities=30% Similarity=0.525 Sum_probs=217.2
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..+|++++.||.|+||.||+|.+..+++.||||.+..... ...+.+..|+.+++.++||||+++++.|.....+|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 3679999999999999999999999999999999975432 2345688899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||++|++|.+++.+ ..+++..+..++.+++.||.|||+.||+||||||+|||++.+|.++|+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~-- 171 (297)
T cd06656 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (297)
T ss_pred ecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--
Confidence 999999999998854 57899999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....|++.|+|||.+.+..++.++|+|||||++|+|++|.
T Consensus 172 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~ 212 (297)
T cd06656 172 ---------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (297)
T ss_pred ---------------------------------------cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 01346899999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+||.+.++......+... ..........++..+++||.+||. +|.+||+ +.+++.||||+..
T Consensus 213 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 275 (297)
T cd06656 213 PPYLNENPLRALYLIATN-GTPELQNPERLSAVFRDFLNRCLEMDVDRRGS---AKELLQHPFLKLA 275 (297)
T ss_pred CCCCCCCcchheeeeccC-CCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhccc
Confidence 999887654443332221 111111223678899999999999 9999999 9999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=342.49 Aligned_cols=255 Identities=31% Similarity=0.521 Sum_probs=217.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ......+..|+.+++.++||||+++++++.+...+|+|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999997643 22556788999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||++|++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++..+.....
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-- 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh--
Confidence 9999999999998776 7899999999999999999999999999999999999999999999999999875432100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC---CCCcchhHHhHHHHHHHH
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~---~y~~~~DiwSlGvil~el 350 (497)
.....+|++.|+|||.+.+. .++.++|+|||||++|+|
T Consensus 157 ---------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~ 197 (262)
T cd06613 157 ---------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIEL 197 (262)
T ss_pred ---------------------------------------ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHH
Confidence 01135789999999999876 889999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCc-ccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCC
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTH-LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpf 416 (497)
++|.+||.+.+.......+...... ........++.++++||.+||+ +|.+||+ +.+|+.|||
T Consensus 198 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~~~~ 262 (262)
T cd06613 198 AELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT---ATKLLQHPF 262 (262)
T ss_pred HhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCC---HHHHhcCCC
Confidence 9999999987766655544432111 1111123567889999999999 9999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=342.49 Aligned_cols=259 Identities=30% Similarity=0.531 Sum_probs=219.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechh--hhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--CeE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE--MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFL 191 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~--~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~l 191 (497)
.+|++.+.||+|+||.||+|.++.+++.||+|++.... .........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 57999999999999999999999999999999986432 11233456788999999999999999999998764 568
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
++||||++|++|.+++...+.+++..+..++.+++.||.|||+.|++||||||+||+++.++.++|+|||+++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 99999999999999998878899999999999999999999999999999999999999999999999999986532100
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
... ......||+.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 ~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 203 (264)
T cd06653 162 SGT--------------------------------------GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEML 203 (264)
T ss_pred cCc--------------------------------------cccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHH
Confidence 000 001356899999999999888999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCc
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff 417 (497)
+|.+||..........++........+|. .++.++.++|.+||.+|..||+ +.+++.|||.
T Consensus 204 ~g~~p~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~~i~~~l~~~~~r~~---~~~~~~~~~~ 264 (264)
T cd06653 204 TEKPPWAEYEAMAAIFKIATQPTKPMLPD--GVSDACRDFLKQIFVEEKRRPT---AEFLLRHPFV 264 (264)
T ss_pred hCCCCCCccCHHHHHHHHHcCCCCCCCCc--ccCHHHHHHHHHHhcCcccCcc---HHHHhcCCCC
Confidence 99999988777666666654333344554 7899999999999998899998 8899999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=342.55 Aligned_cols=253 Identities=33% Similarity=0.535 Sum_probs=217.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++.+.||.|+||.||+|..+.++..||+|.+..... ...+.+|+++++.++||||+++++.+.+...+|+|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence 3679999999999999999999999899999999976532 56788999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||+++++|.+++.. ...+++..+..++.+++.||.|||+.|++||||+|+||+++.++.++|+|||++........
T Consensus 77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-- 154 (256)
T cd06612 77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-- 154 (256)
T ss_pred EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--
Confidence 999999999999865 45789999999999999999999999999999999999999999999999999886532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
......|++.|+|||++.+..++.++|||||||++|+|++|
T Consensus 155 ---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g 195 (256)
T cd06612 155 ---------------------------------------KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEG 195 (256)
T ss_pred ---------------------------------------ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhC
Confidence 01134589999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
.+||...+.......+.... ...+.....++.++.+||.+||. ||.+||+ +.+++.||||
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps---~~~il~~~~~ 256 (256)
T cd06612 196 KPPYSDIHPMRAIFMIPNKP-PPTLSDPEKWSPEFNDFVKKCLVKDPEERPS---AIQLLQHPFI 256 (256)
T ss_pred CCCCCCcchhhhhhhhccCC-CCCCCchhhcCHHHHHHHHHHHhcChhhCcC---HHHHhcCCCC
Confidence 99998876655544443321 11222223678899999999999 9999999 9999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.55 Aligned_cols=260 Identities=28% Similarity=0.464 Sum_probs=216.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc---hhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR---RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~---~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
+|+..+.||+|+||.||+|.+..+++.||+|++....... ......+..|+.+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4788899999999999999999999999999997543211 2235678899999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-cEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~ 272 (497)
||||++|++|.+++.+.+++++..+..++.|++.||.|||+.|++||||+|+||+++.++ .+||+|||++..+......
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998888999999999999999999999999999999999999998876 5999999998766432100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.. ......+||..|+|||++.+..++.++|+|||||++|+|++
T Consensus 161 ~~-------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 203 (268)
T cd06630 161 AG-------------------------------------EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203 (268)
T ss_pred CC-------------------------------------ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHh
Confidence 00 00013468999999999998899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHH---hcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 353 GYPPFYSDDPMSTCRKI---VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i---~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
|.+||...+.......+ ........+| ..+++++.++|.+||. +|.+||+ +.++++||||+
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~---~~~ll~~~~~~ 268 (268)
T cd06630 204 AKPPWNAEKHSNHLALIFKIASATTAPSIP--EHLSPGLRDVTLRCLELQPEDRPP---SRELLKHPVFR 268 (268)
T ss_pred CCCCCCCCCCcchHHHHHHHhccCCCCCCc--hhhCHHHHHHHHHHcCCCcccCcC---HHHHhcCcccC
Confidence 99999765433333222 2212222333 3688999999999998 9999998 99999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=346.89 Aligned_cols=261 Identities=30% Similarity=0.506 Sum_probs=215.4
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeec
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD 187 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~ 187 (497)
.......++|.+...||+|+||.||+|..+.+++.||+|++.... .....+..|+.++..+ +||||++++++|..
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 334445788999999999999999999999999999999986542 1234567899999888 89999999998875
Q ss_pred C-----CeEEEEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEc
Q 010947 188 D-----EFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (497)
Q Consensus 188 ~-----~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~ 258 (497)
. ..+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence 3 368999999999999998753 4579999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-----C
Q 010947 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-----G 333 (497)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-----~ 333 (497)
|||++......... ....+|++.|+|||++... .
T Consensus 171 dfg~~~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~ 209 (291)
T cd06639 171 DFGVSAQLTSTRLR-----------------------------------------RNTSVGTPFWMAPEVIACEQQYDYS 209 (291)
T ss_pred ecccchhccccccc-----------------------------------------ccCccCCccccChhhhcCCCCcccc
Confidence 99998765321100 0134689999999998643 3
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 334 YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 334 y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
++.++|||||||++|||++|.+||...+.......+..+. ...+.....++.++++||.+||. +|.+||+ +.+|+
T Consensus 210 ~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~il 285 (291)
T cd06639 210 YDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNP-PPTLLHPEKWCRSFNHFISQCLIKDFEARPS---VTHLL 285 (291)
T ss_pred cCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCC-CCCCCcccccCHHHHHHHHHHhhcChhhCcC---HHHHh
Confidence 6899999999999999999999999887766666665432 11222223577899999999999 9999999 99999
Q ss_pred CCCCcc
Q 010947 413 VHPWFD 418 (497)
Q Consensus 413 ~Hpff~ 418 (497)
+||||+
T Consensus 286 ~~~~~~ 291 (291)
T cd06639 286 EHPFIK 291 (291)
T ss_pred cCcccC
Confidence 999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=352.74 Aligned_cols=258 Identities=29% Similarity=0.502 Sum_probs=222.5
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|.++..||+|+||.||+|.++.+|+++|||.+... .....+..|+.||.++++|++|+.|++|.....+++||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY 109 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY 109 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence 77888999999999999999999999999987643 3455688899999999999999999999999999999999
Q ss_pred cCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 198 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|..|+..+.+.- +.+|+|.++..++...+.||+|||...-||||||..|||++.+|+.||+|||.|-.+.....
T Consensus 110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA----- 184 (502)
T KOG0574|consen 110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA----- 184 (502)
T ss_pred cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-----
Confidence 999999999864 56899999999999999999999999999999999999999999999999999976532100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
+ .++..|||.|||||++..-+|+..+||||||+...||..|+||
T Consensus 185 ------------------------------K------RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PP 228 (502)
T KOG0574|consen 185 ------------------------------K------RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPP 228 (502)
T ss_pred ------------------------------h------hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCC
Confidence 0 1267899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhh
Q 010947 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 425 (497)
|.+-.+...+..|-.. .+..|-.....|.++.|||++||. +|++|-+ |.++++|||.++-.-..+
T Consensus 229 YsDIHPMRAIFMIPT~-PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~T---A~~L~~H~FiknA~g~~I 294 (502)
T KOG0574|consen 229 YSDIHPMRAIFMIPTK-PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKT---ALRLCEHTFIKNAPGCDI 294 (502)
T ss_pred cccccccceeEeccCC-CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHH---HHHHhhhhhhcCCCcccH
Confidence 9887776554444321 233333334678999999999998 9999988 999999999987654444
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=366.75 Aligned_cols=256 Identities=22% Similarity=0.316 Sum_probs=209.4
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEE
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 184 (497)
+.+..++|++.+.||+|+||.||+|.+..+ +..||||+++.... ......+..|+.+++.+ +|||||+++++
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~ 110 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGA 110 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence 345567899999999999999999986544 35799999976432 23456688999999999 89999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhc------------------------------------------------------
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~------------------------------------------------------ 210 (497)
|.+...+|+|||||++|+|.+++...
T Consensus 111 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (374)
T cd05106 111 CTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSS 190 (374)
T ss_pred ecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccc
Confidence 99999999999999999999998542
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 211 ----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 211 ----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
.++++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+.+......
T Consensus 191 ~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~-- 268 (374)
T cd05106 191 SSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY-- 268 (374)
T ss_pred ccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce--
Confidence 24788899999999999999999999999999999999999999999999999865322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-C
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-G 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G 353 (497)
.......+++.|+|||++.+..|+.++|||||||++|||++ |
T Consensus 269 -------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G 311 (374)
T cd05106 269 -------------------------------------VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLG 311 (374)
T ss_pred -------------------------------------eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCC
Confidence 00012345678999999999999999999999999999997 9
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
.+||.+........+++........| ..+++++++||.+||+ ||.+||+ +.+|.
T Consensus 312 ~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs---~~~l~ 366 (374)
T cd05106 312 KSPYPGILVNSKFYKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERPT---FSQIS 366 (374)
T ss_pred CCCCccccccHHHHHHHHcccCccCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHH
Confidence 99998876655555555432233333 3578999999999999 9999999 66664
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=371.46 Aligned_cols=253 Identities=24% Similarity=0.287 Sum_probs=205.6
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
...|.+.+.||+|+||.||+|.+..+++.||||.... ..+.+|+.+|+.++|||||++++++......|+|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 4579999999999999999999999999999996432 2256799999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||++ .|+|..++... ..+++..++.++.||+.||.|||+.|||||||||+|||++.++.+||+|||+++.+......
T Consensus 239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~- 316 (461)
T PHA03211 239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST- 316 (461)
T ss_pred EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc-
Confidence 9999 47888887653 57999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
......+||+.|+|||++.+..++.++|||||||+||||++|
T Consensus 317 --------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g 358 (461)
T PHA03211 317 --------------------------------------PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVH 358 (461)
T ss_pred --------------------------------------ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHc
Confidence 001146799999999999999999999999999999999998
Q ss_pred CCCCCCCCh-------HHHHHHHhcccCc--ccCCC-----------------------------CccCChhHHHHHHHH
Q 010947 354 YPPFYSDDP-------MSTCRKIVNWRTH--LKFPE-----------------------------EAKLSIEAKDLISKL 395 (497)
Q Consensus 354 ~~PF~~~~~-------~~~~~~i~~~~~~--~~~p~-----------------------------~~~~s~~~~dLI~~l 395 (497)
..|+.+... .....+++..... ..+|. ...++.++.+||.+|
T Consensus 359 ~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 438 (461)
T PHA03211 359 TASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRA 438 (461)
T ss_pred CCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHH
Confidence 877654221 1222233221100 01110 013567899999999
Q ss_pred hh-CccccCCCCCcchhcCCCCccC
Q 010947 396 LC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 396 L~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|. ||.+||+ +.|+|+||||+.
T Consensus 439 L~~DP~~RPs---a~elL~hp~f~~ 460 (461)
T PHA03211 439 LTFDGARRPS---AAELLRLPLFQS 460 (461)
T ss_pred cccChhhCcC---HHHHhhCcccCC
Confidence 99 9999999 999999999974
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=352.33 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=215.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--CeE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFL 191 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~l 191 (497)
..++|++.+.||.|+||.||+|.++.+|..||+|+++..... ......+.+|+.+++.++|+||+++++++.+. +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 457899999999999999999999999999999998754321 22223456799999999999999999998765 568
Q ss_pred EEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 192 YLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 99999996 578888765 4679999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~e 349 (497)
. ......+++.|+|||++.+ ..++.++|+|||||++||
T Consensus 163 ~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~e 201 (309)
T cd07845 163 K-----------------------------------------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201 (309)
T ss_pred C-----------------------------------------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHH
Confidence 0 0012346889999999875 568999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccC-----------------cccCCCC---------ccCChhHHHHHHHHhh-Ccccc
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRT-----------------HLKFPEE---------AKLSIEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~~---------~~~s~~~~dLI~~lL~-dp~~R 402 (497)
|++|.+||.+.+..+.+..+.+... ...++.. ..+++++.+||.+||+ ||++|
T Consensus 202 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 281 (309)
T cd07845 202 LLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281 (309)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhC
Confidence 9999999999888887777664211 0111110 2368899999999999 99999
Q ss_pred CCCCCcchhcCCCCccCC
Q 010947 403 LGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 403 ~~~~~~~eil~Hpff~~i 420 (497)
|+ +.+++.||||++.
T Consensus 282 ~t---~~~il~h~~f~~~ 296 (309)
T cd07845 282 AT---AEEALESSYFKEK 296 (309)
T ss_pred cC---HHHHhcChhhccC
Confidence 99 9999999999854
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=365.18 Aligned_cols=247 Identities=22% Similarity=0.382 Sum_probs=211.1
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
+.+..+.+.+++.||+|-||+|++|.++.+ ..||+|.++...+ ..+.+.+|+.+|++++|++||+|++++..+..
T Consensus 201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 201 WEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCc
Confidence 344455577788999999999999998643 3799999986533 23457899999999999999999999999889
Q ss_pred EEEEEeecCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 191 LYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+|||||||+.|+|.++|.. ...+...+...+++||+.|++||+++++|||||...|||++.++.+||+|||||+....
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 9999999999999999987 46799999999999999999999999999999999999999999999999999995543
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
+..... ...--..-|.|||.+....++.++|||||||+||
T Consensus 356 ~~Y~~~----------------------------------------~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~ 395 (468)
T KOG0197|consen 356 DEYTAS----------------------------------------EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLW 395 (468)
T ss_pred Cceeec----------------------------------------CCCCCCceecCHHHHhhCCcccccceeehhhhHH
Confidence 322110 0111234699999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC
Q 010947 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 349 ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
||+| |+.||.+.+..+..+.+-.+ ..++-| ..|++++.+++..|+. +|++||+.
T Consensus 396 E~fT~G~~py~~msn~ev~~~le~G-yRlp~P--~~CP~~vY~lM~~CW~~~P~~RPtF 451 (468)
T KOG0197|consen 396 ELFTYGRVPYPGMSNEEVLELLERG-YRLPRP--EGCPDEVYELMKSCWHEDPEDRPTF 451 (468)
T ss_pred HHhccCCCCCCCCCHHHHHHHHhcc-CcCCCC--CCCCHHHHHHHHHHhhCCcccCCCH
Confidence 9998 99999999999999888753 444444 5899999999999999 99999993
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=341.98 Aligned_cols=259 Identities=30% Similarity=0.480 Sum_probs=220.9
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|.+.+.||+|+||.||+|....++..||+|+++..... ......+..|+.+++.++|+||+++++.+.+.+.+++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 488999999999999999999989999999999866432 4567789999999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|+++++|.+++.....+++..+..++.+++.||.|||+.||+|+||+|+||+++.++.+||+|||++............
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~- 158 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGE- 158 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccc-
Confidence 9999999999988778999999999999999999999999999999999999999999999999999876432110000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC---CCcchhHHhHHHHHHHHHhC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~---y~~~~DiwSlGvil~ell~G 353 (497)
......|++.|+|||++.... ++.++|+|||||++|+|++|
T Consensus 159 ------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g 202 (264)
T cd06626 159 ------------------------------------EVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202 (264)
T ss_pred ------------------------------------cccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhC
Confidence 011356889999999998766 89999999999999999999
Q ss_pred CCCCCCCChHH-HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 354 YPPFYSDDPMS-TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 354 ~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
..||.+.+... ....+.. .....+|....+++.+.+||.+||. +|.+||+ +.+++.|||+
T Consensus 203 ~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~---~~~i~~~~~~ 264 (264)
T cd06626 203 KRPWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT---ASELLQHPFV 264 (264)
T ss_pred CCCccCCcchHHHHHHHhc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCC---HHHHhcCCCC
Confidence 99997664333 3333332 3455566655679999999999998 9999998 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=339.68 Aligned_cols=253 Identities=30% Similarity=0.505 Sum_probs=221.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|+++++||.|+||.||.++...++..+|+|.+..... .......+.+|+.+++.++|+||++++++|.+.+.+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 58999999999999999999999999999999875432 23445668899999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 197 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|++||+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||+|+||+++.++.+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 156 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--- 156 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc---
Confidence 99999999999764 4689999999999999999999999999999999999999999999999999976532210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
......||+.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08221 157 --------------------------------------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198 (256)
T ss_pred --------------------------------------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCC
Confidence 011357899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
.||.+.+..+....+...... ..+ ..++.++.++|.+||+ +|.+||+ +.++++|||+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~i~~~l~~~p~~R~s---~~~ll~~~~l 256 (256)
T cd08221 199 RTFDATNPLNLVVKIVQGNYT-PVV--SVYSSELISLVHSLLQQDPEKRPT---ADEVLDQPLL 256 (256)
T ss_pred CCCCCCCHHHHHHHHHcCCCC-CCc--cccCHHHHHHHHHHcccCcccCCC---HHHHhhCcCC
Confidence 999998888888777653211 122 4688999999999998 9999998 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=344.73 Aligned_cols=253 Identities=17% Similarity=0.270 Sum_probs=211.1
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
+...+|++.+.||+|+||.||+|..+ ..+..||+|+++... .......+.+|+.++..++||||+++++++...+
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 79 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGN 79 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCC
Confidence 45568999999999999999999875 346689999997642 2334566889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999998764 5799999999999999999999999999999999999999999999999998764321
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
.... ......+++.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 199 (266)
T cd05064 160 EAIY----------------------------------------TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMW 199 (266)
T ss_pred cchh----------------------------------------cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHH
Confidence 1000 001234677899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 349 ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
||++ |.+||.+.+..+....+... .. .|....++..+.++|.+|+. +|.+||+ +++|++
T Consensus 200 ell~~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~li~~c~~~~p~~RP~---~~~i~~ 260 (266)
T cd05064 200 EVMSYGERPYWDMSGQDVIKAVEDG-FR--LPAPRNCPNLLHQLMLDCWQKERGERPR---FSQIHS 260 (266)
T ss_pred HHhcCCCCCcCcCCHHHHHHHHHCC-CC--CCCCCCCCHHHHHHHHHHcCCCchhCCC---HHHHHH
Confidence 9775 99999988877777766542 22 23334788999999999999 9999999 766653
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-44 Score=351.44 Aligned_cols=257 Identities=31% Similarity=0.512 Sum_probs=215.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||.||+|.++.+++.||+|++.+.... ....+.+.+|+.+++.++||||++++++|.++...|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4699999999999999999999999999999998765432 233456788999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||+++++|..+......+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++..+.....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---- 155 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---- 155 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc----
Confidence 9999999988877666799999999999999999999999999999999999999999999999999876532210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G~ 354 (497)
......|++.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 156 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~ 198 (286)
T cd07846 156 -------------------------------------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGE 198 (286)
T ss_pred -------------------------------------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCC
Confidence 0113468999999999875 45788999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcc-----------------cCCC----------CccCChhHHHHHHHHhh-CccccCCCC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHL-----------------KFPE----------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~-----------------~~p~----------~~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
+||.+.+..+....+..+...+ ..|. ...++..+.+||.+||. +|.+||+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~-- 276 (286)
T cd07846 199 PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS-- 276 (286)
T ss_pred CCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh--
Confidence 9998877655544444211110 1111 13578899999999999 9999999
Q ss_pred CcchhcCCCCc
Q 010947 407 GADEIKVHPWF 417 (497)
Q Consensus 407 ~~~eil~Hpff 417 (497)
+.+++.||||
T Consensus 277 -~~~il~~~~~ 286 (286)
T cd07846 277 -SSQLLHHEFF 286 (286)
T ss_pred -HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=340.66 Aligned_cols=254 Identities=31% Similarity=0.553 Sum_probs=217.7
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhh--hchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
+|+..+.||+|+||+||+|....++..||+|.+..... ........+..|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 46778899999999999999988999999999876432 1223456788999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||++|++|.+++.+...+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~--- 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF--- 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccc---
Confidence 99999999999998888899999999999999999999999999999999999999999999999999876532110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC-CCcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-y~~~~DiwSlGvil~ell~G 353 (497)
.....|++.|+|||.+.... ++.++|+|||||++|+|++|
T Consensus 158 ---------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g 198 (258)
T cd06632 158 ---------------------------------------AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATG 198 (258)
T ss_pred ---------------------------------------ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhC
Confidence 01356899999999998766 89999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
.+||..........++........+|. .+++++++||.+||. +|.+||+ +.+++.|||+
T Consensus 199 ~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~~~~ 258 (258)
T cd06632 199 KPPWSQLEGVAAVFKIGRSKELPPIPD--HLSDEAKDFILKCLQRDPSLRPT---AAELLEHPFV 258 (258)
T ss_pred CCCcccCcHHHHHHHHHhcccCCCcCC--CcCHHHHHHHHHHhhcCcccCcC---HHHHhcCCCC
Confidence 999987765555555543222333343 688999999999999 9999998 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=354.60 Aligned_cols=249 Identities=24% Similarity=0.435 Sum_probs=191.7
Q ss_pred eEeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee--cCCeEEEEEee
Q 010947 122 TMIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFLYLIMEY 197 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~l~lVmEy 197 (497)
..||+|+||+||+|+.+. ++..||+|.+..... ...+.+|+.+|+.++||||++++++|. ++..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 579999999999999754 567899999875432 234678999999999999999999885 45688999999
Q ss_pred cCCCchhHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee----cCCCcEEEccccccc
Q 010947 198 LPGGDMMTLLMR---------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCK 264 (497)
Q Consensus 198 ~~gg~L~~~l~~---------~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl----~~~g~vkL~DFGla~ 264 (497)
++ ++|.+++.. ...+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+|+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 96 577777642 1258899999999999999999999999999999999999 567899999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSl 343 (497)
.......... .....+||+.|+|||++.+ ..++.++|||||
T Consensus 161 ~~~~~~~~~~--------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 202 (317)
T cd07867 161 LFNSPLKPLA--------------------------------------DLDPVVVTFWYRAPELLLGARHYTKAIDIWAI 202 (317)
T ss_pred ccCCCccccc--------------------------------------ccCcceecccccCcHHhcCCCccCcHHHHHhH
Confidence 6542210000 0114579999999999976 458999999999
Q ss_pred HHHHHHHHhCCCCCCCCChH---------HHHHHHhc---------ccC---cccCC----------------------C
Q 010947 344 GAIMYEMLVGYPPFYSDDPM---------STCRKIVN---------WRT---HLKFP----------------------E 380 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~---------~~~~~i~~---------~~~---~~~~p----------------------~ 380 (497)
||++|||++|.+||...... ....++.. |.. ...++ .
T Consensus 203 G~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (317)
T cd07867 203 GCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKH 282 (317)
T ss_pred HHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcc
Confidence 99999999999999754321 11111110 000 00000 0
Q ss_pred CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 381 EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 381 ~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
....+..+.+||.+||+ ||.+||+ ++|+++||||
T Consensus 283 ~~~~~~~~~~ll~~~l~~dP~~R~t---~~e~l~hp~f 317 (317)
T cd07867 283 KVKPDSKVFLLLQKLLTMDPTKRIT---SEQALQDPYF 317 (317)
T ss_pred cCCCChHHHHHHHHHhccCcccccC---HHHHhcCCCC
Confidence 11245678999999999 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=350.33 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=217.0
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|++++.||+|+||+||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 4567999999999999999999999999999999987542 23345678899999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||+++|+|..++...+.+++..+..++.+++.||.|||+ .|++||||||+||+++.++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-- 158 (284)
T ss_pred EEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence 99999999999999887889999999999999999999997 699999999999999999999999999986432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
....+||..|+|||++.+..++.++|+|||||++|+|++
T Consensus 159 -----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~t 197 (284)
T cd06620 159 -----------------------------------------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELAL 197 (284)
T ss_pred -----------------------------------------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHh
Confidence 013579999999999988899999999999999999999
Q ss_pred CCCCCCCCChH-----------HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 353 GYPPFYSDDPM-----------STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 353 G~~PF~~~~~~-----------~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|..||...... +....+... ....++. ..++.++.+||.+||. ||.+||+ +.|+++||||..
T Consensus 198 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~dp~~Rpt---~~e~~~~~~~~~ 271 (284)
T cd06620 198 GKFPFAFSNIDDDGQDDPMGILDLLQQIVQE-PPPRLPS-SDFPEDLRDFVDACLLKDPTERPT---PQQLCAMPPFIQ 271 (284)
T ss_pred CCCCCcccchhhhhhhhhhHHHHHHHHHhhc-cCCCCCc-hhcCHHHHHHHHHHhcCCcccCcC---HHHHhcCccccc
Confidence 99999875542 223333321 1222222 2378899999999999 9999999 999999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=350.77 Aligned_cols=259 Identities=31% Similarity=0.493 Sum_probs=215.9
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc--hhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR--RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
+|++.+.||+|+||.||+|.+..+|+.||||++....... ......+..|+.+++.++|+||+++++++.+.+.+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4888999999999999999999999999999998765331 22344577899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||+ +|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||+++........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~- 158 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK- 158 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc-
Confidence 9999 999999997766 7999999999999999999999999999999999999999999999999999865422100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
.....+++.|+|||.+.+ ..++.++|+|||||++|||++
T Consensus 159 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~ 198 (298)
T cd07841 159 ----------------------------------------MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL 198 (298)
T ss_pred ----------------------------------------ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHc
Confidence 012357889999999865 567999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCc------------------ccCCC------CccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTH------------------LKFPE------EAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~------------------~~~p~------~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
|.+||.+.+..+.+.++...... ...+. ...++.++.+||.+||. ||.+||+
T Consensus 199 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s--- 275 (298)
T cd07841 199 RVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT--- 275 (298)
T ss_pred CCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcC---
Confidence 99999888776666555421000 00000 12457889999999999 9999998
Q ss_pred cchhcCCCCccCC
Q 010947 408 ADEIKVHPWFDGV 420 (497)
Q Consensus 408 ~~eil~Hpff~~i 420 (497)
+.+++.||||.+.
T Consensus 276 ~~e~l~~~~~~~~ 288 (298)
T cd07841 276 ARQALEHPYFSND 288 (298)
T ss_pred HHHHhhCccccCC
Confidence 9999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=371.71 Aligned_cols=249 Identities=32% Similarity=0.568 Sum_probs=218.8
Q ss_pred EeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCc
Q 010947 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGD 202 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~ 202 (497)
+||+|+||+||-|+++.|....|||.+.... .....-+..|+.+.+.++|.|||+..|++..+.++-|.||-+|||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 7999999999999999999999999986433 3344558889999999999999999999999999999999999999
Q ss_pred hhHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-CCcEEEcccccccccCCCCcccccccc
Q 010947 203 MMTLLMRK-DTL--TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (497)
Q Consensus 203 L~~~l~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~ 278 (497)
|.++|..+ +++ .|....||..||+.||.|||.+.|||||||-+|+|++. .|.+||+|||-||.+..-+.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP------- 731 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP------- 731 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-------
Confidence 99999775 778 88999999999999999999999999999999999975 68999999999998742110
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
.+.++.||..|||||++.. .+|+.++|||||||++.||.||+||
T Consensus 732 ----------------------------------~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPP 777 (1226)
T KOG4279|consen 732 ----------------------------------CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPP 777 (1226)
T ss_pred ----------------------------------cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCC
Confidence 1236789999999999985 5799999999999999999999999
Q ss_pred CCCC-ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 357 FYSD-DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 357 F~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|... +++...-++--.+.+.++|+ .+|.+++.||.+|.. ||.+||+ |.++|..||++.-
T Consensus 778 F~ElgspqAAMFkVGmyKvHP~iPe--elsaeak~FilrcFepd~~~R~s---A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 778 FVELGSPQAAMFKVGMYKVHPPIPE--ELSAEAKNFILRCFEPDPCDRPS---AKDLLQDPFLQHN 838 (1226)
T ss_pred eeecCChhHhhhhhcceecCCCCcH--HHHHHHHHHHHHHcCCCcccCcc---HHHhccCcccccC
Confidence 9865 45555566666667777886 799999999999999 9999999 9999999999854
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=346.99 Aligned_cols=259 Identities=30% Similarity=0.495 Sum_probs=212.3
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEee--
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ-- 186 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~-- 186 (497)
......++|++++.||+|+||.||+|.++.+++.||+|++.... .....+..|+.++..+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 34456789999999999999999999999999999999986532 1224577899999998 7999999999873
Q ss_pred ---cCCeEEEEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcc
Q 010947 187 ---DDEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSD 259 (497)
Q Consensus 187 ---~~~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~D 259 (497)
+...+|+||||++||+|.+++.. ...+++..+..++.+++.||.|||+.+|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 45679999999999999988752 35689999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----CCC
Q 010947 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGY 334 (497)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~y 334 (497)
||+++.+...... ....+||+.|+|||++.. ..+
T Consensus 168 fg~~~~~~~~~~~-----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~ 206 (286)
T cd06638 168 FGVSAQLTSTRLR-----------------------------------------RNTSVGTPFWMAPEVIACEQQLDSTY 206 (286)
T ss_pred CCceeecccCCCc-----------------------------------------cccccCCCcccChhhhchhhhccccc
Confidence 9998865321100 113569999999999853 458
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 335 ~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+.++|||||||++|||++|.+||...+......++.... .........++.++.+||.+||+ ||.+||+ +.+|+.
T Consensus 207 ~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~ell~ 282 (286)
T cd06638 207 DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNP-PPTLHQPELWSNEFNDFIRKCLTKDYEKRPT---VSDLLQ 282 (286)
T ss_pred cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccC-CCcccCCCCcCHHHHHHHHHHccCCcccCCC---HHHHhh
Confidence 899999999999999999999998876655544443221 11121223567899999999999 9999999 999999
Q ss_pred CCCc
Q 010947 414 HPWF 417 (497)
Q Consensus 414 Hpff 417 (497)
||||
T Consensus 283 ~~~~ 286 (286)
T cd06638 283 HVFI 286 (286)
T ss_pred cccC
Confidence 9997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=346.82 Aligned_cols=255 Identities=31% Similarity=0.507 Sum_probs=211.7
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeec----
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD---- 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~---- 187 (497)
.....|++.+.||.|+||.||+|.+..+++.||+|++.... .....+..|+.++..+ +||||++++++|..
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 34568999999999999999999999999999999986542 2345577899999888 79999999999853
Q ss_pred --CCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 188 --DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 188 --~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 46789999999999999998653 45889999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcch
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMEC 338 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~ 338 (497)
........ .....+|++.|+|||++. ...++.++
T Consensus 169 ~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~ 207 (282)
T cd06636 169 AQLDRTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDENPDATYDYRS 207 (282)
T ss_pred hhhhcccc-----------------------------------------CCCcccccccccCHhhcCcccCcCcCCCccc
Confidence 75431100 011457999999999986 35688899
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 339 DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|+|||||++|||++|.+||....+......+... ...... ...++.++.+||.+||. ||.+||+ +.+|+.||||
T Consensus 208 DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~cl~~~p~~Rp~---~~ell~~~~~ 282 (282)
T cd06636 208 DIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLK-SKKWSKKFIDFIEGCLVKNYLSRPS---TEQLLKHPFI 282 (282)
T ss_pred chhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC-CCCCCc-ccccCHHHHHHHHHHhCCChhhCcC---HHHHhcCCCC
Confidence 9999999999999999999887665555444331 111111 23578999999999999 9999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=346.68 Aligned_cols=274 Identities=40% Similarity=0.724 Sum_probs=227.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lV 194 (497)
++|.+.+.||+|+||.||+|..+.+|+.||+|++.+...........+..|..++..+. ||||++++++|.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998866555555677889999999998 99999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|++|+||+|+||+++.+|+++|+|||++...........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999999986643221100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
...... ....... ..........|++.|+|||++....++.++|+|||||++|++++|.
T Consensus 161 ~~~~~~-------~~~~~~~--------------~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~ 219 (280)
T cd05581 161 NKGDAT-------NIDSQIE--------------KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219 (280)
T ss_pred CCCCCc-------ccccccc--------------ccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCC
Confidence 000000 0000000 0000112457899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCc----chhcCCCCc
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA----DEIKVHPWF 417 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~----~eil~Hpff 417 (497)
+||...+....+..+.. ....+|. .+++.+.+||.+||. +|.+||+ + +++++||||
T Consensus 220 ~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~---~~~~~~~ll~~~~~ 280 (280)
T cd05581 220 PPFRGSNEYLTFQKILK--LEYSFPP--NFPPDAKDLIEKLLVLDPQDRLG---VNEGYDELKAHPFF 280 (280)
T ss_pred CCCCCccHHHHHHHHHh--cCCCCCC--ccCHHHHHHHHHHhcCCHhhCCC---cccCHHHHhcCCCC
Confidence 99998887777777663 3344553 678999999999999 9999999 7 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=358.84 Aligned_cols=262 Identities=29% Similarity=0.469 Sum_probs=213.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 188 (497)
.++|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+..|+.+++.++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 467999999999999999999999999999999986532 1233445677899999999999999999988654
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+|+||||+. ++|...+... +++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 35799999995 5888877543 99999999999999999999999999999999999999999999999999976532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 171 ~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~ 208 (353)
T cd07850 171 SFM------------------------------------------MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (353)
T ss_pred CCC------------------------------------------CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHH
Confidence 110 11356899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCc----------------------------------ccCCC-----CccCChhHH
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTH----------------------------------LKFPE-----EAKLSIEAK 389 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~----------------------------------~~~p~-----~~~~s~~~~ 389 (497)
+|++|..||.+.+....+.+++..-.. ..+|. ....+.+++
T Consensus 209 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (353)
T cd07850 209 EMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR 288 (353)
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHH
Confidence 999999999987765555544321000 00110 113466789
Q ss_pred HHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhh
Q 010947 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 390 dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 427 (497)
+||.+||+ ||.+||+ +.|+|.||||+ .|-....
T Consensus 289 ~li~~~L~~dP~~R~t---~~eiL~~~~~~--~~~~~~~ 322 (353)
T cd07850 289 DLLSKMLVIDPEKRIS---VDDALQHPYIN--VWYDPSE 322 (353)
T ss_pred HHHHHHcCCChhhCcC---HHHHhcChhHh--hccCCcc
Confidence 99999999 9999999 99999999998 3444433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=346.10 Aligned_cols=257 Identities=30% Similarity=0.492 Sum_probs=215.4
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++.+.||.|+||.||+|.+..+|..||+|++...... ......+.+|+.+++.++||||+++++++.+...+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 589999999999999999999999999999999865422 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 197 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|+ |++|.+++.. ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.........
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~--- 155 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR--- 155 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC---
Confidence 99 9999999865 457999999999999999999999999999999999999999999999999999865422100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~G~ 354 (497)
......||+.|+|||++.+. .++.++|||||||++|||++|.
T Consensus 156 -------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 198 (286)
T cd07832 156 -------------------------------------LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198 (286)
T ss_pred -------------------------------------ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence 01135689999999998754 4689999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccC-----------------cccCCCC---------ccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 355 PPFYSDDPMSTCRKIVNWRT-----------------HLKFPEE---------AKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~~---------~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
+||.+.+....+..++..-. .+.++.. ..++.++.+||.+||. +|.+||+
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~--- 275 (286)
T cd07832 199 PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS--- 275 (286)
T ss_pred cCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC---
Confidence 99988877666655543110 1111110 2467899999999999 9999999
Q ss_pred cchhcCCCCcc
Q 010947 408 ADEIKVHPWFD 418 (497)
Q Consensus 408 ~~eil~Hpff~ 418 (497)
+++++.||||.
T Consensus 276 ~~~~l~h~~~~ 286 (286)
T cd07832 276 AAEALRHPYFT 286 (286)
T ss_pred HHHHhhCcCcC
Confidence 99999999994
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=380.14 Aligned_cols=285 Identities=25% Similarity=0.360 Sum_probs=210.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCC-cEEEEE--------------EeechhhhchhHHHHHHHHHHHHHhcCCCcee
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTG-HVYAMK--------------KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~-~~~AiK--------------~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv 179 (497)
.++|++++.||+|+||+||+|..+... ..++.| ++.+...........+.+|+.+|..++|||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 468999999999999999999865432 222222 11111111122345678999999999999999
Q ss_pred EEEEEeecCCeEEEEEeecCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc
Q 010947 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (497)
Q Consensus 180 ~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~ 254 (497)
++++++.+.+..|+|||++ +++|..++... .......++.++.||+.||.|||++|||||||||+|||++.+|.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 46777776432 23456778899999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC
Q 010947 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (497)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y 334 (497)
+||+|||+|+.+..... ......+||+.|+|||++.+..|
T Consensus 306 vkL~DFGla~~~~~~~~----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~ 345 (501)
T PHA03210 306 IVLGDFGTAMPFEKERE----------------------------------------AFDYGWVGTVATNSPEILAGDGY 345 (501)
T ss_pred EEEEeCCCceecCcccc----------------------------------------cccccccCCcCCCCchhhcCCCC
Confidence 99999999986542210 00124689999999999999999
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCC-C--ChHHHHHHHhcccC--cccCCC--------------------------Ccc
Q 010947 335 GMECDWWSLGAIMYEMLVGYPPFYS-D--DPMSTCRKIVNWRT--HLKFPE--------------------------EAK 383 (497)
Q Consensus 335 ~~~~DiwSlGvil~ell~G~~PF~~-~--~~~~~~~~i~~~~~--~~~~p~--------------------------~~~ 383 (497)
+.++|||||||++|||++|..|+.+ . ++...+.+++.... ...+|. ...
T Consensus 346 ~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 425 (501)
T PHA03210 346 CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLG 425 (501)
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcC
Confidence 9999999999999999998765432 2 22233333322100 011111 123
Q ss_pred CChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhc---------CCCcccccCCccccc
Q 010947 384 LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQM---------EAAFIPEVNDELDTQ 443 (497)
Q Consensus 384 ~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~---------~~p~~p~~~~~~d~~ 443 (497)
++.++.++|.+||+ ||.+||+ +.|++.||||.+.++..+..+ ..|+.|.+..+.|+.
T Consensus 426 ~~~~~~~li~kmL~~DP~~Rps---a~elL~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 492 (501)
T PHA03210 426 LPADFEYPLVKMLTFDWHLRPG---AAELLALPLFSAEEEEEILFIHGLKSGAAHFKPIKPACRIESDTA 492 (501)
T ss_pred CChHHHHHHHHHhccCcccCcC---HHHHhhChhhhcCCchHHHHHHhhhccccccccCCchheeccccc
Confidence 56788899999999 9999999 999999999999887766432 235666655554443
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=338.77 Aligned_cols=253 Identities=28% Similarity=0.520 Sum_probs=219.8
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++.+.||+|+||.||++....+|+.||+|.+...... ......+.+|+.+++.++||||+++++.|.+.+..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 589999999999999999999999999999999765432 3344578899999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 197 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|++|++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+|||++.++.++|+|||++........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~--- 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--- 156 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh---
Confidence 99999999998654 3589999999999999999999999999999999999999999999999999876532100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
......|++.|+|||++.+..++.++|+|||||++|+|++|.
T Consensus 157 --------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~ 198 (256)
T cd08218 157 --------------------------------------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLK 198 (256)
T ss_pred --------------------------------------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCC
Confidence 001346899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
.||...+..+....++... ....| ..++.++.++|.+||. +|.+||+ +.+++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~vl~~~~~ 256 (256)
T cd08218 199 HAFEAGNMKNLVLKIIRGS-YPPVS--SHYSYDLRNLVSQLFKRNPRDRPS---VNSILEKNFI 256 (256)
T ss_pred CCccCCCHHHHHHHHhcCC-CCCCc--ccCCHHHHHHHHHHhhCChhhCcC---HHHHhhCcCC
Confidence 9999888887777776532 22233 3688999999999999 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=338.08 Aligned_cols=252 Identities=29% Similarity=0.554 Sum_probs=218.8
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++.+.||+|+||.||+|....+++.+|+|.+..... .......+..|+.+++.++||||+++++.+...+.+++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 58999999999999999999999999999999976543 33456778899999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-cEEEcccccccccCCCCccc
Q 010947 197 YLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 197 y~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~~ 273 (497)
|++|++|.+++... ..+++..+..++.+++.||.|||++||+||||+|+||+++.++ .+||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK-- 157 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc--
Confidence 99999999999764 3589999999999999999999999999999999999998654 589999999986532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
....+|++.|+|||.+.+..++.++|+|||||++|+|++|
T Consensus 158 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~ 197 (256)
T cd08220 158 ----------------------------------------AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASL 197 (256)
T ss_pred ----------------------------------------ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhC
Confidence 0134689999999999988899999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
..||.+.+.......+... ....+|. .++++++++|.+||. +|.+||+ +.++++||||
T Consensus 198 ~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~l~~li~~~l~~~p~~Rpt---~~~ll~~p~~ 256 (256)
T cd08220 198 KRAFEAANLPALVLKIMSG-TFAPISD--RYSPDLRQLILSMLNLDPSKRPQ---LSQIMAQPIC 256 (256)
T ss_pred CCCcccCchHHHHHHHHhc-CCCCCCC--CcCHHHHHHHHHHccCChhhCCC---HHHHhhCCCC
Confidence 9999988877777776642 2223343 689999999999999 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=366.68 Aligned_cols=250 Identities=28% Similarity=0.421 Sum_probs=220.3
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|.-++.||.|+||.||-|++..|.++||||+|.-+.-........+..|+..|..++|||+|..-++|.-+...+|||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 66677899999999999999999999999999876655555667799999999999999999999999999999999999
Q ss_pred cCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 198 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|- |+-.+++.- +.++.+.++..|+.+.+.||.|||+++.||||||..|||++..|.|||+|||.|....+
T Consensus 108 Cl-GSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-------- 178 (948)
T KOG0577|consen 108 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP-------- 178 (948)
T ss_pred Hh-ccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc--------
Confidence 95 566666643 56899999999999999999999999999999999999999999999999999876532
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHhHHHHHHHHHhC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwSlGvil~ell~G 353 (497)
+.+++|||.|||||++. .+.|+-++|||||||+..||.-.
T Consensus 179 -------------------------------------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAER 221 (948)
T KOG0577|consen 179 -------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 221 (948)
T ss_pred -------------------------------------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhc
Confidence 34799999999999997 47799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
+||+.+.+-+..+..|... ....++. ...|..+++||..||. -|.+||+ .++++.|+|..
T Consensus 222 kPPlFnMNAMSALYHIAQN-esPtLqs-~eWS~~F~~Fvd~CLqKipqeRpt---se~ll~H~fv~ 282 (948)
T KOG0577|consen 222 KPPLFNMNAMSALYHIAQN-ESPTLQS-NEWSDYFRNFVDSCLQKIPQERPT---SEELLKHRFVL 282 (948)
T ss_pred CCCccCchHHHHHHHHHhc-CCCCCCC-chhHHHHHHHHHHHHhhCcccCCc---HHHHhhcchhc
Confidence 9999999988888777653 2333332 3678999999999999 8999999 89999999985
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=350.07 Aligned_cols=255 Identities=17% Similarity=0.323 Sum_probs=205.0
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcC----------------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKT----------------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~----------------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp 176 (497)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|..++||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ 79 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP 79 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence 345689999999999999999998643 34479999987542 233456688999999999999
Q ss_pred ceeEEEEEeecCCeEEEEEeecCCCchhHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHcCCE
Q 010947 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-------------------TLTEDEARFYVAETVLAIESIHKHHY 237 (497)
Q Consensus 177 ~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~-------------------~l~e~~~~~~~~qi~~aL~~LH~~~i 237 (497)
||++++++|.+.+.+|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 159 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF 159 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence 99999999999999999999999999999986532 36778899999999999999999999
Q ss_pred EEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccc
Q 010947 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST 317 (497)
Q Consensus 238 iHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 317 (497)
+||||||+|||++.++.+||+|||+++.+....... .....
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~---------------------------------------~~~~~ 200 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYR---------------------------------------IQGRA 200 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeE---------------------------------------ecCcC
Confidence 999999999999999999999999998653221000 01134
Q ss_pred cCCCcccCccccccCCCCcchhHHhHHHHHHHHHh--CCCCCCCCChHHHHHHHhcc----cCcccCCCCccCChhHHHH
Q 010947 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRKIVNW----RTHLKFPEEAKLSIEAKDL 391 (497)
Q Consensus 318 ~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~--G~~PF~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~~~~dL 391 (497)
.+++.|+|||++....++.++|||||||++|||++ |..||.+.+..+....+... ...........++..+.+|
T Consensus 201 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 280 (304)
T cd05096 201 VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYEL 280 (304)
T ss_pred CCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHH
Confidence 56889999999998899999999999999999986 66888877666555444321 0111111123678899999
Q ss_pred HHHHhh-CccccCCCCCcchh
Q 010947 392 ISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 392 I~~lL~-dp~~R~~~~~~~ei 411 (497)
|.+||. ||.+||+ +.+|
T Consensus 281 i~~cl~~~p~~RPs---~~~i 298 (304)
T cd05096 281 MLQCWSRDCRERPS---FSDI 298 (304)
T ss_pred HHHHccCCchhCcC---HHHH
Confidence 999999 9999999 7776
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=363.36 Aligned_cols=256 Identities=22% Similarity=0.307 Sum_probs=207.5
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 185 (497)
.+..++|++.+.||+|+||.||+|.. ..++..||+|+++.... ....+.+.+|+.+|..+ +|||||+++++|
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 34556899999999999999999974 34677899999975432 23345688899999999 899999999999
Q ss_pred ecCCeEEEEEeecCCCchhHHHHhcC------------------------------------------------------
Q 010947 186 QDDEFLYLIMEYLPGGDMMTLLMRKD------------------------------------------------------ 211 (497)
Q Consensus 186 ~~~~~l~lVmEy~~gg~L~~~l~~~~------------------------------------------------------ 211 (497)
.+....|+|||||+||+|.+++....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 99999999999999999999986432
Q ss_pred ---------------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 212 ---------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 212 ---------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 47788899999999999999999999999999999999999999999999998653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
... ......+++.|+|||++.+..++.++|||||||++|||
T Consensus 269 ~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~el 309 (375)
T cd05104 269 NYV---------------------------------------VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEI 309 (375)
T ss_pred ccc---------------------------------------ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHH
Confidence 000 00123466789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++ |.+||.+........+.+........| ...+.++++||.+||+ ||.+||+ +.+|++
T Consensus 310 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~eil~ 369 (375)
T cd05104 310 FSLGSSPYPGMPVDSKFYKMIKEGYRMLSP--ECAPSEMYDIMKSCWDADPLKRPT---FKQIVQ 369 (375)
T ss_pred HhcCCCCCCCCCchHHHHHHHHhCccCCCC--CCCCHHHHHHHHHHccCChhHCcC---HHHHHH
Confidence 98 999998766554444444322222233 3568899999999999 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=359.18 Aligned_cols=263 Identities=29% Similarity=0.491 Sum_probs=213.7
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
.++....|++++.||+||.++||+|..-. ...||+|.+.-. ..+...+.-+++|+.+|.++ .|.+||.||++-..+.
T Consensus 356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~ 433 (677)
T KOG0596|consen 356 IKVKGREYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG 433 (677)
T ss_pred EEECcchhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence 45667789999999999999999998644 346777765432 22344567799999999999 5899999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
++||||||- ..||..+|.++.. +....+++|..|+++|+.++|..||||-||||.|+|+-. |.+||+|||+|+.+..
T Consensus 434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 999999975 6799999987654 343689999999999999999999999999999999987 9999999999998765
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC-----------CCcc
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-----------YGME 337 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-----------y~~~ 337 (497)
++.. ....+.|||+.||+||.+.... .+++
T Consensus 512 DTTs---------------------------------------I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~ 552 (677)
T KOG0596|consen 512 DTTS---------------------------------------IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRK 552 (677)
T ss_pred cccc---------------------------------------eeeccccCcccccCHHHHhhccccccCCCcceeecCc
Confidence 4321 1123689999999999997433 4689
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCC
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hp 415 (497)
+||||||||||+|+.|++||..-. ...-+..|.+-...+.||.-+. ..++.++++.||. ||.+|++ +.++|+||
T Consensus 553 SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~s---i~eLLqhp 628 (677)
T KOG0596|consen 553 SDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWS---IPELLQHP 628 (677)
T ss_pred cchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCC---cHHHhcCc
Confidence 999999999999999999997643 3444556665445567876321 2249999999999 9999999 99999999
Q ss_pred CccCC
Q 010947 416 WFDGV 420 (497)
Q Consensus 416 ff~~i 420 (497)
|...+
T Consensus 629 Fl~~~ 633 (677)
T KOG0596|consen 629 FLQIQ 633 (677)
T ss_pred ccccc
Confidence 99853
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=344.56 Aligned_cols=258 Identities=29% Similarity=0.483 Sum_probs=209.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHH-HHhcCCCceeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-LAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
++|++++.||+|+||.||+|.++.+|+.||||++++... ...+ ..+..|..+ ++..+||||+++++++..+..+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~-~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN-SQEQ-KRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC-cHHH-HHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999976432 1222 234445554 6677999999999999999999999
Q ss_pred EeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcC-CEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 195 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
|||++ |+|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99996 678777654 34699999999999999999999997 9999999999999999999999999998754311
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc----CCCCcchhHHhHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK----KGYGMECDWWSLGA 345 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~----~~y~~~~DiwSlGv 345 (497)
.. .....|++.|+|||++.+ ..++.++|+|||||
T Consensus 158 ~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 195 (283)
T cd06617 158 VA------------------------------------------KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGI 195 (283)
T ss_pred cc------------------------------------------cccccCCccccChhhcCCcccccccCccccchhhHH
Confidence 00 012468899999999864 56789999999999
Q ss_pred HHHHHHhCCCCCCCC-ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChh
Q 010947 346 IMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 346 il~ell~G~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
++|+|++|..||... ...+....+... ....+|. ..+|.++++||.+||. +|.+||+ +.+++.||||....+.
T Consensus 196 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~~~ 270 (283)
T cd06617 196 TMIELATGRFPYDSWKTPFQQLKQVVEE-PSPQLPA-EKFSPEFQDFVNKCLKKNYKERPN---YPELLQHPFFELHLSK 270 (283)
T ss_pred HHHHHHhCCCCCCccccCHHHHHHHHhc-CCCCCCc-cccCHHHHHHHHHHccCChhhCcC---HHHHhcCchhhhcccc
Confidence 999999999999753 333444444431 2233333 2588999999999999 9999999 9999999999976544
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=348.43 Aligned_cols=254 Identities=28% Similarity=0.410 Sum_probs=215.2
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
...|++.+.||+|+||.||+|....+|+.||||++.............+.+|+.+++.++||||++++++|.+.+..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 45699999999999999999999999999999999765444444556788999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||++ |+|.+++.. ...+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---- 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---- 168 (307)
T ss_pred HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC----
Confidence 99997 566666643 567999999999999999999999999999999999999999999999999998654211
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHhHHHHHHHH
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwSlGvil~el 350 (497)
....|++.|+|||++. ...++.++|||||||++|||
T Consensus 169 -----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el 207 (307)
T cd06607 169 -----------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207 (307)
T ss_pred -----------------------------------------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHH
Confidence 1346889999999985 35688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
++|.+||.+.+.......+... .....+. ..++.++++||.+||. +|.+||+ +.+|+.||||..
T Consensus 208 ~tg~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 272 (307)
T cd06607 208 AERKPPLFNMNAMSALYHIAQN-DSPTLSS-NDWSDYFRNFVDSCLQKIPQDRPS---SEELLKHRFVLR 272 (307)
T ss_pred HcCCCCCCCccHHHHHHHHhcC-CCCCCCc-hhhCHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcc
Confidence 9999999988776665555432 1222222 2478899999999999 9999998 999999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=346.54 Aligned_cols=255 Identities=31% Similarity=0.502 Sum_probs=211.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++++.||.|+||.||+|+++.+|+.||||++.... ........+..|+++++.++||||+++++++.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 5899999999999999999999999999999987543 222334568889999999999999999999999999999999
Q ss_pred ecCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 197 YLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 197 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|+. ++|..++.. ...+++..+..++.+++.||.|||+.|++||||+|+||+++.++.+||+|||++..+.....
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--- 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--- 155 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc---
Confidence 995 688888755 35689999999999999999999999999999999999999999999999999875532110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC-CCcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-y~~~~DiwSlGvil~ell~G 353 (497)
......+++.|+|||++.+.. ++.++|+|||||++|||++|
T Consensus 156 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 197 (284)
T cd07860 156 --------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 197 (284)
T ss_pred --------------------------------------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 001345789999999987644 68899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcc----------------cCCC---------CccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHL----------------KFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~----------------~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
..||.+.+......++....... .++. ...+++++++||.+||+ ||.+||+
T Consensus 198 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt--- 274 (284)
T cd07860 198 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS--- 274 (284)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCC---
Confidence 99999877665554443211100 0110 12478899999999999 9999999
Q ss_pred cchhcCCCCc
Q 010947 408 ADEIKVHPWF 417 (497)
Q Consensus 408 ~~eil~Hpff 417 (497)
+.+++.||||
T Consensus 275 ~~~~l~~~~f 284 (284)
T cd07860 275 AKAALAHPFF 284 (284)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=346.20 Aligned_cols=255 Identities=22% Similarity=0.393 Sum_probs=214.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCC-----cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTG-----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~-----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+..++|++++.||+|+||.||+|.....+ ..||+|.+.... .......+.+|+.++..++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~ 79 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK 79 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence 34568999999999999999999876554 679999987542 23344568899999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK 251 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~ 251 (497)
....|++|||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.
T Consensus 80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~ 159 (283)
T cd05048 80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE 159 (283)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence 99999999999999999999764 45788999999999999999999999999999999999999
Q ss_pred CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc
Q 010947 252 YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (497)
Q Consensus 252 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~ 331 (497)
++.+||+|||+++......... ......+|+.|+|||.+.+
T Consensus 160 ~~~~~L~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~ 200 (283)
T cd05048 160 GLTVKISDFGLSRDIYSADYYR---------------------------------------VQSKSLLPVRWMPPEAILY 200 (283)
T ss_pred CCcEEECCCcceeecccccccc---------------------------------------ccCCCcccccccCHHHhcc
Confidence 9999999999998653221000 0113467899999999998
Q ss_pred CCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcc
Q 010947 332 KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409 (497)
Q Consensus 332 ~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ 409 (497)
..++.++|||||||++|||++ |..||.+.+..+....|.... ....| ..+++++.+||.+||+ ||.+||+ +.
T Consensus 201 ~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~l~~~c~~~~p~~Rp~---~~ 274 (283)
T cd05048 201 GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ-LLPCP--EDCPARVYALMIECWNEIPARRPR---FK 274 (283)
T ss_pred CcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCc--ccCCHHHHHHHHHHccCChhhCcC---HH
Confidence 999999999999999999998 999999988888877776532 22233 3789999999999999 9999999 77
Q ss_pred hhcCC
Q 010947 410 EIKVH 414 (497)
Q Consensus 410 eil~H 414 (497)
+|++|
T Consensus 275 ~i~~~ 279 (283)
T cd05048 275 DIHTR 279 (283)
T ss_pred HHHHH
Confidence 77653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=345.91 Aligned_cols=257 Identities=33% Similarity=0.504 Sum_probs=209.9
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCe----
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEF---- 190 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~---- 190 (497)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEM-DEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhc-cccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 46999999999999999999999999999999986542 22233456788999999995 6999999999987665
Q ss_pred -EEEEEeecCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-CCcEEEcccccc
Q 010947 191 -LYLIMEYLPGGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLC 263 (497)
Q Consensus 191 -l~lVmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-~g~vkL~DFGla 263 (497)
+|+||||+++ +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999975 788887542 35899999999999999999999999999999999999998 899999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHh
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 342 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwS 342 (497)
+.+..... ......+++.|+|||++.+ ..++.++||||
T Consensus 159 ~~~~~~~~-----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s 197 (295)
T cd07837 159 RAFSIPVK-----------------------------------------SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197 (295)
T ss_pred eecCCCcc-----------------------------------------ccCCcccccCCCChHHhhCCCCCCchHHHHH
Confidence 76532100 0012357899999999865 55799999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhcccCc---cc------------CCC---------CccCChhHHHHHHHHhh-
Q 010947 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH---LK------------FPE---------EAKLSIEAKDLISKLLC- 397 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~---~~------------~p~---------~~~~s~~~~dLI~~lL~- 397 (497)
|||++|+|++|.+||.+.+......++...... .. +|. ...++.++.+||.+||.
T Consensus 198 lG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 277 (295)
T cd07837 198 VGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRY 277 (295)
T ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccC
Confidence 999999999999999988776666555431100 00 110 13578999999999999
Q ss_pred CccccCCCCCcchhcCCCCcc
Q 010947 398 NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 398 dp~~R~~~~~~~eil~Hpff~ 418 (497)
||.+||+ +.+++.||||+
T Consensus 278 ~P~~R~~---~~eil~~~~~~ 295 (295)
T cd07837 278 DPAKRIS---AKAALTHPYFD 295 (295)
T ss_pred ChhhcCC---HHHHhcCCCcC
Confidence 9999998 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.55 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=206.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++.+.||.|+||.||+|..+.+++.||||.+..... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999875431 22223466899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||++ ++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++........
T Consensus 82 ~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~- 159 (291)
T cd07844 82 FEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKT- 159 (291)
T ss_pred EecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcc-
Confidence 99997 4899988654 46899999999999999999999999999999999999999999999999998754221000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
.....+++.|+|||++.+ ..++.++|||||||++|+|++
T Consensus 160 ----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~ 199 (291)
T cd07844 160 ----------------------------------------YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMAT 199 (291)
T ss_pred ----------------------------------------ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHh
Confidence 012357889999999875 568999999999999999999
Q ss_pred CCCCCCCCC-hHHHHHHHhcccC-----------------cccCC----C-----CccCC--hhHHHHHHHHhh-Ccccc
Q 010947 353 GYPPFYSDD-PMSTCRKIVNWRT-----------------HLKFP----E-----EAKLS--IEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 353 G~~PF~~~~-~~~~~~~i~~~~~-----------------~~~~p----~-----~~~~s--~~~~dLI~~lL~-dp~~R 402 (497)
|.+||.+.. ..+....+..... ...++ . ...++ .++.+||.+||+ +|.+|
T Consensus 200 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 279 (291)
T cd07844 200 GRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKR 279 (291)
T ss_pred CCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccc
Confidence 999997765 2232222211000 00000 0 01344 889999999999 99999
Q ss_pred CCCCCcchhcCCCCc
Q 010947 403 LGAKGADEIKVHPWF 417 (497)
Q Consensus 403 ~~~~~~~eil~Hpff 417 (497)
|+ +.+++.||||
T Consensus 280 ps---~~e~l~~~~f 291 (291)
T cd07844 280 IS---AAEAMKHPYF 291 (291)
T ss_pred cC---HHHHhcCCCC
Confidence 99 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=341.21 Aligned_cols=255 Identities=32% Similarity=0.507 Sum_probs=213.9
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC---
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE--- 189 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~--- 189 (497)
..++|++.+.||.|+||.||+|.++.+++.||+|++..... ....+..|+.+++.+ +||||+++++.|.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 45789999999999999999999999999999999876432 335688999999998 7999999999997644
Q ss_pred ---eEEEEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 190 ---FLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 190 ---~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
.+|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999998865 35799999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----CCCCcc
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGME 337 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~y~~~ 337 (497)
+........ ......||+.|+|||++.. ..++.+
T Consensus 160 ~~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~ 198 (275)
T cd06608 160 SAQLDSTLG-----------------------------------------RRNTFIGTPYWMAPEVIACDEQPDASYDAR 198 (275)
T ss_pred ceecccchh-----------------------------------------hhcCccccccccCHhHhcccccccCCcccc
Confidence 875432110 0013568999999999863 347889
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCC
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpf 416 (497)
+|+|||||+||+|++|.+||..........++.... ....+....++.++++||.+||. ||.+||+ +.+++.|||
T Consensus 199 ~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt---~~~ll~~~~ 274 (275)
T cd06608 199 SDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNP-PPTLKSPENWSKKFNDFISECLIKNYEQRPF---MEELLEHPF 274 (275)
T ss_pred ccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccC-CCCCCchhhcCHHHHHHHHHHhhcChhhCcC---HHHHhcCCC
Confidence 999999999999999999998776666666655422 22222223478899999999999 9999999 999999999
Q ss_pred c
Q 010947 417 F 417 (497)
Q Consensus 417 f 417 (497)
+
T Consensus 275 ~ 275 (275)
T cd06608 275 I 275 (275)
T ss_pred C
Confidence 6
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=338.31 Aligned_cols=257 Identities=30% Similarity=0.529 Sum_probs=221.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||.|++|.||+|.+..+++.||+|++...... .....+..|+.++..++||||+++++++.....+|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 4789999999999999999999999999999999765421 34567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||++|++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.........
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~-- 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ-- 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc--
Confidence 999999999999888899999999999999999999999 99999999999999999999999999998865322100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 157 ---------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~ 197 (264)
T cd06623 157 ---------------------------------------CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197 (264)
T ss_pred ---------------------------------------ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 01346889999999999999999999999999999999999
Q ss_pred CCCCCCC---hHHHHHHHhcccCcccCCCCcc-CChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 355 PPFYSDD---PMSTCRKIVNWRTHLKFPEEAK-LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 355 ~PF~~~~---~~~~~~~i~~~~~~~~~p~~~~-~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
+||...+ ..+....+.. ......+ .. ++..+.++|.+||. +|.+||+ +.+++.||||+.++
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~~l~~~p~~R~~---~~~ll~~~~~~~~~ 263 (264)
T cd06623 198 FPFLPPGQPSFFELMQAICD-GPPPSLP--AEEFSPEFRDFISACLQKDPKKRPS---AAELLQHPFIKKAD 263 (264)
T ss_pred CCCccccccCHHHHHHHHhc-CCCCCCC--cccCCHHHHHHHHHHccCChhhCCC---HHHHHhCHHHHhcc
Confidence 9998773 4444555543 1222233 24 78999999999999 9999998 99999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=337.35 Aligned_cols=248 Identities=31% Similarity=0.537 Sum_probs=214.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++.+.||.|+||.||+|.++.++..||+|.++.... ....+.+..|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999875432 3345678889999999999999999999999999999999
Q ss_pred ecCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 197 YLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 197 y~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|+++|+|.+++.. ...+++..+..++.|++.||.|||+.||+|+||||+||+++.++.++|+|||++..+.....
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~--- 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA--- 155 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc---
Confidence 9999999998864 34689999999999999999999999999999999999999999999999999876532110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
......|++.|+|||++.+..++.++|+||||+++|+|++|.
T Consensus 156 --------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~ 197 (255)
T cd08219 156 --------------------------------------YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK 197 (255)
T ss_pred --------------------------------------ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhcc
Confidence 011357899999999999989999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+||...+.......+.... ....| ..++.++++||.+||. ||.+||+ +.+|+.
T Consensus 198 ~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rp~---~~~il~ 251 (255)
T cd08219 198 HPFQANSWKNLILKVCQGS-YKPLP--SHYSYELRSLIKQMFKRNPRSRPS---ATTILS 251 (255)
T ss_pred CCCCCCCHHHHHHHHhcCC-CCCCC--cccCHHHHHHHHHHHhCCcccCCC---HHHHhh
Confidence 9999888777777665422 22233 3688999999999999 9999999 888775
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=344.31 Aligned_cols=258 Identities=35% Similarity=0.560 Sum_probs=215.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|.++.+++.||+|+++.... .......+..|+.+++.++||||++++++|.+.+.+|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 369999999999999999999999999999999876432 2334467889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++++.+..++.+...+++..+..++.+|+.||.|||+.|++||||+|+||+++.++.+||+|||++.........
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~--- 156 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS--- 156 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc---
Confidence 99998888777766678999999999999999999999999999999999999999999999999998865432100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....+|++.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus 157 -------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~ 199 (288)
T cd07833 157 -------------------------------------PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE 199 (288)
T ss_pred -------------------------------------cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence 01135789999999999887 8899999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCc-----------------ccCCC-----------CccCChhHHHHHHHHhh-CccccCCC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTH-----------------LKFPE-----------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~-----------~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
+||.+.+..+....+...... ..++. ...++.++++||++||. +|.+||+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps- 278 (288)
T cd07833 200 PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT- 278 (288)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc-
Confidence 999877655444333211000 01110 11358899999999999 9999999
Q ss_pred CCcchhcCCCCc
Q 010947 406 KGADEIKVHPWF 417 (497)
Q Consensus 406 ~~~~eil~Hpff 417 (497)
+.+++.||||
T Consensus 279 --~~~il~~~~f 288 (288)
T cd07833 279 --CDELLQHPYF 288 (288)
T ss_pred --HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=343.87 Aligned_cols=254 Identities=28% Similarity=0.486 Sum_probs=217.3
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||.|+||.||+|.++.+++.+|+|.+..... ......+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468888999999999999999999999999999976532 234556888999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||++|++|.+++... ..+++..+..++.+++.||.|||+ .|++||||||+||+++.+|.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~--- 155 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--- 155 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH---
Confidence 999999999999775 789999999999999999999999 999999999999999999999999999987542110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
.....|++.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 156 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 156 ----------------------------------------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred ----------------------------------------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 0125689999999999999999999999999999999999
Q ss_pred CCCCCCC-----ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 354 YPPFYSD-----DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 354 ~~PF~~~-----~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
..||... ...+....+... .....|.. .++.++++||.+||. ||.+||+ +.+++.||||+.
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~~~ 262 (265)
T cd06605 196 RFPYPPENDPPDGIFELLQYIVNE-PPPRLPSG-KFSPDFQDFVNLCLIKDPRERPS---YKELLEHPFIKK 262 (265)
T ss_pred CCCCCccccccccHHHHHHHHhcC-CCCCCChh-hcCHHHHHHHHHHcCCCchhCcC---HHHHhhCchhhc
Confidence 9999765 233444444432 22233331 288999999999999 9999999 999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=350.42 Aligned_cols=255 Identities=30% Similarity=0.543 Sum_probs=216.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|.....||.|+||.||++.+..++..||||++.... ....+.+.+|+.+++.++||||+++++.|...+..|+|||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3455667999999999999999999999999986533 2334568889999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|++|++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++........
T Consensus 100 ~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~----- 173 (292)
T cd06658 100 FLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP----- 173 (292)
T ss_pred CCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-----
Confidence 999999999874 45799999999999999999999999999999999999999999999999999875431100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
.....+||+.|+|||++.+..++.++|+|||||++|||++|..|
T Consensus 174 ------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p 217 (292)
T cd06658 174 ------------------------------------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217 (292)
T ss_pred ------------------------------------cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 00135689999999999988999999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|.+.+.......+... .....+....++..+++||.+||+ ||.+||+ ++++++||||+..
T Consensus 218 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~~~il~~~~~~~~ 278 (292)
T cd06658 218 YFNEPPLQAMRRIRDN-LPPRVKDSHKVSSVLRGFLDLMLVREPSQRAT---AQELLQHPFLKLA 278 (292)
T ss_pred CCCCCHHHHHHHHHhc-CCCccccccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhhcc
Confidence 9988776665555432 122223334678899999999999 9999998 9999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=347.08 Aligned_cols=263 Identities=25% Similarity=0.418 Sum_probs=211.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~l 193 (497)
.++|.....||+|+||.||++.+..++..||||.+.+... ......+..|+.++.++. ||||+++++++.++...++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 3567778899999999999999999999999999876432 234456788999999885 9999999999999999999
Q ss_pred EEeecCCCchhHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 194 IMEYLPGGDMMTLL---M--RKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 194 VmEy~~gg~L~~~l---~--~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
||||+.+ ++.++. . ....+++..+..++.+++.||+|||+ .||+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 81 CMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred EEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 9999854 554432 1 23679999999999999999999997 499999999999999999999999999987543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC---CCCcchhHHhHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLG 344 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~---~y~~~~DiwSlG 344 (497)
.... .....||+.|+|||++.+. .++.++||||||
T Consensus 160 ~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG 197 (288)
T cd06616 160 DSIA------------------------------------------KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLG 197 (288)
T ss_pred cCCc------------------------------------------cccccCccCccCHHHhccccccCCcchhhhhHHH
Confidence 2110 0134689999999999866 689999999999
Q ss_pred HHHHHHHhCCCCCCCCCh-HHHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 345 AIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|++|+|++|.+||..... .+...++... ....++. ...++.++.+||.+||. +|.+||+ +++|+.||||+..
T Consensus 198 ~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~i~~~~~~~~~ 273 (288)
T cd06616 198 ITLYEVATGKFPYPKWNSVFDQLTQVVKG-DPPILSNSEEREFSPSFVNFINLCLIKDESKRPK---YKELLEHPFIKDY 273 (288)
T ss_pred HHHHHHHhCCCCchhcchHHHHHhhhcCC-CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcC---HHHHhcChhhhch
Confidence 999999999999976542 2223333221 1112221 23588999999999999 9999999 9999999999987
Q ss_pred Chhhhh
Q 010947 421 DWARIY 426 (497)
Q Consensus 421 ~w~~l~ 426 (497)
.|....
T Consensus 274 ~~~~~~ 279 (288)
T cd06616 274 EERNVD 279 (288)
T ss_pred hhcchh
Confidence 766554
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=338.74 Aligned_cols=256 Identities=31% Similarity=0.516 Sum_probs=210.1
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
...+.+.....||+|+||.||+|.+..++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34555666678999999999999999999999999987543 234567889999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-CCcEEEcccccccccCC
Q 010947 193 LIMEYLPGGDMMTLLMRK-DTL--TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~-~~l--~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~ 268 (497)
+||||++|++|.+++... ..+ ++..+..++.||+.||.|||+.||+||||||+||+++. ++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999998764 456 88899999999999999999999999999999999986 67999999999875432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC--CCCcchhHHhHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLGAI 346 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~y~~~~DiwSlGvi 346 (497)
.... .....|++.|+|||++.+. .++.++|+|||||+
T Consensus 162 ~~~~-----------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvv 200 (268)
T cd06624 162 INPC-----------------------------------------TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCT 200 (268)
T ss_pred CCCc-----------------------------------------cccCCCCccccChhhhccccccCCchhhhHHHHHH
Confidence 1100 0134589999999998764 48899999999999
Q ss_pred HHHHHhCCCCCCCCChH-HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 347 MYEMLVGYPPFYSDDPM-STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
+|+|++|.+||...... .....+........+|. .+++++++||.+||. +|.+||+ +.+++.||||
T Consensus 201 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt---~~~ll~~~~~ 268 (268)
T cd06624 201 IVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE--SLSAEAKNFILRCFEPDPDKRAS---AHDLLQDPFL 268 (268)
T ss_pred HHHHHhCCCCCccccChhhhHhhhhhhccCCCCCc--ccCHHHHHHHHHHcCCCchhCCC---HHHHHhCCCC
Confidence 99999999999765432 22222211122233443 688999999999999 9999998 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=363.77 Aligned_cols=243 Identities=23% Similarity=0.354 Sum_probs=210.5
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..+...-+.-||.|+.|.||+|+.+ ++.||||+++.- -..++.-|++|+||||+.+.++|.....+|
T Consensus 121 iPFe~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyC 188 (904)
T KOG4721|consen 121 IPFEEISELEWLGSGAQGAVFLGRLH--NETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYC 188 (904)
T ss_pred CCHHHhhhhhhhccCcccceeeeecc--CceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence 33344445667999999999999876 669999987532 123666788999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||||+.|-|.++|...++++......+..+|+.|++|||.+.|||||||.-||||+.+..|||+|||-++.....
T Consensus 189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--- 265 (904)
T KOG4721|consen 189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--- 265 (904)
T ss_pred EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999998865311
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
....+++||..|||||++.+.+.+.++|||||||+||||||
T Consensus 266 ---------------------------------------STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT 306 (904)
T KOG4721|consen 266 ---------------------------------------STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLT 306 (904)
T ss_pred ---------------------------------------hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHh
Confidence 11237999999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|..||.+-+...++.-+-+ ..+.+|-...++.-++=||++|+. .|.+||+ +.+|+.|
T Consensus 307 ~EiPYkdVdssAIIwGVGs--NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPS---Frqil~H 364 (904)
T KOG4721|consen 307 GEIPYKDVDSSAIIWGVGS--NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPS---FRQILLH 364 (904)
T ss_pred cCCCccccchheeEEeccC--CcccccCcccCchHHHHHHHHHHhcCCCCCcc---HHHHHHH
Confidence 9999998887776655554 344455445899999999999999 9999999 8888887
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=330.46 Aligned_cols=261 Identities=25% Similarity=0.440 Sum_probs=221.9
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
.....++.+.+..||.|+.|.|++++.+.+|...|||.|.+.. +..+.+++...++++... ++|+||+.|++|..+.
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 3455667778889999999999999999999999999998764 345566777778777655 5999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+++.||.| +..+..+|.+ +++++|..+-.+...++.||.||.. +||||||+||+|||+|..|++||||||++-.+.
T Consensus 165 dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 165 DVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred hHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence 999999998 5566666654 5789999999999999999999985 699999999999999999999999999997764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CCCCcchhHHhHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLG 344 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~y~~~~DiwSlG 344 (497)
.+..+ ....|.+.|||||.+.- ..|+..+|+||||
T Consensus 244 dSkAh------------------------------------------trsAGC~~YMaPERidp~~~~kYDiRaDVWSlG 281 (391)
T KOG0983|consen 244 DSKAH------------------------------------------TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLG 281 (391)
T ss_pred ccccc------------------------------------------ccccCCccccCccccCCCCCCccchhhhhhhhc
Confidence 33211 02369999999999973 5699999999999
Q ss_pred HHHHHHHhCCCCCCCCC-hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 345 AIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 345 vil~ell~G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|.++||.||..||.+.+ .-+++-+|++ ..+..+|....+|+++++|+..||. |+.+||. -.++|+|||+...
T Consensus 282 ITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~---Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 282 ITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPK---YNKLLEHPFIKRY 355 (391)
T ss_pred cchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCCcccCcCHHHHHHHHHHhhcCcccCcc---hHHHhcCcceeec
Confidence 99999999999999864 5677788887 3456667666799999999999999 9999998 8899999999854
|
|
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=336.60 Aligned_cols=253 Identities=32% Similarity=0.593 Sum_probs=217.2
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec--CCeEEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFLYLI 194 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~l~lV 194 (497)
+|++++.||.|+||.||+|.+..++..||+|++..... .......+..|+.+++.++||||+++++.+.+ ...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 58899999999999999999999999999999976543 33445678889999999999999999987754 4568999
Q ss_pred EeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----cCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIH-----KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 195 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH-----~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
|||+++++|.+++.. ...+++..+..++.+|+.||.||| +.+|+|+||||+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999999865 367999999999999999999999 88999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
...... ......|++.|+|||++.+..++.++|+|||||
T Consensus 160 ~~~~~~-----------------------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~ 198 (265)
T cd08217 160 LGHDSS-----------------------------------------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGC 198 (265)
T ss_pred ccCCcc-----------------------------------------cccccccCCCccChhhhcCCCCCchhHHHHHHH
Confidence 542210 011356899999999999888999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
++|+|++|..||...+.......+... ....+| ..++.++.+||.+||. +|.+||+ +.+|++|||+
T Consensus 199 il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp~---~~~il~~~~~ 265 (265)
T cd08217 199 LIYELCALSPPFTARNQLQLASKIKEG-KFRRIP--YRYSSELNEVIKSMLNVDPDKRPS---TEELLQLPLI 265 (265)
T ss_pred HHHHHHHCCCcccCcCHHHHHHHHhcC-CCCCCc--cccCHHHHHHHHHHccCCcccCCC---HHHHhhCCCC
Confidence 999999999999988766666666542 222333 3688999999999999 9999999 9999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=344.64 Aligned_cols=260 Identities=30% Similarity=0.473 Sum_probs=212.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|++|.||+|.++.+|+.||||++..... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 579999999999999999999999999999999866432 2233456788999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-CCcEEEcccccccccCCCCcc
Q 010947 196 EYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~ 272 (497)
||++ ++|..++..... +++..+..++.||+.||.|||+.|++||||+|+||+++. ++.+||+|||++........
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 9995 578887765443 588899999999999999999999999999999999985 56799999999975432100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHH
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell 351 (497)
.....+|++.|+|||++.+ ..++.++|||||||++|+|+
T Consensus 159 ----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~ 198 (294)
T PLN00009 159 ----------------------------------------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMV 198 (294)
T ss_pred ----------------------------------------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 0013468899999999876 45799999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcc-------------------cCCC------CccCChhHHHHHHHHhh-CccccCCC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHL-------------------KFPE------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~-------------------~~p~------~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
+|.+||.+.+..+...++....... .++. ...++++++++|.+||+ +|.+||+
T Consensus 199 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps- 277 (294)
T PLN00009 199 NQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT- 277 (294)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC-
Confidence 9999999887766666554311100 0000 13578899999999999 9999998
Q ss_pred CCcchhcCCCCccCCC
Q 010947 406 KGADEIKVHPWFDGVD 421 (497)
Q Consensus 406 ~~~~eil~Hpff~~i~ 421 (497)
+.+++.||||.+++
T Consensus 278 --~~~~l~~~~~~~~~ 291 (294)
T PLN00009 278 --ARAALEHEYFKDLG 291 (294)
T ss_pred --HHHHhcCchHhHHh
Confidence 99999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=366.25 Aligned_cols=243 Identities=37% Similarity=0.616 Sum_probs=210.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh-cCCCceeEEEEEeecCCeEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~l~ 192 (497)
..++|++...+|.|+|+.|..|.+..+++.+|+|++.+..- ....|+.++.. -+||||+++.+.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 35678999999999999999999999999999999987621 13356666554 48999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee-cCCCcEEEcccccccccCCCCc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL-DKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl-~~~g~vkL~DFGla~~~~~~~~ 271 (497)
+|||++.||.|.+.+.....+. .++..++++|+.|+.|||.+|+|||||||+|||+ +..|+++|+|||.++.....
T Consensus 393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-- 469 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-- 469 (612)
T ss_pred eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--
Confidence 9999999999998887766666 8888999999999999999999999999999999 69999999999999865321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
+.+.|-|..|.|||++...+|+.+|||||||++||+||
T Consensus 470 ------------------------------------------~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML 507 (612)
T KOG0603|consen 470 ------------------------------------------CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEML 507 (612)
T ss_pred ------------------------------------------hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHH
Confidence 12457889999999999999999999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 352 VGYPPFYSDDPM-STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 352 ~G~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
+|++||...... ++..+|.. .++. ..+|.+|+|||++||+ ||.+||+ +.+++.||||
T Consensus 508 ~G~tp~~~~P~~~ei~~~i~~----~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~---~~~i~~h~w~ 566 (612)
T KOG0603|consen 508 TGRTLFAAHPAGIEIHTRIQM----PKFS--ECVSDEAKDLLQQLLQVDPALRLG---ADEIGAHPWF 566 (612)
T ss_pred hCCCccccCCchHHHHHhhcC----Cccc--cccCHHHHHHHHHhccCChhhCcC---hhhhccCcch
Confidence 999999876555 44444432 2233 4899999999999999 9999999 9999999999
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=337.88 Aligned_cols=250 Identities=22% Similarity=0.353 Sum_probs=212.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+...+|.+.+.||+|+||.||+|..+.++..||+|++.+.. .....+.+|+.++..++||||+++++++..+..+|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 78 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence 45567999999999999999999999999999999987542 23456888999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~ 158 (263)
T cd05052 79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 158 (263)
T ss_pred EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence 999999999999998653 358999999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
... .....+++.|+|||++.+..++.++|||||||++|||
T Consensus 159 ~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 198 (263)
T cd05052 159 YTA----------------------------------------HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198 (263)
T ss_pred eec----------------------------------------cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 000 0022356789999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
++ |.+||.+.+..+....+... ....+| ..++.++.+||.+||+ ||.+||+ +.+++
T Consensus 199 ~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~l~ 256 (263)
T cd05052 199 ATYGMSPYPGIDLSQVYELLEKG-YRMERP--EGCPPKVYELMRACWQWNPSDRPS---FAEIH 256 (263)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHccCCcccCCC---HHHHH
Confidence 98 99999988877777776542 223333 3689999999999999 9999999 66654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=341.38 Aligned_cols=255 Identities=30% Similarity=0.549 Sum_probs=217.6
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|...+.||.|++|.||++.+..++..+|+|++.... ......+.+|+.+++.++||||+++++++...+..|+|||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 4556689999999999999999999999999986432 2334567889999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.........
T Consensus 97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~---- 171 (285)
T cd06648 97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR---- 171 (285)
T ss_pred ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcc----
Confidence 9999999999876 67999999999999999999999999999999999999999999999999988654211000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
.....|++.|+|||++.+..++.++|+|||||++|+|++|..|
T Consensus 172 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p 214 (285)
T cd06648 172 -------------------------------------RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPP 214 (285)
T ss_pred -------------------------------------cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCC
Confidence 0135689999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|.+.++.....++.... ....+....++..+.+||.+||. +|.+||+ +.+++.||||+..
T Consensus 215 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~ 275 (285)
T cd06648 215 YFNEPPLQAMKRIRDNL-PPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT---AAELLNHPFLAKA 275 (285)
T ss_pred CcCCCHHHHHHHHHhcC-CCCCcccccCCHHHHHHHHHHcccChhhCcC---HHHHccCcccccC
Confidence 99888777777666431 11222223478999999999999 9999998 9999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=353.15 Aligned_cols=256 Identities=31% Similarity=0.500 Sum_probs=212.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
.++|++++.||+|+||.||+|.+..+|..||||++.+.. ........+..|+.+|+.++||||++++++|..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 567999999999999999999999999999999986532 22223456788999999999999999999998654
Q ss_pred -eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+||||+ |++|..++. ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 170 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS 170 (343)
T ss_pred ceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence 458999999 789988875 46799999999999999999999999999999999999999999999999999875432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
.. ....|++.|+|||++.+ ..++.++|+|||||++
T Consensus 171 ~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll 206 (343)
T cd07880 171 EM--------------------------------------------TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIM 206 (343)
T ss_pred Cc--------------------------------------------cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHH
Confidence 10 13468899999999876 4589999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcc------------------cCCC---------CccCChhHHHHHHHHhh-Cc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL------------------KFPE---------EAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~------------------~~p~---------~~~~s~~~~dLI~~lL~-dp 399 (497)
|+|++|.+||.+.+....+.+++...... ..|. ...+++++.++|.+||+ ||
T Consensus 207 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 286 (343)
T cd07880 207 AEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDA 286 (343)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCCh
Confidence 99999999999877665555544321110 0000 13578899999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCC
Q 010947 400 NQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i 420 (497)
.+||+ +.+++.||||+..
T Consensus 287 ~~R~t---~~~~l~~~~~~~~ 304 (343)
T cd07880 287 ESRIT---AAEALAHPYFEEF 304 (343)
T ss_pred hhCCC---HHHHhcCccHhhh
Confidence 99999 9999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=346.03 Aligned_cols=257 Identities=30% Similarity=0.526 Sum_probs=218.2
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|.+.+.||.|+||.||+|....++..||+|.+.... ....+.+..|+.+++.++||||++++++|.+.+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 468999999999999999999998899999999986432 23346688899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||++||+|.+++.+ ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~-- 171 (293)
T cd06647 95 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-- 171 (293)
T ss_pred EecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--
Confidence 999999999999854 46899999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....|++.|+|||.+....++.++|+|||||++|+|++|.
T Consensus 172 ---------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~ 212 (293)
T cd06647 172 ---------------------------------------RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212 (293)
T ss_pred ---------------------------------------cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 01346899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+||.+.+.......+..+ ....++....++..+++||.+||. +|.+||+ +.+++.||||+..
T Consensus 213 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~h~~~~~~ 275 (293)
T cd06647 213 PPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHPFLKIA 275 (293)
T ss_pred CCCCCCChhhheeehhcC-CCCCCCCccccCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhcC
Confidence 999887665444333322 222333334678899999999999 9999998 9999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=341.55 Aligned_cols=251 Identities=30% Similarity=0.510 Sum_probs=205.2
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecC--CeEEEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDD--EFLYLI 194 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~--~~l~lV 194 (497)
|.+++.||+|+||.||+|.++.+++.||+|++++... .... .....|+.++..+. ||||+++++++.+. +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6788999999999999999999999999999876421 1222 23456888888884 99999999999987 899999
Q ss_pred EeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||++ |+|.+.+.. ...+++..+..++.|++.||.|||+.|++||||||+||+++. +.+||+|||+++.+.....
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~-- 154 (282)
T cd07831 79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPP-- 154 (282)
T ss_pred EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCC--
Confidence 99996 577777765 457999999999999999999999999999999999999999 9999999999976532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
.....+|+.|+|||++.. ..++.++|||||||++|||++
T Consensus 155 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~ 194 (282)
T cd07831 155 ----------------------------------------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194 (282)
T ss_pred ----------------------------------------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHc
Confidence 012458899999998754 557899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhccc----------------CcccCCC---------CccCChhHHHHHHHHhh-CccccCCCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWR----------------THLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~----------------~~~~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
|.+||.+.+..+....+.... ....+|. ...++.++++||.+||. +|.+||+
T Consensus 195 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~-- 272 (282)
T cd07831 195 LFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT-- 272 (282)
T ss_pred CCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccC--
Confidence 999999887766555543211 1112221 12568999999999999 9999999
Q ss_pred CcchhcCCCCc
Q 010947 407 GADEIKVHPWF 417 (497)
Q Consensus 407 ~~~eil~Hpff 417 (497)
+++++.||||
T Consensus 273 -~~~~l~~~~~ 282 (282)
T cd07831 273 -AKQALRHPYF 282 (282)
T ss_pred -HHHHhhCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=342.34 Aligned_cols=255 Identities=31% Similarity=0.482 Sum_probs=218.2
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|+.++.||.|+||.||+|.++.++..||+|++..... ......+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 57788899999999999999999999999999875432 3345678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|++||+|.+++. .+++++..+..++.+++.||.|||+.+++|+||+|+||+++.++.++|+|||++..+......
T Consensus 83 ~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---- 157 (277)
T cd06640 83 YLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---- 157 (277)
T ss_pred cCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccc----
Confidence 999999999885 467999999999999999999999999999999999999999999999999998765321100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
.....|+..|+|||++.+..++.++|+|||||++|||++|.+|
T Consensus 158 -------------------------------------~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06640 158 -------------------------------------RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred -------------------------------------cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCC
Confidence 0134688999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
|...++......+... ....++ ..++..+.+||.+||. +|.+||+ +.++++||||....
T Consensus 201 ~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~ 260 (277)
T cd06640 201 NSDMHPMRVLFLIPKN-NPPTLT--GEFSKPFKEFIDACLNKDPSFRPT---AKELLKHKFIVKNA 260 (277)
T ss_pred CCCcChHhHhhhhhcC-CCCCCc--hhhhHHHHHHHHHHcccCcccCcC---HHHHHhChHhhhcc
Confidence 9887766665554332 122222 2578899999999999 9999998 99999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=347.39 Aligned_cols=252 Identities=23% Similarity=0.396 Sum_probs=209.0
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcE--EEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV--YAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~--~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
+..++|++.+.||+|+||.||+|.++.++.. +|+|.+... ........+.+|+.++..+ +||||+++++++.+.+
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~ 81 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 81 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCC
Confidence 4567899999999999999999999888765 577766532 2334456788899999999 8999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g 253 (497)
.+|+||||++||+|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+|||++.++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~ 161 (303)
T cd05088 82 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 161 (303)
T ss_pred CceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC
Confidence 9999999999999999996543 478999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC
Q 010947 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (497)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~ 333 (497)
.+||+|||+++...... ......+++.|+|||++.+..
T Consensus 162 ~~kl~dfg~~~~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~ 199 (303)
T cd05088 162 VAKIADFGLSRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSV 199 (303)
T ss_pred cEEeCccccCcccchhh------------------------------------------hcccCCCcccccCHHHHhccC
Confidence 99999999986321100 000123467899999998888
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 334 y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
++.++|||||||++|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||+ +|.+||+ ++++
T Consensus 200 ~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~i 273 (303)
T cd05088 200 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERPS---FAQI 273 (303)
T ss_pred CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHH
Confidence 9999999999999999998 99999988777776665432 122233 3578899999999999 9999999 8888
Q ss_pred cCC
Q 010947 412 KVH 414 (497)
Q Consensus 412 l~H 414 (497)
+.+
T Consensus 274 l~~ 276 (303)
T cd05088 274 LVS 276 (303)
T ss_pred HHH
Confidence 765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=347.94 Aligned_cols=254 Identities=31% Similarity=0.554 Sum_probs=214.9
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|+....||+|+||.||+|.+..+++.||||++..... ...+.+.+|+.++..++||||+++++.|...+..|+||||
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~ 99 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence 4445579999999999999999999999999865432 2345678899999999999999999999999999999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccc
Q 010947 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (497)
Q Consensus 198 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 277 (497)
+++++|..++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..+......
T Consensus 100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~----- 173 (297)
T cd06659 100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK----- 173 (297)
T ss_pred CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-----
Confidence 999999987744 67999999999999999999999999999999999999999999999999998754321100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCC
Q 010947 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (497)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF 357 (497)
....+|++.|+|||++.+..++.++|+|||||++|||++|++||
T Consensus 174 ------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~ 217 (297)
T cd06659 174 ------------------------------------RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPY 217 (297)
T ss_pred ------------------------------------ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 11357999999999999889999999999999999999999999
Q ss_pred CCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 358 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
...+..+....+.... .........++.++.++|.+||+ +|.+||+ +.++++||||...
T Consensus 218 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps---~~~ll~~~~~~~~ 277 (297)
T cd06659 218 FSDSPVQAMKRLRDSP-PPKLKNAHKISPVLRDFLERMLTREPQERAT---AQELLDHPFLLQT 277 (297)
T ss_pred CCCCHHHHHHHHhccC-CCCccccCCCCHHHHHHHHHHhcCCcccCcC---HHHHhhChhhccC
Confidence 9887766665554321 11122223678899999999999 9999998 9999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=337.59 Aligned_cols=252 Identities=30% Similarity=0.504 Sum_probs=211.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|+.+.++..||||.+.............+..|+.+++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57999999999999999999999999999999987655445555667889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 196 EYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 196 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
||+++|+|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999988753 34589999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
......|++.|+|||.+.+..++.++|+|||||++|||+
T Consensus 162 -----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~ 200 (267)
T cd08228 162 -----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred -----------------------------------------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHh
Confidence 011356899999999999889999999999999999999
Q ss_pred hCCCCCCCCCh--HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 352 VGYPPFYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 352 ~G~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|..||..... ......+... .....+. ..++..+++||.+||+ +|.+||+ +.+|++
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~li~~cl~~~p~~Rp~---~~~vl~ 260 (267)
T cd08228 201 ALQSPFYGDKMNLFSLCQKIEQC-DYPPLPT-EHYSEKLRELVSMCIYPDPDQRPD---IGYVHQ 260 (267)
T ss_pred cCCCCCccccccHHHHHHHHhcC-CCCCCCh-hhcCHHHHHHHHHHCCCCcccCcC---HHHHHH
Confidence 99999976542 3344444321 1112221 2577899999999999 9999999 777765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=341.71 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=204.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..+|.+++.||+|+||.||+|.++.+|..||||++..... ......+.+|+.+++.++|+||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 4689999999999999999999999999999999875432 22233567899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||++ ++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-- 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ-- 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--
Confidence 99995 677666644 45688999999999999999999999999999999999999999999999999875421100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
.....++++.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 159 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~ 199 (291)
T cd07870 159 ---------------------------------------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQ 199 (291)
T ss_pred ---------------------------------------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHh
Confidence 0013467999999999875 458899999999999999999
Q ss_pred CCCCCCCCChH-HHHHHHhcccC------------------c---ccCCC-------CccCChhHHHHHHHHhh-Ccccc
Q 010947 353 GYPPFYSDDPM-STCRKIVNWRT------------------H---LKFPE-------EAKLSIEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 353 G~~PF~~~~~~-~~~~~i~~~~~------------------~---~~~p~-------~~~~s~~~~dLI~~lL~-dp~~R 402 (497)
|.+||.+.+.. +...++..... . ...+. ....++++.+||.+||+ ||.+|
T Consensus 200 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R 279 (291)
T cd07870 200 GQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDR 279 (291)
T ss_pred CCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccC
Confidence 99999865432 22222211000 0 00000 01236789999999999 99999
Q ss_pred CCCCCcchhcCCCCc
Q 010947 403 LGAKGADEIKVHPWF 417 (497)
Q Consensus 403 ~~~~~~~eil~Hpff 417 (497)
|+ +.+++.||||
T Consensus 280 ~t---~~~~l~h~~~ 291 (291)
T cd07870 280 IS---AQDALLHPYF 291 (291)
T ss_pred cC---HHHHhcCCCC
Confidence 99 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=341.21 Aligned_cols=254 Identities=30% Similarity=0.508 Sum_probs=211.7
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++++.||.|++|.||+|++..+|..||||+++.... ......+..|+.+++.++||||++++++|.+.+.+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999976532 2234557789999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 197 YLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 197 y~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|++| +|.+++... ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~- 156 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT- 156 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccc-
Confidence 9975 888887653 36899999999999999999999999999999999999999999999999999754321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
....++|+.|+|||++.+ ..++.++|+|||||++|+|++
T Consensus 157 ----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (284)
T cd07836 157 ----------------------------------------FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMIT 196 (284)
T ss_pred ----------------------------------------cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHh
Confidence 013468899999999875 457899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCc----------------ccCCC---------CccCChhHHHHHHHHhh-CccccCCCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTH----------------LKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~----------------~~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
|.+||.+.+..+...++...... ..+|. ...++++++++|.+||+ ||.+||+
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~-- 274 (284)
T cd07836 197 GRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS-- 274 (284)
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC--
Confidence 99999988777666655431100 00110 02468899999999999 9999998
Q ss_pred CcchhcCCCCc
Q 010947 407 GADEIKVHPWF 417 (497)
Q Consensus 407 ~~~eil~Hpff 417 (497)
+.++++||||
T Consensus 275 -~~~~l~~~~f 284 (284)
T cd07836 275 -AHDALQHPWF 284 (284)
T ss_pred -HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=347.05 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=206.4
Q ss_pred CeeEEeEeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--CeEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLY 192 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~l~ 192 (497)
.|++.+.||+|+||.||+|..+. ++..||+|++.............+.+|+.+++.++||||++++++|.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 48899999999999999999988 8999999999874432333445678899999999999999999999988 8899
Q ss_pred EEEeecCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC----CCcEEEcccccc
Q 010947 193 LIMEYLPGGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK----YGHLRLSDFGLC 263 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~----~g~vkL~DFGla 263 (497)
+||||+++ +|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++. +|.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999964 676666432 36899999999999999999999999999999999999999 999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHh
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 342 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwS 342 (497)
+.+....... ......+||+.|+|||++.+ ..++.++|+||
T Consensus 160 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 201 (316)
T cd07842 160 RLFNAPLKPL--------------------------------------ADLDPVVVTIWYRAPELLLGARHYTKAIDIWA 201 (316)
T ss_pred cccCCCcccc--------------------------------------cccCCccccccccCHHHHhCCCCCCcHHHHHH
Confidence 8653221000 00113578999999998876 45899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHH---------HHHHHhc------------------------ccCcccCCC---------
Q 010947 343 LGAIMYEMLVGYPPFYSDDPMS---------TCRKIVN------------------------WRTHLKFPE--------- 380 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~~~~---------~~~~i~~------------------------~~~~~~~p~--------- 380 (497)
|||++|+|++|.+||.+..... ....++. ......++.
T Consensus 202 lG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (316)
T cd07842 202 IGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEK 281 (316)
T ss_pred HHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHh
Confidence 9999999999999998654322 1111110 000111110
Q ss_pred CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 381 EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 381 ~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
....+.++.++|.+||. ||++||+ +.+++.||||
T Consensus 282 ~~~~~~~~~~~i~~~l~~~P~~Rps---~~eil~~~~f 316 (316)
T cd07842 282 HKKPDSQGFDLLRKLLEYDPTKRIT---AEEALEHPYF 316 (316)
T ss_pred ccCCCHHHHHHHHHHhcCCcccCcC---HHHHhcCCCC
Confidence 01567789999999999 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=351.63 Aligned_cols=261 Identities=28% Similarity=0.469 Sum_probs=208.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-----C
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 189 (497)
.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+..|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 468999999999999999999999999999999986422 223345677899999999999999999876543 3
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||||++ ++|..++. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 82 DVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred eEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 5899999995 58887774 467999999999999999999999999999999999999999999999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ 348 (497)
.... ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 160 ~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~ 201 (336)
T cd07849 160 HDHT--------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILA 201 (336)
T ss_pred cccc--------------------------------------CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHH
Confidence 1000 00113578999999998764 56899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhccc--------------------Cccc----CC---CCccCChhHHHHHHHHhh-Ccc
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWR--------------------THLK----FP---EEAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~--------------------~~~~----~p---~~~~~s~~~~dLI~~lL~-dp~ 400 (497)
+|++|++||.+.+.......+.... .... .+ ..+.+++++.+||.+||+ ||+
T Consensus 202 el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~ 281 (336)
T cd07849 202 EMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPH 281 (336)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChh
Confidence 9999999998765433322221100 0000 00 012468899999999999 999
Q ss_pred ccCCCCCcchhcCCCCccCC
Q 010947 401 QRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 401 ~R~~~~~~~eil~Hpff~~i 420 (497)
+||+ +.+++.||||+.+
T Consensus 282 ~Rpt---~~e~l~hp~~~~~ 298 (336)
T cd07849 282 KRIT---VEEALAHPYLEQY 298 (336)
T ss_pred hCcC---HHHHhcCcccccc
Confidence 9998 9999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=339.35 Aligned_cols=252 Identities=32% Similarity=0.505 Sum_probs=216.3
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|++++.||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++||||++++++|.++..+|+||||
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 7788899999999999999999999999999865432 23456788999999999999999999999999999999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccc
Q 010947 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (497)
Q Consensus 198 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 277 (497)
++||+|..++.. ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~----- 157 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK----- 157 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhh-----
Confidence 999999988854 57999999999999999999999999999999999999999999999999998765321100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCC
Q 010947 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (497)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF 357 (497)
.....|+..|+|||.+.+..++.++|+|||||++|+|++|.+||
T Consensus 158 ------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 201 (277)
T cd06641 158 ------------------------------------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPH 201 (277)
T ss_pred ------------------------------------hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCC
Confidence 01356899999999998888999999999999999999999999
Q ss_pred CCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 358 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
...+.......+... ....++ ..++.++.++|.+||. +|.+||+ +.++++||||..
T Consensus 202 ~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~l~~~~~~~ 258 (277)
T cd06641 202 SELHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFIVR 258 (277)
T ss_pred CccchHHHHHHHhcC-CCCCCC--cccCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhh
Confidence 887766665555432 222232 3578899999999999 9999998 999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=341.50 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=210.9
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+..++|.+.+.||+|+||+||+|... .++..+|+|.+.... ......+..|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVE 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence 34578999999999999999999853 345679999987542 3345668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKD-------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~-------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~ 254 (497)
.+.+|+||||+++|+|.+++...+ .+++..+..++.|++.||.|||+.|++||||||+|||++.++.
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~ 158 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 158 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc
Confidence 999999999999999999986543 4899999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC
Q 010947 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (497)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y 334 (497)
+||+|||+++......... ......+++.|+|||++.+..+
T Consensus 159 ~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 199 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYR---------------------------------------VGGHTMLPIRWMPPESIMYRKF 199 (288)
T ss_pred EEeccCCccccccCCceee---------------------------------------cCCCCCccccccCHHHhccCCC
Confidence 9999999998553211000 0012456889999999999999
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 335 GMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 335 ~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
+.++|+|||||++|+|++ |.+||.+.+.......+.... ....+ ..++.++.+||.+||+ ||.+||+ +.++
T Consensus 200 ~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rpt---~~~v 272 (288)
T cd05093 200 TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRP--RTCPKEVYDLMLGCWQREPHMRLN---IKEI 272 (288)
T ss_pred CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHccCChhhCCC---HHHH
Confidence 999999999999999998 999999888877777777532 22233 3688999999999999 9999999 6665
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=341.25 Aligned_cols=253 Identities=22% Similarity=0.378 Sum_probs=211.4
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
...+|.+.+.||+|+||.||+|.... ++..||||+++... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 35678999999999999999998753 46789999987542 222456789999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK--------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~ 254 (497)
...|+||||++||+|.+++... ..+++..+..++.|++.||.|||++|++||||||+|||++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 9999999999999999999754 24789999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC
Q 010947 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (497)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y 334 (497)
+||+|||+++......... ......+++.|+|||++.+..+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~ 201 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYR---------------------------------------VGGHTMLPIRWMPPESIMYRKF 201 (280)
T ss_pred EEECCcccceecccCccee---------------------------------------cCCCCcccceecChhhhccCCc
Confidence 9999999987543211000 0012356889999999999999
Q ss_pred CcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 335 GMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 335 ~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+.++|||||||++|||++ |..||.+.+..+....+.... ....| ..++.++++||.+||+ ||.+||+ +.|++
T Consensus 202 ~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~eil 275 (280)
T cd05049 202 TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGR-LLQRP--RTCPSEVYDIMLGCWKRDPQQRIN---IKDIH 275 (280)
T ss_pred chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCCcccCCC---HHHHH
Confidence 999999999999999998 999999888777777776422 11222 3688999999999999 9999998 77765
Q ss_pred C
Q 010947 413 V 413 (497)
Q Consensus 413 ~ 413 (497)
.
T Consensus 276 ~ 276 (280)
T cd05049 276 E 276 (280)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=339.41 Aligned_cols=254 Identities=17% Similarity=0.250 Sum_probs=209.6
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+..++|++.+.||+|+||.||+|.++ .++..||+|++..... ......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 80 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 45678999999999999999999864 2456799999865321 2234568889999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEE
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKD----------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~----------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL 257 (497)
....|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||+.|++||||||+|||++.++.++|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEE
Confidence 999999999999999999986532 3577888999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcc
Q 010947 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (497)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~ 337 (497)
+|||+++......... ......+++.|+|||++.+..++.+
T Consensus 161 ~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05062 161 GDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMSPESLKDGVFTTY 201 (277)
T ss_pred CCCCCccccCCcceee---------------------------------------cCCCCccCHhhcChhHhhcCCcCch
Confidence 9999987653221100 0002356788999999998999999
Q ss_pred hhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 338 CDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 338 ~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|+|||||++|||++ |.+||.+.+.......+... ....+| ..++..+++||.+||+ ||.+||+ +.+++.
T Consensus 202 ~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~ 273 (277)
T cd05062 202 SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEG-GLLDKP--DNCPDMLFELMRMCWQYNPKMRPS---FLEIIS 273 (277)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 999999999999999 79999988877777666642 222333 3678899999999999 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=343.41 Aligned_cols=256 Identities=30% Similarity=0.494 Sum_probs=212.1
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--CeEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLY 192 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~l~ 192 (497)
.++|++.+.||.|+||.||+|.++.+++.+|+|.++..... ......+.+|+.++..++||||+++++++.+. ..+|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35799999999999999999999999999999999765432 22334567899999999999999999998877 8999
Q ss_pred EEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 193 LIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
+||||++ ++|.+++.... .+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 83 lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 161 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK 161 (293)
T ss_pred EEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence 9999996 58998887644 599999999999999999999999999999999999999999999999999886542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~el 350 (497)
......+++.|+|||++.+. .++.++|+|||||++|+|
T Consensus 162 -----------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l 200 (293)
T cd07843 162 -----------------------------------------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAEL 200 (293)
T ss_pred -----------------------------------------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHH
Confidence 00134578999999998764 468999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCc-----------------------------ccCCCCccCChhHHHHHHHHhh-Ccc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTH-----------------------------LKFPEEAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~-----------------------------~~~p~~~~~s~~~~dLI~~lL~-dp~ 400 (497)
++|.+||.+.+....+.++...-.. -.+|. ..+++.+++||.+||+ +|+
T Consensus 201 ~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~ 279 (293)
T cd07843 201 LTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPA-LSLSDNGFDLLNRLLTYDPA 279 (293)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccc-cCCChHHHHHHHHHhccCcc
Confidence 9999999988777666655421000 00111 1158899999999999 999
Q ss_pred ccCCCCCcchhcCCCCc
Q 010947 401 QRLGAKGADEIKVHPWF 417 (497)
Q Consensus 401 ~R~~~~~~~eil~Hpff 417 (497)
+||+ +.|++.||||
T Consensus 280 ~R~t---~~ell~~~~f 293 (293)
T cd07843 280 KRIS---AEDALKHPYF 293 (293)
T ss_pred ccCC---HHHHhcCCCC
Confidence 9999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=339.94 Aligned_cols=254 Identities=19% Similarity=0.373 Sum_probs=211.0
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEc----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
..++|++.+.||+|+||+||+|... .++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4578999999999999999999853 456789999987532 2334466888999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK-----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~-----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~ 252 (497)
..|+||||+++|+|.+++... ..+++..+..++.+++.||.|||++||+||||||+|||++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 999999999999999998532 247888999999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC
Q 010947 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (497)
Q Consensus 253 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~ 332 (497)
+.+||+|||+++......... ...+..++..|+|||++.+.
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYR---------------------------------------VQPKSLLPIRWMPPEAIMYG 201 (283)
T ss_pred CcEEeccccccccccCCccee---------------------------------------cccCCCccceecChHHhccC
Confidence 999999999998653221100 01134567889999999988
Q ss_pred CCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcch
Q 010947 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (497)
Q Consensus 333 ~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~e 410 (497)
.++.++|+|||||++|||++ |.+||.+.+.......+... ..+..| ..++++++++|.+||+ ||.+||+ +.+
T Consensus 202 ~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~ 275 (283)
T cd05090 202 KFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLPCS--EDCPPRMYSLMTECWQEGPSRRPR---FKD 275 (283)
T ss_pred CCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccCcccCcC---HHH
Confidence 99999999999999999998 99999988776666666542 223333 4689999999999999 9999999 666
Q ss_pred hcCC
Q 010947 411 IKVH 414 (497)
Q Consensus 411 il~H 414 (497)
|+++
T Consensus 276 i~~~ 279 (283)
T cd05090 276 IHTR 279 (283)
T ss_pred HHHH
Confidence 6543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=377.15 Aligned_cols=265 Identities=24% Similarity=0.356 Sum_probs=206.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|.+..+|+.||||++............++.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999999999999999997654333344567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 196 EYLPGGDMMTLLMRK-----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~-----------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
||++||+|.+++.+. ..++...+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998642 234566778899999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlG 344 (497)
............... ...... ..-......+||+.|+|||++.+..++.++||||||
T Consensus 162 ~i~~~~~~~~~l~~~----------~~~s~~-------------s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLG 218 (932)
T PRK13184 162 FKKLEEEDLLDIDVD----------ERNICY-------------SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALG 218 (932)
T ss_pred ecccccccccccccc----------cccccc-------------cccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHH
Confidence 763221100000000 000000 000001135799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|++|||++|.+||.+.+.......... ......+....+++.+.+++.+||. ||.+|++
T Consensus 219 VILyELLTG~~PF~~~~~~ki~~~~~i-~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 219 VILYQMLTLSFPYRRKKGRKISYRDVI-LSPIEVAPYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred HHHHHHHHCCCCCCCcchhhhhhhhhc-cChhhccccccCCHHHHHHHHHHccCChhhCcC
Confidence 999999999999987654433222111 1112222224688999999999999 9999987
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=334.14 Aligned_cols=253 Identities=31% Similarity=0.576 Sum_probs=216.6
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|.+.+.||+|+||.||+|..+.+|..||+|.+..... .......+.+|+.+++.++||||+++++.+.+...+|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 58899999999999999999999999999999976533 22344567889999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc-EEEcccccccccCCCCccc
Q 010947 197 YLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 197 y~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~-vkL~DFGla~~~~~~~~~~ 273 (497)
|+++++|.+++.... .+++..+..++.+++.||.|||+.+++|+||||+||+++.++. +||+|||++........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~-- 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME-- 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc--
Confidence 999999999987643 5899999999999999999999999999999999999998865 69999999876532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
......|++.|+|||++.+..++.++|+|||||++|||++|
T Consensus 158 ---------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08225 158 ---------------------------------------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198 (257)
T ss_pred ---------------------------------------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 01134689999999999888899999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
..||.+.+..+....+.... + .+....++.+++++|.+||. +|.+||+ +.+++.||||
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~~~~~ 257 (257)
T cd08225 199 KHPFEGNNLHQLVLKICQGY--F-APISPNFSRDLRSLISQLFKVSPRDRPS---ITSILKRPFL 257 (257)
T ss_pred CCCCCCccHHHHHHHHhccc--C-CCCCCCCCHHHHHHHHHHhccChhhCcC---HHHHhhCCCC
Confidence 99999887777766665422 1 11123678899999999999 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=352.41 Aligned_cols=263 Identities=27% Similarity=0.437 Sum_probs=213.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee----cCCeE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ----DDEFL 191 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~----~~~~l 191 (497)
++|++.+.||.|+||.||+|..+.+|..||+|++..... .......+..|+.+|+.++||||++++++|. +...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999976432 2234556778999999999999999998876 34578
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||+. |+|.+++.....+++..+..++.||+.||.|||+.||+||||||+||+++.+|.+||+|||+++.......
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 99999995 68999998778899999999999999999999999999999999999999999999999999976532211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~el 350 (497)
.. .......+||..|+|||++.+ ..++.++|+|||||++|||
T Consensus 163 ~~-------------------------------------~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el 205 (334)
T cd07855 163 EH-------------------------------------KYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205 (334)
T ss_pred CC-------------------------------------CcccccccccccccChHHhcCCcccccccchHHHHHHHHHH
Confidence 00 000113579999999999876 5689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcc------------------------cCcccCCC---CccCChhHHHHHHHHhh-Ccccc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNW------------------------RTHLKFPE---EAKLSIEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~------------------------~~~~~~p~---~~~~s~~~~dLI~~lL~-dp~~R 402 (497)
++|.+||.+.+.......+... ......+. ...++.++++||.+||+ +|.+|
T Consensus 206 ~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 285 (334)
T cd07855 206 LGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEER 285 (334)
T ss_pred HcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhC
Confidence 9999999887654443332210 00001110 12468899999999999 99999
Q ss_pred CCCCCcchhcCCCCccCC
Q 010947 403 LGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 403 ~~~~~~~eil~Hpff~~i 420 (497)
|+ +.+++.||||.+.
T Consensus 286 pt---~~~~l~~~~~~~~ 300 (334)
T cd07855 286 IT---VEQALQHPFLAQY 300 (334)
T ss_pred cC---HHHHHhChhhhhc
Confidence 98 9999999999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=334.81 Aligned_cols=250 Identities=22% Similarity=0.393 Sum_probs=210.6
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
.+..++|++++.||+|+||.||+|... ++..||+|.+.... ...+.+..|+.+++.++||||+++++.+.+.+.+
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 356678999999999999999999864 55679999986532 2346788999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
|+||||++||+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.++|+|||++......
T Consensus 77 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05072 77 YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDN 156 (261)
T ss_pred EEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCC
Confidence 9999999999999998653 46889999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
... ......++..|+|||++....++.++|||||||++|+
T Consensus 157 ~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 196 (261)
T cd05072 157 EYT----------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYE 196 (261)
T ss_pred cee----------------------------------------ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHH
Confidence 100 0012346778999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
|++ |..||.+.+.......+... ...|....++.++.+||.+||. +|.+||+ ++++.
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~ 255 (261)
T cd05072 197 IVTYGKIPYPGMSNSDVMSALQRG---YRMPRMENCPDELYDIMKTCWKEKAEERPT---FDYLQ 255 (261)
T ss_pred HHccCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHccCCcccCcC---HHHHH
Confidence 998 99999988877777666542 2334334688999999999999 9999999 65553
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=352.67 Aligned_cols=257 Identities=22% Similarity=0.326 Sum_probs=207.8
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 185 (497)
.+..++|++.+.||.|+||.||+|... .+++.||+|+++... .......+..|+.++..+ +||||++++++|
T Consensus 3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 455678999999999999999999754 345789999987532 123345677899999999 899999999988
Q ss_pred ec-CCeEEEEEeecCCCchhHHHHhc------------------------------------------------------
Q 010947 186 QD-DEFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (497)
Q Consensus 186 ~~-~~~l~lVmEy~~gg~L~~~l~~~------------------------------------------------------ 210 (497)
.. ...+|+||||++||+|.+++...
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 46789999999999999988542
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCC
Q 010947 211 -------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (497)
Q Consensus 211 -------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (497)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.......
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~---------- 230 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---------- 230 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchh----------
Confidence 268899999999999999999999999999999999999999999999999998653221000
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCCh
Q 010947 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDP 362 (497)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~ 362 (497)
...+..+++.|+|||++.+..++.++|||||||++|||++ |.+||.+...
T Consensus 231 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~ 281 (337)
T cd05054 231 -----------------------------RKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQI 281 (337)
T ss_pred -----------------------------hccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 0013456788999999999999999999999999999998 9999988655
Q ss_pred HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 363 MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 363 ~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
.+.....+........| ..+++++.+++.+||+ +|.+||+ +++|++|
T Consensus 282 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~~cl~~~p~~RPs---~~ell~~ 329 (337)
T cd05054 282 DEEFCRRLKEGTRMRAP--EYATPEIYSIMLDCWHNNPEDRPT---FSELVEI 329 (337)
T ss_pred cHHHHHHHhccCCCCCC--ccCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 55444444322233333 3678999999999999 9999999 7787654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=351.54 Aligned_cols=260 Identities=26% Similarity=0.416 Sum_probs=212.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-----C
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 189 (497)
..+|.+.+.||+|+||.||+|.+..++..||||.+.... ........+..|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAF-DNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 357999999999999999999999999999999987542 2233345677899999999999999999887654 3
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||||+. ++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.....
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~ 161 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence 5899999995 789999988888999999999999999999999999999999999999999999999999999765321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ 348 (497)
.. .....+||..|+|||.+.. ..++.++|+|||||++|
T Consensus 162 ~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~ 200 (337)
T cd07858 162 GD-----------------------------------------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA 200 (337)
T ss_pred cc-----------------------------------------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHH
Confidence 10 0113568999999999875 56899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCc--------------------c---cCC----CCccCChhHHHHHHHHhh-Ccc
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTH--------------------L---KFP----EEAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~--------------------~---~~p----~~~~~s~~~~dLI~~lL~-dp~ 400 (497)
+|++|.+||.+.+.......+...... + ..+ ....+++++++||++||+ +|.
T Consensus 201 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 280 (337)
T cd07858 201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPS 280 (337)
T ss_pred HHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChh
Confidence 999999999877654433333210000 0 000 013588999999999999 999
Q ss_pred ccCCCCCcchhcCCCCccCC
Q 010947 401 QRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 401 ~R~~~~~~~eil~Hpff~~i 420 (497)
+||+ +.++++||||..+
T Consensus 281 ~Rps---~~ell~h~~~~~~ 297 (337)
T cd07858 281 KRIT---VEEALAHPYLASL 297 (337)
T ss_pred hccC---HHHHHcCcchhhh
Confidence 9998 9999999999865
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=345.11 Aligned_cols=255 Identities=31% Similarity=0.489 Sum_probs=215.7
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|+.++.||.|+||.||+|.+..++..||+|++..... ......+..|+.+++.++||||+++++.|.+++..|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 36677889999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|++||+|.+++. .+.+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++..+......
T Consensus 83 ~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~---- 157 (277)
T cd06642 83 YLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK---- 157 (277)
T ss_pred ccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchh----
Confidence 999999999885 467999999999999999999999999999999999999999999999999998765321100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
.....|+..|+|||++.+..++.++|+|||||++|||++|.+|
T Consensus 158 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p 200 (277)
T cd06642 158 -------------------------------------RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 200 (277)
T ss_pred -------------------------------------hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCC
Confidence 0134689999999999998999999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
|....+......+... ....++ ..++.++.+||.+||. +|.+||+ +.++++||||....
T Consensus 201 ~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~~~~~ 260 (277)
T cd06642 201 NSDLHPMRVLFLIPKN-SPPTLE--GQYSKPFKEFVEACLNKDPRFRPT---AKELLKHKFITRYT 260 (277)
T ss_pred CcccchhhHHhhhhcC-CCCCCC--cccCHHHHHHHHHHccCCcccCcC---HHHHHHhHHHHHHh
Confidence 9876665554444321 111222 2578899999999999 9999998 99999999997544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=333.57 Aligned_cols=249 Identities=20% Similarity=0.364 Sum_probs=209.0
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|++.+.||+|+||.||+|..+. +..+|+|.+..... ....+..|+.+|+.++||||++++++|.+...+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 76 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI 76 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence 34679999999999999999998754 56799999875432 23457889999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||++||+|.+++.. .+.+++..+..++.+++.||.|||+.||+||||||+||+++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 9999999999999865 356899999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
. .....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 157 ~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~ 196 (256)
T cd05114 157 S----------------------------------------SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT 196 (256)
T ss_pred c----------------------------------------cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHc
Confidence 0 012345678999999998899999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|.+||.+.+..+....+.... ....|. ..+.++.+||.+||+ +|.+||+ +.++++
T Consensus 197 ~g~~p~~~~~~~~~~~~i~~~~-~~~~~~--~~~~~~~~li~~c~~~~p~~Rps---~~~l~~ 253 (256)
T cd05114 197 EGKMPFEKKSNYEVVEMISRGF-RLYRPK--LASMTVYEVMYSCWHEKPEGRPT---FAELLR 253 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHCCC-CCCCCC--CCCHHHHHHHHHHccCCcccCcC---HHHHHH
Confidence 999999988888887776532 222332 568899999999999 9999999 777653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=338.48 Aligned_cols=256 Identities=30% Similarity=0.479 Sum_probs=212.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--CeEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLYL 193 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~l~l 193 (497)
++|+..+.||.|++|.||+|.+..+++.||+|.+..... ......+.+|+++++.++||||++++++|.+. ..+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 479999999999999999999999999999999976432 23445688899999999999999999988653 47899
Q ss_pred EEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 194 IMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
||||++||+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999888653 356899999999999999999999999999999999999999999999999998754211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
. .....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 159 ~-------------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~ 195 (287)
T cd06621 159 L-------------------------------------------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLE 195 (287)
T ss_pred c-------------------------------------------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHH
Confidence 0 012457889999999999999999999999999999
Q ss_pred HHhCCCCCCCC-----ChHHHHHHHhcccCcccCCC----CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 350 MLVGYPPFYSD-----DPMSTCRKIVNWRTHLKFPE----EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 350 ll~G~~PF~~~-----~~~~~~~~i~~~~~~~~~p~----~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|++|..||... ...+....+.... ...++. ....++++.+||.+||. +|.+||+ +.|++.||||+.
T Consensus 196 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~eil~~~~~~~ 271 (287)
T cd06621 196 VAQNRFPFPPEGEPPLGPIELLSYIVNMP-NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPT---PWDMLEHPWIKA 271 (287)
T ss_pred HHhCCCCCCcccCCCCChHHHHHHHhcCC-chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCC---HHHHHhCccccc
Confidence 99999999866 2334444444321 111221 12356789999999999 9999999 999999999975
Q ss_pred C
Q 010947 420 V 420 (497)
Q Consensus 420 i 420 (497)
.
T Consensus 272 ~ 272 (287)
T cd06621 272 Q 272 (287)
T ss_pred c
Confidence 4
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=342.32 Aligned_cols=261 Identities=30% Similarity=0.428 Sum_probs=206.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
.++|++.+.||+|+||.||+|.++.+++.||||++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 4679999999999999999999999999999999865432 1222345678999999999999999999887654
Q ss_pred ---eEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 190 ---FLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 190 ---~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
..|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++..
T Consensus 90 ~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 168 (310)
T cd07865 90 YKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARA 168 (310)
T ss_pred CCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccc
Confidence 4599999995 58888776543 789999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 344 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlG 344 (497)
+........ ......++++.|+|||++.+. .++.++|+||||
T Consensus 169 ~~~~~~~~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG 211 (310)
T cd07865 169 FSLSKNSKP-------------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAG 211 (310)
T ss_pred ccCCcccCC-------------------------------------CCccCcccCccccCcHHhcCCcccCchhhhHHHH
Confidence 543211000 001134688999999998764 478999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhcccCc-----------------ccCCCC-----------ccCChhHHHHHHHHh
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH-----------------LKFPEE-----------AKLSIEAKDLISKLL 396 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~~-----------~~~s~~~~dLI~~lL 396 (497)
|++|||++|.+||.+.+.......+..-... ..+|.. ...+..+++||.+||
T Consensus 212 ~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l 291 (310)
T cd07865 212 CIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLL 291 (310)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHh
Confidence 9999999999999887765443332221000 011110 123677899999999
Q ss_pred h-CccccCCCCCcchhcCCCCc
Q 010947 397 C-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 397 ~-dp~~R~~~~~~~eil~Hpff 417 (497)
+ ||.+||+ ++++++||||
T Consensus 292 ~~~P~~R~t---~~e~l~h~~f 310 (310)
T cd07865 292 VLDPAKRID---ADTALNHDFF 310 (310)
T ss_pred cCChhhccC---HHHHhcCCCC
Confidence 9 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=332.44 Aligned_cols=249 Identities=51% Similarity=0.921 Sum_probs=219.9
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L 203 (497)
||.|+||.||+|.+..+++.||+|++.+...........+..|+.+++.++||||+++++.+.++...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999989999999999887665555677899999999999999999999999999999999999999999
Q ss_pred hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCC
Q 010947 204 MTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (497)
Q Consensus 204 ~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (497)
.+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------------ 148 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------------ 148 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCC------------
Confidence 99998888899999999999999999999999999999999999999999999999999876532210
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChH
Q 010947 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363 (497)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~ 363 (497)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..
T Consensus 149 -----------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~ 199 (250)
T cd05123 149 -----------------------------RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK 199 (250)
T ss_pred -----------------------------cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH
Confidence 011356899999999999888999999999999999999999999888777
Q ss_pred HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 364 STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 364 ~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
.....+.. ..+.+|. .++.++.++|.+||+ ||.+||++..+++++.||||
T Consensus 200 ~~~~~~~~--~~~~~~~--~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 200 EIYEKILK--DPLRFPE--FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHhc--CCCCCCC--CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 77777765 3455554 678999999999999 99999994333999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=338.21 Aligned_cols=261 Identities=31% Similarity=0.522 Sum_probs=224.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..+.|++.+.||.|+||.||+|.+..++..||+|++..... ....+..|+++++.++|+||+++++.|......|+
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEE
Confidence 45669999999999999999999998999999999976432 45567889999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||++|++|.+++.... .+++..+..++.+++.||.|||+.||+|+||+|+||+++.+|.++|+|||++.........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 172 (286)
T cd06614 93 VMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172 (286)
T ss_pred EEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhh
Confidence 999999999999998876 8999999999999999999999999999999999999999999999999998654321000
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.....|++.|+|||++.+..++.++|+|||||++|+|++
T Consensus 173 -----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~ 211 (286)
T cd06614 173 -----------------------------------------RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAE 211 (286)
T ss_pred -----------------------------------------hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHh
Confidence 013458899999999998889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChh
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
|..||...+.......+... .....+....++.++++||.+||+ +|..||+ +.+++.||||....|.
T Consensus 212 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~~~~~ 279 (286)
T cd06614 212 GEPPYLREPPLRALFLITTK-GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS---AEELLQHPFLKKACPK 279 (286)
T ss_pred CCCCCCCCCHHHHHHHHHhc-CCCCCcchhhCCHHHHHHHHHHhccChhhCcC---HHHHhhChHhhccCch
Confidence 99999988776666555432 222333333488999999999999 9999998 9999999999986554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=338.47 Aligned_cols=256 Identities=31% Similarity=0.531 Sum_probs=215.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC---CCceeEEEEEeecCCeEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~l~l 193 (497)
.|++++.||.|+||.||+|.+..+++.||+|++.... .......+.+|+.+++.+. ||||++++++|.+....|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 4778899999999999999999999999999987542 2334566888999999986 9999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||||++|++|.+++.. +.+++..+..++.+++.||.|||+.||+||||+|+||+++.++.++|+|||++..+......
T Consensus 80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~- 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSK- 157 (277)
T ss_pred EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccc-
Confidence 9999999999998855 58999999999999999999999999999999999999999999999999999865422100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~ 352 (497)
.....|++.|+|||.+.+ ..++.++|+|||||++|+|++
T Consensus 158 ----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~ 197 (277)
T cd06917 158 ----------------------------------------RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMAT 197 (277)
T ss_pred ----------------------------------------cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHh
Confidence 013469999999999875 457899999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
|.+||.+.+.......+... ....++. ..++.++.+||.+||. ||.+||+ +.+++.||||+...
T Consensus 198 g~~p~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~~l~~~p~~R~~---~~~il~~~~~~~~~ 262 (277)
T cd06917 198 GNPPYSDVDAFRAMMLIPKS-KPPRLED-NGYSKLLREFVAACLDEEPKERLS---AEELLKSKWIKAHS 262 (277)
T ss_pred CCCCCCCCChhhhhhccccC-CCCCCCc-ccCCHHHHHHHHHHcCCCcccCcC---HHHHhhChHhhccc
Confidence 99999887665554433321 1222222 2378899999999999 9999998 99999999998653
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=339.73 Aligned_cols=254 Identities=31% Similarity=0.510 Sum_probs=211.2
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|++++.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 6788999999999999999999999999999976432 223345678899999999999999999999999999999999
Q ss_pred cCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 198 LPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 198 ~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
++ ++|.+++.... .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..+......
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~--- 155 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--- 155 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc---
Confidence 95 68999987665 7999999999999999999999999999999999999999999999999998754321000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....+++.|+|||++.+. .++.++|+|||||++|+|++|.
T Consensus 156 --------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 197 (283)
T cd07835 156 --------------------------------------YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197 (283)
T ss_pred --------------------------------------cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence 0124578999999988764 5789999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcc----------------cCC---------CCccCChhHHHHHHHHhh-CccccCCCCCc
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHL----------------KFP---------EEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~----------------~~p---------~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~ 408 (497)
+||.+.+......++....... .++ ....++.++.+||.+||+ ||.+||+ +
T Consensus 198 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt---~ 274 (283)
T cd07835 198 PLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS---A 274 (283)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcC---H
Confidence 9999887665555543311000 011 013578899999999999 9999998 9
Q ss_pred chhcCCCCc
Q 010947 409 DEIKVHPWF 417 (497)
Q Consensus 409 ~eil~Hpff 417 (497)
++++.||||
T Consensus 275 ~~il~~~~~ 283 (283)
T cd07835 275 KAALQHPYF 283 (283)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=306.99 Aligned_cols=257 Identities=30% Similarity=0.537 Sum_probs=217.8
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|...+.||+|+||+||+++.+.|++.||+|.++-++- +.+--....+|+-+|+.++|.|||++++....++.+-+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 45566789999999999999999999999999976542 22223457789999999999999999999999999999999
Q ss_pred ecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 197 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|| ..+|..+..+ ++.++.+.++.++.|++.||.|+|+++++||||||.|+||+.+|.+||+|||+|+.+.-..
T Consensus 82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipv----- 155 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV----- 155 (292)
T ss_pred Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCce-----
Confidence 99 5688887765 5679999999999999999999999999999999999999999999999999999765321
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccc-cccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHh-
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY-STVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLV- 352 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~- 352 (497)
.++ ..+-|.+|.+|.++.+ +-|+...|+||.|||+.|+..
T Consensus 156 -------------------------------------rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelana 198 (292)
T KOG0662|consen 156 -------------------------------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_pred -------------------------------------EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhc
Confidence 112 2468999999999987 458999999999999999986
Q ss_pred CCCCCCCCChHHHHHHHhc---------ccCcccCCCC----------------ccCChhHHHHHHHHhh-CccccCCCC
Q 010947 353 GYPPFYSDDPMSTCRKIVN---------WRTHLKFPEE----------------AKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~---------~~~~~~~p~~----------------~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
|.|.|.|.+..++..+|.. |+.-..+|+- +.++...+||+++||. +|.+|++
T Consensus 199 grplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qris-- 276 (292)
T KOG0662|consen 199 GRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS-- 276 (292)
T ss_pred CCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccC--
Confidence 8999999999999888863 4333233321 3466778999999996 9999999
Q ss_pred CcchhcCCCCccCC
Q 010947 407 GADEIKVHPWFDGV 420 (497)
Q Consensus 407 ~~~eil~Hpff~~i 420 (497)
+++.++||||.+.
T Consensus 277 -aeaalqhpyf~d~ 289 (292)
T KOG0662|consen 277 -AEAALQHPYFSDF 289 (292)
T ss_pred -HHHHhcCcccccc
Confidence 9999999999864
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=355.97 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=206.4
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYC 183 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~ 183 (497)
+..+..++|.+++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+.+. |||||++++
T Consensus 31 ~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 4556678899999999999999999987433 3469999997542 2334567889999999996 999999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhc-----------------------------------------------------
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK----------------------------------------------------- 210 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~----------------------------------------------------- 210 (497)
+|.+...+|||||||+||+|.++|...
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 999999999999999999999988542
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCe
Q 010947 211 -------------------------------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (497)
Q Consensus 211 -------------------------------------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NI 247 (497)
..+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2477888899999999999999999999999999999
Q ss_pred eecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcc
Q 010947 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (497)
Q Consensus 248 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 327 (497)
|++.++.+||+|||+++.+...... .......|++.|+|||
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE 309 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNY---------------------------------------VSKGSTFLPVKWMAPE 309 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccc---------------------------------------cccCCcCCCcceEChh
Confidence 9999999999999999865321100 0011346788999999
Q ss_pred ccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC
Q 010947 328 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 328 ~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
++.+..++.++|||||||++|||++ |..||.+..........+........| ..++.++.+||.+||. ||.+||+.
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt~ 387 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP--DHATQEVYDIMVKCWNSEPEKRPSF 387 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHHCccCHhHCcCH
Confidence 9999999999999999999999997 999998765544443333322223333 4688999999999999 99999993
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=359.56 Aligned_cols=252 Identities=24% Similarity=0.434 Sum_probs=221.9
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-chhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe--EEEEEe
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF--LYLIME 196 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~--l~lVmE 196 (497)
...+||+|+|-+||+|.+..+|..||--.++-.++. .....+++..|+.+|+.|+|||||++|+++.+..+ +-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 345899999999999999999999987666555443 34567899999999999999999999999997665 889999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--CEEEcccCCCCeeecCC-CcEEEcccccccccCCCCccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--HYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--~iiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~~~~~ 273 (497)
++.+|+|..|+.+.+.++...++.|+.||+.||.|||++ .|||||||-+||+|+.+ |.|||+|+|||+.+..+
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s---- 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS---- 199 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc----
Confidence 999999999999999999999999999999999999998 69999999999999864 89999999999876432
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
.+.+.+|||.|||||+.. ..|+..+||||||++|+||+|+
T Consensus 200 ---------------------------------------~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~ 239 (632)
T KOG0584|consen 200 ---------------------------------------HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTS 239 (632)
T ss_pred ---------------------------------------ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhc
Confidence 234689999999999996 8999999999999999999999
Q ss_pred CCCCCC-CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCC
Q 010947 354 YPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 354 ~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i 420 (497)
..||.- .++.++|+++..+..+-.|.. --.+++++||.+||.-.++|++ +.|+|.||||..-
T Consensus 240 eYPYsEC~n~AQIYKKV~SGiKP~sl~k--V~dPevr~fIekCl~~~~~R~s---a~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 240 EYPYSECTNPAQIYKKVTSGIKPAALSK--VKDPEVREFIEKCLATKSERLS---AKELLKDPFFDED 302 (632)
T ss_pred cCChhhhCCHHHHHHHHHcCCCHHHhhc--cCCHHHHHHHHHHhcCchhccC---HHHHhhChhhccc
Confidence 999974 578899999998766555543 3478999999999987889999 9999999999864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=349.84 Aligned_cols=261 Identities=29% Similarity=0.450 Sum_probs=219.5
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----eE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-----FL 191 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~l 191 (497)
+|++.+.||.|+||.||+|.+..+++.||||++.+.. ........+..|+.+++.++||||+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 5889999999999999999999999999999997642 12334567889999999999999999999998775 79
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||++ ++|..++.+...+++..+..++.+|+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999997 58999998878999999999999999999999999999999999999999999999999999986543210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~el 350 (497)
. ........||+.|+|||++.+. .++.++|+|||||++|+|
T Consensus 159 ~--------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l 200 (330)
T cd07834 159 E--------------------------------------KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAEL 200 (330)
T ss_pred c--------------------------------------cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHH
Confidence 0 0001235689999999999887 899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccC------------------CC---------CccCChhHHHHHHHHhh-Ccccc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKF------------------PE---------EAKLSIEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~------------------p~---------~~~~s~~~~dLI~~lL~-dp~~R 402 (497)
++|.+||.+.+..+.+..+......... +. ...+++++.+||.+||+ +|.+|
T Consensus 201 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 280 (330)
T cd07834 201 LTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKR 280 (330)
T ss_pred HcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhC
Confidence 9999999998887777666642111000 00 12368899999999999 99999
Q ss_pred CCCCCcchhcCCCCccCC
Q 010947 403 LGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 403 ~~~~~~~eil~Hpff~~i 420 (497)
|+ +++++.||||+++
T Consensus 281 pt---~~~ll~~~~~~~~ 295 (330)
T cd07834 281 IT---ADEALAHPYLAQL 295 (330)
T ss_pred CC---HHHHHhCccHHhh
Confidence 99 9999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=336.17 Aligned_cols=254 Identities=19% Similarity=0.301 Sum_probs=212.6
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+..++|.+.+.||+|+||.||+|..+.. +..||+|.+.... .......+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~ 80 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST 80 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence 4567899999999999999999998654 3789999986543 22344568889999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEE
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL 257 (497)
....|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||
T Consensus 81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence 99999999999999999998653 23678899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcc
Q 010947 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (497)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~ 337 (497)
+|||+++.+....... ......+|..|+|||.+.+..++.+
T Consensus 161 ~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05032 161 GDFGMTRDIYETDYYR---------------------------------------KGGKGLLPVRWMAPESLKDGVFTTK 201 (277)
T ss_pred CCcccchhhccCcccc---------------------------------------cCCCCCccccccCHHHHhcCCCCcc
Confidence 9999988653221000 0012457889999999998889999
Q ss_pred hhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 338 CDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 338 ~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|+|||||++|||++ |.+||.+.+..+....+.. .....+|. .++.++.+||.+||+ +|.+||+ +.+++.
T Consensus 202 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rpt---~~~l~~ 273 (277)
T cd05032 202 SDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGHLDLPE--NCPDKLLELMRMCWQYNPKMRPT---FLEIVS 273 (277)
T ss_pred cchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCCCCCCC--CCCHHHHHHHHHHcCCChhhCCC---HHHHHH
Confidence 999999999999998 9999998887777766653 33444554 578999999999999 9999998 777653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=343.26 Aligned_cols=253 Identities=28% Similarity=0.417 Sum_probs=215.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
..|...+.||+|+||.||+|.+..++..||+|++.............+..|+.+++.++|||++++++++.++...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 34888999999999999999999999999999997654434445567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||++| +|.+++.. ..++++..+..++.+++.||.|||+.||+||||+|+||+++.++.+||+|||++......
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~----- 178 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----- 178 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc-----
Confidence 99975 77777644 567999999999999999999999999999999999999999999999999998643211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHhHHHHHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwSlGvil~ell 351 (497)
....|++.|+|||++. .+.++.++|+|||||++|||+
T Consensus 179 ----------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~ 218 (317)
T cd06635 179 ----------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218 (317)
T ss_pred ----------------------------------------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHH
Confidence 1346899999999984 456899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+|.+||.+.+.......+...... .. ....+++.+++||.+||. +|.+||+ +.++++|||+..
T Consensus 219 ~g~~p~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~il~~~~~~~ 282 (317)
T cd06635 219 ERKPPLFNMNAMSALYHIAQNESP-TL-QSNEWSDYFRNFVDSCLQKIPQDRPT---SEELLKHMFVLR 282 (317)
T ss_pred hCCCCCCCccHHHHHHHHHhccCC-CC-CCccccHHHHHHHHHHccCCcccCcC---HHHHHhChhhhc
Confidence 999999988777766666643221 11 223578899999999999 9999998 999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=327.90 Aligned_cols=253 Identities=32% Similarity=0.559 Sum_probs=221.4
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+..|+++++.++|||++++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 588999999999999999999999999999999876432 3456779999999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|+++++|.+++.....+++..+..++.+++.||.+||+.||+||||+|+||+++.++.++|+|||++.........
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~---- 155 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD---- 155 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc----
Confidence 9999999999988889999999999999999999999999999999999999999999999999999866432100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|.+|
T Consensus 156 -------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p 198 (254)
T cd06627 156 -------------------------------------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPP 198 (254)
T ss_pred -------------------------------------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 0135689999999999888899999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|...+......++... ....+| ..++..++++|.+||. +|++||+ +.+++.||||
T Consensus 199 ~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~---~~~~l~~~~~ 254 (254)
T cd06627 199 YYDLNPMAALFRIVQD-DHPPLP--EGISPELKDFLMQCFQKDPNLRPT---AKQLLKHPWI 254 (254)
T ss_pred CCCccHHHHHHHHhcc-CCCCCC--CCCCHHHHHHHHHHHhCChhhCcC---HHHHhcCCCC
Confidence 9887766655555432 233344 3688999999999999 9999998 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=340.82 Aligned_cols=253 Identities=28% Similarity=0.410 Sum_probs=213.7
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|...+.||+|+||+||+|.+..+|..||||++.............+..|+.+++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66778899999999999999999999999999765444444556788899999999999999999999999999999999
Q ss_pred cCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 198 LPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 198 ~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
+. |+|.+++.. ..++++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-------- 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------- 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC--------
Confidence 96 577777654 45799999999999999999999999999999999999999999999999998753211
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHhHHHHHHHHHhC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwSlGvil~ell~G 353 (497)
.....|++.|+|||++. ...++.++|+|||||++|+|++|
T Consensus 174 -------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g 216 (313)
T cd06633 174 -------------------------------------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 216 (313)
T ss_pred -------------------------------------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhC
Confidence 01356899999999985 45688999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
.+||.+.+......++..... ...+ ...++..+++||.+||. +|.+||+ +.+++.||||...+
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~l~~li~~~l~~~P~~Rp~---~~~~l~~~~~~~~~ 280 (313)
T cd06633 217 KPPLFNMNAMSALYHIAQNDS-PTLQ-SNEWTDSFRGFVDYCLQKIPQERPA---SAELLRHDFVRRDR 280 (313)
T ss_pred CCCCCCCChHHHHHHHHhcCC-CCCC-ccccCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCc
Confidence 999998877666666553211 1111 23577889999999999 9999999 99999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=343.84 Aligned_cols=254 Identities=20% Similarity=0.354 Sum_probs=208.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcE----EEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV----YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~----~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
+...+|++++.||+|+||.||+|.+..++.. ||||+++... .......+..|+.+++.++||||+++++++...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~ 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence 4567899999999999999999998766664 8999986432 233445688899999999999999999998765
Q ss_pred CeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
..++|+||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 577999999999999999764 468999999999999999999999999999999999999999999999999998664
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
...... ......+++.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l 201 (316)
T cd05108 161 ADEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 201 (316)
T ss_pred CCCcce---------------------------------------eccCCccceeecChHHhccCCCCchhhhHHHHHHH
Confidence 221000 00123457789999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|||++ |.+||.+....+.. .++.....+ |....++.++.++|.+||. +|.+||+ +.+++.+
T Consensus 202 ~el~t~g~~p~~~~~~~~~~-~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps---~~~l~~~ 264 (316)
T cd05108 202 WELMTFGSKPYDGIPASEIS-SILEKGERL--PQPPICTIDVYMIMVKCWMIDADSRPK---FRELIIE 264 (316)
T ss_pred HHHHcCCCCCCCCCCHHHHH-HHHhCCCCC--CCCCCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 99997 99999887655543 444433333 3334788999999999999 9999999 7777765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=349.14 Aligned_cols=258 Identities=33% Similarity=0.505 Sum_probs=211.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
..+|.+.+.||+|+||.||+|.++.+|+.||||++.+... .......+..|+.+++.++||||++++++|....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 3579999999999999999999999999999999876432 2223456788999999999999999999887543
Q ss_pred -eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+||||+. ++|..++ ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~ 169 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA 169 (342)
T ss_pred ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence 4699999995 4776654 34699999999999999999999999999999999999999999999999999875421
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
. ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 170 ~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil 205 (342)
T cd07879 170 E--------------------------------------------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIM 205 (342)
T ss_pred C--------------------------------------------CCCceeeecccChhhhcCccccCchHHHHHHHHHH
Confidence 1 013468899999999876 4689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCc---------------------ccCCC------CccCChhHHHHHHHHhh-Cc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTH---------------------LKFPE------EAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~---------------------~~~p~------~~~~s~~~~dLI~~lL~-dp 399 (497)
|||++|+.||.+.+.......++..... ..++. .+.+++++++||.+||+ ||
T Consensus 206 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 285 (342)
T cd07879 206 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDV 285 (342)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCCh
Confidence 9999999999988766655554431100 00110 12467889999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCCChh
Q 010947 400 NQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
.+||+ +.+++.||||+++.+.
T Consensus 286 ~~R~~---~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 286 DKRLT---ATEALEHPYFDSFRDA 306 (342)
T ss_pred hhCcC---HHHHhcCcchhhcccc
Confidence 99998 9999999999987543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=336.31 Aligned_cols=255 Identities=21% Similarity=0.343 Sum_probs=211.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+..|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~ 80 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFE 80 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc
Confidence 345679999999999999999999977 77889999886432 23334568889999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC---cEEE
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKD-------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRL 257 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g---~vkL 257 (497)
....|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.|++||||||+|||++.++ .+||
T Consensus 81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 999999999999999999987653 489999999999999999999999999999999999998765 5999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcc
Q 010947 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (497)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~ 337 (497)
+|||+++.+....... ......+++.|+|||++.+..++.+
T Consensus 161 ~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~ 201 (277)
T cd05036 161 ADFGMARDIYRASYYR---------------------------------------KGGRAMLPIKWMPPEAFLDGIFTSK 201 (277)
T ss_pred ccCccccccCCcccee---------------------------------------cCCCCCccHhhCCHHHHhcCCcCch
Confidence 9999998653211000 0002234568999999998999999
Q ss_pred hhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 338 CDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 338 ~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
+|||||||++|||++ |..||.+.+.......+... ....+| ..++..+.++|.+||+ +|.+||+ +.++++|
T Consensus 202 ~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~cl~~~p~~Rps---~~~vl~~ 274 (277)
T cd05036 202 TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPP--KGCPGPVYRIMTDCWQHTPEDRPN---FATILER 274 (277)
T ss_pred hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCCcccCcC---HHHHHHH
Confidence 999999999999997 99999988777766665542 233344 3688999999999999 9999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=333.13 Aligned_cols=248 Identities=19% Similarity=0.331 Sum_probs=207.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..+|++.+.||+|+||.||+|.++ ++..+|+|++.+... ....+..|+.+++.++||||+++++++.+....|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 457899999999999999999876 466899999875432 223577899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||++|++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999999998653 468999999999999999999999999999999999999999999999999987543211000
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~- 352 (497)
.....++..|+|||++.+..++.++|+|||||++|+|++
T Consensus 158 ----------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~ 197 (256)
T cd05059 158 ----------------------------------------SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197 (256)
T ss_pred ----------------------------------------cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhcc
Confidence 001234567999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|.+||.+.+..+....+... .....| ..++.++.++|.+||+ +|.+||+ +.++++
T Consensus 198 g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rpt---~~~~l~ 253 (256)
T cd05059 198 GKMPYERFSNSEVVESVSAG-YRLYRP--KLAPTEVYTIMYSCWHEKPEDRPA---FKKLLS 253 (256)
T ss_pred CCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHhcCChhhCcC---HHHHHH
Confidence 89999888777777766542 222333 3689999999999999 9999998 777764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=339.34 Aligned_cols=255 Identities=20% Similarity=0.346 Sum_probs=211.9
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCC----------------cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCc
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTG----------------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~----------------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~ 177 (497)
...+|++++.||+|+||.||+|.+..++ ..||+|++..... ......+.+|+.++..++|||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~ 80 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPN 80 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCC
Confidence 3568999999999999999999876543 5689999876532 245567889999999999999
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchhHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCC
Q 010947 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-----------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (497)
Q Consensus 178 Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~N 246 (497)
|++++++|.++...++||||+++++|..++.... .+++..+..++.|++.||.|||+.||+||||||+|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~N 160 (296)
T cd05051 81 IARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRN 160 (296)
T ss_pred EeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhc
Confidence 9999999999999999999999999999997755 68999999999999999999999999999999999
Q ss_pred eeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCc
Q 010947 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (497)
Q Consensus 247 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 326 (497)
|+++.++.++|+|||+++.+....... ......+|+.|+||
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aP 201 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYR---------------------------------------VQGRAPLPIRWMAW 201 (296)
T ss_pred eeecCCCceEEccccceeecccCccee---------------------------------------ecCcCCCCceecCH
Confidence 999999999999999987653221000 01134578899999
Q ss_pred cccccCCCCcchhHHhHHHHHHHHHh--CCCCCCCCChHHHHHHHhcc----cCcccCCCCccCChhHHHHHHHHhh-Cc
Q 010947 327 EVLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRKIVNW----RTHLKFPEEAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 327 E~l~~~~y~~~~DiwSlGvil~ell~--G~~PF~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~~~~dLI~~lL~-dp 399 (497)
|++.+..++.++|||||||++|||++ |..||...+..+.+..+... ......+....++.++.+||.+||+ ||
T Consensus 202 E~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p 281 (296)
T cd05051 202 ESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDE 281 (296)
T ss_pred HHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccCh
Confidence 99998899999999999999999998 78999887777776666542 1122222334678899999999999 99
Q ss_pred cccCCCCCcchhc
Q 010947 400 NQRLGAKGADEIK 412 (497)
Q Consensus 400 ~~R~~~~~~~eil 412 (497)
.+||+ +.+|+
T Consensus 282 ~~Rpt---~~el~ 291 (296)
T cd05051 282 EDRPT---FREIH 291 (296)
T ss_pred hcCCC---HHHHH
Confidence 99999 77774
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=332.26 Aligned_cols=240 Identities=23% Similarity=0.363 Sum_probs=201.1
Q ss_pred EeeecCCeEEEEEEE--cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 123 MIGKGAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
.||+|+||.||+|.. +.++..+|+|+++... ......+.+..|+.+++.++||||+++++.+.+ +..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence 589999999999965 4578899999987543 223445678899999999999999999998764 567899999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
|+|.+++.....+++..+..++.|++.||.|||+.||+||||||.|||++.++.+||+|||+++.+........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~------ 153 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK------ 153 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee------
Confidence 99999998888899999999999999999999999999999999999999999999999999986542210000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~ 359 (497)
......+++.|+|||++....++.++|+|||||++|||++ |.+||.+
T Consensus 154 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 201 (257)
T cd05116 154 --------------------------------AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKG 201 (257)
T ss_pred --------------------------------ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 0012345689999999988889999999999999999998 9999998
Q ss_pred CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC
Q 010947 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
.+..+....+.+. .....|. .+++++++||.+||+ ||.+||+.
T Consensus 202 ~~~~~~~~~i~~~-~~~~~~~--~~~~~l~~li~~~~~~~p~~Rp~~ 245 (257)
T cd05116 202 MKGNEVTQMIESG-ERMECPQ--RCPPEMYDLMKLCWTYGVDERPGF 245 (257)
T ss_pred CCHHHHHHHHHCC-CCCCCCC--CCCHHHHHHHHHHhccCchhCcCH
Confidence 8877777776653 2334443 689999999999999 99999993
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=335.22 Aligned_cols=251 Identities=29% Similarity=0.515 Sum_probs=210.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|.+.+.||+|+||.||+|..+.++..||||.+.+...........+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57889999999999999999999999999999988765545555677889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 196 EYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 196 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
||++|++|.+++.. ...+++..+..++.+|+.||.|||+.|++|+||||+||+++.++.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998863 35689999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
.....+|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 -----------------------------------------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~ 200 (267)
T cd08229 162 -----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred -----------------------------------------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHH
Confidence 001356899999999999999999999999999999999
Q ss_pred hCCCCCCCCCh--HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 352 VGYPPFYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 352 ~G~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+|..||.+... ......+.... ....+. ..++.++++||.+||. ||.+||+ +.+|+
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~li~~~l~~~p~~Rpt---~~~i~ 259 (267)
T cd08229 201 ALQSPFYGDKMNLYSLCKKIEQCD-YPPLPS-DHYSEELRQLVNMCINPDPEKRPD---ITYVY 259 (267)
T ss_pred hCCCCcccccchHHHHhhhhhcCC-CCCCCc-ccccHHHHHHHHHhcCCCcccCCC---HHHHH
Confidence 99999976543 23334443211 111221 3578899999999999 9999999 66553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=347.30 Aligned_cols=260 Identities=26% Similarity=0.434 Sum_probs=209.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 188 (497)
..+|.+.+.||.|+||.||+|.++.+|..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence 368999999999999999999999999999999986643 24456788899999999999999999766543
Q ss_pred --------CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-CCcEEEcc
Q 010947 189 --------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSD 259 (497)
Q Consensus 189 --------~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-~g~vkL~D 259 (497)
..+|+||||++ ++|.+++. .+.+++..++.++.||+.||.|||+.||+||||||+||+++. ++.+||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred ccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 46899999996 58888774 457999999999999999999999999999999999999984 56789999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcch
Q 010947 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 338 (497)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~ 338 (497)
||+++.+....... ......+||..|+|||++.. ..++.++
T Consensus 159 fg~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 200 (342)
T cd07854 159 FGLARIVDPHYSHK--------------------------------------GYLSEGLVTKWYRSPRLLLSPNNYTKAI 200 (342)
T ss_pred cccceecCCccccc--------------------------------------cccccccccccccCHHHHhCccccCchh
Confidence 99997653211000 00012368899999998764 5688999
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccC-----------------------cccCCC---CccCChhHHHHH
Q 010947 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT-----------------------HLKFPE---EAKLSIEAKDLI 392 (497)
Q Consensus 339 DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~-----------------------~~~~p~---~~~~s~~~~dLI 392 (497)
|+|||||++|+|++|..||.+.+..+....++.... ....|. ...++.++++||
T Consensus 201 DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 280 (342)
T cd07854 201 DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFL 280 (342)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHH
Confidence 999999999999999999988776665555432100 000000 125788999999
Q ss_pred HHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 393 SKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 393 ~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
.+||+ ||.+||+ +.+++.||||+.+
T Consensus 281 ~~~L~~dP~~R~t---~~ell~h~~~~~~ 306 (342)
T cd07854 281 EQILTFNPMDRLT---AEEALMHPYMSCY 306 (342)
T ss_pred HHHhCCCchhccC---HHHHhCCCccccc
Confidence 99999 9999998 9999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=326.95 Aligned_cols=256 Identities=34% Similarity=0.542 Sum_probs=219.6
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--CeEEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLYLI 194 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~l~lV 194 (497)
+|.+.+.||+|++|.||+|....++..|++|++...... ......+.+|+.+++.++||||+++++.+.+. ..+|+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 478899999999999999999999999999999765432 34567789999999999999999999999988 899999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||+++++|.+++.+...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~- 158 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGE- 158 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccc-
Confidence 9999999999999887899999999999999999999999999999999999999999999999999998764321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
......++..|+|||.+....++.++|+||||+++|+|++|.
T Consensus 159 --------------------------------------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~ 200 (260)
T cd06606 159 --------------------------------------GTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK 200 (260)
T ss_pred --------------------------------------cccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 011356899999999999888999999999999999999999
Q ss_pred CCCCCCC-hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 355 PPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 355 ~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
.||...+ .......+........+|. .++.++++||.+||. +|.+||+ +.+++.||||
T Consensus 201 ~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 260 (260)
T cd06606 201 PPWSELGNPMAALYKIGSSGEPPEIPE--HLSEEAKDFLRKCLRRDPKKRPT---ADELLQHPFL 260 (260)
T ss_pred CCCCCCCchHHHHHhccccCCCcCCCc--ccCHHHHHHHHHhCcCChhhCCC---HHHHhhCCCC
Confidence 9998765 3333334433223334443 678999999999999 9999998 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.61 Aligned_cols=253 Identities=30% Similarity=0.474 Sum_probs=209.8
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc---CCCceeEEEEEeecCCe----
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEF---- 190 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~---- 190 (497)
|++.+.||+|+||.||+|+++.+++.||+|+++.... .......+.+|+.++..+ +||||++++++|.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6789999999999999999998999999999975432 222334566788877665 69999999999998776
Q ss_pred -EEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 191 -LYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 191 -l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
+|+||||++ ++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++..+.
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999996 58988886643 59999999999999999999999999999999999999999999999999987653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
.... ....+|++.|+|||++.+..++.++|+|||||++
T Consensus 159 ~~~~------------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l 196 (287)
T cd07838 159 FEMA------------------------------------------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIF 196 (287)
T ss_pred CCcc------------------------------------------cccccccccccChHHhccCCCCCcchhhhHHHHH
Confidence 2210 0134588999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccC---cccCC-----------C---------CccCChhHHHHHHHHhh-CccccC
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRT---HLKFP-----------E---------EAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~---~~~~p-----------~---------~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
|+|++|.+||.+.+..+.+.++..... ...++ . ...+++++.+||.+||+ ||.+||
T Consensus 197 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 276 (287)
T cd07838 197 AELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI 276 (287)
T ss_pred HHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC
Confidence 999999999999888777777653110 00001 0 02457889999999999 999999
Q ss_pred CCCCcchhcCCCCc
Q 010947 404 GAKGADEIKVHPWF 417 (497)
Q Consensus 404 ~~~~~~eil~Hpff 417 (497)
+ +.+++.||||
T Consensus 277 ~---~~~il~~~~~ 287 (287)
T cd07838 277 S---AFEALQHPYF 287 (287)
T ss_pred C---HHHHhcCcCC
Confidence 9 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.10 Aligned_cols=244 Identities=24% Similarity=0.356 Sum_probs=202.9
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 201 (497)
+.||+|+||.||+|.++.+++.||+|.+.+.. .......+.+|+.+++.++||||++++++|.+...+|+||||++|+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 36899999999999999999999999886432 2334567889999999999999999999999999999999999999
Q ss_pred chhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 202 DMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 202 ~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~------- 151 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS------- 151 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccc-------
Confidence 9999987644 58999999999999999999999999999999999999999999999999987543210000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~ 359 (497)
......++..|+|||.+.+..++.++|+|||||++|||++ |.+||..
T Consensus 152 --------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~ 199 (252)
T cd05084 152 --------------------------------TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYAN 199 (252)
T ss_pred --------------------------------cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 0001123567999999999999999999999999999997 9999987
Q ss_pred CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
.........+... ....+| ..++..+.+||.+||+ +|.+||+ +.+++
T Consensus 200 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~~~ 247 (252)
T cd05084 200 LSNQQTREAIEQG-VRLPCP--ELCPDAVYRLMERCWEYDPGQRPS---FSTVH 247 (252)
T ss_pred cCHHHHHHHHHcC-CCCCCc--ccCCHHHHHHHHHHcCCChhhCcC---HHHHH
Confidence 7766665555432 223333 3678999999999999 9999999 66664
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=329.96 Aligned_cols=249 Identities=20% Similarity=0.340 Sum_probs=209.0
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++.+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|+.+++.++||||+++++++...+.+|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 45678999999999999999999875 456899999876432 2345788999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 193 LIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+||||++|++|.+++.... .+++..+..++.+++.||.|||+.||+||||||+||+++.++.+||+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999997644 69999999999999999999999999999999999999999999999999998764211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
... .....++..|+|||++.+..++.++|+|||||++|||
T Consensus 158 ~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el 197 (261)
T cd05068 158 YEA----------------------------------------REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEI 197 (261)
T ss_pred ccc----------------------------------------cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHH
Confidence 000 0012234679999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
++ |.+||.+.+.......+... .. .|....++..+.++|.+||. +|.+||+ +.++.
T Consensus 198 ~t~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~li~~~l~~~P~~Rp~---~~~l~ 255 (261)
T cd05068 198 VTYGRMPYPGMTNAEVLQQVDQG-YR--MPCPPGCPKELYDIMLDCWKEDPDDRPT---FETLQ 255 (261)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcC-CC--CCCCCcCCHHHHHHHHHHhhcCcccCCC---HHHHH
Confidence 99 99999998877777776542 12 23234688999999999999 9999999 55553
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=324.50 Aligned_cols=251 Identities=36% Similarity=0.559 Sum_probs=217.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+|+.+++.++||+|+++++.|..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998999999999976542 345678899999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 197 YLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 197 y~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|++|++|.+++... ..+++..+..++.+++.||.+||..|++||||+|+||+++.++.++|+|||++........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---- 153 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---- 153 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc----
Confidence 99999999998775 6899999999999999999999999999999999999999999999999999876532210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
.....|+..|+|||.+.+..++.++|+||||+++|+|++|.+
T Consensus 154 --------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~ 195 (253)
T cd05122 154 --------------------------------------RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKP 195 (253)
T ss_pred --------------------------------------ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCC
Confidence 013568999999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpf 416 (497)
||...+.......+.. ......+....++.++.++|.+||. ||.+||+ +.+++.|||
T Consensus 196 p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t---~~~~l~~~~ 253 (253)
T cd05122 196 PYSELPPMKALFKIAT-NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPT---AEQLLKHPF 253 (253)
T ss_pred CCCCCchHHHHHHHHh-cCCCCcCcccccCHHHHHHHHHHccCChhhCCC---HHHHhcCCC
Confidence 9988765555444433 2233334333458899999999999 9999998 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.76 Aligned_cols=274 Identities=26% Similarity=0.435 Sum_probs=216.1
Q ss_pred CCeeE-EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchh-----------HHHHHHHHHHHHHhcCCCceeEEEE
Q 010947 116 DDFEL-LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-----------QVEHVRAERNLLAEVDSNCIVKLYC 183 (497)
Q Consensus 116 ~~f~~-~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~-----------~~~~~~~E~~il~~l~hp~Iv~l~~ 183 (497)
++|.. .+.||.|+||+||+|.++.+++.||||++......... ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45654 47799999999999999999999999999765432211 0124678999999999999999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
+|...+..|+||||+. |+|.+++.....+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999996 699999988888999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHh
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWS 342 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwS 342 (497)
.............. .. .. ..+ .......+++.|+|||++.+. .++.++|+||
T Consensus 167 ~~~~~~~~~~~~~~------------~~-~~-------------~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 219 (335)
T PTZ00024 167 RRYGYPPYSDTLSK------------DE-TM-------------QRR-EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWS 219 (335)
T ss_pred eecccccccccccc------------cc-cc-------------ccc-ccccccccccCCCCChhcccCCCCCcHHHHHH
Confidence 87643221100000 00 00 000 001134678999999999764 4799999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhcccC---------cccCC----------C-----CccCChhHHHHHHHHhh-
Q 010947 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT---------HLKFP----------E-----EAKLSIEAKDLISKLLC- 397 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~~~~~~~~i~~~~~---------~~~~p----------~-----~~~~s~~~~dLI~~lL~- 397 (497)
|||++|||++|.+||.+.+..+....+..... ....| . ....+.++.+||.+||.
T Consensus 220 lG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 220 VGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCC
Confidence 99999999999999999888777666653111 10000 0 12457889999999999
Q ss_pred CccccCCCCCcchhcCCCCccCC
Q 010947 398 NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 398 dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+|.+||+ +++++.||||++.
T Consensus 300 ~P~~R~s---~~~~l~~~~~~~~ 319 (335)
T PTZ00024 300 NPLERIS---AKEALKHEYFKSD 319 (335)
T ss_pred CchhccC---HHHHhcCcccCCC
Confidence 9999998 9999999999854
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=335.70 Aligned_cols=252 Identities=22% Similarity=0.391 Sum_probs=210.9
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+...+|.+.++||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 78 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTE 78 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence 45678999999999999999999753 356689999887542 3345678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKD---------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~---------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~ 252 (497)
....|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 79 GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQG 158 (280)
T ss_pred CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCC
Confidence 999999999999999999987643 48899999999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC
Q 010947 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (497)
Q Consensus 253 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~ 332 (497)
+.+||+|||+++......... ......+++.|+|||++.+.
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 199 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYR---------------------------------------VGGRTMLPIRWMPPESILYR 199 (280)
T ss_pred CCEEECCCCceeEcCCCceee---------------------------------------cCCCccccccccCHHHhccC
Confidence 999999999987553211000 00123467889999999999
Q ss_pred CCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcch
Q 010947 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (497)
Q Consensus 333 ~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~e 410 (497)
.++.++|||||||++|||++ |.+||......+....+..+. ....| ..+++.+.+||.+||+ ||.+||+ +.+
T Consensus 200 ~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~P~~Rp~---~~~ 273 (280)
T cd05092 200 KFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELERP--RTCPPEVYAIMQGCWQREPQQRMV---IKD 273 (280)
T ss_pred CcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCCC--CCCCHHHHHHHHHHccCChhhCCC---HHH
Confidence 99999999999999999998 999998887777777776532 23333 3688999999999999 9999999 666
Q ss_pred hc
Q 010947 411 IK 412 (497)
Q Consensus 411 il 412 (497)
|+
T Consensus 274 l~ 275 (280)
T cd05092 274 IH 275 (280)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=329.66 Aligned_cols=251 Identities=31% Similarity=0.524 Sum_probs=211.3
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|....+|+.||+|.++........+...+.+|+.+++.++|++|++++++|.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57999999999999999999999999999999998655555555678899999999999999999999999999999999
Q ss_pred eecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 196 EYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 196 Ey~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
||++||+|..++.. ...+++..+..++.+++.||.|||+.||+||||+|+||+++.+|.++|+|||++..+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 99999999998854 34589999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
......|++.|+|||++.+..++.++|+|||||++|+|+
T Consensus 162 -----------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~ 200 (267)
T cd08224 162 -----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 200 (267)
T ss_pred -----------------------------------------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHH
Confidence 011356899999999999999999999999999999999
Q ss_pred hCCCCCCCCCh--HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 352 VGYPPFYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 352 ~G~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+|..||..... .+....+... .....|. ..++.++.++|.+||. +|.+||+ +.+|+
T Consensus 201 ~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~i~~cl~~~p~~Rp~---~~~il 259 (267)
T cd08224 201 ALQSPFYGDKMNLYSLCKKIEKC-DYPPLPA-DHYSEELRDLVSRCINPDPEKRPD---ISYVL 259 (267)
T ss_pred HCCCCcccCCccHHHHHhhhhcC-CCCCCCh-hhcCHHHHHHHHHHcCCCcccCCC---HHHHH
Confidence 99999976542 2333343321 1122232 2578899999999999 9999999 66554
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=338.85 Aligned_cols=257 Identities=21% Similarity=0.320 Sum_probs=211.4
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEE
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 184 (497)
..+..++|.+.+.||+|+||.||+|.. ..++..||+|++++.. .....+.+.+|+.+++.+ +||||++++++
T Consensus 30 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred ccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 446667899999999999999999975 3345689999987542 233456788999999999 79999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
|.+.+.+|+||||+++|+|.+++.+.. .+++.++..++.+++.||.|||+.||+|+||||+|||++.++.++|+|||+
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997643 389999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHh
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwS 342 (497)
++.+...... .......+++.|+|||++.+..++.++||||
T Consensus 188 ~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws 228 (302)
T cd05055 188 ARDIMNDSNY---------------------------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWS 228 (302)
T ss_pred cccccCCCce---------------------------------------eecCCCCcccccCCHhhhccCCCCcHhHHHH
Confidence 9765321100 0001234678999999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 343 lGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++|||++ |.+||.+....+...+....... .+.....++++.+||.+||. +|.+||+ +.+++.
T Consensus 229 lGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ell~ 296 (302)
T cd05055 229 YGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR--MAQPEHAPAEIYDIMKTCWDADPLKRPT---FKQIVQ 296 (302)
T ss_pred HHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc--CCCCCCCCHHHHHHHHHHcCCCchhCcC---HHHHHH
Confidence 9999999998 99999987766665555432222 22223678999999999999 9999999 777653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=339.23 Aligned_cols=259 Identities=28% Similarity=0.447 Sum_probs=210.8
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 190 (497)
.+..++|++.+.||+|+||.||+|.+..+++.||||++++... ......+..|+.++... +||||++++++|.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4567889999999999999999999999999999999976532 22334455677666655 59999999999999999
Q ss_pred EEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+|+||||++ ++|.+++.. ...+++..+..++.+++.||.|||+ .||+||||+|+||+++.++.+||+|||++..+..
T Consensus 89 ~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 89 VFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999999984 577777655 4579999999999999999999997 6999999999999999999999999999875532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC----CCcchhHHhHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDWWSLG 344 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----y~~~~DiwSlG 344 (497)
... .....|++.|+|||++.+.. ++.++||||||
T Consensus 168 ~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG 205 (296)
T cd06618 168 SKA------------------------------------------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLG 205 (296)
T ss_pred CCc------------------------------------------ccCCCCCccccCHhhcCCCCCccccccchhHHHHH
Confidence 110 01235888999999997543 88999999999
Q ss_pred HHHHHHHhCCCCCCCCCh-HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 345 AIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|++|+|++|+.||..... .+.+.+++... ....+....++.++.+||.+||. ||.+||+ +++++.||||..
T Consensus 206 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~il~~~~~~~ 278 (296)
T cd06618 206 ISLVELATGQFPYKNCKTEFEVLTKILQEE-PPSLPPNEGFSPDFCSFVDLCLTKDHRKRPK---YRELLQHPFIRR 278 (296)
T ss_pred HHHHHHHhCCCCCCcchhHHHHHHHHhcCC-CCCCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhc
Confidence 999999999999976432 34455555432 22333333578899999999999 9999999 999999999984
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=325.89 Aligned_cols=253 Identities=32% Similarity=0.598 Sum_probs=220.6
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|.+.+.||.|+||.||+|.+..++..||+|++..... .......+..|+++++.++|||++++++.+.+....++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 58899999999999999999999999999999976432 23445568889999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 197 YLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 197 y~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
|++|++|.+++... ..+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~- 158 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD- 158 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcc-
Confidence 99999999999764 6799999999999999999999999999999999999999999999999999876532210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.....+|++.|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 159 ----------------------------------------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 198 (258)
T cd08215 159 ----------------------------------------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCT 198 (258)
T ss_pred ----------------------------------------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHc
Confidence 0113578999999999998899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|..||...+..+....+... ....+|. .++.++.++|.+||. +|.+||+ +.+++.||||
T Consensus 199 g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~i~~~l~~~p~~Rp~---~~~ll~~~~~ 258 (258)
T cd08215 199 LKHPFEGENLLELALKILKG-QYPPIPS--QYSSELRNLVSSLLQKDPEERPS---IAQILQSPFI 258 (258)
T ss_pred CCCCCCCCcHHHHHHHHhcC-CCCCCCC--CCCHHHHHHHHHHcCCChhhCcC---HHHHhcCCCC
Confidence 99999888777777666542 2223333 688999999999999 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=332.86 Aligned_cols=253 Identities=19% Similarity=0.306 Sum_probs=208.0
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
+...+|++++.||+|+||+||+|.+..++. .||+|++.... .......+..|+.++..+.||||+++++++.+.
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 456789999999999999999999877776 48999987542 233345688899999999999999999998754
Q ss_pred CeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
..+++|||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|||+++.+.
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence 57899999999999999976 3569999999999999999999999999999999999999999999999999998664
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
...... ......+++.|+|||.+.+..++.++|||||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 201 (279)
T cd05109 161 IDETEY---------------------------------------HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTV 201 (279)
T ss_pred ccccee---------------------------------------ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHH
Confidence 221000 00122456789999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++ |.+||...........+... ..... ...++.++.++|.+||. ||.+||+ +.+++.
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~li~~~l~~dp~~Rp~---~~~l~~ 263 (279)
T cd05109 202 WELMTFGAKPYDGIPAREIPDLLEKG-ERLPQ--PPICTIDVYMIMVKCWMIDSECRPR---FRELVD 263 (279)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHCC-CcCCC--CccCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 99998 99999877666555544432 22222 34689999999999999 9999999 777763
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=346.58 Aligned_cols=260 Identities=20% Similarity=0.307 Sum_probs=205.9
Q ss_pred Eeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 123 MIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 123 ~IG~G--~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
.||+| +||+||+|.+..+|+.||||++..... .....+.+.+|+.+++.++||||++++++|.+...+|+||||+++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 46666 999999999999999999999875432 233457788999999999999999999999999999999999999
Q ss_pred CchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccc
Q 010947 201 GDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (497)
Q Consensus 201 g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 278 (497)
|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.++++|||.+............ .
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~-~- 161 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV-V- 161 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc-c-
Confidence 9999998764 35899999999999999999999999999999999999999999999999876433211000000 0
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
. .......++..|+|||++.+ ..++.++|||||||++|+|++|.+|
T Consensus 162 --------------~------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p 209 (328)
T cd08226 162 --------------Y------------------DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209 (328)
T ss_pred --------------c------------------cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 0 00001245677999999976 4578999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCc-------------------------------------------ccCCCCccCChhHHHHHH
Q 010947 357 FYSDDPMSTCRKIVNWRTH-------------------------------------------LKFPEEAKLSIEAKDLIS 393 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~-------------------------------------------~~~p~~~~~s~~~~dLI~ 393 (497)
|.+.........++..... +..+....+++++++||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 289 (328)
T cd08226 210 FQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE 289 (328)
T ss_pred CCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHH
Confidence 9887655555444332110 011111246778999999
Q ss_pred HHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 394 KLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 394 ~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+||+ ||.+||+ +.++++||||+.+
T Consensus 290 ~~l~~dP~~Rpt---a~e~l~~~~~~~~ 314 (328)
T cd08226 290 LCLQQDPEKRPS---ASSLLSHAFFKQV 314 (328)
T ss_pred HHccCCcccCCC---HHHHhhCHHHHHH
Confidence 9999 9999999 9999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=334.17 Aligned_cols=255 Identities=31% Similarity=0.516 Sum_probs=211.9
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--CeEEEEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--EFLYLIM 195 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~~l~lVm 195 (497)
|++.+.||.|+||.||+|....+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+. ..+|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999999999999999998764 2333445678899999999999999999999988 8999999
Q ss_pred eecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||++ ++|.+++.+. ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.+|.+||+|||++.........
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-- 156 (287)
T cd07840 80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-- 156 (287)
T ss_pred cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc--
Confidence 9997 4898888665 57999999999999999999999999999999999999999999999999999865432100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G 353 (497)
......+++.|+|||.+.+ ..++.++|+|||||++|||++|
T Consensus 157 --------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~ 198 (287)
T cd07840 157 --------------------------------------DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198 (287)
T ss_pred --------------------------------------cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhC
Confidence 0012457889999998765 4689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcc---cCCCC-----------------------cc-CChhHHHHHHHHhh-CccccCCC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHL---KFPEE-----------------------AK-LSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~---~~p~~-----------------------~~-~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
.+||.+.+.......+....... .++.. .. +++++.++|.+||+ +|.+||+
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~- 277 (287)
T cd07840 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS- 277 (287)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC-
Confidence 99999888776666554311100 00100 11 38899999999999 9999999
Q ss_pred CCcchhcCCCCc
Q 010947 406 KGADEIKVHPWF 417 (497)
Q Consensus 406 ~~~~eil~Hpff 417 (497)
+.+++.||||
T Consensus 278 --~~~~l~~~~~ 287 (287)
T cd07840 278 --ADQALQHEYF 287 (287)
T ss_pred --HHHHhhCcCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=328.88 Aligned_cols=231 Identities=31% Similarity=0.509 Sum_probs=195.7
Q ss_pred cCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCchhHH
Q 010947 127 GAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL 206 (497)
Q Consensus 127 G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~ 206 (497)
|+||+||+|+++.+++.||+|++.+... ...|...+....||||+++++++.+.+..|+||||++||+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 23355555566799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCC
Q 010947 207 LMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286 (497)
Q Consensus 207 l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 286 (497)
+.+...+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..+...
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----------------- 138 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----------------- 138 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-----------------
Confidence 988888999999999999999999999999999999999999999999999999987654311
Q ss_pred CCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHH
Q 010947 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTC 366 (497)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~ 366 (497)
.....++..|+|||.+.+..++.++|+||+||++|||++|..||......
T Consensus 139 ---------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--- 188 (237)
T cd05576 139 ---------------------------CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--- 188 (237)
T ss_pred ---------------------------cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---
Confidence 01245677899999998888999999999999999999999998643211
Q ss_pred HHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCc
Q 010947 367 RKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWF 417 (497)
Q Consensus 367 ~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff 417 (497)
......+.+|. .+++.+++||.+||+ ||.+|+++ .+++++++||||
T Consensus 189 ---~~~~~~~~~~~--~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 189 ---INTHTTLNIPE--WVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred ---cccccccCCcc--cCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 11112334453 689999999999999 99999985 346899999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=331.03 Aligned_cols=253 Identities=21% Similarity=0.341 Sum_probs=210.4
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
...+|++.+.||+|+||.||+|.++.++. .+|+|.++... .......+..|+.+++.++||||+++++++.+++.
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 34679999999999999999999865543 79999987542 23345678889999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
+|+||||++||+|.+++.+. ..+++..+..++.|++.||.|||+.|++||||||+|||++.+++++|+|||++..+...
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999764 46899999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.... .......+++.|+|||++.+..++.++|+|||||++||
T Consensus 160 ~~~~--------------------------------------~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~e 201 (267)
T cd05066 160 PEAA--------------------------------------YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 201 (267)
T ss_pred ccee--------------------------------------eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHH
Confidence 1000 00012234678999999998899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+++ |..||...+..+....+... ...|....+++.+.+||.+||+ +|.+||+ +.+++
T Consensus 202 ll~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~ 260 (267)
T cd05066 202 VMSYGERPYWEMSNQDVIKAIEEG---YRLPAPMDCPAALHQLMLDCWQKDRNERPK---FEQIV 260 (267)
T ss_pred HhcCCCCCcccCCHHHHHHHHhCC---CcCCCCCCCCHHHHHHHHHHcccCchhCCC---HHHHH
Confidence 886 99999988777777776643 2234334688999999999999 9999999 66654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=337.11 Aligned_cols=257 Identities=20% Similarity=0.351 Sum_probs=213.5
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEE
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 184 (497)
..+..++|++.+.||+|+||.||++..+.. ...+|+|.+.... .......+.+|+.++..+ +||||++++++
T Consensus 7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (293)
T cd05053 7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV 84 (293)
T ss_pred cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 345667899999999999999999988644 3689999987542 233455688899999999 89999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCee
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLL 248 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NIL 248 (497)
+.+...+|+||||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus 85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil 164 (293)
T cd05053 85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL 164 (293)
T ss_pred EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence 99999999999999999999998642 45889999999999999999999999999999999999
Q ss_pred ecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccc
Q 010947 249 LDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328 (497)
Q Consensus 249 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~ 328 (497)
++.++.+||+|||+++.+....... ......+++.|+|||+
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~ 205 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYR---------------------------------------KTTNGRLPVKWMAPEA 205 (293)
T ss_pred EcCCCeEEeCcccccccccccccee---------------------------------------ccCCCCCCccccCHHH
Confidence 9999999999999998654321100 0012235678999999
Q ss_pred cccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC
Q 010947 329 LLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 329 l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
+.+..++.++|||||||++|||++ |..||.+....+.+..+... .....| ..++.++.+||.+||. ||.+||+
T Consensus 206 ~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps-- 280 (293)
T cd05053 206 LFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-YRMEKP--QNCTQELYHLMRDCWHEVPSQRPT-- 280 (293)
T ss_pred hccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccCcccCcC--
Confidence 999999999999999999999997 99999988877777766542 222333 3678999999999999 9999998
Q ss_pred CcchhcCC
Q 010947 407 GADEIKVH 414 (497)
Q Consensus 407 ~~~eil~H 414 (497)
+.+++.+
T Consensus 281 -~~eil~~ 287 (293)
T cd05053 281 -FKQLVED 287 (293)
T ss_pred -HHHHHHH
Confidence 7777653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=388.57 Aligned_cols=258 Identities=29% Similarity=0.472 Sum_probs=221.8
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
++.-...||.|.||.||-|....||...|||-++-.... ......+.+|..+|..++|||+|+.|++-.+.+.+||.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 345566899999999999999999999999988765433 3345568889999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
||.||+|.+++...+..+|...+.|..|++.||.|||++|||||||||+||+++.+|.+|++|||.|..+........
T Consensus 1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~-- 1392 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMP-- 1392 (1509)
T ss_pred HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCC--
Confidence 999999999999988999999999999999999999999999999999999999999999999999988754311000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CCCCcchhHHhHHHHHHHHHhC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~y~~~~DiwSlGvil~ell~G 353 (497)
.. ..+..|||.|||||++.+ .+.+.+.|||||||++.||+||
T Consensus 1393 ------------------------~e-----------l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tG 1437 (1509)
T KOG4645|consen 1393 ------------------------GE-----------LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATG 1437 (1509)
T ss_pred ------------------------HH-----------HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecC
Confidence 00 125789999999999985 5688999999999999999999
Q ss_pred CCCCCCCChHH-HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 354 YPPFYSDDPMS-TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 354 ~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
+.||...+..- +..++.. ....++|+ .+|++.+|||.+||. ||..|.+ +.|++.|.|-+
T Consensus 1438 krPW~~~dne~aIMy~V~~-gh~Pq~P~--~ls~~g~dFle~Cl~~dP~~Rw~---~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1438 KRPWAELDNEWAIMYHVAA-GHKPQIPE--RLSSEGRDFLEHCLEQDPKMRWT---ASQLLEHAFGK 1498 (1509)
T ss_pred CCchhhccchhHHHhHHhc-cCCCCCch--hhhHhHHHHHHHHHhcCchhhhH---HHHHHHhhccc
Confidence 99998765443 3444443 35677887 599999999999999 9999998 88999999865
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=330.51 Aligned_cols=253 Identities=21% Similarity=0.325 Sum_probs=211.8
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
..++|++.+.||+|+||+||+|..+.+ ...||||+++... .......+..|+.+++.++||||+++++.+.+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 356799999999999999999998654 4579999987542 23345568889999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.|+||||+++|+|.+++... +.+++..+..++.+++.||.|||+.||+||||||+|||++.++.++|+|||+++.+...
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999998664 47899999999999999999999999999999999999999999999999999876411
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
... .......+++.|+|||.+.+..++.++|+|||||++|+
T Consensus 160 ~~~---------------------------------------~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~ 200 (266)
T cd05033 160 EAT---------------------------------------YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWE 200 (266)
T ss_pred ccc---------------------------------------eeccCCCCCccccChhhhccCCCccccchHHHHHHHHH
Confidence 000 00012345778999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|++ |..||......+....+... ...|....++..+.+||.+||. +|.+||+ +.+|++
T Consensus 201 l~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~---~~ei~~ 260 (266)
T cd05033 201 VMSYGERPYWDMSNQDVIKAVEDG---YRLPPPMDCPSALYQLMLDCWQKDRNERPT---FSQIVS 260 (266)
T ss_pred HHccCCCCCCCCCHHHHHHHHHcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCcC---HHHHHH
Confidence 998 99999887777777766542 1223334688999999999999 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.31 Aligned_cols=246 Identities=22% Similarity=0.349 Sum_probs=212.3
Q ss_pred eEeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeec
Q 010947 122 TMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 198 (497)
+.||+|+||.||+|..... +..||+|++....... ....+..|+.++..++|+||+++++++.+...+|+||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4699999999999999865 8899999998654322 4677899999999999999999999999999999999999
Q ss_pred CCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 199 PGGDMMTLLMRK---------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 199 ~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875 78999999999999999999999999999999999999999999999999999866432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
... .......+++.|+|||.+....++.++|+|||||++|+
T Consensus 159 ~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 199 (262)
T cd00192 159 DYY---------------------------------------RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWE 199 (262)
T ss_pred ccc---------------------------------------ccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHH
Confidence 100 00113568899999999998899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|++ |..||.+.+..+....+... .....| ..+|+++.++|.+||+ +|.+||+ +.+++.|
T Consensus 200 l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~l~~~ 260 (262)
T cd00192 200 IFTLGATPYPGLSNEEVLEYLRKG-YRLPKP--EYCPDELYELMLSCWQLDPEDRPT---FSELVER 260 (262)
T ss_pred HHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCChHHHHHHHHHccCCcccCcC---HHHHHHh
Confidence 999 69999998888887777652 233444 3679999999999999 9999998 8887754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=331.27 Aligned_cols=250 Identities=20% Similarity=0.317 Sum_probs=206.4
Q ss_pred eeEEeEeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 118 FELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
|.+.+.||+|+||.||+|....+ +..||||+++... ........+..|+.+++.++||||+++++.+.+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 56788999999999999987653 4789999987542 22345567899999999999999999998876544
Q ss_pred -eEEEEEeecCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRK------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
..++||||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 379999999999999988542 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHh
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwS 342 (497)
++.+....... ......+++.|+|||++.+..++.++||||
T Consensus 160 ~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~S 200 (273)
T cd05035 160 SKKIYSGDYYR---------------------------------------QGRIAKMPVKWIAIESLADRVYTSKSDVWA 200 (273)
T ss_pred eeecccccccc---------------------------------------ccccccCCccccCHhhcccCCCCcccchHH
Confidence 98653221000 000223567899999998899999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 343 lGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++|||++ |.+||.+.+..+.+..+... .....| ..++.++.++|.+||. ||.+||+ +.+++.
T Consensus 201 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~e~~~ 267 (273)
T cd05035 201 FGVTMWEIATRGQTPYPGVENHEIYDYLRHG-NRLKQP--EDCLDELYDLMYSCWRADPKDRPT---FTKLRE 267 (273)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 9999999999 99999988887777777653 233344 3689999999999999 9999998 777654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=336.79 Aligned_cols=248 Identities=22% Similarity=0.376 Sum_probs=206.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCc--EEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~ 192 (497)
++|++.++||+|+||.||+|..+.++. .+|+|.++.. ......+.+..|+.++.++ +||||+++++++.+...+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 579999999999999999999887765 4688887632 2233445688899999998 7999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEE
Q 010947 193 LIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vk 256 (497)
+||||+++|+|.+++.... .+++..++.++.|++.||+|||+.||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 488899999999999999999999999999999999999999999
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCc
Q 010947 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (497)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~ 336 (497)
|+|||++........ .....++..|+|||++.+..++.
T Consensus 160 l~dfg~~~~~~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~ 197 (297)
T cd05089 160 IADFGLSRGEEVYVK------------------------------------------KTMGRLPVRWMAIESLNYSVYTT 197 (297)
T ss_pred ECCcCCCccccceec------------------------------------------cCCCCcCccccCchhhccCCCCc
Confidence 999999863211000 00122355799999999899999
Q ss_pred chhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 337 ECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 337 ~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++|||||||++|||++ |.+||.+.+..+...++... .....| ..++.++++||.+||. +|.+||+ +++|++
T Consensus 198 ~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~~ 270 (297)
T cd05089 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKP--RNCDDEVYELMRQCWRDRPYERPP---FAQISV 270 (297)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 9999999999999997 99999998888777777642 122233 3689999999999999 9999999 777754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=328.46 Aligned_cols=250 Identities=20% Similarity=0.360 Sum_probs=209.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|.+++.||+|+||.||+|.... +..+|+|.+..... ....+.+|+.++..++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 76 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI 76 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence 34679999999999999999998754 44699999875432 23457889999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||+++........
T Consensus 77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999999998763 46899999999999999999999999999999999999999999999999998765321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
. .....++..|+|||++.+..++.++|+|||||++|+|++
T Consensus 157 ~----------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~ 196 (256)
T cd05113 157 S----------------------------------------SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYS 196 (256)
T ss_pred e----------------------------------------cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhc
Confidence 0 002346678999999998889999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|..||...+..+....+.+.. ....| ...+..++++|.+||. +|.+||+ +.+|+.+
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~ll~~ 254 (256)
T cd05113 197 LGKMPYERFNNSETVEKVSQGL-RLYRP--HLASEKVYAIMYSCWHEKAEERPT---FQQLLSS 254 (256)
T ss_pred CCCCCcCcCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcCCCcccCCC---HHHHHHh
Confidence 999998888777777776532 22223 3568899999999999 9999999 7777653
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=344.46 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=210.2
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-----
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD----- 188 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----- 188 (497)
..++|.+.+.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.++..++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 35789999999999999999999999999999999976421 223345677899999999999999999888643
Q ss_pred -CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 -EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 -~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
...|+|++++ |++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++...
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3578999987 8899887754 569999999999999999999999999999999999999999999999999987542
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvi 346 (497)
.. .....||+.|+|||++.+ ..++.++|||||||+
T Consensus 172 ~~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~i 207 (345)
T cd07877 172 DE--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCI 207 (345)
T ss_pred cc--------------------------------------------ccccccCCCccCHHHHhCccCCCchhhHHHHHHH
Confidence 11 013468999999999876 578999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhcccCc---------------------ccCCC------CccCChhHHHHHHHHhh-C
Q 010947 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTH---------------------LKFPE------EAKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~~~~~~i~~~~~~---------------------~~~p~------~~~~s~~~~dLI~~lL~-d 398 (497)
+|+|++|.+||.+.+.......+...... ...|. ....++++++||.+||+ |
T Consensus 208 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 287 (345)
T cd07877 208 MAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLD 287 (345)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCC
Confidence 99999999999887665554444321100 00111 01358899999999999 9
Q ss_pred ccccCCCCCcchhcCCCCccC
Q 010947 399 VNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 399 p~~R~~~~~~~eil~Hpff~~ 419 (497)
|.+|++ +.+++.||||..
T Consensus 288 p~~R~t---~~e~l~h~~f~~ 305 (345)
T cd07877 288 SDKRIT---AAQALAHAYFAQ 305 (345)
T ss_pred hhhcCC---HHHHhcChhhhh
Confidence 999998 999999999985
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=346.72 Aligned_cols=256 Identities=29% Similarity=0.484 Sum_probs=214.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF---- 190 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~---- 190 (497)
.++|++.+.||+|+||.||+|++..++..||||++.... ........+..|+.+++.++||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 568999999999999999999999999999999987542 223344567789999999999999999888776554
Q ss_pred --EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 191 --LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 191 --l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+|+||||+ |++|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+||+++.+|.++|+|||++.....
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~ 170 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD 170 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence 89999999 7799988864 5799999999999999999999999999999999999999999999999999875431
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
. .....+|+.|+|||++.+ ..++.++|+|||||++
T Consensus 171 ~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l 206 (343)
T cd07851 171 E--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 206 (343)
T ss_pred c--------------------------------------------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHH
Confidence 1 013468899999999865 4688999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCccc--------------------------CCC-CccCChhHHHHHHHHhh-Cc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLK--------------------------FPE-EAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~--------------------------~p~-~~~~s~~~~dLI~~lL~-dp 399 (497)
|+|++|++||.+.+....+..+.+...... ++. ...+|+++.+||.+||+ ||
T Consensus 207 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P 286 (343)
T cd07851 207 AELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDP 286 (343)
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCCh
Confidence 999999999998887776666654211100 000 02468899999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCC
Q 010947 400 NQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i 420 (497)
.+||+ +.+|+.||||...
T Consensus 287 ~~Rpt---~~ell~h~~~~~~ 304 (343)
T cd07851 287 DKRIT---AAEALAHPYLAEY 304 (343)
T ss_pred hhCCC---HHHHhcCCCcccc
Confidence 99998 9999999999853
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=329.15 Aligned_cols=254 Identities=20% Similarity=0.312 Sum_probs=211.3
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
+..++|+..+.||+|+||.||+|..+.++. .+|||.+.... .......+..|+.+++.++||||+++++++.+.+
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCC
Confidence 456689999999999999999999876665 79999986542 2334556889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..|+||||+++|+|..++... +.+++..+..++.+++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999999998654 5789999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
...... ......+++.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~--------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ 201 (268)
T cd05063 160 DPEGTY--------------------------------------TTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMW 201 (268)
T ss_pred ccccce--------------------------------------eccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHH
Confidence 210000 000123456799999999889999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 349 ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
||++ |..||...+..+....+... ...|....++.++.+||.+||. +|.+||+ +.+|+
T Consensus 202 ell~~g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~---~~~i~ 261 (268)
T cd05063 202 EVMSFGERPYWDMSNHEVMKAINDG---FRLPAPMDCPSAVYQLMLQCWQQDRARRPR---FVDIV 261 (268)
T ss_pred HHHhCCCCCCCcCCHHHHHHHHhcC---CCCCCCCCCCHHHHHHHHHHcCCCcccCcC---HHHHH
Confidence 9997 99999988877777777542 2334334688999999999999 9999998 66665
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=331.98 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=211.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..+|++.+.||.|+||.||+|.++. +..+|+|++..... .....+..|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4578999999999999999999987 88999999876542 2344588899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 195 MEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
|||+++|+|.+++... ..+++..+..++.+|+.||.|||+.||+||||||+||+++.++.+||+|||++.........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 9999999999999753 46899999999999999999999999999999999999999999999999999765321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
..+..+++.|+|||++.+..++.++|||||||++|+|++
T Consensus 161 -----------------------------------------~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~ 199 (261)
T cd05148 161 -----------------------------------------SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199 (261)
T ss_pred -----------------------------------------ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHc
Confidence 012346778999999998899999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
|.+||.+.+..+.+..+... ...|....+++++.++|.+||+ ||.+||+ +.+++
T Consensus 200 ~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt---~~~l~ 255 (261)
T cd05148 200 YGQVPYPGMNNHEVYDQITAG---YRMPCPAKCPQEIYKIMLECWAAEPEDRPS---FKALR 255 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHhC---CcCCCCCCCCHHHHHHHHHHcCCCchhCcC---HHHHH
Confidence 89999988888888777642 2223334789999999999999 9999999 65554
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=364.72 Aligned_cols=308 Identities=36% Similarity=0.611 Sum_probs=264.5
Q ss_pred EeeecCCeEEEEEEE---cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEEEeec
Q 010947 123 MIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYL 198 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~---~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lVmEy~ 198 (497)
++|.|+||+|++|+. ...|..||||++++.....+... +...|+.++..++ ||++|++.+.|+.+..+|++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999998864 45678899999998765544444 7888999999997 999999999999999999999999
Q ss_pred CCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccc
Q 010947 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (497)
Q Consensus 199 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 278 (497)
.||+|...+.....+++...++|.++++.|++++|+.||+|||+|++||+++.+||+++.|||+++.....
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~--------- 150 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE--------- 150 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh---------
Confidence 99999999999899999999999999999999999999999999999999999999999999999865321
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCC
Q 010947 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358 (497)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~ 358 (497)
...|||..|||||++. ++..++||||||+++|||++|..||.
T Consensus 151 ------------------------------------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~ 192 (612)
T KOG0603|consen 151 ------------------------------------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFG 192 (612)
T ss_pred ------------------------------------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCc
Confidence 0239999999999997 88999999999999999999999998
Q ss_pred CCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhh--hcCCCcc
Q 010947 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAFI 433 (497)
Q Consensus 359 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~~~~p~~ 433 (497)
+ ++..+|+. ..+.+|. .++.++++++..|+. +|.+|+++ .++.+|++|+||..|+|+.+. +..|||.
T Consensus 193 ~----~~~~~Il~--~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fk 264 (612)
T KOG0603|consen 193 G----DTMKRILK--AELEMPR--ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFK 264 (612)
T ss_pred h----HHHHHHhh--hccCCch--hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHhhHhhcCCCCCCC
Confidence 8 67777775 4556664 799999999999999 99999997 489999999999999999877 4789999
Q ss_pred cccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCCccCCCCCC
Q 010947 434 PEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQV 491 (497)
Q Consensus 434 p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~~~~ 491 (497)
|.+..+.|+.+|+.+.....+...+....+ .+...-|.||+|..+.++.+++.
T Consensus 265 p~~~~e~~~~~fd~eft~~~P~dsp~~~~~-----~s~~~if~g~sfva~~il~~~~~ 317 (612)
T KOG0603|consen 265 PGSITERDVAQFDPEFTSQVPADSPLLSAS-----GSDHTIFSGPSFVAPGVLEDAVT 317 (612)
T ss_pred CcccchhhhhhcCchhccCCcccCCCCCCC-----ccccchhcCCCccChHHhhcccc
Confidence 999999999999986655444333322211 22337899999999988877443
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-42 Score=336.69 Aligned_cols=253 Identities=20% Similarity=0.321 Sum_probs=211.2
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
...+|.+.+.||+|+||.||+|....+ +..||||+++... .......+..|+.++..++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 445688889999999999999987543 5789999997542 223346688899999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~ 252 (497)
..+++++||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 347888999999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC
Q 010947 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (497)
Q Consensus 253 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~ 332 (497)
+.+||+|||+++........ .......+++.|+|||.+.+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~ 201 (283)
T cd05091 161 LNVKISDLGLFREVYAADYY---------------------------------------KLMGNSLLPIRWMSPEAIMYG 201 (283)
T ss_pred CceEecccccccccccchhe---------------------------------------eeccCccCCccccCHHHHhcC
Confidence 99999999998865321100 001134568899999999988
Q ss_pred CCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcch
Q 010947 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (497)
Q Consensus 333 ~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~e 410 (497)
.++.++|||||||++|||++ |.+||.+....+....+.... ....| ..++.++.+||.+||. +|.+||+ +.+
T Consensus 202 ~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~RP~---~~~ 275 (283)
T cd05091 202 KFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ-VLPCP--DDCPAWVYTLMLECWNEFPSRRPR---FKD 275 (283)
T ss_pred CCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHhCCCcccCCC---HHH
Confidence 89999999999999999998 999999988888887777532 22334 3689999999999999 9999999 777
Q ss_pred hcC
Q 010947 411 IKV 413 (497)
Q Consensus 411 il~ 413 (497)
|+.
T Consensus 276 i~~ 278 (283)
T cd05091 276 IHS 278 (283)
T ss_pred HHH
Confidence 765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=337.92 Aligned_cols=257 Identities=20% Similarity=0.335 Sum_probs=209.8
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 181 (497)
+..+..++|.+.+.||+|+||.||+|++.. ++..+|+|.+.... .......+..|+.++..+ +||||+++
T Consensus 12 ~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 12 RWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred cceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 344556789999999999999999998643 23579999997542 223345688899999999 79999999
Q ss_pred EEEeecCCeEEEEEeecCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCC
Q 010947 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (497)
Q Consensus 182 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~ 245 (497)
+++|.+...+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999999999999997642 4888999999999999999999999999999999
Q ss_pred CeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccC
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 325 (497)
|||++.++.+||+|||+++......... ......+++.|+|
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 210 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------KTTNGRLPVKWMA 210 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhh---------------------------------------ccccCCCccceeC
Confidence 9999999999999999987553211000 0001235578999
Q ss_pred ccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 326 PE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
||++.+..++.++|+|||||++|||++ |.+||.+.+..+....+.. ......| ..++.++++||.+||. +|.+||
T Consensus 211 PE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp 287 (307)
T cd05098 211 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE-GHRMDKP--SNCTNELYMMMRDCWHAVPSQRP 287 (307)
T ss_pred hHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHc-CCCCCCC--CcCCHHHHHHHHHHcccChhhCc
Confidence 999999899999999999999999998 8999988777666665543 2233344 3688999999999999 999999
Q ss_pred CCCCcchhcC
Q 010947 404 GAKGADEIKV 413 (497)
Q Consensus 404 ~~~~~~eil~ 413 (497)
+ +.+++.
T Consensus 288 s---~~evl~ 294 (307)
T cd05098 288 T---FKQLVE 294 (307)
T ss_pred C---HHHHHH
Confidence 8 777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=318.72 Aligned_cols=262 Identities=26% Similarity=0.420 Sum_probs=215.7
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC---
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--- 188 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--- 188 (497)
.+..++|.+.+.||.|||+.||+|+...|++.||+|++.... ..+.+..++|++..++++||||++++.+...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 356789999999999999999999999999999999997664 45677899999999999999999998766543
Q ss_pred --CeEEEEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCC--EEEcccCCCCeeecCCCcEEEccc
Q 010947 189 --EFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDF 260 (497)
Q Consensus 189 --~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDLKp~NILl~~~g~vkL~DF 260 (497)
...||+++|...|+|.+.+.. ...++|.++..|+.+|+.||++||+.. ++||||||.|||++..+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 349999999999999999865 246999999999999999999999998 999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CCCCcc
Q 010947 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGME 337 (497)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~y~~~ 337 (497)
|.++...-. ...+++.-+++.|-.. ..|..|.|||.+.- ...+.+
T Consensus 174 GS~~~a~i~------------------------i~~~~~a~~lQe~a~e--------~Ct~pyRAPELf~vk~~~ti~er 221 (302)
T KOG2345|consen 174 GSATQAPIQ------------------------IEGSRQALRLQEWAEE--------RCTIPYRAPELFNVKSHCTITER 221 (302)
T ss_pred cCccccceE------------------------eechHHHHHHHHHHHH--------hCCCcccCchheecccCcccccc
Confidence 998764321 1123344456666433 36888999999974 446889
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCChH--HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDDPM--STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~~~--~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|||||||+||.|++|..||...-.. ...-.+.+ ..+.+|.....|..+.+||+.||+ ||.+||+ +.+++.
T Consensus 222 tDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n--~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~---i~~ll~ 295 (302)
T KOG2345|consen 222 TDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQN--AQISIPNSSRYSEALHQLIKSMLQVDPNQRPT---IPELLS 295 (302)
T ss_pred cchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeec--cccccCCCCCccHHHHHHHHHHhcCCcccCCC---HHHHHH
Confidence 99999999999999999999532110 11112222 567788887899999999999999 9999999 777765
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=338.75 Aligned_cols=268 Identities=30% Similarity=0.477 Sum_probs=210.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 188 (497)
.++|++.+.||.|+||.||+|.++.+++.||||++...... ......+.+|+.+++.++||||+++++.+.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 57899999999999999999999999999999998764321 22233467899999999999999999877543
Q ss_pred --CeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 189 --EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 189 --~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
..+|+||||+.+ +|...+.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999964 67776654 45799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlG 344 (497)
.......... ..... ........||+.|+|||++.+ ..++.++||||||
T Consensus 165 ~~~~~~~~~~--------------~~~~~----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 214 (311)
T cd07866 165 YDGPPPNPKG--------------GGGGG----------------TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG 214 (311)
T ss_pred ccCCCccccc--------------CCccc----------------ccccccceeccCcCChHHhhCCCccCchhHhHHHH
Confidence 5432110000 00000 001124578999999998865 4589999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhcccCcc---------------------cCCC-----CccCChhHHHHHHHHhh-
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFPE-----EAKLSIEAKDLISKLLC- 397 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~-----~~~~s~~~~dLI~~lL~- 397 (497)
|++|||++|.+||.+.+.......+....... ..|. ...+++++.+||.+||.
T Consensus 215 ~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 294 (311)
T cd07866 215 CVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL 294 (311)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHccc
Confidence 99999999999999888776666554311110 0000 02355789999999999
Q ss_pred CccccCCCCCcchhcCCCCc
Q 010947 398 NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 398 dp~~R~~~~~~~eil~Hpff 417 (497)
||.+||+ +.+++.||||
T Consensus 295 ~p~~R~t---~~ell~~~~f 311 (311)
T cd07866 295 DPYKRLT---ASDALEHPYF 311 (311)
T ss_pred CcccCcC---HHHHhcCCCC
Confidence 9999999 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=336.91 Aligned_cols=252 Identities=30% Similarity=0.544 Sum_probs=212.2
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecC
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 199 (497)
....||+|+||.||++..+.+|..||||++.... ......+.+|+.+++.++||||+++++.|.+.+..|+||||++
T Consensus 24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 3467999999999999999999999999885432 2334568889999999999999999999999999999999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccccc
Q 010947 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (497)
Q Consensus 200 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (497)
+++|.+++. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.+++++|+|||++.........
T Consensus 101 ~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~------- 172 (292)
T cd06657 101 GGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR------- 172 (292)
T ss_pred CCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc-------
Confidence 999998774 457899999999999999999999999999999999999999999999999998754321000
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCC
Q 010947 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (497)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~ 359 (497)
....+||+.|+|||.+.+..++.++|+|||||++|+|++|.+||.+
T Consensus 173 ----------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~ 218 (292)
T cd06657 173 ----------------------------------RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFN 218 (292)
T ss_pred ----------------------------------ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 0135689999999999888899999999999999999999999998
Q ss_pred CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
.+.......+... ....++....+++++.++|.+||. +|.+|++ +.+++.||||...
T Consensus 219 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~---~~~ll~~~~~~~~ 276 (292)
T cd06657 219 EPPLKAMKMIRDN-LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAKA 276 (292)
T ss_pred CCHHHHHHHHHhh-CCcccCCcccCCHHHHHHHHHHHhCCcccCcC---HHHHhcChHHhcc
Confidence 7766555444321 122222223678999999999999 9999999 9999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=338.15 Aligned_cols=253 Identities=26% Similarity=0.402 Sum_probs=212.1
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|...+.||.|+||.||+|+++.++..+|+|.+.............+..|+.+++.++|||++++++++.+....|+|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 47778889999999999999999999999999875433333445667889999999999999999999999999999999
Q ss_pred ecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 197 YLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 197 y~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|+. |+|.+++.. ...+++..+..++.+++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------ 168 (308)
T cd06634 96 YCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------ 168 (308)
T ss_pred ccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc------
Confidence 996 577776643 556999999999999999999999999999999999999999999999999998754211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHhHHHHHHHHHh
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwSlGvil~ell~ 352 (497)
....||+.|+|||++. ...++.++|||||||++|+|++
T Consensus 169 ---------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 209 (308)
T cd06634 169 ---------------------------------------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (308)
T ss_pred ---------------------------------------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc
Confidence 1346899999999985 3567889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|..||...+.......+..... ... ....++..+++||.+||. +|.+||+ +++++.||||...
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~cl~~~P~~Rp~---~~~ll~~~~~~~~ 273 (308)
T cd06634 210 RKPPLFNMNAMSALYHIAQNES-PAL-QSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 273 (308)
T ss_pred CCCCCccccHHHHHHHHhhcCC-CCc-CcccccHHHHHHHHHHhhCCcccCCC---HHHHhhCcccccc
Confidence 9999988766555555543211 111 123678899999999999 9999999 9999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=330.68 Aligned_cols=250 Identities=21% Similarity=0.315 Sum_probs=205.0
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCc--EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC------C
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------E 189 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------~ 189 (497)
|.+.+.||+|+||.||+|....++. .+|+|.++... ......+.+..|..+++.++||||+++++.+... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999887775 59999987642 2345567788999999999999999999876422 2
Q ss_pred eEEEEEeecCCCchhHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 190 FLYLIMEYLPGGDMMTLLMR------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~------~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
..++||||+++|+|..++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999988742 234899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+.+....... ......+++.|+|||++.+..++.++|||||
T Consensus 160 ~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl 200 (272)
T cd05075 160 KKIYNGDYYR---------------------------------------QGRIAKMPVKWIAIESLADRVYTTKSDVWSF 200 (272)
T ss_pred cccCccccee---------------------------------------cCCcccCCcccCCHHHccCCCcChHHHHHHH
Confidence 8654221000 0012346788999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 344 GAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 344 Gvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
||++|||++ |.+||.+....+....+..+. ....+ ..++..++++|.+||+ ||.+||+ +.+|++
T Consensus 201 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~l~~ 266 (272)
T cd05075 201 GVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQP--PDCLDGLYSLMSSCWLLNPKDRPS---FETLRC 266 (272)
T ss_pred HHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCcccCcC---HHHHHH
Confidence 999999999 899999888777777776532 22333 3688899999999999 9999998 777754
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=333.20 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=208.2
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
...+|.+.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 4567999999999999999999854 345679999986543 22345688899999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~ 252 (497)
...++||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999986542 38899999999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC
Q 010947 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (497)
Q Consensus 253 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~ 332 (497)
+.++|+|||+++......... ......|++.|+|||++.+.
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 200 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYR---------------------------------------VGGHTMLPIRWMPPESIMYR 200 (291)
T ss_pred CcEEECCCCcccccCCCceee---------------------------------------cCCCCCcceeecChHHhccC
Confidence 999999999997553221000 01134678899999999999
Q ss_pred CCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcch
Q 010947 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (497)
Q Consensus 333 ~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~e 410 (497)
.++.++|+|||||++|||++ |.+||...+..+....+.... ....+ ..++.++.+||.+||+ +|.+||+ +.+
T Consensus 201 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt---~~~ 274 (291)
T cd05094 201 KFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR-VLERP--RVCPKEVYDIMLGCWQREPQQRLN---IKE 274 (291)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCC-CCCCC--ccCCHHHHHHHHHHcccChhhCcC---HHH
Confidence 99999999999999999998 999998888777666665421 12222 3578899999999999 9999998 666
Q ss_pred hc
Q 010947 411 IK 412 (497)
Q Consensus 411 il 412 (497)
++
T Consensus 275 v~ 276 (291)
T cd05094 275 IY 276 (291)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=338.35 Aligned_cols=256 Identities=30% Similarity=0.461 Sum_probs=210.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-CCeEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEFLY 192 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~l~ 192 (497)
..++|++++.||.|+||.||+|.++.+++.||||++.+.. ........+..|+.+++.++||||++++++|.. ...+|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 4678999999999999999999999999999999987542 223345668889999999999999999999875 56899
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
+||||+ +++|..++. ...+++..+..++.|++.||.|||+.||+||||+|+|||++.++.++|+|||++......
T Consensus 87 lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--- 161 (328)
T cd07856 87 FVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--- 161 (328)
T ss_pred EEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC---
Confidence 999999 678888774 457899999999999999999999999999999999999999999999999998754211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHH
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell 351 (497)
....+|++.|+|||++.+ ..++.++|+|||||++|+|+
T Consensus 162 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~ 200 (328)
T cd07856 162 -----------------------------------------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200 (328)
T ss_pred -----------------------------------------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHH
Confidence 013467889999999866 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcc------------------------cCcccCCC---CccCChhHHHHHHHHhh-CccccC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNW------------------------RTHLKFPE---EAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~------------------------~~~~~~p~---~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
+|.+||.+.+.......+.+. ......|. ...++.++.++|.+||+ +|.+||
T Consensus 201 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~ 280 (328)
T cd07856 201 EGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI 280 (328)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC
Confidence 999999877653332222110 00001111 12478899999999999 999999
Q ss_pred CCCCcchhcCCCCccC
Q 010947 404 GAKGADEIKVHPWFDG 419 (497)
Q Consensus 404 ~~~~~~eil~Hpff~~ 419 (497)
+ +++++.||||..
T Consensus 281 t---~~ell~~~~~~~ 293 (328)
T cd07856 281 S---AAEALAHPYLAP 293 (328)
T ss_pred C---HHHHhcCCcccc
Confidence 8 999999999974
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=328.39 Aligned_cols=248 Identities=21% Similarity=0.358 Sum_probs=205.7
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+...+|++.+.||+|+||.||+|.+..++ .||+|++.+... ..+.+..|+.+++.++||||+++++.+.+ ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 34567999999999999999999886654 599999976432 22457889999999999999999998754 5689
Q ss_pred EEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+||||+++|+|.+++.+. ..+++..+..++.+++.||.|||+.||+||||||+||+++.++.+||+|||+++.+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 999999999999999753 458999999999999999999999999999999999999999999999999997653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
.. ......++..|+|||++.+..++.++|+|||||++|+|
T Consensus 157 ~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~el 196 (262)
T cd05071 157 YT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (262)
T ss_pred cc----------------------------------------cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHH
Confidence 00 00123467889999999989999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
++ |.+||.+....+....+... .. .+....++..+.+||.+||. ||.+||+ +.+++
T Consensus 197 lt~g~~p~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~l~~li~~~l~~~p~~Rp~---~~~~~ 254 (262)
T cd05071 197 TTKGRVPYPGMVNREVLDQVERG-YR--MPCPPECPESLHDLMCQCWRKEPEERPT---FEYLQ 254 (262)
T ss_pred HcCCCCCCCCCChHHHHHHHhcC-CC--CCCccccCHHHHHHHHHHccCCcccCCC---HHHHH
Confidence 99 89999988877777776542 12 22234688999999999999 9999998 55553
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=325.51 Aligned_cols=251 Identities=28% Similarity=0.491 Sum_probs=218.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+|++.+.||.|+||.||+|.++.+++.||+|.+...... ......+..|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 588999999999999999999999999999999865432 3445567789999999999999999999999999999999
Q ss_pred ecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 197 YLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 197 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
|++|++|..++.+ ...+++..+..++.+++.||.|||+.|++||||+|+||+++.++.+||+|||+++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~-- 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM-- 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC--
Confidence 9999999999866 3568999999999999999999999999999999999999999999999999997653210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.....|++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 158 -----------------------------------------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~ 196 (256)
T cd08530 158 -----------------------------------------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMAT 196 (256)
T ss_pred -----------------------------------------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHh
Confidence 013468899999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|++||...+.......+... .....+ ..++.+++++|.+||. +|.+||+ +.++++||+.
T Consensus 197 g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~~l~~p~~ 256 (256)
T cd08530 197 FAPPFEARSMQDLRYKVQRG-KYPPIP--PIYSQDLQNFIRSMLQVKPKLRPN---CDKILASPAV 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHhcC-CCCCCc--hhhCHHHHHHHHHHcCCCcccCCC---HHHHhcCCCC
Confidence 99999988877666666542 122233 3688999999999998 9999999 9999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=335.68 Aligned_cols=260 Identities=29% Similarity=0.503 Sum_probs=210.9
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC---
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--- 189 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--- 189 (497)
...++|++.+.||.|+||.||+|.++.+|+.||+|+++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 346789999999999999999999999999999999976432 2223345778999999999999999999987655
Q ss_pred -------eEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccc
Q 010947 190 -------FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261 (497)
Q Consensus 190 -------~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFG 261 (497)
.+|+||||+++ +|...+... ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999976 666666543 479999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhH
Q 010947 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340 (497)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~Di 340 (497)
++..+...... ......+++.|+|||++.+ ..++.++||
T Consensus 162 ~~~~~~~~~~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~~Di 201 (302)
T cd07864 162 LARLYNSEESR----------------------------------------PYTNKVITLWYRPPELLLGEERYGPAIDV 201 (302)
T ss_pred ccccccCCccc----------------------------------------ccccceeccCccChHHhcCCCCCCchhHH
Confidence 99865422100 0012356888999998865 457899999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccC---cccCC-----------------------CCccCChhHHHHHHH
Q 010947 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT---HLKFP-----------------------EEAKLSIEAKDLISK 394 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~---~~~~p-----------------------~~~~~s~~~~dLI~~ 394 (497)
|||||++|||++|++||...+..+....+..... ...+| ....++..+.+||.+
T Consensus 202 ~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 281 (302)
T cd07864 202 WSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDH 281 (302)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHH
Confidence 9999999999999999998776665555443110 00000 012468899999999
Q ss_pred Hhh-CccccCCCCCcchhcCCCCc
Q 010947 395 LLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 395 lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
||. ||.+||+ +.+++.||||
T Consensus 282 ~l~~~P~~Rp~---~~~il~~~~~ 302 (302)
T cd07864 282 MLTLDPSKRCT---AEEALNSPWL 302 (302)
T ss_pred HccCChhhCCC---HHHHhcCCCC
Confidence 999 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=361.08 Aligned_cols=259 Identities=25% Similarity=0.414 Sum_probs=211.0
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeec-
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD- 187 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~- 187 (497)
...+...++++.++|.+|||+.||+|++...|..||+|++-.. +....+.+++|+++|++|. |+|||.++++...
T Consensus 31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~ 107 (738)
T KOG1989|consen 31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN 107 (738)
T ss_pred EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence 3456677899999999999999999999888899999998654 4566788999999999996 9999999984321
Q ss_pred ---C---CeEEEEEeecCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCC--EEEcccCCCCeeecCCCcEEE
Q 010947 188 ---D---EFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRL 257 (497)
Q Consensus 188 ---~---~~l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDLKp~NILl~~~g~vkL 257 (497)
. -.++|.||||.||.|-+++.. ...|+|.++..|+++++.|+.+||.+. |||||||-|||||+.+|+.||
T Consensus 108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEe
Confidence 1 247899999999999999974 356999999999999999999999987 999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCC
Q 010947 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGY 334 (497)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y 334 (497)
||||.|....... +....+.--+.+- ...-||.|+|||++. +.+.
T Consensus 188 CDFGSatt~~~~~---------------------------~~~~e~~~ve~eI-----~k~TTp~YRsPEMIDlysg~pI 235 (738)
T KOG1989|consen 188 CDFGSATTKILSP---------------------------TSAQEVNYVEEEI-----EKYTTPQYRSPEMIDLYSGLPI 235 (738)
T ss_pred CcccccccccCCC---------------------------ccHHHHHHHHHHH-----HhhCCccccChHHHhhhcCCCC
Confidence 9999987432110 0000111111110 124699999999986 6788
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 335 ~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+.++|||+|||+||-|++...||..... ..|++ ..+.||..+..|..+++||+.||. ||.+||. +-+++
T Consensus 236 ~eKsDIWALGclLYkLCy~t~PFe~sg~----laIln--g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPn---I~Qv~ 305 (738)
T KOG1989|consen 236 GEKSDIWALGCLLYKLCYFTTPFEESGK----LAILN--GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPN---IYQVL 305 (738)
T ss_pred cchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe--ccccCCCCccHHHHHHHHHHHHhccCcccCCC---HHHHH
Confidence 9999999999999999999999987643 24666 566788777899999999999999 9999998 66555
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=327.28 Aligned_cols=248 Identities=21% Similarity=0.387 Sum_probs=205.8
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++++.||+|+||.||+|... ++..+|+|.+..... ....+.+|+.+++.++||+|+++++.+.. ...|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIY 76 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEECC-CCcE
Confidence 45678999999999999999999865 556799999876432 23458899999999999999999988754 5688
Q ss_pred EEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+||||+++|+|.+++... ..+++..+..++.+++.||.|||+.||+||||||+||+++.++.++|+|||++..+....
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999998753 458999999999999999999999999999999999999999999999999997653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
.. ......++..|+|||++.+..++.++|+|||||++|+|
T Consensus 157 ~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l 196 (260)
T cd05070 157 YT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred cc----------------------------------------cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHH
Confidence 00 00123456789999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
++ |.+||.+.+..+....+... ...+.| ...+..+.+||.+||+ +|.+||+ +.++.
T Consensus 197 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt---~~~l~ 254 (260)
T cd05070 197 VTKGRVPYPGMNNREVLEQVERG-YRMPCP--QDCPISLHELMLQCWKKDPEERPT---FEYLQ 254 (260)
T ss_pred HhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcccCcccCcC---HHHHH
Confidence 99 99999988877777776542 222233 4688999999999999 9999999 65554
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=335.49 Aligned_cols=257 Identities=20% Similarity=0.352 Sum_probs=213.1
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEc-------CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-------TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-------~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 181 (497)
+..+..++|.+.+.||+|+||.||+|+.. .++..||+|++.... .......+.+|+.+++.+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 34567788999999999999999999753 234579999987532 233456788999999999 89999999
Q ss_pred EEEeecCCeEEEEEeecCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCC
Q 010947 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (497)
Q Consensus 182 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~ 245 (497)
++++.+...+|+||||+++|+|.+++.+. ..++...+..++.||+.||.|||+.||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999999763 24677889999999999999999999999999999
Q ss_pred CeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccC
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 325 (497)
|||++.++.+||+|||+++.+....... ......+++.|+|
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 207 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYK---------------------------------------KTTNGRLPVKWMA 207 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccc---------------------------------------cccCCCCCceeeC
Confidence 9999999999999999998653221000 0112346788999
Q ss_pred ccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 326 PE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
||++.+..|+.++|||||||++|+|++ |..||.+.+..+....+... .....| ..++.++++||.+||. +|.+||
T Consensus 208 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~cl~~~p~~Rp 284 (304)
T cd05101 208 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDCWHAIPSHRP 284 (304)
T ss_pred chhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcccChhhCC
Confidence 999999999999999999999999998 89999988888877777543 222333 3688999999999999 999999
Q ss_pred CCCCcchhcC
Q 010947 404 GAKGADEIKV 413 (497)
Q Consensus 404 ~~~~~~eil~ 413 (497)
+ +.++++
T Consensus 285 s---~~e~l~ 291 (304)
T cd05101 285 T---FKQLVE 291 (304)
T ss_pred C---HHHHHH
Confidence 8 777765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=326.43 Aligned_cols=248 Identities=23% Similarity=0.374 Sum_probs=206.3
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++++.||+|+||.||+|..+ +++.||+|.+..... ....+..|+.+++.++||||+++++++. .+.+|
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 45678999999999999999999864 567899999875432 2346888999999999999999998874 46789
Q ss_pred EEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+||||+++|+|.+++... ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998653 468999999999999999999999999999999999999999999999999987654211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
... .....++..|+|||++....++.++|+|||||++|||
T Consensus 157 ~~~----------------------------------------~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el 196 (260)
T cd05067 157 YTA----------------------------------------REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEI 196 (260)
T ss_pred ccc----------------------------------------ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHH
Confidence 000 0123567889999999989999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
++ |.+||.+.+..+....+... .....| ..++.++.+||.+||+ +|.+||+ +++++
T Consensus 197 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~ 254 (260)
T cd05067 197 VTYGRIPYPGMTNPEVIQNLERG-YRMPRP--DNCPEELYELMRLCWKEKPEERPT---FEYLR 254 (260)
T ss_pred HhCCCCCCCCCChHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHccCChhhCCC---HHHHH
Confidence 98 99999988777666665432 222233 4678899999999999 9999999 66654
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=326.61 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=200.4
Q ss_pred EeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 123 MIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
.||+|+||.||+|..+ .++..||+|++.... .....+.+.+|+.+++.++||||+++++++.. ..+|+||||++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999765 445679999987542 23345668899999999999999999998864 578999999999
Q ss_pred CchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccccc
Q 010947 201 GDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (497)
Q Consensus 201 g~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (497)
|+|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~----- 153 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK----- 153 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee-----
Confidence 999999875 45799999999999999999999999999999999999999999999999999976532211000
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCC
Q 010947 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 358 (497)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~ 358 (497)
......+++.|+|||++....++.++|+|||||++|||++ |.+||.
T Consensus 154 ---------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 200 (257)
T cd05115 154 ---------------------------------ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYK 200 (257)
T ss_pred ---------------------------------ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcC
Confidence 0001234678999999998889999999999999999996 999999
Q ss_pred CCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 359 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
+....+....+..+ ....+| ..+++++.+||.+||. +|++||+...+.+.++.
T Consensus 201 ~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~ 254 (257)
T cd05115 201 KMKGPEVMSFIEQG-KRLDCP--AECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT 254 (257)
T ss_pred cCCHHHHHHHHHCC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence 88877776666543 233344 3689999999999999 99999994333333333
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=325.35 Aligned_cols=244 Identities=21% Similarity=0.344 Sum_probs=201.6
Q ss_pred eEeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeec
Q 010947 122 TMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 198 (497)
+.||+|+||.||+|....++ ..||+|.+...... .....+..|+.+++.++|||||++++++.. +..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 46999999999999876554 78999999866543 344568889999999999999999998764 4679999999
Q ss_pred CCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccc
Q 010947 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (497)
Q Consensus 199 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 278 (497)
++|+|.+++.....+++..+..++.|++.||.|||..|++||||||+|||++.++.+||+|||+++.+........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~---- 153 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR---- 153 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc----
Confidence 9999999998877899999999999999999999999999999999999999999999999999986532210000
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCC
Q 010947 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPF 357 (497)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF 357 (497)
......++..|+|||.+.+..++.++|+|||||++|+|++ |.+||
T Consensus 154 ----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~ 199 (257)
T cd05060 154 ----------------------------------ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY 199 (257)
T ss_pred ----------------------------------cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCc
Confidence 0001224568999999999999999999999999999998 99999
Q ss_pred CCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 358 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
...+..+....+... .....| ..++..+++||.+||+ +|.+||+ +.+++
T Consensus 200 ~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp~---~~~l~ 249 (257)
T cd05060 200 GEMKGAEVIAMLESG-ERLPRP--EECPQEIYSIMLSCWKYRPEDRPT---FSELE 249 (257)
T ss_pred ccCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHhcCChhhCcC---HHHHH
Confidence 888776666666543 222333 4688999999999999 9999999 65554
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=336.41 Aligned_cols=255 Identities=20% Similarity=0.328 Sum_probs=210.2
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 183 (497)
.+..++|.+.+.||+|+||.||+|+... ....+|+|+++... .......+..|+.+++.+ +||||+++++
T Consensus 8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 85 (314)
T cd05099 8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG 85 (314)
T ss_pred cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence 3456789999999999999999998642 34579999987532 234456788999999999 6999999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCe
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NI 247 (497)
+|.+...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 165 (314)
T cd05099 86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165 (314)
T ss_pred EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence 999999999999999999999999653 3488899999999999999999999999999999999
Q ss_pred eecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcc
Q 010947 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (497)
Q Consensus 248 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 327 (497)
|++.++.+||+|||+++......... ......+++.|+|||
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE 206 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYK---------------------------------------KTSNGRLPVKWMAPE 206 (314)
T ss_pred EEcCCCcEEEcccccccccccccccc---------------------------------------ccccCCCCccccCHH
Confidence 99999999999999998653211000 000123557899999
Q ss_pred ccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC
Q 010947 328 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 328 ~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
++.+..++.++|||||||++|||++ |..||.+.+..+.+..+... ....+| ..++.++++||.+||. +|.+||+
T Consensus 207 ~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~Rps- 282 (314)
T cd05099 207 ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG-HRMDKP--SNCTHELYMLMRECWHAVPTQRPT- 282 (314)
T ss_pred HHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCcccCcC-
Confidence 9999999999999999999999999 99999988887777776653 223333 3678899999999999 9999998
Q ss_pred CCcchhcC
Q 010947 406 KGADEIKV 413 (497)
Q Consensus 406 ~~~~eil~ 413 (497)
+.+++.
T Consensus 283 --~~~ll~ 288 (314)
T cd05099 283 --FKQLVE 288 (314)
T ss_pred --HHHHHH
Confidence 666653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=350.51 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=217.5
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCc---E-EEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEE
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH---V-YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~---~-~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 184 (497)
+.+.+..++-.+.++||+|+||+||+|+.+..+. . ||+|..+.+......++..+..|.++|+.++|||||++||+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3455666777788999999999999999876432 3 89999986555667888999999999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
..+...+|||||+|+||+|.++|.+.+ .++..+...++.+.+.||+|||++++|||||-..|+|++.++.+||+|||||
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 999999999999999999999998876 4999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccc-cccCCCcccCccccccCCCCcchhHHh
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY-STVGTPDYIAPEVLLKKGYGMECDWWS 342 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~Gt~~Y~aPE~l~~~~y~~~~DiwS 342 (497)
+....-.. .. ...-...|+|||.+....|+.++||||
T Consensus 310 ~~~~~~~~------------------------------------------~~~~~klPirWLAPEtl~~~~~s~kTDV~s 347 (474)
T KOG0194|consen 310 RAGSQYVM------------------------------------------KKFLKKLPIRWLAPETLNTGIFSFKTDVWS 347 (474)
T ss_pred cCCcceee------------------------------------------ccccccCcceecChhhhccCccccccchhh
Confidence 75421000 00 011345799999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 343 lGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|||++||+++ |..||.+....+...+|.......+.|. ..+.++..++.+|+. +|++|++
T Consensus 348 fGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~--~~p~~~~~~~~~c~~~~p~~R~t 409 (474)
T KOG0194|consen 348 FGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS--KTPKELAKVMKQCWKKDPEDRPT 409 (474)
T ss_pred eeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC--CCHHHHHHHHHHhccCChhhccC
Confidence 9999999998 8999999999999999965445555554 678889999999998 9999999
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=329.37 Aligned_cols=252 Identities=21% Similarity=0.390 Sum_probs=210.6
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.++|++++.||+|+||.||+|+.+.+ .+.||+|.+.... .......+..|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 46899999999999999999997643 4679999886532 1224567889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccc
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKD---------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DF 260 (497)
..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+++++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997655 6999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhH
Q 010947 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (497)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~Di 340 (497)
|+++........ ......+++.|+|||.+.+..++.++||
T Consensus 162 ~~~~~~~~~~~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di 201 (275)
T cd05046 162 SLSKDVYNSEYY----------------------------------------KLRNALIPLRWLAPEAVQEDDFSTKSDV 201 (275)
T ss_pred ccccccCccccc----------------------------------------ccCCceeEEeecChhhhccCCCCchhhH
Confidence 998743211000 0013457788999999988889999999
Q ss_pred HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 341 WSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 341 wSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||||++|+|++ |..||.+.........+... .+.++....++..+.++|.+||+ +|.+||+ +.+++.
T Consensus 202 ~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~---~~~~l~ 271 (275)
T cd05046 202 WSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--KLELPVPEGCPSRLYKLMTRCWAVNPKDRPS---FSELVS 271 (275)
T ss_pred HHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--CcCCCCCCCCCHHHHHHHHHHcCCCcccCCC---HHHHHH
Confidence 999999999998 88999887766666666542 22333334688999999999999 9999998 777765
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=325.32 Aligned_cols=250 Identities=20% Similarity=0.350 Sum_probs=210.2
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
++..++|.+.+.||+|+||.||+|... .+..||||.+..... ....+..|+.+++.++||||+++++++.+...+
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence 356788999999999999999999875 457799999876432 235588899999999999999999999998999
Q ss_pred EEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
|+||||+++++|.+++... ..+++..+..++.+++.||.|||++||+|+||||+||+++.++.+||+|||+++.+...
T Consensus 77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 9999999999999999764 36899999999999999999999999999999999999999999999999998765321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.... .....++..|+|||.+.+..++.++|+|||||++|+
T Consensus 157 ~~~~----------------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~ 196 (261)
T cd05034 157 EYTA----------------------------------------REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTE 196 (261)
T ss_pred hhhh----------------------------------------hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHH
Confidence 1000 002235678999999998899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
|++ |..||.+.+......++... .....| ..++.++.++|.+||+ +|.+||+ +.++.
T Consensus 197 l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rp~---~~~l~ 255 (261)
T cd05034 197 IVTYGRVPYPGMTNREVLEQVERG-YRMPRP--PNCPEELYDLMLQCWDKDPEERPT---FEYLQ 255 (261)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccCcccCCC---HHHHH
Confidence 998 99999988877777777642 122233 3568899999999999 9999998 66654
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=342.31 Aligned_cols=264 Identities=32% Similarity=0.486 Sum_probs=212.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecC--CeE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDD--EFL 191 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~l 191 (497)
.++|++.+.||+|+||.||+|.+..+|..+|||++.+.. ........+..|+.+++.+ +||||++++++|... ..+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 467999999999999999999999999999999986532 1223345677899999999 999999999988653 468
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||++ ++|..++... .+++..+..++.||+.||.|||+.||+||||||+||+++.+|.+||+|||+++.+.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999996 5998888654 889999999999999999999999999999999999999999999999999986643211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~el 350 (497)
... .......+||+.|+|||++.+ ..++.++|+|||||++|+|
T Consensus 163 ~~~------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el 206 (337)
T cd07852 163 NPE------------------------------------NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM 206 (337)
T ss_pred ccc------------------------------------CcchhcccccccccCceeeeccccccccchHHHHHHHHHHH
Confidence 000 000113579999999998865 5688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCc-----------------------cc---CCC-CccCChhHHHHHHHHhh-Ccccc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTH-----------------------LK---FPE-EAKLSIEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~-----------------------~~---~p~-~~~~s~~~~dLI~~lL~-dp~~R 402 (497)
++|.+||.+........++...... .. +.. ...++.++.+||.+||+ ||.+|
T Consensus 207 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R 286 (337)
T cd07852 207 LLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR 286 (337)
T ss_pred HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccc
Confidence 9999999887766555444332110 00 000 12368899999999999 99999
Q ss_pred CCCCCcchhcCCCCccCC
Q 010947 403 LGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 403 ~~~~~~~eil~Hpff~~i 420 (497)
|+ +.++++||||+.+
T Consensus 287 ps---~~~il~~~~~~~~ 301 (337)
T cd07852 287 LT---AEEALEHPYVAQF 301 (337)
T ss_pred cC---HHHHhhChhhhhh
Confidence 99 9999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=337.79 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=204.2
Q ss_pred Eeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 123 MIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 123 ~IG~G--~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
+||+| ++|.||+++.+.+++.||||++.... ........+..|+.+++.++||||++++++|.+.+..|++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 34444 55667777778899999999998653 2344667899999999999999999999999999999999999999
Q ss_pred CchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccc
Q 010947 201 GDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (497)
Q Consensus 201 g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 278 (497)
|+|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.+|.+||+|||.+..+.........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~--- 160 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV--- 160 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc---
Confidence 9999998753 46899999999999999999999999999999999999999999999999998765321110000
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
.........++..|+|||++.. ..|+.++|+|||||++|||++|.+|
T Consensus 161 -------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~p 209 (314)
T cd08216 161 -------------------------------VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209 (314)
T ss_pred -------------------------------cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCC
Confidence 0000113468889999999976 4689999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCc------------------------------ccCCCCccCChhHHHHHHHHhh-CccccCCC
Q 010947 357 FYSDDPMSTCRKIVNWRTH------------------------------LKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~------------------------------~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
|.................. ...+....++.++.+||.+||+ ||.+||+
T Consensus 210 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt- 288 (314)
T cd08216 210 FKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS- 288 (314)
T ss_pred CCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC-
Confidence 9876544332221110000 0000112346789999999999 9999999
Q ss_pred CCcchhcCCCCccCC
Q 010947 406 KGADEIKVHPWFDGV 420 (497)
Q Consensus 406 ~~~~eil~Hpff~~i 420 (497)
+.+++.||||+.+
T Consensus 289 --~~~ll~~p~~~~~ 301 (314)
T cd08216 289 --ASQLLNHSFFKQC 301 (314)
T ss_pred --HHHHhcCchHhhh
Confidence 9999999999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=338.30 Aligned_cols=261 Identities=27% Similarity=0.402 Sum_probs=208.5
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCC--CcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeec----CC
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTT--GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD----DE 189 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t--~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~----~~ 189 (497)
+|.+.+.||+|+||.||+|++..+ +..||||++.... ........+..|+.++..+ +||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999888 8999999986432 1222345677899999998 59999999986432 35
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|++|||+. ++|..++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+.+...
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999985 689999988888999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ 348 (497)
..... ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 159 ~~~~~-------------------------------------~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~ 201 (332)
T cd07857 159 PGENA-------------------------------------GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILA 201 (332)
T ss_pred ccccc-------------------------------------ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHH
Confidence 11000 00113579999999998765 57899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccC--------------------------cccCCC-CccCChhHHHHHHHHhh-Ccc
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRT--------------------------HLKFPE-EAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~--------------------------~~~~p~-~~~~s~~~~dLI~~lL~-dp~ 400 (497)
+|++|.+||.+.+.......++.... ...++. ...++.++.+||.+||+ ||.
T Consensus 202 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~ 281 (332)
T cd07857 202 ELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPT 281 (332)
T ss_pred HHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcc
Confidence 99999999987765444433332100 011111 12468899999999999 999
Q ss_pred ccCCCCCcchhcCCCCccC
Q 010947 401 QRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 401 ~R~~~~~~~eil~Hpff~~ 419 (497)
+||+ +.+++.||||..
T Consensus 282 ~R~t---~~~ll~~~~~~~ 297 (332)
T cd07857 282 KRIS---VEEALEHPYLAI 297 (332)
T ss_pred cCCC---HHHHhcChhhhh
Confidence 9998 999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=342.55 Aligned_cols=257 Identities=22% Similarity=0.336 Sum_probs=205.5
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSF 185 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~ 185 (497)
.+..++|++.+.||+|+||+||+|.+ ..+++.||||+++... .......+..|+.+|..+ +||||+++++++
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 3 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred ccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 34567899999999999999999984 3567899999997542 223456688899999999 689999999887
Q ss_pred ec-CCeEEEEEeecCCCchhHHHHhc------------------------------------------------------
Q 010947 186 QD-DEFLYLIMEYLPGGDMMTLLMRK------------------------------------------------------ 210 (497)
Q Consensus 186 ~~-~~~l~lVmEy~~gg~L~~~l~~~------------------------------------------------------ 210 (497)
.. ...+|+|||||++|+|.+++...
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 65 45689999999999999998642
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccc
Q 010947 211 -------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (497)
Q Consensus 211 -------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 277 (497)
..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~---- 236 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYV---- 236 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchh----
Confidence 236788889999999999999999999999999999999999999999999997653211000
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCC
Q 010947 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPP 356 (497)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~P 356 (497)
......+++.|+|||++.+..++.++|||||||++|+|++ |..|
T Consensus 237 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 281 (343)
T cd05103 237 -----------------------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281 (343)
T ss_pred -----------------------------------hcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 0012346778999999999999999999999999999997 9999
Q ss_pred CCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|.+..........+........| ..+++++.++|.+||+ ||.+||+ +.+|++|
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~cl~~~p~~Rps---~~eil~~ 335 (343)
T cd05103 282 YPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 335 (343)
T ss_pred CCCccccHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHccCChhhCcC---HHHHHHH
Confidence 98765443333333222233334 3578899999999999 9999998 8888765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=347.81 Aligned_cols=257 Identities=22% Similarity=0.321 Sum_probs=209.9
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEE
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCS 184 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~ 184 (497)
..+..++|.+.+.||+|+||.||+|+++ .+++.||+|+++... .......+..|+.+|..+. |||||+++++
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~ 109 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA 109 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence 4456677899999999999999999864 345689999997542 2333456889999999997 9999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhcC-----------------------------------------------------
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRKD----------------------------------------------------- 211 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~~----------------------------------------------------- 211 (497)
|.+...+|+|||||+||+|.+++.+..
T Consensus 110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 999999999999999999999986431
Q ss_pred ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCC
Q 010947 212 ---------------------------------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (497)
Q Consensus 212 ---------------------------------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~N 246 (497)
.+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 35677788899999999999999999999999999
Q ss_pred eeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCc
Q 010947 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (497)
Q Consensus 247 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 326 (497)
||++.++.+||+|||+++.+....... ...+.+|++.|+||
T Consensus 270 iLl~~~~~~kL~DfGla~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aP 310 (401)
T cd05107 270 VLICEGKLVKICDFGLARDIMRDSNYI---------------------------------------SKGSTFLPLKWMAP 310 (401)
T ss_pred EEEeCCCEEEEEecCcceecccccccc---------------------------------------cCCCcCCCCceeCh
Confidence 999999999999999998643211000 00134678999999
Q ss_pred cccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 327 E~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|++.+..++.++|||||||++|||++ |..||......+.....+.....+..| ..++.++.+||.+|++ +|.+||+
T Consensus 311 E~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~~P~~RPs 388 (401)
T cd05107 311 ESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP--AHASDEIYEIMQKCWEEKFEIRPD 388 (401)
T ss_pred HHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHcCCChhHCcC
Confidence 99998899999999999999999998 899998766555554544432233344 3689999999999999 9999999
Q ss_pred CCCcchhcC
Q 010947 405 AKGADEIKV 413 (497)
Q Consensus 405 ~~~~~eil~ 413 (497)
+.+|+.
T Consensus 389 ---~~ell~ 394 (401)
T cd05107 389 ---FSQLVH 394 (401)
T ss_pred ---HHHHHH
Confidence 777764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.45 Aligned_cols=245 Identities=21% Similarity=0.368 Sum_probs=209.1
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+...+|++.+.||.|+||.||+|... |+.||+|.+..... ...++.+|+.+++.++|+||+++++.+.+....|
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence 45678999999999999999999864 78999999976532 4567889999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 193 LIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 9999999999999997765 79999999999999999999999999999999999999999999999999997652110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
....++..|+|||++....++.++|+|||||++|+|
T Consensus 157 --------------------------------------------~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l 192 (256)
T cd05039 157 --------------------------------------------DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEI 192 (256)
T ss_pred --------------------------------------------ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHH
Confidence 012345679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++ |..||...+.......+... .....| ..+++++.+||.+||. +|.+||+ +.+++.
T Consensus 193 ~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~ 251 (256)
T cd05039 193 YSFGRVPYPRIPLKDVVPHVEKG-YRMEAP--EGCPPEVYKVMKDCWELDPAKRPT---FKQLRE 251 (256)
T ss_pred HhcCCCCCCCCCHHHHHHHHhcC-CCCCCc--cCCCHHHHHHHHHHhccChhhCcC---HHHHHH
Confidence 97 99999888776666555432 222333 3678999999999999 9999999 666653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=325.75 Aligned_cols=255 Identities=21% Similarity=0.342 Sum_probs=210.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
..+|.+.+.||+|+||.||+|..+.+++ .||||++.+.. .......+..|+.+++.++||||+++++++.++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4578999999999999999999887665 69999987542 244556789999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
|+||||+++|+|.+++... +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 9999999999999998763 568999999999999999999999999999999999999999999999999987553211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
... .. .......++..|+|||++.+..++.++|+|||||++|||
T Consensus 161 ~~~-~~-----------------------------------~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~ 204 (269)
T cd05065 161 SDP-TY-----------------------------------TSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 204 (269)
T ss_pred ccc-cc-----------------------------------ccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHH
Confidence 000 00 000011234679999999999999999999999999998
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++ |.+||.+.+..+....+.. ....|....++.++.++|.+||. +|.+||+ +.+|+.
T Consensus 205 l~~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~~ 263 (269)
T cd05065 205 MSYGERPYWDMSNQDVINAIEQ---DYRLPPPMDCPTALHQLMLDCWQKDRNARPK---FGQIVS 263 (269)
T ss_pred hcCCCCCCCCCCHHHHHHHHHc---CCcCCCcccCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 86 9999998887777776653 22333334688999999999999 9999999 777654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.52 Aligned_cols=243 Identities=22% Similarity=0.401 Sum_probs=204.2
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEe-ecCCeE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF-QDDEFL 191 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~~l 191 (497)
+...+|.+.+.||+|+||.||+|... |..||+|.++... ....+..|+.+++.++||+|+++++++ .+....
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 75 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence 44568999999999999999999764 7789999986532 245688899999999999999999865 456789
Q ss_pred EEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
|+||||+++|+|.+++.... .+++..+..++.+++.||.|||+.||+||||||+||+++.++.+||+|||+++.....
T Consensus 76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 155 (256)
T cd05082 76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 155 (256)
T ss_pred EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence 99999999999999987643 4889999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
. ....++..|+|||++.+..++.++|||||||++||
T Consensus 156 ~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~ 191 (256)
T cd05082 156 Q--------------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWE 191 (256)
T ss_pred C--------------------------------------------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHH
Confidence 0 02345678999999998999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
|++ |.+||...+..+....+... .....+ ..+++.++++|.+||+ +|.+||+ +.+++
T Consensus 192 l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt---~~~l~ 250 (256)
T cd05082 192 IYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPVVYDVMKQCWHLDAATRPS---FLQLR 250 (256)
T ss_pred HHhCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHhcCChhhCcC---HHHHH
Confidence 997 99999988777776666542 122233 3688999999999999 9999998 66664
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=332.05 Aligned_cols=255 Identities=17% Similarity=0.351 Sum_probs=205.0
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCC--------------cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCcee
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTG--------------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~--------------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv 179 (497)
...+|++.+.||+|+||.||+|++..++ ..||+|+++... .......+.+|+++++.++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 3468999999999999999999875432 358999987542 233456688999999999999999
Q ss_pred EEEEEeecCCeEEEEEeecCCCchhHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCe
Q 010947 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (497)
Q Consensus 180 ~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NI 247 (497)
++++++......|+||||++|++|.+++.... .+++..+..++.+++.||.|||+.|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 368889999999999999999999999999999999
Q ss_pred eecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcc
Q 010947 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (497)
Q Consensus 248 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 327 (497)
|++.++.+||+|||++..+....... ......+++.|+|||
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE 201 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYR---------------------------------------IQGRAVLPIRWMAWE 201 (295)
T ss_pred EEcCCCcEEecccccccccccCccee---------------------------------------ccCcCcCceeecChh
Confidence 99999999999999997653211000 001235678999999
Q ss_pred ccccCCCCcchhHHhHHHHHHHHHh--CCCCCCCCChHHHHHHHhcc---c-CcccCCCCccCChhHHHHHHHHhh-Ccc
Q 010947 328 VLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRKIVNW---R-THLKFPEEAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 328 ~l~~~~y~~~~DiwSlGvil~ell~--G~~PF~~~~~~~~~~~i~~~---~-~~~~~p~~~~~s~~~~dLI~~lL~-dp~ 400 (497)
++.+..++.++|+|||||++|+|++ |..||...+..+....+... . .....+....+++.+++||.+||. ||.
T Consensus 202 ~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 281 (295)
T cd05097 202 SILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIK 281 (295)
T ss_pred hhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCch
Confidence 9999999999999999999999988 77899887766655544320 0 111112223578899999999999 999
Q ss_pred ccCCCCCcchhc
Q 010947 401 QRLGAKGADEIK 412 (497)
Q Consensus 401 ~R~~~~~~~eil 412 (497)
+||+ +++|+
T Consensus 282 ~RPs---~~~i~ 290 (295)
T cd05097 282 DRPT---FNKIH 290 (295)
T ss_pred hCcC---HHHHH
Confidence 9999 66664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=323.12 Aligned_cols=248 Identities=21% Similarity=0.351 Sum_probs=204.7
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++...||+|+||.||+|.+..++ .+|+|.+..... ..+.+.+|+.+++.++||||+++++++. .+..|
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05069 3 IPRESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY 76 (260)
T ss_pred CChHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence 34567999999999999999999876554 599998865432 2345788999999999999999998875 45688
Q ss_pred EEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 193 LIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+||||+++|+|.+++... ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.++|+|||+++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999999764 348899999999999999999999999999999999999999999999999997653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
.. ......++..|+|||.+.+..++.++|+|||||++|||
T Consensus 157 ~~----------------------------------------~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el 196 (260)
T cd05069 157 YT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 196 (260)
T ss_pred cc----------------------------------------ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHH
Confidence 00 00123467789999999988999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
++ |.+||.+....+....+... .....| ..++..+++||.+||. ||.+||+ +++++
T Consensus 197 ~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~ 254 (260)
T cd05069 197 VTKGRVPYPGMVNREVLEQVERG-YRMPCP--QGCPESLHELMKLCWKKDPDERPT---FEYIQ 254 (260)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHHccCCcccCcC---HHHHH
Confidence 99 99999998877777766542 222233 3688999999999999 9999998 66654
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=329.76 Aligned_cols=253 Identities=22% Similarity=0.364 Sum_probs=209.0
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+..++|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence 346789999999999999999998753 67899999987542 12334568889999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhc----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCC
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK----------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~----------------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~ 245 (497)
...+|+||||+++|+|.+++... ..+++..+..++.|++.||.|||..|++||||||+
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 99999999999999999999643 24778889999999999999999999999999999
Q ss_pred CeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccC
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 325 (497)
|||++.++.++|+|||++..+........ .....+++.|+|
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~---------------------------------------~~~~~~~~~y~a 200 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKA---------------------------------------SENDAIPIRWMP 200 (288)
T ss_pred heEecCCCceEECccccceecccCccccc---------------------------------------cCCCccChhhcC
Confidence 99999999999999999875532210000 002235677999
Q ss_pred ccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 326 PE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
||++.+..++.++|+|||||++|||++ |..||.+.+..+....+.... ....| ..++.++.+||.+||+ ||.+||
T Consensus 201 PE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rp 277 (288)
T cd05050 201 PESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGN-VLSCP--DNCPLELYNLMRLCWSKLPSDRP 277 (288)
T ss_pred HHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHcccCcccCC
Confidence 999998999999999999999999997 889999888877777766432 22233 3678999999999999 999999
Q ss_pred CCCCcchhc
Q 010947 404 GAKGADEIK 412 (497)
Q Consensus 404 ~~~~~~eil 412 (497)
+ +.|++
T Consensus 278 t---~~el~ 283 (288)
T cd05050 278 S---FASIN 283 (288)
T ss_pred C---HHHHH
Confidence 9 65554
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=325.28 Aligned_cols=242 Identities=24% Similarity=0.400 Sum_probs=199.4
Q ss_pred eEeeecCCeEEEEEEEcCCCc--EEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEEeec
Q 010947 122 TMIGKGAFGEVRVCREKTTGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYL 198 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVmEy~ 198 (497)
++||+|+||.||+|..+.++. .+|+|.++.. ........+..|+.++.++ +||||++++++|.....+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 368999999999999988876 4688887642 2233456788999999999 8999999999999999999999999
Q ss_pred CCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 199 PGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 199 ~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
++|+|.+++.... .+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 9999999986543 478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHh
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwS 342 (497)
+....... ......+++.|+|||++....++.++|+||
T Consensus 159 ~~~~~~~~------------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~s 196 (270)
T cd05047 159 SRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSVYTTNSDVWS 196 (270)
T ss_pred ccccchhh------------------------------------------hccCCCCccccCChHHHccCCCCchhhHHH
Confidence 86321100 000123466799999999899999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 343 lGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++|||++ |.+||.+.+..+....+... .....| ..++.++.+||.+||. +|.+||+ +.+++.
T Consensus 197 lG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~il~ 263 (270)
T cd05047 197 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERPS---FAQILV 263 (270)
T ss_pred HHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCC--CcCCHHHHHHHHHHcccChhhCCC---HHHHHH
Confidence 9999999997 99999888777777666532 222233 3578899999999999 9999999 666653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=322.89 Aligned_cols=245 Identities=21% Similarity=0.346 Sum_probs=205.4
Q ss_pred eEeeecCCeEEEEEEEcC-CCc--EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeec
Q 010947 122 TMIGKGAFGEVRVCREKT-TGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~-t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 198 (497)
+.||+|+||.||+|.+.. .+. .||||.+...... .....+..|+.+++.++||||+++++.+.+ ..+++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 333 6999999876532 556778899999999999999999999988 8999999999
Q ss_pred CCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 199 PGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 199 ~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
++|+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++.+.......
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~--- 154 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY--- 154 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce---
Confidence 9999999997754 68999999999999999999999999999999999999999999999999998764221000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYP 355 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~ 355 (497)
.......++..|+|||++.+..++.++|+|||||++|||++ |.+
T Consensus 155 -----------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~ 199 (257)
T cd05040 155 -----------------------------------VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEE 199 (257)
T ss_pred -----------------------------------ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCC
Confidence 00012457889999999999999999999999999999998 999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
||...+..+....+......+..| ..++..+.++|.+||+ +|.+||+ +.+++
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~~~ 252 (257)
T cd05040 200 PWAGLSGSQILKKIDKEGERLERP--EACPQDIYNVMLQCWAHNPADRPT---FAALR 252 (257)
T ss_pred CCCCCCHHHHHHHHHhcCCcCCCC--ccCCHHHHHHHHHHCCCCcccCCC---HHHHH
Confidence 998888777777666433333333 3678899999999999 9999999 66654
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=323.71 Aligned_cols=262 Identities=27% Similarity=0.428 Sum_probs=208.9
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-CCe
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEF 190 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~ 190 (497)
..|+.++.||+|+||.||+|..+.++. .||||+++...- ..+-.....+|+.+++.++||||+.|..+|.. +..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 358999999999999999997655533 799999976522 11222346789999999999999999999887 789
Q ss_pred EEEEEeecCCCchhHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC----CcEEEcccc
Q 010947 191 LYLIMEYLPGGDMMTLLMRK-----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY----GHLRLSDFG 261 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~----g~vkL~DFG 261 (497)
++|++||.+ -||...+.-. ..++...++.++.||+.|+.|||++-|+||||||.|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 999999996 4888887532 468999999999999999999999999999999999999988 899999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhH
Q 010947 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340 (497)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~Di 340 (497)
+++.+...-..-.+ ....|-|.+|.|||.+.+ ..|+.++|+
T Consensus 182 laR~~~~plkpl~s--------------------------------------~d~VVVTiWYRAPELLLGa~hYT~AiDv 223 (438)
T KOG0666|consen 182 LARLFNNPLKPLAS--------------------------------------LDPVVVTIWYRAPELLLGARHYTKAIDV 223 (438)
T ss_pred HHHHhhcccccccc--------------------------------------CCceEEEEEecChHHhcccccccchhhh
Confidence 99987543111000 014678999999999997 569999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHhc---------ccCcccCCCC---------------------
Q 010947 341 WSLGAIMYEMLVGYPPFYSDDP---------MSTCRKIVN---------WRTHLKFPEE--------------------- 381 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~~---------~~~~~~i~~---------~~~~~~~p~~--------------------- 381 (497)
||+|||+.|||+-.|-|.+... .....+|++ |+.--.+|+.
T Consensus 224 WAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~ 303 (438)
T KOG0666|consen 224 WAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYY 303 (438)
T ss_pred HHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHH
Confidence 9999999999999999987531 234455553 3322233331
Q ss_pred ---ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 382 ---AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 382 ---~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
..-++.+.+|+.+||. ||-+|.+ ++++++|+||..-
T Consensus 304 ~~~k~k~~~a~~LL~klL~yDP~kRIt---a~qAleh~yF~~d 343 (438)
T KOG0666|consen 304 HKHKVKDPSALDLLQKLLTYDPIKRIT---AEQALEHPYFTED 343 (438)
T ss_pred HHhcCCCchHHHHHHHHhccCchhhcc---HHHHhcccccccC
Confidence 1125568999999999 9999999 9999999999864
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=329.89 Aligned_cols=254 Identities=33% Similarity=0.534 Sum_probs=212.3
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|++.+.||+|+||.||+|....+++.||+|++.... ........+..|+.+++.++||||+++++++.+...+|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 677889999999999999999999999999998754 2233345677899999999999999999999999999999999
Q ss_pred cCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 198 LPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 198 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
++ ++|.+++.+. ..+++..+..++.+++.||.|||+.||+||||+|+||+++.++.++|+|||+++........
T Consensus 80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~---- 154 (282)
T cd07829 80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT---- 154 (282)
T ss_pred cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccc----
Confidence 97 5899999776 58999999999999999999999999999999999999999999999999999765322100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHhCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~G~~ 355 (497)
.....+++.|+|||++.+. .++.++|+|||||++|||++|.+
T Consensus 155 -------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~ 197 (282)
T cd07829 155 -------------------------------------YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP 197 (282)
T ss_pred -------------------------------------cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCC
Confidence 0123567889999999876 78999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccC----------------cccCCC---------CccCChhHHHHHHHHhh-CccccCCCCCcc
Q 010947 356 PFYSDDPMSTCRKIVNWRT----------------HLKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~----------------~~~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ 409 (497)
||.+.+....+.++...-. ...+|. .+.++.++.++|.+||. ||.+||+ ++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~~ 274 (282)
T cd07829 198 LFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS---AK 274 (282)
T ss_pred CCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCC---HH
Confidence 9998876666555442100 001111 12357899999999999 9999999 99
Q ss_pred hhcCCCCc
Q 010947 410 EIKVHPWF 417 (497)
Q Consensus 410 eil~Hpff 417 (497)
+++.||||
T Consensus 275 ~~l~~p~~ 282 (282)
T cd07829 275 EALKHPYF 282 (282)
T ss_pred HHhhCcCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=335.99 Aligned_cols=258 Identities=19% Similarity=0.332 Sum_probs=211.4
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCC-------CcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t-------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 181 (497)
.+.+...+|.+.+.||+|+||.||+|++... +..||+|+++... .......+..|+.+++.+ +||||+++
T Consensus 6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 3445566899999999999999999986432 2368999887532 233456788999999999 89999999
Q ss_pred EEEeecCCeEEEEEeecCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCC
Q 010947 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (497)
Q Consensus 182 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~ 245 (497)
++.|.+...+|+||||+++|+|.+++.+.. .++...+..++.|++.||.|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999987532 3777888999999999999999999999999999
Q ss_pred CeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccC
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 325 (497)
|||++.++.+||+|||+++......... ......+++.|+|
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 204 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYK---------------------------------------KTTNGRLPVKWMA 204 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccc---------------------------------------cccCCCcCceEcC
Confidence 9999999999999999998653211000 0012335678999
Q ss_pred ccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 326 PE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
||++.+..++.++|||||||++|||++ |.+||.+.+..+....+... .....| ..++.++.+||.+||. +|.+||
T Consensus 205 PE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~Rp 281 (334)
T cd05100 205 PEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTHELYMIMRECWHAVPSQRP 281 (334)
T ss_pred HHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccChhhCc
Confidence 999999999999999999999999998 89999988877777766542 222333 3678899999999999 999999
Q ss_pred CCCCcchhcCC
Q 010947 404 GAKGADEIKVH 414 (497)
Q Consensus 404 ~~~~~~eil~H 414 (497)
+ +.+++.+
T Consensus 282 s---~~ell~~ 289 (334)
T cd05100 282 T---FKQLVED 289 (334)
T ss_pred C---HHHHHHH
Confidence 8 8888764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=325.49 Aligned_cols=253 Identities=30% Similarity=0.487 Sum_probs=212.8
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--chhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
+|.+.+.||+|+||.||+|.+..++..+++|+++..... .......+..|..+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 488999999999999999999888888888887654321 223344577799999999999999999999999999999
Q ss_pred EeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 195 MEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 195 mEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
|||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||+++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999988853 357999999999999999999999999999999999999975 679999999987653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
. ......|++.|+|||.+.+..++.++|+||||+++|+|
T Consensus 160 ~-----------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l 198 (260)
T cd08222 160 D-----------------------------------------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198 (260)
T ss_pred c-----------------------------------------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHH
Confidence 0 00134688999999999888899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
++|..||.+.+.......+.... ...+| ..++.++.++|.+||. +|.+||+ +.++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~il~~~~~ 260 (260)
T cd08222 199 CCLAHAFEGQNFLSVVLRIVEGP-TPSLP--ETYSRQLNSIMQSMLNKDPSLRPS---AAEILRNPFI 260 (260)
T ss_pred HhCCCCCCCccHHHHHHHHHcCC-CCCCc--chhcHHHHHHHHHHhcCChhhCcC---HHHHhhCCCC
Confidence 99999998877777666665421 22233 3678899999999999 9999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=320.61 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=211.3
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
|++.+.||.|+||.||+|.+..++ ..||+|++..... ......+..|+.++..++||||+++++.+.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999998766 8999999975432 2256778999999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 194 IMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
||||++|++|.+++..... +++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||+++.......
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999976554 99999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
.. .....+++.|+|||.+.+..++.++|+|||||++|+|+
T Consensus 159 ~~----------------------------------------~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~ 198 (258)
T smart00219 159 YK----------------------------------------KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIF 198 (258)
T ss_pred cc----------------------------------------cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHH
Confidence 00 00123788999999998888999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 352 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+ |.+||.+.+.......+.... ....+ ..++.++.++|.+||+ ||.+||+ +.+++.
T Consensus 199 ~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt---~~~ll~ 256 (258)
T smart00219 199 TLGESPYPGMSNEEVLEYLKKGY-RLPKP--ENCPPEIYKLMLQCWAEDPEDRPT---FSELVE 256 (258)
T ss_pred hCCCCCCCCCCHHHHHHHHhcCC-CCCCC--CcCCHHHHHHHHHHCcCChhhCcC---HHHHHh
Confidence 8 899999888777777776533 23333 3589999999999999 9999998 777764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=326.16 Aligned_cols=249 Identities=24% Similarity=0.340 Sum_probs=196.4
Q ss_pred eeEEeEeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec--CCeE
Q 010947 118 FELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFL 191 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~l 191 (497)
|.+++.||+|+||+||++.. ..++..||+|+++... .......+.+|+.+|+.++||||+++++++.. ...+
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 48899999999999988753 3568899999987542 12234567889999999999999999998765 3468
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 162 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 162 (283)
T ss_pred EEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcch
Confidence 999999999999999865 5699999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
.. .......++..|+|||++.+..++.++|||||||++|||+
T Consensus 163 ~~--------------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~ 204 (283)
T cd05080 163 YY--------------------------------------RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204 (283)
T ss_pred hh--------------------------------------ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHH
Confidence 00 0001234667799999999889999999999999999999
Q ss_pred hCCCCCCCCChHH--------------HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 352 VGYPPFYSDDPMS--------------TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 352 ~G~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+|..||....... .....+........| ..++.++.+||.+||. +|++||+ +.+++
T Consensus 205 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps---~~~i~ 275 (283)
T cd05080 205 THCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCP--KNCPQEVYILMKNCWETEAKFRPT---FRSLI 275 (283)
T ss_pred hCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCC--CCCCHHHHHHHHHHhccChhhCCC---HHHHH
Confidence 9999986543210 011111111111222 3678999999999999 9999999 66665
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=319.76 Aligned_cols=249 Identities=19% Similarity=0.296 Sum_probs=207.9
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
...+|++.+.||.|+||.||+|.+. ++..+|+|.+..... ....+..|+.+++.++||+|+++++++.+....|+
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL 76 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence 3568999999999999999999875 467899999875432 12457889999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||++||+|.+++... +.+++..+..++.+++.||.|||+.|++||||||+||+++.++.+||+|||++.........
T Consensus 77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 77 VFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999999998764 56899999999999999999999999999999999999999999999999998754321100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
. .....++..|+|||++.+..++.++|+|||||++|||++
T Consensus 157 ~----------------------------------------~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~ 196 (256)
T cd05112 157 S----------------------------------------STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196 (256)
T ss_pred c----------------------------------------cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHc
Confidence 0 002345678999999998999999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|.+||...........+.... ....| ...+.++.+|+.+||+ +|.+||+ +.++++
T Consensus 197 ~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rp~---~~~~l~ 253 (256)
T cd05112 197 EGKTPYENRSNSEVVETINAGF-RLYKP--RLASQSVYELMQHCWKERPEDRPS---FSLLLH 253 (256)
T ss_pred CCCCCCCcCCHHHHHHHHhCCC-CCCCC--CCCCHHHHHHHHHHcccChhhCCC---HHHHHH
Confidence 999998887777776665321 22222 3578899999999999 9999998 777765
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=325.33 Aligned_cols=253 Identities=20% Similarity=0.326 Sum_probs=203.9
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcE----EEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV----YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~----~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
+..++|++++.||+|+||+||+|.+..++.. +|+|.+.... .......+..|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~- 80 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG- 80 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence 3456899999999999999999999877774 6666664321 12234567778888999999999999998754
Q ss_pred CeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
...++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 567899999999999999976 4579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
..... .......|+..|+|||++.+..++.++|+|||||++
T Consensus 161 ~~~~~---------------------------------------~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il 201 (279)
T cd05111 161 PDDKK---------------------------------------YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201 (279)
T ss_pred CCCcc---------------------------------------cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHH
Confidence 21100 001124577889999999989999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++ |..||.+.........+.. ...+..| ..++.++.++|.+|+. ||.+||+ +.++++
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~li~~c~~~~p~~Rps---~~el~~ 263 (279)
T cd05111 202 WEMMSYGAEPYAGMRPHEVPDLLEK-GERLAQP--QICTIDVYMVMVKCWMIDENVRPT---FKELAN 263 (279)
T ss_pred HHHHcCCCCCCCCCCHHHHHHHHHC-CCcCCCC--CCCCHHHHHHHHHHcCCCcccCcC---HHHHHH
Confidence 99998 9999998876665444433 2222333 3567899999999999 9999999 777654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=327.60 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=204.2
Q ss_pred CeeEEeEeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
+|++.+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.|...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 57889999999999999998753 23579999886542 123456788999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCe
Q 010947 192 YLIMEYLPGGDMMTLLMRK------------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NI 247 (497)
|+||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999988542 2478889999999999999999999999999999999
Q ss_pred eecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcc
Q 010947 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (497)
Q Consensus 248 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 327 (497)
|++.++.+||+|||+++......... ......++..|+|||
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~apE 199 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYV---------------------------------------KRSKGRIPVKWMAIE 199 (290)
T ss_pred EEcCCCcEEeccccccccccCccchh---------------------------------------cccCCCCCccccCHH
Confidence 99999999999999987653211000 001234677899999
Q ss_pred ccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC
Q 010947 328 VLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 328 ~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
++.+..++.++|+|||||++|||++ |.+||.+..+......+.. ....+....++.++.+||.+||+ +|.+||+
T Consensus 200 ~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~- 275 (290)
T cd05045 200 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKT---GYRMERPENCSEEMYNLMLTCWKQEPDKRPT- 275 (290)
T ss_pred HHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC---CCCCCCCCCCCHHHHHHHHHHccCCcccCCC-
Confidence 9988899999999999999999998 9999988877766655443 12222234688999999999999 9999999
Q ss_pred CCcchhc
Q 010947 406 KGADEIK 412 (497)
Q Consensus 406 ~~~~eil 412 (497)
+.+++
T Consensus 276 --~~~i~ 280 (290)
T cd05045 276 --FADIS 280 (290)
T ss_pred --HHHHH
Confidence 66664
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=323.82 Aligned_cols=247 Identities=31% Similarity=0.474 Sum_probs=202.3
Q ss_pred eEEeEeeecCCeEEEEEEEc----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 119 ELLTMIGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 119 ~~~~~IG~G~fG~V~~~~~~----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.+.+.||.|+||.||+|... ..+..|+||+++.. ......+.+.+|+.+++.++||||+++++++.....+++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccc
Confidence 46789999999999999988 34668999999542 2233467789999999999999999999999988889999
Q ss_pred EeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 195 MEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
|||+++|+|.++|... ..+++.....++.||+.||.|||+.+|+|+||+|+|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999886 68999999999999999999999999999999999999999999999999999876221100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
. ......+...|+|||++....++.++||||||+++|||++
T Consensus 160 ~---------------------------------------~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~ 200 (259)
T PF07714_consen 160 K---------------------------------------NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILT 200 (259)
T ss_dssp E---------------------------------------ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHT
T ss_pred c---------------------------------------cccccccccccccccccccccccccccccccccccccccc
Confidence 0 0113457788999999999999999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
|..||...+..+...++... .....| ..++..+.++|.+||. ||.+||+ +.+|+
T Consensus 201 ~~~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~C~~~~p~~RPs---~~~i~ 256 (259)
T PF07714_consen 201 LGKFPFSDYDNEEIIEKLKQG-QRLPIP--DNCPKDIYSLIQQCWSHDPEKRPS---FQEIL 256 (259)
T ss_dssp TSSGTTTTSCHHHHHHHHHTT-EETTSB--TTSBHHHHHHHHHHT-SSGGGS-----HHHHH
T ss_pred ccccccccccccccccccccc-ccceec--cchhHHHHHHHHHHcCCChhhCcC---HHHHH
Confidence 78999988888888787542 333333 3689999999999999 9999999 77765
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=324.80 Aligned_cols=253 Identities=18% Similarity=0.293 Sum_probs=209.9
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcC----CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKT----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD- 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 187 (497)
+..++|.+.+.||+|+||.||+|.+.. ++..||+|++... ....+...+.+|..+++.++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 456789999999999999999999876 3578999998643 234456778899999999999999999997665
Q ss_pred CCeEEEEEeecCCCchhHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK--------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSD 259 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~D 259 (497)
....++++||+++|+|..++... ..+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 57889999999999999998653 4589999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchh
Q 010947 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (497)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~D 339 (497)
||+++.+....... ......++..|+|||++.+..++.++|
T Consensus 161 ~g~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~apE~~~~~~~~~~~D 201 (280)
T cd05043 161 NALSRDLFPMDYHC---------------------------------------LGDNENRPVKWMALESLVNKEYSSASD 201 (280)
T ss_pred CCCcccccCCceEE---------------------------------------eCCCCCcchhccCHHHHhcCCCCchhh
Confidence 99998653321100 001234667899999999899999999
Q ss_pred HHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 340 WWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 340 iwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
||||||++||+++ |.+||...++.+....+... ...+....+++++.++|.+||+ ||.+||+ +.+++
T Consensus 202 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~~ 270 (280)
T cd05043 202 VWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG---YRLAQPINCPDELFAVMACCWALDPEERPS---FSQLV 270 (280)
T ss_pred HHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcC---CCCCCCCcCCHHHHHHHHHHcCCChhhCCC---HHHHH
Confidence 9999999999998 99999988877766655532 2223334678999999999999 9999999 66665
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=324.11 Aligned_cols=252 Identities=21% Similarity=0.332 Sum_probs=210.3
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
+...+|++.+.||+|+||+||+|..+.+|. .+|+|++.+... ......+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence 445789999999999999999999877765 589998876532 3345668889999999999999999999887
Q ss_pred CeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
...++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 7889999999999999998764 569999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
...... ......+++.|+|||.+....++.++|+|||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 201 (279)
T cd05057 161 VDEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTV 201 (279)
T ss_pred Ccccce---------------------------------------ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHH
Confidence 221000 00012346789999999888999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
||+++ |.+||.+....+....+... ..+..| ..++.++.++|.+||. ||..||+ +.+++
T Consensus 202 ~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~l~~~p~~Rp~---~~~l~ 262 (279)
T cd05057 202 WELMTFGAKPYEGIPAVEIPDLLEKG-ERLPQP--PICTIDVYMVLVKCWMIDAESRPT---FKELI 262 (279)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHhCC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCCC---HHHHH
Confidence 99998 99999998877777776653 233333 3678899999999999 9999998 55543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=328.88 Aligned_cols=254 Identities=19% Similarity=0.364 Sum_probs=204.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcC----------------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCce
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKT----------------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~----------------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~I 178 (497)
.++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+..|+.+++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4579999999999999999986532 34579999987542 23345678899999999999999
Q ss_pred eEEEEEeecCCeEEEEEeecCCCchhHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCe
Q 010947 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-----------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (497)
Q Consensus 179 v~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~-----------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NI 247 (497)
+++++++.+.+..|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999987642 367788999999999999999999999999999999
Q ss_pred eecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcc
Q 010947 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (497)
Q Consensus 248 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 327 (497)
|++.++.++|+|||+++.+....... ......+++.|+|||
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe 202 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYR---------------------------------------IQGRAVLPIRWMSWE 202 (296)
T ss_pred EEcCCCCEEeccCcccccccCCccee---------------------------------------ccCcCcCccccCCHH
Confidence 99999999999999998653221000 000234567899999
Q ss_pred ccccCCCCcchhHHhHHHHHHHHHh--CCCCCCCCChHHHHHHHhcc----cCcccCCCCccCChhHHHHHHHHhh-Ccc
Q 010947 328 VLLKKGYGMECDWWSLGAIMYEMLV--GYPPFYSDDPMSTCRKIVNW----RTHLKFPEEAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 328 ~l~~~~y~~~~DiwSlGvil~ell~--G~~PF~~~~~~~~~~~i~~~----~~~~~~p~~~~~s~~~~dLI~~lL~-dp~ 400 (497)
+.....++.++|+|||||++|||++ |..||...+..+...+...+ .....+|....+++.+.+||.+||. ||.
T Consensus 203 ~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 282 (296)
T cd05095 203 SILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAK 282 (296)
T ss_pred HHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcc
Confidence 9988899999999999999999998 78999877666655443211 1122233334688999999999999 999
Q ss_pred ccCCCCCcchhc
Q 010947 401 QRLGAKGADEIK 412 (497)
Q Consensus 401 ~R~~~~~~~eil 412 (497)
+||+ +.+|.
T Consensus 283 ~Rp~---~~~i~ 291 (296)
T cd05095 283 ERPS---FQEIH 291 (296)
T ss_pred cCCC---HHHHH
Confidence 9999 65553
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=320.20 Aligned_cols=248 Identities=21% Similarity=0.358 Sum_probs=205.7
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
.+..++|.+.+.||+|+||.||+|... .+..+|+|.+.... .....+.+|+.+++.++|+||+++++.+.+ ...
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence 356788999999999999999999864 45579999887542 234568889999999999999999999887 778
Q ss_pred EEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
|+||||+++|+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.+||+|||++..+...
T Consensus 76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 9999999999999999763 35788899999999999999999999999999999999999999999999998765321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
... ......++..|+|||++....++.++|+|||||++|+
T Consensus 156 ~~~----------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~ 195 (260)
T cd05073 156 EYT----------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLME 195 (260)
T ss_pred Ccc----------------------------------------cccCCcccccccCHhHhccCCcCccccchHHHHHHHH
Confidence 100 0002346678999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
|++ |.+||.+.+.......+... ...+....++.++.++|.+||+ +|.+||+ +.++
T Consensus 196 l~t~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~l 253 (260)
T cd05073 196 IVTYGRIPYPGMSNPEVIRALERG---YRMPRPENCPEELYNIMMRCWKNRPEERPT---FEYI 253 (260)
T ss_pred HHhcCCCCCCCCCHHHHHHHHhCC---CCCCCcccCCHHHHHHHHHHcccCcccCcC---HHHH
Confidence 998 99999988777666666542 2223234688999999999999 9999998 5554
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=318.66 Aligned_cols=244 Identities=25% Similarity=0.346 Sum_probs=204.5
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 201 (497)
+.||.|+||.||+|.+.. ++.||+|++...... .....+..|+++++.++||||+++++++.+....|+||||++|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 369999999999999877 999999998765332 34567889999999999999999999999999999999999999
Q ss_pred chhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 202 DMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 202 ~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
+|.+++.. ...+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||++...........
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~------ 151 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVS------ 151 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceec------
Confidence 99999865 35689999999999999999999999999999999999999999999999999876532110000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~ 359 (497)
.....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+
T Consensus 152 ---------------------------------~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~ 198 (251)
T cd05041 152 ---------------------------------DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198 (251)
T ss_pred ---------------------------------cccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCcc
Confidence 001234677999999998899999999999999999999 8999988
Q ss_pred CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
.........+... ..+..| ..++.++.+||.+||+ +|.+||+ +.++++
T Consensus 199 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~ell~ 247 (251)
T cd05041 199 MSNQQTRERIESG-YRMPAP--QLCPEEIYRLMLQCWAYDPENRPS---FSEIYN 247 (251)
T ss_pred CCHHHHHHHHhcC-CCCCCC--ccCCHHHHHHHHHHhccChhhCcC---HHHHHH
Confidence 8776666666532 222333 4688999999999999 9999998 777764
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=317.95 Aligned_cols=243 Identities=24% Similarity=0.373 Sum_probs=201.7
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg 201 (497)
++||+|+||.||+|... ++..||+|++.... .......+.+|+.+++.++||||+++++.+.+....|+||||++||
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999864 67899999987542 1223346888999999999999999999999999999999999999
Q ss_pred chhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccC
Q 010947 202 DMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280 (497)
Q Consensus 202 ~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 280 (497)
+|.+++... ..+++..+..++.+++.||.|||+.|++||||||+||+++.++.+||+|||++..........
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~------- 150 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS------- 150 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccccc-------
Confidence 999998653 468999999999999999999999999999999999999999999999999987543211000
Q ss_pred CCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCC
Q 010947 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYS 359 (497)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~ 359 (497)
.....+++.|+|||++.+..++.++|+|||||++|+|++ |..||.+
T Consensus 151 ---------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~ 197 (250)
T cd05085 151 ---------------------------------SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197 (250)
T ss_pred ---------------------------------CCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCC
Confidence 001235678999999998889999999999999999998 9999998
Q ss_pred CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 360 ~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
.........+... ....+| ..++.++.+||.+||. +|.+||+ +.++++
T Consensus 198 ~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~~ 246 (250)
T cd05085 198 MTNQQAREQVEKG-YRMSCP--QKCPDDVYKVMQRCWDYKPENRPK---FSELQK 246 (250)
T ss_pred CCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcccCcccCCC---HHHHHH
Confidence 8777776666542 223333 3688999999999999 9999998 666643
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=327.18 Aligned_cols=252 Identities=31% Similarity=0.528 Sum_probs=207.9
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEEEe
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
|.+.+.||.|+||+||+|....+++.||||++.+... ........+|+..++.++ ||||+++++++.+++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFY--SWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhcc--chhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 6788999999999999999999999999999875432 112223456888999998 9999999999999999999999
Q ss_pred ecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 197 YLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 197 y~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|+ +|+|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--- 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC---
Confidence 99 889999887754 789999999999999999999999999999999999999999999999999876532110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G 353 (497)
.....|+..|+|||++.+ ..++.++|+|||||++|||++|
T Consensus 155 ---------------------------------------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g 195 (283)
T cd07830 155 ---------------------------------------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL 195 (283)
T ss_pred ---------------------------------------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhC
Confidence 013468899999998854 5589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcc-----------------cCCC---------CccCChhHHHHHHHHhh-CccccCCCC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHL-----------------KFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~-----------------~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
.+||.+.+..+...++...-... .+|. ....+.++++||++||+ ||.+||+
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt-- 273 (283)
T cd07830 196 RPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT-- 273 (283)
T ss_pred CCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCC--
Confidence 99998887766655544211110 0000 01236789999999999 9999999
Q ss_pred CcchhcCCCCc
Q 010947 407 GADEIKVHPWF 417 (497)
Q Consensus 407 ~~~eil~Hpff 417 (497)
+.|++.||||
T Consensus 274 -~~ei~~~~~~ 283 (283)
T cd07830 274 -ASQALQHPYF 283 (283)
T ss_pred -HHHHhhCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=356.90 Aligned_cols=251 Identities=25% Similarity=0.422 Sum_probs=215.9
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 184 (497)
...+...+....+.||+|+||+||+|+... ....||||.++... +......|++|+++|+.++|||||+|+|+
T Consensus 480 ~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGV 557 (774)
T KOG1026|consen 480 VLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGV 557 (774)
T ss_pred eeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEE
Confidence 345667788899999999999999998632 34579999998654 23356779999999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRK--------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD 250 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~ 250 (497)
|..++.+|||+|||..|||..+|... .+|+..+...++.||+.|++||-++.+|||||-..|+||.
T Consensus 558 C~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVg 637 (774)
T KOG1026|consen 558 CREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVG 637 (774)
T ss_pred EccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceec
Confidence 99999999999999999999999642 2388899999999999999999999999999999999999
Q ss_pred CCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc
Q 010947 251 KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330 (497)
Q Consensus 251 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~ 330 (497)
++..|||+||||++..-...+.... + ...-...|||||.+.
T Consensus 638 e~l~VKIsDfGLsRdiYssDYYk~~--------------~-------------------------~t~lPIRWMppEsIl 678 (774)
T KOG1026|consen 638 ENLVVKISDFGLSRDIYSSDYYKVR--------------G-------------------------NTLLPIRWMPPESIL 678 (774)
T ss_pred cceEEEecccccchhhhhhhhhccc--------------C-------------------------CceeeeecCCHHHhh
Confidence 9999999999999976443221100 0 011235699999999
Q ss_pred cCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 331 KKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 331 ~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
.+.|+.++||||+||+|||+++ |..|+++.+.++.++.|.++.- +.-|+ .++.++.+|+..|+. .|.+||+
T Consensus 679 y~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~Pe--~CP~~vY~LM~~CW~~~P~~RPs 751 (774)
T KOG1026|consen 679 YGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCPE--NCPTEVYSLMLECWNENPKRRPS 751 (774)
T ss_pred cCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCCC--CCCHHHHHHHHHHhhcCcccCCC
Confidence 9999999999999999999997 9999999999999999988543 66665 899999999999999 9999999
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=321.91 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=207.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
+...+|.+.+.||+|+||.||+|.+..+ ...||||...... .....+.+.+|+.+++.++||||+++++++.+ .
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 3456799999999999999999987544 3469999886542 13345678899999999999999999998876 4
Q ss_pred eEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..|+||||+++|+|.+++.+. ..+++..+..++.+++.||.|||+.|++||||||+|||++.++.+||+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 578999999999999999764 3589999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
..... .....+++.|+|||.+....++.++|+|||||++|
T Consensus 160 ~~~~~----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 199 (270)
T cd05056 160 ESYYK----------------------------------------ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 199 (270)
T ss_pred cccee----------------------------------------cCCCCccccccChhhhccCCCCchhhhHHHHHHHH
Confidence 21000 00223567899999998889999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 349 ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
||++ |.+||.+.+..+....+... ..+..| ..++.++.+||.+|+. +|.+||+ +.+++.
T Consensus 200 el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt---~~~~~~ 260 (270)
T cd05056 200 EILMLGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSKRPR---FTELKA 260 (270)
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHcC-CcCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 9996 99999988777766666542 233344 3789999999999999 9999998 666653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=325.88 Aligned_cols=253 Identities=23% Similarity=0.392 Sum_probs=201.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--C
Q 010947 116 DDFELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD--E 189 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--~ 189 (497)
.-|.+++.||+|+||.||+|.. +.++..||+|.++... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3478899999999999999984 4578899999986442 233456788999999999999999999998875 6
Q ss_pred eEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..|+||||++||+|.+++.+. ..+++..+..++.+++.||.|||+.||+||||||+|||++.++.++|+|||+++.+..
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 789999999999999998664 4689999999999999999999999999999999999999999999999999986542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
..... .......|+..|+|||++.+..++.++|+|||||++|
T Consensus 162 ~~~~~--------------------------------------~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 162 DKEYY--------------------------------------TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred Cccce--------------------------------------eecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 21000 0001345778899999999889999999999999999
Q ss_pred HHHhCCCCCCCCC--------------hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 349 EMLVGYPPFYSDD--------------PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 349 ell~G~~PF~~~~--------------~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
||++|..|+.... ........+.... ..|....++.++.+||.+||+ +|.+||+ +.+++.
T Consensus 204 ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt---~~~il~ 278 (284)
T cd05079 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK--RLPRPPNCPEEVYQLMRKCWEFQPSKRTT---FQNLIE 278 (284)
T ss_pred hhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc--cCCCCCCCCHHHHHHHHHHccCCcccCcC---HHHHHH
Confidence 9999887754321 0111111222111 223334689999999999999 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=322.91 Aligned_cols=253 Identities=24% Similarity=0.410 Sum_probs=200.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec--C
Q 010947 115 ADDFELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--D 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~ 188 (497)
..+|++++.||+|+||.||+|.. ..++..||||++.... ......+..|+.+++.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 79 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 79 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence 45799999999999999999974 4578899999987542 3445678899999999999999999987643 4
Q ss_pred CeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
..+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|||+++.+.
T Consensus 80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 5789999999999999999764 468999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
...... .......++..|+|||++.+..++.++|||||||++
T Consensus 160 ~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 201 (284)
T cd05081 160 QDKEYY--------------------------------------KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVL 201 (284)
T ss_pred CCCcce--------------------------------------eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHH
Confidence 221000 000012345569999999988999999999999999
Q ss_pred HHHHhCCCCCCCCChHH---------------HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 348 YEMLVGYPPFYSDDPMS---------------TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~---------------~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
|||++|..|+....... ....++.. ...+|....++.++.+||.+||. +|++||+ +.+|
T Consensus 202 ~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei 276 (284)
T cd05081 202 YELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN--NGRLPAPPGCPAEIYAIMKECWNNDPSQRPS---FSEL 276 (284)
T ss_pred HHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc--CCcCCCCCCCCHHHHHHHHHHccCChhhCCC---HHHH
Confidence 99999987765432110 01112221 12233334688999999999999 9999999 7776
Q ss_pred cC
Q 010947 412 KV 413 (497)
Q Consensus 412 l~ 413 (497)
+.
T Consensus 277 ~~ 278 (284)
T cd05081 277 AL 278 (284)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=324.41 Aligned_cols=235 Identities=18% Similarity=0.265 Sum_probs=192.7
Q ss_pred EeeecCCeEEEEEEEcCCCc-------EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 123 MIGKGAFGEVRVCREKTTGH-------VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~~~t~~-------~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
.||+|+||.||+|..+.++. .+|+|.+.+.. ....+.+..|..+++.++||||+++++++.++...++||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 68999999999999866543 48888876543 334456788999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc--------EEEccccccccc
Q 010947 196 EYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--------LRLSDFGLCKPL 266 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~--------vkL~DFGla~~~ 266 (497)
||+++|+|..++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++|+|||++...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 9999999999997644 5899999999999999999999999999999999999988765 689999987643
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGv 345 (497)
... ....|++.|+|||++.+ ..++.++|||||||
T Consensus 159 ~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 193 (258)
T cd05078 159 LPK---------------------------------------------EILLERIPWVPPECIENPQNLSLAADKWSFGT 193 (258)
T ss_pred CCc---------------------------------------------hhccccCCccCchhccCCCCCCchhhHHHHHH
Confidence 211 13468899999999986 45899999999999
Q ss_pred HHHHHHhC-CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 346 IMYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 346 il~ell~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++|||++| .+||...+...... +.. ....+|. ..+.++.+||.+||+ ||.+||+ +++|++
T Consensus 194 ~l~~l~~g~~~~~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~il~ 255 (258)
T cd05078 194 TLWEIFSGGDKPLSALDSQKKLQ-FYE--DRHQLPA--PKWTELANLINQCMDYEPDFRPS---FRAIIR 255 (258)
T ss_pred HHHHHHcCCCCChhhccHHHHHH-HHH--ccccCCC--CCcHHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 99999998 56776665544332 222 2334453 467899999999999 9999999 777765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=322.13 Aligned_cols=250 Identities=19% Similarity=0.260 Sum_probs=193.8
Q ss_pred eEeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecC
Q 010947 122 TMIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 199 (497)
+.||+|+||+||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.|.+...+|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997533 34578888775432 22334567889999999999999999999999999999999999
Q ss_pred CCchhHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 200 GGDMMTLLMRKD-----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 200 gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
+|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~- 157 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI- 157 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhee-
Confidence 999999986643 24678889999999999999999999999999999999999999999999986532211000
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-------CCCCcchhHHhHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-------KGYGMECDWWSLGAIM 347 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-------~~y~~~~DiwSlGvil 347 (497)
......+++.|+|||++.. ..++.++|||||||++
T Consensus 158 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05042 158 --------------------------------------TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM 199 (269)
T ss_pred --------------------------------------ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence 0013456788999999753 4568899999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCC---CccCChhHHHHHHHHhhCccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPE---EAKLSIEAKDLISKLLCNVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~---~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~ 413 (497)
|||++ |.+||......+....++.. ....+|. ...++....+++..|+.||.+||++..+.+++.
T Consensus 200 ~el~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 200 WELFTAADQPYPDLSDEQVLKQVVRE-QDIKLPKPQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHhCCCCCCCcCCHHHHHHHHhhc-cCccCCCCcccccCCHHHHHHHHHHhcCcccccCHHHHHHHhc
Confidence 99999 88899887766666555432 2222222 235788889999888889999999444444443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=325.33 Aligned_cols=254 Identities=33% Similarity=0.531 Sum_probs=211.8
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|++.+.||.|++|.||+|....+|+.+|+|.+..... .......+..|+.+++.++||+|+++++++.+...+|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 5678899999999999999999999999999876532 223455678899999999999999999999999999999999
Q ss_pred cCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 198 LPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 198 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
+++ +|..++... ..+++..+..++.+++.||.|||+.||+|+||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~----- 153 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR----- 153 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-----
Confidence 965 888887663 6899999999999999999999999999999999999999999999999999876543210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHhCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~G~~ 355 (497)
......++..|+|||.+.+. .++.++|+|||||++|+|++|++
T Consensus 154 ------------------------------------~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~ 197 (283)
T cd05118 154 ------------------------------------PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP 197 (283)
T ss_pred ------------------------------------cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 00124588899999999876 78999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCc-----------------ccCCC---------CccCChhHHHHHHHHhh-CccccCCCCCc
Q 010947 356 PFYSDDPMSTCRKIVNWRTH-----------------LKFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~-----------------~~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~~~~ 408 (497)
||.+.+..+...++...-.. ..+|. ...++.++++||.+||. ||.+||+ +
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~---~ 274 (283)
T cd05118 198 LFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT---A 274 (283)
T ss_pred CCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcC---H
Confidence 99888776665554321000 01111 12478899999999999 9999999 9
Q ss_pred chhcCCCCc
Q 010947 409 DEIKVHPWF 417 (497)
Q Consensus 409 ~eil~Hpff 417 (497)
.+++.||||
T Consensus 275 ~~ll~~~~~ 283 (283)
T cd05118 275 EQALAHPYF 283 (283)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=345.76 Aligned_cols=257 Identities=19% Similarity=0.273 Sum_probs=209.6
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
..+.+..+++.+...||+|+||+||+|++.. .||||+++.... ...+.+.|++|+.++++.+|-||+-+.|+|-.+
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 4566777888899999999999999998864 499999987653 455889999999999999999999999999887
Q ss_pred CeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.. .||+.+|+|.+|+.+|.-. ..|.....+.|+.||++|+.|||.++|||||||..||++.+++.|||+||||+..-.
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 76 8999999999999999653 468899999999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CCCCcchhHHhHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLG 344 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~y~~~~DiwSlG 344 (497)
.-. +. .-.....|...|||||++.. .+|+..+||||||
T Consensus 540 ~w~-------------g~--------------------------~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFG 580 (678)
T KOG0193|consen 540 RWS-------------GE--------------------------QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFG 580 (678)
T ss_pred eec-------------cc--------------------------cccCCCccchhhhcHHHHhhcccCCCCcccchhhhh
Confidence 100 00 00113458889999999973 6799999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhcccCcccC-CCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKF-PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~-p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
|++|||++|..||...+.++++..+-.+-..... .....++.++++|+..|+. ++++||. ..+||
T Consensus 581 iV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~---F~~il 647 (678)
T KOG0193|consen 581 IVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPL---FPQLL 647 (678)
T ss_pred HHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCcc---HHHHH
Confidence 9999999999999976666655444332000110 1124577799999999999 9999998 55555
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=319.99 Aligned_cols=246 Identities=22% Similarity=0.277 Sum_probs=193.3
Q ss_pred eEeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecC
Q 010947 122 TMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 199 (497)
+.||+|+||.||+|... .++..+|+|.++.... ......+.+|+.+++.++||||+++++.+.+...+|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 36899999999999864 3566899999875432 2233468889999999999999999999999999999999999
Q ss_pred CCchhHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 200 GGDMMTLLMRKD-----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 200 gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
+|+|.+++.... .+++..++.++.|++.||.|||+.|++||||||+||+++.++++||+|||+++.........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~- 157 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV- 157 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceee-
Confidence 999999986532 45677888999999999999999999999999999999999999999999987432111000
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-------CCCcchhHHhHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-------GYGMECDWWSLGAIM 347 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-------~y~~~~DiwSlGvil 347 (497)
......|++.|+|||++.+. .++.++|+|||||++
T Consensus 158 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l 199 (269)
T cd05087 158 --------------------------------------TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI 199 (269)
T ss_pred --------------------------------------cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHH
Confidence 00134678899999998642 368899999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCC---CccCChhHHHHHHHHhhCccccCCCCCcchhc
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPE---EAKLSIEAKDLISKLLCNVNQRLGAKGADEIK 412 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~---~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil 412 (497)
|||++ |.+||......+........ ....++. ...++..+.++|.+|+.+|.+||+ +++|+
T Consensus 200 ~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rpt---~~~l~ 264 (269)
T cd05087 200 WELFELGSQPYRHLSDEQVLTYTVRE-QQLKLPKPRLKLPLSDRWYEVMQFCWLQPEQRPS---AEEVH 264 (269)
T ss_pred HHHHhCCCCCCCCCChHHHHHHHhhc-ccCCCCCCccCCCCChHHHHHHHHHhcCcccCCC---HHHHH
Confidence 99996 99999877665554443321 1222222 124678899999999889999999 66654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=335.34 Aligned_cols=207 Identities=27% Similarity=0.378 Sum_probs=177.7
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+......+++|.....||+|+||.||+|.... |..||||++....... ...|.+|+.+|..++|||+|+|+|+|.+
T Consensus 67 ~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 67 YDELRKATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred HHHHHHHHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 33444456889999999999999999998765 3799999887543211 3449999999999999999999999999
Q ss_pred CC-eEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCC---EEEcccCCCCeeecCCCcEEEcccc
Q 010947 188 DE-FLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHH---YIHRDIKPDNLLLDKYGHLRLSDFG 261 (497)
Q Consensus 188 ~~-~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~---iiHrDLKp~NILl~~~g~vkL~DFG 261 (497)
.+ ..+||+|||++|+|.++|.... +++|.....|+.+++.||+|||... ||||||||.|||+|.++..||+|||
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFG 222 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFG 222 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCcc
Confidence 88 5999999999999999998765 8999999999999999999999853 9999999999999999999999999
Q ss_pred cccccCC-CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccc-cCCCcccCccccccCCCCcchh
Q 010947 262 LCKPLDC-STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLKKGYGMECD 339 (497)
Q Consensus 262 la~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~Gt~~Y~aPE~l~~~~y~~~~D 339 (497)
+|+.... ... ..+. .||.+|+|||++..+..+.++|
T Consensus 223 La~~~~~~~~~------------------------------------------~~~~~~gt~gY~~PEy~~~g~lt~KsD 260 (361)
T KOG1187|consen 223 LAKLGPEGDTS------------------------------------------VSTTVMGTFGYLAPEYASTGKLTEKSD 260 (361)
T ss_pred CcccCCccccc------------------------------------------eeeecCCCCccCChhhhccCCcCcccc
Confidence 9975432 110 0012 7999999999999999999999
Q ss_pred HHhHHHHHHHHHhCCCCCCCC
Q 010947 340 WWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 340 iwSlGvil~ell~G~~PF~~~ 360 (497)
||||||+|.||++|+.|....
T Consensus 261 VySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 261 VYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cccchHHHHHHHhCCcccCCC
Confidence 999999999999999888753
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=326.39 Aligned_cols=253 Identities=18% Similarity=0.298 Sum_probs=205.3
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
+...+|+..+.||+|+||.||+|.+..+|. .+|+|.+..... ......+.+|+.+++.++||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~ 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence 345789999999999999999999887776 468888765321 22334578899999999999999999998764
Q ss_pred CeEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
..++|+||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+.
T Consensus 82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 4679999999999999987643 68999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
...... ......++..|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~~---------------------------------------~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l 201 (303)
T cd05110 161 GDEKEY---------------------------------------NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTI 201 (303)
T ss_pred Cccccc---------------------------------------ccCCCccccccCCHHHhccCCCChHHHHHHHHHHH
Confidence 221000 01123467889999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++ |..||.+......... +.....+ |....++..+.++|.+|+. +|.+||+ +.+++.
T Consensus 202 ~el~t~g~~p~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~li~~c~~~~p~~Rp~---~~~l~~ 263 (303)
T cd05110 202 WELMTFGGKPYDGIPTREIPDL-LEKGERL--PQPPICTIDVYMVMVKCWMIDADSRPK---FKELAA 263 (303)
T ss_pred HHHHhCCCCCCCCCCHHHHHHH-HHCCCCC--CCCCCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 99997 9999988765554443 3322233 3334678899999999998 9999999 777665
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.24 Aligned_cols=236 Identities=20% Similarity=0.247 Sum_probs=190.4
Q ss_pred EeeecCCeEEEEEEEcCC------------CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 123 MIGKGAFGEVRVCREKTT------------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~~~t------------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
.||+|+||.||+|..... ...+|+|++.... ......+..|..++..++||||+++++++.++..
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 689999999999985322 2358889876542 2334467888999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc-------EEEccccc
Q 010947 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-------LRLSDFGL 262 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~-------vkL~DFGl 262 (497)
.++||||+++|+|..++.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++.++. ++++|||+
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999999988865 356999999999999999999999999999999999999987664 89999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-cCCCCcchhHH
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWW 341 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~y~~~~Diw 341 (497)
+...... ...+||+.|+|||++. +..++.++|||
T Consensus 159 ~~~~~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~Diw 193 (262)
T cd05077 159 PITVLSR---------------------------------------------QECVERIPWIAPECVEDSKNLSIAADKW 193 (262)
T ss_pred CccccCc---------------------------------------------ccccccccccChhhhcCCCCCCchhHHH
Confidence 8654211 1346888999999987 46789999999
Q ss_pred hHHHHHHHHH-hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 342 SLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 342 SlGvil~ell-~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
||||++|||+ .|.+||.+....+.. +... ...... ...+.++.+||.+||. ||.+||+ +.+|+.+
T Consensus 194 slG~~l~el~~~~~~p~~~~~~~~~~-~~~~--~~~~~~--~~~~~~~~~li~~cl~~dp~~Rp~---~~~il~~ 260 (262)
T cd05077 194 SFGTTLWEICYNGEIPLKDKTLAEKE-RFYE--GQCMLV--TPSCKELADLMTHCMNYDPNQRPF---FRAIMRD 260 (262)
T ss_pred HHHHHHHHHHhCCCCCCCCcchhHHH-HHHh--cCccCC--CCChHHHHHHHHHHcCCChhhCcC---HHHHHHh
Confidence 9999999998 589998876544432 2222 111111 2356789999999999 9999999 7787753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=320.95 Aligned_cols=236 Identities=20% Similarity=0.250 Sum_probs=191.1
Q ss_pred EeeecCCeEEEEEEEcCC------------------------CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCce
Q 010947 123 MIGKGAFGEVRVCREKTT------------------------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI 178 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~~~t------------------------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~I 178 (497)
.||+|+||.||+|....+ ...||+|++.... ......+..|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 589999999999975322 2358999986543 2234567889999999999999
Q ss_pred eEEEEEeecCCeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC----
Q 010947 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---- 253 (497)
Q Consensus 179 v~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g---- 253 (497)
+++++++.+....|+||||++||+|..++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999998865 46789999999999999999999999999999999999998654
Q ss_pred ---cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc
Q 010947 254 ---HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330 (497)
Q Consensus 254 ---~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~ 330 (497)
.+||+|||++...... ....|++.|+|||++.
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---------------------------------------------~~~~~~~~~~aPe~~~ 193 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---------------------------------------------EERVERIPWIAPECVP 193 (274)
T ss_pred ccceeeecCCccccccccc---------------------------------------------cccccCCcccCchhhc
Confidence 4899999987643210 0235788899999987
Q ss_pred c-CCCCcchhHHhHHHHHHHHH-hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 331 K-KGYGMECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 331 ~-~~y~~~~DiwSlGvil~ell-~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
+ ..++.++|+|||||++|||+ +|.+||.+....+... ... ....+|. ..++++.+||.+||+ +|.+||+
T Consensus 194 ~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-~~~--~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps--- 265 (274)
T cd05076 194 GGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER-FYE--KKHRLPE--PSCKELATLISQCLTYEPTQRPS--- 265 (274)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH-HHH--hccCCCC--CCChHHHHHHHHHcccChhhCcC---
Confidence 5 56899999999999999995 6999998876554433 222 2223343 356789999999999 9999998
Q ss_pred cchhcCC
Q 010947 408 ADEIKVH 414 (497)
Q Consensus 408 ~~eil~H 414 (497)
+.+|+++
T Consensus 266 ~~~il~~ 272 (274)
T cd05076 266 FRTILRD 272 (274)
T ss_pred HHHHHHh
Confidence 8888753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.44 Aligned_cols=241 Identities=20% Similarity=0.350 Sum_probs=201.5
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
...+|++.+.||+|+||.||++. .+++.||+|++.... ....+.+|+.+++.++||||+++++++..+ ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 34679999999999999999886 468899999986532 235688899999999999999999998765 4799
Q ss_pred EEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 194 IMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
||||++||+|.+++.... .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||+++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 999999999999997643 58999999999999999999999999999999999999999999999999987542110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
....++..|+|||++.+..++.++|+|||||++|||+
T Consensus 155 -------------------------------------------~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~ 191 (254)
T cd05083 155 -------------------------------------------DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVF 191 (254)
T ss_pred -------------------------------------------CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHH
Confidence 0123456799999999889999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 352 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+ |.+||.+.+..+....+... ...+....++..+++||.+||. +|..||+ +.+++
T Consensus 192 ~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~---~~~l~ 248 (254)
T cd05083 192 SYGRAPYPKMSLKEVKECVEKG---YRMEPPEGCPADVYVLMTSCWETEPKKRPS---FHKLR 248 (254)
T ss_pred hCCCCCCccCCHHHHHHHHhCC---CCCCCCCcCCHHHHHHHHHHcCCChhhCcC---HHHHH
Confidence 7 99999988877766666542 2222223688999999999999 9999998 66554
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.80 Aligned_cols=247 Identities=19% Similarity=0.288 Sum_probs=197.7
Q ss_pred eEeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee-cCCeEEEEEee
Q 010947 122 TMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFLYLIMEY 197 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~l~lVmEy 197 (497)
+.||+|+||.||+|.... .+..||||.+.... .......+..|+.+++.++||||+++++.+. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998753 34579999885421 2334567888999999999999999999765 45678999999
Q ss_pred cCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 198 LPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 198 ~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
+++|+|.+++.+. ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.+........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~-- 156 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV-- 156 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceee--
Confidence 9999999998764 4567888889999999999999999999999999999999999999999999976532110000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYP 355 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~ 355 (497)
.......+++.|+|||++.+..++.++|||||||++|||++ |.+
T Consensus 157 -----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~ 201 (262)
T cd05058 157 -----------------------------------HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201 (262)
T ss_pred -----------------------------------cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCC
Confidence 00012356788999999998999999999999999999999 577
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
||...+..+....+..+. ....| ..++..+.++|.+||. +|.+||+ +.+|+.
T Consensus 202 ~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~li~~cl~~~p~~Rp~---~~~il~ 254 (262)
T cd05058 202 PYPDVDSFDITVYLLQGR-RLLQP--EYCPDPLYEVMLSCWHPKPEMRPT---FSELVS 254 (262)
T ss_pred CCCCCCHHHHHHHHhcCC-CCCCC--CcCCHHHHHHHHHHcCCChhhCCC---HHHHHH
Confidence 888777777666665432 22233 3578899999999999 9999999 777654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=359.55 Aligned_cols=269 Identities=31% Similarity=0.482 Sum_probs=204.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-------
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------- 188 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------- 188 (497)
.||+.+.+||+||||.||+|+++-+|..||||++.-.. .......+.+|+.+|++++|||||++|.++...
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 57999999999999999999999999999999997653 455567789999999999999999998765100
Q ss_pred --------------------------------------------------------------------------------
Q 010947 189 -------------------------------------------------------------------------------- 188 (497)
Q Consensus 189 -------------------------------------------------------------------------------- 188 (497)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeEEEEEeecCCCchhHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHcC
Q 010947 189 --------------------------------EFLYLIMEYLPGGDMMTLLMRKDTL-TEDEARFYVAETVLAIESIHKH 235 (497)
Q Consensus 189 --------------------------------~~l~lVmEy~~gg~L~~~l~~~~~l-~e~~~~~~~~qi~~aL~~LH~~ 235 (497)
..+||-||||+...|.+++.++... ....+..+++||+.||.|+|+.
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 1369999999887776666554433 4788899999999999999999
Q ss_pred CEEEcccCCCCeeecCCCcEEEcccccccccCCC-CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccc
Q 010947 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS-TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLA 314 (497)
Q Consensus 236 ~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 314 (497)
|||||||||.||+++.++.|||+|||+|+..... .........+++..++... -.
T Consensus 717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~------------------------~~ 772 (1351)
T KOG1035|consen 717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDG------------------------DL 772 (1351)
T ss_pred ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCc------------------------cc
Confidence 9999999999999999999999999999873210 0001111111111111110 01
Q ss_pred ccccCCCcccCccccccCC---CCcchhHHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcccCcccCCCC--ccCChhH
Q 010947 315 YSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEE--AKLSIEA 388 (497)
Q Consensus 315 ~~~~Gt~~Y~aPE~l~~~~---y~~~~DiwSlGvil~ell~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~--~~~s~~~ 388 (497)
++.+||.-|+|||++.+.. |+.++|+||||||+|||+. ||...-+ ..++.++. ...+++|.. ..--+..
T Consensus 773 Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR--~g~iP~~~~f~~~~~~~e 847 (1351)
T KOG1035|consen 773 TSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLR--KGSIPEPADFFDPEHPEE 847 (1351)
T ss_pred ccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcc--cCCCCCCcccccccchHH
Confidence 3679999999999998754 9999999999999999986 5754322 22333333 234444411 1234567
Q ss_pred HHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 389 ~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
..+|+.||. ||.+||+ |.|+|++.||.
T Consensus 848 ~slI~~Ll~hdP~kRPt---A~eLL~s~llp 875 (1351)
T KOG1035|consen 848 ASLIRWLLSHDPSKRPT---ATELLNSELLP 875 (1351)
T ss_pred HHHHHHHhcCCCccCCC---HHHHhhccCCC
Confidence 899999999 9999999 99999999997
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=318.45 Aligned_cols=244 Identities=25% Similarity=0.389 Sum_probs=200.5
Q ss_pred eEeeecCCeEEEEEEEcCCC------cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 122 TMIGKGAFGEVRVCREKTTG------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
+.||+|+||.||+|..+... ..+|||.+.+.. .......+.+|+.+++.++||||++++++|.+....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 36899999999999986544 689999886542 1233456788999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-----cEEEcccccc
Q 010947 196 EYLPGGDMMTLLMRK-------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-----HLRLSDFGLC 263 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-----~vkL~DFGla 263 (497)
||++||+|.+++... ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++ .++|+|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999998642 3478899999999999999999999999999999999999888 8999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+......... ......++..|+|||++.+..++.++|+|||
T Consensus 159 ~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 199 (269)
T cd05044 159 RDIYKSDYYR---------------------------------------KEGEGLLPVRWMAPESLLDGKFTTQSDVWSF 199 (269)
T ss_pred cccccccccc---------------------------------------cCcccCCCccccCHHHHccCCcccchhHHHH
Confidence 7653211000 0002346788999999999999999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 344 GAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 344 Gvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
||++|||++ |..||...+..+....+... ..+..+ ..++..+.+||.+||+ +|.+||+ +.+|+
T Consensus 200 G~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp~---~~~i~ 264 (269)
T cd05044 200 GVLMWEILTLGQQPYPALNNQEVLQHVTAG-GRLQKP--ENCPDKIYQLMTNCWAQDPSERPT---FDRIQ 264 (269)
T ss_pred HHHHHHHHHcCCCCCcccCHHHHHHHHhcC-CccCCc--ccchHHHHHHHHHHcCCCcccCCC---HHHHH
Confidence 999999998 99999887777766665432 223333 3688999999999999 9999999 66654
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=315.73 Aligned_cols=250 Identities=29% Similarity=0.523 Sum_probs=206.7
Q ss_pred CeeEEeEeeecCCeEEEEEEEcC-CCcEEEEEEeechhh-------hchhHHHHHHHHHHHHHh-cCCCceeEEEEEeec
Q 010947 117 DFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEM-------LRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQD 187 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~-t~~~~AiK~l~k~~~-------~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~ 187 (497)
+|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+..|+.++.. ++||||+++++.|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999987 788999999864321 122344567778888865 799999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
++..|+||||++|++|.+++.. ...+++..+..++.|++.||.|||+ .|++||||+|+|||++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988743 3569999999999999999999996 7899999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHh
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwS 342 (497)
+....... ......|+..|+|||++.+..++.++|+||
T Consensus 161 ~~~~~~~~------------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~s 198 (269)
T cd08528 161 AKQKQPES------------------------------------------KLTSVVGTILYSCPEIVKNEPYGEKADVWA 198 (269)
T ss_pred eeeccccc------------------------------------------ccccccCcccCcChhhhcCCCCchHHHHHH
Confidence 97643211 011356899999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++|+|++|.+||...+.......+...... +.+ ...+++++.+||.+||. ||.+||+ +.|+..
T Consensus 199 lG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~l~~li~~cl~~~p~~Rp~---~~e~~~ 265 (269)
T cd08528 199 FGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE-PLP-EGMYSEDVTDVITSCLTPDAEARPD---IIQVSA 265 (269)
T ss_pred HHHHHHHHHhCCCcccccCHHHHHHHHhhccCC-cCC-cccCCHHHHHHHHHHCCCCCccCCC---HHHHHH
Confidence 999999999999999888777666666542211 122 23578999999999999 9999998 666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=342.02 Aligned_cols=241 Identities=32% Similarity=0.490 Sum_probs=195.3
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC------e
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE------F 190 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------~ 190 (497)
-+..-+.||+||||.||+++++.||+.||||.+++.. .....+....|+++|++++|||||+++++-.+.. .
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 3566778999999999999999999999999998754 3445667888999999999999999998865443 4
Q ss_pred EEEEEeecCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC--CCc--EEEcccccc
Q 010947 191 LYLIMEYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--YGH--LRLSDFGLC 263 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~--~g~--vkL~DFGla 263 (497)
-.+|||||+||||+..|.+. ..|+|.+.+.++..++.||.|||++|||||||||+||++-. +|. -||+|||.|
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 57999999999999999763 46999999999999999999999999999999999999853 343 699999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHh
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWS 342 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwS 342 (497)
+.++.+. +..|.+||+.|++||++.. +.|+..||.||
T Consensus 172 rel~d~s------------------------------------------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS 209 (732)
T KOG4250|consen 172 RELDDNS------------------------------------------LFTSLVGTEEYLHPELYERQKKYTATVDLWS 209 (732)
T ss_pred ccCCCCC------------------------------------------eeeeecCchhhcChHHHhhccCcCceeehhh
Confidence 9886542 2348999999999999994 88999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC----hHHHHHHHhc-------------------ccCcccCCCCccCChhHHH----HHHHH
Q 010947 343 LGAIMYEMLVGYPPFYSDD----PMSTCRKIVN-------------------WRTHLKFPEEAKLSIEAKD----LISKL 395 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~----~~~~~~~i~~-------------------~~~~~~~p~~~~~s~~~~d----LI~~l 395 (497)
|||++|+++||..||.... ..++...++. |...+++| ..+|+.... .+..+
T Consensus 210 ~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p--~~Ls~~l~~~~~kwLa~~ 287 (732)
T KOG4250|consen 210 FGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQP--NHLSRGLATRLTKWLASM 287 (732)
T ss_pred hhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCc--ccccHHHHhhhhHHHHHH
Confidence 9999999999999996532 2223333321 44444444 356665544 45556
Q ss_pred hh-CccccC
Q 010947 396 LC-NVNQRL 403 (497)
Q Consensus 396 L~-dp~~R~ 403 (497)
|. +|.+|.
T Consensus 288 L~~~~~~~~ 296 (732)
T KOG4250|consen 288 LEWNPRKRG 296 (732)
T ss_pred HhhhHHHhC
Confidence 66 899998
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=313.98 Aligned_cols=234 Identities=19% Similarity=0.274 Sum_probs=192.4
Q ss_pred eEeeecCCeEEEEEEEcCCC----------cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 122 TMIGKGAFGEVRVCREKTTG----------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~----------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
+.||+|+||.||+|.+..++ ..+|+|++..... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998776 3478887765431 14668889999999999999999999888 778
Q ss_pred EEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-------cEEEcccccc
Q 010947 192 YLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-------HLRLSDFGLC 263 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-------~vkL~DFGla 263 (497)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 99999999999999998765 799999999999999999999999999999999999999888 8999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC--CCCcchhHH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWW 341 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~y~~~~Diw 341 (497)
...... ....++..|+|||++... .++.++|+|
T Consensus 156 ~~~~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~ 190 (259)
T cd05037 156 ITVLSR---------------------------------------------EERVERIPWIAPECIRNGQASLTIAADKW 190 (259)
T ss_pred cccccc---------------------------------------------cccccCCCccChhhhcCCCCCcchhhHHH
Confidence 754311 024577889999999876 789999999
Q ss_pred hHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 342 SLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 342 SlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
||||++|||++ |..||...+......... .......| .+..+.+||.+||. +|.+||+ +.++++
T Consensus 191 slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt---~~~il~ 256 (259)
T cd05037 191 SFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP----DCAELANLINQCWTYDPTKRPS---FRAILR 256 (259)
T ss_pred HHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC----CchHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 99999999999 688887765443333222 22222222 23789999999999 9999998 777653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=318.21 Aligned_cols=254 Identities=24% Similarity=0.373 Sum_probs=204.1
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEc----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec--C
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREK----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--D 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~ 188 (497)
..+|.+++.||+|+||.||+|... .++..||+|++...... .....+..|+.+++.+.||||+++++++.+ .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 356888999999999999999864 34889999999865432 356678999999999999999999998877 6
Q ss_pred CeEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
...|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 68999999999999999997644 69999999999999999999999999999999999999999999999999998664
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
....... ......++..|+|||.+.+..++.++|+|||||++
T Consensus 161 ~~~~~~~--------------------------------------~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l 202 (284)
T cd05038 161 EDKDYYY--------------------------------------VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTL 202 (284)
T ss_pred cCCccee--------------------------------------ccCCCCCcccccCcHHHccCCCCcccchHHHhhhh
Confidence 2210000 00012355679999999988999999999999999
Q ss_pred HHHHhCCCCCCCCChHH--------------HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 348 YEMLVGYPPFYSDDPMS--------------TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
|||++|..||....... .....+.. ....+....++.++.+||.+||. +|.+||+ +.+|+
T Consensus 203 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt---~~ei~ 277 (284)
T cd05038 203 YELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE--GERLPRPPSCPDEVYDLMKLCWEAEPQDRPS---FADLI 277 (284)
T ss_pred heeeccCCCcccccchhccccccccccccHHHHHHHHHc--CCcCCCCccCCHHHHHHHHHHhccChhhCCC---HHHHH
Confidence 99999999987643221 12222222 22233334678899999999999 9999999 66665
Q ss_pred C
Q 010947 413 V 413 (497)
Q Consensus 413 ~ 413 (497)
.
T Consensus 278 ~ 278 (284)
T cd05038 278 L 278 (284)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=322.93 Aligned_cols=261 Identities=25% Similarity=0.437 Sum_probs=210.6
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-C-C----ceeEE
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-S-N----CIVKL 181 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-h-p----~Iv~l 181 (497)
++.......+|.+++.+|+|+||+|-.|.+..++..||||+++.-. .-.+..+-|+++|.++. + | .+|.+
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m 156 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQM 156 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence 3444455788999999999999999999999999999999997543 22344677999999883 2 2 47888
Q ss_pred EEEeecCCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC--------
Q 010947 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------- 251 (497)
Q Consensus 182 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-------- 251 (497)
..+|.-.++.|||+|.+ |-++.++|..+ .+|+...++.+++|++.++.|||+.+++|-||||+|||+..
T Consensus 157 ~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 157 RDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred ehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEec
Confidence 88999999999999998 77999999764 46999999999999999999999999999999999999942
Q ss_pred ------------CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccC
Q 010947 252 ------------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (497)
Q Consensus 252 ------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 319 (497)
+-+|+|+|||.|+..... ..+.|.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--------------------------------------------hs~iVs 271 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEH--------------------------------------------HSTIVS 271 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccC--------------------------------------------cceeee
Confidence 336899999998754321 125789
Q ss_pred CCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHH---HHHHHhcc----------------cCcccCCC
Q 010947 320 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMS---TCRKIVNW----------------RTHLKFPE 380 (497)
Q Consensus 320 t~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~---~~~~i~~~----------------~~~~~~p~ 380 (497)
|..|.|||++.+-+++..||+||+||||+|+.+|...|+..+..+ +.++|+.- ...+..|+
T Consensus 272 TRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e 351 (415)
T KOG0671|consen 272 TRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPE 351 (415)
T ss_pred ccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCcc
Confidence 999999999999999999999999999999999999999877554 44555420 00111111
Q ss_pred C--------------------ccC---ChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 381 E--------------------AKL---SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 381 ~--------------------~~~---s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
. ... -.++.|||++||. ||.+|++ +.|+|.||||+..
T Consensus 352 ~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiT---l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 352 VSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRIT---LREALSHPFFARL 412 (415)
T ss_pred ccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccccc---HHHHhcCHHhhcC
Confidence 0 001 1237799999999 9999999 9999999999864
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=315.36 Aligned_cols=250 Identities=22% Similarity=0.364 Sum_probs=203.5
Q ss_pred eeEEeEeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 118 FELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
|.+.++||+|+||.||+|..+. ++..||||++.... ......+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 5678899999999999998643 57899999997543 23345667889999999999999999999886432
Q ss_pred -eEEEEEeecCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRK------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
..++++||+++|+|..++... ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 347899999999998887432 2578999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHh
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwS 342 (497)
++......... ......+++.|++||.+.+..++.++||||
T Consensus 160 ~~~~~~~~~~~---------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~sDi~s 200 (273)
T cd05074 160 SKKIYSGDYYR---------------------------------------QGCASKLPVKWLALESLADNVYTTHSDVWA 200 (273)
T ss_pred cccccCCccee---------------------------------------cCCCccCchhhcCHhHHhcCccchhhhhHH
Confidence 98653221000 001234667899999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 343 LGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 343 lGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++|||++ |.+||.+.+..+....+..+. .+..+ ..++..+.+++.+||. +|.+||+ +.+++.
T Consensus 201 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~~~l~~~p~~Rps---~~~~~~ 267 (273)
T cd05074 201 FGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLKQP--PDCLEDVYELMCQCWSPEPKCRPS---FQHLRD 267 (273)
T ss_pred HHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 9999999999 999999888777777776532 22233 3678899999999999 9999998 776654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=338.98 Aligned_cols=263 Identities=30% Similarity=0.499 Sum_probs=222.8
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEee-
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ- 186 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~- 186 (497)
.......+-|++..+||.|.+|+||+++.+.+++..|+|++..... ..+.+..|.+||+.. +|||++.+||+|.
T Consensus 12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 3344556789999999999999999999999999999999876532 234467788999876 7999999999886
Q ss_pred ----cCCeEEEEEeecCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccc
Q 010947 187 ----DDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (497)
Q Consensus 187 ----~~~~l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DF 260 (497)
.++.++||||||.||+.-+++.. ...+.|..+..|+.+++.||.+||...+||||||-.|||++.+|.|||+||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeee
Confidence 35689999999999999999865 357999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----CCCC
Q 010947 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYG 335 (497)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~y~ 335 (497)
|++..++.... ...+.+|||.|||||++.. ..|+
T Consensus 168 GvSaQldsT~g-----------------------------------------rRnT~iGtP~WMAPEViac~e~~d~tyd 206 (953)
T KOG0587|consen 168 GVSAQLDSTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDESPDATYD 206 (953)
T ss_pred eeeeeeecccc-----------------------------------------cccCcCCCcccccceeeecccCCCCCcc
Confidence 99987753210 1236799999999999974 4578
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 336 ~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
..||+||||++..||.-|.||+.+..+...+-.|... .++.+-.+...|.++.|||..||. |-++||. ..+++.|
T Consensus 207 ~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~---~~~ll~h 282 (953)
T KOG0587|consen 207 YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPS---TEELLKH 282 (953)
T ss_pred cccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCccccchhhHHHHHHHHHHHHHhhccccCcc---hhhhccC
Confidence 8999999999999999999999999888777666532 223332234789999999999998 9999998 9999999
Q ss_pred CCccCC
Q 010947 415 PWFDGV 420 (497)
Q Consensus 415 pff~~i 420 (497)
||....
T Consensus 283 pFi~e~ 288 (953)
T KOG0587|consen 283 PFITEQ 288 (953)
T ss_pred Cccccc
Confidence 999843
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=351.66 Aligned_cols=254 Identities=23% Similarity=0.381 Sum_probs=215.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCc-----EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH-----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~-----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+......+.+.||+|+||.||.|....-.. .||||.+.+. .+..++..|..|..+|+.++|||||+++|++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 446778889999999999999999865432 3899998764 456677889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK-------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DF 260 (497)
....+|++|||.||||..+|... ..++..+...++.+|+.|++||+++++|||||...|+||+....+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 99999999999999999999765 35899999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhH
Q 010947 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (497)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~Di 340 (497)
|||+.+....+.. +..+ ..-...|||||.+..+.++.++||
T Consensus 847 GlArDiy~~~yyr----------------------------------~~~~-----a~lPvkWm~PEsl~d~iFtskSDv 887 (1025)
T KOG1095|consen 847 GLARDIYDKDYYR----------------------------------KHGE-----AMLPVKWMPPESLKDGIFTSKSDV 887 (1025)
T ss_pred chhHhhhhchhee----------------------------------ccCc-----cccceecCCHHHHhhcccccccch
Confidence 9999543221110 0000 011246999999999999999999
Q ss_pred HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 341 WSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 341 wSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||||+|||+++ |.+||.+.+..+...-.+... .+..| ..|+..+.+++..|+. +|++||+ +..|+.
T Consensus 888 WsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P--~~CP~~ly~lM~~CW~~~pe~RP~---F~~i~~ 956 (1025)
T KOG1095|consen 888 WSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPP--SYCPEKLYQLMLQCWKHDPEDRPS---FRTIVE 956 (1025)
T ss_pred hhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCC--CCCChHHHHHHHHHccCChhhCcc---HHHHHh
Confidence 999999999998 999999999888887777643 55555 4899999999999999 9999999 555554
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=316.46 Aligned_cols=257 Identities=16% Similarity=0.149 Sum_probs=190.5
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhH--------HHHHHHHHHHHHhcCCCceeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQ--------VEHVRAERNLLAEVDSNCIVKL 181 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t---~~~~AiK~l~k~~~~~~~~--------~~~~~~E~~il~~l~hp~Iv~l 181 (497)
+...+|.+.+.||+|+||+||+|....+ +..+|+|+..........+ ......+...+..++|++|+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 4557899999999999999999998877 6778888643221100000 0111223344556789999999
Q ss_pred EEEeecCC----eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEE
Q 010947 182 YCSFQDDE----FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (497)
Q Consensus 182 ~~~~~~~~----~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL 257 (497)
++++.... ..|++||++. .++.+.+.....+++..++.++.|++.||.|||+.||+||||||+|||++.++.++|
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 98765443 4578899874 467777766566889999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcc
Q 010947 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (497)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~ 337 (497)
+|||+|+.+........ ..........||+.|+|||++.+..|+.+
T Consensus 168 ~DFGla~~~~~~~~~~~----------------------------------~~~~~~~~~~gt~~y~ape~~~~~~~~~~ 213 (294)
T PHA02882 168 IDYGIASHFIIHGKHIE----------------------------------YSKEQKDLHRGTLYYAGLDAHNGACVTRR 213 (294)
T ss_pred EEcCCceeeccCCcccc----------------------------------cccccccccCCCccccCHHHhCCCCCCcH
Confidence 99999987642210000 00000113579999999999999999999
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCChH-HH--------HHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDDPM-ST--------CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~~~-~~--------~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
+|||||||++|||++|.+||.+.+.. .. ..++.. ....++ .++.++.+++..|+. +|++||+
T Consensus 214 ~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~rp~--- 285 (294)
T PHA02882 214 GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHE--GKIKIK---NANKFIYDFIECVTKLSYEEKPD--- 285 (294)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhh--hhhccC---CCCHHHHHHHHHHHhCCCCCCCC---
Confidence 99999999999999999999877322 21 122222 112222 568899999999999 9999998
Q ss_pred cchhc
Q 010947 408 ADEIK 412 (497)
Q Consensus 408 ~~eil 412 (497)
.++|+
T Consensus 286 ~~~l~ 290 (294)
T PHA02882 286 YDALI 290 (294)
T ss_pred HHHHH
Confidence 66664
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=311.54 Aligned_cols=246 Identities=17% Similarity=0.235 Sum_probs=192.1
Q ss_pred EeeecCCeEEEEEEEcCC--CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCC
Q 010947 123 MIGKGAFGEVRVCREKTT--GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~~~t--~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
.||+|+||.||+|....+ ...+++|.+.... .......+.+|+.+++.++||||+++++.|.+....|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 599999999999975433 2346667665432 123356788999999999999999999999999999999999999
Q ss_pred CchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 201 GDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 201 g~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
|+|.+++.+. ..+++..+..++.||+.||.|||+.+++||||||+|||++.++++||+|||++.........
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~---- 155 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI---- 155 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhh----
Confidence 9999998753 34667788899999999999999999999999999999999999999999998642211000
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-------CCCCcchhHHhHHHHHHH
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-------KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-------~~y~~~~DiwSlGvil~e 349 (497)
......+|++.|+|||++.. ..++.++|||||||++||
T Consensus 156 -----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~e 200 (268)
T cd05086 156 -----------------------------------ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWE 200 (268)
T ss_pred -----------------------------------hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHH
Confidence 00113578999999999853 345789999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccC-cccCCC-CccCChhHHHHHHHHhhCccccCCCCCcchhc
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRT-HLKFPE-EAKLSIEAKDLISKLLCNVNQRLGAKGADEIK 412 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~-~~~~p~-~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil 412 (497)
|++ |.+||...+..+.+..++.... .+..|. ...+++.+.++|..|+.+|.+||+ +.+|+
T Consensus 201 l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~~~P~~Rp~---~~~i~ 263 (268)
T cd05086 201 LFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCWLSPEKRAT---AEEVH 263 (268)
T ss_pred HHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHhhCcccCCC---HHHHH
Confidence 997 6789988777777776654321 111111 134788899999999989999999 77664
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=309.29 Aligned_cols=268 Identities=28% Similarity=0.458 Sum_probs=219.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
..+|.-++.+|.|+- .|..+-+.-++++||+|++... ........+..+|..++..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 356888899999998 7777888889999999998765 333444567889999999999999999999987543
Q ss_pred -eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+||||| .++|...+. -.++...+++++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+.-+.
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 579999999 568887775 4578899999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
. .+.+..+.|..|.|||++.+.+|...+||||+|||+.
T Consensus 171 ~------------------------------------------~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~g 208 (369)
T KOG0665|consen 171 D------------------------------------------FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 208 (369)
T ss_pred c------------------------------------------cccCchhheeeccCchheeccCCcccchhhhhhhHHH
Confidence 2 1123578999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCc-----------------------------ccCCCC---------ccCChhHHH
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTH-----------------------------LKFPEE---------AKLSIEAKD 390 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~-----------------------------~~~p~~---------~~~s~~~~d 390 (497)
||++|..-|.|.+..+.+.+|...-++ -.||+. ..-+..++|
T Consensus 209 Eli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ard 288 (369)
T KOG0665|consen 209 ELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARD 288 (369)
T ss_pred HHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHH
Confidence 999999999998877776666531110 012221 122446899
Q ss_pred HHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhcCCCccc
Q 010947 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIP 434 (497)
Q Consensus 391 LI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p 434 (497)
|+.+||. ||++|.+ ++++|+||||+ -|-.-.++++|..|
T Consensus 289 ll~~MLvi~pe~Ris---v~daL~HPY~~--vw~~~~ev~ap~pe 328 (369)
T KOG0665|consen 289 LLSKMLVIDPEKRIS---VDDALRHPYIK--VWYDPDEVEAPPPE 328 (369)
T ss_pred HHHHhhccChhhccc---HHHHhcCCeee--eecccccccCCCCc
Confidence 9999999 9999999 99999999999 68666666666555
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=341.39 Aligned_cols=264 Identities=20% Similarity=0.323 Sum_probs=184.0
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCC----CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEE-
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS- 184 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~- 184 (497)
+..+..++|++.+.||+|+||.||+|++..+ +..||+|++..... .+....+ .+....+.+++.+...
T Consensus 126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~ 198 (566)
T PLN03225 126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGF 198 (566)
T ss_pred CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhh
Confidence 4456788999999999999999999999988 99999998764321 1111111 1111122222222211
Q ss_pred -----eecCCeEEEEEeecCCCchhHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHcCCEEE
Q 010947 185 -----FQDDEFLYLIMEYLPGGDMMTLLMRKDT--------------------LTEDEARFYVAETVLAIESIHKHHYIH 239 (497)
Q Consensus 185 -----~~~~~~l~lVmEy~~gg~L~~~l~~~~~--------------------l~e~~~~~~~~qi~~aL~~LH~~~iiH 239 (497)
..+...++|||||+++|+|.+++..... ..+..+..++.||+.||.|||+.||||
T Consensus 199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH 278 (566)
T PLN03225 199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH 278 (566)
T ss_pred hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 2456679999999999999999865321 123456789999999999999999999
Q ss_pred cccCCCCeeecC-CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccc
Q 010947 240 RDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (497)
Q Consensus 240 rDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (497)
|||||+|||++. ++.+||+|||+|+.+...... .....+
T Consensus 279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~----------------------------------------~~~~~~ 318 (566)
T PLN03225 279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINY----------------------------------------IPKEFL 318 (566)
T ss_pred CcCCHHHEEEeCCCCcEEEEeCCCcccccccccc----------------------------------------CCcccc
Confidence 999999999986 689999999999865321100 012468
Q ss_pred CCCcccCccccccC----------------------CCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhc-----
Q 010947 319 GTPDYIAPEVLLKK----------------------GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN----- 371 (497)
Q Consensus 319 Gt~~Y~aPE~l~~~----------------------~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~----- 371 (497)
||+.|+|||.+... .++.++|||||||+||||+++..|+. +....+.+++.
T Consensus 319 ~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~--~~~~~~~~~l~~~~~~ 396 (566)
T PLN03225 319 LDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD--SNLIQFNRQLKRNDYD 396 (566)
T ss_pred cCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc--hHHHHHHHHHHhcCCc
Confidence 99999999976432 24456799999999999999766543 22222222221
Q ss_pred ---ccCccc--CC-C-------CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhh
Q 010947 372 ---WRTHLK--FP-E-------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 372 ---~~~~~~--~p-~-------~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 425 (497)
|..... .+ . ....+..++|||.+||+ ||.+||+ +.++|+||||.+..+..+
T Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t---a~e~L~Hpff~~~~~~~~ 461 (566)
T PLN03225 397 LVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS---AKAALAHPYFDREGLLGL 461 (566)
T ss_pred HHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC---HHHHhCCcCcCCCCcccc
Confidence 100000 00 0 01123456799999999 9999999 999999999999887644
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=308.50 Aligned_cols=261 Identities=28% Similarity=0.476 Sum_probs=212.8
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHH-HhcCCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~~~~~~ 189 (497)
..+..++.+-+..||.|+||+|++-.++.+|+..|||.++.... .....+++.|.+.. +.-++||||++||+...+.
T Consensus 59 ~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG 136 (361)
T KOG1006|consen 59 HTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG 136 (361)
T ss_pred cccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC
Confidence 34556677778899999999999999999999999999986543 33445677777765 5568999999999999999
Q ss_pred eEEEEEeecCCCchhHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 190 FLYLIMEYLPGGDMMTLLM-----RKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
..++.||+| ..+|..+.+ ++..++|...-.+....+.||.||.. +.|||||+||+|||++..|.+||||||+|
T Consensus 137 dcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIc 215 (361)
T KOG1006|consen 137 DCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGIC 215 (361)
T ss_pred ceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccch
Confidence 999999999 456655432 35679999999999999999999985 69999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWW 341 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~Diw 341 (497)
-.+..+... +.-+|...|||||.+.. .+|+.++|+|
T Consensus 216 GqLv~SiAk------------------------------------------T~daGCrpYmAPERi~p~~~gyDiRSDvW 253 (361)
T KOG1006|consen 216 GQLVDSIAK------------------------------------------TVDAGCRPYMAPERIDPSDKGYDIRSDVW 253 (361)
T ss_pred HhHHHHHHh------------------------------------------hhccCCccccChhccCCccCCcchhhhhh
Confidence 766432110 12468899999999974 5799999999
Q ss_pred hHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcccCcc-cCCC-CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 342 SLGAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHL-KFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 342 SlGvil~ell~G~~PF~~~~~-~~~~~~i~~~~~~~-~~p~-~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|||++|||+.||..|+.+.+. .+++..++.+..+. .++. ....|..++.+|.-||. |-..||. ..+++.|||+
T Consensus 254 SLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpk---y~~Lk~~~fy 330 (361)
T KOG1006|consen 254 SLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPK---YDDLKKFPFY 330 (361)
T ss_pred hhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcc---hhhhhcCchh
Confidence 999999999999999988654 45555666544333 2232 24589999999999998 9999998 8899999999
Q ss_pred cC
Q 010947 418 DG 419 (497)
Q Consensus 418 ~~ 419 (497)
+.
T Consensus 331 r~ 332 (361)
T KOG1006|consen 331 RM 332 (361)
T ss_pred hh
Confidence 74
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=307.06 Aligned_cols=263 Identities=29% Similarity=0.429 Sum_probs=210.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------- 187 (497)
...|+-+..||+|.||+||+|+.+.+|+.||+|++.... .+.+--....+|+.+|..++|+|++.++..|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 345777788999999999999999999999998764321 112222346789999999999999998876642
Q ss_pred -CCeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 188 -DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 188 -~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
...+||||.+|+ -||..+|... -.|+..+++.++.++..||.|+|...|+|||+||+|+||+.+|.+||+|||+++.
T Consensus 95 ~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 95 DRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred ccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 235999999995 5899998665 5799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlG 344 (497)
+..+..... . | .+..+-|.+|.+||.+.+ ..|+++.|+|..|
T Consensus 174 fs~~~n~~k---------------------p-------------r---ytnrvvTLwYrppEllLG~r~yg~~iDiWgAg 216 (376)
T KOG0669|consen 174 FSTSKNVVK---------------------P-------------R---YTNRVVTLWYRPPELLLGDREYGPPIDIWGAG 216 (376)
T ss_pred eecccccCC---------------------C-------------C---cccceeeeecCCHHHhhcccccCCcchhHhHH
Confidence 753321100 0 0 124578999999999987 6799999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhc---------ccCcccCC-----------CC-----------ccCChhHHHHHH
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVN---------WRTHLKFP-----------EE-----------AKLSIEAKDLIS 393 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~---------~~~~~~~p-----------~~-----------~~~s~~~~dLI~ 393 (497)
|||.||.+|.+-|.+++...++.-|.. |+....+| .. -.-++++.||+.
T Consensus 217 CimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle 296 (376)
T KOG0669|consen 217 CIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLE 296 (376)
T ss_pred HHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHH
Confidence 999999999999999998877766542 32221111 10 012457899999
Q ss_pred HHhh-CccccCCCCCcchhcCCCCccC
Q 010947 394 KLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 394 ~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+||. ||.+|+. +.++++|.||..
T Consensus 297 ~ll~~DP~kR~~---ad~alnh~~F~k 320 (376)
T KOG0669|consen 297 KLLKLDPTKRID---ADQALNHDFFWK 320 (376)
T ss_pred HHhccCcccCcc---hHhhhchhhhhc
Confidence 9999 9999998 899999999964
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=291.08 Aligned_cols=253 Identities=30% Similarity=0.496 Sum_probs=207.9
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecC--Ce
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDD--EF 190 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~--~~ 190 (497)
..++|++++.+|+|.|++||.|....+++.++||+++.-. .+.+.+|+.||..+. ||||++|+++..|. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 3578999999999999999999999999999999997542 345889999999996 99999999998875 45
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC-CcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~ 269 (497)
..||+||+.+.|...+. ..|+.-.+++|+.|++.||.|+|+.||+|||+||.|++||.. -.++|+|+|||..+...
T Consensus 110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 77999999998887765 568999999999999999999999999999999999999965 56999999999877644
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ 348 (497)
... ...+.+..|--||.+.. +.|+.+.|+|||||++.
T Consensus 187 ~eY------------------------------------------nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA 224 (338)
T KOG0668|consen 187 KEY------------------------------------------NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224 (338)
T ss_pred cee------------------------------------------eeeeehhhcCCchheeechhccccHHHHHHHHHHH
Confidence 211 13466778899999985 67999999999999999
Q ss_pred HHHhCCCCCC-CCChHHHHHHHhc-----------ccCcccCC----------------------CCccCChhHHHHHHH
Q 010947 349 EMLVGYPPFY-SDDPMSTCRKIVN-----------WRTHLKFP----------------------EEAKLSIEAKDLISK 394 (497)
Q Consensus 349 ell~G~~PF~-~~~~~~~~~~i~~-----------~~~~~~~p----------------------~~~~~s~~~~dLI~~ 394 (497)
.|++.+-||. |.+..+++-+|.. .+..+.++ ...-+++++.|||.+
T Consensus 225 ~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldk 304 (338)
T KOG0668|consen 225 SMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDK 304 (338)
T ss_pred HHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHH
Confidence 9999988874 5555555444432 00111111 112357999999999
Q ss_pred Hhh-CccccCCCCCcchhcCCCCccCC
Q 010947 395 LLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 395 lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
||. |-.+|++ |.|++.||||..+
T Consensus 305 lLrYDHqeRlT---akEam~HpyF~~~ 328 (338)
T KOG0668|consen 305 LLRYDHQERLT---AKEAMAHPYFAPV 328 (338)
T ss_pred HHhhccccccc---hHHHhcCchHHHH
Confidence 999 9999999 9999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=324.96 Aligned_cols=265 Identities=21% Similarity=0.282 Sum_probs=190.9
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEc----------------CCCcEEEEEEeechhhhc-----------hhHHHHH
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREK----------------TTGHVYAMKKLKKSEMLR-----------RGQVEHV 163 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~----------------~t~~~~AiK~l~k~~~~~-----------~~~~~~~ 163 (497)
.++..++|++.++||+|+||.||+|... ..++.||||.+....... ....+..
T Consensus 140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~ 219 (507)
T PLN03224 140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG 219 (507)
T ss_pred CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence 4567889999999999999999999652 235679999986432110 0112234
Q ss_pred HHHHHHHHhcCCCce-----eEEEEEeec--------CCeEEEEEeecCCCchhHHHHhc--------------------
Q 010947 164 RAERNLLAEVDSNCI-----VKLYCSFQD--------DEFLYLIMEYLPGGDMMTLLMRK-------------------- 210 (497)
Q Consensus 164 ~~E~~il~~l~hp~I-----v~l~~~~~~--------~~~l~lVmEy~~gg~L~~~l~~~-------------------- 210 (497)
..|+.++.+++|.++ ++++++|.. ....+|||||+++|+|.++|...
T Consensus 220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 457777777776654 556665542 35689999999999999988642
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCC
Q 010947 211 ----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286 (497)
Q Consensus 211 ----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 286 (497)
..+++..++.++.|++.||.|||+.+|+||||||+|||++.++.+||+|||++..+.......
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~------------- 366 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN------------- 366 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-------------
Confidence 123567788999999999999999999999999999999999999999999997543211000
Q ss_pred CCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC--------------------CC--cchhHHhHH
Q 010947 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--------------------YG--MECDWWSLG 344 (497)
Q Consensus 287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--------------------y~--~~~DiwSlG 344 (497)
.....+|+.|+|||++.... |+ ..+|+||+|
T Consensus 367 ---------------------------~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlG 419 (507)
T PLN03224 367 ---------------------------PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAG 419 (507)
T ss_pred ---------------------------ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHH
Confidence 00234589999999986432 22 247999999
Q ss_pred HHHHHHHhCCC-CCCCCChH----HHHHHHh-----cccCcccCCCCccCChhHHHHHHHHhh-Cc---cccCCCCCcch
Q 010947 345 AIMYEMLVGYP-PFYSDDPM----STCRKIV-----NWRTHLKFPEEAKLSIEAKDLISKLLC-NV---NQRLGAKGADE 410 (497)
Q Consensus 345 vil~ell~G~~-PF~~~~~~----~~~~~i~-----~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp---~~R~~~~~~~e 410 (497)
||+|+|++|.. ||.+.... ..+...+ .......++....+++.++|||.+||+ +| .+|++ +.|
T Consensus 420 vil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlS---a~e 496 (507)
T PLN03224 420 VLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLS---VGQ 496 (507)
T ss_pred HHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCC---HHH
Confidence 99999999985 77542211 1111111 111234455455789999999999998 66 56888 999
Q ss_pred hcCCCCcc
Q 010947 411 IKVHPWFD 418 (497)
Q Consensus 411 il~Hpff~ 418 (497)
+|+||||.
T Consensus 497 aL~Hp~f~ 504 (507)
T PLN03224 497 ALSHRFFL 504 (507)
T ss_pred HhCCCCcC
Confidence 99999995
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=337.43 Aligned_cols=267 Identities=40% Similarity=0.728 Sum_probs=220.5
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
.-...+|+.++.|-.|+||.||+++++.|.+.+|+ .++|..++-++ ||....+|++|
T Consensus 79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~lilRn----------ilt~a~npfvv------------ 135 (1205)
T KOG0606|consen 79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNLILRN----------ILTFAGNPFVV------------ 135 (1205)
T ss_pred CCCccccceeEeeccCCCCceeeeeccccccchhh-cccccchhhhc----------cccccCCccee------------
Confidence 34568999999999999999999999999999999 55554432221 66666777777
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
||-..++..-++++.+. +.|++|||+-||+|||+||+|.||+.-||+|++|||+++.......
T Consensus 136 ---------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 77777877666776554 8899999999999999999999999999999999999987543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhh-cccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKN-RRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
. +. ...+.++. +.......||||.|+|||++..++|+..+|||++|+|+||.
T Consensus 199 t--------nl-------------------~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeF 251 (1205)
T KOG0606|consen 199 T--------NL-------------------KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEF 251 (1205)
T ss_pred c--------hh-------------------hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHH
Confidence 0 00 00000000 11112357999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCC-ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQM 428 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~ 428 (497)
+.|+.||.++++.+++..++. ..+.+|+. ..+.+|++++|.+||. +|..|++..++-++++|+||.++||..|...
T Consensus 252 LVgcvpffGdtpeelfg~vis--d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~~llRq 329 (1205)
T KOG0606|consen 252 LVGCVPFFGDTPEELFGQVIS--DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWKSLLRQ 329 (1205)
T ss_pred heeeeeccCCCHHHHHhhhhh--hhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccchhhhh
Confidence 999999999999999999886 44555553 4688999999999999 9999999999999999999999999999999
Q ss_pred CCCcccccCCcccccCccc
Q 010947 429 EAAFIPEVNDELDTQNFEK 447 (497)
Q Consensus 429 ~~p~~p~~~~~~d~~~f~~ 447 (497)
.++|+|.+..+.|+++|+.
T Consensus 330 kaefvpql~~eddtsyfdT 348 (1205)
T KOG0606|consen 330 KAEFVPQLESEDDTSYFDT 348 (1205)
T ss_pred hccccccccccccchhhcc
Confidence 9999999999999999985
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=290.18 Aligned_cols=241 Identities=47% Similarity=0.809 Sum_probs=205.2
Q ss_pred CCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCchhHHH
Q 010947 128 AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL 207 (497)
Q Consensus 128 ~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l 207 (497)
+||.||+|....+|+.+|+|++........ ...+..|+.+++.++|++|+++++.+.+....++||||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 689999999999999999999976543221 567889999999999999999999999989999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCC
Q 010947 208 MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287 (497)
Q Consensus 208 ~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 287 (497)
.....+++..+..++.+++.+|.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~----------------- 141 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG----------------- 141 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----------------
Confidence 776669999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCC-CChHHHH
Q 010947 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS-DDPMSTC 366 (497)
Q Consensus 288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~-~~~~~~~ 366 (497)
......|++.|+|||.+....++.++|+||||+++|+|++|..||.. .+.....
T Consensus 142 -------------------------~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~ 196 (244)
T smart00220 142 -------------------------LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELF 196 (244)
T ss_pred -------------------------ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence 01135689999999999988899999999999999999999999988 4444444
Q ss_pred HHHhcccCcccCCCC-ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 367 RKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 367 ~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
..+... ....+.. ..++.++.++|.+||. +|.+||+ +.++++||||
T Consensus 197 ~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~---~~~~~~~~~~ 244 (244)
T smart00220 197 KKIGKP--KPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT---AEEALQHPFF 244 (244)
T ss_pred HHHhcc--CCCCccccccCCHHHHHHHHHHccCCchhccC---HHHHhhCCCC
Confidence 444432 2222211 1288899999999999 9999998 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=315.24 Aligned_cols=261 Identities=25% Similarity=0.444 Sum_probs=213.7
Q ss_pred HHHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC------Ccee
Q 010947 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS------NCIV 179 (497)
Q Consensus 106 ~~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h------p~Iv 179 (497)
++++-.++...+|.+....|+|-|++|..|.+...|..||||+|...++... .=..|++||++|.. -+++
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~K----tGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHK----TGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhh----hhhHHHHHHHHhhccCchhhhHHH
Confidence 4444556677889999999999999999999999999999999988765332 24579999999842 4789
Q ss_pred EEEEEeecCCeEEEEEeecCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-cE
Q 010947 180 KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HL 255 (497)
Q Consensus 180 ~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-~v 255 (497)
+|+-.|...+++|||+|-+ ..+|.++|.+.+ .|....++.|+.|+..||..|-..||+|.||||+|||++... .+
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence 9999999999999999988 679999998754 588999999999999999999999999999999999999764 58
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCC
Q 010947 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335 (497)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~ 335 (497)
||||||.|.......+ +.+.-+..|.|||++.+.+|+
T Consensus 577 KLCDfGSA~~~~enei-------------------------------------------tPYLVSRFYRaPEIiLG~~yd 613 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI-------------------------------------------TPYLVSRFYRAPEIILGLPYD 613 (752)
T ss_pred eeccCccccccccccc-------------------------------------------cHHHHHHhccCcceeecCccc
Confidence 9999999875533211 023345579999999999999
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCC----------------------------------
Q 010947 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE---------------------------------- 381 (497)
Q Consensus 336 ~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~---------------------------------- 381 (497)
+..|+||+||+||||.||+..|.|.+...++.-.+..++. ||..
T Consensus 614 ~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk--~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~v 691 (752)
T KOG0670|consen 614 YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGK--FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTV 691 (752)
T ss_pred CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCC--CcHHHhhhcchhhhhcccccceEEEeccccccceeEEE
Confidence 9999999999999999999999998877776554432111 1110
Q ss_pred ------------------------ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 382 ------------------------AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 382 ------------------------~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
..+=..++||+.+||. ||++|++ +.++|.||||.+
T Consensus 692 m~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit---~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 692 MVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRIT---VNQALKHPFITE 751 (752)
T ss_pred ecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCC---HHHHhcCCcccC
Confidence 0112237899999999 9999999 999999999964
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=312.91 Aligned_cols=246 Identities=24% Similarity=0.369 Sum_probs=207.8
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCC--C--cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTT--G--HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t--~--~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
..+...+.+.||.|-||.||.|....- | --||||..+++.. ....+.|.+|..+|+.++|||||+|+|+|.+ .
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 334445567899999999999987543 2 2599999887653 3447789999999999999999999999876 4
Q ss_pred eEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+||||+++-|.|..+|+.+ ..|+......|+.||+.||.|||+..+|||||...|||+.....|||+||||++-+..
T Consensus 464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 678999999999999999764 5799999999999999999999999999999999999999999999999999998765
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
+.+... ....-...|||||.+.-..++.++|+|.|||+||
T Consensus 544 ~~yYka----------------------------------------S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmW 583 (974)
T KOG4257|consen 544 DAYYKA----------------------------------------SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMW 583 (974)
T ss_pred cchhhc----------------------------------------cccccceeecCccccchhcccchhhHHHHHHHHH
Confidence 432210 0112245799999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC
Q 010947 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 349 ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
|+|. |.-||.+....+.+..|-++ ..++.|+ .|++.+..|+.+|+. +|.+||..
T Consensus 584 EIl~lGvkPfqgvkNsDVI~~iEnG-eRlP~P~--nCPp~LYslmskcWayeP~kRPrf 639 (974)
T KOG4257|consen 584 EILSLGVKPFQGVKNSDVIGHIENG-ERLPCPP--NCPPALYSLMSKCWAYEPSKRPRF 639 (974)
T ss_pred HHHHhcCCccccccccceEEEecCC-CCCCCCC--CCChHHHHHHHHHhccCcccCCcH
Confidence 9986 99999998888877777664 4555554 899999999999999 99999983
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=307.61 Aligned_cols=250 Identities=21% Similarity=0.348 Sum_probs=216.3
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
..+++...+..+...||.|-||.||.|.++.-.-.||||.++.+. ..++.|..|..+|+.++|||+|+|+++|..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 345666777888899999999999999999888899999998654 3577899999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
..+|||+|||..|+|.++|...+ -++.-....++.||.+|++||..+++|||||-..|+|+..+..||++||||++.+
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM 415 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM 415 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence 99999999999999999998754 3677777888899999999999999999999999999999999999999999988
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
..+++.-+ ....-...|.|||-+....++.++|+|+|||+
T Consensus 416 tgDTYTAH----------------------------------------AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVL 455 (1157)
T KOG4278|consen 416 TGDTYTAH----------------------------------------AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVL 455 (1157)
T ss_pred cCCceecc----------------------------------------cCccCcccccCcccccccccccchhhHHHHHH
Confidence 65432110 01123457999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC
Q 010947 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 347 l~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
|||+.| |-.||.|-+..+.|.-+-+ .....-|+ .|++.+..|++.|++ .|.+||+.
T Consensus 456 LWEIATYGMsPYPGidlSqVY~LLEk-gyRM~~Pe--GCPpkVYeLMraCW~WsPsDRPsF 513 (1157)
T KOG4278|consen 456 LWEIATYGMSPYPGIDLSQVYGLLEK-GYRMDGPE--GCPPKVYELMRACWNWSPSDRPSF 513 (1157)
T ss_pred HHHHHhcCCCCCCCccHHHHHHHHhc-cccccCCC--CCCHHHHHHHHHHhcCCcccCccH
Confidence 999997 9999999998888766554 34555565 899999999999999 99999993
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=292.88 Aligned_cols=260 Identities=28% Similarity=0.461 Sum_probs=213.0
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----e
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE-----F 190 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~ 190 (497)
.|.+..+.||.|+||+||.+.+..+|+.||+|++..- ..+-...+++.+|..+|...+|.|++...+..+... .
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqE 131 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQE 131 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHH
Confidence 4566678999999999999999999999999998643 223334567889999999999999999988877543 4
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|.|+|+| ..||...+-+...++.+.++-+++||+.||.|||+.||+||||||.|+|++.+..+||||||||+.-....
T Consensus 132 iYV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 132 LYVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 78999999 56999999888999999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~e 349 (497)
++.+ +..+-|-.|.|||++++ ..|+.++||||+|||+.|
T Consensus 211 ---------------------------------------~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaE 250 (449)
T KOG0664|consen 211 ---------------------------------------RLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 250 (449)
T ss_pred ---------------------------------------hhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHH
Confidence 0111 13466888999999997 569999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhccc---------------------CcccCCC---------CccCChhHHHHHHHHhh-C
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWR---------------------THLKFPE---------EAKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~---------------------~~~~~p~---------~~~~s~~~~dLI~~lL~-d 398 (497)
+|-.+..|...++.+.++-|..-- ....-|. ...-..++.+++.+||. |
T Consensus 251 LLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d 330 (449)
T KOG0664|consen 251 LLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFD 330 (449)
T ss_pred HHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCC
Confidence 999999999999888877665311 1111111 11234568899999999 9
Q ss_pred ccccCCCCCcchhcCCCCccCC
Q 010947 399 VNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 399 p~~R~~~~~~~eil~Hpff~~i 420 (497)
|..|.+ .++.+.|++....
T Consensus 331 ~dkris---~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 331 PDKRIS---VEEALQHRYLEEG 349 (449)
T ss_pred Cccccc---Hhhhccccccccc
Confidence 999998 8899999998754
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.42 Aligned_cols=272 Identities=28% Similarity=0.421 Sum_probs=210.4
Q ss_pred eeEEeEeeecCCeE-EEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEE
Q 010947 118 FELLTMIGKGAFGE-VRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 118 f~~~~~IG~G~fG~-V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
|..-+++|.|+-|+ ||+|... |+.||||.+-.. ....+.+|+..|... +|||||+.||.-++..++||+.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 44456889999885 7888764 779999987533 334578899999887 6999999999999999999999
Q ss_pred eecCCCchhHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC---CC--cEEEccccccccc
Q 010947 196 EYLPGGDMMTLLMRKDT----LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YG--HLRLSDFGLCKPL 266 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~----l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~---~g--~vkL~DFGla~~~ 266 (497)
|.| ..+|.+++..... ......+..+.|++.||.+||+.+||||||||.||||+. ++ .++|+|||+|+.+
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 5699999976311 111456788999999999999999999999999999986 34 6899999999998
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
..+.... +| .....||-+|+|||++....-+.++||+|||||
T Consensus 662 ~~~~sS~------------------------------------~r--~s~~sGt~GW~APE~L~~~~~~~avDiFslGCv 703 (903)
T KOG1027|consen 662 AGGKSSF------------------------------------SR--LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCV 703 (903)
T ss_pred CCCcchh------------------------------------hc--ccCCCCcccccCHHHHhccccCcccchhhcCce
Confidence 6542111 00 125679999999999999888899999999999
Q ss_pred HHHHHhC-CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhh
Q 010947 347 MYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 347 l~ell~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
+|..++| ..||.+.- +...+|+.....+..-.. ....+|+|||.+||. +|..||+ |.++|.||||- +|+.
T Consensus 704 fyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~-~~d~eA~dLI~~ml~~dP~~RPs---a~~VL~HPlFW--~~ek 775 (903)
T KOG1027|consen 704 FYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEP-LPDCEAKDLISRMLNPDPQLRPS---ATDVLNHPLFW--DSEK 775 (903)
T ss_pred EEEEecCCccCCCchH--HhhhhhhcCccceeeecc-CchHHHHHHHHHhcCCCcccCCC---HHHHhCCCccC--ChHH
Confidence 9999996 89997653 333467765444322110 111199999999999 9999999 99999999994 3333
Q ss_pred hhhcCCCcccccCCcccccCcccc
Q 010947 425 IYQMEAAFIPEVNDELDTQNFEKF 448 (497)
Q Consensus 425 l~~~~~p~~p~~~~~~d~~~f~~~ 448 (497)
- -.|.-++.+..+..+.+..
T Consensus 776 r----L~Fl~dvSDRvE~e~r~~~ 795 (903)
T KOG1027|consen 776 R----LSFLRDVSDRVEKENRDSP 795 (903)
T ss_pred H----HHHHHhhhhhhhhhhccCc
Confidence 2 2466677777777766643
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=308.80 Aligned_cols=203 Identities=32% Similarity=0.537 Sum_probs=182.8
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHH-----HHHHHHHHHHHhcC---CCceeEEEEEe
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV-----EHVRAERNLLAEVD---SNCIVKLYCSF 185 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~-----~~~~~E~~il~~l~---hp~Iv~l~~~~ 185 (497)
...+|..++.+|.|+||+|++|.++.+...|+||.+.|..+.-...+ -.+-.|+.||..++ |+||++++.+|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 45679999999999999999999999999999999999876544433 34667999999997 99999999999
Q ss_pred ecCCeEEEEEeec-CCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 186 QDDEFLYLIMEYL-PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 186 ~~~~~l~lVmEy~-~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
++++++||+||-. +|.||++++..+..++|.+++.++.|++.|+++||+.||||||||-+|+.++.+|.+||+|||.|.
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999975 567999999999999999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSL 343 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSl 343 (497)
....+. .-.++||.+|.|||++.+.+| +..-|||+|
T Consensus 719 ~~ksgp-------------------------------------------fd~f~gtv~~aapevl~g~~y~gk~qdiwal 755 (772)
T KOG1152|consen 719 YTKSGP-------------------------------------------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWAL 755 (772)
T ss_pred hhcCCC-------------------------------------------cceeeeeccccchhhhCCCccCCCcchhhhh
Confidence 554321 115799999999999999888 889999999
Q ss_pred HHHHHHHHhCCCCCCC
Q 010947 344 GAIMYEMLVGYPPFYS 359 (497)
Q Consensus 344 Gvil~ell~G~~PF~~ 359 (497)
|++||-++....||+.
T Consensus 756 gillytivykenpyyn 771 (772)
T KOG1152|consen 756 GILLYTIVYKENPYYN 771 (772)
T ss_pred hheeeEEEeccCCCcC
Confidence 9999999999999985
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=316.70 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=222.4
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
.++......+.++||.|.||+|++|+.+..|+ .||||.++... ...+...|..|..||-+++||||++|-++...
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk 701 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK 701 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEec
Confidence 45777788899999999999999999988775 69999998543 46677889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
.+.+.||.|||++|+|..+|..+ +.|+..+..-+++.|+.|+.||-+.|+|||||...|||++.+..+|++||||++.+
T Consensus 702 s~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 702 SKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred CceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999999999765 57999999999999999999999999999999999999999999999999999977
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccc---CCCcccCccccccCCCCcchhHHhH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV---GTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
..+. .. +++.. -...|.|||.+...+++.++|+||+
T Consensus 782 edd~--~~---------------------------------------~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSy 820 (996)
T KOG0196|consen 782 EDDP--EA---------------------------------------AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSY 820 (996)
T ss_pred ccCC--Cc---------------------------------------cccccCCccceeecChhHhhhcccCchhhcccc
Confidence 5432 00 01111 2357999999999999999999999
Q ss_pred HHHHHHHH-hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 344 GAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 344 Gvil~ell-~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
||+|||.+ +|..||...+.++.+..|.. .+.+|.+..++..+..|+..|++ |-..||. ..+|.+
T Consensus 821 GIVmWEVmSyGERPYWdmSNQdVIkaIe~---gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~---F~qiV~ 886 (996)
T KOG0196|consen 821 GIVMWEVMSYGERPYWDMSNQDVIKAIEQ---GYRLPPPMDCPAALYQLMLDCWQKDRNRRPK---FAQIVS 886 (996)
T ss_pred ceEEEEecccCCCcccccchHHHHHHHHh---ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCC---HHHHHH
Confidence 99999966 59999999999999988874 45666667999999999999999 9999998 777664
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=304.28 Aligned_cols=255 Identities=18% Similarity=0.308 Sum_probs=208.0
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
++..+...+.+.||+|-||+|.+|.... +..||+|+++.... ......|..|+.+|.+++|||||.|+++|..++.+
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi 610 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL 610 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence 3455667888999999999999998643 57999999986542 34457799999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
++|||||++|||..++..+. .+.-.....++.||++|+.||.+.+||||||.+.|+|++.++++||+|||+++.+-..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence 99999999999999998863 2344566679999999999999999999999999999999999999999999976543
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
....-. -..+-...|||||.+..++++.++|+|+|||+|||
T Consensus 691 ~yy~vq---------------------------------------gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE 731 (807)
T KOG1094|consen 691 DYYRVQ---------------------------------------GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 731 (807)
T ss_pred Cceeee---------------------------------------cceeeeeeehhHHHHHhccccchhhhhhhHHHHHH
Confidence 221100 01345578999999999999999999999999999
Q ss_pred HHh--CCCCCCCCChHHHHHHHhc---ccCc-ccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 350 MLV--GYPPFYSDDPMSTCRKIVN---WRTH-LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 350 ll~--G~~PF~~~~~~~~~~~i~~---~~~~-~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
+++ ...||......+..++... .... ...+.+.-++..+..||.+|+. |.++||+ .+++
T Consensus 732 ~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPs---Fe~l 797 (807)
T KOG1094|consen 732 VFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPS---FEQL 797 (807)
T ss_pred HHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCC---HHHH
Confidence 875 7889988777666655432 1111 1122235788899999999999 9999999 7776
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=268.32 Aligned_cols=228 Identities=28% Similarity=0.486 Sum_probs=185.9
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHH-hcCCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~ 189 (497)
..+..++...+..||+|+||.|-+.++..+|...|+|.+...- .....++...|+++.. ..++|++|.+|+.+.+..
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg 118 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG 118 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence 4456667777889999999999999999999999999997542 3344556777888765 458999999999999999
Q ss_pred eEEEEEeecCCCchhHH----HHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 190 FLYLIMEYLPGGDMMTL----LMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~----l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
.+++.||.|. .+|..+ +.+.+.++|..+-.++..++.||.|||+ +.+||||+||+||||+.+|++|+||||+|-
T Consensus 119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccce
Confidence 9999999994 566544 3446789999999999999999999997 599999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccc-ccCCCcccCcccccc----CCCCcchh
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYS-TVGTPDYIAPEVLLK----KGYGMECD 339 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~Gt~~Y~aPE~l~~----~~y~~~~D 339 (497)
.+..+. +.+ -.|.-.|||||.+.. .+|+.++|
T Consensus 198 ~L~dSi-------------------------------------------Akt~daGCkpYmaPEri~~e~n~~gY~vksD 234 (282)
T KOG0984|consen 198 YLVDSI-------------------------------------------AKTMDAGCKPYMAPERINPELNQKGYSVKSD 234 (282)
T ss_pred eehhhh-------------------------------------------HHHHhcCCCccCChhhcCcccCcccceeehh
Confidence 664321 112 468889999999863 58999999
Q ss_pred HHhHHHHHHHHHhCCCCCCC-CChHHHHHHHhcccCcccCCCCccCCh
Q 010947 340 WWSLGAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSI 386 (497)
Q Consensus 340 iwSlGvil~ell~G~~PF~~-~~~~~~~~~i~~~~~~~~~p~~~~~s~ 386 (497)
|||||+.++||.+++.||.. .++-+++.+++.. ....+|.. .+|+
T Consensus 235 vWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee-p~P~Lp~~-~FS~ 280 (282)
T KOG0984|consen 235 VWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE-PSPQLPAD-TFSP 280 (282)
T ss_pred hhhhhhhhhhhhhccccccccCCHHHHHHHHhcC-CCCCCccc-ccCC
Confidence 99999999999999999976 4677888888863 34445543 3444
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=307.53 Aligned_cols=248 Identities=21% Similarity=0.352 Sum_probs=210.9
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcC-CCc--EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKT-TGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~-t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
..++..+.+.||+|+||.|+.|.+.. +|+ .||||+++..... .....|.+|+.+|.+++|||+++||++..+ ..
T Consensus 108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp 184 (1039)
T KOG0199|consen 108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QP 184 (1039)
T ss_pred cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence 34556677899999999999998865 344 4899999865532 256789999999999999999999999988 67
Q ss_pred EEEEEeecCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 191 LYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+.||||++++|+|.+.|.+ +..|-......|+.||+.|+.||.++++|||||-..|+|+-....|||+||||.+.+..
T Consensus 185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 7899999999999999976 45788899999999999999999999999999999999999999999999999998754
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
.... +. ++-...-...|+|||.+....++.++|+|++||++|
T Consensus 265 ned~---Yv-----------------------------------m~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiW 306 (1039)
T KOG0199|consen 265 NEDM---YV-----------------------------------MAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIW 306 (1039)
T ss_pred CCcc---eE-----------------------------------ecCCCcCcccccCHhHhccccccccchhhhhhhhHH
Confidence 3211 10 011122345799999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC
Q 010947 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 349 ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
||++ |.-||.|....+++++|- ....+.-|. .||.++.+++..|+. +|.+||+.
T Consensus 307 EMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk--~csedIY~imk~cWah~paDRptF 362 (1039)
T KOG0199|consen 307 EMFTYGEEPWVGCRGIQILKNID-AGERLPRPK--YCSEDIYQIMKNCWAHNPADRPTF 362 (1039)
T ss_pred hhhccCCCCCCCCCHHHHHHhcc-ccccCCCCC--CChHHHHHHHHHhccCCccccccH
Confidence 9998 899999999999999887 345666664 899999999999999 99999983
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=334.98 Aligned_cols=238 Identities=19% Similarity=0.285 Sum_probs=185.3
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|....+||+|+||.||+|..+.++..||||++...... ...|+.++++++|||||+++++|.+....|+|||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 456677899999999999999999999999998653211 2246888999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---cCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH---KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH---~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||+||+|.+++. .+++..+..++.+++.||.||| +.+|+||||||+||+++.++..++. ||.+......
T Consensus 764 y~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---- 835 (968)
T PLN00113 764 YIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---- 835 (968)
T ss_pred CCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC----
Confidence 999999999995 4899999999999999999999 6699999999999999999888875 6654322100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
....||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 836 -----------------------------------------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg 874 (968)
T PLN00113 836 -----------------------------------------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTG 874 (968)
T ss_pred -----------------------------------------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhC
Confidence 124689999999999999999999999999999999999
Q ss_pred CCCCCCCChH--HH---HHHHhc------ccCc-c--cCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 354 YPPFYSDDPM--ST---CRKIVN------WRTH-L--KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 354 ~~PF~~~~~~--~~---~~~i~~------~~~~-~--~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+.||...... .. ...... +..+ + ..+.......++.+++.+|+. ||.+||+ +.|+++
T Consensus 875 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt---~~evl~ 946 (968)
T PLN00113 875 KSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC---ANDVLK 946 (968)
T ss_pred CCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcC---HHHHHH
Confidence 9999543210 11 110000 0000 0 000001122357789999999 9999998 777654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=306.55 Aligned_cols=260 Identities=28% Similarity=0.486 Sum_probs=224.2
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|+++..+|.|+||.||+++++.+++..|+|+++-.. .....-+.+|+-+++..+|||||.+++++.-...+++
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEE
Confidence 4688999999999999999999999999999999997543 3345557889999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
+||||.||+|.+...-.++++|.++.+.+.+.+.||+|||+.|-+|||||-.|||++..|.+||.|||.+-.+.....
T Consensus 90 cMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-- 167 (829)
T KOG0576|consen 90 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-- 167 (829)
T ss_pred EEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh--
Confidence 999999999999988889999999999999999999999999999999999999999999999999999876532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHhHHHHHHHH
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwSlGvil~el 350 (497)
...++.|||.|||||+-. .++|...||+|++|+...|+
T Consensus 168 ---------------------------------------KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 168 ---------------------------------------KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred ---------------------------------------hhhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 012789999999999975 68899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhc-ccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 351 LVGYPPFYSDDPMSTCRKIVN-WRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~-~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
---.+|-....++....-... ...++..-+....++-+-+|++.+|. +|.+||+ ++-+|.|||...-
T Consensus 209 ~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt---aeklL~h~fvs~~ 277 (829)
T KOG0576|consen 209 GELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT---AEKLLQHPFVSQT 277 (829)
T ss_pred hhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC---hhhheeceeeccc
Confidence 999999887777665543322 22233333445788999999999998 9999999 8889999999754
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=287.53 Aligned_cols=295 Identities=24% Similarity=0.425 Sum_probs=208.6
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
....|.++..||.|+|+.||++.+.. .++.||+|.+..... ..++.+|+++|..+ .+.||+++.+++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-----PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC-----chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 34568899999999999999999877 788999999865432 34588999999988 5899999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-CCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~ 268 (497)
...+||||++..+..+++. .++-.+++.|+.+++.||.++|++|||||||||.|+|.+. .++-.|+|||||...+.
T Consensus 109 ~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred eeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 9999999999998888874 4678999999999999999999999999999999999985 47789999999984322
Q ss_pred CCccccccc----ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhH
Q 010947 269 STLQEQDFT----IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343 (497)
Q Consensus 269 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSl 343 (497)
.......-. ......+...... ...............+..++....+..|||+|.|||++.. ...+.++||||.
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~-~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~ 264 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQ-SVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSA 264 (418)
T ss_pred hhhhhhhhhhhcccCCccccCccccc-ccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeec
Confidence 110000000 0000000000000 0000000000000001233444557899999999999986 456899999999
Q ss_pred HHHHHHHHhCCCCCCCCC-hHHHHHHHh-------------------ccc-Cc-------------cc----CC------
Q 010947 344 GAIMYEMLVGYPPFYSDD-PMSTCRKIV-------------------NWR-TH-------------LK----FP------ 379 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~-~~~~~~~i~-------------------~~~-~~-------------~~----~p------ 379 (497)
|||+.-++++..||.... .......|. -|. .. +. .+
T Consensus 265 GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~ 344 (418)
T KOG1167|consen 265 GVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNT 344 (418)
T ss_pred cceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccce
Confidence 999999999999986432 111111110 111 00 00 00
Q ss_pred ----CCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 380 ----EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 380 ----~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
.....+..+.||+.+||. ||.+|.+ |++.|.||||...
T Consensus 345 ~~~~~~d~~~~~~~dlLdk~le~np~kRit---AEeALkHpFF~~~ 387 (418)
T KOG1167|consen 345 EREIGSDVFPALLLDLLDKCLELNPQKRIT---AEDALKHPFFDEA 387 (418)
T ss_pred eeccccccccHHHHHHHHHHccCChhhccc---HHHHhcCcCCcch
Confidence 001245579999999999 9999999 9999999999854
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=277.32 Aligned_cols=134 Identities=22% Similarity=0.432 Sum_probs=116.1
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-----C---CceeEEEEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----S---NCIVKLYCS 184 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-----h---p~Iv~l~~~ 184 (497)
+...+|-+.++||-|-|++||+|.+..+.+.||||+.+..... .+....|+.+|++++ | .+||+|++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY----tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY----TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH----HHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 3448899999999999999999999999999999999866432 345678999998872 3 479999999
Q ss_pred eec----CCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecC
Q 010947 185 FQD----DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDK 251 (497)
Q Consensus 185 ~~~----~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~ 251 (497)
|.. ..++|||+|++ |.+|..++... ..++...++.|+.||+.||.|||. .||||-||||+|||+..
T Consensus 151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCS 223 (590)
T ss_pred ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeec
Confidence 973 46899999999 88999998764 579999999999999999999996 69999999999999953
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=300.04 Aligned_cols=255 Identities=25% Similarity=0.389 Sum_probs=208.9
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcC---C----CcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKT---T----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~---t----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 181 (497)
..++..++..+.+.||.|+||.|++|..+. . ...||||.++.... ..+...+..|+.+|+.+ .||||+.+
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~l 367 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNL 367 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhh
Confidence 344555666777899999999999997531 1 34699999986543 35677899999999987 69999999
Q ss_pred EEEeecCCeEEEEEeecCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCC
Q 010947 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (497)
Q Consensus 182 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~ 245 (497)
.+++.....+++|+||+..|+|..+|...+ .++..+...++.||+.|++||++.++|||||-..
T Consensus 368 lG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaR 447 (609)
T KOG0200|consen 368 LGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAAR 447 (609)
T ss_pred eeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhh
Confidence 999999999999999999999999997765 4889999999999999999999999999999999
Q ss_pred CeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCC--Ccc
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT--PDY 323 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt--~~Y 323 (497)
|||++.+..+||+|||+|+.......... ....|| ..|
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~----------------------------------------~~~~~~LP~kW 487 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRT----------------------------------------KSSAGTLPVKW 487 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEe----------------------------------------cCCCCccceee
Confidence 99999999999999999996543221100 011222 249
Q ss_pred cCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCC-hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-Ccc
Q 010947 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 324 ~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~ 400 (497)
||||.+....|+.++|+||+||+||||++ |.+||.+-. ..+.+..+..+ .....|. .++.+..++++.|+. +|+
T Consensus 488 mApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G-~r~~~P~--~c~~eiY~iM~~CW~~~p~ 564 (609)
T KOG0200|consen 488 MAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEG-NRMEQPE--HCSDEIYDLMKSCWNADPE 564 (609)
T ss_pred cCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcC-CCCCCCC--CCCHHHHHHHHHHhCCCcc
Confidence 99999999999999999999999999998 999999865 45555555443 4555665 789999999999999 999
Q ss_pred ccCCCCCcchhc
Q 010947 401 QRLGAKGADEIK 412 (497)
Q Consensus 401 ~R~~~~~~~eil 412 (497)
+||+ ..++.
T Consensus 565 ~RP~---F~~~~ 573 (609)
T KOG0200|consen 565 DRPT---FSECV 573 (609)
T ss_pred cCCC---HHHHH
Confidence 9999 54443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-33 Score=274.85 Aligned_cols=244 Identities=23% Similarity=0.340 Sum_probs=193.1
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh--cCCCceeEEEEEeecCC---
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQDDE--- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~~~--- 189 (497)
....+++.+||+|.||.||+|... ++.||||++... +.+.+.+|.+|.+. ++|+||++++++-....
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 455777889999999999999865 589999998643 34568899999876 58999999998765433
Q ss_pred -eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC---------CEEEcccCCCCeeecCCCcEEEcc
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH---------HYIHRDIKPDNLLLDKYGHLRLSD 259 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------~iiHrDLKp~NILl~~~g~vkL~D 259 (497)
.++||+||.+.|+|.++|.. ..+++.....++..++.||.|||.. +|+|||||..|||+..++...|+|
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred cceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 78999999999999999954 7899999999999999999999952 599999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC-CC---
Q 010947 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YG--- 335 (497)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-y~--- 335 (497)
||||..+....... + +...|||..|||||++.+.- +.
T Consensus 360 FGLAl~~~p~~~~~-d--------------------------------------~~~qVGT~RYMAPEvLEgainl~d~~ 400 (534)
T KOG3653|consen 360 FGLALRLEPGKPQG-D--------------------------------------THGQVGTRRYMAPEVLEGAINLQDRD 400 (534)
T ss_pred cceeEEecCCCCCc-c--------------------------------------hhhhhhhhhhcCHHHHhhhcccccHH
Confidence 99999886432110 0 11468999999999997632 22
Q ss_pred --cchhHHhHHHHHHHHHhCCC------------CCC---C--CChHHHHHHHhcccCcccCCCCc---cCChhHHHHHH
Q 010947 336 --MECDWWSLGAIMYEMLVGYP------------PFY---S--DDPMSTCRKIVNWRTHLKFPEEA---KLSIEAKDLIS 393 (497)
Q Consensus 336 --~~~DiwSlGvil~ell~G~~------------PF~---~--~~~~~~~~~i~~~~~~~~~p~~~---~~s~~~~dLI~ 393 (497)
...||||+|.|||||++... ||. | .+..++...++..+....+|+.- .--.-+++.|.
T Consensus 401 Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~E 480 (534)
T KOG3653|consen 401 AFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIE 480 (534)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHH
Confidence 46899999999999998643 332 1 12345556666666777777631 12335788999
Q ss_pred HHhh-CccccCCCC
Q 010947 394 KLLC-NVNQRLGAK 406 (497)
Q Consensus 394 ~lL~-dp~~R~~~~ 406 (497)
.|+. ||+.|+++.
T Consensus 481 eCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 481 ECWDHDAEARLTAG 494 (534)
T ss_pred HHcCCchhhhhhhH
Confidence 9998 999999954
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-31 Score=253.40 Aligned_cols=212 Identities=42% Similarity=0.676 Sum_probs=182.5
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|.+.+.||.|++|.||+|....+++.+|||.+...... .....+..|+..+..++|+|++++++.+......++|+||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 56788999999999999999988999999999865422 2456788999999999999999999999999999999999
Q ss_pred cCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 198 LPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 198 ~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
+++++|.+++..... +++..+..++.+++.+|.+||+.+++|+||+|.||+++.++.++|+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~---- 154 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA---- 154 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc----
Confidence 999999999987666 899999999999999999999999999999999999999999999999998866432100
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccc-ccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l-~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
......++..|++||.+ ....++.++|+||||+++|+|++|++
T Consensus 155 ------------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~ 198 (225)
T smart00221 155 ------------------------------------LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPE 198 (225)
T ss_pred ------------------------------------cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCC
Confidence 00135688899999999 66778889999999999999999999
Q ss_pred CCCC-CChH-HHHHHHhc
Q 010947 356 PFYS-DDPM-STCRKIVN 371 (497)
Q Consensus 356 PF~~-~~~~-~~~~~i~~ 371 (497)
||.+ .+.. ...+.|..
T Consensus 199 pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 199 PFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred CccccchhHHHHHHHHhc
Confidence 9988 4444 55555554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=286.00 Aligned_cols=243 Identities=19% Similarity=0.295 Sum_probs=202.5
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
....++||.|+||+||+|.+-..|+ +||||++..... ......+..|.-+|.+++|||+++|++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4456799999999999999865554 699999876543 233456889999999999999999999998766 779
Q ss_pred EEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
|++|||+|.|.++++. ++.+-......|..||+.|+.|||.+++|||||-..|+|+..-.++||+|||+|+.+..+...
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999975 467999999999999999999999999999999999999999999999999999987654211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.. +....-.+.|||-|.+....|+.++|||||||.+||++|
T Consensus 855 y~---------------------------------------~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmT 895 (1177)
T KOG1025|consen 855 YS---------------------------------------APGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMT 895 (1177)
T ss_pred cc---------------------------------------ccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHh
Confidence 00 011223467999999999999999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC
Q 010947 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
|..|+.+....++-. ++.....+.-| +.++.++.-++.+|+. |+..||+.
T Consensus 896 FGa~Py~gi~~~eI~d-lle~geRLsqP--piCtiDVy~~mvkCwmid~~~rp~f 947 (1177)
T KOG1025|consen 896 FGAKPYDGIPAEEIPD-LLEKGERLSQP--PICTIDVYMVMVKCWMIDADSRPTF 947 (1177)
T ss_pred cCCCccCCCCHHHhhH-HHhccccCCCC--CCccHHHHHHHHHHhccCcccCccH
Confidence 999999987666544 44433445444 4899999999999998 99999983
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.5e-32 Score=266.20 Aligned_cols=251 Identities=25% Similarity=0.365 Sum_probs=190.2
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh--cCCCceeEEEEEe
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSF 185 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~ 185 (497)
+-..+....+..+.+.||+|.||+||.|+++ |+.||||++...+ .....+|.+|... ++|+||+.++++-
T Consensus 203 lLVQRTiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 203 LLVQRTIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred hHhHHhhhheeEEEEEecCccccceeecccc--CCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 3334455678999999999999999999876 8899999996432 2346678888764 6999999999775
Q ss_pred ecC----CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--------CEEEcccCCCCeeecCCC
Q 010947 186 QDD----EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--------HYIHRDIKPDNLLLDKYG 253 (497)
Q Consensus 186 ~~~----~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------~iiHrDLKp~NILl~~~g 253 (497)
..+ ..++||.+|.+.|+|+++|.+ ..++.+....++..++.||.|||.. .|.|||||..|||+.++|
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~ 353 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG 353 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC
Confidence 433 369999999999999999976 7899999999999999999999942 499999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC
Q 010947 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (497)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~ 333 (497)
.+-|+|+|||-..+.... ...++ .+..|||-.|||||++...-
T Consensus 354 ~C~IADLGLAv~h~~~t~---~idi~----------------------------------~N~rVGTKRYMAPEvLdeti 396 (513)
T KOG2052|consen 354 TCCIADLGLAVRHDSDTD---TIDIP----------------------------------PNPRVGTKRYMAPEVLDETI 396 (513)
T ss_pred cEEEeeceeeEEecccCC---cccCC----------------------------------CCCccceeeccChHHhhhhc
Confidence 999999999987654321 01110 12469999999999997532
Q ss_pred C------CcchhHHhHHHHHHHHHhC----------CCCCCCC----ChHHHHHHHhc-ccCcccCCCCccCChh---HH
Q 010947 334 Y------GMECDWWSLGAIMYEMLVG----------YPPFYSD----DPMSTCRKIVN-WRTHLKFPEEAKLSIE---AK 389 (497)
Q Consensus 334 y------~~~~DiwSlGvil~ell~G----------~~PF~~~----~~~~~~~~i~~-~~~~~~~p~~~~~s~~---~~ 389 (497)
- -..+||||||.||||++.. .+||++. ...+...+++- .+....+|..-.-.+. +-
T Consensus 397 n~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~ 476 (513)
T KOG2052|consen 397 NMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMA 476 (513)
T ss_pred ChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHH
Confidence 1 2468999999999999853 4788763 23344445442 2334445543222223 34
Q ss_pred HHHHHHhh-CccccCC
Q 010947 390 DLISKLLC-NVNQRLG 404 (497)
Q Consensus 390 dLI~~lL~-dp~~R~~ 404 (497)
.|++.|+. +|.-|++
T Consensus 477 klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 477 KLMKECWYANPAARLT 492 (513)
T ss_pred HHHHHhhcCCchhhhH
Confidence 56778887 9999998
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=243.11 Aligned_cols=211 Identities=43% Similarity=0.705 Sum_probs=185.7
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCch
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDM 203 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L 203 (497)
||.|++|.||+|....+++.+++|++....... ....+.+|+.++..+.|++|+++++++......++||||++|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997654221 346688999999999999999999999999999999999999999
Q ss_pred hHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-CCcEEEcccccccccCCCCcccccccccCC
Q 010947 204 MTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281 (497)
Q Consensus 204 ~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 281 (497)
..++... ..++...+..++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~---------- 148 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS---------- 148 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----------
Confidence 9998765 57999999999999999999999999999999999999999 89999999999986543210
Q ss_pred CCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHhCCCCCCCC
Q 010947 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSD 360 (497)
Q Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~G~~PF~~~ 360 (497)
......++..|++||.+... .++.+.|+||||+++++|
T Consensus 149 -------------------------------~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------- 187 (215)
T cd00180 149 -------------------------------LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------- 187 (215)
T ss_pred -------------------------------hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------
Confidence 00134688899999999877 889999999999999999
Q ss_pred ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCC
Q 010947 361 DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415 (497)
Q Consensus 361 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hp 415 (497)
..+.++|.+||+ +|.+||+ +.++++|+
T Consensus 188 -------------------------~~~~~~l~~~l~~~p~~R~~---~~~l~~~~ 215 (215)
T cd00180 188 -------------------------PELKDLIRKMLQKDPEKRPS---AKEILEHL 215 (215)
T ss_pred -------------------------HHHHHHHHHHhhCCcccCcC---HHHHhhCC
Confidence 478999999998 9999998 88888875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=248.38 Aligned_cols=238 Identities=22% Similarity=0.399 Sum_probs=187.3
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEE-EEeecCCeEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY-CSFQDDEFLYL 193 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~-~~~~~~~~l~l 193 (497)
+.|.+.+.||+|.||++.+|+++.++..+++|.+.+... ....|.+|...--.+ .|.||+.-| ..|++.+.+.+
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 569999999999999999999999999999999987643 344577777655444 589999988 56899999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec--CCCcEEEcccccccccCCCCc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~--~~g~vkL~DFGla~~~~~~~~ 271 (497)
+|||+|-|||.+-+.. ..+-|...+.+++|+++||.|+|+.++||||||.+||||- +...|||||||+.+..+...
T Consensus 100 ~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV- 177 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV- 177 (378)
T ss_pred eeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee-
Confidence 9999999999887744 5689999999999999999999999999999999999993 33479999999987653210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CC--CCcchhHHhHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KG--YGMECDWWSLGAI 346 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~--y~~~~DiwSlGvi 346 (497)
. -.--+..|.+||++.. +. ..+.+|+|.||+|
T Consensus 178 -----------------------------~--------------~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi 214 (378)
T KOG1345|consen 178 -----------------------------K--------------YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGII 214 (378)
T ss_pred -----------------------------h--------------hhhhhcccCCcHHHhhccccceEecccccchheeee
Confidence 0 0123556899998763 22 4788999999999
Q ss_pred HHHHHhCCCCCCCCChH-HHHHHHhcccC--cccCCCC-ccCChhHHHHHHHHhh-Ccccc
Q 010947 347 MYEMLVGYPPFYSDDPM-STCRKIVNWRT--HLKFPEE-AKLSIEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~-~~~~~i~~~~~--~~~~p~~-~~~s~~~~dLI~~lL~-dp~~R 402 (497)
+|.+|||.+||...... .-+.+-+.|.. ....|.. ..+|+.+..+.++-|. ++++|
T Consensus 215 ~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 215 FFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred eeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 99999999999854322 22333333322 2234432 4689999999999998 88888
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=297.32 Aligned_cols=227 Identities=13% Similarity=0.167 Sum_probs=154.6
Q ss_pred CC-CceeEEEEEe-------ecCCeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCC
Q 010947 174 DS-NCIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244 (497)
Q Consensus 174 ~h-p~Iv~l~~~~-------~~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp 244 (497)
.| +||++++++| .....++++|||+ +++|.++|.. ...+++.+++.++.||+.||.|||++|||||||||
T Consensus 30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP 108 (793)
T PLN00181 30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP 108 (793)
T ss_pred hHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence 44 5777777777 2335688899988 6799999965 35699999999999999999999999999999999
Q ss_pred CCeeecCCCcEEEcccccccccCCCCc---ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhh-hcccccccccCC
Q 010947 245 DNLLLDKYGHLRLSDFGLCKPLDCSTL---QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQK-NRRMLAYSTVGT 320 (497)
Q Consensus 245 ~NILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~Gt 320 (497)
+||||+..|.+|++|||++........ ...++....... ..+.+... ....... .........+||
T Consensus 109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~---------~~~~~~~~-~~~~~~~~~~~~~~~~~~gt 178 (793)
T PLN00181 109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREE---------ILSERRIE-KLEEVKKQPFPMKQILAMEM 178 (793)
T ss_pred hhEEEcccCcEEEeeccccCcccccccCcccccccccccccc---------cccccchh-hhhccccCCCcccccccCCC
Confidence 999999888888888888865422110 000000000000 00000000 0000000 000001135799
Q ss_pred CcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCC-CccCChhHHHHHHHHhh-C
Q 010947 321 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 321 ~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-d 398 (497)
+.|||||++.+..|+.++|||||||+||||++|.+||.... .....+... .+|. .....+++.+++.+||. +
T Consensus 179 ~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~L~~~ 252 (793)
T PLN00181 179 SWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHR----VLPPQILLNWPKEASFCLWLLHPE 252 (793)
T ss_pred cceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHh----hcChhhhhcCHHHHHHHHHhCCCC
Confidence 99999999999999999999999999999999999976432 122222211 1111 11235577899999999 9
Q ss_pred ccccCCCCCcchhcCCCCccCC
Q 010947 399 VNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 399 p~~R~~~~~~~eil~Hpff~~i 420 (497)
|.+||+ +.||++||||...
T Consensus 253 P~~Rps---~~eil~h~~~~~~ 271 (793)
T PLN00181 253 PSCRPS---MSELLQSEFINEP 271 (793)
T ss_pred hhhCcC---hHHHhhchhhhhh
Confidence 999999 9999999999753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-30 Score=277.58 Aligned_cols=324 Identities=34% Similarity=0.565 Sum_probs=266.0
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
+...++|.+.+-+-+|++|.++.+.-..+|...++|+..+...+...+.+..+.+..++-...+|.++..+..|.....+
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 45778899999999999999999999899999999999988888887788888888888888899999999888778889
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
+|||+|+.||+|...|...++.+++.++.++..+++++++||...++|||++|.|+|+..+||.+++|||.......-..
T Consensus 880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p 959 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP 959 (1205)
T ss_pred chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence 99999999999999999989999999999999999999999999999999999999999999999999996554332111
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
... .. |.+..+..+....... ..+...- ..+ .....+||+.|.+||.+.+...+..+|||++|++++|.+
T Consensus 960 ~~~-~s-g~~~~~~~~~~~~~~~-----~~~l~~~-~~~--~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l 1029 (1205)
T KOG0606|consen 960 TTD-LS-GPSSSGTPRRLSRSER-----RPQLSAD-EAR--RKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVL 1029 (1205)
T ss_pred cCC-cc-cccccCcccccccccc-----ccccccc-hhh--ccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhh
Confidence 000 00 0000000100000000 0000000 001 123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCC-ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhcC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQME 429 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~ 429 (497)
+|.+||....++..+++|.+.. ...|.. ...+.++++++.++|. +|.+|.++.++.++..||||++++|+.+....
T Consensus 1030 ~g~pp~na~tpq~~f~ni~~~~--~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~q~ 1107 (1205)
T KOG0606|consen 1030 TGIPPFNAETPQQIFENILNRD--IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLALQK 1107 (1205)
T ss_pred cCCCCCCCcchhhhhhccccCC--CCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccccc
Confidence 9999999999999999999743 344432 3678999999999999 99999998888899999999999999999999
Q ss_pred CCcccccCCcccccCccc
Q 010947 430 AAFIPEVNDELDTQNFEK 447 (497)
Q Consensus 430 ~p~~p~~~~~~d~~~f~~ 447 (497)
.+|+|...+..|+++|..
T Consensus 1108 ~~~~p~~~s~~dtS~~~~ 1125 (1205)
T KOG0606|consen 1108 AEFVPQPESTQDTSYFES 1125 (1205)
T ss_pred CccCCCCCCCCccchhhc
Confidence 999999999999999975
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-27 Score=231.95 Aligned_cols=261 Identities=39% Similarity=0.605 Sum_probs=206.7
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC-ceeEEEEEeecCCeEEEEEe
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~~~~~~~l~lVmE 196 (497)
|.+...||.|+||.||++.+. ..+|+|.+.+...........+.+|..++..+.|+ +|++++..+......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788899999999999999887 78999999877654444567789999999999988 79999999988888899999
Q ss_pred ecCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-cEEEcccccccccCCCCcc
Q 010947 197 YLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 197 y~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~ 272 (497)
|+.|+++..++.... .+++..+..++.|++.++.|+|+.|++||||||+||+++..+ .++++|||+++.+......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999997776654 799999999999999999999999999999999999999998 7999999999855322110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CCCCcchhHHhHHHHHHH
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~y~~~~DiwSlGvil~e 349 (497)
.... ......+||+.|+|||.+.+ ..++...|+||+|+++++
T Consensus 159 ~~~~-----------------------------------~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~ 203 (384)
T COG0515 159 SSIP-----------------------------------ALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE 203 (384)
T ss_pred cccc-----------------------------------ccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHH
Confidence 0000 01225789999999999987 578999999999999999
Q ss_pred HHhCCCCCCCCCh----HHHHHHHhcccCc-ccCCCCccC----ChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 350 MLVGYPPFYSDDP----MSTCRKIVNWRTH-LKFPEEAKL----SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 350 ll~G~~PF~~~~~----~~~~~~i~~~~~~-~~~p~~~~~----s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+++|..||..... ......+...... ...+..... ...+.+++.+++. +|..|.+ ..+...++|...
T Consensus 204 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~---~~~~~~~~~~~~ 280 (384)
T COG0515 204 LLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS---SSSDLSHDLLAH 280 (384)
T ss_pred HHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCC---HHHHhhchHhhC
Confidence 9999999887763 3444444432222 111111111 2578999999999 9999998 555555655543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-29 Score=226.90 Aligned_cols=161 Identities=21% Similarity=0.236 Sum_probs=130.1
Q ss_pred CchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccccc
Q 010947 201 GDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (497)
Q Consensus 201 g~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (497)
|+|.+++.. ...+++.+++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------- 62 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------- 62 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----------
Confidence 789999976 456999999999999999999999999 999999999999999 9998754311
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCC
Q 010947 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359 (497)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~ 359 (497)
...||+.|+|||++.+..|+.++|||||||++|||++|.+||..
T Consensus 63 ------------------------------------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~ 106 (176)
T smart00750 63 ------------------------------------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNE 106 (176)
T ss_pred ------------------------------------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence 23689999999999999999999999999999999999999976
Q ss_pred CChH-HHHHHHhcccCccc---CCCCccCCh--hHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 360 DDPM-STCRKIVNWRTHLK---FPEEAKLSI--EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 360 ~~~~-~~~~~i~~~~~~~~---~p~~~~~s~--~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
.... .....+........ .+....++. ++++||.+||. +|.+||+ +.+++.|+|+.
T Consensus 107 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~---~~~ll~~~~~~ 169 (176)
T smart00750 107 ERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREA---ANHYLAHCRAL 169 (176)
T ss_pred cchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccC---HHHHHHHHHHH
Confidence 5432 33333332111110 011123444 69999999999 9999999 99999999975
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-29 Score=268.68 Aligned_cols=264 Identities=23% Similarity=0.378 Sum_probs=204.0
Q ss_pred eEEeEeeecCCeEEEEEEEcCCCcEEEEEEeech---hhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS---EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 119 ~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~---~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
....++|.|++|.|+.+......+.++.|..... ......-...+..|.-+-..+.|||++.....+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 3567899999999998888777777777765421 1111111122666777778889999988877777666666669
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||++ ||..++.+.+.++..++..++.|++.||.|+|..||.||||||+|+|++.+|.+||+|||.+..+.......
T Consensus 401 E~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~-- 477 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN-- 477 (601)
T ss_pred hcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchh--
Confidence 99999 999999988899999999999999999999999999999999999999999999999999998764331100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCc-chhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM-ECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~-~~DiwSlGvil~ell~G~ 354 (497)
-......+|+..|+|||++.+..|.+ .+||||.||+++.|++|+
T Consensus 478 -----------------------------------~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 478 -----------------------------------IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred -----------------------------------hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 01233689999999999999999965 799999999999999999
Q ss_pred CCCCCCChHHHH---HHHhcccCcccCC--CCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChh
Q 010947 355 PPFYSDDPMSTC---RKIVNWRTHLKFP--EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 355 ~PF~~~~~~~~~---~~i~~~~~~~~~p--~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
.||......+.. ..-..+.....-| ....++.+.+.+|.+||+ ||.+|.+ +++|++.+||+.|+=.
T Consensus 523 ~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~t---i~~i~~d~W~~~i~~c 594 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRIT---IEQILNDEWIRSIECC 594 (601)
T ss_pred CccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheec---HHHHhhChHhhhcceE
Confidence 999765433221 1111111111111 124578899999999999 9999999 9999999999987633
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=230.75 Aligned_cols=258 Identities=20% Similarity=0.280 Sum_probs=208.1
Q ss_pred HHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCC-----cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEE
Q 010947 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTG-----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181 (497)
Q Consensus 107 ~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~-----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l 181 (497)
+++...+..++++...++-+|.||.||.|.++... +.+-+|.++.. .+.-|+..+..|--++..+.|||+..+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V 352 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSV 352 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccce
Confidence 34555566778999999999999999999765432 23445555432 245577888899999999999999999
Q ss_pred EEEee-cCCeEEEEEeecCCCchhHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC
Q 010947 182 YCSFQ-DDEFLYLIMEYLPGGDMMTLLMRK--------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (497)
Q Consensus 182 ~~~~~-~~~~l~lVmEy~~gg~L~~~l~~~--------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~ 252 (497)
.+++. +....+.++.++.-|+|..+|... ..++-.+...++.|++.|++|||+.|+||.||...|.+||+.
T Consensus 353 ~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 353 LGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ 432 (563)
T ss_pred eEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh
Confidence 88775 455677889999899999999721 347778889999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC
Q 010947 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (497)
Q Consensus 253 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~ 332 (497)
-.+||+|=.|++.+-+..++- .|.+ --....||+||.+.+.
T Consensus 433 LqVkltDsaLSRDLFP~DYhc----LGDn-----------------------------------EnRPvkWMslEal~n~ 473 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHC----LGDN-----------------------------------ENRPVKWMSLEALQNS 473 (563)
T ss_pred eeEEeccchhccccCcccccc----cCCC-----------------------------------CCCcccccCHHHHhhh
Confidence 999999999998764433221 1110 1123469999999999
Q ss_pred CCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcch
Q 010947 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (497)
Q Consensus 333 ~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~e 410 (497)
.|+.++|+|||||+||||+| |+.|+..-++.++...+..+ ..+.-|. +++.++..++--|+. +|++||+ .++
T Consensus 474 ~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG-yRlaQP~--NCPDeLf~vMacCWallpeeRPs---f~Q 547 (563)
T KOG1024|consen 474 HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG-YRLAQPF--NCPDELFTVMACCWALLPEERPS---FSQ 547 (563)
T ss_pred hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc-ceecCCC--CCcHHHHHHHHHHHhcCcccCCC---HHH
Confidence 99999999999999999998 99999999999998887764 4555554 899999999999999 9999999 555
Q ss_pred h
Q 010947 411 I 411 (497)
Q Consensus 411 i 411 (497)
+
T Consensus 548 l 548 (563)
T KOG1024|consen 548 L 548 (563)
T ss_pred H
Confidence 3
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-27 Score=237.61 Aligned_cols=146 Identities=16% Similarity=0.136 Sum_probs=117.7
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcC-CCcEEEEEEeechhh--hchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~-t~~~~AiK~l~k~~~--~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
....++|.+.+.||+|+||+||+|.++. ++..||||++..... ........+.+|+.+|+.++|+||+..+..+
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--- 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--- 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence 3456789999999999999999999876 788889998753211 1223355689999999999999998543322
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEccc-CCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI-KPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDL-Kp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
...|||||||+|++|.. +. ... ...++.+++.||.|||+.||+|||| ||+|||++.++.+||+|||+|+.+.
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 45799999999999963 21 111 1467889999999999999999999 9999999999999999999999764
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-25 Score=223.18 Aligned_cols=211 Identities=26% Similarity=0.361 Sum_probs=169.2
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCC-cEEEEEEeechhhhchhHHHHHHHHHHHHHhcC----CCceeEEEEEe-ecCCe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTG-HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD----SNCIVKLYCSF-QDDEF 190 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~-~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~----hp~Iv~l~~~~-~~~~~ 190 (497)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+.......... .+..|..++..+. .+++..++..+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999987775 67999988764322111 4677888888876 36899999988 58889
Q ss_pred EEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC-----CcEEEcccccc
Q 010947 191 LYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-----GHLRLSDFGLC 263 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~-----g~vkL~DFGla 263 (497)
-|+||+.+ |-+|.++.... +.|+...+..++.|++.+|++||+.|+|||||||+|+++... ..+.|.|||+|
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999998 88999987543 579999999999999999999999999999999999999876 35999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+........... ..+. |.......||..|+++.+..+...+...|+||+
T Consensus 175 r~~~~~~~~~~~-----------------~~~~--------------r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~ 223 (322)
T KOG1164|consen 175 RRFKYVGDSGGN-----------------LRPP--------------RPQKGLFRGTLRYASINVHLGIEQGRRDDLESL 223 (322)
T ss_pred ccccccCCCCcc-----------------cccC--------------CCCccCCCCccccccHHHhCCCccCCchhhhhH
Confidence 943211000000 0000 000113569999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCh
Q 010947 344 GAIMYEMLVGYPPFYSDDP 362 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~ 362 (497)
+.++.|++.|..||.+...
T Consensus 224 ~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 224 FYMLLELLKGSLPWEALEM 242 (322)
T ss_pred HHHHHHHhcCCCCCccccc
Confidence 9999999999999977654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=206.00 Aligned_cols=275 Identities=20% Similarity=0.255 Sum_probs=200.9
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC-CceeEEEEEeecCCeE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFL 191 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~l 191 (497)
+....|.+++.||.|+||.+|+|....+|..||||+-.... .-.++.-|..+...+++ ..|..+..++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45678999999999999999999999999999999865432 11236678888888865 6788888888888899
Q ss_pred EEEEeecCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC---cEEEcccccccccC
Q 010947 192 YLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPLD 267 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g---~vkL~DFGla~~~~ 267 (497)
.|||+++ |-+|.+++. +...|+...+..++-|++.-|+|+|.+++|||||||+|+|+.-+- .+.|+|||||+.+-
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999999 889998875 457899999999999999999999999999999999999997654 48899999999875
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
...... ..|.| +. ....||..|.+--...+...+...|+=|+|.+|
T Consensus 166 d~~t~~-------------------HIpyr----------e~-----r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvL 211 (341)
T KOG1163|consen 166 DIRTRQ-------------------HIPYR----------ED-----RNLTGTARYASINAHLGIEQSRRDDMESVGYVL 211 (341)
T ss_pred cccccc-------------------cCccc----------cC-----Cccceeeeehhhhhhhhhhhhhhhhhhhhccee
Confidence 432110 01111 11 146799999998888777889999999999999
Q ss_pred HHHHhCCCCCCCCC---hHHHHHHHhcccCcccCCC-CccCChhHHHHHHHHhh-CccccCCCCCcch-------hcCCC
Q 010947 348 YEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADE-------IKVHP 415 (497)
Q Consensus 348 ~ell~G~~PF~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~e-------il~Hp 415 (497)
....-|..||.+.. ..+-+++|...+...+... ...++.|..-.+.-|-. --++-|...=..+ -|+|.
T Consensus 212 mYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~ 291 (341)
T KOG1163|consen 212 MYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQ 291 (341)
T ss_pred eeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcccc
Confidence 99999999998853 4566777776333222110 13455565555544432 2222222100111 13444
Q ss_pred CccCCChhhhhh
Q 010947 416 WFDGVDWARIYQ 427 (497)
Q Consensus 416 ff~~i~w~~l~~ 427 (497)
+=--.||..+.+
T Consensus 292 ~d~iyDW~~lkq 303 (341)
T KOG1163|consen 292 YDYIYDWTMLKQ 303 (341)
T ss_pred CCeEeeHHHHHH
Confidence 433468988875
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7e-25 Score=209.10 Aligned_cols=219 Identities=22% Similarity=0.346 Sum_probs=181.9
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l 191 (497)
+..-.|.+.+.||.|+||+.++|...-++++||||.-... ...-.++.|....+.| ..+.|...|++-+...+-
T Consensus 25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk-----S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK-----SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred EecccceeccccccCcceeeecccccccCceEEEEecccc-----CCcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 4456799999999999999999999999999999975332 2233477788888877 569999999999999999
Q ss_pred EEEEeecCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-----cEEEcccccccc
Q 010947 192 YLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-----HLRLSDFGLCKP 265 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-----~vkL~DFGla~~ 265 (497)
.||||++ |-+|.+++. +.+.|+...+..++.|++.-++|+|++.+|+|||||+|+||..-| .|.|+|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9999999 888888875 456799999999999999999999999999999999999997654 489999999998
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
+.......+ .|.| + ..+..||..||+--...+..-+..-|+=|||=
T Consensus 179 YrDp~TkqH-------------------IPYr----------E-----~KSLsGTARYMSINTHlGrEQSRRDDLEaLGH 224 (449)
T KOG1165|consen 179 YRDPKTKQH-------------------IPYR----------E-----HKSLSGTARYMSINTHLGREQSRRDDLEALGH 224 (449)
T ss_pred hcCcccccc-------------------Cccc----------c-----ccccccceeeeEeeccccchhhhhhhHHHhhh
Confidence 754421110 1111 1 12678999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCC---ChHHHHHHHhc
Q 010947 346 IMYEMLVGYPPFYSD---DPMSTCRKIVN 371 (497)
Q Consensus 346 il~ell~G~~PF~~~---~~~~~~~~i~~ 371 (497)
+++..|-|..||.|. +..+-+++|-.
T Consensus 225 vFmYFLRGsLPWQGLKA~tnK~kYeKIGe 253 (449)
T KOG1165|consen 225 VFMYFLRGSLPWQGLKADTNKEKYEKIGE 253 (449)
T ss_pred hhhhhccCCCccccccCcchHHHHHHhcc
Confidence 999999999999874 55677777765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.3e-25 Score=205.07 Aligned_cols=143 Identities=19% Similarity=0.192 Sum_probs=112.5
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhH-----------------------HHHHHHHHHHHHhcCCCc
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-----------------------VEHVRAERNLLAEVDSNC 177 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~-----------------------~~~~~~E~~il~~l~hp~ 177 (497)
...||+|+||.||+|... +|+.||||+++......... ......|..+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 457999999999999986 89999999998653211110 123345999999998777
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HcCCEEEcccCCCCeeecCCCcEE
Q 010947 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI-HKHHYIHRDIKPDNLLLDKYGHLR 256 (497)
Q Consensus 178 Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~~iiHrDLKp~NILl~~~g~vk 256 (497)
+......... ..+|||||++|+++...+.....+++..+..++.|++.+|.+| |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 6433222222 2379999999988776654567899999999999999999999 799999999999999998 48899
Q ss_pred EcccccccccC
Q 010947 257 LSDFGLCKPLD 267 (497)
Q Consensus 257 L~DFGla~~~~ 267 (497)
|+|||+|....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.4e-24 Score=204.68 Aligned_cols=143 Identities=17% Similarity=0.194 Sum_probs=116.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHH------HHHHHHHHHhcCCCceeEEEEEee
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH------VRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~------~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
+...+|.++++||.|+||.||++.. ++..||||++............. +.+|+..+.++.||+|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 3467899999999999999999755 46689999997654333333333 578999999999999999988766
Q ss_pred cC--------CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEc
Q 010947 187 DD--------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (497)
Q Consensus 187 ~~--------~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~ 258 (497)
+. ...+|||||++|.+|.++. .+++. ...+++.+|..||..|++||||||+||+++.+| ++|+
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 43 3578999999999998773 23332 456999999999999999999999999999999 9999
Q ss_pred cccccccc
Q 010947 259 DFGLCKPL 266 (497)
Q Consensus 259 DFGla~~~ 266 (497)
|||.++..
T Consensus 177 Dfg~~~~~ 184 (232)
T PRK10359 177 DLSGKRCT 184 (232)
T ss_pred ECCCcccc
Confidence 99987654
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=197.19 Aligned_cols=144 Identities=19% Similarity=0.162 Sum_probs=114.5
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch-----------------------hHHHHHHHHHHHHHhcCCCc
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR-----------------------GQVEHVRAERNLLAEVDSNC 177 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~-----------------------~~~~~~~~E~~il~~l~hp~ 177 (497)
.+.||+|+||.||+|.+. +|+.||||+++....... ........|...+..+.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 899999999986521100 00223467899999999998
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEE
Q 010947 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLR 256 (497)
Q Consensus 178 Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vk 256 (497)
|.......... .||||||++|+++.........+++..+..++.+++.+|.+||+ .||+||||||+|||++ ++.++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 74433322222 47999999988665443345678899999999999999999999 9999999999999999 89999
Q ss_pred EcccccccccCC
Q 010947 257 LSDFGLCKPLDC 268 (497)
Q Consensus 257 L~DFGla~~~~~ 268 (497)
|+|||+|+.+..
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=192.43 Aligned_cols=203 Identities=19% Similarity=0.226 Sum_probs=145.7
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchh-HHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-QVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~-~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lVm 195 (497)
+.+...||+|+||+|+++.. .+..++.+.+.-....... ....+.+|+++|+++. |++|+.++++ ...|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34567899999999998764 5778888887765543222 1224789999999995 4789999875 3468999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEccc-CCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDI-KPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDL-Kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||+.|.+|...+.. . ...++.|++.+|.++|+.||+|||| ||+|||++.+|+++|+|||+|..........
T Consensus 78 eyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~- 149 (218)
T PRK12274 78 SYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM- 149 (218)
T ss_pred eeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH-
Confidence 99999998654321 1 2357889999999999999999999 7999999999999999999998543211000
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHHHHHHHHh
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvil~ell~ 352 (497)
.--....+.+..+.. ...++.|++|+...- ..--...+|++.|+-+|.++|
T Consensus 150 ---------------------r~L~~rDl~~llk~~------~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~ 202 (218)
T PRK12274 150 ---------------------RLLAREDLRHLLKHK------RMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVT 202 (218)
T ss_pred ---------------------HHHHHHHHHHHHHHH------HhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHh
Confidence 000001111111111 126889999986542 222367899999999999999
Q ss_pred CCCCCCCCC
Q 010947 353 GYPPFYSDD 361 (497)
Q Consensus 353 G~~PF~~~~ 361 (497)
|..|+.+++
T Consensus 203 ~~~~~~~~~ 211 (218)
T PRK12274 203 RRVLHWEDN 211 (218)
T ss_pred ccCCccccC
Confidence 999988765
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.3e-24 Score=206.72 Aligned_cols=275 Identities=25% Similarity=0.333 Sum_probs=187.8
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCC-----------------------------------cEEEEEEeechh
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTG-----------------------------------HVYAMKKLKKSE 153 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~-----------------------------------~~~AiK~l~k~~ 153 (497)
...++..++|++...||+|.-..||.++....| =+.|||.|-.-+
T Consensus 150 ~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~ 229 (598)
T KOG4158|consen 150 IDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFE 229 (598)
T ss_pred hhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccc
Confidence 345688899999999999999999988765421 135666654322
Q ss_pred hhchh--HHHHHHHHH------HH-----------HH-----hcCCCceeEEEEEeecC---------------------
Q 010947 154 MLRRG--QVEHVRAER------NL-----------LA-----EVDSNCIVKLYCSFQDD--------------------- 188 (497)
Q Consensus 154 ~~~~~--~~~~~~~E~------~i-----------l~-----~l~hp~Iv~l~~~~~~~--------------------- 188 (497)
..+.. ..+.+-+|. .. +. ..+|||||+++++|.+.
T Consensus 230 ~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p 309 (598)
T KOG4158|consen 230 HDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYP 309 (598)
T ss_pred cCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecc
Confidence 11110 111122221 00 11 13699999999988654
Q ss_pred ------CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec--CCC--cEEEc
Q 010947 189 ------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYG--HLRLS 258 (497)
Q Consensus 189 ------~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~--~~g--~vkL~ 258 (497)
..+|+||.-++ -+|+.+|.. ...+....+.+++|++.|+.|||++||.|||||.+|||+. .++ .+.|+
T Consensus 310 ~g~g~~~tlylvMkrY~-~tLr~yl~~-~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVva 387 (598)
T KOG4158|consen 310 SGAGEPKTLYLVMKRYR-QTLREYLWT-RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVA 387 (598)
T ss_pred cccCCCceEEEehhcch-hhHHHHHhc-CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEc
Confidence 35899999884 589999854 5577788889999999999999999999999999999994 333 47899
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC--C--
Q 010947 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--Y-- 334 (497)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--y-- 334 (497)
|||.|---+.....- +... | .-+.-|.-.-||||+....+ .
T Consensus 388 DFGCcLAd~~hGlql------------------py~S----------~-------~Vd~GGNa~lmAPEi~ta~PGp~av 432 (598)
T KOG4158|consen 388 DFGCCLADDNHGLQL------------------PYES----------D-------EVDLGGNAKLMAPEIATAVPGPNAV 432 (598)
T ss_pred ccceeeecccccccc------------------cccc----------c-------cccCCCcceecchhhhhcCCCCcee
Confidence 999875322111100 0000 0 01345788899999987422 1
Q ss_pred --CcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 335 --GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 335 --~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
-.++|.|+.|.+.||++....||++....-.-.+-.....-..+|+ .+++.+++|+..+|+ ||++|++..-|..+
T Consensus 433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~--~vpp~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPS--RVPPVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred eccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcc--cCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence 2478999999999999999999998543322111111112233443 799999999999999 99999997667777
Q ss_pred cCCCCccCCCh
Q 010947 412 KVHPWFDGVDW 422 (497)
Q Consensus 412 l~Hpff~~i~w 422 (497)
++-..|..-+|
T Consensus 511 l~LsLw~~~~~ 521 (598)
T KOG4158|consen 511 LNLSLWRMGED 521 (598)
T ss_pred HHHHHhcCchH
Confidence 76555554444
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.7e-23 Score=199.00 Aligned_cols=232 Identities=24% Similarity=0.324 Sum_probs=151.0
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC-----------CceeEEEE---
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-----------NCIVKLYC--- 183 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-----------p~Iv~l~~--- 183 (497)
+.....||.|+++.||.|++..||+.+|+|++...........+.+++|.-....+.+ ..++.+--
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 5567899999999999999999999999999876654445566777776654444322 12222110
Q ss_pred -----EeecC---C-----eEEEEEeecCCCchhHHHH---hcCCC---CHHHHH-HHHHHHHHHHHHHHcCCEEEcccC
Q 010947 184 -----SFQDD---E-----FLYLIMEYLPGGDMMTLLM---RKDTL---TEDEAR-FYVAETVLAIESIHKHHYIHRDIK 243 (497)
Q Consensus 184 -----~~~~~---~-----~l~lVmEy~~gg~L~~~l~---~~~~l---~e~~~~-~~~~qi~~aL~~LH~~~iiHrDLK 243 (497)
++... . +.+++|+-+ -+||..++. ..... ....++ .+..|++..+.+||..|+||+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 11111 1 347888887 568877753 22222 122333 344899999999999999999999
Q ss_pred CCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcc
Q 010947 244 PDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323 (497)
Q Consensus 244 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y 323 (497)
|+|++++.+|.++|+||+.....+.. ......+..|
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~--------------------------------------------~~~~~~~~~~ 208 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTR--------------------------------------------YRCSEFPVAF 208 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEE--------------------------------------------EEGGGS-TTT
T ss_pred eeeEEEcCCCCEEEcChHHHeecCce--------------------------------------------eeccCCCccc
Confidence 99999999999999999987654311 0012345779
Q ss_pred cCcccccc--------CCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHH
Q 010947 324 IAPEVLLK--------KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKL 395 (497)
Q Consensus 324 ~aPE~l~~--------~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~l 395 (497)
.+||.... -.++.+.|.|+||+++|.|.+|..||....+...... .|.....++..+++||..|
T Consensus 209 ~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~--------~f~~C~~~Pe~v~~LI~~l 280 (288)
T PF14531_consen 209 TPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW--------DFSRCRDMPEPVQFLIRGL 280 (288)
T ss_dssp S-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG--------GGTTSS---HHHHHHHHHH
T ss_pred CChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc--------cchhcCCcCHHHHHHHHHH
Confidence 99998754 2478999999999999999999999986543322111 2222236788999999999
Q ss_pred hh-Ccccc
Q 010947 396 LC-NVNQR 402 (497)
Q Consensus 396 L~-dp~~R 402 (497)
|. +|.+|
T Consensus 281 L~~~~~~R 288 (288)
T PF14531_consen 281 LQRNPEDR 288 (288)
T ss_dssp T-SSGGGS
T ss_pred ccCCcccC
Confidence 99 99987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-24 Score=231.78 Aligned_cols=243 Identities=23% Similarity=0.337 Sum_probs=182.8
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechh-hhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE-MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~-~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
+|...+.||.+.|=+|.+|++.. | .|+||++-+.. ...-.....-..|+. ...++|||.+.+.-+-..++..|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 68888999999999999998754 3 59999997654 222222333333444 66779999999888877888899999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
+|+ ..+|++.|..+.-+..-+.+.|+.|++.||.-+|..||+|+|||.+||||+....+.|+||...|..-....+..+
T Consensus 101 qyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 999 4599999988778899999999999999999999999999999999999999999999999987754332222111
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC-----------CCcchhHHhHH
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-----------YGMECDWWSLG 344 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-----------y~~~~DiwSlG 344 (497)
+++- . -+-..-.+|+|||.+.... .+++.||||+|
T Consensus 180 f~fF-----------F-----------------------DTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G 225 (1431)
T KOG1240|consen 180 FTFF-----------F-----------------------DTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG 225 (1431)
T ss_pred ceEE-----------E-----------------------ecCCceeeecChHhhhccccccccCCcccccChhhhhhhhh
Confidence 1100 0 0001123699999987522 57899999999
Q ss_pred HHHHHHHh-CCCCCCC-----------CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 345 AIMYEMLV-GYPPFYS-----------DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 345 vil~ell~-G~~PF~~-----------~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
|+++||++ |.|||.- .++...+++| -+...+.||..||+ ||.+|++ |++.
T Consensus 226 CViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I--------------ed~~~Rnlil~Mi~rdPs~RlS---Aedy 288 (1431)
T KOG1240|consen 226 CVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI--------------EDVSLRNLILSMIQRDPSKRLS---AEDY 288 (1431)
T ss_pred HHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC--------------cCccHHHHHHHHHccCchhccC---HHHH
Confidence 99999998 7999841 1122222222 12368999999999 9999999 8888
Q ss_pred cCC
Q 010947 412 KVH 414 (497)
Q Consensus 412 l~H 414 (497)
|+-
T Consensus 289 L~~ 291 (1431)
T KOG1240|consen 289 LQK 291 (1431)
T ss_pred HHh
Confidence 764
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.8e-22 Score=186.14 Aligned_cols=137 Identities=15% Similarity=0.227 Sum_probs=109.3
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-----CCCceeEEEEEeecCC---eE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-----DSNCIVKLYCSFQDDE---FL 191 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-----~hp~Iv~l~~~~~~~~---~l 191 (497)
-.+.||+|+||.||. +..++.. +||++.... ....+.+.+|+.+++.+ +||||+++|+++.++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 356899999999995 6666655 699987643 22345689999999999 6799999999999874 44
Q ss_pred E-EEEee--cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHcCCEEEcccCCCCeeecCC----CcEEEcccccc
Q 010947 192 Y-LIMEY--LPGGDMMTLLMRKDTLTEDEARFYVAETVLAI-ESIHKHHYIHRDIKPDNLLLDKY----GHLRLSDFGLC 263 (497)
Q Consensus 192 ~-lVmEy--~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL-~~LH~~~iiHrDLKp~NILl~~~----g~vkL~DFGla 263 (497)
+ +|||| +++|+|.+++.+ ..+++. ..++.+++.++ +|||+++||||||||+|||++.. +.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 558999999965 457666 35688888888 99999999999999999999743 47999995544
Q ss_pred cc
Q 010947 264 KP 265 (497)
Q Consensus 264 ~~ 265 (497)
+.
T Consensus 157 ~~ 158 (210)
T PRK10345 157 ST 158 (210)
T ss_pred cc
Confidence 43
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-22 Score=183.77 Aligned_cols=239 Identities=18% Similarity=0.258 Sum_probs=192.8
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+...+..++..|.....|+.|+|++. |..++.|+++..+... .....|..|.-.|+-..||||+.+++.|+...++.
T Consensus 187 id~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~-risrdfneefp~lrifshpnilpvlgacnsppnlv 263 (448)
T KOG0195|consen 187 IDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTA-RISRDFNEEFPALRIFSHPNILPVLGACNSPPNLV 263 (448)
T ss_pred cchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhhcch-hhcchhhhhCcceeeecCCchhhhhhhccCCCCce
Confidence 34455667788999999999999876 5577888887655432 23345888888899999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcC-CEEE-cccCCCCeeecCCCcEEEc--cccccccc
Q 010947 193 LIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKH-HYIH-RDIKPDNLLLDKYGHLRLS--DFGLCKPL 266 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~-~iiH-rDLKp~NILl~~~g~vkL~--DFGla~~~ 266 (497)
++..|||-|+|+.+|.... ..+..++..++.+++.|+.|||+. .+|- --|....++||++.+.+|+ |--++..-
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe 343 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE 343 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec
Confidence 9999999999999997654 367789999999999999999997 3444 3588889999998877764 22221100
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC---CcchhHHhH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY---GMECDWWSL 343 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y---~~~~DiwSl 343 (497)
....-.|.||+||.+...+- -.++|+|||
T Consensus 344 ------------------------------------------------~gr~y~pawmspealqrkped~n~raadmwsf 375 (448)
T KOG0195|consen 344 ------------------------------------------------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSF 375 (448)
T ss_pred ------------------------------------------------cccccCcccCCHHHHhcCchhcchhhhhHHHH
Confidence 01234689999999987654 458999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
.+++||+.|...||...++.+.-.+|.-..-...+|+ .+|+....|+.-|+. ||.+||.
T Consensus 376 aillwel~trevpfadlspmecgmkialeglrv~ipp--gis~hm~klm~icmnedpgkrpk 435 (448)
T KOG0195|consen 376 AILLWELNTREVPFADLSPMECGMKIALEGLRVHIPP--GISRHMNKLMNICMNEDPGKRPK 435 (448)
T ss_pred HHHHHHhhccccccccCCchhhhhhhhhccccccCCC--CccHHHHHHHHHHhcCCCCcCCC
Confidence 9999999999999999999998888876555566775 899999999999999 9999998
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=183.71 Aligned_cols=146 Identities=16% Similarity=0.132 Sum_probs=116.7
Q ss_pred CeeEEeEeeecCCeEEEEEE-EcCCCcEEEEEEeechhhhc-------------------hh--HHHHHHHHHHHHHhcC
Q 010947 117 DFELLTMIGKGAFGEVRVCR-EKTTGHVYAMKKLKKSEMLR-------------------RG--QVEHVRAERNLLAEVD 174 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~-~~~t~~~~AiK~l~k~~~~~-------------------~~--~~~~~~~E~~il~~l~ 174 (497)
.|.+.+.||+|+||.||+|. +..+|..||||+++...... .. ....+..|..++..+.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999998 67789999999997542110 00 1123568999999997
Q ss_pred CCc--eeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC-EEEcccCCCCeeecC
Q 010947 175 SNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH-YIHRDIKPDNLLLDK 251 (497)
Q Consensus 175 hp~--Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~-iiHrDLKp~NILl~~ 251 (497)
+.+ +.+++.. ...||||||++|++|...+.....+....+..++.|++.+|.+||+.| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 533 4455542 234799999999888776545566777788899999999999999999 99999999999999
Q ss_pred CCcEEEcccccccccC
Q 010947 252 YGHLRLSDFGLCKPLD 267 (497)
Q Consensus 252 ~g~vkL~DFGla~~~~ 267 (497)
++.++|+|||+|....
T Consensus 184 ~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 184 DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCCEEEEEChhhhccC
Confidence 8899999999998654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=178.54 Aligned_cols=137 Identities=23% Similarity=0.297 Sum_probs=113.9
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhh-----hchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-----LRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~-----~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+.||+|++|.||+|.. +|..+++|+...... ........+.+|..++..+.|++|+....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999986 677899998654321 111223457889999999999988776666667778899999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
|++|++|.+++..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||++..
T Consensus 80 ~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999865332 7788999999999999999999999999999999 78999999999874
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.8e-21 Score=209.36 Aligned_cols=199 Identities=23% Similarity=0.328 Sum_probs=157.8
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC---CCceeEEEEEeec
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLYCSFQD 187 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~ 187 (497)
.++....|.|-+.||+|+||+||+|.... |+.||+|+=+...... |.-=..++.+|+ -+.|..+..++.-
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~ 765 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVF 765 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence 34667889999999999999999999877 9999999977654322 111222333343 2445555555555
Q ss_pred CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-------CCcEEEccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------YGHLRLSDF 260 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-------~g~vkL~DF 260 (497)
.+.-+||+||.+.|+|.+++...+.+++..+.+++.|++.-|++||..+|||+||||+|+||.. .--++|+||
T Consensus 766 ~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 766 QNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred CCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEec
Confidence 5667799999999999999998889999999999999999999999999999999999999953 235899999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhH
Q 010947 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (497)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~Di 340 (497)
|-|-.+..-... ......++|-.+--+|+..+.++++.+|.
T Consensus 846 G~siDm~lfp~~---------------------------------------~~F~~~~~td~f~C~EM~~grpWtYq~Dy 886 (974)
T KOG1166|consen 846 GRSIDMKLFPDG---------------------------------------TKFKAVWHTDLFDCIEMREGRPWTYQIDY 886 (974)
T ss_pred ccceeeeEcCCC---------------------------------------cEEeeeeccccchhHHHhcCCCCchhhhh
Confidence 988654321000 01225678899999999999999999999
Q ss_pred HhHHHHHHHHHhCCC
Q 010947 341 WSLGAIMYEMLVGYP 355 (497)
Q Consensus 341 wSlGvil~ell~G~~ 355 (497)
|.|..+++-||+|+.
T Consensus 887 fGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 887 FGLAATVHVMLFGKY 901 (974)
T ss_pred HHHHHHHHHHHHHHH
Confidence 999999999999864
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.2e-22 Score=213.98 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=210.2
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEc-CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~-~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~ 192 (497)
...|.+.+.||+|+|+.|-++... .+...+|+|.+.... .......++..|..+-..+. |+|++.+++...+.+..+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 456889999999999999988763 345567888776543 23444566777888888876 999999999999999999
Q ss_pred EEEeecCCCchhHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-cCCEEEcccCCCCeeecCCC-cEEEcccccccccCC
Q 010947 193 LIMEYLPGGDMMTLL-MRKD-TLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDC 268 (497)
Q Consensus 193 lVmEy~~gg~L~~~l-~~~~-~l~e~~~~~~~~qi~~aL~~LH-~~~iiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~ 268 (497)
++++|..||++...+ .... ..+...+.+++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..+..
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999988 5544 6888999999999999999999 99999999999999999999 999999999987643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccC-CCcccCccccccCC-CCcchhHHhHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG-TPDYIAPEVLLKKG-YGMECDWWSLGAI 346 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G-t~~Y~aPE~l~~~~-y~~~~DiwSlGvi 346 (497)
.. .........+| ++.|+|||...+.. .+...|+||.|++
T Consensus 178 ~~--------------------------------------g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~ 219 (601)
T KOG0590|consen 178 KN--------------------------------------GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIV 219 (601)
T ss_pred cC--------------------------------------CcceeeecccCCCCCCCCcccccchhhcCCCccccccccc
Confidence 10 00011235688 99999999999854 4789999999999
Q ss_pred HHHHHhCCCCCCCCChHHH-HHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 347 MYEMLVGYPPFYSDDPMST-CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~~~-~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+.-|++|..|+........ +.........+.......++..+.+++.++|. +|..|.+ .+++..+||+..
T Consensus 220 l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s---~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 220 LSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLS---IEELKLDNWLSS 291 (601)
T ss_pred ccccccCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccc---cccccccccccc
Confidence 9999999999875443321 11112211222233346789999999999998 9999998 999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.3e-20 Score=171.65 Aligned_cols=134 Identities=22% Similarity=0.269 Sum_probs=107.1
Q ss_pred EeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----chhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
.||+|+||.||+|. .+|..+++|+....... ......++.+|+.++..+.|+++.....++.+....++||||
T Consensus 1 ~ig~G~~~~vy~~~--~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGD--FLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEee--cCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 48999999999998 46788999986543211 112346678899999999887654444444456667899999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 198 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
++|++|.+++..... .++.+++.+|.+||+.|++|||++|+|||++ ++.++++|||+++..
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988754321 7889999999999999999999999999999 899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-19 Score=169.13 Aligned_cols=140 Identities=20% Similarity=0.177 Sum_probs=109.7
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch-------------------hHHHHHHHHHHHHHhcCCC--
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR-------------------GQVEHVRAERNLLAEVDSN-- 176 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~-------------------~~~~~~~~E~~il~~l~hp-- 176 (497)
|.+.+.||+|+||.||+|... +|+.||||++........ ........|..++..+.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 777899999999999999874 799999999865321000 0112356788889888777
Q ss_pred ceeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEE
Q 010947 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (497)
Q Consensus 177 ~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vk 256 (497)
.++..+. ....++||||++|++|..+... .....++.+++.++.++|+.||+||||||+||+++.++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 4444443 2345899999999998765421 34567889999999999999999999999999999999999
Q ss_pred EcccccccccCC
Q 010947 257 LSDFGLCKPLDC 268 (497)
Q Consensus 257 L~DFGla~~~~~ 268 (497)
|+|||+|.....
T Consensus 166 liDfg~~~~~~~ 177 (198)
T cd05144 166 IIDWPQMVSTDH 177 (198)
T ss_pred EEECCccccCCC
Confidence 999999976643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.5e-19 Score=188.41 Aligned_cols=138 Identities=25% Similarity=0.273 Sum_probs=111.7
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechh-----hhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE-----MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~-----~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
|...+.||+|+||+||+|.... ..+++|+..... .......+.+.+|+.++..++|++|+....++.+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 4557899999999999987643 345555432211 111123456889999999999999988777777777789
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
+||||++|++|.+++. ....++.+++.+|.+||+.||+||||||+|||+ .++.++|+|||+|+..
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999999885 356789999999999999999999999999999 6789999999999864
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.9e-19 Score=163.32 Aligned_cols=140 Identities=16% Similarity=0.204 Sum_probs=101.0
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHH---------------------HHHHHHHHHHhcCCCc--
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE---------------------HVRAERNLLAEVDSNC-- 177 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~---------------------~~~~E~~il~~l~hp~-- 177 (497)
.+.||+|+||.||+|.+. +|+.||||++............ ....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999876 8899999998764321111111 1135666666664433
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEE
Q 010947 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLR 256 (497)
Q Consensus 178 Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vk 256 (497)
+.+.++. ...++||||++|+.+........... ..++.++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~ 154 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY 154 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence 4444443 23589999999965432211111111 6788999999999999999 9999999999999999 89999
Q ss_pred EcccccccccC
Q 010947 257 LSDFGLCKPLD 267 (497)
Q Consensus 257 L~DFGla~~~~ 267 (497)
|+|||.|....
T Consensus 155 liDfg~a~~~~ 165 (187)
T cd05119 155 IIDVPQAVEID 165 (187)
T ss_pred EEECccccccc
Confidence 99999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-19 Score=182.43 Aligned_cols=181 Identities=27% Similarity=0.382 Sum_probs=135.2
Q ss_pred CeEEEEEeecCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
.++||.|++|.-.+|.++|.++. ..+......++.|+..|++| +|.+|||+||.||.+..+..+||.|||+...
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts 405 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS 405 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence 36899999999999999997543 35667888899999999999 9999999999999999999999999999876
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
...... ..+.... ...-+||..||+||.+.+..|+.++||||||+
T Consensus 406 ~~~~~~------------------~~~~~a~-----------------~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGl 450 (516)
T KOG1033|consen 406 QDKDET------------------VAPAAAS-----------------HTQQVGTLLYMSPEQIRGQQYSEKVDIYALGL 450 (516)
T ss_pred cccCCc------------------ccchhhh-----------------hhhcccccccCCHHHHhhhhhhhhcchhhHHH
Confidence 543210 0011111 11458999999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCC-ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 346 il~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
||+|+++ -..+|... .+..-|- ...+|+. ..=-++..+|+.+||. .|.+||+ +.+.-.|+|.
T Consensus 451 il~EL~~~f~T~~er~---~t~~d~r----~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~---~~~~~~~~~~ 515 (516)
T KOG1033|consen 451 ILAELLIQFSTQFERI---ATLTDIR----DGIIPPEFLQDYPEEYTLLQQLLSPSPEERPS---AIEVALHEFL 515 (516)
T ss_pred HHHHHHHHhccHHHHH---Hhhhhhh----cCCCChHHhhcCcHHHHHHHHhcCCCcccCch---HHHHhhhhhc
Confidence 9999998 33443221 1222222 2234421 1223466799999999 9999996 6666666664
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=156.56 Aligned_cols=138 Identities=20% Similarity=0.295 Sum_probs=105.7
Q ss_pred eEee-ecCCeEEEEEEEcCCCcEEEEEEeechhhh----------chhHHHHHHHHHHHHHhcCCCce--eEEEEEeecC
Q 010947 122 TMIG-KGAFGEVRVCREKTTGHVYAMKKLKKSEML----------RRGQVEHVRAERNLLAEVDSNCI--VKLYCSFQDD 188 (497)
Q Consensus 122 ~~IG-~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~----------~~~~~~~~~~E~~il~~l~hp~I--v~l~~~~~~~ 188 (497)
.+|| .||.|+||.+... +..++||.+....+. .......+.+|..++..+.|++| +..++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3677 7888888887653 678999988653321 11233567889999999998775 5666554332
Q ss_pred -Ce---EEEEEeecCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 189 -EF---LYLIMEYLPG-GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 189 -~~---l~lVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
.. .++||||++| .+|.+++.. ..+++.. +.+++.+|.+||+.||+||||||+|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 2599999998 688888754 4566654 568999999999999999999999999999999999999998
Q ss_pred ccc
Q 010947 264 KPL 266 (497)
Q Consensus 264 ~~~ 266 (497)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=7e-17 Score=142.59 Aligned_cols=133 Identities=20% Similarity=0.273 Sum_probs=113.2
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC--CceeEEEEEeecCCeEEEEEee
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~l~lVmEy 197 (497)
+++.||.|+++.||++.... ..+++|....... ...+..|..++..+.| +++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999998753 6899999865432 3468889999999976 5899999988888889999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC---CEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH---HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 198 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
++|+.+..+ +......++.+++.+|.+||.. +++|+||+|+|||++..+.++++|||++...
T Consensus 75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 999877654 5566777889999999999985 7999999999999999999999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.2e-17 Score=168.24 Aligned_cols=197 Identities=23% Similarity=0.264 Sum_probs=152.1
Q ss_pred HHhcCCCceeEEEEEeecCCeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCE-EEcccCCCCe
Q 010947 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHY-IHRDIKPDNL 247 (497)
Q Consensus 170 l~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~i-iHrDLKp~NI 247 (497)
|+.+.|.|+.++++.+.+...++.|.+||.-|+|.+.+.. .-.++......++.+|+.||.|||...| .|+.|++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3568899999999999999999999999999999999977 3468888888999999999999998765 9999999999
Q ss_pred eecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcc
Q 010947 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (497)
Q Consensus 248 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 327 (497)
+++....+||+|||+.......... .. .....-..-|.|||
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~--------------------~~-------------------~~~~~~~~lw~aPe 121 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEP--------------------EA-------------------HHPIRKALLWTAPE 121 (484)
T ss_pred eeeeeEEEEechhhhcccccccccc--------------------cc-------------------cchhHHHHhccCHH
Confidence 9999999999999997654310000 00 00011234589999
Q ss_pred ccccCC-------CCcchhHHhHHHHHHHHHhCCCCCCCC----ChHHHHHHHhcccCcccCCC---CccCChhHHHHHH
Q 010947 328 VLLKKG-------YGMECDWWSLGAIMYEMLVGYPPFYSD----DPMSTCRKIVNWRTHLKFPE---EAKLSIEAKDLIS 393 (497)
Q Consensus 328 ~l~~~~-------y~~~~DiwSlGvil~ell~G~~PF~~~----~~~~~~~~i~~~~~~~~~p~---~~~~s~~~~dLI~ 393 (497)
.+.... -+.+.|+||+|++++|+++..-||... ++.+...++.+.......|. ...+.+++..++.
T Consensus 122 llr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~ 201 (484)
T KOG1023|consen 122 LLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVA 201 (484)
T ss_pred HhcccccccccccccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHH
Confidence 998632 367799999999999999999999763 23345555554222222332 1245667999999
Q ss_pred HHhh-CccccCCC
Q 010947 394 KLLC-NVNQRLGA 405 (497)
Q Consensus 394 ~lL~-dp~~R~~~ 405 (497)
+|+. +|..||+.
T Consensus 202 ~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 202 RCWEEIPEKRPSI 214 (484)
T ss_pred HhcccChhhCccH
Confidence 9999 99999994
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.8e-16 Score=162.68 Aligned_cols=145 Identities=19% Similarity=0.326 Sum_probs=98.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--------------------------c-----hhHHHHHH
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--------------------------R-----RGQVEHVR 164 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~--------------------------~-----~~~~~~~~ 164 (497)
.+|+. +.||.|++|.||.|+.+.+|+.||||++++.... + ....+.+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 7899999999999999988999999999754100 0 01122344
Q ss_pred HHHHHHHhc----------CCCceeEEEEEeec-CCeEEEEEeecCCCchhHH--HHhcC----CCCHHHHHHHHHHHHH
Q 010947 165 AERNLLAEV----------DSNCIVKLYCSFQD-DEFLYLIMEYLPGGDMMTL--LMRKD----TLTEDEARFYVAETVL 227 (497)
Q Consensus 165 ~E~~il~~l----------~hp~Iv~l~~~~~~-~~~l~lVmEy~~gg~L~~~--l~~~~----~l~e~~~~~~~~qi~~ 227 (497)
.|+++.... .+...+.+-.++.+ ...-+|||||+.|+++.++ +...+ .+.+..+..++.|++
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 455444333 12222222222221 2345699999999999764 33333 255555556666654
Q ss_pred HHHHHHcCCEEEcccCCCCeeecCCC----cEEEcccccccccCC
Q 010947 228 AIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDC 268 (497)
Q Consensus 228 aL~~LH~~~iiHrDLKp~NILl~~~g----~vkL~DFGla~~~~~ 268 (497)
..|++|+|+||.||+++.+| .++++|||++..++.
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 58999999999999999988 999999999987743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.6e-15 Score=155.18 Aligned_cols=263 Identities=19% Similarity=0.218 Sum_probs=194.1
Q ss_pred CCeeEEeEeee--cCCeEEEEEEE--cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCe
Q 010947 116 DDFELLTMIGK--GAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 116 ~~f~~~~~IG~--G~fG~V~~~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 190 (497)
..|.+.+.+|. |.+|.||.+.. ..++..+|+|.-+... .....-.+=.+|..-...+ .|++.|+.+..+...+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCc
Confidence 45777889999 99999999998 8899999999843321 1111222233455555555 48999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHcCCEEEcccCCCCeeecCC-CcEEEccccccc
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVL----AIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCK 264 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~----aL~~LH~~~iiHrDLKp~NILl~~~-g~vkL~DFGla~ 264 (497)
+|+-+|+| |.+|..+...... +++..+..+..+... ||.++|..+++|-|+||+||++..+ ...+++|||+..
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred ceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeE
Confidence 99999999 6788888766554 888889999999998 9999999999999999999999999 789999999999
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlG 344 (497)
.+.......... .....-|..-|++||.. +.-++...|++|||
T Consensus 272 ~i~~~~~~~~~~------------------------------------~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ 314 (524)
T KOG0601|consen 272 KISDGNFSSVFK------------------------------------VSKRPEGDCIYAAKELL-NGLATFASDIFSLG 314 (524)
T ss_pred EccCCcccccee------------------------------------eeecCCCCceEeChhhh-ccccchHhhhcchh
Confidence 886554321100 00123577789999987 57789999999999
Q ss_pred HHHHHHHhCCCCCCCC-Ch-HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 345 AIMYEMLVGYPPFYSD-DP-MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 345 vil~ell~G~~PF~~~-~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
.++.+-.+|..++... +. -...++.. .+..+- ...+.++...+..|+. +|..|++ +..+++|++.+...
T Consensus 315 ev~l~~~l~~~~~~~g~~~~W~~~r~~~---ip~e~~--~~~s~~l~~~~~~~~d~~~~~~~~---~q~~~~l~~i~s~~ 386 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNSSWSQLRQGY---IPLEFC--EGGSSSLRSVTSQMLDEDPRLRLT---AQILTALNVIHSKL 386 (524)
T ss_pred hhhHhhHhhcccccCCCCCCcccccccc---Cchhhh--cCcchhhhhHHHHhcCcchhhhhH---HHHHhccccccchh
Confidence 9999998887665432 11 11111111 111121 2456677778888888 8889988 88899999998655
Q ss_pred hhhh
Q 010947 422 WARI 425 (497)
Q Consensus 422 w~~l 425 (497)
.-++
T Consensus 387 ~~~~ 390 (524)
T KOG0601|consen 387 FVHL 390 (524)
T ss_pred hhcc
Confidence 4444
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.9e-14 Score=148.82 Aligned_cols=140 Identities=18% Similarity=0.262 Sum_probs=95.3
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh---ch------------------------h----HHH------HHH
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RR------------------------G----QVE------HVR 164 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~---~~------------------------~----~~~------~~~ 164 (497)
+.||.|++|.||+|+.+ +|+.||||+.+..... .. . -.. .+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 57999999999999875 7899999998653100 00 0 000 133
Q ss_pred HHHHHHHhc----C-CCce--eEEEEEeecCCeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHcC
Q 010947 165 AERNLLAEV----D-SNCI--VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVL-AIESIHKH 235 (497)
Q Consensus 165 ~E~~il~~l----~-hp~I--v~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~-aL~~LH~~ 235 (497)
.|...+..+ . +++| .++|..+ ....+|||||++|++|.+++... ...+ ...++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 444444443 2 3432 2333222 23457999999999998876432 1222 2334444544 47789999
Q ss_pred CEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 236 ~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
|++|+|+||.||+++.+|.++|+|||++..++
T Consensus 277 g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998775
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.49 E-value=9.6e-14 Score=126.06 Aligned_cols=128 Identities=20% Similarity=0.228 Sum_probs=96.0
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCce-eEEEEEeecCCeEEEEEeecC
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI-VKLYCSFQDDEFLYLIMEYLP 199 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~l~lVmEy~~ 199 (497)
++.|+.|.++.||+++.. +..|++|+...... ....+..|..++..+.+..+ .++++... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999998864 77899999765421 11235678888888765444 44555433 23579999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCE-----EEcccCCCCeeecCCCcEEEcccccccc
Q 010947 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY-----IHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 200 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~i-----iHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
|.++... ......++.+++.+|..||..++ +|+|++|.||+++ ++.++++|||.|..
T Consensus 75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 9887643 11123456889999999999884 9999999999999 67899999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.47 E-value=6.7e-13 Score=122.81 Aligned_cols=141 Identities=13% Similarity=0.150 Sum_probs=102.9
Q ss_pred eEeeecCCeEEEEEEEcC------CCcEEEEEEeechhh--------h-----------chhHHHH----HHHHHHHHHh
Q 010947 122 TMIGKGAFGEVRVCREKT------TGHVYAMKKLKKSEM--------L-----------RRGQVEH----VRAERNLLAE 172 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~------t~~~~AiK~l~k~~~--------~-----------~~~~~~~----~~~E~~il~~ 172 (497)
..||.|-=+.||.|.... .+..+|||+.+.+.. . +.+.... ...|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999997643 357899999864211 0 1112222 3489999988
Q ss_pred cCC--CceeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HcCCEEEcccCCCCeee
Q 010947 173 VDS--NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI-HKHHYIHRDIKPDNLLL 249 (497)
Q Consensus 173 l~h--p~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L-H~~~iiHrDLKp~NILl 249 (497)
+.. -.+...+.+ ..-+|||||+.++.+..-..+...+++..+..+..+++.+|..| |..||||+||+|.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 743 355555554 34569999997655533222334566677778889999999998 89999999999999999
Q ss_pred cCCCcEEEcccccccccC
Q 010947 250 DKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 250 ~~~g~vkL~DFGla~~~~ 267 (497)
+ +|.+.|+|||.|-..+
T Consensus 159 ~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 159 H-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred E-CCcEEEEECCCceeCC
Confidence 7 4789999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=3.5e-14 Score=146.93 Aligned_cols=251 Identities=24% Similarity=0.264 Sum_probs=184.2
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEc-CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCe
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~-~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 190 (497)
....+|..+..||.|.|+.|+.+..+ .++..|++|.+.+.......++. -..|+-+...+ -|.+++..+..|...+.
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34568999999999999999998866 67789999988765433333332 33455555544 58999999988888888
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC-CcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~ 269 (497)
.|+=.|||.|+++.........+.+...+....|++.|+.++|+..++|+|+||+||++..+ +..+++|||..+.+...
T Consensus 341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee
Confidence 99999999999988776556678899999999999999999999999999999999999986 78899999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCc-c-cCccccccCCCCcchhHHhHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPD-Y-IAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~-Y-~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
.. ...++-. | .+|.......+..+.|++|||.-+
T Consensus 421 ~~--------------------------------------------~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~ 456 (524)
T KOG0601|consen 421 SG--------------------------------------------VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSV 456 (524)
T ss_pred cc--------------------------------------------cccccccccccchhhccccccccccccccccccc
Confidence 10 1112223 3 355555567889999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
.+.++|.+--.... ....|.. . ..|.....+.++..+.+.++. ++..|+. +.++..|+=|.
T Consensus 457 ~e~~~~~~ls~~~~---~~~~i~~--~--~~p~~~~~~~~~q~~~kv~~~~~~~~~~l---~~~l~~~~~~~ 518 (524)
T KOG0601|consen 457 DEAITGSPLSESGV---QSLTIRS--G--DTPNLPGLKLQLQVLLKVMINPDRKRRPS---AVELSLHSEFY 518 (524)
T ss_pred cccccCcccCcccc---cceeeec--c--cccCCCchHHhhhhhhhhhcCCccccchh---hhhhcccchhh
Confidence 99999875422211 1112222 1 122222445778888888887 8888877 66666665543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.2e-12 Score=134.85 Aligned_cols=169 Identities=19% Similarity=0.277 Sum_probs=130.2
Q ss_pred EEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCC
Q 010947 134 VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTL 213 (497)
Q Consensus 134 ~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l 213 (497)
.|..+.++.+|.|.+.+.+.- .....+.+-+.-|+.++||||++++..+..+..+|||+|-+. .|..++.. +
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~---l 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE---L 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---h
Confidence 456678899999999876532 344557778888999999999999999999999999999984 56666654 3
Q ss_pred CHHHHHHHHHHHHHHHHHHH-cCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCC
Q 010947 214 TEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292 (497)
Q Consensus 214 ~e~~~~~~~~qi~~aL~~LH-~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 292 (497)
+...+..-+.||+.||.||| ..+++|++|.-+-|+++..|+.||++|.++........
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--------------------- 160 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--------------------- 160 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc---------------------
Confidence 47778888999999999998 67899999999999999999999999998864421110
Q ss_pred CCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
+ +....---.|..|+.+.... -..|.|-|||+++|++.|
T Consensus 161 --~------------------~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 161 --P------------------AKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --c------------------cccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 0 00111122366676554332 567999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.40 E-value=4.1e-13 Score=129.01 Aligned_cols=217 Identities=19% Similarity=0.230 Sum_probs=154.7
Q ss_pred HHHHHHHHHhcCCCceeEEEEEeecCC-----eEEEEEeecCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH
Q 010947 163 VRAERNLLAEVDSNCIVKLYCSFQDDE-----FLYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIH 233 (497)
Q Consensus 163 ~~~E~~il~~l~hp~Iv~l~~~~~~~~-----~l~lVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH 233 (497)
.+.-.+-|-.+.|.|||+++.++.+.. ...++.|||..|+|..+|++. ..+.....+.++-||+.||.|||
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLh 193 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLH 193 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhh
Confidence 334445566778999999998887654 478999999999999999763 45888889999999999999999
Q ss_pred cC--CEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 010947 234 KH--HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311 (497)
Q Consensus 234 ~~--~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (497)
+. .|+|+++..+-|++..+|-+|+.--...... .. .+..+.
T Consensus 194 s~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h-~s------------------------------------~~~~~~ 236 (458)
T KOG1266|consen 194 SCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTH-PS------------------------------------VNSTRE 236 (458)
T ss_pred ccCCccccCCcchhheeecCCceEEecccCccccc-hh------------------------------------hhhhhH
Confidence 86 6999999999999999999988532111000 00 000000
Q ss_pred cccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC-CCCCChHHHHHHHhcccCcccCCCCccCChhHHH
Q 010947 312 MLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP-FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390 (497)
Q Consensus 312 ~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P-F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~d 390 (497)
.-..-..|-++|.|||.=.....+.++|||++|....||..|..- -.+.+..+.-..|.+-...+. ..--++
T Consensus 237 ~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~ 309 (458)
T KOG1266|consen 237 AEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRG 309 (458)
T ss_pred hhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccC
Confidence 000012467889999987767778899999999999999998754 333333222233322101111 123468
Q ss_pred HHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 391 LI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
+|.+||. .|..||+ +.+++.||..-.+.-..+.
T Consensus 310 ~i~kcl~~eP~~rp~---ar~llfHpllfeVhslkll 343 (458)
T KOG1266|consen 310 SITKCLEGEPNGRPD---ARLLLFHPLLFEVHSLKLL 343 (458)
T ss_pred cCcccccCCCCCCcc---hhhhhcCceeeecchHHHH
Confidence 9999999 9999998 9999999999888766654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.7e-11 Score=110.01 Aligned_cols=134 Identities=21% Similarity=0.229 Sum_probs=98.2
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeec-----hhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKK-----SEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k-----~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
..|++|+=+.++.+.+. |..+.+|.=.+ ..+-..--..+..+|..+|+.+.--.|..-+-++.|.....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999988653 44566664222 112122223567789999998865555444444456677779999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
|++|-.|.+.+... ...++..+-.-+.-||..||||+||.++||++..++ +.++||||+..
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99998888888665 244666777778889999999999999999999855 99999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=1.8e-11 Score=115.84 Aligned_cols=141 Identities=16% Similarity=0.242 Sum_probs=106.7
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC--CceeEEEEEeecC---CeEEEEE
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDD---EFLYLIM 195 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~---~~l~lVm 195 (497)
++.||.|.++.||++.... |..|++|+....... .....+..|..++..+.+ ..+.+++.+.... +..|+||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~ 79 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM 79 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence 3578999999999998743 678999998654321 123457889999998865 3456677766553 2668999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK----------------------------------------- 234 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~----------------------------------------- 234 (497)
||++|+++...+.. ..+++.....++.+++.+|..||+
T Consensus 80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 99999888775532 456777777777777777777773
Q ss_pred ---------------CCEEEcccCCCCeeecC--CCcEEEcccccccc
Q 010947 235 ---------------HHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKP 265 (497)
Q Consensus 235 ---------------~~iiHrDLKp~NILl~~--~g~vkL~DFGla~~ 265 (497)
..++|+|++|.|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34699999999999998 67789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=3.3e-10 Score=101.38 Aligned_cols=144 Identities=22% Similarity=0.276 Sum_probs=104.5
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEe-----echhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKL-----KKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l-----~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.+..|-+|+-+.|+.+.+ .|+.+.||.= +-..+...-...+..+|..+|.++.--.|.--.-+|.|...-.|+
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 567889999999998865 5888888742 222222223345688899999888654444333445566677799
Q ss_pred EeecCC-CchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc---EEEcccccccc
Q 010947 195 MEYLPG-GDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKP 265 (497)
Q Consensus 195 mEy~~g-g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~---vkL~DFGla~~ 265 (497)
|||++| .++.+++... ..........++..|-..|.-||..+|||+||..+||++..+|. +.|+|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999987 4677776553 22333333678888889999999999999999999999977663 58999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-09 Score=111.20 Aligned_cols=210 Identities=17% Similarity=0.230 Sum_probs=152.6
Q ss_pred CeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec----CCeEEEEEeecCC-Cch
Q 010947 129 FGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DEFLYLIMEYLPG-GDM 203 (497)
Q Consensus 129 fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~l~lVmEy~~g-g~L 203 (497)
-.+.|+|....+|..|++|+++-......+. ...-++.++++.|+|||++..+|.+ +..++||++|.|+ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk---~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNK---DTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCccc---chHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3578999999999999999996544333322 3345778999999999999988873 4579999999986 567
Q ss_pred hHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 204 MTLLMR---------------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 204 ~~~l~~---------------~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.++... ....+|.....|+.|+..||.++|+.|+.-+-|.|.+||++.+..++|+..|....+..
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 766422 22467899999999999999999999999999999999999998999998887655432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
+. + +-+.+ -..-|.=.||.+++
T Consensus 446 d~------------------------------------------------~-------~~le~---~Qq~D~~~lG~ll~ 467 (655)
T KOG3741|consen 446 DP------------------------------------------------T-------EPLES---QQQNDLRDLGLLLL 467 (655)
T ss_pred CC------------------------------------------------C-------cchhH---HhhhhHHHHHHHHH
Confidence 21 0 00111 12468888999999
Q ss_pred HHHhCCCCCC-CCChHHH-HHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 349 EMLVGYPPFY-SDDPMST-CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 349 ell~G~~PF~-~~~~~~~-~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
-|.||..--. .+..++. ...|. ...|.+++++|.-+.. .+.+ .+ +.+++.|
T Consensus 468 aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~-ks---I~~llp~ 521 (655)
T KOG3741|consen 468 ALATGTENSNRTDSTQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFRE-KS---IQDLLPM 521 (655)
T ss_pred HHhhcccccccccchHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCccc-cc---HHHHHHH
Confidence 9999965422 2222222 22222 2578899999988887 6664 23 6676654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=9.3e-11 Score=123.33 Aligned_cols=169 Identities=20% Similarity=0.304 Sum_probs=121.2
Q ss_pred HHHHHHHHHHcC-CEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHH
Q 010947 224 ETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302 (497)
Q Consensus 224 qi~~aL~~LH~~-~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (497)
+++.||.|+|.. ++||++|.|++|.++.+|..||+.|+++-......-..-. ...+.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~-------------~yd~~--------- 164 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFS-------------EYDPP--------- 164 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccc-------------cCCCC---------
Confidence 444899999975 8999999999999999999999999998654332110000 00000
Q ss_pred HHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH-hCCCCCCCCChHHHHHHHhcccCcccCCCC
Q 010947 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEE 381 (497)
Q Consensus 303 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell-~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~ 381 (497)
+.....-...|.|||++.+...+.++|++||||++|-+. .|+.-|.+.+....+..-.+...--.+-..
T Consensus 165 ----------lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s 234 (700)
T KOG2137|consen 165 ----------LPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS 234 (700)
T ss_pred ----------CChhhccCcccccchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc
Confidence 001224567899999999988899999999999999999 566666665443333332221111122223
Q ss_pred ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhh
Q 010947 382 AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 382 ~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 427 (497)
..+++++++=+.++|. ++.-||+ +.+++.-|||.+..-..|+.
T Consensus 235 ~~~p~el~~~l~k~l~~~~~~rp~---~~~l~~~~ff~D~~~~aLrf 278 (700)
T KOG2137|consen 235 NNLPSELRESLKKLLNGDSAVRPT---LDLLLSIPFFSDPGLKALRF 278 (700)
T ss_pred ccCcHHHHHHHHHHhcCCcccCcc---hhhhhcccccCCchhhhhhh
Confidence 5799999999999998 9999996 88999999999876666553
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-09 Score=99.74 Aligned_cols=129 Identities=22% Similarity=0.250 Sum_probs=83.5
Q ss_pred EEEEEEEcCCCcEEEEEEeechhh-----------------------hchhHHHHHHHHHHHHHhcCCC--ceeEEEEEe
Q 010947 131 EVRVCREKTTGHVYAMKKLKKSEM-----------------------LRRGQVEHVRAERNLLAEVDSN--CIVKLYCSF 185 (497)
Q Consensus 131 ~V~~~~~~~t~~~~AiK~l~k~~~-----------------------~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~~ 185 (497)
.||.|.. ..|..+|||+.+.... .........++|...|..+..- ++.+++.+-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888876 4577999999864210 0011134578899999998765 456665442
Q ss_pred ecCCeEEEEEeecC--CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHcCCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 186 QDDEFLYLIMEYLP--GGDMMTLLMRKDTLTEDEARFYVAETVLAIES-IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 186 ~~~~~l~lVmEy~~--gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~-LH~~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
.-+|||||++ |..+..+. . ..++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~-~-~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLK-D-VDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHH-H-CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHH-h-ccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 2359999998 65554433 2 223355667778888885555 579999999999999999986 999999999
Q ss_pred ccccC
Q 010947 263 CKPLD 267 (497)
Q Consensus 263 a~~~~ 267 (497)
|....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 87543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.00 E-value=5.4e-09 Score=102.03 Aligned_cols=133 Identities=13% Similarity=0.076 Sum_probs=92.2
Q ss_pred EEEEEEEcCCCcEEEEEEeechhhh---ch-----hHHHHHHHHHHHHHhcCCCce--eEEEEEeec-----CCeEEEEE
Q 010947 131 EVRVCREKTTGHVYAMKKLKKSEML---RR-----GQVEHVRAERNLLAEVDSNCI--VKLYCSFQD-----DEFLYLIM 195 (497)
Q Consensus 131 ~V~~~~~~~t~~~~AiK~l~k~~~~---~~-----~~~~~~~~E~~il~~l~hp~I--v~l~~~~~~-----~~~l~lVm 195 (497)
.|..+.. .|+.|.||........ +. .....+.+|...+..+..-.| +.+.+++.. ...-+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3554443 4678999977433211 11 111246788888877632222 222222221 23468999
Q ss_pred eecCCC-chhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-------CCcEEEcccccccc
Q 010947 196 EYLPGG-DMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------YGHLRLSDFGLCKP 265 (497)
Q Consensus 196 Ey~~gg-~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-------~g~vkL~DFGla~~ 265 (497)
|+++|- +|.+++.. ....++.....++.+++..+.-||..||+|+||++.|||++. ++.+.|+||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999886 78888753 345677788899999999999999999999999999999985 46799999998853
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=2.8e-08 Score=93.49 Aligned_cols=127 Identities=22% Similarity=0.245 Sum_probs=90.7
Q ss_pred CCcEEEEEEeechh----hhchhHHHHHHHHHHHHHhcCCCc--eeEEEEEeecC----CeEEEEEeecCCC-chhHHHH
Q 010947 140 TGHVYAMKKLKKSE----MLRRGQVEHVRAERNLLAEVDSNC--IVKLYCSFQDD----EFLYLIMEYLPGG-DMMTLLM 208 (497)
Q Consensus 140 t~~~~AiK~l~k~~----~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~~~----~~l~lVmEy~~gg-~L~~~l~ 208 (497)
.++.|-+|.+...- ...........+|...+..+..-. ++..+++.... ...+||+|+++|. +|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 35566666543221 111122345677887776664322 23333333221 2458999999985 7999987
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC---cEEEccccccccc
Q 010947 209 RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPL 266 (497)
Q Consensus 209 ~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g---~vkL~DFGla~~~ 266 (497)
....++......++.+++..+.-||..||+|+|++|.|||++.++ .+.|+||+-++..
T Consensus 111 ~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 755578888899999999999999999999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.80 E-value=3.6e-08 Score=98.40 Aligned_cols=233 Identities=15% Similarity=0.167 Sum_probs=150.9
Q ss_pred eEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeE--------EEEEeecCC
Q 010947 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVK--------LYCSFQDDE 189 (497)
Q Consensus 119 ~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~--------l~~~~~~~~ 189 (497)
...+.||+|+-+.+|-.-.- + ..+-|++++..... ...-+..|... +||-+-. |++.- ...
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~-d~VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~-~~~ 83 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--R-DQVAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGGR-RGK 83 (637)
T ss_pred CCCccccCCccceeeecchh--h-chhheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCCC-ccc
Confidence 34568999999999954322 2 23558887654211 11233344433 5664332 22211 122
Q ss_pred eEEEEEeecCCCc-hhHHH---H---hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 190 FLYLIMEYLPGGD-MMTLL---M---RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 190 ~l~lVmEy~~gg~-L~~~l---~---~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
..-++|..++|-. ...++ . +...+.+..+...+.+++.|..-||..|.+-+|+.++|+|+++++.|.|.|=..
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDs 163 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDS 163 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccc
Confidence 3678898887742 22222 1 123477888999999999999999999999999999999999999999987442
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcc
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGME 337 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~ 337 (497)
...-..+ ......+|.+.|.+||... +..-+..
T Consensus 164 fqi~~ng------------------------------------------~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~ 201 (637)
T COG4248 164 FQINANG------------------------------------------TLHLCPVGVSEFTPPELQTLPSFVGFERTAN 201 (637)
T ss_pred eeeccCC------------------------------------------ceEecccCccccCCHHHhccccccccCCCcc
Confidence 2111111 1122578999999999876 3445778
Q ss_pred hhHHhHHHHHHHHHhC-CCCCCCCC-------hHHHHHHHhcc---------cCc---ccCCCCccCChhHHHHHHHHhh
Q 010947 338 CDWWSLGAIMYEMLVG-YPPFYSDD-------PMSTCRKIVNW---------RTH---LKFPEEAKLSIEAKDLISKLLC 397 (497)
Q Consensus 338 ~DiwSlGvil~ell~G-~~PF~~~~-------~~~~~~~i~~~---------~~~---~~~p~~~~~s~~~~dLI~~lL~ 397 (497)
.|-|.|||++|++|.| ..||.|-. +.++ .|..+ ... ..-+...-+++++..|..++..
T Consensus 202 hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~--~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~ 279 (637)
T COG4248 202 HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET--DIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFT 279 (637)
T ss_pred ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh--hhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhc
Confidence 9999999999999997 89997632 2221 22211 000 1111124588999999999997
Q ss_pred C---ccccCCC
Q 010947 398 N---VNQRLGA 405 (497)
Q Consensus 398 d---p~~R~~~ 405 (497)
+ +.-||++
T Consensus 280 ~~~~~~~RP~a 290 (637)
T COG4248 280 ESGVATPRPTA 290 (637)
T ss_pred ccCCCCCCCCH
Confidence 4 4578885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=4e-10 Score=117.35 Aligned_cols=244 Identities=19% Similarity=0.222 Sum_probs=161.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCc-eeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~l~lV 194 (497)
.-+....-+++|+++++++.+...+...+ .+.+... ...+-++++|.+++||| .+..++.++.+.+..++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34666677899999999988765554444 5554332 23566899999999999 77777888888999999
Q ss_pred EeecCCC-chh-HHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 195 MEYLPGG-DMM-TLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 195 mEy~~gg-~L~-~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
|+++.+| +-. ......-.|.+-+.......-..+|+++|+.-=+||| |||... +..++.||+....+....
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-- 385 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-- 385 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc--
Confidence 9999887 221 1111111233444555666777899999998778998 887766 788999999876553210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
...+..+|+.++|||+.....+....|.||+|+--.+|.-
T Consensus 386 ----------------------------------------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap 425 (829)
T KOG0576|consen 386 ----------------------------------------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAP 425 (829)
T ss_pred ----------------------------------------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCC
Confidence 1125789999999999999999999999999998888888
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCC-CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|-+|-.+ +......+-+......+-. ..+-...-.++...|+. .|..|+. ..+.+.|.+|++-
T Consensus 426 ~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv---~mgacfsKvfngC 490 (829)
T KOG0576|consen 426 GLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKV---HMGACFSKVFNGC 490 (829)
T ss_pred CCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcc---hhhHHHHHHhccC
Confidence 8887544 1111111111110111100 00111111245666776 6776666 5556777777754
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.72 E-value=1.8e-07 Score=87.42 Aligned_cols=142 Identities=18% Similarity=0.275 Sum_probs=92.6
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHH------HHHHHHHHHhc---CCCceeEEEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH------VRAERNLLAEV---DSNCIVKLYC 183 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~------~~~E~~il~~l---~hp~Iv~l~~ 183 (497)
+...+|.+++++-......|.+.. -.|..|.+|..+............ ..+++..+..+ .....+.++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 456789999999888888888765 457899999987543211111111 12233322222 2223333322
Q ss_pred Ee-----ecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEc
Q 010947 184 SF-----QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (497)
Q Consensus 184 ~~-----~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~ 258 (497)
+. .-....+|||||++|..|.+... +++ .+...++.+|.-||+.|+.|+|..|.|++++.++ ++++
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iI 176 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRII 176 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEE
Confidence 22 22234569999999988876542 333 2445677889999999999999999999999655 9999
Q ss_pred ccccccc
Q 010947 259 DFGLCKP 265 (497)
Q Consensus 259 DFGla~~ 265 (497)
||+..+.
T Consensus 177 D~~~k~~ 183 (229)
T PF06176_consen 177 DTQGKRM 183 (229)
T ss_pred ECccccc
Confidence 9987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.64 E-value=2.3e-07 Score=88.43 Aligned_cols=140 Identities=18% Similarity=0.203 Sum_probs=101.5
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhh-----------------hc--hhHHHHHHHHHHHHHhcCCC--
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-----------------LR--RGQVEHVRAERNLLAEVDSN-- 176 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~-----------------~~--~~~~~~~~~E~~il~~l~hp-- 176 (497)
..+...||-|-=+.||.|... .|.++|||.-+-... .+ .-.....++|.++|..+...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 345679999999999999864 688999997542110 00 01123467788889888544
Q ss_pred ceeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEE
Q 010947 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256 (497)
Q Consensus 177 ~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vk 256 (497)
.|.+.++. +...+||||+.|-.|... +++.+.+..++..|+.-+.-+-..||||+|+.+=|||++.+|.+.
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 45555443 556799999998766543 224555666667777766666689999999999999999999999
Q ss_pred EcccccccccC
Q 010947 257 LSDFGLCKPLD 267 (497)
Q Consensus 257 L~DFGla~~~~ 267 (497)
++||--|...+
T Consensus 243 vIDwPQ~v~~~ 253 (304)
T COG0478 243 VIDWPQAVPIS 253 (304)
T ss_pred EEeCcccccCC
Confidence 99998876543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.8e-07 Score=95.04 Aligned_cols=142 Identities=20% Similarity=0.304 Sum_probs=90.1
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhh--------------------hch-----------hHHHHH------H
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--------------------LRR-----------GQVEHV------R 164 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~--------------------~~~-----------~~~~~~------~ 164 (497)
..|+.+|-|.||.|+.+. |+.||||+.+..-. ... .-.+.+ +
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 579999999999999865 99999999874210 000 001122 2
Q ss_pred HHHHHHHhc-----CCCc--eeEEEEEeecCCeEEEEEeecCCCchhHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 010947 165 AERNLLAEV-----DSNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKHH 236 (497)
Q Consensus 165 ~E~~il~~l-----~hp~--Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~~ 236 (497)
.|..-+.++ +.|+ |.++|.-+. ..-.|+|||++|-.+.+.. .+...++...+.....++. +.-+=..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t--~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYT--TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhcc--CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 333333333 2343 233332222 3345999999999888874 2224555333332222222 22333489
Q ss_pred EEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 237 iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+.|.|.+|.||+++.+|++-+.|||+...++.
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999887653
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.53 E-value=9.5e-07 Score=82.29 Aligned_cols=139 Identities=11% Similarity=0.140 Sum_probs=100.0
Q ss_pred eecCCeEEEEEEEcCCCcEEEEEEeechh---hhchhHHHHHHHHHHHHHhcCCCc--eeEEEEEee--c--CCeEEEEE
Q 010947 125 GKGAFGEVRVCREKTTGHVYAMKKLKKSE---MLRRGQVEHVRAERNLLAEVDSNC--IVKLYCSFQ--D--DEFLYLIM 195 (497)
Q Consensus 125 G~G~fG~V~~~~~~~t~~~~AiK~l~k~~---~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~--~--~~~l~lVm 195 (497)
|+||-+-|+..... |+.|=+|.-...- +.-+.....+.+|...|..+..-+ +.+....-. . .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 67888889876543 4468888764211 111334566889999998874322 444432211 1 12367999
Q ss_pred eecCC-CchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc--EEEcccccccc
Q 010947 196 EYLPG-GDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKP 265 (497)
Q Consensus 196 Ey~~g-g~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~--vkL~DFGla~~ 265 (497)
|-++| -||.+++... .+.++.....++.++..+|.-||..|+.|+|+-+.|||++.+|. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 98854 5888887553 34577778899999999999999999999999999999987777 99999987764
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.48 E-value=2e-06 Score=81.30 Aligned_cols=139 Identities=19% Similarity=0.187 Sum_probs=95.2
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchh-------------------H--HHHHHHHHHHHHhcC--CCce
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG-------------------Q--VEHVRAERNLLAEVD--SNCI 178 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~-------------------~--~~~~~~E~~il~~l~--hp~I 178 (497)
..|..|--+.||+|.. .++..+|+|+++.+...... + ....+.|..-|.++. +-.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677888889999875 46789999999754321111 1 123456666666652 2334
Q ss_pred eEEEEEeecCCeEEEEEeecCCCch-hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEE
Q 010947 179 VKLYCSFQDDEFLYLIMEYLPGGDM-MTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLR 256 (497)
Q Consensus 179 v~l~~~~~~~~~l~lVmEy~~gg~L-~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vk 256 (497)
.+-+.++ .-.|||||+...-+ .-.| +.-++..+++..+..+++..+.-|-. .|+||+||..=|||+. +|.+.
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~ 206 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY 206 (268)
T ss_pred CCceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence 4444443 23499999954311 1112 22234455788889999999998887 8999999999999999 89999
Q ss_pred EcccccccccC
Q 010947 257 LSDFGLCKPLD 267 (497)
Q Consensus 257 L~DFGla~~~~ 267 (497)
|+|||-|....
T Consensus 207 iID~~QaV~~~ 217 (268)
T COG1718 207 IIDVSQAVTID 217 (268)
T ss_pred EEECccccccC
Confidence 99999987664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.48 E-value=1.7e-06 Score=82.59 Aligned_cols=133 Identities=20% Similarity=0.167 Sum_probs=83.4
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCc--eeEEEEEeecCCeEEEEEeecC
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC--IVKLYCSFQDDEFLYLIMEYLP 199 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~~~~~l~lVmEy~~ 199 (497)
..||.|..+.||++ .|..+++|...... ....+.+|.+++..+..-. +.+.+.+..+.+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 57899999999974 25567889876422 2234688999998875432 4666777777777889999999
Q ss_pred CCc-hhHHH---------------------Hhc--CC--CCHHHHHHHHH----------HHHH-HHHHHH----cCCEE
Q 010947 200 GGD-MMTLL---------------------MRK--DT--LTEDEARFYVA----------ETVL-AIESIH----KHHYI 238 (497)
Q Consensus 200 gg~-L~~~l---------------------~~~--~~--l~e~~~~~~~~----------qi~~-aL~~LH----~~~ii 238 (497)
|.+ +...+ ..- .. ++... ..+.. .+.. ...+|. ...++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 863 11111 000 00 11100 00100 0111 122222 12578
Q ss_pred EcccCCCCeeecCCCcEEEcccccccc
Q 010947 239 HRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 239 HrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
|+|+.|.||+++.++ +.|+||+.|..
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 999999999999988 99999998864
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.44 E-value=4.3e-06 Score=79.34 Aligned_cols=138 Identities=21% Similarity=0.329 Sum_probs=82.3
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC--ceeEEEEEee---cCCeEEEEE
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCSFQ---DDEFLYLIM 195 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~~~---~~~~l~lVm 195 (497)
++.|+.|..+.||++.... ..+++|+.... .....+..|..++..+... -+.+++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998754 48999997654 2334577788888777432 2455555332 334579999
Q ss_pred eecCCCchhH----------------HHH---hc----CCCCHHH------HHHH---------------HHHHHH-HHH
Q 010947 196 EYLPGGDMMT----------------LLM---RK----DTLTEDE------ARFY---------------VAETVL-AIE 230 (497)
Q Consensus 196 Ey~~gg~L~~----------------~l~---~~----~~l~e~~------~~~~---------------~~qi~~-aL~ 230 (497)
++++|..+.. .+. .. ..+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987777 111 11 0111000 0000 111222 233
Q ss_pred HHH-------cCCEEEcccCCCCeeec-CCCcEEEcccccccc
Q 010947 231 SIH-------KHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKP 265 (497)
Q Consensus 231 ~LH-------~~~iiHrDLKp~NILl~-~~g~vkL~DFGla~~ 265 (497)
.++ ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 333 24699999999999999 667778999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.3e-06 Score=97.19 Aligned_cols=201 Identities=19% Similarity=0.228 Sum_probs=143.8
Q ss_pred HHHHHHHHHHHHhcCCCceeEEEEEeecCC----eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC
Q 010947 160 VEHVRAERNLLAEVDSNCIVKLYCSFQDDE----FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235 (497)
Q Consensus 160 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~ 235 (497)
+.....|...+.++.|+|++.++.+-.... .+.+..|+|.+-++...+...+..+...++.+..+++.||.++|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 334455667778889999999886654332 2345568999999999999999999999999999999999999998
Q ss_pred CEEEcccCCC---CeeecCCCcEEEc--ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhc
Q 010947 236 HYIHRDIKPD---NLLLDKYGHLRLS--DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNR 310 (497)
Q Consensus 236 ~iiHrDLKp~---NILl~~~g~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (497)
...|.-|... +-..+..+.+.++ ||+.++.+......
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-------------------------------------- 347 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-------------------------------------- 347 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccc--------------------------------------
Confidence 6666555444 4445566677776 88887765432111
Q ss_pred ccccccccCCCcccCccccccCCCCcc--hhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCCh-h
Q 010947 311 RMLAYSTVGTPDYIAPEVLLKKGYGME--CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSI-E 387 (497)
Q Consensus 311 ~~~~~~~~Gt~~Y~aPE~l~~~~y~~~--~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~-~ 387 (497)
.+..-+..+.|||......+..+ .|+|++|.....+..|..+-.-. .....++ + ..+. +
T Consensus 348 ----~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~~l--------~---~~~~~~ 409 (1351)
T KOG1035|consen 348 ----FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVSLL--------D---VLSTSE 409 (1351)
T ss_pred ----hhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhhhh--------c---cccchh
Confidence 12334556788888877666554 69999999999999876552211 1111111 1 1121 6
Q ss_pred HHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 388 AKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 388 ~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
..++..+|+. ++++|++ +.+++.|||.+.
T Consensus 410 ~~d~~~~~~~~~~~~Rl~---~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 410 LLDALPKCLDEDSEERLS---ALELLTHPFLRF 439 (1351)
T ss_pred hhhhhhhhcchhhhhccc---hhhhhhchhccc
Confidence 7888889987 8999999 999999999874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.4e-06 Score=89.06 Aligned_cols=141 Identities=23% Similarity=0.287 Sum_probs=89.9
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhh----------------------------hchhHHHHHHHHHHHH---
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM----------------------------LRRGQVEHVRAERNLL--- 170 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~----------------------------~~~~~~~~~~~E~~il--- 170 (497)
+.||.-+.|.|+.|+.+. |+.||||+-+..-- .-.+-.+.+..|++.+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 479999999999999876 99999999764210 0000111223333332
Q ss_pred -------HhcCCCc------eeEEEEEeecCCeEEEEEeecCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCC
Q 010947 171 -------AEVDSNC------IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHH 236 (497)
Q Consensus 171 -------~~l~hp~------Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~ 236 (497)
..+.|-. |.++|..+.. .-.|+||||+|..+.++.. ....++...+...+.++.. +-+=..|
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st--~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G 321 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLST--KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG 321 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcCc--ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence 2223434 5555544433 3459999999987766531 2344555544433333322 2233468
Q ss_pred EEEcccCCCCeeecC----CCcEEEcccccccccC
Q 010947 237 YIHRDIKPDNLLLDK----YGHLRLSDFGLCKPLD 267 (497)
Q Consensus 237 iiHrDLKp~NILl~~----~g~vkL~DFGla~~~~ 267 (497)
++|.|=.|.||+++. ++.+.+-|||+...+.
T Consensus 322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999994 5689999999998764
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.25 E-value=9.5e-06 Score=78.26 Aligned_cols=134 Identities=17% Similarity=0.109 Sum_probs=82.2
Q ss_pred eeecCC-eEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEEEeecCCC
Q 010947 124 IGKGAF-GEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYLPGG 201 (497)
Q Consensus 124 IG~G~f-G~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lVmEy~~gg 201 (497)
|-.|.+ ..||++... +..+.+|+..... ...+..|..++..+. +--+.+++++..+.+..++|||+++|.
T Consensus 6 ~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 6 VTEGQSGATVYRLDGK--NPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred cCCCCCcCeEEEEcCC--CCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 444555 789988643 4578888875432 224667888887773 344567777777666788999999997
Q ss_pred chhHHH-------------------HhcC----CCCHH------HHHHH-------------------HHHHHHHHHHH-
Q 010947 202 DMMTLL-------------------MRKD----TLTED------EARFY-------------------VAETVLAIESI- 232 (497)
Q Consensus 202 ~L~~~l-------------------~~~~----~l~e~------~~~~~-------------------~~qi~~aL~~L- 232 (497)
.|.... .+-. ++... ..... +.++...|...
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 765431 0000 11100 00000 11111111111
Q ss_pred ---HcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 233 ---HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 233 ---H~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
....++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123599999999999999988889999998864
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.6e-05 Score=73.57 Aligned_cols=129 Identities=21% Similarity=0.330 Sum_probs=90.1
Q ss_pred CCCeeEEeEeeecCC-eEEEEEEEcCCCcEEEEEEeechhhh---------ch---------hHHHHHHHHHHHHHhc--
Q 010947 115 ADDFELLTMIGKGAF-GEVRVCREKTTGHVYAMKKLKKSEML---------RR---------GQVEHVRAERNLLAEV-- 173 (497)
Q Consensus 115 ~~~f~~~~~IG~G~f-G~V~~~~~~~t~~~~AiK~l~k~~~~---------~~---------~~~~~~~~E~~il~~l-- 173 (497)
..+++.++.||.|+- |.||+++.. |+.||+|+++.-... .. ....-|..|.+...++
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 478999999999999 999999764 779999994321100 00 1123366677765555
Q ss_pred -CCCce--eEEEEEeecC------------------CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 010947 174 -DSNCI--VKLYCSFQDD------------------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232 (497)
Q Consensus 174 -~hp~I--v~l~~~~~~~------------------~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~L 232 (497)
.+..+ |+.+++..-. ....||.||++... .++. .-+.+|..-|..+
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~----~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQI----RDIPQMLRDLKIL 180 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccch----hHHHHHHHHHHHH
Confidence 44555 8888877311 12467888887643 2222 3356778888999
Q ss_pred HcCCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 233 H~~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
|+.||+-+|+++.|.. .-||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999987 3489999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.3e-05 Score=88.77 Aligned_cols=81 Identities=23% Similarity=0.400 Sum_probs=57.1
Q ss_pred EEeEeeecCCeEEEEEEEcCCC--cEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCce--eEEEEEeecC---CeE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTG--HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCI--VKLYCSFQDD---EFL 191 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~--~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~I--v~l~~~~~~~---~~l 191 (497)
.++.|+.|.++.+|+......+ ..+++|+........ ....+.+|..+|+.+. |++| .++++.+.+. ...
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998765432 467788764432211 1235778999999885 6654 7778877764 467
Q ss_pred EEEEeecCCCc
Q 010947 192 YLIMEYLPGGD 202 (497)
Q Consensus 192 ~lVmEy~~gg~ 202 (497)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.3e-05 Score=70.04 Aligned_cols=136 Identities=19% Similarity=0.269 Sum_probs=93.5
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-------------chhHHHHHHHHHHHHHhcC------CCceeEE
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-------------RRGQVEHVRAERNLLAEVD------SNCIVKL 181 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-------------~~~~~~~~~~E~~il~~l~------hp~Iv~l 181 (497)
...||+|+.=.||. + ......+||++...... ........++|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35799999999994 3 33445789999876500 0112334555665554444 7899999
Q ss_pred EEEeecCCeEEEEEeecCC------CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC--
Q 010947 182 YCSFQDDEFLYLIMEYLPG------GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-- 253 (497)
Q Consensus 182 ~~~~~~~~~l~lVmEy~~g------g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-- 253 (497)
||..+++.-+-+|+|.+.. -+|.+++ ..+.+++ .....+. .-..||-..+|+.+||+|.||++....
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999999999999998743 2577777 4455666 3333333 345677889999999999999996432
Q ss_pred --cEEEcc-ccccc
Q 010947 254 --HLRLSD-FGLCK 264 (497)
Q Consensus 254 --~vkL~D-FGla~ 264 (497)
.+.|+| ||-..
T Consensus 158 ~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 158 EFRLVLIDGLGEKE 171 (199)
T ss_pred ceEEEEEeCCCCcc
Confidence 578888 66543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.08 E-value=1.6e-05 Score=71.40 Aligned_cols=130 Identities=15% Similarity=0.167 Sum_probs=90.7
Q ss_pred eEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeec
Q 010947 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYL 198 (497)
Q Consensus 119 ~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~ 198 (497)
.+.+.||+|.+|.||+|.+. |..+|+|+-+.+. ....+..|..+|..+..-++..=.+.+. .-.+.|||+
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg---~~~i~me~i 94 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR--GGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG---EDFIRMEYI 94 (201)
T ss_pred hhhhhhhcccccEEEEeecc--CceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec---hhhhhhhhh
Confidence 34568999999999999865 6699999876432 3455888999999887766654333332 223569999
Q ss_pred CCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccC-CCCeeecCCCcEEEcccccccc
Q 010947 199 PGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIK-PDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 199 ~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLK-p~NILl~~~g~vkL~DFGla~~ 265 (497)
.|-.|.++-... + +.-+..++.+-.-|-..||-|..|. |..++|..++.+.|+||..|+.
T Consensus 95 ~G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 95 DGRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred cCcchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 998887665321 2 2223344444445667899999986 5666666667999999999874
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.04 E-value=6.8e-07 Score=101.29 Aligned_cols=201 Identities=14% Similarity=0.083 Sum_probs=141.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--chhHHHHHHHHHHHHHhcCCCceeEEEEEeec--CCe
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEF 190 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~ 190 (497)
..++++.--||-|.+++--.-+.+.. -+.+|+.+..... .+...+....|++.++...|++++..+.-..+ ...
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid--~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~e 1305 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKID--WFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTE 1305 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhhc--eeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChH
Confidence 45666666667666654322221211 3566666543321 22234456677777788899998877655443 345
Q ss_pred EEEEEeecCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcC-----CEEEcccCCCCeeecCCCcEEEcccc
Q 010947 191 LYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKH-----HYIHRDIKPDNLLLDKYGHLRLSDFG 261 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~-----~iiHrDLKp~NILl~~~g~vkL~DFG 261 (497)
.|.+++|+.+|++.+.+.+. ..+.+..+.....+.+++..-+|++ --+|++||+-|.+|..+..+|++++|
T Consensus 1306 e~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~g 1385 (2724)
T KOG1826|consen 1306 EYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGG 1385 (2724)
T ss_pred HHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccc
Confidence 78999999999999999764 2344444443444447888887764 27899999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHH
Q 010947 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341 (497)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~Diw 341 (497)
+.+...... ......++++.|++|++...-.++.++|+|
T Consensus 1386 LdKIknp~~-----------------------------------------sf~Gl~l~sp~~v~qli~N~ik~t~rsdil 1424 (2724)
T KOG1826|consen 1386 LDKIKNPVL-----------------------------------------SFFGLELCSPIYVLQLIKNEIKFTKRSDIL 1424 (2724)
T ss_pred cccccCchH-----------------------------------------hhhhhhhCCHHHHHHHHHHHHhhhhHHHHH
Confidence 998322110 011246789999999999999999999999
Q ss_pred hHHHHHHHHHhCCCCCC
Q 010947 342 SLGAIMYEMLVGYPPFY 358 (497)
Q Consensus 342 SlGvil~ell~G~~PF~ 358 (497)
+.|+-+|+.-.|.+||.
T Consensus 1425 r~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHHHhcccHHHH
Confidence 99999999999998884
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=6.1e-05 Score=72.26 Aligned_cols=74 Identities=11% Similarity=0.160 Sum_probs=45.0
Q ss_pred EeEeeecCCe-EEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC---ceeEEEEEeecC---CeEEE
Q 010947 121 LTMIGKGAFG-EVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN---CIVKLYCSFQDD---EFLYL 193 (497)
Q Consensus 121 ~~~IG~G~fG-~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp---~Iv~l~~~~~~~---~~l~l 193 (497)
+..|+.|+.. .||.+ +..+.+|...... ....+..|..+|..+... -+...++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRL-----GDDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEc-----CCceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3467777766 58875 2357778754321 234588899998877431 234444433322 23579
Q ss_pred EEeecCCCchh
Q 010947 194 IMEYLPGGDMM 204 (497)
Q Consensus 194 VmEy~~gg~L~ 204 (497)
||++++|.++.
T Consensus 72 l~~~i~G~~l~ 82 (235)
T cd05155 72 VYRWLEGETAT 82 (235)
T ss_pred EEEeecCCCCC
Confidence 99999986653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.0001 Score=70.50 Aligned_cols=137 Identities=14% Similarity=0.215 Sum_probs=81.1
Q ss_pred EeEeeecCCeEEEEEEEcC-CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEEEeec
Q 010947 121 LTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYL 198 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~-t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lVmEy~ 198 (497)
++.|..|-...||++.... .++.|++|+...... ......+|..++..+. +...+++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888889999986543 356889998754311 1112346888888774 3344555554432 3899999
Q ss_pred CCCchhHH--------------HH---hcC-CC----------C-HHHHHHHHHH----------------------H--
Q 010947 199 PGGDMMTL--------------LM---RKD-TL----------T-EDEARFYVAE----------------------T-- 225 (497)
Q Consensus 199 ~gg~L~~~--------------l~---~~~-~l----------~-e~~~~~~~~q----------------------i-- 225 (497)
+|-.+... |. ... .. . ...+..+... +
T Consensus 75 ~G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 154 (235)
T cd05157 75 PGRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRD 154 (235)
T ss_pred CCCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHH
Confidence 98665211 11 000 11 0 1122222111 1
Q ss_pred -HHHHHH-HH----cCCEEEcccCCCCeeecC-CCcEEEcccccccc
Q 010947 226 -VLAIES-IH----KHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKP 265 (497)
Q Consensus 226 -~~aL~~-LH----~~~iiHrDLKp~NILl~~-~g~vkL~DFGla~~ 265 (497)
+..|.. +- ..+++|+|+.|.|||++. ++.+.|+||..|..
T Consensus 155 ~~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 155 EISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 111111 11 246999999999999998 57899999998864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00062 Score=70.15 Aligned_cols=81 Identities=20% Similarity=0.224 Sum_probs=54.6
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--c--hhHHHHHHHHHHHHHhcC---CCceeEEEEEeecCCeEE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--R--RGQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~--~--~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~l~ 192 (497)
-.+.||.|.++.||.+.....++.++||.-...... . ....++...|.+.|..+. ...+++++.+ +....+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 457899999999999988644358999985321100 0 123456777888887752 3456777766 445577
Q ss_pred EEEeecCCCc
Q 010947 193 LIMEYLPGGD 202 (497)
Q Consensus 193 lVmEy~~gg~ 202 (497)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999998743
|
|
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=97.78 E-value=2.2e-05 Score=58.88 Aligned_cols=60 Identities=27% Similarity=0.615 Sum_probs=40.0
Q ss_pred cCCChhhhh--hcCCCcccccCCcccccCccc-ccccccccCCCCCCCcccccccC-cCCcccCceeeC
Q 010947 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFEK-FEESDNQTKTSSKTGPWRKMLSS-KDINFVGYTYKN 482 (497)
Q Consensus 418 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~f~g~~~~~ 482 (497)
++|||+.|. ++.|||+|.+.+..|++||+. +.... ...+... + .+... ....|.||||.+
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~~~~d~s~fd~~~~~~~-~~~s~~~--~--~~~~~~~~~~F~gfsy~~ 64 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIKSPTDTSNFDDEFTEET-PVLTPVD--S--PASGGSQQEPFRGFSYVF 64 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccCCccHHhHcCCcCCCCC-CCCCCCC--c--cccccccccccCCCcccC
Confidence 479999996 589999999999999999987 44332 2111111 1 11111 146899999963
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00054 Score=68.21 Aligned_cols=77 Identities=10% Similarity=0.032 Sum_probs=53.5
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC---CceeEEEEEeec---CCeEEE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS---NCIVKLYCSFQD---DEFLYL 193 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h---p~Iv~l~~~~~~---~~~l~l 193 (497)
-.+.||.|..+.||..... +..+.+|..+.. .....+..|...|+.+.. -.+.++++.+.+ .+.-+|
T Consensus 18 ~~~~i~~G~~~~vy~~~~~--~~~~~~k~~~~~-----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~L 90 (297)
T PRK10593 18 RVECISEQPYAALWALYDS--QGNPMPLMARSF-----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVL 90 (297)
T ss_pred eeeecCCccceeEEEEEcC--CCCEEEEEeccc-----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEE
Confidence 3567999999999987532 235677774321 012357889999987743 357788877754 356899
Q ss_pred EEeecCCCch
Q 010947 194 IMEYLPGGDM 203 (497)
Q Consensus 194 VmEy~~gg~L 203 (497)
|||+++|+.+
T Consensus 91 VmE~i~G~~~ 100 (297)
T PRK10593 91 LLERLRGVSV 100 (297)
T ss_pred EEeccCCEec
Confidence 9999998754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00012 Score=67.65 Aligned_cols=99 Identities=19% Similarity=0.250 Sum_probs=79.5
Q ss_pred HHHHHHHHhcCC-CceeEEEEEeecCCeEEEEEeecCCCchhHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHc---CC
Q 010947 164 RAERNLLAEVDS-NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL---LMRKDTLTEDEARFYVAETVLAIESIHK---HH 236 (497)
Q Consensus 164 ~~E~~il~~l~h-p~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~---l~~~~~l~e~~~~~~~~qi~~aL~~LH~---~~ 236 (497)
..|.-+|..+.+ +++++++|+|-+ ++|.||++.+++... +..-...++.....++.+++..+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 347778888866 699999999843 479999987766421 2222356899999999999999999997 35
Q ss_pred EEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 237 iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
+.-.|++|+|+-++.+|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00016 Score=70.23 Aligned_cols=133 Identities=17% Similarity=0.194 Sum_probs=77.0
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCc-eeEEEEEeecCCeEEEEEeecCCCc
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGD 202 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~l~lVmEy~~gg~ 202 (497)
+..|-.+.+|++. .++..|++|+....... ..+ ...+|..+++.+.... ..++++.+. -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~--~~~-~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKA--LGV-DRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCccccc--ccC-cHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 4568888999876 45668889876543211 001 2466888888875432 334444432 258999999865
Q ss_pred hhH--------------HHHh---cC----CCCH-HHHHHHHHHH---------HHHHHHHHc--------CCEEEcccC
Q 010947 203 MMT--------------LLMR---KD----TLTE-DEARFYVAET---------VLAIESIHK--------HHYIHRDIK 243 (497)
Q Consensus 203 L~~--------------~l~~---~~----~l~e-~~~~~~~~qi---------~~aL~~LH~--------~~iiHrDLK 243 (497)
+.. .+.+ .. +++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 431 1111 11 1111 1222222111 111222211 258999999
Q ss_pred CCCeeecCCCcEEEccccccccc
Q 010947 244 PDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 244 p~NILl~~~g~vkL~DFGla~~~ 266 (497)
|.|||++.++ +.|+||..|..-
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcC
Confidence 9999999877 789999988643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00041 Score=69.13 Aligned_cols=137 Identities=18% Similarity=0.175 Sum_probs=82.4
Q ss_pred EeEeeecCCeEEEEEEEcC------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC-ceeEEEEEeecCCeEEE
Q 010947 121 LTMIGKGAFGEVRVCREKT------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp-~Iv~l~~~~~~~~~l~l 193 (497)
++.|..|-...||++.... +++.|++|+..... .......+|..++..+... -..++++++.+ .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4567778788999887543 25789999976532 1122356788888777432 23456666542 26
Q ss_pred EEeecCCCchhHH--------------HH---hcC-CC--------C--HHHHHH-------------------------
Q 010947 194 IMEYLPGGDMMTL--------------LM---RKD-TL--------T--EDEARF------------------------- 220 (497)
Q Consensus 194 VmEy~~gg~L~~~--------------l~---~~~-~l--------~--e~~~~~------------------------- 220 (497)
||||++|..+... |. +.. .. + +.....
T Consensus 75 v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (302)
T cd05156 75 IEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELS 154 (302)
T ss_pred hhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHH
Confidence 8999998765431 10 000 00 0 000000
Q ss_pred -HHHHHHHHHHHHH---------cCCEEEcccCCCCeeecCC----CcEEEcccccccc
Q 010947 221 -YVAETVLAIESIH---------KHHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKP 265 (497)
Q Consensus 221 -~~~qi~~aL~~LH---------~~~iiHrDLKp~NILl~~~----g~vkL~DFGla~~ 265 (497)
...++...+..|- ..+++|+|+.|.|||++.+ +.+.|+||..|..
T Consensus 155 ~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 155 LFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 1112222233443 2368999999999999985 8899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0015 Score=64.82 Aligned_cols=139 Identities=15% Similarity=0.090 Sum_probs=82.8
Q ss_pred eEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC--ceeEEEEE------eecCCe
Q 010947 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCS------FQDDEF 190 (497)
Q Consensus 119 ~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~------~~~~~~ 190 (497)
.-++.|..|....+|++.. .+..+++|+.... ....+..|..++..+.+. .+++++.. ....+.
T Consensus 17 ~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 17 LSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hheecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 3366788888889998764 3457999987641 123455677777766322 24444432 223456
Q ss_pred EEEEEeecCCCchhH----H-------H---Hhc-CCC----------CHHHH--H--------HHHHHHHHHHHHHHc-
Q 010947 191 LYLIMEYLPGGDMMT----L-------L---MRK-DTL----------TEDEA--R--------FYVAETVLAIESIHK- 234 (497)
Q Consensus 191 l~lVmEy~~gg~L~~----~-------l---~~~-~~l----------~e~~~--~--------~~~~qi~~aL~~LH~- 234 (497)
.++||+|++|..+.. . | ... ..+ .+... . .....+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999999866422 0 1 000 000 00000 0 011112233444442
Q ss_pred ------CCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 235 ------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 235 ------~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
.+++|+|+.|.|||++.++.+.|+||+.|..
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987789999998863
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0017 Score=65.62 Aligned_cols=83 Identities=17% Similarity=0.168 Sum_probs=51.6
Q ss_pred EeeecCCeEEEEEEEcCCCcEEEEEEeechhhh----chhHHHHHHHHHHHHHhcC--CC-ceeEEEEEeecCCeEEEEE
Q 010947 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML----RRGQVEHVRAERNLLAEVD--SN-CIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 123 ~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~----~~~~~~~~~~E~~il~~l~--hp-~Iv~l~~~~~~~~~l~lVm 195 (497)
.||.|...-||++.....++.++||.-..-.-. -.-...+..-|...|.... .| .++++|. | |+....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~-D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-F-DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-E-ccccceehH
Confidence 579999999999997543467999975422111 1233456667888886653 35 3444444 3 445556999
Q ss_pred eecCCC-chhHHH
Q 010947 196 EYLPGG-DMMTLL 207 (497)
Q Consensus 196 Ey~~gg-~L~~~l 207 (497)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999653 343444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.39 E-value=0.0016 Score=65.13 Aligned_cols=143 Identities=17% Similarity=0.130 Sum_probs=83.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC--ceeEEEEEe------ec
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCSF------QD 187 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~~------~~ 187 (497)
.....++.++.|....||++.. . +..|++|+..... ....+..|..++..+... .+++.+... ..
T Consensus 22 ~~~~~i~~~~~G~~n~~y~v~t-~-~~~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~ 94 (307)
T TIGR00938 22 GELLSLKGIAEGVENSNYLLTT-D-VGRYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTL 94 (307)
T ss_pred CCceeccccCCccccceEEEEe-C-CCcEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhc
Confidence 3455577888888889998764 2 3368889875421 122344566666665321 134443321 22
Q ss_pred CCeEEEEEeecCCCchh-----------HHH---Hh-cCCCC--------HH---H--HH----------HHHHHHHHHH
Q 010947 188 DEFLYLIMEYLPGGDMM-----------TLL---MR-KDTLT--------ED---E--AR----------FYVAETVLAI 229 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~-----------~~l---~~-~~~l~--------e~---~--~~----------~~~~qi~~aL 229 (497)
.+..++||||++|..+. ..+ .. ...++ .. . .. .....+...+
T Consensus 95 ~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~ 174 (307)
T TIGR00938 95 AGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKEL 174 (307)
T ss_pred CCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHH
Confidence 45678999999985432 111 11 00110 00 0 00 0011233345
Q ss_pred HHHH-------cCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 230 ESIH-------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 230 ~~LH-------~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
+++. ..+++|+|+.+.||+++.++.+.|+||+.|..
T Consensus 175 ~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 175 DYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred HHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 5553 26899999999999999988779999998863
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0029 Score=63.55 Aligned_cols=31 Identities=26% Similarity=0.288 Sum_probs=26.8
Q ss_pred CCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 235 ~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
.++||+|+.|.|||++.+...-|+||+.|..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999999765568999998863
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0056 Score=61.36 Aligned_cols=140 Identities=22% Similarity=0.279 Sum_probs=94.8
Q ss_pred eEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-------------------chhHH----HHHHHHHHHHHhcCC
Q 010947 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-------------------RRGQV----EHVRAERNLLAEVDS 175 (497)
Q Consensus 119 ~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-------------------~~~~~----~~~~~E~~il~~l~h 175 (497)
++-..|..|--+.||.|.. .+|..+|||+++.+-+. ..+.. -....|++-|+++..
T Consensus 147 ~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~ 225 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN 225 (520)
T ss_pred ecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 3446788899999999875 56888999998754321 11111 123446666666643
Q ss_pred -----CceeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-cCCEEEcccCCCCeee
Q 010947 176 -----NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLL 249 (497)
Q Consensus 176 -----p~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH-~~~iiHrDLKp~NILl 249 (497)
|--+-| ..-.|||+|+.+.....-.-+.-.++...++.+-.+++.-+.-|- ..++||.||.-=|+|+
T Consensus 226 aGIP~PePIlL-------k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 226 AGIPCPEPILL-------KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY 298 (520)
T ss_pred cCCCCCCceee-------ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence 322222 123499999953222222223456888888888888888888775 4699999999999999
Q ss_pred cCCCcEEEcccccccccC
Q 010947 250 DKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 250 ~~~g~vkL~DFGla~~~~ 267 (497)
-. |++.|+|.+-+-..+
T Consensus 299 hd-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVEHD 315 (520)
T ss_pred EC-CEEEEEEccccccCC
Confidence 76 899999998876543
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0074 Score=61.40 Aligned_cols=141 Identities=14% Similarity=0.189 Sum_probs=81.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcC----CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCce-eEEEEEeecCCe
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKT----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI-VKLYCSFQDDEF 190 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~ 190 (497)
+...+ ..|-.|-...+|++.... +++.|.+|+..... ...+. -.+|..++..+..-.+ .++++.|...
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g-- 109 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG-- 109 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc--
Confidence 34444 455558888999986432 34689999886532 11122 2568888887754333 3556666432
Q ss_pred EEEEEeecCCCchhHH--------------H---HhcC------CCCHHHHHHHHHHH-----------------HHHHH
Q 010947 191 LYLIMEYLPGGDMMTL--------------L---MRKD------TLTEDEARFYVAET-----------------VLAIE 230 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~--------------l---~~~~------~l~e~~~~~~~~qi-----------------~~aL~ 230 (497)
.|+||++|..|... | .+.. ......+..+..++ ...+.
T Consensus 110 --~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~ 187 (344)
T PLN02236 110 --RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEIN 187 (344)
T ss_pred --eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHH
Confidence 68999987655321 1 0101 11122222332111 11111
Q ss_pred HH--------HcCCEEEcccCCCCeeecC-CCcEEEcccccccc
Q 010947 231 SI--------HKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKP 265 (497)
Q Consensus 231 ~L--------H~~~iiHrDLKp~NILl~~-~g~vkL~DFGla~~ 265 (497)
.| +...++|+|+++.|||++. ++.+.|+||..|..
T Consensus 188 ~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 188 LLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 11 2236899999999999986 47899999998864
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.00074 Score=66.41 Aligned_cols=138 Identities=16% Similarity=0.171 Sum_probs=93.5
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc------------hh-------HHHHHHHHHHHHHhc-CCC
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR------------RG-------QVEHVRAERNLLAEV-DSN 176 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~------------~~-------~~~~~~~E~~il~~l-~hp 176 (497)
-+.+...||-|--+-||.|-+ ..|.++++|.-+-..+.- +. ..-....|...|+.+ .|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367788999999999999876 457899999643211100 00 011234577777766 343
Q ss_pred cee-EEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcE
Q 010947 177 CIV-KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHL 255 (497)
Q Consensus 177 ~Iv-~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~v 255 (497)
+=| +.+ |.+..++|||++.|-.|...-.- ..+..+...+..-|.-|-.+|+||+|..-=||+++.++++
T Consensus 172 fpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 172 FPVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 322 222 34567899999998777654311 1233344555566777889999999999999999999999
Q ss_pred EEcccccccc
Q 010947 256 RLSDFGLCKP 265 (497)
Q Consensus 256 kL~DFGla~~ 265 (497)
+++||--+-.
T Consensus 242 ~vIDFPQmvS 251 (465)
T KOG2268|consen 242 VVIDFPQMVS 251 (465)
T ss_pred EEeechHhhc
Confidence 9999976653
|
|
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.90 E-value=0.00044 Score=48.67 Aligned_cols=48 Identities=31% Similarity=0.361 Sum_probs=25.6
Q ss_pred ccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCCc
Q 010947 435 EVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFE 484 (497)
Q Consensus 435 ~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~ 484 (497)
.|+++.|++|||.....+.+..+.. ..+..+..+.+.+|.||||+++.
T Consensus 1 ~v~~~~DtsnFD~eFt~~~~~~t~~--~~~~~~~~~~~~~F~GFTy~~~s 48 (48)
T PF00433_consen 1 KVKSETDTSNFDPEFTEEPPVDTPP--SDPSPLSSSMQENFQGFTYVNPS 48 (48)
T ss_dssp S-SSTT-GTTSCHHHHTSSSSS--S----HHHHCTSSGGGGTT-CEETCT
T ss_pred CCCchhhhhhcCcccccCCCCCCCc--ccCCcccccccCcCCCCeecCCC
Confidence 3678999999998444433322222 11222334455669999999863
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.014 Score=60.11 Aligned_cols=77 Identities=16% Similarity=0.149 Sum_probs=50.9
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch----hHHHHHHHHHHHHHhcC---CCceeEEEEEeecCCeEE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR----GQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~----~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~l~ 192 (497)
..+.||.|....||++... +..|+||.-........ ....+...|...|..+. ...+.++|+++.+ ..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 4678999999999998863 45688997542211111 13444555677776553 2477788887663 356
Q ss_pred EEEeecCC
Q 010947 193 LIMEYLPG 200 (497)
Q Consensus 193 lVmEy~~g 200 (497)
+||||+++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999977
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.88 E-value=0.0079 Score=59.22 Aligned_cols=32 Identities=28% Similarity=0.453 Sum_probs=26.9
Q ss_pred CEEEcccCCCCeeecCCCc-EEEcccccccccC
Q 010947 236 HYIHRDIKPDNLLLDKYGH-LRLSDFGLCKPLD 267 (497)
Q Consensus 236 ~iiHrDLKp~NILl~~~g~-vkL~DFGla~~~~ 267 (497)
.++|+|++|.|||++.++. .-|+||+.+...+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 5899999999999997565 5699999987543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.034 Score=55.38 Aligned_cols=29 Identities=28% Similarity=0.591 Sum_probs=26.1
Q ss_pred CCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 235 ~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
.+++|+|+.+.|||++. +.+.|+||+.|.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 58999999999999998 678999999775
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.67 E-value=0.012 Score=60.36 Aligned_cols=86 Identities=19% Similarity=0.225 Sum_probs=55.3
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc---hhHHHHHHHHHHHHHhcC--CC-ceeEEEEEeecCCeEEEE
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR---RGQVEHVRAERNLLAEVD--SN-CIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~---~~~~~~~~~E~~il~~l~--hp-~Iv~l~~~~~~~~~l~lV 194 (497)
++.||.|.-.-||++.+...++.++||.-..-.-.. .-..++.+-|.++|+... .| .++++|.+ |+....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 778999999999999874435678998643211111 234566777888887653 35 45555543 45556699
Q ss_pred EeecCCC-chhHHHH
Q 010947 195 MEYLPGG-DMMTLLM 208 (497)
Q Consensus 195 mEy~~gg-~L~~~l~ 208 (497)
||+++.. .|...|.
T Consensus 112 MEdL~~~~ilR~~Li 126 (409)
T PRK12396 112 MEDLSDHTILRTALI 126 (409)
T ss_pred HHhCcccHHHHHHHH
Confidence 9999653 3444443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.016 Score=58.65 Aligned_cols=142 Identities=15% Similarity=0.217 Sum_probs=79.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCce-eEEEEEeecCCe
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCI-VKLYCSFQDDEF 190 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~I-v~l~~~~~~~~~ 190 (497)
.++..+..+ ..|=-..+|++..... +..|.+|+..... . ..-.-.+|..+++.+..-.+ .++++.+.. .
T Consensus 14 ~~~i~i~~l-~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G- 86 (330)
T PLN02421 14 DSDFSVERI-SGGITNLLLKVSVKEENGNEVSVTVRLFGPNT---D-YVIDRERELQAIKYLSAAGFGAKLLGVFGN-G- 86 (330)
T ss_pred cCceEEEEe-CCcccceEEEEEecCCCCCCceEEEEEecCCc---C-eEechHHHHHHHHHHHhcCCCCceeEEeCC-c-
Confidence 345555444 4477788998865432 2378999876432 1 11123468888887754443 455666532 2
Q ss_pred EEEEEeecCCCchhH--------------HHH---hcC-C----C-CHHHHHHHHHHH----------------------
Q 010947 191 LYLIMEYLPGGDMMT--------------LLM---RKD-T----L-TEDEARFYVAET---------------------- 225 (497)
Q Consensus 191 l~lVmEy~~gg~L~~--------------~l~---~~~-~----l-~e~~~~~~~~qi---------------------- 225 (497)
+|.+|++|-.|.. .|. ... + + ....+..|..++
T Consensus 87 --~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l 164 (330)
T PLN02421 87 --MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEEL 164 (330)
T ss_pred --EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHH
Confidence 5899997765421 111 101 0 1 122222232221
Q ss_pred ---HHHHHHHH-cC----CEEEcccCCCCeeecC-CCcEEEcccccccc
Q 010947 226 ---VLAIESIH-KH----HYIHRDIKPDNLLLDK-YGHLRLSDFGLCKP 265 (497)
Q Consensus 226 ---~~aL~~LH-~~----~iiHrDLKp~NILl~~-~g~vkL~DFGla~~ 265 (497)
+..+..+. .. -++|.||.|.|||++. ++.++++||..|..
T Consensus 165 ~~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 165 RDEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred HHHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 11111121 22 3899999999999975 57899999998863
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.51 E-value=0.0067 Score=60.73 Aligned_cols=73 Identities=23% Similarity=0.422 Sum_probs=57.4
Q ss_pred cCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
...++|++|++- |+.+.. ...-..+++..++.+.+..|.-+... .+-|||+..+||||+ +|.|.|+||-+|+.
T Consensus 297 e~~y~yl~~kdh-gt~is~----ik~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 297 ETLYLYLHFKDH-GTPISI----IKADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred CceEEEEEEecC-Cceeee----eecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 345788999986 665532 12345677788888888877777754 789999999999999 89999999999984
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.038 Score=55.22 Aligned_cols=149 Identities=15% Similarity=0.167 Sum_probs=85.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC--CceeEEEEEeecCC--eE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDE--FL 191 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~--~l 191 (497)
....++..+-.|..-.+|... .+++.+++. ... ............+|..+|+.+.- .-+...++.|.++. ..
T Consensus 25 ~~~~~v~~~~~G~sn~t~~~~--~~~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~p 100 (321)
T COG3173 25 AGLLIVEEISGGWSNDTFRLG--DTGQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTP 100 (321)
T ss_pred CCCceeeeccCCcccceEEEe--cCCceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCc
Confidence 345556666445444444433 337788888 321 12223344556778888877643 23345566666655 67
Q ss_pred EEEEeecCCCchhH------------------HHHh---c-----------CCCCHHHHHHHHHHH--------------
Q 010947 192 YLIMEYLPGGDMMT------------------LLMR---K-----------DTLTEDEARFYVAET-------------- 225 (497)
Q Consensus 192 ~lVmEy~~gg~L~~------------------~l~~---~-----------~~l~e~~~~~~~~qi-------------- 225 (497)
|.||+|+.|..+.+ .|.. - +.+...+...+..+.
T Consensus 101 f~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 101 FYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred eEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 89999998832221 1110 0 000111111121111
Q ss_pred HHHHHHHHc--------CCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 226 VLAIESIHK--------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 226 ~~aL~~LH~--------~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..-..+|+. ..++|+|+.+.||+++..+-+=+.||+++...++
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 222344443 2589999999999999998899999999986553
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.052 Score=54.27 Aligned_cols=30 Identities=13% Similarity=0.153 Sum_probs=28.0
Q ss_pred CEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 236 ~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
+++|+|+.++|||++.++.+.++||..|..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.33 E-value=0.03 Score=57.77 Aligned_cols=80 Identities=19% Similarity=0.191 Sum_probs=46.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCC-CcE-----EEEEEeechhhhchhHHHHHHHHHHHHHhcCC-CceeEEEEEeecC
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTT-GHV-----YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDD 188 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t-~~~-----~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~ 188 (497)
+++++ +.|..|-.+.+|++..... +.. |.+.+.... ....-.-.+|..+++.+.. ..-.++++.|..
T Consensus 51 ~~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~- 124 (383)
T PTZ00384 51 EFIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD- 124 (383)
T ss_pred ccEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC-
Confidence 34444 4555588899999875432 223 333332111 1111123468888888854 444566777643
Q ss_pred CeEEEEEeecCCCchh
Q 010947 189 EFLYLIMEYLPGGDMM 204 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~ 204 (497)
++|.||++|-.|.
T Consensus 125 ---g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 ---FTIQEWVEGNTMG 137 (383)
T ss_pred ---EEEEEEeccccCC
Confidence 5999999986653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.098 Score=51.74 Aligned_cols=76 Identities=20% Similarity=0.236 Sum_probs=46.5
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc---CCCceeEEEEEeecCCeEEEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.+-.+.||.|....+|... .+++.|.+|+-.... ...+..|..-|+.+ ..-.+++.+.+....+.-|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3445678999999999876 678899999876321 23467788877777 234577788777766667999
Q ss_pred EeecCCC
Q 010947 195 MEYLPGG 201 (497)
Q Consensus 195 mEy~~gg 201 (497)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.015 Score=60.74 Aligned_cols=79 Identities=20% Similarity=0.166 Sum_probs=55.2
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCC-----------ccCChhHHHHHHHHhh-CccccC
Q 010947 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-----------AKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 336 ~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-----------~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
+++||||+|.++.|+..|..-+......+....|... ...+.. ..++....++..+|+- .|..|+
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~---~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~ 186 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKY---YTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRP 186 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHh---ccCchhHHHHHHHHHHHHhhhHhHHHHhccCCcccccccc
Confidence 3999999999999999998887766655555544431 111110 1245556778888887 889998
Q ss_pred CCCCcchhcCCCCccCC
Q 010947 404 GAKGADEIKVHPWFDGV 420 (497)
Q Consensus 404 ~~~~~~eil~Hpff~~i 420 (497)
. ..++..|+-|..+
T Consensus 187 l---~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 187 L---PMELSKRCSFTEV 200 (725)
T ss_pred c---hhHHhcCccHHHH
Confidence 5 6678888888755
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.44 E-value=0.043 Score=51.50 Aligned_cols=31 Identities=32% Similarity=0.638 Sum_probs=22.2
Q ss_pred CCEEEcccCCCCeee-cCCCcEEEcccccccc
Q 010947 235 HHYIHRDIKPDNLLL-DKYGHLRLSDFGLCKP 265 (497)
Q Consensus 235 ~~iiHrDLKp~NILl-~~~g~vkL~DFGla~~ 265 (497)
..++|+||.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 468999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.017 Score=57.18 Aligned_cols=51 Identities=25% Similarity=0.454 Sum_probs=36.9
Q ss_pred HHHHHHHHHHHHHHHHHHc----CCEEEcccCCCCeeecCCC------------------cEEEccccccccc
Q 010947 216 DEARFYVAETVLAIESIHK----HHYIHRDIKPDNLLLDKYG------------------HLRLSDFGLCKPL 266 (497)
Q Consensus 216 ~~~~~~~~qi~~aL~~LH~----~~iiHrDLKp~NILl~~~g------------------~vkL~DFGla~~~ 266 (497)
+-+++++.||++-.-.+-. .+++|-||||+|||+=... .++|.||.+|...
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 351 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQVA 351 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHHc
Confidence 4678888998876645533 4699999999999993322 3567788887643
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.00 E-value=0.56 Score=54.66 Aligned_cols=31 Identities=32% Similarity=0.455 Sum_probs=26.4
Q ss_pred CCEEEcccCCCCeeecCCC--cEE-Ecccccccc
Q 010947 235 HHYIHRDIKPDNLLLDKYG--HLR-LSDFGLCKP 265 (497)
Q Consensus 235 ~~iiHrDLKp~NILl~~~g--~vk-L~DFGla~~ 265 (497)
.++||.|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4799999999999999875 565 999998753
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.99 E-value=0.02 Score=56.91 Aligned_cols=52 Identities=25% Similarity=0.378 Sum_probs=36.2
Q ss_pred HHHHHHHHHHHHHHHHHHH----cCCEEEcccCCCCeeecCC------------------CcEEEccccccccc
Q 010947 215 EDEARFYVAETVLAIESIH----KHHYIHRDIKPDNLLLDKY------------------GHLRLSDFGLCKPL 266 (497)
Q Consensus 215 e~~~~~~~~qi~~aL~~LH----~~~iiHrDLKp~NILl~~~------------------g~vkL~DFGla~~~ 266 (497)
.+-+++++.||++-.--+- -.+++|-||||+|||+=+. -.++|.||.+|...
T Consensus 274 ~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 274 VEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3456778888876542232 2479999999999999322 14678899988754
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.81 E-value=0.36 Score=50.79 Aligned_cols=81 Identities=17% Similarity=0.134 Sum_probs=49.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcC--------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCcee-EEEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKT--------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV-KLYCS 184 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~--------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv-~l~~~ 184 (497)
..++. -++.|..|-...+|++.... +++.|.+++..... . ..-.-..|..++..+..-.|. ++++.
T Consensus 104 ~~~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e-~lIdR~~E~~v~~~ls~~gi~P~l~~~ 178 (442)
T PTZ00296 104 TEDDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---D-ELYNPISEFEVYKTMSKYRIAPQLLNT 178 (442)
T ss_pred CcccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---c-ceeCHHHHHHHHHHHHHCCCCCceEEE
Confidence 34455 56777778888899987542 15678999875431 1 111234577777766443333 45565
Q ss_pred eecCCeEEEEEeecCCCch
Q 010947 185 FQDDEFLYLIMEYLPGGDM 203 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L 203 (497)
|. -+.|.||++|-.|
T Consensus 179 f~----gg~I~efi~g~~l 193 (442)
T PTZ00296 179 FS----GGRIEEWLYGDPL 193 (442)
T ss_pred eC----CCEEEEeeCCccC
Confidence 53 2368999988633
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 497 | ||||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-81 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-80 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-78 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-78 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 2e-78 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-77 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 7e-77 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-73 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 9e-65 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-64 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-64 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-64 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-64 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 4e-64 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-64 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-64 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-64 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-64 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 8e-64 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-64 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-64 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-63 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-63 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-63 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-63 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-63 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-63 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-63 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-63 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-63 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-63 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-63 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-63 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-63 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-63 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-63 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-63 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-63 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-63 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-63 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-62 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-62 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-62 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-62 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-62 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-62 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-62 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-62 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-62 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-62 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-62 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-62 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-62 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-62 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-62 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-62 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 5e-62 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-62 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-61 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-61 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-58 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-53 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-53 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-52 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-50 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-50 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-50 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-50 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-49 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-49 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-49 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-49 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-49 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 2e-49 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-49 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-49 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-49 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-49 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-48 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-48 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-48 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-48 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-48 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-48 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-44 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-44 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-44 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-44 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-43 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-43 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-43 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-43 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-43 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-43 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 3e-43 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-43 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-43 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 5e-43 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 5e-43 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 5e-43 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-43 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-43 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 5e-43 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 6e-43 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-43 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-42 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-42 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-42 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-42 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-42 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 5e-39 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-38 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-37 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-37 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-36 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-36 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-36 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-35 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-35 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-34 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-34 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-34 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-34 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-33 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-33 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-33 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-33 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-33 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-32 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-32 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-32 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-32 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-32 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-32 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-32 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-32 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-32 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-32 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-32 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-32 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-32 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-32 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 4e-32 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-32 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-32 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-32 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 7e-32 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-32 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 8e-32 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-32 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-32 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-32 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-32 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-31 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-31 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-31 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-31 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-31 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-31 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-31 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-31 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-31 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-31 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-31 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-31 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-31 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 3e-31 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-31 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-31 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-31 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-31 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-31 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-30 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-30 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-30 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-30 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-30 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-30 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 4e-30 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-29 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-29 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-29 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-29 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-29 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-28 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-28 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-28 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-28 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-28 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-28 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-28 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-28 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-28 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-28 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 6e-28 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-28 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 7e-28 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-28 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-28 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-28 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-27 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-27 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-27 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-27 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-27 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-27 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-27 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-27 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-27 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-27 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-27 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-27 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-27 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-26 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-26 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-26 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-26 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-26 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-26 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-26 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-26 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-26 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-26 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-26 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-26 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-26 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-26 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-26 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-26 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-26 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-26 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-26 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-26 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-26 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 5e-26 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-26 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-26 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-26 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-26 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-26 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-25 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-25 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-25 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-25 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-25 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-25 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-25 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-25 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-25 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-25 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-25 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-25 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-25 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 6e-25 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-25 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-25 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 8e-25 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-24 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-24 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-24 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-24 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-24 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-24 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-24 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 5e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-24 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-24 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-24 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 9e-24 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-23 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-23 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-23 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-22 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-22 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-22 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-22 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-22 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-22 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-22 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 9e-22 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-21 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-21 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-21 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-21 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-21 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-20 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-20 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-20 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-20 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-20 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-20 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-20 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-20 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-20 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-20 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-20 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-20 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-20 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-20 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-20 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-20 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-19 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-19 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-19 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-19 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-19 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-19 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-19 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-19 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-19 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-19 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-19 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-19 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-19 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-19 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 4e-19 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-19 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 4e-19 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-19 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-19 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-19 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-19 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-19 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 6e-19 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-19 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-19 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-18 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-18 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 9e-18 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-17 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-17 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-17 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-16 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-16 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-16 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-16 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-16 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-16 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-16 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-16 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-16 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 4e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-16 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 5e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-16 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 5e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 5e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 5e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 6e-16 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-16 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-14 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-14 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-14 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-13 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-13 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-13 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-13 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-13 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-13 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 6e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 6e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 7e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-13 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-12 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-12 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-12 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-11 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-11 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 3e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-11 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-11 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 5e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 5e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-11 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-10 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-10 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 3e-10 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-10 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 6e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-10 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 9e-10 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-09 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 3e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 4e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-09 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-09 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 5e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-09 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 6e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-09 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-09 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-09 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 7e-09 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 7e-09 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-09 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 8e-09 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-09 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 9e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 9e-09 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-09 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-09 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-08 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-08 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 3e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 4e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-08 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 5e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-08 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 6e-08 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 9e-08 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-07 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-07 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-07 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-07 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-07 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-07 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 5e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 5e-07 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-07 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-07 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 7e-07 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 7e-07 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-07 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 7e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 7e-07 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 8e-07 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 8e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 8e-07 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 8e-07 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 9e-07 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-06 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-06 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-06 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-06 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-06 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-06 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-06 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 3e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-06 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-06 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-06 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 5e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 5e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 6e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 6e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 6e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 6e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 6e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 7e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-06 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-05 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-05 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-05 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-05 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-05 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-05 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-05 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 5e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-05 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 5e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-05 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-05 | ||
| 4ax8_A | 569 | Medium Resolution Structure Of The Bifunctional Kin | 7e-05 | ||
| 4azs_A | 569 | High Resolution (2.2 A) Crystal Structure Of Wbdd. | 7e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-05 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 9e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 9e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 9e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 9e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-04 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-04 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-04 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-04 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-04 | ||
| 4azw_A | 471 | Crystal Structure Of Monomeric Wbdd Length = 471 | 2e-04 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-04 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-04 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-04 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-04 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-04 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-04 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-04 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 3e-04 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-04 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-04 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 5e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-04 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 6e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-04 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-04 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-04 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-04 |
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4AX8|A Chain A, Medium Resolution Structure Of The Bifunctional Kinase- Methyltransferase Wbdd Length = 569 | Back alignment and structure |
|
| >pdb|4AZS|A Chain A, High Resolution (2.2 A) Crystal Structure Of Wbdd. Length = 569 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4AZW|A Chain A, Crystal Structure Of Monomeric Wbdd Length = 471 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 485 bits (1251), Expect = e-170
Identities = 154/413 (37%), Positives = 224/413 (54%), Gaps = 53/413 (12%)
Query: 93 NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS 152
+ FL+ E +RL+ ++ DDFE+L +IG+GAF EV V + K TG VYAMK + K
Sbjct: 38 YVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKW 97
Query: 153 EMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-D 211
+ML+RG+V R ER++L D I +L+ +FQD+ +LYL+MEY GGD++TLL + +
Sbjct: 98 DMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE 157
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
+ + ARFY+AE V+AI+S+H+ Y+HRDIKPDN+LLD+ GH+RL+DFG C L
Sbjct: 158 RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL----- 212
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
+G+ + + VGTPDY++PE+L
Sbjct: 213 ---------RADGTVR--------------------------SLVAVGTPDYLSPEILQA 237
Query: 332 KG-------YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAK- 383
G YG ECDWW+LG YEM G PFY+D T KIV+++ HL P +
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEG 297
Query: 384 LSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQ 443
+ EA+D I +LLC RLG GA + + HP+F G+DW + F P+ DT
Sbjct: 298 VPEEARDFIQRLLCPPETRLGRGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDFEGATDTC 357
Query: 444 NFEKFEESDNQTKT---SSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVPG 493
NF+ E+ + + + + FVGY+Y + + +VPG
Sbjct: 358 NFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALRDS-EVPG 409
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-166
Identities = 158/414 (38%), Positives = 234/414 (56%), Gaps = 52/414 (12%)
Query: 76 ILEKKLADADVSEEDQN-NLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRV 134
L+ + D D +N N+ FL + + +++ +M A+D+E++ +IG+GAFGEV++
Sbjct: 28 GLDALVYDLDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQL 87
Query: 135 CREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194
R K+T VYAMK L K EM++R ER+++A +S +V+L+ +FQDD +LY++
Sbjct: 88 VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147
Query: 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254
MEY+PGGD++ L+ D + E ARFY AE VLA+++IH +IHRD+KPDN+LLDK GH
Sbjct: 148 MEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH 206
Query: 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLA 314
L+L+DFG C ++ K +
Sbjct: 207 LKLADFGTCMKMN----------------------------------------KEGMVRC 226
Query: 315 YSTVGTPDYIAPEVLLKKG----YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV 370
+ VGTPDYI+PEVL +G YG ECDWWS+G +YEMLVG PFY+D + T KI+
Sbjct: 227 DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286
Query: 371 NWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQ--M 428
N + L FP++ +S EAK+LI L + RLG G +EIK H +F WA
Sbjct: 287 NHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDT 346
Query: 429 EAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482
A +P+++ ++DT NF+ EE + +T P K + FVG+TY +
Sbjct: 347 VAPVVPDLSSDIDTSNFDDLEEDKGEEETF----PIPKAFVGNQLPFVGFTYYS 396
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 476 bits (1226), Expect = e-166
Identities = 160/413 (38%), Positives = 234/413 (56%), Gaps = 49/413 (11%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAM 146
+ N+L++LE + ++++ ++ +DFE+L +IG+GAFGEV V + K V+AM
Sbjct: 45 PLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAM 104
Query: 147 KKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL 206
K L K EML+R + R ER++L DS I L+ +FQDD LYL+M+Y GGD++TL
Sbjct: 105 KILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTL 164
Query: 207 LMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265
L + +D L E+ ARFY+AE V+AI+S+H+ HY+HRDIKPDN+L+D GH+RL+DFG C
Sbjct: 165 LSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224
Query: 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325
L ++ + + VGTPDYI+
Sbjct: 225 LM----------------------------------------EDGTVQSSVAVGTPDYIS 244
Query: 326 PEVLL-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE 380
PE+L K YG ECDWWSLG MYEML G PFY++ + T KI+N + +FP
Sbjct: 245 PEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT 304
Query: 381 E-AKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDE 439
+ +S AKDLI +L+C+ RLG G ++ K HP+F G+DW I EA +IPEV+
Sbjct: 305 QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSP 364
Query: 440 LDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVP 492
DT NF+ ++ + + P S + FVG+TY + +++D
Sbjct: 365 TDTSNFDVDDDC--LKNSETMPPPTHTAFSGHHLPFVGFTYTSSCVLSDRSCL 415
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 391 bits (1006), Expect = e-134
Identities = 124/347 (35%), Positives = 187/347 (53%), Gaps = 54/347 (15%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K DF++L +G G+FG V + R + G YAMK LKK ++R QVEH ER +L+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
V I++++ +FQD + +++IM+Y+ GG++ +LL + A+FY AE LA+E
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H I+RD+KP+N+LLDK GH++++DFG K + T
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--------------------- 160
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
Y+ GTPDYIAPEV+ K Y DWWS G ++YEML
Sbjct: 161 -----------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEML 197
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGA 408
GY PFY + M T KI+N L+FP + + KDL+S+L+ +++QRLG G
Sbjct: 198 AGYTPFYDSNTMKTYEKILNAE--LRFPPF--FNEDVKDLLSRLITRDLSQRLGNLQNGT 253
Query: 409 DEIKVHPWFDGVDWARIYQ--MEAAFIPEV-NDELDTQNFEKFEESD 452
+++K HPWF V W ++ +E + P + + DT F+K+ E D
Sbjct: 254 EDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEED 300
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 390 bits (1003), Expect = e-134
Identities = 128/381 (33%), Positives = 202/381 (53%), Gaps = 53/381 (13%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAM 146
E + L K E ++ ++ D F+ + +G G+FG V + + K +G+ YAM
Sbjct: 12 QESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAM 71
Query: 147 KKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL 206
K L K ++++ Q+EH E+ +L V+ +VKL SF+D+ LY++MEY+ GG+M +
Sbjct: 72 KILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSH 131
Query: 207 LMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
L R +E ARFY A+ VL E +H I+RD+KP+NLL+D+ G+++++DFG K +
Sbjct: 132 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV 191
Query: 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326
T ++ GTP+ +AP
Sbjct: 192 KGRT--------------------------------------------WTLCGTPEALAP 207
Query: 327 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSI 386
E++L KGY DWW+LG ++YEM GYPPF++D P+ KIV+ + ++FP + S
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK--VRFP--SHFSS 263
Query: 387 EAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEVNDELD 441
+ KDL+ LL ++ +R G G ++IK H WF DW IYQ +EA FIP+ D
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGD 323
Query: 442 TQNFEKFEESDNQTKTSSKTG 462
T NF+ +EE + + + K G
Sbjct: 324 TSNFDDYEEEEIRVSINEKCG 344
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-128
Identities = 101/337 (29%), Positives = 167/337 (49%), Gaps = 47/337 (13%)
Query: 102 ETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE 161
+ Q K +DF+ ++G+G+F V + RE T YA+K L+K +++ +V
Sbjct: 16 QHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVP 75
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
+V ER++++ +D VKLY +FQDDE LY + Y G+++ + + + E RFY
Sbjct: 76 YVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
AE V A+E +H IHRD+KP+N+LL++ H++++DFG K L
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS-------------- 181
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341
+ R S VGT Y++PE+L +K D W
Sbjct: 182 ---------PESKQARA----------------NSFVGTAQYVSPELLTEKSACKSSDLW 216
Query: 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVN 400
+LG I+Y+++ G PPF + + +KI+ FPE+ +A+DL+ KLL +
Sbjct: 217 ALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE--YDFPEK--FFPKARDLVEKLLVLDAT 272
Query: 401 QRLGAK---GADEIKVHPWFDGVDWARIYQMEAAFIP 434
+RLG + G +K HP+F+ V W ++Q +
Sbjct: 273 KRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 309
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 363 bits (935), Expect = e-123
Identities = 119/404 (29%), Positives = 191/404 (47%), Gaps = 53/404 (13%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAM 146
+ N ++ DF L +IGKG+FG+V + R K YA+
Sbjct: 9 ELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAV 68
Query: 147 KKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMT 205
K L+K +L++ + +H+ +ERN+L + + +V L+ SFQ + LY +++Y+ GG++
Sbjct: 69 KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFY 128
Query: 206 LLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265
L R+ E ARFY AE A+ +H + ++RD+KP+N+LLD GH+ L+DFGLCK
Sbjct: 129 HLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK- 187
Query: 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325
E ++H + GTP+Y+A
Sbjct: 188 -----------------------------------ENIEHNST-----TSTFCGTPEYLA 207
Query: 326 PEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLS 385
PEVL K+ Y DWW LGA++YEML G PPFYS + I+N L+ ++
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN--KPLQLKPN--IT 263
Query: 386 IEAKDLISKLLC-NVNQRLGAK-GADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELD 441
A+ L+ LL + +RLGAK EIK H +F ++W + ++ F P V+ D
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPND 323
Query: 442 TQNFEKF---EESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482
++F+ E N + + + F+G++Y
Sbjct: 324 LRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAP 367
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 359 bits (925), Expect = e-122
Identities = 123/356 (34%), Positives = 183/356 (51%), Gaps = 54/356 (15%)
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRR 157
+ K+ + FELL ++GKG +G+V R+ TG ++AMK LKK+ ++R
Sbjct: 2 SSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRN 61
Query: 158 G-QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED 216
H +AERN+L EV IV L +FQ LYLI+EYL GG++ L R+ ED
Sbjct: 62 AKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMED 121
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
A FY+AE +A+ +H+ I+RD+KP+N++L+ GH++L+DFGLCK
Sbjct: 122 TACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK------------ 169
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
E + ++ GT +Y+APE+L++ G+
Sbjct: 170 ------------------------ESIHDGTV-----THTFCGTIEYMAPEILMRSGHNR 200
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLL 396
DWWSLGA+MY+ML G PPF ++ T KI+ L P L+ EA+DL+ KLL
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK--CKLNLPPY--LTQEARDLLKKLL 256
Query: 397 C-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ--MEAAFIPEVNDELDTQNFEK 447
N RLGA A E++ HP+F ++W + +E F P + E D F+
Sbjct: 257 KRNAASRLGAGPGDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQSEEDVSQFDS 312
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 357 bits (919), Expect = e-121
Identities = 121/387 (31%), Positives = 182/387 (47%), Gaps = 59/387 (15%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K+ +DF+ L ++GKG FG+V + REK TG YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
+ L +FQ + L +MEY GG++ L R+ TE+ ARFY AE V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H ++RDIK +NL+LDK GH++++DFGLCK + +
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKE----GISDGATM-------------- 162
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ GTP+Y+APEVL YG DWW LG +MYEM+
Sbjct: 163 -----------------------KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGA 408
G PFY+ D I+ ++FP LS EAK L++ LL + QRLG A
Sbjct: 200 CGRLPFYNQDHERLFELILM--EEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 409 DEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKF----EESDNQTKTSSKTG 462
E+ H +F ++W + ++ F P+V E+DT+ F+ + G
Sbjct: 256 KEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLG 315
Query: 463 PWRKMLSSKDINFVGYTYKNFEIVNDY 489
+ F + Y + D+
Sbjct: 316 LLELDQREEQEMFEDFDY-----IADW 337
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 356 bits (916), Expect = e-121
Identities = 123/353 (34%), Positives = 188/353 (53%), Gaps = 54/353 (15%)
Query: 103 TEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLRRGQ 159
T +++ K FELL ++G+G+FG+V + ++ +YAMK LKK+ + R +
Sbjct: 11 THHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDR 70
Query: 160 VEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR 219
V + ER++L EV+ IVKL+ +FQ + LYLI+++L GGD+ T L ++ TE++ +
Sbjct: 71 V-RTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK 129
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
FY+AE LA++ +H I+RD+KP+N+LLD+ GH++L+DFGL K
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--------------- 174
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339
E + H +K AYS GT +Y+APEV+ ++G+ D
Sbjct: 175 ---------------------ESIDHEKK-----AYSFCGTVEYMAPEVVNRRGHTQSAD 208
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-N 398
WWS G +M+EML G PF D T I+ L P+ LS EA+ L+ L N
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGKDRKETMTMILK--AKLGMPQF--LSPEAQSLLRMLFKRN 264
Query: 399 VNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEK 447
RLGA G +EIK H +F +DW ++Y ++ F P DT F+
Sbjct: 265 PANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIHPPFKPATGRPEDTFYFDP 317
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-119
Identities = 117/378 (30%), Positives = 181/378 (47%), Gaps = 54/378 (14%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
+ K+ +DF L M+GKG+FG+V + K T +A+K LKK +L VE E+
Sbjct: 10 LQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKR 69
Query: 169 LLAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+L+ + + ++C+FQ E L+ +MEYL GGD+M + A FY AE +L
Sbjct: 70 VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 129
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ +H ++RD+K DN+LLDK GH++++DFG+CK
Sbjct: 130 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK----------------------- 166
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
E + K + GTPDYIAPE+LL + Y DWWS G ++
Sbjct: 167 -------------ENMLGDAK-----TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLL 208
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
YEML+G PF+ D I + +P L EAKDL+ KL +RLG +
Sbjct: 209 YEMLIGQSPFHGQDEEELFHSIRM--DNPFYPRW--LEKEAKDLLVKLFVREPEKRLGVR 264
Query: 407 GADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPW 464
G +I+ HP F ++W + +++ F P+V D NF+ +E N+ S
Sbjct: 265 G--DIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFD--KEFLNEKPRLSFADR- 319
Query: 465 RKMLSSKDINFVGYTYKN 482
+ S F +++ N
Sbjct: 320 ALINSMDQNMFRNFSFMN 337
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-119
Identities = 115/386 (29%), Positives = 185/386 (47%), Gaps = 65/386 (16%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
+++G D+FE + ++GKG+FG+V + R K TG +YA+K LKK +L+ VE E+
Sbjct: 16 SSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKR 75
Query: 169 LLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+L+ ++ + +L+C FQ + L+ +ME++ GGD+M + + E ARFY AE +
Sbjct: 76 ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS 135
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
A+ +H I+RD+K DN+LLD GH +L+DFG+CK + T
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE----GICNGVTT---------- 181
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
+ GTPDYIAPE+L + YG DWW++G ++
Sbjct: 182 ---------------------------ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLL 214
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
YEML G+ PF +++ I+N + +P L +A ++ + N RLG+
Sbjct: 215 YEMLCGHAPFEAENEDDLFEAILN--DEVVYPTW--LHEDATGILKSFMTKNPTMRLGSL 270
Query: 407 ---GADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEK-FEESDNQTKTSSK 460
G I HP+F +DWA++ Q+E F P + D NF+ F +
Sbjct: 271 TQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIKSREDVSNFDPDF--------IKEE 322
Query: 461 ---TGPWRKMLSSKD-INFVGYTYKN 482
T L + F + Y +
Sbjct: 323 PVLTPIDEGHLPMINQDEFRNFEYVS 348
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 352 bits (905), Expect = e-119
Identities = 126/373 (33%), Positives = 194/373 (52%), Gaps = 56/373 (15%)
Query: 87 SEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHV 143
+ LL + T + K+G ++FELL ++G GA+G+V + R+ TG +
Sbjct: 25 GGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKL 84
Query: 144 YAMKKLKKSEMLRRG-QVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGG 201
YAMK LKK+ ++++ EH R ER +L + + +V L+ +FQ + L+LI++Y+ GG
Sbjct: 85 YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGG 144
Query: 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261
++ T L +++ TE E + YV E VLA+E +HK I+RDIK +N+LLD GH+ L+DFG
Sbjct: 145 ELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFG 204
Query: 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321
L K + ER AY GT
Sbjct: 205 LSKE------------------FVADETER----------------------AYDFCGTI 224
Query: 322 DYIAPEVLL--KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH--LK 377
+Y+AP+++ G+ DWWSLG +MYE+L G PF D ++ +I
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 378 FPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAF 432
+P+E +S AKDLI +LL + +RLG + ADEIK H +F ++W + ++ A F
Sbjct: 285 YPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPF 342
Query: 433 IPEVNDELDTQNF 445
P + DELD NF
Sbjct: 343 KPVIRDELDVSNF 355
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 351 bits (902), Expect = e-118
Identities = 90/346 (26%), Positives = 158/346 (45%), Gaps = 61/346 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
+ + D FE+L IGKG+FG+V + ++ T +YAMK + K + + R +V +V E
Sbjct: 8 ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
++ ++ +V L+ SFQD+E ++++++ L GGD+ L + E+ + ++ E V+A
Sbjct: 68 IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ + IHRD+KPDN+LLD++GH+ ++DF +
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA------------------------ 163
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK---GYGMECDWWSLGA 345
+ + + GT Y+APE+ + GY DWWSLG
Sbjct: 164 ----------------MLPRETQ--ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGV 205
Query: 346 IMYEMLVGYPPFY---SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401
YE+L G P++ S T + +P S E L+ KLL N +Q
Sbjct: 206 TAYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPSA--WSQEMVSLLKKLLEPNPDQ 261
Query: 402 RLGAKGADEIKVHPWFDGVDWARIYQ--MEAAFIPEVNDELDTQNF 445
R +++ P+ + ++W ++Q + FIP N
Sbjct: 262 RFS--QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNK----GRLNC 301
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 349 bits (898), Expect = e-118
Identities = 104/386 (26%), Positives = 180/386 (46%), Gaps = 55/386 (14%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
R +M DF L ++GKG+FG+V + K T +YA+K LKK +++ VE E+
Sbjct: 13 NRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKR 72
Query: 169 LLAEVDSNC-IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+LA + +L+ FQ + LY +MEY+ GGD+M + + E A FY AE +
Sbjct: 73 VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 132
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ + I+RD+K DN++LD GH++++DFG+CK
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK----------------------- 169
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
E + + GTPDYIAPE++ + YG DWW+ G ++
Sbjct: 170 -------------ENIWDGVT-----TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLL 211
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA- 405
YEML G PF +D + I+ ++ +P+ +S EA + L+ + +RLG
Sbjct: 212 YEMLAGQAPFEGEDEDELFQSIME--HNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCG 267
Query: 406 -KGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTG 462
+G +IK H +F +DW ++ +++ + P+ + +NF++ +
Sbjct: 268 PEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKACGR-NAENFDR--FFTRHPPVLTPPD 324
Query: 463 PWRKMLSSKDINFVGYTYKNFEIVND 488
+ + F G+++ N E +
Sbjct: 325 Q-EVIRNIDQSEFEGFSFVNSEFLKP 349
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 341 bits (877), Expect = e-115
Identities = 114/388 (29%), Positives = 187/388 (48%), Gaps = 66/388 (17%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+G DF+LL +IG+G++ +V + R K T +YAMK +KK + ++ V+ E+++
Sbjct: 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFE 64
Query: 172 EVDSNC--IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ SN +V L+ FQ + L+ ++EY+ GGD+M + R+ L E+ ARFY AE LA+
Sbjct: 65 QA-SNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+H+ I+RD+K DN+LLD GH++L+D+G+CK L+ D T
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE----GLRPGDTT------------ 167
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ GTP+YIAPE+L + YG DWW+LG +M+E
Sbjct: 168 -------------------------STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFE 202
Query: 350 MLVGYPPF---------YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NV 399
M+ G PF + + I+ ++ P LS++A ++ L +
Sbjct: 203 MMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRS--LSVKAASVLKSFLNKDP 258
Query: 400 NQRLGA---KGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQ 454
+RLG G +I+ HP+F VDW + Q+ F P ++ E NF+ + N+
Sbjct: 259 KERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGLDNFDS--QFTNE 316
Query: 455 TKTSSKTGPWRKMLSSKDINFVGYTYKN 482
+ + F G+ Y N
Sbjct: 317 PVQLTPDDD-DIVRKIDQSEFEGFEYIN 343
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 344 bits (884), Expect = e-114
Identities = 125/393 (31%), Positives = 189/393 (48%), Gaps = 55/393 (13%)
Query: 61 KEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFEL 120
+E +Q + D N+ + +E + +H++ ++FE
Sbjct: 97 EEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAK----PKHRVTMNEFEY 152
Query: 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
L ++GKG FG+V + +EK TG YAMK LKK ++ + +V H E +L +
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH-YIH 239
L SFQ + L +MEY GG++ L R+ +ED ARFY AE V A++ +H ++
Sbjct: 213 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 272
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQ 299
RD+K +NL+LDK GH++++DFGLCK
Sbjct: 273 RDLKLENLMLDKDGHIKITDFGLCK----------------------------------- 297
Query: 300 QEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYS 359
E ++ + GTP+Y+APEVL YG DWW LG +MYEM+ G PFY+
Sbjct: 298 -EGIKDGAT-----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN 351
Query: 360 DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPW 416
D I+ ++FP L EAK L+S LL + QRLG + A EI H +
Sbjct: 352 QDHEKLFELILM--EEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407
Query: 417 FDGVDWARIY--QMEAAFIPEVNDELDTQNFEK 447
F G+ W +Y ++ F P+V E DT+ F++
Sbjct: 408 FAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 440
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 338 bits (868), Expect = e-113
Identities = 112/400 (28%), Positives = 188/400 (47%), Gaps = 64/400 (16%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG 158
E T +G DF+LL +IG+G++ +V + R K T +YAM+ +KK +
Sbjct: 35 EAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDE 94
Query: 159 QVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE 217
++ V+ E+++ + ++ +V L+ FQ + L+ ++EY+ GGD+M + R+ L E+
Sbjct: 95 DIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH 154
Query: 218 ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277
ARFY AE LA+ +H+ I+RD+K DN+LLD GH++L+D+G+CK
Sbjct: 155 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK------------- 201
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337
E L+ + GTP+YIAPE+L + YG
Sbjct: 202 -----------------------EGLRPGDT-----TSTFCGTPNYIAPEILRGEDYGFS 233
Query: 338 CDWWSLGAIMYEMLVGYPPF---------YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEA 388
DWW+LG +M+EM+ G PF + + I+ ++ P LS++A
Sbjct: 234 VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPRS--LSVKA 289
Query: 389 KDLISKLLC-NVNQRLGA---KGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDT 442
++ L + +RLG G +I+ HP+F VDW + Q+ F P ++ E
Sbjct: 290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNISGEFGL 349
Query: 443 QNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKN 482
NF+ + N+ + + F G+ Y N
Sbjct: 350 DNFDS--QFTNEPVQLTPDDD-DIVRKIDQSEFEGFEYIN 386
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-111
Identities = 99/371 (26%), Positives = 165/371 (44%), Gaps = 63/371 (16%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG 158
+ ++ L+ MG D F ++G+G FGEV C+ K TG +YA KKL K + +R
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 159 QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMM----TLLMRKDTLT 214
+ E+ +LA+V S IV L +F+ L L+M + GGD+ +
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ 287
Query: 215 EDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274
E A FY A+ V +E +H+ + I+RD+KP+N+LLD G++R+SD GL
Sbjct: 288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV---------- 337
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334
E A +T+ GTP ++APE+LL + Y
Sbjct: 338 ---------------ELKAGQTKTK----------------GYAGTPGFMAPELLLGEEY 366
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTC----RKIVNWRTHLKFPEEAKLSIEAKD 390
D+++LG +YEM+ PF + ++++ + +P+ K S +KD
Sbjct: 367 DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPD--KFSPASKD 422
Query: 391 LISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY--QMEAAFIPEVN-----DEL 440
LL + +RLG + D ++ HP F + W ++ + F+P+ +
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSRTVYAKNIQ 482
Query: 441 DTQNFEKFEES 451
D F +
Sbjct: 483 DVGAFSTVKGV 493
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 340 bits (873), Expect = e-111
Identities = 117/466 (25%), Positives = 196/466 (42%), Gaps = 81/466 (17%)
Query: 34 ESTDEEALSNVTKQKVAAAKQYIENHYKEQMKNLQERRERRNILEKKLADADVSEEDQNN 93
T + + V +Q V Q +E + + R + AD S
Sbjct: 111 SHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIY---- 166
Query: 94 LLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSE 153
+ ++ L+R + + F ++GKG FGEV C+ + TG +YA KKL+K
Sbjct: 167 -----FNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKR 221
Query: 154 MLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKD 211
+ +R E+ +L +V+S +V L +++ + L L++ + GGD+ + M +
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQA 281
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
E A FY AE +E +H+ ++RD+KP+N+LLD +GH+R+SD GL
Sbjct: 282 GFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV------- 334
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
G + G VGT Y+APEV+
Sbjct: 335 ---HVPEGQTIKGR--------------------------------VGTVGYMAPEVVKN 359
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTC----RKIVNWRTHLKFPEEAKLSIE 387
+ Y DWW+LG ++YEM+ G PF R + ++ E + S +
Sbjct: 360 ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSE--RFSPQ 415
Query: 388 AKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDE--L 440
A+ L S+LLC + +RLG + A E+K HP F +++ R+ +E F P+
Sbjct: 416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQAIYCK 475
Query: 441 DTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDIN-FVGYTYKNFEI 485
D + E+F S+ G L D + + + + I
Sbjct: 476 DVLDIEQF---------STVKGV---ELEPTDQDFYQKFATGSVPI 509
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 339 bits (871), Expect = e-110
Identities = 112/415 (26%), Positives = 194/415 (46%), Gaps = 61/415 (14%)
Query: 83 DADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH 142
A + + + K R +M DF L ++GKG+FG+V + K T
Sbjct: 308 RAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDE 367
Query: 143 VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGG 201
+YA+K LKK +++ VE E+ +LA + +L+ FQ + LY +MEY+ GG
Sbjct: 368 LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427
Query: 202 DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261
D+M + + E A FY AE + + + I+RD+K DN++LD GH++++DFG
Sbjct: 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFG 487
Query: 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321
+CK E T + GTP
Sbjct: 488 MCK-------------------------ENIWDGVTT----------------KTFCGTP 506
Query: 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE 381
DYIAPE++ + YG DWW+ G ++YEML G PF +D + I+ ++ +P+
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME--HNVAYPKS 564
Query: 382 AKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAFIPEV 436
+S EA + L+ + +RLG +G +IK H +F +DW ++ +++ + P+
Sbjct: 565 --MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 622
Query: 437 NDELDTQNFEK-FEESDNQTKTSSK-TGPWRKMLSSKD-INFVGYTYKNFEIVND 488
+ + +NF++ F T+ T P ++++ + D F G+++ N E +
Sbjct: 623 SGR-NAENFDRFF------TRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEFLKP 670
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 334 bits (857), Expect = e-107
Identities = 105/377 (27%), Positives = 173/377 (45%), Gaps = 68/377 (18%)
Query: 88 EEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK 147
+ + +F + K E + +DF + +IG+G FGEV CR+ TG +YAMK
Sbjct: 165 FIESDKFTRFCQWKNVE----LNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMK 220
Query: 148 KLKKSEMLRRGQVEHVRAERNLLAEVDSNC---IVKLYCSFQDDEFLYLIMEYLPGGDMM 204
L K + + ER +L+ V + IV + +F + L I++ + GGD+
Sbjct: 221 CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLH 280
Query: 205 TLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
L + +E + RFY AE +L +E +H ++RD+KP N+LLD++GH+R+SD GL
Sbjct: 281 YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 340
Query: 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI 324
+ K + +++VGT Y+
Sbjct: 341 ----------------------------------------DFSKKK---PHASVGTHGYM 357
Query: 325 APEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMST---CRKIVNWRTHLKFPE 380
APEVL K Y DW+SLG +++++L G+ PF R + ++ P+
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD 415
Query: 381 EAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAFIPE 435
S E + L+ LL +VN+RLG +GA E+K P+F +DW ++ + IP
Sbjct: 416 --SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 473
Query: 436 VN-----DELDTQNFEK 447
D D +F++
Sbjct: 474 RGEVNAADAFDIGSFDE 490
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 299 bits (767), Expect = 4e-99
Identities = 97/316 (30%), Positives = 144/316 (45%), Gaps = 51/316 (16%)
Query: 103 TEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH 162
T + + K DDF++ +GKG FG V + REK + A+K L KS++ + G
Sbjct: 1 TALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQ 60
Query: 163 VRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
+R E + + + I+++Y F D + +YL++E+ P G++ L + E + ++
Sbjct: 61 LRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFM 120
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
E A+ H+ IHRDIKP+NLL+ G L+++DFG
Sbjct: 121 EELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSV------------------ 162
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
H RR + GT DY+ PE++ K + + D W
Sbjct: 163 ----------------------HAPSLRR---RTMCGTLDYLPPEMIEGKTHDEKVDLWC 197
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401
G + YE LVG PPF S T R+IV LKFP LS +KDLISKLL + Q
Sbjct: 198 AGVLCYEFLVGMPPFDSPSHTETHRRIV--NVDLKFPP--FLSDGSKDLISKLLRYHPPQ 253
Query: 402 RLGAKGADEIKVHPWF 417
RL + HPW
Sbjct: 254 RL---PLKGVMEHPWV 266
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 2e-98
Identities = 94/310 (30%), Positives = 143/310 (46%), Gaps = 51/310 (16%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
++ + +DFE+ +GKG FG V + REK + + A+K L K+++ + G +R E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+ + + I++LY F D +YLI+EY P G + L + E Y+ E A
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+ H IHRDIKP+NLLL G L+++DFG
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV------------------------ 157
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
H +RR GT DY+ PE++ + + + D WSLG + Y
Sbjct: 158 ----------------HAPSSRR---TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCY 198
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407
E LVG PPF ++ T ++I R FP+ ++ A+DLIS+LL N +QR
Sbjct: 199 EFLVGKPPFEANTYQETYKRIS--RVEFTFPD--FVTEGARDLISRLLKHNPSQRP---M 251
Query: 408 ADEIKVHPWF 417
E+ HPW
Sbjct: 252 LREVLEHPWI 261
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 1e-83
Identities = 89/304 (29%), Positives = 148/304 (48%), Gaps = 50/304 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DF++ ++GKG+F V TG A+K + K M + G V+ V+ E + ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
I++LY F+D ++YL++E G+M L + +E+EAR ++ + + + +H
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRD+ NLLL + +++++DFGL +T + +E+
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGL------ATQLKMP-------------HEK--- 168
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
T GTP+YI+PE+ + +G+E D WSLG + Y +L+G
Sbjct: 169 -HYT------------------LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413
PPF +D +T K+V + P LSIEAKDLI +LL N RL +
Sbjct: 210 PPFDTDTVKNTLNKVV--LADYEMPSF--LSIEAKDLIHQLLRRNPADRL---SLSSVLD 262
Query: 414 HPWF 417
HP+
Sbjct: 263 HPFM 266
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 2e-83
Identities = 87/303 (28%), Positives = 142/303 (46%), Gaps = 49/303 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +GKG F + + T V+A K + KS +L+ Q E + E ++ +
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V + F+D++F+++++E ++ L R+ LTE EAR+Y+ + VL + +H++
Sbjct: 75 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 134
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRD+K NL L++ +++ DFGL +T E D ER
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYD-------------GER---- 171
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K+ GTP+YIAPEVL KKG+ E D WS+G IMY +LVG P
Sbjct: 172 KKV------------------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 213
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414
PF + T +I + P+ ++ A LI K+L + R +E+
Sbjct: 214 PFETSCLKETYLRIK--KNEYSIPKH--INPVAASLIQKMLQTDPTARP---TINELLND 266
Query: 415 PWF 417
+F
Sbjct: 267 EFF 269
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 259 bits (663), Expect = 6e-83
Identities = 87/303 (28%), Positives = 142/303 (46%), Gaps = 49/303 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +GKG F + + T V+A K + KS +L+ Q E + E ++ +
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V + F+D++F+++++E ++ L R+ LTE EAR+Y+ + VL + +H++
Sbjct: 101 QHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRN 160
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRD+K NL L++ +++ DFGL +T E D ER
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGL------ATKVEYD-------------GER---- 197
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
K+ GTP+YIAPEVL KKG+ E D WS+G IMY +LVG P
Sbjct: 198 KKV------------------LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKP 239
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414
PF + T +I + P+ ++ A LI K+L + R +E+
Sbjct: 240 PFETSCLKETYLRIK--KNEYSIPKH--INPVAASLIQKMLQTDPTARP---TINELLND 292
Query: 415 PWF 417
+F
Sbjct: 293 EFF 295
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 5e-82
Identities = 77/319 (24%), Positives = 136/319 (42%), Gaps = 52/319 (16%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A DFE + ++G+GAFG+V R YA+KK++ +E ++ + +E LLA ++
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLN 60
Query: 175 SNCIVKLYCSFQDDE-------------FLYLIMEYLPGGDMMTLLM-RKDTLTEDEARF 220
+V+ Y ++ + L++ MEY G + L+ DE
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+ + A+ IH IHRD+KP N+ +D+ ++++ DFGL K
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAK---------------- 164
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECD 339
N++ S + + + L S +GT Y+A EVL G Y + D
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLT-----------SAIGTAMYVATEVLDGTGHYNEKID 213
Query: 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-N 398
+SLG I +EM+ YP + ++ +K+ + + K +I L+ +
Sbjct: 214 MYSLGIIFFEMI--YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHD 271
Query: 399 VNQRLGAKGADEIKVHPWF 417
N+R GA+ + W
Sbjct: 272 PNKRPGAR---TLLNSGWL 287
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 250 bits (640), Expect = 8e-80
Identities = 67/320 (20%), Positives = 115/320 (35%), Gaps = 56/320 (17%)
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
+ Y + F+ L+ +G G++GEV R K G +YA+K+ +
Sbjct: 42 QSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DR 100
Query: 161 EHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEA 218
AE +V C V+L ++++ LYL E G + +L E +
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV 159
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
Y+ +T+LA+ +H +H D+KP N+ L G +L DFGL L
Sbjct: 160 WGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL------------ 207
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
G P Y+APE+ L+ YG
Sbjct: 208 ------------------------------GTAGAGEVQEGDPRYMAPEL-LQGSYGTAA 236
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC- 397
D +SLG + E+ + + +++ +F LS E + ++ +L
Sbjct: 237 DVFSLGLTILEVACNMELPHGGEGW---QQLRQGYLPPEFTA--GLSSELRSVLVMMLEP 291
Query: 398 NVNQRLGAKGADEIKVHPWF 417
+ R A+ + P
Sbjct: 292 DPKLRATAE---ALLALPVL 308
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 243 bits (621), Expect = 2e-76
Identities = 58/366 (15%), Positives = 125/366 (34%), Gaps = 94/366 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR--------------RGQVE 161
+D+ ++ + +G F ++ +C + YA+KK +KS + + + + +
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--------MRKDTL 213
+ E ++ ++ + + + + +Y+I EY+ ++ +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 214 TEDEARFYVAETVLAIESIHKHHYI-HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
+ + + + IH I HRD+KP N+L+DK G ++LSDFG +
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE-------- 200
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
+ + + GT +++ PE +
Sbjct: 201 --------------------------------YMVDKKI---KGSRGTYEFMPPEFFSNE 225
Query: 333 G--YGMECDWWSLGAIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEEAK------ 383
G + D WSLG +Y M PF + I ++++P +
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT--KNIEYPLDRNHFLYPL 283
Query: 384 -----------LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAA 431
LS E D + L N +R+ +++ H W + + +
Sbjct: 284 TNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI---TSEDALKHEWLADTNIEDLREFSKE 340
Query: 432 FIPEVN 437
+
Sbjct: 341 LYKKRK 346
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 1e-73
Identities = 75/332 (22%), Positives = 134/332 (40%), Gaps = 63/332 (18%)
Query: 102 ETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE 161
TE + Q + + +L IG G +V + +YA+K + E ++
Sbjct: 14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLD 71
Query: 162 HVRAERNLLAEVD--SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEAR 219
R E L ++ S+ I++LY D+++Y++ME D+ + L +K ++ E +
Sbjct: 72 SYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERK 130
Query: 220 FYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279
Y + A+ +IH+H +H D+KP N L+ G L+L DFG+ + T
Sbjct: 131 SYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT--------- 180
Query: 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--------- 330
++ S VGT +Y+ PE +
Sbjct: 181 ------------------------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENG 210
Query: 331 --KKGYGMECDWWSLGAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIE 387
K + D WSLG I+Y M G PF + +S I++ ++FP+ +
Sbjct: 211 KSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKD 268
Query: 388 AKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
+D++ L + QR+ E+ HP+
Sbjct: 269 LQDVLKCCLKRDPKQRI---SIPELLAHPYVQ 297
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 4e-73
Identities = 82/308 (26%), Positives = 140/308 (45%), Gaps = 54/308 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D++++ +GKGAF VR C KTTG +A K + ++ R + + E + ++
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ S Q++ F YL+ + + GG++ ++ ++ +E +A + + + +I H +
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HR++KP+NLLL K ++L+DFGL
Sbjct: 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---------------------------- 156
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + GTP Y++PEVL K Y D W+ G I+Y +LV
Sbjct: 157 ------------EVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 202
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPF+ +D +I +P ++ EAK LI +L N +R+ AD
Sbjct: 203 GYPPFWDEDQHRLYAQIK--AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI---TAD 257
Query: 410 EIKVHPWF 417
+ PW
Sbjct: 258 QALKVPWI 265
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 233 bits (595), Expect = 1e-72
Identities = 72/305 (23%), Positives = 130/305 (42%), Gaps = 51/305 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + L IG+G+FG+ + + G Y +K++ S M + + E R E +LA +
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK-EREESRREVAVLANMKH 82
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIH 233
IV+ SF+++ LY++M+Y GGD+ + ED+ + + LA++ +H
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+HRDIK N+ L K G ++L DFG+ + L+ +
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV----------------------- 179
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
LA + +GTP Y++PE+ K Y + D W+LG ++YE+
Sbjct: 180 ------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTL 221
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
F + + KI++ + S + + L+S+L N R + I
Sbjct: 222 KHAFEAGSMKNLVLKIIS-GSFPPVSL--HYSYDLRSLVSQLFKRNPRDRP---SVNSIL 275
Query: 413 VHPWF 417
+
Sbjct: 276 EKGFI 280
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 230 bits (589), Expect = 9e-72
Identities = 80/376 (21%), Positives = 143/376 (38%), Gaps = 68/376 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-- 174
+ +L IG G +V + +YA+K + E ++ R E L ++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQH 67
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
S+ I++LY D+++Y++ME D+ + L +K ++ E + Y + A+ +IH+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +H D+KP N L+ G L+L DFG+ + T
Sbjct: 127 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT------------------------ 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----------KKGYGMECDWWSL 343
++ S VGT +Y+ PE + K + D WSL
Sbjct: 162 ---------------TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 206
Query: 344 GAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401
G I+Y M G PF + +S I++ ++FP+ + +D++ L + Q
Sbjct: 207 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQ 264
Query: 402 RLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDT----QNFEKFEESDNQTKT 457
R+ E+ HP+ + + QM E+ L + ++
Sbjct: 265 RI---SIPELLAHPYVQ-IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYE 320
Query: 458 SSKTGPWRKMLSSKDI 473
G SSK
Sbjct: 321 HYSGGESHNSSSSKTF 336
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 2e-71
Identities = 85/324 (26%), Positives = 134/324 (41%), Gaps = 63/324 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD- 174
+++E ++G+G VR C K T YA+K + + E L EVD
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 175 ------SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
I++L +++ + F +L+ + + G++ L K TL+E E R + +
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
I ++HK + +HRD+KP+N+LLD +++L+DFG LD +
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD----PGEKLR----------- 181
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYGMECDWWS 342
GTP Y+APE++ GYG E D WS
Sbjct: 182 ---------------------------EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 214
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NV 399
G IMY +L G PPF+ M R I+ + +F S KDL+S+ L
Sbjct: 215 TGVIMYTLLAGSPPFWHRKQMLMLRMIM--SGNYQFGSPEWDDYSDTVKDLVSRFLVVQP 272
Query: 400 NQRLGAKGADEIKVHPWFDGVDWA 423
+R A+E HP+F
Sbjct: 273 QKRY---TAEEALAHPFFQQYVVE 293
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 3e-71
Identities = 86/308 (27%), Positives = 145/308 (47%), Gaps = 55/308 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + ++ M+GKG+FGEV C+++ T YA+K + K+ + + E LL ++D
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL+ +D Y++ E GG++ ++++ +E +A + + I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ +HRD+KP+N+LL +K +++ DFGL
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST---------------------------- 172
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+Q+N +M +GT YIAPEV L+ Y +CD WS G I+Y +L
Sbjct: 173 ------------CFQQNTKM--KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLS 217
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
G PPFY + +++ F +S +AKDLI K+L + + R+ A
Sbjct: 218 GTPPFYGKNEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275
Query: 410 EIKVHPWF 417
E HPW
Sbjct: 276 E---HPWI 280
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-70
Identities = 81/308 (26%), Positives = 139/308 (45%), Gaps = 54/308 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D++++ +GKGAF VR C KTTG +A K + ++ R + + E + ++
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQH 87
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ S Q++ F YL+ + + GG++ ++ ++ +E +A + + + +I H +
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HR++KP+NLLL K ++L+DFGL
Sbjct: 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAI---------------------------- 179
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + GTP Y++PEVL K Y D W+ G I+Y +LV
Sbjct: 180 ------------EVNDSEAW--HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPF+ +D +I +P ++ EAK LI +L N +R+ A
Sbjct: 226 GYPPFWDEDQHRLYAQIK--AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITAD--- 280
Query: 410 EIKVHPWF 417
+ PW
Sbjct: 281 QALKVPWI 288
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-70
Identities = 83/310 (26%), Positives = 139/310 (44%), Gaps = 57/310 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
F + ++G GAF EV + +++ TG ++A+K +KKS + + E +L ++
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKS---PAFRDSSLENEIAVLKKIKH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV L ++ YL+M+ + GG++ ++ + TE +A + + + A++ +H++
Sbjct: 66 ENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHEN 125
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLL ++ + ++DFGL K +
Sbjct: 126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST------------------- 166
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
GTP Y+APEVL +K Y D WS+G I Y +L
Sbjct: 167 ------------------------ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPFY + KI + +F +S AKD I LL + N+R +
Sbjct: 203 GYPPFYEETESKLFEKIK--EGYYEFESPFWDDISESAKDFICHLLEKDPNERY---TCE 257
Query: 410 EIKVHPWFDG 419
+ HPW DG
Sbjct: 258 KALSHPWIDG 267
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 2e-70
Identities = 85/326 (26%), Positives = 142/326 (43%), Gaps = 57/326 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEHVRAERNLLAE 172
D +E+ +G G F VR CR+K TG YA K +KK + R E + E N+L E
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ I+ L+ F++ + LI+E + GG++ L K++LTEDEA ++ + + + +
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYL 124
Query: 233 HKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L ++L DFG+ ++ +F
Sbjct: 125 HSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE----AGNEFK----------- 169
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 170 ---------------------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 202
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGA 405
+L G PF + T I + F EE S AKD I +LL + +R+
Sbjct: 203 ILLSGASPFLGETKQETLTNIS--AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTI 260
Query: 406 KGADEIKVHPWFDGVDWARIYQMEAA 431
+ E H W + + ++
Sbjct: 261 AQSLE---HSWIKAIRRRNVRGEDSG 283
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 223 bits (571), Expect = 6e-70
Identities = 73/311 (23%), Positives = 132/311 (42%), Gaps = 59/311 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D F +G GAFG+V + E+++G +K + K + +E + AE +L +D
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDH 79
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGD----MMTLLMRKDTLTEDEARFYVAETVLAIES 231
I+K++ F+D +Y++ME GG+ +++ R L+E + + + A+
Sbjct: 80 PNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAY 139
Query: 232 IHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H +H+D+KP+N+L + +++ DFGL +
Sbjct: 140 FHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE------------------------ 175
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
++ + + GT Y+APEV K+ +CD WS G +MY
Sbjct: 176 ----------------LFKSDEHS--TNAAGTALYMAPEV-FKRDVTFKCDIWSAGVVMY 216
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAK 406
+L G PF +K + E L+ +A DL+ ++L + +R A
Sbjct: 217 FLLTGCLPFTGTSLEEVQQKAT--YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAA 274
Query: 407 GADEIKVHPWF 417
++ H WF
Sbjct: 275 ---QVLHHEWF 282
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 8e-70
Identities = 89/343 (25%), Positives = 150/343 (43%), Gaps = 64/343 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAE 172
D +++ +G G F V+ CREK+TG YA K +KK + + E + E ++L +
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
V + ++ L+ +++ + LI+E + GG++ L +K++L+E+EA ++ + + + +
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 233 HKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L H++L DFGL ++ +F
Sbjct: 132 HTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----DGVEFK----------- 176
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 177 ---------------------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGA 405
+L G PF D T I F EE S AKD I KLL +RL
Sbjct: 210 ILLSGASPFLGDTKQETLANIT--SVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTI 267
Query: 406 KGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKF 448
+ A HPW VD + ++ +NF K
Sbjct: 268 QEALR---HPWITPVD-------NQQAMVRRESVVNLENFRKQ 300
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-69
Identities = 87/308 (28%), Positives = 141/308 (45%), Gaps = 57/308 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L IG+G++GEV++ +K T A KK+ K + V+ + E ++ +D
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++LY +F+D+ +YL+ME GG++ ++ K E +A + + + A+ HK
Sbjct: 66 PNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKL 125
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ HRD+KP+N L L+L DFGL
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---------------------------- 157
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
++ + M + VGTP Y++P+V L+ YG ECD WS G +MY +L
Sbjct: 158 ------------RFKPGKMM--RTKVGTPYYVSPQV-LEGLYGPECDEWSAGVMMYVLLC 202
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPF + KI FPE+ +S +A+ LI +LL + QR+ +
Sbjct: 203 GYPPFSAPTDSEVMLKIR--EGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSL--- 257
Query: 410 EIKVHPWF 417
+ H WF
Sbjct: 258 QALEHEWF 265
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 3e-69
Identities = 82/349 (23%), Positives = 134/349 (38%), Gaps = 87/349 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEV 173
+ L IG+G++G VRV E T + A+K + K+++ + VE ++ E L+ ++
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGD------------------------------- 202
I +LY ++D++++ L+ME GG
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 203 ---------MMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL--DK 251
E + + A+ +H HRDIKP+N L +K
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 252 YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311
++L DFGL K E
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGM---------------------------------- 231
Query: 312 MLAYSTVGTPDYIAPEVL--LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKI 369
+ GTP ++APEVL + YG +CD WS G +++ +L+G PF + T ++
Sbjct: 232 ---TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQV 288
Query: 370 VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+N + + P LS A+DL+S LL NV++R A HPW
Sbjct: 289 LNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAM---RALQHPWI 334
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 223 bits (570), Expect = 3e-69
Identities = 87/321 (27%), Positives = 139/321 (43%), Gaps = 63/321 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLL 170
D++ + +G GA GEV++ E+ T A+K K +V E +L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+++ CI+K+ F D E Y+++E + GG++ ++ L E + Y + +LA++
Sbjct: 70 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 128
Query: 231 SIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+H++ IHRD+KP+N+LL ++ ++++DFG K L E
Sbjct: 129 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLM---------- 173
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLG 344
+ GTP Y+APEVL GY D WSLG
Sbjct: 174 ---------------------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206
Query: 345 AIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVN 400
I++ L GYPPF +S +I F E A++S +A DL+ KLL +
Sbjct: 207 VILFICLSGYPPFSEHRTQVSLKDQIT--SGKYNFIPEVWAEVSEKALDLVKKLLVVDPK 264
Query: 401 QRLGAKGADEIKVHPWFDGVD 421
R +E HPW D
Sbjct: 265 ARF---TTEEALRHPWLQDED 282
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 4e-69
Identities = 90/308 (29%), Positives = 148/308 (48%), Gaps = 54/308 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D ++ ++GKG+FGEV +C++K TG A+K + K ++ ++ E + E LL ++D
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDH 85
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KLY F+D + YL+ E GG++ ++ + +E +A + + + I +HK+
Sbjct: 86 PNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKN 145
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLLL K ++R+ DFGL
Sbjct: 146 KIVHRDLKPENLLLESKSKDANIRIIDFGLST---------------------------- 177
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
H++ +++M +GT YIAPEV L Y +CD WS G I+Y +L
Sbjct: 178 ------------HFEASKKM--KDKIGTAYYIAPEV-LHGTYDEKCDVWSTGVILYILLS 222
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
G PPF + +K+ + F K+S AKDLI K+L + R+ A+
Sbjct: 223 GCPPFNGANEYDILKKVE--KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISAR--- 277
Query: 410 EIKVHPWF 417
+ H W
Sbjct: 278 DALDHEWI 285
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 5e-69
Identities = 94/402 (23%), Positives = 161/402 (40%), Gaps = 82/402 (20%)
Query: 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEH 162
M + + D +++ +G G F V+ CREK+TG YA K +KK + R E
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 163 VRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
+ E ++L +V I+ L+ +++ + LI+E + GG++ L +K++L+E+EA ++
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFI 121
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
+ + + +H H D+KP+N++L H++L DFGL ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE----------- 170
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
+ + + GTP+++APE++ + G+E
Sbjct: 171 --------------------DGVEFK-----------NIFGTPEFVAPEIVNYEPLGLEA 199
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLL 396
D WS+G I Y +L G PF D T I F EE + S AKD I KLL
Sbjct: 200 DMWSIGVITYILLSGASPFLGDTKQETLANIT--AVSYDFDEEFFSQTSELAKDFIRKLL 257
Query: 397 C-NVNQRLGAKGADEIKVHPWFDGVD-------------------------WARIYQMEA 430
+RL + A HPW VD W + + +
Sbjct: 258 VKETRKRLTIQEALR---HPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVS 314
Query: 431 AFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKD 472
+ + E+ N + + RK L +
Sbjct: 315 LCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKALHPRR 356
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 5e-69
Identities = 85/317 (26%), Positives = 136/317 (42%), Gaps = 62/317 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLL 170
++ +IG+G VR C + TGH +A+K + S E R E ++L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 171 AEV-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+V I+ L S++ F++L+ + + G++ L K L+E E R + + A+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+H ++ +HRD+KP+N+LLD +RLSDFG
Sbjct: 214 SFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC------------------------- 248
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYGMECDWWSL 343
H + ++ GTP Y+APE+L GYG E D W+
Sbjct: 249 ---------------HLEPGEKL--RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVN 400
G I++ +L G PPF+ + R I+ +F S KDLIS+LL +
Sbjct: 292 GVILFTLLAGSPPFWHRRQILMLRMIM--EGQYQFSSPEWDDRSSTVKDLISRLLQVDPE 349
Query: 401 QRLGAKGADEIKVHPWF 417
RL A++ HP+F
Sbjct: 350 ARL---TAEQALQHPFF 363
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 6e-69
Identities = 79/376 (21%), Positives = 142/376 (37%), Gaps = 68/376 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-- 174
+ +L IG G +V + +YA+K + E ++ R E L ++
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 114
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
S+ I++LY D+++Y++ME D+ + L +K ++ E + Y + A+ +IH+
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 173
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +H D+KP N L+ G L+L DFG+ + T
Sbjct: 174 HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDT------------------------ 208
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----------KKGYGMECDWWSL 343
++ S VG +Y+ PE + K + D WSL
Sbjct: 209 ---------------TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL 253
Query: 344 GAIMYEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401
G I+Y M G PF + +S I++ ++FP+ + +D++ L + Q
Sbjct: 254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQ 311
Query: 402 RLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDT----QNFEKFEESDNQTKT 457
R+ E+ HP+ + + QM E+ L + ++
Sbjct: 312 RI---SIPELLAHPYVQ-IQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYE 367
Query: 458 SSKTGPWRKMLSSKDI 473
G SSK
Sbjct: 368 HYSGGESHNSSSSKTF 383
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 224 bits (574), Expect = 1e-68
Identities = 84/319 (26%), Positives = 140/319 (43%), Gaps = 59/319 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLL 170
D++ + +G GA GEV++ E+ T A++ K +V E +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+++ CI+K+ F D E Y+++E + GG++ ++ L E + Y + +LA++
Sbjct: 195 KKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQ 253
Query: 231 SIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+H++ IHRD+KP+N+LL ++ ++++DFG K L E
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK-----ILGETSLM---------- 298
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDWWSLG 344
+ GTP Y+APEVL GY D WSLG
Sbjct: 299 ---------------------------RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 345 AIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
I++ L GYPPF +S +I + + + A++S +A DL+ KLL + R
Sbjct: 332 VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391
Query: 403 LGAKGADEIKVHPWFDGVD 421
+E HPW D
Sbjct: 392 F---TTEEALRHPWLQDED 407
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 4e-68
Identities = 86/336 (25%), Positives = 150/336 (44%), Gaps = 57/336 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + ++ M+GKG+FGEV C+++ T YA+K + K+ + + E LL ++D
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLDH 80
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL+ +D Y++ E GG++ ++++ +E +A + + I +HKH
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH 140
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ +HRD+KP+N+LL +K +++ DFGL
Sbjct: 141 NIVHRDLKPENILLESKEKDCDIKIIDFGLST---------------------------- 172
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+Q+N +M +GT YIAPEV L+ Y +CD WS G I+Y +L
Sbjct: 173 ------------CFQQNTKM--KDRIGTAYYIAPEV-LRGTYDEKCDVWSAGVILYILLS 217
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
G PPFY + +++ F +S +AKDLI K+L + + R+ A
Sbjct: 218 GTPPFYGKNEYDILKRVE--TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITAT--- 272
Query: 410 EIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNF 445
+ HPW + + + + F
Sbjct: 273 QCLEHPWIQKYSSETPTISDLPSLESAMTNI--RQF 306
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 5e-68
Identities = 78/314 (24%), Positives = 134/314 (42%), Gaps = 59/314 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ--VEHVRAERNLLAEV 173
D +EL +IGKG F VR C + TG +A+K + ++ E ++ E ++ +
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAI 229
IV+L ++ D LY++ E++ G D+ ++++ +E A Y+ + + A+
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEAL 143
Query: 230 ESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
H ++ IHRD+KP +LL + ++L FG+ L S G G
Sbjct: 144 RYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES---------GLVAGG-- 192
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
VGTP ++APEV+ ++ YG D W G I
Sbjct: 193 ------------------------------RVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRL 403
++ +L G PFY I+ + K + +S AKDL+ ++L + +R+
Sbjct: 223 LFILLSGCLPFYGTKER-LFEGII--KGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI 279
Query: 404 GAKGADEIKVHPWF 417
A HPW
Sbjct: 280 TVYEALN---HPWL 290
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 5e-68
Identities = 80/316 (25%), Positives = 141/316 (44%), Gaps = 57/316 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAE 172
D ++ +G G F V+ CREK+TG YA K +KK + E + E ++L E
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ ++ L+ +++ + LI+E + GG++ L K++LTE+EA ++ + + + +
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 130
Query: 233 HKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L +++ DFGL +D +F
Sbjct: 131 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID----FGNEFK----------- 175
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 176 ---------------------------NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGA 405
+L G PF D T + + +F +E S AKD I +LL + +R+
Sbjct: 209 ILLSGASPFLGDTKQETLANVS--AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTI 266
Query: 406 KGADEIKVHPWFDGVD 421
+ + + HPW D
Sbjct: 267 QDSLQ---HPWIKPKD 279
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-67
Identities = 73/309 (23%), Positives = 131/309 (42%), Gaps = 57/309 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLY 182
+G+G F VR C K+TG YA K LKK + + E +L S ++ L+
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLH 95
Query: 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHR 240
+++ + LI+EY GG++ +L + + ++E++ + + + + +H+++ +H
Sbjct: 96 EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 241 DIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
D+KP N+LL G +++ DFG+ + +
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIG------------------------------ 185
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
+L+ +GTP+Y+APE+L D W++G I Y +L PF
Sbjct: 186 -HACELR-----------EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPF 233
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414
+D T I + ++ + EE +S A D I LL N +R A+ H
Sbjct: 234 VGEDNQETYLNIS--QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS---H 288
Query: 415 PWFDGVDWA 423
W D+
Sbjct: 289 SWLQQWDFE 297
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 3e-67
Identities = 83/308 (26%), Positives = 142/308 (46%), Gaps = 53/308 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++++L +GKGAF VR C + G YA + L + + E + +
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTK-KLSARDHQKLEREARICRLLKH 69
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ S ++ YLI + + GG++ ++ ++ +E +A + + + A+ H+
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQM 129
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HR++KP+NLLL K ++L+DFGL ++
Sbjct: 130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE------------------------- 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + + GTP Y++PEVL K YG D W+ G I+Y +LV
Sbjct: 165 --------------GEQQAW--FGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPF+ +D ++I FP ++ EAKDLI+K+L N ++R+ A A
Sbjct: 209 GYPPFWDEDQHRLYQQIK--AGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEAL 266
Query: 410 EIKVHPWF 417
+ HPW
Sbjct: 267 K---HPWI 271
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 4e-67
Identities = 87/309 (28%), Positives = 131/309 (42%), Gaps = 68/309 (22%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKL 181
+G+G+F R C K + +A+K + K + + E L + N IVKL
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPN-IVKL 71
Query: 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRD 241
+ F D +L+ME L GG++ + +K +E EA + + + V A+ +H +HRD
Sbjct: 72 HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRD 131
Query: 242 IKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRT 298
+KP+NLL + +++ DFG A K
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGF------------------------------ARLKPP 161
Query: 299 QQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFY 358
+ L+ + T Y APE+L + GY CD WSLG I+Y ML G PF
Sbjct: 162 DNQPLK-----------TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQ 210
Query: 359 SDDPMSTC-------RKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGA 408
S D TC +KI + F E +S EAKDLI LL + N+RL
Sbjct: 211 SHDRSLTCTSAVEIMKKIK--KGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMS-- 266
Query: 409 DEIKVHPWF 417
++ + W
Sbjct: 267 -GLRYNEWL 274
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 3e-66
Identities = 87/358 (24%), Positives = 149/358 (41%), Gaps = 58/358 (16%)
Query: 68 QERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMG--ADDFELLTMIG 125
++RR ++ E+ N + + Y + K D +++ +G
Sbjct: 107 RKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELG 166
Query: 126 KGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185
GAFG V E+ TG+ +A K + E VR E ++ + +V L+ +F
Sbjct: 167 TGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 186 QDDEFLYLIMEYLPGGDMM-TLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKP 244
+DD + +I E++ GG++ + + ++EDEA Y+ + + +H+++Y+H D+KP
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 245 DNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQ 302
+N++ + L+L DFGL LD +Q +
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLD----PKQSVKV------------------------ 315
Query: 303 LQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
T GT ++ APEV K G D WS+G + Y +L G PF ++
Sbjct: 316 --------------TTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 361
Query: 363 MSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
T R + + A +S + KD I KLL + N R+ A E HPW
Sbjct: 362 DETLRNVK--SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE---HPWL 414
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 3e-66
Identities = 85/362 (23%), Positives = 156/362 (43%), Gaps = 58/362 (16%)
Query: 64 MKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTM 123
M+ + + K +++ D+ + + KK + D +++L
Sbjct: 1 MRGSHHHHHHGSKVRGKYDGPKINDYDK--FYEDIWKKYVPQPVEVKQGSVYDYYDILEE 58
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
+G GAFG V C EK TG V+ K + V+ E +++ ++ ++ L+
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHD 115
Query: 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDI 242
+F+D + LI+E+L GG++ + +D ++E E Y+ + ++ +H+H +H DI
Sbjct: 116 AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDI 175
Query: 243 KPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQ 300
KP+N++ K +++ DFGL L+ ++ +
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLN----PDEIVKV---------------------- 209
Query: 301 EQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSD 360
T T ++ APE++ ++ G D W++G + Y +L G PF +
Sbjct: 210 ----------------TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 253
Query: 361 DPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
D + T + + R +F E+A +S EAKD I LL +RL A E HPW
Sbjct: 254 DDLETLQNVK--RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE---HPWL 308
Query: 418 DG 419
G
Sbjct: 309 KG 310
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 220 bits (562), Expect = 4e-66
Identities = 88/336 (26%), Positives = 154/336 (45%), Gaps = 57/336 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ ++ + +G GA+GEV +CR+K T A+K ++K+ + + E +L +D
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVAVLKLLDH 95
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KLY F+D YL+ME GG++ ++ + E +A + + + + +HKH
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKH 155
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+ +HRD+KP+NLLL +K +++ DFGL
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSA---------------------------- 187
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
++ ++M +GT YIAPEV L+K Y +CD WS+G I++ +L
Sbjct: 188 ------------VFENQKKM--KERLGTAYYIAPEV-LRKKYDEKCDVWSIGVILFILLA 232
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
GYPPF RK+ + F +S AKDLI ++L + +R+ A+
Sbjct: 233 GYPPFGGQTDQEILRKVE--KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQ--- 287
Query: 410 EIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNF 445
+ HPW + + +E + + + + F
Sbjct: 288 QALEHPWIKEMCSKKESGIELPSLANAIENM--RKF 321
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 6e-66
Identities = 74/308 (24%), Positives = 124/308 (40%), Gaps = 57/308 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + + +G+G FG V C E ++ Y K +K + V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNIARH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMM-TLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I+ L+ SF+ E L +I E++ G D+ + L E E YV + A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 235 HHYIHRDIKPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ H DI+P+N++ + +++ +FG + L +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK----PGDNFRL-------------- 162
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
P+Y APEV D WSLG ++Y +L
Sbjct: 163 ------------------------LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGAKGAD 409
G PF ++ I+ F EEA ++SIEA D + +LL R+ A A
Sbjct: 199 GINPFLAETNQQIIENIM--NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEAL 256
Query: 410 EIKVHPWF 417
+ HPW
Sbjct: 257 Q---HPWL 261
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 219 bits (561), Expect = 8e-66
Identities = 89/318 (27%), Positives = 145/318 (45%), Gaps = 64/318 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM----------LRRGQVEHVRA 165
+ + + +G GA+GEV +C+EK A+K +KKS+ E +
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
E +LL +D I+KL+ F+D ++ YL+ E+ GG++ ++ + E +A + +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 226 VLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ I +HKH+ +HRDIKP+N+LL + ++++ DFGL
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS------------------ 197
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ K+ ++ +GT YIAPEV LKK Y +CD WS
Sbjct: 198 ----------------------FFSKDYKL--RDRLGTAYYIAPEV-LKKKYNEKCDVWS 232
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NV 399
G IMY +L GYPPF + +K+ + F +S EAK+LI +L +
Sbjct: 233 CGVIMYILLCGYPPFGGQNDQDIIKKVE--KGKYYFDFNDWKNISDEAKELIKLMLTYDY 290
Query: 400 NQRLGAKGADEIKVHPWF 417
N+R A+ E W
Sbjct: 291 NKRCTAE---EALNSRWI 305
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 9e-66
Identities = 80/314 (25%), Positives = 137/314 (43%), Gaps = 60/314 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D+E+L IG G++G + R K+ G + K+L M + + + +E NLL E+
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEA-EKQMLVSEVNLLRELKH 64
Query: 176 NCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAI 229
IV+ Y D + LY++MEY GGD+ +++ + + L E+ + + LA+
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 230 ESIHKHHY-----IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ H+ +HRD+KP N+ LD +++L DFGL + L+ T
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-------------- 170
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
A + VGTP Y++PE + + Y + D WSLG
Sbjct: 171 ---------------------------SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLG 203
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403
++YE+ PPF + KI + P + S E ++I+++L R
Sbjct: 204 CLLYELCALMPPFTAFSQKELAGKIRE-GKFRRIPY--RYSDELNEIITRMLNLKDYHRP 260
Query: 404 GAKGADEIKVHPWF 417
+EI +P
Sbjct: 261 ---SVEEILENPLI 271
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-65
Identities = 83/316 (26%), Positives = 134/316 (42%), Gaps = 62/316 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +E+ IG G++ + C K T +A+K + KS+ ++E LL
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEI------LLRYGQH 75
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+ L + D +++Y++ E + GG+++ ++R+ +E EA + +E +H
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135
Query: 236 HYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+HRD+KP N+L +R+ DFG K L
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL------------------------- 170
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
R + L + T +++APEVL ++GY CD WSLG ++Y ML
Sbjct: 171 -----RAENGLL-----------MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214
Query: 352 VGYPPFYS---DDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGA 405
GY PF + D P +I +S AKDL+SK+L + +QRL
Sbjct: 215 TGYTPFANGPDDTPEEILARIG--SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL-- 270
Query: 406 KGADEIKVHPWFDGVD 421
A + HPW D
Sbjct: 271 -TAALVLRHPWIVHWD 285
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-65
Identities = 65/323 (20%), Positives = 109/323 (33%), Gaps = 81/323 (25%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DF+ + +IG G FG+V + + G Y +K++K + E E LA++D
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLD 62
Query: 175 SNCIVKLYCSFQDDE----------------FLYLIMEYLPGGDMMTLL--MRKDTLTED 216
IV + + L++ ME+ G + + R + L +
Sbjct: 63 HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
A + ++ IH I+RD+KP N+ L +++ DFGL L
Sbjct: 123 LALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---------- 172
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
+ GT Y++PE + + YG
Sbjct: 173 --------------------------------KNDGKRTRSKGTLRYMSPEQISSQDYGK 200
Query: 337 ECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKL 395
E D ++LG I+ E+L V F + + R + + K L+ KL
Sbjct: 201 EVDLYALGLILAELLHVCDTAFETSKFFTDLRDG-------IISD--IFDKKEKTLLQKL 251
Query: 396 LC-NVNQRLGAKGADEIKVHPWF 417
L R EI
Sbjct: 252 LSKKPEDRP---NTSEILRTLTV 271
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 2e-65
Identities = 88/311 (28%), Positives = 140/311 (45%), Gaps = 59/311 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D FE+ + +G+GA V C++K T YA+K LKK+ + VR E +L +
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSH 107
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I+KL F+ + L++E + GG++ ++ K +E +A V + + A+ +H++
Sbjct: 108 PNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHEN 167
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLL L+++DFGL K
Sbjct: 168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSK---------------------------- 199
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ M + GTP Y APE+L YG E D WS+G I Y +L
Sbjct: 200 ------------IVEHQVLM--KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLC 245
Query: 353 GYPPFYSD-DPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGA 408
G+ PFY + R+I+ F ++S+ AKDL+ KL+ + +RL A
Sbjct: 246 GFEPFYDERGDQFMFRRIL--NCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
Query: 409 DEIKVHPWFDG 419
+ HPW G
Sbjct: 304 LQ---HPWVTG 311
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 2e-64
Identities = 77/307 (25%), Positives = 134/307 (43%), Gaps = 56/307 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
++G G FG+V C E TG A K +K M + E V+ E +++ ++D
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDK---EEVKNEISVMNQLDHA 146
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKH 235
+++LY +F+ + L+MEY+ GG++ ++ + LTE + ++ + I +H+
Sbjct: 147 NLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQM 206
Query: 236 HYIHRDIKPDNLLL-DKYGH-LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +H D+KP+N+L ++ +++ DFGL +
Sbjct: 207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-------------------------- 240
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
++ GTP+++APEV+ D WS+G I Y +L G
Sbjct: 241 --------------PREKL--KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEA--KLSIEAKDLISKLLC-NVNQRLGAKGADE 410
PF D+ T I+ +E +S EAK+ ISKLL + R+ A A +
Sbjct: 285 LSPFLGDNDAETLNNIL--ACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342
Query: 411 IKVHPWF 417
HPW
Sbjct: 343 ---HPWL 346
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 2e-64
Identities = 89/317 (28%), Positives = 136/317 (42%), Gaps = 68/317 (21%)
Query: 116 DDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DD++L ++G G G+V C + TG A+K L S R+ +V+H
Sbjct: 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ-EVDH------HWQASG 80
Query: 175 SNCIVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLA 228
IV + +++ L +IME + GG++ + + + TE EA + + A
Sbjct: 81 GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 229 IESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
I+ +H H+ HRD+KP+NLL +K L+L+DFG K + LQ
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ------------- 187
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345
+ TP Y+APEVL + Y CD WSLG
Sbjct: 188 ------------------------------TPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 217
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVN--WRTHLKFPEE--AKLSIEAKDLISKLLC-NVN 400
IMY +L G+PPFYS+ + + FP +++S +AK LI LL +
Sbjct: 218 IMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPT 277
Query: 401 QRLGAKGADEIKVHPWF 417
+RL + HPW
Sbjct: 278 ERL---TITQFMNHPWI 291
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 1e-63
Identities = 79/323 (24%), Positives = 131/323 (40%), Gaps = 67/323 (20%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC--IVK 180
++G+GA V+ C T YA+K ++K R V E +L + +++
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR---SRVFREVEMLYQC-QGHRNVLE 75
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHR 240
L F++++ YL+ E + GG +++ + ++ E EA V + A++ +H HR
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHR 135
Query: 241 DIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
D+KP+N+L ++ +++ DF L +
Sbjct: 136 DLKPENILCEHPNQVSPVKICDFDLGSGIK------------------------------ 165
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLGAIMYEMLV 352
+ + G+ +Y+APEV+ Y CD WSLG I+Y +L
Sbjct: 166 --LNGDCSPISTPEL--LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLS 221
Query: 353 GYPPFYSDDPMSTCRKIVNWRT-------------HLKFPEE--AKLSIEAKDLISKLLC 397
GYPPF +FP++ A +S AKDLISKLL
Sbjct: 222 GYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLV 281
Query: 398 -NVNQRLGAKGADEIKVHPWFDG 419
+ QRL A ++ HPW G
Sbjct: 282 RDAKQRL---SAAQVLQHPWVQG 301
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-63
Identities = 67/349 (19%), Positives = 117/349 (33%), Gaps = 90/349 (25%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+ L ++G+GA V R K TG ++A+K LR V+ E +L
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLK 62
Query: 172 EVDSNCIVKLYCSFQDD--EFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETV 226
+++ IVKL+ ++ LIME+ P G + T+L L E E + + V
Sbjct: 63 KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 227 LAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + ++ +HR+IKP N++ D +L+DFG + L+
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE------------ 170
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--------LKKGY 334
S GT +Y+ P++ +K Y
Sbjct: 171 ------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKY 200
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN---------------------WR 373
G D WS+G Y G PF + ++++
Sbjct: 201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPID 260
Query: 374 THLKFPEEAKLSIEAKDLISKLL-----CNVNQRLGAKGADEIKVHPWF 417
P LS + L++ +L + + G D+
Sbjct: 261 WSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW---GFDQFFAETSD 306
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 6e-63
Identities = 88/329 (26%), Positives = 140/329 (42%), Gaps = 76/329 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ L IGKG++G V++ + YAMK L K +++R+ R
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 178 -----------------------IVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDT 212
+VKL D ++ LY++ E + G +M +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKP 133
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
L+ED+ARFY + + IE +H IHRDIKP NLL+ + GH++++DFG+
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS--------- 184
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--L 330
+ K L +TVGTP ++APE L
Sbjct: 185 --------------------------------NEFKGSDALLSNTVGTPAFMAPESLSET 212
Query: 331 KKGY-GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAK 389
+K + G D W++G +Y + G PF + M KI L+FP++ ++ + K
Sbjct: 213 RKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIK--SQALEFPDQPDIAEDLK 270
Query: 390 DLISKLLC-NVNQRLGAKGADEIKVHPWF 417
DLI+++L N R+ EIK+HPW
Sbjct: 271 DLITRMLDKNPESRI---VVPEIKLHPWV 296
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 6e-63
Identities = 91/322 (28%), Positives = 132/322 (40%), Gaps = 77/322 (23%)
Query: 116 DDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DD+++ + ++G G G+V K T +A+K L+ RR E L
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA- 111
Query: 175 SNC--IVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVA 223
S C IV++ +++ + L ++ME L GG+ L R TE EA +
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMK 168
Query: 224 ETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
AI+ +H + HRD+KP+NLL L+L+DFG
Sbjct: 169 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF------------------ 210
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
A + T L + TP Y+APEVL + Y CD
Sbjct: 211 -------------AKETTSHNSLT-----------TPCYTPYYVAPEVLGPEKYDKSCDM 246
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN--WRTHLKFPEE--AKLSIEAKDLISKLL 396
WSLG IMY +L GYPPFYS+ ++ + +FP +++S E K LI LL
Sbjct: 247 WSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLL 306
Query: 397 C-NVNQRLGAKGADEIKVHPWF 417
QR+ E HPW
Sbjct: 307 KTEPTQRMTIT---EFMNHPWI 325
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 8e-63
Identities = 73/289 (25%), Positives = 120/289 (41%), Gaps = 53/289 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+F + IG+G F EV G A+KK++ +++ E +LL +++
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIES 231
++K Y SF +D L +++E GD+ ++ +K + E Y + A+E
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H +HRDIKP N+ + G ++L D GL + T
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT--------------------- 190
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
A+S VGTP Y++PE + + GY + D WSLG ++YEM
Sbjct: 191 --------------------TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA 230
Query: 352 VGYPPFYSDD--PMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLL 396
PFY D S C+KI +P S E + L++ +
Sbjct: 231 ALQSPFYGDKMNLYSLCKKIEQ----CDYPPLPSDHYSEELRQLVNMCI 275
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 9e-63
Identities = 69/323 (21%), Positives = 126/323 (39%), Gaps = 57/323 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DFE + +G+G FG V + K YA+K+++ E V E LA+++
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL--AREKVMREVKALAKLEH 62
Query: 176 NCIVKLYCSFQDDE------------FLYLIMEYLPGGDMMTLLMRKDTLTEDEARF--- 220
IV+ + ++ + +LY+ M+ ++ + + T+ E E
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+ A+E +H +HRD+KP N+ +++ DFGL +D
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD------------- 169
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
+ ++EQ VGT Y++PE + Y + D
Sbjct: 170 ----------------QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-N 398
+SLG I++E+L YP + + T + N LKFP + ++ +L +
Sbjct: 214 FSLGLILFELL--YPFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPS 267
Query: 399 VNQRLGAKGADEIKVHPWFDGVD 421
+R A I + F+ +D
Sbjct: 268 PMERP---EAINIIENAVFEDLD 287
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 6e-62
Identities = 65/331 (19%), Positives = 115/331 (34%), Gaps = 55/331 (16%)
Query: 101 KETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV 160
+E Y + + + + +G+G F V + GH YA+K++ E
Sbjct: 14 RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDR 70
Query: 161 EHVRAERNLLAEVDSNCIVKLYCSFQDDEF----LYLIMEYLPGGD----MMTLLMRKDT 212
E + E ++ + I++L + +L++ + G + L + +
Sbjct: 71 EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272
LTED+ + + +E+IH Y HRD+KP N+LL G L D G
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA------ 184
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
Q LQ W + T Y APE+ +
Sbjct: 185 ------------------CIHVEGSRQALTLQDW--------AAQRCTISYRAPELFSVQ 218
Query: 333 GY---GMECDWWSLGAIMYEMLVGYPPFYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIE 387
+ D WSLG ++Y M+ G P+ S + N L P+ + S
Sbjct: 219 SHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---QLSIPQSPRHSSA 275
Query: 388 AKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
L++ ++ + +QR +
Sbjct: 276 LWQLLNSMMTVDPHQRP---HIPLLLSQLEA 303
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 8e-62
Identities = 71/307 (23%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D++L+ +G+GA+GEV++ + T A+K + + E+++ E + ++
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK Y ++ YL +EY GG++ + + E +A+ + + + + +H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HRDIKP+NLLLD+ +L++SDFGL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA-----------------------------TVF 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354
+ +E+L + GT Y+APE+L ++ + D WS G ++ ML G
Sbjct: 156 RYNNRERLLN----------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 355 PPFYSDDPMSTC---RKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410
P+ D P +C K+ L+ K+L N + R+ +
Sbjct: 206 LPW--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPD 258
Query: 411 IKVHPWF 417
IK W+
Sbjct: 259 IKKDRWY 265
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 9e-62
Identities = 37/357 (10%), Positives = 96/357 (26%), Gaps = 106/357 (29%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--------------- 167
++G+ ++ TG + + +E ++ ++ E
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 168 ----------NLLAEVDSNCIVKLYCSFQDDEFL--YLIME------YLPGGDMMTLLMR 209
+L+ + ++++ +D L + + G +++
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
+L + + + S+H + +H ++P +++LD+ G + L+ F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR 259
Query: 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329
+ + + PE+
Sbjct: 260 V---------------------------------------------VSSVSRGFEPPELE 274
Query: 330 L-----------KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKF 378
+ D W+LG ++Y + P D + I F
Sbjct: 275 ARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWI--------F 326
Query: 379 PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIP 434
+ + L+ L RL + P ++ + +A +P
Sbjct: 327 RSCKNIPQPVRALLEGFLRYPKEDRL---LPLQAMETPEYEQLR-----TELSAALP 375
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-61
Identities = 75/313 (23%), Positives = 125/313 (39%), Gaps = 67/313 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE---HVRAERNLLAE 172
++ L ++GKG FG V T A+K + ++ +L + E LL +
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 173 VDSNC----IVKLYCSFQDDEFLYLIMEY-LPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
V + +++L F+ E L++E LP D+ + K L E +R + + V
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 228 AIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
AI+ H +HRDIK +N+L+D + G +L DFG + L ++ +T
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS-----GALLHDEPYT--------- 196
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGA 345
GT Y PE + + Y + WSLG
Sbjct: 197 -----------------------------DFDGTRVYSPPEWISRHQYHALPATVWSLGI 227
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404
++Y+M+ G PF D ++I+ L FP +S + LI + L + R
Sbjct: 228 LLYDMVCGDIPFERD------QEILEAE--LHFPA--HVSPDCCALIRRCLAPKPSSRP- 276
Query: 405 AKGADEIKVHPWF 417
+EI + PW
Sbjct: 277 --SLEEILLDPWM 287
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 3e-61
Identities = 75/354 (21%), Positives = 131/354 (37%), Gaps = 65/354 (18%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMK-----KLKKSEMLRRGQVEHVRAERNLLA 171
+ ++ +G GAFG V +K +K K+ + + ++ V E +L+
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIME-YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
V+ I+K+ F++ F L+ME + G D+ + R L E A + + V A+
Sbjct: 85 RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ IHRDIK +N+++ + ++L DFG G
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY----------LERGKLFY------- 187
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYE 349
+ GT +Y APEVL+ Y G E + WSLG +Y
Sbjct: 188 -------------------------TFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYT 222
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408
++ PF + V + P +S E L+S LL +R
Sbjct: 223 LVFEENPFCEL------EETV--EAAIHPPY--LVSKELMSLVSGLLQPVPERRT---TL 269
Query: 409 DEIKVHPWF-DGVDWARIYQMEAAFIPEV-NDELDTQNFEKFEESDNQTKTSSK 460
+++ PW V+ A E + + + L + E S + + +
Sbjct: 270 EKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQE 323
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 8e-61
Identities = 90/355 (25%), Positives = 139/355 (39%), Gaps = 57/355 (16%)
Query: 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
H ++ + IG G FG R+ R+K T + A+K +++ + E+V+ E
Sbjct: 17 HDSD--RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINH 70
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+ IV+ L +IMEY GG++ + +EDEARF+ + + +
Sbjct: 71 RSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 231 SIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H HRD+K +N LLD L++ DFG S
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGY------SKSSVLH------------- 171
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
Q + STVGTP YIAPEVLL++ Y G D WS G +
Sbjct: 172 ------------SQPK-----------STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTL 208
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404
Y MLVG PF + RK + P++ ++S E LIS++ + R+
Sbjct: 209 YVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRIS 268
Query: 405 AKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSS 459
EIK H WF A + E Q+ + + ++ +
Sbjct: 269 IP---EIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPA 320
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-60
Identities = 82/311 (26%), Positives = 136/311 (43%), Gaps = 53/311 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
R K+G + L +G G FG+V++ + TGH A+K L + ++ V ++ E
Sbjct: 6 GRVKIG--HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQ 63
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L I+KLY +++MEY+ GG++ + + + E EAR + + A
Sbjct: 64 NLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSA 123
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ H+H +HRD+KP+N+LLD + + +++DFGL N
Sbjct: 124 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------------------N 159
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
RT + G+P+Y APEV+ + Y G E D WS G I+
Sbjct: 160 MMSDGEFLRT------------------SCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
Y +L G PF + + +KI PE L+ L+ +L + +R
Sbjct: 202 YALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEY--LNRSVATLLMHMLQVDPLKRA--- 254
Query: 407 GADEIKVHPWF 417
+I+ H WF
Sbjct: 255 TIKDIREHEWF 265
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 4e-60
Identities = 71/307 (23%), Positives = 130/307 (42%), Gaps = 53/307 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D++L+ +G+GA+GEV++ + T A+K + + E+++ E + ++
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 64
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK Y ++ YL +EY GG++ + + E +A+ + + + + +H
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 124
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HRDIKP+NLLLD+ +L++SDFGL
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLA-----------------------------TVF 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354
+ +E+L + GT Y+APE+L ++ + D WS G ++ ML G
Sbjct: 156 RYNNRERLLN----------KMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205
Query: 355 PPFYSDDPMSTC---RKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410
P+ D P +C K+ L+ K+L N + R+ +
Sbjct: 206 LPW--DQPSDSCQEYSDWK--EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPD 258
Query: 411 IKVHPWF 417
IK W+
Sbjct: 259 IKKDRWY 265
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 1e-59
Identities = 68/334 (20%), Positives = 117/334 (35%), Gaps = 87/334 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L ++G+GA V R K TG ++A+K LR V+ E +L +++
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 176 NCIVKLYCSFQDD--EFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIE 230
IVKL+ ++ LIME+ P G + T+L L E E + + V +
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 231 SIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ ++ +HR+IKP N++ D +L+DFG + L+
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE------------------- 167
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--------LKKGYGMEC 338
EQ S GT +Y+ P++ +K YG
Sbjct: 168 ------------DDEQFV-----------SLYGTEEYLHPDMYERAVLRKDHQKKYGATV 204
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN---------------------WRTHLK 377
D WS+G Y G PF + ++++
Sbjct: 205 DLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGD 264
Query: 378 FPEEAKLSIEAKDLISKLL-----CNVNQRLGAK 406
P LS + L++ +L + + G
Sbjct: 265 MPVSCSLSRGLQVLLTPVLANILEADQEKCWGFD 298
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 8e-59
Identities = 73/311 (23%), Positives = 124/311 (39%), Gaps = 65/311 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH---VRAERNLLAE 172
+++ ++G G FG V + A+K ++K + G++ + V E LL +
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 173 VDSNC--IVKLYCSFQDDEFLYLIMEY-LPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
V S +++L F+ + LI+E P D+ + + L E+ AR + + + A+
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 162
Query: 230 ESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H +HRDIK +N+L+D G L+L DFG L
Sbjct: 163 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-----------------AL------ 199
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
+ + GT Y PE + Y G WSLG ++
Sbjct: 200 ---------LKDTVYTDF-----------DGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 239
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
Y+M+ G PF D +I+ + + F + ++S E + LI L + R
Sbjct: 240 YDMVCGDIPFEHD------EEIIRGQ--VFFRQ--RVSSECQHLIRWCLALRPSDRP--- 286
Query: 407 GADEIKVHPWF 417
+EI+ HPW
Sbjct: 287 TFEEIQNHPWM 297
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 1e-58
Identities = 78/394 (19%), Positives = 137/394 (34%), Gaps = 85/394 (21%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+G F ++G GA G + V R A+K++ E LL
Sbjct: 20 IVGKISFCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILPE------CFSFADREVQLLR 72
Query: 172 EVDS--NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLA 228
E D N +++ +C+ +D +F Y+ +E + + +KD E + +T
Sbjct: 73 ESDEHPN-VIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSG 130
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+ +H + +HRD+KP N+L+ +SDFGLCK L
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA---------------V 175
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKKGYGMECDW 340
G + R GT +IAPE+L K+ D
Sbjct: 176 GRHSFSRR-----------------------SGVPGTEGWIAPEMLSEDCKENPTYTVDI 212
Query: 341 WSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC- 397
+S G + Y ++ G PF I+ L E + A++LI K++
Sbjct: 213 FSAGCVFYYVISEGSHPFGKSLQRQA--NILLGACSLDCLHPEKHEDVIARELIEKMIAM 270
Query: 398 NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDEL-----DTQNFEKFEESD 452
+ +R A + HP+F + + F +V+D + D ++ E
Sbjct: 271 DPQKRP---SAKHVLKHPFF------WSLEKQLQFFQDVSDRIEKESLDGPIVKQLERGG 321
Query: 453 NQTKTSSKTGPWRKMLSSKDINFVG----YTYKN 482
WR+ ++ + Y +
Sbjct: 322 RAV----VKMDWRENITVPLQTDLRKFRTYKGGS 351
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-58
Identities = 81/303 (26%), Positives = 138/303 (45%), Gaps = 52/303 (17%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
++ LL IGKG F +V++ R TG A+K + K++ L ++ + E ++ ++
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHP 74
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
IVKL+ + ++ LYLIMEY GG++ L+ + E EAR + V A++ H+
Sbjct: 75 NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 134
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRD+K +NLLLD +++++DFG +FT+G L+
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFS----------NEFTVGGKLDAF----------- 173
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGYP 355
G P Y APE+ K Y G E D WSLG I+Y ++ G
Sbjct: 174 ---------------------CGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414
PF + +++ K+ +S + ++L+ + L N +R ++I
Sbjct: 213 PFDGQNLKELRERVLR----GKYRIPFYMSTDCENLLKRFLVLNPIKRG---TLEQIMKD 265
Query: 415 PWF 417
W
Sbjct: 266 RWI 268
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 7e-58
Identities = 82/408 (20%), Positives = 139/408 (34%), Gaps = 97/408 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ ++G G+ G V V + G A+K++ + E LL E D
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFC------DIALMEIKLLTESDD 67
Query: 176 -NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-------TLTEDEARFYVAETVL 227
+++ YCS D FLY+ +E ++ L+ K+ E + +
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 228 AIESIHKHHYIHRDIKPDNLLLD-------------KYGHLRLSDFGLCKPLDCSTLQEQ 274
+ +H IHRD+KP N+L+ + + +SDFGLCK L
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK-----KLDSG 181
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---- 330
+ NLN GT + APE+L
Sbjct: 182 QSSFRTNLNNP--------------------------------SGTSGWRAPELLEESNN 209
Query: 331 ---KKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWR---THLKFPEEAK 383
K+ D +S+G + Y +L G PF + I+ +K +
Sbjct: 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRS 267
Query: 384 LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDT 442
L EA DLIS+++ + +R A ++ HP F + F+ +V+D L+
Sbjct: 268 LIAEATDLISQMIDHDPLKRPTAM---KVLRHPLF------WPKSKKLEFLLKVSDRLEI 318
Query: 443 QNFEKFEESDNQTKTSSKT----GPWRKMLSSKDI----NFVGYTYKN 482
+N + + S G W + + Y
Sbjct: 319 ENRDPPSALLMKFDAGSDFVIPSGDWTVKFDKTFMDNLERYRKYHSSK 366
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 1e-57
Identities = 88/355 (24%), Positives = 156/355 (43%), Gaps = 54/355 (15%)
Query: 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRA 165
M + + +G + + +G+G+FG+V++ T A+K + + + + V
Sbjct: 1 MAISKRHIG--PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER 58
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
E + L + I+KLY + +++EY GG++ ++ K +TEDE R + +
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ AIE H+H +HRD+KP+NLLLD +++++DFGL
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS---------------------- 155
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLG 344
N +T + G+P+Y APEV+ K Y G E D WS G
Sbjct: 156 --NIMTDGNFLKT------------------SCGSPNYAAPEVINGKLYAGPEVDVWSCG 195
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403
++Y MLVG PF + + +K+ P+ LS A+ LI +++ + QR+
Sbjct: 196 IVLYVMLVGRLPFDDEFIPNLFKKVN--SCVYVMPDF--LSPGAQSLIRRMIVADPMQRI 251
Query: 404 GAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTS 458
EI+ PWF+ + ME + + ++ E S++ +
Sbjct: 252 ---TIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEA 303
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 6e-57
Identities = 91/353 (25%), Positives = 154/353 (43%), Gaps = 54/353 (15%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
R K+G + L +G G FG+V+V + + TGH A+K L + ++ V +R E
Sbjct: 11 GRVKIG--HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L I+KLY ++++MEY+ GG++ + + L E E+R + +
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ H+H +HRD+KP+N+LLD + + +++DFGL N
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS------------------------N 164
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIM 347
RT + G+P+Y APEV+ + Y G E D WS G I+
Sbjct: 165 MMSDGEFLRT------------------SCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206
Query: 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
Y +L G PF D + +KI P+ L+ L+ +L + +R K
Sbjct: 207 YALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQY--LNPSVISLLKHMLQVDPMKRATIK 262
Query: 407 GADEIKVHPWF-DGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTS 458
+I+ H WF + + + ++DE + EKFE S+ + +
Sbjct: 263 ---DIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSC 312
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-56
Identities = 38/335 (11%), Positives = 89/335 (26%), Gaps = 90/335 (26%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE---------- 172
++G+ ++ TG + + +E ++ ++ E L
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 173 ------------VDSNCIVKLYCSFQDDEFLYLIMEYLP-----------GGDMMTLLMR 209
V K+ D+ ++++ + G +++
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 210 KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
+L + + + S+H + +H ++P +++LD+ G + L+ F S
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS 264
Query: 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329
+ + P+ A +L
Sbjct: 265 AV-----SPIG-----------------------------------RGFAPPETTAERML 284
Query: 330 L-----KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKL 384
D W+LG +Y + P D + I F +
Sbjct: 285 PFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI--------FRSCKNI 336
Query: 385 SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
+ L+ L RL + P ++
Sbjct: 337 PQPVRALLEGFLRYPKEDRL---LPLQAMETPEYE 368
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 4e-56
Identities = 73/380 (19%), Positives = 126/380 (33%), Gaps = 80/380 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+E+ +G G FG V + TG A+K+ ++ L E E ++ +++
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNH 71
Query: 176 NCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETV 226
+V + L L MEY GGD+ L + + L E R +++
Sbjct: 72 PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
A+ +H++ IHRD+KP+N++L ++ D G K LD
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD---------------- 175
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
Q E VGT Y+APE+L +K Y + D+WS
Sbjct: 176 ---------------QGELCT-----------EFVGTLQYLAPELLEQKKYTVTVDYWSF 209
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIV----------------NWRTHLKFPEEAKLSIE 387
G + +E + G+ PF + V + P LS
Sbjct: 210 GTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGI 269
Query: 388 AKDLISKLL-----CNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDT 442
+ + L + QR + F +D ++ +
Sbjct: 270 LAGKLERWLQCMLMWHQRQRG---TDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTY 326
Query: 443 QNFEKFEESDNQTKTSSKTG 462
E + ++ TG
Sbjct: 327 PVTENENLQNLKSWLQQDTG 346
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 2e-55
Identities = 66/308 (21%), Positives = 122/308 (39%), Gaps = 55/308 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVE-HVRAERNLLAEVDSN 176
+ + ++G+G++G+V+ + T A+K LKK ++ R E +V+ E LL +
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 177 CIVKLY--CSFQDDEFLYLIMEYLPGG--DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+++L ++ + +Y++MEY G +M+ + K +A Y + + +E +
Sbjct: 67 NVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGLEYL 125
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +H+DIKP NLLL G L++S G+
Sbjct: 126 HSQGIVHKDIKPGNLLLTTGGTLKISALGVA----------------------------- 156
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGY-GMECDWWSLGAIMYEM 350
A + ++ G+P + PE+ + G + D WS G +Y +
Sbjct: 157 EALHPFAADDTCR----------TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNI 206
Query: 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
G PF D+ I + P + DL+ +L +R
Sbjct: 207 TTGLYPFEGDNIYKLFENIG--KGSYAIPGD--CGPPLSDLLKGMLEYEPAKRF---SIR 259
Query: 410 EIKVHPWF 417
+I+ H WF
Sbjct: 260 QIRQHSWF 267
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 6e-55
Identities = 73/334 (21%), Positives = 120/334 (35%), Gaps = 56/334 (16%)
Query: 85 DVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVY 144
+ + + L + L+ + EY + +G+G+FGEV ++K TG
Sbjct: 33 ETEDNEGVLLTEKLKPVDYEY------REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQC 86
Query: 145 AMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMM 204
A+KK++ E A + S IV LY + ++ ++ + ME L GG +
Sbjct: 87 AVKKVRLEVFRVE--------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG 138
Query: 205 TLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLC 263
L+ + L ED A +Y+ + + +E +H +H D+K DN+LL G L DFG
Sbjct: 139 QLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323
L L + GT +
Sbjct: 199 LCLQPDGL------------------------------------GKSLLTGDYIPGTETH 222
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAK 383
+APEV++ K + D WS +M ML G P+ C KI +
Sbjct: 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-EPPPIREIPPS 281
Query: 384 LSIEAKDLISK-LLCNVNQRLGAKGADEIKVHPW 416
+ I + L R A E++
Sbjct: 282 CAPLTAQAIQEGLRKEPVHRASAM---ELRRKVG 312
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 6e-55
Identities = 45/342 (13%), Positives = 79/342 (23%), Gaps = 89/342 (26%)
Query: 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN 176
+L+ + G V + R+ +A+K R ++E + A +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 177 CIVKLYCSFQ--------------------------DDEFLYLIMEYLPGGDMMTLL--- 207
+ + L+M D+ L
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTL 181
Query: 208 ----MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263
+ + A+ + ++ +H PDNL + G L L D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDY 323
+ ++ Y
Sbjct: 242 WKVGTRG--------------------------------------------PASSVPVTY 257
Query: 324 IAPEVLLKKG--YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNW-----RTHL 376
E L + + W LG +Y + + PF P L
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL 317
Query: 377 KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
F L K LI + L + +RL E P F
Sbjct: 318 AFGSCTPLPDFVKTLIGRFLNFDRRRRL---LPLEAMETPEF 356
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-54
Identities = 52/312 (16%), Positives = 101/312 (32%), Gaps = 49/312 (15%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+F L IG G FG V C ++ G +YA+K+ KK + +R
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL----MRKDTLTEDEARFYVAETVLAIE 230
+ +V+ + ++ +D+ + + EY GG + + E E + + + +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ---DFTIGNNLNGSSQ 287
IH +H DIKP N+ + + + + S D ++
Sbjct: 130 YIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--- 186
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 346
G ++A EVL + + D ++L
Sbjct: 187 --------------------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALT 220
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLG 404
+ P + D +I + P LS E +L+ ++ + +R
Sbjct: 221 VVCAAGAEPLPRNGDQW---HEIRQ----GRLPRIPQVLSQEFTELLKVMIHPDPERRPS 273
Query: 405 AKGADEIKVHPW 416
A + H
Sbjct: 274 AM---ALVKHSV 282
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 2e-54
Identities = 49/330 (14%), Positives = 96/330 (29%), Gaps = 74/330 (22%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAE 166
++G+ + ++G+GAF +V + + +K K + +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQL 117
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK-----DTLTEDEARFY 221
L + +K Y + L+ E G ++ + + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLL-----------DKYGHLRLSDFGLCKPLDCST 270
+ IE +H IH DIKPDN +L D L L D G
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI------ 231
Query: 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330
++ + K + T + E+L
Sbjct: 232 -------------------------------DMKLFPKGTIF--TAKCETSGFQCVEMLS 258
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
K + + D++ + A +Y ML G ++ + F L + +
Sbjct: 259 NKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------CKPEGLFRRLPHLDM-WNE 310
Query: 391 LISKLLCNVNQ--RLGAKGADEIKVHPWFD 418
+L N+ L + K+ F
Sbjct: 311 FFHVML-NIPDCHHLPSLDLLRQKLKKVFQ 339
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 4e-50
Identities = 87/307 (28%), Positives = 132/307 (42%), Gaps = 57/307 (18%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAE 172
+ F L IGKG+FGEV + T V A+K L+++E ++E ++ E +L++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE----DEIEDIQQEITVLSQ 76
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
DS + K Y S+ D L++IMEYL GG + L + L E + + E + ++ +
Sbjct: 77 CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYL 135
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H IHRDIK N+LL ++G ++L+DFG+ L T
Sbjct: 136 HSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT-DTQI-------------------- 174
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
KR + VGTP ++APEV+ + Y + D WSLG E+
Sbjct: 175 ---KRN-----------------TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAR 214
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410
G PP PM I P E S K+ + L + R AK E
Sbjct: 215 GEPPHSELHPMKVLFLIPKNNP----PTLEGNYSKPLKEFVEACLNKEPSFRPTAK---E 267
Query: 411 IKVHPWF 417
+ H +
Sbjct: 268 LLKHKFI 274
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-50
Identities = 83/293 (28%), Positives = 138/293 (47%), Gaps = 49/293 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG+GA G V + TG A++++ + ++ E + E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV S+ + L+++MEYL GG + T ++ + + E + E + A+E +H +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSL-TDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK DN+LL G ++L+DFG C + P
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------------------------PEQS 171
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
KR+ + VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 172 KRS-----------------TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 356 PFYSDDPMSTCRKIVNWRT-HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
P+ +++P+ I T L+ PE KLS +D +++ L +V +R AK
Sbjct: 215 PYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRGSAK 265
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-50
Identities = 81/293 (27%), Positives = 137/293 (46%), Gaps = 49/293 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG+G+ G V + REK +G A+K + + RR E + E ++ +
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR---ELLFNEVVIMRDYQH 101
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+V++Y S+ E L+++ME+L GG + T ++ + L E++ + A+ +H
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGAL-TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK D++LL G ++LSDFG C + P
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS------------------------KDVP 196
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
KR S VGTP ++APEV+ + Y E D WSLG ++ EM+ G P
Sbjct: 197 KRK-----------------SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239
Query: 356 PFYSDDPMSTCRKIVNWRT-HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
P++SD P+ +++ + LK K+S +D + ++L + +R A+
Sbjct: 240 PYFSDSPVQAMKRLRDSPPPKLKNSH--KVSPVLRDFLERMLVRDPQERATAQ 290
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 81/304 (26%), Positives = 130/304 (42%), Gaps = 61/304 (20%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
++GKG +G V R+ + A+K + S + + E L + IV+
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRY-----SQPLHEEIALHKHLKHKNIVQ 83
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHY 237
SF ++ F+ + ME +PGG + LL K E FY + + ++ +H +
Sbjct: 84 YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQI 143
Query: 238 IHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRDIK DN+L++ Y G L++SDFG K
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSK-------------------------------- 171
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGY 354
+L + GT Y+APE++ K +GYG D WSLG + EM G
Sbjct: 172 -----RLAGINPCTE----TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222
Query: 355 PPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISK-LLCNVNQRLGAKGADEIK 412
PPFY +P + K+ ++ H + PE +S EAK I K + ++R A ++
Sbjct: 223 PPFYELGEPQAAMFKVGMFKVHPEIPES--MSAEAKAFILKCFEPDPDKRACAN---DLL 277
Query: 413 VHPW 416
V +
Sbjct: 278 VDEF 281
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 1e-48
Identities = 75/321 (23%), Positives = 127/321 (39%), Gaps = 61/321 (19%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMK--KLKKSEMLRRGQVEHVRAERNLLAE 172
DD+EL +IG GA V+ A+K L+K + ++ + E +++
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQ 69
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKD-----TLTEDEARFYVAE 224
IV Y SF + L+L+M+ L GG D++ ++ K L E + E
Sbjct: 70 CHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILRE 129
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ +E +HK+ IHRD+K N+LL + G ++++DFG+ L
Sbjct: 130 VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL------------------ 171
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
+ + R + VGTP ++APEV+ + +GY + D WS
Sbjct: 172 -ATGGDITRNKVRK-----------------TFVGTPCWMAPEVMEQVRGYDFKADIWSF 213
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT------HLKFPEEAKLSIEAKDLISKLLC 397
G E+ G P++ PM + K + +IS L
Sbjct: 214 GITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQ 273
Query: 398 -NVNQRLGAKGADEIKVHPWF 417
+ +R A E+ H +F
Sbjct: 274 KDPEKRPTAA---ELLRHKFF 291
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-47
Identities = 83/296 (28%), Positives = 129/296 (43%), Gaps = 55/296 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ F++L +G+G++G V K TG + A+K++ ++ + E +++ + DS
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDS 83
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+VK Y S+ + L+++MEY G D++ L R TLTEDE + T+ +E +
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYL 141
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H IHRDIK N+LL+ GH +L+DFG+ L
Sbjct: 142 HFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLT------------------------D 177
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
KR + +GTP ++APEV+ + GY D WSLG EM
Sbjct: 178 TMAKRN-----------------TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220
Query: 353 GYPPFYSDDPMSTCRKIVNWRT-HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
G PP+ PM I + PE S D + + L + QR A
Sbjct: 221 GKPPYADIHPMRAIFMIPTNPPPTFRKPE--LWSDNFTDFVKQCLVKSPEQRATAT 274
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 7e-47
Identities = 66/325 (20%), Positives = 119/325 (36%), Gaps = 58/325 (17%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
Q ++G + ++ +G F V ++ +G YA+K+L +E + + E
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN---RAIIQEVC 77
Query: 169 LLAEVDSN-CIVKLYCSF-------QDDEFLYLIMEYLPGGDMMTLLMR---KDTLTEDE 217
+ ++ + IV+ + + +L++ L G ++ L + + L+ D
Sbjct: 78 FMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDT 137
Query: 218 ARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
+T A++ +H+ IHRD+K +NLLL G ++L DFG +
Sbjct: 138 VLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI--------- 188
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKK 332
+ P Q+ L + R TP Y PE++
Sbjct: 189 -------------SHYPDYSWSAQRRALVEEEITR-------NTTPMYRTPEIIDLYSNF 228
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLI 392
G + D W+LG I+Y + PF + +IVN P LI
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVN--GKYSIPPHDTQYTVFHSLI 282
Query: 393 SKLLC-NVNQRLGAKGADEIKVHPW 416
+L N +RL E+
Sbjct: 283 RAMLQVNPEERL---SIAEVVHQLQ 304
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-46
Identities = 90/329 (27%), Positives = 141/329 (42%), Gaps = 61/329 (18%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG 158
+K EY ++R + +E++ +G GAFG+V + K TG + A K ++
Sbjct: 2 MRKSREYEHVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EE 58
Query: 159 QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTE 215
++E E +LA D IVKL ++ D L++++E+ PGG +M L LTE
Sbjct: 59 ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL--DRGLTE 116
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275
+ + + + A+ +H IHRD+K N+L+ G +RL+DFG+ TLQ
Sbjct: 117 PQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL-KTLQ--- 172
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL----- 330
KR S +GTP ++APEV++
Sbjct: 173 --------------------KRD-----------------SFIGTPYWMAPEVVMCETMK 195
Query: 331 KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT-HLKFPEEAKLSIEAK 389
Y + D WSLG + EM PP + +PM KI L P K S+E +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPS--KWSVEFR 253
Query: 390 DLISKLLC-NVNQRLGAKGADEIKVHPWF 417
D + L N R A ++ HP+
Sbjct: 254 DFLKIALDKNPETRPSAA---QLLEHPFV 279
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 9e-46
Identities = 74/355 (20%), Positives = 126/355 (35%), Gaps = 61/355 (17%)
Query: 58 NHYKEQMKNLQERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADD 117
++Y + + N+ + D + +L K+ + L
Sbjct: 2 SYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSL------KDPDVAELFFKDDPEKL 55
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
++ + + +L+MEY G L + K L E E + + +H H+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRD+K N+LL + G ++L DFG S +
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGS-----ASIMA-----------------------PA 207
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLVGY 354
S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 208 N-----------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFP--EEAKLSIEAKDLISKLLC-NVNQRLGAK 406
PP ++ + MS I + P + S ++ + L R ++
Sbjct: 251 PPLFNMNAMSALYHIAQNES----PALQSGHWSEYFRNFVDSCLQKIPQDRPTSE 301
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 7e-45
Identities = 51/255 (20%), Positives = 93/255 (36%), Gaps = 41/255 (16%)
Query: 115 ADDFELLTMIGKGA--FGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ELLT+IGKG V + R K TG ++++ E V ++ E ++
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN-LEACSNEMVTFLQGELHVSKL 82
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIE 230
+ IV +F D L+++ ++ G L+ D + E + + + A++
Sbjct: 83 FNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH Y+HR +K ++L+ G + LS
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSN--------------------------- 175
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL--LKKGYGMECDWWSLGAIMY 348
Q+ +V +++PEVL +GY + D +S+G
Sbjct: 176 -------LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228
Query: 349 EMLVGYPPFYSDDPM 363
E+ G+ PF
Sbjct: 229 ELANGHVPFKDMPAT 243
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 4e-44
Identities = 67/320 (20%), Positives = 122/320 (38%), Gaps = 61/320 (19%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRA 165
QR++ +D E L +G G G+V R + TGHV A+K+++ E +R ++
Sbjct: 18 QRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDL--- 74
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
+L D IV+ + +F + +++ ME + + + E
Sbjct: 75 -DVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAI 133
Query: 226 VLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
V A+ + KH IHRD+KP N+LLD+ G ++L DFG+ G ++
Sbjct: 134 VKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGIS---------------GRLVDD 178
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGMECD 339
+++ + G Y+APE + K Y + D
Sbjct: 179 KAKDR---------------------------SAGCAAYMAPERIDPPDPTKPDYDIRAD 211
Query: 340 WWSLGAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC- 397
WSLG + E+ G P+ + K++ P S + + + L
Sbjct: 212 VWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ-EEPPLLPGHMGFSGDFQSFVKDCLTK 270
Query: 398 NVNQRLGAKGADEIKVHPWF 417
+ +R ++ H +
Sbjct: 271 DHRKRPKYN---KLLEHSFI 287
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-43
Identities = 60/362 (16%), Positives = 115/362 (31%), Gaps = 98/362 (27%)
Query: 116 DDFELLTMIGKGAFGEV---------------------------RVCRE----------- 137
DFE + +G+G FG V +V RE
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 138 -----------------KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK 180
+ ++ + + ++ + + + V
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 181 LYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE---ARFYVAETVLAIESIHKHHY 237
+LY+ M+ ++ + R+ +L + E + A+E +H
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+KP N+ +++ DFGL +D + + PA
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMD------------QDEEEQTVLTPMPAYATH 233
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
T VGT Y++PE + Y + D +SLG I++E+L Y
Sbjct: 234 T-----------------GQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--YSFS 274
Query: 358 YSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415
+ + + N LKFP + + ++ +L + +R A +I +
Sbjct: 275 TQMERVRIITDVRN----LKFPLLFTQKYPQEHMMVQDMLSPSPTERP---EATDIIENA 327
Query: 416 WF 417
F
Sbjct: 328 IF 329
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-43
Identities = 69/324 (21%), Positives = 128/324 (39%), Gaps = 64/324 (19%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRA 165
Q A+D + L IG+GA+G V K +G + A+K+++ + ++ ++
Sbjct: 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDL--- 71
Query: 166 ERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGG--DMMTLLM--RKDTLTEDEARFY 221
++ D IV+ Y + + ++ ME + + D + E+
Sbjct: 72 -DVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 222 VAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
TV A+ + IHRDIKP N+LLD+ G+++L DFG+ G
Sbjct: 131 TLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS---------------GQ 175
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKKGYGM 336
++ ++ G Y+APE + ++GY +
Sbjct: 176 LVDSIAKTR---------------------------DAGCRPYMAPERIDPSASRQGYDV 208
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPM-STCRKIVNWRT-HLKFPEEAKLSIEAKDLISK 394
D WSLG +YE+ G P+ + + ++V L EE + S + ++
Sbjct: 209 RSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNL 268
Query: 395 LLC-NVNQRLGAKGADEIKVHPWF 417
L + ++R K E+ HP+
Sbjct: 269 CLTKDESKRPKYK---ELLKHPFI 289
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 75/317 (23%), Positives = 129/317 (40%), Gaps = 66/317 (20%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---KSEMLRRGQVEHVRAERNLLA 171
ADD E + +G+GA+G V R +G + A+K+++ S+ +R ++ +
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDL----DISMR 61
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGG---DMMTLLMRKDTLTEDEARFYVAETVLA 228
VD V Y + + +++ ME + ++ + T+ ED V A
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKA 121
Query: 229 IESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+E +H K IHRD+KP N+L++ G +++ DFG+ L
Sbjct: 122 LEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD------------------ 163
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL----KKGYGMECDWWS 342
+A G Y+APE + +KGY ++ D WS
Sbjct: 164 -------------------------VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 343 LGAIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVN 400
LG M E+ + P+ S P +++V + + P + K S E D S+ L N
Sbjct: 199 LGITMIELAILRFPYDSWGTPFQQLKQVVEEPS-PQLPAD-KFSAEFVDFTSQCLKKNSK 256
Query: 401 QRLGAKGADEIKVHPWF 417
+R E+ HP+F
Sbjct: 257 ERPTYP---ELMQHPFF 270
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-42
Identities = 87/361 (24%), Positives = 146/361 (40%), Gaps = 75/361 (20%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV- 173
A FEL+ ++G G +G+V R TG + A+K + + + E ++ E N+L +
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYS 78
Query: 174 DSNCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
I Y +F D+ L+L+ME+ G + L+ + +TL E+ + E
Sbjct: 79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREI 138
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ + +H+H IHRDIK N+LL + ++L DFG+ LD T+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-RTVG------------- 184
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-----GYGMECDW 340
+R + +GTP ++APEV+ Y + D
Sbjct: 185 ----------RRN-----------------TFIGTPYWMAPEVIACDENPDATYDFKSDL 217
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFP--EEAKLSIEAKDLISKLLC- 397
WSLG EM G PP PM I P + K S + + I L
Sbjct: 218 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA----PRLKSKKWSKKFQSFIESCLVK 273
Query: 398 NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKT 457
N +QR + ++ HP+ R E ++ D +D ++ E+ + + +
Sbjct: 274 NHSQRPATE---QLMKHPFI------RDQPNERQVRIQLKDHIDRTKKKRGEKDETEYEY 324
Query: 458 S 458
S
Sbjct: 325 S 325
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-42
Identities = 58/302 (19%), Positives = 114/302 (37%), Gaps = 57/302 (18%)
Query: 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183
IG+G+F V + T A +L+ + L + + + + E +L + IV+ Y
Sbjct: 34 IGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 184 SFQD----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY-- 237
S++ + + L+ E + G + T L R + R + + + ++ +H
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 238 IHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
IHRD+K DN+ + G +++ D GL S
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF-------------------------- 186
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
A + +GTP+++APE+ ++ Y D ++ G M EM P
Sbjct: 187 -----------------AKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEMATSEYP 228
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415
+ + + V ++ E K++I + N ++R K ++ H
Sbjct: 229 YSECQNAAQIYRRVTSGVKPASFDK-VAIPEVKEIIEGCIRQNKDERYSIK---DLLNHA 284
Query: 416 WF 417
+F
Sbjct: 285 FF 286
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-42
Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 56/287 (19%)
Query: 79 KKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREK 138
KKL + ++ E+ + L FL +K+ + ++ DDFE ++ +G G G V K
Sbjct: 2 KKLEELELDEQQRKRLEAFLTQKQ------KVGELKDDDFEKISELGAGNGGVVFKVSHK 55
Query: 139 TTGHVYAMKK--LKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196
+G V A K L+ +R + E +L E +S IV Y +F D + + ME
Sbjct: 56 PSGLVMARKLIHLEIKPAIRN----QIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111
Query: 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHL 255
++ GG + +L + + E + + + KH +HRD+KP N+L++ G +
Sbjct: 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEI 171
Query: 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAY 315
+L DFG+ L S +A
Sbjct: 172 KLCDFGVSGQLIDS-------------------------------------------MAN 188
Query: 316 STVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP 362
S VGT Y++PE L Y ++ D WS+G + EM VG P D
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 8e-37
Identities = 79/348 (22%), Positives = 130/348 (37%), Gaps = 97/348 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSE-------MLRRGQVEHVRAER 167
D + +T +G+G +GEV + T A+K+++ + E +R E
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIR---------EV 84
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+LL E+ I++L + L+LI EY D+ + + ++ + ++ + +
Sbjct: 85 SLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLIN 143
Query: 228 AIESIHKHHYIHRDIKPDNLLLD-----KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ H +HRD+KP NLLL + L++ DFGL + F I
Sbjct: 144 GVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA----------FGI---- 189
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDW 340
P R ++ + T Y PE+LL + Y D
Sbjct: 190 ------------PIRQ----------------FTHEIITLWYRPPEILLGSRHYSTSVDI 221
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKI---------VNWRTHLKFPE----------- 380
WS+ I EML+ P F D + KI W P+
Sbjct: 222 WSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGK 281
Query: 381 ------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421
A L E DL++ +L + +R+ AK A E HP+F D
Sbjct: 282 TLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE---HPYFSHND 326
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 74/341 (21%), Positives = 131/341 (38%), Gaps = 86/341 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRA----ERNLLA 171
+ +E + IG+G++G V CR + TG + A+KK +SE ++ E +L
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-----DDPVIKKIALREIRMLK 57
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIE 230
++ +V L F+ L+L+ EY ++ L + + E + +T+ A+
Sbjct: 58 QLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVN 116
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
HKH+ IHRD+KP+N+L+ K+ ++L DFG + L
Sbjct: 117 FCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLL------------------------ 152
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
P Y V T Y +PE+L+ YG D W++G +
Sbjct: 153 --TGPSDY----------------YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFA 194
Query: 349 EMLVGYPPFYSDDPMSTCRKIV---------NW--------RTHLKFPEE---------- 381
E+L G P + + I + + +K P+
Sbjct: 195 ELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKF 254
Query: 382 AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVD 421
+S A L+ L + +RL + HP+F+ +
Sbjct: 255 PNISYPALGLLKGCLHMDPTERLTCEQLLH---HPYFENIR 292
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 82/349 (23%), Positives = 137/349 (39%), Gaps = 86/349 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRA----ERNLLA 171
+ +E L ++G+G++G V CR K TG + A+KK +S+ + V+ E LL
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-----DDKMVKKIAMREIKLLK 79
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIE 230
++ +V L + + YL+ E++ ++ L + + L + Y+ + + I
Sbjct: 80 QLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
H H+ IHRDIKP+N+L+ + G ++L DFG + L
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTL------------------------ 174
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGAIMY 348
AAP Y V T Y APE+L+ YG D W++G ++
Sbjct: 175 --AAPGEV----------------YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVT 216
Query: 349 EMLVGYPPFYSDDPMSTCRKIV---------NWRTH--------LKFPEE---------- 381
EM +G P F D + I+ + ++ PE
Sbjct: 217 EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRY 276
Query: 382 AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQME 429
KLS DL K L + ++R H +F +A + E
Sbjct: 277 PKLSEVVIDLAKKCLHIDPDKRPFCAELLH---HDFFQMDGFAERFSQE 322
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 82/351 (23%), Positives = 131/351 (37%), Gaps = 103/351 (29%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH--------VRAE 166
+ F+ L +G G + V KTTG A+K++K ++ +R E
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK---------LDSEEGTPSTAIR-E 53
Query: 167 RNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL------MRKDTLTEDEARF 220
+L+ E+ IV+LY + L L+ E++ D+ + L + ++
Sbjct: 54 ISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
+ + + + H++ +HRD+KP NLL++K G L+L DFGL + F I
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA----------FGI-- 160
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMEC 338
P T +S+ V T Y AP+VL+ + Y
Sbjct: 161 --------------PVNT----------------FSSEVVTLWYRAPDVLMGSRTYSTSI 190
Query: 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKI----------------------------- 369
D WS G I+ EM+ G P F + + I
Sbjct: 191 DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRP 250
Query: 370 -VNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
+ R L+ + L D + LL N + RL AK A HPWF
Sbjct: 251 PRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH---HPWFA 298
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 8e-36
Identities = 77/344 (22%), Positives = 130/344 (37%), Gaps = 94/344 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH--------VRAER 167
+ + L +G+G + V + K T ++ A+K+++ +EH +R E
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR---------LEHEEGAPCTAIR-EV 51
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
+LL ++ IV L+ ++ L L+ EYL D+ L + + + ++ + +
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL 110
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ H+ +HRD+KP NLL+++ G L+L+DFGL + +I
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA----------KSI-------- 152
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P +T Y V T Y P++LL Y + D W +G
Sbjct: 153 --------PTKT----------------YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVG 188
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKI---------VNWRTHLKFPEEAK------------ 383
I YEM G P F I W L E
Sbjct: 189 CIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALL 248
Query: 384 -----LSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVD 421
L + DL++KLL R+ A+ A + HP+F +
Sbjct: 249 SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK---HPFFLSLG 289
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 70/344 (20%), Positives = 125/344 (36%), Gaps = 86/344 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH----VRAERNLLA 171
+E + IG GA+G V R+ +GH A+K ++ G VR E LL
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRV-PNGGGGGGGLPISTVR-EVALLR 66
Query: 172 EVDSNC---IVKLYCSFQDDEF-----LYLIMEYLPGGDMMTLL--MRKDTLTEDEARFY 221
+++ +V+L + L+ E++ D+ T L L + +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + ++ +H + +HRD+KP+N+L+ G ++L+DFGL + ++
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI----------YSY--- 172
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341
+ W Y APEVLL+ Y D W
Sbjct: 173 -------------QMALTPVVVTLW----------------YRAPEVLLQSTYATPVDMW 203
Query: 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEEA---------- 382
S+G I EM P F + KI +W + P A
Sbjct: 204 SVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQ 263
Query: 383 ----KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421
++ L+ ++L N ++R+ A A + H + +
Sbjct: 264 SVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ---HSYLHKDE 304
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 87/343 (25%), Positives = 137/343 (39%), Gaps = 93/343 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAER 167
+ + L IG+G +G V + G +A+KK++ + E +R E
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIR---------EI 51
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
++L E+ + IVKLY + L L+ E+L D+ LL + + L A+ ++ + +
Sbjct: 52 SILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLL 110
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
I H +HRD+KP NLL+++ G L+++DFGL + F I
Sbjct: 111 NGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARA----------FGI-------- 152
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P R Y+ + T Y AP+VL+ K Y D WS+G
Sbjct: 153 --------PVRK----------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVG 188
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKI---------VNWRTHLKFPE--------------- 380
I EM+ G P F +I NW + P+
Sbjct: 189 CIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248
Query: 381 -EAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVD 421
L DL+SK+L + NQR+ AK A E H +F +
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALE---HAYFKENN 288
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 84/344 (24%), Positives = 136/344 (39%), Gaps = 94/344 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAER 167
+ ++ L +G+G +G V ++ G + A+K+++ +E +R E
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIR---------EI 70
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
+LL E+ IV L + L L+ E++ D+ +L K L + + + Y+ + +
Sbjct: 71 SLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLL 129
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ H+H +HRD+KP NLL++ G L+L+DFGL + F I
Sbjct: 130 RGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARA----------FGI-------- 171
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P R+ Y+ V T Y AP+VL+ K Y D WS+G
Sbjct: 172 --------PVRS----------------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIG 207
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKI---------VNWRTH--------LKFPEEAK---- 383
I EM+ G P F KI W F K
Sbjct: 208 CIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWS 267
Query: 384 -----LSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVD 421
E DL+S +L + N+R+ A+ A HP+F +D
Sbjct: 268 SIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN---HPYFKDLD 308
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-35
Identities = 81/341 (23%), Positives = 133/341 (39%), Gaps = 93/341 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAER 167
+E L IG+G +G V + + T + A+K+++ + LR E
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR---------EI 52
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
LL E+ IV+L+ D+ L L+ E+ D+ L + + ++ + +
Sbjct: 53 CLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLL 111
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ H + +HRD+KP NLL+++ G L+L++FGL + F I
Sbjct: 112 KGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARA----------FGI-------- 153
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLG 344
P R YS V T Y P+VL K Y D WS G
Sbjct: 154 --------PVRC----------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAG 189
Query: 345 AIMYEML-VGYPPFYSDDPMSTCRKIV------------------NWRTHLKFPEE---- 381
I E+ G P F +D ++I +++ + +P
Sbjct: 190 CIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLV 249
Query: 382 ---AKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFD 418
KL+ +DL+ LL CN QR+ A+ A + HP+F
Sbjct: 250 NVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ---HPYFS 287
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 83/338 (24%), Positives = 133/338 (39%), Gaps = 84/338 (24%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH------VRAERN 168
A +E L +G+G F V R+K T + A+KK+K + R + + +R E
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIK---LGHRSEAKDGINRTALR-EIK 64
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVL 227
LL E+ I+ L +F + L+ +++ D+ ++ LT + Y+ T+
Sbjct: 65 LLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+E +H+H +HRD+KP+NLLLD+ G L+L+DFGL K F
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS----------FGS--------- 164
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYST-VGTPDYIAPEVLL-KKGYGMECDWWSLGA 345
P R Y+ V T Y APE+L + YG+ D W++G
Sbjct: 165 -------PNRA----------------YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC 201
Query: 346 IMYEMLVGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEEA-------------- 382
I+ E+L+ P D + +I W P+
Sbjct: 202 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF 261
Query: 383 -KLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFD 418
+ DLI L N R+ A A + +F
Sbjct: 262 SAAGDDLLDLIQGLFLFNPCARITATQALK---MKYFS 296
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-34
Identities = 76/370 (20%), Positives = 140/370 (37%), Gaps = 98/370 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLK-KSEM-------LRRGQVEHVRAE 166
+E + IG+GA+G+V R+ K G A+K+++ ++ +R E
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR---------E 61
Query: 167 RNLLAEVDSNC---IVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTED 216
+L +++ +V+L+ + L L+ E++ D+ T L + + + +
Sbjct: 62 VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTE 120
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
+ + + + ++ +H H +HRD+KP N+L+ G ++L+DFGL + +
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI----------Y 170
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336
+ + W Y APEVLL+ Y
Sbjct: 171 SF----------------QMALTSVVVTLW----------------YRAPEVLLQSSYAT 198
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV---------NWRTHLKFPEEA----- 382
D WS+G I EM P F + KI+ +W + P +A
Sbjct: 199 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 258
Query: 383 ---------KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAF 432
+ KDL+ K L N +R+ A A HP+F ++ +
Sbjct: 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS---HPYFQDLERCKENLDSHLP 315
Query: 433 IPEVNDELDT 442
+ EL+T
Sbjct: 316 PSQNTSELNT 325
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 90/380 (23%), Positives = 138/380 (36%), Gaps = 107/380 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDS 175
+ +IG G+FG V + +G + A+KK+ K R E ++ ++D
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR---------ELQIMRKLDH 106
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTL--LMR-----KDTLTEDEARFYV 222
IV+L F +D+ +L L+++Y+P T+ + R K TL + Y+
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVKLYM 162
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ ++ IH HRDIKP NLLLD L+L DFG K L
Sbjct: 163 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-------------- 208
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
+ ++Y + + Y APE++ Y D
Sbjct: 209 --------------------------RGEPNVSY--ICSRYYRAPELIFGATDYTSSIDV 240
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN---------WR------THLKFPE----- 380
WS G ++ E+L+G P F D + +I+ R T KFP+
Sbjct: 241 WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP 300
Query: 381 -----EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIP 434
+ EA L S+LL RL E H +FD + +P
Sbjct: 301 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPL---EACAHSFFDE------LRDPNVKLP 351
Query: 435 EVNDELDTQNFEKFEESDNQ 454
D NF E S N
Sbjct: 352 NGRDTPALFNFTTQELSSNP 371
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 6e-33
Identities = 76/348 (21%), Positives = 126/348 (36%), Gaps = 98/348 (28%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
DD++L+ +G+G + EV T +K LK V+ + +R +L +
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP--------VKKKKIKREIKILENL 87
Query: 174 -DSNCIVKLYCSFQDDE--FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ L +D L+ E++ D L TLT+ + RFY+ E + A++
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALD 144
Query: 231 SIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H +HRD+KP N+++D ++ LRL D+GL
Sbjct: 145 YCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA-------------------------- 178
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
P + V + + PE+L+ + Y D WSLG ++
Sbjct: 179 -EFYHP-------------GQEYNVR--VASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 222
Query: 349 EMLVGYPPFY-----------------SDDPMSTCRKI-----------------VNWRT 374
M+ PF+ ++D K W
Sbjct: 223 SMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWER 282
Query: 375 HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421
+ + +S EA D + KLL + RL A+ A E HP+F V
Sbjct: 283 FVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME---HPYFYTVV 327
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 6e-32
Identities = 90/377 (23%), Positives = 138/377 (36%), Gaps = 108/377 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVDS 175
+ +IG G+FG V + + V A+KK+ K R E ++ V
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRFKNR---------ELQIMRIVKH 91
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTL--LMR-----KDTLTEDEARFYV 222
+V L F +D+ FL L++EY+P T+ R K T+ + Y+
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVP----ETVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + ++ IH HRDIKP NLLLD G L+L DFG K L
Sbjct: 148 YQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-------------- 193
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
++Y + + Y APE++ Y D
Sbjct: 194 --------------------------AGEPNVSY--ICSRYYRAPELIFGATNYTTNIDI 225
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN---------WR------THLKFPE----- 380
WS G +M E++ G P F + + +I+ + KFP+
Sbjct: 226 WSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHP 285
Query: 381 -----EAKLSIEAKDLISKLL-CNVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIP 434
+ +A DLIS+LL + RL A E HP+FD + A +P
Sbjct: 286 FSKVFRPRTPPDAIDLISRLLEYTPSARLTAI---EALCHPFFDE------LRTGEARMP 336
Query: 435 EVNDELDTQNFEKFEES 451
+ N+ K E S
Sbjct: 337 NGRELPPLFNWTKEELS 353
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 8e-32
Identities = 78/376 (20%), Positives = 122/376 (32%), Gaps = 113/376 (30%)
Query: 94 LLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--- 150
+ K + E + +E L IG+G FGEV R + TG A+KK+
Sbjct: 1 MAKQYDSVECPFCD------EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN 54
Query: 151 -----KSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY--------CSFQDDEFLYLIMEY 197
LR E +L + +V L + +YL+ ++
Sbjct: 55 EKEGFPITALR---------EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDF 105
Query: 198 LPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLR 256
D+ LL T E + + + + IH++ +HRD+K N+L+ + G L+
Sbjct: 106 CEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLK 164
Query: 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQH-----WQKNRR 311
L+DFGL + K +Q + + W
Sbjct: 165 LADFGLARAFS--------------------------LAKNSQPNRYTNRVVTLW----- 193
Query: 312 MLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV 370
Y PE+LL ++ YG D W G IM EM P + I
Sbjct: 194 -----------YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALIS 242
Query: 371 N-----------------WRTHLKFPEEAK-----------LSIEAKDLISKLLC-NVNQ 401
L+ + K A DLI KLL + Q
Sbjct: 243 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQ 302
Query: 402 RLGAKGADEIKVHPWF 417
R+ + A H +F
Sbjct: 303 RIDSDDALN---HDFF 315
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 56/247 (22%), Positives = 102/247 (41%), Gaps = 40/247 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
++++ +G G V + + A+K + + ++ E + +++
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHY 237
IV + ++D+ YL+MEY+ G + + L+ D A + + + I+ H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRDIKP N+L+D L++ DFG+ K L ++L
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL-------------------------- 166
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357
TQ +GT Y +PE + D +S+G ++YEMLVG PPF
Sbjct: 167 TQTN--------------HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212
Query: 358 YSDDPMS 364
+ +S
Sbjct: 213 NGETAVS 219
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 63/288 (21%), Positives = 106/288 (36%), Gaps = 65/288 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ E+ ++G+GAFG V C+ K A+K+++ + E L+ V+
Sbjct: 8 KEIEVEEVVGRGAFGVV--CKAKWRAKDVAIKQIESESER-----KAFIVELRQLSRVNH 60
Query: 176 NCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIES 231
IVKLY + L+MEY GG + +L + T A + + +
Sbjct: 61 PNIVKLYGACLNP---VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 232 IHKHHY---IHRDIKPDNLLLDK-YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+H IHRD+KP NLLL L++ DFG + + T
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGT------ACDIQTHMT---------- 161
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
+ G+ ++APEV Y +CD +S G I+
Sbjct: 162 ----------------------------NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIIL 193
Query: 348 YEMLVGYPPFYS-DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISK 394
+E++ PF P V+ T + I + L+++
Sbjct: 194 WEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI--ESLMTR 239
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 53/244 (21%), Positives = 92/244 (37%), Gaps = 42/244 (17%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSN 176
+ L ++G+G G+V + + A+K + + ++ E +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMS-ETLSSDPVFRTRMQREARTAGRLQEP 94
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
+V ++ + D LY+ M + G D+ +L R+ L A V + A+++ H
Sbjct: 95 HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
HRD+KP+N+L+ L DFG+ L
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL------------------------- 189
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356
TQ +TVGT Y+APE + D ++L ++YE L G PP
Sbjct: 190 -TQ--------------LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
Query: 357 FYSD 360
+ D
Sbjct: 235 YQGD 238
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 55/250 (22%), Positives = 101/250 (40%), Gaps = 33/250 (13%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-SEMLRRGQVEHVRAERNLLAEVD 174
D ++GKG FG+ + TG V MK+L + E +R E ++ ++
Sbjct: 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQR----TFLKEVKVMRCLE 65
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV-LAIESIH 233
++K D+ L I EY+ GG + ++ D+ R A+ + + +H
Sbjct: 66 HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH 125
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ IHRD+ N L+ + ++ ++DFGL + L + T L
Sbjct: 126 SMNIIHRDLNSHNCLVRENKNVVVADFGL------ARLMVDEKTQPEGLRSL-------- 171
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+K R Y+ VG P ++APE++ + Y + D +S G ++ E++
Sbjct: 172 -------------KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGR 218
Query: 354 YPPFYSDDPM 363
P
Sbjct: 219 VNADPDYLPR 228
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 9e-29
Identities = 58/284 (20%), Positives = 100/284 (35%), Gaps = 66/284 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK----SEMLRRGQVEHVRAERNLLA 171
++ E IGKG FG V R V A+K L E + + + E +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVA-ETVLA 228
++ IVKLY ++ME++P GD+ L+ K + + + + L
Sbjct: 79 NLNHPNIVKLYGLMH----NPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 229 IESIHKHHY--IHRDIKPDNLLLDKYG-----HLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
IE + + +HRD++ N+ L +++DFGL S +
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGL------SQQSVHSVS---- 184
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECD 339
+G ++APE + + Y + D
Sbjct: 185 ----------------------------------GLLGNFQWMAPETIGAEEESYTEKAD 210
Query: 340 WWSLGAIMYEMLVGYPPF--YSDDPMSTCRKIVNWRTHLKFPEE 381
+S I+Y +L G PF YS + I PE+
Sbjct: 211 TYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 59/273 (21%), Positives = 101/273 (36%), Gaps = 53/273 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + IG G+FG V R + G A+K L + + +V E ++ +
Sbjct: 37 CDLNIKEKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRH 93
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIE 230
IV + + L ++ EYL G + LL + L E + +
Sbjct: 94 PNIVLFMGAVTQPPN--LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMN 151
Query: 231 SIHKHHY--IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+H + +HR++K NLL+DK +++ DFGL S L+ F
Sbjct: 152 YLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGL------SRLKASTFLSSK-------- 197
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
S GTP+++APEVL + + D +S G I++
Sbjct: 198 ---------------------------SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE 381
E+ P+ + +P + L+ P
Sbjct: 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRN 263
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 45/162 (27%), Positives = 72/162 (44%), Gaps = 27/162 (16%)
Query: 116 DDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
DD+++ ++G G G+V K T +A+K L+ RR E L
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRAS 68
Query: 175 S--NCIVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVA 223
+ IV++ +++ + L ++ME L GG+ L R TE EA +
Sbjct: 69 QCPH-IVRIVDVYENLYAGRKCLLIVMECLDGGE---LFSRIQDRGDQAFTEREASEIMK 124
Query: 224 ETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGL 262
AI+ +H + HRD+KP+NLL L+L+DFG
Sbjct: 125 SIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 35/101 (34%), Positives = 46/101 (45%), Gaps = 9/101 (8%)
Query: 324 IAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN--WRTHLKFPEE 381
A E + Y CD WSLG IMY +L GYPPFYS+ ++ + +FP
Sbjct: 166 FAKETT-GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 382 --AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
+++S E K LI LL QR+ E HPW
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMTIT---EFMNHPWIMQ 262
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 59/255 (23%), Positives = 108/255 (42%), Gaps = 44/255 (17%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ-VEHVRAERNLLAEV 173
+D +EL ++G G EV + R+ A+K L+ +++ R R E A +
Sbjct: 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLR-ADLARDPSFYLRFRREAQNAAAL 69
Query: 174 DSNCIVKLYCSFQDDEFL----YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ IV +Y + + + Y++MEY+ G + ++ + +T A +A+ A+
Sbjct: 70 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 129
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
H++ IHRD+KP N+++ +++ DFG+ + + S T +
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAV------- 179
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+GT Y++PE D +SLG ++YE
Sbjct: 180 ----------------------------IGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211
Query: 350 MLVGYPPFYSDDPMS 364
+L G PPF D P+S
Sbjct: 212 VLTGEPPFTGDSPVS 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 83/350 (23%), Positives = 129/350 (36%), Gaps = 98/350 (28%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKK--LKKSEMLRRGQVEHVRAERNLLAE 172
D F++ M G+G FG V++ +EK+TG A+KK R Q LA
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ------IMQDLAV 75
Query: 173 VDSNCIVKLYCSF-------QDDEFLYLIMEYLPGGD----MMTLLMRKDTLTEDEARFY 221
+ IV+L F + D +L ++MEY+P R+ + +
Sbjct: 76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134
Query: 222 VAETVLAIESIHKHHY--IHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCSTLQEQDFTI 278
+ + + +I +H HRDIKP N+L+++ G L+L DFG K L
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS----------- 183
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 337
+ +AY + + Y APE++ + Y
Sbjct: 184 -----------------------------PSEPNVAY--ICSRYYRAPELIFGNQHYTTA 212
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPM---------------STCRKIVNWRTHLKFP--- 379
D WS+G I EM++G P F D+ RK+ T +
Sbjct: 213 VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSK 272
Query: 380 ----------EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
K + EA DL+S LL +R+ E HP+FD
Sbjct: 273 GIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY---EALCHPYFD 319
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 41/274 (14%), Positives = 80/274 (29%), Gaps = 58/274 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
LT + + GE+ + + G+ +K LK + R + E L
Sbjct: 10 KQLNFLTKLNENHSGEL--WKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFSH 66
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEA-RFYVA-ETVLAIES 231
++ + C LI ++P G + +L D++ A + +
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126
Query: 232 IHKHHY--IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+H + ++++D+ R+S +
Sbjct: 127 LHTLEPLIPRHALNSRSVMIDEDMTARISMADV--------------------------- 159
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME---CDWWSLGAI 346
K + Q + P ++APE L KK D WS +
Sbjct: 160 ------KFSFQSP-------------GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVL 200
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE 380
++E++ PF M K+ P
Sbjct: 201 LWELVTREVPFADLSNMEIGMKVALEGLRPTIPP 234
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 54/266 (20%), Positives = 95/266 (35%), Gaps = 65/266 (24%)
Query: 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCR-EKTTGHVYAMKKLKKS---EMLRRGQVEH 162
+L + A +E+ I G G + + G +K L S E
Sbjct: 71 QLNPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAM----- 125
Query: 163 VRAERNLLAEVDSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE 217
AER LAEV IV+++ D Y++MEY+ G + L E
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183
Query: 218 ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277
A Y+ E + A+ +H ++ D+KP+N++L + L+L D G
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLTE-EQLKLIDLG---------------- 226
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV-GTPDYIAPEVLLKKGYGM 336
A R+ ++ + GTP + APE+ ++ G +
Sbjct: 227 ---------------AV---------------SRINSFGYLYGTPGFQAPEI-VRTGPTV 255
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +++G + + + P
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNGRYV 281
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 60/250 (24%), Positives = 108/250 (43%), Gaps = 38/250 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK--------SEMLRRGQVEHVRAER 167
D +E+ +IG G++G V +K V A+KK+ + +LR E
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR---------EI 103
Query: 168 NLLAEVDSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
+L ++ + +VK+ + + LY+++E D L LTE + +
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL 162
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
++ ++ +H +HRD+KP N L+++ +++ DFGL + T+
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR------------TVDYPE 210
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWW 341
NG+SQ P R++ + V T Y APE++L ++ Y D W
Sbjct: 211 NGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH--VVTRWYRAPELILLQENYTEAIDVW 268
Query: 342 SLGAIMYEML 351
S+G I E+L
Sbjct: 269 SIGCIFAELL 278
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 60/278 (21%), Positives = 101/278 (36%), Gaps = 58/278 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRRGQVEHVRAERNLLAEVD 174
+ L +IG G FG+V R G A+K + +E+VR E L A +
Sbjct: 7 AELTLEEIIGIGGFGKV--YRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK 64
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I+ L + L L+ME+ GG + +L + D + + + +H
Sbjct: 65 HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHD 123
Query: 235 HHY---IHRDIKPDNLLLDKYGH--------LRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
IHRD+K N+L+ + L+++DFGL +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR------------------- 164
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
W + +M S G ++APEV+ + D WS
Sbjct: 165 ---------------------EWHRTTKM---SAAGAYAWMAPEVIRASMFSKGSDVWSY 200
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE 381
G +++E+L G PF D ++ + + L P
Sbjct: 201 GVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPST 238
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 9e-27
Identities = 49/258 (18%), Positives = 92/258 (35%), Gaps = 51/258 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ E+ +IGKG FG+V + G V A++ + Q++ + E +
Sbjct: 33 EQLEIGELIGKGRFGQV--YHGRWHGEV-AIRLIDIERDNED-QLKAFKREVMAYRQTRH 88
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHK 234
+V + L +I G + +++ K L ++ R E V + +H
Sbjct: 89 ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+H+D+K N+ D G + ++DFGL F+I L + ++
Sbjct: 149 KGILHKDLKSKNVFYDN-GKVVITDFGL-------------FSISGVLQAGRREDKLRIQ 194
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---------LKKGYGMECDWWSLGA 345
G ++APE++ K + D ++LG
Sbjct: 195 N-----------------------GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231
Query: 346 IMYEMLVGYPPFYSDDPM 363
I YE+ PF +
Sbjct: 232 IWYELHAREWPFKTQPAE 249
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 49/255 (19%), Positives = 101/255 (39%), Gaps = 52/255 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG G+FG V + K G V A+K L + + Q++ + E +L +
Sbjct: 24 GQITVGQRIGSGSFGTV--YKGKWHGDV-AVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRH 79
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVA-ETVLAIESI 232
I+ + L ++ ++ G + L +T E + +A +T ++ +
Sbjct: 80 VNILLFMGYST---APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYL 136
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H IHRD+K +N+ L + +++ DFGL +T + +
Sbjct: 137 HAKSIIHRDLKSNNIFLHEDNTVKIGDFGL------ATEKSR------------------ 172
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDWWSLGAIMYE 349
W + + G+ ++APEV+ + Y + D ++ G ++YE
Sbjct: 173 -------------WSGSHQFEQ--LSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYE 217
Query: 350 MLVGYPPFYSDDPMS 364
++ G P+ + +
Sbjct: 218 LMTGQLPYSNINNRD 232
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-26
Identities = 69/367 (18%), Positives = 123/367 (33%), Gaps = 109/367 (29%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL------------------------- 149
+ + L +G G+FG V + +G +A+KK+
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKL 65
Query: 150 ------KKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGD- 202
E + Q + +N + + +++L +IMEY+P
Sbjct: 66 VDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TL 124
Query: 203 ---MMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLS 258
+ + + ++ + Y+ + A+ IH HRDIKP NLL++ K L+L
Sbjct: 125 HKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLC 184
Query: 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318
DFG K L + +AY +
Sbjct: 185 DFGSAKKLI----------------------------------------PSEPSVAY--I 202
Query: 319 GTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM-------------- 363
+ Y APE++L Y D WS+G + E+++G P F + +
Sbjct: 203 CSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT 262
Query: 364 -STCRKIVNWRTHLKFPEEAKLSI----------EAKDLISKLLC-NVNQRLGAKGADEI 411
++ T ++FP A DL+ ++L + R+ E
Sbjct: 263 KEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRI---NPYEA 319
Query: 412 KVHPWFD 418
HP+FD
Sbjct: 320 MAHPFFD 326
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 60/255 (23%), Positives = 114/255 (44%), Gaps = 31/255 (12%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
D++ + +IG+G++G V + +K T A+KK+ + M ++ R R +L +
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFED-LIDCKRILREITILNRL 82
Query: 174 DSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
S+ I++LY + LY+++E D+ L LTE+ + + +L
Sbjct: 83 KSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLG 141
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
IH+ IHRD+KP N LL++ +++ DFGL + ++ S ++
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN-----------------SEKD 184
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347
+ ++ + +++ ++ V T Y APE++L + Y D WS G I
Sbjct: 185 TNIVNDLEENEEPGPHNKNLKKQLTSH--VVTRWYRAPELILLQENYTKSIDIWSTGCIF 242
Query: 348 YEMLVGYPPFYSDDP 362
E+L +D
Sbjct: 243 AELLNMLQSHINDPT 257
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 81/345 (23%), Positives = 140/345 (40%), Gaps = 83/345 (24%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAE 172
+ DF+L +++G+GA+G V K TG + A+KK++ + R R +L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFAL----RTLREIKILKH 65
Query: 173 VDSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAE 224
I+ ++ SF++ +Y+I E M T L + L++D ++++ +
Sbjct: 66 FKHENIITIFNIQRPDSFENFNEVYIIQEL-----MQTDLHRVISTQMLSDDHIQYFIYQ 120
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
T+ A++ +H + IHRD+KP NLL++ L++ DFGL + +D S + T
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT------- 173
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
+ M+ + V T Y APEV+L Y D WS
Sbjct: 174 ----------------------GQQSGMVEF--VATRWYRAPEVMLTSAKYSRAMDVWSC 209
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIV------------------NWRTHLK-FPEEAKL 384
G I+ E+ + P F D I R ++K P
Sbjct: 210 GCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAA 269
Query: 385 SI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
+ + DL+ ++L + +R+ AK A E HP+
Sbjct: 270 PLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE---HPYLQT 311
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 70/276 (25%), Positives = 116/276 (42%), Gaps = 59/276 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKS--------------EMLRRGQVE 161
+EL+ +GKGA+G V ++ TG V A+KK+ + +L
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILT----- 63
Query: 162 HVRAERNLLAEVDSNCIVKLYCSFQDDEF--LYLIMEYLPGGDMMTLL---MRKDTLTED 216
+ N IV L + D +YL+ +Y M T L +R + L
Sbjct: 64 ELSGHEN---------IVNLLNVLRADNDRDVYLVFDY-----METDLHAVIRANILEPV 109
Query: 217 EARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276
++ V + + I+ +H +HRD+KP N+LL+ H++++DFGL + +
Sbjct: 110 HKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNI 169
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYG 335
+ N N + ++++P + Y V T Y APE+LL Y
Sbjct: 170 PLSINENTENFDDDQPI------------------LTDY--VATRWYRAPEILLGSTKYT 209
Query: 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN 371
D WSLG I+ E+L G P F M+ +I+
Sbjct: 210 KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 78/346 (22%), Positives = 132/346 (38%), Gaps = 101/346 (29%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
+ ++ L+ +G GA+G V + TG A+KKL + S + + R R LL
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK------RTYRELRLL 82
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFY 221
+ ++ L S ++ +YL+ M L ++ LT+D +F
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-----MGADLNNIVKCQKLTDDHVQFL 137
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + ++ IH IHRD+KP NL +++ L++ DFGL
Sbjct: 138 IYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA------------------ 179
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
R A + T Y V T Y APE++L Y D
Sbjct: 180 ---------RHTADEMTG---------------Y--VATRWYRAPEIMLNWMHYNQTVDI 213
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNW-----------------RTHLK-FPEEA 382
WS+G IM E+L G F D + + I+ R +++ +
Sbjct: 214 WSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP 273
Query: 383 KLSI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
K++ A DL+ K+L + ++R+ A A H +F
Sbjct: 274 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA---HAYFA 316
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 81/344 (23%), Positives = 138/344 (40%), Gaps = 96/344 (27%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
+ T +G GA+G V +K +G A+KKL + SE+ + RA R LL
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK------RAYRELLLL 77
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAE 224
+ ++ L S ++ YL+M ++ D+ ++ +E++ ++ V +
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQ 134
Query: 225 TVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNG 284
+ ++ IH +HRD+KP NL +++ L++ DFGL
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA--------------------- 173
Query: 285 SSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSL 343
R A + T Y V T Y APEV+L Y D WS+
Sbjct: 174 ------RHADAEMTG---------------Y--VVTRWYRAPEVILSWMHYNQTVDIWSV 210
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIV-----------------NWRTHLK-FPEEAKLS 385
G IM EML G F D + +I+ +++++ P+ +
Sbjct: 211 GCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKD 270
Query: 386 I---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
+A DL+ K+L +V++RL A A HP+F+
Sbjct: 271 FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT---HPFFEP 311
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 75/356 (21%), Positives = 130/356 (36%), Gaps = 108/356 (30%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
++ L IG GA G V + A+KKL + ++ + RA R L+
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK------RAYRELVLM 115
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYV 222
V+ I+ L + ++ + +YL+ME M L + + L + + +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-----MDANLCQVIQMELDHERMSYLL 170
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + I+ +H IHRD+KP N+++ L++ DFGL +
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--------------- 215
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ M Y V T Y APEV+L GY D WS
Sbjct: 216 -------------------------TSFMMTPY--VVTRYYRAPEVILGMGYKENVDIWS 248
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIV----------------NWRTHLK--------- 377
+G IM EM+ F D + K++ R +++
Sbjct: 249 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLT 308
Query: 378 ----FPEEAKLSI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
FP+ + +A+DL+SK+L + +R+ A + HP+ +
Sbjct: 309 FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ---HPYINV 361
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 6e-23
Identities = 76/343 (22%), Positives = 128/343 (37%), Gaps = 89/343 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER--NLLAEV 173
+ L+ IG+GA+G V + A+KK+ E Q R R +L
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ----RTLREIKILLRF 82
Query: 174 DSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAET 225
I+ + + + + +Y++ + M T L ++ L+ D +++ +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDL-----METDLYKLLKTQHLSNDHICYFLYQI 137
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
+ ++ IH + +HRD+KP NLLL+ L++ DFGL
Sbjct: 138 LRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA---------------------- 175
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344
R H + Y V T Y APE++L KGY D WS+G
Sbjct: 176 -----------RVADPDHDHTGF---LTEY--VATRWYRAPEIMLNSKGYTKSIDIWSVG 219
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNW-----------------RTHLK-FPEEAKLSI 386
I+ EML P F + I+ R +L P + K+
Sbjct: 220 CILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPW 279
Query: 387 ---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
+A DL+ K+L N ++R+ + A HP+ +
Sbjct: 280 NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA---HPYLEQ 319
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 9e-23
Identities = 65/348 (18%), Positives = 118/348 (33%), Gaps = 91/348 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQV--EHV----RAER-- 167
+ + I G++G V + V A+K++ + R R R
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 168 NLLAEVDSNCIVKLY---CSFQDDEF--LYLIMEYLPGGDMMTLL-MRKDTLTEDEARFY 221
LL I+ L F++ LYL+ E + D+ ++ ++ ++ +++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYF 139
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ +L + +H+ +HRD+ P N+LL + + DF L
Sbjct: 140 MYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA------------------ 181
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
R + Y V Y APE++++ KG+ D
Sbjct: 182 ---------REDTA-------------DANKTHY--VTHRWYRAPELVMQFKGFTKLVDM 217
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNW-----------------RTHLK--FPEE 381
WS G +M EM F + KIV R +L+
Sbjct: 218 WSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNV 277
Query: 382 AKLSI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
+ A DLI+K+L N +R+ ++ HP+F+
Sbjct: 278 PARAWTAVVPTADPVALDLIAKMLEFNPQRRI---STEQALRHPYFES 322
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 88/347 (25%), Positives = 132/347 (38%), Gaps = 101/347 (29%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
+ L +G GA+G V + TG A+KKL + SE+ + RA R LL
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK------RAYRELRLL 78
Query: 171 AEVDSNCIVKLY------CSFQDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFY 221
+ ++ L + D YL+M + M T L M+ + L ED +F
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-----MGTDLGKLMKHEKLGEDRIQFL 133
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
V + + + IH IHRD+KP NL +++ L++ DFGL
Sbjct: 134 VYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------------------ 175
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDW 340
R A + T Y V T Y APEV+L Y D
Sbjct: 176 ---------RQADSEMTG---------------Y--VVTRWYRAPEVILNWMRYTQTVDI 209
Query: 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIV-----------------NWRTHLK-FPEEA 382
WS+G IM EM+ G F D + ++I+ + ++K PE
Sbjct: 210 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 269
Query: 383 KLSI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
K A +L+ K+L + QR+ A A HP+F+
Sbjct: 270 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA---HPYFES 313
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 68/353 (19%), Positives = 120/353 (33%), Gaps = 105/353 (29%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKL---KKSEMLR--RGQVEHVRAERNLLAE 172
+ L +G G G V + A+KK+ + R E ++
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR--------EIKIIRR 64
Query: 173 VDSNCIVKLY------------CSFQDDEF--LYLIMEYLPGGDMMTLL---MRKDTLTE 215
+D + IVK++ E +Y++ EY M T L + + L E
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-----METDLANVLEQGPLLE 119
Query: 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQEQ 274
+ AR ++ + + ++ IH + +HRD+KP NL ++ L++ DFGL + +D
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMD------- 172
Query: 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KG 333
H+ + + T Y +P +LL
Sbjct: 173 -----------------------------PHYSHKGHLSEG--LVTKWYRSPRLLLSPNN 201
Query: 334 YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIV----------------NWRTHLK 377
Y D W+ G I EML G F + + I+ +++
Sbjct: 202 YTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIR 261
Query: 378 -FPEEAKLSI---------EAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
E + EA D + ++L + RL A+ A HP+
Sbjct: 262 NDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS---HPYMSI 311
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 61/254 (24%), Positives = 110/254 (43%), Gaps = 59/254 (23%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAE--VD 174
+E+L +IGKG+FG+V + A+K ++ + R+ E +R +L + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE-IRILEHLRKQDKDN 157
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLAI 229
+ ++ + +F + + E L M L L++K+ + R + + +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLS----MNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+++HK+ IH D+KP+N+LL + G +++ DFG S
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS----------------------SCY 251
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347
++R Y+ + + Y APEV+L YGM D WSLG I+
Sbjct: 252 EHQRV----------------------YTYIQSRFYRAPEVILGARYGMPIDMWSLGCIL 289
Query: 348 YEMLVGYPPFYSDD 361
E+L GYP +D
Sbjct: 290 AELLTGYPLLPGED 303
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 5e-22
Identities = 77/357 (21%), Positives = 133/357 (37%), Gaps = 110/357 (30%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK---SEMLRRGQVEHVRAER--NLL 170
++ L IG GA G V + A+KKL + ++ + RA R L+
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK------RAYRELVLM 78
Query: 171 AEVDSNCIVKLY---------CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
V+ I+ L FQD +Y++ME + ++ ++ + L + +
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQD---VYIVMELM-DANLCQVI--QMELDHERMSYL 132
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ + + I+ +H IHRD+KP N+++ L++ DFGL +
Sbjct: 133 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG-------------- 178
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWW 341
+ M Y V T Y APEV+L GY D W
Sbjct: 179 --------------------------TSFMMTPY--VVTRYYRAPEVILGMGYKENVDIW 210
Query: 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIV----------------NWRTHLK-------- 377
S+G IM EM+ G F D + K++ RT+++
Sbjct: 211 SVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGY 270
Query: 378 -----FP---------EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419
FP + +A+DL+SK+L + ++R+ A + HP+ +
Sbjct: 271 SFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ---HPYINV 324
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 2e-21
Identities = 67/367 (18%), Positives = 124/367 (33%), Gaps = 110/367 (29%)
Query: 115 ADDFELLTM-IGKGAFGEV--RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
D FE +G+G +G V ++ YA+K+++ + + E LL
Sbjct: 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREI-----ALLR 73
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL---------MRKDTLTEDEARF 220
E+ ++ L D ++L+ +Y D+ ++ + L +
Sbjct: 74 ELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKS 132
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLCKPLDCSTLQEQDF 276
+ + + I +H + +HRD+KP N+L+ + G ++++D G + F
Sbjct: 133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL----------F 182
Query: 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYG 335
P + L V T Y APE+LL + Y
Sbjct: 183 NS----------------PLKP----LADLDPV--------VVTFWYRAPELLLGARHYT 214
Query: 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCR---------KIV---------NWRTHLK 377
D W++G I E+L P F+ +I +W K
Sbjct: 215 KAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKK 274
Query: 378 FPE-------------------------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
PE + K +A L+ KLL + +R+ ++ A +
Sbjct: 275 MPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ- 333
Query: 412 KVHPWFD 418
P+F
Sbjct: 334 --DPYFL 338
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 16/157 (10%), Positives = 49/157 (31%), Gaps = 2/157 (1%)
Query: 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
++ + LL G + + A+ + +L ++ + L
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
+ +D + ++ ++ E++ GG + + + + A + A +
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAAD 143
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ H+ P + + G + L+ +
Sbjct: 144 AAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPDAN 180
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 51/272 (18%), Positives = 96/272 (35%), Gaps = 67/272 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN--LLAEV 173
D+ +LL +IG+G +G V + A+K + ++ E+N + +
Sbjct: 13 DNLKLLELIGRGRYGAV--YKGSLDERPVAVKVFSFANR------QNFINEKNIYRVPLM 64
Query: 174 DSNCIVKLY-----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV-- 226
+ + I + + L+MEY P G + L ++ + +A +V
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTR 122
Query: 227 --------LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
L +K HRD+ N+L+ G +SDFGL S + +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL------SMRLTGNRLV 176
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-------LK 331
++ +E VGT Y+APEVL
Sbjct: 177 RPGEEDNAAISE---------------------------VGTIRYMAPEVLEGAVNLRDX 209
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM 363
+ + D ++LG I +E+ + + + +
Sbjct: 210 ESALKQVDMYALGLIYWEIFMRCTDLFPGESV 241
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 57/266 (21%), Positives = 85/266 (31%), Gaps = 62/266 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A L IGKG FGEV R K G A+K E + AE +
Sbjct: 41 ARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLR 94
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + D L+L+ +Y G + L + T+T + T +
Sbjct: 95 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 153
Query: 231 SIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+H K HRD+K N+L+ K G ++D GL D +T I N
Sbjct: 154 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT---DTIDIAPN- 209
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG------YGM 336
VGT Y+APEVL
Sbjct: 210 ---------------------------------HRVGTKRYMAPEVLDDSINMKHFESFK 236
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +++G + +E+ +
Sbjct: 237 RADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 52/266 (19%), Positives = 80/266 (30%), Gaps = 62/266 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A +++ IGKG +GEV K G A+K +E E +
Sbjct: 36 AKQIQMVKQIGKGRYGEV--WMGKWRGEKVAVKVFFTTEE----ASWFRETEIYQTVLMR 89
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + LYLI +Y G + L + TL +V +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL-KSTTLDAKSMLKLAYSSVSGLC 148
Query: 231 SIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+H K HRD+K N+L+ K G ++D GL T +
Sbjct: 149 HLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-- 206
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYGM 336
VGT Y+ PEVL +
Sbjct: 207 -----------------------------------VGTKRYMPPEVLDESLNRNHFQSYI 231
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +S G I++E+ +
Sbjct: 232 MADMYSFGLILWEVARRCVSGGIVEE 257
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 52/268 (19%), Positives = 81/268 (30%), Gaps = 64/268 (23%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A D LL +GKG +GEV R G A+K + + E +
Sbjct: 7 ARDITLLECVGKGRYGEV--WRGSWQGENVAVKIFSSRDE----KSWFRETELYNTVMLR 60
Query: 175 SNCIVKLY----CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV---- 226
I+ S L+LI Y G + L + TL + ++
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVS-CLRIVLSIASGL 118
Query: 227 -----LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ K HRD+K N+L+ K G ++D GL + + Q +
Sbjct: 119 AHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL------AVMHSQSTNQLDV 172
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL------LKKGYG 335
N VGT Y+APEVL
Sbjct: 173 GN-------------------------------NPRVGTKRYMAPEVLDETIQVDCFDSY 201
Query: 336 MECDWWSLGAIMYEMLVGYPPFYSDDPM 363
D W+ G +++E+ +
Sbjct: 202 KRVDIWAFGLVLWEVARRMVSNGIVEDY 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 64/265 (24%), Positives = 102/265 (38%), Gaps = 61/265 (23%)
Query: 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHV 163
++ + D +E+ ++IGKG+FG+V ++ A+K +K K L + Q+E V
Sbjct: 43 DYIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE-V 101
Query: 164 RAERNLLAE--VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTED 216
R + IV L F L L+ E L L L+R ++ +
Sbjct: 102 RLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS----YNLYDLLRNTNFRGVSLN 157
Query: 217 EARFYVAETVLAIESIH--KHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPLDCSTLQ 272
R + + A+ + + IH D+KP+N+LL +++ DFG
Sbjct: 158 LTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----------- 206
Query: 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332
S Q +R Y + + Y +PEVLL
Sbjct: 207 -----------SSCQLGQRI----------------------YQYIQSRFYRSPEVLLGM 233
Query: 333 GYGMECDWWSLGAIMYEMLVGYPPF 357
Y + D WSLG I+ EM G P F
Sbjct: 234 PYDLAIDMWSLGCILVEMHTGEPLF 258
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 4e-19
Identities = 49/270 (18%), Positives = 103/270 (38%), Gaps = 65/270 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVE-----HVR-AERNLL 170
+ L+ +G G F V + ++ AMK ++ + E V A+
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 171 AEVDSNCIVKLYCSFQ----DDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAE 224
+ +N I+KL F + + ++ E L G +++ L+ + + + + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQ 139
Query: 225 TVLAIESIHKH-HYIHRDIKPDNLLLD------KYGHLRLSDFGLCKPLDCSTLQEQDFT 277
+L ++ +H+ IH DIKP+N+L++ ++++D G
Sbjct: 140 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG---------------- 183
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337
+ +E +++ T +Y +PEVLL +G
Sbjct: 184 ------NACWYDEH----------------------YTNSIQTREYRSPEVLLGAPWGCG 215
Query: 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCR 367
D WS +++E++ G F D+ S +
Sbjct: 216 ADIWSTACLIFELITGDFLFEPDEGHSYTK 245
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 53/257 (20%), Positives = 99/257 (38%), Gaps = 51/257 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNL-LAEVDS 175
F ++ +G G FG V +C+ YA+K ++ + R ++E + + ++++
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE-ADILKKIQNDDINN 95
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLAIE 230
N IVK + F + + LI E L +L ++ ++ ++ + Y E + A+
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLG----PSLYEIITRNNYNGFHIEDIKLYCIEILKALN 151
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ---------DFTIGNN 281
+ K H D+KP+N+LLD + + DF
Sbjct: 152 YLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF----- 206
Query: 282 LNGSS-QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
G + ++ S + T Y APEV+L G+ + D
Sbjct: 207 --GCATFKSDYH----------------------GSIINTRQYRAPEVILNLGWDVSSDM 242
Query: 341 WSLGAIMYEMLVGYPPF 357
WS G ++ E+ G F
Sbjct: 243 WSFGCVLAELYTGSLLF 259
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 51/266 (19%), Positives = 89/266 (33%), Gaps = 65/266 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+LL + +G FG V + A+K + Q E L +
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKH 77
Query: 176 NCIVKL--YC--SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDE--------AR--FY 221
I++ D L+LI + G + L + + ++ +E AR Y
Sbjct: 78 ENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAY 136
Query: 222 VAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ E + ++ HK HRDIK N+LL ++DFGL + E + G+
Sbjct: 137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL------ALKFEAGKSAGDT 190
Query: 282 LNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-----LKKGYGM 336
VGT Y+APEVL ++ +
Sbjct: 191 H---------------------------------GQVGTRRYMAPEVLEGAINFQRDAFL 217
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDP 362
D +++G +++E+
Sbjct: 218 RIDMYAMGLVLWELASRCTAADGPVD 243
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 9/157 (5%)
Query: 116 DDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+ + +G+G FG+V + TG + A+K LK + + E ++L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQ--HRSGWKQEIDILR 88
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
+ I+K C L L+MEY+P G + L + ++ + + + +
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGM 147
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
+H HYIHRD+ N+LLD +++ DFGL K +
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 52/253 (20%), Positives = 102/253 (40%), Gaps = 47/253 (18%)
Query: 118 FELLTMIGKGAFGEVRVCR-EKTTGHVYAMKKLK-KSEMLRRGQVEHVRAERNLLAE--V 173
+E++ +G+GAFG+V C K G A+K +K + E ++ +L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE-IQVLEHLNTTDPN 74
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLA 228
+ V++ F+ + ++ E L ++ ++++ D R + +
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLG----LSTYDFIKENGFLPFRLDHIRKMAYQICKS 130
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL---CKPLDCSTLQEQDFTIGNNLNGS 285
+ +H + H D+KP+N+L + + + + + L ++ DF GS
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF-------GS 183
Query: 286 S-QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
+ ++E + V T Y APEV+L G+ CD WS+G
Sbjct: 184 ATYDDEHH----------------------STLVSTRHYRAPEVILALGWSQPCDVWSIG 221
Query: 345 AIMYEMLVGYPPF 357
I+ E +G+ F
Sbjct: 222 CILIEYYLGFTVF 234
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 48/253 (18%), Positives = 98/253 (38%), Gaps = 47/253 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVY-AMKKLK-KSEMLRRGQVEHVRAERNLLAE--V 173
+E++ +G+G FG+V C + G A+K ++ + ++E + + + +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE-INVLKKIKEKDKE 79
Query: 174 DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTL--LMRKDT---LTEDEARFYVAETVLA 228
+ V + F + + E L ++++ R + A
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLG----KNTFEFLKENNFQPYPLPHVRHMAYQLCHA 135
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG---LCKPLDCSTLQEQDFTIGNNLNGS 285
+ +H++ H D+KP+N+L L + K + ++++ DF GS
Sbjct: 136 LRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF-------GS 188
Query: 286 S-QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344
+ ++E + V T Y PEV+L+ G+ CD WS+G
Sbjct: 189 ATFDHEHH----------------------TTIVATRHYRPPEVILELGWAQPCDVWSIG 226
Query: 345 AIMYEMLVGYPPF 357
I++E G+ F
Sbjct: 227 CILFEYYRGFTLF 239
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 4e-18
Identities = 48/160 (30%), Positives = 74/160 (46%), Gaps = 12/160 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ L +GKG FG V +CR + T V A+KKL+ S + E +L
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHSTE---EHLRDFEREIEIL 65
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVL 227
+ + IVK C L LIMEYLP G + L + K+ + + Y ++
Sbjct: 66 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+E + YIHRD+ N+L++ +++ DFGL K L
Sbjct: 126 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 165
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 48/268 (17%), Positives = 91/268 (33%), Gaps = 31/268 (11%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL---AEVD 174
+ ++ +G G F V + + AMK +K +E E E LL D
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT----ETALDEIRLLKSVRNSD 94
Query: 175 SN-----CIVKLYCSFQ----DDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVA 223
N +V+L F+ + + ++ E L G ++ +++ + L + +
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 224 ETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + ++ +H IH DIKP+N+LL S + +
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTA 213
Query: 283 NGSSQNNERPAAPKRTQQEQLQH--------WQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334
++ N + ++ W + T Y + EVL+ GY
Sbjct: 214 PATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIGSGY 270
Query: 335 GMECDWWSLGAIMYEMLVGYPPFYSDDP 362
D WS + +E+ G F
Sbjct: 271 NTPADIWSTACMAFELATGDYLFEPHSG 298
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 48/160 (30%), Positives = 73/160 (45%), Gaps = 12/160 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ L +GKG FG V +CR + T V A+KKL+ S + E +L
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVV-AVKKLQHSTE---EHLRDFEREIEIL 96
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
+ + IVK C L LIMEYLP G + L K+ + + Y ++
Sbjct: 97 KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 156
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+E + YIHRD+ N+L++ +++ DFGL K L
Sbjct: 157 GMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP 196
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 43/194 (22%), Positives = 77/194 (39%), Gaps = 48/194 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE----- 172
+++ IG+G+FG + A+K E R++ L +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF------------EPRRSDAPQLRDEYRTY 59
Query: 173 ---VDSNCIVKLYCSFQDDEFLYLIMEYLPG---GDMMTLLMRKDTLTEDEARFYVAETV 226
I +Y Q+ L+++ L G D++ L RK ++ +TV
Sbjct: 60 KLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSV----------KTV 108
Query: 227 L--------AIESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKP-LDCSTLQ 272
++SIH+ ++RDIKPDN L+ + + + DFG+ K D T Q
Sbjct: 109 AMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168
Query: 273 EQDFTIGNNLNGSS 286
+ NL+G++
Sbjct: 169 HIPYREKKNLSGTA 182
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 15/162 (9%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKK--SEMLRRGQVEHVRAERN 168
+ + +G+G FG+V +CR + T V A+K LK + E
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQV-AVKSLKPESGGNHIADLKK----EIE 75
Query: 169 LLAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAET 225
+L + IVK C+ + LIME+LP G + L K+ + + Y +
Sbjct: 76 ILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQI 135
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
++ + Y+HRD+ N+L++ +++ DFGL K ++
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 177
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 4e-17
Identities = 45/162 (27%), Positives = 75/162 (46%), Gaps = 12/162 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ ++ +GKG FG V +CR + T V A+K+L+ S Q + E +L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALV-AVKQLQHSGPD---QQRDFQREIQIL 78
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
+ S+ IVK + L L+MEYLP G + L + L Y ++
Sbjct: 79 KALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269
+E + +HRD+ N+L++ H++++DFGL K L
Sbjct: 139 GMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 5e-17
Identities = 39/172 (22%), Positives = 69/172 (40%), Gaps = 49/172 (28%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE----- 172
F + IG G FGE+R+ + T A+K +E +++ L
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK------------LEPMKSRAPQLHLEYRFY 58
Query: 173 ---VDSNCIVKLYCSFQDDEFLYLIMEYLPGG----DMMTLLMRKDTLTEDEARFYVAET 225
+ I ++Y ++ +++E L G D+ L R +L +T
Sbjct: 59 KQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSL----------KT 106
Query: 226 VL--------AIESIHKHHYIHRDIKPDNLLLDKYGHLR-----LSDFGLCK 264
VL +E +H + I+RD+KP+N L+ + G+ + DF L K
Sbjct: 107 VLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 6e-17
Identities = 43/169 (25%), Positives = 67/169 (39%), Gaps = 45/169 (26%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER-NLLAEV--- 173
+ L IG G+FG++ + + G A+K E V+ + L E
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL------------ECVKTKHPQLHIESKIY 58
Query: 174 ----DSNCIVKLYCSFQDDEFLYLIMEYLPG---GDMMTLLMRKDTLTEDEARFYVAETV 226
I + + ++ ++ME L G D+ RK +L +TV
Sbjct: 59 KMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSL----------KTV 107
Query: 227 L--------AIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCK 264
L IE IH ++IHRD+KPDN L+ + + DFGL K
Sbjct: 108 LLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 7e-16
Identities = 40/155 (25%), Positives = 68/155 (43%), Gaps = 7/155 (4%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D L IG+G FGEV R + + A+K +++ E +L +
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPD--LKAKFLQEARILKQYSH 171
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
IV+L C+ + +Y++ME + GGD +T L L V + +E +
Sbjct: 172 PNIVRLIGVCT--QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
IHRD+ N L+ + L++SDFG+ +
Sbjct: 230 ESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 43/193 (22%), Positives = 71/193 (36%), Gaps = 35/193 (18%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK---------KSEM--LRRGQVEHVRAE 166
+ L IG G FG + + A +K SE+ +R + +
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 167 RNLLAEVDSNCIVKLYCS----FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYV 222
++D I Y S F+ + +++ME L G D+ + + T +
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKK------- 150
Query: 223 AETVL--------AIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKP-LDCSTL 271
TVL +E IH++ Y+H DIK NLLL + L+D+GL
Sbjct: 151 -STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNH 209
Query: 272 QEQDFTIGNNLNG 284
++ NG
Sbjct: 210 KQYQENPRKGHNG 222
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 51/190 (26%), Positives = 75/190 (39%), Gaps = 46/190 (24%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAE-RNLLAEV--- 173
F L IG G+FGE+ + T A+K E+V+ + LL E
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL------------ENVKTKHPQLLYESKIY 56
Query: 174 ----DSNCIVKLYCSFQDDEFLYLIMEYLPG---GDMMTLLMRKDTLTEDEARFYVAETV 226
I + + ++ L+M+ L G D+ RK +L +TV
Sbjct: 57 RILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSL----------KTV 105
Query: 227 L--------AIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKP-LDCSTLQEQ 274
L +E +H ++HRDIKPDN L+ + + DFGL K D ST Q
Sbjct: 106 LMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI 165
Query: 275 DFTIGNNLNG 284
+ NL G
Sbjct: 166 PYRENKNLTG 175
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-15
Identities = 37/158 (23%), Positives = 65/158 (41%), Gaps = 9/158 (5%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
D LL +G G+FG VR + V A+K LK + + ++ E N +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAI 229
+D +++LY + ++ E P G ++ L + Y + +
Sbjct: 78 LDHRNLIRLYGVVL---TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ +IHRD+ NLLL +++ DFGL + L
Sbjct: 135 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 35/198 (17%), Positives = 69/198 (34%), Gaps = 42/198 (21%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHV-----YAMKKLKK--------SEMLRRGQVEHVR 164
+++ IG+G FG + + ++ V +K + +R
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 165 AERNLLAEVDSNCIVKLYCS----FQDDEFLYLIMEYLPGGDMMTLLM---RKDTLTEDE 217
+ ++ + K + S + ++IM+ G D+ + ++ +
Sbjct: 97 QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSR---- 151
Query: 218 ARFYVAETVL--------AIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKP-L 266
+TVL +E IH+H Y+H DIK NLLL+ + L D+GL
Sbjct: 152 ------KTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYC 205
Query: 267 DCSTLQEQDFTIGNNLNG 284
+ +G
Sbjct: 206 PEGVHKAYAADPKRCHDG 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 37/160 (23%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+F+ + ++G GAFG V EK V A+K+L+++ + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATS--PKANKEILDEAYVM 71
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
A VD+ + +L C + LI + +P G ++ + KD + + +
Sbjct: 72 ASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +HRD+ N+L+ H++++DFGL K L
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 27/173 (15%), Positives = 59/173 (34%), Gaps = 33/173 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHV--------YAMKKLKKSEMLRRGQVEHVRAERNL 169
++L + + G + +T +++K K L Q RA + L
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103
Query: 170 -------LAEVDSNCIVKLYCS-FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFY 221
L I D++ +L++ L G + + L
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPK------HVL 156
Query: 222 VAETVL--------AIESIHKHHYIHRDIKPDNLLL--DKYGHLRLSDFGLCK 264
+VL A+E +H++ Y+H ++ +N+ + + + L+ +G
Sbjct: 157 SERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 321
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIES 231
+V+LY S +E +Y++ EY+ G ++ L + L + A+ +
Sbjct: 322 EKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 378
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ + +Y+HRD++ N+L+ + +++DFGL + +++ ++T + Q +
Sbjct: 379 VERMNYVHRDLRAANILVGENLVCKVADFGLAR-----LIEDNEYT-------ARQGAKF 426
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
P K T APE L + ++ D WS G ++ E+
Sbjct: 427 PI--KWT--------------------------APEAALYGRFTIKSDVWSFGILLTELT 458
Query: 352 -VGYPPF 357
G P+
Sbjct: 459 TKGRVPY 465
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 4e-14
Identities = 37/148 (25%), Positives = 69/148 (46%), Gaps = 8/148 (5%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181
+G G FG V+ + K A+K LK + E + E N++ ++D+ IV++
Sbjct: 25 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA-EANVMQQLDNPYIVRM 83
Query: 182 Y--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIH 239
C E L+ME G + L + + + V + + ++ + + +++H
Sbjct: 84 IGICE---AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
RD+ N+LL + ++SDFGL K L
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALR 168
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 73.3 bits (180), Expect = 5e-14
Identities = 36/151 (23%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 275
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+V+L C+ + Y+I E++ G+++ L + ++ + + A+E
Sbjct: 276 PNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 333
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ K ++IHR++ N L+ + ++++DFGL
Sbjct: 334 LEKKNFIHRNLAARNCLVGENHLVKVADFGL 364
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-14
Identities = 30/150 (20%), Positives = 63/150 (42%), Gaps = 10/150 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + IG G FG V + V A+K +++ M E E ++ ++
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAM----SEEDFIEEAEVMMKLSH 62
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESI 232
+V+LY C + + L+ E++ G + L ++ + + + +
Sbjct: 63 PKLVQLYGVCL--EQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL 120
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ IHRD+ N L+ + +++SDFG+
Sbjct: 121 EEACVIHRDLAARNCLVGENQVIKVSDFGM 150
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 6e-14
Identities = 54/247 (21%), Positives = 103/247 (41%), Gaps = 53/247 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP----EAFLQEAQVMKKLRH 238
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIES 231
+V+LY S +E +Y++ EY+ G ++ L + L + A+ +
Sbjct: 239 EKLVQLYAVVS---EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAY 295
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ + +Y+HRD++ N+L+ + +++DFGL + +++ ++T + Q +
Sbjct: 296 VERMNYVHRDLRAANILVGENLVCKVADFGLAR-----LIEDNEYT-------ARQGAKF 343
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
P K T APE L + ++ D WS G ++ E+
Sbjct: 344 PI--KWT--------------------------APEAALYGRFTIKSDVWSFGILLTELT 375
Query: 352 -VGYPPF 357
G P+
Sbjct: 376 TKGRVPY 382
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 53/249 (21%), Positives = 93/249 (37%), Gaps = 52/249 (20%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ EL IG+G FG+V + + A+K K E E + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDS--VREKFLQEALTMRQ 447
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAI 229
D IVKL + + +++IME G++ + L +RK +L Y + A+
Sbjct: 448 FDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ ++HRDI N+L+ ++L DFGL + +++ +
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR-----YMEDSTYYKA---------- 549
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ P + W +APE + + + D W G M+E
Sbjct: 550 SKGKLPIK--------W-----------------MAPESINFRRFTSASDVWMFGVCMWE 584
Query: 350 ML-VGYPPF 357
+L G PF
Sbjct: 585 ILMHGVKPF 593
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 37/160 (23%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+F+ + ++G GAFG V EK V A+K+L+++ + + E ++
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATS--PKANKEILDEAYVM 71
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
A VD+ + +L C + LI + +P G ++ + KD + + +
Sbjct: 72 ASVDNPHVCRLLGICL---TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 128
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +HRD+ N+L+ H++++DFGL K L
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 44/153 (28%), Positives = 70/153 (45%), Gaps = 11/153 (7%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+D L ++G+G FGEV V + A+K KK L E +E ++
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLD--NKEKFMSEAVIMKN 69
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAI 229
+D IVKL +E ++IME P G++ L R K++L Y + A+
Sbjct: 70 LDHPHIVKLIGIIE---EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAM 126
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ + +HRDI N+L+ ++L DFGL
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGL 159
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 55/253 (21%), Positives = 92/253 (36%), Gaps = 55/253 (21%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ +IG G GEV R V A+K LK R Q +E +++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTER--QRRDFLSEASIMGQ 106
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAI 229
D I++L + ++ EY+ G + T L T + + +
Sbjct: 107 FDHPNIIRLEGVVT--RGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ Y+HRD+ N+L+D ++SDFGL + L+ + D
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE----DDPDA------------- 207
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLGAI 346
AY+T G I APE + + + D WS G +
Sbjct: 208 ------------------------AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243
Query: 347 MYEML-VGYPPFY 358
M+E+L G P++
Sbjct: 244 MWEVLAYGERPYW 256
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 3e-13
Identities = 39/158 (24%), Positives = 69/158 (43%), Gaps = 11/158 (6%)
Query: 116 DDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ EL IG+G FG+V + + A+K K E E + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDS--VREKFLQEALTMRQ 72
Query: 173 VDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAI 229
D IVKL + + +++IME G++ + L +RK +L Y + A+
Sbjct: 73 FDHPHIVKLIGVIT---ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTAL 129
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ ++HRDI N+L+ ++L DFGL + ++
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 37/150 (24%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++ LL +G G FG V++ + K V A+K +K+ M + E + ++
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSM----SEDEFFQEAQTMMKLSH 62
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
+VK Y CS + +Y++ EY+ G ++ L L + + + +
Sbjct: 63 PKLVKFYGVCS--KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL 120
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
H +IHRD+ N L+D+ +++SDFG+
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGM 150
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 4e-13
Identities = 37/151 (24%), Positives = 72/151 (47%), Gaps = 10/151 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 68
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+V+L C+ + Y+I E++ G+++ L + ++ + + A+E
Sbjct: 69 PNLVQLLGVCT--REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEY 126
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ K ++IHRD+ N L+ + ++++DFGL
Sbjct: 127 LEKKNFIHRDLAARNCLVGENHLVKVADFGL 157
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 6e-13
Identities = 35/150 (23%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D L +G G FG V+ + + V A+K +K+ M + E ++ +
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSM----SEDEFIEEAKVMMNLSH 78
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
+V+LY C+ +++I EY+ G ++ L + + + A+E +
Sbjct: 79 EKLVQLYGVCT--KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL 136
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++HRD+ N L++ G +++SDFGL
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGL 166
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 6e-13
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK+ M + AE NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSP----DAFLAEANLMKQLQH 67
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+V+LY + E +Y+I EY+ G ++ L LT ++ A+ +
Sbjct: 68 QRLVRLYAVVT---QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAF 124
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
I + +YIHRD++ N+L+ +++DFGL
Sbjct: 125 IEERNYIHRDLRAANILVSDTLSCKIADFGL 155
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 7e-13
Identities = 47/254 (18%), Positives = 97/254 (38%), Gaps = 55/254 (21%)
Query: 115 ADDFELLTMIGKGAFGEVR--VCREKTTGHVY-AMKKLKKSEMLRRGQVEHVRAERNLLA 171
A + + ++G G FGEV + + + A+K LK + Q E +++
Sbjct: 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEK--QRRDFLGEASIMG 101
Query: 172 EVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLA 228
+ D I++L + + + ++ EY+ G + + L T + +
Sbjct: 102 QFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASG 159
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
++ + Y+HRD+ N+L++ ++SDFGL + L+
Sbjct: 160 MKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--------------------- 198
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLGA 345
+ AY+T G I +PE + + + D WS G
Sbjct: 199 --------------------DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGI 238
Query: 346 IMYEML-VGYPPFY 358
+++E++ G P++
Sbjct: 239 VLWEVMSYGERPYW 252
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 8e-13
Identities = 50/255 (19%), Positives = 93/255 (36%), Gaps = 58/255 (22%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+IG G FGEV + K V A+K LK + Q E ++
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPV-AIKTLKAGYTEK--QRVDFLGEAGIM 100
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVL 227
+ + I++L S + + +I EY+ G + L + + + +
Sbjct: 101 GQFSHHNIIRLEGVIS--KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAA 158
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
++ + +Y+HRD+ N+L++ ++SDFGL + L
Sbjct: 159 GMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL--------------------- 197
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI---APEVLLKKGYGMECDWWSLG 344
++ Y+T G I APE + + + D WS G
Sbjct: 198 --------------------EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFG 237
Query: 345 AIMYEML-VGYPPFY 358
+M+E++ G P++
Sbjct: 238 IVMWEVMTYGERPYW 252
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 39/151 (25%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L +G G FGEV + V A+K +K M VE AE N++ +
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKV-AVKTMKPGSM----SVEAFLAEANVMKTLQH 242
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+ +VKL+ + E +Y+I E++ G ++ L + + A+ +
Sbjct: 243 DKLVKLHAVVT---KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAF 299
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
I + +YIHRD++ N+L+ +++DFGL
Sbjct: 300 IEQRNYIHRDLRAANILVSASLVCKIADFGL 330
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 9e-13
Identities = 37/151 (24%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +LL IGKG FG+V G+ A+K +K + AE +++ ++
Sbjct: 21 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 73
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+ +V+L ++ LY++ EY+ G ++ L + L D + + A+E
Sbjct: 74 SNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 132
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ ++++HRD+ N+L+ + ++SDFGL
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 163
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 37/151 (24%), Positives = 74/151 (49%), Gaps = 12/151 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +LL IGKG FG+V G+ A+K +K + AE +++ ++
Sbjct: 193 KELKLLQTIGKGEFGDV--MLGDYRGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 245
Query: 176 NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETVLAIES 231
+ +V+L ++ LY++ EY+ G ++ L + L D + + A+E
Sbjct: 246 SNLVQLLGVIV-EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 304
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ ++++HRD+ N+L+ + ++SDFGL
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 2e-12
Identities = 32/160 (20%), Positives = 63/160 (39%), Gaps = 14/160 (8%)
Query: 116 DDFELLTMIGKGAFGEV-----RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ L ++G G FG V E V +K ++ + + V +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPV-CIKVIEDKSGRQ--SFQAVTDHMLAI 69
Query: 171 AEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVL 227
+D IV+L C L L+ +YLP G ++ + + L + +
Sbjct: 70 GSLDHAHIVRLLGLCP---GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAK 126
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +H +HR++ N+LL ++++DFG+ L
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 28/165 (16%), Positives = 62/165 (37%), Gaps = 23/165 (13%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVY-------AMKKLKKSEMLRRGQVEHVRAERN 168
+D +G+G F ++ + G +K L K+ E +
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS---ESFFEAAS 64
Query: 169 LLAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAET 225
+++++ +V Y C + L+ E++ G + T L + K+ + +
Sbjct: 65 MMSKLSHKHLVLNYGVCV--CGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQL 122
Query: 226 VLAIESIHKHHYIHRDIKPDNLLLDKYGHLR--------LSDFGL 262
A+ + ++ IH ++ N+LL + + LSD G+
Sbjct: 123 AAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 5e-12
Identities = 56/261 (21%), Positives = 100/261 (38%), Gaps = 63/261 (24%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH-VRAERNLLAEVDSNCIVKL 181
+G+G FG V + A+KKL + +++ E ++A+ +V+L
Sbjct: 38 KMGEGGFG--VVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 182 Y-CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTED-EARFYVAE-TVLAIESIHKHHY 237
S D+ L+ Y+P G ++ L T R +A+ I +H++H+
Sbjct: 96 LGFSSDGDDLC-LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
IHRDIK N+LLD+ ++SDFGL + +
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASE------------------------------ 184
Query: 298 TQQEQLQHWQKNRRMLAYST--VGTPDYIAPE----VLLKKGYGMECDWWSLGAIMYEML 351
+ ++ VGT Y+APE + K D +S G ++ E++
Sbjct: 185 --KFAQTV---------MTSRIVGTTAYMAPEALRGEITPK-----SDIYSFGVVLLEII 228
Query: 352 VGYPPFYSDDPMSTCRKIVNW 372
G P D + +++
Sbjct: 229 TGLPAV---DEHREPQLLLDI 246
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 39/149 (26%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181
+G G FG VR V R + A+K LK+ E + E ++ ++D+ IV+L
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 401
Query: 182 Y--CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIESIHKHHYI 238
C E L L+ME GG + L+ +++ + + + + ++ + + +++
Sbjct: 402 IGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
HR++ N+LL + ++SDFGL K L
Sbjct: 459 HRNLAARNVLLVNRHYAKISDFGLSKALG 487
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 8e-12
Identities = 39/164 (23%), Positives = 65/164 (39%), Gaps = 20/164 (12%)
Query: 116 DDFELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
F L M+GKG FG VR + + V A+K LK + +E E +
Sbjct: 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKV-AVKMLKADIIASS-DIEEFLREAACMK 80
Query: 172 EVDSNCIVKLY-CSFQDD-----EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
E D + KL S + +I+ ++ GD+ L + E+ +
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFL-LASRIGENPFNLPLQTL 139
Query: 226 VLAIESIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
V + I ++IHRD+ N +L + + ++DFGL
Sbjct: 140 VRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGL 183
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 31/150 (20%), Positives = 69/150 (46%), Gaps = 9/150 (6%)
Query: 119 ELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+IGKG FG V + + + A+K L + ++ QVE E L+ ++
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQ--QVEAFLREGLLMRGLN 80
Query: 175 SNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIESI 232
++ L + ++++ Y+ GD++ + + T + + + +E +
Sbjct: 81 HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYL 140
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ ++HRD+ N +LD+ ++++DFGL
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGL 170
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 39/171 (22%), Positives = 72/171 (42%), Gaps = 27/171 (15%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D +L +G+GAFG+V + + T V A+K LK+ + + +E +
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHS--EHRALMSELKI 83
Query: 170 LAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
L + + +V L + L +I+E+ G++ T L R + + A + +
Sbjct: 84 LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L +E + IHRD+ N+LL + +++ DFGL
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL 194
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 27/150 (18%), Positives = 63/150 (42%), Gaps = 9/150 (6%)
Query: 119 ELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+IG+G FG V + + H A+K L + + +V E ++ +
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIG--EVSQFLTEGIIMKDFS 84
Query: 175 SNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMT-LLMRKDTLTEDEARFYVAETVLAIESI 232
++ L + + +++ Y+ GD+ + T + + + ++ +
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL 144
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++HRD+ N +LD+ ++++DFGL
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGL 174
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-11
Identities = 41/171 (23%), Positives = 73/171 (42%), Gaps = 30/171 (17%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ + +G GAFG+V + +E V A+K LK + + E + +E +
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHAD--EKEALMSELKI 102
Query: 170 LAEVDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAET 225
++ + N IV L C+ + +I EY GD++ L RK + E + F +A +
Sbjct: 103 MSHLGQHEN-IVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANS 159
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ + + IHRD+ N+LL ++ DFGL
Sbjct: 160 TASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 210
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-11
Identities = 40/149 (26%), Positives = 73/149 (48%), Gaps = 10/149 (6%)
Query: 124 IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL 181
+G G FG VR V R + A+K LK+ E + E ++ ++D+ IV+L
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA--DTEEMMREAQIMHQLDNPYIVRL 75
Query: 182 Y--CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYI 238
C E L L+ME GG + L+ +++ + + + + ++ + + +++
Sbjct: 76 IGVCQ---AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
HRD+ N+LL + ++SDFGL K L
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALG 161
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 65.3 bits (158), Expect = 3e-11
Identities = 48/341 (14%), Positives = 103/341 (30%), Gaps = 93/341 (27%)
Query: 5 RSWLQKLQPRDK-----MRGSGK--------------KKEAGG----NGSNEESTDE--E 39
R L +L+P + GSGK K N N S + E
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE 200
Query: 40 ALSNVTKQKVAAAKQYIENHY---------KEQMKNLQERRERRN---IL----EKKLAD 83
L + Q ++ + +++ L + + N +L K +
Sbjct: 201 MLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN 260
Query: 84 A-D------VSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVC- 135
A + ++ + + FL T ++ L H M E+ +++ K + + R
Sbjct: 261 AFNLSCKILLTTRFK-QVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLK--YLDCRPQD 317
Query: 136 --REKTTGHVYAMK---KLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKL--------Y 182
RE T + + + + + +HV ++ L + + + L +
Sbjct: 318 LPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMF 375
Query: 183 --CS-FQDD--------EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
S F ++ + ++ L + + + + S
Sbjct: 376 DRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI--------S 427
Query: 232 IHKHHYIHRDIKPDNL------LLDKYGHLRLSDFGLCKPL 266
I Y+ +K +N ++D Y + D P
Sbjct: 428 IP-SIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPP 467
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 6e-05
Identities = 83/562 (14%), Positives = 157/562 (27%), Gaps = 151/562 (26%)
Query: 15 DKMRGSGKKKEAG---GNGSNEESTDEEALSNVTKQKVAAAKQYIEN----HYKEQMKNL 67
D + K+E + T + ++KQ+ ++++E +YK M +
Sbjct: 40 DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQE-EMVQKFVEEVLRINYKFLMSPI 98
Query: 68 Q-ERRERRNILEKKLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGK 126
+ E+R+ + + D D K+ + Y++L++ + + + + G
Sbjct: 99 KTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGV 158
Query: 127 GAFGE----VRVCREKTT-----GHVY--AMKKLKKSE-MLRRGQVEHVRAERNLLAEVD 174
G+ + VC ++ +K E +L Q + + N + D
Sbjct: 159 LGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSD 218
Query: 175 SNCIVKLYCSFQDDEFLYLIME--YLPGGDMMTLLMRKD---------------TL--TE 215
+ +KL E L+ Y LL+ + L T
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKSKPY-----ENCLLVLLNVQNAKAWNAFNLSCKILLTTR 273
Query: 216 DE--ARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL----CK--PLD 267
+ F A T I H + D + +LLL KY R D L P
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPD-EVKSLLL-KYLDCRPQD--LPREVLTTNPRR 329
Query: 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327
S I ++ + A + + + + + V P
Sbjct: 330 LS-------IIAESI------RDGLATWDNWK--HVNCDKLTTIIESSLNVLEPA----- 369
Query: 328 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPEEAKL 384
+K M++ L +P P I W + +
Sbjct: 370 -EYRK--------------MFDRLSVFP----PSAHIPTILLSLI--W---FDVIKSDVM 405
Query: 385 SIEAKDLISKLLCN------------VNQRLGAKGADEIKVHPWFDGVDWARI---YQME 429
+ L L + L K +E +H I Y +
Sbjct: 406 VV-VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH--------RSIVDHYNIP 456
Query: 430 AAF-----IPEVNDE----------LDTQNFEKFEESDN--------QTKTSSKTGPWRK 466
F IP D+ + ++ E+ + K + W
Sbjct: 457 KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNA 516
Query: 467 MLSSKDINFVGYTYKNFEIVND 488
S + YK + ND
Sbjct: 517 SGSILNTLQQLKFYKPYICDND 538
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 29/165 (17%), Positives = 71/165 (43%), Gaps = 23/165 (13%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ + +G+G+FG V V +++ V A+K + ++ +R + E ++
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRV-AIKTVNEAASMR--ERIEFLNEASV 81
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
+ E + + +V+L S + +IME + GD+ + L R
Sbjct: 82 MKEFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 226 VLAI--------ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++ + ++ + ++HRD+ N ++ + +++ DFG+
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 184
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 27/150 (18%), Positives = 63/150 (42%), Gaps = 9/150 (6%)
Query: 119 ELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+IG+G FG V + + H A+K L + + +V E ++ +
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHC-AVKSLNRITDIG--EVSQFLTEGIIMKDFS 148
Query: 175 SNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESI 232
++ L + + +++ Y+ GD+ + T + + + ++ +
Sbjct: 149 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL 208
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++HRD+ N +LD+ ++++DFGL
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGL 238
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 6e-11
Identities = 48/267 (17%), Positives = 94/267 (35%), Gaps = 73/267 (27%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L+ +G GAFGEV + + + V A+K L + + E +
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQ--DELDFLMEALI 86
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV- 226
+++ + IV+ +++ME + GGD+ + L + + + +
Sbjct: 87 ISKFNHQNIVRCIGVSL--QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 227 LAI------ESIHKHHYIHRDIKPDNLLLDKYGHLRL---SDFGLCKPLDCSTLQEQDFT 277
+A + + ++H+IHRDI N LL G R+ DFG+ + +
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD-----IYRAS-- 197
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI-----APEVLLKK 332
Y G + PE ++
Sbjct: 198 -------------------------------------YYRKGGCAMLPVKWMPPEAFMEG 220
Query: 333 GYGMECDWWSLGAIMYEML-VGYPPFY 358
+ + D WS G +++E+ +GY P+
Sbjct: 221 IFTSKTDTWSFGVLLWEIFSLGYMPYP 247
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 6e-11
Identities = 31/163 (19%), Positives = 63/163 (38%), Gaps = 19/163 (11%)
Query: 116 DDFELLTMIGKGAFGEVR----VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+ L ++G+G FG V + T+ V A+K +K +R E + E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKV-AVKTMKLDNSSQREIEEFLS-EAACMK 91
Query: 172 EVDSNCIVKLY-CSFQDD----EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETV 226
+ +++L + +I+ ++ GD+ T L L + +
Sbjct: 92 DFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL-LYSRLETGPKHIPLQTLL 150
Query: 227 LAIESIHK-------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ I +++HRD+ N +L + ++DFGL
Sbjct: 151 KFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 39/173 (22%), Positives = 69/173 (39%), Gaps = 30/173 (17%)
Query: 116 DDFELLTMIGKGAFGEV--------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER 167
D L +G+GAFG+V + K V A+K LK + + + +E
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDDATEK--DLSDLVSEM 91
Query: 168 NLLAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVA 223
++ + + I+ L QD LY+I+EY G++ L R + V
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 150
Query: 224 ETVLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E + + + IHRD+ N+L+ + ++++DFGL
Sbjct: 151 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 203
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 47/267 (17%), Positives = 90/267 (33%), Gaps = 73/267 (27%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L+ +G GAFGEV + + + V A+K L + + E +
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQ--DELDFLMEALI 127
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+++ + IV+ ++++E + GGD+ + L + + + +
Sbjct: 128 ISKFNHQNIVRCIGVSL--QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 228 AIESIHK-------HHYIHRDIKPDNLLLDKYGHLRL---SDFGLCKPLDCSTLQEQDFT 277
I +H+IHRDI N LL G R+ DFG+ + +
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD-----IYRAG-- 238
Query: 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYI-----APEVLLKK 332
Y G + PE ++
Sbjct: 239 -------------------------------------YYRKGGCAMLPVKWMPPEAFMEG 261
Query: 333 GYGMECDWWSLGAIMYEML-VGYPPFY 358
+ + D WS G +++E+ +GY P+
Sbjct: 262 IFTSKTDTWSFGVLLWEIFSLGYMPYP 288
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 38/173 (21%), Positives = 68/173 (39%), Gaps = 30/173 (17%)
Query: 116 DDFELLTMIGKGAFGEV--------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER 167
D L +G+G FG+V + K V A+K LK + + + +E
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV-AVKMLKDDATEK--DLSDLVSEM 137
Query: 168 NLLAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVA 223
++ + + I+ L QD LY+I+EY G++ L R + V
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVP 196
Query: 224 ETVLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E + + + IHRD+ N+L+ + ++++DFGL
Sbjct: 197 EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 249
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 2e-10
Identities = 40/168 (23%), Positives = 66/168 (39%), Gaps = 38/168 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKS------------EMLRRGQVEH 162
++F+ +IG G FG +V + G A+K+ E L H
Sbjct: 39 NNFDHKFLIGHGVFG--KVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL--SFCRH 94
Query: 163 VRAERNLLAEVDSNCIVKL--YCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTED---E 217
+L V L +C + + LI +Y+ G++ L D T E
Sbjct: 95 ----PHL---------VSLIGFC--DERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE 139
Query: 218 ARFYVA-ETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
R + + +H IHRD+K N+LLD+ +++DFG+ K
Sbjct: 140 QRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 42/171 (24%), Positives = 70/171 (40%), Gaps = 30/171 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCR------EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D L +G+GAFG+V + K V A+K LK + R + + E L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLV-AVKALKDPTLAAR---KDFQREAEL 70
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFYVAET 225
L + IVK Y C D + L ++ EY+ GD+ L D + + + A+
Sbjct: 71 LTNLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKG 128
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L + + H++HRD+ N L+ +++ DFG+
Sbjct: 129 ELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGM 179
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 3e-10
Identities = 41/175 (23%), Positives = 70/175 (40%), Gaps = 34/175 (19%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ +G GAFG+V + + V A+K LK S L + E + +E +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTV-AVKMLKPSAHLT--EREALMSELKV 79
Query: 170 LAEVDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVA 223
L+ + + N IV L C+ +I EY GD++ L R + + +
Sbjct: 80 LSYLGNHMN-IVNLLGACT--IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIME 136
Query: 224 ETVLAIES----------------IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ LA++ + + IHRD+ N+LL ++ DFGL
Sbjct: 137 DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGL 191
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 35/171 (20%), Positives = 59/171 (34%), Gaps = 29/171 (16%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ +G+ FG+V + T V A+K LK E R E L
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAV-AIKTLKDKAEGP--LREEFRHEAML 65
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAET 225
A + +V L + D+ L +I Y GD+ L + ++
Sbjct: 66 RARLQHPNVVCLLGVVT--KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 226 VLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L HH +H+D+ N+L+ ++++SD GL
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGL 174
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-10
Identities = 38/175 (21%), Positives = 73/175 (41%), Gaps = 29/175 (16%)
Query: 116 DDFELLTMIGKGAFGEV---RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+D + +IG+G FG+V R+ ++ A+K++K+ E +L +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDA-AIKRMKEYASKD--DHRDFAGELEVLCK 81
Query: 173 VDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTEDEARFYVAETV 226
+ N I+ L C +LYL +EY P G+++ L R A +
Sbjct: 82 LGHHPN-IINLLGACE--HRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 138
Query: 227 LAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
L+ + + +IHRD+ N+L+ + +++DFGL + +
Sbjct: 139 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQE 193
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-10
Identities = 37/178 (20%), Positives = 70/178 (39%), Gaps = 35/178 (19%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+ L +G+G FG+V + V A+K LK++ ++ + +E N+
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTV-AVKMLKENASPS--ELRDLLSEFNV 79
Query: 170 LAEVDSNCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L +V+ ++KLY QD L LI+EY G + L + + +
Sbjct: 80 LKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSS 138
Query: 229 IESIHK------------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
++ + +HRD+ N+L+ + +++SDFGL
Sbjct: 139 LDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGL 196
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 8e-10
Identities = 39/170 (22%), Positives = 69/170 (40%), Gaps = 29/170 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCR------EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
D L +G+GAFG+V + E+ V A+K LK++ R + + E L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLV-AVKALKEASESAR---QDFQREAEL 96
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLL-MRKDTLTEDEARFYVAETV 226
L + IV+ + C+ + L ++ EY+ GD+ L VA
Sbjct: 97 LTMLQHQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGP 154
Query: 227 LAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
L + + H++HRD+ N L+ + +++ DFG+
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGM 204
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 39/178 (21%), Positives = 70/178 (39%), Gaps = 35/178 (19%)
Query: 116 DDFELLTMIGKGAFGEV------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ E ++G GAFG+V + + + V A+K LK+ + E + +E +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQV-AVKMLKEKADSS--EREALMSELKM 101
Query: 170 LAEVDSNC-IVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+ ++ S+ IV L +YLI EY GD++ L K ++ Y + L
Sbjct: 102 MTQLGSHENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 228 AIESIHK-----------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E +HRD+ N+L+ +++ DFGL
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 218
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 34/175 (19%)
Query: 116 DDFELLTMIGKGAFGEV--------RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAER 167
D L +G+GAFG+V + V A+K LK + + + +E
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV-AVKMLKSDATEK--DLSDLISEM 125
Query: 168 NLLAEVDS--NCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLM--RKDTLTEDEARFY 221
++ + N I+ L C+ D LY+I+EY G++ L R L +
Sbjct: 126 EMMKMIGKHKN-IINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSH 182
Query: 222 VAETVLAIESIHK--------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
E L+ + + IHRD+ N+L+ + ++++DFGL
Sbjct: 183 NPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 237
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 42/179 (23%), Positives = 68/179 (37%), Gaps = 37/179 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCR------EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
++ E + IG+GAFG V R + V A+K LK+ + E L
Sbjct: 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMV-AVKMLKEEASAD--MQADFQREAAL 103
Query: 170 LAEVDSNCIVKLY--CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+AE D+ IVKL C+ + + L+ EY+ GD+ L T T
Sbjct: 104 MAEFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 228 AIESIHK------------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGL 262
+ S ++HRD+ N L+ + ++++DFGL
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 56.0 bits (134), Expect = 8e-09
Identities = 32/200 (16%), Positives = 61/200 (30%), Gaps = 48/200 (24%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKL-----KKSEMLRRGQVEHVRAERNLL 170
+ + IG+G FGEV + A+K + + E + E +
Sbjct: 20 EKLQRCEKIGEGVFGEV--FQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 171 AEVD-----------------SNCIVKLYC----------------------SFQDDEFL 191
E+ S V+ F D+ L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLD 250
++++E+ GG + MR + A+ + + ++ + HRD+ N+LL
Sbjct: 138 FIVLEFEFGGIDL-EQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 251 KYGHLRLSDFGLCKPLDCST 270
K +L K +
Sbjct: 197 KTSLKKLHYTLNGKSSTIPS 216
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 4e-08
Identities = 45/177 (25%), Positives = 72/177 (40%), Gaps = 46/177 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKS-------------EMLRRGQ 159
D+F ++G+G FG+V K G + A+K+LK+ EM+
Sbjct: 30 DNFSNKNILGRGGFGKVY----KGRLADGTLVAVKRLKEERTQGGELQFQTEVEMI--SM 83
Query: 160 VEHVRAERNLLAEVDSNCIVKL--YCSFQDDEFLYLIMEYLPGGDMMTLL--MRKDTLTE 215
H RNL ++L +C L+ Y+ G + + L +
Sbjct: 84 AVH----RNL---------LRLRGFCM--TPTERLLVYPYMANGSVASCLRERPESQPPL 128
Query: 216 D-EARFYVAE-TVLAIESIHKH---HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
D R +A + + +H H IHRD+K N+LLD+ + DFGL K +D
Sbjct: 129 DWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMD 185
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 33/173 (19%), Positives = 59/173 (34%), Gaps = 13/173 (7%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D +L +G+GAFG+V + T A+K LK+ + + +E +L
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKIL 79
Query: 171 AEVDS--NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+ N + L + L +I+E+ G++ T L K Y +
Sbjct: 80 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP----YKTKGARF 135
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNN 281
+ I D+K + S F K L +E + +
Sbjct: 136 RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKD 188
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 23/150 (15%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKK-LKKS-------EMLRRGQVEHVRAERNLLAEVD 174
+IGKGA E + R+ +K+ +KK E +R+ E LA V
Sbjct: 343 LIGKGA--EADIKRDSYLDFDVIIKERVKKGYRDERLDENIRK---SRTAREARYLALVK 397
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
I Y D + ++M Y+ G KD + ++ Y ++ +HK
Sbjct: 398 DFGIPAPYIFDVDLDNKRIMMSYINGKLA------KDVIEDNLDIAYKIGEIVG--KLHK 449
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264
+ IH D+ N + D L + DFGL K
Sbjct: 450 NDVIHNDLTTSNFIFD--KDLYIIDFGLGK 477
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 497 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.95 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.43 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.22 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.2 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.54 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.5 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.41 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.28 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.22 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.96 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.73 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.55 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.5 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.42 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.33 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.18 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.1 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.06 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.02 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.78 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.99 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.74 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-73 Score=565.95 Aligned_cols=279 Identities=36% Similarity=0.674 Sum_probs=253.3
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
+...+||+++++||+|+||+||+|+++.||+.||||++.+..+.+....+.+.+|+++|+.++|||||+++++|++++++
T Consensus 28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 34567899999999999999999999999999999999988777777788899999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|||||||+||+|.+++.+.+.++|..+++|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~ 187 (311)
T 4aw0_A 108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 187 (311)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999997643210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
...+.+.||||.|||||++.+..|+.++|||||||++|||+
T Consensus 188 ---------------------------------------~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml 228 (311)
T 4aw0_A 188 ---------------------------------------QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 228 (311)
T ss_dssp ---------------------------------------CCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------cccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHH
Confidence 01133689999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC---CcchhcCCCCccCCChhhhhh
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~---~~~eil~Hpff~~i~w~~l~~ 427 (497)
+|.+||.+.+..+++.+|++ ..+.+|. .+|++++|||.+||+ ||.+|+++. +..+|++||||+++||+.|.+
T Consensus 229 ~G~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~ 304 (311)
T 4aw0_A 229 AGLPPFRAGNEGLIFAKIIK--LEYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 304 (311)
T ss_dssp HSSCSSCCSSHHHHHHHHHH--TCCCCCT--TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred hCCCCCCCCCHHHHHHHHHc--CCCCCCc--ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcC
Confidence 99999999999999999987 4566775 799999999999999 999999932 123479999999999999998
Q ss_pred cCCCcc
Q 010947 428 MEAAFI 433 (497)
Q Consensus 428 ~~~p~~ 433 (497)
..||.+
T Consensus 305 ~~pP~l 310 (311)
T 4aw0_A 305 QTPPKL 310 (311)
T ss_dssp SCCCCC
T ss_pred CCCCCC
Confidence 888764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-70 Score=590.79 Aligned_cols=290 Identities=34% Similarity=0.643 Sum_probs=256.9
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHH---HHHhcCCCceeEEEEEeec
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN---LLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~---il~~l~hp~Iv~l~~~~~~ 187 (497)
..++.+||+++++||+|+||+||+|+++.||+.||||++.+..+........+.+|+. +++.++|||||+++++|++
T Consensus 184 ~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC
T ss_pred CCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE
Confidence 3678899999999999999999999999999999999999887766666666666654 4556789999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+++|||||||+||+|.++|.+.+.|++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+.
T Consensus 264 ~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~ 343 (689)
T 3v5w_A 264 PDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 343 (689)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAI 346 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvi 346 (497)
... ..+.||||.|||||++.+ .+|+.++||||||||
T Consensus 344 ~~~-------------------------------------------~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvi 380 (689)
T 3v5w_A 344 KKK-------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380 (689)
T ss_dssp SCC-------------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHH
T ss_pred CCC-------------------------------------------CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHH
Confidence 221 236799999999999974 689999999999999
Q ss_pred HHHHHhCCCCCCCCC---hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCC
Q 010947 347 MYEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGV 420 (497)
Q Consensus 347 l~ell~G~~PF~~~~---~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i 420 (497)
||||++|.+||.+.+ ..++...+.. ..+.+|. .+|+++++||.+||+ ||.+|+|. .+++||++||||+++
T Consensus 381 lYEmLtG~~PF~~~~~~~~~~i~~~i~~--~~~~~p~--~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 381 LFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHSSCTTCGGGCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHhhcC--CCCCCCc--cCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 999999999998743 3455666665 4556665 799999999999999 99999995 579999999999999
Q ss_pred Chhhhh--hcCCCcccccCCcccccCccc
Q 010947 421 DWARIY--QMEAAFIPEVNDELDTQNFEK 447 (497)
Q Consensus 421 ~w~~l~--~~~~p~~p~~~~~~d~~~f~~ 447 (497)
||+.+. +++|||+|.+.+..++++||.
T Consensus 457 dW~~l~~~~~~pP~~P~~~~~~~~~~fD~ 485 (689)
T 3v5w_A 457 DWQMVFLQKYPPPLIPPRGEVNAADAFDI 485 (689)
T ss_dssp CHHHHHTTCSCCSCCCCTTCSSTTBCCC-
T ss_pred CHHHHHcCCCCcCccCCCCCCCcCCCCCC
Confidence 999997 478999999988888777763
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-71 Score=552.05 Aligned_cols=278 Identities=41% Similarity=0.739 Sum_probs=242.5
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
.++..++|++++.||+|+||+||+|++. .+++.||||++++..... .....+.+|+.+|+.++|||||+++++|++
T Consensus 19 ~~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 19 EKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVRTKMERDILVEVNHPFIVKLHYAFQT 97 (304)
T ss_dssp CCCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEE-EECC------CCCCCCCCTTEECEEEEEEE
T ss_pred ccCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcCh-HHHHHHHHHHHHHHHCCCCCCCeEEEEEEE
Confidence 3455678999999999999999999984 478899999998765332 223457889999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
++.+|||||||+||+|.+++.+.+.+++.+++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+...
T Consensus 98 ~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 98 EGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp TTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998643
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
... ....+.+|||.|||||++.+.+|+.++|||||||++
T Consensus 178 ~~~-----------------------------------------~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvil 216 (304)
T 3ubd_A 178 DHE-----------------------------------------KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLM 216 (304)
T ss_dssp --------------------------------------------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHH
T ss_pred CCC-----------------------------------------ccccccccCcccCCHHHhccCCCCCCCcccchHHHH
Confidence 211 012367999999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChhh
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~~ 424 (497)
|||++|.+||.+.+..+++.+|.+ ..+.+|. .+|+++++||.+||+ ||.+||++. +++|+++||||+++||+.
T Consensus 217 yemltG~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~ 292 (304)
T 3ubd_A 217 FEMLTGTLPFQGKDRKETMTMILK--AKLGMPQ--FLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292 (304)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred HHHHhCCCCCCCcCHHHHHHHHHc--CCCCCCC--cCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence 999999999999999999999987 4556665 799999999999999 999999963 578999999999999999
Q ss_pred hh--hcCCCccc
Q 010947 425 IY--QMEAAFIP 434 (497)
Q Consensus 425 l~--~~~~p~~p 434 (497)
+. +++|||+|
T Consensus 293 l~~~~~~pP~~P 304 (304)
T 3ubd_A 293 LYRREIHPPFKP 304 (304)
T ss_dssp HHTTCSCCSSCC
T ss_pred HHhCCCCcCcCC
Confidence 97 47899998
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-69 Score=558.58 Aligned_cols=353 Identities=42% Similarity=0.792 Sum_probs=290.0
Q ss_pred hhHHHHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEE
Q 010947 103 TEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182 (497)
Q Consensus 103 ~~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 182 (497)
....++.+.++..++|+++++||+|+||+||+|+++.+|+.||||++++..........++..|+.++..++||||++++
T Consensus 48 ~~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~ 127 (412)
T 2vd5_A 48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH 127 (412)
T ss_dssp HHHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred hhhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence 34456677788899999999999999999999999999999999999987766666677799999999999999999999
Q ss_pred EEeecCCeEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccc
Q 010947 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261 (497)
Q Consensus 183 ~~~~~~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFG 261 (497)
++|++.+.+|||||||+||+|.+++.+.+ .+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||
T Consensus 128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 128 FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp EEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred EEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeech
Confidence 99999999999999999999999998754 79999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-------cCCC
Q 010947 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-------KKGY 334 (497)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-------~~~y 334 (497)
+|+.+...... .....+||+.|+|||++. ...|
T Consensus 208 la~~~~~~~~~----------------------------------------~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~ 247 (412)
T 2vd5_A 208 SCLKLRADGTV----------------------------------------RSLVAVGTPDYLSPEILQAVGGGPGTGSY 247 (412)
T ss_dssp TCEECCTTSCE----------------------------------------ECSSCCSCGGGCCHHHHHHHHTCTTCSEE
T ss_pred hheeccCCCcc----------------------------------------ccceeccccCcCCHHHHhhcccCcCCCCC
Confidence 99876432100 012468999999999997 3579
Q ss_pred CcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCC-CccCChhHHHHHHHHhhCccccCCCCCcchhcC
Q 010947 335 GMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLCNVNQRLGAKGADEIKV 413 (497)
Q Consensus 335 ~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~ 413 (497)
+.++|||||||++|||++|.+||.+.+..+++.+|+.+...+.+|. ...+|+++++||++||++|.+|+++.+++||++
T Consensus 248 ~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 248 GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPPETRLGRGGAGDFRT 327 (412)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSSCGGGCTTTTTHHHHHT
T ss_pred ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcCChhhcCCCCCHHHHhc
Confidence 9999999999999999999999999999999999998665566664 247999999999999999999999889999999
Q ss_pred CCCccCCChhhhhhcCCCcccccCCcccccCcccccccccccCCC---CCCCcccccccCcCCcccCceeeCCccCCCCC
Q 010947 414 HPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTS---SKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQ 490 (497)
Q Consensus 414 Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~~~ 490 (497)
||||++++|+.+.+..|||+|.+.++.|++||+.+.+........ .............+..|.||||.+ ..+.+.+
T Consensus 328 Hpff~~i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~-~~~~~~~ 406 (412)
T 2vd5_A 328 HPFFFGLDWDGLRDSVPPFTPDFEGATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSC-MALRDSE 406 (412)
T ss_dssp SGGGTTCCSTTSTTSCCSCCCC-----CCSSCC--CCCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSC-CCCCGGG
T ss_pred CCCcCCCCHHHHhhcCCCCCCcCCCcccccccCcccccccccccccCCCcccccCCCccccCCCCCCCcccC-ccccccc
Confidence 999999999999999999999999999999999764432211000 000000001123467899999998 5688899
Q ss_pred CCCCCC
Q 010947 491 VPGMGY 496 (497)
Q Consensus 491 ~~~~~~ 496 (497)
.||++|
T Consensus 407 ~~~~~~ 412 (412)
T 2vd5_A 407 VPGPTP 412 (412)
T ss_dssp CC----
T ss_pred CCCCCC
Confidence 999986
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-67 Score=547.73 Aligned_cols=343 Identities=44% Similarity=0.816 Sum_probs=289.0
Q ss_pred HHHHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEE
Q 010947 105 YMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (497)
Q Consensus 105 ~~~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 184 (497)
...+...++..++|+++++||+|+||+||+|+++.+++.||||++.+..........++.+|+.+++.++|||||+++++
T Consensus 58 ~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 137 (410)
T 3v8s_A 58 INKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137 (410)
T ss_dssp HHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEE
T ss_pred HHHHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 34456677889999999999999999999999999999999999998776666666778999999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
|++...+|||||||+||+|.+++.. ..+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+
T Consensus 138 ~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~ 216 (410)
T 3v8s_A 138 FQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM 216 (410)
T ss_dssp EECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeE
Confidence 9999999999999999999999865 579999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC----CCcchhH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG----YGMECDW 340 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~----y~~~~Di 340 (497)
.+...... ...+.+||+.|+|||++.+.+ |+.++||
T Consensus 217 ~~~~~~~~----------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~Di 256 (410)
T 3v8s_A 217 KMNKEGMV----------------------------------------RCDTAVGTPDYISPEVLKSQGGDGYYGRECDW 256 (410)
T ss_dssp ECCTTSEE----------------------------------------ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHH
T ss_pred eeccCCcc----------------------------------------cccCCcCCccccCHHHhhccCCCcCCCCcceE
Confidence 76432110 122578999999999998765 8899999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccCC
Q 010947 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|||||++|||++|.+||.+.+..+++.+|+.+...+.+|....+|+++++||.+||+++.+|+++.+++||++||||+++
T Consensus 257 wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 257 WSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred ecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999987667788877789999999999999966666666679999999999999
Q ss_pred Chhhh--hhcCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCCccCCCCCCC
Q 010947 421 DWARI--YQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQVP 492 (497)
Q Consensus 421 ~w~~l--~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~~~~~ 492 (497)
+|+.+ .++.|||+|.+.++.|++||+.+++......+.. .+ ......+..|.||||.+....-....|
T Consensus 337 ~w~~~~~~~~~~p~~p~~~~~~d~~~fd~~~~~~~~~~~~~--~~--~~~~~~~~~f~~f~~~~~~~~~~~~~~ 406 (410)
T 3v8s_A 337 QWAWETLRDTVAPVVPDLSSDIDTSNFDDLEEDKGEEETFP--IP--KAFVGNQLPFVGFTYYSNRRYLSSANP 406 (410)
T ss_dssp SCCSTTGGGSCCSCCCCCSSTTCCTTSCCCCSCCSCCCCCC--CC--SSCCCTTGGGTTCCEECC---------
T ss_pred CHHHHhhcccCCCCCCcCCCccchhhcCCccccccccccCC--Cc--hhhcccccccccceEeCcccccccCCC
Confidence 98755 4689999999999999999998766543222111 11 122235678999999998766554444
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-67 Score=547.23 Aligned_cols=343 Identities=46% Similarity=0.840 Sum_probs=289.9
Q ss_pred HHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 107 ~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
.+...++..++|+++++||+|+||+||+|+++.+++.||||++.+...........+.+|+.++..++|||||+++++|+
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 45566788899999999999999999999999999999999999876666666667899999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
+.+.+|||||||+||+|.+++.+ .+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~ 224 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLK 224 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhh
Confidence 99999999999999999999987 57899999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDW 340 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~Di 340 (497)
+...... .....+||+.|+|||++. ...|+.++||
T Consensus 225 ~~~~~~~----------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~Dv 264 (437)
T 4aw2_A 225 LMEDGTV----------------------------------------QSSVAVGTPDYISPEILQAMEGGKGRYGPECDW 264 (437)
T ss_dssp CCTTSCE----------------------------------------ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHH
T ss_pred cccCCCc----------------------------------------ccccccCCcCeeChHHHhhcccCCCCCCCcCee
Confidence 5432110 112468999999999997 4679999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCC-ccCChhHHHHHHHHhhCccccCCCCCcchhcCCCCccC
Q 010947 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEE-AKLSIEAKDLISKLLCNVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~-~~~s~~~~dLI~~lL~dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|||||++|||++|.+||.+.+..+++.+|+.+...+.+|.. ..+|+++++||++||+.+.+|+++.+++||++||||++
T Consensus 265 wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 265 WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred HHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 99999999999999999999999999999987666777764 46999999999999995566767777999999999999
Q ss_pred CChhhhhhcCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCCccCCCCCC
Q 010947 420 VDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVNDYQV 491 (497)
Q Consensus 420 i~w~~l~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~~~~~ 491 (497)
++|+.+.+++|||+|.+.++.|++||+..+.......+.. .+........+..|.||||+++..+.+...
T Consensus 345 i~w~~l~~~~~p~~P~~~~~~d~~~fd~~~~~~~~~~~~~--~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~ 414 (437)
T 4aw2_A 345 IDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMP--PPTHTAFSGHHLPFVGFTYTSSCVLSDRSC 414 (437)
T ss_dssp CCTTTGGGSCCSCCCCCSSTTCCTTSCCC--------------------CCTTGGGTTCCEESSCTTSTTSC
T ss_pred CCHHHHhhCCCCCCCcCCCccchhhcCCcccccccccCCC--CCccccccccCccccCCCcCCchhhccCCc
Confidence 9999999999999999999999999987554322111111 111112344678999999999988766543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-66 Score=523.42 Aligned_cols=327 Identities=35% Similarity=0.686 Sum_probs=276.3
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
..+..++|+++++||+|+||+||+|+++.+|+.||||++++...........+..|+.+|..+ +|||||+++++|++.+
T Consensus 18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 97 (353)
T 3txo_A 18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD 97 (353)
T ss_dssp -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence 346678999999999999999999999999999999999987766677788899999999988 7999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+|||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 99999999999999999999899999999999999999999999999999999999999999999999999999854221
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.. ...+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 178 ~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 216 (353)
T 3txo_A 178 GV-----------------------------------------TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYE 216 (353)
T ss_dssp -------------------------------------------------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHH
T ss_pred Cc-----------------------------------------cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHH
Confidence 10 1225789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC---CCcchhcCCCCccCCChhhh
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~---~~~~eil~Hpff~~i~w~~l 425 (497)
|++|.+||.+.+..+++.+|.. ..+.+|. .+++++++||++||+ ||.+||++ .++++|++||||++++|+.+
T Consensus 217 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l 292 (353)
T 3txo_A 217 MLCGHAPFEAENEDDLFEAILN--DEVVYPT--WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292 (353)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence 9999999999999999999987 4556664 699999999999999 99999995 45589999999999999999
Q ss_pred h--hcCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCCcc
Q 010947 426 Y--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEI 485 (497)
Q Consensus 426 ~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~ 485 (497)
. ++.|||+|.+.++.|++||+.....+.+..++..... +.......|.||||.+.+.
T Consensus 293 ~~~~~~~p~~p~~~~~~~~~~f~~~~~~~~~~~~~~~~~~---~~~~~~~~f~~f~~~~~~~ 351 (353)
T 3txo_A 293 NHRQIEPPFRPRIKSREDVSNFDPDFIKEEPVLTPIDEGH---LPMINQDEFRNFEYVSPEL 351 (353)
T ss_dssp HTTCSCCSCCCCCCSTTCCTTSCHHHHTSCCCCCCCCTTS---GGGSCGGGGTTCCEECC--
T ss_pred hcCcCCCCccCCCCCcccccccCcccccCCCcCCCccccc---cCcccccccCCceeeCccc
Confidence 7 4889999999999999999964433332222211111 1112346899999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-65 Score=517.00 Aligned_cols=326 Identities=37% Similarity=0.651 Sum_probs=277.1
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+.+|+.++||||++++++|++.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 45689999999999999999999999999999999999877666677888999999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
+||||++||+|..++.+.+.+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~- 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA- 160 (337)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC-
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC-
Confidence 9999999999999999889999999999999999999999999999999999999999999999999999985422110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
...+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 161 ----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 200 (337)
T 1o6l_A 161 ----------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC 200 (337)
T ss_dssp ----------------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhc
Confidence 0125789999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh--
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ-- 427 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~-- 427 (497)
|.+||.+.+....+..|.. ..+.+|. .+|+++++||.+||+ ||.+|||. .++++|++||||.+++|+.+.+
T Consensus 201 g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~ 276 (337)
T 1o6l_A 201 GRLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKK 276 (337)
T ss_dssp SSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCC
Confidence 9999999999888888886 4556665 789999999999999 99999964 3699999999999999999974
Q ss_pred cCCCcccccCCcccccCcccccccccccCCCCC-CCcccccc---cCcCCcccCceeeCC
Q 010947 428 MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSK-TGPWRKML---SSKDINFVGYTYKNF 483 (497)
Q Consensus 428 ~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~f~g~~~~~~ 483 (497)
+.|||+|.+.++.|++||+..........++.. ......+. ...+..|.||+|.+.
T Consensus 277 ~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 336 (337)
T 1o6l_A 277 LLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIAD 336 (337)
T ss_dssp SCCSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECC
T ss_pred CCCCCCCCCCCcchhhcccchhccCccCcCCCcccccccccccccccccccCCCceecCC
Confidence 789999999999999999853322221111111 11111111 113478999999875
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-66 Score=520.28 Aligned_cols=255 Identities=29% Similarity=0.531 Sum_probs=229.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
..|++++.||+|+||+||+|+++.||+.||||++.+.... ..+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5699999999999999999999999999999999865432 3345789999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||+||+|.+++.+ +.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 151 Ey~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~---- 225 (346)
T 4fih_A 151 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---- 225 (346)
T ss_dssp CCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC----
T ss_pred eCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC----
Confidence 99999999998865 6799999999999999999999999999999999999999999999999999987643210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
...+.||||.|||||++.+.+|+.++||||||||+|||++|.+
T Consensus 226 -------------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 268 (346)
T 4fih_A 226 -------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 268 (346)
T ss_dssp -------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 1236799999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||.+.+..+.+..|... ....++....+|+++++||.+||+ ||.+||+ ++|+|+||||+.
T Consensus 269 PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~e~l~Hp~~~~ 329 (346)
T 4fih_A 269 PYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAK 329 (346)
T ss_dssp TTTTSCHHHHHHHHHHS-SCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGG
T ss_pred CCCCcCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhcC
Confidence 99999999998888753 233344445799999999999999 9999998 999999999975
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-66 Score=507.80 Aligned_cols=254 Identities=31% Similarity=0.587 Sum_probs=217.1
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999999987666666677899999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||| +|+|.+++.+.+.+++.+++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~---- 166 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN---- 166 (275)
T ss_dssp EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC----
Confidence 9999 78999999999999999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~ell~G 353 (497)
...+.+|||.|||||++.+..| +.++|||||||++|||++|
T Consensus 167 --------------------------------------~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg 208 (275)
T 3hyh_A 167 --------------------------------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 208 (275)
T ss_dssp ----------------------------------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHC
Confidence 1125789999999999998886 5899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
++||.+.+..+++.+|.+ ....+|. .+|+++++||.+||+ ||.+||+ ++|+++||||+
T Consensus 209 ~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~R~s---~~eil~hpw~k 267 (275)
T 3hyh_A 209 RLPFDDESIPVLFKNISN--GVYTLPK--FLSPGAAGLIKRMLIVNPLNRIS---IHEIMQDDWFK 267 (275)
T ss_dssp SCSSCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHSCSSGGGSCC---HHHHHHCHHHH
T ss_pred CCCCCCCCHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHccCChhHCcC---HHHHHcCcccc
Confidence 999999999999999887 3455664 799999999999999 9999998 99999999997
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-65 Score=528.74 Aligned_cols=327 Identities=33% Similarity=0.652 Sum_probs=272.2
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 190 (497)
.+..++|+++++||+|+||+||+|+++.+++.||||++++...........+..|+.+|..+ +|||||+++++|++...
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 46678999999999999999999999999999999999987766666667789999999876 89999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|||||||+||+|..++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~ 207 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 207 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC
Confidence 99999999999999999988999999999999999999999999999999999999999999999999999998532110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
....+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 208 -----------------------------------------~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyel 246 (396)
T 4dc2_A 208 -----------------------------------------DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 246 (396)
T ss_dssp -----------------------------------------CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred -----------------------------------------CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHH
Confidence 012257899999999999999999999999999999999
Q ss_pred HhCCCCCCCC---------ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC---CcchhcCCCCc
Q 010947 351 LVGYPPFYSD---------DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---GADEIKVHPWF 417 (497)
Q Consensus 351 l~G~~PF~~~---------~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~---~~~eil~Hpff 417 (497)
++|.+||.+. .....+..|.. ..+.+|. .+|+++++||++||+ ||.+||++. +++||++||||
T Consensus 247 l~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff 322 (396)
T 4dc2_A 247 MAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322 (396)
T ss_dssp HHSSCSSTTTTC------CCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTT
T ss_pred HhCCCCCcccccccccchhhHHHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccc
Confidence 9999999643 22345566665 4566775 799999999999999 999999963 57899999999
Q ss_pred cCCChhhhhh--cCCCcccccCCcccccCcccccccccccCCCCCCCccccccc-CcCCcccCceeeCCccCC
Q 010947 418 DGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLS-SKDINFVGYTYKNFEIVN 487 (497)
Q Consensus 418 ~~i~w~~l~~--~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~g~~~~~~~~~~ 487 (497)
++++|+.+.+ +.|||+|.+.++.|++||+.....+....++.. ...+. ..+..|.||||.++..+.
T Consensus 323 ~~i~w~~l~~~~~~pp~~p~~~~~~d~~~fd~~~~~~~~~~~~~~----~~~~~~~~~~~f~~f~~~~~~~~~ 391 (396)
T 4dc2_A 323 RNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDD----DDIVRKIDQSEFEGFEYINPLLMS 391 (396)
T ss_dssp TTCCHHHHHTTCSCCSCCCCCCSSTTGGGSCHHHHTSCCCCCCCC----HHHHTTSCGGGGTTCCEECC----
T ss_pred cCCCHHHHHcCCCCCCCcCCCCCccchhhcChhhccCCCccCCCc----chhhccccccccCCcEeECccccc
Confidence 9999999974 789999999999999999974443322211111 11122 234589999999987653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-65 Score=517.97 Aligned_cols=258 Identities=28% Similarity=0.505 Sum_probs=225.5
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|++++.+||
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi 100 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI 100 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999987654 34456789999999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 194 IMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|||||+||+|.++|... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+....
T Consensus 101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~- 179 (350)
T 4b9d_A 101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV- 179 (350)
T ss_dssp EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence 99999999999999654 457999999999999999999999999999999999999999999999999998653110
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
....+.|||+.|||||++.+..|+.++||||||||||||+
T Consensus 180 ----------------------------------------~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml 219 (350)
T 4b9d_A 180 ----------------------------------------ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC 219 (350)
T ss_dssp ----------------------------------------HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 0122578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+|.+||.+.+..+++.+|++... ..++ ..+|+++++||.+||+ ||.+||+ ++|+|+||||..
T Consensus 220 tG~~PF~~~~~~~~~~~i~~~~~-~~~~--~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~ 282 (350)
T 4b9d_A 220 TLKHAFEAGSMKNLVLKIISGSF-PPVS--LHYSYDLRSLVSQLFKRNPRDRPS---VNSILEKGFIAK 282 (350)
T ss_dssp HSSCSCCCSSHHHHHHHHHHTCC-CCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHT
T ss_pred HCCCCCCCcCHHHHHHHHHcCCC-CCCC--ccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHHhhc
Confidence 99999999999999999987432 2233 4799999999999999 9999998 999999999974
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-65 Score=519.49 Aligned_cols=328 Identities=32% Similarity=0.630 Sum_probs=279.4
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
.++..++|+++++||+|+||+||+|+++.+|+.||||++++.........+++..|+.+|..+ +||||++++++|++.+
T Consensus 15 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~ 94 (353)
T 2i0e_A 15 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 94 (353)
T ss_dssp ----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSS
T ss_pred CCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCC
Confidence 346678999999999999999999999999999999999988766667778899999999887 8999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||||++||+|.+++.+.+.+++..+++|++||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 95 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 95 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999854221
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.. ...+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 175 ~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 213 (353)
T 2i0e_A 175 GV-----------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 213 (353)
T ss_dssp TC-----------------------------------------CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHH
T ss_pred Cc-----------------------------------------ccccccCCccccChhhhcCCCcCCcccccchHHHHHH
Confidence 10 1225789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhh
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~ 426 (497)
|++|.+||.+.+..+++.+|+. ..+.+|. .+|+++++||.+||+ ||.+||+. .++++|++||||++++|+.+.
T Consensus 214 ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~ 289 (353)
T 2i0e_A 214 MLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 289 (353)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHH
T ss_pred HHcCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHHH
Confidence 9999999999999999999987 4556665 799999999999999 99999985 358999999999999999996
Q ss_pred --hcCCCcccccCCcccccCcccccccccccCCCCCCCcccccccCcCCcccCceeeCCccCC
Q 010947 427 --QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFVGYTYKNFEIVN 487 (497)
Q Consensus 427 --~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~~~~~ 487 (497)
++.|||+|.+.++ |++||+.+........++.. . ..........|.||||.+++.+.
T Consensus 290 ~~~~~~p~~p~~~~~-~~~~f~~~~~~~~~~~~~~~--~-~~~~~~~~~~f~~f~~~~~~~~~ 348 (353)
T 2i0e_A 290 RKEIQPPYKPKACGR-NAENFDRFFTRHPPVLTPPD--Q-EVIRNIDQSEFEGFSFVNSEFLK 348 (353)
T ss_dssp TTCSCCSCCCCCCCC---CHHHHHHHHSCCCCCCCC--H-HHHHHSCTTTTCSCCEECTTCCC
T ss_pred hCCCCCCcCCCCCCc-chhhccchhccCCcccCCcc--c-cccccccccccCCCeeeCccccC
Confidence 4889999999998 99999975543322211111 0 00111245689999999987643
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-64 Score=513.52 Aligned_cols=324 Identities=35% Similarity=0.646 Sum_probs=252.7
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
..+..++|.+++.||+|+||+||+|+++.+|+.||||++++...........+..|+.++..+ +||||++++++|++.+
T Consensus 12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~ 91 (345)
T 1xjd_A 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE 91 (345)
T ss_dssp ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence 356788999999999999999999999999999999999987766666778889999999876 9999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||||++||+|.+++.+.+.+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 92 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 92 NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999854321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.. ...+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 172 ~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 210 (345)
T 1xjd_A 172 DA-----------------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYE 210 (345)
T ss_dssp TC-----------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHH
Confidence 10 0225789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcc-hhcCCCCccCCChhhhh-
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD-EIKVHPWFDGVDWARIY- 426 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~-eil~Hpff~~i~w~~l~- 426 (497)
|++|.+||.+.+..+++.+|... ...+|. .+|+++++||.+||+ ||.+||+ +. +|++||||++++|+.+.
T Consensus 211 ll~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dp~~R~~---~~~~i~~hp~f~~~~w~~l~~ 283 (345)
T 1xjd_A 211 MLIGQSPFHGQDEEELFHSIRMD--NPFYPR--WLEKEAKDLLVKLFVREPEKRLG---VRGDIRQHPLFREINWEELER 283 (345)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHSCSSGGGSBT---TBSCGGGSGGGTTCCHHHHHT
T ss_pred HhcCCCCCCCCCHHHHHHHHHhC--CCCCCc--ccCHHHHHHHHHHhcCCHhHcCC---ChHHHHcCccccCCCHHHHhh
Confidence 99999999999999999998863 445664 799999999999999 9999999 55 99999999999999996
Q ss_pred -hcCCCcccccCCcccccCcccccccccccCCCCCCCccccccc-CcCCcccCceeeCCccC
Q 010947 427 -QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLS-SKDINFVGYTYKNFEIV 486 (497)
Q Consensus 427 -~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~f~g~~~~~~~~~ 486 (497)
++.|||+|.+.++.|++||+.....+.+..+... ...+. ..+..|.||+|.+....
T Consensus 284 ~~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~----~~~~~~~~~~~f~~f~~~~~~~~ 341 (345)
T 1xjd_A 284 KEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFAD----RALINSMDQNMFRNFSFMNPGME 341 (345)
T ss_dssp TCSCC------------------------------------------CCTTTTCCC------
T ss_pred CCCCCCcCCCCCCcchhhhcchhhcccCccCCccc----ccccccccccccCCCeeeChhhh
Confidence 4789999999999999999963332222111111 11111 23468999999887544
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-64 Score=521.28 Aligned_cols=255 Identities=29% Similarity=0.532 Sum_probs=228.9
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
+.|++++.||+|+||+||+|+++.||+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTC---SSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 569999999999999999999999999999999986543 23345889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||+||+|.+++. .+.+++.+++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||+|+.+.....
T Consensus 228 Ey~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~---- 302 (423)
T 4fie_A 228 EFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP---- 302 (423)
T ss_dssp ECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC----
T ss_pred eCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc----
Confidence 9999999999885 46799999999999999999999999999999999999999999999999999987643210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
...+.|||+.|||||++.+..|+.++|||||||++|||++|.+
T Consensus 303 -------------------------------------~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~ 345 (423)
T 4fie_A 303 -------------------------------------RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEP 345 (423)
T ss_dssp -------------------------------------CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 1236799999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||.+.+..+.+..|... ....++....+|+++++||.+||+ ||.+|++ ++|+|+||||+.
T Consensus 346 PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t---a~ell~Hp~~~~ 406 (423)
T 4fie_A 346 PYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLDRLLVRDPAQRAT---AAELLKHPFLAK 406 (423)
T ss_dssp TTTTSCHHHHHHHHHHS-CCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGG
T ss_pred CCCCcCHHHHHHHHHcC-CCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHHhcC
Confidence 99999999998888753 223344445799999999999999 9999998 999999999985
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-64 Score=516.64 Aligned_cols=329 Identities=35% Similarity=0.634 Sum_probs=246.0
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHH-HHhcCCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-LAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~i-l~~l~hp~Iv~l~~~~~~~~ 189 (497)
..+..++|+++++||+|+||+||+|+++.+++.||||++.+..........++..|+.+ ++.++|||||+++++|++.+
T Consensus 33 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~ 112 (373)
T 2r5t_A 33 PHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD 112 (373)
T ss_dssp TTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSS
T ss_pred CCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCC
Confidence 34667899999999999999999999999999999999998876666667778888887 46789999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||||++||+|.+++.+.+.+++..+++|++||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999864221
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.. ...+.+||+.|+|||++.+..|+.++|||||||++||
T Consensus 193 ~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 231 (373)
T 2r5t_A 193 NS-----------------------------------------TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYE 231 (373)
T ss_dssp CC-----------------------------------------CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHH
Confidence 10 1125789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC-CCcchhcCCCCccCCChhhhh-
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA-KGADEIKVHPWFDGVDWARIY- 426 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~-~~~~eil~Hpff~~i~w~~l~- 426 (497)
|++|.+||.+.+..+++.+|+.. .+.+|. .+++++++||.+||+ ||.+|+++ .++++|++||||++++|+.+.
T Consensus 232 ll~G~~Pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~ 307 (373)
T 2r5t_A 232 MLYGLPPFYSRNTAEMYDNILNK--PLQLKP--NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLIN 307 (373)
T ss_dssp HHHSSCTTCCSBHHHHHHHHHHS--CCCCCS--SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred HHcCCCCCCCCCHHHHHHHHHhc--ccCCCC--CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHHHh
Confidence 99999999999999999999873 455664 799999999999999 99999996 357899999999999999996
Q ss_pred -hcCCCcccccCCcccccCcccccccccccCCCCCCC---cccccccCcCCcccCceeeCCc
Q 010947 427 -QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTG---PWRKMLSSKDINFVGYTYKNFE 484 (497)
Q Consensus 427 -~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~f~g~~~~~~~ 484 (497)
++.|||+|.+.++.|++||+.....+.......... .....+...+..|.||||.+..
T Consensus 308 ~~~~pp~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 369 (373)
T 2r5t_A 308 KKITPPFNPNVSGPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPT 369 (373)
T ss_dssp TCSCCSCCCSCCC-------------------------------------------------
T ss_pred CCCCCCCCCCCCCcchhhhcCcccccccccccccCCccccccccccccccccCCCCcccCch
Confidence 478999999999999999996333222111000000 0001111235679999998764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-63 Score=491.24 Aligned_cols=254 Identities=23% Similarity=0.409 Sum_probs=219.4
Q ss_pred CCe-eEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec----CCe
Q 010947 116 DDF-ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DEF 190 (497)
Q Consensus 116 ~~f-~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~ 190 (497)
.+| .+.+.||+|+||+||+|+++.++..||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+ +..
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 345 677889999999999999999999999999987643 34456779999999999999999999999875 457
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC--EEEcccCCCCeeecC-CCcEEEcccccccccC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLD 267 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDLKp~NILl~~-~g~vkL~DFGla~~~~ 267 (497)
+|||||||+||+|.+++.+.+.+++..++.|+.||+.||.|||++| ||||||||+||||+. +|++||+|||+|+...
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~ 183 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence 9999999999999999999999999999999999999999999998 999999999999985 7999999999997542
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
.. ...+.+|||.|||||++. ++|+.++|||||||++
T Consensus 184 ~~-------------------------------------------~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvil 219 (290)
T 3fpq_A 184 AS-------------------------------------------FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCM 219 (290)
T ss_dssp TT-------------------------------------------SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHH
T ss_pred CC-------------------------------------------ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHH
Confidence 11 123679999999999986 4699999999999999
Q ss_pred HHHHhCCCCCCCCCh-HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 348 YEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 348 ~ell~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|||+||.+||.+.+. ..++..+.....+..++ ..+++++++||.+||. ||.+||+ ++|+++||||+.
T Consensus 220 yelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~R~s---~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 220 LEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC-
T ss_pred HHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCC--ccCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccC
Confidence 999999999987554 45556665533333333 3688999999999999 9999998 999999999974
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-63 Score=503.66 Aligned_cols=324 Identities=34% Similarity=0.656 Sum_probs=273.4
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 190 (497)
.+..++|++++.||+|+||+||+|+++.+|+.||||++.+...........+..|+.++..+ +|||||+++++|++...
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45678899999999999999999999999999999999987766666778899999999987 89999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|+||||++||+|..++.+.+.+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+......
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 99999999999999999988899999999999999999999999999999999999999999999999999998532110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
. ...+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 165 ~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 203 (345)
T 3a8x_A 165 D-----------------------------------------TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 203 (345)
T ss_dssp C-----------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred C-----------------------------------------cccccCCCccccCccccCCCCCChHHhHHHHHHHHHHH
Confidence 0 01257899999999999999999999999999999999
Q ss_pred HhCCCCCCC---------CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC---CCcchhcCCCCc
Q 010947 351 LVGYPPFYS---------DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA---KGADEIKVHPWF 417 (497)
Q Consensus 351 l~G~~PF~~---------~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~---~~~~eil~Hpff 417 (497)
++|.+||.. ......+..|.. ..+.+|. .+|+++++||.+||+ ||.+||++ .++++|++||||
T Consensus 204 l~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f 279 (345)
T 3a8x_A 204 MAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQIRIPR--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279 (345)
T ss_dssp HHSSCTTTTTTC-------CHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGG
T ss_pred HhCCCCcCCcccccccccccHHHHHHHHHc--CCCCCCC--CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCcc
Confidence 999999975 233445566665 4456665 789999999999999 99999995 246899999999
Q ss_pred cCCChhhhh--hcCCCcccccCCcccccCcccccccccccCCCCCCCcccccc-cCcCCcccCceeeCCc
Q 010947 418 DGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML-SSKDINFVGYTYKNFE 484 (497)
Q Consensus 418 ~~i~w~~l~--~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~g~~~~~~~ 484 (497)
++++|+.+. ++.|||+|.+.++.|++||+.....+....+... .... ......|.||||.+++
T Consensus 280 ~~~~w~~~~~~~~~~p~~p~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~f~~f~~~~~~ 345 (345)
T 3a8x_A 280 RNVDWDMMEQKQVVPPFKPNISGEFGLDNFDSQFTNEPVQLTPDD----DDIVRKIDQSEFEGFEYINPL 345 (345)
T ss_dssp TTCCHHHHHTTCSCCSCCCCCCTTTCGGGSCHHHHTSCSSCCCCC----HHHHTTSCGGGGTTCCEECCC
T ss_pred CCCCHHHHHhCCCCCCcCCCCCCcchhhhcCcccccCcccCCCcc----ccccccccccccCCCEeeCCC
Confidence 999999997 4789999999999999999863322211111110 1111 1234689999998753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-64 Score=503.64 Aligned_cols=250 Identities=28% Similarity=0.407 Sum_probs=218.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|++.+.||+|+||+||+|+++.||+.||||++++... ..+|+.+|+.++|||||+++++|++++.+||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i 127 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI 127 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45679999999999999999999999999999999986542 2369999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-cEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~~ 272 (497)
|||||+||+|.++|.+.+.+++..++.|+.||+.||.|||++|||||||||+||||+.+| ++||+|||+|+.+......
T Consensus 128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~ 207 (336)
T 4g3f_A 128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG 207 (336)
T ss_dssp EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence 999999999999999999999999999999999999999999999999999999999988 6999999999976532111
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.. .....+.||||.|||||++.+..|+.++|||||||++|||++
T Consensus 208 ~~------------------------------------~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemlt 251 (336)
T 4g3f_A 208 KS------------------------------------LLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLN 251 (336)
T ss_dssp ------------------------------------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred cc------------------------------------eecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHH
Confidence 00 001125789999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcc-cCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHL-KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~-~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
|.+||.+.+..+++.+|......+ .+| ..+|+++++||.+||+ ||.+||+ +.|++
T Consensus 252 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s---a~el~ 308 (336)
T 4g3f_A 252 GCHPWTQYFRGPLCLKIASEPPPIREIP--PSCAPLTAQAIQEGLRKEPVHRAS---AMELR 308 (336)
T ss_dssp SSCSSTTTCCSCCHHHHHHSCCGGGGSC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred CcCCCCCCCHHHHHHHHHcCCCCchhcC--ccCCHHHHHHHHHHccCCHhHCcC---HHHHH
Confidence 999999998888888888754332 244 3799999999999999 9999998 88874
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-62 Score=497.19 Aligned_cols=293 Identities=41% Similarity=0.826 Sum_probs=269.0
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
.....++|++++.||+|+||.||+|+++.+|+.||||++.+.........+++.+|+.+|+.++||||++++++|++...
T Consensus 36 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 36 NTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34566899999999999999999999999999999999998776666777889999999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 116 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~- 194 (350)
T 1rdq_E 116 LYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred EEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC-
Confidence 9999999999999999998889999999999999999999999999999999999999999999999999999865321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
..+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 195 -------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 231 (350)
T 1rdq_E 195 -------------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEM 231 (350)
T ss_dssp -------------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHH
T ss_pred -------------------------------------------cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHH
Confidence 1256899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhh-
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY- 426 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~- 426 (497)
++|.+||.+.+..+.+.+|... .+.+|. .+|+++++||.+||+ ||.+||+. .++++|++||||++++|..+.
T Consensus 232 l~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~ 307 (350)
T 1rdq_E 232 AAGYPPFFADQPIQIYEKIVSG--KVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQ 307 (350)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHT
T ss_pred hhCCCCCCCCCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhh
Confidence 9999999999999999999874 456664 789999999999999 99999983 568999999999999999997
Q ss_pred -hcCCCcccccCCcccccCccccccc
Q 010947 427 -QMEAAFIPEVNDELDTQNFEKFEES 451 (497)
Q Consensus 427 -~~~~p~~p~~~~~~d~~~f~~~~~~ 451 (497)
+++|||+|.+.++.|++||+.+.+.
T Consensus 308 ~~~~~p~~p~~~~~~~~~~f~~~~~~ 333 (350)
T 1rdq_E 308 RKVEAPFIPKFKGPGDTSNFDDYEEE 333 (350)
T ss_dssp TCSCCSCCCCCCSTTCCTTSCCCCCC
T ss_pred ccCCCCCCCCCCCccccccccccccc
Confidence 4789999999999999999976554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-63 Score=543.73 Aligned_cols=327 Identities=32% Similarity=0.641 Sum_probs=283.9
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
..+..++|+++++||+|+||+||+|+++.+++.||||++++.........+.+..|+.+|..+ +||+|+.++++|++.+
T Consensus 336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~ 415 (674)
T 3pfq_A 336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD 415 (674)
T ss_dssp ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence 346678999999999999999999999999999999999987766667778889999999987 7999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+||||||++||+|..++...+.+++..+++|++||+.||.|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 99999999999999999998899999999999999999999999999999999999999999999999999999864321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.. ...+.+||+.|+|||++.+..|+.++|||||||+|||
T Consensus 496 ~~-----------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilye 534 (674)
T 3pfq_A 496 GV-----------------------------------------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYE 534 (674)
T ss_dssp TC-----------------------------------------CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHH
T ss_pred Cc-----------------------------------------ccccccCCCcccCHhhhcCCCCCccceEechHHHHHH
Confidence 10 1225789999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhh
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~ 426 (497)
|++|.+||.+.+..+++.+|+. ..+.+|. .+|+++++||++||+ ||.+||+. .+++||++||||+++||+.+.
T Consensus 535 lltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~ 610 (674)
T 3pfq_A 535 MLAGQAPFEGEDEDELFQSIME--HNVAYPK--SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLE 610 (674)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHS--SCCCCCT--TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHT
T ss_pred HHcCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHHH
Confidence 9999999999999999999997 4566775 799999999999999 99999995 356999999999999999997
Q ss_pred --hcCCCcccccCCcccccCcccccccccccCCCCCCCcccccc-cCcCCcccCceeeCCccCC
Q 010947 427 --QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKML-SSKDINFVGYTYKNFEIVN 487 (497)
Q Consensus 427 --~~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~f~g~~~~~~~~~~ 487 (497)
++.|||+|.+.+ .|++||+.+.....+..++.. ...+ ...+..|.||||.+++.+.
T Consensus 611 ~~~~~pp~~p~~~~-~~~~~f~~~~~~~~~~~~~~~----~~~~~~~~~~~f~~f~~~~~~~~~ 669 (674)
T 3pfq_A 611 RKEIQPPYKPKASG-RNAENFDRFFTRHPPVLTPPD----QEVIRNIDQSEFEGFSFVNSEFLK 669 (674)
T ss_dssp TTCSCCSCCCBCCG-GGHHHHTTTTTSSCSSCCCCC----HHHHTTCCGGGGTTCCEECSSCCC
T ss_pred hCCCCCCCCCcCCC-CchhhcCchhccCCCccCCCc----hhhhhcccccccCCCcccChhhhc
Confidence 488999999998 999999987665443322211 1112 2234689999999987654
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-62 Score=491.30 Aligned_cols=291 Identities=42% Similarity=0.840 Sum_probs=254.0
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++++.||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+++.++||||++++++|++...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 45678999999999999999999999999999999999876666667788999999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
+||||++||+|.+++.+...+++..+++++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.....
T Consensus 83 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC---
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc---
Confidence 99999999999999998889999999999999999999999999999999999999999999999999999865321
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
..+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 160 -----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 198 (318)
T 1fot_A 160 -----------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198 (318)
T ss_dssp -----------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHh
Confidence 125689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhh--h
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--Q 427 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~ 427 (497)
|.+||.+.+....+.+|+.. .+.+|. .+++++++||.+||+ ||.+|++. .++++|++||||++++|+.+. +
T Consensus 199 g~~pf~~~~~~~~~~~i~~~--~~~~p~--~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~~~ 274 (318)
T 1fot_A 199 GYTPFYDSNTMKTYEKILNA--ELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRN 274 (318)
T ss_dssp SSCTTCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHHHhCC
Confidence 99999999999999999873 456664 789999999999999 99999964 269999999999999999997 4
Q ss_pred cCCCcccccC-CcccccCccccccc
Q 010947 428 MEAAFIPEVN-DELDTQNFEKFEES 451 (497)
Q Consensus 428 ~~~p~~p~~~-~~~d~~~f~~~~~~ 451 (497)
+.|||+|.+. ++.|+++|+.+.+.
T Consensus 275 ~~~p~~p~~~~~~~d~~~f~~~~~~ 299 (318)
T 1fot_A 275 IETPYEPPIQQGQGDTSQFDKYPEE 299 (318)
T ss_dssp SCCSCCCCC----------------
T ss_pred CCCCCCCCcCCCccchhhcCCCCcc
Confidence 7899999998 58999999987654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-61 Score=497.05 Aligned_cols=266 Identities=24% Similarity=0.416 Sum_probs=225.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec------C
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------D 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~ 188 (497)
.++|++++.||+|+||+||+|+++.||+.||||++++... .......+.+|+.+|+.++|||||+++++|.+ .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccC
Confidence 3679999999999999999999999999999999976532 23445678899999999999999999998764 4
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+.+|||||||+ |+|.+++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+..
T Consensus 132 ~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 132 KSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred CEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 67999999995 78999999889999999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil 347 (497)
.... ......+.|||+.|||||++.+. .|+.++||||+|||+
T Consensus 211 ~~~~-------------------------------------~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il 253 (398)
T 4b99_A 211 SPAE-------------------------------------HQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 253 (398)
T ss_dssp ------------------------------------------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred Cccc-------------------------------------cccccccceeChHhcCHHHhcCCCCCCChhheehhHHHH
Confidence 2110 00112367999999999998875 579999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCccc------------------CCC---------CccCChhHHHHHHHHhh-Cc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLK------------------FPE---------EAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~------------------~p~---------~~~~s~~~~dLI~~lL~-dp 399 (497)
|||++|.+||.+.+..+++..|+....... +|. ...+|++++|||.+||+ ||
T Consensus 254 ~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 333 (398)
T 4b99_A 254 GEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEP 333 (398)
T ss_dssp HHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSST
T ss_pred HHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCCh
Confidence 999999999999999999888875322111 111 12579999999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCCCh
Q 010947 400 NQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i~w 422 (497)
.+|++ ++|+|+||||+....
T Consensus 334 ~~R~t---a~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 334 SARIS---AAAALRHPFLAKYHD 353 (398)
T ss_dssp TTSCC---HHHHTTSGGGTTTCC
T ss_pred hHCcC---HHHHhcCHhhCcCCC
Confidence 99998 999999999997653
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-62 Score=481.98 Aligned_cols=268 Identities=25% Similarity=0.424 Sum_probs=205.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC------
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE------ 189 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------ 189 (497)
+||++++.||+|+||+||+|+++.+|+.||||+++... .....+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 36999999999999999999999999999999997643 2334567899999999999999999999987543
Q ss_pred ------eEEEEEeecCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccc
Q 010947 190 ------FLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (497)
Q Consensus 190 ------~l~lVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DF 260 (497)
++|||||||+||+|.+++..... .++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 48999999999999999987655 445678999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhH
Q 010947 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (497)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~Di 340 (497)
|+|+.+........... +. .......+.||||.|||||++.+..|+.++||
T Consensus 163 Gla~~~~~~~~~~~~~~-----------------~~------------~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~Di 213 (299)
T 4g31_A 163 GLVTAMDQDEEEQTVLT-----------------PM------------PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDI 213 (299)
T ss_dssp CCC-------------------------------------------------------CCCTTSCHHHHTTCCCCTHHHH
T ss_pred ccceecCCCcccccccc-----------------cc------------ccccccCCcccCccccCHHHHcCCCCCCHHHH
Confidence 99997754321100000 00 00011235799999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcccCcccCCC-CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 341 WSLGAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|||||++|||++ ||.+... ......+.+ ..+|. ....++++++||.+||+ ||.+||+ +.|+++||||
T Consensus 214 wSlGvilyell~---Pf~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~h~~~ 283 (299)
T 4g31_A 214 FSLGLILFELLY---PFSTQMERVRTLTDVRN----LKFPPLFTQKYPCEYVMVQDMLSPSPMERPE---AINIIENAVF 283 (299)
T ss_dssp HHHHHHHHHHHS---CCSSHHHHHHHHHHHHT----TCCCHHHHHHCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGG
T ss_pred HHHHHHHHHHcc---CCCCccHHHHHHHHHhc----CCCCCCCcccCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhh
Confidence 999999999996 8865432 223333332 23442 23567889999999999 9999998 9999999999
Q ss_pred cCCChhh
Q 010947 418 DGVDWAR 424 (497)
Q Consensus 418 ~~i~w~~ 424 (497)
++++|..
T Consensus 284 ~~~~~p~ 290 (299)
T 4g31_A 284 EDLDFPG 290 (299)
T ss_dssp CCC----
T ss_pred CCCCCCC
Confidence 9999853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-60 Score=514.79 Aligned_cols=264 Identities=29% Similarity=0.507 Sum_probs=236.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||+|+||+||+|+++.||+.||||++.+.. ....+.+.+|+.+|+.++|||||+++++|+++..+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999999999999999997654 23346788999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC--CcEEEcccccccccCCCCc
Q 010947 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY--GHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 195 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~--g~vkL~DFGla~~~~~~~~ 271 (497)
||||+||+|.++|.. .+.|++.+++.|+.||+.||.|||++||+||||||+|||++.+ |++||+|||+|+.+....
T Consensus 233 ~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~- 311 (573)
T 3uto_A 233 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ- 311 (573)
T ss_dssp EECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred EeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence 999999999999864 4689999999999999999999999999999999999999854 899999999999764321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
...+.|||+.|||||++.+.+|+.++||||||||||||+
T Consensus 312 -----------------------------------------~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml 350 (573)
T 3uto_A 312 -----------------------------------------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 350 (573)
T ss_dssp -----------------------------------------EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 122579999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
+|.+||.+.+..+++.+|......+..+....+|++++|||.+||+ ||.+||+ +.|+|+||||+..+|....
T Consensus 351 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t---~~e~l~Hpw~~~~~~~~~~ 423 (573)
T 3uto_A 351 SGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGRD 423 (573)
T ss_dssp HSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTSCCCCTTTT
T ss_pred HCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcCcCCCCCCCch
Confidence 9999999999999999998754444333345799999999999999 9999998 9999999999999886543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-60 Score=481.74 Aligned_cols=283 Identities=27% Similarity=0.443 Sum_probs=214.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCe
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 190 (497)
.++|++++.||+|+||+||+|+++ .+++.||||++.+.. ....+.+|+.+|+.+ +|||||+++++|++.++
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 467999999999999999999875 467899999987542 234578899999988 69999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC-CcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~-g~vkL~DFGla~~~~~~ 269 (497)
+|||||||+||+|.+++ +.+++.+++.|+.||+.||+|||++|||||||||+|||++.+ |++||+|||+|+.....
T Consensus 95 ~~lvmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999999999998 469999999999999999999999999999999999999877 89999999999876544
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ 348 (497)
......+........ .... ........++....+.|||+.|+|||++.+. .|+.++||||+|||+|
T Consensus 172 ~~~~~~~~~~~~~~~------~~~~-------~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 172 KIELLKFVQSEAQQE------RCSQ-------NKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp SCGGGGGC---------------------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ccccccccccccccc------cccc-------ccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 322111110000000 0000 0000000111223467999999999999875 5899999999999999
Q ss_pred HHHhCCCCCCCC-ChHHHHHHHhcccCc--------------------------------------------------cc
Q 010947 349 EMLVGYPPFYSD-DPMSTCRKIVNWRTH--------------------------------------------------LK 377 (497)
Q Consensus 349 ell~G~~PF~~~-~~~~~~~~i~~~~~~--------------------------------------------------~~ 377 (497)
||++|++||.+. +..+.+.+|....+. ..
T Consensus 239 ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 318 (361)
T 4f9c_A 239 SLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATN 318 (361)
T ss_dssp HHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC-------------------
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccc
Confidence 999999999654 444554444321000 00
Q ss_pred CCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 378 FPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 378 ~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
.+....+|++++|||++||+ ||.+|++ |+|+|+||||++++
T Consensus 319 ~~~~~~is~~a~DLl~~lL~~dP~~R~t---a~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 319 LEGWNEVPDEAYDLLDKLLDLNPASRIT---AEEALLHPFFKDMS 360 (361)
T ss_dssp ---CTTCCHHHHHHHHHHTCSCTTTSCC---HHHHHTSGGGTTC-
T ss_pred ccccccCCHHHHHHHHHHCcCChhHCcC---HHHHhcCcccCCCC
Confidence 11124689999999999999 9999999 99999999999875
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-59 Score=488.05 Aligned_cols=296 Identities=40% Similarity=0.731 Sum_probs=251.0
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
...+..++|++++.||+|+||.||+|+++.+|+.||||++.+..........++.+|+.+|+.++||||++++++|.+.+
T Consensus 142 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 221 (446)
T 4ejn_A 142 KHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHD 221 (446)
T ss_dssp --CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETT
T ss_pred ccCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCC
Confidence 34566789999999999999999999999999999999998876555666677889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|||||||+||+|..++.....+++..++.++.||+.||.|||+ .|||||||||+|||++.+|++||+|||+|+....
T Consensus 222 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 222 RLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 999999999999999999988999999999999999999999998 9999999999999999999999999999975422
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
... ...+.+||+.|+|||++.+..|+.++|||||||++|
T Consensus 302 ~~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 340 (446)
T 4ejn_A 302 DGA-----------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMY 340 (446)
T ss_dssp ----------------------------------------------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHH
T ss_pred CCc-----------------------------------------ccccccCCccccCHhhcCCCCCCCccchhhhHHHHH
Confidence 110 012578999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhh
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l 425 (497)
||++|.+||.+.+.......+.. ..+.+|. .+++++++||.+||. ||.+||+. .+++|+++||||.+++|..+
T Consensus 341 ell~g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~ 416 (446)
T 4ejn_A 341 EMMCGRLPFYNQDHEKLFELILM--EEIRFPR--TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416 (446)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred HHhhCCCCCCCCCHHHHHHHHHh--CCCCCCc--cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence 99999999999999888888876 4455664 689999999999999 99999942 24999999999999999999
Q ss_pred hh--cCCCcccccCCcccccCcccccc
Q 010947 426 YQ--MEAAFIPEVNDELDTQNFEKFEE 450 (497)
Q Consensus 426 ~~--~~~p~~p~~~~~~d~~~f~~~~~ 450 (497)
.+ +.|||+|.+.++.|+++|++...
T Consensus 417 ~~~~~~pp~~p~~~~~~~~~~~~~~~~ 443 (446)
T 4ejn_A 417 YEKKLSPPFKPQVTSETDTRYFDEEFT 443 (446)
T ss_dssp HTTCSCCSCCCSCSSTTCCTTC-----
T ss_pred hhCcCCCCccCCCCCccchhhcchhhh
Confidence 74 78999999999999999987443
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=465.45 Aligned_cols=257 Identities=22% Similarity=0.394 Sum_probs=221.2
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
.+..++|.+.+.||+|+||+||+|++. .++..||||+++... ....+.+.+|+.+|++++|||||+++++|.
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~ 85 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCV 85 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEe
Confidence 456688999999999999999999875 357899999997542 344567999999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRK-------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~-------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g 253 (497)
+++.+|||||||+||+|.++|.+. ..+++.++..++.||+.||.|||+++||||||||+|||++.++
T Consensus 86 ~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~ 165 (299)
T 4asz_A 86 EGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL 165 (299)
T ss_dssp SSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred eCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC
Confidence 999999999999999999999764 3699999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC
Q 010947 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (497)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~ 333 (497)
++||+|||+|+........ ......+||+.|||||++.+..
T Consensus 166 ~~Ki~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~~~~~~ 206 (299)
T 4asz_A 166 LVKIGDFGMSRDVYSTDYY---------------------------------------RVGGHTMLPIRWMPPESIMYRK 206 (299)
T ss_dssp CEEECCCSCHHHHTGGGCE---------------------------------------EETTTEEECGGGCCHHHHHHCC
T ss_pred cEEECCcccceecCCCCce---------------------------------------eecCceecChhhcCHHHHcCCC
Confidence 9999999999865322100 0112457999999999999999
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 334 y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
|+.++|||||||+||||+| |.+||.+.+..+....|.... .+..|. .+|+++.+||.+||. ||.+||+ +.+|
T Consensus 207 ~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~p~--~~~~~~~~li~~cl~~dP~~RPs---~~~i 280 (299)
T 4asz_A 207 FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQRPR--TCPQEVYELMLGCWQREPHMRKN---IKGI 280 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-CCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCc--cchHHHHHHHHHHcCCChhHCcC---HHHH
Confidence 9999999999999999998 999999999999998888642 344554 799999999999999 9999998 8888
Q ss_pred cCCCCcc
Q 010947 412 KVHPWFD 418 (497)
Q Consensus 412 l~Hpff~ 418 (497)
|+|++
T Consensus 281 --~~~L~ 285 (299)
T 4asz_A 281 --HTLLQ 285 (299)
T ss_dssp --HHHHH
T ss_pred --HHHHH
Confidence 55664
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-58 Score=471.27 Aligned_cols=281 Identities=32% Similarity=0.655 Sum_probs=248.9
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
...+..++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|+.++|||||+++++|++..
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34567789999999999999999999999999999999999877666777888999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||||++||+|..++.....+++..++.|+.||+.||.|||+.|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CCCCcchhHHhHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAI 346 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~y~~~~DiwSlGvi 346 (497)
. ...+.+||+.|+|||++.. .+|+.++|||||||+
T Consensus 169 ~------------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~i 206 (384)
T 4fr4_A 169 T------------------------------------------QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVT 206 (384)
T ss_dssp C------------------------------------------CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHH
T ss_pred C------------------------------------------ceeccCCCccccCCeeeccCCCCCCCccceeechHHH
Confidence 1 0125789999999999974 469999999999999
Q ss_pred HHHHHhCCCCCCCCC---hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCCh
Q 010947 347 MYEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 347 l~ell~G~~PF~~~~---~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
+|||++|.+||.+.+ ..+....+.. ....+|. .+|+++.+||.+||+ ||.+||++ ++++++||||++++|
T Consensus 207 l~elltG~~Pf~~~~~~~~~~~~~~~~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~s~--~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 207 AYELLRGRRPYHIRSSTSSKEIVHTFET--TVVTYPS--AWSQEMVSLLKKLLEPNPDQRFSQ--LSDVQNFPYMNDINW 280 (384)
T ss_dssp HHHHHHSSCSSCCCTTSCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCS--HHHHHTSGGGTTCCH
T ss_pred HHHHHhCCCCCCCCCCccHHHHHHHHhh--cccCCCC--cCCHHHHHHHHHHhcCCHhHhccc--HHHHHcChhhhcCCH
Confidence 999999999998543 3444444443 3445554 789999999999999 99999983 889999999999999
Q ss_pred hhhhh--cCCCcccccCC
Q 010947 423 ARIYQ--MEAAFIPEVND 438 (497)
Q Consensus 423 ~~l~~--~~~p~~p~~~~ 438 (497)
+.+.+ +.|||+|....
T Consensus 281 ~~~~~~~~~p~~~p~~~~ 298 (384)
T 4fr4_A 281 DAVFQKRLIPGFIPNKGR 298 (384)
T ss_dssp HHHHTTCSCCCCCCSCCS
T ss_pred HHHHhCCCCCCCCCCCCC
Confidence 99974 78999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-58 Score=488.75 Aligned_cols=292 Identities=33% Similarity=0.622 Sum_probs=254.4
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
...+..++|.++++||+|+||+||+|+++.+|+.||||++.+..........++..|+.+|+.++|||||+++++|++..
T Consensus 179 ~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~ 258 (543)
T 3c4z_A 179 AQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT 258 (543)
T ss_dssp TSCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred cccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence 35677899999999999999999999999999999999999877666667788999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
.+|+||||++||+|..++... ..+++..+++|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~ 338 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVE 338 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeee
Confidence 999999999999999998763 3699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
+..... ...+.+||+.|+|||++.+..|+.++|||||||
T Consensus 339 ~~~~~~-----------------------------------------~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGv 377 (543)
T 3c4z_A 339 LKAGQT-----------------------------------------KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGV 377 (543)
T ss_dssp CCTTCC-----------------------------------------CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHH
T ss_pred ccCCCc-----------------------------------------ccccccCCccccChhhhcCCCCChHHhcCcchH
Confidence 542210 012468999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC----hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCcc
Q 010947 346 IMYEMLVGYPPFYSDD----PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFD 418 (497)
Q Consensus 346 il~ell~G~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~ 418 (497)
++|||++|.+||.+.+ ..+....|.. ....+|. .+|+++++||.+||+ ||.+||+.. ++++|++||||+
T Consensus 378 ilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~ 453 (543)
T 3c4z_A 378 TLYEMIAARGPFRARGEKVENKELKQRVLE--QAVTYPD--KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR 453 (543)
T ss_dssp HHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred HHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccCCCc--ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence 9999999999998763 4566677765 3455664 799999999999999 999999853 578999999999
Q ss_pred CCChhhhhh--cCCCcccccC-----CcccccCcc
Q 010947 419 GVDWARIYQ--MEAAFIPEVN-----DELDTQNFE 446 (497)
Q Consensus 419 ~i~w~~l~~--~~~p~~p~~~-----~~~d~~~f~ 446 (497)
+++|..+.+ +.|||+|.+. +..|+.+|+
T Consensus 454 ~i~w~~l~~~~~~pp~~P~~~~~~~~~~~d~~~f~ 488 (543)
T 3c4z_A 454 DISWRQLEAGMLTPPFVPDSRTVYAKNIQDVGAFS 488 (543)
T ss_dssp TCCHHHHHTTCSCCSCCCCSSSCCSCC----CCCC
T ss_pred CCCHHHHHcCCCCCCCCCCccccccCCchhhhhcc
Confidence 999999984 7899999875 344555554
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-58 Score=462.58 Aligned_cols=293 Identities=42% Similarity=0.767 Sum_probs=239.1
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhc-hhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
..+..++|++++.||+|+||.||+|++. .+|+.||||++++..... ......+.+|+.+|+.++||||++++++|.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 4566789999999999999999999985 689999999998764332 234566888999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
+.+.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999998899999999999999999999999999999999999999999999999999999754
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
.... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 172 ~~~~-----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 210 (327)
T 3a62_A 172 IHDG-----------------------------------------TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGAL 210 (327)
T ss_dssp ------------------------------------------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHH
T ss_pred ccCC-----------------------------------------ccccccCCCcCccCHhhCcCCCCCCcccchhHHHH
Confidence 2110 01124689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCccCCChh
Q 010947 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWA 423 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~~i~w~ 423 (497)
+|||++|.+||.+.+..+...+|.. ..+.+|. .+++++++||.+||. ||.+||++. +++++++||||++++|+
T Consensus 211 l~el~~g~~pf~~~~~~~~~~~i~~--~~~~~p~--~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 211 MYDMLTGAPPFTGENRKKTIDKILK--CKLNLPP--YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHHh--CCCCCCC--CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 9999999999999999888888886 3445554 789999999999999 999999754 68999999999999999
Q ss_pred hhhh--cCCCcccccCCcccccCcccc
Q 010947 424 RIYQ--MEAAFIPEVNDELDTQNFEKF 448 (497)
Q Consensus 424 ~l~~--~~~p~~p~~~~~~d~~~f~~~ 448 (497)
.+.. ..|||.|.+.++.|+++|+..
T Consensus 287 ~~~~~~~~~p~~p~~~~~~~~~~~~~~ 313 (327)
T 3a62_A 287 ELLARKVEPPFKPLLQSEEDVSQFDSK 313 (327)
T ss_dssp HHHTTCSCCSCCCC-------------
T ss_pred HHhhccCCCCCCCCcCChhhhhhcchh
Confidence 9874 789999999999999999853
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-58 Score=491.57 Aligned_cols=294 Identities=34% Similarity=0.658 Sum_probs=251.6
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+.+..+..++|+++++||+|+||+||+|+++.+|+.||||++.+..+........+.+|+.+|+.++|||||+++++|++
T Consensus 176 l~~~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET 255 (576)
T ss_dssp HHTSCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhcCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee
Confidence 34556888999999999999999999999999999999999998776666677889999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
.+.+|+|||||+||+|.+++...+ .+++..+++|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.
T Consensus 256 ~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 256 KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999999999997654 499999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
+.... ...+.+||+.|+|||++.+..|+.++|||||||
T Consensus 336 ~~~~~------------------------------------------~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGv 373 (576)
T 2acx_A 336 VPEGQ------------------------------------------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGC 373 (576)
T ss_dssp CCTTC------------------------------------------CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHH
T ss_pred cccCc------------------------------------------cccccCCCccccCHHHHcCCCCCccchHHHHHH
Confidence 54221 012468999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC----hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCcc
Q 010947 346 IMYEMLVGYPPFYSDD----PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFD 418 (497)
Q Consensus 346 il~ell~G~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff~ 418 (497)
++|||++|.+||.+.+ ...+...+.. ....+|. .+|+++++||.+||+ ||.+||+.. +++||++||||+
T Consensus 374 ilyeLltG~~PF~~~~~~~~~~~i~~~i~~--~~~~~p~--~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~ 449 (576)
T 2acx_A 374 LLYEMIAGQSPFQQRKKKIKREEVERLVKE--VPEEYSE--RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449 (576)
T ss_dssp HHHHHHHSSCSSSCSSSCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred HHHHHHhCCCCCcccccchhHHHHHHHhhc--ccccCCc--cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence 9999999999998764 3455555654 3445553 799999999999999 999999753 589999999999
Q ss_pred CCChhhhhh--cCCCcccccC-----CcccccCccc
Q 010947 419 GVDWARIYQ--MEAAFIPEVN-----DELDTQNFEK 447 (497)
Q Consensus 419 ~i~w~~l~~--~~~p~~p~~~-----~~~d~~~f~~ 447 (497)
+++|+.+.. +.|||+|.+. +..|+.+|..
T Consensus 450 ~i~w~~l~~~~~~pp~~p~~~~~~~~~~~d~~~f~~ 485 (576)
T 2acx_A 450 KLNFKRLGAGMLEPPFKPDPQAIYCKDVLDIEQFST 485 (576)
T ss_dssp TCCHHHHHTTCSCCSCCCCCCCCCC-----------
T ss_pred cCCHHHHhcCCCCCCCCCCccccccCCcccHhhccc
Confidence 999999984 7899999874 3445555543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=460.59 Aligned_cols=255 Identities=21% Similarity=0.373 Sum_probs=215.8
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 185 (497)
..+..++|.+.+.||+|+||+||+|+++ .++..||||+++... ....+.+.+|+.+|++++|||||+++++|
T Consensus 36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVC 112 (329)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence 3456678999999999999999999875 368899999997642 34456799999999999999999999999
Q ss_pred ecCCeEEEEEeecCCCchhHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec
Q 010947 186 QDDEFLYLIMEYLPGGDMMTLLMRK---------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD 250 (497)
Q Consensus 186 ~~~~~l~lVmEy~~gg~L~~~l~~~---------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~ 250 (497)
.+.+.+|||||||+||+|.++|.+. +++++.++..|+.||+.||.|||+++||||||||+||||+
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~ 192 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG 192 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence 9999999999999999999999653 4699999999999999999999999999999999999999
Q ss_pred CCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc
Q 010947 251 KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330 (497)
Q Consensus 251 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~ 330 (497)
.++++||+|||+|+.+...... ......+||+.|||||++.
T Consensus 193 ~~~~~Ki~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~~~ 233 (329)
T 4aoj_A 193 QGLVVKIGDFGMSRDIYSTDYY---------------------------------------RVGGRTMLPIRWMPPESIL 233 (329)
T ss_dssp TTTEEEECCCC-------------------------------------------------------CCCCGGGCCHHHHT
T ss_pred CCCcEEEcccccceeccCCCcc---------------------------------------eecCcccccccccChhhhc
Confidence 9999999999999865322100 0112468999999999999
Q ss_pred cCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCc
Q 010947 331 KKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (497)
Q Consensus 331 ~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~ 408 (497)
+..|+.++|||||||+||||+| |++||.+.+..+....|... ..+..|. .+++++.+||.+||. ||.+||+ +
T Consensus 234 ~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g-~~~~~p~--~~~~~~~~li~~cl~~dP~~RPs---~ 307 (329)
T 4aoj_A 234 YRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELERPR--ACPPEVYAIMRGCWQREPQQRHS---I 307 (329)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHT-CCCCCCT--TCCHHHHHHHHHHCCSSTTTSCC---H
T ss_pred CCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CCCCCcc--cccHHHHHHHHHHcCcChhHCcC---H
Confidence 9999999999999999999999 99999999998888888764 3455554 799999999999999 9999998 8
Q ss_pred chhcC
Q 010947 409 DEIKV 413 (497)
Q Consensus 409 ~eil~ 413 (497)
.||+.
T Consensus 308 ~ei~~ 312 (329)
T 4aoj_A 308 KDVHA 312 (329)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 88865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-57 Score=452.18 Aligned_cols=256 Identities=20% Similarity=0.267 Sum_probs=209.2
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.+++..+++.+.+.||+|+||+||+|+++. .||||+++... ......+.+.+|+.+|++++|||||++++++.+ +
T Consensus 30 ~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 30 YWEIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp CCBCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CcEEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 457888999999999999999999998643 59999997543 234456789999999999999999999998754 5
Q ss_pred eEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|||||||+||+|.++|... ..+++.++..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 689999999999999999754 6799999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CCCCcchhHHhHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGA 345 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~y~~~~DiwSlGv 345 (497)
.... ....+.+||+.|||||++.+ ..|+.++|||||||
T Consensus 185 ~~~~---------------------------------------~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gv 225 (307)
T 3omv_A 185 WSGS---------------------------------------QQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGI 225 (307)
T ss_dssp ------------------------------------------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHH
T ss_pred CCcc---------------------------------------eeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHH
Confidence 1100 01225789999999999964 46999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhccc-CcccCCC-CccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWR-THLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~~~~~~i~~~~-~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+||||+||.+||.+.+.......++... .....+. ...+|+++++||.+||. ||.+||+ +.||+
T Consensus 226 vl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ei~ 292 (307)
T 3omv_A 226 VLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPL---FPQIL 292 (307)
T ss_dssp HHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCC---HHHHH
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcC---HHHHH
Confidence 9999999999999877666555554321 1111111 24689999999999999 9999998 66654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=453.83 Aligned_cols=256 Identities=21% Similarity=0.344 Sum_probs=219.7
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
++...++++++.||+|+||+||+|+.. .+++.||||+++... .....+.+.+|+.+|++++|||||+++++|.
T Consensus 22 ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~ 99 (308)
T 4gt4_A 22 EISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99 (308)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence 466778999999999999999999863 467899999997542 2334567999999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD 250 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~ 250 (497)
+++.+|||||||+||+|.++|... ..+++..+..++.||+.||.|||+++||||||||+||||+
T Consensus 100 ~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~ 179 (308)
T 4gt4_A 100 KDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY 179 (308)
T ss_dssp SSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEEC
Confidence 999999999999999999999643 4589999999999999999999999999999999999999
Q ss_pred CCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc
Q 010947 251 KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL 330 (497)
Q Consensus 251 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~ 330 (497)
.++++||+|||+|+.+...... ....+.+||+.|||||++.
T Consensus 180 ~~~~~Ki~DFGlar~~~~~~~~---------------------------------------~~~~~~~gt~~ymAPE~l~ 220 (308)
T 4gt4_A 180 DKLNVKISDLGLFREVYAADYY---------------------------------------KLLGNSLLPIRWMAPEAIM 220 (308)
T ss_dssp GGGCEEECCSCCBCGGGGGGCB---------------------------------------CSSSSSCBCGGGCCHHHHH
T ss_pred CCCCEEECCcccceeccCCCce---------------------------------------eEecccccCCcccCHHHHh
Confidence 9999999999999865322100 0112468999999999999
Q ss_pred cCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCc
Q 010947 331 KKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (497)
Q Consensus 331 ~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~ 408 (497)
+..|+.++|||||||+||||+| |.+||.+.+..+....|.+. ..++.|. .+++++.+||.+||. ||.+||+ +
T Consensus 221 ~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~~~~~~~li~~C~~~dP~~RPs---~ 294 (308)
T 4gt4_A 221 YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QVLPCPD--DCPAWVYALMIECWNEFPSRRPR---F 294 (308)
T ss_dssp HCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---H
T ss_pred CCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCcc--cchHHHHHHHHHHcCCChhHCcC---H
Confidence 9999999999999999999998 89999999999988888764 3344454 799999999999999 9999999 8
Q ss_pred chhcCC
Q 010947 409 DEIKVH 414 (497)
Q Consensus 409 ~eil~H 414 (497)
.||+++
T Consensus 295 ~ei~~~ 300 (308)
T 4gt4_A 295 KDIHSR 300 (308)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 887653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-57 Score=456.03 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=220.5
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC-CceeEEE
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLY 182 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~ 182 (497)
.++++..++|++.+.||+|+||+||+|.++.+ ++.||||+++... .....+.+.+|+.+|..++| ||||+++
T Consensus 57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 34677889999999999999999999998654 3689999997643 23345678999999999976 8999999
Q ss_pred EEeec-CCeEEEEEeecCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCC
Q 010947 183 CSFQD-DEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (497)
Q Consensus 183 ~~~~~-~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~ 245 (497)
++|.+ ...+|||||||+||+|.++|... ..+++..+..|+.||+.||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 99865 46799999999999999999753 34899999999999999999999999999999999
Q ss_pred CeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccC
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 325 (497)
|||++.++++||+|||+|+.+...... ....+.+||+.|||
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~---------------------------------------~~~~~~~gt~~ymA 255 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDY---------------------------------------VRKGDARLPLKWMA 255 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTS---------------------------------------EEETTEEECGGGCC
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCc---------------------------------------eeeccccccccccC
Confidence 999999999999999999876432110 01125689999999
Q ss_pred ccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 326 PE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
||++.+..|+.++|||||||+||||+| |.+||.+.+..+.+.+++.....+..|. .+|+++++||.+||. ||.+||
T Consensus 256 PE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~--~~~~~~~~li~~c~~~dP~~RP 333 (353)
T 4ase_A 256 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRP 333 (353)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCc--cCCHHHHHHHHHHcCcChhHCc
Confidence 999999999999999999999999998 9999998776555555554334555664 789999999999999 999999
Q ss_pred CCCCcchhcCC
Q 010947 404 GAKGADEIKVH 414 (497)
Q Consensus 404 ~~~~~~eil~H 414 (497)
+ +.+|++|
T Consensus 334 t---~~eil~~ 341 (353)
T 4ase_A 334 T---FSELVEH 341 (353)
T ss_dssp C---HHHHHHH
T ss_pred C---HHHHHHH
Confidence 8 8999876
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-55 Score=447.08 Aligned_cols=266 Identities=32% Similarity=0.544 Sum_probs=237.2
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|+.++||||++++++|.+...+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 4679999999999999999999999999999999987643221 1356788999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC----cEEEcccccccccC
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLD 267 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g----~vkL~DFGla~~~~ 267 (497)
|+||||++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++ ++||+|||+|+.+.
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~ 170 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170 (361)
T ss_dssp EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECC
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcC
Confidence 99999999999999998888999999999999999999999999999999999999998877 79999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
.... ....+||+.|+|||++.+..|+.++|||||||++
T Consensus 171 ~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil 208 (361)
T 2yab_A 171 DGVE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208 (361)
T ss_dssp TTCC------------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHH
T ss_pred CCCc------------------------------------------cccCCCCccEECchHHcCCCCCccccHHHHHHHH
Confidence 2210 1246899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhh
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
|+|++|.+||.+.+..+.+.+|.... ..++. ...+|+++++||.+||+ ||.+||+ +.|+++||||.+++|..
T Consensus 209 ~~ll~g~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~~~~~~ 283 (361)
T 2yab_A 209 YILLSGASPFLGDTKQETLANITAVS--YDFDEEFFSQTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDTQQ 283 (361)
T ss_dssp HHHHHSCCSSCCSSHHHHHHHHHTTC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSTTTSCSSHHH
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHhcC--CCCCchhccCCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcCcCCCchhh
Confidence 99999999999999999999988643 33432 24789999999999999 9999999 99999999999999987
Q ss_pred hhh
Q 010947 425 IYQ 427 (497)
Q Consensus 425 l~~ 427 (497)
...
T Consensus 284 ~~~ 286 (361)
T 2yab_A 284 AMV 286 (361)
T ss_dssp HHH
T ss_pred hhh
Confidence 653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=433.86 Aligned_cols=260 Identities=29% Similarity=0.534 Sum_probs=233.8
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
....++|++++.||+|+||.||+|++..+|+.||||++.+... .......+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 89 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTL 89 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence 3456789999999999999999999999999999999987543 344566788999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+.......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 169 (328)
T 3fe3_A 90 YLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK 169 (328)
T ss_dssp EEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG
T ss_pred EEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc
Confidence 99999999999999999889999999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCC-cchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG-MECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~-~~~DiwSlGvil~el 350 (497)
....+||+.|+|||++.+..+. .++|||||||++|+|
T Consensus 170 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 207 (328)
T 3fe3_A 170 ------------------------------------------LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTL 207 (328)
T ss_dssp ------------------------------------------GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHH
Confidence 1256899999999999988875 899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
++|.+||.+.+..+...++... ...+|. .+|+++.+||.+||. ||.+||+ ++|+++||||+...
T Consensus 208 l~g~~pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 208 VSGSLPFDGQNLKELRERVLRG--KYRIPF--YMSTDCENLLKRFLVLNPIKRGT---LEQIMKDRWINAGH 272 (328)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHCCSSTTTSCC---HHHHTTCTTTTTTC
T ss_pred HhCCCCCCCCCHHHHHHHHHhC--CCCCCC--CCCHHHHHHHHHHCCCChhHCcC---HHHHhcCHhhcCCC
Confidence 9999999999999998888863 445554 689999999999999 9999999 99999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-55 Score=443.44 Aligned_cols=290 Identities=42% Similarity=0.758 Sum_probs=240.9
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhc-hhHHHHHHHHHHHHHhc-CCCceeEEEEEee
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ 186 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~---~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~ 186 (497)
.+..++|++++.||+|+||.||+|++. .+|+.||||++++..... ....+.+..|+.+|..+ .||||++++++|.
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 129 (355)
T 1vzo_A 50 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129 (355)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred cccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEe
Confidence 345579999999999999999999984 589999999997654321 22334567899999999 6999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
+...+|+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+++.+
T Consensus 130 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 130 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred eCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLG 344 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlG 344 (497)
..... ......+||+.|+|||++.+ ..++.++||||||
T Consensus 210 ~~~~~----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG 249 (355)
T 1vzo_A 210 VADET----------------------------------------ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 249 (355)
T ss_dssp CGGGG----------------------------------------GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH
T ss_pred ccCCC----------------------------------------CcccCcccCcCccChhhhcCCCCCCCchhhHHHHH
Confidence 32110 01124689999999999985 4578999999999
Q ss_pred HHHHHHHhCCCCCCCCC----hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC--CcchhcCCCCc
Q 010947 345 AIMYEMLVGYPPFYSDD----PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWF 417 (497)
Q Consensus 345 vil~ell~G~~PF~~~~----~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~--~~~eil~Hpff 417 (497)
|++|||++|..||...+ .......+.. ....+|. .++..+++||.+||. ||.+||+.. +++++++||||
T Consensus 250 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f 325 (355)
T 1vzo_A 250 VLMYELLTGASPFTVDGEKNSQAEISRRILK--SEPPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325 (355)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred HHHHHHHHCCCCCccCCccchHHHHHHHHhc--cCCCCCc--ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence 99999999999997543 2334444443 2334443 689999999999999 999999543 59999999999
Q ss_pred cCCChhhhhh--cCCCcccccCCcccccCc
Q 010947 418 DGVDWARIYQ--MEAAFIPEVNDELDTQNF 445 (497)
Q Consensus 418 ~~i~w~~l~~--~~~p~~p~~~~~~d~~~f 445 (497)
..++|..+.. +++||.|.+.++.|++||
T Consensus 326 ~~~~~~~l~~~~~~~p~~p~~~~~~d~~~~ 355 (355)
T 1vzo_A 326 QKINWDDLAAKKVPAPFKPVIRDELDVSNF 355 (355)
T ss_dssp TTCCHHHHHTTCSCCSCCCCCCC-CCC---
T ss_pred hcCChhHhhhccCCCCCCCccccccccccC
Confidence 9999999984 679999999999999987
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-54 Score=435.89 Aligned_cols=280 Identities=30% Similarity=0.545 Sum_probs=235.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lV 194 (497)
++|++++.||+|+||+||+|.++.+|+.||||++.+... ...+|++++..+ +||||++++++|.+...+|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 469999999999999999999999999999999987542 134688888777 799999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC----CcEEEcccccccccCCCC
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~----g~vkL~DFGla~~~~~~~ 270 (497)
||||+||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||+... +.+||+|||+|+.+....
T Consensus 95 ~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~ 174 (342)
T 2qr7_A 95 TELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN 174 (342)
T ss_dssp ECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT
T ss_pred EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC
Confidence 9999999999999988899999999999999999999999999999999999998543 359999999998654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
. ...+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 175 ~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 213 (342)
T 2qr7_A 175 G-----------------------------------------LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213 (342)
T ss_dssp C-----------------------------------------CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred C-----------------------------------------ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHH
Confidence 0 01256899999999999988899999999999999999
Q ss_pred HhCCCCCCC---CChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 351 LVGYPPFYS---DDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 351 l~G~~PF~~---~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
++|.+||.+ .+..+....|......+..+....+|+++++||.+||. ||.+||+ +.++++||||. +|+.+.
T Consensus 214 l~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~~il~hp~~~--~~~~~~ 288 (342)
T 2qr7_A 214 LTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT---AALVLRHPWIV--HWDQLP 288 (342)
T ss_dssp HHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHH--TGGGSC
T ss_pred hcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCCeec--Cccccc
Confidence 999999986 35566777777643333322235799999999999999 9999999 99999999995 588776
Q ss_pred --hcCCCcccccCCcccccCcccc
Q 010947 427 --QMEAAFIPEVNDELDTQNFEKF 448 (497)
Q Consensus 427 --~~~~p~~p~~~~~~d~~~f~~~ 448 (497)
++.+|+.|.........+|...
T Consensus 289 ~~~~~~~~~p~~~~~~~~~~~~~~ 312 (342)
T 2qr7_A 289 QYQLNRQDAPHLVKGAMAATYSAL 312 (342)
T ss_dssp CSCCCCCCCHHHHHHHHHHHHHHH
T ss_pred cccCCCccchhhhhhHHHHHHhhh
Confidence 3667888775544444455543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=423.12 Aligned_cols=264 Identities=30% Similarity=0.540 Sum_probs=233.6
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
++|.+.+.||+|+||.||+|.++.+|+.||+|++.+...... ...+.+.+|+.+|+.++||||++++++|.+...+|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 469999999999999999999999999999999987543221 13567889999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC----cEEEcccccccccCC
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDC 268 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g----~vkL~DFGla~~~~~ 268 (497)
+||||++||+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+|+....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 9999999999999998888999999999999999999999999999999999999999888 899999999987642
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
... ....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 171 ~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 208 (326)
T 2y0a_A 171 GNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208 (326)
T ss_dssp TSC------------------------------------------CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CCc------------------------------------------cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHH
Confidence 210 11467999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhh
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 425 (497)
+|++|.+||.+.+..+....+.... ..++. ...+|+++++||.+||+ ||.+||+ +.++++||||.+.+|...
T Consensus 209 ~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~~~~~ 283 (326)
T 2y0a_A 209 ILLSGASPFLGDTKQETLANVSAVN--YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQA 283 (326)
T ss_dssp HHHHSCCSSCCSSHHHHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTSCCSHHHH
T ss_pred HHHHCcCCCCCCCHHHHHHHHHhcC--CCcCccccccCCHHHHHHHHHHccCChhhCCC---HHHHhcCCCccCCcchhh
Confidence 9999999999998888888877532 33332 24689999999999999 9999999 999999999999998765
Q ss_pred h
Q 010947 426 Y 426 (497)
Q Consensus 426 ~ 426 (497)
.
T Consensus 284 ~ 284 (326)
T 2y0a_A 284 L 284 (326)
T ss_dssp H
T ss_pred h
Confidence 4
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-53 Score=430.15 Aligned_cols=258 Identities=32% Similarity=0.583 Sum_probs=230.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|.++.+|+.||+|++.+... .......+.+|+.+++.++|||||+++++|.+.+.+|+||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 569999999999999999999999999999999987543 3345667899999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC---cEEEcccccccccCCCCcc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g---~vkL~DFGla~~~~~~~~~ 272 (497)
|||+||+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+++.......
T Consensus 108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~- 186 (362)
T 2bdw_A 108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 186 (362)
T ss_dssp CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS-
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc-
Confidence 9999999999998888999999999999999999999999999999999999998654 599999999986542210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
....+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 187 -----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 225 (362)
T 2bdw_A 187 -----------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLV 225 (362)
T ss_dssp -----------------------------------------CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHH
Confidence 114689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|.+||.+.+..+.+..|......+..+....+++++++||.+||. ||.+||+ +.++++||||..
T Consensus 226 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~~~~ 290 (362)
T 2bdw_A 226 GYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICN 290 (362)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCcccCC
Confidence 999999999888888888754444444445789999999999999 9999999 999999999975
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=439.78 Aligned_cols=259 Identities=32% Similarity=0.593 Sum_probs=230.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|.++.+|+.||+|++.+... .......+.+|+.+++.++|||||+++++|.+.+.+|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 469999999999999999999999999999999987543 2344567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec---CCCcEEEcccccccccCCCCcc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD---KYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~---~~g~vkL~DFGla~~~~~~~~~ 272 (497)
|||+||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.......
T Consensus 90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~- 168 (444)
T 3soa_A 90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ- 168 (444)
T ss_dssp CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC-
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc-
Confidence 9999999999999989999999999999999999999999999999999999998 468899999999976542210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.....+||+.|+|||++.+..|+.++|||||||++|+|++
T Consensus 169 ----------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~ 208 (444)
T 3soa_A 169 ----------------------------------------AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208 (444)
T ss_dssp ----------------------------------------BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh
Confidence 0124689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|.+||.+.+..+.+..+......+..|....+|+++++||.+||. ||.+||+ +.|+++||||..
T Consensus 209 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---a~e~L~hp~~~~ 273 (444)
T 3soa_A 209 GYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRIT---AAEALKHPWISH 273 (444)
T ss_dssp SSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSCTTHH
T ss_pred CCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCC---HHHHhcCccccC
Confidence 999999999999999998755555555556799999999999999 9999999 999999999964
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=414.12 Aligned_cols=257 Identities=30% Similarity=0.511 Sum_probs=225.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..+|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 4679999999999999999999999999999999976542 2345688999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||++||+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 171 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--- 171 (297)
T ss_dssp EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC---
T ss_pred EECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc---
Confidence 999999999999865 4799999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.
T Consensus 172 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 213 (297)
T 3fxz_A 172 --------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213 (297)
T ss_dssp --------------------------------------CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 012468999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+||.+.+.......+... ....++....+++.+++||.+||. ||.+||+ +.|+++||||+..
T Consensus 214 ~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~h~~~~~~ 276 (297)
T 3fxz_A 214 PPYLNENPLRALYLIATN-GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGS---AKELLQHQFLKIA 276 (297)
T ss_dssp CTTTTSCHHHHHHHHHHH-CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCGGGGGC
T ss_pred CCCCCCCHHHHHHHHHhC-CCCCCCCccccCHHHHHHHHHHccCChhHCcC---HHHHhhChhhccc
Confidence 999998887776666542 222233335799999999999999 9999999 9999999999853
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=427.93 Aligned_cols=256 Identities=31% Similarity=0.563 Sum_probs=225.3
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|.+.+.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+++.++||||++++++|.+...+|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 45789999999999999999999999999999999987655444445678899999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||||+ +|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.......
T Consensus 87 v~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~-- 163 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-- 163 (336)
T ss_dssp EECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT--
T ss_pred EEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc--
Confidence 99999 789999998889999999999999999999999999999999999999999999999999999986532210
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~ell~ 352 (497)
..+.+||+.|+|||++.+..| +.++|||||||++|+|++
T Consensus 164 ----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~ 203 (336)
T 3h4j_B 164 ----------------------------------------LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203 (336)
T ss_dssp ----------------------------------------TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHh
Confidence 124689999999999998876 789999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|.+||.+........++.. ....+|. .+|+++++||.+||. ||.+||+ ++|+++||||+.
T Consensus 204 g~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~~ 264 (336)
T 3h4j_B 204 GRLPFDDEFIPNLFKKVNS--CVYVMPD--FLSPGAQSLIRRMIVADPMQRIT---IQEIRRDPWFNV 264 (336)
T ss_dssp SSCSSBCSSSTTCBCCCCS--SCCCCCT--TSCHHHHHHHHTTSCSSGGGSCC---HHHHTTCHHHHT
T ss_pred CCCCCCCccHHHHHHHHHc--CCCCCcc--cCCHHHHHHHHHHcCCChhHCcC---HHHHHhChhhcc
Confidence 9999988765555444432 2334443 689999999999999 9999999 999999999975
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-53 Score=422.34 Aligned_cols=255 Identities=28% Similarity=0.474 Sum_probs=227.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|.+.+.||+|+||.||+|.++.+++.||+|++.... .....+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 578999999999999999999999999999999987542 3345688999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC--CCcEEEcccccccccCCCCc
Q 010947 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~ 271 (497)
||||+||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++.+.....
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~ 159 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc
Confidence 9999999999999765 47999999999999999999999999999999999999997 78999999999987643210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 160 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 197 (321)
T 1tki_A 160 ------------------------------------------FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp ------------------------------------------EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 12467999999999999988999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+|.+||.+.+..+....+.... ..++. ...+|+++++||.+||. ||.+||+ +.|+++||||+..
T Consensus 198 ~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt---~~e~l~hp~~~~~ 264 (321)
T 1tki_A 198 SGINPFLAETNQQIIENIMNAE--YTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQK 264 (321)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTC--CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHSC
T ss_pred hCCCCCcCCCHHHHHHHHHcCC--CCCChhhhccCCHHHHHHHHHHcCCChhHCcC---HHHHhcChhhccC
Confidence 9999999999999888888743 33332 24789999999999999 9999999 9999999999853
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-53 Score=418.68 Aligned_cols=251 Identities=24% Similarity=0.281 Sum_probs=193.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC----eE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----FL 191 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~l 191 (497)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.... .......|+.++..++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 4688999999999999999986 588999999975431 1122334555667889999999999998653 68
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--------CEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--------HYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
|||||||+||+|.++|.. ..+++..+..++.|++.||.|||+. +||||||||+||||+.+|++||+|||+|
T Consensus 77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 999999999999999965 5799999999999999999999987 9999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC------CCCcc
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK------GYGME 337 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~------~y~~~ 337 (497)
+......... .....+.+||+.|||||++.+. .|+.+
T Consensus 156 ~~~~~~~~~~-------------------------------------~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k 198 (303)
T 3hmm_A 156 VRHDSATDTI-------------------------------------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp EEEETTTTEE-------------------------------------SCC-----CCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred ccccCCCCce-------------------------------------eeecccccccccccCHHHhcccccccCCccChh
Confidence 8764321100 0011246899999999999754 47889
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCC---------------hHHHHHHHhcccCcccCCCC---ccCChhHHHHHHHHhh-C
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDD---------------PMSTCRKIVNWRTHLKFPEE---AKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~---------------~~~~~~~i~~~~~~~~~p~~---~~~s~~~~dLI~~lL~-d 398 (497)
+|||||||+||||+||.+||.... .......+........+|.. ..++..+.+||.+||. |
T Consensus 199 ~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~d 278 (303)
T 3hmm_A 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278 (303)
T ss_dssp HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSS
T ss_pred HhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccC
Confidence 999999999999999987764221 12333344433333344432 1234568899999999 9
Q ss_pred ccccCCCCCcchhcC
Q 010947 399 VNQRLGAKGADEIKV 413 (497)
Q Consensus 399 p~~R~~~~~~~eil~ 413 (497)
|.+||+ +.||++
T Consensus 279 P~~RPt---~~ei~~ 290 (303)
T 3hmm_A 279 GAARLT---ALRIKK 290 (303)
T ss_dssp GGGSCC---HHHHHH
T ss_pred HhHCcC---HHHHHH
Confidence 999998 777764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-52 Score=428.42 Aligned_cols=278 Identities=29% Similarity=0.495 Sum_probs=213.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCC--eE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDE--FL 191 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~--~l 191 (497)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|..+. |||||+++++|..++ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 468999999999999999999999999999999997542 23445567888999999997 999999999997544 79
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+|||||+ |+|..++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.+.....
T Consensus 87 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999996 689988865 6899999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~el 350 (497)
............ ...+. .........+||+.|+|||++.+ ..|+.++||||||||+|||
T Consensus 165 ~~~~~~~~~~~~-------------------~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 224 (388)
T 3oz6_A 165 VTNNIPLSINEN-------------------TENFD-DDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEI 224 (388)
T ss_dssp CCCCGGGCCC-----------------------------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred cccccccccccc-------------------ccccc-cccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHH
Confidence 100000000000 00000 00011235789999999999986 6799999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCC----------------------------------------------CccC
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPE----------------------------------------------EAKL 384 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~----------------------------------------------~~~~ 384 (497)
++|.+||.+.+....+.+|+.. +..|. ...+
T Consensus 225 l~g~~pf~~~~~~~~~~~i~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (388)
T 3oz6_A 225 LCGKPIFPGSSTMNQLERIIGV---IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADC 301 (388)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHH---HCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHh---cCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccC
Confidence 9999999999988888777631 11111 1267
Q ss_pred ChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 385 SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 385 s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
++++.+||.+||+ ||.+||+ ++|+++||||+.+.
T Consensus 302 ~~~~~dll~~~L~~dP~~R~t---~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 302 NEEALDLLDKLLQFNPNKRIS---ANDALKHPFVSIFH 336 (388)
T ss_dssp CHHHHHHHHHHCCSSGGGSCC---HHHHTTSTTTTTTC
T ss_pred CHHHHHHHHHhhccCcccCCC---HHHHhCCHHHHHhc
Confidence 8999999999999 9999999 99999999987654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-52 Score=437.47 Aligned_cols=261 Identities=30% Similarity=0.547 Sum_probs=235.2
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
...+..++|.+.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34566789999999999999999999999999999999998876555556678999999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||||++||+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+.....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~ 348 (497)
.. ..+.+||+.|+|||++.+..| +.++|||||||++|
T Consensus 170 ~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 207 (476)
T 2y94_A 170 EF------------------------------------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILY 207 (476)
T ss_dssp CC------------------------------------------BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHH
T ss_pred cc------------------------------------------ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHH
Confidence 10 124689999999999998776 78999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+|++|.+||.+.+....+.+|... ....|. .+++++++||.+||. ||.+||+ +.+|++||||+.
T Consensus 208 elltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~Li~~~L~~dP~~Rpt---~~eil~hp~~~~ 272 (476)
T 2y94_A 208 ALLCGTLPFDDDHVPTLFKKICDG--IFYTPQ--YLNPSVISLLKHMLQVDPMKRAT---IKDIREHEWFKQ 272 (476)
T ss_dssp HHHHSSCSSCCSSSHHHHHHHHTT--CCCCCT--TCCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHT
T ss_pred HHhhCCCCCCCCCHHHHHHHHhcC--CcCCCc--cCCHHHHHHHHHHcCCCchhCcC---HHHHHhCHHhhh
Confidence 999999999999988888888863 344443 689999999999999 9999999 999999999985
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-52 Score=423.42 Aligned_cols=262 Identities=30% Similarity=0.549 Sum_probs=223.3
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch--hHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR--GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~--~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
++|++.+.||+|+||+||+|.++.+|+.||||++.+...... ...+.+.+|+.+++.++|||||+++++|.+.+.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 469999999999999999999999999999999986543322 235678999999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc---EEEccccccccc
Q 010947 194 IMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPL 266 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~---vkL~DFGla~~~ 266 (497)
|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 99999999998887543 35899999999999999999999999999999999999987655 999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
..... .....+||+.|+|||++.+..|+.++|||||||+
T Consensus 184 ~~~~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 222 (351)
T 3c0i_A 184 GESGL-----------------------------------------VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222 (351)
T ss_dssp CTTSC-----------------------------------------BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHH
T ss_pred cCCCe-----------------------------------------eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHH
Confidence 43210 0124689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCCh
Q 010947 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
+|+|++|.+||.+. ..+.+..+.........+....+|+++++||.+||. ||.+||+ +.++++||||++.++
T Consensus 223 l~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 223 LFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERIT---VYEALNHPWLKERDR 295 (351)
T ss_dssp HHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHTHHH
T ss_pred HHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcChhhcCCcc
Confidence 99999999999885 345666666532222111124689999999999999 9999999 999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=424.59 Aligned_cols=260 Identities=28% Similarity=0.533 Sum_probs=228.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||+|+||.||+|.++.+|+.||+|++.... ......+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 367999999999999999999999999999999997653 22345688999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC--CCcEEEcccccccccCCCCc
Q 010947 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~ 271 (497)
||||+||+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++. .+.+||+|||+|+.+.....
T Consensus 127 ~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 206 (387)
T 1kob_A 127 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI 206 (387)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc
Confidence 99999999999987654 7999999999999999999999999999999999999974 57899999999987643210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 207 ------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 244 (387)
T 1kob_A 207 ------------------------------------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL 244 (387)
T ss_dssp ------------------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHH
Confidence 11457999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCCh
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
+|.+||.+.+..+...++......+..+....+|+++++||.+||+ ||.+||+ +.++++||||++..+
T Consensus 245 tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 245 SGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGDHS 313 (387)
T ss_dssp HSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSCCT
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhhCccccCCcc
Confidence 9999999999888888887643333222234789999999999999 9999999 999999999997654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=412.15 Aligned_cols=266 Identities=28% Similarity=0.502 Sum_probs=219.9
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
.....++|++++.||+|+||+||+|++. +|+.||+|++.... ........+.+|+.+++.++||||++++++|.+...
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 93 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERC 93 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSC
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCE
Confidence 3445688999999999999999999985 58999999997643 233345678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
+|+||||++| +|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 94 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 94 LTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp EEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred EEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9999999974 787777654 45999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ 348 (497)
... ....+||+.|+|||++.+ ..|+.++|||||||++|
T Consensus 173 ~~~-----------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 211 (311)
T 3niz_A 173 VRS-----------------------------------------YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211 (311)
T ss_dssp CC--------------------------------------------CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHH
T ss_pred ccc-----------------------------------------ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHH
Confidence 100 114579999999999976 56899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCccc---CCC-----------------------CccCChhHHHHHHHHhh-Cccc
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLK---FPE-----------------------EAKLSIEAKDLISKLLC-NVNQ 401 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~---~p~-----------------------~~~~s~~~~dLI~~lL~-dp~~ 401 (497)
+|++|.+||.+.+..+....+........ ++. ...+++++++||.+||+ ||.+
T Consensus 212 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 291 (311)
T 3niz_A 212 EMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNK 291 (311)
T ss_dssp HHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTT
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhH
Confidence 99999999998877777666653111100 000 12478899999999999 9999
Q ss_pred cCCCCCcchhcCCCCccCCChh
Q 010947 402 RLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 402 R~~~~~~~eil~Hpff~~i~w~ 423 (497)
||+ ++|+++||||+++++.
T Consensus 292 Rpt---~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 292 RIS---ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp SCC---HHHHHTSGGGTTSCTT
T ss_pred CCC---HHHHhcCcccccCCcc
Confidence 999 9999999999998753
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=405.81 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=216.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|+++.+|+.||||++..... .......+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 689999999999999999999999999999999986542 3344567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++|+.+..+....+.+++..++.++.|++.||.|||++||+||||||+|||++.+|++||+|||+|+.......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 156 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR---- 156 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS----
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc----
Confidence 9997644444444467899999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC-CCcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-y~~~~DiwSlGvil~ell~G~ 354 (497)
.....+||+.|+|||++.+.. |+.++|||||||++|+|++|.
T Consensus 157 -------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~ 199 (292)
T 3o0g_A 157 -------------------------------------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp -------------------------------------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred -------------------------------------cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcC
Confidence 011457999999999998765 899999999999999999877
Q ss_pred CC-CCCCChHHHHHHHhcccCcc---------------cCC----------CCccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 355 PP-FYSDDPMSTCRKIVNWRTHL---------------KFP----------EEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 355 ~P-F~~~~~~~~~~~i~~~~~~~---------------~~p----------~~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
.| |.+.+..+....+....... .++ ....+++++++||.+||+ ||.+||+
T Consensus 200 ~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t--- 276 (292)
T 3o0g_A 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS--- 276 (292)
T ss_dssp CCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred CCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCC---
Confidence 76 55666666666664311100 000 012578999999999999 9999998
Q ss_pred cchhcCCCCccCC
Q 010947 408 ADEIKVHPWFDGV 420 (497)
Q Consensus 408 ~~eil~Hpff~~i 420 (497)
++|+++||||+++
T Consensus 277 ~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 277 AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHHTSGGGTTC
T ss_pred HHHHhcCcccccC
Confidence 9999999999975
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-52 Score=425.49 Aligned_cols=275 Identities=21% Similarity=0.328 Sum_probs=224.5
Q ss_pred CCCCCeeEEeEeeec--CCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 113 MGADDFELLTMIGKG--AFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G--~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
...++|++++.||+| +||.||+|+++.+|+.||||++..... .......+.+|+.+++.++|||||+++++|.+.+.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence 456789999999999 999999999999999999999987543 34456778899999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~ 180 (389)
T 3gni_B 101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180 (389)
T ss_dssp EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence 99999999999999999775 6799999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAI 346 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvi 346 (497)
....... ........+||+.|+|||++.+ ..|+.++|||||||+
T Consensus 181 ~~~~~~~----------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 226 (389)
T 3gni_B 181 HGQRQRV----------------------------------VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGIT 226 (389)
T ss_dssp TTEECSC----------------------------------BCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHH
T ss_pred ccccccc----------------------------------cccccccccccccccCHHHHhccCCCCCcHhHHHHHHHH
Confidence 2110000 0000113589999999999987 679999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhcccCc------------------------------------------ccCCCCccC
Q 010947 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTH------------------------------------------LKFPEEAKL 384 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~~~~~~i~~~~~~------------------------------------------~~~p~~~~~ 384 (497)
+|||++|.+||.+.+.......++..... ...+....+
T Consensus 227 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (389)
T 3gni_B 227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF 306 (389)
T ss_dssp HHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------C
T ss_pred HHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccccc
Confidence 99999999999987766655444321100 001112358
Q ss_pred ChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhh
Q 010947 385 SIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 385 s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 425 (497)
++++++||.+||. ||.+||+ +.|+++||||+.+.|...
T Consensus 307 s~~~~~li~~~L~~dP~~Rpt---a~ell~hp~f~~~~~~~~ 345 (389)
T 3gni_B 307 SPHFHHFVEQCLQRNPDARPS---ASTLLNHSFFKQIKRRAS 345 (389)
T ss_dssp CHHHHHHHHHHTCSCTTTSCC---HHHHTTSGGGGGC---CC
T ss_pred CHHHHHHHHHHhhcCcccCCC---HHHHhcCHHHHHHhhcch
Confidence 8999999999999 9999999 999999999999887543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=408.66 Aligned_cols=259 Identities=36% Similarity=0.670 Sum_probs=220.3
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-----------------------hhHHHHHHHHHHH
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-----------------------RGQVEHVRAERNL 169 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~-----------------------~~~~~~~~~E~~i 169 (497)
+..++|++.+.||+|+||.||+|+++.+|+.||||++.+..... ....+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 34578999999999999999999999999999999998654322 1123568899999
Q ss_pred HHhcCCCceeEEEEEeec--CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCe
Q 010947 170 LAEVDSNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNL 247 (497)
Q Consensus 170 l~~l~hp~Iv~l~~~~~~--~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NI 247 (497)
|+.++||||+++++++.+ ...+|+||||+++|+|.+++ ....+++..+..++.||+.||.|||+.||+||||||+||
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni 168 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL 168 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence 999999999999999987 56899999999999998875 446799999999999999999999999999999999999
Q ss_pred eecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcc
Q 010947 248 LLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (497)
Q Consensus 248 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 327 (497)
|++.+|++||+|||+++.+..... .....+||+.|+|||
T Consensus 169 l~~~~~~~kl~Dfg~~~~~~~~~~-----------------------------------------~~~~~~gt~~y~aPE 207 (298)
T 2zv2_A 169 LVGEDGHIKIADFGVSNEFKGSDA-----------------------------------------LLSNTVGTPAFMAPE 207 (298)
T ss_dssp EECTTSCEEECCCTTCEECSSSSC-----------------------------------------EECCCCSCGGGCCGG
T ss_pred EECCCCCEEEecCCCccccccccc-----------------------------------------cccCCcCCccccChh
Confidence 999999999999999986642210 012467999999999
Q ss_pred ccccCC---CCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 328 VLLKKG---YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 328 ~l~~~~---y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
++.+.. ++.++|||||||++|+|++|.+||.+.+.......+.. ..+.+|....+++++++||.+||. ||.+||
T Consensus 208 ~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~ 285 (298)
T 2zv2_A 208 SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKS--QALEFPDQPDIAEDLKDLITRMLDKNPESRI 285 (298)
T ss_dssp GCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC
T ss_pred hhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHHHhc--ccCCCCCccccCHHHHHHHHHHhhcChhhCC
Confidence 998765 47899999999999999999999999888777777765 345566556799999999999999 999999
Q ss_pred CCCCcchhcCCCCcc
Q 010947 404 GAKGADEIKVHPWFD 418 (497)
Q Consensus 404 ~~~~~~eil~Hpff~ 418 (497)
+ +.|+++||||.
T Consensus 286 s---~~e~l~hp~~~ 297 (298)
T 2zv2_A 286 V---VPEIKLHPWVT 297 (298)
T ss_dssp C---HHHHTTCHHHH
T ss_pred C---HHHHhcCcccc
Confidence 9 99999999995
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-52 Score=441.41 Aligned_cols=264 Identities=34% Similarity=0.612 Sum_probs=236.6
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+...........+.+|+.+|+.++|||||+++++|.+...+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 45799999999999999999999999999999999877655555677899999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee---cCCCcEEEcccccccccCCCCc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~ 271 (497)
||||.||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.+.....
T Consensus 105 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 184 (484)
T 3nyv_A 105 GEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184 (484)
T ss_dssp ECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc
Confidence 9999999999999988999999999999999999999999999999999999999 5678999999999987643210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
....+||+.|+|||++.+ .|+.++|||||||++|+|+
T Consensus 185 ------------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll 221 (484)
T 3nyv_A 185 ------------------------------------------MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILL 221 (484)
T ss_dssp ------------------------------------------HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHH
Confidence 114579999999999865 7999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhh
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
+|.+||.+.+..+...++......+..|....+|+++++||.+||+ ||.+||+ +.++++||||+...+..
T Consensus 222 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~h~~~~~~~~~~ 292 (484)
T 3nyv_A 222 SGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRIS---ARDALDHEWIQTYTKEQ 292 (484)
T ss_dssp HSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSHHHHHHTC--
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhhChhhccccccc
Confidence 9999999999999999998765555666666899999999999999 9999999 99999999998765543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-51 Score=399.23 Aligned_cols=264 Identities=31% Similarity=0.571 Sum_probs=234.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++.+.||+|+||.||+|.++.+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 5789999999999999999999999999999999986543 344556788999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc---EEEcccccccccCCCCc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~---vkL~DFGla~~~~~~~~ 271 (497)
|||++||+|.+.+.....+++..+..++.|++.||.|||+.||+||||||+|||++.++. +||+|||++........
T Consensus 84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 999999999999988899999999999999999999999999999999999999987665 99999999976542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
.....||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 164 ------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~ 201 (284)
T 3kk8_A 164 ------------------------------------------WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201 (284)
T ss_dssp ------------------------------------------CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHH
Confidence 11467999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhh
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
+|.+||.+.+.......+.........+....+++++.+||.+||. ||.+||+ +.|+++||||.+..+..
T Consensus 202 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 202 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRIT---ADQALKVPWICNRERVA 272 (284)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSHHHHSCCCGG
T ss_pred HCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCC---HHHHhcCccccCChhHH
Confidence 9999999999888888887654444444445789999999999999 9999999 99999999999765544
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-51 Score=402.06 Aligned_cols=260 Identities=36% Similarity=0.619 Sum_probs=233.0
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
...+..++|++.+.||+|+||.||+|++..++..||||++.+...........+.+|+.+++.++||||+++++++.+.+
T Consensus 8 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 87 (284)
T 2vgo_A 8 KRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK 87 (284)
T ss_dssp --CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred ccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence 34566789999999999999999999999999999999998765544445567899999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||||+++|+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++......
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 88 RIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence 99999999999999999998889999999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
. ....+||+.|+|||++.+..++.++|+|||||++|+
T Consensus 168 ~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 204 (284)
T 2vgo_A 168 R-------------------------------------------RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYE 204 (284)
T ss_dssp C-------------------------------------------BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHH
T ss_pred c-------------------------------------------cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHH
Confidence 0 114679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|++|.+||.+.+..+....+.. ....+|. .++.++++||.+||. ||.+||+ +.++++||||+.
T Consensus 205 l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~ll~h~~~~~ 268 (284)
T 2vgo_A 205 FLVGMPPFDSPSHTETHRRIVN--VDLKFPP--FLSDGSKDLISKLLRYHPPQRLP---LKGVMEHPWVKA 268 (284)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHSCSSGGGSCC---HHHHHTCHHHHH
T ss_pred HHHCCCCCCCCCHhHHHHHHhc--cccCCCC--cCCHHHHHHHHHHhhcCHhhCCC---HHHHhhCHHHHh
Confidence 9999999999888888888876 3445554 689999999999999 9999999 999999999974
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=402.46 Aligned_cols=259 Identities=35% Similarity=0.601 Sum_probs=231.2
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
..+..++|++.+.||+|+||.||+|.+..++..||+|++.+...........+.+|+.+++.++||||++++++|.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred ceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCE
Confidence 34667899999999999999999999999999999999987665555556778999999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|+||||+++|+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.......
T Consensus 84 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~ 163 (279)
T 3fdn_A 84 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 163 (279)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999986442110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
....+||+.|+|||++.+..++.++|||||||++|+|
T Consensus 164 -------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 200 (279)
T 3fdn_A 164 -------------------------------------------RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 200 (279)
T ss_dssp -----------------------------------------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred -------------------------------------------ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHH
Confidence 1145799999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
++|.+||.+.+..+....+.. ....+|. .+++++++||.+||. ||.+||+ +.|+++||||.+
T Consensus 201 ~~g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~e~l~h~~~~~ 263 (279)
T 3fdn_A 201 LVGKPPFEANTYQETYKRISR--VEFTFPD--FVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITA 263 (279)
T ss_dssp HHSSCTTCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHCCSSGGGSCC---HHHHHHCHHHHH
T ss_pred HHCCCCCCCCcHHHHHHHHHh--CCCCCCC--cCCHHHHHHHHHHhccChhhCCC---HHHHhhCccccC
Confidence 999999999988888887765 3444554 689999999999999 9999999 999999999975
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=434.23 Aligned_cols=293 Identities=26% Similarity=0.392 Sum_probs=209.7
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-----C
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-----D 188 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-----~ 188 (497)
..++|++++.||+|+||+||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.. .
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccC
Confidence 3478999999999999999999999999999999997642 234456778999999999999999999999943 3
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+|+||||+ +|+|..++.....+++..++.++.||+.||.|||+.|||||||||+|||++.+|++||+|||+|+....
T Consensus 130 ~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 130 DELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDY 208 (458)
T ss_dssp CCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred ceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccC
Confidence 6799999998 689999998888899999999999999999999999999999999999999999999999999987653
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHH--HhhhcccccccccCCCcccCcccc-ccCCCCcchhHHhHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQH--WQKNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGA 345 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~Gt~~Y~aPE~l-~~~~y~~~~DiwSlGv 345 (497)
.......... .+ +........ .....+......+||++|+|||++ .+..|+.++|||||||
T Consensus 209 ~~~~~~~~~~---------------~~-~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~ 272 (458)
T 3rp9_A 209 PENGNSQLPI---------------SP-REDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272 (458)
T ss_dssp CTTCCCCCC-------------------------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred cccccccccc---------------Cc-cccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHH
Confidence 3211000000 00 000000000 000011123367899999999986 4677999999999999
Q ss_pred HHHHHHh-----------CCCCCCCCCh--------------------HHHHHHHhcccCcc------------------
Q 010947 346 IMYEMLV-----------GYPPFYSDDP--------------------MSTCRKIVNWRTHL------------------ 376 (497)
Q Consensus 346 il~ell~-----------G~~PF~~~~~--------------------~~~~~~i~~~~~~~------------------ 376 (497)
|+|||++ |.+||.+.+. ...+..|.+.-...
T Consensus 273 il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~ 352 (458)
T 3rp9_A 273 IFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIR 352 (458)
T ss_dssp HHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHT
T ss_pred HHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHH
Confidence 9999999 7888877542 12222222100000
Q ss_pred cCCC---------CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhh
Q 010947 377 KFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 377 ~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 427 (497)
.+|. ...+++++++||.+||+ ||.+||+ ++|+|+||||++++|..+..
T Consensus 353 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---~~e~L~Hp~f~~~~~~~~e~ 410 (458)
T 3rp9_A 353 IFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT---INECLAHPFFKEVRIAEVET 410 (458)
T ss_dssp TSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGTTTCCGGGCC
T ss_pred hcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC---HHHHhcCHhhhhcCCCccCC
Confidence 0000 13569999999999999 9999998 99999999999999988764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=412.00 Aligned_cols=265 Identities=32% Similarity=0.551 Sum_probs=234.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
++|++.+.||+|+||.||+|+++.+|+.||||++.+...... ...+.+.+|+.+++.++||||++++++|.+...+|
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 569999999999999999999999999999999987543221 13567889999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC----cEEEcccccccccCC
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDC 268 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g----~vkL~DFGla~~~~~ 268 (497)
+||||++||+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.++ ++||+|||+++....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 9999999999999998888899999999999999999999999999999999999999888 899999999986542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
... ....+||+.|+|||++.+..++.++|||||||++|
T Consensus 172 ~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 209 (321)
T 2a2a_A 172 GVE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209 (321)
T ss_dssp TCC------------------------------------------CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred ccc------------------------------------------ccccCCCCCccCcccccCCCCCCccccHHHHHHHH
Confidence 210 11457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhh
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 425 (497)
+|++|..||.+.+..+....+.... ..++. ...+++++++||.+||. ||.+||+ +.++++||||.+++|...
T Consensus 210 ~l~~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~hp~~~~~~~~~~ 284 (321)
T 2a2a_A 210 ILLSGASPFLGDTKQETLANITSVS--YDFDEEFFSHTSELAKDFIRKLLVKETRKRLT---IQEALRHPWITPVDNQQA 284 (321)
T ss_dssp HHHHSCCSSCCSSHHHHHHHHHTTC--CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCC---HHHHHHSTTTSCSSHHHH
T ss_pred HHHHCCCCCCCCCHHHHHHHHHhcc--cccChhhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhcCccccCCCcccc
Confidence 9999999999999888888887632 23332 14689999999999999 9999999 999999999999999876
Q ss_pred hh
Q 010947 426 YQ 427 (497)
Q Consensus 426 ~~ 427 (497)
..
T Consensus 285 ~~ 286 (321)
T 2a2a_A 285 MV 286 (321)
T ss_dssp HH
T ss_pred cc
Confidence 53
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=412.10 Aligned_cols=260 Identities=26% Similarity=0.473 Sum_probs=220.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||+|+||+||+|+++.+++.||||++...... ...+.+.+|+.+++.++|||||++++++.+.+..|+|
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 57899999999999999999999999999999999754321 2234578899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||||+||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--- 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 160 (323)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc---
Confidence 99999999999998888899999999999999999999999999999999999999999999999999986532210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~ell~G 353 (497)
.......+||+.|+|||++.+..+ +.++|||||||++|+|++|
T Consensus 161 ------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 161 ------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp ------------------------------------ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------------------ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 001125689999999999988776 7899999999999999999
Q ss_pred CCCCCCCChH-HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 354 YPPFYSDDPM-STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 354 ~~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
.+||.+.+.. ..+..... .....+....+++++.+||.+||. ||.+||+ ++|+++||||...
T Consensus 205 ~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~eil~h~~~~~~ 268 (323)
T 3tki_A 205 ELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (323)
T ss_dssp SCSCSSSCTTSHHHHHHHT--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred CCCCCCCchHHHHHHHHhc--ccccCCccccCCHHHHHHHHHHccCChhhCcC---HHHHhhChhhccc
Confidence 9999876554 23333332 222233345799999999999999 9999999 9999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=414.55 Aligned_cols=266 Identities=27% Similarity=0.430 Sum_probs=217.7
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
....++|++++.||+|+||+||+|++..+++.||||++..... .......+.+|+.+++.++||||+++++++.+...+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEE
Confidence 3456789999999999999999999999999999999976532 233345677899999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec-----CCCcEEEccccccccc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-----KYGHLRLSDFGLCKPL 266 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~-----~~g~vkL~DFGla~~~ 266 (497)
|+||||++ |+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ..+.+||+|||+|+..
T Consensus 109 ~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~ 187 (329)
T 3gbz_A 109 HLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187 (329)
T ss_dssp EEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHH
T ss_pred EEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcccc
Confidence 99999997 59999999888999999999999999999999999999999999999994 5556999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 345 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGv 345 (497)
..... .....+||+.|+|||++.+. .|+.++|||||||
T Consensus 188 ~~~~~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~ 226 (329)
T 3gbz_A 188 GIPIR-----------------------------------------QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIAC 226 (329)
T ss_dssp C----------------------------------------------------CCTTCCHHHHTTCCCCCTHHHHHHHHH
T ss_pred CCccc-----------------------------------------ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHH
Confidence 42210 01145789999999999874 5899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhcccCccc----------------CCC----------CccCChhHHHHHHHHhh-C
Q 010947 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK----------------FPE----------EAKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~~~~~~i~~~~~~~~----------------~p~----------~~~~s~~~~dLI~~lL~-d 398 (497)
++|||++|.+||.+.+..+...++........ +|. ...+++++++||.+||+ |
T Consensus 227 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 306 (329)
T 3gbz_A 227 IWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMD 306 (329)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSS
T ss_pred HHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCC
Confidence 99999999999999988887777764211100 000 01278999999999999 9
Q ss_pred ccccCCCCCcchhcCCCCccCCChh
Q 010947 399 VNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 399 p~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
|.+||+ +.|+++||||++++|+
T Consensus 307 P~~R~t---~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 307 PVKRIS---AKNALEHPYFSHNDFD 328 (329)
T ss_dssp GGGSCC---HHHHHTSGGGSSSCSC
T ss_pred hhhCCC---HHHHhCCcccCCCCCC
Confidence 999999 9999999999999986
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-51 Score=418.33 Aligned_cols=256 Identities=33% Similarity=0.560 Sum_probs=213.6
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
...++|++++.||+|+||+||+|+++.+++.||||++.+.... .+.+.+|+.+++.++|||||+++++|.+...+|
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 4467899999999999999999999999999999999865422 245788999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc--EEEcccccccccCCCC
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPLDCST 270 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~ 270 (497)
+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~ 172 (361)
T 3uc3_A 93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172 (361)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence 99999999999999988889999999999999999999999999999999999999987765 9999999987432110
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcc-hhHHhHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME-CDWWSLGAIMYE 349 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~-~DiwSlGvil~e 349 (497)
...+.+||+.|+|||++.+..++.+ +|||||||++|+
T Consensus 173 ------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~e 210 (361)
T 3uc3_A 173 ------------------------------------------QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYV 210 (361)
T ss_dssp --------------------------------------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHH
Confidence 0124679999999999998888655 899999999999
Q ss_pred HHhCCCCCCCCCh----HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 350 MLVGYPPFYSDDP----MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 350 ll~G~~PF~~~~~----~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|++|.+||.+.+. ......+.. ....+|....+|+++++||.+||. ||.+||+ +.|+++||||..
T Consensus 211 ll~g~~Pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~~ 280 (361)
T 3uc3_A 211 MLVGAYPFEDPEEPRDYRKTIQRILS--VKYSIPDDIRISPECCHLISRIFVADPATRIS---IPEIKTHSWFLK 280 (361)
T ss_dssp HHHSSCSCC----CCCHHHHHHHHHT--TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCC---HHHHHTSHHHHT
T ss_pred HHhCCCCCCCCccHHHHHHHHHHHhc--CCCCCCCcCCCCHHHHHHHHHHccCChhHCcC---HHHHHhCcchhc
Confidence 9999999987544 344455554 344566656789999999999999 9999999 999999999953
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=435.76 Aligned_cols=259 Identities=32% Similarity=0.635 Sum_probs=231.6
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++|||||++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 569999999999999999999999999999999987543 2334567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec---CCCcEEEcccccccccCCCCcc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD---KYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~---~~g~vkL~DFGla~~~~~~~~~ 272 (497)
|||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 101 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~- 179 (486)
T 3mwu_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179 (486)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---
T ss_pred EcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc-
Confidence 9999999999998889999999999999999999999999999999999999995 456799999999986532210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
....+||+.|+|||++.+ .|+.++|||||||++|+|++
T Consensus 180 -----------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~ 217 (486)
T 3mwu_A 180 -----------------------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217 (486)
T ss_dssp -------------------------------------------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHh
Confidence 114689999999999875 59999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
|.+||.+.+..+...++......+..|....+|+++++||.+||+ ||.+||+ +.++++||||+...
T Consensus 218 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 218 GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYS 284 (486)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHHHCHHHHHTC
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcC---HHHHhcCHhhccCc
Confidence 999999999999999998766666666667899999999999999 9999999 99999999998654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=415.92 Aligned_cols=259 Identities=34% Similarity=0.565 Sum_probs=213.1
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
...++|++.+.||+|+||.||+|+++.+++.||||++.+.. ..+.+.+|+.+|+.++||||++++++|.+...+|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 124 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEIS 124 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEE
Confidence 34567999999999999999999999999999999998643 2345788999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC---CCcEEEcccccccccCCC
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~ 269 (497)
+||||++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++.....
T Consensus 125 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 125 LVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 99999999999999988888999999999999999999999999999999999999976 899999999999865321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
. .....+||+.|+|||++.+..|+.++|||||||++||
T Consensus 205 ~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 242 (349)
T 2w4o_A 205 V------------------------------------------LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYI 242 (349)
T ss_dssp --------------------------------------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHH
T ss_pred c------------------------------------------ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHH
Confidence 0 0124679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHH-HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 350 MLVGYPPFYSDDPMS-TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 350 ll~G~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
|++|..||.+..... .+..+.........|....++.++++||.+||+ ||.+||+ +.++++||||.+..
T Consensus 243 ll~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 243 LLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT---TFQALQHPWVTGKA 313 (349)
T ss_dssp HHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTTSTT
T ss_pred HHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcC---HHHHhcCcccCCCc
Confidence 999999998766544 666777644333333335789999999999999 9999999 99999999998754
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=409.21 Aligned_cols=263 Identities=29% Similarity=0.476 Sum_probs=208.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||+|+||.||+|.++.+|+.||||+++... .......+.+|+.+++.++|||||+++++|.+++.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 467999999999999999999999999999999997653 222335678899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 195 MEYLPGGDMMTLLMRK------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
|||++ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+....
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99997 5999988654 3599999999999999999999999999999999999999999999999999986542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
... .....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 161 ~~~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 199 (317)
T 2pmi_A 161 PVN-----------------------------------------TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCIL 199 (317)
T ss_dssp CCC-----------------------------------------CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred Ccc-----------------------------------------cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHH
Confidence 210 0114579999999999986 4689999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcc---------cCC---------------------CCccCChhHHHHHHHHhh
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------KFP---------------------EEAKLSIEAKDLISKLLC 397 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~---------~~p---------------------~~~~~s~~~~dLI~~lL~ 397 (497)
|||++|.+||.+.+..+....+....... ..| ....++.++++||.+||+
T Consensus 200 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~ 279 (317)
T 2pmi_A 200 AEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279 (317)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSC
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCC
Confidence 99999999999998888777765421100 000 012578899999999999
Q ss_pred -CccccCCCCCcchhcCCCCccCCChhh
Q 010947 398 -NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 398 -dp~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
||.+||+ +.|+++||||.+..|..
T Consensus 280 ~dP~~Rpt---~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 280 LNPDMRLS---AKQALHHPWFAEYYHHA 304 (317)
T ss_dssp SSGGGSCC---HHHHTTSGGGGGGCC--
T ss_pred CCcccCCC---HHHHhCChhhhcccchh
Confidence 9999999 99999999999776543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=434.67 Aligned_cols=261 Identities=33% Similarity=0.595 Sum_probs=225.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|+++.++..||||++.+.... ......+.+|+.+|+.++|||||+++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 3699999999999999999999999999999999876432 223456889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC---CcEEEcccccccccCCCCcc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~~~ 272 (497)
|||+||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.. +.+||+|||+|+......
T Consensus 116 e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-- 193 (494)
T 3lij_A 116 ECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-- 193 (494)
T ss_dssp ECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB--
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc--
Confidence 999999999999888999999999999999999999999999999999999999764 559999999998654221
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.....+||+.|+|||++. ..|+.++|||||||++|+|++
T Consensus 194 ----------------------------------------~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~ 232 (494)
T 3lij_A 194 ----------------------------------------KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLA 232 (494)
T ss_dssp ----------------------------------------CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHh
Confidence 012468999999999986 579999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChh
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
|.+||.+.+..+...++......+..|....+|+++++||.+||+ ||.+||+ +.++++||||+...+.
T Consensus 233 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~e~l~hp~~~~~~~~ 301 (494)
T 3lij_A 233 GYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRIS---AQQALEHPWIKEMCSK 301 (494)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTCHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCcc---HHHHhcCcccccCccc
Confidence 999999999999999988755555445456799999999999999 9999999 9999999999865443
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=410.05 Aligned_cols=254 Identities=31% Similarity=0.531 Sum_probs=199.3
Q ss_pred CeeEE---eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEE
Q 010947 117 DFELL---TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 117 ~f~~~---~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~ 192 (497)
+|++. +.||+|+||.||+|.++.+|+.||||++.+. ....+.+|+.++..+. ||||++++++|.+...+|
T Consensus 9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 35554 7899999999999999999999999999754 2345778999999997 999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC---cEEEcccccccccCCC
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPLDCS 269 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g---~vkL~DFGla~~~~~~ 269 (497)
+||||++||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999999999988999999999999999999999999999999999999998766 8999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.. ...+.+||+.|+|||++.+..|+.++|||||||++|+
T Consensus 163 ~~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ 201 (325)
T 3kn6_A 163 NQ-----------------------------------------PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYT 201 (325)
T ss_dssp --------------------------------------------------------------CCCCHHHHHHHHHHHHHH
T ss_pred CC-----------------------------------------cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHH
Confidence 10 0124679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCh-------HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 350 MLVGYPPFYSDDP-------MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 350 ll~G~~PF~~~~~-------~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|++|.+||.+.+. .+...++......+..+....+|+++++||.+||+ ||.+||+ +.++++||||++.
T Consensus 202 ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~h~w~~~~ 277 (325)
T 3kn6_A 202 MLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK---MSGLRYNEWLQDG 277 (325)
T ss_dssp HHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCC---TTTSTTCGGGCTT
T ss_pred HHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCC---HHHHhcChhhccC
Confidence 9999999987543 45666666533222222224689999999999999 9999999 9999999999863
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=397.40 Aligned_cols=268 Identities=32% Similarity=0.541 Sum_probs=231.3
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhh------hchhHHHHHHHHHHHHHhcC-CCceeEEEEEee
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM------LRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQ 186 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~------~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~ 186 (497)
..++|++.+.||+|+||.||+|.++.+|+.||||++..... ......+.+.+|+.+++.+. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 35789999999999999999999999999999999975431 11223456888999999995 999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
+...+|+||||++||+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++...
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 99999999999999999999988889999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc------cCCCCcchhH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDW 340 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~------~~~y~~~~Di 340 (497)
..... ....+||+.|+|||++. ...++.++||
T Consensus 175 ~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di 212 (298)
T 1phk_A 175 DPGEK------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDM 212 (298)
T ss_dssp CTTCC------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHH
T ss_pred CCCcc------------------------------------------cccccCCccccCHHHhccccccccccCCccccc
Confidence 42210 11457999999999985 4568999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|||||++|+|++|..||.+.+.......+.........|....++.++.+||.+||. ||.+||+ +.++++||||++
T Consensus 213 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~ 289 (298)
T 1phk_A 213 WSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQ 289 (298)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCT
T ss_pred HhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCC---HHHHHhChHhhh
Confidence 999999999999999999998888888887654444444445789999999999999 9999998 999999999999
Q ss_pred CChhhhh
Q 010947 420 VDWARIY 426 (497)
Q Consensus 420 i~w~~l~ 426 (497)
..|+.++
T Consensus 290 ~~~~~~~ 296 (298)
T 1phk_A 290 YVVEEVR 296 (298)
T ss_dssp TC-----
T ss_pred ccchhhc
Confidence 9887764
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-51 Score=434.21 Aligned_cols=261 Identities=33% Similarity=0.591 Sum_probs=227.0
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch----------hHHHHHHHHHHHHHhcCCCceeEEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR----------GQVEHVRAERNLLAEVDSNCIVKLYC 183 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~----------~~~~~~~~E~~il~~l~hp~Iv~l~~ 183 (497)
..++|.+++.||+|+||+||+|+++.++..||||++.+...... ...+.+.+|+.+|+.++|||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 35789999999999999999999999999999999987643321 23567889999999999999999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC---cEEEccc
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDF 260 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g---~vkL~DF 260 (497)
+|.+...+|+|||||+||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+||
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999998889999999999999999999999999999999999999999876 6999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhH
Q 010947 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (497)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~Di 340 (497)
|+|+....... ....+||+.|+|||++. ..|+.++||
T Consensus 194 g~a~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~-~~~~~~~Di 230 (504)
T 3q5i_A 194 GLSSFFSKDYK------------------------------------------LRDRLGTAYYIAPEVLK-KKYNEKCDV 230 (504)
T ss_dssp TTCEECCTTSC------------------------------------------BCCCCSCTTTCCHHHHT-TCBCTHHHH
T ss_pred CCCEEcCCCCc------------------------------------------cccccCCcCCCCHHHhc-cCCCchHHH
Confidence 99986643210 12468999999999986 569999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|||||++|+|++|.+||.+.+..+....+......+..+....+|+++++||.+||+ ||.+||+ ++|+++||||+.
T Consensus 231 wslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~e~l~h~~~~~ 307 (504)
T 3q5i_A 231 WSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCT---AEEALNSRWIKK 307 (504)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCC---HHHHhcCHhhhh
Confidence 999999999999999999999999999988754444433345799999999999999 9999999 999999999975
Q ss_pred C
Q 010947 420 V 420 (497)
Q Consensus 420 i 420 (497)
.
T Consensus 308 ~ 308 (504)
T 3q5i_A 308 Y 308 (504)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=401.85 Aligned_cols=259 Identities=29% Similarity=0.447 Sum_probs=215.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|++ .+|+.||||++..... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6799999999999999999998 6789999999976432 2223456788999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||+++ +|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 155 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--- 155 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc---
Confidence 99975 898888764 6799999999999999999999999999999999999999999999999999986532110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G 353 (497)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 156 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (288)
T 1ob3_A 156 --------------------------------------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197 (288)
T ss_dssp --------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 0113579999999999976 4589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcc---------c-------CC---------CCccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHL---------K-------FP---------EEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~---------~-------~p---------~~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
.+||.+.+..+...++....... . ++ ....+++++++||.+||. ||.+||+
T Consensus 198 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt--- 274 (288)
T 1ob3_A 198 TPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT--- 274 (288)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---
T ss_pred CCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC---
Confidence 99999988877776665311100 0 00 012478999999999999 9999999
Q ss_pred cchhcCCCCccCCC
Q 010947 408 ADEIKVHPWFDGVD 421 (497)
Q Consensus 408 ~~eil~Hpff~~i~ 421 (497)
+.|+++||||++.|
T Consensus 275 ~~e~l~hp~f~~~n 288 (288)
T 1ob3_A 275 AKQALEHAYFKENN 288 (288)
T ss_dssp HHHHHTSGGGGC--
T ss_pred HHHHhcCcchhhcC
Confidence 99999999998753
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=422.55 Aligned_cols=290 Identities=27% Similarity=0.404 Sum_probs=219.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-----
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD----- 188 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----- 188 (497)
..++|++++.||+|+||.||+|+++.+|+.||||++.+.. ........+.+|+.+|+.++||||+++++++...
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence 3578999999999999999999999999999999997642 2344556789999999999999999999999876
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+|+||||+. |+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~ 181 (432)
T 3n9x_A 103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181 (432)
T ss_dssp CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence 57999999985 69999998888899999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccc-ccCCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL-LKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l-~~~~y~~~~DiwSlGvil 347 (497)
............ ...+. ......+....+.+||+.|+|||++ ....|+.++||||||||+
T Consensus 182 ~~~~~~~~~~~~--------~~~~~-----------~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il 242 (432)
T 3n9x_A 182 EKDTNIVNDLEE--------NEEPG-----------PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242 (432)
T ss_dssp ------------------------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred cccccccccccc--------ccccc-----------ccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHH
Confidence 311000000000 00000 0000011123467999999999986 456799999999999999
Q ss_pred HHHHh-----------CCCCCCCCCh-----------------HHHHHHHhcccC----------------------ccc
Q 010947 348 YEMLV-----------GYPPFYSDDP-----------------MSTCRKIVNWRT----------------------HLK 377 (497)
Q Consensus 348 ~ell~-----------G~~PF~~~~~-----------------~~~~~~i~~~~~----------------------~~~ 377 (497)
|||++ |.++|.+.+. ......|+..-. ...
T Consensus 243 ~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~ 322 (432)
T 3n9x_A 243 AELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHR 322 (432)
T ss_dssp HHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC
T ss_pred HHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCC
Confidence 99998 5566655431 122222221000 000
Q ss_pred CCC-----CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhh
Q 010947 378 FPE-----EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 378 ~p~-----~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~ 427 (497)
.+. ...+|+++++||.+||+ ||.+||+ ++|+++||||++++|.....
T Consensus 323 ~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t---a~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 323 KPINLKQKYPSISDDGINLLESMLKFNPNKRIT---IDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp CCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTCGGGTTTCCTTTC-
T ss_pred CCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCC---HHHHhcChhhhhccCcccCc
Confidence 010 13589999999999999 9999998 99999999999999988764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=406.62 Aligned_cols=265 Identities=26% Similarity=0.484 Sum_probs=228.9
Q ss_pred CCeeEE-eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEE
Q 010947 116 DDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 116 ~~f~~~-~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~l 193 (497)
+.|.+. +.||+|+||.||+|.++.+|+.||||++.+.... ......+.+|+.++..+ .||||++++++|.+...+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 457777 8999999999999999999999999999865432 23356688999999988 56999999999999999999
Q ss_pred EEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC---CCcEEEcccccccccCC
Q 010947 194 IMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~---~g~vkL~DFGla~~~~~ 268 (497)
||||++||+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999998553 67999999999999999999999999999999999999998 78999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
... ....+||+.|+|||++.+..++.++|||||||++|
T Consensus 187 ~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 224 (327)
T 3lm5_A 187 ACE------------------------------------------LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224 (327)
T ss_dssp -------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred ccc------------------------------------------cccccCCcCccCCeeecCCCCCchhhHHHHHHHHH
Confidence 210 11467999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
+|++|.+||.+.+..+....+.........+....+++++++||.+||. ||.+||+ ++++++||||++++|+.+.
T Consensus 225 ~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 225 MLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPT---AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTCGGGCCCCTTCC-
T ss_pred HHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcC---HHHHhCCHhhccccccccc
Confidence 9999999999999888888877644443333345789999999999999 9999999 9999999999999998764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-51 Score=418.26 Aligned_cols=258 Identities=31% Similarity=0.540 Sum_probs=220.5
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecC
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 199 (497)
..+.||+|+||.||+|.+..+|..||+|+++.... ...+.+.+|+.+|+.++|||||+++++|.+.+.+|||||||+
T Consensus 93 ~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~ 169 (373)
T 2x4f_A 93 KTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVD 169 (373)
T ss_dssp EEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred cceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCC
Confidence 36789999999999999999999999999986532 344568899999999999999999999999999999999999
Q ss_pred CCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee--cCCCcEEEcccccccccCCCCcccccc
Q 010947 200 GGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 200 gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl--~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+.....
T Consensus 170 ~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~----- 244 (373)
T 2x4f_A 170 GGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK----- 244 (373)
T ss_dssp TCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB-----
T ss_pred CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc-----
Confidence 99999988654 469999999999999999999999999999999999999 5678999999999987643210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPP 356 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~P 356 (497)
....+||+.|+|||++.+..++.++|||||||++|||++|.+|
T Consensus 245 -------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 287 (373)
T 2x4f_A 245 -------------------------------------LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287 (373)
T ss_dssp -------------------------------------CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred -------------------------------------cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 1145799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhh
Q 010947 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 357 F~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 425 (497)
|.+.+..+.+.+|......+..+....+++++++||.+||+ ||.+||+ +.|+++||||.+..|...
T Consensus 288 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps---~~e~l~hp~~~~~~~~~~ 354 (373)
T 2x4f_A 288 FLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRIS---ASEALKHPWLSDHKLHSR 354 (373)
T ss_dssp TCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHCHHHHHH
T ss_pred CCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCC---HHHHhcCcCcCCCchhhh
Confidence 99999988888888643333222234689999999999999 9999999 999999999998766543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-51 Score=421.23 Aligned_cols=252 Identities=34% Similarity=0.545 Sum_probs=209.7
Q ss_pred CCCeeEE-eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHH-hcCCCceeEEEEEeec----C
Q 010947 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKLYCSFQD----D 188 (497)
Q Consensus 115 ~~~f~~~-~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~----~ 188 (497)
.++|.+. ++||+|+||+||+|.++.+|+.||||++... ..+.+|+.++. ..+||||++++++|.+ .
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4678887 7999999999999999999999999999743 23567888874 5589999999998875 6
Q ss_pred CeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC---CCcEEEcccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~---~g~vkL~DFGla 263 (497)
.++|||||||+||+|.+++...+ .+++..++.++.||+.||.|||+.|||||||||+|||++. ++.+||+|||+|
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 78999999999999999997653 5999999999999999999999999999999999999998 789999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+...... ...+.+||+.|+|||++.+..|+.++|||||
T Consensus 212 ~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 249 (400)
T 1nxk_A 212 KETTSHN------------------------------------------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249 (400)
T ss_dssp EECC-----------------------------------------------------CTTCCGGGSCCCCSSSHHHHHHH
T ss_pred cccCCCC------------------------------------------ccccCCCCCCccCHhhcCCCCCCCcccHHHH
Confidence 8653210 0124689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHH----HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 344 GAIMYEMLVGYPPFYSDDPMS----TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~----~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
|||+|||++|.+||.+.+... ....+......+..+....+|+++++||.+||+ ||.+||+ +.++++||||.
T Consensus 250 G~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~eil~hp~~~ 326 (400)
T 1nxk_A 250 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIM 326 (400)
T ss_dssp HHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHH
T ss_pred HHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccc
Confidence 999999999999998765432 445555543334444445799999999999999 9999998 99999999997
Q ss_pred C
Q 010947 419 G 419 (497)
Q Consensus 419 ~ 419 (497)
.
T Consensus 327 ~ 327 (400)
T 1nxk_A 327 Q 327 (400)
T ss_dssp T
T ss_pred C
Confidence 5
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-51 Score=430.44 Aligned_cols=256 Identities=27% Similarity=0.438 Sum_probs=211.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 188 (497)
.++|++++.||+|+||+||+|.+..+|+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 478999999999999999999999999999999998653 3344566788999999999999999999999755
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+|||||||++ +|...+. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+....
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred CeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 457999999965 5666664 3599999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
.. .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 217 ~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 254 (464)
T 3ttj_A 217 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254 (464)
T ss_dssp CC------------------------------------------CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred Cc------------------------------------------ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence 11 012468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcc-------------------------c----CCCC---------ccCChhHHH
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHL-------------------------K----FPEE---------AKLSIEAKD 390 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~-------------------------~----~p~~---------~~~s~~~~d 390 (497)
||++|++||.+.+..+.+.+|+...... . +|.. ...++++++
T Consensus 255 ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 334 (464)
T 3ttj_A 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334 (464)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHH
Confidence 9999999999999888877776421110 0 0100 001567999
Q ss_pred HHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 391 LI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||.+||. ||.+||+ ++|+++||||+.
T Consensus 335 Ll~~mL~~dP~~R~t---a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 335 LLSKMLVIDPAKRIS---VDDALQHPYINV 361 (464)
T ss_dssp HHHHHSCSSTTTSCC---HHHHHTSTTTGG
T ss_pred HHHHHcCCChhhCCC---HHHHhcChhhhh
Confidence 9999999 9999999 999999999984
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=411.90 Aligned_cols=267 Identities=31% Similarity=0.512 Sum_probs=226.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh--chhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML--RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~--~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
++|++.+.||+|+||.||+|.++.++..||||++.+.... .....+.+.+|+.+++.++|||||+++++|.+.+.+|+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 4699999999999999999999999999999999876532 24456779999999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHH
Q 010947 194 IMEYLPGGDMMTLLMR----------------------------------------KDTLTEDEARFYVAETVLAIESIH 233 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~----------------------------------------~~~l~e~~~~~~~~qi~~aL~~LH 233 (497)
|||||+||+|.+++.. ...+++..++.++.||+.||.|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998842 112467888999999999999999
Q ss_pred cCCEEEcccCCCCeeecCCC--cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 010947 234 KHHYIHRDIKPDNLLLDKYG--HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311 (497)
Q Consensus 234 ~~~iiHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (497)
+.||+||||||+|||++.++ .+||+|||+|+.+....... .
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~-------------------------------------~ 228 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGE-------------------------------------Y 228 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccc-------------------------------------c
Confidence 99999999999999998776 89999999998653211000 0
Q ss_pred cccccccCCCcccCcccccc--CCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHH
Q 010947 312 MLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAK 389 (497)
Q Consensus 312 ~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 389 (497)
......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+....+......+..|....++++++
T Consensus 229 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (345)
T 3hko_A 229 YGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLAR 308 (345)
T ss_dssp ------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHH
T ss_pred ccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHH
Confidence 00124679999999999975 6789999999999999999999999999999888888887555555555456899999
Q ss_pred HHHHHHhh-CccccCCCCCcchhcCCCCccCCCh
Q 010947 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 390 dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
+||.+||. ||.+||+ +.++++||||+++.|
T Consensus 309 ~li~~~l~~~p~~Rps---~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 309 DLLSNLLNRNVDERFD---AMRALQHPWISQFSD 339 (345)
T ss_dssp HHHHHHSCSCTTTSCC---HHHHHHSHHHHTTSS
T ss_pred HHHHHHcCCChhHCCC---HHHHhcChhhccChH
Confidence 99999999 9999999 999999999998754
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-50 Score=394.33 Aligned_cols=260 Identities=31% Similarity=0.518 Sum_probs=233.2
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
...++|.+.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+|
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEE
Confidence 34568999999999999999999999999999999998776555666778899999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
+||||++|++|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.......
T Consensus 92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 170 (294)
T 2rku_A 92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE- 170 (294)
T ss_dssp EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcc-
Confidence 9999999999999998888999999999999999999999999999999999999999999999999999986532210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.....+||+.|+|||++.+..++.++|+|||||++|+|++
T Consensus 171 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~ 210 (294)
T 2rku_A 171 ----------------------------------------RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 210 (294)
T ss_dssp ----------------------------------------CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHh
Confidence 0114579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|..||.+....+....+.. ....+|. .+++++.+||.+||. ||.+||+ ++++++||||...
T Consensus 211 g~~p~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~~~~~~~ 272 (294)
T 2rku_A 211 GKPPFETSCLKETYLRIKK--NEYSIPK--HINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 272 (294)
T ss_dssp SSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred CCCCCCCCCHHHHHHHHhh--ccCCCcc--ccCHHHHHHHHHHcccChhhCcC---HHHHhhChheecC
Confidence 9999999888888777765 3344554 789999999999999 9999998 9999999999854
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=394.79 Aligned_cols=253 Identities=34% Similarity=0.607 Sum_probs=225.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++.+.||+|+||.||+|.++.++..||+|++.+... ...+.+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 469999999999999999999999999999999986542 33566889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee---cCCCcEEEcccccccccCCCCcc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||++||+|.+++.....+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||++........
T Consensus 86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~- 164 (277)
T 3f3z_A 86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM- 164 (277)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC-
T ss_pred eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc-
Confidence 999999999999888999999999999999999999999999999999999999 7889999999999986543210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
....+||+.|+|||++.+. ++.++|||||||++|+|++
T Consensus 165 -----------------------------------------~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~ 202 (277)
T 3f3z_A 165 -----------------------------------------MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLC 202 (277)
T ss_dssp -----------------------------------------BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHH
Confidence 1146799999999998654 9999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|.+||.+.+..+....+... ...+|. ...+++++.+||.+||. ||.+||+ +.++++||||+.
T Consensus 203 g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s---~~~~l~h~~~~~ 267 (277)
T 3f3z_A 203 GYPPFSAPTDSEVMLKIREG--TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRIT---SLQALEHEWFEK 267 (277)
T ss_dssp SSCSSCCSSHHHHHHHHHHC--CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHTTSHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhC--CCCCCchhhhcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHHhc
Confidence 99999999888888888763 334443 23689999999999999 9999999 999999999974
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=399.42 Aligned_cols=266 Identities=27% Similarity=0.428 Sum_probs=219.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||+|+||+||+|++..+|+.||||++.... ........+.+|+.+++.++||||++++++|.+.+.+|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 468999999999999999999999999999999987653 2233456688899999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||++|++|..++.....+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--- 157 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD--- 157 (311)
T ss_dssp EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc---
Confidence 99999999999988888899999999999999999999999999999999999999999999999999986542110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G 353 (497)
.....+||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 158 --------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 199 (311)
T 4agu_A 158 --------------------------------------YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199 (311)
T ss_dssp ----------------------------------------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhC
Confidence 0114579999999999986 6789999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccC-----------------cccCCC----------CccCChhHHHHHHHHhh-CccccCCC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRT-----------------HLKFPE----------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~-----------------~~~~p~----------~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
.+||.+.+..+....+..... ....|. ...+++++.+||.+||. ||.+||+
T Consensus 200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt- 278 (311)
T 4agu_A 200 VPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT- 278 (311)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC-
T ss_pred CCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC-
Confidence 999999887766655432110 111111 13588999999999999 9999999
Q ss_pred CCcchhcCCCCccCCChhhh
Q 010947 406 KGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 406 ~~~~eil~Hpff~~i~w~~l 425 (497)
++|+++||||+++.|...
T Consensus 279 --~~ell~hp~f~~~~~~~~ 296 (311)
T 4agu_A 279 --CEQLLHHPYFENIREIED 296 (311)
T ss_dssp --HHHHHTSGGGTTCC----
T ss_pred --HHHHhcChHHHhccCHHH
Confidence 999999999999876543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=394.84 Aligned_cols=258 Identities=34% Similarity=0.635 Sum_probs=203.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999999999999999999876554445567789999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-- 167 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE-- 167 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--
Confidence 9999999999999765 6799999999999999999999999999999999999999999999999999986532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
.....+||+.|+|||++.+..++.++|+|||||++|+|++|
T Consensus 168 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 208 (278)
T 3cok_A 168 ---------------------------------------KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208 (278)
T ss_dssp ---------------------------------------------------------------CTHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhC
Confidence 01145799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
.+||...+.......+.. .....| ..++.++++||.+||. ||.+||+ +.++++||||...
T Consensus 209 ~~p~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 269 (278)
T 3cok_A 209 RPPFDTDTVKNTLNKVVL--ADYEMP--SFLSIEAKDLIHQLLRRNPADRLS---LSSVLDHPFMSRN 269 (278)
T ss_dssp SCSSCCCSCC-----CCS--SCCCCC--TTSCHHHHHHHHHHSCSSGGGSCC---HHHHTTSTTTC--
T ss_pred CCCCCChhHHHHHHHHhh--cccCCc--cccCHHHHHHHHHHcccCHhhCCC---HHHHhcCccccCC
Confidence 999998776666655543 233344 3689999999999999 9999999 9999999999853
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=401.32 Aligned_cols=262 Identities=26% Similarity=0.405 Sum_probs=214.5
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc--hhHHHHHHHHHHHHHhc---CCCceeEEEEEeec
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR--RGQVEHVRAERNLLAEV---DSNCIVKLYCSFQD 187 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~--~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~ 187 (497)
+..++|++++.||+|+||+||+|+++.+|+.||||++....... ......+.+|+.+++.+ +||||++++++|.+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 44678999999999999999999999999999999997543211 11123456677777666 49999999999987
Q ss_pred CC-----eEEEEEeecCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccc
Q 010947 188 DE-----FLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (497)
Q Consensus 188 ~~-----~l~lVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DF 260 (497)
.. .+|+||||+. |+|.+++..... +++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 55 5899999996 699999977654 999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhH
Q 010947 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340 (497)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~Di 340 (497)
|+|+....... ....+||+.|+|||++.+..|+.++||
T Consensus 165 g~a~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di 202 (308)
T 3g33_A 165 GLARIYSYQMA------------------------------------------LTPVVVTLWYRAPEVLLQSTYATPVDM 202 (308)
T ss_dssp SCTTTSTTCCC------------------------------------------SGGGGCCCSSCCHHHHHTSCCCSTHHH
T ss_pred ccccccCCCcc------------------------------------------cCCccccccccCchHHcCCCCCchHHH
Confidence 99986532210 124689999999999999999999999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCc---------ccCC-----C---------CccCChhHHHHHHHHhh
Q 010947 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH---------LKFP-----E---------EAKLSIEAKDLISKLLC 397 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~---------~~~p-----~---------~~~~s~~~~dLI~~lL~ 397 (497)
|||||++|+|++|.+||.+.+..+...++...... ..++ . ...+++++.+||.+||.
T Consensus 203 wslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 282 (308)
T 3g33_A 203 WSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLT 282 (308)
T ss_dssp HHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhc
Confidence 99999999999999999999988888777642111 1111 0 13578999999999999
Q ss_pred -CccccCCCCCcchhcCCCCccCC
Q 010947 398 -NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 398 -dp~~R~~~~~~~eil~Hpff~~i 420 (497)
||.+||+ +.|+++||||+..
T Consensus 283 ~dP~~R~t---~~e~l~h~~~~~~ 303 (308)
T 3g33_A 283 FNPHKRIS---AFRALQHSYLHKD 303 (308)
T ss_dssp SSTTTSCC---HHHHHTSTTC---
T ss_pred CCCccCCC---HHHHhcCccccCC
Confidence 9999999 9999999999864
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-50 Score=400.68 Aligned_cols=255 Identities=30% Similarity=0.538 Sum_probs=224.0
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEee
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy 197 (497)
|...+.||+|+||.||+|+++.+|+.||||++.... ....+.+.+|+.+++.++||||++++++|...+.+|+||||
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 888889999999999999999999999999997543 23455688999999999999999999999999999999999
Q ss_pred cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccc
Q 010947 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFT 277 (497)
Q Consensus 198 ~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 277 (497)
++||+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++........
T Consensus 124 ~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~----- 197 (321)
T 2c30_A 124 LQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK----- 197 (321)
T ss_dssp CCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC-----
T ss_pred CCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc-----
Confidence 999999998854 57999999999999999999999999999999999999999999999999999865422100
Q ss_pred ccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCC
Q 010947 278 IGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPF 357 (497)
Q Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF 357 (497)
....+||+.|+|||++.+..++.++|||||||++|||++|.+||
T Consensus 198 ------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf 241 (321)
T 2c30_A 198 ------------------------------------RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPY 241 (321)
T ss_dssp ------------------------------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ------------------------------------cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 11468999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 358 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
.+.+..+....+.... ...++....+++++++||.+||+ ||.+||+ +.++++||||....
T Consensus 242 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~ 302 (321)
T 2c30_A 242 FSDSPVQAMKRLRDSP-PPKLKNSHKVSPVLRDFLERMLVRDPQERAT---AQELLDHPFLLQTG 302 (321)
T ss_dssp TTSCHHHHHHHHHHSS-CCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGGGCC
T ss_pred CCCCHHHHHHHHhcCC-CCCcCccccCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhccCC
Confidence 9998888877776532 22233335789999999999999 9999998 99999999997543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=402.39 Aligned_cols=260 Identities=31% Similarity=0.523 Sum_probs=233.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
....+|.+.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 117 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF 117 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence 34568999999999999999999999999999999998776555666778999999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
+||||++|++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999999865422100
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 198 -----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 236 (335)
T 2owb_A 198 -----------------------------------------KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 236 (335)
T ss_dssp -----------------------------------------BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 114679999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|..||.+....+.+..+.. ....+|. .+++++.+||.+||. ||.+||+ +.++++||||...
T Consensus 237 g~~pf~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps---~~ell~~~~~~~~ 298 (335)
T 2owb_A 237 GKPPFETSCLKETYLRIKK--NEYSIPK--HINPVAASLIQKMLQTDPTARPT---INELLNDEFFTSG 298 (335)
T ss_dssp SSCTTCCSSHHHHHHHHHH--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---GGGGGGSHHHHTS
T ss_pred CcCCCCCCCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHHHccCChhHCcC---HHHHhcCccccCC
Confidence 9999999888888777765 3344554 789999999999999 9999999 9999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=411.89 Aligned_cols=260 Identities=31% Similarity=0.479 Sum_probs=215.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
.++|++++.||+|+||.||+|.++.+|+.||||++.+.. ........+.+|+.+|+.++||||++++++|....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 467999999999999999999999999999999997642 23344567889999999999999999999998763
Q ss_pred -eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 180 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence 469999999 8999999865 6799999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
. ....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 181 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 216 (367)
T 1cm8_A 181 E--------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 216 (367)
T ss_dssp S--------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHH
Confidence 1 114689999999999987 7899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCccc------------------CCC---------CccCChhHHHHHHHHhh-Cc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLK------------------FPE---------EAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~------------------~p~---------~~~~s~~~~dLI~~lL~-dp 399 (497)
|||++|.+||.+.+..+.+..|+....... +|. ...+++++.+||.+||+ ||
T Consensus 217 ~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP 296 (367)
T 1cm8_A 217 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 296 (367)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCCh
Confidence 999999999999988877777654211100 000 13578999999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCCChhh
Q 010947 400 NQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
.+|++ ++++++||||+.+.+..
T Consensus 297 ~~R~t---~~e~l~hp~f~~~~~~~ 318 (367)
T 1cm8_A 297 EQRVT---AGEALAHPYFESLHDTE 318 (367)
T ss_dssp TTSCC---HHHHHHSGGGTTTC---
T ss_pred hHCCC---HHHHhcChHHHhhcCCc
Confidence 99999 99999999999876544
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=412.13 Aligned_cols=290 Identities=29% Similarity=0.449 Sum_probs=237.2
Q ss_pred HHhcCCCCHHHHHHHHHHHHhhhhhHHHHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhH
Q 010947 80 KLADADVSEEDQNNLLKFLEKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ 159 (497)
Q Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~ 159 (497)
+++..+..++.......++... .....+..++|++++.||+|+||.||+|.+..++..||+|++.... ....
T Consensus 3 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~ 74 (360)
T 3eqc_A 3 KLEELELDEQQRKRLEAFLTQK------QKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAI 74 (360)
T ss_dssp ---CCCCCHHHHHHHHHHHHHH------HTCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHH
T ss_pred chhhhhhhhhhhhhHHHHhhhh------hcccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHH
Confidence 3445566666555544444322 2345677789999999999999999999999999999999998642 3344
Q ss_pred HHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC-CEE
Q 010947 160 VEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH-HYI 238 (497)
Q Consensus 160 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~-~ii 238 (497)
...+.+|+.+++.++||||++++++|.+.+.+|+||||++||+|.+++...+.+++..+..++.+++.||.|||+. ||+
T Consensus 75 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~ 154 (360)
T 3eqc_A 75 RNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 154 (360)
T ss_dssp HHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 5678999999999999999999999999999999999999999999999888999999999999999999999996 999
Q ss_pred EcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccc
Q 010947 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (497)
Q Consensus 239 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (497)
||||||+|||++.++++||+|||+++..... .....+
T Consensus 155 H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-------------------------------------------~~~~~~ 191 (360)
T 3eqc_A 155 HRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-------------------------------------------MANSFV 191 (360)
T ss_dssp CSCCSGGGEEECTTCCEEECCCCCCHHHHHH-------------------------------------------C----C
T ss_pred cCCccHHHEEECCCCCEEEEECCCCcccccc-------------------------------------------cccCCC
Confidence 9999999999999999999999998754210 012468
Q ss_pred CCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHH-------------------------------
Q 010947 319 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCR------------------------------- 367 (497)
Q Consensus 319 Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~------------------------------- 367 (497)
||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..+...
T Consensus 192 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (360)
T 3eqc_A 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271 (360)
T ss_dssp CCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------------
T ss_pred CCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCC
Confidence 9999999999999999999999999999999999999998876544322
Q ss_pred -----------HHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhh
Q 010947 368 -----------KIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 368 -----------~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 425 (497)
.+... .....+ ...+|.++++||.+||. ||.+||+ +.++++||||++.+|..+
T Consensus 272 ~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~~~~~~~~ 336 (360)
T 3eqc_A 272 RPPMAIFELLDYIVNE-PPPKLP-SGVFSLEFQDFVNKCLIKNPAERAD---LKQLMVHAFIKRSDAEEV 336 (360)
T ss_dssp --CCCHHHHHHHHHHS-CCCCCC-TTTSCHHHHHHHHHHHCSSTTTSCC---HHHHHTSHHHHHHHHSCC
T ss_pred CCcccchhhhhHHhcc-CCCCCC-cccccHHHHHHHHHHhhcChhhCCC---HHHHhhChHhhcchHhhh
Confidence 22221 111122 23578999999999999 9999999 999999999997766554
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=405.97 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=212.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|.+++.||+|+||+||+|+++.+++.||||++..... ......+.+|+.+|+.++||||++++++|.+.+.+|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 689999999999999999999999999999999975431 111123456999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||++ |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--- 155 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--- 155 (324)
T ss_dssp ECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred cccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc---
Confidence 9996 5888888764 4599999999999999999999999999999999999999999999999999975432110
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G 353 (497)
.....+||+.|+|||++.+ ..|+.++|||||||++|+|++|
T Consensus 156 --------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 197 (324)
T 3mtl_A 156 --------------------------------------TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATG 197 (324)
T ss_dssp ---------------------------------------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 0114579999999999986 6789999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcc---cCC--------------C---------CccCChhHHHHHHHHhh-CccccCCCC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHL---KFP--------------E---------EAKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~---~~p--------------~---------~~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
.+||.+.+..+....+....... .+| . ...+++++++||.+||+ ||.+||+
T Consensus 198 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t-- 275 (324)
T 3mtl_A 198 RPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS-- 275 (324)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC--
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC--
Confidence 99999998887777665421111 011 0 12578999999999999 9999999
Q ss_pred CcchhcCCCCccCCC
Q 010947 407 GADEIKVHPWFDGVD 421 (497)
Q Consensus 407 ~~~eil~Hpff~~i~ 421 (497)
++|+++||||.++.
T Consensus 276 -~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 276 -AEDAMKHPFFLSLG 289 (324)
T ss_dssp -HHHHTTSGGGGGGC
T ss_pred -HHHHhcChhhhhcc
Confidence 99999999999765
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=398.78 Aligned_cols=256 Identities=32% Similarity=0.612 Sum_probs=225.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|.+.+.||+|+||.||+|+++.+|+.||+|++..... .....+.+|+.+++.++||||++++++|.+...+|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 469999999999999999999999999999999986532 22345788999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee---cCCCcEEEcccccccccCCCCcc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||++||+|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||+ +.++.+||+|||+++......
T Consensus 86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-- 163 (304)
T 2jam_A 86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-- 163 (304)
T ss_dssp CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT--
T ss_pred EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc--
Confidence 999999999999888899999999999999999999999999999999999999 788999999999987532110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
....+||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 164 -----------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 202 (304)
T 2jam_A 164 -----------------------------------------MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202 (304)
T ss_dssp -----------------------------------------THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHH
Confidence 113579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|.+||.+.+.......+......+..+....+++++++||.+||. ||.+||+ +.++++||||.+.
T Consensus 203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~ 268 (304)
T 2jam_A 203 GYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYT---CEKALSHPWIDGN 268 (304)
T ss_dssp SSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCC---HHHHHTSHHHHSS
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCccccCC
Confidence 999999998888888887644333333335789999999999999 9999999 9999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=409.94 Aligned_cols=258 Identities=33% Similarity=0.595 Sum_probs=225.6
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----chhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
++|++.+.||+|+||.||+|+++.+|+.||||++...... .....+.+.+|+.++..+ +||||++++++|....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4699999999999999999999999999999999764311 112245678899999998 8999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||||++||+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++..+...
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999988889999999999999999999999999999999999999999999999999999866422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc------CCCCcchhHHhH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK------KGYGMECDWWSL 343 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~------~~y~~~~DiwSl 343 (497)
.. ....+||+.|+|||++.+ ..|+.++|||||
T Consensus 254 ~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~sl 291 (365)
T 2y7j_A 254 EK------------------------------------------LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291 (365)
T ss_dssp CC------------------------------------------BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHH
T ss_pred cc------------------------------------------cccCCCCCCccChhhccccccccCcCCCchhhHHhH
Confidence 10 124689999999999863 368999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
||++|+|++|.+||.+.+.......+.........|....+++++.+||.+||+ ||.+||+ +.++++||||+
T Consensus 292 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~f~ 364 (365)
T 2y7j_A 292 GVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT---AEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGC
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCcccC
Confidence 999999999999999988888888887644333333335789999999999999 9999999 99999999996
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=411.62 Aligned_cols=274 Identities=27% Similarity=0.414 Sum_probs=219.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
.++|++++.||+|+||.||+|.+..+|+.||||++.+.. ........+.+|+.+++.++||||++++++|.+..
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 102 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence 478999999999999999999999999999999998643 23345567889999999999999999999998765
Q ss_pred -eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+||||++ |+|.+++. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 103 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 103 QDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp CEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred cceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 7899999996 57888874 4699999999999999999999999999999999999999999999999999975432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
.. .....+||+.|+|||++.+..|+.++|||||||++|
T Consensus 180 ~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 217 (371)
T 2xrw_A 180 SF------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 217 (371)
T ss_dssp ----------------------------------------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred cc------------------------------------------ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHH
Confidence 10 011468999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcc----------------------------------cCCCC----ccCChhHHH
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHL----------------------------------KFPEE----AKLSIEAKD 390 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~----------------------------------~~p~~----~~~s~~~~d 390 (497)
+|++|.+||.+.+..+.+.+++...... .+|.. ...++++++
T Consensus 218 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 297 (371)
T 2xrw_A 218 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 297 (371)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHH
Confidence 9999999999998888877776421110 01100 012568999
Q ss_pred HHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhcCCCcccccC
Q 010947 391 LISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVN 437 (497)
Q Consensus 391 LI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~ 437 (497)
||.+||+ ||.+||+ ++|+++||||...........++|++|...
T Consensus 298 li~~mL~~dP~~R~t---~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~ 342 (371)
T 2xrw_A 298 LLSKMLVIDASKRIS---VDEALQHPYINVWYDPSEAEAPPPKIPDKQ 342 (371)
T ss_dssp HHHHHSCSSGGGSCC---HHHHHHSHHHHTTCCHHHHTCCCCCCCTTT
T ss_pred HHHHHCcCChhhCCC---HHHHhCCcchhhhcCccccCCCCCCCCChh
Confidence 9999999 9999999 999999999986544444456677777644
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=405.58 Aligned_cols=264 Identities=24% Similarity=0.379 Sum_probs=220.3
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC----
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE---- 189 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~---- 189 (497)
..++|++.+.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++.+..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3578999999999999999999999999999999998765545555677899999999999999999999987654
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
..|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+...
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred ccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 34999999999999999998899999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.... ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 170 ~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 211 (311)
T 3ork_A 170 GNSV--------------------------------------TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211 (311)
T ss_dssp --------------------------------------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred cccc--------------------------------------ccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHH
Confidence 1000 00124679999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
|++|.+||.+.+..+....+..............+|+++.+||.+||. ||.+||+ +.+++.|+|++
T Consensus 212 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 278 (311)
T 3ork_A 212 VLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ---TAAEMRADLVR 278 (311)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred HHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChh---hHHHHHHHHHH
Confidence 999999999998887776666532221111124689999999999999 9999998 88899999986
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=404.15 Aligned_cols=268 Identities=30% Similarity=0.547 Sum_probs=215.3
Q ss_pred CCCeeEE-eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh-cCCCceeEEEEEeecCCeEE
Q 010947 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 115 ~~~f~~~-~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~l~ 192 (497)
.+.|++. +.||+|+||.||+|.+..+++.||||++.+.. ......+.+|+.++.. .+||||++++++|.+.+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4678885 78999999999999999999999999997653 2345568899999988 47999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc---EEEcccccccccCCC
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLDCS 269 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~---vkL~DFGla~~~~~~ 269 (497)
+||||++||+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 99999999999999998889999999999999999999999999999999999999998776 999999999865322
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----CCCCcchhHHhHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----KGYGMECDWWSLG 344 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----~~y~~~~DiwSlG 344 (497)
..... .........+||+.|+|||++.+ ..|+.++||||||
T Consensus 168 ~~~~~----------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG 213 (316)
T 2ac3_A 168 GDCSP----------------------------------ISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLG 213 (316)
T ss_dssp ------------------------------------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHH
T ss_pred Ccccc----------------------------------ccccccccccCCcCccChHHhhcccccccCCCcccccHhHH
Confidence 10000 00000124679999999999975 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCCh---------------HHHHHHHhcccCcccCCCC--ccCChhHHHHHHHHhh-CccccCCCC
Q 010947 345 AIMYEMLVGYPPFYSDDP---------------MSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAK 406 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~---------------~~~~~~i~~~~~~~~~p~~--~~~s~~~~dLI~~lL~-dp~~R~~~~ 406 (497)
|++|||++|.+||.+... ......+.. ....+|.. ..+++++++||.+||+ ||.+||+
T Consensus 214 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps-- 289 (316)
T 2ac3_A 214 VILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE--GKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS-- 289 (316)
T ss_dssp HHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH--CCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC--
T ss_pred HHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhc--cCcccCchhcccCCHHHHHHHHHHhhCChhhCCC--
Confidence 999999999999987642 334555554 33344432 4689999999999999 9999999
Q ss_pred CcchhcCCCCccCCChhh
Q 010947 407 GADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 407 ~~~eil~Hpff~~i~w~~ 424 (497)
+.|+++||||++..|..
T Consensus 290 -~~e~l~hp~~~~~~~~~ 306 (316)
T 2ac3_A 290 -AAQVLQHPWVQGCAPEN 306 (316)
T ss_dssp -HHHHHHSTTCC------
T ss_pred -HHHHhcChhhcCCCCcc
Confidence 99999999999876654
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=407.93 Aligned_cols=261 Identities=28% Similarity=0.503 Sum_probs=220.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch-----hHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR-----GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~-----~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
++|++++.||+|+||.||+|+++.+++.||||++.+...... .....+.+|+.+|+.++||||++++++|.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 469999999999999999999999999999999987643221 133456789999999999999999999999999
Q ss_pred EEEEEeecCCC-chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGG-DMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg-~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
+|+||||+.+| +|..++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999777 99999988889999999999999999999999999999999999999999999999999999866432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~ 348 (497)
.. ..+.+||+.|+|||++.+..+ +.++|||||||++|
T Consensus 184 ~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 221 (335)
T 3dls_A 184 KL------------------------------------------FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLY 221 (335)
T ss_dssp CC------------------------------------------BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHH
T ss_pred Cc------------------------------------------eeccCCCccccChhhhcCCCCCCCcccchhHHHHHH
Confidence 10 124679999999999998877 88999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC------CC
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG------VD 421 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~------i~ 421 (497)
+|++|..||..... +.. .....| ..+++++++||.+||. ||.+||+ +.++++||||+. ++
T Consensus 222 el~~g~~pf~~~~~------~~~--~~~~~~--~~~~~~l~~li~~~L~~dP~~Rps---~~ell~hp~~~~~~~~~~~~ 288 (335)
T 3dls_A 222 TLVFEENPFCELEE------TVE--AAIHPP--YLVSKELMSLVSGLLQPVPERRTT---LEKLVTDPWVTQPVNLADYT 288 (335)
T ss_dssp HHHHSSCSCSSGGG------GTT--TCCCCS--SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHHCTTTTCCCCGGGCC
T ss_pred HHHhCCCchhhHHH------HHh--hccCCC--cccCHHHHHHHHHHccCChhhCcC---HHHHhcCccccCCccccccC
Confidence 99999999976321 111 222233 3689999999999999 9999999 999999999964 56
Q ss_pred hhhhhhcCCC
Q 010947 422 WARIYQMEAA 431 (497)
Q Consensus 422 w~~l~~~~~p 431 (497)
|+.+.....|
T Consensus 289 ~~~~~~~~~~ 298 (335)
T 3dls_A 289 WEEVFRVNKP 298 (335)
T ss_dssp HHHHC-----
T ss_pred HHHHhhhcCC
Confidence 7776654433
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-50 Score=390.92 Aligned_cols=260 Identities=29% Similarity=0.539 Sum_probs=223.6
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
..+..++|.+.+.||+|+||.||+|.++.+|+.||||++.............+.+|+.+++.++||||+++++++.+...
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 85 (276)
T 2h6d_A 6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD 85 (276)
T ss_dssp -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence 44567899999999999999999999999999999999987655445556778999999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 99999999999999999888899999999999999999999999999999999999999999999999999997653211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYE 349 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~e 349 (497)
. ....+||+.|+|||++.+..+ +.++|+|||||++|+
T Consensus 166 ~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~ 203 (276)
T 2h6d_A 166 F------------------------------------------LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYA 203 (276)
T ss_dssp -----------------------------------------------------CCTGGGTTSCCCHHHHHHHHHHHHHHH
T ss_pred c------------------------------------------eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHH
Confidence 0 113579999999999988766 689999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|++|..||.+.+.......+... ...+|. .++.++.+||.+||. ||.+||+ +.++++||||+.
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~--~~~~~l~~li~~~l~~~p~~Rps---~~~~l~h~~~~~ 267 (276)
T 2h6d_A 204 LLCGTLPFDDEHVPTLFKKIRGG--VFYIPE--YLNRSVATLLMHMLQVDPLKRAT---IKDIREHEWFKQ 267 (276)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHT
T ss_pred HHhCCCCCCCCcHHHHHHHhhcC--cccCch--hcCHHHHHHHHHHccCChhhCCC---HHHHHhChhhcc
Confidence 99999999998888877777652 334443 689999999999999 9999999 999999999975
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=396.78 Aligned_cols=264 Identities=30% Similarity=0.533 Sum_probs=227.6
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
++|++++.||+|+||.||+|+++.+|+.||+|++++...... ...+.+.+|+.+++.++||||+++++++.+...+|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 469999999999999999999999999999999987543221 13567889999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC----cEEEcccccccccCC
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDC 268 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g----~vkL~DFGla~~~~~ 268 (497)
+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+||+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999998888999999999999999999999999999999999999999877 899999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
... ....+||+.|+|||++.+..++.++|||||||++|
T Consensus 165 ~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 202 (283)
T 3bhy_A 165 GNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 202 (283)
T ss_dssp -------------------------------------------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred CCc------------------------------------------ccccCCCcCccCcceecCCCCCcchhhhhHHHHHH
Confidence 110 11357999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhh
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
+|++|..||.+.+..+....+.........+....+++.+.+||.+||. ||.+||+ +.++++||||+.+.|..
T Consensus 203 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 203 ILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMT---IAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCC---HHHHHHCHHHHHHHHCC
T ss_pred HHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcC---HHHHHhCHHHHHHHHHh
Confidence 9999999999998888887776533222111124688999999999999 9999999 99999999999765543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-50 Score=407.63 Aligned_cols=263 Identities=24% Similarity=0.427 Sum_probs=222.7
Q ss_pred hHHHHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-----CCce
Q 010947 104 EYMRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----SNCI 178 (497)
Q Consensus 104 ~~~~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-----hp~I 178 (497)
..+.+....+..++|.+++.||+|+||+||+|++..+++.||||++.... .....+..|+.+++.+. ||||
T Consensus 23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 33456666777899999999999999999999999999999999997532 23445777999999886 9999
Q ss_pred eEEEEEeecCCeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-----
Q 010947 179 VKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK----- 251 (497)
Q Consensus 179 v~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~----- 251 (497)
|+++++|.+.+.+|+||||+ ||+|.+++.... .+++..++.++.||+.||.|||+.|||||||||+|||++.
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~ 177 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEK 177 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCE
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccc
Confidence 99999999999999999999 999999997754 5999999999999999999999999999999999999975
Q ss_pred --------------------CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcc
Q 010947 252 --------------------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRR 311 (497)
Q Consensus 252 --------------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 311 (497)
++.+||+|||+|+.....
T Consensus 178 ~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~------------------------------------------ 215 (360)
T 3llt_A 178 SLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY------------------------------------------ 215 (360)
T ss_dssp EEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC------------------------------------------
T ss_pred cccchhcccccccccccccCCCCEEEEeccCceecCCC------------------------------------------
Confidence 789999999999754321
Q ss_pred cccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCccc--------------
Q 010947 312 MLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK-------------- 377 (497)
Q Consensus 312 ~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~-------------- 377 (497)
..+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+....+......++
T Consensus 216 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 293 (360)
T 3llt_A 216 --HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSK 293 (360)
T ss_dssp --CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGG
T ss_pred --CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCcc
Confidence 1146799999999999999999999999999999999999999999887777666543211110
Q ss_pred ----------CCCC------------------ccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 378 ----------FPEE------------------AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 378 ----------~p~~------------------~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
+|.. ...++.+.+||.+||+ ||.+||+ +.|+++||||+
T Consensus 294 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---a~elL~hp~f~ 360 (360)
T 3llt_A 294 YVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS---PAELLKHKFLE 360 (360)
T ss_dssp GEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGC
T ss_pred ccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCC---HHHHhcCcccC
Confidence 1110 1124778899999999 9999999 99999999995
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=392.72 Aligned_cols=255 Identities=28% Similarity=0.533 Sum_probs=217.6
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|.+.+.||+|+||.||+|.++.++..||+|++.+... ....+.+.+|+.+|+.++||||++++++|.+...+|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 569999999999999999999999999999999987542 334567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee---cCCCcEEEcccccccccCC
Q 010947 196 EYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~ 268 (497)
||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999998543 679999999999999999999999999999999999999 5568899999999976532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
... ....+||+.|+|||++. ..++.++|||||||++|
T Consensus 180 ~~~------------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~ 216 (285)
T 3is5_A 180 DEH------------------------------------------STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMY 216 (285)
T ss_dssp -------------------------------------------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHH
T ss_pred ccc------------------------------------------CcCcccccCcCChHHhc-cCCCcccCeehHHHHHH
Confidence 110 11467999999999985 57899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+|++|..||.+.+..+....+......... ....+++++.+||.+||. ||.+||+ +.|+++||||+.
T Consensus 217 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~f~~ 284 (285)
T 3is5_A 217 FLLTGCLPFTGTSLEEVQQKATYKEPNYAV-ECRPLTPQAVDLLKQMLTKDPERRPS---AAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCC---HHHHHTSGGGGC
T ss_pred HHHhCCCCCCCCCHHHHHhhhccCCccccc-ccCcCCHHHHHHHHHHccCChhhCcC---HHHHhcCHHhhc
Confidence 999999999998887777766543222222 123589999999999999 9999999 999999999975
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=403.75 Aligned_cols=254 Identities=27% Similarity=0.396 Sum_probs=222.0
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
..|.+++.||+|+||.||+|++..+|+.||||++.............+.+|+.+|+.++|||||+++++|.+.+.+|+||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 34999999999999999999999999999999998654444455677899999999999999999999999999999999
Q ss_pred eecCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||+. |+|.+++. ....+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+++.....
T Consensus 134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~----- 207 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 207 (348)
T ss_dssp ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-----
T ss_pred ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC-----
Confidence 9997 67877775 4568999999999999999999999999999999999999999999999999999754311
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHhHHHHHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwSlGvil~ell 351 (497)
...+||+.|+|||++. ...|+.++|||||||++|||+
T Consensus 208 ----------------------------------------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 208 ----------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp ----------------------------------------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence 1467999999999985 567999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+|.+||.+.+.......+......... ...+++++++||.+||. ||.+||+ ++++++||||...
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps---~~~ll~h~~~~~~ 312 (348)
T 1u5q_A 248 ERKPPLFNMNAMSALYHIAQNESPALQ--SGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLRE 312 (348)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHSC
T ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcccChhhCcC---HHHHhhChhhhcc
Confidence 999999998887777777653322222 24689999999999999 9999999 9999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=420.69 Aligned_cols=263 Identities=32% Similarity=0.599 Sum_probs=214.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-----hhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-----RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~-----~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.++|.+.+.||+|+||+||+|.++.+++.||||++.+..... ......+.+|+.+|+.++|||||+++++|.. .
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 367999999999999999999999999999999998754321 1122347889999999999999999999865 4
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC---cEEEccccccccc
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HLRLSDFGLCKPL 266 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g---~vkL~DFGla~~~ 266 (497)
.+|+|||||+||+|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+..
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~ 292 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 292 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence 5799999999999999998888999999999999999999999999999999999999997654 5999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CCCCcchhHHhH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSL 343 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~y~~~~DiwSl 343 (497)
.... .....+||+.|+|||++.+ ..|+.++|||||
T Consensus 293 ~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl 330 (419)
T 3i6u_A 293 GETS------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330 (419)
T ss_dssp C-----------------------------------------------------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred CCCc------------------------------------------cccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence 3211 0124689999999999864 678899999999
Q ss_pred HHHHHHHHhCCCCCCCCChH-HHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 344 GAIMYEMLVGYPPFYSDDPM-STCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~-~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||++|+|++|.+||.+.... .....+... ...++. ...+++++++||.+||. ||.+||+ ++++++||||++
T Consensus 331 G~il~~lltg~~pf~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~e~l~hp~~~~ 405 (419)
T 3i6u_A 331 GVILFICLSGYPPFSEHRTQVSLKDQITSG--KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQD 405 (419)
T ss_dssp HHHHHHHHHSSCSSCCCSSSCCHHHHHHTT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSGGGCC
T ss_pred HHHHHHHHHCCCCCCCCcchHHHHHHHhcC--CCCCCchhhcccCHHHHHHHHHHccCChhHCcC---HHHHhCCcccCC
Confidence 99999999999999876543 333444432 222221 24689999999999999 9999999 999999999999
Q ss_pred CChhhh
Q 010947 420 VDWARI 425 (497)
Q Consensus 420 i~w~~l 425 (497)
.+|...
T Consensus 406 ~~~~~~ 411 (419)
T 3i6u_A 406 EDMKRK 411 (419)
T ss_dssp HHHHHH
T ss_pred hhHHHH
Confidence 887664
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-49 Score=387.14 Aligned_cols=256 Identities=22% Similarity=0.389 Sum_probs=219.0
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec----CC
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DE 189 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~ 189 (497)
....|.+.+.||+|+||.||+|.+..++..||+|++..... .......+.+|+.+++.++||||++++++|.+ ..
T Consensus 24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCE
T ss_pred CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCc
Confidence 34569999999999999999999999999999999986543 34456778999999999999999999998875 46
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC--EEEcccCCCCeeec-CCCcEEEccccccccc
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLD-KYGHLRLSDFGLCKPL 266 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~ 266 (497)
.+|+||||++||+|.+++.....+++..+..++.||+.||.|||+.| |+||||||+|||++ .++.+||+|||++...
T Consensus 103 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred eEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 79999999999999999988889999999999999999999999999 99999999999998 7899999999999754
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
.... ....+||+.|+|||++. ..++.++|||||||+
T Consensus 183 ~~~~-------------------------------------------~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~ 218 (290)
T 1t4h_A 183 RASF-------------------------------------------AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMC 218 (290)
T ss_dssp CTTS-------------------------------------------BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHH
T ss_pred cccc-------------------------------------------cccccCCcCcCCHHHHh-ccCCCcchHHHHHHH
Confidence 3211 12467999999999886 569999999999999
Q ss_pred HHHHHhCCCCCCCCCh-HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 347 MYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 347 l~ell~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+|+|++|..||.+... ......+........++ ...++++.+||.+||. ||.+||+ +.++++||||++
T Consensus 219 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~ell~h~~f~~ 288 (290)
T 1t4h_A 219 MLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC-
T ss_pred HHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC--CCCCHHHHHHHHHHccCChhhCCC---HHHHhhCccccc
Confidence 9999999999988544 44445554432222333 3678899999999999 9999998 999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=410.03 Aligned_cols=259 Identities=30% Similarity=0.438 Sum_probs=212.2
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 188 (497)
..+|.++++||+|+||+||+|++..++. ||+|++.+.... ..+|+.+|+.++|||||+++++|...
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence 3569999999999999999999987776 888877654321 23699999999999999999998543
Q ss_pred CeEEEEEeecCCCchhHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec-CCCcEEEccccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCK 264 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~-~~g~vkL~DFGla~ 264 (497)
.++|+||||++++.+..+. .....+++..++.++.||+.||.|||+.||+||||||+|||++ .+|++||+|||+|+
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 3489999999875443332 2256899999999999999999999999999999999999999 79999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSL 343 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSl 343 (497)
.+..... ..+.+||+.|+|||++.+. .|+.++|||||
T Consensus 191 ~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 228 (394)
T 4e7w_A 191 ILIAGEP------------------------------------------NVSYICSRYYRAPELIFGATNYTTNIDIWST 228 (394)
T ss_dssp ECCTTCC------------------------------------------CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred cccCCCC------------------------------------------CcccccCcCccCHHHHcCCCCCCcHHHHHHH
Confidence 7632210 1146899999999999764 59999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcccCc---------------ccCCC----------CccCChhHHHHHHHHhh-
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH---------------LKFPE----------EAKLSIEAKDLISKLLC- 397 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~~~---------------~~~p~----------~~~~s~~~~dLI~~lL~- 397 (497)
||++|||++|.+||.+.+..+.+..|+..... ..+|. ...+++++++||.+||+
T Consensus 229 G~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (394)
T 4e7w_A 229 GCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEY 308 (394)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCC
Confidence 99999999999999999888777766542110 11111 12488999999999999
Q ss_pred CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 398 NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 398 dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
||.+||+ +.|+++||||+++.|....
T Consensus 309 dP~~R~t---~~e~l~hp~f~~~~~~~~~ 334 (394)
T 4e7w_A 309 TPSARLT---AIEALCHPFFDELRTGEAR 334 (394)
T ss_dssp SGGGSCC---HHHHHTSGGGSTTTSSCCC
T ss_pred ChhhCCC---HHHHhcChhhhhhcccccc
Confidence 9999999 9999999999999876543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-49 Score=394.47 Aligned_cols=251 Identities=26% Similarity=0.403 Sum_probs=205.9
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh-cCCCceeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
++|++++.||+|+||+||+|+++.+|+.||||++........ .......|+..+.. .+||||++++++|.+...+|+|
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPK-DRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChH-HHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 569999999999999999999999999999999875432222 23334445555544 4999999999999999999999
Q ss_pred EeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 195 MEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||+ +|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~-- 212 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-- 212 (311)
T ss_dssp EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC--
Confidence 9999 77888888664 4699999999999999999999999999999999999999999999999999886532210
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
....+||+.|+|||++.+ .++.++|||||||++|||++|
T Consensus 213 ----------------------------------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g 251 (311)
T 3p1a_A 213 ----------------------------------------GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACN 251 (311)
T ss_dssp ------------------------------------------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHT
T ss_pred ----------------------------------------CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhC
Confidence 114579999999999875 799999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
..||.+.. ....+........++ ..+++++.+||.+||+ ||.+||+ +.++++||||+.
T Consensus 252 ~~~~~~~~---~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~~~~ 310 (311)
T 3p1a_A 252 MELPHGGE---GWQQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDPKLRAT---AEALLALPVLRQ 310 (311)
T ss_dssp CCCCSSHH---HHHHHTTTCCCHHHH--TTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGSC
T ss_pred CCCCCCcc---HHHHHhccCCCcccc--cCCCHHHHHHHHHHcCCChhhCcC---HHHHHhCccccC
Confidence 87776543 233343322222222 3689999999999999 9999999 999999999974
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=394.78 Aligned_cols=255 Identities=28% Similarity=0.437 Sum_probs=212.1
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeec--CCeE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD--DEFL 191 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~--~~~l 191 (497)
.++|++++.||+|+||+||+|++..+++.||||++.... ...+.+|+.+++.+. ||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 467999999999999999999999999999999987432 355889999999997 9999999999987 6789
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-cEEEcccccccccCCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCST 270 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~ 270 (497)
|+||||+++++|..++. .+++..++.++.||+.||.|||+.||+||||||+|||++.++ .+||+|||+|+......
T Consensus 109 ~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~ 185 (330)
T 3nsz_A 109 ALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185 (330)
T ss_dssp EEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred EEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC
Confidence 99999999999999884 499999999999999999999999999999999999999777 89999999998654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~e 349 (497)
. ....+||+.|+|||++.+ ..++.++|||||||++|+
T Consensus 186 ~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 223 (330)
T 3nsz_A 186 E------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 223 (330)
T ss_dssp C------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred c------------------------------------------cccccccccccChhhhcCCCcCCchhhHHHHHHHHHH
Confidence 0 114579999999999987 679999999999999999
Q ss_pred HHhCCCCCCCC-ChHHHHHHHhccc-----------Cc----------------------ccCCCCccCChhHHHHHHHH
Q 010947 350 MLVGYPPFYSD-DPMSTCRKIVNWR-----------TH----------------------LKFPEEAKLSIEAKDLISKL 395 (497)
Q Consensus 350 ll~G~~PF~~~-~~~~~~~~i~~~~-----------~~----------------------~~~p~~~~~s~~~~dLI~~l 395 (497)
|++|..||... +..+....+.... .. ........+++++++||.+|
T Consensus 224 ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 303 (330)
T 3nsz_A 224 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 303 (330)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTT
T ss_pred HHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHH
Confidence 99999999643 3333322222100 00 01111123799999999999
Q ss_pred hh-CccccCCCCCcchhcCCCCccCCChh
Q 010947 396 LC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 396 L~-dp~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
|+ ||.+||+ ++|+++||||+++.|+
T Consensus 304 L~~dP~~Rpt---a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 304 LRYDHQSRLT---AREAMEHPYFYTVVKD 329 (330)
T ss_dssp SCSSGGGSCC---HHHHHTSGGGTTCC--
T ss_pred hcCCcccCCC---HHHHhcCccHhhhccC
Confidence 99 9999999 9999999999999876
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=393.00 Aligned_cols=263 Identities=22% Similarity=0.363 Sum_probs=219.2
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
.+..++|++++.||+|+||.||+|++..++..||+|++.............+.+|+.+++.++||||+++++++.+.+.+
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~ 86 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY 86 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEE
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeE
Confidence 34467899999999999999999999999999999999765544455667899999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+||||++||+|.+++...+++++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|||+|+.+.....
T Consensus 87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999999999889999999999999999999999999999999999999999999999999999986532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
. .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 167 ~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll 206 (294)
T 4eqm_A 167 T----------------------------------------QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEML 206 (294)
T ss_dssp ------------------------------------------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHH
T ss_pred c----------------------------------------ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHH
Confidence 0 011467999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCc-ccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTH-LKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~-~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
+|.+||.+.+......+.+..... ........+++.+.++|.+||. ||.+||+ ..+.+.+.|.
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~---~~~~l~~~l~ 271 (294)
T 4eqm_A 207 VGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK---TIQEMKDDLS 271 (294)
T ss_dssp HSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS---SHHHHHHHHH
T ss_pred hCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc---cHHHHHHHHH
Confidence 999999998887776666542211 1011124689999999999999 9999996 3344444443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=402.43 Aligned_cols=265 Identities=28% Similarity=0.399 Sum_probs=217.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------- 187 (497)
.++|++++.||+|+||.||+|+++.+|+.||||++..... .......+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 4689999999999999999999999999999999976542 22233457789999999999999999999987
Q ss_pred -CCeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 188 -DEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 188 -~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
.+.+|+||||++| +|...+.. ...+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+.
T Consensus 95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 173 (351)
T 3mi9_A 95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 173 (351)
T ss_dssp --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence 4468999999975 77766654 36799999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLG 344 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlG 344 (497)
+........ ......+||+.|+|||++.+ ..|+.++||||||
T Consensus 174 ~~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG 216 (351)
T 3mi9_A 174 FSLAKNSQP-------------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG 216 (351)
T ss_dssp CCCCSSSSC-------------------------------------CCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHH
T ss_pred ccccccccc-------------------------------------cccCCcccccCccCchhhcCCCCCCcHhHHHHHH
Confidence 643211000 00124689999999999976 5689999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhcccCccc---CCCCc-------------------------cCChhHHHHHHHHh
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK---FPEEA-------------------------KLSIEAKDLISKLL 396 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~---~p~~~-------------------------~~s~~~~dLI~~lL 396 (497)
|++|+|++|.+||.+.+.......+......+. +|... ..++++++||.+||
T Consensus 217 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 296 (351)
T 3mi9_A 217 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 296 (351)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHS
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHh
Confidence 999999999999999988877777654222211 11100 13788999999999
Q ss_pred h-CccccCCCCCcchhcCCCCccCCC
Q 010947 397 C-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 397 ~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
+ ||.+||+ ++|+++||||.+..
T Consensus 297 ~~dP~~R~t---~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 297 VLDPAQRID---SDDALNHDFFWSDP 319 (351)
T ss_dssp CSSGGGSCC---HHHHHTSGGGGSSS
T ss_pred cCChhhCCC---HHHHhCCCCcCCCC
Confidence 9 9999999 99999999998654
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=398.54 Aligned_cols=265 Identities=24% Similarity=0.428 Sum_probs=210.8
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC------
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE------ 189 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~------ 189 (497)
++|++++.||+|+||.||+|+++.+|+.||||++.... .....+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 46999999999999999999999999999999997643 2345567899999999999999999999986543
Q ss_pred ---------------------------------------------------eEEEEEeecCCCchhHHHHhcCC---CCH
Q 010947 190 ---------------------------------------------------FLYLIMEYLPGGDMMTLLMRKDT---LTE 215 (497)
Q Consensus 190 ---------------------------------------------------~l~lVmEy~~gg~L~~~l~~~~~---l~e 215 (497)
++|+|||||+||+|.+++..... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999977543 566
Q ss_pred HHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCC
Q 010947 216 DEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295 (497)
Q Consensus 216 ~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (497)
..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+............. +.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~--------------~~-- 227 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT--------------PM-- 227 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------------------
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccc--------------cc--
Confidence 67899999999999999999999999999999999999999999999987654321100000 00
Q ss_pred ccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCc
Q 010947 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH 375 (497)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~ 375 (497)
.........+||+.|+|||++.+..|+.++|||||||++|||++|..|+... ......+..
T Consensus 228 -------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~---- 288 (332)
T 3qd2_B 228 -------------PAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER--VRIITDVRN---- 288 (332)
T ss_dssp -----------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHT----
T ss_pred -------------cccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhc----
Confidence 0000112468999999999999999999999999999999999998875321 222233332
Q ss_pred ccCCC-CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 376 LKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 376 ~~~p~-~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
..+|. ....++++++||.+||. ||.+||+ +.|+++||||+++
T Consensus 289 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 289 LKFPLLFTQKYPQEHMMVQDMLSPSPTERPE---ATDIIENAIFENL 332 (332)
T ss_dssp TCCCHHHHHHCHHHHHHHHHHHCSSGGGSCC---HHHHHHSTTCCCC
T ss_pred cCCCcccccCChhHHHHHHHHccCCCCcCCC---HHHHhhchhhhcC
Confidence 22332 13567899999999999 9999999 9999999999875
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=406.25 Aligned_cols=260 Identities=27% Similarity=0.438 Sum_probs=205.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD------ 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~------ 188 (497)
.++|++++.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 378999999999999999999999999999999997642 2334556788999999999999999999998754
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+|+||||+ |++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+|+....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence 5689999999 7899998865 6799999999999999999999999999999999999999999999999999975421
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
. ....+||+.|+|||++.+ ..|+.++|||||||++
T Consensus 185 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 220 (367)
T 2fst_X 185 E--------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIM 220 (367)
T ss_dssp --------------------------------------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHH
Confidence 1 114689999999999987 7899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcc---------------------cCCC------CccCChhHHHHHHHHhh-Cc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFPE------EAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~~~~dLI~~lL~-dp 399 (497)
|||++|.+||.+.+..+.+..|+...... ..|. ...+++++++||.+||+ ||
T Consensus 221 ~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP 300 (367)
T 2fst_X 221 AELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDS 300 (367)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSG
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCc
Confidence 99999999999998877777665421110 0010 12468899999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCCChhh
Q 010947 400 NQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
.+||+ +.++++||||..+....
T Consensus 301 ~~R~t---~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 301 DKRIT---AAQALAHAYFAQYHDPD 322 (367)
T ss_dssp GGSCC---HHHHHTSGGGTTTCCGG
T ss_pred ccCcC---HHHHhcChhhhhccCCC
Confidence 99999 99999999999765443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=410.39 Aligned_cols=256 Identities=30% Similarity=0.462 Sum_probs=212.0
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec------CC
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------DE 189 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~~ 189 (497)
.+|++++.||+|+||+||+|+++.+|+.||||++.+... ...+|+.+|+.++|||||+++++|.. ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 469999999999999999999999999999999976431 13469999999999999999988843 23
Q ss_pred eEEEEEeecCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC-CcEEEccccccc
Q 010947 190 FLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-GHLRLSDFGLCK 264 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~-g~vkL~DFGla~ 264 (497)
++++||||+++ +|..++. ....+++..++.++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||+|+
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 57899999975 5665553 24679999999999999999999999999999999999999965 678999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSL 343 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSl 343 (497)
.+..... ..+.+||+.|+|||++.+. .|+.++|||||
T Consensus 206 ~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSl 243 (420)
T 1j1b_A 206 QLVRGEP------------------------------------------NVSYICSRYYRAPELIFGATDYTSSIDVWSA 243 (420)
T ss_dssp ECCTTCC------------------------------------------CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHH
T ss_pred hcccCCC------------------------------------------ceeeeeCCCcCCHHHHcCCCCCCchhhhHHH
Confidence 6532210 1146899999999999764 79999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhccc---------------CcccCCC----------CccCChhHHHHHHHHhh-
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWR---------------THLKFPE----------EAKLSIEAKDLISKLLC- 397 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dLI~~lL~- 397 (497)
|||+|||++|.+||.+.+..+.+.+|+... ..+.+|. ...+++++++||.+||+
T Consensus 244 G~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~ 323 (420)
T 1j1b_A 244 GCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEY 323 (420)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCS
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccC
Confidence 999999999999999998877776665411 1112221 12578999999999999
Q ss_pred CccccCCCCCcchhcCCCCccCCChhh
Q 010947 398 NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 398 dp~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
||.+|++ +.|+++||||+++.+..
T Consensus 324 dP~~R~t---~~e~l~hp~f~~~~~~~ 347 (420)
T 1j1b_A 324 TPTARLT---PLEACAHSFFDELRDPN 347 (420)
T ss_dssp SGGGSCC---HHHHHTSGGGGGGGCTT
T ss_pred ChhHCCC---HHHHhCCHhhccccccc
Confidence 9999999 99999999998776543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=402.74 Aligned_cols=267 Identities=22% Similarity=0.455 Sum_probs=231.6
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhH--------------HHHHHHHHHHHHhcCCCc
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ--------------VEHVRAERNLLAEVDSNC 177 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~--------------~~~~~~E~~il~~l~hp~ 177 (497)
....++|.+++.||+|+||.||+|.+ +|+.||||++.......... ...+.+|+.+++.++|||
T Consensus 27 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 104 (348)
T 2pml_X 27 DKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY 104 (348)
T ss_dssp CEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTT
T ss_pred ccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCC
Confidence 34567999999999999999999998 89999999998765432211 267899999999999999
Q ss_pred eeEEEEEeecCCeEEEEEeecCCCchhHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCee
Q 010947 178 IVKLYCSFQDDEFLYLIMEYLPGGDMMTL------LMR--KDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLL 248 (497)
Q Consensus 178 Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~------l~~--~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NIL 248 (497)
|+++++++.+.+.+|+||||++||+|.++ +.. ...+++..+..++.||+.||.|||+ .||+||||||+|||
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil 184 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL 184 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEE
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEE
Confidence 99999999999999999999999999998 655 5789999999999999999999999 99999999999999
Q ss_pred ecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccc
Q 010947 249 LDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEV 328 (497)
Q Consensus 249 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~ 328 (497)
++.++++||+|||++....... ....+||+.|+|||+
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~~~-------------------------------------------~~~~~~~~~y~aPE~ 221 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVDKK-------------------------------------------IKGSRGTYEFMPPEF 221 (348)
T ss_dssp ECTTSCEEECCCTTCEECBTTE-------------------------------------------ECSSCSCGGGCCGGG
T ss_pred EcCCCcEEEecccccccccccc-------------------------------------------ccCCCCCcCccCchh
Confidence 9999999999999998653220 114679999999999
Q ss_pred cccC-CCCc-chhHHhHHHHHHHHHhCCCCCCCCCh-HHHHHHHhcccCcccCCCC-----------------ccCChhH
Q 010947 329 LLKK-GYGM-ECDWWSLGAIMYEMLVGYPPFYSDDP-MSTCRKIVNWRTHLKFPEE-----------------AKLSIEA 388 (497)
Q Consensus 329 l~~~-~y~~-~~DiwSlGvil~ell~G~~PF~~~~~-~~~~~~i~~~~~~~~~p~~-----------------~~~s~~~ 388 (497)
+.+. .++. ++|||||||++|||++|.+||.+.+. .+....+... ...+|.. ..+++++
T Consensus 222 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 299 (348)
T 2pml_X 222 FSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK--NIEYPLDRNHFLYPLTNKKSTCSNNFLSNED 299 (348)
T ss_dssp GSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSC--CCCCCCSSSSSTTTTCC--------CCCHHH
T ss_pred hcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhcc--CcCCccchhhhhccccccccccchhhcCHHH
Confidence 9877 6766 99999999999999999999998776 6777777653 3344421 4689999
Q ss_pred HHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhc
Q 010947 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQM 428 (497)
Q Consensus 389 ~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~ 428 (497)
.+||.+||+ ||.+||+ +.++++||||.+++|..+.+.
T Consensus 300 ~~li~~~L~~dP~~Rps---~~e~l~hp~f~~~~~~~~~~~ 337 (348)
T 2pml_X 300 IDFLKLFLRKNPAERIT---SEDALKHEWLADTNIEDLREF 337 (348)
T ss_dssp HHHHHHHCCSSGGGSCC---HHHHHTSGGGTTCCHHHHHHH
T ss_pred HHHHHHHccCChhhCCC---HHHHhcCccccCCCHHHHHHH
Confidence 999999999 9999998 999999999999999988653
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=405.12 Aligned_cols=256 Identities=28% Similarity=0.481 Sum_probs=212.3
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee------
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ------ 186 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~------ 186 (497)
...++|++++.||+|+||+||+|++..+|+.||||++...... ..+|+.+|+.++|||||+++++|.
T Consensus 4 ~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-------KNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp --CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred cccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-------HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 4567899999999999999999999999999999999764321 236999999999999999999984
Q ss_pred --------------------------------cCCeEEEEEeecCCCchhHHHH----hcCCCCHHHHHHHHHHHHHHHH
Q 010947 187 --------------------------------DDEFLYLIMEYLPGGDMMTLLM----RKDTLTEDEARFYVAETVLAIE 230 (497)
Q Consensus 187 --------------------------------~~~~l~lVmEy~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~ 230 (497)
+..++|+||||++ |+|.+.+. ....+++..++.++.||+.||.
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~ 155 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence 3445999999997 57666654 3578999999999999999999
Q ss_pred HHHcCCEEEcccCCCCeeec-CCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhh
Q 010947 231 SIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKN 309 (497)
Q Consensus 231 ~LH~~~iiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 309 (497)
|||+.||+||||||+|||++ .++.+||+|||+|+.+.....
T Consensus 156 ~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~-------------------------------------- 197 (383)
T 3eb0_A 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-------------------------------------- 197 (383)
T ss_dssp HHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--------------------------------------
T ss_pred HHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--------------------------------------
Confidence 99999999999999999998 689999999999986643210
Q ss_pred cccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccC--------------
Q 010947 310 RRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT-------------- 374 (497)
Q Consensus 310 ~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~-------------- 374 (497)
....+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+..+....|+....
T Consensus 198 ----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~ 273 (383)
T 3eb0_A 198 ----SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHY 273 (383)
T ss_dssp ----CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC
T ss_pred ----CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccc
Confidence 1146799999999998874 599999999999999999999999999988887777753111
Q ss_pred -cccCCC----------CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 375 -HLKFPE----------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 375 -~~~~p~----------~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
...+|. ...+++++++||.+||. ||.+||+ +.|+++||||+.+.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t---~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 274 TEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN---PYEAMAHPFFDHLR 329 (383)
T ss_dssp --CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC---HHHHHTSGGGHHHH
T ss_pred ccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC---HHHHhcCHHHHHHH
Confidence 111111 12578999999999999 9999999 99999999998653
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=401.90 Aligned_cols=266 Identities=29% Similarity=0.458 Sum_probs=216.3
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc--hhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR--RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~--~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
..++|++++.||+|+||.||+|+++.+|+.||||++....... ......+.+|+.+++.++||||++++++|.+...+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 3568999999999999999999999999999999997643221 11124577899999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
|+||||+++ +|..++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+.+....
T Consensus 88 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 166 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 166 (346)
T ss_dssp EEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred EEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence 999999975 888888654 469999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~e 349 (497)
. .....+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 167 ~-----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 205 (346)
T 1ua2_A 167 R-----------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAE 205 (346)
T ss_dssp C-----------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHH
T ss_pred c-----------------------------------------cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHH
Confidence 0 0114679999999999976 458999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcc---cCC------C---------------CccCChhHHHHHHHHhh-CccccCC
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHL---KFP------E---------------EAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~---~~p------~---------------~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|++|.+||.+.+..+.+.++....... .+| . ...++.++++||.+||. ||.+||+
T Consensus 206 ll~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 285 (346)
T 1ua2_A 206 LLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285 (346)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC
Confidence 999999999999888887776421111 001 0 03567899999999999 9999999
Q ss_pred CCCcchhcCCCCccCCChhh
Q 010947 405 AKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 405 ~~~~~eil~Hpff~~i~w~~ 424 (497)
+.|+++||||.+..|..
T Consensus 286 ---~~ell~h~~f~~~~~~~ 302 (346)
T 1ua2_A 286 ---ATQALKMKYFSNRPGPT 302 (346)
T ss_dssp ---HHHHHTSGGGTSSSCCC
T ss_pred ---HHHHhcChhhhcCCCCC
Confidence 99999999999876543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=384.20 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=221.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||.||+|.++.+++.||||++..... ....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 469999999999999999999999999999999976542 234567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||++||+|.+++.....+++..+..++.|++.||.|||+.||+||||||+||+++.+|.+||+|||++..+......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~--- 161 (276)
T 2yex_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE--- 161 (276)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE---
T ss_pred EecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch---
Confidence 99999999999987788999999999999999999999999999999999999999999999999999865321100
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~ell~G~ 354 (497)
......+||+.|+|||++.+..+ +.++|||||||++|+|++|.
T Consensus 162 ------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 205 (276)
T 2yex_A 162 ------------------------------------RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 205 (276)
T ss_dssp ------------------------------------CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSS
T ss_pred ------------------------------------hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCC
Confidence 01124679999999999988775 78999999999999999999
Q ss_pred CCCCCCChH-HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 355 PPFYSDDPM-STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 355 ~PF~~~~~~-~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
.||.+.+.. ..+..+... ....+....+++++++||.+||. ||.+||+ +.++++||||+..
T Consensus 206 ~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 268 (276)
T 2yex_A 206 LPWDQPSDSCQEYSDWKEK--KTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNKP 268 (276)
T ss_dssp CCCSCSCTTSHHHHHHHTT--CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTCC
T ss_pred CCCCCCchHHHHHHHhhhc--ccccCchhhcCHHHHHHHHHHCCCCchhCCC---HHHHhcCccccCh
Confidence 999876543 333333332 22233335789999999999999 9999999 9999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=392.50 Aligned_cols=269 Identities=29% Similarity=0.473 Sum_probs=225.6
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
.......++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.
T Consensus 12 ~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 88 (302)
T 2j7t_A 12 RRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHD 88 (302)
T ss_dssp BSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC
T ss_pred ccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC
Confidence 333344578999999999999999999999999999999997543 33456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
+.+|+||||++||+|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++....
T Consensus 89 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 89 GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp -CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999999998866 4679999999999999999999999999999999999999999999999999976421
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhHHh
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWS 342 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~DiwS 342 (497)
... ......+||+.|+|||++. +..++.++||||
T Consensus 169 ~~~-----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~s 207 (302)
T 2j7t_A 169 KTL-----------------------------------------QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWS 207 (302)
T ss_dssp HHH-----------------------------------------HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHH
T ss_pred ccc-----------------------------------------cccccccCChhhcCCeeeccccCCCCCCchhhhHHH
Confidence 000 0011457999999999984 677899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
|||++|+|++|.+||.+.+.......+..... ...+....++.++.+||.+||. ||.+||+ +.++++||||.++.
T Consensus 208 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 208 LGITLIEMAQIEPPHHELNPMRVLLKIAKSDP-PTLLTPSKWSVEFRDFLKIALDKNPETRPS---AAQLLEHPFVSSIT 283 (302)
T ss_dssp HHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSSGGGSCHHHHHHHHHHSCSCTTTSCC---HHHHTTSTTTTTCC
T ss_pred HHHHHHHHhcCCCCCccCCHHHHHHHHhccCC-cccCCccccCHHHHHHHHHHcccChhhCCC---HHHHhcChHHhhhc
Confidence 99999999999999999888877777765322 2222335789999999999999 9999999 99999999999998
Q ss_pred hhhh
Q 010947 422 WARI 425 (497)
Q Consensus 422 w~~l 425 (497)
|...
T Consensus 284 ~~~~ 287 (302)
T 2j7t_A 284 SNKA 287 (302)
T ss_dssp CCHH
T ss_pred cchh
Confidence 8654
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=412.23 Aligned_cols=263 Identities=18% Similarity=0.185 Sum_probs=203.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc--CCCceeEEEEE-------e
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV--DSNCIVKLYCS-------F 185 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l--~hp~Iv~l~~~-------~ 185 (497)
..+|.+.+.||+|+||.||+|+++.+|+.||||++.+...........++.|+.++..+ +||||++++.. +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 34599999999999999999999999999999999986654556677788886555544 69998886643 3
Q ss_pred ecC-----------------CeEEEEEeecCCCchhHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHcCCEEEcc
Q 010947 186 QDD-----------------EFLYLIMEYLPGGDMMTLLMRKD-TLTEDEA------RFYVAETVLAIESIHKHHYIHRD 241 (497)
Q Consensus 186 ~~~-----------------~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~------~~~~~qi~~aL~~LH~~~iiHrD 241 (497)
... ..+|||||||+ |+|.+++...+ .+++... ..++.||+.||.|||++||||||
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 322 34899999998 89999997643 3444444 46669999999999999999999
Q ss_pred cCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCC
Q 010947 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321 (497)
Q Consensus 242 LKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 321 (497)
|||+|||++.+|++||+|||+|+..... .....||+
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~~t~ 255 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGTR--------------------------------------------GPASSVPV 255 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTCE--------------------------------------------EEGGGSCG
T ss_pred CCHHHEEECCCCCEEEEecceeeecCCC--------------------------------------------ccCccCCc
Confidence 9999999999999999999999865321 01346779
Q ss_pred cccCcccccc--CCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHH--HHH---HhcccCcccCCCCccCChhHHHHHHH
Q 010947 322 DYIAPEVLLK--KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMST--CRK---IVNWRTHLKFPEEAKLSIEAKDLISK 394 (497)
Q Consensus 322 ~Y~aPE~l~~--~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~--~~~---i~~~~~~~~~p~~~~~s~~~~dLI~~ 394 (497)
.|+|||++.+ ..|+.++|||||||++|||++|.+||.+..+... +.. +......+.+|....+++++++||.+
T Consensus 256 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335 (371)
T ss_dssp GGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHH
T ss_pred CCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHH
Confidence 9999999987 7899999999999999999999999988743211 111 11112344455556899999999999
Q ss_pred Hhh-CccccCCCCCcchhcCCCCccCCChhhh
Q 010947 395 LLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 395 lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 425 (497)
||+ ||.+||+ +.++++||||+++.|..-
T Consensus 336 ~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 336 FLNFDRRRRLL---PLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp HTCSSTTTCCC---HHHHTTSHHHHHHHHHHH
T ss_pred HcCCChhhCCC---HHHHhcCHHHHHHHHHHh
Confidence 999 9999999 999999999998877643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=400.46 Aligned_cols=261 Identities=26% Similarity=0.441 Sum_probs=218.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-----C
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 189 (497)
..+|++++.||+|+||.||+|.+..++..||||++.... .......+.+|+.+|..++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 368999999999999999999999999999999997532 233456788999999999999999999998765 4
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||||+. |+|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 7899999996 699998855 67999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ 348 (497)
.... ......+||+.|+|||++.+ ..++.++|||||||++|
T Consensus 182 ~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ 223 (364)
T 3qyz_A 182 HDHT--------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA 223 (364)
T ss_dssp GCBC--------------------------------------CTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHH
T ss_pred CCcc--------------------------------------ccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHH
Confidence 1000 01124689999999998764 55899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcc------------------cCCC---------CccCChhHHHHHHHHhh-Ccc
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHL------------------KFPE---------EAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~------------------~~p~---------~~~~s~~~~dLI~~lL~-dp~ 400 (497)
+|++|.+||.+.+..+....+....... .+|. ...+++++.+||.+||+ ||.
T Consensus 224 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 303 (364)
T 3qyz_A 224 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 303 (364)
T ss_dssp HHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTT
T ss_pred HHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChh
Confidence 9999999999988877777765311110 0010 13578999999999999 999
Q ss_pred ccCCCCCcchhcCCCCccCC
Q 010947 401 QRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 401 ~R~~~~~~~eil~Hpff~~i 420 (497)
+||+ +.|+++||||+..
T Consensus 304 ~R~t---~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 304 KRIE---VEQALAHPYLEQY 320 (364)
T ss_dssp TSCC---HHHHHTSGGGTTT
T ss_pred hCCC---HHHHhcCcchhhc
Confidence 9998 9999999999976
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=406.20 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=218.6
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC--CCceeEEEEEeecCCe
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--SNCIVKLYCSFQDDEF 190 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~~ 190 (497)
+...+|++++.||+|+||+||+|.+.. ++.||||++..... .......+.+|+.+|..+. |||||++++++.+.+.
T Consensus 53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~ 130 (390)
T 2zmd_A 53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY 130 (390)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCE
Confidence 445679999999999999999998765 89999999986543 3445677899999999996 5999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+||||| +.+|+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+|+.+....
T Consensus 131 ~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~ 208 (390)
T 2zmd_A 131 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT 208 (390)
T ss_dssp EEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred EEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence 999999 56899999999888999999999999999999999999999999999999996 5899999999998654221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----------CCCCcchh
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----------KGYGMECD 339 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----------~~y~~~~D 339 (497)
.. ......+||+.|+|||++.+ ..|+.++|
T Consensus 209 ~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~D 249 (390)
T 2zmd_A 209 TS---------------------------------------VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249 (390)
T ss_dssp --------------------------------------------CCSCCCGGGCCHHHHHCC------------CCHHHH
T ss_pred cc---------------------------------------ccCCCCCcCCCccChHHhhhccccccccccccCCCChhh
Confidence 00 01125689999999999975 46899999
Q ss_pred HHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 340 WWSLGAIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 340 iwSlGvil~ell~G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
|||||||+|||++|.+||.+.. ....+..++.....+.+|. ..+.++++||.+||. ||.+||+ +.|+++||||
T Consensus 250 iwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps---~~ell~hp~~ 324 (390)
T 2zmd_A 250 VWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPYV 324 (390)
T ss_dssp HHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHH
T ss_pred HHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc--cchHHHHHHHHHHcccChhhCCC---HHHHhhCcCc
Confidence 9999999999999999998754 3455666666444555554 568899999999999 9999999 9999999999
Q ss_pred cCC
Q 010947 418 DGV 420 (497)
Q Consensus 418 ~~i 420 (497)
...
T Consensus 325 ~~~ 327 (390)
T 2zmd_A 325 QIQ 327 (390)
T ss_dssp HSC
T ss_pred ccc
Confidence 854
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=399.97 Aligned_cols=267 Identities=29% Similarity=0.462 Sum_probs=223.7
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|++++.||+|+||.||+|++..+|+.||||++.... ........+.+|+.+++.++||||++++++|.+.+.+|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 4578999999999999999999999999999999997643 223344567889999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||||++|++|..++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++.+.....
T Consensus 102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-- 179 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE-- 179 (331)
T ss_dssp EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--
Confidence 999999999999887788899999999999999999999999999999999999999999999999999976532110
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHHHHh
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ell~ 352 (497)
.....+||+.|+|||++.+. .++.++|||||||++|+|++
T Consensus 180 ---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 220 (331)
T 4aaa_A 180 ---------------------------------------VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM 220 (331)
T ss_dssp -------------------------------------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred ---------------------------------------ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHh
Confidence 01145799999999999875 78999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCc-----------------ccCCC----------CccCChhHHHHHHHHhh-CccccCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTH-----------------LKFPE----------EAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~-----------------~~~p~----------~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|.+||.+.+..+....+...... ...|. ...+++++.+||.+||. ||.+||+
T Consensus 221 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 300 (331)
T 4aaa_A 221 GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300 (331)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCC
Confidence 99999998877776665431111 11111 12578999999999999 9999999
Q ss_pred CCCcchhcCCCCccCCChhhh
Q 010947 405 AKGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 405 ~~~~~eil~Hpff~~i~w~~l 425 (497)
+.|+++||||+..+|...
T Consensus 301 ---~~ell~hp~f~~~~~~~~ 318 (331)
T 4aaa_A 301 ---CAELLHHDFFQMDGFAER 318 (331)
T ss_dssp ---GGGGGGSHHHHGGGHHHH
T ss_pred ---HHHHhcCchhccCChhhh
Confidence 999999999998766543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=398.49 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=216.7
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC--CceeEEEEEeecCC
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDE 189 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~ 189 (497)
.+...+|++++.||+|+||.||+|.+ .+++.||||++.... ........+.+|+.+|..+.| |||+++++++.+..
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 35567899999999999999999987 468899999998654 233445678999999999987 99999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|+||| +.+|+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+|+.+...
T Consensus 83 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 83 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 9999999 56899999999989999999999999999999999999999999999999997 689999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----------CCCCcch
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----------KGYGMEC 338 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----------~~y~~~~ 338 (497)
... ......+||+.|+|||++.+ ..|+.++
T Consensus 161 ~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 201 (343)
T 3dbq_A 161 TTS---------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201 (343)
T ss_dssp ------------------------------------------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred ccc---------------------------------------ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence 100 00124689999999999975 6789999
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCC
Q 010947 339 DWWSLGAIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (497)
Q Consensus 339 DiwSlGvil~ell~G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpf 416 (497)
|||||||++|||++|.+||.+.. .......++.......+|. ..+.++.+||.+||. ||.+||+ +.++++|||
T Consensus 202 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~L~~dp~~Rpt---~~e~l~hp~ 276 (343)
T 3dbq_A 202 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRIS---IPELLAHPY 276 (343)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHH
T ss_pred hHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcc--cCCHHHHHHHHHHcCCChhHCCC---HHHHHhCcc
Confidence 99999999999999999998753 3345555655444455554 678899999999999 9999999 999999999
Q ss_pred ccC
Q 010947 417 FDG 419 (497)
Q Consensus 417 f~~ 419 (497)
|..
T Consensus 277 ~~~ 279 (343)
T 3dbq_A 277 VQI 279 (343)
T ss_dssp HHS
T ss_pred ccc
Confidence 974
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=388.61 Aligned_cols=261 Identities=31% Similarity=0.623 Sum_probs=228.9
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||.||+|+++.+++.||||++.+... .......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 469999999999999999999999999999999986543 2334567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC---CcEEEcccccccccCCCCcc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~~~ 272 (497)
||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+ +.+||+|||++........
T Consensus 101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~- 179 (287)
T 2wei_A 101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK- 179 (287)
T ss_dssp CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS-
T ss_pred EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc-
Confidence 999999999999888899999999999999999999999999999999999999764 4799999999986532210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.....||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus 180 -----------------------------------------~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~ 217 (287)
T 2wei_A 180 -----------------------------------------MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLS 217 (287)
T ss_dssp -----------------------------------------CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHh
Confidence 013468999999999865 48999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChh
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
|.+||.+.+..+....+.........|....+|+++.+||.+||. ||.+||+ +.++++||||+..+|+
T Consensus 218 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 218 GTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRIT---ATQCLEHPWIQKYSSE 286 (287)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHSHHHHHHCCC
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcC---HHHHhcCHHHhccccC
Confidence 999999998888888887654444455445789999999999999 9999999 9999999999876553
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=415.86 Aligned_cols=249 Identities=15% Similarity=0.208 Sum_probs=206.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHH---HHHhcCCCceeEEE-------EE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN---LLAEVDSNCIVKLY-------CS 184 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~---il~~l~hp~Iv~l~-------~~ 184 (497)
.++|.+.+.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999999999999999998765555666778999994 55566899999998 56
Q ss_pred eecCC-----------------eEEEEEeecCCCchhHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHcCCEEEc
Q 010947 185 FQDDE-----------------FLYLIMEYLPGGDMMTLLMRKDTLTE-------DEARFYVAETVLAIESIHKHHYIHR 240 (497)
Q Consensus 185 ~~~~~-----------------~l~lVmEy~~gg~L~~~l~~~~~l~e-------~~~~~~~~qi~~aL~~LH~~~iiHr 240 (497)
+.+.+ ..||||||+ +|+|.+++...+.+++ ..+..++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 65543 389999999 7899999987666666 7778899999999999999999999
Q ss_pred ccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCC
Q 010947 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (497)
Q Consensus 241 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt 320 (497)
||||+|||++.+|.+||+|||+|+..... ..+.+|
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~g- 265 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDGAR--------------------------------------------VVSSVS- 265 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETTCE--------------------------------------------EECCCC-
T ss_pred CCCHHHEEEcCCCCEEEEechhheecCCc--------------------------------------------ccCCCC-
Confidence 99999999999999999999999853210 124678
Q ss_pred CcccCccccccC-----------CCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHH
Q 010947 321 PDYIAPEVLLKK-----------GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAK 389 (497)
Q Consensus 321 ~~Y~aPE~l~~~-----------~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 389 (497)
+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.......+.. ....++++++
T Consensus 266 ~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~ 337 (377)
T 3byv_A 266 RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVR 337 (377)
T ss_dssp TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS--------SCCCCCHHHH
T ss_pred cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh--------hccCCCHHHH
Confidence 999999999987 899999999999999999999999987665444333322 1136899999
Q ss_pred HHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 390 dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+||.+||+ ||.+||+ +.++++||||+++
T Consensus 338 ~li~~~L~~dp~~Rpt---~~e~l~hp~f~~~ 366 (377)
T 3byv_A 338 ALLEGFLRYPKEDRLL---PLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHHTCSSGGGCCC---HHHHHTSHHHHHH
T ss_pred HHHHHHcCCCchhCCC---HHHHhhChHHHHH
Confidence 99999999 9999998 9999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=397.60 Aligned_cols=262 Identities=32% Similarity=0.617 Sum_probs=215.9
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----chhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
++|.+.+.||+|+||.||+|.++.+++.||||++.+.... .......+.+|+.+|+.++||||+++++++.+..
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 4699999999999999999999999999999999765421 1223345788999999999999999999987665
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc---EEEcccccccccC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGLCKPLD 267 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~---vkL~DFGla~~~~ 267 (497)
+|+||||++||+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988889999999999999999999999999999999999999987665 9999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHhHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLG 344 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwSlG 344 (497)
... .....+||+.|+|||++. ...++.++||||||
T Consensus 169 ~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 206 (322)
T 2ycf_A 169 ETS------------------------------------------LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 206 (322)
T ss_dssp CCH------------------------------------------HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHH
T ss_pred ccc------------------------------------------ccccccCCcCccCchhhccCCCCCCCchhhHHHHH
Confidence 210 011357999999999974 46789999999999
Q ss_pred HHHHHHHhCCCCCCCCChH-HHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 345 AIMYEMLVGYPPFYSDDPM-STCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~-~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|++|+|++|.+||.+.... .....+... ...++. ...++.++.+||.+||. ||.+||+ +.++++||||.+.
T Consensus 207 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 207 VILFICLSGYPPFSEHRTQVSLKDQITSG--KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFT---TEEALRHPWLQDE 281 (322)
T ss_dssp HHHHHHHHSSCSSCSTTCSSCHHHHHHHT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC---HHHHHTSGGGCCH
T ss_pred HHHHHHHhCCCCCcccchHHHHHHHHHhC--ccccCchhhhhcCHHHHHHHHHHcccCHhhCCC---HHHHhhCcCcCCH
Confidence 9999999999999876543 333334332 222221 13689999999999999 9999999 9999999999988
Q ss_pred Chhhh
Q 010947 421 DWARI 425 (497)
Q Consensus 421 ~w~~l 425 (497)
+|...
T Consensus 282 ~~~~~ 286 (322)
T 2ycf_A 282 DMKRK 286 (322)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=407.04 Aligned_cols=255 Identities=24% Similarity=0.438 Sum_probs=215.0
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc------CCCceeEEEEEeec
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV------DSNCIVKLYCSFQD 187 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l------~hp~Iv~l~~~~~~ 187 (497)
...+|++++.||+|+||+||+|.+..+++.||||++.... .....+..|+.++..+ .|+||++++++|..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~ 170 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF 170 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc
Confidence 3567999999999999999999999999999999997643 2334567788888776 57799999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc--EEEcccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--LRLSDFGLC 263 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~--vkL~DFGla 263 (497)
...+|+||||+. |+|.+++.... .+++..++.++.||+.||.|||+.|||||||||+|||++.++. +||+|||+|
T Consensus 171 ~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 171 RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence 999999999995 68999887653 4999999999999999999999999999999999999999987 999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+..... ..+.+||+.|+|||++.+..|+.++|||||
T Consensus 250 ~~~~~~--------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 285 (429)
T 3kvw_A 250 CYEHQR--------------------------------------------VYTYIQSRFYRAPEVILGARYGMPIDMWSL 285 (429)
T ss_dssp EETTCC--------------------------------------------CCSSCSCGGGCCHHHHHTBCCCTHHHHHHH
T ss_pred eecCCc--------------------------------------------ccccCCCCCccChHHHhCCCCCchHHHHhH
Confidence 754321 124689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcccCcc------------------cCC--------------------------
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHL------------------KFP-------------------------- 379 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~------------------~~p-------------------------- 379 (497)
||++|||++|.+||.+.+..+.+..++...... .+|
T Consensus 286 G~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 365 (429)
T 3kvw_A 286 GCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLR 365 (429)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEE
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhcc
Confidence 999999999999999998877776665310000 000
Q ss_pred --C---------CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 380 --E---------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 380 --~---------~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
. ....++++++||.+||+ ||.+||+ ++|+++||||+..
T Consensus 366 ~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt---a~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 366 GPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT---PGQALRHPWLRRR 415 (429)
T ss_dssp CSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC---HHHHHTSTTTC--
T ss_pred CCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC---HHHHhCChhhccC
Confidence 0 01237889999999999 9999999 9999999999853
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=392.91 Aligned_cols=275 Identities=26% Similarity=0.432 Sum_probs=221.2
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-----
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD----- 188 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~----- 188 (497)
..++|.+.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+++.++||||+++++++...
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCcc
Confidence 4578999999999999999999999999999999996432 233455678899999999999999999987654
Q ss_pred CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
..+|+||||+. |+|.+++.. ..+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+....
T Consensus 87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 164 (353)
T 2b9h_A 87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164 (353)
T ss_dssp CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence 67999999996 689988865 6799999999999999999999999999999999999999999999999999987643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
........ ..........+||+.|+|||++.+ ..++.++|||||||++
T Consensus 165 ~~~~~~~~-------------------------------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 213 (353)
T 2b9h_A 165 SAADNSEP-------------------------------TGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCIL 213 (353)
T ss_dssp ----------------------------------------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHH
T ss_pred ccccccCc-------------------------------cccccchhhccccccccCCeeeccCCCccchhhHHHHHHHH
Confidence 21100000 000001124689999999998865 7799999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcc----------------------cCCC------CccCChhHHHHHHHHhh-C
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL----------------------KFPE------EAKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~----------------------~~p~------~~~~s~~~~dLI~~lL~-d 398 (497)
|+|++|.+||.+.+.......+....... ..+. ...+++++++||.+||. |
T Consensus 214 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 293 (353)
T 2b9h_A 214 AELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFD 293 (353)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSS
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcC
Confidence 99999999999988766655544211110 0110 13689999999999999 9
Q ss_pred ccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 399 VNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 399 p~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
|.+||+ +.++++||||+.+.|....
T Consensus 294 P~~Rpt---~~ell~hp~~~~~~~~~~~ 318 (353)
T 2b9h_A 294 PAKRIT---AKEALEHPYLQTYHDPNDE 318 (353)
T ss_dssp GGGSCC---HHHHHTSGGGTTTCCTTSS
T ss_pred cccCCC---HHHHhcCccccccCCcccc
Confidence 999999 9999999999988765543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=384.90 Aligned_cols=259 Identities=28% Similarity=0.455 Sum_probs=204.8
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
++..++|++++.||+|+||.||+|++..+|+.||||++..... .......+..+..+++.++||||+++++++.+.+..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 4567899999999999999999999999999999999976432 223334455556668889999999999999999999
Q ss_pred EEEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcC-CEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 192 YLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
|+||||++ |+|.+++.. ...+++..++.++.|++.||.|||+. ||+||||||+|||++.++.+||+|||+|+..
T Consensus 82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99999997 587777643 46899999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccc----ccCCCCcchhHHh
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKKGYGMECDWWS 342 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l----~~~~y~~~~DiwS 342 (497)
..... ....+||+.|+|||++ .+..++.++||||
T Consensus 161 ~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~s 198 (290)
T 3fme_A 161 VDDVA------------------------------------------KDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198 (290)
T ss_dssp ---------------------------------------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHH
T ss_pred ccccc------------------------------------------ccccCCCccccChhhcChhhcCcCCCcHHHHHH
Confidence 32210 1134799999999996 5677899999999
Q ss_pred HHHHHHHHHhCCCCCCCC-ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 343 LGAIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|||++|+|++|..||.+. ........+... .....+ ...+++++.+||.+||. ||.+||+ +.++++||||..
T Consensus 199 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rpt---~~e~l~hp~f~~ 272 (290)
T 3fme_A 199 LGITMIELAILRFPYDSWGTPFQQLKQVVEE-PSPQLP-ADKFSAEFVDFTSQCLKKNSKERPT---YPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHHHHHTSCSSCCCSCHHHHHHHHHHS-CCCCCC-TTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTSHHHHH
T ss_pred HHHHHHHHHHCCCCccccCchHHHHHHHhcc-CCCCcc-cccCCHHHHHHHHHHhhcChhhCcC---HHHHHhCccccc
Confidence 999999999999999863 444444444432 222222 24689999999999999 9999999 999999999973
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=390.33 Aligned_cols=268 Identities=30% Similarity=0.490 Sum_probs=222.0
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEee
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQ 186 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~ 186 (497)
+.......++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+|+.+++.+ +||||++++++|.
T Consensus 16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 4445556789999999999999999999999999999999997542 2335688899999998 8999999999998
Q ss_pred c------CCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEc
Q 010947 187 D------DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (497)
Q Consensus 187 ~------~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~ 258 (497)
. ...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~ 171 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLV 171 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEEC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEe
Confidence 6 56899999999999999999764 579999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCC
Q 010947 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKG 333 (497)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~ 333 (497)
|||++........ .....+||+.|+|||++. +..
T Consensus 172 Dfg~~~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~ 210 (326)
T 2x7f_A 172 DFGVSAQLDRTVG-----------------------------------------RRNTFIGTPYWMAPEVIACDENPDAT 210 (326)
T ss_dssp CCTTTC------------------------------------------------------CCGGGCCHHHHC--------
T ss_pred eCcCceecCcCcc-----------------------------------------ccccccCCccccChhhhccccccCcC
Confidence 9999876532100 011457999999999997 567
Q ss_pred CCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 334 YGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 334 y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
++.++|||||||++|+|++|.+||.+.+.......+..... .......++.++++||.+||. ||.+||+ +.+++
T Consensus 211 ~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll 285 (326)
T 2x7f_A 211 YDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--PRLKSKKWSKKFQSFIESCLVKNHSQRPA---TEQLM 285 (326)
T ss_dssp CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCCSCSCSCHHHHHHHHHHCCSSGGGSCC---HHHHH
T ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--ccCCccccCHHHHHHHHHHhccChhhCCC---HHHHh
Confidence 89999999999999999999999998887777666654322 111224689999999999999 9999999 99999
Q ss_pred CCCCccCCChhhh
Q 010947 413 VHPWFDGVDWARI 425 (497)
Q Consensus 413 ~Hpff~~i~w~~l 425 (497)
+||||++..+...
T Consensus 286 ~hp~~~~~~~~~~ 298 (326)
T 2x7f_A 286 KHPFIRDQPNERQ 298 (326)
T ss_dssp TSHHHHCCTTHHH
T ss_pred hChHHhhCccccc
Confidence 9999998876553
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=380.94 Aligned_cols=250 Identities=21% Similarity=0.334 Sum_probs=211.0
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lV 194 (497)
++|++++.||+|+||.||+|.++.+++.||||++..... .......+.+|+.++..+ +||||++++++|.+.+.+|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 469999999999999999999999999999999986432 233445677899999888 999999999999999999999
Q ss_pred EeecCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC------------------
Q 010947 195 MEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY------------------ 252 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~------------------ 252 (497)
|||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999765 679999999999999999999999999999999999999854
Q ss_pred -CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc
Q 010947 253 -GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (497)
Q Consensus 253 -g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~ 331 (497)
+.+||+|||++...... ...+||+.|+|||++.+
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---------------------------------------------~~~~gt~~y~aPE~~~~ 204 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---------------------------------------------QVEEGDSRFLANEVLQE 204 (289)
T ss_dssp CCCEEECCCTTCEETTCS---------------------------------------------CCCCCCGGGCCHHHHTT
T ss_pred ceEEEEcccccccccCCc---------------------------------------------cccCCCccccChhHhcC
Confidence 47999999999865321 13469999999999986
Q ss_pred C-CCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcc
Q 010947 332 K-GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409 (497)
Q Consensus 332 ~-~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ 409 (497)
. .++.++|||||||++|+|++|.+||.... ....+... ....+| ..+++++.+||.+||. ||.+||+ +.
T Consensus 205 ~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps---~~ 275 (289)
T 1x8b_A 205 NYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQG-RLPRIP--QVLSQEFTELLKVMIHPDPERRPS---AM 275 (289)
T ss_dssp CCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTT-CCCCCS--SCCCHHHHHHHHHHTCSSGGGSCC---HH
T ss_pred CCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcC-CCCCCC--cccCHHHHHHHHHHhCCCcccCCC---HH
Confidence 5 66789999999999999999998886543 33344432 122334 3789999999999999 9999999 99
Q ss_pred hhcCCCCccCC
Q 010947 410 EIKVHPWFDGV 420 (497)
Q Consensus 410 eil~Hpff~~i 420 (497)
++++||||.+.
T Consensus 276 ~ll~h~~~~~~ 286 (289)
T 1x8b_A 276 ALVKHSVLLSA 286 (289)
T ss_dssp HHHTCTTC---
T ss_pred HHhhChHhhhh
Confidence 99999999864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=386.18 Aligned_cols=261 Identities=25% Similarity=0.443 Sum_probs=221.1
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-hhHHHHHHHHHHHHHhcCCCceeEEEEEee--cCCeE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFL 191 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~l 191 (497)
.++|.+.+.||+|+||.||+|.+..++..||+|++.+..... ......+.+|+.+++.++||||+++++++. +...+
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 468999999999999999999999999999999998765432 345677899999999999999999999984 45689
Q ss_pred EEEEeecCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 192 YLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
|+||||+++| |.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999876 7677655 457999999999999999999999999999999999999999999999999999865422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC--CCcchhHHhHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLGAIM 347 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--y~~~~DiwSlGvil 347 (497)
.... ......||+.|+|||++.+.. ++.++|||||||++
T Consensus 163 ~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 163 AADD---------------------------------------TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp CSSC---------------------------------------EECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred cccc---------------------------------------ccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 1000 012457999999999998644 47899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCCh
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
|+|++|..||.+.+..+....+... ...+|. .+++++.+||.+||. ||.+||+ +.++++||||+....
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~i~~~--~~~~~~--~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 204 YNITTGLYPFEGDNIYKLFENIGKG--SYAIPG--DCGPPLSDLLKGMLEYEPAKRFS---IRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHC--CCCCCS--SSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSHHHHSCCC
T ss_pred HHHHhCCCCCCCchHHHHHHHHhcC--CCCCCC--ccCHHHHHHHHHHccCChhhCCC---HHHHhcCcccccCCC
Confidence 9999999999999888888887763 344443 689999999999999 9999998 999999999987643
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=385.88 Aligned_cols=263 Identities=31% Similarity=0.508 Sum_probs=222.4
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|++++.||+|+||.||+|.+..+|+.||||++.... ....+.+|+.++..++||||+++++++.+...+|+
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 4578999999999999999999999999999999997643 23458889999999999999999999999999999
Q ss_pred EEeecCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||++||+|.+++. ....+++..+..++.+|+.||.|||+.||+||||||+|||++.+|.+||+|||++........
T Consensus 102 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~- 180 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA- 180 (314)
T ss_dssp EEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS-
T ss_pred EeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc-
Confidence 999999999999986 356899999999999999999999999999999999999999999999999999976532210
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 181 ----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 220 (314)
T 3com_A 181 ----------------------------------------KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAE 220 (314)
T ss_dssp ----------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHH
T ss_pred ----------------------------------------ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHh
Confidence 0114579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
|.+||.+.+.......+... ....+.....++.++.+||.+||. ||.+||+ +.++++||||.+..+..+.
T Consensus 221 g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt---~~~ll~~~~~~~~~~~~~~ 291 (314)
T 3com_A 221 GKPPYADIHPMRAIFMIPTN-PPPTFRKPELWSDNFTDFVKQCLVKSPEQRAT---ATQLLQHPFVRSAKGVSIL 291 (314)
T ss_dssp SSCTTTTSCHHHHHHHHHHS-CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHTCCCGGGG
T ss_pred CCCCCCCCChHHHHHHHhcC-CCcccCCcccCCHHHHHHHHHHccCChhhCcC---HHHHHhCHHHhcCCcchHH
Confidence 99999988776665555432 222233334689999999999999 9999999 9999999999988766554
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=408.14 Aligned_cols=263 Identities=24% Similarity=0.383 Sum_probs=197.7
Q ss_pred CeeE-EeEeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee--cCCeE
Q 010947 117 DFEL-LTMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFL 191 (497)
Q Consensus 117 ~f~~-~~~IG~G~fG~V~~~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~l 191 (497)
.|++ .++||+|+||+||+|+++ .+++.||||++..... ...+.+|+.+|+.++|||||+++++|. +...+
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 4666 458999999999999976 4688999999975432 234778999999999999999999994 57789
Q ss_pred EEEEeecCCCchhHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee----cCCCcEEEc
Q 010947 192 YLIMEYLPGGDMMTLLMRK---------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLS 258 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl----~~~g~vkL~ 258 (497)
|+||||+. |+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.+||+
T Consensus 96 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 99999995 5888877532 249999999999999999999999999999999999999 778999999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcc
Q 010947 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 337 (497)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~ 337 (497)
|||+|+.+....... ......+||+.|+|||++.+ ..|+.+
T Consensus 175 Dfg~a~~~~~~~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~ 216 (405)
T 3rgf_A 175 DMGFARLFNSPLKPL--------------------------------------ADLDPVVVTFWYRAPELLLGARHYTKA 216 (405)
T ss_dssp CTTCCC------------------------------------------------------CCCTTCCHHHHTTCCSCCHH
T ss_pred ECCCceecCCCCccc--------------------------------------ccCCCceecCcccCchhhcCCCcccch
Confidence 999998654221000 00124689999999999987 459999
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCCh---------HHHHHHHhcccCccc---------CCC-------------------
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDDP---------MSTCRKIVNWRTHLK---------FPE------------------- 380 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~~---------~~~~~~i~~~~~~~~---------~p~------------------- 380 (497)
+||||||||+|||++|.+||.+... .+.+..|+..-.... .|.
T Consensus 217 ~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 296 (405)
T 3rgf_A 217 IDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLI 296 (405)
T ss_dssp HHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHH
T ss_pred hhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhh
Confidence 9999999999999999999987654 244444442111100 000
Q ss_pred ------CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 381 ------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 381 ------~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
....++++.+||.+||+ ||.+||+ ++|+|+||||.+..|....
T Consensus 297 ~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t---a~e~L~hp~f~~~~~~~~~ 346 (405)
T 3rgf_A 297 KYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT---SEQAMQDPYFLEDPLPTSD 346 (405)
T ss_dssp HHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGTSSSCCCSS
T ss_pred hhHhhcCCCCCHHHHHHHHHHccCCcccCCC---HHHHhcChhhccCCCCccc
Confidence 01227889999999999 9999999 9999999999987765443
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=399.27 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=217.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE---
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL--- 191 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l--- 191 (497)
.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+++.++||||++++++|.+....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 368999999999999999999999999999999997643 2334456788999999999999999999999887765
Q ss_pred ---EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 192 ---YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 192 ---~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
|+||||+. |+|..++. ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~ 196 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 196 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred eeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence 99999996 68888773 4599999999999999999999999999999999999999999999999999975431
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
. ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 197 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (371)
T 4exu_A 197 E--------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 232 (371)
T ss_dssp -----------------------------------------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred C--------------------------------------------cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHH
Confidence 1 114679999999999987 7899999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcc---------------------cCCC------CccCChhHHHHHHHHhh-Cc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFPE------EAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~~~~dLI~~lL~-dp 399 (497)
|+|++|.+||.+.+..+....++...... ..+. ...+++++++||.+||+ ||
T Consensus 233 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 312 (371)
T 4exu_A 233 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 312 (371)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCT
T ss_pred HHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCCh
Confidence 99999999999998877777765311110 0000 12579999999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCCChhh
Q 010947 400 NQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
.+||+ +.|+++||||+.+....
T Consensus 313 ~~Rpt---~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 313 DKRLT---AAQALTHPFFEPFRDPE 334 (371)
T ss_dssp TTSCC---HHHHHTSGGGTTTCCGG
T ss_pred hhcCC---HHHHhcCcccccCCCcc
Confidence 99999 99999999999776544
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=387.32 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=214.3
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
....+..++|++.+.||+|+||+||+|++ +|..||||++.+... .......+.+|+.+|+.++||||++++++|.+.
T Consensus 30 ~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 106 (309)
T 3p86_A 30 DDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP 106 (309)
T ss_dssp --CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred ccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence 34556778999999999999999999976 578999999976542 344556788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCC--EEEcccCCCCeeecCCCcEEEcccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
..+|+||||++||+|.+++...+. +++..+..++.||+.||.|||+.| |+||||||+|||++.++.+||+|||+|
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 999999999999999999977553 999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+....... .....+||+.|+|||++.+..++.++|||||
T Consensus 187 ~~~~~~~~-----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 225 (309)
T 3p86_A 187 RLKASTFL-----------------------------------------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225 (309)
T ss_dssp --------------------------------------------------------CCTTSCHHHHTTCCCCTTHHHHHH
T ss_pred cccccccc-----------------------------------------ccccCCCCccccChhhhcCCCCCchhhHHHH
Confidence 75432100 0114679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
||++|||++|..||.+.+..+....+........+|. .+++++.+||.+||. ||.+||+ +.++++
T Consensus 226 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rps---~~~ll~ 291 (309)
T 3p86_A 226 GVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPR--NLNPQVAAIIEGCWTNEPWKRPS---FATIMD 291 (309)
T ss_dssp HHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 9999999999999999988888777765444555554 799999999999999 9999999 888765
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=401.62 Aligned_cols=260 Identities=21% Similarity=0.362 Sum_probs=211.3
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC--------CCcee
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--------SNCIV 179 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~--------hp~Iv 179 (497)
+....+..++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+|+.+. ||||+
T Consensus 29 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv 104 (397)
T 1wak_A 29 VKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVV 104 (397)
T ss_dssp SCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBC
T ss_pred EehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceee
Confidence 3444455688999999999999999999999999999999997542 33456888999999885 78899
Q ss_pred EEEEEee----cCCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcC-CEEEcccCCCCeeecCC
Q 010947 180 KLYCSFQ----DDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKY 252 (497)
Q Consensus 180 ~l~~~~~----~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDLKp~NILl~~~ 252 (497)
+++++|. +...+|+||||+ +|+|.+.+... ..+++..++.++.||+.||.|||++ |||||||||+|||++.+
T Consensus 105 ~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~ 183 (397)
T 1wak_A 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183 (397)
T ss_dssp CEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCC
T ss_pred eeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEecc
Confidence 9999998 667899999999 66666666554 5699999999999999999999998 99999999999999977
Q ss_pred C-------------------------------------------------cEEEcccccccccCCCCcccccccccCCCC
Q 010947 253 G-------------------------------------------------HLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283 (497)
Q Consensus 253 g-------------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 283 (497)
+ .+||+|||+|+.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-------------- 249 (397)
T 1wak_A 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-------------- 249 (397)
T ss_dssp HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--------------
T ss_pred chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--------------
Confidence 6 7999999999865321
Q ss_pred CCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCCh-
Q 010947 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDP- 362 (497)
Q Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~- 362 (497)
....+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 250 ------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 299 (397)
T 1wak_A 250 ------------------------------FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGE 299 (397)
T ss_dssp ------------------------------SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred ------------------------------CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCccc
Confidence 1145799999999999999999999999999999999999999986542
Q ss_pred -----HHHHHHHhcccCccc--------------------------------------CCCCccCChhHHHHHHHHhh-C
Q 010947 363 -----MSTCRKIVNWRTHLK--------------------------------------FPEEAKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 363 -----~~~~~~i~~~~~~~~--------------------------------------~p~~~~~s~~~~dLI~~lL~-d 398 (497)
......+......++ ++....+++++++||.+||+ |
T Consensus 300 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 379 (397)
T 1wak_A 300 EYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELI 379 (397)
T ss_dssp SSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSS
T ss_pred ccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccC
Confidence 222222221101000 00012345678999999999 9
Q ss_pred ccccCCCCCcchhcCCCCccC
Q 010947 399 VNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 399 p~~R~~~~~~~eil~Hpff~~ 419 (497)
|.+||+ +.|+++||||++
T Consensus 380 P~~Rpt---~~e~l~hp~~~~ 397 (397)
T 1wak_A 380 PEKRAT---AAECLRHPWLNS 397 (397)
T ss_dssp GGGSCC---HHHHHTSGGGGC
T ss_pred hhhcCC---HHHHhhCccccC
Confidence 999999 999999999974
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=396.86 Aligned_cols=258 Identities=31% Similarity=0.458 Sum_probs=201.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
.++|++.+.||+|+||.||+|+++.+|+.||||++...... ......++..+..++||||++++++|.+..
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 46899999999999999999999999999999998764322 223566788888899999999999986533
Q ss_pred --eEEEEEeecCCCchhHH----HHhcCCCCHHHHHHHHHHHHHHHHHHH--cCCEEEcccCCCCeeecC-CCcEEEccc
Q 010947 190 --FLYLIMEYLPGGDMMTL----LMRKDTLTEDEARFYVAETVLAIESIH--KHHYIHRDIKPDNLLLDK-YGHLRLSDF 260 (497)
Q Consensus 190 --~l~lVmEy~~gg~L~~~----l~~~~~l~e~~~~~~~~qi~~aL~~LH--~~~iiHrDLKp~NILl~~-~g~vkL~DF 260 (497)
++|+||||++|+ |... +.....+++..+..++.|++.||.||| +.||+||||||+|||++. ++.+||+||
T Consensus 98 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 389999999875 4333 335678999999999999999999999 999999999999999997 899999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchh
Q 010947 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECD 339 (497)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~D 339 (497)
|+|+.+..... ....+||+.|+|||++.+. .++.++|
T Consensus 177 g~a~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~D 214 (360)
T 3e3p_A 177 GSAKKLSPSEP------------------------------------------NVAYICSRYYRAPELIFGNQHYTTAVD 214 (360)
T ss_dssp TTCBCCCTTSC------------------------------------------CCSTTSCGGGCCHHHHTTCSSCCTHHH
T ss_pred CCceecCCCCC------------------------------------------cccccCCcceeCHHHHcCCCCCCcHHH
Confidence 99986542210 1145799999999999764 4899999
Q ss_pred HHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcc---------------c------------CC-CCccCChhHHHH
Q 010947 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------K------------FP-EEAKLSIEAKDL 391 (497)
Q Consensus 340 iwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~---------------~------------~p-~~~~~s~~~~dL 391 (497)
||||||++|+|++|.+||.+.+....+..+....... . ++ .....++++++|
T Consensus 215 i~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 294 (360)
T 3e3p_A 215 IWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDL 294 (360)
T ss_dssp HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHH
Confidence 9999999999999999999998887777765411100 0 00 011257899999
Q ss_pred HHHHhh-CccccCCCCCcchhcCCCCccCCCh
Q 010947 392 ISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 392 I~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
|.+||+ ||.+||+ +.|+++||||+++.+
T Consensus 295 i~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 295 LSALLQYLPEERMK---PYEALCHPYFDELHD 323 (360)
T ss_dssp HHHHTCSSGGGSCC---HHHHTTSGGGGGGGC
T ss_pred HHHHhccCccccCC---HHHHhcCccccccCC
Confidence 999999 9999999 999999999998653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=387.83 Aligned_cols=260 Identities=26% Similarity=0.440 Sum_probs=216.8
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEE-cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC------ceeEE
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN------CIVKL 181 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~-~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp------~Iv~l 181 (497)
+...+..++|++++.||+|+||.||+|.+ +.+++.||||+++... ...+.+.+|+.+++.++|+ +|+++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 34455568999999999999999999998 5688999999997542 3345688899999888765 49999
Q ss_pred EEEeecCCeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC--------
Q 010947 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-------- 251 (497)
Q Consensus 182 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-------- 251 (497)
+++|.+.+.+|+||||+ +|+|.+++...+ ++++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 899999997765 6899999999999999999999999999999999999987
Q ss_pred -----------CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCC
Q 010947 252 -----------YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (497)
Q Consensus 252 -----------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt 320 (497)
++.+||+|||+++..... ....+||
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------~~~~~gt 197 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH--------------------------------------------HSTLVST 197 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC--------------------------------------------CCSSCSC
T ss_pred CccccccccccCCCceEeeCcccccCccc--------------------------------------------cccccCC
Confidence 678999999999754311 1146799
Q ss_pred CcccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCccc-------------------C---
Q 010947 321 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK-------------------F--- 378 (497)
Q Consensus 321 ~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~-------------------~--- 378 (497)
+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+......++ +
T Consensus 198 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 277 (339)
T 1z57_A 198 RHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH 277 (339)
T ss_dssp GGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTT
T ss_pred ccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhcccccccc
Confidence 999999999999999999999999999999999999998887665544432111000 0
Q ss_pred ------------------CCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 379 ------------------PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 379 ------------------p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
......++++.+||.+||+ ||.+||+ +.|+++||||+.+
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 335 (339)
T 1z57_A 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT---LREALKHPFFDLL 335 (339)
T ss_dssp SHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGG
T ss_pred ccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC---HHHHhcCHHHHHH
Confidence 0011235678999999999 9999999 9999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=380.71 Aligned_cols=255 Identities=32% Similarity=0.495 Sum_probs=223.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.+.|++++.||+|+||.||+|.+..+++.||||++..... ....+.+.+|+.+++.++||||++++++|.+...+|+|
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 3569999999999999999999999999999999976542 33466789999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||++||+|.+++.. +.+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||++.........
T Consensus 99 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-- 175 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-- 175 (303)
T ss_dssp EECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCC--
T ss_pred EEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccc--
Confidence 999999999999854 67999999999999999999999999999999999999999999999999999865422100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
....+||+.|+|||++.+..++.++|||||||++|+|++|.
T Consensus 176 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (303)
T 3a7i_A 176 ---------------------------------------RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGE 216 (303)
T ss_dssp ---------------------------------------BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------------cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCC
Confidence 11467999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+||...+.......+... ....++ ..++.++.+||.+||+ ||.+||+ +.++++||||..
T Consensus 217 ~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~~~~~~ 276 (303)
T 3a7i_A 217 PPHSELHPMKVLFLIPKN-NPPTLE--GNYSKPLKEFVEACLNKEPSFRPT---AKELLKHKFILR 276 (303)
T ss_dssp CTTTTSCHHHHHHHHHHS-CCCCCC--SSCCHHHHHHHHHHCCSSGGGSCC---HHHHTTCHHHHH
T ss_pred CCCCCcCHHHHHHHhhcC-CCCCCc--cccCHHHHHHHHHHcCCChhhCcC---HHHHhhChhhhc
Confidence 999988877776666542 222333 3689999999999999 9999998 999999999963
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=391.50 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=216.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF---- 190 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~---- 190 (497)
.++|.+.+.||+|+||.||+|.++.+|+.||||++.... ........+.+|+.+++.++||||++++++|.+...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 468999999999999999999999999999999997643 233445678899999999999999999999987654
Q ss_pred --EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 191 --LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 191 --l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+|+||||+. |+|.+++. ..+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+++....
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 178 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA 178 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence 499999996 68888774 3599999999999999999999999999999999999999999999999999875421
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
. ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 179 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il 214 (353)
T 3coi_A 179 E--------------------------------------------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIM 214 (353)
T ss_dssp -------------------------------------------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHH
T ss_pred C--------------------------------------------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHH
Confidence 1 013579999999999987 7789999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCc--------------------------ccCCC-CccCChhHHHHHHHHhh-Cc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTH--------------------------LKFPE-EAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~--------------------------~~~p~-~~~~s~~~~dLI~~lL~-dp 399 (497)
|+|++|.+||.+.+..+....+...... ..++. ...+++++++||.+||+ ||
T Consensus 215 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp 294 (353)
T 3coi_A 215 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDV 294 (353)
T ss_dssp HHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCT
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCc
Confidence 9999999999998877776666431100 01110 13679999999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCCChhh
Q 010947 400 NQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
.+||+ +.++++||||..+....
T Consensus 295 ~~Rpt---~~e~l~hp~f~~~~~~~ 316 (353)
T 3coi_A 295 DKRLT---AAQALTHPFFEPFRDPE 316 (353)
T ss_dssp TTSCC---HHHHHTSGGGTTTCCGG
T ss_pred ccCCC---HHHHhcCcchhhccCcc
Confidence 99999 99999999999765443
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=393.82 Aligned_cols=256 Identities=20% Similarity=0.344 Sum_probs=219.0
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEc-------CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEE
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREK-------TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY 182 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~-------~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 182 (497)
..+..++|.+.+.||+|+||.||+|++. .++..||||+++... .......+.+|+.+|+.+ +|||||+++
T Consensus 76 ~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~ 153 (370)
T 2psq_A 76 WEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL 153 (370)
T ss_dssp TBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEE
T ss_pred ccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence 3456688999999999999999999875 345679999997642 344567789999999999 899999999
Q ss_pred EEeecCCeEEEEEeecCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCC
Q 010947 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (497)
Q Consensus 183 ~~~~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~N 246 (497)
++|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 154 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred EEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 99999999999999999999999997643 48999999999999999999999999999999999
Q ss_pred eeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCc
Q 010947 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (497)
Q Consensus 247 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 326 (497)
||++.+|++||+|||+|+.+....... ......||+.|+||
T Consensus 234 Ill~~~~~~kl~DFG~a~~~~~~~~~~---------------------------------------~~~~~~~t~~y~aP 274 (370)
T 2psq_A 234 VLVTENNVMKIADFGLARDINNIDYYK---------------------------------------KTTNGRLPVKWMAP 274 (370)
T ss_dssp EEECTTCCEEECCCSSCEETTCCCTTC---------------------------------------TTTTTTSCGGGCCH
T ss_pred EEECCCCCEEEccccCCcccCccccee---------------------------------------cccCCCcccceECH
Confidence 999999999999999998654321100 01135688999999
Q ss_pred cccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 327 E~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|++.+..|+.++|||||||++|||++ |.+||.+.+..+....+... .....| ..++.++.+||.+||. ||.+||+
T Consensus 275 E~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt 351 (370)
T 2psq_A 275 EALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKP--ANCTNELYMMMRDCWHAVPSQRPT 351 (370)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred hHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCcC
Confidence 99999999999999999999999999 99999998888887777653 233344 3789999999999999 9999998
Q ss_pred CCCcchhcC
Q 010947 405 AKGADEIKV 413 (497)
Q Consensus 405 ~~~~~eil~ 413 (497)
+.|+++
T Consensus 352 ---~~ell~ 357 (370)
T 2psq_A 352 ---FKQLVE 357 (370)
T ss_dssp ---HHHHHH
T ss_pred ---HHHHHH
Confidence 888765
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=388.00 Aligned_cols=257 Identities=25% Similarity=0.419 Sum_probs=213.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC--e
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--F 190 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~ 190 (497)
...++|.+.+.||+|+||+||+|+++.+|+.||||++..... ....+.+.+|+.+|+.++||||+++++++.+.. .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 456789999999999999999999999999999999986543 233566789999999999999999999988655 8
Q ss_pred EEEEEeecCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee----cCCCcEEEcccccc
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLC 263 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl----~~~g~vkL~DFGla 263 (497)
+|+||||++||+|.+++..... +++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999976543 9999999999999999999999999999999999999 78889999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc--------cCCCC
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--------KKGYG 335 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~--------~~~y~ 335 (497)
+....... ..+.+||+.|+|||++. +..|+
T Consensus 164 ~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 201 (319)
T 4euu_A 164 RELEDDEQ------------------------------------------FVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201 (319)
T ss_dssp EECCTTCC------------------------------------------BCCCCSCGGGCCHHHHHHHTSCCCCCCCBC
T ss_pred eecCCCCc------------------------------------------eeecccCCCccCHHHhhhccccccccCCCC
Confidence 87643210 12467999999999986 57899
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCC----hHHHHHHHhcccCcc-----------------cCCC----CccCChhHHH
Q 010947 336 MECDWWSLGAIMYEMLVGYPPFYSDD----PMSTCRKIVNWRTHL-----------------KFPE----EAKLSIEAKD 390 (497)
Q Consensus 336 ~~~DiwSlGvil~ell~G~~PF~~~~----~~~~~~~i~~~~~~~-----------------~~p~----~~~~s~~~~d 390 (497)
.++|||||||++|||++|.+||.... ..+...+++...... .+|. ...++..+.+
T Consensus 202 ~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 281 (319)
T 4euu_A 202 ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281 (319)
T ss_dssp TTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHH
Confidence 99999999999999999999997533 244455555422110 1111 1245667899
Q ss_pred HHHHHhh-CccccCCCCCcchhcCCCC
Q 010947 391 LISKLLC-NVNQRLGAKGADEIKVHPW 416 (497)
Q Consensus 391 LI~~lL~-dp~~R~~~~~~~eil~Hpf 416 (497)
||.+||. ||.+||+ ++|+++||=
T Consensus 282 ll~~~L~~dP~~R~s---~~ell~h~~ 305 (319)
T 4euu_A 282 VLANILEADQEKCWG---FDQFFAETS 305 (319)
T ss_dssp HHHHHSCCCTTTSCC---HHHHHHHHH
T ss_pred HHHHhccCChhhhcc---HHHhhhccH
Confidence 9999999 9999999 999999873
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=391.69 Aligned_cols=254 Identities=20% Similarity=0.291 Sum_probs=209.9
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcE----EEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHV----YAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~----~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
.+..++|++++.||+|+||+||+|.+..++.. ||+|++.... .......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 45678999999999999999999999888876 6666664332 1222344678999999999999999999886
Q ss_pred CCeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
...+|+||||++||+|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|++||+|||+|+.+
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCccccc
Confidence 45689999999999999999764 57999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
....... ......||+.|+|||++.+..|+.++|||||||+
T Consensus 166 ~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 206 (325)
T 3kex_A 166 PPDDKQL---------------------------------------LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVT 206 (325)
T ss_dssp CCCTTCC---------------------------------------C-----CCTTTSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred Ccccccc---------------------------------------cccCCCCcccccChHHhccCCCChhhHhHHhHHH
Confidence 4321100 0113568899999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 347 l~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|+|++ |.+||.+....+....+... .....|. .+++++.+||.+||. ||.+||+ +.++++
T Consensus 207 l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~~l~~dp~~Rps---~~el~~ 269 (325)
T 3kex_A 207 VWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQPQ--ICTIDVYMVMVKCWMIDENIRPT---FKELAN 269 (325)
T ss_dssp HHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCCT--TBCTTTTHHHHHHTCSCTTTSCC---HHHHHH
T ss_pred HHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCCC--cCcHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 999999 99999998877777666643 2334443 688999999999999 9999998 655544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=386.79 Aligned_cols=274 Identities=26% Similarity=0.430 Sum_probs=201.5
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
..+..++|++.+.||+|+||.||+|.+..+++.||||++..... ......+.+|+.+++.++||||++++++|.+.+.
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 45678899999999999999999999988999999999875432 2334568889999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 191 LYLIMEYLPGGDMMTLLMR--------KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~--------~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
.|+||||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999864 45699999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHH
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWW 341 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~Diw 341 (497)
+.......... +.......+||+.|+|||++.+ ..++.++|||
T Consensus 168 ~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~ 211 (303)
T 2vwi_A 168 SAFLATGGDIT------------------------------------RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIW 211 (303)
T ss_dssp HHHCC---------------------------------------------------CCCTTCCHHHHHHHHCCCTHHHHH
T ss_pred hheeccCCCcc------------------------------------chhhhcccCCCccccCHHHhccccCCCchhhHH
Confidence 98654221000 0000124679999999999976 6789999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCc-ccC-----CCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTH-LKF-----PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 342 SlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~-~~~-----p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
||||++|+|++|..||.+.+.............. +.. .....+++++++||.+||. ||.+||+ +.++++|
T Consensus 212 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h 288 (303)
T 2vwi_A 212 SFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT---AAELLRH 288 (303)
T ss_dssp HHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCC---HHHHHTS
T ss_pred HHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcC---HHHHhhC
Confidence 9999999999999999988776666555432111 100 0113678999999999999 9999999 9999999
Q ss_pred CCccCCChhhh
Q 010947 415 PWFDGVDWARI 425 (497)
Q Consensus 415 pff~~i~w~~l 425 (497)
|||....+..+
T Consensus 289 ~~~~~~~~~~~ 299 (303)
T 2vwi_A 289 KFFQKAKNKEF 299 (303)
T ss_dssp TTC--------
T ss_pred hhhhcCCCCcc
Confidence 99998766544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=395.94 Aligned_cols=261 Identities=27% Similarity=0.404 Sum_probs=214.9
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CC-----ceeEEEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SN-----CIVKLYC 183 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp-----~Iv~l~~ 183 (497)
......++|++.+.||+|+||+||+|+++.+++.||||+++... .....+..|+.++..+. |+ +|+.+++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 33445689999999999999999999999999999999997542 23455777888888774 44 5999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--cCCEEEcccCCCCeeec--CCCcEEE
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIH--KHHYIHRDIKPDNLLLD--KYGHLRL 257 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH--~~~iiHrDLKp~NILl~--~~g~vkL 257 (497)
+|...+.+|+||||++ |+|.+++... ..+++..++.++.|++.||.||| +.|||||||||+|||++ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 9999999999999995 5999999765 46999999999999999999999 57999999999999995 4788999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcc
Q 010947 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (497)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~ 337 (497)
+|||+|+..... ....+||+.|+|||++.+..|+.+
T Consensus 203 ~DFG~a~~~~~~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~ 238 (382)
T 2vx3_A 203 VDFGSSCQLGQR--------------------------------------------IYQYIQSRFYRSPEVLLGMPYDLA 238 (382)
T ss_dssp CCCTTCEETTCC--------------------------------------------CCSSCSCGGGCCHHHHTTCCCCTH
T ss_pred EeccCceecccc--------------------------------------------cccccCCccccChHHHcCCCCCcH
Confidence 999999865321 114689999999999999999999
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCccc----------------CCCC-------------------c
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK----------------FPEE-------------------A 382 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~----------------~p~~-------------------~ 382 (497)
+|||||||++|||++|.+||.+.+..+...+|+....... +|.. .
T Consensus 239 ~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (382)
T 2vx3_A 239 IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTR 318 (382)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCS
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchh
Confidence 9999999999999999999999988888777764211000 0000 0
Q ss_pred -------------------------cCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCCh
Q 010947 383 -------------------------KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDW 422 (497)
Q Consensus 383 -------------------------~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w 422 (497)
..++++++||.+||+ ||.+||+ +.|+|+||||+...|
T Consensus 319 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpt---a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 319 KLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQ---PYYALQHSFFKKTAD 381 (382)
T ss_dssp CHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCC---HHHHTTSGGGCC---
T ss_pred hHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCC---HHHHhcCcccccCCC
Confidence 001378999999999 9999999 999999999997654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=388.32 Aligned_cols=265 Identities=23% Similarity=0.411 Sum_probs=219.0
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCC-cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCc------eeEEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTG-HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC------IVKLY 182 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~-~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~------Iv~l~ 182 (497)
......++|++++.||+|+||+||+|.+..++ ..||||+++... .....+..|+.+++.+.|++ ++.++
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~ 88 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLMS 88 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEE
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEee
Confidence 34455689999999999999999999998877 689999997542 23456788999999987665 99999
Q ss_pred EEeecCCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee-----------
Q 010947 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----------- 249 (497)
Q Consensus 183 ~~~~~~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl----------- 249 (497)
++|.....+|+||||+ +|+|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+
T Consensus 89 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 89 DWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp EEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECC
T ss_pred eeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccc
Confidence 9999999999999999 66777777654 369999999999999999999999999999999999999
Q ss_pred --------cCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCC
Q 010947 250 --------DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321 (497)
Q Consensus 250 --------~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 321 (497)
+.++.+||+|||+++..... ....+||+
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------------------------------------------~~~~~gt~ 203 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEH--------------------------------------------HTTIVATR 203 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSC--------------------------------------------CCSSCSCG
T ss_pred cccccccccCCCcEEEeecCcccccccc--------------------------------------------ccCCcCCC
Confidence 67889999999999754311 11467999
Q ss_pred cccCccccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCccc-------------------C----
Q 010947 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK-------------------F---- 378 (497)
Q Consensus 322 ~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~-------------------~---- 378 (497)
.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+......++ +
T Consensus 204 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 283 (355)
T 2eu9_A 204 HYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS 283 (355)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTS
T ss_pred cccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccccccccc
Confidence 99999999999999999999999999999999999998877665544432111100 0
Q ss_pred -----------------CCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 379 -----------------PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 379 -----------------p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
......+.++.+||.+||. ||.+||+ +.|+++||||.+++|....
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt---~~e~l~hp~f~~~~~~~~~ 346 (355)
T 2eu9_A 284 SDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT---LAEALLHPFFAGLTPEERS 346 (355)
T ss_dssp HHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC---HHHHTTSGGGGGCCHHHHC
T ss_pred chhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC---HHHHhcChhhcCCChhhcc
Confidence 0011234578999999999 9999999 9999999999999987654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=385.70 Aligned_cols=264 Identities=25% Similarity=0.412 Sum_probs=213.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee--------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-------- 186 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-------- 186 (497)
.++|.+++.||+|+||.||+|.+..+|+.||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence 578999999999999999999999999999999987542 345567889999999999999999998874
Q ss_pred ------cCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec-CCCcEEEcc
Q 010947 187 ------DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSD 259 (497)
Q Consensus 187 ------~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~-~~g~vkL~D 259 (497)
+...+|+||||++ |+|.+++. .+.+++..++.++.|++.||.|||+.||+||||||+|||++ .++.+||+|
T Consensus 87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred ccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 4468999999997 69999885 46799999999999999999999999999999999999997 567999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcch
Q 010947 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMEC 338 (497)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~ 338 (497)
||+++......... .......||+.|+|||++.+ ..++.++
T Consensus 165 fg~~~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 206 (320)
T 2i6l_A 165 FGLARIMDPHYSHK--------------------------------------GHLSEGLVTKWYRSPRLLLSPNNYTKAI 206 (320)
T ss_dssp CTTCBCC----------------------------------------------CCCGGGSCCTTCCHHHHHCTTCCCHHH
T ss_pred CccccccCCCcccc--------------------------------------cccccccccccccCcHHhcCcccCCchh
Confidence 99998653221000 00124578999999999875 7799999
Q ss_pred hHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcc--------------------cCCC------CccCChhHHHHH
Q 010947 339 DWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHL--------------------KFPE------EAKLSIEAKDLI 392 (497)
Q Consensus 339 DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~--------------------~~p~------~~~~s~~~~dLI 392 (497)
|||||||++|||++|.+||.+.+..+....+....... ..+. ...++.++++||
T Consensus 207 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 286 (320)
T 2i6l_A 207 DMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFL 286 (320)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHH
T ss_pred hhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHH
Confidence 99999999999999999999998877777766421100 0010 135899999999
Q ss_pred HHHhh-CccccCCCCCcchhcCCCCccCCChhh
Q 010947 393 SKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424 (497)
Q Consensus 393 ~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~ 424 (497)
.+||+ ||.+||+ +.++++||||..++|..
T Consensus 287 ~~~L~~dP~~Rpt---~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 287 EQILTFSPMDRLT---AEEALSHPYMSIYSFPM 316 (320)
T ss_dssp HTTSCSSGGGSCC---HHHHHTSHHHHTTCC--
T ss_pred HHHcCCCccccCC---HHHHhCCcccccccCcc
Confidence 99999 9999998 99999999999887754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=399.54 Aligned_cols=267 Identities=18% Similarity=0.280 Sum_probs=223.5
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEE-----EcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~-----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 185 (497)
..+..++|++++.||+|+||+||+|+ ...++..||||++.... .......+.+|+.+++.++|||||+++++|
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 143 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS 143 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 34566889999999999999999999 44577899999997532 233455688899999999999999999999
Q ss_pred ecCCeEEEEEeecCCCchhHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC---cE
Q 010947 186 QDDEFLYLIMEYLPGGDMMTLLMRKD-------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG---HL 255 (497)
Q Consensus 186 ~~~~~l~lVmEy~~gg~L~~~l~~~~-------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g---~v 255 (497)
.+....|+|||||+||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+| .+
T Consensus 144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~ 223 (367)
T 3l9p_A 144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 223 (367)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence 99999999999999999999997653 499999999999999999999999999999999999999655 49
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCC
Q 010947 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335 (497)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~ 335 (497)
||+|||+|+.+...... ......+||+.|+|||++.+..|+
T Consensus 224 kL~DFG~a~~~~~~~~~---------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~ 264 (367)
T 3l9p_A 224 KIGDFGMARDIYRAGYY---------------------------------------RKGGCAMLPVKWMPPEAFMEGIFT 264 (367)
T ss_dssp EECCCHHHHHHHHHSSC---------------------------------------TTCCGGGSCGGGCCHHHHHHCCCC
T ss_pred EECCCcccccccccccc---------------------------------------ccCCCcCCcccEECHHHhcCCCCC
Confidence 99999999854211000 001245789999999999999999
Q ss_pred cchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 336 MECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 336 ~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
.++|||||||++|||++ |.+||.+.+..+....+.... ....| ..++.++.+||.+||. ||.+||+ +.+|++
T Consensus 265 ~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~dP~~Rps---~~eil~ 338 (367)
T 3l9p_A 265 SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRPN---FAIILE 338 (367)
T ss_dssp HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccCCHHHHHHHHHHcCCCHhHCcC---HHHHHH
Confidence 99999999999999998 999999999888888877532 22333 4789999999999999 9999999 999999
Q ss_pred CCCccCCChhh
Q 010947 414 HPWFDGVDWAR 424 (497)
Q Consensus 414 Hpff~~i~w~~ 424 (497)
|.++-.-+.+.
T Consensus 339 ~l~~~~~~~~~ 349 (367)
T 3l9p_A 339 RIEYCTQDPDV 349 (367)
T ss_dssp HHHHHHHCHHH
T ss_pred HHHHHhhChhh
Confidence 98875444333
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=385.78 Aligned_cols=257 Identities=21% Similarity=0.323 Sum_probs=218.4
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
..+..++|.+.+.||+|+||+||+|+++.++. .||||+++... .....+.+.+|+.+|+.++||||++++++|.+
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 45677899999999999999999999986655 49999997542 23445678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
.+.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.+
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999654 57999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
....... .......||+.|+|||++.+..++.++|||||||+
T Consensus 202 ~~~~~~~--------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~i 243 (325)
T 3kul_A 202 EDDPDAA--------------------------------------YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVV 243 (325)
T ss_dssp C----CC--------------------------------------EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHH
T ss_pred ccCccce--------------------------------------eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHH
Confidence 4321100 00113457889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 347 l~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|||++ |..||.+.+..+....+... ...|....+++++.+||.+||. ||.+||+ +.+|++
T Consensus 244 l~ell~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~eil~ 306 (325)
T 3kul_A 244 MWEVLAYGERPYWNMTNRDVISSVEEG---YRLPAPMGCPHALHQLMLDCWHKDRAQRPR---FSQIVS 306 (325)
T ss_dssp HHHHHTTSCCTTTTSCHHHHHHHHHTT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHcCCCCCcccCCHHHHHHHHHcC---CCCCCCCCcCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 999999 99999999888888887753 2233334799999999999999 9999998 777764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=388.38 Aligned_cols=276 Identities=22% Similarity=0.337 Sum_probs=206.3
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEE
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 184 (497)
+....+..++|++.+.||+|+||.||+|+++.++. .||||+++.... .....+.+.+|+.+++.++||||++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 45566778899999999999999999999887765 899999976532 34456778999999999999999999999
Q ss_pred eecCCeE------EEEEeecCCCchhHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC
Q 010947 185 FQDDEFL------YLIMEYLPGGDMMTLLMRKD------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY 252 (497)
Q Consensus 185 ~~~~~~l------~lVmEy~~gg~L~~~l~~~~------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~ 252 (497)
+.+.... |+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9877655 99999999999999986543 69999999999999999999999999999999999999999
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC
Q 010947 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (497)
Q Consensus 253 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~ 332 (497)
|.+||+|||+|+......... ......||+.|+|||++.+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~ 214 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYR---------------------------------------QGCASKLPVKWLALESLADN 214 (323)
T ss_dssp SCEEECCCCC--------------------------------------------------------CCGGGCCHHHHHHC
T ss_pred CCEEEeecccccccccccccc---------------------------------------ccccccCcccccCchhhcCC
Confidence 999999999998654221100 01134578899999999999
Q ss_pred CCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCC----
Q 010947 333 GYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK---- 406 (497)
Q Consensus 333 ~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~---- 406 (497)
.++.++|||||||++|||++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+||+..
T Consensus 215 ~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 291 (323)
T 3qup_A 215 LYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RLKQP--PECMEEVYDLMYQCWSADPKQRPSFTCLRM 291 (323)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred CCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CCCCC--CccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999 999999998888888877532 23333 4789999999999999 999999832
Q ss_pred CcchhcCCCCccCCChhhhh
Q 010947 407 GADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 407 ~~~eil~Hpff~~i~w~~l~ 426 (497)
.+++++.|||+.+..++.+.
T Consensus 292 ~l~~~l~~~~~~~~~~~pl~ 311 (323)
T 3qup_A 292 ELENILGHLSVLSTSQDPLY 311 (323)
T ss_dssp HHHHHHHC------------
T ss_pred HHHHHHHHhhhcCCCCCCCC
Confidence 25678899999987666554
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=387.19 Aligned_cols=273 Identities=20% Similarity=0.265 Sum_probs=219.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~ 192 (497)
..++|++.+.||+|+||+||+|++..+|+.||||++..... ...+..|+.+++.+ +||||+++++++.+....|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 35789999999999999999999999999999999875432 12477899999999 9999999999999999999
Q ss_pred EEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc-----EEEccccccccc
Q 010947 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCKPL 266 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~-----vkL~DFGla~~~ 266 (497)
+||||+ ||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++. +||+|||+|+.+
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 9999999976 468999999999999999999999999999999999999999887 999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
......... +. ......+||+.|+|||++.+..++.++|||||||+
T Consensus 161 ~~~~~~~~~----------------~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 206 (330)
T 2izr_A 161 IDPETKKHI----------------PY------------------REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHM 206 (330)
T ss_dssp BCTTTCCBC----------------CC------------------CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred ecCCCCccc----------------cc------------------cccCCcCCCccccChHHHcCCCCCchhHHHHHHHH
Confidence 432110000 00 00125789999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC---hHHHHHHHhcccCcccCCCC--ccCChhHHHHHHHHhh-CccccCCCCCcchhcC-------
Q 010947 347 MYEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV------- 413 (497)
Q Consensus 347 l~ell~G~~PF~~~~---~~~~~~~i~~~~~~~~~p~~--~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~------- 413 (497)
+|||++|.+||.+.+ ..+.+.++..... ..|.. ....+++.+||.+||. ||.+||+ +++|++
T Consensus 207 l~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~---~~~l~~~l~~~~~ 281 (330)
T 2izr_A 207 FMYFLRGSLPWQGLKADTLKERYQKIGDTKR--ATPIEVLCENFPEMATYLRYVRRLDFFEKPD---YDYLRKLFTDLFD 281 (330)
T ss_dssp HHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH--HSCHHHHTTTCHHHHHHHHHHHHCCTTCCCC---HHHHHHHHHHHHH
T ss_pred HHHHhcCCCCccccccccHHHHHHHHHhhhc--cCCHHHHhccChHHHHHHHHHHhCCCCCCCC---HHHHHHHHHHHHH
Confidence 999999999998843 4455555544221 22211 1123399999999999 9999999 554443
Q ss_pred ---CCCccCCChhhhhhcCCCc
Q 010947 414 ---HPWFDGVDWARIYQMEAAF 432 (497)
Q Consensus 414 ---Hpff~~i~w~~l~~~~~p~ 432 (497)
.++...++|.. ..+++|+
T Consensus 282 ~~~~~~~~~~dw~~-~~~~~p~ 302 (330)
T 2izr_A 282 RKGYMFDYEYDWIG-KQLPTPV 302 (330)
T ss_dssp HTTCCCSCCCTTTT-SCCCCCC
T ss_pred HcCCCCCCCccCCC-CCcCCCC
Confidence 45566788983 3345555
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=377.85 Aligned_cols=257 Identities=31% Similarity=0.553 Sum_probs=221.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee--cCCeEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ--DDEFLY 192 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~--~~~~l~ 192 (497)
.++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++. +...+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 4689999999999999999999999999999999986543 3345667899999999999999999999875 467899
Q ss_pred EEEeecCCCchhHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHcCC-----EEEcccCCCCeeecCCCcEEEcccccc
Q 010947 193 LIMEYLPGGDMMTLLMRK----DTLTEDEARFYVAETVLAIESIHKHH-----YIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~~LH~~~-----iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
+||||++||+|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999999753 34999999999999999999999999 999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+....... .....+||+.|+|||++.+..++.++|||||
T Consensus 164 ~~~~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 202 (279)
T 2w5a_A 164 RILNHDTS-----------------------------------------FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSL 202 (279)
T ss_dssp HHC---CH-----------------------------------------HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHH
T ss_pred eeeccccc-----------------------------------------cccccCCCccccChHHhccCCCCchhhHHHH
Confidence 86532110 0113579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||++|+|++|.+||.+.+..+....+.... ...+|. .++.++.+||.+||. ||.+||+ +.+|++|||+.+
T Consensus 203 G~il~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~--~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~~~~~~ 273 (279)
T 2w5a_A 203 GCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPY--RYSDELNEIITRMLNLKDYHRPS---VEEILENPLILE 273 (279)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHTC-CCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTCCG
T ss_pred HHHHHHHHHCCCCCcccCHHHHHHHHhhcc-cccCCc--ccCHHHHHHHHHHcCCCcccCCC---HHHHHhChhhhh
Confidence 999999999999999988887777776532 223443 689999999999999 9999999 999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=385.45 Aligned_cols=262 Identities=27% Similarity=0.448 Sum_probs=218.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEc-CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc---CCCceeEEEEEee----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREK-TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQ---- 186 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~-~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~---- 186 (497)
.++|++++.||+|+||.||+|++. .+|+.||||++...... ......+.+|+.+++.+ +||||++++++|.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 468999999999999999999995 67899999999764321 11122355677777666 8999999999987
Q ss_pred -cCCeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 187 -DDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 187 -~~~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
....+|+||||++ |+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5678999999997 69999987643 4999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+...... .....+||+.|+|||++.+..++.++|||||
T Consensus 168 ~~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 205 (326)
T 1blx_A 168 RIYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSV 205 (326)
T ss_dssp CCCCGGG------------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHH
T ss_pred ccccCCC------------------------------------------CccccccccceeCHHHHhcCCCCcchhHHHH
Confidence 7553110 0124679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcc---------cCcccCC--------------CCccCChhHHHHHHHHhh-Cc
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNW---------RTHLKFP--------------EEAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~---------~~~~~~p--------------~~~~~s~~~~dLI~~lL~-dp 399 (497)
||++|+|++|.+||.+.+......+++.. ......+ ....++.++++||.+||. ||
T Consensus 206 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 285 (326)
T 1blx_A 206 GCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNP 285 (326)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSST
T ss_pred HHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCc
Confidence 99999999999999999888877777631 1111000 013588999999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCCChh
Q 010947 400 NQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
.+||+ +.++++||||.+++|.
T Consensus 286 ~~Rpt---~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 286 AKRIS---AYSALSHPYFQDLERC 306 (326)
T ss_dssp TTSCC---HHHHHTSGGGTTCCCC
T ss_pred ccCCC---HHHHhcCccccccchh
Confidence 99999 9999999999988754
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-48 Score=392.29 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=218.1
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEE-----EcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEE
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLY 182 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~-----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~ 182 (497)
....+..++|++.+.||+|+||.||+|+ ...+++.||||+++... .......+.+|+.++..+ +|||||+++
T Consensus 15 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 15 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3456778899999999999999999999 45567899999997643 233456789999999999 789999999
Q ss_pred EEeecCC-eEEEEEeecCCCchhHHHHhcCC-------------------------------------------------
Q 010947 183 CSFQDDE-FLYLIMEYLPGGDMMTLLMRKDT------------------------------------------------- 212 (497)
Q Consensus 183 ~~~~~~~-~l~lVmEy~~gg~L~~~l~~~~~------------------------------------------------- 212 (497)
++|.+.+ .+|+|||||+||+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998754 49999999999999999976533
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 213 -----------------LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 213 -----------------l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.+.......
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~-- 250 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV-- 250 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCE--
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccch--
Confidence 8999999999999999999999999999999999999999999999999998653221000
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~ 354 (497)
......||+.|+|||++.+..|+.++|||||||++|||++ |.
T Consensus 251 -------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 293 (359)
T 3vhe_A 251 -------------------------------------RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 293 (359)
T ss_dssp -------------------------------------EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred -------------------------------------hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCC
Confidence 0114578999999999999999999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
+||.+....+.....+........| ..+++++.+||.+||. ||.+||+ +.++++|
T Consensus 294 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps---~~ell~~ 349 (359)
T 3vhe_A 294 SPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPT---FSELVEH 349 (359)
T ss_dssp CSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CCCCccchhHHHHHHHHcCCCCCCC--CCCCHHHHHHHHHHccCChhhCCC---HHHHHHH
Confidence 9999877655555555433444444 3789999999999999 9999998 8888765
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=391.46 Aligned_cols=261 Identities=23% Similarity=0.374 Sum_probs=210.6
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhh--------hchhHHHHHHHHHHHHHhcCCCceeEEEEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--------LRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~--------~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 184 (497)
...++|.+.+.||+|+||.||+|.+.. |..||||++..... ......+.+.+|+.+++.++||||++++++
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 97 (362)
T 3pg1_A 19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI 97 (362)
T ss_dssp HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence 446889999999999999999998754 89999999965322 122234678999999999999999999999
Q ss_pred ee-----cCCeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEc
Q 010947 185 FQ-----DDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLS 258 (497)
Q Consensus 185 ~~-----~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~ 258 (497)
|. ....+|+||||++ |+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~ 176 (362)
T 3pg1_A 98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC 176 (362)
T ss_dssp EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence 84 3447899999997 6888777654 479999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcc
Q 010947 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGME 337 (497)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~ 337 (497)
|||+|+....... ....+||+.|+|||++.+ ..++.+
T Consensus 177 Dfg~~~~~~~~~~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~ 214 (362)
T 3pg1_A 177 DFNLAREDTADAN------------------------------------------KTHYVTHRWYRAPELVMQFKGFTKL 214 (362)
T ss_dssp CTTC---------------------------------------------------------CGGGCCHHHHTTCTTCCTH
T ss_pred ecCcccccccccc------------------------------------------cceecccceecCcHHhcCCCCCCcH
Confidence 9999975422110 114579999999999987 779999
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcc----------------------cCCC------CccCChhHH
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHL----------------------KFPE------EAKLSIEAK 389 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~----------------------~~p~------~~~~s~~~~ 389 (497)
+|||||||++|+|++|.+||.+.+..+....+....... ..|. ...+++.+.
T Consensus 215 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (362)
T 3pg1_A 215 VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVAL 294 (362)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHH
T ss_pred hHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHH
Confidence 999999999999999999999988877777765321111 0111 135688999
Q ss_pred HHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 390 dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+||.+||. ||.+||+ +.++++||||+++
T Consensus 295 ~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 323 (362)
T 3pg1_A 295 DLIAKMLEFNPQRRIS---TEQALRHPYFESL 323 (362)
T ss_dssp HHHHHHTCSSGGGSCC---HHHHHTSGGGTTT
T ss_pred HHHHHHhcCChhhCCC---HHHHHcCchhhhc
Confidence 99999999 9999999 9999999999976
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=371.88 Aligned_cols=253 Identities=18% Similarity=0.292 Sum_probs=218.3
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
..+..++|++++.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 5 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred EEeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCc
Confidence 3466789999999999999999999986 467899999986532 23458899999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 159 (269)
T 4hcu_A 80 ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 159 (269)
T ss_dssp EEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccc
Confidence 99999999999999999653 56999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.. .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 160 ~~----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 199 (269)
T 4hcu_A 160 QY----------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 199 (269)
T ss_dssp HH----------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cc----------------------------------------ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHH
Confidence 10 00124568889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +.++++|
T Consensus 200 ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~~ll~~ 260 (269)
T 4hcu_A 200 VFSEGKIPYENRSNSEVVEDISTG-FRLYKP--RLASTHVYQIMNHCWRERPEDRPA---FSRLLRQ 260 (269)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HhcCCCCCCCCCCHHHHHHHHhcC-ccCCCC--CcCCHHHHHHHHHHccCCcccCcC---HHHHHHH
Confidence 999 99999999988888887753 122233 4689999999999999 9999998 8888764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=387.98 Aligned_cols=253 Identities=34% Similarity=0.555 Sum_probs=186.1
Q ss_pred CCCCeeEEe-EeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec----C
Q 010947 114 GADDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----D 188 (497)
Q Consensus 114 ~~~~f~~~~-~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~ 188 (497)
..++|.+++ +||+|+||+||+|.++.+|+.||||++..... ........+..+.||||++++++|.. .
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-------HHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-------HHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 457899965 69999999999999999999999999976421 11223334567799999999999876 5
Q ss_pred CeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC---CCcEEEcccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~---~g~vkL~DFGla 263 (497)
..+|+|||||+||+|.+++.... .+++..++.++.||+.||.|||+.||+||||||+|||++. ++.+||+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 56999999999999999997754 6999999999999999999999999999999999999986 455999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+...... ....+||+.|+|||++.+..|+.++|||||
T Consensus 179 ~~~~~~~-------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl 215 (336)
T 3fhr_A 179 KETTQNA-------------------------------------------LQTPCYTPYYVAPEVLGPEKYDKSCDMWSL 215 (336)
T ss_dssp EEC-----------------------------------------------------------------CHHHHHHHHHHH
T ss_pred eeccccc-------------------------------------------cccCCCCcCccChhhhCCCCCCchhhHHHH
Confidence 7653210 114579999999999998999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHH----HHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 344 GAIMYEMLVGYPPFYSDDPMST----CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~----~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
||++|+|++|.+||.+...... ...+......+..+....+++++++||.+||. ||.+||+ +.++++||||.
T Consensus 216 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~~~ 292 (336)
T 3fhr_A 216 GVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT---ITQFMNHPWIN 292 (336)
T ss_dssp HHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---HHHHHHSHHHH
T ss_pred HHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccc
Confidence 9999999999999987765443 22233222233333345789999999999999 9999999 99999999998
Q ss_pred C
Q 010947 419 G 419 (497)
Q Consensus 419 ~ 419 (497)
.
T Consensus 293 ~ 293 (336)
T 3fhr_A 293 Q 293 (336)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=368.42 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=217.3
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
.+..++|++++.||+|+||.||+|.++ ++..||+|++..... ....+.+|+.++..++||||+++++++.+...+
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 456788999999999999999999876 566899999976542 234588999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
|+||||++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999997754 59999999999999999999999999999999999999999999999999998654321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
.. ......||+.|+|||++.+..++.++|||||||++|+|
T Consensus 159 ~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 198 (268)
T 3sxs_A 159 YV----------------------------------------SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEV 198 (268)
T ss_dssp EE----------------------------------------ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHH
T ss_pred hh----------------------------------------cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHH
Confidence 10 01134678899999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
++ |.+||.+.+.......+.... ....| ..+++++.+||.+||. ||.+||+ +.++++|
T Consensus 199 ~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 258 (268)
T 3sxs_A 199 FSLGKMPYDLYTNSEVVLKVSQGH-RLYRP--HLASDTIYQIMYSCWHELPEKRPT---FQQLLSS 258 (268)
T ss_dssp HTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HcCCCCCccccChHHHHHHHHcCC-CCCCC--CcChHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 99 999999988888877776532 22233 3689999999999999 9999998 8887764
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=374.69 Aligned_cols=272 Identities=28% Similarity=0.490 Sum_probs=211.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec--------
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-------- 187 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-------- 187 (497)
++|++++.||+|+||.||+|++..+|+.||||++... ......+.+|+.+++.++||||++++++|.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 4699999999999999999999999999999999753 2345678899999999999999999998865
Q ss_pred -----CCeEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccc
Q 010947 188 -----DEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFG 261 (497)
Q Consensus 188 -----~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFG 261 (497)
...+|+||||++||+|.+++...+ .+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 457899999999999999997644 68899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhH
Q 010947 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDW 340 (497)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~Di 340 (497)
+++........... . .. ..+ .........+||+.|+|||++.+. .++.++||
T Consensus 162 ~~~~~~~~~~~~~~-------~--~~-----~~~-------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 214 (303)
T 1zy4_A 162 LAKNVHRSLDILKL-------D--SQ-----NLP-------------GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM 214 (303)
T ss_dssp CCSCTTC----------------------------------------------------CTTSCHHHHTSCSCCCTHHHH
T ss_pred chhhcccccchhcc-------c--cc-----ccc-------------ccccccccCCCcccccCcccccCCCCCcchhhH
Confidence 99865432100000 0 00 000 000011246799999999999864 68999999
Q ss_pred HhHHHHHHHHHhCCCCCCCC-ChHHHHHHHhcccCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCC
Q 010947 341 WSLGAIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~-~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpf 416 (497)
|||||++|+|++ ||... +.......+... ...+|. ...+++.+++||.+||. ||.+||+ +.++++|||
T Consensus 215 ~slG~il~~l~~---p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~h~~ 286 (303)
T 1zy4_A 215 YSLGIIFFEMIY---PFSTGMERVNILKKLRSV--SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPG---ARTLLNSGW 286 (303)
T ss_dssp HHHHHHHHHHHS---CCSSHHHHHHHHHHHHST--TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCC---HHHHHHSSC
T ss_pred HHHHHHHHHHHh---ccCCchhHHHHHHhcccc--ccccCccccccchHHHHHHHHHHHhcCcccCcC---HHHHhCCCC
Confidence 999999999998 55532 334445555432 223332 23567889999999999 9999999 999999999
Q ss_pred ccCCChhhhh
Q 010947 417 FDGVDWARIY 426 (497)
Q Consensus 417 f~~i~w~~l~ 426 (497)
|....++...
T Consensus 287 ~~~~~~~~~~ 296 (303)
T 1zy4_A 287 LPVKHQDEVI 296 (303)
T ss_dssp SCCCCHHHHH
T ss_pred cCCCChHHHH
Confidence 9988777653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=383.00 Aligned_cols=261 Identities=27% Similarity=0.437 Sum_probs=219.9
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hHHHHHHHHHHHHHhcC--CCceeEEEE
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVD--SNCIVKLYC 183 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~--hp~Iv~l~~ 183 (497)
.......++|++.+.||+|+||.||+|.+..+++.||||++........ .....+..|+.+++.+. ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 3445567889999999999999999999999999999999987643321 11234667999999996 599999999
Q ss_pred EeecCCeEEEEEeecCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec-CCCcEEEcccc
Q 010947 184 SFQDDEFLYLIMEYLPG-GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFG 261 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~-~~g~vkL~DFG 261 (497)
+|.+.+.+|+||||+.+ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+|||
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 99999999999999976 89999999889999999999999999999999999999999999999999 78999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhH
Q 010947 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDW 340 (497)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~Di 340 (497)
+++...... ....+||+.|+|||++.+..+ +.++||
T Consensus 196 ~~~~~~~~~-------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di 232 (320)
T 3a99_A 196 SGALLKDTV-------------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAV 232 (320)
T ss_dssp TCEECCSSC-------------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHH
T ss_pred ccccccccc-------------------------------------------ccCCCCCccCCChHHhccCCCCCccchH
Confidence 998654211 114579999999999987776 788999
Q ss_pred HhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 341 WSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|||||++|||++|..||...+ .+.. ....++ ..+++++.+||.+||. ||.+||+ +++|++||||.+
T Consensus 233 ~slG~il~el~~g~~pf~~~~------~~~~--~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~hp~~~~ 299 (320)
T 3a99_A 233 WSLGILLYDMVCGDIPFEHDE------EIIR--GQVFFR--QRVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQD 299 (320)
T ss_dssp HHHHHHHHHHHHSSCSCCSHH------HHHH--CCCCCS--SCCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSS
T ss_pred HhHHHHHHHHHHCCCCCCChh------hhhc--cccccc--ccCCHHHHHHHHHHccCChhhCcC---HHHHhcCHhhcC
Confidence 999999999999999997542 2222 223344 3689999999999999 9999999 999999999998
Q ss_pred CChhhh
Q 010947 420 VDWARI 425 (497)
Q Consensus 420 i~w~~l 425 (497)
+.+...
T Consensus 300 ~~~~~~ 305 (320)
T 3a99_A 300 VLLPQE 305 (320)
T ss_dssp CCCHHH
T ss_pred ccCccc
Confidence 765443
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=377.14 Aligned_cols=259 Identities=21% Similarity=0.316 Sum_probs=221.2
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEE
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 183 (497)
....+..++|.+.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 93 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYG 93 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEE
Confidence 345567789999999999999999999983 456899999997542 3445677899999999999999999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHcCCEEE
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDT------------------------LTEDEARFYVAETVLAIESIHKHHYIH 239 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~------------------------l~e~~~~~~~~qi~~aL~~LH~~~iiH 239 (497)
++.+.+.+|+||||++||+|.+++..... +++..+..++.||+.||.|||++||+|
T Consensus 94 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 173 (314)
T 2ivs_A 94 ACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVH 173 (314)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred EEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcc
Confidence 99999999999999999999999976543 899999999999999999999999999
Q ss_pred cccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccC
Q 010947 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (497)
Q Consensus 240 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 319 (497)
|||||+|||++.++.+||+|||+++......... ......|
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~ 214 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV---------------------------------------KRSQGRI 214 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEE---------------------------------------CSSCCCS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccce---------------------------------------eccCCCC
Confidence 9999999999999999999999998664321100 0113468
Q ss_pred CCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-
Q 010947 320 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC- 397 (497)
Q Consensus 320 t~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~- 397 (497)
|+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+.......+... .....| ..+++++.+||.+||.
T Consensus 215 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~ 291 (314)
T 2ivs_A 215 PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG-HRMERP--DNCSEEMYRLMLQCWKQ 291 (314)
T ss_dssp CGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCS
T ss_pred cccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcC-CcCCCC--ccCCHHHHHHHHHHccC
Confidence 899999999999999999999999999999999 99999998888877776653 233333 4789999999999999
Q ss_pred CccccCCCCCcchhcCC
Q 010947 398 NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 398 dp~~R~~~~~~~eil~H 414 (497)
||.+||+ +.++++|
T Consensus 292 dp~~Rps---~~~l~~~ 305 (314)
T 2ivs_A 292 EPDKRPV---FADISKD 305 (314)
T ss_dssp SGGGSCC---HHHHHHH
T ss_pred ChhhCcC---HHHHHHH
Confidence 9999998 8887653
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=373.75 Aligned_cols=261 Identities=30% Similarity=0.482 Sum_probs=214.8
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
..+..++|....+||+|+||.||+|.+..++..||||++.... ....+.+.+|+.+++.++||||++++++|.+.+.
T Consensus 17 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 17 YDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp EEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred ccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3344556666679999999999999999999999999997643 3344668899999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-CCcEEEccccccccc
Q 010947 191 LYLIMEYLPGGDMMTLLMRK---DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPL 266 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-~g~vkL~DFGla~~~ 266 (497)
+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 99999999999999999765 25679999999999999999999999999999999999997 899999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC--CCcchhHHhHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG--YGMECDWWSLG 344 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~--y~~~~DiwSlG 344 (497)
..... ......||+.|+|||++.+.. ++.++||||||
T Consensus 174 ~~~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG 212 (295)
T 2clq_A 174 AGINP-----------------------------------------CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLG 212 (295)
T ss_dssp CC----------------------------------------------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHH
T ss_pred CCCCC-----------------------------------------cccccCCCccccChhhhcCCCCCCCcHHHHHHHH
Confidence 32110 011457999999999997643 89999999999
Q ss_pred HHHHHHHhCCCCCCCCChHH-HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 345 AIMYEMLVGYPPFYSDDPMS-TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~-~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|++|+|++|..||...+... .............+| ..+++++.+||.+||. ||.+||+ +.++++||||+..
T Consensus 213 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~Rps---~~~ll~~~~~~~~ 285 (295)
T 2clq_A 213 CTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIP--ESMSAEAKAFILKCFEPDPDKRAC---ANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCC--TTSCHHHHHHHHHTTCSSTTTSCC---HHHHHTSGGGCC-
T ss_pred HHHHHHHHCCCCccCCCchhHHHHhhcccccccccc--ccCCHHHHHHHHHHccCChhhCCC---HHHHhcChhhhhc
Confidence 99999999999997654322 222222212233344 3789999999999999 9999999 9999999999854
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=383.16 Aligned_cols=259 Identities=20% Similarity=0.337 Sum_probs=216.6
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 183 (497)
...+..++|.+.+.||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.++..+ +||||+++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 34567789999999999999999999973 356789999997543 233446788999999999 9999999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEc
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD-----------------------TLTEDEARFYVAETVLAIESIHKHHYIHR 240 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~-----------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHr 240 (497)
+|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999999999999999999997643 37999999999999999999999999999
Q ss_pred ccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCC
Q 010947 241 DIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGT 320 (497)
Q Consensus 241 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt 320 (497)
||||+|||++.++.+||+|||+++........ .......||
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~t 237 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNY---------------------------------------VVRGNARLP 237 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTS---------------------------------------EEETTEEEC
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccc---------------------------------------eeccCccCc
Confidence 99999999999999999999999865322100 001245689
Q ss_pred CcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-C
Q 010947 321 PDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 321 ~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-d 398 (497)
+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.........++........| ..+++++.+||.+||. |
T Consensus 238 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~d 315 (344)
T 1rjb_A 238 VKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFD 315 (344)
T ss_dssp GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSS
T ss_pred cCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHcCCC
Confidence 99999999999999999999999999999998 999999887666666665533333334 4789999999999999 9
Q ss_pred ccccCCCCCcchhcCC
Q 010947 399 VNQRLGAKGADEIKVH 414 (497)
Q Consensus 399 p~~R~~~~~~~eil~H 414 (497)
|.+||+ +.++++|
T Consensus 316 p~~Rps---~~~l~~~ 328 (344)
T 1rjb_A 316 SRKRPS---FPNLTSF 328 (344)
T ss_dssp GGGSCC---HHHHHHH
T ss_pred chhCcC---HHHHHHH
Confidence 999999 8888764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=380.39 Aligned_cols=262 Identities=19% Similarity=0.325 Sum_probs=212.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|.+.+.||+|+||+||+|.++.+++.||+|++... .......+.+|+.+++.++||||++++++|.++..+|
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 83 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN 83 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence 4567899999999999999999999999999999998653 2445667899999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.......
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 84 FITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp EEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 99999999999999987 56799999999999999999999999999999999999999999999999999987643321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
..... ..............+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 164 ~~~~~---------------------------~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 216 (310)
T 3s95_A 164 QPEGL---------------------------RSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216 (310)
T ss_dssp -------------------------------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred ccccc---------------------------ccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHh
Confidence 10000 000000111123578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHH-----HHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 352 VGYPPFYSDDPMST-----CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 352 ~G~~PF~~~~~~~~-----~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|..||........ ...... ...| ..+++++.+||.+||. ||.+||+ +.++++
T Consensus 217 ~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~~~l~~li~~~l~~dP~~Rps---~~~l~~ 275 (310)
T 3s95_A 217 GRVNADPDYLPRTMDFGLNVRGFLD----RYCP--PNCPPSFFPITVRCCDLDPEKRPS---FVKLEH 275 (310)
T ss_dssp HTCCSSTTTSCBCTTSSBCHHHHHH----HTCC--TTCCTTHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred cCCCCCcchhhhHHHHhhhhhcccc----ccCC--CCCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 99999976432111 111111 1123 3688899999999999 9999999 888775
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=368.58 Aligned_cols=252 Identities=24% Similarity=0.380 Sum_probs=206.6
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc-hhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
.+..++|++.+.||+|+||.||+|.+. |..||||++....... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPN 80 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCc
Confidence 356789999999999999999999874 7899999997654322 2335678899999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC---EEEcccCCCCeeecC--------CCcEEEcc
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH---YIHRDIKPDNLLLDK--------YGHLRLSD 259 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~---iiHrDLKp~NILl~~--------~g~vkL~D 259 (497)
+|+||||++||+|.+++. ...+++..+..++.|++.||.|||+.| |+||||||+|||++. ++.+||+|
T Consensus 81 ~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 81 LCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred eEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 999999999999999884 568999999999999999999999999 999999999999986 78899999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchh
Q 010947 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (497)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~D 339 (497)
||+++...... .....||+.|+|||++.+..++.++|
T Consensus 160 fg~~~~~~~~~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~D 196 (271)
T 3dtc_A 160 FGLAREWHRTT-------------------------------------------KMSAAGAYAWMAPEVIRASMFSKGSD 196 (271)
T ss_dssp CCC--------------------------------------------------------CCGGGSCHHHHHHCCCSHHHH
T ss_pred CCccccccccc-------------------------------------------ccCCCCccceeCHHHhccCCCCchhh
Confidence 99997543210 11357999999999999999999999
Q ss_pred HHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 340 WWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 340 iwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
||||||++|+|++|..||.+.+.......+.........| ..+++++.+||.+||. ||.+||+ +.++++|
T Consensus 197 i~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~ 267 (271)
T 3dtc_A 197 VWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP--STCPEPFAKLMEDCWNPDPHSRPS---FTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCC--cccCHHHHHHHHHHhcCCcccCcC---HHHHHHH
Confidence 9999999999999999999988877777776543334444 4789999999999999 9999999 8887753
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=390.48 Aligned_cols=257 Identities=23% Similarity=0.331 Sum_probs=218.8
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.+.+..++|.+.+.||+|+||.||+|+++.++..||||+++... .......+.+|+.+|+.++|||||++++++.+..
T Consensus 108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 34566788999999999999999999999999999999997542 2334456888999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999999999997654 699999999999999999999999999999999999999999999999999986432
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
..... ......+|+.|+|||++.+..|+.++|||||||++|
T Consensus 266 ~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~ 306 (377)
T 3cbl_A 266 GVYAA---------------------------------------SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLW 306 (377)
T ss_dssp SEEEC---------------------------------------CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred Cceee---------------------------------------cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHH
Confidence 21000 000234678899999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 349 ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
||++ |.+||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+||+ +.+|++
T Consensus 307 el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps---~~~i~~ 367 (377)
T 3cbl_A 307 ETFSLGASPYPNLSNQQTREFVEKG-GRLPCP--ELCPDAVFRLMEQCWAYEPGQRPS---FSTIYQ 367 (377)
T ss_dssp HHHTTSCCSSTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCCchhCcC---HHHHHH
Confidence 9998 99999998887777666542 334444 3689999999999999 9999998 777653
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=372.01 Aligned_cols=256 Identities=20% Similarity=0.348 Sum_probs=217.9
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
.....+..++|++++.||+|+||.||+|.+. ++..||||++..... ....+.+|+.++..++||||++++++|.+
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 90 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTK 90 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEec
Confidence 3456678889999999999999999999876 577899999986532 23458899999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
.+.+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 170 (283)
T 3gen_A 91 QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV 170 (283)
T ss_dssp SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGB
T ss_pred CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccc
Confidence 9999999999999999999976 567999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
...... ......||+.|+|||++.+..++.++|||||||+
T Consensus 171 ~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~ 210 (283)
T 3gen_A 171 LDDEYT----------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVL 210 (283)
T ss_dssp CCHHHH----------------------------------------STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHH
T ss_pred cccccc----------------------------------------cccCCccCcccCCHHHhccCCCCchhhHHHHHHH
Confidence 321100 0113467889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 347 l~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
+|+|++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+||+ +.++++|
T Consensus 211 l~~l~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~~ 274 (283)
T 3gen_A 211 MWEIYSLGKMPYERFTNSETAEHIAQGL-RLYRP--HLASEKVYTIMYSCWHEKADERPT---FKILLSN 274 (283)
T ss_dssp HHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhCCCCCccccChhHHHHHHhccc-CCCCC--CcCCHHHHHHHHHHccCChhHCcC---HHHHHHH
Confidence 999998 999999998888888877532 22233 4689999999999999 9999999 8888764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-47 Score=381.98 Aligned_cols=258 Identities=22% Similarity=0.341 Sum_probs=220.9
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEE
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 183 (497)
....+..++|++++.||+|+||.||+|++. .+++.||||++++.. .......+.+|+.+++.++||||+++++
T Consensus 40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~ 117 (343)
T 1luf_A 40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLG 117 (343)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 345677889999999999999999999987 455899999997643 2344567899999999999999999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEE
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK------------------------DTLTEDEARFYVAETVLAIESIHKHHYIH 239 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~------------------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiH 239 (497)
+|.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+|
T Consensus 118 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH 197 (343)
T 1luf_A 118 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 197 (343)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred EEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 999999999999999999999999763 57999999999999999999999999999
Q ss_pred cccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccC
Q 010947 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (497)
Q Consensus 240 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 319 (497)
|||||+|||++.++.+||+|||+++......... ......|
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~ 238 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYK---------------------------------------ADGNDAI 238 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC-------------------------------------------CCB
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCcccc---------------------------------------ccCCCcc
Confidence 9999999999999999999999998653211000 0113568
Q ss_pred CCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-
Q 010947 320 TPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC- 397 (497)
Q Consensus 320 t~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~- 397 (497)
|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+....+.... ...+| ..+++++.+||.+||.
T Consensus 239 t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~ 315 (343)
T 1luf_A 239 PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNLMRLCWSK 315 (343)
T ss_dssp CGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCS
T ss_pred cceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCC-cCCCC--CCCCHHHHHHHHHHccc
Confidence 999999999999999999999999999999999 999999998888888777532 23344 3789999999999999
Q ss_pred CccccCCCCCcchhcC
Q 010947 398 NVNQRLGAKGADEIKV 413 (497)
Q Consensus 398 dp~~R~~~~~~~eil~ 413 (497)
||.+||+ +.++++
T Consensus 316 ~p~~Rps---~~~~~~ 328 (343)
T 1luf_A 316 LPADRPS---FCSIHR 328 (343)
T ss_dssp SGGGSCC---HHHHHH
T ss_pred CcccCCC---HHHHHH
Confidence 9999998 777764
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=387.64 Aligned_cols=255 Identities=24% Similarity=0.434 Sum_probs=208.7
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-----------CCceeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----------SNCIVK 180 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-----------hp~Iv~ 180 (497)
.+...+|.+++.||+|+||+||+|++..+++.||||++.+.. .....+.+|+.++..+. ||||++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~ 90 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK 90 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence 355689999999999999999999999999999999997543 23455778999988876 899999
Q ss_pred EEEEeecCC----eEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcC-CEEEcccCCCCeeec---
Q 010947 181 LYCSFQDDE----FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLD--- 250 (497)
Q Consensus 181 l~~~~~~~~----~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDLKp~NILl~--- 250 (497)
++++|.... .+++||||+ |++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+|||++
T Consensus 91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~ 169 (373)
T 1q8y_A 91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVD 169 (373)
T ss_dssp CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEE
T ss_pred HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccC
Confidence 999988654 799999999 99999999763 4599999999999999999999998 999999999999995
Q ss_pred ---CCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcc
Q 010947 251 ---KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPE 327 (497)
Q Consensus 251 ---~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE 327 (497)
..+.+||+|||+|+..... ....+||+.|+|||
T Consensus 170 ~~~~~~~~kl~Dfg~a~~~~~~--------------------------------------------~~~~~~t~~y~aPE 205 (373)
T 1q8y_A 170 SPENLIQIKIADLGNACWYDEH--------------------------------------------YTNSIQTREYRSPE 205 (373)
T ss_dssp TTTTEEEEEECCCTTCEETTBC--------------------------------------------CCSCCSCGGGCCHH
T ss_pred CCcCcceEEEcccccccccCCC--------------------------------------------CCCCCCCccccCcH
Confidence 3448999999999865321 11357999999999
Q ss_pred ccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCC------hHHHHHHHhcccC---------------------------
Q 010947 328 VLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD------PMSTCRKIVNWRT--------------------------- 374 (497)
Q Consensus 328 ~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~------~~~~~~~i~~~~~--------------------------- 374 (497)
++.+..|+.++|||||||++|||++|.+||.+.+ .......+.....
T Consensus 206 ~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 285 (373)
T 1q8y_A 206 VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNIS 285 (373)
T ss_dssp HHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCC
T ss_pred HHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccc
Confidence 9999999999999999999999999999998654 2222333321100
Q ss_pred -------------cccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 375 -------------HLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 375 -------------~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
...+| ..++.++++||.+||+ ||.+||+ +.|+++||||++.
T Consensus 286 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rpt---~~ell~hp~f~~~ 340 (373)
T 1q8y_A 286 KLKFWPLEDVLTEKYKFS--KDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDT 340 (373)
T ss_dssp CCCBCCHHHHHHHTTCCC--HHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTC
T ss_pred cccccchhhhhhhcccCC--cchHHHHHHHHHHHhccCccccCC---HHHHhhChhhhcc
Confidence 01122 2457789999999999 9999999 9999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=374.00 Aligned_cols=256 Identities=21% Similarity=0.311 Sum_probs=207.4
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.++..++||||+++++++.+++.+|+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 35789999999999999999999999999999999987654444556778999999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
||||++|++|.+++...+.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~- 190 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT- 190 (309)
T ss_dssp EEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-
Confidence 9999999999999998889999999999999999999999999999999999999999999999999998765322100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
.....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 191 ---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 231 (309)
T 2h34_A 191 ---------------------------------------QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTG 231 (309)
T ss_dssp ---------------------------------------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHC
Confidence 01145799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
.+||.+.+.......+... ..........+++++.+||.+||. ||.+||+ ++++++
T Consensus 232 ~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~--s~~~l~ 288 (309)
T 2h34_A 232 SPPYQGDQLSVMGAHINQA-IPRPSTVRPGIPVAFDAVIARGMAKNPEDRYV--TCGDLS 288 (309)
T ss_dssp SCSSCSCHHHHHHHHHHSC-CCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCS--SHHHHH
T ss_pred CCCCCCchHHHHHHHhccC-CCCccccCCCCCHHHHHHHHHhccCCHHHHHH--hHHHHH
Confidence 9999987765444444321 111111124689999999999999 9999994 166654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=384.78 Aligned_cols=258 Identities=20% Similarity=0.339 Sum_probs=221.0
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCC-------CcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t-------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 181 (497)
...+..++|.+.+.||+|+||.||+|++..+ +..||||++.... .......+.+|+.+++.+ +|||||++
T Consensus 63 ~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~ 140 (382)
T 3tt0_A 63 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 140 (382)
T ss_dssp TTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhh
Confidence 4466778999999999999999999997543 3579999997652 344557788999999999 99999999
Q ss_pred EEEeecCCeEEEEEeecCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCC
Q 010947 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (497)
Q Consensus 182 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~ 245 (497)
+++|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+
T Consensus 141 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 141 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 999999999999999999999999997753 4999999999999999999999999999999999
Q ss_pred CeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccC
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 325 (497)
|||++.++.+||+|||+|+......... ......||+.|+|
T Consensus 221 NIll~~~~~~kL~DFG~a~~~~~~~~~~---------------------------------------~~~~~~~t~~y~a 261 (382)
T 3tt0_A 221 NVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------KTTNGRLPVKWMA 261 (382)
T ss_dssp GEEECTTCCEEECSCSCCCCSSCCCTTC---------------------------------------CCTTCCCGGGGSC
T ss_pred eEEEcCCCcEEEcccCcccccccccccc---------------------------------------cccCCCCCcceeC
Confidence 9999999999999999998654321100 0113568899999
Q ss_pred ccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 326 PE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
||++.+..++.++|||||||++|||++ |..||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dP~~Rp 338 (382)
T 3tt0_A 262 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKP--SNCTNELYMMMRDCWHAVPSQRP 338 (382)
T ss_dssp HHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCC--SSCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcCCChhhCc
Confidence 999999999999999999999999999 99999999888887777653 233334 4789999999999999 999999
Q ss_pred CCCCcchhcCC
Q 010947 404 GAKGADEIKVH 414 (497)
Q Consensus 404 ~~~~~~eil~H 414 (497)
+ +.+|++|
T Consensus 339 s---~~ell~~ 346 (382)
T 3tt0_A 339 T---FKQLVED 346 (382)
T ss_dssp C---HHHHHHH
T ss_pred C---HHHHHHH
Confidence 9 8888763
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=370.74 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=207.4
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
...+..++|++.+.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 3456678999999999999999999998654 4579999987542 2344567889999999999999999999985
Q ss_pred cCCeEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
++.+|+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 467899999999999999997654 699999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
....... ......||+.|+|||++.+..++.++|||||||
T Consensus 166 ~~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 205 (281)
T 1mp8_A 166 MEDSTYY----------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGV 205 (281)
T ss_dssp -----------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred cCccccc----------------------------------------ccccCCCcccccChhhcccCCCCCccCchHHHH
Confidence 5422100 011345788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 346 il~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++|||++ |.+||.+.+..+....+.... ...+| ..+++++.+||.+||. ||.+||+ +.++++
T Consensus 206 ~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 269 (281)
T 1mp8_A 206 CMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRPR---FTELKA 269 (281)
T ss_dssp HHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 9999997 999999988888887777532 23344 4789999999999999 9999998 777764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=379.27 Aligned_cols=269 Identities=17% Similarity=0.252 Sum_probs=226.0
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEE
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC 183 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~ 183 (497)
....+..++|++.+.||+|+||.||+|.++ .+++.||||++.... .......+.+|+.+++.++||||+++++
T Consensus 18 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 345567788999999999999999999886 467889999997543 2334556889999999999999999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g 253 (497)
++.+.+..|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 999999999999999999999998653 4579999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC
Q 010947 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (497)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~ 333 (497)
.+||+|||+++........ .......||+.|+|||++.+..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~~~~~ 216 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYY---------------------------------------RKGGKGLLPVRWMSPESLKDGV 216 (322)
T ss_dssp CEEECCTTCCCGGGGGGCE---------------------------------------EGGGSSEECGGGCCHHHHHHCC
T ss_pred eEEECcCcccccccccccc---------------------------------------ccccCCCCCCCccChhhhccCC
Confidence 9999999999865321100 0012356899999999999999
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 334 y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
++.++|||||||++|+|++ |.+||.+.+..+....+.... ....| ..++.++.+||.+||. ||.+||+ +.++
T Consensus 217 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~e~ 290 (322)
T 1p4o_A 217 FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRPS---FLEI 290 (322)
T ss_dssp CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC-cCCCC--CCCCHHHHHHHHHHcCCCcccCcC---HHHH
Confidence 9999999999999999999 899999988888887776532 22333 4789999999999999 9999998 7777
Q ss_pred cCC------CCccCCChhh
Q 010947 412 KVH------PWFDGVDWAR 424 (497)
Q Consensus 412 l~H------pff~~i~w~~ 424 (497)
++| |+|..++|..
T Consensus 291 l~~L~~~~~~~~~~~~~~~ 309 (322)
T 1p4o_A 291 ISSIKEEMEPGFREVSFYY 309 (322)
T ss_dssp HHHHGGGSCTTHHHHCSTT
T ss_pred HHHHHHhhccCCccccccc
Confidence 765 6666655443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=371.62 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=221.9
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
....+..++|++.+.||+|+||.||+|.++.++..||+|++... ....+.+.+|+.+++.++||||+++++++.+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 81 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE 81 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 45667888999999999999999999999999999999999754 33456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
..+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999999999764 45999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
...... ......||+.|+|||++.+..++.++|||||||+
T Consensus 162 ~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 201 (288)
T 3kfa_A 162 TGDTYT----------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 201 (288)
T ss_dssp CSSSSE----------------------------------------EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred cCCccc----------------------------------------cccCCccccCcCChhhhccCCCCchhhHHHHHHH
Confidence 432110 0113568899999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 347 l~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|+|++ |.+||.+.+.......+... .....| ..+++++.+||.+||. ||.+||+ +.++++
T Consensus 202 l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~~~~ 264 (288)
T 3kfa_A 202 LWEIATYGMSPYPGIDLSQVYELLEKD-YRMERP--EGCPEKVYELMRACWQWNPSDRPS---FAEIHQ 264 (288)
T ss_dssp HHHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhcc-CCCCCC--CCCCHHHHHHHHHHhCCChhhCcC---HHHHHH
Confidence 999999 99999998887777766542 223333 4789999999999999 9999998 777754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=372.62 Aligned_cols=246 Identities=18% Similarity=0.267 Sum_probs=208.0
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCC-------cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTG-------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~-------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 184 (497)
++..++|.+.+.||+|+||.||+|+++.++ ..||+|++.+.. ....+.+.+|+.+++.++||||++++++
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 456788999999999999999999998877 469999997643 3445678899999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc--------E
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH--------L 255 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~--------v 255 (497)
|.+.+..|+||||++||+|.+++..... +++..+..++.||+.||.|||+.||+||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 9999999999999999999999977654 999999999999999999999999999999999999999887 9
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCC
Q 010947 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGY 334 (497)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y 334 (497)
||+|||++...... ....||+.|+|||++.+ ..+
T Consensus 161 kl~Dfg~~~~~~~~---------------------------------------------~~~~~~~~y~aPE~~~~~~~~ 195 (289)
T 4fvq_A 161 KLSDPGISITVLPK---------------------------------------------DILQERIPWVPPECIENPKNL 195 (289)
T ss_dssp EECCCCSCTTTSCH---------------------------------------------HHHHHTTTTSCHHHHHCGGGC
T ss_pred eeccCcccccccCc---------------------------------------------cccCCcCcccCHHHhCCCCCC
Confidence 99999998754211 12468999999999987 779
Q ss_pred CcchhHHhHHHHHHHHHhCC-CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 335 GMECDWWSLGAIMYEMLVGY-PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 335 ~~~~DiwSlGvil~ell~G~-~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+.++|||||||++|||++|. +||...+..... .+.. ....+|. .+++++.+||.+||. ||.+||+ +.+++
T Consensus 196 ~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-~~~~--~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps---~~~ll 267 (289)
T 4fvq_A 196 NLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-QFYE--DRHQLPA--PKAAELANLINNCMDYEPDHRPS---FRAII 267 (289)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-HHHH--TTCCCCC--CSSCTTHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred CchhHHHHHHHHHHHHHcCCCCCccccchHHHH-HHhh--ccCCCCC--CCCHHHHHHHHHHcCCChhHCcC---HHHHH
Confidence 99999999999999999955 555554444333 3333 2333443 568899999999999 9999998 88887
Q ss_pred C
Q 010947 413 V 413 (497)
Q Consensus 413 ~ 413 (497)
+
T Consensus 268 ~ 268 (289)
T 4fvq_A 268 R 268 (289)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=367.82 Aligned_cols=258 Identities=19% Similarity=0.226 Sum_probs=211.0
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~ 190 (497)
.+..++|++.+.||+|+||.||+|.+..+|+.||||++..... ...+.+|+.++..+ +|++|+++++++.+...
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 4556789999999999999999999999999999999875432 23477899999998 89999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc-----EEEccccccc
Q 010947 191 LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH-----LRLSDFGLCK 264 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~-----vkL~DFGla~ 264 (497)
.|+||||+ ||+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.+|. +||+|||+|+
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred eEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 99999999 999999997654 6999999999999999999999999999999999999988776 9999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlG 344 (497)
........... +. ......+||+.|+|||++.+..++.++||||||
T Consensus 160 ~~~~~~~~~~~----------------~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 205 (298)
T 1csn_A 160 FYRDPVTKQHI----------------PY------------------REKKNLSGTARYMSINTHLGREQSRRDDLEALG 205 (298)
T ss_dssp ESBCTTTCCBC----------------CC------------------CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred ccccccccccc----------------cc------------------cCccCCCCCcccCCchhhcCCCCChHHHHHHHH
Confidence 76533111000 00 001256899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC---hHHHHHHHhcccCcccCCC-CccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 345 AIMYEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 345 vil~ell~G~~PF~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
|++|||++|.+||.+.+ ..+.+..+.........+. ...+++++.+||.+||. ||.+||+ +.+|+
T Consensus 206 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~---~~~l~ 275 (298)
T 1csn_A 206 HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD---YDYLQ 275 (298)
T ss_dssp HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC---HHHHH
T ss_pred HHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCC---HHHHH
Confidence 99999999999998843 4444445443211111111 13689999999999999 9999998 65554
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=375.10 Aligned_cols=267 Identities=27% Similarity=0.467 Sum_probs=218.4
Q ss_pred HHHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC--CCceeEEEE
Q 010947 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD--SNCIVKLYC 183 (497)
Q Consensus 106 ~~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~ 183 (497)
+.++...+..++|++++.||+|+||.||+|.+. +++.||||++..... .......+.+|+.++..+. ||||+++++
T Consensus 18 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~ 95 (313)
T 3cek_A 18 LYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95 (313)
T ss_dssp --CCEEEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred CCeeeeeeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEE
Confidence 345566677888999999999999999999875 588999999976432 3345677899999999997 599999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
++.+...+|+||| +.+|+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++. +.+||+|||++
T Consensus 96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~ 173 (313)
T 3cek_A 96 YEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIA 173 (313)
T ss_dssp EEECSSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSS
T ss_pred EeecCCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccc
Confidence 9999999999999 568999999998889999999999999999999999999999999999999975 89999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----------C
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-----------K 332 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-----------~ 332 (497)
+.+...... ......+||+.|+|||++.+ .
T Consensus 174 ~~~~~~~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 214 (313)
T 3cek_A 174 NQMQPDTTS---------------------------------------VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214 (313)
T ss_dssp CC-----------------------------------------------------CCGGGCCHHHHTTCC----------
T ss_pred ccccCcccc---------------------------------------ccccCCCCCCCcCCHHHHhhcccccccccccc
Confidence 865322100 00114579999999999975 4
Q ss_pred CCCcchhHHhHHHHHHHHHhCCCCCCCCC-hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcch
Q 010947 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (497)
Q Consensus 333 ~y~~~~DiwSlGvil~ell~G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~e 410 (497)
.++.++|||||||++|+|++|..||.... .......+........+|. ..+.++.+||.+||. ||.+||+ +.+
T Consensus 215 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dp~~Rps---~~e 289 (313)
T 3cek_A 215 KISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD--IPEKDLQDVLKCCLKRDPKQRIS---IPE 289 (313)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCC--CSCHHHHHHHHHHTCSSTTTSCC---HHH
T ss_pred cCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcc--cchHHHHHHHHHHccCCcccCcC---HHH
Confidence 78999999999999999999999998754 3344555555334444553 578899999999999 9999999 999
Q ss_pred hcCCCCccCC
Q 010947 411 IKVHPWFDGV 420 (497)
Q Consensus 411 il~Hpff~~i 420 (497)
+++||||...
T Consensus 290 ll~h~~~~~~ 299 (313)
T 3cek_A 290 LLAHPYVQIQ 299 (313)
T ss_dssp HHTSHHHHCC
T ss_pred HhcCccccCC
Confidence 9999999853
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=373.98 Aligned_cols=257 Identities=22% Similarity=0.312 Sum_probs=217.7
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEE
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 184 (497)
..+..++|.+.+.||+|+||.||+|.+ ..++..||||++.... .....+.+.+|+.+++.+ +||||++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 456678999999999999999999985 4567899999997653 223456788999999999 99999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCC
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRKD------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~N 246 (497)
|.+.+..|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 175 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence 999999999999999999999997654 48999999999999999999999999999999999
Q ss_pred eeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCc
Q 010947 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (497)
Q Consensus 247 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 326 (497)
||++.++.+||+|||+++........ .......||+.|+||
T Consensus 176 il~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aP 216 (313)
T 1t46_A 176 ILLTHGRITKICDFGLARDIKNDSNY---------------------------------------VVKGNARLPVKWMAP 216 (313)
T ss_dssp EEEETTTEEEECCCGGGSCTTSCTTS---------------------------------------EECSSSEECGGGCCH
T ss_pred EEEcCCCCEEEccccccccccccccc---------------------------------------eeccCCCCcceeeCh
Confidence 99999999999999999866432110 001135688999999
Q ss_pred cccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 327 E~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|++.+..++.++|||||||++|+|++ |.+||.+.........++........| ..+++++.+||.+||. ||.+||+
T Consensus 217 E~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps 294 (313)
T 1t46_A 217 ESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPT 294 (313)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCc--ccCCHHHHHHHHHHcCCCchhCcC
Confidence 99999999999999999999999999 999999877666555555432222233 4789999999999999 9999998
Q ss_pred CCCcchhcC
Q 010947 405 AKGADEIKV 413 (497)
Q Consensus 405 ~~~~~eil~ 413 (497)
+.++++
T Consensus 295 ---~~ell~ 300 (313)
T 1t46_A 295 ---FKQIVQ 300 (313)
T ss_dssp ---HHHHHH
T ss_pred ---HHHHHH
Confidence 888765
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=364.83 Aligned_cols=249 Identities=17% Similarity=0.239 Sum_probs=215.5
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC--
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-- 188 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-- 188 (497)
..+..++|++.+.||+|+||.||+|++. +..||||++..... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence 3466789999999999999999999975 78999999986532 234456789999999999999999999999887
Q ss_pred CeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCC--EEEcccCCCCeeecCCCcEEEccccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
..+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.| |+||||||+|||++.+|.++|+|||++.
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence 78999999999999999998765 4999999999999999999999999 9999999999999999999999999875
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCc---chhHH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM---ECDWW 341 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~---~~Diw 341 (497)
.... ...+||+.|+|||++.+..++. ++|||
T Consensus 162 ~~~~----------------------------------------------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~ 195 (271)
T 3kmu_A 162 SFQS----------------------------------------------PGRMYAPAWVAPEALQKKPEDTNRRSADMW 195 (271)
T ss_dssp TTSC----------------------------------------------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHH
T ss_pred eecc----------------------------------------------cCccCCccccChhhhccCCCCCCCchhhHH
Confidence 4321 1357999999999998766544 79999
Q ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 342 SlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
||||++|||++|..||.+.+.......+........+|. .+++++.+||.+||. ||.+||+ +.++++
T Consensus 196 slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~~il~ 263 (271)
T 3kmu_A 196 SFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPP--GISPHVSKLMKICMNEDPAKRPK---FDMIVP 263 (271)
T ss_dssp HHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCC--CCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 999999999999999999988888777775444444553 789999999999999 9999998 777764
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=377.59 Aligned_cols=254 Identities=20% Similarity=0.344 Sum_probs=207.7
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEE----EEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVY----AMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~----AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
+..++|++++.||+|+||+||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||++++++|.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 45678999999999999999999998887765 677665432 233456788999999999999999999999876
Q ss_pred CeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
. .++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+.+.
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred C-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 5 7899999999999999977 4679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
...... ......||+.|+|||++.+..|+.++|||||||++
T Consensus 169 ~~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 209 (327)
T 3poz_A 169 AEEKEY---------------------------------------HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209 (327)
T ss_dssp TTCC----------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcccc---------------------------------------cccCCCccccccChHHhccCCCCchhhhhhhHHHH
Confidence 321100 01134678999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|||++ |.+||.+.+..+....+... .....| ..++.++.+||.+||. ||.+||+ +.+++.|
T Consensus 210 ~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps---~~ell~~ 272 (327)
T 3poz_A 210 WELMTFGSKPYDGIPASEISSILEKG-ERLPQP--PICTIDVYMIMVKCWMIDADSRPK---FRELIIE 272 (327)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCCC--TTBCHHHHHHHHHHTCSCGGGSCC---HHHHHHH
T ss_pred HHHHhcCCCCccCCCHHHHHHHHHcC-CCCCCC--ccCCHHHHHHHHHHcCCChhhCCC---HHHHHHH
Confidence 99999 99999998877776665542 223333 4789999999999999 9999999 8888764
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=374.65 Aligned_cols=262 Identities=25% Similarity=0.393 Sum_probs=203.6
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
.....++|++++.||+|+||.||+|+++.+|+.||||++..... .......+..+..+++.++||||+++++++.+.+.
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 20 YQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp EECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 34566889999999999999999999999999999999986532 12223345555567888899999999999999999
Q ss_pred EEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcC-CEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+|+||||+ ++.+..++.. ...+++..+..++.||+.||.|||+. ||+||||||+|||++.++++||+|||+++....
T Consensus 99 ~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 99 VFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp EEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred EEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 99999999 6666665544 46799999999999999999999995 999999999999999999999999999876532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhHHhH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSL 343 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~DiwSl 343 (497)
... ....+||+.|+|||++. ...++.++|||||
T Consensus 178 ~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl 215 (318)
T 2dyl_A 178 DKA------------------------------------------KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSL 215 (318)
T ss_dssp ---------------------------------------------------CCTTCCHHHHC--------CCTHHHHHHH
T ss_pred Ccc------------------------------------------ccccCCCccccChhhcccccccccCCccccchhhH
Confidence 110 11357999999999995 5678999999999
Q ss_pred HHHHHHHHhCCCCCCCC-ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 344 GAIMYEMLVGYPPFYSD-DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
||++|+|++|..||... ...+....+... ....+|....+++++.+||.+||. ||.+||+ +.++++||||+..
T Consensus 216 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 216 GISLVELATGQFPYKNCKTDFEVLTKVLQE-EPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK---YNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHHHSSCTTTTCCSHHHHHHHHHHS-CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC---HHHHTTSHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCCccHHHHHHHhcc-CCCCCCccCCCCHHHHHHHHHHccCChhHCcC---HHHHhhCHHHHhc
Confidence 99999999999999874 445556666543 233445445789999999999999 9999999 9999999999853
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=380.30 Aligned_cols=266 Identities=26% Similarity=0.443 Sum_probs=197.1
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHH-HHHhcCCCceeEEEEEeec
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN-LLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~-il~~l~hp~Iv~l~~~~~~ 187 (497)
....+..++|.+++.||+|+||.||+|.++.+|+.||||++.... .......+..|.. +++.++||||+++++++.+
T Consensus 15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~ 92 (327)
T 3aln_A 15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR 92 (327)
T ss_dssp EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence 345677899999999999999999999999999999999997642 1223334445555 6778899999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHcC-CEEEcccCCCCeeecCCCcEEEcccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVAETVLAIESIHKH-HYIHRDIKPDNLLLDKYGHLRLSDFG 261 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~-~iiHrDLKp~NILl~~~g~vkL~DFG 261 (497)
.+.+|+||||++| +|.+++.. ...+++..+..++.|++.||.|||+. ||+||||||+|||++.+|.+||+|||
T Consensus 93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg 171 (327)
T 3aln_A 93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG 171 (327)
T ss_dssp SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence 9999999999975 78777753 57899999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccc----ccCCCCcc
Q 010947 262 LCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL----LKKGYGME 337 (497)
Q Consensus 262 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l----~~~~y~~~ 337 (497)
+++....... ....+||+.|+|||++ .+..++.+
T Consensus 172 ~~~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~~~~ 209 (327)
T 3aln_A 172 ISGQLVDSIA------------------------------------------KTRDAGCRPYMAPERIDPSASRQGYDVR 209 (327)
T ss_dssp SSCC------------------------------------------------------------------------CCSH
T ss_pred Cceecccccc------------------------------------------cccCCCCccccCceeeccccCcCCCCch
Confidence 9976532110 0134799999999999 46679999
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCChH-HHHHHHhcccCcccCC--CCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDDPM-STCRKIVNWRTHLKFP--EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~~~-~~~~~i~~~~~~~~~p--~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|||||||++|+|++|..||.+.+.. +....+... ....++ ....+++++.+||.+||. ||.+||+ +.++++
T Consensus 210 ~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~ 285 (327)
T 3aln_A 210 SDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK---YKELLK 285 (327)
T ss_dssp HHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS-CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCC---HHHHTT
T ss_pred hhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC-CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcC---HHHHHh
Confidence 99999999999999999999875432 222222221 111222 124689999999999999 9999999 999999
Q ss_pred CCCccCCChh
Q 010947 414 HPWFDGVDWA 423 (497)
Q Consensus 414 Hpff~~i~w~ 423 (497)
||||....+.
T Consensus 286 hp~~~~~~~~ 295 (327)
T 3aln_A 286 HPFILMYEER 295 (327)
T ss_dssp SHHHHHHHHS
T ss_pred ChHHHHhHhh
Confidence 9999865543
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=398.30 Aligned_cols=263 Identities=24% Similarity=0.363 Sum_probs=204.6
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
..+...+|.+.++||+|+||+|+. ....+|+.||||++.+.... .+.+|+.+|+.+ +|||||++++++.+..
T Consensus 19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 91 (432)
T 3p23_A 19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQ 91 (432)
T ss_dssp EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 345566799999999999999764 45578999999999764321 255799999998 7999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC---C--CcEEEcccccc
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---Y--GHLRLSDFGLC 263 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~---~--g~vkL~DFGla 263 (497)
.+|||||||+ |+|.+++.... .+++..+..++.||+.||.|||++|||||||||+|||++. + ..+||+|||+|
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a 170 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC 170 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence 9999999995 69999987653 4666678899999999999999999999999999999953 2 35889999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDW 340 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~Di 340 (497)
+.+....... ......+||+.|+|||++. ...++.++||
T Consensus 171 ~~~~~~~~~~--------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~t~~~Di 212 (432)
T 3p23_A 171 KKLAVGRHSF--------------------------------------SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDI 212 (432)
T ss_dssp ECC--------------------------------------------------CCSCTTSCCGGGTSCC---CCCTHHHH
T ss_pred eeccCCCcce--------------------------------------eeccccCCCcCccChhhhhcccccCCCcHHHH
Confidence 8764221000 0012468999999999998 4667889999
Q ss_pred HhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 341 WSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 341 wSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
|||||++|||++ |.+||...........+.... ....+.....+..+++||.+||+ ||.+||+ +.++++||||.
T Consensus 213 wSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~evl~hp~f~ 288 (432)
T 3p23_A 213 FSAGCVFYYVISEGSHPFGKSLQRQANILLGACS-LDCLHPEKHEDVIARELIEKMIAMDPQKRPS---AKHVLKHPFFW 288 (432)
T ss_dssp HHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCC-CTTSCTTCHHHHHHHHHHHHHSCSSGGGSCC---HHHHHTSTTTC
T ss_pred HHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCC-ccccCccccccHHHHHHHHHHHhCCHhhCCC---HHHHHhCcccc
Confidence 999999999999 999997665444332222211 11111223456779999999999 9999999 99999999999
Q ss_pred CCChh
Q 010947 419 GVDWA 423 (497)
Q Consensus 419 ~i~w~ 423 (497)
+++|.
T Consensus 289 ~~~~~ 293 (432)
T 3p23_A 289 SLEKQ 293 (432)
T ss_dssp CHHHH
T ss_pred ChHHH
Confidence 98883
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-46 Score=365.91 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=210.3
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhH----HHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ----VEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~----~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
..+..++|++.+.||+|+||.||+|++..+++.||||++.......... .+.+.+|+.+++.++||||+++++++.
T Consensus 14 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 14 PTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMH 93 (287)
T ss_dssp CBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEET
T ss_pred hhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeec
Confidence 3466789999999999999999999999999999999997654322222 256889999999999999999999998
Q ss_pred cCCeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCC--EEEcccCCCCeeecCCCc-----EEEc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGH-----LRLS 258 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDLKp~NILl~~~g~-----vkL~ 258 (497)
+.. ++||||++||+|.+++... ..+++..+..++.|++.||.|||+.| |+||||||+|||++.++. +||+
T Consensus 94 ~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 94 NPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp TTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred CCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 766 6999999999998888654 47999999999999999999999999 999999999999988876 9999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc--cCCCCc
Q 010947 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--KKGYGM 336 (497)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~--~~~y~~ 336 (497)
|||+|+..... ....+||+.|+|||++. ...++.
T Consensus 172 Dfg~~~~~~~~--------------------------------------------~~~~~g~~~y~aPE~~~~~~~~~~~ 207 (287)
T 4f0f_A 172 DFGLSQQSVHS--------------------------------------------VSGLLGNFQWMAPETIGAEEESYTE 207 (287)
T ss_dssp CCTTCBCCSSC--------------------------------------------EECCCCCCTTSCGGGSSCSSCEECH
T ss_pred CCCcccccccc--------------------------------------------ccccCCCccccCchhhccCCCCcCc
Confidence 99999743211 11467999999999994 456899
Q ss_pred chhHHhHHHHHHHHHhCCCCCCCCChHHH--HHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMST--CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 337 ~~DiwSlGvil~ell~G~~PF~~~~~~~~--~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++|||||||++|+|++|..||.+.+.... ...+........+| ..+++++.+||.+||. ||.+||+ +.++++
T Consensus 208 ~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~ 282 (287)
T 4f0f_A 208 KADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIP--EDCPPRLRNVIELCWSGDPKKRPH---FSYIVK 282 (287)
T ss_dssp HHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred hhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCC--cccCHHHHHHHHHHhcCChhhCcC---HHHHHH
Confidence 99999999999999999999987654333 34444322333344 3789999999999999 9999999 777764
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=374.75 Aligned_cols=258 Identities=21% Similarity=0.334 Sum_probs=218.6
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCc-----EEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGH-----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~-----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 183 (497)
...+..++|.+.+.||+|+||.||+|.+..++. .||+|++.... .......+.+|+.+++.+ +||||+++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 456778899999999999999999999977664 79999997643 233456788999999999 8999999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRK--------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL 249 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~--------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl 249 (497)
+|.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999999999998653 358999999999999999999999999999999999999
Q ss_pred cCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccc
Q 010947 250 DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL 329 (497)
Q Consensus 250 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l 329 (497)
+.++.+||+|||+++........ .......||+.|+|||++
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~~~~y~aPE~~ 238 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNY---------------------------------------IVKGNARLPVKWMAPESI 238 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTS---------------------------------------EECSSCEECGGGSCHHHH
T ss_pred CCCCeEEECccccccccccccce---------------------------------------eecCCCCCCccccCHHHh
Confidence 99999999999999865322100 001135688999999999
Q ss_pred ccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 330 LKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 330 ~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
.+..++.++|||||||++|||++ |.+||.+.........++........| ..+++++.+||.+||. ||.+||+
T Consensus 239 ~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps--- 313 (333)
T 2i1m_A 239 FDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP--AFAPKNIYSIMQACWALEPTHRPT--- 313 (333)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---
T ss_pred ccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC--CCCCHHHHHHHHHHhccChhhCcC---
Confidence 99999999999999999999998 999999877666666665533333333 4689999999999999 9999998
Q ss_pred cchhcC
Q 010947 408 ADEIKV 413 (497)
Q Consensus 408 ~~eil~ 413 (497)
+.++++
T Consensus 314 ~~~l~~ 319 (333)
T 2i1m_A 314 FQQICS 319 (333)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888765
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=370.79 Aligned_cols=255 Identities=26% Similarity=0.414 Sum_probs=206.1
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEE----EcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
.+..++|++++.||+|+||+||+|+ +..+++.||||++.... ....+.+.+|+.+++.++||||++++++|.+
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 4567889999999999999999998 56689999999997542 3445678899999999999999999999864
Q ss_pred --CCeEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 188 --DEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 188 --~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
...+|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++++||+|||+++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999997754 59999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlG 344 (497)
......... .......||+.|+|||++.+..++.++||||||
T Consensus 163 ~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 204 (295)
T 3ugc_A 163 VLPQDKEFF--------------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSFG 204 (295)
T ss_dssp ---------------------------------------------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred cccCCccee--------------------------------------eeccCCCCccceeCcHHhcCCCCChHHHHHHHH
Confidence 654221000 001134688899999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChH----------------HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 345 AIMYEMLVGYPPFYSDDPM----------------STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~----------------~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
|++|||++|..||...... .....+.. ... .|....+++++.+||.+||. ||.+||+
T Consensus 205 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps--- 278 (295)
T 3ugc_A 205 VVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN-NGR--LPRPDGCPDEIYMIMTECWNNNVNQRPS--- 278 (295)
T ss_dssp HHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT-TCC--CCCCTTCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred HHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc-cCc--CCCCcCcCHHHHHHHHHHcCCChhhCCC---
Confidence 9999999999998653211 11122221 122 33334789999999999999 9999998
Q ss_pred cchhcC
Q 010947 408 ADEIKV 413 (497)
Q Consensus 408 ~~eil~ 413 (497)
+.+++.
T Consensus 279 ~~el~~ 284 (295)
T 3ugc_A 279 FRDLAL 284 (295)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777653
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=384.84 Aligned_cols=257 Identities=19% Similarity=0.327 Sum_probs=207.5
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEc---CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREK---TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~---~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
..+...+|.+.+.||+|+||.||+|+++ .++..||||+++... .......+.+|+.+|+.++||||+++++++.+
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3456678999999999999999999887 467789999997542 33455678999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
...+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 999999999999999999997654 6999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
....... .......||+.|+|||++.+..++.++|||||||+
T Consensus 198 ~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~i 239 (373)
T 2qol_A 198 EDDPEAA--------------------------------------YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIV 239 (373)
T ss_dssp ------------------------------------------------------CTTSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred ccCCccc--------------------------------------eeccCCCcCCCccChhhhccCCcCchhcHHHHHHH
Confidence 4221000 00012346889999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 347 l~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|||++ |..||.+.+..+....+... ...|....++.++.+||.+||. ||.+||+ +.+|++
T Consensus 240 l~ellt~g~~P~~~~~~~~~~~~i~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~~i~~ 302 (373)
T 2qol_A 240 LWEVMSYGERPYWEMSNQDVIKAVDEG---YRLPPPMDCPAALYQLMLDCWQKDRNNRPK---FEQIVS 302 (373)
T ss_dssp HHHHHTTC-CTTTTCCHHHHHHHHHTT---EECCCCTTCBHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHcC---CCCCCCccccHHHHHHHHHHhCcChhhCcC---HHHHHH
Confidence 999998 99999998888877777642 2333334789999999999999 9999998 777664
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=361.81 Aligned_cols=252 Identities=18% Similarity=0.287 Sum_probs=217.3
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
..+..++|++.+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 77 (267)
T 3t9t_A 3 WVIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAP 77 (267)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred eEEchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3456788999999999999999999986 677899999986542 23568899999999999999999999999999
Q ss_pred EEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 78 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~ 157 (267)
T 3t9t_A 78 ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157 (267)
T ss_dssp CEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCH
T ss_pred eEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccc
Confidence 99999999999999999765 56999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
.. .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 158 ~~----------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 197 (267)
T 3t9t_A 158 QY----------------------------------------TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWE 197 (267)
T ss_dssp HH----------------------------------------HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred cc----------------------------------------cccccccccccccChhhhcCCCccchhchhhhHHHHHH
Confidence 00 00113568899999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+||+ +.++++
T Consensus 198 l~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 257 (267)
T 3t9t_A 198 VFSEGKIPYENRSNSEVVEDISTGF-RLYKP--RLASTHVYQIMNHCWRERPEDRPA---FSRLLR 257 (267)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTC-CCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HhccCCCCCCCCCHHHHHHHHhcCC-cCCCC--ccCcHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 999 999999988888888777532 22233 3689999999999999 9999998 888765
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=373.42 Aligned_cols=259 Identities=22% Similarity=0.338 Sum_probs=216.1
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEE-----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCRE-----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~-----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 183 (497)
...+..++|.+.+.||+|+||.||+|++ ..+++.||||++.... .......+.+|+.++..+ +||||+++++
T Consensus 21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 4456778999999999999999999985 3567899999997643 233456788999999999 7899999999
Q ss_pred EeecCC-eEEEEEeecCCCchhHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCC
Q 010947 184 SFQDDE-FLYLIMEYLPGGDMMTLLMRKDT----------------LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (497)
Q Consensus 184 ~~~~~~-~l~lVmEy~~gg~L~~~l~~~~~----------------l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~N 246 (497)
+|.+.+ .+|+||||++||+|.+++..... +++..+..++.||+.||.|||+.||+||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 988654 59999999999999999977544 8999999999999999999999999999999999
Q ss_pred eeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCc
Q 010947 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (497)
Q Consensus 247 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 326 (497)
||++.++++||+|||+++........ .......||+.|+||
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~---------------------------------------~~~~~~~~t~~y~aP 219 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDY---------------------------------------VRKGDARLPLKWMAP 219 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTS---------------------------------------EEETTEEECGGGCCH
T ss_pred EEECCCCCEEECCCccccccccCccc---------------------------------------eeccCCCcceeecCc
Confidence 99999999999999999865422110 001145689999999
Q ss_pred cccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 327 E~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|++.+..++.++|||||||++|+|++ |.+||.+..........+........| ..+++++.+||.+||. ||.+||+
T Consensus 220 E~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps 297 (316)
T 2xir_A 220 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPT 297 (316)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC--CCCCHHHHHHHHHHcCCChhhCcC
Confidence 99999999999999999999999998 999998876555444444323333444 3689999999999999 9999998
Q ss_pred CCCcchhcCC
Q 010947 405 AKGADEIKVH 414 (497)
Q Consensus 405 ~~~~~eil~H 414 (497)
+.++++|
T Consensus 298 ---~~ell~~ 304 (316)
T 2xir_A 298 ---FSELVEH 304 (316)
T ss_dssp ---HHHHHHH
T ss_pred ---HHHHHHH
Confidence 8888765
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=374.39 Aligned_cols=252 Identities=29% Similarity=0.491 Sum_probs=207.1
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hHHHHHHHHHHHHHhc----CCCceeEEEEEe
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEV----DSNCIVKLYCSF 185 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l----~hp~Iv~l~~~~ 185 (497)
...++|++.+.||+|+||.||+|++..+++.||||++........ .....+..|+.++..+ +||||++++++|
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~ 107 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWF 107 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEE
Confidence 446789999999999999999999999999999999976543221 1223356789999888 899999999999
Q ss_pred ecCCeEEEEEee-cCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec-CCCcEEEcccccc
Q 010947 186 QDDEFLYLIMEY-LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLC 263 (497)
Q Consensus 186 ~~~~~l~lVmEy-~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~-~~g~vkL~DFGla 263 (497)
.+.+..|+|||| +.|++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus 108 ~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 108 ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp -----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred ecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 999999999999 78999999999888999999999999999999999999999999999999999 8899999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCC-cchhHHh
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG-MECDWWS 342 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~-~~~DiwS 342 (497)
+...... .....||+.|+|||++.+..+. .++||||
T Consensus 188 ~~~~~~~-------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s 224 (312)
T 2iwi_A 188 ALLHDEP-------------------------------------------YTDFDGTRVYSPPEWISRHQYHALPATVWS 224 (312)
T ss_dssp EECCSSC-------------------------------------------BCCCCSCTTTSCHHHHHHSCBCHHHHHHHH
T ss_pred hhcccCc-------------------------------------------ccccCCcccccCceeeecCCCCCccchHHH
Confidence 8654221 1145799999999999877764 5899999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|||++|+|++|..||.+.. .+.. ....+|. .++.++++||.+||. ||.+||+ +.++++||||+..
T Consensus 225 lG~il~~l~~g~~pf~~~~------~~~~--~~~~~~~--~~~~~~~~li~~~l~~~p~~Rps---~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 225 LGILLYDMVCGDIPFERDQ------EILE--AELHFPA--HVSPDCCALIRRCLAPKPSSRPS---LEEILLDPWMQTP 290 (312)
T ss_dssp HHHHHHHHHHSSCSCCSHH------HHHH--TCCCCCT--TSCHHHHHHHHHHTCSSTTTSCC---HHHHHHSTTTCC-
T ss_pred HHHHHHHHHHCCCCCCChH------HHhh--hccCCcc--cCCHHHHHHHHHHccCChhhCcC---HHHHhcChhhcCc
Confidence 9999999999999997532 2222 2344553 689999999999999 9999999 9999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=372.87 Aligned_cols=257 Identities=21% Similarity=0.349 Sum_probs=218.1
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEc-------CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-------TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-------~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 181 (497)
...+..++|.+.+.||+|+||.||+|++. .++..||||++.... .......+.+|+.+++.+ +||||+++
T Consensus 29 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 29 KWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 44566789999999999999999999985 457789999997643 234556788999999999 99999999
Q ss_pred EEEeecCCeEEEEEeecCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCC
Q 010947 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (497)
Q Consensus 182 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~ 245 (497)
+++|.+.+.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999997654 3899999999999999999999999999999999
Q ss_pred CeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccC
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 325 (497)
|||++.+|.+||+|||+++......... ......||+.|+|
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 227 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYK---------------------------------------KTTNGRLPVKWMA 227 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEE---------------------------------------CCSCCCCCGGGCC
T ss_pred eEEEcCCCCEEEcccccccccccccccc---------------------------------------ccCCCCcccceeC
Confidence 9999999999999999998664321100 0113468899999
Q ss_pred ccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 326 PE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
||++.+..++.++|||||||++|||++ |.+||.+.+..+....+.... ....| ..++.++.+||.+||. ||.+||
T Consensus 228 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rp 304 (334)
T 2pvf_A 228 PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGH-RMDKP--ANCTNELYMMMRDCWHAVPSQRP 304 (334)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred hHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCC-CCCCC--ccCCHHHHHHHHHHccCChhhCc
Confidence 999999999999999999999999999 999999988888777766532 23333 4789999999999999 999999
Q ss_pred CCCCcchhcC
Q 010947 404 GAKGADEIKV 413 (497)
Q Consensus 404 ~~~~~~eil~ 413 (497)
+ +.++++
T Consensus 305 s---~~ell~ 311 (334)
T 2pvf_A 305 T---FKQLVE 311 (334)
T ss_dssp C---HHHHHH
T ss_pred C---HHHHHH
Confidence 8 888775
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=375.02 Aligned_cols=252 Identities=23% Similarity=0.401 Sum_probs=213.6
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEE--EEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVY--AMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~--AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
+..++|++.+.||+|+||.||+|+++.+|..+ |+|++.... .......+.+|+.++..+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 55688999999999999999999999888865 999987532 233455688999999999 9999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g 253 (497)
.+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997654 799999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC
Q 010947 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (497)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~ 333 (497)
.+||+|||+++...... ......+|+.|+|||++.+..
T Consensus 180 ~~kL~Dfg~~~~~~~~~------------------------------------------~~~~~~~~~~y~aPE~~~~~~ 217 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSV 217 (327)
T ss_dssp CEEECCTTCEESSCEEC------------------------------------------CC----CCTTTCCHHHHHHCE
T ss_pred eEEEcccCcCccccccc------------------------------------------cccCCCCCccccChhhhcccc
Confidence 99999999987432110 001345789999999999999
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 334 y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
++.++|||||||++|||++ |.+||.+.+..+....+... .....| ..+++++++||.+||. ||.+||+ +.++
T Consensus 218 ~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~el 291 (327)
T 1fvr_A 218 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERPS---FAQI 291 (327)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-CCCCCC--CCCCHHHHHHHHHHccCChhhCcC---HHHH
Confidence 9999999999999999998 99999999888877776642 222333 4789999999999999 9999998 8888
Q ss_pred cCC
Q 010947 412 KVH 414 (497)
Q Consensus 412 l~H 414 (497)
+.|
T Consensus 292 l~~ 294 (327)
T 1fvr_A 292 LVS 294 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 764
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=396.82 Aligned_cols=254 Identities=21% Similarity=0.345 Sum_probs=219.8
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.+.+...+|.+.+.||+|+||.||+|.++.++..||||+++... ...+.+.+|+.+|+.++|||||+++++|.+..
T Consensus 214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~ 289 (495)
T 1opk_A 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 289 (495)
T ss_dssp CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 34566778999999999999999999999999999999997643 23566889999999999999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+|||||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 290 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 290 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp SCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred cEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999999999763 459999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
..... ......+|+.|+|||++....|+.++|||||||++
T Consensus 370 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l 409 (495)
T 1opk_A 370 GDTYT----------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLL 409 (495)
T ss_dssp TCCEE----------------------------------------CCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------ecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHH
Confidence 22110 01134578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +.+|++
T Consensus 410 ~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~RPs---~~el~~ 471 (495)
T 1opk_A 410 WEIATYGMSPYPGIDLSQVYELLEKD-YRMERP--EGCPEKVYELMRACWQWNPSDRPS---FAEIHQ 471 (495)
T ss_dssp HHHHTTSCCSSTTCCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCcChhHCcC---HHHHHH
Confidence 99999 99999998888777766542 233344 4789999999999999 9999998 777754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=365.55 Aligned_cols=258 Identities=22% Similarity=0.320 Sum_probs=215.2
Q ss_pred hcCCCCCCeeEEe-EeeecCCeEEEEEEE--cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 110 RHKMGADDFELLT-MIGKGAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 110 ~~~~~~~~f~~~~-~IG~G~fG~V~~~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
...+...+|.+.+ .||+|+||.||+|.+ ..+++.||||++.... ......+.+.+|+.+++.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 4456677899998 999999999999954 5678899999997653 2334456789999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
..+.+|+||||++||+|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 56778999999999999999998888999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
........ ......||+.|+|||++.+..++.++|||||||+
T Consensus 168 ~~~~~~~~--------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 209 (291)
T 1xbb_A 168 RADENYYK--------------------------------------AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVL 209 (291)
T ss_dssp CTTCSEEE--------------------------------------C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred ccCCCccc--------------------------------------ccccCCCCceeeChHHhccCCCChhhhHHHHHHH
Confidence 43211000 0112457899999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 347 l~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|+|++ |.+||.+.+..+....+... ....+| ..+++++.+||.+||. ||.+||+ +.++++
T Consensus 210 l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~l~~ 272 (291)
T 1xbb_A 210 MWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCP--AGCPREMYDLMNLCWTYDVENRPG---FAAVEL 272 (291)
T ss_dssp HHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSCC---HHHHHH
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 999999 99999998888777776653 233444 3789999999999999 9999998 777654
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=363.37 Aligned_cols=256 Identities=23% Similarity=0.339 Sum_probs=216.5
Q ss_pred CCCCCCeeEEe-EeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 112 KMGADDFELLT-MIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 112 ~~~~~~f~~~~-~IG~G~fG~V~~~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
.+..++|.+.. .||+|+||.||+|.++ .++..||||+++... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C
Confidence 45567888887 9999999999999864 467889999998642 3445677899999999999999999999994 5
Q ss_pred CeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
+.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 5689999999999999998654 569999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
...... .......||+.|+|||++.+..++.++|||||||++
T Consensus 162 ~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 203 (287)
T 1u59_A 162 ADDSYY--------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTM 203 (287)
T ss_dssp TCSCEE--------------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHH
T ss_pred cCccee--------------------------------------eccccccccccccCHHHhccCCCCchhhHHHHHHHH
Confidence 321100 001134679999999999989999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|||++ |.+||.+.+..+....+... ....+| ..+++++.+||.+||. ||.+||+ +.++++|
T Consensus 204 ~ellt~g~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~~ 266 (287)
T 1u59_A 204 WEALSYGQKPYKKMKGPEVMAFIEQG-KRMECP--PECPPELYALMSDCWIYKWEDRPD---FLTVEQR 266 (287)
T ss_dssp HHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred HHHHcCCCCCcccCCHHHHHHHHhcC-CcCCCC--CCcCHHHHHHHHHHcCCChhhCcC---HHHHHHH
Confidence 99998 99999998888877777653 233444 3789999999999999 9999998 8888765
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=373.54 Aligned_cols=254 Identities=19% Similarity=0.228 Sum_probs=202.0
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE- 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~- 189 (497)
..+..++|++++.||+|+||+||+|++. ++.||||++.... ........|+.+++.++|||||++++++.+..
T Consensus 19 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 92 (322)
T 3soc_A 19 LYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92 (322)
T ss_dssp EEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred cccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence 3456788999999999999999999875 7899999997543 23334556888899999999999999998743
Q ss_pred ---eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC----------CEEEcccCCCCeeecCCCcEE
Q 010947 190 ---FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH----------HYIHRDIKPDNLLLDKYGHLR 256 (497)
Q Consensus 190 ---~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~----------~iiHrDLKp~NILl~~~g~vk 256 (497)
.+|+|||||++|+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+|
T Consensus 93 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k 171 (322)
T 3soc_A 93 VDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171 (322)
T ss_dssp SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred CCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence 47999999999999999965 5699999999999999999999999 999999999999999999999
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-----
Q 010947 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK----- 331 (497)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~----- 331 (497)
|+|||+|+.+....... .....+||+.|+|||++.+
T Consensus 172 L~DFg~a~~~~~~~~~~---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ 212 (322)
T 3soc_A 172 IADFGLALKFEAGKSAG---------------------------------------DTHGQVGTRRYMAPEVLEGAINFQ 212 (322)
T ss_dssp ECCCTTCEEECTTSCCC---------------------------------------CCTTCCCCGGGCCHHHHTTCCCCC
T ss_pred EccCCcccccccccCcc---------------------------------------ccccCccCccccCHhhcccccccC
Confidence 99999998764321100 0124689999999999986
Q ss_pred CCCCcchhHHhHHHHHHHHHhCCCCCCCCCh----------------HHHHHHHhcccCcccCCC---CccCChhHHHHH
Q 010947 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDP----------------MSTCRKIVNWRTHLKFPE---EAKLSIEAKDLI 392 (497)
Q Consensus 332 ~~y~~~~DiwSlGvil~ell~G~~PF~~~~~----------------~~~~~~i~~~~~~~~~p~---~~~~s~~~~dLI 392 (497)
..++.++|||||||++|||++|.+||.+... ......+........++. ....++++.+||
T Consensus 213 ~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 292 (322)
T 3soc_A 213 RDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETI 292 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHH
T ss_pred cCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHH
Confidence 3567789999999999999999999976431 222222332222222221 112345699999
Q ss_pred HHHhh-CccccCCCCCcchhcC
Q 010947 393 SKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 393 ~~lL~-dp~~R~~~~~~~eil~ 413 (497)
.+||. ||.+||+ +.++++
T Consensus 293 ~~cl~~dP~~Rps---~~ell~ 311 (322)
T 3soc_A 293 EECWDHDAEARLS---AGCVGE 311 (322)
T ss_dssp HHHTCSSGGGSCC---HHHHHH
T ss_pred HHHccCChhhCcC---HHHHHH
Confidence 99999 9999999 777764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=374.95 Aligned_cols=261 Identities=18% Similarity=0.291 Sum_probs=216.6
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEE-----EcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~-----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
.+..++|.+++.||+|+||.||+|+ ...++..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 4667899999999999999999998 55678899999996432 2334556889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC---CcEE
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRK-------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLR 256 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~---g~vk 256 (497)
+...+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.+ +.+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999999765 348999999999999999999999999999999999999944 4699
Q ss_pred EcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCc
Q 010947 257 LSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGM 336 (497)
Q Consensus 257 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~ 336 (497)
|+|||+++......... ......||+.|+|||++.+..++.
T Consensus 184 l~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ 224 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYR---------------------------------------KGGCAMLPVKWMPPEAFMEGIFTS 224 (327)
T ss_dssp ECCCHHHHHHHC---------------------------------------------CCGGGSCGGGCCHHHHHHCCCCH
T ss_pred ECccccccccccccccc---------------------------------------cCCCcCCCcceeCHhHhcCCCCCc
Confidence 99999997553221000 011357899999999999999999
Q ss_pred chhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 337 ECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 337 ~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
++|||||||++|+|++ |.+||.+.+..+....+.... ....| ..+++.+.+||.+||. ||.+||+ +.++++|
T Consensus 225 ~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 298 (327)
T 2yfx_A 225 KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPP--KNCPGPVYRIMTQCWQHQPEDRPN---FAIILER 298 (327)
T ss_dssp HHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHhcCChhhCcC---HHHHHHH
Confidence 9999999999999998 999999988887777776532 22333 4789999999999999 9999998 9999999
Q ss_pred CCccC
Q 010947 415 PWFDG 419 (497)
Q Consensus 415 pff~~ 419 (497)
.|+-.
T Consensus 299 l~~~~ 303 (327)
T 2yfx_A 299 IEYCT 303 (327)
T ss_dssp HHHHH
T ss_pred HHHHh
Confidence 88753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=373.13 Aligned_cols=253 Identities=20% Similarity=0.338 Sum_probs=208.1
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEE----EEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVY----AMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~----AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
+..++|++++.||+|+||.||+|++..+++.+ |+|.+.... .......+.+|+.+++.++||||++++++|.+.
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 56789999999999999999999999888866 555554321 233456788999999999999999999999876
Q ss_pred CeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
. .++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+...
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred C-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 5 7899999999999999976 4579999999999999999999999999999999999999999999999999998654
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
..... .......||+.|+|||++.+..|+.++|||||||++
T Consensus 169 ~~~~~---------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 209 (327)
T 3lzb_A 169 AEEKE---------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 209 (327)
T ss_dssp --------------------------------------------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred Ccccc---------------------------------------ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHH
Confidence 22100 001134678899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++ |.+||.+.+..+....+... ..... ...++.++.+||.+||. ||.+||+ +.+++.
T Consensus 210 ~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps---~~ell~ 271 (327)
T 3lzb_A 210 WELMTFGSKPYDGIPASEISSILEKG-ERLPQ--PPICTIDVYMIMRKCWMIDADSRPK---FRELII 271 (327)
T ss_dssp HHHHTTSCCTTTTCCGGGHHHHHHTT-CCCCC--CTTBCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCC--CccCCHHHHHHHHHHcCCChhHCcC---HHHHHH
Confidence 99999 99999998887777666542 22333 34789999999999999 9999999 888876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=386.09 Aligned_cols=248 Identities=21% Similarity=0.388 Sum_probs=213.8
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
..+.+..++|++++.||+|+||.||+|... |+.||||+++... ..+.+.+|+.+|+.++|||||++++++.+.
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 258 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEE 258 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECT
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcC
Confidence 345678889999999999999999999875 7799999997643 345688999999999999999999998765
Q ss_pred C-eEEEEEeecCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 189 E-FLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 189 ~-~l~lVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
. .+|+|||||+||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 338 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 338 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccc
Confidence 4 79999999999999999987653 79999999999999999999999999999999999999999999999999985
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
.... .....+|+.|+|||++.+..|+.++|||||||
T Consensus 339 ~~~~--------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~ 374 (450)
T 1k9a_A 339 ASST--------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGI 374 (450)
T ss_dssp CC--------------------------------------------------CCCTTTSCHHHHHSSCCCHHHHHHHHHH
T ss_pred cccc--------------------------------------------ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHH
Confidence 4211 01235789999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 346 il~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++|||++ |.+||.+.+..+....+... ..+..| ..+++++.+||.+||. ||.+||+ +.+++.
T Consensus 375 ~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dp~~Rpt---~~~l~~ 438 (450)
T 1k9a_A 375 LLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYDVMKNCWHLDAATRPT---FLQLRE 438 (450)
T ss_dssp HHHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CcCCHHHHHHHHHHcCCChhHCcC---HHHHHH
Confidence 9999998 99999998887777777653 233444 4789999999999999 9999998 766653
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=365.44 Aligned_cols=257 Identities=22% Similarity=0.368 Sum_probs=207.8
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEE----EcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
.+....|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+++.++||||++++++|.+
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 3455679999999999999999999 56789999999997653 23445678999999999999999999999987
Q ss_pred C--CeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 188 D--EFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 188 ~--~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
. ..+|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 679999999999999999954 4679999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlG 344 (497)
......... .......||+.|+|||++.+..++.++||||||
T Consensus 175 ~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 216 (302)
T 4e5w_A 175 AIETDKEYY--------------------------------------TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFG 216 (302)
T ss_dssp ECCTTCCEE--------------------------------------ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHH
T ss_pred cccCCCcce--------------------------------------eccCCCCCCccccCCeeecCCCCCcchhHHHHH
Confidence 764321100 011245789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCC--------------ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcc
Q 010947 345 AIMYEMLVGYPPFYSD--------------DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409 (497)
Q Consensus 345 vil~ell~G~~PF~~~--------------~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ 409 (497)
|++|+|++|..|+... .........+........| ..+++++.+||.+||. ||.+||+ +.
T Consensus 217 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~ 291 (302)
T 4e5w_A 217 VTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP--PNCPDEVYQLMRKCWEFQPSNRTS---FQ 291 (302)
T ss_dssp HHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHTTCSSGGGSCC---HH
T ss_pred HHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCC--CCCCHHHHHHHHHHcCCCCCCCCC---HH
Confidence 9999999999986422 1122222222222233333 4789999999999999 9999998 77
Q ss_pred hhcC
Q 010947 410 EIKV 413 (497)
Q Consensus 410 eil~ 413 (497)
++++
T Consensus 292 ~ll~ 295 (302)
T 4e5w_A 292 NLIE 295 (302)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=365.98 Aligned_cols=255 Identities=29% Similarity=0.497 Sum_probs=205.0
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
....+|++.+.||+|+||.||+|.+..+|+.||||++.............+.+|+.+++.++||||++++++|.+.+.+|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34568999999999999999999999999999999998755445556677899999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 193 LIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 99999999999999864 46699999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
... ......||+.|+|||++.+..++.++|||||||++|
T Consensus 189 ~~~-----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ 227 (310)
T 2wqm_A 189 KTT-----------------------------------------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLY 227 (310)
T ss_dssp ---------------------------------------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CCc-----------------------------------------cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHH
Confidence 110 011457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCC--hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 349 EMLVGYPPFYSDD--PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 349 ell~G~~PF~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|++|..||.+.. .......+.... ....+ ...+++++.+||.+||. ||.+||+ +.++++
T Consensus 228 ~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~l~~li~~~l~~dp~~Rps---~~~il~ 290 (310)
T 2wqm_A 228 EMAALQSPFYGDKMNLYSLCKKIEQCD-YPPLP-SDHYSEELRQLVNMCINPDPEKRPD---VTYVYD 290 (310)
T ss_dssp HHHHSSCTTC---CCHHHHHHHHHTTC-SCCCC-TTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHhCCCCCcccchhHHHHHHHhhccc-CCCCc-ccccCHHHHHHHHHHcCCChhhCCC---HHHHHH
Confidence 9999999998753 334444554322 11122 24689999999999999 9999998 888765
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=370.62 Aligned_cols=257 Identities=20% Similarity=0.302 Sum_probs=212.3
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
..+...+|.+.+.||+|+||.||+|.++.++ ..||||++.... .......+.+|+.+++.++||||+++++++.
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS 116 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence 3567789999999999999999999987653 359999997542 2344556889999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 117 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 117 KYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred cCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999999999764 6799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
........ .......||+.|+|||++.+..++.++|||||||
T Consensus 197 ~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 238 (333)
T 1mqb_A 197 LEDDPEAT--------------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI 238 (333)
T ss_dssp ----------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred hccccccc--------------------------------------cccCCCCccccccCchhcccCCCCchhhhHHHHH
Confidence 54221000 0011345788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 346 il~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++|||++ |..||.+.+..+....+... ...|....+++++.+||.+||. ||.+||+ +.++++
T Consensus 239 il~ellt~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 302 (333)
T 1mqb_A 239 VMWEVMTYGERPYWELSNHEVMKAINDG---FRLPTPMDCPSAIYQLMMQCWQQERARRPK---FADIVS 302 (333)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHTT---CCCCCCTTCBHHHHHHHHHHTCSSTTTSCC---HHHHHH
T ss_pred HHHHHHcCCCCCcccCCHHHHHHHHHCC---CcCCCcccCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 9999998 99999998888888777653 2233334789999999999999 9999998 777765
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=365.13 Aligned_cols=258 Identities=21% Similarity=0.339 Sum_probs=208.5
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcC-CCc--EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKT-TGH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~-t~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
.+..++|++++.||+|+||.||+|++.. ++. .||||+++..........+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3556789999999999999999998643 333 6999999876544455667899999999999999999999999876
Q ss_pred CeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
. .++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 5 88999999999999999764 579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
...... .......||+.|+|||++.+..++.++|||||||++
T Consensus 173 ~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 214 (291)
T 1u46_A 173 QNDDHY--------------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTL 214 (291)
T ss_dssp C-CCEE--------------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred ccccch--------------------------------------hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHH
Confidence 321100 001135688999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|+|++ |.+||.+.+..+....+......... ...++.++++||.+||. ||.+||+ +.++++
T Consensus 215 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 277 (291)
T 1u46_A 215 WEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPT---FVALRD 277 (291)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCcccCCHHHHHHHHHccCCCCCC--CcCcCHHHHHHHHHHccCCcccCcC---HHHHHH
Confidence 99999 99999999988888888764333333 34789999999999999 9999998 888775
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=388.87 Aligned_cols=252 Identities=21% Similarity=0.343 Sum_probs=215.2
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.+.+..++|.+.+.||+|+||+||+|.++ ++..||||+++... ...+.+.+|+.+|+.++|||||++++++. ..
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 34567788999999999999999999985 46789999998643 23567899999999999999999999986 56
Q ss_pred eEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 789999999999999999754 368999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
..... ......+|+.|+|||++....|+.++|||||||++
T Consensus 336 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l 375 (454)
T 1qcf_A 336 DNEYT----------------------------------------AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILL 375 (454)
T ss_dssp CHHHH----------------------------------------TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHH
Confidence 21100 01134578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +++|+.
T Consensus 376 ~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dp~~RPt---~~~i~~ 437 (454)
T 1qcf_A 376 MEIVTYGRIPYPGMSNPEVIRALERG-YRMPRP--ENCPEELYNIMMRCWKNRPEERPT---FEYIQS 437 (454)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHccCChhHCcC---HHHHHH
Confidence 99999 99999999888888777653 223333 4799999999999999 9999999 777653
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=371.24 Aligned_cols=255 Identities=24% Similarity=0.397 Sum_probs=210.3
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEE----EcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee--
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCR----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-- 186 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~----~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-- 186 (497)
+..++|++++.||+|+||.||+|+ ...++..||||++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 456789999999999999999999 46789999999997643 344567899999999999999999999886
Q ss_pred cCCeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
+...+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 55679999999999999999976 45699999999999999999999999999999999999999999999999999987
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
........ .......||+.|+|||++.+..++.++|||||||
T Consensus 177 ~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 218 (327)
T 3lxl_A 177 LPLDKDYY--------------------------------------VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGV 218 (327)
T ss_dssp CCTTCSEE--------------------------------------ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHH
T ss_pred cccCCccc--------------------------------------eeeccCCccccccCHHHhccCCCChHHhHHHHHH
Confidence 64321100 0011356899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChH--------------HHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcch
Q 010947 346 IMYEMLVGYPPFYSDDPM--------------STCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~--------------~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~e 410 (497)
++|+|++|..||...... ......+........ ...+++++.+||.+||. ||.+||+ +.+
T Consensus 219 il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps---~~e 293 (327)
T 3lxl_A 219 VLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPA--PPACPAEVHELMKLCWAPSPQDRPS---FSA 293 (327)
T ss_dssp HHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCC---HHH
T ss_pred HHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCC--CCcccHHHHHHHHHHcCCChhhCcC---HHH
Confidence 999999999999754322 111222221222233 34789999999999999 9999999 777
Q ss_pred hcC
Q 010947 411 IKV 413 (497)
Q Consensus 411 il~ 413 (497)
+++
T Consensus 294 ll~ 296 (327)
T 3lxl_A 294 LGP 296 (327)
T ss_dssp HHH
T ss_pred HHH
Confidence 753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=361.64 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=212.8
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
..+..++|.+.+.||+|+||.||+|.+.. ++..||+|++.+.. .....+.+.+|+.+++.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 7 YGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE 84 (281)
T ss_dssp CSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS
T ss_pred ceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC
Confidence 34567889999999999999999998754 34469999998653 23345678999999999999999999999875
Q ss_pred CCeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
+ ..|+||||++||+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 85 E-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp S-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred C-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 4 568999999999999999765 45999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
...... ......||+.|+|||++.+..++.++|||||||+
T Consensus 164 ~~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 203 (281)
T 3cc6_A 164 EDEDYY----------------------------------------KASVTRLPIKWMSPESINFRRFTTASDVWMFAVC 203 (281)
T ss_dssp -------------------------------------------------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred cccccc----------------------------------------ccccCCCCcceeCchhhccCCCCchhccHHHHHH
Confidence 322100 0113467899999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 347 l~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
+|+|++ |.+||...+.......+... .....| ..+++.+.+||.+||. ||.+||+ +.+++++
T Consensus 204 l~~llt~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~ell~~ 267 (281)
T 3cc6_A 204 MWEILSFGKQPFFWLENKDVIGVLEKG-DRLPKP--DLCPPVLYTLMTRCWDYDPSDRPR---FTELVCS 267 (281)
T ss_dssp HHHHHTTTCCTTTTSCGGGHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhCCCCCcccCChHHHHHHHhcC-CCCCCC--CCCCHHHHHHHHHHccCCchhCcC---HHHHHHH
Confidence 999998 99999988777777666542 233333 4689999999999999 9999998 8887753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=378.86 Aligned_cols=275 Identities=17% Similarity=0.195 Sum_probs=206.0
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCC-----CcEEEEEEeechhhhchh--------HHHHHHHHHHHHHhcCCCcee
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTT-----GHVYAMKKLKKSEMLRRG--------QVEHVRAERNLLAEVDSNCIV 179 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t-----~~~~AiK~l~k~~~~~~~--------~~~~~~~E~~il~~l~hp~Iv 179 (497)
+..++|++.+.||+|+||.||+|.++.+ ++.||||++......... ....+..|+..+..++||||+
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv 111 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP 111 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence 3456899999999999999999998765 578999998764311111 112244566677788999999
Q ss_pred EEEEEeecC----CeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec--CC
Q 010947 180 KLYCSFQDD----EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KY 252 (497)
Q Consensus 180 ~l~~~~~~~----~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~--~~ 252 (497)
++++++.+. .++||||||| ||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++ .+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~ 190 (364)
T 3op5_A 112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP 190 (364)
T ss_dssp CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence 999998764 5689999999 99999999775 6799999999999999999999999999999999999999 88
Q ss_pred CcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC
Q 010947 253 GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK 332 (497)
Q Consensus 253 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~ 332 (497)
+++||+|||+|+.+......... ........+||+.|+|||++.+.
T Consensus 191 ~~~kl~DFG~a~~~~~~~~~~~~----------------------------------~~~~~~~~~gt~~y~aPE~~~~~ 236 (364)
T 3op5_A 191 DQVYLVDYGLAYRYCPEGVHKAY----------------------------------AADPKRCHDGTIEFTSIDAHNGV 236 (364)
T ss_dssp TCEEECCCTTCEESSGGGCCCCS----------------------------------SCCSSCCCCCCTTTCCHHHHTTC
T ss_pred CeEEEEECCcceecccCCccccc----------------------------------ccCcccccCCCCCccCHHHhCCC
Confidence 99999999999876432110000 00001246799999999999999
Q ss_pred CCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhc--ccCcc------cCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVN--WRTHL------KFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 333 ~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~--~~~~~------~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
.|+.++|||||||++|||++|..||.+............ ....+ .++ ...+++++.+||..||. ||.+||
T Consensus 237 ~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~~p~~RP 315 (364)
T 3op5_A 237 APSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFP-AANAPGEIAKYMETVKLLDYTEKP 315 (364)
T ss_dssp CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSC-TTCCCHHHHHHHHHHHTCCTTCCC
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcc-cccCHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999999986433222221111 00000 111 13678999999999999 999999
Q ss_pred CCCCcchhcC----------CCCccCCChhhhh
Q 010947 404 GAKGADEIKV----------HPWFDGVDWARIY 426 (497)
Q Consensus 404 ~~~~~~eil~----------Hpff~~i~w~~l~ 426 (497)
+ +.+|++ .++...++|....
T Consensus 316 ~---~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 316 L---YENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp C---HHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred C---HHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 9 555543 3444555555443
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=358.60 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=214.0
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.+.+..++|++++.||+|+||.||+|.+. ++..||||++..... ..+.+.+|+.+++.++||||+++++++.+ +
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~ 80 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-C
Confidence 34566789999999999999999999875 567899999976432 24568899999999999999999998864 5
Q ss_pred eEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 6899999999999999996543 79999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 161 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 200 (279)
T 1qpc_A 161 DNEYT----------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (279)
T ss_dssp SSCEE----------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred Ccccc----------------------------------------cccCCCCccCccChhhhccCCCCchhhhHHHHHHH
Confidence 32110 01134678899999999989999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +.++++
T Consensus 201 ~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 262 (279)
T 1qpc_A 201 TEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRP--DNCPEELYQLMRLCWKERPEDRPT---FDYLRS 262 (279)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCc--ccccHHHHHHHHHHhccChhhCCC---HHHHHH
Confidence 99999 99999998888887777653 222333 4789999999999999 9999998 777654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=382.99 Aligned_cols=253 Identities=26% Similarity=0.427 Sum_probs=208.2
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC--e
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE--F 190 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~--~ 190 (497)
...++|.+.+.||+|+||+||+|+++.+|+.||||++..... ......+.+|+.+|+.++||||+++++++.+.. .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 446789999999999999999999999999999999986543 233556788999999999999999999998755 7
Q ss_pred EEEEEeecCCCchhHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee----cCCCcEEEcccccc
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDT---LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL----DKYGHLRLSDFGLC 263 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~---l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl----~~~g~vkL~DFGla 263 (497)
+|+|||||+||+|.+++..... +++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 8999999999999999976433 9999999999999999999999999999999999999 78888999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--------CCCC
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--------KGYG 335 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--------~~y~ 335 (497)
+...... ...+.+||+.|+|||++.+ ..|+
T Consensus 164 ~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~ 201 (396)
T 4eut_A 164 RELEDDE------------------------------------------QFVSLYGTEEYLHPDMYERAVLRKDHQKKYG 201 (396)
T ss_dssp EECCCGG------------------------------------------GSSCSSSCCTTCCHHHHHHHCC--CHHHHHH
T ss_pred eEccCCC------------------------------------------ccccccCCccccCHHHhhccccccccccCCC
Confidence 8654221 0124679999999999875 5688
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCC----ChHHHHHHHhcccCcc-----------------cCCCC----ccCChhHHH
Q 010947 336 MECDWWSLGAIMYEMLVGYPPFYSD----DPMSTCRKIVNWRTHL-----------------KFPEE----AKLSIEAKD 390 (497)
Q Consensus 336 ~~~DiwSlGvil~ell~G~~PF~~~----~~~~~~~~i~~~~~~~-----------------~~p~~----~~~s~~~~d 390 (497)
.++|||||||++|||++|.+||.+. ...+...+++...... .+|.. ..++..+.+
T Consensus 202 ~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ 281 (396)
T 4eut_A 202 ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTP 281 (396)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchH
Confidence 9999999999999999999999753 3345555555422110 11111 235567889
Q ss_pred HHHHHhh-CccccCCCCCcchhc
Q 010947 391 LISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 391 LI~~lL~-dp~~R~~~~~~~eil 412 (497)
||.+||. ||.+|++ +.+++
T Consensus 282 ll~~~L~~dP~~R~s---~~e~l 301 (396)
T 4eut_A 282 VLANILEADQEKCWG---FDQFF 301 (396)
T ss_dssp HHHHHSCCCTTTSCC---HHHHH
T ss_pred HHHHhhccChhhhcc---HHHHH
Confidence 9999999 9999999 77654
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=366.39 Aligned_cols=260 Identities=19% Similarity=0.297 Sum_probs=209.8
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEE
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~---t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 184 (497)
+....+..++|.+.+.||+|+||.||+|.... ++..||+|++..... .......+.+|+.+++.++||||++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34556677899999999999999999998765 556899999976432 33445678899999999999999999999
Q ss_pred eecCC-----eEEEEEeecCCCchhHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC
Q 010947 185 FQDDE-----FLYLIMEYLPGGDMMTLLM------RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (497)
Q Consensus 185 ~~~~~-----~l~lVmEy~~gg~L~~~l~------~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g 253 (497)
+.+.. ..|+||||+++|+|.+++. ....+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 98755 4599999999999999984 235699999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC
Q 010947 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (497)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~ 333 (497)
.+||+|||+++......... ......||+.|+|||++.+..
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~~~~ 225 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYR---------------------------------------QGRIAKMPVKWIAIESLADRV 225 (313)
T ss_dssp CEEECSCSCC-------------------------------------------------------CCGGGSCHHHHHSSC
T ss_pred cEEEeecCcceecccccccC---------------------------------------cccccCCCccccCchhhcCCC
Confidence 99999999998653221000 011346889999999999999
Q ss_pred CCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 334 YGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 334 y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
++.++|||||||++|+|++ |.+||.+.+..+....+.... ....| ..+++++.+||.+||. ||.+||+ +.++
T Consensus 226 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~~l 299 (313)
T 3brb_A 226 YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLKQP--EDCLDELYEIMYSCWRTDPLDRPT---FSVL 299 (313)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCCCB--TTCCHHHHHHHHHTTCSSGGGSCC---HHHH
T ss_pred ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCCCC--ccccHHHHHHHHHHcCCChhhCcC---HHHH
Confidence 9999999999999999999 999999988888887777532 23333 4789999999999999 9999998 8887
Q ss_pred cC
Q 010947 412 KV 413 (497)
Q Consensus 412 l~ 413 (497)
+.
T Consensus 300 ~~ 301 (313)
T 3brb_A 300 RL 301 (313)
T ss_dssp HH
T ss_pred HH
Confidence 65
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=383.70 Aligned_cols=255 Identities=27% Similarity=0.393 Sum_probs=196.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lV 194 (497)
+.|.+.++||+|+||+||.+ ...+|+.||||++.... .+.+.+|+.+|..+ +|||||++++++.+...+|+|
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 44666789999999999875 45689999999987542 23467899999876 899999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC-------------Cc
Q 010947 195 MEYLPGGDMMTLLMRKDTL-------TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY-------------GH 254 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l-------~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~-------------g~ 254 (497)
||||. |+|.+++...... ++..+..++.||+.||.|||++|||||||||+|||++.+ ++
T Consensus 88 ~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 99995 6999999765433 233456799999999999999999999999999999754 48
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---
Q 010947 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--- 331 (497)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--- 331 (497)
+||+|||+|+.+....... .......+||+.|+|||++.+
T Consensus 167 ~kL~DFG~a~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~ 209 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSF-------------------------------------RTNLNNPSGTSGWRAPELLEESNN 209 (434)
T ss_dssp EEECCCTTCEECCC---------------------------------------------------CCTTSCHHHHSCCCT
T ss_pred EEEcccccceecCCCCccc-------------------------------------eeeecCCCCCCCccCHHHhccccc
Confidence 9999999998764321000 000124689999999999975
Q ss_pred ----CCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCccc---CCCCccCChhHHHHHHHHhh-Ccccc
Q 010947 332 ----KGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLK---FPEEAKLSIEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 332 ----~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~---~p~~~~~s~~~~dLI~~lL~-dp~~R 402 (497)
..++.++|||||||++|||++ |.+||.+..... ..++.....+. ......+++++++||.+||+ ||.+|
T Consensus 210 ~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 287 (434)
T 2rio_A 210 LQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKR 287 (434)
T ss_dssp TSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGS
T ss_pred cccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhC
Confidence 678999999999999999999 999998765443 23443222211 11123467899999999999 99999
Q ss_pred CCCCCcchhcCCCCccCC
Q 010947 403 LGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 403 ~~~~~~~eil~Hpff~~i 420 (497)
|+ +.+|++||||.+.
T Consensus 288 ps---~~eil~hp~f~~~ 302 (434)
T 2rio_A 288 PT---AMKVLRHPLFWPK 302 (434)
T ss_dssp CC---HHHHHTSGGGSCH
T ss_pred CC---HHHHHhCCccCCc
Confidence 99 9999999999753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=358.83 Aligned_cols=266 Identities=19% Similarity=0.271 Sum_probs=208.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEE-EeecCCeEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYC-SFQDDEFLYL 193 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~-~~~~~~~l~l 193 (497)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+..|+.++..+.|++++..+. ++.+....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 46899999999999999999999999999999997654322 23778999999998877666554 4567888999
Q ss_pred EEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee---cCCCcEEEcccccccccCCC
Q 010947 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~ 269 (497)
||||+ ||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence 99999 9999999974 4679999999999999999999999999999999999999 78999999999999876533
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
...... +. ......+||+.|+|||++.+..++.++|||||||++|+
T Consensus 162 ~~~~~~----------------~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 207 (296)
T 4hgt_A 162 RTHQHI----------------PY------------------RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp TTCCBC----------------CC------------------CCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred ccCccC----------------CC------------------CcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHH
Confidence 211000 00 00124689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCh---HHHHHHHhcccCcccCCC---CccCChhHHHHHHHHhh-CccccCCCCCcchhcC---------
Q 010947 350 MLVGYPPFYSDDP---MSTCRKIVNWRTHLKFPE---EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV--------- 413 (497)
Q Consensus 350 ll~G~~PF~~~~~---~~~~~~i~~~~~~~~~p~---~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~--------- 413 (497)
|++|.+||.+.+. ......+... ....|. ...+++++.+||.+||. ||.+||+ +.++++
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~l~~~l~~~~~~~ 282 (296)
T 4hgt_A 208 FNLGSLPWQGLKAATKRQKYERISEK--KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD---YSYLRQLFRNLFHRQ 282 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHH--HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC---HHHHHHHHHHHHHHH
T ss_pred HhcCCCCCcccchhhhhhhhhhhhcc--cccchhhhhhccCCHHHHHHHHHHHhcCCCCCCC---HHHHHHHHHHHHHHh
Confidence 9999999987543 2333333321 122221 13678999999999999 9999999 666554
Q ss_pred -CCCccCCChhhh
Q 010947 414 -HPWFDGVDWARI 425 (497)
Q Consensus 414 -Hpff~~i~w~~l 425 (497)
.+|-..+||+.+
T Consensus 283 ~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 283 GFSYDYVFDWNML 295 (296)
T ss_dssp TCCTTCCCGGGGC
T ss_pred CCCccCccchhhc
Confidence 455566677654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-46 Score=374.50 Aligned_cols=261 Identities=20% Similarity=0.219 Sum_probs=201.8
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcC---CCcEEEEEEeechhhhc--------hhHHHHHHHHHHHHHhcCCCceeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKT---TGHVYAMKKLKKSEMLR--------RGQVEHVRAERNLLAEVDSNCIVKL 181 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~---t~~~~AiK~l~k~~~~~--------~~~~~~~~~E~~il~~l~hp~Iv~l 181 (497)
+..++|.+.+.||+|+||.||+|.+.. ++..||||++....... ......+..|+.++..++||||+++
T Consensus 34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~ 113 (345)
T 2v62_A 34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF 113 (345)
T ss_dssp TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence 445789999999999999999999987 78899999997643111 1112346678889999999999999
Q ss_pred EEEeec----CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC--cE
Q 010947 182 YCSFQD----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG--HL 255 (497)
Q Consensus 182 ~~~~~~----~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g--~v 255 (497)
++++.+ ...+|+||||+ ||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++ .+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 192 (345)
T 2v62_A 114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV 192 (345)
T ss_dssp EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence 999987 78999999999 999999998878999999999999999999999999999999999999999887 99
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCC
Q 010947 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335 (497)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~ 335 (497)
||+|||+|+.+........ .........+||+.|+|||++.+..++
T Consensus 193 kL~Dfg~a~~~~~~~~~~~----------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~ 238 (345)
T 2v62_A 193 YLADYGLSYRYCPNGNHKQ----------------------------------YQENPRKGHNGTIEFTSLDAHKGVALS 238 (345)
T ss_dssp EECCCTTCEESSGGGCCCC----------------------------------CCCCGGGCSCSCTTTCCHHHHHTCCCC
T ss_pred EEEeCCCceeccccccccc----------------------------------chhccccccCCCccccCHHHhcCCCCC
Confidence 9999999987642210000 000011256899999999999999999
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCC--ChHHHHHHHhcccCcccCCC-------CccCChhHHHHHHHHhh-CccccCCC
Q 010947 336 MECDWWSLGAIMYEMLVGYPPFYSD--DPMSTCRKIVNWRTHLKFPE-------EAKLSIEAKDLISKLLC-NVNQRLGA 405 (497)
Q Consensus 336 ~~~DiwSlGvil~ell~G~~PF~~~--~~~~~~~~i~~~~~~~~~p~-------~~~~s~~~~dLI~~lL~-dp~~R~~~ 405 (497)
.++|||||||++|||++|..||.+. +.......... ....+|. ...+++++++||.+||. ||.+||+
T Consensus 239 ~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps- 315 (345)
T 2v62_A 239 RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTN--LLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN- 315 (345)
T ss_dssp HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHH--HHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC-
T ss_pred chhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHh--hcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCC-
Confidence 9999999999999999999999653 22222211111 1112221 12688999999999999 9999999
Q ss_pred CCcchhcC
Q 010947 406 KGADEIKV 413 (497)
Q Consensus 406 ~~~~eil~ 413 (497)
+++|++
T Consensus 316 --~~~l~~ 321 (345)
T 2v62_A 316 --YQALKK 321 (345)
T ss_dssp --HHHHHH
T ss_pred --HHHHHH
Confidence 776654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=371.05 Aligned_cols=260 Identities=21% Similarity=0.283 Sum_probs=210.7
Q ss_pred hhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 109 ~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
.......++|++.+.||+|+||.||+|++ .+|+.||||++.... ....+.+.+|+.+++.++||||++++++|.+.
T Consensus 32 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 32 VDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp SCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred HHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 34445678999999999999999999996 468899999987542 34456788999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
+.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 99999999999999999986543 59999999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlG 344 (497)
........ ......+||+.|+|||++.+..++.++||||||
T Consensus 188 ~~~~~~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 228 (321)
T 2qkw_B 188 KGTELDQT---------------------------------------HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFG 228 (321)
T ss_dssp ECSSSSCC---------------------------------------CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHH
T ss_pred cccccccc---------------------------------------ccccccCCCccccCHHHhcCCCCCcccchHhHH
Confidence 64321100 001145799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHH-------HHhccc------CcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcch
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCR-------KIVNWR------THLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~-------~i~~~~------~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~e 410 (497)
|++|||++|.+||.+..+.+... ...... ..+.......++.++.+||.+||. ||.+||+ +.+
T Consensus 229 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps---~~e 305 (321)
T 2qkw_B 229 VVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPS---MGD 305 (321)
T ss_dssp HHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCC---HHH
T ss_pred HHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcC---HHH
Confidence 99999999999998765432211 010100 000001113456779999999999 9999999 888
Q ss_pred hcCC
Q 010947 411 IKVH 414 (497)
Q Consensus 411 il~H 414 (497)
+++|
T Consensus 306 ll~~ 309 (321)
T 2qkw_B 306 VLWK 309 (321)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=358.75 Aligned_cols=260 Identities=18% Similarity=0.276 Sum_probs=201.0
Q ss_pred HHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 107 ~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
.....++..++|++.+.||+|+||.||+|++. ..||+|+++... ......+.+.+|+.+++.++||||+++++++
T Consensus 15 ~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~- 89 (289)
T 3og7_A 15 AADDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS- 89 (289)
T ss_dssp ---CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-
T ss_pred CCCCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-
Confidence 34456788899999999999999999999754 359999997543 2344567789999999999999999999954
Q ss_pred cCCeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
....+++||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++.
T Consensus 90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 90 TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence 56678999999999999999854 45799999999999999999999999999999999999999999999999999975
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc---cCCCCcchhHHh
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWS 342 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~---~~~y~~~~DiwS 342 (497)
....... ......+||+.|+|||++. +..++.++||||
T Consensus 170 ~~~~~~~---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s 210 (289)
T 3og7_A 170 KSRWSGS---------------------------------------HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYA 210 (289)
T ss_dssp -----------------------------------------------------CCCTTCCHHHHC----CCSCHHHHHHH
T ss_pred ccccccc---------------------------------------ccccccCCCccccCchhhcccCCCCCCcccchHH
Confidence 4321100 0011457999999999997 567899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHHhccc-CcccCCC-CccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWR-THLKFPE-EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~~~~~~~~i~~~~-~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++|+|++|..||.+.+.......++... .....+. ...+++++.+||.+||. ||.+||+ +.++++
T Consensus 211 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 281 (289)
T 3og7_A 211 FGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPS---FPRILA 281 (289)
T ss_dssp HHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCC---HHHHHH
Confidence 9999999999999999876655554444321 1111111 23688999999999999 9999998 777764
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.09 Aligned_cols=252 Identities=20% Similarity=0.273 Sum_probs=209.0
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE-E
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL-Y 192 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l-~ 192 (497)
.|.+.+.||+|+||+||+|.+..++. .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 46778999999999999999766554 79999987532 344567788999999999999999999999876655 9
Q ss_pred EEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
+||||+.+|+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.+|.+||+|||+|+.......
T Consensus 100 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 179 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY 179 (298)
T ss_dssp EEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGG
T ss_pred EEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcc
Confidence 99999999999999976 45799999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
... .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 180 ~~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 222 (298)
T 3pls_A 180 YSV-------------------------------------QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222 (298)
T ss_dssp GCS-------------------------------------CCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccc-------------------------------------ccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHh
Confidence 000 0011457899999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 352 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +.++++
T Consensus 223 ~g~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~ll~ 280 (298)
T 3pls_A 223 TRGAPPYRHIDPFDLTHFLAQG-RRLPQP--EYCPDSLYQVMQQCWEADPAVRPT---FRVLVG 280 (298)
T ss_dssp HTSCCTTTTSCGGGHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred hCCCCCCccCCHHHHHHHhhcC-CCCCCC--ccchHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 9 56666667777766666543 223333 4789999999999999 9999998 777764
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=359.95 Aligned_cols=253 Identities=28% Similarity=0.360 Sum_probs=199.9
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh--cCCCceeEEEEEeec--
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQD-- 187 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~-- 187 (497)
.+..++|++++.||+|+||+||+|++ +|+.||||++.... ...+..|.+++.. ++||||+++++++.+
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~ 75 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR 75 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence 34567899999999999999999987 68899999987542 2345567777766 799999999988654
Q ss_pred --CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCEEEcccCCCCeeecCCCcEEE
Q 010947 188 --DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH--------KHHYIHRDIKPDNLLLDKYGHLRL 257 (497)
Q Consensus 188 --~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~~iiHrDLKp~NILl~~~g~vkL 257 (497)
...+|+||||+++|+|.+++. ...+++..+..++.|++.||.||| +.||+||||||+|||++.++++||
T Consensus 76 ~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 76 HSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp TTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 456899999999999999994 467999999999999999999999 999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-----
Q 010947 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK----- 332 (497)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~----- 332 (497)
+|||+|+......... .......+||+.|+|||++.+.
T Consensus 155 ~Dfg~a~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~ 197 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQL-------------------------------------DVGNNPRVGTKRYMAPEVLDETIQVDC 197 (301)
T ss_dssp CCCTTCEEEETTTTEE-------------------------------------ECCCCCCCCCGGGCCHHHHTTCCCTTC
T ss_pred eeCCCeeecccccccc-------------------------------------cccccccccccceeChhhhcCcCCCCc
Confidence 9999998654321110 0001245899999999999876
Q ss_pred -CCCcchhHHhHHHHHHHHHhC----------CCCCCCCC----hHHHHHHHhc-ccCcccCCCC---ccCChhHHHHHH
Q 010947 333 -GYGMECDWWSLGAIMYEMLVG----------YPPFYSDD----PMSTCRKIVN-WRTHLKFPEE---AKLSIEAKDLIS 393 (497)
Q Consensus 333 -~y~~~~DiwSlGvil~ell~G----------~~PF~~~~----~~~~~~~i~~-~~~~~~~p~~---~~~s~~~~dLI~ 393 (497)
.++.++|||||||++|||++| .+||.... .......+.. ......+|.. ..+++++.+||.
T Consensus 198 ~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 277 (301)
T 3q4u_A 198 FDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHH
T ss_pred ccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHH
Confidence 556799999999999999999 89997532 2233333332 2222233321 235678999999
Q ss_pred HHhh-CccccCCCCCcchhcC
Q 010947 394 KLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 394 ~lL~-dp~~R~~~~~~~eil~ 413 (497)
+||. ||.+||+ +.+|++
T Consensus 278 ~cl~~dP~~Rps---~~~i~~ 295 (301)
T 3q4u_A 278 ECWYQNPSARLT---ALRIKK 295 (301)
T ss_dssp HHCCSSGGGSCC---HHHHHH
T ss_pred HHhhcChhhCCC---HHHHHH
Confidence 9999 9999998 777764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=358.00 Aligned_cols=243 Identities=25% Similarity=0.416 Sum_probs=207.6
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec--------
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-------- 187 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-------- 187 (497)
.+|++++.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||++++++|.+
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 46999999999999999999999999999999997643 236689999999999999999998864
Q ss_pred --------CCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEE
Q 010947 188 --------DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257 (497)
Q Consensus 188 --------~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL 257 (497)
...+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 45689999999999999999754 57999999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcc
Q 010947 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME 337 (497)
Q Consensus 258 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~ 337 (497)
+|||+++....... .....||+.|+|||++.+..++.+
T Consensus 164 ~Dfg~~~~~~~~~~------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~ 201 (284)
T 2a19_B 164 GDFGLVTSLKNDGK------------------------------------------RTRSKGTLRYMSPEQISSQDYGKE 201 (284)
T ss_dssp CCCTTCEESSCCSC------------------------------------------CCCCCSCCTTSCHHHHHCSCCCTH
T ss_pred Ccchhheecccccc------------------------------------------ccccCCcccccChhhhccCCCcch
Confidence 99999987643210 113579999999999999999999
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCC
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPW 416 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpf 416 (497)
+|||||||++|+|++|..||... ......+.. ..++ ..++.++++||.+||. ||.+||+ +.++++|++
T Consensus 202 ~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~----~~~~--~~~~~~~~~li~~~l~~dp~~Rps---~~e~l~~l~ 270 (284)
T 2a19_B 202 VDLYALGLILAELLHVCDTAFET--SKFFTDLRD----GIIS--DIFDKKEKTLLQKLLSKKPEDRPN---TSEILRTLT 270 (284)
T ss_dssp HHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHT----TCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHH
T ss_pred hhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhc----cccc--ccCCHHHHHHHHHHccCChhhCcC---HHHHHHHHH
Confidence 99999999999999999998532 222333322 1233 3688999999999999 9999998 999999877
Q ss_pred cc
Q 010947 417 FD 418 (497)
Q Consensus 417 f~ 418 (497)
.-
T Consensus 271 ~~ 272 (284)
T 2a19_B 271 VW 272 (284)
T ss_dssp HH
T ss_pred HH
Confidence 53
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=363.83 Aligned_cols=262 Identities=23% Similarity=0.366 Sum_probs=208.3
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee----c
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ----D 187 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~----~ 187 (497)
.+..++|++++.||+|+||.||+|++..+|+.||||++.... ......+.+|+.+++.++||||+++++++. .
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence 356678999999999999999999999999999999987542 345567889999999999999999999887 3
Q ss_pred CCeEEEEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
...+|+||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 4589999999999999999876 467999999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC---CCcchhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG---YGMECDW 340 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~---y~~~~Di 340 (497)
+......... ........ .....||+.|+|||++.+.. ++.++||
T Consensus 182 ~~~~~~~~~~------------------------~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di 229 (317)
T 2buj_A 182 NQACIHVEGS------------------------RQALTLQD--------WAAQRCTISYRAPELFSVQSHCVIDERTDV 229 (317)
T ss_dssp EESCEEEESH------------------------HHHHHHHH--------HHHHHSCGGGCCGGGSSCCSEEEECTHHHH
T ss_pred hhcccccccc------------------------cccccccc--------cccccCCcccCCHhHhccCCCcCCCchhhH
Confidence 7643210000 00000000 11356899999999997654 7899999
Q ss_pred HhHHHHHHHHHhCCCCCCCCC--hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 341 WSLGAIMYEMLVGYPPFYSDD--PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 341 wSlGvil~ell~G~~PF~~~~--~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|||||++|+|++|..||.... .......+. ....+|....+++++.+||.+||. ||.+||+ +.++++|
T Consensus 230 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~ 300 (317)
T 2buj_A 230 WSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ---NQLSIPQSPRHSSALWQLLNSMMTVDPHQRPH---IPLLLSQ 300 (317)
T ss_dssp HHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH---CC--CCCCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHHHHHHhCCCChhhhhcccchhhHHhh---ccCCCCccccCCHHHHHHHHHHhhcChhhCCC---HHHHHHH
Confidence 999999999999999995421 111222222 233445555789999999999999 9999998 8888764
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=368.97 Aligned_cols=264 Identities=20% Similarity=0.259 Sum_probs=209.3
Q ss_pred HHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 107 RLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 107 ~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
.+....+..++|++.+.||+|+||.||+|+. .+|+.||||++....... ....+.+|+.+++.++||||++++++|.
T Consensus 21 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 97 (326)
T 3uim_A 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCM 97 (326)
T ss_dssp CTHHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEEC
T ss_pred cHHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEe
Confidence 4455667789999999999999999999975 468899999998654221 1225788999999999999999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHcC---CEEEcccCCCCeeecCCCcEEEcc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRKD----TLTEDEARFYVAETVLAIESIHKH---HYIHRDIKPDNLLLDKYGHLRLSD 259 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~~LH~~---~iiHrDLKp~NILl~~~g~vkL~D 259 (497)
+....|+||||++||+|.+++.... .+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~D 177 (326)
T 3uim_A 98 TPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177 (326)
T ss_dssp CSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECC
T ss_pred cCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEecc
Confidence 9999999999999999999997643 499999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchh
Q 010947 260 FGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECD 339 (497)
Q Consensus 260 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~D 339 (497)
||+|+........ .....+||+.|+|||++.+..++.++|
T Consensus 178 fg~~~~~~~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~D 217 (326)
T 3uim_A 178 FGLAKLMDYKDTH----------------------------------------VTTAVRGTIGHIAPEYLSTGKSSEKTD 217 (326)
T ss_dssp CSSCEECCSSSSC----------------------------------------EECCCCSCGGGCCHHHHHHSEECHHHH
T ss_pred CccccccCccccc----------------------------------------ccccccCCcCccCHHHhccCCCCcccc
Confidence 9999876432110 012456999999999999999999999
Q ss_pred HHhHHHHHHHHHhCCCCCCCC-----ChHHHHHHHhcccCcc----------cCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 340 WWSLGAIMYEMLVGYPPFYSD-----DPMSTCRKIVNWRTHL----------KFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 340 iwSlGvil~ell~G~~PF~~~-----~~~~~~~~i~~~~~~~----------~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
||||||++|+|++|.+||... ........+....... ..+.....+.++.+||.+||. ||.+||
T Consensus 218 i~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp 297 (326)
T 3uim_A 218 VFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP 297 (326)
T ss_dssp HHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC
T ss_pred chhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC
Confidence 999999999999999999521 1111111111100000 000112345779999999999 999999
Q ss_pred CCCCcchhcCCCC
Q 010947 404 GAKGADEIKVHPW 416 (497)
Q Consensus 404 ~~~~~~eil~Hpf 416 (497)
+ +.+|++|-.
T Consensus 298 s---~~ell~~L~ 307 (326)
T 3uim_A 298 K---MSEVVRMLE 307 (326)
T ss_dssp C---HHHHHHHHH
T ss_pred C---HHHHHHHhc
Confidence 9 888887654
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-45 Score=382.39 Aligned_cols=252 Identities=20% Similarity=0.353 Sum_probs=210.9
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.+.+..++|++.+.||+|+||.||+|.++. +..||||+++.... ..+.+.+|+.+|+.++||||+++++++.+ +
T Consensus 178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 345667889999999999999999999875 45799999986432 23568899999999999999999999876 6
Q ss_pred eEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 789999999999999999653 569999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
..... ......||+.|+|||++.+..++.++|||||||++
T Consensus 332 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l 371 (452)
T 1fmk_A 332 DNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 371 (452)
T ss_dssp ---------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------cccCCcccccccCHhHHhcCCCCccccHHhHHHHH
Confidence 21100 00134578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +++|+.
T Consensus 372 ~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rpt---~~~l~~ 433 (452)
T 1fmk_A 372 TELTTKGRVPYPGMVNREVLDQVERG-YRMPCP--PECPESLHDLMCQCWRKEPEERPT---FEYLQA 433 (452)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHccCChhhCcC---HHHHHH
Confidence 99999 99999999888888777643 233333 4789999999999999 9999998 777764
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=356.71 Aligned_cols=247 Identities=21% Similarity=0.384 Sum_probs=206.0
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD- 188 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~- 188 (497)
...+..++|++.+.||+|+||.||+|.+. |+.||||++.... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 15 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 87 (278)
T 1byg_A 15 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK 87 (278)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred cccCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence 34567789999999999999999999874 7899999997542 345688999999999999999999987654
Q ss_pred CeEEEEEeecCCCchhHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
..+|+||||++||+|.+++..... +++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 167 (278)
T 1byg_A 88 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 167 (278)
T ss_dssp -CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccc
Confidence 579999999999999999976543 899999999999999999999999999999999999999999999999998754
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
.... ....||+.|+|||++.+..++.++|||||||+
T Consensus 168 ~~~~--------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 203 (278)
T 1byg_A 168 SSTQ--------------------------------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGIL 203 (278)
T ss_dssp ----------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHH
T ss_pred cccc--------------------------------------------cCCCccccccCHHHhCCCCCCchhcHHHHHHH
Confidence 3110 12468899999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 347 l~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|+|++ |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +.++++
T Consensus 204 l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~~l~~ 266 (278)
T 1byg_A 204 LWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAP--DGCPPAVYEVMKNCWHLDAAMRPS---FLQLRE 266 (278)
T ss_dssp HHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCc--ccCCHHHHHHHHHHhcCChhhCCC---HHHHHH
Confidence 999998 99999998887777777643 223333 4789999999999999 9999998 777654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=372.30 Aligned_cols=241 Identities=18% Similarity=0.256 Sum_probs=197.0
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEE-----EEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC---CCceeEEE
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVC-----REKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLY 182 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~-----~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~ 182 (497)
..+..++|.+.+.||+|+||+||+| ....+++.||||++.... ...+..|+.++..+. |+||+.++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~ 133 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFY 133 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 4466788999999999999999999 467789999999997542 234677888887776 89999999
Q ss_pred EEeecCCeEEEEEeecCCCchhHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC------
Q 010947 183 CSFQDDEFLYLIMEYLPGGDMMTLLMR-----KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK------ 251 (497)
Q Consensus 183 ~~~~~~~~l~lVmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~------ 251 (497)
+++.+.+..|||||||+||+|.+++.. ...+++..+..++.||+.||.|||+.|||||||||+|||++.
T Consensus 134 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 134 SAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp EEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-
T ss_pred eeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcc
Confidence 999999999999999999999999974 467999999999999999999999999999999999999998
Q ss_pred -----CCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCc
Q 010947 252 -----YGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (497)
Q Consensus 252 -----~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 326 (497)
++++||+|||+|+.+...... ......+||+.|+||
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~---------------------------------------~~~~~~~gt~~y~aP 254 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKG---------------------------------------TIFTAKCETSGFQCV 254 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTT---------------------------------------EEECCSSCTTSCCCH
T ss_pred ccccccCCEEEeeCchhhhhhccCCC---------------------------------------ceeeeecCCCCCCCh
Confidence 899999999999765311000 012256899999999
Q ss_pred cccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 327 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 327 E~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|++.+..|+.++|||||||++|||++|.+||....... +.....++. ...+....+++.+||. +|.+|+.
T Consensus 255 E~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~~~~~~~-~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 255 EMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-------CKPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp HHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-------EEECSCCTT-CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred HHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-------eeechhccc-cCcHHHHHHHHHHHcCCCCCCcch
Confidence 99999999999999999999999999999997543211 111111221 1356788999999999 9999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=359.52 Aligned_cols=231 Identities=33% Similarity=0.569 Sum_probs=190.9
Q ss_pred CCCeeEE-eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHH-HhcCCCceeEEEEEeec----C
Q 010947 115 ADDFELL-TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL-AEVDSNCIVKLYCSFQD----D 188 (497)
Q Consensus 115 ~~~f~~~-~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il-~~l~hp~Iv~l~~~~~~----~ 188 (497)
.++|.++ ++||+|+||.||+|.++.+++.||||++.... .+.+|+.++ +..+||||++++++|.+ .
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH--------HHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 4678887 78999999999999999999999999997532 356788887 56699999999999886 7
Q ss_pred CeEEEEEeecCCCchhHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC---CCcEEEcccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~---~g~vkL~DFGla 263 (497)
..+|+||||++||+|.+++.... .+++..+..++.||+.||.|||+.||+||||||+|||++. ++.+||+|||+|
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999998754 6999999999999999999999999999999999999998 789999999998
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
.... +..|+.++|||||
T Consensus 168 ~~~~---------------------------------------------------------------~~~~~~~~Diwsl 184 (299)
T 3m2w_A 168 KETT---------------------------------------------------------------GEKYDKSCDMWSL 184 (299)
T ss_dssp EECT---------------------------------------------------------------TCGGGGHHHHHHH
T ss_pred cccc---------------------------------------------------------------cccCCchhhHHHH
Confidence 6431 2446789999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhccc--CcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWR--THLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~--~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
||++|||++|.+||.+.+.......+.... ....+|. ...+++++++||.+||+ ||.+||+ +.|+++||||.
T Consensus 185 G~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps---~~e~l~hp~~~ 261 (299)
T 3m2w_A 185 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIM 261 (299)
T ss_dssp HHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCC---HHHHHTSHHHH
T ss_pred HHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCC---HHHHhcChhhc
Confidence 999999999999998766544322221111 1122221 14689999999999999 9999998 99999999998
Q ss_pred C
Q 010947 419 G 419 (497)
Q Consensus 419 ~ 419 (497)
.
T Consensus 262 ~ 262 (299)
T 3m2w_A 262 Q 262 (299)
T ss_dssp T
T ss_pred c
Confidence 5
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=357.36 Aligned_cols=254 Identities=17% Similarity=0.282 Sum_probs=209.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEe-ecCCe
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF-QDDEF 190 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-~~~~~ 190 (497)
..+|++.+.||+|+||.||+|.+..+ +..||+|++.... .......+.+|+.+++.++||||+++++++ .+++.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence 35699999999999999999997544 3368999987532 344567788999999999999999999985 55678
Q ss_pred EEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.|+||||++||+|.+++.. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+|+.....
T Consensus 102 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 102 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp CEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred eEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 8999999999999999975 356899999999999999999999999999999999999999999999999999866432
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
..... .......||+.|+|||++.+..++.++|||||||++|+
T Consensus 182 ~~~~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 224 (298)
T 3f66_A 182 EYYSV-------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 224 (298)
T ss_dssp GGCBC------------------------------------------CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred chhcc-------------------------------------ccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHH
Confidence 11000 00124578999999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 350 MLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 350 ll~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|++ |.+||.+.+..+....+.... ....| ..++.++.+||.+||. ||.+||+ +.++++
T Consensus 225 l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~l~~li~~~l~~~p~~Rps---~~ell~ 284 (298)
T 3f66_A 225 LMTRGAPPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRPS---FSELVS 284 (298)
T ss_dssp HHTTSCCSSTTSCTTTHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHhCCCCCCccCCHHHHHHHHhcCC-CCCCC--ccCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 999 778888877777777776532 22223 3689999999999999 9999998 777764
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=394.48 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=208.8
Q ss_pred CeeEE-eEeeecCCeEEEEEEE--cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 117 DFELL-TMIGKGAFGEVRVCRE--KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 117 ~f~~~-~~IG~G~fG~V~~~~~--~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
.+.+. +.||+|+||+||+|.+ +.+++.||||+++... ......+.+.+|+.+|+.++|||||++++++.+ +.+|+
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~l 446 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWML 446 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEE
Confidence 34443 4899999999999955 4567899999997653 334456779999999999999999999999875 45889
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||||+||+|.+++.....+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+.......
T Consensus 447 v~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 447 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred EEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 99999999999999888899999999999999999999999999999999999999999999999999998764321100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV- 352 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~- 352 (497)
.......||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 527 --------------------------------------~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~ 568 (635)
T 4fl3_A 527 --------------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSY 568 (635)
T ss_dssp ----------------------------------------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred --------------------------------------ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhC
Confidence 00113457899999999999999999999999999999998
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
|.+||.+.+..+....+... .....|. .+++++.+||.+||. ||.+||+ +.+|+
T Consensus 569 G~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs---~~~l~ 623 (635)
T 4fl3_A 569 GQKPYRGMKGSEVTAMLEKG-ERMGCPA--GCPREMYDLMNLCWTYDVENRPG---FAAVE 623 (635)
T ss_dssp TCCSSTTCCHHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHHTCSSTTTSCC---HHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcC-CCCCCCC--CCCHHHHHHHHHHcCCCHhHCcC---HHHHH
Confidence 99999999988888777653 2344443 789999999999999 9999999 66664
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=382.54 Aligned_cols=247 Identities=17% Similarity=0.231 Sum_probs=195.6
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----chhHHHHHHHHHHHHHhcC---------CCcee
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEVD---------SNCIV 179 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l~---------hp~Iv 179 (497)
..++|++++.||+|+||+||+|++ +|+.||||++.+.... .....+.+.+|+.+|+.++ |||||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv 95 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI 95 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence 346799999999999999999987 6899999999875421 2233467889999998886 66666
Q ss_pred EEEEEe-----------------ec-------------CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHH
Q 010947 180 KLYCSF-----------------QD-------------DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229 (497)
Q Consensus 180 ~l~~~~-----------------~~-------------~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL 229 (497)
++.+++ .+ ...+|||||||++|++.+.+.+ ..+++..++.++.||+.||
T Consensus 96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHH
T ss_pred hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHH
Confidence 666553 32 7889999999999987777744 6799999999999999999
Q ss_pred HHHH-cCCEEEcccCCCCeeecCCC--------------------cEEEcccccccccCCCCcccccccccCCCCCCCCC
Q 010947 230 ESIH-KHHYIHRDIKPDNLLLDKYG--------------------HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288 (497)
Q Consensus 230 ~~LH-~~~iiHrDLKp~NILl~~~g--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 288 (497)
.||| +.|||||||||+|||++.+| .+||+|||+|+.....
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------------------- 235 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------------------- 235 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------------------
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------------------
Confidence 9999 99999999999999999987 9999999999865321
Q ss_pred CCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH-HHHHHhCCCCCCCCCh-HHHH
Q 010947 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI-MYEMLVGYPPFYSDDP-MSTC 366 (497)
Q Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi-l~ell~G~~PF~~~~~-~~~~ 366 (497)
..+||+.|+|||++.+.. +.++||||||++ .++++.|..||.+... ....
T Consensus 236 ---------------------------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~ 287 (336)
T 2vuw_A 236 ---------------------------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLT 287 (336)
T ss_dssp ---------------------------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHH
T ss_pred ---------------------------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHH
Confidence 358999999999998766 899999998777 8889999999954221 1223
Q ss_pred HHHhc---ccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc-CCCCcc
Q 010947 367 RKIVN---WRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK-VHPWFD 418 (497)
Q Consensus 367 ~~i~~---~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil-~Hpff~ 418 (497)
..+.. .......+....+|+++++||.+||+ | + ++|++ +||||+
T Consensus 288 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s---a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 288 DKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S---ATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S---HHHHHHHCGGGC
T ss_pred HhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C---HHHHHhcCCCcC
Confidence 33332 11111111123588999999999998 5 4 99999 999995
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=357.02 Aligned_cols=242 Identities=26% Similarity=0.431 Sum_probs=197.8
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++.+.||+|+||+||+|++. ++.||||++... ...+.+.+|+.+++.++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 45678999999999999999999874 779999998643 244568899999999999999999998874 478
Q ss_pred EEEeecCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHc---CCEEEcccCCCCeeecCCCc-EEEcccccccc
Q 010947 193 LIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHK---HHYIHRDIKPDNLLLDKYGH-LRLSDFGLCKP 265 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~---~~iiHrDLKp~NILl~~~g~-vkL~DFGla~~ 265 (497)
+||||++||+|.+++.... .+++..+..++.|++.||.|||+ .||+||||||+|||++.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 9999999999999997654 37899999999999999999999 89999999999999998887 79999999875
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
.... .....||+.|+|||++.+..++.++|||||||
T Consensus 156 ~~~~--------------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 191 (307)
T 2eva_A 156 IQTH--------------------------------------------MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGI 191 (307)
T ss_dssp -----------------------------------------------------CCTTSSCHHHHTCCCCCTHHHHHHHHH
T ss_pred cccc--------------------------------------------cccCCCCCceEChhhhCCCCCCcHHHHHHHHH
Confidence 4211 01346999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCh--HHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 346 IMYEMLVGYPPFYSDDP--MSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 346 il~ell~G~~PF~~~~~--~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++|||++|..||..... ......+... .....+ ..+++++.+||.+||. ||.+||+ +.++++
T Consensus 192 il~el~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps---~~ell~ 256 (307)
T 2eva_A 192 ILWEVITRRKPFDEIGGPAFRIMWAVHNG-TRPPLI--KNLPKPIESLMTRCWSKDPSQRPS---MEEIVK 256 (307)
T ss_dssp HHHHHHHTCCTTTTTCSSHHHHHHHHHTT-CCCCCB--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHCCCCchhhCccHHHHHHHHhcC-CCCCcc--cccCHHHHHHHHHHhcCChhhCcC---HHHHHH
Confidence 99999999999986432 2233333321 222222 4789999999999999 9999998 777765
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=353.46 Aligned_cols=254 Identities=19% Similarity=0.266 Sum_probs=204.8
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEE-EEeecCCeEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY-CSFQDDEFLYL 193 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~-~~~~~~~~l~l 193 (497)
.++|++.+.||+|+||.||+|++..+|+.||||++..... ...+.+|+.+++.+.|++++..+ .++.+....|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 5789999999999999999999999999999999876432 12478899999999988765555 44467788999
Q ss_pred EEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee---cCCCcEEEcccccccccCCC
Q 010947 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~ 269 (497)
||||+ +|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+|+.....
T Consensus 83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence 99999 9999999974 4679999999999999999999999999999999999999 48899999999999876533
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
...... +. ......+||+.|+|||++.+..++.++|||||||++||
T Consensus 162 ~~~~~~----------------~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~ 207 (296)
T 3uzp_A 162 RTHQHI----------------PY------------------RENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMY 207 (296)
T ss_dssp TTCCBC----------------CC------------------CCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred cccccc----------------cc------------------ccccccccccccCChhhhcCCCCCcchhhHHHHHHHHH
Confidence 211000 00 00124689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCC---hHHHHHHHhcccCcccCCC---CccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 350 MLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPE---EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 350 ll~G~~PF~~~~---~~~~~~~i~~~~~~~~~p~---~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|++|..||.+.+ ..+.+..+... ....|. ...+|+++.+||.+||+ ||.+||+ +.++++
T Consensus 208 l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~l~~ 273 (296)
T 3uzp_A 208 FNLGSLPWQGLKAATKRQKYERISEK--KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD---YSYLRQ 273 (296)
T ss_dssp HHHSSCTTSSCCCSSSSSHHHHHHHH--HHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC---HHHHHH
T ss_pred HHhCCCCCCCcCchhhhhhhhhhccc--ccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCC---HHHHHH
Confidence 999999998743 33444444432 122221 13688999999999999 9999998 666653
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=379.81 Aligned_cols=274 Identities=19% Similarity=0.233 Sum_probs=217.9
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC-CceeEEEEEeecCCeEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~l~ 192 (497)
..++|++++.||+|+||.||+|++..+++.||||++...... ..+..|+.++..+.| ++|+.+..++.+....|
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~ 79 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNV 79 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEE
Confidence 357899999999999999999999999999999998754322 236789999999987 56666777777888999
Q ss_pred EEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeee---cCCCcEEEcccccccccCC
Q 010947 193 LIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl---~~~g~vkL~DFGla~~~~~ 268 (497)
|||||+ ||+|.+++.. ...+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||+|+.+..
T Consensus 80 lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 80 LVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 999999 9999999975 5679999999999999999999999999999999999999 6889999999999987653
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
....... +. ......+||+.|+|||++.+..++.++||||||||||
T Consensus 159 ~~~~~~~----------------~~------------------~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ 204 (483)
T 3sv0_A 159 TSTHQHI----------------PY------------------RENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLM 204 (483)
T ss_dssp TTTCCBC----------------CC------------------CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred Ccccccc----------------cc------------------ccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHH
Confidence 3211000 00 0012568999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCh---HHHHHHHhcccCcccCC-CCccCChhHHHHHHHHhh-CccccCCCCCcc-------hhcCCCC
Q 010947 349 EMLVGYPPFYSDDP---MSTCRKIVNWRTHLKFP-EEAKLSIEAKDLISKLLC-NVNQRLGAKGAD-------EIKVHPW 416 (497)
Q Consensus 349 ell~G~~PF~~~~~---~~~~~~i~~~~~~~~~p-~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~-------eil~Hpf 416 (497)
||++|..||.+... .+.+.++.........+ ....++.++.+||.+||. ||.+||+...+. ..+.|+|
T Consensus 205 elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~ 284 (483)
T 3sv0_A 205 YFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF 284 (483)
T ss_dssp HHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred HHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCc
Confidence 99999999987543 34444443311111000 013678999999999999 999999832211 1235899
Q ss_pred ccCCChhhhhh
Q 010947 417 FDGVDWARIYQ 427 (497)
Q Consensus 417 f~~i~w~~l~~ 427 (497)
+..+||..+..
T Consensus 285 ~~~~dW~~~~~ 295 (483)
T 3sv0_A 285 DYVFDWTILKY 295 (483)
T ss_dssp SSCCHHHHHTC
T ss_pred cCCcCchhhcc
Confidence 99999998864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=392.02 Aligned_cols=253 Identities=23% Similarity=0.343 Sum_probs=210.0
Q ss_pred CCCCCeeEEe-EeeecCCeEEEEEEEcC--CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 113 MGADDFELLT-MIGKGAFGEVRVCREKT--TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~-~IG~G~fG~V~~~~~~~--t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
+..+++.+.+ .||+|+||.||+|.++. ++..||||++++.. .....+.+.+|+.+|+.++|||||+++++|.+ +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 4556677777 89999999999998763 56679999998642 23456779999999999999999999999987 5
Q ss_pred eEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.+..
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA 488 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred CeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence 699999999999999999654 5699999999999999999999999999999999999999999999999999986542
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
..... .......||+.|+|||++.+..|+.++|||||||+||
T Consensus 489 ~~~~~--------------------------------------~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ 530 (613)
T 2ozo_A 489 DDSYY--------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 530 (613)
T ss_dssp ---------------------------------------------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred CCcee--------------------------------------eeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHH
Confidence 21000 0001235778999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 349 ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
||++ |.+||.+.+..+....|... ..+.+|. .+++++.+||.+||. ||.+||+ +.+|+
T Consensus 531 ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~~~~l~~li~~cl~~dP~~RPs---~~~l~ 590 (613)
T 2ozo_A 531 EALSYGQKPYKKMKGPEVMAFIEQG-KRMECPP--ECPPELYALMSDCWIYKWEDRPD---FLTVE 590 (613)
T ss_dssp HHHTTSCCTTTTCCSHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHTTCSSTTTSCC---HHHHH
T ss_pred HHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--cCCHHHHHHHHHHcCCChhHCcC---HHHHH
Confidence 9998 99999999888888888764 2344553 799999999999999 9999999 65553
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=362.71 Aligned_cols=263 Identities=22% Similarity=0.366 Sum_probs=192.0
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEe---
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSF--- 185 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~--- 185 (497)
...+...+|++.+.||+|+||.||+|++..+|+.||||++.... ......+.+|+.++..+. ||||+++++++
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~ 98 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIG 98 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEEC
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhcccccccc
Confidence 34456678999999999999999999999999999999986543 334556889999999995 99999999998
Q ss_pred -----ecCCeEEEEEeecCCCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHcCC--EEEcccCCCCeeecCCCcE
Q 010947 186 -----QDDEFLYLIMEYLPGGDMMTLLMR---KDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLDKYGHL 255 (497)
Q Consensus 186 -----~~~~~l~lVmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDLKp~NILl~~~g~v 255 (497)
.....+|+||||+. |+|.+++.. .+.+++..+..++.||+.||.|||+.| |+||||||+|||++.++++
T Consensus 99 ~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~ 177 (337)
T 3ll6_A 99 KEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTI 177 (337)
T ss_dssp TTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCE
T ss_pred ccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCE
Confidence 34456899999995 799888865 467999999999999999999999999 9999999999999999999
Q ss_pred EEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccc---ccC
Q 010947 256 RLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVL---LKK 332 (497)
Q Consensus 256 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l---~~~ 332 (497)
||+|||+++........... . . ...........+||+.|+|||++ .+.
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~----~---------~----------------~~~~~~~~~~~~~t~~y~aPE~~~~~~~~ 228 (337)
T 3ll6_A 178 KLCDFGSATTISHYPDYSWS----A---------Q----------------RRALVEEEITRNTTPMYRTPEIIDLYSNF 228 (337)
T ss_dssp EBCCCTTCBCCSSCC------------------------------------------------------------CCTTS
T ss_pred EEecCccceeccccCccccc----c---------c----------------ccccchhhccccCCCCcCChhhhhccccC
Confidence 99999999876432110000 0 0 00000001145799999999999 567
Q ss_pred CCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 333 GYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 333 ~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
.++.++|||||||++|+|++|..||.+......... ....+....++..+.+||.+||. ||.+||+ +.++
T Consensus 229 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~e~ 299 (337)
T 3ll6_A 229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG------KYSIPPHDTQYTVFHSLIRAMLQVNPEERLS---IAEV 299 (337)
T ss_dssp CSSHHHHHHHHHHHHHHHHHSSCCC------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCC---HHHH
T ss_pred CCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC------cccCCcccccchHHHHHHHHHccCChhhCcC---HHHH
Confidence 789999999999999999999999987654433322 22333345678899999999999 9999998 8898
Q ss_pred cCC
Q 010947 412 KVH 414 (497)
Q Consensus 412 l~H 414 (497)
++|
T Consensus 300 l~~ 302 (337)
T 3ll6_A 300 VHQ 302 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=360.23 Aligned_cols=254 Identities=23% Similarity=0.324 Sum_probs=205.7
Q ss_pred CCCC-eeEEeEeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-
Q 010947 114 GADD-FELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD- 187 (497)
Q Consensus 114 ~~~~-f~~~~~IG~G~fG~V~~~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~- 187 (497)
...+ |++++.||+|+||+||+|.. ..+++.||||++.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 3344 59999999999999988865 3478899999998652 23445678999999999999999999999987
Q ss_pred -CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 188 -DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 188 -~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
...+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++..
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred CCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 4689999999999999999965 45999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
....... .......||+.|+|||++.+..++.++|||||||+
T Consensus 185 ~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 226 (318)
T 3lxp_A 185 PEGHEYY--------------------------------------RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVT 226 (318)
T ss_dssp CTTCSEE--------------------------------------EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHH
T ss_pred ccccccc--------------------------------------ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHH
Confidence 4321100 00113568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHH--------------HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 347 MYEMLVGYPPFYSDDPMS--------------TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~~--------------~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
+|+|++|..||....... .....+........ ...+++++.+||.+||. ||.+||+ +.++
T Consensus 227 l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps---~~el 301 (318)
T 3lxp_A 227 LYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPR--PDKCPAEVYHLMKNCWETEASFRPT---FENL 301 (318)
T ss_dssp HHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred HHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCC--CccccHHHHHHHHHHcCCCcccCcC---HHHH
Confidence 999999999997643210 11222222222233 34789999999999999 9999998 7777
Q ss_pred cC
Q 010947 412 KV 413 (497)
Q Consensus 412 l~ 413 (497)
++
T Consensus 302 l~ 303 (318)
T 3lxp_A 302 IP 303 (318)
T ss_dssp HH
T ss_pred HH
Confidence 63
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=370.47 Aligned_cols=253 Identities=17% Similarity=0.284 Sum_probs=202.0
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee-cCCeE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ-DDEFL 191 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-~~~~l 191 (497)
..|.+.+.||+|+||+||+|....++ ..||+|+++.. ........+.+|+.+++.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 35889999999999999999976443 46899998753 23445677999999999999999999999865 45688
Q ss_pred EEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+|+.+....
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 9999999999999999764 458999999999999999999999999999999999999999999999999998653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
.... .......||+.|+|||++.+..++.++|||||||++|||
T Consensus 247 ~~~~-------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el 289 (373)
T 3c1x_A 247 FDSV-------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289 (373)
T ss_dssp ------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred cccc-------------------------------------cccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHH
Confidence 0000 001135688999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 351 LV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 351 l~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++ |.+||.+.+..+....+.... ....| ..++.++.+||.+||. ||.+||+ +.++++
T Consensus 290 lt~~~~p~~~~~~~~~~~~~~~~~-~~~~p--~~~~~~l~~li~~cl~~dp~~RPs---~~ell~ 348 (373)
T 3c1x_A 290 MTRGAPPYPDVNTFDITVYLLQGR-RLLQP--EYCPDPLYEVMLKCWHPKAEMRPS---FSELVS 348 (373)
T ss_dssp HTTSCCSCTTSCSSCHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HhCcCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCChhhCcC---HHHHHH
Confidence 99 788998887777777776532 23333 3689999999999999 9999998 877765
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=384.96 Aligned_cols=252 Identities=20% Similarity=0.353 Sum_probs=214.7
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.+.+..++|++.+.||+|+||+||+|.+.. +..||||+++.... ..+.+.+|+.+|+.++|||||++++++.+ .
T Consensus 261 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 261 AWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp CSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 355677889999999999999999999865 45799999986532 23568899999999999999999999876 6
Q ss_pred eEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+|||||||+||+|.++|... ..+++..+..++.||+.||.|||++|||||||||+|||++.++.+||+|||+++.+.
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 789999999999999999753 569999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
..... ......||+.|+|||++....|+.++|||||||+|
T Consensus 415 ~~~~~----------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l 454 (535)
T 2h8h_A 415 DNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 454 (535)
T ss_dssp CHHHH----------------------------------------TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCcee----------------------------------------cccCCcCcccccCHHHhccCCCCchhhHHHHHHHH
Confidence 21000 01134578899999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++ |..||.+....+....+... ..+..| ..++.++.+||.+||. ||.+||+ +++|+.
T Consensus 455 ~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~RPt---~~~l~~ 516 (535)
T 2h8h_A 455 TELTTKGRVPYPGMVNREVLDQVERG-YRMPCP--PECPESLHDLMCQCWRKEPEERPT---FEYLQA 516 (535)
T ss_dssp HHHTTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--CCCCHHHHHHHHHHcCCChhHCcC---HHHHHH
Confidence 99999 99999999888888777643 223333 4789999999999999 9999999 777764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=366.01 Aligned_cols=253 Identities=15% Similarity=0.196 Sum_probs=201.6
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCC--------CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeE------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTT--------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVK------ 180 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t--------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~------ 180 (497)
.++|.+.+.||+|+||.||+|++..| ++.||||++.+. ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47899999999999999999999874 889999999764 24778999999999999987
Q ss_pred ---------EEEEeec-CCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCee
Q 010947 181 ---------LYCSFQD-DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLL 248 (497)
Q Consensus 181 ---------l~~~~~~-~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NIL 248 (497)
+++++.. ...+|+||||+ ||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 5566654 78899999999 99999999875 78999999999999999999999999999999999999
Q ss_pred ecCCC--cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCc
Q 010947 249 LDKYG--HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (497)
Q Consensus 249 l~~~g--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 326 (497)
++.++ .+||+|||+|+.+......... ........+||+.|+||
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~----------------------------------~~~~~~~~~gt~~y~aP 237 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAY----------------------------------VEGSRSPHEGDLEFISM 237 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCC----------------------------------CTTSSCTTCSCTTTCCH
T ss_pred EcCCCCceEEEecCcceeeccCCCccccc----------------------------------cccccccccCCccccCH
Confidence 99998 9999999999876432100000 00001245899999999
Q ss_pred cccccCCCCcchhHHhHHHHHHHHHhCCCCCCCCC--hHHHHHHHhccc-CcccCCC----CccCChhHHHHHHHHhh-C
Q 010947 327 EVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDD--PMSTCRKIVNWR-THLKFPE----EAKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 327 E~l~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~--~~~~~~~i~~~~-~~~~~p~----~~~~s~~~~dLI~~lL~-d 398 (497)
|++.+..++.++|||||||++|||++|..||.+.. .......+.... ....++. ...+++++.+||.+||. |
T Consensus 238 E~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 317 (352)
T 2jii_A 238 DLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALT 317 (352)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCC
T ss_pred HHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCC
Confidence 99999999999999999999999999999998764 222222222111 1111111 13578999999999999 9
Q ss_pred ccccCCCCCcchhcC
Q 010947 399 VNQRLGAKGADEIKV 413 (497)
Q Consensus 399 p~~R~~~~~~~eil~ 413 (497)
|.+||+ +++|++
T Consensus 318 p~~Rps---~~~l~~ 329 (352)
T 2jii_A 318 YEEKPP---YAMLRN 329 (352)
T ss_dssp TTCCCC---HHHHHH
T ss_pred hhhCCC---HHHHHH
Confidence 999999 777654
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-44 Score=358.82 Aligned_cols=257 Identities=23% Similarity=0.353 Sum_probs=193.3
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHH--HhcCCCceeEEEEEee--
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL--AEVDSNCIVKLYCSFQ-- 186 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il--~~l~hp~Iv~l~~~~~-- 186 (497)
..+..++|++++.||+|+||.||+|+. +++.||||++.... ...+..|.+++ ..++||||+++++.+.
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 456789999999999999999999975 68899999997543 12334455554 4589999999997543
Q ss_pred ---cCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC---------CEEEcccCCCCeeecCCCc
Q 010947 187 ---DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH---------HYIHRDIKPDNLLLDKYGH 254 (497)
Q Consensus 187 ---~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~---------~iiHrDLKp~NILl~~~g~ 254 (497)
....+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||++.+|.
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~ 158 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT 158 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence 34468999999999999999965 4569999999999999999999999 9999999999999999999
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---
Q 010947 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--- 331 (497)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--- 331 (497)
+||+|||+|+.+......... .......+.+||+.|+|||++.+
T Consensus 159 ~kL~DFG~a~~~~~~~~~~~~---------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~ 205 (336)
T 3g2f_A 159 CVISDFGLSMRLTGNRLVRPG---------------------------------EEDNAAISEVGTIRYMAPEVLEGAVN 205 (336)
T ss_dssp EEECCCTTCEECSSSSCC------------------------------------------CCTTSCGGGCCHHHHTTCCC
T ss_pred EEEeeccceeecccccccCcc---------------------------------ccccccccCCCccceeCchhhcCCcc
Confidence 999999999876533211000 00001125689999999999986
Q ss_pred ----CCCCcchhHHhHHHHHHHHHhCCCCCCCCCh-----------------HHHHHH-HhcccCcccCCC----CccCC
Q 010947 332 ----KGYGMECDWWSLGAIMYEMLVGYPPFYSDDP-----------------MSTCRK-IVNWRTHLKFPE----EAKLS 385 (497)
Q Consensus 332 ----~~y~~~~DiwSlGvil~ell~G~~PF~~~~~-----------------~~~~~~-i~~~~~~~~~p~----~~~~s 385 (497)
..++.++|||||||++|||++|..||..... ...... +........+|. ...++
T Consensus 206 ~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 285 (336)
T 3g2f_A 206 LRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285 (336)
T ss_dssp GGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHH
T ss_pred cccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchH
Confidence 4567899999999999999999777643221 111111 222122223332 12355
Q ss_pred hhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 386 IEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 386 ~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+++.+||.+||. ||.+||+ +.|++
T Consensus 286 ~~l~~li~~cl~~dP~~Rps---~~e~l 310 (336)
T 3g2f_A 286 RSLKETIEDCWDQDAEARLT---AQXAE 310 (336)
T ss_dssp HHHHHHHHHHSCSSGGGSCC---HHHHH
T ss_pred HHHHHHHHHHhcCChhhCcc---hHHHH
Confidence 689999999999 9999999 77774
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=357.29 Aligned_cols=257 Identities=26% Similarity=0.402 Sum_probs=207.7
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEE----cCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCRE----KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~----~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
..+..++|++++.||+|+||.||+|+. ..+|+.||||++... .....+.+.+|+.+++.++||||+++++++.
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCY 112 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence 345667899999999999999999984 568999999999764 2345567899999999999999999999887
Q ss_pred cCC--eEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 187 DDE--FLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 187 ~~~--~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
+.. .+|+||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus 113 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~ 192 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192 (326)
T ss_dssp C----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred ecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcch
Confidence 644 789999999999999999775 46999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+......... .......||+.|+|||++.+..++.++|||||
T Consensus 193 ~~~~~~~~~~--------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 234 (326)
T 2w1i_A 193 KVLPQDKEYY--------------------------------------KVKEPGESPIFWYAPESLTESKFSVASDVWSF 234 (326)
T ss_dssp EECCSSCSEE--------------------------------------ECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHH
T ss_pred hhcccccccc--------------------------------------ccccCCCCceeEECchhhcCCCCCchhhHHHH
Confidence 8764321100 00113467889999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChH------------H---HHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 344 GAIMYEMLVGYPPFYSDDPM------------S---TCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~------------~---~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
||++|||++|..||...... . .....+.....+..| ..+++++.+||.+||. ||.+||+
T Consensus 235 G~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps--- 309 (326)
T 2w1i_A 235 GVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP--DGCPDEIYMIMTECWNNNVNQRPS--- 309 (326)
T ss_dssp HHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred HHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCC--CcccHHHHHHHHHHcCCChhhCcC---
Confidence 99999999999998643110 0 111122211222333 4789999999999999 9999998
Q ss_pred cchhcC
Q 010947 408 ADEIKV 413 (497)
Q Consensus 408 ~~eil~ 413 (497)
+.++++
T Consensus 310 ~~el~~ 315 (326)
T 2w1i_A 310 FRDLAL 315 (326)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777763
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=396.01 Aligned_cols=264 Identities=26% Similarity=0.421 Sum_probs=211.6
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec------C
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------D 188 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~ 188 (497)
.++|++.+.||+|+||.||+|.++.+|+.||||++.... .......+.+|+.+++.++||||+++++++.+ .
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 478999999999999999999999999999999987642 34456678899999999999999999998765 6
Q ss_pred CeEEEEEeecCCCchhHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc---EEEccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH---LRLSDFGL 262 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~---vkL~DFGl 262 (497)
+..|+|||||+||+|.+++.... .+++..++.++.+++.||.|||+.||+||||||+|||++.++. +||+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 78899999999999999997644 6999999999999999999999999999999999999997765 99999999
Q ss_pred ccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHh
Q 010947 263 CKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342 (497)
Q Consensus 263 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwS 342 (497)
++....... ....+||+.|+|||++.+..++.++||||
T Consensus 171 a~~~~~~~~------------------------------------------~~~~~gt~~Y~APE~l~~~~~s~ksDIwS 208 (676)
T 3qa8_A 171 AKELDQGEL------------------------------------------CTEFVGTLQYLAPELLEQKKYTVTVDYWS 208 (676)
T ss_dssp CCBTTSCCC------------------------------------------CCCCCSCCTTCSSCSSCCSCCSTTHHHHH
T ss_pred ccccccccc------------------------------------------cccccCCcccCChHHhccCCCCchhHHHH
Confidence 986542210 12468999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHH---------HHh---------cccCcccCCC--CccCChhHHHHHHHHhh-Cccc
Q 010947 343 LGAIMYEMLVGYPPFYSDDPMSTCR---------KIV---------NWRTHLKFPE--EAKLSIEAKDLISKLLC-NVNQ 401 (497)
Q Consensus 343 lGvil~ell~G~~PF~~~~~~~~~~---------~i~---------~~~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~ 401 (497)
|||++|+|++|..||.+........ .+. .+...++.|. ...+++++.+||.+||. ||.+
T Consensus 209 LGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~k 288 (676)
T 3qa8_A 209 FGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ 288 (676)
T ss_dssp HHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC-
T ss_pred HHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhh
Confidence 9999999999999998754322110 000 0111111111 12467889999999999 9999
Q ss_pred cCCCCCcchhcCCCCccCCChhhhhh
Q 010947 402 RLGAKGADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 402 R~~~~~~~eil~Hpff~~i~w~~l~~ 427 (497)
||+ +.+++.||||.. ++.+.+
T Consensus 289 RPT---a~elL~hp~F~~--l~~iL~ 309 (676)
T 3qa8_A 289 RGT---DPQNPNVGCFQA--LDSILS 309 (676)
T ss_dssp --C---CTTCCCCTTHHH--HHHHHC
T ss_pred CcC---HHHHhcCHHHHH--HHHHHh
Confidence 999 889999999986 455553
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=354.50 Aligned_cols=253 Identities=25% Similarity=0.340 Sum_probs=197.7
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh--cCCCceeEEEEEeecC--
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQDD-- 188 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~~-- 188 (497)
...++|++++.||+|+||.||+|++. |+.||||++.... ......|.+++.. ++||||+++++++.+.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 33467999999999999999999875 8899999996542 2234456666655 4999999999999877
Q ss_pred --CeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC--------CEEEcccCCCCeeecCCCcEEEc
Q 010947 189 --EFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--------HYIHRDIKPDNLLLDKYGHLRLS 258 (497)
Q Consensus 189 --~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------~iiHrDLKp~NILl~~~g~vkL~ 258 (497)
..+|+||||++||+|.+++.. ..+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 789999999999999999955 5799999999999999999999998 99999999999999999999999
Q ss_pred ccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcc-
Q 010947 259 DFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGME- 337 (497)
Q Consensus 259 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~- 337 (497)
|||+|+.+....... .....+.+||+.|+|||++.+..++..
T Consensus 185 Dfg~a~~~~~~~~~~-------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 227 (337)
T 3mdy_A 185 DLGLAVKFISDTNEV-------------------------------------DIPPNTRVGTKRYMPPEVLDESLNRNHF 227 (337)
T ss_dssp CCTTCEECC----------------------------------------------CCSSCSCGGGCCHHHHTTCCCTTCT
T ss_pred eCCCceeeccccccc-------------------------------------cCCCCCCccCcceeChhhcccccCCccc
Confidence 999998664321100 000124689999999999988776665
Q ss_pred -----hhHHhHHHHHHHHHhC----------CCCCCCCC----hHHHHHHHh-cccCcccCCC---CccCChhHHHHHHH
Q 010947 338 -----CDWWSLGAIMYEMLVG----------YPPFYSDD----PMSTCRKIV-NWRTHLKFPE---EAKLSIEAKDLISK 394 (497)
Q Consensus 338 -----~DiwSlGvil~ell~G----------~~PF~~~~----~~~~~~~i~-~~~~~~~~p~---~~~~s~~~~dLI~~ 394 (497)
+|||||||++|||++| ..||.... .......+. .......+|. ...+++++.+||.+
T Consensus 228 ~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 307 (337)
T 3mdy_A 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTE 307 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHH
T ss_pred cCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHH
Confidence 9999999999999999 77776532 222233332 2122223332 12466789999999
Q ss_pred Hhh-CccccCCCCCcchhcCC
Q 010947 395 LLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 395 lL~-dp~~R~~~~~~~eil~H 414 (497)
||+ ||.+||+ +.++++|
T Consensus 308 ~l~~dP~~Rps---~~ell~~ 325 (337)
T 3mdy_A 308 CWAHNPASRLT---ALRVKKT 325 (337)
T ss_dssp HSCSSGGGSCC---HHHHHHH
T ss_pred hhhhChhhCCC---HHHHHHH
Confidence 999 9999998 8888763
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=386.45 Aligned_cols=255 Identities=24% Similarity=0.359 Sum_probs=213.9
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCC---CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ 186 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t---~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~ 186 (497)
...+..++|++.+.||+|+||.||+|.+..+ +..||||++.... .....+.+.+|+.+|+.++|||||++++++.
T Consensus 384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 3445667899999999999999999998654 4579999987532 2344567889999999999999999999985
Q ss_pred cCCeEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
++.+|+||||++||+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.+|++||+|||+|+.
T Consensus 462 -~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 -ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred -cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 466899999999999999997654 699999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
....... ......||+.|+|||++.+..|+.++|||||||
T Consensus 541 ~~~~~~~----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~ 580 (656)
T 2j0j_A 541 MEDSTYY----------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGV 580 (656)
T ss_dssp CCC--------------------------------------------------CCGGGCCHHHHHHCCCCHHHHHHHHHH
T ss_pred cCCCcce----------------------------------------eccCCCCCcceeCHHHhcCCCCCchhhHHHHHH
Confidence 5322100 011346789999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 346 IMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 346 il~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++|||++ |.+||.+.+..+....+... ....+| ..+++++.+||.+||. ||.+||+ +.+|++
T Consensus 581 il~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~~l~~dP~~RPs---~~el~~ 644 (656)
T 2j0j_A 581 CMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPMP--PNCPPTLYSLMTKCWAYDPSRRPR---FTELKA 644 (656)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHHHHT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHHcCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccccHHHHHHHHHHcCCChhHCcC---HHHHHH
Confidence 9999997 99999999888888887753 233444 3789999999999999 9999998 777764
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=374.01 Aligned_cols=250 Identities=16% Similarity=0.199 Sum_probs=197.3
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC-Cc----------e----
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NC----------I---- 178 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~----------I---- 178 (497)
....|...++||+|+||+||+|++..+|+.||||++...........+.+++|..++..+.| ++ +
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 34568899999999999999999999999999999985443333345678899999998876 21 1
Q ss_pred -------eEEEEEeec-----CCeEEEEEeecCCCchhHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHcCCEEE
Q 010947 179 -------VKLYCSFQD-----DEFLYLIMEYLPGGDMMTLLMR-------KDTLTEDEARFYVAETVLAIESIHKHHYIH 239 (497)
Q Consensus 179 -------v~l~~~~~~-----~~~l~lVmEy~~gg~L~~~l~~-------~~~l~e~~~~~~~~qi~~aL~~LH~~~iiH 239 (497)
..++..+.. ...++++|+++ +|+|.+++.. ...+++..+..++.||+.||.|||++||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH 234 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH 234 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 111111221 23467888876 7899998842 235788889999999999999999999999
Q ss_pred cccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccC
Q 010947 240 RDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVG 319 (497)
Q Consensus 240 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 319 (497)
|||||+|||++.+|.+||+|||+|+..... ..+.+|
T Consensus 235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--------------------------------------------~~~~~g 270 (413)
T 3dzo_A 235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--------------------------------------------AVSPIG 270 (413)
T ss_dssp SCCCGGGEEECTTCCEEECCGGGCEETTEE--------------------------------------------ECCCCC
T ss_pred CCcccceEEEecCCeEEEEeccceeecCCc--------------------------------------------cccCCC
Confidence 999999999999999999999998864311 124678
Q ss_pred CCcccCcccc----------ccCCCCcchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHH
Q 010947 320 TPDYIAPEVL----------LKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAK 389 (497)
Q Consensus 320 t~~Y~aPE~l----------~~~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 389 (497)
+.|+|||++ .+..|+.++|||||||++|||++|+.||.+.+.......+.. ....+|++++
T Consensus 271 -~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~ 341 (413)
T 3dzo_A 271 -RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVR 341 (413)
T ss_dssp -TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHH
T ss_pred -CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHH
Confidence 999999999 556689999999999999999999999988766554433332 2236789999
Q ss_pred HHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 390 dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
+||.+||. ||.+||+ +.++++||||+.+
T Consensus 342 ~li~~~l~~dP~~Rpt---~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 342 ALLEGFLRYPKEDRLL---PLQAMETPEYEQL 370 (413)
T ss_dssp HHHHHHTCSSGGGSCC---HHHHTTSHHHHHH
T ss_pred HHHHHHccCChhhCcC---HHHHHhCHHHHHH
Confidence 99999999 9999999 9999999999865
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=352.52 Aligned_cols=251 Identities=24% Similarity=0.317 Sum_probs=200.7
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-chhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
|...+.||+|+||.||+|.. ++..||||++...... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 44458999999999999975 6789999999764322 23345678999999999999999999999999999999999
Q ss_pred ecCCCchhHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 197 YLPGGDMMTLLMR---KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 197 y~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|++||+|.+++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++........
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~- 189 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT- 189 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC-
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc-
Confidence 9999999999864 346999999999999999999999999999999999999999999999999999865422100
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
......+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 190 --------------------------------------~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g 230 (307)
T 2nru_A 190 --------------------------------------VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITG 230 (307)
T ss_dssp --------------------------------------EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHC
T ss_pred --------------------------------------ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHC
Confidence 00114579999999998864 589999999999999999999
Q ss_pred CCCCCCCChHHHHHH----HhcccCcc------cCC-CCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 354 YPPFYSDDPMSTCRK----IVNWRTHL------KFP-EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~----i~~~~~~~------~~p-~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
.+||.+......... +......+ .++ .....+..+.+||.+||. ||.+||+ +.++++
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps---~~~l~~ 299 (307)
T 2nru_A 231 LPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPD---IKKVQQ 299 (307)
T ss_dssp CCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCC---HHHHHH
T ss_pred CCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcC---HHHHHH
Confidence 999987654322222 21110000 011 112456789999999999 9999999 777764
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=358.89 Aligned_cols=262 Identities=19% Similarity=0.250 Sum_probs=212.3
Q ss_pred HHHhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEe
Q 010947 106 MRLQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSF 185 (497)
Q Consensus 106 ~~~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~ 185 (497)
..++...+..++|++.+.||+|+||.||+|.+.. .||+|+++.... .....+.+.+|+.+++.++||||+++++++
T Consensus 23 ~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~ 98 (319)
T 2y4i_B 23 IFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGAC 98 (319)
T ss_dssp CCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEE
T ss_pred cccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEE
Confidence 3456778889999999999999999999998754 499999976432 222334577899999999999999999999
Q ss_pred ecCCeEEEEEeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 186 QDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 186 ~~~~~l~lVmEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
.+...+|+||||++||+|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++ +|.+||+|||+++
T Consensus 99 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~ 177 (319)
T 2y4i_B 99 MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFS 177 (319)
T ss_dssp ECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC
T ss_pred ecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcc
Confidence 99999999999999999999997654 699999999999999999999999999999999999998 6899999999987
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---------CCCC
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---------KGYG 335 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---------~~y~ 335 (497)
......... .........||+.|+|||++.+ ..++
T Consensus 178 ~~~~~~~~~------------------------------------~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~ 221 (319)
T 2y4i_B 178 ISGVLQAGR------------------------------------REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS 221 (319)
T ss_dssp ----------------------------------------------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCC
T ss_pred ccccccccc------------------------------------cccccccCCCcccccChHHhhhccccccccccCCC
Confidence 543211000 0001124579999999999974 4579
Q ss_pred cchhHHhHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 336 ~~~DiwSlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
.++|||||||++|||++|..||.+.+.......+....... .....++.++.+||.+||. ||.+||+ +.++++
T Consensus 222 ~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt---~~~l~~ 295 (319)
T 2y4i_B 222 KHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN--LSQIGMGKEISDILLFCWAFEQEERPT---FTKLMD 295 (319)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC--CCCSSCCTTHHHHHHHHHCSSTTTSCC---HHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC--CCcCCCCHHHHHHHHHHhcCChhhCcC---HHHHHH
Confidence 99999999999999999999999988888877776532221 1223688999999999999 9999998 777764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=351.86 Aligned_cols=251 Identities=25% Similarity=0.328 Sum_probs=201.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh--cCCCceeEEEEEeecCC---
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE--VDSNCIVKLYCSFQDDE--- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~--l~hp~Iv~l~~~~~~~~--- 189 (497)
.++|.+.+.||+|+||.||+|.+ +|+.||||++.... ...+..|.+++.. ++||||+++++++.+..
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 35799999999999999999987 58899999996542 3456778888887 79999999999998876
Q ss_pred -eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------cCCEEEcccCCCCeeecCCCcEEEccc
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDF 260 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH--------~~~iiHrDLKp~NILl~~~g~vkL~DF 260 (497)
.+|+||||+++|+|.+++.+ ..+++..+..++.|++.||.||| +.||+||||||+|||++.++.+||+||
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df 191 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence 89999999999999999965 57999999999999999999999 899999999999999999999999999
Q ss_pred ccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC------CC
Q 010947 261 GLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK------GY 334 (497)
Q Consensus 261 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~------~y 334 (497)
|+++.......... ......+||+.|+|||++.+. .+
T Consensus 192 g~~~~~~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 234 (342)
T 1b6c_B 192 GLAVRHDSATDTID-------------------------------------IAPNHRVGTKRYMAPEVLDDSINMKHFES 234 (342)
T ss_dssp TTCEEEETTTTEEE-------------------------------------ECCCSCCCCGGGCCHHHHTSCCCTTCHHH
T ss_pred CCceeccccccccc-------------------------------------cccccCCcCcccCCHhhhccccccccccc
Confidence 99986543211000 001245799999999999865 34
Q ss_pred CcchhHHhHHHHHHHHHhC----------CCCCCCCC-----hHHHHHHHhcccCcccCCCC---ccCChhHHHHHHHHh
Q 010947 335 GMECDWWSLGAIMYEMLVG----------YPPFYSDD-----PMSTCRKIVNWRTHLKFPEE---AKLSIEAKDLISKLL 396 (497)
Q Consensus 335 ~~~~DiwSlGvil~ell~G----------~~PF~~~~-----~~~~~~~i~~~~~~~~~p~~---~~~s~~~~dLI~~lL 396 (497)
+.++|||||||++|||++| ..||.... .......+........+|.. ..++..+.+||.+||
T Consensus 235 ~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 314 (342)
T 1b6c_B 235 FKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECW 314 (342)
T ss_dssp HHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHC
T ss_pred CCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHh
Confidence 4789999999999999999 78997653 23334444433223333321 234567899999999
Q ss_pred h-CccccCCCCCcchhcCC
Q 010947 397 C-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 397 ~-dp~~R~~~~~~~eil~H 414 (497)
. ||.+||+ +.+|++|
T Consensus 315 ~~dp~~Rps---~~~i~~~ 330 (342)
T 1b6c_B 315 YANGAARLT---ALRIKKT 330 (342)
T ss_dssp CSSGGGSCC---HHHHHHH
T ss_pred ccChhhCCC---HHHHHHH
Confidence 9 9999999 8888764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=341.02 Aligned_cols=225 Identities=12% Similarity=0.113 Sum_probs=188.7
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++.+.||+|+||.||+|++..+|+.||||++.............+.+|..++..++||||+++++++.+.+.+|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 55578999999999999999999999999999999998765444555677899999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
+||||++|++|.+++.. + ....++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred EEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----------
Confidence 99999999999999854 3 4666788899999999999999999999999999999999999998544
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
|++ .++.++|||||||++|||++
T Consensus 175 --------------------------------------------------~~~-------~~~~~~Di~slG~il~ellt 197 (286)
T 3uqc_A 175 --------------------------------------------------TMP-------DANPQDDIRGIGASLYALLV 197 (286)
T ss_dssp --------------------------------------------------CCT-------TCCHHHHHHHHHHHHHHHHH
T ss_pred --------------------------------------------------ccC-------CCCchhHHHHHHHHHHHHHH
Confidence 222 37889999999999999999
Q ss_pred CCCCCCCCChHHHHH---HHhcccCcccCC--CCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 353 GYPPFYSDDPMSTCR---KIVNWRTHLKFP--EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 353 G~~PF~~~~~~~~~~---~i~~~~~~~~~p--~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|.+||.+.+..+... ++.. .....+ ....+++++++||.+||. ||.+| + +.++++
T Consensus 198 g~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s---~~el~~ 258 (286)
T 3uqc_A 198 NRWPLPEAGVRSGLAPAERDTA--GQPIEPADIDRDIPFQISAVAARSVQGDGGIR-S---ASTLLN 258 (286)
T ss_dssp SEECSCCCSBCCCSEECCBCTT--SCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-C---HHHHHH
T ss_pred CCCCCCcCCcchhhHHHHHHhc--cCCCChhhcccCCCHHHHHHHHHHcccCCccC-C---HHHHHH
Confidence 999999876543221 1111 111111 124689999999999999 99999 7 888765
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=381.27 Aligned_cols=243 Identities=22% Similarity=0.300 Sum_probs=200.8
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcC-CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKT-TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~-t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
.+..++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+|..++|||||+++++|.+.+.
T Consensus 76 ~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 76 DIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDR 153 (681)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECT
T ss_pred CEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCC
Confidence 3445889999999999999999999976 78999999987532 23345668899999999999999999999987655
Q ss_pred -----EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 191 -----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 191 -----l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
+||||||++|++|.+++.. .+++..+..++.||+.||.|||++|||||||||+|||++.+ .+||+|||+++.
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence 7999999999999988754 79999999999999999999999999999999999999985 999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
.... ...+||+.|+|||++.+. ++.++|||||||
T Consensus 231 ~~~~---------------------------------------------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~ 264 (681)
T 2pzi_A 231 INSF---------------------------------------------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGR 264 (681)
T ss_dssp TTCC---------------------------------------------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHH
T ss_pred cccC---------------------------------------------CccCCCccccCHHHHcCC-CCCceehhhhHH
Confidence 5321 146799999999998754 589999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
++|+|++|.+||.+..... .........+++.+.+||.+||. ||.+||+ ..+.+.|+|+.
T Consensus 265 ~l~~l~~g~~~~~~~~~~~----------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~---~~~~l~~~l~~ 325 (681)
T 2pzi_A 265 TLAALTLDLPTRNGRYVDG----------LPEDDPVLKTYDSYGRLLRRAIDPDPRQRFT---TAEEMSAQLTG 325 (681)
T ss_dssp HHHHHHSCCCEETTEECSS----------CCTTCHHHHHCHHHHHHHHHHTCSSGGGSCS---SHHHHHHHHHH
T ss_pred HHHHHHhCCCCCccccccc----------ccccccccccCHHHHHHHhhhccCChhhCCC---HHHHHHHHHHH
Confidence 9999999999987632110 00011112357889999999999 9999998 67888888875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.93 Aligned_cols=189 Identities=16% Similarity=0.179 Sum_probs=138.3
Q ss_pred eeecCCeEEEEEEEcCCCcEEEEEEeechhhh-------chhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCCeEEEEE
Q 010947 124 IGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-------RRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 124 IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-------~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++.|++|.+..++...+|+.||+|++.+.... .....+.+.+|+++|+++ .|+||++++++|+++..+||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 56777888888888888999999999865321 122345689999999999 7999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||+||+|.++|.+.+++++. .|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 322 Eyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~---- 394 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS---- 394 (569)
T ss_dssp ECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---C----
T ss_pred ecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCc----
Confidence 999999999999998899875 4789999999999999999999999999999999999999999986542210
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
...+.+||+.|||||++.+ .+..++|+||+|+++++|.+|..
T Consensus 395 -------------------------------------~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 395 -------------------------------------WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp -------------------------------------CSHHHHHHHHHHHHHHC------------------CCCCTTHH
T ss_pred -------------------------------------cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccc
Confidence 1125789999999999975 46788999999999998877655
Q ss_pred CC
Q 010947 356 PF 357 (497)
Q Consensus 356 PF 357 (497)
||
T Consensus 437 ~~ 438 (569)
T 4azs_A 437 NW 438 (569)
T ss_dssp HH
T ss_pred hh
Confidence 54
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.8e-30 Score=277.70 Aligned_cols=193 Identities=19% Similarity=0.192 Sum_probs=147.7
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----chhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----RRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-----~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
..+.||+|+||+||+| ...+..+|+|+....... .....+.+.+|+.+|+.++||||+.+..++.+.+..|||
T Consensus 340 ~~~~LG~G~fg~Vy~~--~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRD--SYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEE--ECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEE--EECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3568999999999999 455789999987543221 122345689999999999999999554444566777999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||||+||+|.+++.. +..++.|++.||.|||++||+||||||+|||++. ++||+|||+|+.......
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~--- 484 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED--- 484 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH---
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc---
Confidence 999999999999865 6689999999999999999999999999999999 999999999987642210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc--CCCCcchhHHhHHHHHHHHHh
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK--KGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~--~~y~~~~DiwSlGvil~ell~ 352 (497)
.... ......+.+||+.|+|||++.. .+|+..+|+||.++-..+.+.
T Consensus 485 ---------------------------~~~~----~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~ 533 (540)
T 3en9_A 485 ---------------------------KAVD----LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVE 533 (540)
T ss_dssp ---------------------------HHHH----HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHH
T ss_pred ---------------------------cccc----hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHH
Confidence 0000 0001225789999999999987 779999999999999999888
Q ss_pred CCCCCC
Q 010947 353 GYPPFY 358 (497)
Q Consensus 353 G~~PF~ 358 (497)
++.+|.
T Consensus 534 ~r~rY~ 539 (540)
T 3en9_A 534 RRARYV 539 (540)
T ss_dssp TCSCCC
T ss_pred hccccC
Confidence 877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.2e-28 Score=237.14 Aligned_cols=134 Identities=13% Similarity=0.129 Sum_probs=108.5
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---------------hHHHHHHHHHHHHHhcCCCceeEEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---------------GQVEHVRAERNLLAEVDSNCIVKLY 182 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~---------------~~~~~~~~E~~il~~l~hp~Iv~l~ 182 (497)
|.+.+.||+|+||.||+|.+ .+|+.||||+++....... .....+.+|+.+|+.++| ++++
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCcC
Confidence 44559999999999999999 8899999999975432111 234568899999999984 4454
Q ss_pred EEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 183 ~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
.++.. +..|+|||||+||+|.+ +. ...+..++.|++.||.|||+.||+||||||+|||++ +|++||+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 44433 56799999999999988 42 134567999999999999999999999999999999 99999999999
Q ss_pred cc
Q 010947 263 CK 264 (497)
Q Consensus 263 a~ 264 (497)
|+
T Consensus 239 a~ 240 (282)
T 1zar_A 239 SV 240 (282)
T ss_dssp CE
T ss_pred Ce
Confidence 86
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9.4e-23 Score=197.52 Aligned_cols=142 Identities=15% Similarity=0.133 Sum_probs=110.9
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcE--EEEEEeechhhhc---------------------hhHHHHHHHHHHHHHhc
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHV--YAMKKLKKSEMLR---------------------RGQVEHVRAERNLLAEV 173 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~--~AiK~l~k~~~~~---------------------~~~~~~~~~E~~il~~l 173 (497)
-|++.+.||+|+||.||+|.+..+|+. ||||+++...... ......+.+|..+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999998778989 9999976532110 01123578899999999
Q ss_pred CCCce--eEEEEEeecCCeEEEEEeecCC-C----chhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-cCCEEEcccCCC
Q 010947 174 DSNCI--VKLYCSFQDDEFLYLIMEYLPG-G----DMMTLLMRKDTLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPD 245 (497)
Q Consensus 174 ~hp~I--v~l~~~~~~~~~l~lVmEy~~g-g----~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH-~~~iiHrDLKp~ 245 (497)
.|++| +.++.. ...||||||+.+ | +|.++... .++..+..++.|++.||.||| +.|||||||||+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~ 200 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEY 200 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTT
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHH
Confidence 88753 344432 356899999942 4 56655422 345678899999999999999 999999999999
Q ss_pred CeeecCCCcEEEcccccccccC
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~ 267 (497)
|||++. .++|+|||+|....
T Consensus 201 NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 201 NIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp SEEESS--SEEECCCTTCEETT
T ss_pred HEEEcC--cEEEEECcccccCC
Confidence 999998 99999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=4.1e-20 Score=187.28 Aligned_cols=139 Identities=14% Similarity=0.151 Sum_probs=101.3
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh-----------ch----hHH----HHHHHHHHHHHhcCCCc
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML-----------RR----GQV----EHVRAERNLLAEVDSNC 177 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~-----------~~----~~~----~~~~~E~~il~~l~hp~ 177 (497)
-|++...||.|+||.||+|.+. +|+.||||+++..... .. ... .....|...|..+.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3899999999999999999874 6999999998643210 00 000 11234666676664443
Q ss_pred ee--EEEEEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC--
Q 010947 178 IV--KLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-- 253 (497)
Q Consensus 178 Iv--~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-- 253 (497)
+. ..+.. ...+|||||++|++|..+.. ...+..++.||+.+|.+||+.|||||||||.|||++.+|
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 32 22221 12369999999998866532 234567889999999999999999999999999999877
Q ss_pred --------cEEEccccccccc
Q 010947 254 --------HLRLSDFGLCKPL 266 (497)
Q Consensus 254 --------~vkL~DFGla~~~ 266 (497)
.+.|+||+-+-..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 4899999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.43 E-value=6.8e-13 Score=127.83 Aligned_cols=140 Identities=12% Similarity=0.063 Sum_probs=111.0
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lV 194 (497)
..|.+...+|.|+++.||++.. .+..+++|+....... ....+.+|..+|+.+. +..+.++++++.+....|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 3688999999999999999864 3679999998753211 1234788999998884 67788899988888899999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc----------------------------------------
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK---------------------------------------- 234 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------- 234 (497)
|||++|.+|...+. +......++.++..+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred EEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence 99999999876531 223345678889999999998
Q ss_pred -------------------CCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 235 -------------------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 235 -------------------~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
..++|+|++|.|||++.++.+.|+||+.|..
T Consensus 164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4599999999999998765667999998864
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.32 E-value=3.1e-12 Score=122.41 Aligned_cols=136 Identities=13% Similarity=0.089 Sum_probs=100.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCc--eeEEEEEeecCCeEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC--IVKLYCSFQDDEFLY 192 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~~~~~~~l~ 192 (497)
..++.+..+.+.|+.+.||++.. .+|..|++|+..... ...+..|..+++.+.+.. +.++++++.+.+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 34566655545667799999854 567789999976431 134678999998885444 566888888888899
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC------------------------------------
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH------------------------------------ 236 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~------------------------------------ 236 (497)
+||||++|.+|. . ...+ ...++.+++.+|..||+..
T Consensus 92 ~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (264)
T 1nd4_A 92 LLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ 163 (264)
T ss_dssp EEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred EEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence 999999998884 2 1122 2245667777777777643
Q ss_pred ----------------------EEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 237 ----------------------YIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 237 ----------------------iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
++|+|++|.|||++.++.+.|+|||.|..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998776677999999864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.22 E-value=3.6e-11 Score=121.36 Aligned_cols=143 Identities=19% Similarity=0.256 Sum_probs=107.6
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEee--chhhhchhHHHHHHHHHHHHHhcC--CCceeEEEEEeecC---Ce
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLK--KSEMLRRGQVEHVRAERNLLAEVD--SNCIVKLYCSFQDD---EF 190 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~--k~~~~~~~~~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~---~~ 190 (497)
...++.|+.|.++.||++... +..+++|+.. ..... .....+.+|..+++.+. +..+++++..+.+. ..
T Consensus 40 ~~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~ 115 (359)
T 3dxp_A 40 PLSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR 115 (359)
T ss_dssp CCEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred CceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence 345778999999999998753 4688999876 33211 12235778999999886 45578888888776 45
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc------------------------------------
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK------------------------------------ 234 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~------------------------------------ 234 (497)
.|+||||++|..+.+.. ...+++.+...++.+++.+|..||+
T Consensus 116 ~~~vme~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (359)
T 3dxp_A 116 AFYIMEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES 193 (359)
T ss_dssp CEEEEECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred eEEEEEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence 88999999998875421 2347888889999999999999996
Q ss_pred ----------------------CCEEEcccCCCCeeecCCCc--EEEccccccccc
Q 010947 235 ----------------------HHYIHRDIKPDNLLLDKYGH--LRLSDFGLCKPL 266 (497)
Q Consensus 235 ----------------------~~iiHrDLKp~NILl~~~g~--vkL~DFGla~~~ 266 (497)
.+++|+|++|.|||++.++. +.|+||+.|...
T Consensus 194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 36999999999999997753 699999998753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.20 E-value=2.2e-11 Score=120.01 Aligned_cols=134 Identities=18% Similarity=0.219 Sum_probs=99.2
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCc--eeEEEEEeecCC---eEEEE
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNC--IVKLYCSFQDDE---FLYLI 194 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~--Iv~l~~~~~~~~---~l~lV 194 (497)
++.++.|....||++. ..+++|+.... .....+..|..+|+.+ .+.. +.+++....+.. ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4569999999999863 46899986533 2345688899999877 3322 445555544333 34899
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc----------------------------------------
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK---------------------------------------- 234 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~---------------------------------------- 234 (497)
||+++|..|..... ..++..+...++.+++..|..||+
T Consensus 95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 99999988875432 357777788888888888888885
Q ss_pred ------------------CCEEEcccCCCCeeecC--CCcEEEccccccccc
Q 010947 235 ------------------HHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPL 266 (497)
Q Consensus 235 ------------------~~iiHrDLKp~NILl~~--~g~vkL~DFGla~~~ 266 (497)
..++|+|++|.|||++. .+.+.|+||+.+...
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 24799999999999998 456889999998754
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=2.6e-07 Score=90.97 Aligned_cols=135 Identities=16% Similarity=0.142 Sum_probs=92.3
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC---ceeEEEEEee-cCCeEEEEE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN---CIVKLYCSFQ-DDEFLYLIM 195 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp---~Iv~l~~~~~-~~~~l~lVm 195 (497)
-+..++.|....||++ |..+++|+-... .....+..|..+|..+.+. .+.+.+.+.. ..+..|+||
T Consensus 23 ~v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~ 92 (306)
T 3tdw_A 23 SVESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGY 92 (306)
T ss_dssp CEEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEE
T ss_pred eeeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEE
Confidence 3556899999999987 567889985322 2345688999999988642 2455555553 455678999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK----------------------------------------- 234 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~----------------------------------------- 234 (497)
||++|..|..... ..++..+...++.++...|..||+
T Consensus 93 e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (306)
T 3tdw_A 93 RKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD 170 (306)
T ss_dssp ECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred eccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence 9999988765321 223444444444444444444442
Q ss_pred -------------------CCEEEcccCCCCeeecC---CCc-EEEccccccccc
Q 010947 235 -------------------HHYIHRDIKPDNLLLDK---YGH-LRLSDFGLCKPL 266 (497)
Q Consensus 235 -------------------~~iiHrDLKp~NILl~~---~g~-vkL~DFGla~~~ 266 (497)
..++|+|++|.|||++. ++. +.|+||+.+...
T Consensus 171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 24699999999999997 455 489999988754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=5.5e-07 Score=86.47 Aligned_cols=133 Identities=18% Similarity=0.148 Sum_probs=91.8
Q ss_pred EeeecCCe-EEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEEEeecCC
Q 010947 123 MIGKGAFG-EVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYLPG 200 (497)
Q Consensus 123 ~IG~G~fG-~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lVmEy~~g 200 (497)
.+..|..| .||.......+..+.+|+-... ....+..|..+|+.+. +--+.+++.++.+.+..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34556555 6998877777778999986543 2345778999988774 22366788888888999999999999
Q ss_pred CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcC---------------------------------------------
Q 010947 201 GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH--------------------------------------------- 235 (497)
Q Consensus 201 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~--------------------------------------------- 235 (497)
.++.+..... ......+..++...|.-||..
T Consensus 105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 8776654221 111222333333444444421
Q ss_pred -------------CEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 236 -------------HYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 236 -------------~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
.++|+|+.|.|||++.++.+-|+||+.|..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 279999999999999877778999999874
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=2.9e-07 Score=93.93 Aligned_cols=80 Identities=18% Similarity=0.202 Sum_probs=50.4
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhh-hch---hHHHHHHHHHHHHHhcCC--Cc-eeEEEEEeecCCeEE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM-LRR---GQVEHVRAERNLLAEVDS--NC-IVKLYCSFQDDEFLY 192 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~-~~~---~~~~~~~~E~~il~~l~h--p~-Iv~l~~~~~~~~~l~ 192 (497)
.++.||.|.++.||++....++..|++|....... ... .....+..|.++|..+.. |. +.+++++ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999997666678899998653211 000 123446778888887742 43 4455543 344567
Q ss_pred EEEeecCCC
Q 010947 193 LIMEYLPGG 201 (497)
Q Consensus 193 lVmEy~~gg 201 (497)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999874
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.28 E-value=6.4e-06 Score=81.56 Aligned_cols=137 Identities=10% Similarity=0.131 Sum_probs=78.2
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-----CCceeEEE-E--EeecCCeE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----SNCIVKLY-C--SFQDDEFL 191 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-----hp~Iv~l~-~--~~~~~~~l 191 (497)
-++.|+.|..+.||++... +..+++|+..... ..+..|..++..+. .|.++... + +..+.+..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~-------~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTD--SGAVCLKRIHRPE-------KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEET--TEEEEEEEECSCH-------HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeC--CCCEEEEecCCCH-------HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 4456777889999998753 3359999987521 22334455554442 24433310 0 12345678
Q ss_pred EEEEeecCCCchh--------------HHHHh-cCCC-------------CHH--------H------------------
Q 010947 192 YLIMEYLPGGDMM--------------TLLMR-KDTL-------------TED--------E------------------ 217 (497)
Q Consensus 192 ~lVmEy~~gg~L~--------------~~l~~-~~~l-------------~e~--------~------------------ 217 (497)
|+||||++|..+. ..+.. ...+ .+. .
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999986542 11111 0111 110 0
Q ss_pred -----HHHHHHHHHHHHHHHH-------------cCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 218 -----ARFYVAETVLAIESIH-------------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 218 -----~~~~~~qi~~aL~~LH-------------~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
...+...+..++.+|+ ..+++|+|++|.|||++.++.+.|+||+.|..
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111222334566665 36899999999999998888999999998864
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=5.4e-06 Score=82.97 Aligned_cols=87 Identities=8% Similarity=0.026 Sum_probs=56.2
Q ss_pred eeEEeEe-eecCCeEEEEEEEcC------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-C--CceeEEEEEeec
Q 010947 118 FELLTMI-GKGAFGEVRVCREKT------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-S--NCIVKLYCSFQD 187 (497)
Q Consensus 118 f~~~~~I-G~G~fG~V~~~~~~~------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-h--p~Iv~l~~~~~~ 187 (497)
...++.| +.|..+.+|++.... ++..+++|+..............+..|..+|+.+. + -.+.+++.++.+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4456778 889999999886531 15678999865432000000123667888887774 2 346777777765
Q ss_pred C---CeEEEEEeecCCCchh
Q 010947 188 D---EFLYLIMEYLPGGDMM 204 (497)
Q Consensus 188 ~---~~l~lVmEy~~gg~L~ 204 (497)
. ...|+||||++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 5 3568999999986654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.96 E-value=3.8e-05 Score=78.83 Aligned_cols=33 Identities=12% Similarity=0.163 Sum_probs=29.1
Q ss_pred HcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 233 H~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
+...++|+|++|.|||++.++ +.|+||+.|...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 467899999999999999877 999999998753
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00012 Score=71.93 Aligned_cols=77 Identities=18% Similarity=0.160 Sum_probs=59.6
Q ss_pred eEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC---CCceeEEEEEeecCCeEEEEE
Q 010947 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD---SNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 119 ~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~---hp~Iv~l~~~~~~~~~l~lVm 195 (497)
.-++.|+.|....||++.. ++..|++|+.... ....+..|...|+.+. ...+++++....+.+..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 3467789999999998864 4678999987643 2345788988888773 356778888887778899999
Q ss_pred eecCCCch
Q 010947 196 EYLPGGDM 203 (497)
Q Consensus 196 Ey~~gg~L 203 (497)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.73 E-value=6.6e-05 Score=73.25 Aligned_cols=133 Identities=11% Similarity=-0.028 Sum_probs=74.8
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEEEeec-
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLIMEYL- 198 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lVmEy~- 198 (497)
++.|+.|....+|++ ..|++|+....... ......|..+++.+. +....++++.+. +.-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecC
Confidence 788999999999998 46889987653110 011245777776653 222245665543 3346899999
Q ss_pred CCCchhHH---------------H---HhcC-CC----C-HHHHHHHHHH--------------HHHHHHH----HH---
Q 010947 199 PGGDMMTL---------------L---MRKD-TL----T-EDEARFYVAE--------------TVLAIES----IH--- 233 (497)
Q Consensus 199 ~gg~L~~~---------------l---~~~~-~l----~-e~~~~~~~~q--------------i~~aL~~----LH--- 233 (497)
+|..|... | .... .+ . ...+..+... +...+.. +.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 66444311 0 1111 01 1 1111111111 1111111 11
Q ss_pred -cCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 234 -KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 234 -~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
...++|+|+.|.||| ..++.+.|+||..|...
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 124899999999999 56678899999988643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.55 E-value=0.00022 Score=72.05 Aligned_cols=141 Identities=16% Similarity=0.199 Sum_probs=84.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeec
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD 187 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~ 187 (497)
+.++ ++.|..|-...+|++.... ++..|.+|+.... ......+.+|..+++.+. +....++++.+.+
T Consensus 51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~----~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~ 125 (379)
T 3feg_A 51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI----LQGVDSLVLESVMFAILAERSLGPQLYGVFPE 125 (379)
T ss_dssp GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc----cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence 4444 3567778888999987642 3568999986431 112344568988887773 3344667777654
Q ss_pred CCeEEEEEeecCCCchhH--------------HH---Hhc-----CCC--CHHHHHHHHHHHHH----------------
Q 010947 188 DEFLYLIMEYLPGGDMMT--------------LL---MRK-----DTL--TEDEARFYVAETVL---------------- 227 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~--------------~l---~~~-----~~l--~e~~~~~~~~qi~~---------------- 227 (497)
. +||||++|..|.. .| ... ... -..++..+..++-.
T Consensus 126 g----~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 201 (379)
T 3feg_A 126 G----RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS 201 (379)
T ss_dssp E----EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred c----cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence 2 9999999855421 11 111 111 13455555544321
Q ss_pred ---HHHHHH----c----CCEEEcccCCCCeeecCC----CcEEEcccccccc
Q 010947 228 ---AIESIH----K----HHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKP 265 (497)
Q Consensus 228 ---aL~~LH----~----~~iiHrDLKp~NILl~~~----g~vkL~DFGla~~ 265 (497)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..|..
T Consensus 202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 223332 2 369999999999999886 7899999999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.0004 Score=71.40 Aligned_cols=74 Identities=20% Similarity=0.262 Sum_probs=49.9
Q ss_pred EEeEeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeE
Q 010947 120 LLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l 191 (497)
-++.|+.|....||++.... ++..|.+|+..... ....+..|..++..+. +...+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 45678889999999998643 25789999884321 0133456888888774 3334667776643
Q ss_pred EEEEeecCCCc
Q 010947 192 YLIMEYLPGGD 202 (497)
Q Consensus 192 ~lVmEy~~gg~ 202 (497)
.+||||++|..
T Consensus 148 g~v~e~l~G~~ 158 (429)
T 1nw1_A 148 GRLEEYIPSRP 158 (429)
T ss_dssp EEEECCCCEEE
T ss_pred CEEEEEeCCcc
Confidence 28999998743
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00018 Score=70.59 Aligned_cols=143 Identities=11% Similarity=0.018 Sum_probs=79.0
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCc--eeEEEEE------eec
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC--IVKLYCS------FQD 187 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~--Iv~l~~~------~~~ 187 (497)
....-++.|+.|....||++... +| .|++|+..... .. ..+..|..++..+.... +.+++.. ...
T Consensus 22 ~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~---~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~ 94 (322)
T 2ppq_A 22 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 94 (322)
T ss_dssp CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CH---HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence 34455678888999999998753 33 68899987531 11 23455777776653211 2233221 112
Q ss_pred CCeEEEEEeecCCCchhH--------------HHHhc-CCC--------C---HHHH-H-----------HHHHHHHHHH
Q 010947 188 DEFLYLIMEYLPGGDMMT--------------LLMRK-DTL--------T---EDEA-R-----------FYVAETVLAI 229 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~--------------~l~~~-~~l--------~---e~~~-~-----------~~~~qi~~aL 229 (497)
.+..++||+|++|..+.. .+... ..+ . +... . .+...+...+
T Consensus 95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~ 174 (322)
T 2ppq_A 95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI 174 (322)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence 356789999999864311 01110 011 1 0000 0 0001133344
Q ss_pred HHHH-------cCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 230 ESIH-------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 230 ~~LH-------~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
..++ ..+++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 5554 24799999999999999876668999998763
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.42 E-value=0.00045 Score=69.34 Aligned_cols=76 Identities=14% Similarity=0.068 Sum_probs=44.8
Q ss_pred EEeEeeecCCeEEEEEEEcC--------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCe
Q 010947 120 LLTMIGKGAFGEVRVCREKT--------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEF 190 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~--------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~ 190 (497)
-++.|+.|....||++.... .+..|++|+...... .......|..++..+. +..+.++++.+.
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~---- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN---- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC----
Confidence 35678888889999987643 136889998764311 1111356788887764 322446666552
Q ss_pred EEEEEeecCCCch
Q 010947 191 LYLIMEYLPGGDM 203 (497)
Q Consensus 191 l~lVmEy~~gg~L 203 (497)
-++||||++|..+
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 2689999988543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00062 Score=66.86 Aligned_cols=137 Identities=12% Similarity=0.160 Sum_probs=77.6
Q ss_pred eEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCC--ceeEEEEE-----eecCCeEEEE
Q 010947 122 TMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN--CIVKLYCS-----FQDDEFLYLI 194 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp--~Iv~l~~~-----~~~~~~l~lV 194 (497)
..|+ |....||++.. .+|+.|++|+...... ....+..|..++..+... .+++++.. ....+..++|
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998753 3466799999863311 123456677777766321 13333332 1224566899
Q ss_pred EeecCCCchh-----------HH---HHh---c------CCCCHHHH----H------------------HHHHHHHHHH
Q 010947 195 MEYLPGGDMM-----------TL---LMR---K------DTLTEDEA----R------------------FYVAETVLAI 229 (497)
Q Consensus 195 mEy~~gg~L~-----------~~---l~~---~------~~l~e~~~----~------------------~~~~qi~~aL 229 (497)
|+|++|..+. .. +.. . ..++.... . ..+..++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999885431 01 111 0 01121110 0 1111222222
Q ss_pred HHH----HcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 230 ESI----HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 230 ~~L----H~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
.-+ +...++|+|++|.|||++ + .+.|+||+.|...
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 222 234689999999999999 4 8999999988643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00066 Score=66.96 Aligned_cols=33 Identities=27% Similarity=0.335 Sum_probs=28.5
Q ss_pred cCCEEEcccCCCCeeecCC----CcEEEccccccccc
Q 010947 234 KHHYIHRDIKPDNLLLDKY----GHLRLSDFGLCKPL 266 (497)
Q Consensus 234 ~~~iiHrDLKp~NILl~~~----g~vkL~DFGla~~~ 266 (497)
...++|+|+.|.|||++.+ +.+.|+||+.|...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3579999999999999875 68999999998754
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0075 Score=58.03 Aligned_cols=79 Identities=16% Similarity=0.065 Sum_probs=54.3
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC--C-ceeEEEEEeecCCeEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--N-CIVKLYCSFQDDEFLY 192 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p-~Iv~l~~~~~~~~~l~ 192 (497)
....-+..+|.|..+.||+++. .+|+.|.+|+-..... .....+..|...|+.+.. + -++++++. +. -+
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~ 86 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT 86 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence 4567788999999999999875 5688999998654321 112346789998887732 2 34455544 22 36
Q ss_pred EEEeecCCCc
Q 010947 193 LIMEYLPGGD 202 (497)
Q Consensus 193 lVmEy~~gg~ 202 (497)
+||||++++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998764
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0019 Score=64.11 Aligned_cols=32 Identities=19% Similarity=0.193 Sum_probs=28.4
Q ss_pred CCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 235 ~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
..++|+|+.|.|||++.++.+.|+||+.+...
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 46999999999999998888999999887654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0035 Score=57.65 Aligned_cols=120 Identities=19% Similarity=0.178 Sum_probs=79.6
Q ss_pred CchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH-cCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccccc
Q 010947 201 GDMMTLLMRK-DTLTEDEARFYVAETVLAIESIH-KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278 (497)
Q Consensus 201 g~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH-~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 278 (497)
-+|.++|... .+++|+++..++.|.+.+|.-+- ...-..+=+-|..|++..+|.|-+.+ +.+.
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-------------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-------------- 97 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence 3788888764 68999999999999999988762 11111233456889999999988764 2111
Q ss_pred cCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCC
Q 010947 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPF 357 (497)
Q Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF 357 (497)
.....+.|||... ...+.+.=|||||+++|.-|- |-++
T Consensus 98 ---------------------------------------~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e- 136 (229)
T 2yle_A 98 ---------------------------------------AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE- 136 (229)
T ss_dssp ------------------------------------------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT-
T ss_pred ---------------------------------------ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc-
Confidence 1122356787763 455678889999999998874 2111
Q ss_pred CCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh
Q 010947 358 YSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC 397 (497)
Q Consensus 358 ~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~ 397 (497)
.....+|+++..||..|..
T Consensus 137 ---------------------~eE~eLS~~LE~LL~~Mt~ 155 (229)
T 2yle_A 137 ---------------------NEERELSPPLEQLIDHMAN 155 (229)
T ss_dssp ---------------------TEEECCCHHHHHHHHHHTT
T ss_pred ---------------------ccchhhCHHHHHHHHHHHh
Confidence 1224799999999999985
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0059 Score=63.16 Aligned_cols=76 Identities=13% Similarity=0.203 Sum_probs=48.6
Q ss_pred EEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCc-eeEEEEEeecCCeEEEEEeec
Q 010947 120 LLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLIMEYL 198 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~l~lVmEy~ 198 (497)
-++.|+.|-...+|++.....+..|++|+..... ...+ ....|..++..+...+ ..++++.|. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 4567888999999999875445789999875421 1111 1246888888885433 456777763 2 2599999
Q ss_pred CCCch
Q 010947 199 PGGDM 203 (497)
Q Consensus 199 ~gg~L 203 (497)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 88443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.99 E-value=0.031 Score=57.11 Aligned_cols=76 Identities=16% Similarity=0.165 Sum_probs=48.6
Q ss_pred EEeEeeecCCeEEEEEEEcCC-------CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeE
Q 010947 120 LLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t-------~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l 191 (497)
-++.|..|-...+|++..... +..|++++..... ...-...+|..+++.+. +....++++.+. +
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~-- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP--E-- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--
Confidence 456677788899999886521 5789999865421 11111346888887763 334556666543 2
Q ss_pred EEEEeecCCCch
Q 010947 192 YLIMEYLPGGDM 203 (497)
Q Consensus 192 ~lVmEy~~gg~L 203 (497)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.74 E-value=0.12 Score=52.12 Aligned_cols=30 Identities=30% Similarity=0.438 Sum_probs=25.7
Q ss_pred CEEEcccCCCCeee------cCCCcEEEcccccccc
Q 010947 236 HYIHRDIKPDNLLL------DKYGHLRLSDFGLCKP 265 (497)
Q Consensus 236 ~iiHrDLKp~NILl------~~~g~vkL~DFGla~~ 265 (497)
.++|+|+.+.|||+ +.++.+.++||.+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 37899999999999 4567899999999874
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 497 | ||||
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-90 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-86 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-85 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-83 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-78 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 7e-78 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-75 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-74 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-72 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-72 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-72 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-71 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-71 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-71 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 8e-70 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-69 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 8e-69 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-66 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-65 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 8e-62 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-59 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-58 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-55 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-54 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-54 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-54 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-53 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-52 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 6e-51 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-51 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-50 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-50 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-49 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-49 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 8e-49 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-48 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 5e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 5e-46 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 7e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-45 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-45 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-44 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-43 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 6e-41 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-40 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-33 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-14 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (703), Expect = 5e-90
Identities = 101/330 (30%), Positives = 168/330 (50%), Gaps = 47/330 (14%)
Query: 109 QRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN 168
Q K +DF+ ++G+G+F V + RE T YA+K L+K +++ +V +V ER+
Sbjct: 1 QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60
Query: 169 LLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+++ +D VKLY +FQDDE LY + Y G+++ + + + E RFY AE V A
Sbjct: 61 VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 120
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+E +H IHRD+KP+N+LL++ H++++DFG K
Sbjct: 121 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK------------------------ 156
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
++++ A S VGT Y++PE+L +K D W+LG I+Y
Sbjct: 157 ---------------VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 201
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK- 406
+++ G PPF + + +KI+ FPE K +A+DL+ KLL + +RLG +
Sbjct: 202 QLVAGLPPFRAGNEYLIFQKIIKLE--YDFPE--KFFPKARDLVEKLLVLDATKRLGCEE 257
Query: 407 --GADEIKVHPWFDGVDWARIYQMEAAFIP 434
G +K HP+F+ V W ++Q +
Sbjct: 258 MEGYGPLKAHPFFESVTWENLHQQTPPKLT 287
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 265 bits (679), Expect = 4e-86
Identities = 114/370 (30%), Positives = 177/370 (47%), Gaps = 56/370 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-D 174
+DF L M+GKG+FG+V + K T +A+K LKK +L VE E+ +L+ +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK 234
+ ++C+FQ E L+ +MEYL GGD+M + A FY AE +L ++ +H
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
++RD+K DN+LLDK GH++++DFG+CK + F
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTF------------------ 163
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
GTPDYIAPE+LL + Y DWWS G ++YEML+G
Sbjct: 164 -----------------------CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413
PF+ D I +P L EAKDL+ KL +RLG +I+
Sbjct: 201 SPFHGQDEEELFHSIRMDN--PFYPR--WLEKEAKDLLVKLFVREPEKRLGV--RGDIRQ 254
Query: 414 HPWFDGVDWARIY--QMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSK 471
HP F ++W + +++ F P+V D NF+K ++ + + R +++S
Sbjct: 255 HPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFAD----RALINSM 310
Query: 472 DIN-FVGYTY 480
D N F +++
Sbjct: 311 DQNMFRNFSF 320
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 263 bits (672), Expect = 7e-85
Identities = 122/387 (31%), Positives = 180/387 (46%), Gaps = 59/387 (15%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
K+ +DF+ L ++GKG FG+V + REK TG YAMK L+K ++ + +V H E +L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIES 231
+ L +FQ + L +MEY GG++ L R+ TE+ ARFY AE V A+E
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+H ++RDIK +NL+LDK GH++++DFGLCK
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--------------------- 159
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ GTP+Y+APEVL YG DWW LG +MYEM+
Sbjct: 160 --------------------ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GA 408
G PFY+ D I+ ++FP LS EAK L++ LL + QRLG A
Sbjct: 200 CGRLPFYNQDHERLFELILMEE--IRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDA 255
Query: 409 DEIKVHPWFDGVDWARIYQ--MEAAFIPEVNDELDTQNFEKFEES----DNQTKTSSKTG 462
E+ H +F ++W + Q + F P+V E+DT+ F+ + G
Sbjct: 256 KEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLG 315
Query: 463 PWRKMLSSKDINFVGYTYKNFEIVNDY 489
+ F + Y + D+
Sbjct: 316 LLELDQREEQEMFEDFDY-----IADW 337
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 258 bits (660), Expect = 3e-83
Identities = 123/343 (35%), Positives = 186/343 (54%), Gaps = 54/343 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DF++L +G G+FG V + R + G YAMK LKK ++R QVEH ER +L+ V
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++++ +FQD + +++IM+Y+ GG++ +LL + A+FY AE LA+E +H
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
I+RD+KP+N+LLDK GH++++DFG K + T
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT------------------------- 158
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
Y+ GTPDYIAPEV+ K Y DWWS G ++YEML GY
Sbjct: 159 -------------------YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIK 412
PFY + M T KI+N L+FP + + KDL+S+L+ +++QRLG G +++K
Sbjct: 200 PFYDSNTMKTYEKILNAE--LRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVK 255
Query: 413 VHPWFDGVDWARIY--QMEAAFIPEV-NDELDTQNFEKFEESD 452
HPWF V W ++ +E + P + + DT F+K+ E D
Sbjct: 256 NHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEED 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 247 bits (631), Expect = 1e-78
Identities = 129/390 (33%), Positives = 206/390 (52%), Gaps = 57/390 (14%)
Query: 82 ADADVSEEDQNNLLKFLEKKETEYMR----LQRHKMGADDFELLTMIGKGAFGEVRVCRE 137
A A +Q ++ +FL K + ++++ ++ D F+ + +G G+FG V + +
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKH 62
Query: 138 KTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEY 197
K +G+ YAMK L K ++++ Q+EH E+ +L V+ +VKL SF+D+ LY++MEY
Sbjct: 63 KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122
Query: 198 LPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRL 257
+ GG+M + L R +E ARFY A+ VL E +H I+RD+KP+NLL+D+ G++++
Sbjct: 123 VAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQV 182
Query: 258 SDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYST 317
+DFG K + T ++
Sbjct: 183 TDFGFAKRVKGRT--------------------------------------------WTL 198
Query: 318 VGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLK 377
GTP+ +APE++L KGY DWW+LG ++YEM GYPPF++D P+ KI ++
Sbjct: 199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI--VSGKVR 256
Query: 378 FPEEAKLSIEAKDLISKLLC-NVNQRLGAK--GADEIKVHPWFDGVDWARIYQ--MEAAF 432
FP S + KDL+ LL ++ +R G G ++IK H WF DW IYQ +EA F
Sbjct: 257 FPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPF 314
Query: 433 IPEVNDELDTQNFEKFEESDNQTKTSSKTG 462
IP+ DT NF+ +EE + + + K G
Sbjct: 315 IPKFKGPGDTSNFDDYEEEEIRVSINEKCG 344
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 242 bits (619), Expect = 7e-78
Identities = 91/303 (30%), Positives = 138/303 (45%), Gaps = 51/303 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+DFE+ +GKG FG V + REK + + A+K L K+++ + G +R E + + +
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
I++LY F D +YLI+EY P G + L + E Y+ E A+ H
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSK 125
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIKP+NLLL G L+++DFG S
Sbjct: 126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR------------------------ 161
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ GT DY+ PE++ + + + D WSLG + YE LVG P
Sbjct: 162 -------------------TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP 202
Query: 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414
PF ++ T ++I FP+ ++ A+DLIS+LL N +QR + E+ H
Sbjct: 203 PFEANTYQETYKRISRVE--FTFPD--FVTEGARDLISRLLKHNPSQRPMLR---EVLEH 255
Query: 415 PWF 417
PW
Sbjct: 256 PWI 258
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 239 bits (610), Expect = 2e-75
Identities = 86/362 (23%), Positives = 155/362 (42%), Gaps = 54/362 (14%)
Query: 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+H D +++ +G GAFG V E+ TG+ +A K + E VR E
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQT 76
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLA 228
++ + +V L+ +F+DD + +I E++ GG++ + + ++EDEA Y+ +
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 229 IESIHKHHYIHRDIKPDNLLL--DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
+ +H+++Y+H D+KP+N++ + L+L DFGL LD
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD------------------- 177
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
+ T GT ++ APEV K G D WS+G +
Sbjct: 178 -----------------------PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVL 214
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405
Y +L G PF ++ T R + + ++ + +S + KD I KLL + N R+
Sbjct: 215 SYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM-- 272
Query: 406 KGADEIKVHPWFDGVDW-ARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPW 464
+ HPW + R Q+ ++ ++ D + T+ ++ + E S
Sbjct: 273 -TIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTK-YDAWPEPLPPLGRISNYSSL 330
Query: 465 RK 466
RK
Sbjct: 331 RK 332
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 238 bits (607), Expect = 1e-74
Identities = 105/380 (27%), Positives = 166/380 (43%), Gaps = 64/380 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERN---LLAE 172
+DF + +IG+G FGEV CR+ TG +YAMK L K + + ER L++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
D IV + +F + L I++ + GGD+ L + +E + RFY AE +L +E +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H ++RD+KP N+LLD++GH+R+SD GL
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---------------------- 161
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEML 351
+++VGT Y+APEVL K Y DW+SLG +++++L
Sbjct: 162 ---------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 200
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGA 408
G+ PF +I + S E + L+ LL +VN+RLG +GA
Sbjct: 201 RGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGA 259
Query: 409 DEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELDTQNF--EKFEESDNQTKTSSKTGPW 464
E+K P+F +DW ++ + IP + F F+E D +
Sbjct: 260 QEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGI-------- 311
Query: 465 RKMLSSKDINFVGYTYKNFE 484
K+L S + + E
Sbjct: 312 -KLLDSDQELYRNFPLTISE 330
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 230 bits (588), Expect = 1e-72
Identities = 86/336 (25%), Positives = 146/336 (43%), Gaps = 52/336 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D ++ ++G GAF EV + +K T + A+K + K + G+ + E +L ++
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKH 66
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV L ++ LYLIM+ + GG++ ++ K TE +A + + + A++ +H
Sbjct: 67 PNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL 126
Query: 236 HYIHRDIKPDNLLL---DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+KP+NLL D+ + +SDFGL K D +
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---------------------- 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ + GTP Y+APEVL +K Y D WS+G I Y +L
Sbjct: 165 --------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 204
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
GYPPFY ++ +I+ P +S AKD I L+ + +R ++
Sbjct: 205 GYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF---TCEQA 261
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEK 447
HPW G D A + + ++ +++
Sbjct: 262 LQHPWIAG-DTALDKNIHQSVSEQIKKNFAKSKWKQ 296
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 229 bits (584), Expect = 2e-72
Identities = 85/316 (26%), Positives = 137/316 (43%), Gaps = 59/316 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR------RGQVEHVRAERNL 169
+++E ++G+G VR C K T YA+K + + + E E ++
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 170 LAEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
L +V + I++L +++ + F +L+ + + G++ L K TL+E E R + +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
I ++HK + +HRD+KP+N+LLD +++L+DFG LD
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE------------------ 164
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGMECDWWS 342
GTP Y+APE++ GYG E D WS
Sbjct: 165 ------------------------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWS 200
Query: 343 LGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQ 401
G IMY +L G PPF+ M R I++ PE S KDL+S+ L +
Sbjct: 201 TGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQK 260
Query: 402 RLGAKGADEIKVHPWF 417
R A+E HP+F
Sbjct: 261 RY---TAEEALAHPFF 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 230 bits (587), Expect = 7e-72
Identities = 77/356 (21%), Positives = 150/356 (42%), Gaps = 53/356 (14%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +++L +G GAFG V C EK TG V+ K + L + V+ E +++ ++
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK---YTVKNEISIMNQLHH 85
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
++ L+ +F+D + LI+E+L GG++ + +D ++E E Y+ + ++ +H+
Sbjct: 86 PKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 235 HHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H +H DIKP+N++ + K +++ DFGL L+
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---------------------- 183
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ T T ++ APE++ ++ G D W++G + Y +L
Sbjct: 184 --------------------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
G PF +D + T + + + +S EAKD I LL +RL +
Sbjct: 224 GLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL---TVHDA 280
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKM 467
HPW G ++ ++ ++ ++ + + + + RK
Sbjct: 281 LEHPWLKGDHSNLTSRIPSSRYNKIRQKIK-EKYADWPAPQPAIGRIANFSSLRKH 335
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (581), Expect = 2e-71
Identities = 119/355 (33%), Positives = 188/355 (52%), Gaps = 52/355 (14%)
Query: 99 EKKETEYMRLQRHKMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEML 155
+ T + K+G ++FELL ++G GA+G+V + R+ TG +YAMK LKK+ ++
Sbjct: 7 HELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV 66
Query: 156 RRGQ-VEHVRAERNLLAEV-DSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTL 213
++ + EH R ER +L + S +V L+ +FQ + L+LI++Y+ GG++ T L +++
Sbjct: 67 QKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERF 126
Query: 214 TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273
TE E + YV E VLA+E +HK I+RDIK +N+LLD GH+ L+DFGL
Sbjct: 127 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS---------- 176
Query: 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL--K 331
+ + + AY GT +Y+AP+++
Sbjct: 177 ------------------------------KEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDL 391
G+ DWWSLG +MYE+L G PF D ++ +I + P ++S AKDL
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDL 266
Query: 392 ISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QMEAAFIPEVNDELD 441
I +LL + +RLG + ADEIK H +F ++W + ++ A F P + DELD
Sbjct: 267 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDELD 321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (576), Expect = 2e-71
Identities = 69/305 (22%), Positives = 124/305 (40%), Gaps = 47/305 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+D++L+ +G+GA+GEV++ + T A+K + + E+++ E + ++
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 62
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+VK Y ++ YL +EY GG++ + + E +A+ + + + + +H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
HRDIKP+NLLLD+ +L++SDFGL
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFR---------------------------- 154
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVGY 354
NR L GT Y+APE+L ++ + D WS G ++ ML G
Sbjct: 155 -----------YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE 203
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413
P+ K+ L+ K+L N + R+ +IK
Sbjct: 204 LPWDQPSDSCQEYSDWK-EKKTYLNPWKKIDSAPLALLHKILVENPSARI---TIPDIKK 259
Query: 414 HPWFD 418
W++
Sbjct: 260 DRWYN 264
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 3e-71
Identities = 76/309 (24%), Positives = 131/309 (42%), Gaps = 55/309 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D +E++ +G GAFG+V + K T + A K + ++E E ++LA D
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDH 68
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHK 234
IVKL +F + L++++E+ GG + +++ + LTE + + +T+ A+ +H
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
+ IHRD+K N+L G ++L+DFG+
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT--------------------------- 161
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349
S +GTP ++APEV++ + Y + D WSLG + E
Sbjct: 162 --------------RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207
Query: 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408
M PP + +PM KI + ++ S KD + K L NV+ R
Sbjct: 208 MAEIEPPHHELNPMRVLLKIAKSEPP-TLAQPSRWSSNFKDFLKKCLEKNVDARW---TT 263
Query: 409 DEIKVHPWF 417
++ HP+
Sbjct: 264 SQLLQHPFV 272
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 8e-70
Identities = 77/352 (21%), Positives = 130/352 (36%), Gaps = 90/352 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
DDFE ++ +G G G V K +G V A K + ++ + E +L E +S
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNS 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH-K 234
IV Y +F D + + ME++ GG + +L + + E + + + K
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRD+KP N+L++ G ++L DFG+ L S
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------------------------- 158
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
+A S VGT Y++PE L Y ++ D WS+G + EM VG
Sbjct: 159 ------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 200
Query: 355 PPFYSDD--------------------------------------PMSTCRKIVNWRTHL 376
P D P +++++ +
Sbjct: 201 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE 260
Query: 377 KFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425
P+ S+E +D ++K L N +R K ++ VH + D +
Sbjct: 261 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK---QLMVHAFIKRSDAEEV 309
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (565), Expect = 2e-69
Identities = 80/304 (26%), Positives = 135/304 (44%), Gaps = 52/304 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG+GA G V + TG A++++ + ++ E + E ++ E +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK---ELIINEILVMRENKN 76
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV S+ + L+++MEYL GG + ++ E + E + A+E +H +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSN 135
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
IHRDIK DN+LL G ++L+DFG C +
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-------------------------- 169
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355
+ + VGTP ++APEV+ +K YG + D WSLG + EM+ G P
Sbjct: 170 ---------------QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
Query: 356 PFYSDDPMSTCRKIV-NWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413
P+ +++P+ I N L+ PE KLS +D +++ L +V +R A E+
Sbjct: 215 PYLNENPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLDMDVEKRG---SAKELLQ 269
Query: 414 HPWF 417
H +
Sbjct: 270 HQFL 273
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 220 bits (562), Expect = 8e-69
Identities = 71/339 (20%), Positives = 121/339 (35%), Gaps = 54/339 (15%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
F L IG G+FG V R+ V A+KK+ S + + + E L ++
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
++ + + +L+MEY G L + K L E E + + +H H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+ IHRD+K N+LL + G ++L DFG + +
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------------------------- 169
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEMLV 352
S VGTP ++APEV+L + Y + D WSLG E+
Sbjct: 170 --------------------SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
PP ++ + MS I + + S ++ + L R ++ +
Sbjct: 210 RKPPLFNMNAMSALYHIAQNESP--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSE---VL 264
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
H + + + ELD + K ++
Sbjct: 265 LKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKK 303
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 1e-68
Identities = 81/314 (25%), Positives = 140/314 (44%), Gaps = 60/314 (19%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A+D+E+L IG G++G + R K+ G + K+L M + + + +E NLL E+
Sbjct: 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELK 61
Query: 175 SNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLA 228
IV+ Y D + LY++MEY GGD+ +++ + + L E+ + + LA
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA 121
Query: 229 IESIHK-----HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLN 283
++ H+ H +HRD+KP N+ LD +++L DFGL + L+
Sbjct: 122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN---------------- 165
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
+ A + VGTP Y++PE + + Y + D WSL
Sbjct: 166 -------------------------HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200
Query: 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
G ++YE+ PPF + KI + + P + S E ++I+++L R
Sbjct: 201 GCLLYELCALMPPFTAFSQKELAGKIREGK-FRRIPY--RYSDELNEIITRMLNLKDYHR 257
Query: 403 LGAKGADEIKVHPW 416
+ EI +P
Sbjct: 258 PSVE---EILENPL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (544), Expect = 5e-66
Identities = 70/306 (22%), Positives = 116/306 (37%), Gaps = 53/306 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + + +G+G FG V C E ++ Y K +K V+ E ++L
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHK 234
I+ L+ SF+ E L +I E++ G D+ + L E E YV + A++ +H
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 235 HHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
H+ H DI+P+N++ + +++ +FG + L
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---------------------- 158
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
P+Y APEV D WSLG ++Y +L
Sbjct: 159 --------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
G PF ++ I+N ++SIEA D + +LL R+ A E
Sbjct: 199 GINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM---TASEA 255
Query: 412 KVHPWF 417
HPW
Sbjct: 256 LQHPWL 261
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 1e-65
Identities = 78/320 (24%), Positives = 136/320 (42%), Gaps = 53/320 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---RRGQVEHVRAERNLLAE 172
D ++ +G G F V+ CREK+TG YA K +KK R E + E ++L E
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
+ ++ L+ +++ + LI+E + GG++ L K++LTE+EA ++ + + + +
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 233 HKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
H H D+KP+N++L +++ DFGL +D
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---------------- 173
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ GTP+++APE++ + G+E D WS+G I Y
Sbjct: 174 --------------------------KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 207
Query: 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407
+L G PF D T + + + S AKD I +LL + +R+ +
Sbjct: 208 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQ- 266
Query: 408 ADEIKVHPWFDGVDWARIYQ 427
+ HPW D +
Sbjct: 267 --DSLQHPWIKPKDTQQALS 284
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 202 bits (515), Expect = 3e-62
Identities = 66/303 (21%), Positives = 118/303 (38%), Gaps = 45/303 (14%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+D +EL ++G G EV + R+ A+K L+ R E A ++
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 175 SNCIVKLYCSFQDDE----FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
IV +Y + + + Y++MEY+ G + ++ + +T A +A+ A+
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 125
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
H++ IHRD+KP N+++ +++ DFG+ + +
Sbjct: 126 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI------------------------ 161
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
N + +GT Y++PE D +SLG ++YE+
Sbjct: 162 --------------ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207
Query: 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD 409
L G PPF D P+S + V LS + ++ K L N R A
Sbjct: 208 LTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT--AA 265
Query: 410 EIK 412
E++
Sbjct: 266 EMR 268
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 8e-62
Identities = 58/309 (18%), Positives = 117/309 (37%), Gaps = 59/309 (19%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC 177
+ IG+G+F V + T A +L+ ++ + + + + E +L +
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPN 69
Query: 178 IVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
IV+ Y S++ + + L+ E + G + T L R + R + + + ++ +H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 234 KHHY--IHRDIKPDNLLL-DKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IHRD+K DN+ + G +++ D GL S
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--------------------- 168
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
A + +GTP+++APE+ ++ Y D ++ G M EM
Sbjct: 169 ----------------------FAKAVIGTPEFMAPEM-YEEKYDESVDVYAFGMCMLEM 205
Query: 351 LVGYPPFYSDDPMST-CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408
P+ + R++ + F + E K++I + N ++R K
Sbjct: 206 ATSEYPYSECQNAAQIYRRVTSGVKPASFDKV--AIPEVKEIIEGCIRQNKDERYSIK-- 261
Query: 409 DEIKVHPWF 417
++ H +F
Sbjct: 262 -DLLNHAFF 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 1e-59
Identities = 93/377 (24%), Positives = 153/377 (40%), Gaps = 77/377 (20%)
Query: 106 MRLQRHKMGADDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVR 164
++++++ + DD+++ + ++G G G+V K T +A+K L+ RR H R
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWR 60
Query: 165 AERNLLAEVDSNCIVKLYCSFQD----DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEA 218
A + IV++ +++ + L ++ME L GG++ + + + TE EA
Sbjct: 61 ASQ-------CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREA 113
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY---GHLRLSDFGLCKPLDCSTLQEQD 275
+ AI+ +H + HRD+KP+NLL L+L+DFG K
Sbjct: 114 SEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--- 170
Query: 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYG 335
+ TP Y+APEVL + Y
Sbjct: 171 ---------------------------------------TTPCYTPYYVAPEVLGPEKYD 191
Query: 336 MECDWWSLGAIMYEMLVGYPPFYSDDPMSTC----RKIVNWRTHLKFPEEAKLSIEAKDL 391
CD WSLG IMY +L GYPPFYS+ ++ +I + PE +++S E K L
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKML 251
Query: 392 ISKLLC-NVNQRLGAKGADEIKVHPWFDG--------VDWARIYQMEAAFIPEVNDELDT 442
I LL QR+ E HPW + +R+ + + +V +E+ T
Sbjct: 252 IRNLLKTEPTQRM---TITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEM-T 307
Query: 443 QNFEKFEESDNQTKTSS 459
Q K
Sbjct: 308 SALATMRVDYEQIKIKK 324
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (486), Expect = 4e-58
Identities = 74/315 (23%), Positives = 123/315 (39%), Gaps = 65/315 (20%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEH---VRAERNLLA 171
+++ ++G G FG V + A+K ++K + G++ + V E LL
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 172 EVDSNC--IVKLYCSFQDDEFLYLIMEYL-PGGDMMTLLMRKDTLTEDEARFYVAETVLA 228
+V S +++L F+ + LI+E P D+ + + L E+ AR + + + A
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 229 IESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ H +HRDIK +N+L+D G L+L DFG L +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---------------- 166
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 346
GT Y PE + Y G WSLG +
Sbjct: 167 ---------------------------TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA 405
+Y+M+ G PF D+ + R + F + ++S E + LI L + R
Sbjct: 200 LYDMVCGDIPFEHDEEII--------RGQVFFRQ--RVSSECQHLIRWCLALRPSDRP-- 247
Query: 406 KGADEIKVHPWFDGV 420
+EI+ HPW V
Sbjct: 248 -TFEEIQNHPWMQDV 261
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 7e-57
Identities = 75/327 (22%), Positives = 120/327 (36%), Gaps = 72/327 (22%)
Query: 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEM--LRRGQVEHVRAERNLLAEVDSN 176
E L +G+G F V R+K T + A+KK+K + G E LL E+
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
I+ L +F + L+ +++ + + LT + Y+ T+ +E +H+H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 237 YIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPK 296
+HRD+KP+NLLLD+ G L+L+DFGL K
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFG----------------------------- 151
Query: 297 RTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYP 355
+ V T Y APE+L + YG+ D W++G I+ E+L+ P
Sbjct: 152 ------------SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199
Query: 356 PFYSDDPMSTCRKIVN---------WRTHLKFPEEA---------------KLSIEAKDL 391
D + +I W P+ + DL
Sbjct: 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
Query: 392 ISKLLC-NVNQRLGAKGADEIKVHPWF 417
I L N R+ A + +F
Sbjct: 260 IQGLFLFNPCARI---TATQALKMKYF 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-55
Identities = 61/314 (19%), Positives = 116/314 (36%), Gaps = 51/314 (16%)
Query: 117 DFELLTM----IGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D +LLT+ +G G FG V+ + K A+K LK E + + AE N++
Sbjct: 4 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVM 62
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
++D+ IV++ + + + L+ME G + L + + + V + + ++
Sbjct: 63 QQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMK 121
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ + +++HRD+ N+LL + ++SDFGL K L
Sbjct: 122 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD--------------------- 160
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
+N + APE + + + D WS G +M+E
Sbjct: 161 -----------------ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEA 203
Query: 351 L-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408
G P+ + + P E DL++ +V R G
Sbjct: 204 FSYGQKPYRGMKGSEVTAMLEKGE-RMGCPAG--CPREMYDLMNLCWTYDVENRPGFAAV 260
Query: 409 DEIKVHPWFDGVDW 422
+ + ++D V+
Sbjct: 261 ELRLRNYYYDVVNE 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-54
Identities = 85/380 (22%), Positives = 133/380 (35%), Gaps = 95/380 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +IG G+FG V + +G + A+KK+ + + + E ++ ++D
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDH 72
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETV 226
IV+L F +D+ +L L+++Y+P K TL + Y+ +
Sbjct: 73 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGS 285
++ IH HRDIKP NLLLD L+L DFG K L
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN------------- 179
Query: 286 SQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLG 344
S + + Y APE++ Y D WS G
Sbjct: 180 -----------------------------VSYICSRYYRAPELIFGATDYTSSIDVWSAG 210
Query: 345 AIMYEMLVGYPPFYSDDPMSTCRKIVN---------------WRTHLKFPE--------- 380
++ E+L+G P F D + +I+ T KFP+
Sbjct: 211 CVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKV 270
Query: 381 -EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVND 438
+ EA L S+LL RL E H +FD + + +P D
Sbjct: 271 FRPRTPPEAIALCSRLLEYTPTARL---TPLEACAHSFFDELRDPNV------KLPNGRD 321
Query: 439 ELDTQNFEKFEESDNQTKTS 458
NF E S N +
Sbjct: 322 TPALFNFTTQELSSNPPLAT 341
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (459), Expect = 4e-54
Identities = 49/298 (16%), Positives = 104/298 (34%), Gaps = 51/298 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ IG G+FG V + A+K L + + Q++ + E +L +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ-QLQAFKNEVGVLRKTRH 63
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHK 234
I+ + L ++ ++ G + L +T + +T ++ +H
Sbjct: 64 VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRD+K +N+ L + +++ DFGL + Q +
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL---------------- 166
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL---KKGYGMECDWWSLGAIMYEML 351
G+ ++APEV+ K Y + D ++ G ++YE++
Sbjct: 167 -----------------------SGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEE--AKLSIEAKDLISKLLC-NVNQRLGAK 406
G P+ + + +V + + K L+++ L ++R
Sbjct: 204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFP 261
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 9e-54
Identities = 71/340 (20%), Positives = 114/340 (33%), Gaps = 79/340 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+E L IG+G FGEV R + TG A+KK+ + G E +L +
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKH 68
Query: 176 NCIVKLYCSFQDDEF--------LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
+V L + +YL+ ++ L T E + + +
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQ 287
+ IH++ +HRD+K N+L+ + G L+L+DFGL + +
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLA------------------ 170
Query: 288 NNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAI 346
+ ++ + V T Y PE+LL ++ YG D W G I
Sbjct: 171 -------------------KNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 211
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVN----------------------------WRTHLKF 378
M EM P + I R
Sbjct: 212 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDR 271
Query: 379 PEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417
+ A DLI KLL + QR+ +D+ H +F
Sbjct: 272 LKAYVRDPYALDLIDKLLVLDPAQRI---DSDDALNHDFF 308
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 2e-53
Identities = 80/333 (24%), Positives = 125/333 (37%), Gaps = 73/333 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++F+ + IG+G +G V R K TG V A+KK++ + G E +LL E++
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL-DTETEGVPSTAIREISLLKELNH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT-LTEDEARFYVAETVLAIESIHK 234
IVKL + LYL+ E+L + T + + Y+ + + + H
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
H +HRD+KP NLL++ G ++L+DFGL +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY--------------------- 159
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353
V T Y APE+LL Y D WSLG I EM+
Sbjct: 160 --------------------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199
Query: 354 YPPFYSDDPMSTCRKIVN---------WRTHLKFPEE----------------AKLSIEA 388
F D + +I W P+ L +
Sbjct: 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDG 259
Query: 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420
+ L+S++L + N+R+ AK HP+F V
Sbjct: 260 RSLLSQMLHYDPNKRISAK---AALAHPFFQDV 289
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 6e-53
Identities = 77/369 (20%), Positives = 133/369 (36%), Gaps = 78/369 (21%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+ L+ IG+GA+G V + A+KK+ E + + E +L
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFR 64
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + + ++ +L G D+ LL + L+ D +++ + + ++
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLK 123
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH + +HRD+KP NLLL+ L++ DFGL + D
Sbjct: 124 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD--------------------- 162
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYE 349
+ V T Y APE++L GY D WS+G I+ E
Sbjct: 163 -----------------HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 205
Query: 350 MLVGYPPFYSDDPMSTCRKIVN------------------WRTHLKFPEEAK-------- 383
ML P F + I+ L P + K
Sbjct: 206 MLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFP 265
Query: 384 -LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELD 441
+A DL+ K+L N ++R+ ++ HP+ + + + A + + ELD
Sbjct: 266 NADSKALDLLDKMLTFNPHKRI---EVEQALAHPYLEQ-YYDPSDEPIAEAPFKFDMELD 321
Query: 442 TQNFEKFEE 450
EK +E
Sbjct: 322 DLPKEKLKE 330
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 7e-53
Identities = 62/318 (19%), Positives = 116/318 (36%), Gaps = 53/318 (16%)
Query: 106 MRLQRHKMGADDFELLTMIGKGAFGEVR--VCREKTTGHVYAMKKLKKSEMLRRGQVEHV 163
+ L+R + D E +G G FG VR V R + A+K LK+ + E +
Sbjct: 3 LFLKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEM 56
Query: 164 RAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYV 222
E ++ ++D+ IV+L Q + L L+ME GG + L+ +++ + +
Sbjct: 57 MREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL 115
Query: 223 AETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+ + ++ + + +++HRD+ N+LL + ++SDFGL K L +
Sbjct: 116 HQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS----- 170
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWS 342
+ + APE + + + D WS
Sbjct: 171 ---------------------------------AGKWPLKWYAPECINFRKFSSRSDVWS 197
Query: 343 LGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVN 400
G M+E L G P+ I + ++ P E E L+S
Sbjct: 198 YGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPE--CPPELYALMSDCWIYKWE 254
Query: 401 QRLGAKGADEIKVHPWFD 418
R ++ ++
Sbjct: 255 DRPDFLTVEQRMRACYYS 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 2e-52
Identities = 54/296 (18%), Positives = 99/296 (33%), Gaps = 47/296 (15%)
Query: 113 MGADDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNL 169
+G D LL +G G+FG VR A+K LK + + ++ E N
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 170 LAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLA 228
+ +D +++LY + ++ E P G ++ L + Y +
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 229 IESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQN 288
+ + +IHRD+ NLLL +++ DFGL + L +
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN------------------- 164
Query: 289 NERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348
+ ++ + APE L + + D W G ++
Sbjct: 165 -------------------DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205
Query: 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
EM G P+ + KI L PE+ + +++ + R
Sbjct: 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRPED--CPQDIYNVMVQCWAHKPEDR 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 175 bits (445), Expect = 7e-52
Identities = 60/328 (18%), Positives = 122/328 (37%), Gaps = 60/328 (18%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D + +G G +GEV K A+K LK+ M +VE E ++ E+
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKH 72
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+V+L + Y+I E++ G+++ L + ++ + + A+E +
Sbjct: 73 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE 132
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
K ++IHRD+ N L+ + ++++DFGL + + T
Sbjct: 133 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA------------------ 174
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
+ APE L + ++ D W+ G +++E+
Sbjct: 175 ----------------------GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 212
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
Y +S +++ ++ PE + +L+ N + R +
Sbjct: 213 GMSPYPGIDLSQVYELLEKDYRMERPEG--CPEKVYELMRACWQWNPSDRPSFA-----E 265
Query: 413 VHPWFDGVDWARIYQMEAAFIPEVNDEL 440
+H F+ ++Q E++ EV EL
Sbjct: 266 IHQAFE-----TMFQ-ESSISDEVEKEL 287
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 173 bits (438), Expect = 6e-51
Identities = 77/330 (23%), Positives = 124/330 (37%), Gaps = 73/330 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + L IG+G +G V + G +A+KK++ E G E ++L E+
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNY-GETFALKKIRL-EKEDEGIPSTTIREISILKELKH 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
+ IVKLY + L L+ E+L L + + L A+ ++ + + I H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+HRD+KP NLL+++ G L+++DFGL + +
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK----------------------- 156
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 354
+ T Y AP+VL+ Y D WS+G I EM+ G
Sbjct: 157 ------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
Query: 355 PPFYSDDPMSTCRKIV---------NWRTHLKFPEE----------------AKLSIEAK 389
P F +I NW + P+ L
Sbjct: 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGI 258
Query: 390 DLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
DL+SK+L + NQR+ AK + H +F
Sbjct: 259 DLLSKMLKLDPNQRITAK---QALEHAYFK 285
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (439), Expect = 8e-51
Identities = 73/342 (21%), Positives = 127/342 (37%), Gaps = 78/342 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCRE-KTTGHVYAMKKLKKSEMLRRGQVEHVR--AERNLLAE 172
+E + IG+GA+G+V R+ K G A+K+++ + +R A L
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 173 VDSNCIVKLYCSFQDDEF-----LYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETV 226
+ +V+L+ L L+ E++ L + + + + + + +
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 227 LAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSS 286
++ +H H +HRD+KP N+L+ G ++L+DFGL +
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR---------------------- 164
Query: 287 QNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346
+ +M S V T Y APEVLL+ Y D WS+G I
Sbjct: 165 --------------------IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 204
Query: 347 MYEMLVGYPPFYSDDPMSTCRKIVN---------WRTHLKFPEEA--------------K 383
EM P F + KI++ W + P +A
Sbjct: 205 FAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTD 264
Query: 384 LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWAR 424
+ KDL+ K L N +R+ A HP+F ++ +
Sbjct: 265 IDELGKDLLLKCLTFNPAKRI---SAYSALSHPYFQDLERCK 303
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 1e-50
Identities = 55/308 (17%), Positives = 112/308 (36%), Gaps = 63/308 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +LL IGKG FG+V + + G+ A+K +K + AE +++ ++
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRH 59
Query: 176 NCIVKLY-CSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESI 232
+ +V+L ++ LY++ EY+ G ++ L + L D + + A+E +
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
++++HRD+ N+L+ + ++SDFGL K +
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------------------- 157
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML- 351
+ + APE L +K + + D WS G +++E+
Sbjct: 158 ----------------------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGA-- 408
G P+ ++ K +++ + R
Sbjct: 196 FGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252
Query: 409 --DEIKVH 414
+ IK H
Sbjct: 253 QLEHIKTH 260
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-50
Identities = 50/294 (17%), Positives = 104/294 (35%), Gaps = 51/294 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
D L +G G FG V+ + + + A+K +K+ M + E ++ +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSH 58
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHK 234
+V+LY +++I EY+ G ++ L + + + A+E +
Sbjct: 59 EKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
++HRD+ N L++ G +++SDFGL +
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSR------------------------------ 148
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML-VG 353
+ + + + + PEVL+ + + D W+ G +M+E+ +G
Sbjct: 149 ----------YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 198
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
P+ T I L+ S + ++ ++R K
Sbjct: 199 KMPYERFTNSETAEHIAQG---LRLYRPHLASEKVYTIMYSCWHEKADERPTFK 249
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 2e-49
Identities = 53/348 (15%), Positives = 110/348 (31%), Gaps = 47/348 (13%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK--SEMLRRGQVEHVRAERNLLAE 172
+F+ + ++G GAFG V G + K E + + E ++A
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESI 232
VD+ + +L + G + + KD + + + + +
Sbjct: 68 VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 233 HKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERP 292
+HRD+ N+L+ H++++DFGL K L
Sbjct: 128 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----------------------- 164
Query: 293 AAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352
+ A ++A E +L + Y + D WS G ++E++
Sbjct: 165 ----------------EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 208
Query: 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411
Y P S I+ L P +I+ ++ K + + R + E+
Sbjct: 209 FGSKPYDGIPASEISSILEKGERLPQPPI--CTIDVYMIMVKCWMIDADSRPKFR---EL 263
Query: 412 KVHPWFDGVDWARIYQMEAAFIPEVNDELDTQNFEKFEESDNQTKTSS 459
+ D R ++ + D+ + + ++
Sbjct: 264 IIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVD 311
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 3e-49
Identities = 59/353 (16%), Positives = 123/353 (34%), Gaps = 82/353 (23%)
Query: 89 EDQNNLLKFLEKKETEYMRLQRHKMGAD--------DFELLTMIGKGAFGEVRVCREKTT 140
E Q +++ + EY + + D + E ++G GAFG+V
Sbjct: 2 ESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGI 61
Query: 141 GH-----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSN-CIVKLYCSFQDDEFLYLI 194
A+K LK+ + E + +E ++ ++ S+ IV L + +YLI
Sbjct: 62 SKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLI 119
Query: 195 MEYLPGGDMMTLLMRK-----------------------DTLTEDEARFYVAETVLAIES 231
EY GD++ L K + LT ++ + + +E
Sbjct: 120 FEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEF 179
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ +HRD+ N+L+ +++ DFGL + +
Sbjct: 180 LEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM------------------------ 215
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ ++ + ++APE L + Y ++ D WS G +++E+
Sbjct: 216 ---------------SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 260
Query: 352 -VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
+G P+ + K++ + P + E ++ + +R
Sbjct: 261 SLGVNPYPGIPVDANFYKLIQNGFKMDQPF--YATEEIYIIMQSCWAFDSRKR 311
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 168 bits (427), Expect = 4e-49
Identities = 51/313 (16%), Positives = 103/313 (32%), Gaps = 47/313 (15%)
Query: 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKK-SEMLRRGQVEHVRAERNLL 170
++ ++ +IG G FGEV K G +K Q +E +++
Sbjct: 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIM 81
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAI 229
+ D ++ L + +I E++ G + + L + D T + + +
Sbjct: 82 GQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGM 141
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ + +Y+HRD+ N+L++ ++SDFGL + L+ T +
Sbjct: 142 KYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGG-------- 193
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ APE + + + D WS G +M+E
Sbjct: 194 ----------------------------KIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225
Query: 350 ML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG 407
++ G P++ I + P L+ + N R
Sbjct: 226 VMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQ 282
Query: 408 A----DEIKVHPW 416
D++ +P
Sbjct: 283 IVNTLDKMIRNPN 295
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 8e-49
Identities = 89/395 (22%), Positives = 142/395 (35%), Gaps = 103/395 (26%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G GA+G V + TG A+KKL + + E LL +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRH 76
Query: 176 NCIVKLYCSFQDDEFL------YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
++ L F DE L YL+M ++ G + LM+ + L ED +F V + + +
Sbjct: 77 ENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 134
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 135 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM------------------- 175
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348
V T Y APEV+L Y D WS+G IM
Sbjct: 176 -------------------------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 210
Query: 349 EMLVGYPPFYSDDPMSTCRKIVN------------------WRTHLKFPEEAK------- 383
EM+ G F D + ++I+ PE K
Sbjct: 211 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL 270
Query: 384 --LSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDEL 440
S A +L+ K+L + QR+ A E HP+F+ + DE
Sbjct: 271 TNASPLAVNLLEKMLVLDAEQRVTAG---EALAHPYFESLHDT-------------EDEP 314
Query: 441 DTQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINF 475
Q ++ + ++T W+++ + ++F
Sbjct: 315 QVQKYDDSFDDVDRTLD-----EWKRVTYKEVLSF 344
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 167 bits (424), Expect = 2e-48
Identities = 75/367 (20%), Positives = 128/367 (34%), Gaps = 97/367 (26%)
Query: 99 EKKETEYMRLQRHKM---GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML 155
+ EY + H + DD++L+ +G+G + EV T +K LK
Sbjct: 15 THRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV--- 71
Query: 156 RRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKDT 212
+ + ++ E +L + I+ L +D L+ E++ D L
Sbjct: 72 ---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--- 125
Query: 213 LTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCSTL 271
LT+ + RFY+ E + A++ H +HRD+KP N+++D ++ LRL D+GL +
Sbjct: 126 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
V + + PE+L+
Sbjct: 186 Y------------------------------------------NVRVASRYFKGPELLVD 203
Query: 332 -KGYGMECDWWSLGAIMYEMLVGYPPFY-SDDPMSTCRKIVN------------------ 371
+ Y D WSLG ++ M+ PF+ D +I
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 372 ---------------WRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415
W + + +S EA D + KLL + RL A+ E HP
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR---EAMEHP 320
Query: 416 WFDGVDW 422
+F V
Sbjct: 321 YFYTVVK 327
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-48
Identities = 54/305 (17%), Positives = 106/305 (34%), Gaps = 52/305 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ L +G+G FGEV + T V A+K LK M E E ++ ++
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQEAQVMKKLRH 71
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD--TLTEDEARFYVAETVLAIESIH 233
+V+LY ++ +Y++ EY+ G ++ L + L + A+ + +
Sbjct: 72 EKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 130
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +Y+HRD++ N+L+ + +++DFGL + ++
Sbjct: 131 RMNYVHRDLRAANILVGENLVCKVADFGLARLIE-------------------------- 164
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
N + APE L + ++ D WS G ++ E+
Sbjct: 165 --------------DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412
Y V + P E DL+ + +R +
Sbjct: 211 GRVPYPGMVNREVLDQVERGYRMPCPPE--CPESLHDLMCQCWRKEPEERPTFEYLQAF- 267
Query: 413 VHPWF 417
+ +F
Sbjct: 268 LEDYF 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 4e-48
Identities = 55/290 (18%), Positives = 104/290 (35%), Gaps = 51/290 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ +L+ +G G FGEV + V A+K LK+ M + AE NL+ ++
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSM----SPDAFLAEANLMKQLQH 67
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDT--LTEDEARFYVAETVLAIESIH 233
+V+LY + +Y+I EY+ G ++ L LT ++ A+ + I
Sbjct: 68 QRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE 126
Query: 234 KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPA 293
+ +YIHRD++ N+L+ +++DFGL + ++
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIE-------------------------- 160
Query: 294 APKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353
N + APE + + ++ D WS G ++ E++
Sbjct: 161 --------------DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206
Query: 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
Y + + + P+ E L+ R
Sbjct: 207 GRIPYPGMTNPEVIQNLERGYRMVRPD--NCPEELYQLMRLCWKERPEDR 254
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 5e-48
Identities = 48/293 (16%), Positives = 96/293 (32%), Gaps = 49/293 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ + IG G FG V + A+K +++ M E E ++ ++
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSH 59
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL-AIESIHK 234
+V+LY + + L+ E++ G + L + L E + V + + +
Sbjct: 60 PKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE 119
Query: 235 HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAA 294
IHRD+ N L+ + +++SDFG+ +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTR------------------------------ 149
Query: 295 PKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354
++ + T + +PEV Y + D WS G +M+E+
Sbjct: 150 ----------FVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199
Query: 355 PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
Y + S + ++ L P S +++ R
Sbjct: 200 KIPYENRSNSEVVEDISTGFRLYKPRL--ASTHVYQIMNHCWKERPEDRPAFS 250
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 162 bits (410), Expect = 9e-47
Identities = 49/326 (15%), Positives = 97/326 (29%), Gaps = 49/326 (15%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
+ + L IG G+FG++ + + G A+K + + E + +
Sbjct: 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQ 60
Query: 175 S-NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH 233
I + + ++ ++ME L + + + IE IH
Sbjct: 61 GGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 234 KHHYIHRDIKPDNLL---LDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
++IHRD+KPDN L K + + DFGL K +
Sbjct: 121 SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA--------------------- 159
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
+ Q + GT Y + L D SLG ++
Sbjct: 160 -------------RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206
Query: 351 LVGYPPFYSDDPMSTCRKIVNW-RTHLKFPEEA---KLSIEAKDLISKLLC-NVNQRLGA 405
+G P+ + +K + P E E ++ + +
Sbjct: 207 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 266
Query: 406 KGADEIKVHPWF-DGVDWARIYQMEA 430
++ + + G + ++
Sbjct: 267 SYLRQLFRNLFHRQGFSYDYVFDWNM 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-46
Identities = 58/297 (19%), Positives = 102/297 (34%), Gaps = 52/297 (17%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTT---GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE 172
+ EL IG+G FG+V + A+K K E E + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQ 64
Query: 173 VDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIES 231
D IVKL ++ +++IME G++ + L + +L Y + A+
Sbjct: 65 FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 232 IHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
+ ++HRDI N+L+ ++L DFGL + ++ ST
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST--------------------- 162
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
A ++APE + + + D W G M+E+L
Sbjct: 163 -------------------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203
Query: 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAK 406
+ G PF +I N + P L++K + ++R
Sbjct: 204 MHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFT 257
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 160 bits (405), Expect = 5e-46
Identities = 57/318 (17%), Positives = 104/318 (32%), Gaps = 75/318 (23%)
Query: 116 DDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
++ E + IG+GAFG V R + A+K LK+ + E L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALM 70
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------- 211
AE D+ IVKL + + L+ EY+ GD+ L
Sbjct: 71 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130
Query: 212 -----TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266
L+ E + + + + ++HRD+ N L+ + ++++DFGL + +
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 190
Query: 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326
+ + D ++ P
Sbjct: 191 YSADYYKADGND---------------------------------------AIPIRWMPP 211
Query: 327 EVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLS 385
E + Y E D W+ G +++E+ G P+Y + + L PE
Sbjct: 212 ESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACPEN--CP 268
Query: 386 IEAKDLISKLLC-NVNQR 402
+E +L+ R
Sbjct: 269 LELYNLMRLCWSKLPADR 286
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 7e-46
Identities = 72/331 (21%), Positives = 120/331 (36%), Gaps = 73/331 (22%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+E L IG+G +G V + + T + A+K+++ + G E LL E+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKH 60
Query: 176 NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKH 235
IV+L+ D+ L L+ E+ L + + ++ + + + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 236 HYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAP 295
+ +HRD+KP NLL+++ G L+L++FGL +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV------------------------- 155
Query: 296 KRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG- 353
+ V T Y P+VL Y D WS G I E+
Sbjct: 156 ----------------RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199
Query: 354 YPPFYSDDPMSTCRKIVN---------WRTHLKFPEEA----------------KLSIEA 388
P F +D ++I W + K P+ KL+
Sbjct: 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATG 259
Query: 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
+DL+ LL N QR+ A+E HP+F
Sbjct: 260 RDLLQNLLKCNPVQRI---SAEEALQHPYFS 287
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-45
Identities = 52/310 (16%), Positives = 104/310 (33%), Gaps = 64/310 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-D 174
+D + +IG+G FG+V R K G + E + E +L ++
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 175 SNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------------TLTEDEA 218
I+ L + + +LYL +EY P G+++ L + TL+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 219 RFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTI 278
+ A+ ++ + + +IHRD+ N+L+ + +++DFGL + + +
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK------ 183
Query: 279 GNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMEC 338
++A E L Y
Sbjct: 184 ------------------------------------TMGRLPVRWMAIESLNYSVYTTNS 207
Query: 339 DWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC 397
D WS G +++E++ G P+ K+ + + E DL+ +
Sbjct: 208 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWR 264
Query: 398 -NVNQRLGAK 406
+R
Sbjct: 265 EKPYERPSFA 274
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 3e-45
Identities = 79/395 (20%), Positives = 143/395 (36%), Gaps = 101/395 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
+ ++ L+ +G GA+G V + TG A+KKL + + E LL +
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKH 76
Query: 176 NCIVKLYCSFQDDEFL-----YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
++ L F L ++ +L G D+ + ++ LT+D +F + + + ++
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI-VKCQKLTDDHVQFLIYQILRGLK 135
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
IH IHRD+KP NL +++ L++ DFGL + D
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-------------------- 175
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYE 349
V T Y APE++L Y D WS+G IM E
Sbjct: 176 ------------------------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211
Query: 350 MLVGYPPFYSDDPMSTCRKIVN---------------------WRTHLKFPEE------A 382
+L G F D + + I+ ++ + P+
Sbjct: 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFI 271
Query: 383 KLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDELD 441
+ A DL+ K+L + ++R+ A + H +F + +DE
Sbjct: 272 GANPLAVDLLEKMLVLDSDKRITAA---QALAHAYFAQY-------------HDPDDEPV 315
Query: 442 TQNFEKFEESDNQTKTSSKTGPWRKMLSSKDINFV 476
+++ ES + W+ + + I+FV
Sbjct: 316 ADPYDQSFESRDLLIDE-----WKSLTYDEVISFV 345
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 1e-44
Identities = 77/377 (20%), Positives = 132/377 (35%), Gaps = 96/377 (25%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS 175
++ L IG GA G V + A+KKL + + + E L+ V+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVNH 75
Query: 176 NCIVKLYCSF------QDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAI 229
I+ L F ++ + +YL+ME + + M D + + + + + I
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---HERMSYLLYQMLCGI 132
Query: 230 ESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNN 289
+ +H IHRD+KP N+++ L++ DFGL + S
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF------------------- 173
Query: 290 ERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349
+ V T Y APEV+L GY D WS+G IM E
Sbjct: 174 -----------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210
Query: 350 MLVGYPPFYSDDPMSTCRKIVNW-------------------------RTHLKFPE---- 380
M+ F D + K++ L FP+
Sbjct: 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPD 270
Query: 381 ---------EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEA 430
+ +A+DL+SK+L + +R+ D+ HP+ + W ++EA
Sbjct: 271 SLFPADSEHNKLKASQARDLLSKMLVIDPAKRI---SVDDALQHPYIN--VWYDPAEVEA 325
Query: 431 AFIPEVNDELDTQNFEK 447
+ +LD +
Sbjct: 326 PPPQIYDKQLDEREHTI 342
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 156 bits (395), Expect = 1e-44
Identities = 44/289 (15%), Positives = 87/289 (30%), Gaps = 49/289 (16%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-N 176
+++ IG+G+FG + A+K + R +R E +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGCT 61
Query: 177 CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH 236
I +Y Q+ L+++ L L + + + + ++SIH+
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS 121
Query: 237 YIHRDIKPDNLLLDKY-----GHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNER 291
++RDIKPDN L+ + + + DFG+ K ++
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPY-------------- 167
Query: 292 PAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351
+ GT Y++ L + D +LG + L
Sbjct: 168 --------------------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 207
Query: 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKL----SIEAKDLISKLL 396
G P+ + +K + +L E +
Sbjct: 208 RGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYAR 256
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-43
Identities = 58/317 (18%), Positives = 107/317 (33%), Gaps = 69/317 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ +G GAFG+V + A+K LK S L + E + +E +L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVL 80
Query: 171 AEVDSN-CIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------ 211
+ + ++ IV L + +I EY GD++ L RK
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
L ++ + + + + + IHRD+ N+LL ++ DFGL + +
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIK---- 196
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
+ ++ + ++APE +
Sbjct: 197 -----------------------------------NDSNYVVKGNARLPVKWMAPESIFN 221
Query: 332 KGYGMECDWWSLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKD 390
Y E D WS G ++E+ +G P+ S K++ + PE E D
Sbjct: 222 CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEH--APAEMYD 279
Query: 391 LISKLLC-NVNQRLGAK 406
++ + +R K
Sbjct: 280 IMKTCWDADPLKRPTFK 296
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 1e-43
Identities = 52/293 (17%), Positives = 96/293 (32%), Gaps = 48/293 (16%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLA 171
+IG G FGEV KT+ A+K LK Q E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMG 64
Query: 172 EVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIE 230
+ + I++L + + +I EY+ G + L KD + + + ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 124
Query: 231 SIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNE 290
+ +Y+HRD+ N+L++ ++SDFGL + L+
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE----------------------- 161
Query: 291 RPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350
+ APE + + + D WS G +M+E+
Sbjct: 162 ---------------DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 206
Query: 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
+ Y + K +N L P + L+ + +R
Sbjct: 207 MTYGERPYWELSNHEVMKAINDGFRLPTPMD--CPSAIYQLMMQCWQQERARR 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-42
Identities = 42/287 (14%), Positives = 97/287 (33%), Gaps = 49/287 (17%)
Query: 123 MIGKGAFGEV---RVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIV 179
+IG+G FG V + A+K L + G+V E ++ + ++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 180 KLY-CSFQDDEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHY 237
L + + +++ Y+ GD+ + T + + + ++ + +
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151
Query: 238 IHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKR 297
+HRD+ N +LD+ ++++DFGL + + G
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG------------------ 193
Query: 298 TQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPP 356
++A E L + + + D WS G +++E++ G PP
Sbjct: 194 -------------------AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 234
Query: 357 FYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQR 402
+ + ++ R + + +++ K R
Sbjct: 235 YPDVNTFDITVYLLQGR---RLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 6e-41
Identities = 54/315 (17%), Positives = 105/315 (33%), Gaps = 66/315 (20%)
Query: 116 DDFELLTMIGKGAFGEVRVCR-----EKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
D +L +G+GAFG+V + T A+K LK+ + + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILI 71
Query: 171 AEVDSNCIVKL-YCSFQDDEFLYLIMEYLPGGDMMTLL----------------MRKDTL 213
+V L + L +I+E+ G++ T L + KD L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 214 TEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273
T + Y + +E + IHRD+ N+LL + +++ DFGL + +
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIY------ 185
Query: 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333
+ + ++APE + +
Sbjct: 186 ---------------------------------KDPDYVRKGDARLPLKWMAPETIFDRV 212
Query: 334 YGMECDWWSLGAIMYEMLVGY-PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLI 392
Y ++ D WS G +++E+ P+ + + T ++ P+ + E +
Sbjct: 213 YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTM 270
Query: 393 SKLLC-NVNQRLGAK 406
+QR
Sbjct: 271 LDCWHGEPSQRPTFS 285
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-41
Identities = 44/322 (13%), Positives = 107/322 (33%), Gaps = 64/322 (19%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLL 170
+ + +G+G+FG V K A+K + ++ +R + E +++
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVM 77
Query: 171 AEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKD----------TLTEDEARF 220
E + + +V+L + +IME + GD+ + L + +
Sbjct: 78 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137
Query: 221 YVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGN 280
E + ++ + ++HRD+ N ++ + +++ DFG+ + + + +
Sbjct: 138 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG-- 195
Query: 281 NLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDW 340
+ +++PE L + D
Sbjct: 196 -------------------------------------LLPVRWMSPESLKDGVFTTYSDV 218
Query: 341 WSLGAIMYEML-VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-N 398
WS G +++E+ + P+ R ++ L P+ +L+ N
Sbjct: 219 WSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDN--CPDMLFELMRMCWQYN 275
Query: 399 VNQRLGAK---GADEIKVHPWF 417
R + + ++ P F
Sbjct: 276 PKMRPSFLEIISSIKEEMEPGF 297
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 1e-40
Identities = 53/316 (16%), Positives = 105/316 (33%), Gaps = 68/316 (21%)
Query: 116 DDFELLTMIGKGAFGEVRVCREKTT-------GHVYAMKKLKKSEMLRRGQVEHVRAERN 168
D L +G+GAFG+V + A+K LK + + +E
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEME 70
Query: 169 LLAEVDS-NCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------D 211
++ + I+ L + D LY+I+EY G++ L + +
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 130
Query: 212 TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271
L+ + + +E + IHRD+ N+L+ + ++++DFGL + +
Sbjct: 131 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331
++ ++APE L
Sbjct: 191 YKKTTNG---------------------------------------RLPVKWMAPEALFD 211
Query: 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDL 391
+ Y + D WS G +++E+ Y P+ K++ + P + E +
Sbjct: 212 RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSN--CTNELYMM 269
Query: 392 ISKLLC-NVNQRLGAK 406
+ +QR K
Sbjct: 270 MRDCWHAVPSQRPTFK 285
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 1e-36
Identities = 55/278 (19%), Positives = 85/278 (30%), Gaps = 62/278 (22%)
Query: 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD 174
A L IGKG FGEV R K G A+K E + AE +
Sbjct: 2 ARTIVLQESIGKGRFGEV--WRGKWRGEEVAVKIFSSREE----RSWFREAEIYQTVMLR 55
Query: 175 SNCIVKLYCSFQDDEF----LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIE 230
I+ + D L+L+ +Y G + L + T+T + T +
Sbjct: 56 HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLA 114
Query: 231 SIH--------KHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNL 282
+H K HRD+K N+L+ K G ++D GL D +T
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT------------ 162
Query: 283 NGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL------KKGYGM 336
+ VGT Y+APEVL
Sbjct: 163 -------------------------DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFK 197
Query: 337 ECDWWSLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRT 374
D +++G + +E+ + +
Sbjct: 198 RADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 127 bits (320), Expect = 2e-33
Identities = 63/392 (16%), Positives = 127/392 (32%), Gaps = 105/392 (26%)
Query: 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNL-------L 170
+ L+ +G G F V + ++ AMK ++ ++ + ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 171 AEVDSNCIVKLYCSFQD--DEFLYLIMEYLPGGDMMTLLMRKD---TLTEDEARFYVAET 225
+ +N I+KL F ++++M + G+ + L++K + + +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 226 VLAIESIHKHHYI-HRDIKPDNLLLDKYGHLR-LSDFGLCKPLDCSTLQEQDFTIGNNLN 283
+L ++ +H+ I H DIKP+N+L++ L + + E
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY-------- 186
Query: 284 GSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343
+++ T +Y +PEVLL +G D WS
Sbjct: 187 -------------------------------TNSIQTREYRSPEVLLGAPWGCGADIWST 215
Query: 344 GAIMYEMLVGYPPFYSDD---------------------PMSTCRKIVNWRTHL------ 376
+++E++ G F D+ P R RT
Sbjct: 216 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLL 275
Query: 377 -----------------KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418
K+ + E D +S +L + +R A + HPW
Sbjct: 276 RNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG---GLVNHPWLK 332
Query: 419 GVDWARIYQMEAAFIPEVNDELDTQNFEKFEE 450
D + ++ D + FEE
Sbjct: 333 --DTLGMEEIRVPDRELYGSGSDIPGW--FEE 360
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 68.7 bits (167), Expect = 5e-14
Identities = 20/160 (12%), Positives = 50/160 (31%), Gaps = 28/160 (17%)
Query: 123 MIGKGAFGEVRVCREKTTGHVYAMKKLKKS---------------EMLRRGQVEHVRAER 167
++G+G V C + +K K + R E
Sbjct: 7 LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 168 NLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVL 227
L ++ + K+Y + ++ME + ++ + + + +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV-------RVENPDEVLDMILE 114
Query: 228 AIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267
+ + +H D+ N+L+ + G + + DF +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 497 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.2 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.92 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.21 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.07 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.43 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-72 Score=564.87 Aligned_cols=326 Identities=37% Similarity=0.651 Sum_probs=279.5
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
+++.++|++++.||+|+||+||+|+++.||+.||||++++..........++.+|+.+|+.++|||||+++++|++++.+
T Consensus 1 ~i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEE
T ss_pred CCchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccc
Confidence 35678999999999999999999999999999999999988777777788899999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|+|||||+||+|..++.+.+.+++..+++|++||+.||+|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999986532210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
...+.+||+.|+|||++.+.+|+.++|||||||++|||+
T Consensus 161 -----------------------------------------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml 199 (337)
T d1o6la_ 161 -----------------------------------------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 199 (337)
T ss_dssp -----------------------------------------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHH
Confidence 123579999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhhh-
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIYQ- 427 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~~- 427 (497)
+|.+||.+.+..+++.++.. ..+.+|. .+|+++++||++||+ ||.+|++. .+++||++||||++++|..+.+
T Consensus 200 ~G~~pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~ 275 (337)
T d1o6la_ 200 CGRLPFYNQDHERLFELILM--EEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK 275 (337)
T ss_dssp HSSCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred HCCCCCCCcCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHHHHhC
Confidence 99999999999999999887 4567775 799999999999999 99999974 3589999999999999999974
Q ss_pred -cCCCcccccCCcccccCcccccccccccCCCCCCC----cccccccCcCCcccCceeeC
Q 010947 428 -MEAAFIPEVNDELDTQNFEKFEESDNQTKTSSKTG----PWRKMLSSKDINFVGYTYKN 482 (497)
Q Consensus 428 -~~~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~f~g~~~~~ 482 (497)
+.|||+|.+.++.|+++|+..........+++... ............|.||+|..
T Consensus 276 ~~~~p~~P~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~v~ 335 (337)
T d1o6la_ 276 KLLPPFKPQVTSEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335 (337)
T ss_dssp CSCCSCCCCCSSTTCCTTSCHHHHTSCCC--------------------CCTTTTCCEEC
T ss_pred CCCCCCCCCCCChhhhhhcCchhhhccCCCCCCccccccccccccchhhhhccCCCEeeC
Confidence 78999999999999999986433222111111110 00001122345799999975
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-69 Score=537.12 Aligned_cols=314 Identities=35% Similarity=0.666 Sum_probs=250.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHH-hcCCCceeEEEEEeecCCeEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLA-EVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
.++|+++++||+|+||+||+|+++.||+.||||++++.........+++..|..++. .++|||||+++++|.+++.+||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999999877666667777888888775 6899999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||||+||+|.+++.....+++.+++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~-- 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA-- 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccc--
Confidence 999999999999999999999999999999999999999999999999999999999999999999999986532210
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
.....+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 159 ---------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG 199 (320)
T d1xjda_ 159 ---------------------------------------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIG 199 (320)
T ss_dssp ---------------------------------------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred ---------------------------------------cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhC
Confidence 01246899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcc-hhcCCCCccCCChhhhh--hcC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGAD-EIKVHPWFDGVDWARIY--QME 429 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~-eil~Hpff~~i~w~~l~--~~~ 429 (497)
++||.+.+..+++.+|.. ..+.+|. .+|+++++||++||+ ||.+||+ +. ++++||||++++|+.+. ++.
T Consensus 200 ~~PF~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~dli~~~L~~dP~~R~s---~~~~l~~hpff~~~~~~~l~~~~~~ 272 (320)
T d1xjda_ 200 QSPFHGQDEEELFHSIRM--DNPFYPR--WLEKEAKDLLVKLFVREPEKRLG---VRGDIRQHPLFREINWEELERKEID 272 (320)
T ss_dssp SCSSCCSSHHHHHHHHHH--CCCCCCT--TSCHHHHHHHHHHSCSSGGGSBT---TBSCGGGSGGGTTCCHHHHHTTCSC
T ss_pred CCCCCCCCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHhcccCCCCCcC---HHHHHHhCchhccCCHHHHHhcCCC
Confidence 999999999999999886 3455664 789999999999999 9999999 64 89999999999999986 478
Q ss_pred CCcccccCCcccccCcccccccccccCCCCCCCcccccccCc-CCcccCcee
Q 010947 430 AAFIPEVNDELDTQNFEKFEESDNQTKTSSKTGPWRKMLSSK-DINFVGYTY 480 (497)
Q Consensus 430 ~p~~p~~~~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~f~g~~~ 480 (497)
||++|.+.++.|++||+.....+.+..+. ..+.++.+. +..|.||+|
T Consensus 273 pp~~p~~~~~~d~~~f~~~~~~~~~~~~~----~~~~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 273 PPFRPKVKSPFDCSNFDKEFLNEKPRLSF----ADRALINSMDQNMFRNFSF 320 (320)
T ss_dssp C------------------------------------------CCTTTTCCC
T ss_pred CCCCCCCCCccchhhcChHhhhCCccCCC----CcccccCchhhcccCcCcC
Confidence 99999999999999998644332221111 112233343 457999998
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-68 Score=532.27 Aligned_cols=290 Identities=42% Similarity=0.844 Sum_probs=253.6
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|++++.||+|+||+||+|+++.+|+.||||++++.........+++.+|+.+|+.++|||||+++++|.+++.+|+
T Consensus 2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 81 (316)
T d1fota_ 2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 81 (316)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence 35789999999999999999999999999999999998776666778889999999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccc
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQE 273 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~ 273 (497)
|||||+||+|..++.....+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~---- 157 (316)
T d1fota_ 82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV---- 157 (316)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence 9999999999999999999999999999999999999999999999999999999999999999999999875321
Q ss_pred ccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhC
Q 010947 274 QDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G 353 (497)
..+.+||+.|+|||++.+..|+.++|||||||++|||++|
T Consensus 158 ----------------------------------------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG 197 (316)
T d1fota_ 158 ----------------------------------------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 197 (316)
T ss_dssp ----------------------------------------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHS
T ss_pred ----------------------------------------cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhC
Confidence 1257899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCChhhhh--hc
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDWARIY--QM 428 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w~~l~--~~ 428 (497)
.+||.+.+..+.+.+|.+. ...+|. .+|+++++||.+||. ||.+|++. +++++|++||||++++|+.+. ++
T Consensus 198 ~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~~~~ 273 (316)
T d1fota_ 198 YTPFYDSNTMKTYEKILNA--ELRFPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNI 273 (316)
T ss_dssp SCTTCCSSHHHHHHHHHHC--CCCCCT--TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHTTCS
T ss_pred CCCCCCcCHHHHHHHHHcC--CCCCCC--CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHHHHhCCC
Confidence 9999999999999999873 455664 799999999999999 99999853 469999999999999999986 47
Q ss_pred CCCcccccCC-cccccCccccccc
Q 010947 429 EAAFIPEVND-ELDTQNFEKFEES 451 (497)
Q Consensus 429 ~~p~~p~~~~-~~d~~~f~~~~~~ 451 (497)
++||+|.+.. ..|+++|+++.++
T Consensus 274 ~~p~~p~~~~~~~d~~~f~~~~~~ 297 (316)
T d1fota_ 274 ETPYEPPIQQGQGDTSQFDKYPEE 297 (316)
T ss_dssp CCSCCCCC----------------
T ss_pred CcCCCCCcCCCcchhhhcCCCccc
Confidence 8999998644 5689999887654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.6e-68 Score=537.29 Aligned_cols=292 Identities=41% Similarity=0.835 Sum_probs=267.5
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
...++|++++.||+|+||+||+|+++.||+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+...+|
T Consensus 38 ~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 117 (350)
T d1rdqe_ 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred CCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccc
Confidence 44578999999999999999999999999999999999877666677788999999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
+||||+.||+|..++.+.+.+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 118 ~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--- 194 (350)
T d1rdqe_ 118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--- 194 (350)
T ss_dssp EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred cccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc---
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999876421
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
..+.+||+.|||||++.+..|+.++|||||||++|||++
T Consensus 195 -----------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemlt 233 (350)
T d1rdqe_ 195 -----------------------------------------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233 (350)
T ss_dssp -----------------------------------------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHh
Confidence 125689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC--CCCcchhcCCCCccCCChhhhhh--
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG--AKGADEIKVHPWFDGVDWARIYQ-- 427 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~--~~~~~eil~Hpff~~i~w~~l~~-- 427 (497)
|.+||.+.+....+.+|.. ..+.+|. .+|+++++||++||+ ||.+|+. ++++++|++||||++++|..+.+
T Consensus 234 G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~ 309 (350)
T d1rdqe_ 234 GYPPFFADQPIQIYEKIVS--GKVRFPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRK 309 (350)
T ss_dssp SSCSSCCSSHHHHHHHHHH--CCCCCCT--TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTC
T ss_pred CCCCCCCcCHHHHHHHHhc--CCCCCCc--cCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHHHhcC
Confidence 9999999999999999987 3455554 799999999999999 9999974 24699999999999999999974
Q ss_pred cCCCcccccCCcccccCcccccccc
Q 010947 428 MEAAFIPEVNDELDTQNFEKFEESD 452 (497)
Q Consensus 428 ~~~p~~p~~~~~~d~~~f~~~~~~~ 452 (497)
++|||+|.+.++.|++||+.+.+.+
T Consensus 310 ~~~p~~p~~~~~~d~s~~~~~~~~~ 334 (350)
T d1rdqe_ 310 VEAPFIPKFKGPGDTSNFDDYEEEE 334 (350)
T ss_dssp SCCSCCCCCCSTTCCTTSCCCCCCC
T ss_pred CCcCccCCCCCcchhhhcCCCCccc
Confidence 7899999999999999998876543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-68 Score=526.98 Aligned_cols=280 Identities=36% Similarity=0.671 Sum_probs=249.8
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
+...++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 4 ~~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~ 83 (288)
T d1uu3a_ 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL 83 (288)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEE
T ss_pred CCCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEE
Confidence 34557899999999999999999999999999999999987766677778899999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
|||||||+||+|.+++...+.+++..++.++.|++.||.|||+.|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999987643210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
. ....+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 164 ~---------------------------------------~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell 204 (288)
T d1uu3a_ 164 Q---------------------------------------ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 204 (288)
T ss_dssp ---------------------------------------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred c---------------------------------------cccccccCCccccCceeeccCCCCcccceehhhHHHHHHh
Confidence 0 0122578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCC---cchhcCCCCccCCChhhhhh
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKG---ADEIKVHPWFDGVDWARIYQ 427 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~---~~eil~Hpff~~i~w~~l~~ 427 (497)
+|.+||.+.+..+++.+|.+. .+.+|. .+|+++++||.+||+ ||.+||++.. ...|++||||++++|+.|.+
T Consensus 205 ~g~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~ 280 (288)
T d1uu3a_ 205 AGLPPFRAGNEYLIFQKIIKL--EYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280 (288)
T ss_dssp HSSCSSCCSSHHHHHHHHHTT--CCCCCT--TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGG
T ss_pred hCCCCCCCcCHHHHHHHHHcC--CCCCCc--cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhc
Confidence 999999999999999999874 456665 799999999999999 9999999321 12368999999999999999
Q ss_pred cCCCccc
Q 010947 428 MEAAFIP 434 (497)
Q Consensus 428 ~~~p~~p 434 (497)
..||-+|
T Consensus 281 ~~pP~l~ 287 (288)
T d1uu3a_ 281 QTPPKLT 287 (288)
T ss_dssp SCCCCCC
T ss_pred CCCCCCC
Confidence 8888766
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.5e-65 Score=517.20 Aligned_cols=287 Identities=34% Similarity=0.654 Sum_probs=239.3
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHH---HHHHHhcCCCceeEEEEEeecCC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAE---RNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E---~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
++.++|+++++||+|+||+||+|+++.||+.||||++.+...........+.+| +.+++.++|||||+++++|.+++
T Consensus 1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~ 80 (364)
T d1omwa3 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 80 (364)
T ss_dssp CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence 356899999999999999999999999999999999987665444434444444 56667778999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
.+|||||||+||+|.++|.+...+++..++.|+.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999866422
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ 348 (497)
. ....+||+.|+|||++.. ..|+.++|||||||++|
T Consensus 161 ~-------------------------------------------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvily 197 (364)
T d1omwa3 161 K-------------------------------------------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLF 197 (364)
T ss_dssp C-------------------------------------------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHH
T ss_pred c-------------------------------------------ccccccccccchhHHhhcCCCCCcccchhHHHHHHH
Confidence 1 124689999999999974 67999999999999999
Q ss_pred HHHhCCCCCCCCChHHHH---HHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccCCCh
Q 010947 349 EMLVGYPPFYSDDPMSTC---RKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDGVDW 422 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~---~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~i~w 422 (497)
||++|.+||.+.+..... ..+. .....+|. .+|+++++||.+||+ ||.+||+. .+|+||++||||++++|
T Consensus 198 emltG~~Pf~~~~~~~~~~~~~~~~--~~~~~~~~--~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~ 273 (364)
T d1omwa3 198 KLLRGHSPFRQHKTKDKHEIDRMTL--TMAVELPD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 273 (364)
T ss_dssp HHHHSSCSSCSSCSSCHHHHHHHSS--SCCCCCCS--SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhcc--cCCCCCCC--CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCH
Confidence 999999999876543332 2222 23344443 799999999999999 99999985 34899999999999999
Q ss_pred hhhh--hcCCCcccccCCcccccCcc
Q 010947 423 ARIY--QMEAAFIPEVNDELDTQNFE 446 (497)
Q Consensus 423 ~~l~--~~~~p~~p~~~~~~d~~~f~ 446 (497)
..+. +++|||+|........+.|+
T Consensus 274 ~~~~~~~~~~p~~p~~~~~~~~~~~d 299 (364)
T d1omwa3 274 QMVFLQKYPPPLIPPRGEVNAADAFD 299 (364)
T ss_dssp HHHHTTCSCCSCCCCCC---------
T ss_pred HHHhcCCCCcCcCCCCCCCCcCCccc
Confidence 9987 47899999877665555444
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-65 Score=495.31 Aligned_cols=257 Identities=35% Similarity=0.604 Sum_probs=236.7
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
...++|++++.||+|+||+||+|+++.+|+.||||++.+....+......+.+|+.+|+.++|||||+++++|.+++.+|
T Consensus 3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 82 (263)
T d2j4za1 3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 82 (263)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence 45679999999999999999999999999999999999877666666778999999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 193 LIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+......
T Consensus 83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~-- 160 (263)
T d2j4za1 83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-- 160 (263)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC--
T ss_pred EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc--
Confidence 999999999999999998999999999999999999999999999999999999999999999999999998653211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
....+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 161 -----------------------------------------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~ 199 (263)
T d2j4za1 161 -----------------------------------------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 199 (263)
T ss_dssp -----------------------------------------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhc
Confidence 124689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|.+||.+.+..+++.+|.. ..+.+|. .+|+++++||.+||+ ||.+||+ ++|+++||||.+
T Consensus 200 G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L~~dp~~R~t---~~eil~hp~~~~ 260 (263)
T d2j4za1 200 GKPPFEANTYQETYKRISR--VEFTFPD--FVTEGARDLISRLLKHNPSQRPM---LREVLEHPWITA 260 (263)
T ss_dssp SSCTTCCSSHHHHHHHHHT--TCCCCCT--TSCHHHHHHHHHHTCSSGGGSCC---HHHHHTCHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHc--CCCCCCc--cCCHHHHHHHHHHccCCHhHCcC---HHHHHcCcCcCC
Confidence 9999999999999998886 4455665 799999999999999 9999998 999999999963
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-64 Score=487.54 Aligned_cols=259 Identities=26% Similarity=0.472 Sum_probs=221.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv 81 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 81 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence 4689999999999999999999999999999999986542 22345688999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
||||+||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--- 158 (271)
T d1nvra_ 82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--- 158 (271)
T ss_dssp EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE---
T ss_pred EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc---
Confidence 99999999999998888999999999999999999999999999999999999999999999999999987642210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvil~ell~G 353 (497)
.....+.+||+.|+|||++.+..| +.++|||||||++|||++|
T Consensus 159 ------------------------------------~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G 202 (271)
T d1nvra_ 159 ------------------------------------ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 202 (271)
T ss_dssp ------------------------------------ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred ------------------------------------cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence 011235789999999999998876 6789999999999999999
Q ss_pred CCCCCCCChHHH-HHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 354 YPPFYSDDPMST-CRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 354 ~~PF~~~~~~~~-~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
.+||.+.+.... +..+.. .....+....+|+++++||.+||+ ||.+||+ ++|+++||||+.
T Consensus 203 ~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hpwf~~ 265 (271)
T d1nvra_ 203 ELPWDQPSDSCQEYSDWKE--KKTYLNPWKKIDSAPLALLHKILVENPSARIT---IPDIKKDRWYNK 265 (271)
T ss_dssp SCSCSSSSTTSHHHHHHHT--TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTCTTTTC
T ss_pred CCCCCCCChHHHHHHHHhc--CCCCCCccccCCHHHHHHHHHHcCCChhHCcC---HHHHhcCHhhCc
Confidence 999987654433 333333 222233335799999999999999 9999998 999999999973
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-63 Score=488.33 Aligned_cols=267 Identities=29% Similarity=0.514 Sum_probs=232.3
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhch---hHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRR---GQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~---~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++++...... ...+.+.+|+.+|+.++|||||+++++|.+++.+
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 3579999999999999999999999999999999987644322 2356789999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC----cEEEcccccccccC
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG----HLRLSDFGLCKPLD 267 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g----~vkL~DFGla~~~~ 267 (497)
|||||||+||+|.+++...+.+++..++.++.||+.||.|||+.|||||||||+|||++.+| ++||+|||+|+...
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999999889999999999999999999999999999999999999998876 59999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
.... ..+.+||+.|+|||++.+..|+.++|||||||++
T Consensus 169 ~~~~------------------------------------------~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvil 206 (293)
T d1jksa_ 169 FGNE------------------------------------------FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 206 (293)
T ss_dssp TSCB------------------------------------------CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHH
T ss_pred CCcc------------------------------------------ccccCCCCcccCHHHHcCCCCCCcccchhhhHHH
Confidence 3211 1246899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
|||++|.+||.+.+..+++.+|......+..+....+|+++++||++||+ ||.+||+ ++|+++||||++.+|....
T Consensus 207 yell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~~~~~~~l 283 (293)
T d1jksa_ 207 YILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMT---IQDSLQHPWIKPKDTQQAL 283 (293)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSTTTCC-------
T ss_pred HHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCChhHhh
Confidence 99999999999999999999998743332222234789999999999999 9999998 9999999999999998765
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-63 Score=493.15 Aligned_cols=258 Identities=32% Similarity=0.581 Sum_probs=218.1
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+.... .....+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 35699999999999999999999999999999999876542 2335688999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec---CCCcEEEcccccccccCCCCc
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD---KYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~---~~g~vkL~DFGla~~~~~~~~ 271 (497)
||||+||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||+. .+|++||+|||+|+......
T Consensus 86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~- 164 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS- 164 (307)
T ss_dssp ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-
Confidence 99999999999999889999999999999999999999999999999999999995 57899999999998653221
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
...+.+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 165 -----------------------------------------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell 203 (307)
T d1a06a_ 165 -----------------------------------------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 203 (307)
T ss_dssp -------------------------------------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHH
Confidence 012568999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+|.+||.+.+..++..+|......+..|....+|+++++||.+||. ||.+||+ ++|+++||||++
T Consensus 204 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~~ 269 (307)
T d1a06a_ 204 CGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFT---CEQALQHPWIAG 269 (307)
T ss_dssp HSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCC---HHHHHHSTTTTS
T ss_pred hCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCC
Confidence 9999999999999999999866555555556899999999999999 9999998 999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-63 Score=485.61 Aligned_cols=255 Identities=30% Similarity=0.516 Sum_probs=226.6
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|+++.+|+.||||++++... ...+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 579999999999999999999999999999999986543 23466899999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|||+||+|.+++.+ +.+++.+++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.....
T Consensus 97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~---- 171 (293)
T d1yhwa1 97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS---- 171 (293)
T ss_dssp ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC----
T ss_pred EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc----
Confidence 99999999988754 6799999999999999999999999999999999999999999999999999987643211
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
.....+||+.|+|||++.+..|+.++|||||||++|||++|.+
T Consensus 172 -------------------------------------~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 172 -------------------------------------KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp -------------------------------------CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred -------------------------------------cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 1125689999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 356 PFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||.+.+..+....+.... ...++....+|+++++||.+||. ||.+||+ ++|+|+||||+.
T Consensus 215 Pf~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~Hp~~~~ 275 (293)
T d1yhwa1 215 PYLNENPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRGS---AKELLQHQFLKI 275 (293)
T ss_dssp TTTTSCHHHHHHHHHHHC-SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCC---HHHHTTCGGGGG
T ss_pred CCCCCCHHHHHHHHHhCC-CCCCCCcccCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCC
Confidence 999998888777776532 22333335799999999999999 9999998 999999999973
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.4e-62 Score=493.24 Aligned_cols=264 Identities=29% Similarity=0.504 Sum_probs=234.6
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 4689999999999999999999999999999999976542 3456788999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC--CCcEEEcccccccccCCCCc
Q 010947 195 MEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK--YGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 195 mEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~ 271 (497)
||||+||+|.+++.. .+.+++..++.|+.||+.||.|||++|||||||||+|||++. +|.+||+|||+|+.+.....
T Consensus 102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~ 181 (350)
T d1koaa2 102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS 181 (350)
T ss_dssp ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence 999999999999854 467999999999999999999999999999999999999964 68899999999987643211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
..+.+||+.|||||++.+..|+.++|||||||++|||+
T Consensus 182 ------------------------------------------~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell 219 (350)
T d1koaa2 182 ------------------------------------------VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL 219 (350)
T ss_dssp ------------------------------------------EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHH
T ss_pred ------------------------------------------cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHH
Confidence 12578999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhh
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIY 426 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~ 426 (497)
+|.+||.+.+..+++.+|......+..+....+|+++++||.+||+ ||.+||+ ++|+|+||||...+|....
T Consensus 220 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~eil~hp~~~~~~~~~~~ 292 (350)
T d1koaa2 220 SGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMT---IHQALEHPWLTPGNAPGRD 292 (350)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCC---HHHHHHSTTTSCTTCCSCC
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCCCCCCch
Confidence 9999999999999999998754443333335799999999999999 9999998 9999999999988775443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-62 Score=479.69 Aligned_cols=257 Identities=30% Similarity=0.487 Sum_probs=226.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
+.|++++.||+|+||+||+|+++.+|..||||++.+.. ....+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 46999999999999999999999999999999997653 334566889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||+||+|.+++.+ .+++++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+......
T Consensus 89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~---- 164 (288)
T d2jfla1 89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 164 (288)
T ss_dssp ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----
Confidence 99999999999765 4679999999999999999999999999999999999999999999999999997542100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-----cCCCCcchhHHhHHHHHHH
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-----KKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-----~~~y~~~~DiwSlGvil~e 349 (497)
....+.+||+.|+|||++. +..|+.++|||||||++||
T Consensus 165 -------------------------------------~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilye 207 (288)
T d2jfla1 165 -------------------------------------QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIE 207 (288)
T ss_dssp -------------------------------------HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHH
T ss_pred -------------------------------------ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHH
Confidence 0112578999999999984 4668999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|++|.+||.+.+..+.+.+|.... ...++....+|+++++||.+||+ ||.+||+ ++|+++||||..-
T Consensus 208 mltg~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t---~~ell~hp~~~~~ 275 (288)
T d2jfla1 208 MAEIEPPHHELNPMRVLLKIAKSE-PPTLAQPSRWSSNFKDFLKKCLEKNVDARWT---TSQLLQHPFVTVD 275 (288)
T ss_dssp HHHSSCTTTTSCGGGHHHHHHHSC-CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCC---HHHHTTSGGGCCC
T ss_pred HhhCCCCCCCCCHHHHHHHHHcCC-CCCCCccccCCHHHHHHHHHHccCChhHCcC---HHHHhcCcccCCC
Confidence 999999999999999998888643 22333345799999999999999 9999998 9999999999753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-63 Score=493.72 Aligned_cols=264 Identities=30% Similarity=0.461 Sum_probs=224.7
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeE
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFL 191 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l 191 (497)
++..++|++++.||+|+||+||+|+++.+|+.||||++++.. .......+.+|+.+|+.++|||||+++++|.++..+
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 79 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 79 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 356789999999999999999999999999999999998642 234456788999999999999999999999999999
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
|||||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +|||||||||+|||++.+|++||+|||+|+.+...
T Consensus 80 ~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 80 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 9999999999999999998999999999999999999999997 59999999999999999999999999999864211
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
...+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 159 ------------------------------------------~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~el 196 (322)
T d1s9ja_ 159 ------------------------------------------MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 196 (322)
T ss_dssp ------------------------------------------TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHH
Confidence 12357999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHH------------------------------------------HHhcccCcccCCCCccCChhH
Q 010947 351 LVGYPPFYSDDPMSTCR------------------------------------------KIVNWRTHLKFPEEAKLSIEA 388 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~------------------------------------------~i~~~~~~~~~p~~~~~s~~~ 388 (497)
++|++||.+.+..+... .+.. .....+|. ..+|+++
T Consensus 197 l~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~s~~~ 274 (322)
T d1s9ja_ 197 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVN-EPPPKLPS-GVFSLEF 274 (322)
T ss_dssp HHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHT-SCCCCCCB-TTBCHHH
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhc-cCCccCcc-ccCCHHH
Confidence 99999998765432211 1111 01111221 2478999
Q ss_pred HHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhh
Q 010947 389 KDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARI 425 (497)
Q Consensus 389 ~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l 425 (497)
+|||.+||+ ||.+||+ ++|+|+||||+..+|+.+
T Consensus 275 ~dli~~~L~~dP~~R~t---a~e~L~Hpf~~~~~~~~~ 309 (322)
T d1s9ja_ 275 QDFVNKCLIKNPAERAD---LKQLMVHAFIKRSDAEEV 309 (322)
T ss_dssp HHHHHHHTCSSTTTSCC---HHHHHTSHHHHHHHHSCC
T ss_pred HHHHHHHcCCChhHCcC---HHHHhhCHhhCcCCcccc
Confidence 999999999 9999999 999999999997766543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.8e-62 Score=482.51 Aligned_cols=253 Identities=26% Similarity=0.391 Sum_probs=228.3
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
.|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.+|+.++|||||+++++|.+++.+|||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 39999999999999999999999999999999987765556667789999999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
||+||+|..++...+++++..++.++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.....
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~------- 168 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------- 168 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-------
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-------
Confidence 9999999888888889999999999999999999999999999999999999999999999999999854311
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CCCCcchhHHhHHHHHHHHHhC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~y~~~~DiwSlGvil~ell~G 353 (497)
.+.+||+.|+|||++.+ ..|+.++|||||||++|||++|
T Consensus 169 --------------------------------------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g 210 (309)
T d1u5ra_ 169 --------------------------------------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 210 (309)
T ss_dssp --------------------------------------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHC
Confidence 14689999999999964 4689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
.+||.+.+..+.+.++...... .+....+|+++++||.+||+ ||.+||+ ++|+++||||..
T Consensus 211 ~~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~Rpt---~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 211 KPPLFNMNAMSALYHIAQNESP--ALQSGHWSEYFRNFVDSCLQKIPQDRPT---SEVLLKHRFVLR 272 (309)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCC--CCSCTTSCHHHHHHHHHHTCSSGGGSCC---HHHHTTCHHHHS
T ss_pred CCCCCCCCHHHHHHHHHhCCCC--CCCCCCCCHHHHHHHHHHCcCChhHCcC---HHHHHhCHHhcC
Confidence 9999999988888888764322 22334789999999999999 9999998 999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-61 Score=471.21 Aligned_cols=255 Identities=32% Similarity=0.572 Sum_probs=216.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec--CCeEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD--DEFLY 192 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~--~~~l~ 192 (497)
.++|++++.||+|+||+||+|+++.||+.||||++.+... .....+.+.+|+.+|+.++|||||+++++|.+ ++.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 4689999999999999999999999999999999987654 34556778999999999999999999999865 56799
Q ss_pred EEEeecCCCchhHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHcCC-----EEEcccCCCCeeecCCCcEEEcccccc
Q 010947 193 LIMEYLPGGDMMTLLMR----KDTLTEDEARFYVAETVLAIESIHKHH-----YIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~~LH~~~-----iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
||||||+||+|.+++.+ ...+++..++.++.||+.||.|||+.| ||||||||+|||++.+|.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999999864 467999999999999999999999876 999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+.+..... ...+.+||+.|+|||++.+..|+.++|||||
T Consensus 162 ~~~~~~~~-----------------------------------------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSl 200 (269)
T d2java1 162 RILNHDTS-----------------------------------------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSL 200 (269)
T ss_dssp HHC----------------------------------------------------CCCSCCCHHHHTTCCCCHHHHHHHH
T ss_pred eecccCCC-----------------------------------------ccccCCCCcccCCHHHHcCCCCChHHHHHhh
Confidence 87642210 1125789999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
||++|||++|.+||.+.+..++..+|.+... ..+| ..+|+++++||.+||. ||.+||+ ++||++|||.
T Consensus 201 Gvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-~~~~--~~~s~~l~~li~~~L~~dp~~Rps---~~ell~hp~i 269 (269)
T d2java1 201 GCLLYELCALMPPFTAFSQKELAGKIREGKF-RRIP--YRYSDELNEIITRMLNLKDYHRPS---VEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-CCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHTSTTC
T ss_pred CHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-CCCC--cccCHHHHHHHHHHcCCChhHCcC---HHHHHhCCcC
Confidence 9999999999999999999999888876432 2344 3799999999999999 9999998 9999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-61 Score=486.60 Aligned_cols=257 Identities=29% Similarity=0.548 Sum_probs=229.2
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|+++.+|+.||||++++... .....+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 579999999999999999999999999999999987542 23456888999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeec--CCCcEEEcccccccccCCCCcc
Q 010947 196 EYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLD--KYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~--~~g~vkL~DFGla~~~~~~~~~ 272 (497)
|||+||+|.+++.+.+ ++++.+++.++.||+.||.|||++|||||||||+|||++ .+|++||+|||+|+.+.....
T Consensus 106 E~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~- 184 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI- 184 (352)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC-
T ss_pred EcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc-
Confidence 9999999998876544 699999999999999999999999999999999999998 578999999999987653211
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
..+.+||+.|+|||++.+..|+.++|||||||++|||++
T Consensus 185 -----------------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyellt 223 (352)
T d1koba_ 185 -----------------------------------------VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 223 (352)
T ss_dssp -----------------------------------------EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHh
Confidence 225689999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCC
Q 010947 353 GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 353 G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i 420 (497)
|.+||.+.+..+.+.+|......+..+....+|+++++||.+||+ ||.+||+ ++|+|+||||++.
T Consensus 224 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~Hp~~~~~ 289 (352)
T d1koba_ 224 GLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLT---VHDALEHPWLKGD 289 (352)
T ss_dssp SCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHTSTTTSSC
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhCCC
Confidence 999999999999999988744333333335799999999999999 9999998 9999999999874
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.1e-60 Score=467.00 Aligned_cols=260 Identities=33% Similarity=0.566 Sum_probs=233.0
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc------hhHHHHHHHHHHHHHhcC-CCceeEEEEEeec
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR------RGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD 187 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~------~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~ 187 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++.+..... ....+.+.+|+.+|+.++ |||||+++++|.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 368999999999999999999999999999999998754322 123356889999999997 9999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
++++|||||||+||+|.+++...+.+++..++.|+.||+.||+|||++|||||||||+|||++.++++||+|||+|+.+.
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc------CCCCcchhHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK------KGYGMECDWW 341 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~------~~y~~~~Diw 341 (497)
.... ....+||+.|+|||++.+ ..|+.++|||
T Consensus 162 ~~~~------------------------------------------~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diw 199 (277)
T d1phka_ 162 PGEK------------------------------------------LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 199 (277)
T ss_dssp TTCC------------------------------------------BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH
T ss_pred CCCc------------------------------------------eeeeeccCCCCCHHHhhccccccCCCCCchheEc
Confidence 3210 124689999999999963 4578999999
Q ss_pred hHHHHHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 342 SLGAIMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 342 SlGvil~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
|+||++|||++|.+||.+.+......+|.+....+..|....+|+++++||.+||+ ||.+||+ ++||++||||+.
T Consensus 200 slGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s---~~eil~h~~~~~ 275 (277)
T d1phka_ 200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT---AEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCC---HHHHTTSGGGCT
T ss_pred ccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHHHH
Confidence 99999999999999999999999999999866555555556899999999999999 9999998 999999999985
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-60 Score=464.50 Aligned_cols=251 Identities=23% Similarity=0.411 Sum_probs=218.1
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec----CCeEEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD----DEFLYL 193 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~----~~~l~l 193 (497)
|++.+.||+|+||+||+|+++.++..||+|++..... .....+.+.+|+++|+.++|||||+++++|.+ ...+||
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence 4677889999999999999999999999999987643 34456779999999999999999999999875 457899
Q ss_pred EEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCC--EEEcccCCCCeeec-CCCcEEEcccccccccCCCC
Q 010947 194 IMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHH--YIHRDIKPDNLLLD-KYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~--iiHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~ 270 (497)
|||||+||+|.+++.+...+++..++.++.||+.||+|||++| ||||||||+|||++ .+|++||+|||+|+.....
T Consensus 90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~- 168 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS- 168 (270)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-
T ss_pred EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC-
Confidence 9999999999999999899999999999999999999999998 99999999999997 5799999999999754321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
...+.+|||.|+|||++.+ +|+.++|||||||++|||
T Consensus 169 ------------------------------------------~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel 205 (270)
T d1t4ha_ 169 ------------------------------------------FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEM 205 (270)
T ss_dssp ------------------------------------------SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHH
T ss_pred ------------------------------------------ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHH
Confidence 1225789999999999864 699999999999999999
Q ss_pred HhCCCCCCCCC-hHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 351 LVGYPPFYSDD-PMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 351 l~G~~PF~~~~-~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
++|.+||.+.. ..+++.++.....+..++ ..+++++++||.+||. ||++||+ ++|+++||||+
T Consensus 206 ~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~s---~~ell~Hp~fk 270 (270)
T d1t4ha_ 206 ATSEYPYSECQNAAQIYRRVTSGVKPASFD--KVAIPEVKEIIEGCIRQNKDERYS---IKDLLNHAFFQ 270 (270)
T ss_dssp HHSSCTTTTCSSHHHHHHHHTTTCCCGGGG--GCCCHHHHHHHHHHSCSSGGGSCC---HHHHHTSGGGC
T ss_pred HHCCCCCCCcccHHHHHHHHHcCCCCcccC--ccCCHHHHHHHHHHccCCHhHCcC---HHHHhCCcccC
Confidence 99999998754 455566666543333333 3689999999999999 9999998 99999999996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-61 Score=480.41 Aligned_cols=289 Identities=41% Similarity=0.743 Sum_probs=245.1
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEE---cCCCcEEEEEEeechhhhc-hhHHHHHHHHHHHHHhcCC-CceeEEEEEee
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCRE---KTTGHVYAMKKLKKSEMLR-RGQVEHVRAERNLLAEVDS-NCIVKLYCSFQ 186 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~---~~t~~~~AiK~l~k~~~~~-~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~ 186 (497)
++..++|++++.||+|+||+||+|++ +.+|+.||||++++..... ....+.+.+|+.+|++++| |||++++++|.
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 35668899999999999999999987 4478999999998654322 2234567889999999977 89999999999
Q ss_pred cCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 187 DDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
+...+|+||||+.||+|.+++...+.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+||+|||+|+.+
T Consensus 100 ~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 100 TETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp ETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred cCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC--CCCcchhHHhHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK--GYGMECDWWSLG 344 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~--~y~~~~DiwSlG 344 (497)
...... ...+.+||+.|+|||.+.+. .++.++||||||
T Consensus 180 ~~~~~~----------------------------------------~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG 219 (322)
T d1vzoa_ 180 VADETE----------------------------------------RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG 219 (322)
T ss_dssp CGGGGG----------------------------------------GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH
T ss_pred cccccc----------------------------------------cccccccccccchhHHhhcCCcCCCchhhhHHHH
Confidence 432110 12256899999999999764 478899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhcc--cCcccCCCCccCChhHHHHHHHHhh-CccccCCC--CCcchhcCCCCccC
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNW--RTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGA--KGADEIKVHPWFDG 419 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~--~~~~eil~Hpff~~ 419 (497)
|+||||++|.+||.+.+..+....+... .....+|. .+|+++++||.+||. ||.+|++. .+++|+++||||++
T Consensus 220 ~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~--~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc--cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999887655554444432 23344443 799999999999999 99999985 36899999999999
Q ss_pred CChhhhhh--cCCCcccccCCcccc
Q 010947 420 VDWARIYQ--MEAAFIPEVNDELDT 442 (497)
Q Consensus 420 i~w~~l~~--~~~p~~p~~~~~~d~ 442 (497)
++|+.+.. +++||+|.+.++.|+
T Consensus 298 i~~~~l~~~~~~~p~~p~~~~~~~~ 322 (322)
T d1vzoa_ 298 INWDDLAAKKVPAPFKPVIRDELDV 322 (322)
T ss_dssp CCHHHHHTTCSCCSCCCCCCC-CCC
T ss_pred CCHHHHHhCCCCcCCCCCCCCCCCC
Confidence 99999984 899999999998874
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-60 Score=473.81 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=227.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lV 194 (497)
.++|++++.||+|+||+||+|.++.||+.||||++++.. .....+.+|+.+|+.++|||||+++++|.+++++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999998653 2334588999999999999999999999999999999
Q ss_pred EeecCCCchhHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCC--CcEEEcccccccccCCCCc
Q 010947 195 MEYLPGGDMMTLLMRKD-TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKY--GHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~--g~vkL~DFGla~~~~~~~~ 271 (497)
||||+||+|.+++...+ .+++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+......
T Consensus 80 mE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~- 158 (321)
T d1tkia_ 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD- 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-
Confidence 99999999999997655 79999999999999999999999999999999999999854 489999999998754321
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
...+.+||+.|+|||++.+..|+.++|||||||++|+|+
T Consensus 159 -----------------------------------------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll 197 (321)
T d1tkia_ 159 -----------------------------------------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLL 197 (321)
T ss_dssp -----------------------------------------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHH
T ss_pred -----------------------------------------cccccccccccccchhccCCCCCchhhcccHHHHHHHHH
Confidence 112568999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccC
Q 010947 352 VGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 352 ~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~ 419 (497)
+|.+||.+.+..+.+.+|.+....+..+....+|+++++||.+||. ||.+||+ ++|+++||||+.
T Consensus 198 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~ 263 (321)
T d1tkia_ 198 SGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMT---ASEALQHPWLKQ 263 (321)
T ss_dssp HSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCC---HHHHHHSHHHHS
T ss_pred hCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcC---HHHHhcCHhhcc
Confidence 9999999999999999998743332222224689999999999999 9999998 999999999974
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-59 Score=460.71 Aligned_cols=259 Identities=29% Similarity=0.433 Sum_probs=217.0
Q ss_pred eEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchh--HHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEe
Q 010947 119 ELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRG--QVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIME 196 (497)
Q Consensus 119 ~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~--~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmE 196 (497)
+.+++||+|+||+||+|+++.+|+.||||++++....... ....+.+|+.+|+.++|||||+++++|.+++++|||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 3578999999999999999999999999999765432221 23468899999999999999999999999999999999
Q ss_pred ecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccccc
Q 010947 197 YLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDF 276 (497)
Q Consensus 197 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 276 (497)
||.||++..++.....+++..++.++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+.......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~----- 155 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR----- 155 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-----
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcc-----
Confidence 999998888877778899999999999999999999999999999999999999999999999999986543210
Q ss_pred cccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhCCC
Q 010947 277 TIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGYP 355 (497)
Q Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G~~ 355 (497)
...+.+||+.|+|||++.. ..|+.++|||||||++|||++|.+
T Consensus 156 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~ 199 (299)
T d1ua2a_ 156 ------------------------------------AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 199 (299)
T ss_dssp ------------------------------------CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred ------------------------------------cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcC
Confidence 0125689999999999875 568999999999999999999999
Q ss_pred CCCCCChHHHHHHHhcccCcc---------c---------CCC------CccCChhHHHHHHHHhh-CccccCCCCCcch
Q 010947 356 PFYSDDPMSTCRKIVNWRTHL---------K---------FPE------EAKLSIEAKDLISKLLC-NVNQRLGAKGADE 410 (497)
Q Consensus 356 PF~~~~~~~~~~~i~~~~~~~---------~---------~p~------~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~e 410 (497)
||.+.+..+++.+|....... . +|. ...+|++++|||.+||+ ||.+||+ |+|
T Consensus 200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~s---a~e 276 (299)
T d1ua2a_ 200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---ATQ 276 (299)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC---HHH
T ss_pred CCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcC---HHH
Confidence 999999988888776421110 0 010 12578999999999999 9999999 999
Q ss_pred hcCCCCccCCC
Q 010947 411 IKVHPWFDGVD 421 (497)
Q Consensus 411 il~Hpff~~i~ 421 (497)
+|+||||++..
T Consensus 277 ~L~Hp~f~~~p 287 (299)
T d1ua2a_ 277 ALKMKYFSNRP 287 (299)
T ss_dssp HHTSGGGTSSS
T ss_pred HhCCHhhCCCC
Confidence 99999998643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-59 Score=467.41 Aligned_cols=252 Identities=33% Similarity=0.559 Sum_probs=211.4
Q ss_pred CCCeeEEe-EeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHh-cCCCceeEEEEEeec----C
Q 010947 115 ADDFELLT-MIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAE-VDSNCIVKLYCSFQD----D 188 (497)
Q Consensus 115 ~~~f~~~~-~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~-l~hp~Iv~l~~~~~~----~ 188 (497)
.++|.++. +||+|+||+||+|+++.||+.||||++++.. .+.+|+.++.+ .+|||||+++++|++ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 46899875 6999999999999999999999999997543 36679988755 589999999999976 4
Q ss_pred CeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC---CCcEEEcccccc
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLC 263 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~---~g~vkL~DFGla 263 (497)
.++|||||||+||+|.+++.+. ..|++.+++.|+.||+.||.|||++||+||||||+|||++. .+++||+|||+|
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 6799999999999999999764 36999999999999999999999999999999999999985 567999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhH
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSL 343 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSl 343 (497)
+....... ..+.+||+.|+|||++.+..|+.++|||||
T Consensus 162 ~~~~~~~~------------------------------------------~~~~~gt~~y~aPE~~~~~~y~~~~DiwSl 199 (335)
T d2ozaa1 162 KETTSHNS------------------------------------------LTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 199 (335)
T ss_dssp EECCCCCC------------------------------------------CCCCSCCCSSCCCCCCCGGGGSHHHHHHHH
T ss_pred eeccCCCc------------------------------------------cccccCCcccCCcHHHcCCCCCHHHHHHhh
Confidence 87643211 125689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHhcc--cCcccCCC--CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 344 GAIMYEMLVGYPPFYSDDPMSTCRKIVNW--RTHLKFPE--EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 344 Gvil~ell~G~~PF~~~~~~~~~~~i~~~--~~~~~~p~--~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
||++|+|+||.+||.+.+.......+... .....+|. ...+|+++++||++||+ ||.+||+ +.|+++||||.
T Consensus 200 Gvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~eil~hp~~~ 276 (335)
T d2ozaa1 200 GVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT---ITEFMNHPWIM 276 (335)
T ss_dssp HHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCC---HHHHHHSHHHH
T ss_pred chhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcC---HHHHHcCHHhh
Confidence 99999999999999887765554443321 12233443 35699999999999999 9999998 99999999996
Q ss_pred C
Q 010947 419 G 419 (497)
Q Consensus 419 ~ 419 (497)
.
T Consensus 277 ~ 277 (335)
T d2ozaa1 277 Q 277 (335)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=451.24 Aligned_cols=261 Identities=30% Similarity=0.476 Sum_probs=216.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|+++.+|+.||||+++... ........+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 68999999999999999999999999999999997653 22334567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||.|+.+...... ...+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--- 157 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--- 157 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB---
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc---
Confidence 99976544433333 45699999999999999999999999999999999999999999999999999986543210
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC-CCcchhHHhHHHHHHHHHhC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVG 353 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-y~~~~DiwSlGvil~ell~G 353 (497)
.....+||+.|+|||++.... ++.++|+|||||++|+|++|
T Consensus 158 --------------------------------------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G 199 (298)
T d1gz8a_ 158 --------------------------------------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTR 199 (298)
T ss_dssp --------------------------------------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHS
T ss_pred --------------------------------------cceeecccceeeehhhhccccCCCccccccccchhhhHHhhC
Confidence 012468999999999988766 48899999999999999999
Q ss_pred CCCCCCCChHHHHHHHhcccCc---c-------------cCCC---------CccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 354 YPPFYSDDPMSTCRKIVNWRTH---L-------------KFPE---------EAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 354 ~~PF~~~~~~~~~~~i~~~~~~---~-------------~~p~---------~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
++||.+.+..+...++...... . .++. ...+|++++|||++||+ ||.+||+
T Consensus 200 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t--- 276 (298)
T d1gz8a_ 200 RALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS--- 276 (298)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC---
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcC---
Confidence 9999999888777766531110 0 0000 13578999999999999 9999998
Q ss_pred cchhcCCCCccCCC
Q 010947 408 ADEIKVHPWFDGVD 421 (497)
Q Consensus 408 ~~eil~Hpff~~i~ 421 (497)
++|+++||||++++
T Consensus 277 ~~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 277 AKAALAHPFFQDVT 290 (298)
T ss_dssp HHHHHTSGGGTTCC
T ss_pred HHHHhCCHhhccCC
Confidence 99999999998763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-58 Score=448.49 Aligned_cols=251 Identities=29% Similarity=0.471 Sum_probs=216.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhH---HHHHHHHHHHHHhcC--CCceeEEEEEeecCC
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQ---VEHVRAERNLLAEVD--SNCIVKLYCSFQDDE 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~---~~~~~~E~~il~~l~--hp~Iv~l~~~~~~~~ 189 (497)
.++|++.+.||+|+||+||+|+++.+|+.||||++.+........ ...+.+|+.+|+.++ |||||+++++|.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 467999999999999999999999999999999998765433221 223668999999986 899999999999999
Q ss_pred eEEEEEeecCC-CchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-CCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPG-GDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-YGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~g-g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-~g~vkL~DFGla~~~~ 267 (497)
.+|+||||+.+ +++.+++.....+++.+++.++.||+.||.|||++|||||||||+|||++. ++.+||+|||+|+...
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 99999999976 688888888899999999999999999999999999999999999999985 4799999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC-CcchhHHhHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY-GMECDWWSLGAI 346 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y-~~~~DiwSlGvi 346 (497)
... ..+.+||+.|+|||++.+..| +.++|||||||+
T Consensus 163 ~~~-------------------------------------------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvi 199 (273)
T d1xwsa_ 163 DTV-------------------------------------------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGIL 199 (273)
T ss_dssp SSC-------------------------------------------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHH
T ss_pred ccc-------------------------------------------ccccccCCCcCCHHHHcCCCCCCcccccccceee
Confidence 211 125689999999999987765 678999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCC
Q 010947 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVD 421 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~ 421 (497)
+|||++|.+||.+.+ .+.. ....+|. .+|+++++||.+||. ||.+||+ ++|+++||||+++.
T Consensus 200 lyell~g~~Pf~~~~------~i~~--~~~~~~~--~~s~~~~~li~~~L~~dp~~R~s---~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 200 LYDMVCGDIPFEHDE------EIIR--GQVFFRQ--RVSSECQHLIRWCLALRPSDRPT---FEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHSSCSCCSHH------HHHH--CCCCCSS--CCCHHHHHHHHHHTCSSGGGSCC---HHHHHTSGGGSSCC
T ss_pred ehhHhhCCCCCCCch------HHhh--cccCCCC--CCCHHHHHHHHHHccCCHhHCcC---HHHHhcCHhhCCCC
Confidence 999999999997642 3443 3444554 799999999999999 9999998 99999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.2e-57 Score=445.85 Aligned_cols=262 Identities=25% Similarity=0.406 Sum_probs=219.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC----e
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----F 190 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~ 190 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++++....+......+.+|+.+|+.++|||||++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 467999999999999999999999999999999998876655666778999999999999999999999988644 4
Q ss_pred EEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 270 (497)
+|||||||+||+|..++...+.+++.+++.++.||+.||.|||++|||||||||+|||++.++.++|+|||+++......
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~ 165 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence 89999999999999999999999999999999999999999999999999999999999999999999999987653221
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
.. .....+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 166 ~~--------------------------------------~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyel 207 (277)
T d1o6ya_ 166 NS--------------------------------------VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEV 207 (277)
T ss_dssp ---------------------------------------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cc--------------------------------------ccccccccCcccccCHHHHcCCCCCcceecccchHHHHHH
Confidence 00 0012257899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWF 417 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff 417 (497)
+||.+||.+.+..+...+++.............+|+++++||.+||. ||.+||+ ++++++ |+|.
T Consensus 208 ltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~--sa~~l~-~~l~ 272 (277)
T d1o6ya_ 208 LTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ--TAAEMR-ADLV 272 (277)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS--SHHHHH-HHHH
T ss_pred HhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh--HHHHHH-HHHH
Confidence 99999999999988888887644333222335799999999999999 9999995 265544 5544
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-57 Score=448.07 Aligned_cols=263 Identities=26% Similarity=0.418 Sum_probs=216.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCC-CcEEEEEEeechhhhchhHHHHHHHHHHHHHhc---CCCceeEEEEEeec---
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTT-GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV---DSNCIVKLYCSFQD--- 187 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t-~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l---~hp~Iv~l~~~~~~--- 187 (497)
.++|++++.||+|+||+||+|++..+ ++.||||++++.... ......+.+|+.+|+.+ +|||||+++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 36899999999999999999999765 678999999764322 22223355677777665 79999999999853
Q ss_pred --CCeEEEEEeecCCCchhHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 188 --DEFLYLIMEYLPGGDMMTLLM-RKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 188 --~~~l~lVmEy~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
...+|+|||||.||++..... ....+++..++.++.|++.||+|||++|||||||||+|||++.+|.+||+|||+++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 357899999999887765443 34579999999999999999999999999999999999999999999999999987
Q ss_pred ccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHH
Q 010947 265 PLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLG 344 (497)
Q Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlG 344 (497)
...... ...+.+||+.|+|||++.+..|+.++||||||
T Consensus 165 ~~~~~~------------------------------------------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG 202 (305)
T d1blxa_ 165 IYSFQM------------------------------------------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVG 202 (305)
T ss_dssp CCCGGG------------------------------------------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHH
T ss_pred hhcccc------------------------------------------cCCCcccChhhcCcchhcCCCCChhehhhchH
Confidence 543210 11257899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHHhccc---------CcccCC--------------CCccCChhHHHHHHHHhh-Ccc
Q 010947 345 AIMYEMLVGYPPFYSDDPMSTCRKIVNWR---------THLKFP--------------EEAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 345 vil~ell~G~~PF~~~~~~~~~~~i~~~~---------~~~~~p--------------~~~~~s~~~~dLI~~lL~-dp~ 400 (497)
|++|||++|.+||.+.+..+++.+|+... .....+ ....+|++++|||.+||+ ||.
T Consensus 203 ~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 282 (305)
T d1blxa_ 203 CIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 282 (305)
T ss_dssp HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTT
T ss_pred HHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChh
Confidence 99999999999999999888888776411 000000 013578999999999999 999
Q ss_pred ccCCCCCcchhcCCCCccCCChh
Q 010947 401 QRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 401 ~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
+||+ ++|+|+||||+++++.
T Consensus 283 ~R~s---a~e~L~Hpff~~i~~~ 302 (305)
T d1blxa_ 283 KRIS---AYSALSHPYFQDLERC 302 (305)
T ss_dssp TSCC---HHHHHTSGGGTTCCCC
T ss_pred HCcC---HHHHhcChhhcCchhh
Confidence 9998 9999999999998753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-57 Score=449.35 Aligned_cols=258 Identities=21% Similarity=0.341 Sum_probs=218.7
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCc-----EEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEE
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGH-----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCS 184 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~-----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~ 184 (497)
+++..++|++.++||+|+||+||+|+++.+++ .||+|++.... .......+.+|+.+|.++ +|||||+++++
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEE
Confidence 45667899999999999999999999876654 69999987543 233445688999999988 89999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcc
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRK-----------------------DTLTEDEARFYVAETVLAIESIHKHHYIHRD 241 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~-----------------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrD 241 (497)
|.+.+.+|||||||+||+|.++|... ..+++..++.|+.||+.||.|||++||||||
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred EeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999999999999999654 3489999999999999999999999999999
Q ss_pred cCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCC
Q 010947 242 IKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTP 321 (497)
Q Consensus 242 LKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~ 321 (497)
|||+|||++.+|++||+|||+|+........ ....+.+||+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~ 230 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNY---------------------------------------VVRGNARLPV 230 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTS---------------------------------------EEETTEEECG
T ss_pred CchhccccccCCeEEEeeccccccccCCCce---------------------------------------eeeccccCCC
Confidence 9999999999999999999999865322100 0112467999
Q ss_pred cccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-Cc
Q 010947 322 DYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 322 ~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp 399 (497)
.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..+.+.+++.....+..| ..+|+++++||.+||+ ||
T Consensus 231 ~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p--~~~~~~l~~li~~cl~~dP 308 (325)
T d1rjba_ 231 KWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP--FYATEEIYIIMQSCWAFDS 308 (325)
T ss_dssp GGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC--TTCCHHHHHHHHHHTCSSG
T ss_pred ccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCC--CcCCHHHHHHHHHHcCCCh
Confidence 9999999999999999999999999999997 899999988777777777654445555 4799999999999999 99
Q ss_pred cccCCCCCcchhcCC
Q 010947 400 NQRLGAKGADEIKVH 414 (497)
Q Consensus 400 ~~R~~~~~~~eil~H 414 (497)
.+||+ ++||++|
T Consensus 309 ~~RPt---~~ei~~~ 320 (325)
T d1rjba_ 309 RKRPS---FPNLTSF 320 (325)
T ss_dssp GGSCC---HHHHHHH
T ss_pred hHCcC---HHHHHHH
Confidence 99998 8888765
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.7e-57 Score=443.77 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=218.9
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+.++++..++|++.+.||+|+||+||+|+++.+|+.||||++++.. ...+.+.+|+.+|+.++|||||+++++|.+
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHHhCCCCCEecCCccEee
Confidence 3456778889999999999999999999999999999999997643 234568999999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
++.+|||||||++|+|..++... ..+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceee
Confidence 99999999999999999999764 5799999999999999999999999999999999999999999999999999986
Q ss_pred cCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHH
Q 010947 266 LDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGA 345 (497)
Q Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGv 345 (497)
....... ......||+.|+|||++.+..|+.++|||||||
T Consensus 165 ~~~~~~~----------------------------------------~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv 204 (287)
T d1opja_ 165 MTGDTYT----------------------------------------AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 204 (287)
T ss_dssp CCSSSSE----------------------------------------EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHH
T ss_pred cCCCCce----------------------------------------eeccccccccccChHHHcCCCCCchhhhhhHHH
Confidence 6432111 011356899999999999999999999999999
Q ss_pred HHHHHHhCCCCCC-CCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 346 IMYEMLVGYPPFY-SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 346 il~ell~G~~PF~-~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
++|||++|..||. +.+..+....+.. ...+.+|. .+|+++++||.+||. ||.+||+ +.+|++
T Consensus 205 ~l~ell~~~~p~~~~~~~~~~~~~i~~-~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rps---~~ei~~ 268 (287)
T d1opja_ 205 LLWEIATYGMSPYPGIDLSQVYELLEK-DYRMERPE--GCPEKVYELMRACWQWNPSDRPS---FAEIHQ 268 (287)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHT-TCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHHhCCCCCCCcchHHHHHHHHhc-CCCCCCCc--cchHHHHHHHHHHcCCCHhHCcC---HHHHHH
Confidence 9999999665554 5555555444433 33445553 799999999999999 9999998 888854
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-56 Score=439.64 Aligned_cols=258 Identities=29% Similarity=0.439 Sum_probs=218.9
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|+++ +|+.||||+++.... .....+.+.+|+.+|+.++|||||+++++|.+++.+|+||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 68999999999999999999985 789999999976542 3344567889999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
||+.++++..+....+.+++..++.++.||+.||+|||+.|||||||||+|||++.+|.+||+|||+|.........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~--- 156 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--- 156 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccc---
Confidence 99988888888777889999999999999999999999999999999999999999999999999999876432110
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil~ell~G~ 354 (497)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+
T Consensus 157 --------------------------------------~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~ 198 (286)
T d1ob3a_ 157 --------------------------------------YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (286)
T ss_dssp -------------------------------------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCC
Confidence 114579999999999976 45799999999999999999999
Q ss_pred CCCCCCChHHHHHHHhcccCccc---------CC----------------CCccCChhHHHHHHHHhh-CccccCCCCCc
Q 010947 355 PPFYSDDPMSTCRKIVNWRTHLK---------FP----------------EEAKLSIEAKDLISKLLC-NVNQRLGAKGA 408 (497)
Q Consensus 355 ~PF~~~~~~~~~~~i~~~~~~~~---------~p----------------~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~ 408 (497)
+||.+.+..+.+.++........ .+ ....+|++++|||++||. ||++||+ +
T Consensus 199 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s---~ 275 (286)
T d1ob3a_ 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT---A 275 (286)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC---H
T ss_pred CCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcC---H
Confidence 99999988888777653111100 00 013578999999999999 9999998 9
Q ss_pred chhcCCCCccC
Q 010947 409 DEIKVHPWFDG 419 (497)
Q Consensus 409 ~eil~Hpff~~ 419 (497)
+|+|+||||++
T Consensus 276 ~ell~Hp~f~~ 286 (286)
T d1ob3a_ 276 KQALEHAYFKE 286 (286)
T ss_dssp HHHHTSGGGGC
T ss_pred HHHhcCcccCc
Confidence 99999999974
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-57 Score=439.78 Aligned_cols=254 Identities=21% Similarity=0.325 Sum_probs=213.3
Q ss_pred eEeeecCCeEEEEEEEc--CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEEeecC
Q 010947 122 TMIGKGAFGEVRVCREK--TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIMEYLP 199 (497)
Q Consensus 122 ~~IG~G~fG~V~~~~~~--~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~ 199 (497)
+.||+|+||+||+|.++ .+++.||||+++... .+....+.+.+|+.+|++++|||||+++++|.++ ..|||||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999865 456789999997643 3344567799999999999999999999999764 5789999999
Q ss_pred CCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccccccc
Q 010947 200 GGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIG 279 (497)
Q Consensus 200 gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 279 (497)
||+|.+++.+...+++..+..++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~------ 164 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY------ 164 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE------
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccc------
Confidence 99999999988999999999999999999999999999999999999999999999999999998764321110
Q ss_pred CCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh-CCCCCC
Q 010947 280 NNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFY 358 (497)
Q Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~ 358 (497)
.......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.
T Consensus 165 --------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~ 212 (277)
T d1xbba_ 165 --------------------------------KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 212 (277)
T ss_dssp --------------------------------EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred --------------------------------ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCC
Confidence 00124579999999999999999999999999999999998 999999
Q ss_pred CCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh---cCCCCccCCC
Q 010947 359 SDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI---KVHPWFDGVD 421 (497)
Q Consensus 359 ~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei---l~Hpff~~i~ 421 (497)
+.+..+....|... ..+.+|. .+|+++++||.+||. ||.+||+ +.+| |+|+|+..++
T Consensus 213 ~~~~~~~~~~i~~~-~~~~~p~--~~~~~~~~li~~cl~~dp~~RPs---~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 213 GMKGSEVTAMLEKG-ERMGCPA--GCPREMYDLMNLCWTYDVENRPG---FAAVELRLRNYYYDVVN 273 (277)
T ss_dssp TCCHHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHHTCSSTTTSCC---HHHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHcC-CCCCCCc--ccCHHHHHHHHHHcCCCHhHCcC---HHHHHHHhhCHHhhcCC
Confidence 99888888777753 3445554 799999999999999 9999999 6655 6788775443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-56 Score=437.31 Aligned_cols=262 Identities=22% Similarity=0.341 Sum_probs=220.5
Q ss_pred CCCCCeeEEeE-eeecCCeEEEEEEEcCC--CcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 113 MGADDFELLTM-IGKGAFGEVRVCREKTT--GHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~~-IG~G~fG~V~~~~~~~t--~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
+..++|.+.+. ||+|+||+||+|.++.+ +..||||++++.. .....+.+.+|+.+|++++|||||++++++.+ +
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-S
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-C
Confidence 44567888885 99999999999987644 4579999997642 34456779999999999999999999999876 4
Q ss_pred eEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|||||||+||+|.+++.. +..+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.+..
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccc
Confidence 68999999999999999765 46799999999999999999999999999999999999999999999999999987653
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
..... ......+||+.|+|||++.+..|+.++|||||||++|
T Consensus 162 ~~~~~--------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~ 203 (285)
T d1u59a_ 162 DDSYY--------------------------------------TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMW 203 (285)
T ss_dssp CSCEE--------------------------------------CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHH
T ss_pred ccccc--------------------------------------ccccccccCccccChHHHhCCCCCccchhhcchHHHH
Confidence 21110 0011457999999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 349 ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
||+| |.+||.+.+..+....|... ..+.+|. .+|+++.+||.+||. ||++||+..++.+.|+|+|+.
T Consensus 204 E~lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~--~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 204 EALSYGQKPYKKMKGPEVMAFIEQG-KRMECPP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCT--TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCC--cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9998 99999998888888888764 3445554 799999999999999 999999944445557888874
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-55 Score=439.39 Aligned_cols=255 Identities=28% Similarity=0.433 Sum_probs=212.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeec--CCeE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQD--DEFL 191 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~--~~~l 191 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ...+.+|+.+|+.+. ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 467999999999999999999999999999999997542 345788999999985 9999999999974 4679
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-cEEEcccccccccCCCC
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPLDCST 270 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~ 270 (497)
|+|||||++|+|..+. +.+++..++.++.||+.||.|||++|||||||||+|||++.++ .+||+|||+|+......
T Consensus 108 ~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~ 184 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184 (328)
T ss_dssp EEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred eEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence 9999999999998764 5799999999999999999999999999999999999998755 69999999998764321
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMYE 349 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~e 349 (497)
. ....+||+.|+|||++.+. .|+.++|||||||++||
T Consensus 185 ~------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e 222 (328)
T d3bqca1 185 E------------------------------------------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLAS 222 (328)
T ss_dssp C------------------------------------------CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred c------------------------------------------ccccccCccccCcccccCCCCCCcccchhhhhhhhHH
Confidence 0 1246899999999998864 58999999999999999
Q ss_pred HHhCCCCCCCCCh-HHHHHHHhcc---------------------------------cCcccCCCCccCChhHHHHHHHH
Q 010947 350 MLVGYPPFYSDDP-MSTCRKIVNW---------------------------------RTHLKFPEEAKLSIEAKDLISKL 395 (497)
Q Consensus 350 ll~G~~PF~~~~~-~~~~~~i~~~---------------------------------~~~~~~p~~~~~s~~~~dLI~~l 395 (497)
|++|..||..... ......+... ......+....+|++++|||++|
T Consensus 223 ~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~m 302 (328)
T d3bqca1 223 MIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKL 302 (328)
T ss_dssp HHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHH
T ss_pred hccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHH
Confidence 9999999976543 2222222110 00011111245899999999999
Q ss_pred hh-CccccCCCCCcchhcCCCCccCCChh
Q 010947 396 LC-NVNQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 396 L~-dp~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
|+ ||.+||+ ++|+|+||||+++.|+
T Consensus 303 L~~dP~~R~t---a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 303 LRYDHQSRLT---AREAMEHPYFYTVVKD 328 (328)
T ss_dssp SCSSGGGSCC---HHHHHTSGGGTTSCCC
T ss_pred ccCChhHCcC---HHHHhcCcccCCCCCC
Confidence 99 9999999 9999999999999985
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-56 Score=431.94 Aligned_cols=257 Identities=22% Similarity=0.367 Sum_probs=218.6
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.+++..++|++++.||+|+||+||+|+++ ++..||||++++... ..+.+.+|+.+|++++|||||++++++.+ +
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CeecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 44567789999999999999999999975 577899999976432 33568999999999999999999998755 5
Q ss_pred eEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+|+|||||++|+|.+++... ..+++..+..++.||+.||.|||++|||||||||+||||+.++++||+|||+|+.+.
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 679999999999999877543 369999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
..... ......||+.|+|||++.+..|+.++|||||||++
T Consensus 161 ~~~~~----------------------------------------~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl 200 (272)
T d1qpca_ 161 DNEYT----------------------------------------AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILL 200 (272)
T ss_dssp SSCEE----------------------------------------CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHH
T ss_pred CCccc----------------------------------------cccccCCcccccChHHHhCCCCCchhhhhhhHHHH
Confidence 32110 01246799999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC--CCCcc
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV--HPWFD 418 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~--Hpff~ 418 (497)
|||+| |.+||...+..+....+..+ ..+..| ..+++++++||.+||. ||.+||+ +++|++ |+||.
T Consensus 201 ~ellt~~~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~P~~Rpt---~~ei~~~L~~~ft 269 (272)
T d1qpca_ 201 TEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRP--DNCPEELYQLMRLCWKERPEDRPT---FDYLRSVLEDFFT 269 (272)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCc--ccChHHHHHHHHHHcCCCHhHCcC---HHHHHHHhhhhhh
Confidence 99999 56667777777777777653 233444 4799999999999999 9999998 889887 78875
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=427.43 Aligned_cols=251 Identities=18% Similarity=0.298 Sum_probs=208.8
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEE
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLY 192 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~ 192 (497)
+..++|++++.||+|+||+||+|+++ ++..||||++++... ..+.+.+|+.+++.++|||||+++++|.+++.+|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence 45678999999999999999999986 567899999976432 2356889999999999999999999999999999
Q ss_pred EEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 193 LIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 193 lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
+|||||++|+|.+++... ..+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+.......
T Consensus 77 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 77 LVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp EEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence 999999999999998654 5689999999999999999999999999999999999999999999999999986542210
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEML 351 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell 351 (497)
. .....+||+.|+|||++.+..|+.++|||||||++|||+
T Consensus 157 ~----------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~ 196 (263)
T d1sm2a_ 157 T----------------------------------------SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF 196 (263)
T ss_dssp ------------------------------------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred e----------------------------------------eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHH
Confidence 0 011457999999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 352 V-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 352 ~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
| |.+||.+.+..+....+... .....| ..+++++.+||.+||. ||.+||+ +++|++|
T Consensus 197 t~~~~~~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~~p~~Rps---~~~il~~ 255 (263)
T d1sm2a_ 197 SEGKIPYENRSNSEVVEDISTG-FRLYKP--RLASTHVYQIMNHCWKERPEDRPA---FSRLLRQ 255 (263)
T ss_dssp TTSCCTTCSCCHHHHHHHHHHT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHhc-CCCCCc--cccCHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 9 67778777887888887763 233444 3789999999999999 9999998 8898875
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-55 Score=444.23 Aligned_cols=259 Identities=31% Similarity=0.469 Sum_probs=213.6
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC-----
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----- 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----- 189 (497)
.++|++++.||+|+||+||+|.++.+|+.||||++++.. ......+.+.+|+.+|+.++|||||+++++|.+.+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 578999999999999999999999999999999998653 34455677899999999999999999999998665
Q ss_pred -eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 -FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 -~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+||||| |++|..++ +.+.+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+....
T Consensus 96 ~~~~lv~e~~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~ 173 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173 (346)
T ss_dssp CCCEEEEECC-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ceEEEEEecc-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCC
Confidence 579999999 66777665 557899999999999999999999999999999999999999999999999999986532
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGAIM 347 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGvil 347 (497)
. ....+||+.|+|||++.+ ..++.++|||||||++
T Consensus 174 ~--------------------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (346)
T d1cm8a_ 174 E--------------------------------------------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209 (346)
T ss_dssp S--------------------------------------------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred c--------------------------------------------cccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence 1 124689999999999986 4579999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHHhcccCcc---------------------cCC------CCccCChhHHHHHHHHhh-Cc
Q 010947 348 YEMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFP------EEAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 348 ~ell~G~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p------~~~~~s~~~~dLI~~lL~-dp 399 (497)
|||++|.+||.+.+.......+....... ... ....+|++++|||.+||+ ||
T Consensus 210 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 289 (346)
T d1cm8a_ 210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289 (346)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred HHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCCh
Confidence 99999999999988776665544311110 000 013579999999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCCChh
Q 010947 400 NQRLGAKGADEIKVHPWFDGVDWA 423 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i~w~ 423 (497)
.+||+ +.|||+||||+++.+.
T Consensus 290 ~~R~t---a~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 290 EQRVT---AGEALAHPYFESLHDT 310 (346)
T ss_dssp TTSCC---HHHHHHSGGGTTTC--
T ss_pred hHCcC---HHHHhcChhhCcCCCc
Confidence 99999 9999999999987643
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=442.51 Aligned_cols=252 Identities=31% Similarity=0.472 Sum_probs=210.8
Q ss_pred CeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEee------cCCe
Q 010947 117 DFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQ------DDEF 190 (497)
Q Consensus 117 ~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~------~~~~ 190 (497)
+|..+++||+|+||+||+|+++.+|+.||||++.+.... ..+|+.+|+.++|||||+++++|. +..+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceE
Confidence 699999999999999999999999999999999765421 346999999999999999999985 3346
Q ss_pred EEEEEeecCCCchhHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC-cEEEccccccccc
Q 010947 191 LYLIMEYLPGGDMMTLL---MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG-HLRLSDFGLCKPL 266 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l---~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g-~vkL~DFGla~~~ 266 (497)
+|||||||++|.+..+. .....+++..++.++.||+.||+|||++|||||||||+|||++.++ .+||+|||+|+.+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence 89999999876444333 3456799999999999999999999999999999999999999876 8999999999866
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc-CCCCcchhHHhHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK-KGYGMECDWWSLGA 345 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~-~~y~~~~DiwSlGv 345 (497)
.... ...+.+||+.|+|||++.+ ..|+.++|||||||
T Consensus 174 ~~~~------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~ 211 (350)
T d1q5ka_ 174 VRGE------------------------------------------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 211 (350)
T ss_dssp CTTS------------------------------------------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred cCCc------------------------------------------ccccccccccccChHHhhcccCCCcceeecccce
Confidence 4221 0125689999999999875 57999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhccc---------------CcccCCC----------CccCChhHHHHHHHHhh-Cc
Q 010947 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWR---------------THLKFPE----------EAKLSIEAKDLISKLLC-NV 399 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~~~~~~i~~~~---------------~~~~~p~----------~~~~s~~~~dLI~~lL~-dp 399 (497)
++|||++|.+||.+.+..+.+.+|.... ....+|. ...+|++++|||.+||+ ||
T Consensus 212 il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP 291 (350)
T d1q5ka_ 212 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291 (350)
T ss_dssp HHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSG
T ss_pred EEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCCh
Confidence 9999999999999988887777765310 0111111 13579999999999999 99
Q ss_pred cccCCCCCcchhcCCCCccCC
Q 010947 400 NQRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 400 ~~R~~~~~~~eil~Hpff~~i 420 (497)
.+||+ +.|+|+||||+++
T Consensus 292 ~~R~t---a~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 292 TARLT---PLEACAHSFFDEL 309 (350)
T ss_dssp GGSCC---HHHHHTSGGGGGG
T ss_pred hHCcC---HHHHhcCHhhccc
Confidence 99999 9999999999865
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-55 Score=435.59 Aligned_cols=258 Identities=21% Similarity=0.312 Sum_probs=208.8
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCCc---EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTGH---VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~---~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
++..++|++.++||+|+||+||+|+++.+++ .||||++.... .....+.+.+|+.+|++++|||||+++++|.++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 4566889999999999999999999987765 58899886542 234556799999999999999999999999999
Q ss_pred CeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
+.+|+|||||+||+|.+++... +.+++.++..++.||+.||.|||++|||||||||+|||++.+|++||+|||+|+.+.
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999999988764 579999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
....... ........||+.|+|||++.+..|+.++|||||||++
T Consensus 180 ~~~~~~~------------------------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 180 DDTSDPT------------------------------------YTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp ----------------------------------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred CCCCcce------------------------------------eeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence 3211000 0001134689999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||+| |.+||.+.+..+....|... ..++.| ..+++++.+||.+||. ||.+||+ +.||++
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~~P~~RPs---~~ei~~ 285 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQD-YRLPPP--MDCPSALHQLMLDCWQKDRNHRPK---FGQIVN 285 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSTTTSCC---HHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCC--ccchHHHHHHHHHHcCCCHhHCcC---HHHHHH
Confidence 99998 89999999988888888753 233333 4799999999999999 9999998 777764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=431.47 Aligned_cols=257 Identities=18% Similarity=0.242 Sum_probs=209.8
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCe
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEF 190 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 190 (497)
+++..++|++.+.||+|+||+||+|+.+ ..||||+++... ......+.+.+|+.+|++++|||||++++++. ...
T Consensus 3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~ 77 (276)
T d1uwha_ 3 WEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ 77 (276)
T ss_dssp CBCCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred cccccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence 4677889999999999999999999753 369999997653 23456678999999999999999999999765 456
Q ss_pred EEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 191 LYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 191 l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
+|||||||+||+|.+++... ..+++..+..++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.....
T Consensus 78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 89999999999999999754 56999999999999999999999999999999999999999999999999999865321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc---CCCCcchhHHhHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK---KGYGMECDWWSLGAI 346 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~---~~y~~~~DiwSlGvi 346 (497)
... ....+.+||+.|||||++.+ ..|+.++|||||||+
T Consensus 158 ~~~---------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~ 198 (276)
T d1uwha_ 158 SGS---------------------------------------HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIV 198 (276)
T ss_dssp -----------------------------------------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHH
T ss_pred CCc---------------------------------------ccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHH
Confidence 100 01125689999999999974 458999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHHhcccCc-ccCC-CCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 347 MYEMLVGYPPFYSDDPMSTCRKIVNWRTH-LKFP-EEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 347 l~ell~G~~PF~~~~~~~~~~~i~~~~~~-~~~p-~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
+|||+||..||.+.+.......++..... ...+ ....+|+++++||.+||. ||.+||+ +.+|++|
T Consensus 199 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt---~~~il~~ 266 (276)
T d1uwha_ 199 LYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL---FPQILAS 266 (276)
T ss_dssp HHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 99999999999987766555554432111 1111 124689999999999999 9999998 8888765
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=436.78 Aligned_cols=264 Identities=27% Similarity=0.350 Sum_probs=216.2
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-------
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------- 187 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------- 187 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|+.++||||++++++|.+
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 4689999999999999999999999999999999977543 23345668899999999999999999999865
Q ss_pred -CCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 188 -DEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 188 -~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
+..+|+|||||.++.+.........+++..++.++.||+.||.|||++|||||||||+|||++.++.+||+|||+|+.+
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999988887777666788999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGA 345 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGv 345 (497)
........ ....+.+||+.|+|||++.+. .|+.++|||||||
T Consensus 168 ~~~~~~~~-------------------------------------~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGv 210 (318)
T d3blha1 168 SLAKNSQP-------------------------------------NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC 210 (318)
T ss_dssp CC-----C-------------------------------------CCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred cccccccc-------------------------------------ccccceecCHHHhhHHHHcCCCCCCcHHHcccCCc
Confidence 43211100 011256899999999999864 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHHhcccCcccCCC----------------------------CccCChhHHHHHHHHhh
Q 010947 346 IMYEMLVGYPPFYSDDPMSTCRKIVNWRTHLKFPE----------------------------EAKLSIEAKDLISKLLC 397 (497)
Q Consensus 346 il~ell~G~~PF~~~~~~~~~~~i~~~~~~~~~p~----------------------------~~~~s~~~~dLI~~lL~ 397 (497)
++|||++|.+||.+.+.......+........... ....+++++|||.+||.
T Consensus 211 il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~ 290 (318)
T d3blha1 211 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV 290 (318)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSC
T ss_pred eeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCc
Confidence 99999999999999888777766654211111000 01247889999999999
Q ss_pred -CccccCCCCCcchhcCCCCccC
Q 010947 398 -NVNQRLGAKGADEIKVHPWFDG 419 (497)
Q Consensus 398 -dp~~R~~~~~~~eil~Hpff~~ 419 (497)
||++|++ ++|+|+||||+.
T Consensus 291 ~dP~~R~s---a~elL~Hpff~~ 310 (318)
T d3blha1 291 LDPAQRID---SDDALNHDFFWS 310 (318)
T ss_dssp SSTTTSCC---HHHHHHSGGGSS
T ss_pred CChhHCcC---HHHHHcChhhcc
Confidence 9999999 999999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-55 Score=421.90 Aligned_cols=250 Identities=20% Similarity=0.356 Sum_probs=220.5
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEE
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~l 193 (497)
..++|++++.||+|+||+||+|+++ ++..||||++++... ..+.+.+|+.+++.++|||||+++++|.+++.+|+
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~i 76 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI 76 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEE
Confidence 4689999999999999999999985 778999999987543 23468899999999999999999999999999999
Q ss_pred EEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcc
Q 010947 194 IMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQ 272 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~ 272 (497)
||||+++|+|..++.. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++++||+|||+|+.+......
T Consensus 77 v~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 77 ITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp EEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred EEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 9999999999998655 467999999999999999999999999999999999999999999999999999866432110
Q ss_pred cccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHh
Q 010947 273 EQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLV 352 (497)
Q Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~ 352 (497)
.....+||+.|+|||++.+..|+.++|||||||++|||+|
T Consensus 157 ----------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t 196 (258)
T d1k2pa_ 157 ----------------------------------------SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 196 (258)
T ss_dssp ----------------------------------------CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred ----------------------------------------eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHh
Confidence 0113579999999999999999999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 353 -GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 353 -G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
|+.||.+.+..++..+|.+. ..+..| ..+++++++||.+||. ||++||+ +++|++|
T Consensus 197 ~g~~Pf~~~~~~~~~~~i~~~-~~~~~p--~~~~~~l~~li~~cl~~dP~~RPt---~~eil~~ 254 (258)
T d1k2pa_ 197 LGKMPYERFTNSETAEHIAQG-LRLYRP--HLASEKVYTIMYSCWHEKADERPT---FKILLSN 254 (258)
T ss_dssp TSCCTTTTSCHHHHHHHHHTT-CCCCCC--TTCCHHHHHHHHHTTCSSGGGSCC---HHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHhC-CCCCCc--ccccHHHHHHHHHHccCCHhHCcC---HHHHHHH
Confidence 89999999999999888764 244445 4789999999999999 9999998 9999886
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-54 Score=422.08 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=222.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCCeEEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDEFLYLIM 195 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~l~lVm 195 (497)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ........+.+|+.+|+.++|||||+++++|.+...+++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 58999999999999999999999999999999997654 34456678999999999999999999999999999999999
Q ss_pred eecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCccccc
Q 010947 196 EYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQD 275 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~ 275 (497)
|++.|++|..++...+.+++..++.++.|++.||+|||++|||||||||+|||++.++++||+|||+|+........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--- 157 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--- 157 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC---
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcc---
Confidence 99999999999988889999999999999999999999999999999999999999999999999999876432110
Q ss_pred ccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC-CCcchhHHhHHHHHHHHHhCC
Q 010947 276 FTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG-YGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~-y~~~~DiwSlGvil~ell~G~ 354 (497)
.....+++.|+|||++.... ++.++|||||||++|||++|.
T Consensus 158 --------------------------------------~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~ 199 (292)
T d1unla_ 158 --------------------------------------YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_dssp --------------------------------------CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTS
T ss_pred --------------------------------------ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCC
Confidence 11356889999999998765 699999999999999999999
Q ss_pred CCC-CCCChHHHHHHHhcccCcc---------cCC----------------CCccCChhHHHHHHHHhh-CccccCCCCC
Q 010947 355 PPF-YSDDPMSTCRKIVNWRTHL---------KFP----------------EEAKLSIEAKDLISKLLC-NVNQRLGAKG 407 (497)
Q Consensus 355 ~PF-~~~~~~~~~~~i~~~~~~~---------~~p----------------~~~~~s~~~~dLI~~lL~-dp~~R~~~~~ 407 (497)
.|| .+.+..+...++....... ..+ ....+|+++++||.+||+ ||.+||+
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s--- 276 (292)
T d1unla_ 200 RPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS--- 276 (292)
T ss_dssp CCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC---
T ss_pred CCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcC---
Confidence 885 4556666666654311110 000 013578999999999999 9999999
Q ss_pred cchhcCCCCccCC
Q 010947 408 ADEIKVHPWFDGV 420 (497)
Q Consensus 408 ~~eil~Hpff~~i 420 (497)
|+|+|+||||+++
T Consensus 277 a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 277 AEEALQHPYFSDF 289 (292)
T ss_dssp HHHHTTSGGGSSC
T ss_pred HHHHhcChhhcCC
Confidence 9999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-54 Score=423.06 Aligned_cols=255 Identities=24% Similarity=0.356 Sum_probs=209.6
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
+++..++|++.+.||+|+||+||+|++..++ ..||||+++... .....+.+.+|+.+|+.++|||||+++++|.
T Consensus 2 ~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 78 (273)
T d1mp8a_ 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 78 (273)
T ss_dssp CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred CCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 3466789999999999999999999987553 468899886432 3445667999999999999999999999986
Q ss_pred CCeEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
++.+|+|||||++|+|..++.. ...+++..++.++.||+.||.|||+.|||||||||+|||++.++.+||+|||+|+.+
T Consensus 79 ~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 79 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 4678999999999999998765 457999999999999999999999999999999999999999999999999999865
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
...... .....+||+.|+|||++.+..|+.++|||||||+
T Consensus 159 ~~~~~~----------------------------------------~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvi 198 (273)
T d1mp8a_ 159 EDSTYY----------------------------------------KASKGKLPIKWMAPESINFRRFTSASDVWMFGVC 198 (273)
T ss_dssp ----------------------------------------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHH
T ss_pred cCCcce----------------------------------------eccceecCcccchhhHhccCCCCCccccccchHH
Confidence 422110 0124579999999999999999999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 347 MYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 347 l~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
+|||++ |.+||.+.+..+.+.++.+.. .+++| ..+|+++++||.+||+ ||.+||+ +.||++|
T Consensus 199 l~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~--~~~~~~~~~li~~cl~~dp~~Rps---~~ei~~~ 262 (273)
T d1mp8a_ 199 MWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMP--PNCPPTLYSLMTKCWAYDPSRRPR---FTELKAQ 262 (273)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred HHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCC--CCCCHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 999998 899999999999999888642 34444 4799999999999999 9999998 8888765
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=424.04 Aligned_cols=266 Identities=20% Similarity=0.357 Sum_probs=218.6
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
.+.+..++|++.+.||+|+||+||+|+++.+ ..||||+++.... ..+.+.+|+.+|+.++|||||+++++|.+ +
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~ 84 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 84 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-C
Confidence 4567778999999999999999999998765 5699999976532 23568899999999999999999999865 5
Q ss_pred eEEEEEeecCCCchhHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPGGDMMTLLMR--KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+|+|||||++|+|..++.. ...+++.++..++.||+.||.|||+.||+||||||+||||+.+|++||+|||+|+...
T Consensus 85 ~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 85 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhcc
Confidence 57899999999999988854 3579999999999999999999999999999999999999999999999999998653
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
.+... .....+||+.|+|||++....++.++|||||||++
T Consensus 165 ~~~~~----------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil 204 (285)
T d1fmka3 165 DNEYT----------------------------------------ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILL 204 (285)
T ss_dssp ---------------------------------------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CCCce----------------------------------------eeccccccccccChHHHhCCCCCcHHhhhcchHHH
Confidence 22110 01245799999999999999999999999999999
Q ss_pred HHHHhC-CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC--CCCccCCChh
Q 010947 348 YEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV--HPWFDGVDWA 423 (497)
Q Consensus 348 ~ell~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~--Hpff~~i~w~ 423 (497)
|||++| .+||.+....+.+..+... ...+.| ..+|+++++||.+||. ||++||+ +++|+. |+||...
T Consensus 205 ~el~t~~~p~~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~dP~~Rps---~~~i~~~L~~~~~~~--- 275 (285)
T d1fmka3 205 TELTTKGRVPYPGMVNREVLDQVERG-YRMPCP--PECPESLHDLMCQCWRKEPEERPT---FEYLQAFLEDYFTST--- 275 (285)
T ss_dssp HHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCC--TTSCHHHHHHHHHHTCSSGGGSCC---HHHHHHHHHTTTSCS---
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHhc-CCCCCC--cccCHHHHHHHHHHcccCHhHCcC---HHHHHHHHhhhhcCC---
Confidence 999995 5666667777777777642 233344 4799999999999999 9999998 999877 8888753
Q ss_pred hhhhcCCCcccc
Q 010947 424 RIYQMEAAFIPE 435 (497)
Q Consensus 424 ~l~~~~~p~~p~ 435 (497)
.|++.|.
T Consensus 276 -----~p~~~p~ 282 (285)
T d1fmka3 276 -----EPQYQPG 282 (285)
T ss_dssp -----CCCCCCS
T ss_pred -----CCCCCCC
Confidence 4566654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-54 Score=433.49 Aligned_cols=261 Identities=27% Similarity=0.433 Sum_probs=211.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC----eE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----FL 191 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~l 191 (497)
++|++++.||+|+||+||+|+++.+|+.||||++.+.. .....+.+.+|+.+|+.++|||||++++++..+. ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 57999999999999999999999999999999997643 2444567889999999999999999999987653 23
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTL 271 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~ 271 (497)
+++|+|+.||+|.+++.. +.+++..++.++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence 444556679999999865 5799999999999999999999999999999999999999999999999999986543211
Q ss_pred ccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccc-cCCCCcchhHHhHHHHHHHH
Q 010947 272 QEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLL-KKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~-~~~y~~~~DiwSlGvil~el 350 (497)
.. ......+||+.|+|||++. +..|+.++||||+||++|||
T Consensus 165 ~~--------------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~em 206 (345)
T d1pmea_ 165 HT--------------------------------------GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 206 (345)
T ss_dssp BC--------------------------------------CTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHH
T ss_pred cc--------------------------------------eeeccccccceechHHHhhcCCCCCchhhhhccCceehHH
Confidence 00 0122568999999999985 46689999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhcccCc------------------ccCCC---------CccCChhHHHHHHHHhh-Ccccc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWRTH------------------LKFPE---------EAKLSIEAKDLISKLLC-NVNQR 402 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~~~------------------~~~p~---------~~~~s~~~~dLI~~lL~-dp~~R 402 (497)
++|.+||.+.+..++...+...... ...+. ...+|+++++||.+||+ ||.+|
T Consensus 207 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 286 (345)
T d1pmea_ 207 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 286 (345)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTS
T ss_pred hhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHC
Confidence 9999999988876665554321000 00110 13678999999999999 99999
Q ss_pred CCCCCcchhcCCCCccCC
Q 010947 403 LGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 403 ~~~~~~~eil~Hpff~~i 420 (497)
|+ ++|+|+||||+..
T Consensus 287 ~t---a~e~L~hpf~~~~ 301 (345)
T d1pmea_ 287 IE---VEQALAHPYLEQY 301 (345)
T ss_dssp CC---HHHHHTSGGGTTT
T ss_pred cC---HHHHhcCHhhccC
Confidence 98 9999999999854
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=437.40 Aligned_cols=271 Identities=27% Similarity=0.391 Sum_probs=213.5
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec------CC
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD------DE 189 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~------~~ 189 (497)
++|+++++||+|+||+||+|+++.||+.||||++.+.. ........+.+|+.+|+.++|||||+++++|.. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 67999999999999999999999999999999998754 344556678999999999999999999999964 46
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
++|+|||||.||.+ ..+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 89999999966544 444 357999999999999999999999999999999999999999999999999998754321
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYE 349 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~e 349 (497)
. .....+||+.|+|||++.+..|+.++||||+||++||
T Consensus 173 ~------------------------------------------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~e 210 (355)
T d2b1pa1 173 F------------------------------------------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_dssp --------------------------------------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred c------------------------------------------ccccccccccccChhhhcCCCCCCCcccccccchHHH
Confidence 1 0124689999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHHhcccCc--------------------cc---------CCC---------CccCChhHHHH
Q 010947 350 MLVGYPPFYSDDPMSTCRKIVNWRTH--------------------LK---------FPE---------EAKLSIEAKDL 391 (497)
Q Consensus 350 ll~G~~PF~~~~~~~~~~~i~~~~~~--------------------~~---------~p~---------~~~~s~~~~dL 391 (497)
|++|++||.+.+......+++..... .. ++. ...+|++++||
T Consensus 211 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dl 290 (355)
T d2b1pa1 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHH
Confidence 99999999998877776666421100 00 000 02357789999
Q ss_pred HHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhcCCCcccc
Q 010947 392 ISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPE 435 (497)
Q Consensus 392 I~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~ 435 (497)
|++||+ ||++||+ |+|+|+||||+..-|.......+|.+.+
T Consensus 291 l~~mL~~dP~~R~t---a~elL~Hpw~~~~~~~~~~~~~~~~~~~ 332 (355)
T d2b1pa1 291 LSKMLVIDPAKRIS---VDDALQHPYINVWYDPAEVEAPPPQIYD 332 (355)
T ss_dssp HHHHSCSSTTTSCC---HHHHHTSTTTGGGCCHHHHTCCCC----
T ss_pred HHHHCcCChhHCcC---HHHHhcCcccCCCCCcccccCCCCCCCC
Confidence 999999 9999999 9999999999976555554555554443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-54 Score=428.08 Aligned_cols=255 Identities=20% Similarity=0.334 Sum_probs=211.5
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCc----EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGH----VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD 188 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~----~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 188 (497)
+..++|+++++||+|+||+||+|.++.+|+ .||+|+++... .....+.+.+|+.+|++++|||||+++++|.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 345789999999999999999999988876 47888776532 234456789999999999999999999999875
Q ss_pred CeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 189 EFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 189 ~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
..++||||+.+|+|.+.+... ..+++..++.++.||+.||.|||++|||||||||+|||++.++++||+|||+|+.+.
T Consensus 84 -~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp -SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred -CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecc
Confidence 567889999999999887664 679999999999999999999999999999999999999999999999999998764
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
..... ......+||+.|+|||++.+..|+.++|||||||++
T Consensus 163 ~~~~~---------------------------------------~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil 203 (317)
T d1xkka_ 163 AEEKE---------------------------------------YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTV 203 (317)
T ss_dssp TTCC-----------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccccc---------------------------------------ccccccccCccccChHHHhcCCCChhhhhhhHHHHH
Confidence 32110 011245799999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHP 415 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hp 415 (497)
|||+| |.+||.+.+..+....+..+ ..+..| ..+++++++||.+||. ||.+||+ +.||+.|.
T Consensus 204 ~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~p--~~~~~~~~~li~~cl~~dP~~RPs---~~eil~~l 267 (317)
T d1xkka_ 204 WELMTFGSKPYDGIPASEISSILEKG-ERLPQP--PICTIDVYMIMVKCWMIDADSRPK---FRELIIEF 267 (317)
T ss_dssp HHHHTTSCCTTTTSCGGGHHHHHHHT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSCC---HHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCC--cccCHHHHHHHHHhCCCChhhCcC---HHHHHHHH
Confidence 99998 89999988888777766553 334444 4799999999999999 9999999 99999883
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=417.83 Aligned_cols=256 Identities=20% Similarity=0.281 Sum_probs=208.6
Q ss_pred CCCCCCeeEEeEeeecCCeEEEEEEEcCCC----cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec
Q 010947 112 KMGADDFELLTMIGKGAFGEVRVCREKTTG----HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD 187 (497)
Q Consensus 112 ~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~----~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 187 (497)
++..+.|++.++||+|+||+||+|.++.++ ..||||+++... .......+.+|+.+|+.++|||||++++++.+
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~ 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec
Confidence 466788999999999999999999987665 479999997543 23445668899999999999999999999999
Q ss_pred CCeEEEEEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccccccc
Q 010947 188 DEFLYLIMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPL 266 (497)
Q Consensus 188 ~~~l~lVmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~ 266 (497)
.+.+|+|||||.+|++.+++... ..+++.++..++.||+.||+|||+.|||||||||+||||+.++++||+|||+|+.+
T Consensus 81 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 81 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999999987654 57999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHH
Q 010947 267 DCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAI 346 (497)
Q Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvi 346 (497)
....... .......||+.|+|||++.+..|+.++|||||||+
T Consensus 161 ~~~~~~~--------------------------------------~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvi 202 (283)
T d1mqba_ 161 EDDPEAT--------------------------------------YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIV 202 (283)
T ss_dssp ---------------------------------------------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHH
T ss_pred cCCCccc--------------------------------------eEeccCCCCccccCHHHHccCCCCCcccccccHHH
Confidence 4321000 00113579999999999999999999999999999
Q ss_pred HHHHHhC-CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 347 MYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 347 l~ell~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
+|||++| .+||.+.+..+.+..+... ..++.| ..++.++++||.+||. ||.+||+ +.||++
T Consensus 203 l~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~l~~li~~cl~~~p~~RPt---~~eil~ 265 (283)
T d1mqba_ 203 MWEVMTYGERPYWELSNHEVMKAINDG-FRLPTP--MDCPSAIYQLMMQCWQQERARRPK---FADIVS 265 (283)
T ss_dssp HHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCC--TTCBHHHHHHHHHHTCSSTTTSCC---HHHHHH
T ss_pred HHHHHhCCCCccccCCHHHHHHHHhcc-CCCCCc--hhhHHHHHHHHHHHCcCCHhHCcC---HHHHHH
Confidence 9999995 5556666666777666542 333444 4789999999999999 9999998 888765
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-54 Score=435.08 Aligned_cols=257 Identities=27% Similarity=0.421 Sum_probs=214.7
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecC-----C
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDD-----E 189 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-----~ 189 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++.+.. .+......+.+|+.+|+.++|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 468999999999999999999999999999999998653 2344556788999999999999999999999743 3
Q ss_pred eEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCS 269 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 269 (497)
..++||+|+.||+|.+++.. +.+++..++.++.||+.||.|||++|||||||||+|||++.+|.+|++|||+|......
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~ 174 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE 174 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGG
T ss_pred ceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcc
Confidence 34666778889999998854 67999999999999999999999999999999999999999999999999998754211
Q ss_pred CcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccC-CCCcchhHHhHHHHHH
Q 010947 270 TLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKK-GYGMECDWWSLGAIMY 348 (497)
Q Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~-~y~~~~DiwSlGvil~ 348 (497)
..+.+||+.|+|||++.+. .++.++|||||||++|
T Consensus 175 --------------------------------------------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~ 210 (348)
T d2gfsa1 175 --------------------------------------------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 210 (348)
T ss_dssp --------------------------------------------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHH
T ss_pred --------------------------------------------cccccccccccCchhhcCCccCCcccchhhhhHHHH
Confidence 1256899999999998765 4689999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHHhcccCcc---------------------cCCC------CccCChhHHHHHHHHhh-Ccc
Q 010947 349 EMLVGYPPFYSDDPMSTCRKIVNWRTHL---------------------KFPE------EAKLSIEAKDLISKLLC-NVN 400 (497)
Q Consensus 349 ell~G~~PF~~~~~~~~~~~i~~~~~~~---------------------~~p~------~~~~s~~~~dLI~~lL~-dp~ 400 (497)
+|++|.+||.+.+.......|....... ..+. ...+|++++|||.+||+ ||.
T Consensus 211 ~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~ 290 (348)
T d2gfsa1 211 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 290 (348)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChh
Confidence 9999999999998888777775422111 0110 13589999999999999 999
Q ss_pred ccCCCCCcchhcCCCCccCC
Q 010947 401 QRLGAKGADEIKVHPWFDGV 420 (497)
Q Consensus 401 ~R~~~~~~~eil~Hpff~~i 420 (497)
+|++ +.|+|+||||+.+
T Consensus 291 ~R~t---a~elL~Hp~f~~~ 307 (348)
T d2gfsa1 291 KRIT---AAQALAHAYFAQY 307 (348)
T ss_dssp GSCC---HHHHHTSGGGTTT
T ss_pred hCcC---HHHHhcCHhhCCC
Confidence 9998 9999999999864
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-54 Score=417.08 Aligned_cols=256 Identities=21% Similarity=0.354 Sum_probs=208.4
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCC-Cc--EEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTT-GH--VYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t-~~--~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 189 (497)
+..+||++++.||+|+||+||+|+...+ ++ .||||++++.........+.+.+|+.+|+.++|||||+++++|.+ .
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4567899999999999999999987543 33 689999988766556667789999999999999999999999976 4
Q ss_pred eEEEEEeecCCCchhHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMR-KDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDC 268 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~ 268 (497)
.+|+|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+..
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence 67899999999999988765 45799999999999999999999999999999999999999999999999999997643
Q ss_pred CCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHH
Q 010947 269 STLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMY 348 (497)
Q Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ 348 (497)
..... ......+||+.|+|||++.+..|+.++|||||||++|
T Consensus 164 ~~~~~--------------------------------------~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~ 205 (273)
T d1u46a_ 164 NDDHY--------------------------------------VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLW 205 (273)
T ss_dssp -CCEE--------------------------------------EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred CCCcc--------------------------------------eecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHH
Confidence 31110 0112456889999999999999999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 349 EMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 349 ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
||++ |.+||.+.+..+...+|......++.| ..+|+++++||.+||. ||++||+ +.+|+
T Consensus 206 emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPt---~~ei~ 266 (273)
T d1u46a_ 206 EMFTYGQEPWIGLNGSQILHKIDKEGERLPRP--EDCPQDIYNVMVQCWAHKPEDRPT---FVALR 266 (273)
T ss_dssp HHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred HHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc--ccccHHHHHHHHHHcCCChhHCcC---HHHHH
Confidence 9998 899999999999999998754444444 4799999999999999 9999998 77764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=421.69 Aligned_cols=259 Identities=22% Similarity=0.325 Sum_probs=206.7
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 183 (497)
++++..++|++++.||+|+||+||+|+++. +++.||||+++... .....+.+..|..++.++ +|||||.+++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 345667899999999999999999999764 45689999997543 233445677788877766 6899999999
Q ss_pred Eeec-CCeEEEEEeecCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCC
Q 010947 184 SFQD-DEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDN 246 (497)
Q Consensus 184 ~~~~-~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~N 246 (497)
++.+ +..+|+|||||+||+|.+++... ..+++..+..|+.||+.||.|||++|||||||||+|
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~N 164 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccc
Confidence 8765 45789999999999999999653 348999999999999999999999999999999999
Q ss_pred eeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCc
Q 010947 247 LLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAP 326 (497)
Q Consensus 247 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 326 (497)
||++.+|++||+|||+|+........ ....+.+||+.|+||
T Consensus 165 ILl~~~~~~Kl~DFGla~~~~~~~~~---------------------------------------~~~~~~~gt~~y~AP 205 (299)
T d1ywna1 165 ILLSEKNVVKICDFGLARDIYKDPDY---------------------------------------VRKGDARLPLKWMAP 205 (299)
T ss_dssp EEECGGGCEEECC------CCSCTTS---------------------------------------CCTTSCCCGGGGCCH
T ss_pred eeECCCCcEEEccCcchhhccccccc---------------------------------------cccCceeeCccccch
Confidence 99999999999999999865422100 011246899999999
Q ss_pred cccccCCCCcchhHHhHHHHHHHHHhC-CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCC
Q 010947 327 EVLLKKGYGMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 327 E~l~~~~y~~~~DiwSlGvil~ell~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|++.+..|+.++|||||||++|||++| .+||.+.+..+.+.+++.....+..|. .+|+++++||.+||+ ||.+||+
T Consensus 206 E~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~cl~~dP~~Rpt 283 (299)
T d1ywna1 206 ETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD--YTTPEMYQTMLDCWHGEPSQRPT 283 (299)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCc--cCCHHHHHHHHHHcCCChhHCcC
Confidence 999999999999999999999999986 578888776666666555444555554 789999999999999 9999998
Q ss_pred CCCcchhcCC
Q 010947 405 AKGADEIKVH 414 (497)
Q Consensus 405 ~~~~~eil~H 414 (497)
++||++|
T Consensus 284 ---~~eil~~ 290 (299)
T d1ywna1 284 ---FSELVEH 290 (299)
T ss_dssp ---HHHHHHH
T ss_pred ---HHHHHHH
Confidence 8998876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.4e-53 Score=417.72 Aligned_cols=258 Identities=22% Similarity=0.328 Sum_probs=220.5
Q ss_pred HhhcCCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEE
Q 010947 108 LQRHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLY 182 (497)
Q Consensus 108 ~~~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~ 182 (497)
+...++..++|++++.||+|+||+||+|+.+ .++..||||++++.. .......+.+|+.+|+.++||||++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~ 82 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLL 82 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccce
Confidence 3445667789999999999999999999975 356789999997543 234566799999999999999999999
Q ss_pred EEeecCCeEEEEEeecCCCchhHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHcCCEE
Q 010947 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------------TLTEDEARFYVAETVLAIESIHKHHYI 238 (497)
Q Consensus 183 ~~~~~~~~l~lVmEy~~gg~L~~~l~~~~------------------------~l~e~~~~~~~~qi~~aL~~LH~~~ii 238 (497)
++|.+...+++||||+++|+|.+++.... .+++..+..++.|++.||+|||+.|||
T Consensus 83 ~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv 162 (301)
T d1lufa_ 83 GVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 162 (301)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred eeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence 99999999999999999999999996532 389999999999999999999999999
Q ss_pred EcccCCCCeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhccccccccc
Q 010947 239 HRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTV 318 (497)
Q Consensus 239 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (497)
||||||+|||++.++++||+|||+|+.+...... ....+.+
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~---------------------------------------~~~~~~~ 203 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY---------------------------------------KADGNDA 203 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB---------------------------------------C----CC
T ss_pred eeEEcccceEECCCCcEEEccchhheeccCCccc---------------------------------------cccCCCC
Confidence 9999999999999999999999999865422100 0122567
Q ss_pred CCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC-CCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh
Q 010947 319 GTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY-PPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC 397 (497)
Q Consensus 319 Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~-~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~ 397 (497)
||+.|+|||++.+..|+.++|||||||++|||++|. +||.+.+..+....+..+. ....| ..+++++.+||.+||+
T Consensus 204 ~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~-~~~~p--~~~~~~~~~li~~cl~ 280 (301)
T d1lufa_ 204 IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGN-ILACP--ENCPLELYNLMRLCWS 280 (301)
T ss_dssp BCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTC
T ss_pred cCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCC-CCCCC--ccchHHHHHHHHHHcC
Confidence 999999999999999999999999999999999984 7899999999988887643 33444 3789999999999999
Q ss_pred -CccccCCCCCcchhc
Q 010947 398 -NVNQRLGAKGADEIK 412 (497)
Q Consensus 398 -dp~~R~~~~~~~eil 412 (497)
||.+||+ +.||+
T Consensus 281 ~~P~~RPt---~~ev~ 293 (301)
T d1lufa_ 281 KLPADRPS---FCSIH 293 (301)
T ss_dssp SSGGGSCC---HHHHH
T ss_pred CChhHCcC---HHHHH
Confidence 9999998 77774
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-53 Score=419.14 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=214.8
Q ss_pred CCCCCeeEEeEeeecCCeEEEEEEEcCCCcE--EEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEEEeecCC
Q 010947 113 MGADDFELLTMIGKGAFGEVRVCREKTTGHV--YAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYCSFQDDE 189 (497)
Q Consensus 113 ~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~--~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~~ 189 (497)
+..++|++.++||+|+||+||+|+++.+|.. ||||++++.. .....+.+.+|+.+|..+ +|||||+++++|.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 5668999999999999999999999988875 6777775432 233456789999999998 7999999999999999
Q ss_pred eEEEEEeecCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYG 253 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g 253 (497)
.+|+||||++||+|.++|... ..+++..+..++.||+.||.|||+.|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999654 5699999999999999999999999999999999999999999
Q ss_pred cEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC
Q 010947 254 HLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG 333 (497)
Q Consensus 254 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~ 333 (497)
.+||+|||+|+...... .....+||+.|+|||.+.+..
T Consensus 165 ~~kl~DfG~a~~~~~~~------------------------------------------~~~~~~gt~~y~aPE~l~~~~ 202 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYV------------------------------------------KKTMGRLPVRWMAIESLNYSV 202 (309)
T ss_dssp CEEECCTTCEESSCEEC------------------------------------------CC----CCTTTCCHHHHHHCE
T ss_pred ceEEccccccccccccc------------------------------------------cccceecCCcccchHHhccCC
Confidence 99999999998543211 011357999999999999999
Q ss_pred CCcchhHHhHHHHHHHHHhC-CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchh
Q 010947 334 YGMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEI 411 (497)
Q Consensus 334 y~~~~DiwSlGvil~ell~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~ei 411 (497)
|+.++|||||||++|||++| .+||.+.+..+.+..|.++ ..+..| ..+++++++||.+||. ||++||+ +.+|
T Consensus 203 ~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~~li~~cl~~dP~~RPs---~~ei 276 (309)
T d1fvra_ 203 YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP--LNCDDEVYDLMRQCWREKPYERPS---FAQI 276 (309)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCCCCC--TTBCHHHHHHHHHHTCSSGGGSCC---HHHH
T ss_pred CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-CCCCCC--ccCCHHHHHHHHHHcCCChhHCcC---HHHH
Confidence 99999999999999999996 4689888888888888764 334444 4799999999999999 9999998 9999
Q ss_pred cCC
Q 010947 412 KVH 414 (497)
Q Consensus 412 l~H 414 (497)
++|
T Consensus 277 l~~ 279 (309)
T d1fvra_ 277 LVS 279 (309)
T ss_dssp HHH
T ss_pred HHH
Confidence 876
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-53 Score=409.62 Aligned_cols=246 Identities=21% Similarity=0.389 Sum_probs=208.6
Q ss_pred cCCCCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-CC
Q 010947 111 HKMGADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DE 189 (497)
Q Consensus 111 ~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~ 189 (497)
+++..++|++++.||+|+||.||+|+.+ |..||||+++++. ..+.+.+|+.+|++++|||||+++++|.+ ++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence 4567789999999999999999999984 6799999997643 34568899999999999999999998854 56
Q ss_pred eEEEEEeecCCCchhHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccC
Q 010947 190 FLYLIMEYLPGGDMMTLLMRK--DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLD 267 (497)
Q Consensus 190 ~l~lVmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~ 267 (497)
.+|+||||+++|+|.++|... ..+++..++.++.||+.||.|||+.+||||||||+|||++.+|++||+|||+++...
T Consensus 75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 154 (262)
T ss_dssp CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC
Confidence 789999999999999999654 359999999999999999999999999999999999999999999999999998543
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
.. .....||+.|+|||++.+..|+.++|||||||++
T Consensus 155 ~~--------------------------------------------~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il 190 (262)
T d1byga_ 155 ST--------------------------------------------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILL 190 (262)
T ss_dssp ---------------------------------------------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred CC--------------------------------------------CccccccccCCChHHHhCCCCChHHHHHhHHHHH
Confidence 21 0135689999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcC
Q 010947 348 YEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKV 413 (497)
Q Consensus 348 ~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~ 413 (497)
|||++ |.+||.+.+..+....|.+. ..+.+|. .+++++++||.+||. ||.+||+ +.+|++
T Consensus 191 ~el~t~~~~p~~~~~~~~~~~~i~~~-~~~~~~~--~~~~~~~~li~~cl~~dP~~Rps---~~~l~~ 252 (262)
T d1byga_ 191 WEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPD--GCPPAVYEVMKNCWHLDAAMRPS---FLQLRE 252 (262)
T ss_dssp HHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCT--TCCHHHHHHHHHHTCSSGGGSCC---HHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCc--cCCHHHHHHHHHHcccCHhHCcC---HHHHHH
Confidence 99998 89999999888888888763 3445554 789999999999999 9999999 777765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-52 Score=411.58 Aligned_cols=257 Identities=20% Similarity=0.347 Sum_probs=215.3
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcCCC-------cEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKTTG-------HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKL 181 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~t~-------~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l 181 (497)
++.+..++|++++.||+|+||.||+|+...++ ..||||++++.. .......+.+|..++..+ +|||||++
T Consensus 7 ~~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~ 84 (299)
T d1fgka_ 7 RWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINL 84 (299)
T ss_dssp TTBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cCcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEec
Confidence 34567789999999999999999999986654 379999997643 234456788898888887 89999999
Q ss_pred EEEeecCCeEEEEEeecCCCchhHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCC
Q 010947 182 YCSFQDDEFLYLIMEYLPGGDMMTLLMRK----------------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (497)
Q Consensus 182 ~~~~~~~~~l~lVmEy~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~ 245 (497)
+++|.++..+|+|||||++|+|.+++... ..+++..+..++.||+.||+|||+.|||||||||+
T Consensus 85 ~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 85 LGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp EEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 99999999999999999999999999654 34899999999999999999999999999999999
Q ss_pred CeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccC
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 325 (497)
|||++.+|.+||+|||+++......... .....+||+.|+|
T Consensus 165 NiLl~~~~~~kl~dfg~~~~~~~~~~~~---------------------------------------~~~~~~~~~~y~a 205 (299)
T d1fgka_ 165 NVLVTEDNVMKIADFGLARDIHHIDYYK---------------------------------------KTTNGRLPVKWMA 205 (299)
T ss_dssp GEEECTTCCEEECSTTCCCCGGGCCTTC---------------------------------------CCTTSCCGGGGSC
T ss_pred ceeecCCCCeEeccchhhcccccccccc---------------------------------------ccccCCCChhhhh
Confidence 9999999999999999998764321110 1124689999999
Q ss_pred ccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 326 PE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
||++.++.|+.++|||||||++|||++ |.+||.+.+..+.+..+.+. ..+.+|. .+|+++++||.+||. ||.+||
T Consensus 206 PE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~-~~~~~p~--~~~~~l~~li~~cl~~dP~~Rp 282 (299)
T d1fgka_ 206 PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKPS--NCTNELYMMMRDCWHAVPSQRP 282 (299)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT-CCCCCCS--SCCHHHHHHHHHHTCSSGGGSC
T ss_pred hhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcC-CCCCCCc--cchHHHHHHHHHHccCCHhHCc
Confidence 999999999999999999999999998 79999998888887777653 4445554 799999999999999 999999
Q ss_pred CCCCcchhcC
Q 010947 404 GAKGADEIKV 413 (497)
Q Consensus 404 ~~~~~~eil~ 413 (497)
+ +.||++
T Consensus 283 s---~~eil~ 289 (299)
T d1fgka_ 283 T---FKQLVE 289 (299)
T ss_dssp C---HHHHHH
T ss_pred C---HHHHHH
Confidence 8 888765
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-52 Score=411.79 Aligned_cols=258 Identities=22% Similarity=0.312 Sum_probs=221.5
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEc-----CCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhc-CCCceeEEEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREK-----TTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEV-DSNCIVKLYC 183 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~-----~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~ 183 (497)
.+++..++|++.+.||+|+||+||+|+.+ .+++.||||++++.. .......+.+|+.+++.+ +|||||++++
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 35577789999999999999999999864 466789999998653 234556788999999998 6999999999
Q ss_pred EeecCCeEEEEEeecCCCchhHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCC
Q 010947 184 SFQDDEFLYLIMEYLPGGDMMTLLMRKD------------------TLTEDEARFYVAETVLAIESIHKHHYIHRDIKPD 245 (497)
Q Consensus 184 ~~~~~~~l~lVmEy~~gg~L~~~l~~~~------------------~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~ 245 (497)
+|.+...+|||||||+||+|.+++.+.. .+++..+..++.||+.||.|||++|||||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999997543 5899999999999999999999999999999999
Q ss_pred CeeecCCCcEEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccC
Q 010947 246 NLLLDKYGHLRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIA 325 (497)
Q Consensus 246 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a 325 (497)
|||++.++++||+|||+++........ ......+||+.|+|
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~---------------------------------------~~~~~~~gt~~y~a 215 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNY---------------------------------------VVKGNARLPVKWMA 215 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTS---------------------------------------EECSSSEECGGGCC
T ss_pred cccccccCcccccccchheeccCCCcc---------------------------------------eEeeecccChHHcC
Confidence 999999999999999999866432110 01124689999999
Q ss_pred ccccccCCCCcchhHHhHHHHHHHHHh-CCCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccC
Q 010947 326 PEVLLKKGYGMECDWWSLGAIMYEMLV-GYPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRL 403 (497)
Q Consensus 326 PE~l~~~~y~~~~DiwSlGvil~ell~-G~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~ 403 (497)
||++.+..++.++|||||||++|||+| |.+||.+.+..+.+.+++.....+..| ..+|+++++||.+||. ||.+||
T Consensus 216 PE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RP 293 (311)
T d1t46a_ 216 PESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRP 293 (311)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCc
Confidence 999999999999999999999999998 777788877777777777655555555 3789999999999999 999999
Q ss_pred CCCCcchhcC
Q 010947 404 GAKGADEIKV 413 (497)
Q Consensus 404 ~~~~~~eil~ 413 (497)
+ +++|++
T Consensus 294 s---~~~il~ 300 (311)
T d1t46a_ 294 T---FKQIVQ 300 (311)
T ss_dssp C---HHHHHH
T ss_pred C---HHHHHH
Confidence 8 888764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-52 Score=411.45 Aligned_cols=263 Identities=17% Similarity=0.246 Sum_probs=224.5
Q ss_pred hcCCCCCCeeEEeEeeecCCeEEEEEEEcC-----CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEE
Q 010947 110 RHKMGADDFELLTMIGKGAFGEVRVCREKT-----TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCS 184 (497)
Q Consensus 110 ~~~~~~~~f~~~~~IG~G~fG~V~~~~~~~-----t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~ 184 (497)
.+++..++|++.+.||+|+||+||+|.++. ++..||||++++.. .......+.+|+.++++++|||||+++++
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~ 91 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGV 91 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEE
T ss_pred ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 456778999999999999999999998853 35689999997643 33455678999999999999999999999
Q ss_pred eecCCeEEEEEeecCCCchhHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCc
Q 010947 185 FQDDEFLYLIMEYLPGGDMMTLLMRK----------DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGH 254 (497)
Q Consensus 185 ~~~~~~l~lVmEy~~gg~L~~~l~~~----------~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~ 254 (497)
|..+..+++|||||++|+|.+++... ..+++..+..++.+++.||.|||+++||||||||+|||++.+++
T Consensus 92 ~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 92 VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC
T ss_pred EecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce
Confidence 99999999999999999999998643 34789999999999999999999999999999999999999999
Q ss_pred EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCC
Q 010947 255 LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGY 334 (497)
Q Consensus 255 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y 334 (497)
+||+|||+|+.+...... ......+||+.|+|||.+.+..|
T Consensus 172 ~Kl~DFGla~~~~~~~~~---------------------------------------~~~~~~~~t~~y~aPe~l~~~~~ 212 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYY---------------------------------------RKGGKGLLPVRWMSPESLKDGVF 212 (308)
T ss_dssp EEECCTTCCCGGGGGGCE---------------------------------------EGGGSSEECGGGCCHHHHHHCCC
T ss_pred EEEeecccceeccCCcce---------------------------------------eeccceecccccCCHHHHccCCC
Confidence 999999999866322100 01124579999999999999999
Q ss_pred CcchhHHhHHHHHHHHHhC-CCCCCCCChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhc
Q 010947 335 GMECDWWSLGAIMYEMLVG-YPPFYSDDPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIK 412 (497)
Q Consensus 335 ~~~~DiwSlGvil~ell~G-~~PF~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil 412 (497)
+.++|||||||++|||+|| .+||.+.+..+.+..+.+.. .+..| ..+++++++||.+||. ||.+||+ +++|+
T Consensus 213 ~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p--~~~~~~l~~li~~cl~~~P~~RPs---~~~il 286 (308)
T d1p4oa_ 213 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKP--DNCPDMLFELMRMCWQYNPKMRPS---FLEII 286 (308)
T ss_dssp CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHH
T ss_pred CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCc--ccchHHHHHHHHHHcCCChhHCcC---HHHHH
Confidence 9999999999999999998 58999999999998888643 33344 4789999999999999 9999998 88887
Q ss_pred C------CCCccC
Q 010947 413 V------HPWFDG 419 (497)
Q Consensus 413 ~------Hpff~~ 419 (497)
+ +|+|+.
T Consensus 287 ~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 287 SSIKEEMEPGFRE 299 (308)
T ss_dssp HHHGGGSCTTHHH
T ss_pred HHHHHhcCCCCcC
Confidence 5 566553
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.4e-51 Score=401.86 Aligned_cols=263 Identities=18% Similarity=0.245 Sum_probs=202.7
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCc-eeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNC-IVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~-Iv~l~~~~~~~~~l~lV 194 (497)
++|++++.||+|+||+||+|+++.+|+.||||++...... ..+..|+++++.++|++ |+.+++++.+.+..|+|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5699999999999999999999999999999998764321 23678999999998765 55566777888899999
Q ss_pred EeecCCCchhHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC---CCcEEEcccccccccCCCC
Q 010947 195 MEYLPGGDMMTLL-MRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK---YGHLRLSDFGLCKPLDCST 270 (497)
Q Consensus 195 mEy~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~---~g~vkL~DFGla~~~~~~~ 270 (497)
|||+. |+|...+ .....+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+.+....
T Consensus 82 me~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 160 (299)
T ss_dssp EECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred EEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence 99995 5555554 44568999999999999999999999999999999999998864 4579999999999775432
Q ss_pred cccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHH
Q 010947 271 LQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEM 350 (497)
Q Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~el 350 (497)
..... + .....+.+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 161 ~~~~~----------------~------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el 206 (299)
T d1ckia_ 161 THQHI----------------P------------------YRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 206 (299)
T ss_dssp TCCBC----------------C------------------CCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHH
T ss_pred cccce----------------e------------------ccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHH
Confidence 11000 0 0011256899999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHHhccc-CcccCCC---CccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCcc
Q 010947 351 LVGYPPFYSDDPMSTCRKIVNWR-THLKFPE---EAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFD 418 (497)
Q Consensus 351 l~G~~PF~~~~~~~~~~~i~~~~-~~~~~p~---~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~ 418 (497)
++|.+||.+.........+.... .....|. ...+|+++.+||.+||. ||.+||+...+.++++|+|.+
T Consensus 207 ~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 207 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred HhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHH
Confidence 99999998866544433332111 1111111 13689999999999999 999999844445667787654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-49 Score=394.27 Aligned_cols=250 Identities=17% Similarity=0.281 Sum_probs=204.1
Q ss_pred EEeEeeecCCeEEEEEEEcCCC---cEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeec-CCeEEEEE
Q 010947 120 LLTMIGKGAFGEVRVCREKTTG---HVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQD-DEFLYLIM 195 (497)
Q Consensus 120 ~~~~IG~G~fG~V~~~~~~~t~---~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~l~lVm 195 (497)
+.++||+|+||+||+|++..++ ..||||++++. ......+.+.+|+++|++++|||||++++++.+ +..+|+||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3678999999999999986653 36999999753 245566789999999999999999999998765 56899999
Q ss_pred eecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEcccccccccCCCCcccc
Q 010947 196 EYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGLCKPLDCSTLQEQ 274 (497)
Q Consensus 196 Ey~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 274 (497)
|||++|+|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||+++..........
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 999999999988754 4578889999999999999999999999999999999999999999999999987643321100
Q ss_pred cccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHHHHHHhCC
Q 010947 275 DFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIMYEMLVGY 354 (497)
Q Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil~ell~G~ 354 (497)
.......||+.|+|||++....|+.++|||||||++|||++|.
T Consensus 189 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~ 231 (311)
T d1r0pa_ 189 -------------------------------------HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRG 231 (311)
T ss_dssp -------------------------------------TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred -------------------------------------eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCC
Confidence 0011357999999999999999999999999999999999977
Q ss_pred CCCCCC-ChHHHHHHHhcccCcccCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCC
Q 010947 355 PPFYSD-DPMSTCRKIVNWRTHLKFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVH 414 (497)
Q Consensus 355 ~PF~~~-~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~H 414 (497)
.||... +..+....+... ..+..| ..+++++.+||.+||. ||++||+ +.||++|
T Consensus 232 ~p~~~~~~~~~~~~~i~~g-~~~~~p--~~~~~~l~~li~~cl~~dP~~RPs---~~ei~~~ 287 (311)
T d1r0pa_ 232 APPYPDVNTFDITVYLLQG-RRLLQP--EYCPDPLYEVMLKCWHPKAEMRPS---FSELVSR 287 (311)
T ss_dssp CCSCC------CHHHHHTT-CCCCCC--TTCCHHHHHHHHHHTCSSGGGSCC---HHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcC-CCCCCc--ccCcHHHHHHHHHHcCCCHhHCcC---HHHHHHH
Confidence 776654 444555666654 233444 3789999999999999 9999999 8999876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=9.6e-49 Score=385.58 Aligned_cols=250 Identities=19% Similarity=0.228 Sum_probs=203.9
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC-CceeEEEEEeecCCeEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-NCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-p~Iv~l~~~~~~~~~l~l 193 (497)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...++.|+++++.+.| ++|+.+++++.+....|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 4689999999999999999999999999999999865432 1236778999998876 899999999999999999
Q ss_pred EEeecCCCchhHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecC-----CCcEEEcccccccccC
Q 010947 194 IMEYLPGGDMMTLLMRK-DTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDK-----YGHLRLSDFGLCKPLD 267 (497)
Q Consensus 194 VmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~-----~g~vkL~DFGla~~~~ 267 (497)
||||+ ||+|.+++... ..+++..+..++.|++.||+|||++|||||||||+|||++. ++.+||+|||+|+.+.
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99999 78999988765 47999999999999999999999999999999999999974 5789999999999765
Q ss_pred CCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCCCCcchhHHhHHHHH
Q 010947 268 CSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKGYGMECDWWSLGAIM 347 (497)
Q Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~y~~~~DiwSlGvil 347 (497)
........ +. ....+.+||+.|||||++.+..|+.++|||||||++
T Consensus 158 ~~~~~~~~----------------~~------------------~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (293)
T d1csna_ 158 DPVTKQHI----------------PY------------------REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVF 203 (293)
T ss_dssp CTTTCCBC----------------CC------------------CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred cCccccce----------------ee------------------cccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHH
Confidence 33111000 00 011257899999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCC---hHHHHHHHhcccCcccCCC-CccCChhHHHHHHHHhh-CccccCC
Q 010947 348 YEMLVGYPPFYSDD---PMSTCRKIVNWRTHLKFPE-EAKLSIEAKDLISKLLC-NVNQRLG 404 (497)
Q Consensus 348 ~ell~G~~PF~~~~---~~~~~~~i~~~~~~~~~p~-~~~~s~~~~dLI~~lL~-dp~~R~~ 404 (497)
|||++|.+||.+.. ....+.++.........+. ...+|+++.+||..|+. +|.+||.
T Consensus 204 ~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~ 265 (293)
T d1csna_ 204 MYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPD 265 (293)
T ss_dssp HHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCC
T ss_pred HHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcC
Confidence 99999999998654 3344444443222111111 13688999999999999 9999997
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-48 Score=385.30 Aligned_cols=251 Identities=24% Similarity=0.295 Sum_probs=191.4
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCCCceeEEEEEeecCC----eE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDSNCIVKLYCSFQDDE----FL 191 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~----~l 191 (497)
.+|.+.+.||+|+||.||+|+. +|+.||||+++.... .......|+..+..++|||||++++++.+++ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 5789999999999999999986 588999999975431 1112223444456789999999999997643 68
Q ss_pred EEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHc--------CCEEEcccCCCCeeecCCCcEEEcccccc
Q 010947 192 YLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHK--------HHYIHRDIKPDNLLLDKYGHLRLSDFGLC 263 (497)
Q Consensus 192 ~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~--------~~iiHrDLKp~NILl~~~g~vkL~DFGla 263 (497)
|+|||||++|+|.++|.+ ..+++.....++.+++.||.|||+ +|||||||||+||||+.+|++||+|||+|
T Consensus 77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 999999999999999965 579999999999999999999996 59999999999999999999999999999
Q ss_pred cccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCccccccCC------CCcc
Q 010947 264 KPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLKKG------YGME 337 (497)
Q Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~~~------y~~~ 337 (497)
+.......... ......+||+.|+|||++.+.. ++.+
T Consensus 156 ~~~~~~~~~~~-------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k 198 (303)
T d1vjya_ 156 VRHDSATDTID-------------------------------------IAPNHRVGTKRYMAPEVLDDSINMKHFESFKR 198 (303)
T ss_dssp EEEETTTTEEC-------------------------------------C----CCSCGGGCCHHHHTTCSCTTCHHHHHH
T ss_pred ccccCCCccee-------------------------------------ccccceecccCcCChhhccccccccCCCcCcc
Confidence 87643211100 0012468999999999987542 6789
Q ss_pred hhHHhHHHHHHHHHhCCCCCCCCC--------------hHHHHHHH-hcccCcccCCCC---ccCChhHHHHHHHHhh-C
Q 010947 338 CDWWSLGAIMYEMLVGYPPFYSDD--------------PMSTCRKI-VNWRTHLKFPEE---AKLSIEAKDLISKLLC-N 398 (497)
Q Consensus 338 ~DiwSlGvil~ell~G~~PF~~~~--------------~~~~~~~i-~~~~~~~~~p~~---~~~s~~~~dLI~~lL~-d 398 (497)
+|||||||+||||+||.+||.... ..+..... ........+|.. .....++.+||.+||. |
T Consensus 199 ~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~d 278 (303)
T d1vjya_ 199 ADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 278 (303)
T ss_dssp HHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSS
T ss_pred hhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccC
Confidence 999999999999999998874321 11222222 222222233331 1233458999999999 9
Q ss_pred ccccCCCCCcchhcC
Q 010947 399 VNQRLGAKGADEIKV 413 (497)
Q Consensus 399 p~~R~~~~~~~eil~ 413 (497)
|.+||+ +.||++
T Consensus 279 p~~Rps---~~ei~~ 290 (303)
T d1vjya_ 279 GAARLT---ALRIKK 290 (303)
T ss_dssp GGGSCC---HHHHHH
T ss_pred HhHCcC---HHHHHH
Confidence 999999 888765
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-47 Score=384.90 Aligned_cols=272 Identities=22% Similarity=0.366 Sum_probs=205.5
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-----------CCceeEEEE
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-----------SNCIVKLYC 183 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-----------hp~Iv~l~~ 183 (497)
..+|+++++||+|+||+||+|+++.+|+.||||++++... ..+.+.+|+.+++.+. |||||+++.
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 3569999999999999999999999999999999987542 2345677888887764 578999987
Q ss_pred Eee--cCCeEEEEEeecCCCchhHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHc-CCEEEcccCCCCeeecCCCc---
Q 010947 184 SFQ--DDEFLYLIMEYLPGGDMMTLLM---RKDTLTEDEARFYVAETVLAIESIHK-HHYIHRDIKPDNLLLDKYGH--- 254 (497)
Q Consensus 184 ~~~--~~~~l~lVmEy~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~~LH~-~~iiHrDLKp~NILl~~~g~--- 254 (497)
++. .....++||+++.++....... ....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 775 4567778888876665443332 23579999999999999999999997 89999999999999987664
Q ss_pred ---EEEcccccccccCCCCcccccccccCCCCCCCCCCCCCCCCccchHHHHHHHhhhcccccccccCCCcccCcccccc
Q 010947 255 ---LRLSDFGLCKPLDCSTLQEQDFTIGNNLNGSSQNNERPAAPKRTQQEQLQHWQKNRRMLAYSTVGTPDYIAPEVLLK 331 (497)
Q Consensus 255 ---vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~l~~ 331 (497)
++|+|||.|...... ....+||+.|+|||++..
T Consensus 168 ~~~~kl~dfg~s~~~~~~--------------------------------------------~~~~~gt~~y~aPE~~~~ 203 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH--------------------------------------------YTNSIQTREYRSPEVLLG 203 (362)
T ss_dssp EEEEEECCCTTCEETTBC--------------------------------------------CCSCCSCGGGCCHHHHHT
T ss_pred cceeeEeecccccccccc--------------------------------------------cccccccccccChhhccc
Confidence 999999998754321 125689999999999999
Q ss_pred CCCCcchhHHhHHHHHHHHHhCCCCCCCCChH------HHHHHHhcccC------------------------c---c--
Q 010947 332 KGYGMECDWWSLGAIMYEMLVGYPPFYSDDPM------STCRKIVNWRT------------------------H---L-- 376 (497)
Q Consensus 332 ~~y~~~~DiwSlGvil~ell~G~~PF~~~~~~------~~~~~i~~~~~------------------------~---~-- 376 (497)
..|+.++|+||+||++++|++|++||.+.+.. .....++..-. . .
T Consensus 204 ~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (362)
T d1q8ya_ 204 APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 283 (362)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCB
T ss_pred cCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccC
Confidence 99999999999999999999999999764321 11111110000 0 0
Q ss_pred ---------cCCCCccCChhHHHHHHHHhh-CccccCCCCCcchhcCCCCccCCChhhhhhcCCCcccccCCc
Q 010947 377 ---------KFPEEAKLSIEAKDLISKLLC-NVNQRLGAKGADEIKVHPWFDGVDWARIYQMEAAFIPEVNDE 439 (497)
Q Consensus 377 ---------~~p~~~~~s~~~~dLI~~lL~-dp~~R~~~~~~~eil~Hpff~~i~w~~l~~~~~p~~p~~~~~ 439 (497)
.+......+++++|||.+||+ ||.+||+ |+|+|+||||+++.+ ..++..|..|...+.
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt---a~e~L~Hp~f~~~~~--~~~~~~p~~~~~~~~ 351 (362)
T d1q8ya_ 284 WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD---AGGLVNHPWLKDTLG--MEEIRVPDRELYGSG 351 (362)
T ss_dssp CCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC---HHHHHTCGGGTTCTT--CTTCCCTTSCTTCBS
T ss_pred CchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC---HHHHhcCcccCCCCC--cccCCCCCcccCCCC
Confidence 000012457889999999999 9999999 999999999996652 223455555555433
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=8.5e-27 Score=213.46 Aligned_cols=137 Identities=14% Similarity=0.161 Sum_probs=108.5
Q ss_pred eeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhh---------------chhHHHHHHHHHHHHHhcCCCceeEEE
Q 010947 118 FELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEML---------------RRGQVEHVRAERNLLAEVDSNCIVKLY 182 (497)
Q Consensus 118 f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~---------------~~~~~~~~~~E~~il~~l~hp~Iv~l~ 182 (497)
+.+.+.||+|+||+||+|++. +|+.||||+++..... ..........|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999874 7899999997642211 011123455688899999999999988
Q ss_pred EEeecCCeEEEEEeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHHcCCEEEcccCCCCeeecCCCcEEEccccc
Q 010947 183 CSFQDDEFLYLIMEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIHKHHYIHRDIKPDNLLLDKYGHLRLSDFGL 262 (497)
Q Consensus 183 ~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH~~~iiHrDLKp~NILl~~~g~vkL~DFGl 262 (497)
+... .++||||++++.+.. +++..+..++.|++.||.|||++||+||||||+|||++.+ .++|+|||+
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 6532 369999998876533 4556678899999999999999999999999999999965 589999999
Q ss_pred ccccC
Q 010947 263 CKPLD 267 (497)
Q Consensus 263 a~~~~ 267 (497)
|+...
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 97653
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=2.5e-07 Score=86.18 Aligned_cols=140 Identities=11% Similarity=0.053 Sum_probs=90.1
Q ss_pred CCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEeecCCeEEEE
Q 010947 116 DDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQDDEFLYLI 194 (497)
Q Consensus 116 ~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~l~lV 194 (497)
..|+..+..+.|+.+.||++. ..+..+.+|+....... ....+.+|..++..+. +--+.++++++.+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 356777766656668999775 45667888887654322 2234667888877663 33356777888888899999
Q ss_pred EeecCCCchhHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 010947 195 MEYLPGGDMMTLLMRKDTLTEDEARFYVAETVLAIESIH----------------------------------------- 233 (497)
Q Consensus 195 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~~LH----------------------------------------- 233 (497)
|++++|..+....... .. ...++.++...|..||
T Consensus 89 ~~~l~G~~~~~~~~~~--~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDE--QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp EECCSSEEHHHHTTTC--SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred EEeccccccccccccc--cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccccc
Confidence 9999998775443110 00 1111112222222222
Q ss_pred ------------c------CCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 234 ------------K------HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 234 ------------~------~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
. ..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred chHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1 1389999999999999876677999998864
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.20 E-value=3.6e-06 Score=83.38 Aligned_cols=81 Identities=17% Similarity=0.214 Sum_probs=50.0
Q ss_pred EeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhc----hhHHHHHHHHHHHHHhcC-C--CceeEEEEEeecCCeEEE
Q 010947 121 LTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLR----RGQVEHVRAERNLLAEVD-S--NCIVKLYCSFQDDEFLYL 193 (497)
Q Consensus 121 ~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~----~~~~~~~~~E~~il~~l~-h--p~Iv~l~~~~~~~~~l~l 193 (497)
.+.||.|....||++....+++.|++|.-....... .....+...|..+|..+. + ..+++++++ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567899999999999887778889999754211110 112344566888887652 2 345556654 3445569
Q ss_pred EEeecCCCch
Q 010947 194 IMEYLPGGDM 203 (497)
Q Consensus 194 VmEy~~gg~L 203 (497)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.92 E-value=2.1e-05 Score=72.23 Aligned_cols=136 Identities=12% Similarity=0.069 Sum_probs=81.3
Q ss_pred EeeecCC-eEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC--CceeEEEEEeecCCeEEEEEeecC
Q 010947 123 MIGKGAF-GEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS--NCIVKLYCSFQDDEFLYLIMEYLP 199 (497)
Q Consensus 123 ~IG~G~f-G~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h--p~Iv~l~~~~~~~~~l~lVmEy~~ 199 (497)
.+..|.. +.||++.. .++..+.+|.-.... ...+..|..+|+.+.. --+.++++...+++..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455543 68898764 456678888765432 1235667777776632 235677888888888999999998
Q ss_pred CCchhHH--------------HHhc-------CCCC--HHH-----HHHHH---------------HHHHHHHHHHHc--
Q 010947 200 GGDMMTL--------------LMRK-------DTLT--EDE-----ARFYV---------------AETVLAIESIHK-- 234 (497)
Q Consensus 200 gg~L~~~--------------l~~~-------~~l~--e~~-----~~~~~---------------~qi~~aL~~LH~-- 234 (497)
|-++... |.+- .++. ... ...+. ......+..+..
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 8654321 1110 0010 000 00000 001112233322
Q ss_pred -----CCEEEcccCCCCeeecCCCcEEEcccccccc
Q 010947 235 -----HHYIHRDIKPDNLLLDKYGHLRLSDFGLCKP 265 (497)
Q Consensus 235 -----~~iiHrDLKp~NILl~~~g~vkL~DFGla~~ 265 (497)
..++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 2389999999999999876678999998864
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.21 E-value=0.00071 Score=66.23 Aligned_cols=79 Identities=19% Similarity=0.295 Sum_probs=52.4
Q ss_pred CCCeeEEeEeeecCCeEEEEEEEcC-------CCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcC-CCceeEEEEEee
Q 010947 115 ADDFELLTMIGKGAFGEVRVCREKT-------TGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVD-SNCIVKLYCSFQ 186 (497)
Q Consensus 115 ~~~f~~~~~IG~G~fG~V~~~~~~~-------t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~ 186 (497)
.+++++ +.|+.|-.-.+|++.... .++.|.+++.-... .. ....+|..+++.+. +.-..+++++|.
T Consensus 42 ~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~----~~-idr~~E~~i~~~ls~~gl~Pkll~~~~ 115 (395)
T d1nw1a_ 42 LEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE----TE-SHLVAESVIFTLLSERHLGPKLYGIFS 115 (395)
T ss_dssp GGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC----CH-HHHHHHHHHHHHHHHTTSSSCEEEEET
T ss_pred ccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc----hh-hHHHHHHHHHHHHHhCCCCCeEEEEcC
Confidence 344554 578889999999998753 24567777765321 12 23457888888774 444567788775
Q ss_pred cCCeEEEEEeecCCCch
Q 010947 187 DDEFLYLIMEYLPGGDM 203 (497)
Q Consensus 187 ~~~~l~lVmEy~~gg~L 203 (497)
+ .+||||++|..|
T Consensus 116 ~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 116 G----GRLEEYIPSRPL 128 (395)
T ss_dssp T----EEEECCCCEEEC
T ss_pred C----ceEEEEeccccC
Confidence 3 589999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.07 E-value=0.00043 Score=65.96 Aligned_cols=68 Identities=7% Similarity=0.155 Sum_probs=42.4
Q ss_pred CeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC---CceeEEE----EEeecCCeEEEEEeecCCC
Q 010947 129 FGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS---NCIVKLY----CSFQDDEFLYLIMEYLPGG 201 (497)
Q Consensus 129 fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h---p~Iv~l~----~~~~~~~~l~lVmEy~~gg 201 (497)
--.||+++. .+|..|++|+.+... ...+.+..|...+..+.. |-...+. ..+......+.|+++++|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 468999875 568889999987542 123446678887776632 2111111 2223456788999999874
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.43 E-value=0.01 Score=55.49 Aligned_cols=144 Identities=12% Similarity=0.045 Sum_probs=76.1
Q ss_pred CCCCeeEEeEeeecCCeEEEEEEEcCCCcEEEEEEeechhhhchhHHHHHHHHHHHHHhcCC-----CceeEEE---EEe
Q 010947 114 GADDFELLTMIGKGAFGEVRVCREKTTGHVYAMKKLKKSEMLRRGQVEHVRAERNLLAEVDS-----NCIVKLY---CSF 185 (497)
Q Consensus 114 ~~~~f~~~~~IG~G~fG~V~~~~~~~t~~~~AiK~l~k~~~~~~~~~~~~~~E~~il~~l~h-----p~Iv~l~---~~~ 185 (497)
......-++.|..|---+.|++... +..|++|++.+.. ... .+..|..+|..+.. |..+... ...
T Consensus 16 ~lg~~~~~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~--~~~---~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~ 88 (316)
T d2ppqa1 16 DVGSLTSYKGIAEGVENSNFLLHTT--KDPLILTLYEKRV--EKN---DLPFFLGLMQHLAAKGLSCPLPLPRKDGELLG 88 (316)
T ss_dssp CCCCEEEEEEECC---EEEEEEEES--SCCEEEEEECC-----CC---HHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCE
T ss_pred CCCCceEeecCCCCcccCeEEEEEC--CCcEEEEEcCCCC--CHH---HHHHHHHHHHhhhhccccccccceecCCCcce
Confidence 3445555667778888899988753 3359999986532 122 24445666655532 2222110 011
Q ss_pred ecCCeEEEEEeecCCCchhH--------------HHHhc---------CCCC------------------HHHHHHHHHH
Q 010947 186 QDDEFLYLIMEYLPGGDMMT--------------LLMRK---------DTLT------------------EDEARFYVAE 224 (497)
Q Consensus 186 ~~~~~l~lVmEy~~gg~L~~--------------~l~~~---------~~l~------------------e~~~~~~~~q 224 (497)
.-......++.++.|..... .+... .... .......+..
T Consensus 89 ~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 168 (316)
T d2ppqa1 89 ELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRP 168 (316)
T ss_dssp EETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHH
T ss_pred eeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHH
Confidence 12345566777776643211 00000 0000 0111222333
Q ss_pred HHHHHHHHHc----CCEEEcccCCCCeeecCCCcEEEccccccc
Q 010947 225 TVLAIESIHK----HHYIHRDIKPDNLLLDKYGHLRLSDFGLCK 264 (497)
Q Consensus 225 i~~aL~~LH~----~~iiHrDLKp~NILl~~~g~vkL~DFGla~ 264 (497)
+...+.-.+. .|+||+|+.++||+++.+...-|+||+.|.
T Consensus 169 ~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 169 EIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 3333444332 479999999999999988777899999986
|